Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" TUBB8 bA631M21.2 ENSG00000261456 "Tubulin beta 8 class VIII" Q3ZCM7 10 46888-74163 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.4;Early spermatids: 11.7;Late spermatids: 3.4;Spermatocytes: 13.0;Spermatogonia: 15.9" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.3" "HPA043640, HPA046280" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 49: Eosinophils - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.75e-2)" "unprognostic (6.02e-2)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (2.78e-1)" "unprognostic (1.80e-1)" "unprognostic (7.74e-2)" "unprognostic (8.33e-3)" "unprognostic (1.50e-1)" "unprognostic (4.15e-3)" "unprognostic (7.17e-2)" "unprognostic (3.30e-2)" "unprognostic (1.33e-3)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (2.19e-2)" "unprognostic (6.86e-3)" 0.1 0.1 0.4 0.1 0.4 0.0 0.2 0.3 0.6 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.3 0.3 0.7 0.0 0.1 0.1 0.3 0.3 0.4 0.3 0.3 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.1 2.4 0.3 0.0 0.7 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.3 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.1 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.7 0.4 0.1 0.1 0.0 0.0 0.7 0.0 0.2 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 13.0 15.9 0.0 0.0 0.0 0.0 0.4 0.0 0.6 ZMYND11 BS69 ENSG00000015171 "Zinc finger MYND-type containing 11" Q15326 10 134465-254637 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015816 Supported Nucleoplasm NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA015816: AB_1845427" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (3.00e-1)" "unprognostic (1.12e-1)" "unprognostic (9.12e-2)" "unprognostic (2.33e-2)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (1.80e-2)" "unprognostic (3.73e-2)" "unprognostic (4.47e-3)" "unprognostic (6.35e-2)" "prognostic favorable (4.76e-7)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (9.04e-2)" "unprognostic (1.42e-1)" 41.7 37.1 50.7 26.3 58.8 11.3 45.8 60.0 64.6 47.4 38.5 54.8 29.9 55.0 46.6 42.8 39.8 35.6 58.0 50.7 54.8 51.1 34.9 39.0 26.3 54.1 52.8 55.3 46.4 99.7 27.7 34.8 54.8 52.8 33.8 43.2 46.1 56.0 58.1 33.1 30.9 50.9 52.4 32.7 39.2 33.1 54.1 23.8 88.0 64.7 24.8 46.7 31.1 59.1 64.0 64.6 53.8 42.9 57.3 55.0 33.3 63.0 35.8 43.7 40.5 39.2 62.3 0.1 19.8 78.4 13.8 38.3 28.9 44.2 55.8 25.1 25.1 71.8 33.4 42.3 64.6 19.5 38.8 38.4 60.6 42.3 38.3 56.8 55.6 32.8 19.5 44.7 76.0 75.4 29.3 27.3 17.4 69.3 10.7 28.4 34.4 34.5 58.0 72.7 24.3 44.3 72.3 83.3 34.1 29.4 74.9 37.8 72.2 43.4 15.8 89.2 48.8 37.0 48.4 4.6 44.2 36.1 30.3 15.6 2.3 19.5 11.9 3.5 10.4 5.2 8.3 11.9 3.8 3.1 9.2 9.1 1.0 14.7 1.7 4.5 8.9 5.0 50.7 58.8 60.0 64.6 50.7 54.8 54.1 52.8 54.8 52.4 54.1 59.1 51.2 60.9 51.4 90.8 25.3 25.9 27.0 17.5 34.1 37.5 46.3 33.8 103.0 31.5 31.9 33.1 12.5 15.2 39.4 14.6 50.9 29.3 28.6 27.0 50.3 45.7 25.9 25.0 110.8 31.8 4.6 45.7 27.5 37.1 46.2 42.1 35.3 28.1 14.4 20.2 118.0 26.2 16.2 25.1 14.9 27.1 39.1 21.7 24.9 94.6 13.9 62.5 34.0 128.2 131.5 28.1 14.5 56.1 31.1 44.1 19.1 41.9 23.7 22.0 13.1 56.9 49.8 26.8 25.6 32.2 27.8 12.4 32.6 28.5 22.1 29.8 DIP2C KIAA0934 ENSG00000151240 "Disco interacting protein 2 homolog C" Q9Y2E4 10 274190-689668 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Astrocytes: 125.4;Excitatory neurons: 219.3;Inhibitory neurons: 269.9;Oligodendrocyte precursor cells: 216.2;Oligodendrocytes: 421.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-2197: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030264, HPA059325" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Cytosol" Vesicles "HPA030264: AB_10600903, HPA059325: AB_2683979" "unprognostic (1.72e-2)" "unprognostic (3.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (8.32e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (1.58e-1)" "unprognostic (2.00e-1)" "unprognostic (6.28e-3)" "unprognostic (5.94e-2)" "unprognostic (3.65e-2)" "prognostic favorable (2.46e-6)" "unprognostic (8.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.09e-3)" "unprognostic (9.10e-3)" 12.7 7.7 13.8 3.7 18.3 0.2 8.3 18.8 19.9 11.0 0.0 22.1 4.5 12.1 5.4 9.1 8.8 8.6 14.1 13.6 10.7 14.7 8.9 4.9 2.4 16.8 14.6 13.3 8.0 8.1 6.2 4.6 17.4 8.4 4.4 9.4 4.2 9.1 34.5 4.8 7.0 12.4 7.2 3.3 7.3 7.2 18.1 2.1 5.3 20.8 1.5 10.5 7.5 32.6 0.7 6.3 11.5 6.1 19.0 20.5 9.5 13.9 8.6 10.5 8.5 1.8 1.9 0.5 3.6 22.5 2.7 0.1 7.1 1.2 6.4 0.3 6.4 0.1 4.5 2.0 9.2 0.0 8.6 16.9 5.5 6.6 0.0 16.4 2.3 0.1 0.0 1.2 8.0 17.4 0.7 0.0 3.0 5.4 2.6 9.9 4.8 2.0 7.5 7.2 5.8 8.2 2.4 5.0 20.1 6.0 6.6 0.0 0.1 11.1 2.9 33.3 4.6 0.8 14.3 7.2 13.9 0.3 6.4 0.0 0.1 0.0 0.1 0.0 0.1 0.7 0.2 0.2 0.0 1.0 0.3 0.3 0.0 0.1 0.0 0.1 0.1 0.1 13.8 18.3 18.8 19.9 13.6 10.7 16.8 14.6 17.4 7.2 18.1 32.6 12.6 9.6 5.8 125.4 4.0 7.9 5.4 2.2 7.4 18.6 11.8 10.0 30.3 17.2 4.7 3.7 22.9 5.2 0.6 2.2 0.0 8.5 19.0 7.9 18.5 7.8 10.8 0.0 219.3 4.0 5.8 15.4 10.2 8.8 20.3 16.3 10.4 24.2 6.2 1.7 269.9 6.2 2.0 3.5 5.2 6.1 11.5 3.6 23.2 44.0 0.6 19.4 1.0 216.2 421.7 7.7 1.3 19.5 0.9 7.7 10.2 17.0 5.3 20.5 6.6 22.7 17.6 21.7 22.5 4.3 3.8 3.8 2.0 5.6 5.7 8.9 LARP4B "KIAA0217, LARP5" ENSG00000107929 "La ribonucleoprotein 4B" Q92615 10 806914-931705 "Predicted intracellular proteins, Predicted membrane proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036566, HPA042738" Approved Enhanced Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Cytosol "HPA036566: AB_10673624, HPA042738: AB_2678137" "unprognostic (3.02e-3)" "unprognostic (1.43e-1)" "unprognostic (9.77e-2)" "unprognostic (4.80e-2)" "unprognostic (2.00e-2)" "unprognostic (3.13e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (8.95e-2)" "unprognostic (2.74e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-2)" "unprognostic (1.65e-1)" "unprognostic (1.40e-1)" "unprognostic (8.10e-3)" "unprognostic (1.62e-1)" "unprognostic (6.47e-2)" "unprognostic (2.54e-2)" 14.3 19.9 13.1 17.2 13.3 18.5 13.6 15.3 17.4 13.4 20.9 17.0 19.4 13.1 10.3 25.2 13.3 12.8 22.2 16.4 14.9 13.8 13.0 20.2 22.1 16.0 12.0 13.0 16.5 17.1 12.7 15.1 15.6 16.2 15.6 14.5 16.8 12.3 38.7 22.3 18.5 10.9 12.1 19.4 21.9 18.9 13.2 16.0 22.2 22.3 19.7 15.9 16.7 14.1 50.0 42.7 21.7 24.5 19.0 19.1 32.2 33.0 15.7 35.6 34.2 58.1 56.4 59.9 12.0 33.0 10.6 51.6 38.5 28.0 30.5 38.1 27.9 51.6 29.5 33.9 31.3 37.3 42.5 21.2 31.7 36.8 20.4 19.9 24.8 28.8 65.5 39.3 28.9 50.9 53.0 33.8 23.2 49.5 16.5 36.1 18.7 41.5 28.6 38.5 21.4 30.2 32.5 62.5 25.4 21.1 59.3 35.6 34.4 27.6 7.2 87.8 34.2 39.2 51.2 58.3 30.5 30.0 17.6 11.4 8.2 9.7 5.4 9.0 5.7 4.2 6.0 6.2 7.3 5.2 5.7 6.0 8.0 5.4 7.9 8.3 6.1 3.9 13.1 13.3 15.3 17.4 16.4 14.9 16.0 12.0 15.6 12.1 13.2 14.1 23.7 51.3 62.1 59.4 22.4 30.3 15.6 16.2 23.9 20.5 21.6 15.4 43.5 28.6 30.7 23.9 27.1 17.2 24.6 38.5 5.9 17.4 14.7 42.0 24.5 21.2 13.8 22.7 87.7 16.3 13.2 19.4 44.9 43.4 7.6 31.0 14.6 19.1 21.5 23.5 84.1 35.1 18.3 34.7 25.3 7.1 17.4 30.3 17.8 83.4 33.4 15.7 14.4 65.9 71.6 33.2 27.2 24.0 25.5 27.0 32.5 16.2 33.4 22.4 26.3 23.4 18.3 27.8 23.8 28.8 42.6 46.2 20.7 26.1 34.7 35.6 GTPBP4 "CRFG, FLJ10686, FLJ10690, NGB, NOG1" ENSG00000107937 "GTP binding protein 4" Q9BZE4 10 988434-1019932 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039618, HPA056468" Uncertain Supported "Nuclear membrane,Nucleoli,Nucleoli rim" No No "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" "Nucleoli, Nucleoli rim" "Nuclear membrane" "HPA039618: AB_10795292, HPA056468: AB_2683141" "unprognostic (2.11e-3)" "unprognostic (3.10e-3)" "unprognostic (7.77e-3)" "prognostic unfavorable (4.57e-4)" "unprognostic (3.72e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (8.85e-12)" "unprognostic (9.06e-2)" "unprognostic (1.72e-1)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.38e-5)" "unprognostic (7.90e-2)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (3.67e-2)" 15.6 19.6 8.0 12.6 8.5 26.9 12.8 8.6 8.7 8.4 9.4 9.5 8.6 11.0 8.8 11.4 9.2 7.9 11.1 8.8 9.5 9.4 10.9 8.5 13.9 9.1 9.4 9.8 11.9 10.3 7.8 10.2 9.1 9.0 10.8 8.9 7.8 8.4 26.6 9.5 8.2 12.2 9.5 9.4 9.2 21.0 9.4 12.0 9.8 14.8 15.6 18.3 8.7 10.1 57.0 49.4 37.1 34.9 27.9 31.1 27.3 52.3 18.8 62.6 53.3 73.2 43.3 87.0 15.2 45.5 21.3 43.6 77.4 52.0 71.2 41.8 50.9 94.7 35.3 45.4 44.5 41.3 47.1 43.1 42.7 72.7 51.6 25.5 34.7 62.9 98.3 33.5 60.1 57.0 62.0 40.3 56.2 77.9 33.8 59.3 35.5 57.6 37.9 37.4 19.3 57.3 37.3 44.7 66.3 36.7 61.8 42.3 32.4 30.3 16.4 71.5 65.2 45.0 86.9 103.5 33.9 43.5 24.9 18.2 9.6 3.6 12.4 16.2 14.3 12.0 11.7 12.6 12.9 11.2 12.7 12.5 1.5 18.4 13.3 8.6 16.6 8.9 8.0 8.5 8.6 8.7 8.8 9.5 9.1 9.4 9.1 9.5 9.4 10.1 36.2 57.7 74.3 5.9 41.8 62.7 100.0 52.8 35.3 26.1 28.1 27.4 32.6 21.5 83.5 29.5 18.8 50.3 37.4 18.4 33.2 57.7 70.9 46.8 51.9 49.2 22.1 37.4 9.3 44.1 54.9 48.9 33.6 78.8 66.9 40.1 20.0 27.5 34.7 23.5 8.9 29.9 40.7 26.0 24.4 20.9 24.8 33.1 23.2 8.4 39.5 26.5 22.6 6.0 10.2 72.2 17.3 29.3 37.0 84.7 10.6 25.6 55.8 32.7 19.7 58.5 51.4 88.7 84.9 47.0 67.2 95.4 37.5 57.7 32.6 102.6 IDI2 IPPI2 ENSG00000148377 "Isopentenyl-diphosphate delta isomerase 2" Q9BXS1 10 1018910-1025859 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "skeletal muscle: 273.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Glandular and luminal cells: 1.1;Horizontal cells: 1.7;Skeletal myocytes: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041254 Uncertain Vesicles NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" Vesicles "HPA041254: AB_10794270" "unprognostic (6.69e-3)" "unprognostic (4.05e-2)" "unprognostic (1.64e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 1.2 0.0 0.0 273.8 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.0 11.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.4 0.3 0.0 0.1 0.2 0.2 0.0 0.6 0.3 0.5 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.9 0.5 0.4 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.2 1.7 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 IDI1 ENSG00000067064 "Isopentenyl-diphosphate delta isomerase 1" Q13907 10 1039152-1049119 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039169 Approved NA NA 28000 "Cluster 2: Granulocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 15: Hepatocytes - Hemostasis" "HPA039169: AB_10674280" "unprognostic (1.61e-2)" "unprognostic (2.59e-2)" "unprognostic (4.58e-2)" "unprognostic (1.97e-1)" "unprognostic (5.72e-3)" "unprognostic (1.27e-1)" "unprognostic (1.76e-2)" "unprognostic (1.97e-1)" "unprognostic (3.72e-2)" "unprognostic (3.88e-2)" "unprognostic (2.59e-1)" "unprognostic (2.26e-1)" "prognostic favorable (1.46e-4)" "unprognostic (9.63e-2)" "unprognostic (2.01e-2)" "unprognostic (2.19e-3)" "unprognostic (2.61e-2)" 32.2 93.7 36.9 36.6 38.9 133.9 152.1 44.6 44.2 24.5 36.9 37.3 66.7 17.0 28.5 50.5 16.7 21.9 24.6 39.9 46.8 41.3 160.2 39.9 39.0 49.4 46.9 26.7 31.3 25.9 43.9 23.4 51.1 50.2 34.3 37.5 26.3 13.4 105.9 37.9 34.8 17.7 42.4 44.0 37.2 25.3 44.0 26.3 21.8 44.7 39.8 20.0 30.8 47.0 89.5 33.4 173.4 42.0 71.1 154.1 25.2 36.7 41.5 42.4 88.7 89.6 136.8 80.9 23.6 40.8 101.7 75.8 97.8 177.8 38.3 27.9 93.8 78.2 50.1 103.2 83.9 30.4 37.5 99.3 73.2 119.3 15.6 18.1 33.4 75.0 54.5 111.1 72.2 72.4 59.1 51.9 69.0 74.6 19.5 67.2 82.0 89.5 185.7 79.7 26.6 31.6 46.4 96.5 100.7 53.5 99.3 103.8 33.4 22.7 12.9 66.8 27.2 64.3 64.7 151.3 28.2 89.4 20.4 76.0 15.1 37.6 27.6 28.3 27.5 25.8 21.0 22.7 13.9 26.0 15.3 22.6 41.4 24.2 33.5 14.4 24.8 26.6 36.9 38.9 44.6 44.2 39.9 46.8 49.4 46.9 51.1 42.4 44.0 47.0 119.2 73.7 144.3 53.8 176.2 89.6 80.4 175.7 58.1 77.4 110.0 70.0 79.0 51.5 109.6 40.5 37.5 63.3 233.5 167.5 150.6 62.9 277.8 61.5 28.6 64.6 106.0 31.1 36.2 102.6 53.6 62.8 79.5 108.2 100.7 60.5 67.1 322.8 86.9 63.9 41.0 107.6 156.6 59.1 63.2 101.5 26.4 88.8 133.4 20.6 55.8 130.9 118.4 47.3 65.1 81.9 130.9 29.7 60.2 116.6 70.5 63.5 65.6 70.3 26.3 62.3 73.4 82.5 37.0 79.2 144.6 187.2 154.9 171.1 65.0 121.2 WDR37 KIAA0982 ENSG00000047056 "WD repeat domain 37" Q9Y2I8 10 1049538-1132384 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 184.8;Late spermatids: 92.9;NK-cells: 86.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037376, HPA037565" Enhanced Approved "Intermediate filaments" No No "Cluster 48: NK-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 34: Spermatids - Unknown function" "Intermediate filaments" "HPA037376: AB_10672789, HPA037565: AB_10696937" "unprognostic (1.50e-2)" "unprognostic (2.07e-1)" "unprognostic (9.08e-3)" "unprognostic (8.51e-3)" "unprognostic (1.81e-1)" "prognostic favorable (1.75e-5)" "unprognostic (2.59e-3)" "unprognostic (3.56e-2)" "unprognostic (1.80e-1)" "unprognostic (1.62e-2)" "prognostic favorable (1.46e-6)" "unprognostic (3.16e-1)" "unprognostic (4.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.34e-5)" "unprognostic (5.98e-2)" 8.4 16.5 10.4 9.3 10.5 22.2 7.8 0.4 18.7 8.1 2.0 8.9 7.3 7.9 8.9 9.1 7.8 6.1 17.6 13.1 2.5 8.7 10.3 10.3 12.5 1.5 1.9 9.7 10.1 9.8 14.6 6.3 2.9 8.1 6.7 14.9 7.6 5.1 18.3 11.5 11.2 6.6 0.0 21.0 10.3 21.2 3.1 10.3 9.5 15.7 9.8 7.0 7.9 9.7 12.4 9.0 11.6 9.4 10.9 15.8 8.2 15.5 8.4 9.5 9.4 11.3 10.4 6.1 9.2 20.3 2.0 11.2 6.1 18.1 8.1 7.4 10.0 14.8 9.6 7.7 7.7 8.8 16.0 19.8 13.6 13.6 4.8 11.3 21.0 12.1 9.1 7.3 15.2 10.9 9.8 6.9 6.4 9.6 4.8 14.9 6.5 10.5 13.2 13.8 5.2 10.1 7.2 13.3 11.9 8.8 12.8 17.9 27.7 7.5 2.5 24.8 12.5 13.4 13.3 8.2 17.4 9.9 5.4 6.0 4.8 3.5 10.0 6.2 8.7 5.5 5.6 7.4 5.2 4.4 6.3 7.3 3.8 11.2 7.1 4.8 5.3 5.2 10.4 10.5 0.4 18.7 13.1 2.5 1.5 1.9 2.9 0.0 3.1 9.7 10.5 3.2 8.1 33.6 14.5 13.4 13.0 7.5 10.2 16.3 8.4 7.2 23.3 5.7 7.9 11.0 12.5 6.2 27.4 8.6 0.0 4.8 184.8 5.7 8.6 13.6 10.7 6.5 65.3 6.1 4.2 9.0 13.3 11.1 12.0 7.3 30.7 7.0 9.0 8.4 59.7 8.1 8.2 18.8 13.7 92.9 12.5 14.8 16.0 43.1 23.7 5.3 86.5 36.7 47.3 9.5 8.3 18.0 9.6 13.6 7.2 4.8 4.9 14.7 6.6 13.0 8.5 11.6 14.3 11.9 12.4 11.4 19.1 10.1 5.9 19.7 ADARB2 "ADAR3, hRED2, RED2" ENSG00000185736 "Adenosine deaminase RNA specific B2 (inactive)" Q9NS39 10 1177313-1737525 "Predicted intracellular proteins" "mRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 46.7" "Group enriched" "Detected in many" 4 "Inhibitory neurons: 1726.7;Oligodendrocyte precursor cells: 693.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 4.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (2.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.64e-2)" "unprognostic (7.44e-3)" "unprognostic (2.12e-1)" "unprognostic (2.62e-2)" "unprognostic (2.53e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (9.58e-2)" "unprognostic (9.28e-3)" "unprognostic (3.41e-1)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.04e-1)" "unprognostic (3.11e-1)" "unprognostic (3.81e-3)" 0.1 0.2 18.8 0.0 25.9 0.2 0.8 15.6 18.1 0.7 0.2 2.3 0.1 0.2 0.0 0.3 1.1 0.0 0.4 12.9 20.7 0.3 0.1 0.6 0.2 21.7 20.2 0.1 3.5 0.0 0.4 0.1 21.7 0.5 0.0 3.0 4.2 0.8 0.0 0.3 0.8 0.0 16.4 0.1 0.7 2.9 29.7 1.0 0.1 0.1 0.4 0.6 0.5 46.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.1 4.7 1.1 0.0 0.0 0.4 0.1 18.8 25.9 15.6 18.1 12.9 20.7 21.7 20.2 21.7 16.4 29.7 46.7 0.3 0.0 0.0 57.8 0.7 0.0 0.1 0.0 4.6 11.1 1.7 0.6 1.9 2.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 40.9 1.6 0.1 0.5 0.0 0.0 9.2 0.0 0.0 0.3 0.5 0.3 0.0 4.8 4.6 0.0 0.2 1.7 1726.7 0.0 0.0 0.0 0.0 133.9 0.3 0.0 3.6 6.5 0.0 30.5 2.1 693.7 254.6 0.0 0.0 0.4 0.0 0.1 0.1 2.9 0.0 1.4 6.6 0.0 0.4 1.2 1.0 3.3 0.0 0.0 0.6 0.2 0.3 0.1 PFKP "PFK-C, PFKF" ENSG00000067057 "Phosphofructokinase, platelet" Q01813 10 3066333-3137718 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 277.0" "Cell type enhanced" "Detected in many" "Early spermatids: 459.8;Late spermatids: 516.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018257, HPA056484" Uncertain Supported Cytosol No No 1900000 "Cluster 10: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 34: Spermatids - Unknown function" Cytosol "HPA018257: AB_10960391, HPA056484: AB_2683147" "unprognostic (1.16e-1)" "unprognostic (2.41e-3)" "unprognostic (5.79e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.55e-4)" "prognostic unfavorable (8.72e-6)" "unprognostic (1.36e-3)" "unprognostic (2.38e-1)" "unprognostic (8.51e-2)" "unprognostic (2.37e-2)" "unprognostic (8.82e-2)" "unprognostic (6.02e-3)" "unprognostic (2.60e-2)" "unprognostic (9.74e-2)" "unprognostic (2.06e-1)" "unprognostic (4.54e-3)" 35.0 11.5 41.6 41.5 39.3 14.4 23.5 13.8 49.9 26.3 61.7 43.8 48.8 55.5 5.6 67.1 34.9 34.1 128.6 60.4 65.0 44.6 4.7 19.1 32.5 30.7 50.9 19.1 15.9 15.2 29.9 15.5 58.0 35.6 30.7 277.0 39.8 62.0 70.4 40.3 59.6 44.1 8.3 19.1 36.8 141.1 47.0 29.7 38.5 21.0 21.2 64.7 42.8 31.7 314.8 420.2 25.9 0.6 26.8 56.9 336.9 187.2 66.6 186.2 222.8 444.5 320.4 37.0 147.8 134.9 174.9 243.0 141.7 292.3 173.1 102.1 111.0 132.0 189.1 24.2 65.2 53.7 203.4 27.0 61.2 190.0 96.0 273.7 367.8 153.7 37.0 1.3 195.7 239.8 182.5 44.4 42.9 133.9 149.3 138.8 46.9 150.1 185.7 115.9 69.5 64.7 133.7 111.0 172.0 307.8 93.7 80.3 449.2 124.6 65.3 380.5 199.3 195.4 200.1 135.7 331.0 98.0 78.5 30.8 8.5 2.9 26.8 4.2 21.2 13.7 26.2 25.0 14.5 15.3 9.6 15.4 1.3 26.7 1.6 22.5 37.6 16.5 41.6 39.3 13.8 49.9 60.4 65.0 30.7 50.9 58.0 8.3 47.0 31.7 30.5 3.2 7.0 128.6 14.8 28.7 58.5 96.8 14.8 40.4 10.3 7.7 147.4 8.6 57.9 64.4 54.2 7.8 16.3 72.6 43.0 115.7 459.8 41.2 9.0 36.0 37.2 10.3 49.4 10.8 205.8 25.9 35.7 63.8 55.9 25.8 14.6 0.7 33.9 42.1 25.9 23.1 124.1 7.6 31.4 516.3 7.5 14.3 19.6 15.0 15.4 113.1 16.5 16.1 6.7 116.8 57.2 6.8 14.2 80.9 53.2 5.9 62.6 133.4 13.1 43.2 34.6 149.4 3.5 25.1 22.6 26.5 28.8 11.2 28.9 64.2 PITRM1 "hMP1, KIAA1104, MP1, PreP" ENSG00000107959 "Pitrilysin metallopeptidase 1" Q5JRX3 10 3137728-3172841 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 186.1;Late spermatids: 98.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006753, HPA006754" Enhanced Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 18: U-2197 - ECM organization" "Cluster 34: Spermatids - Unknown function" Mitochondria "HPA006753: AB_1079624, HPA006754: AB_1079623" "unprognostic (1.83e-3)" "unprognostic (7.01e-3)" "unprognostic (2.19e-1)" "unprognostic (1.69e-1)" "unprognostic (3.20e-2)" "unprognostic (6.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (6.31e-2)" "unprognostic (3.41e-1)" "unprognostic (1.00e-2)" "unprognostic (3.32e-1)" "unprognostic (7.10e-2)" "unprognostic (3.99e-1)" "unprognostic (5.80e-2)" "unprognostic (4.76e-3)" "unprognostic (2.08e-2)" 40.8 64.9 22.7 19.1 24.9 26.0 36.9 23.8 34.2 40.9 22.9 40.9 19.6 40.5 23.8 38.4 38.0 18.3 60.2 25.2 24.5 50.5 44.9 40.4 21.0 25.3 26.0 54.4 41.1 33.3 42.3 17.0 26.0 42.6 22.1 49.6 41.3 22.1 94.9 39.2 32.7 25.8 21.0 30.4 37.0 43.6 26.1 42.4 41.7 59.6 21.7 43.6 38.4 28.5 81.8 67.2 21.7 31.7 62.1 67.6 22.3 125.9 51.0 92.5 49.1 55.5 45.5 38.5 39.5 70.7 33.2 55.8 37.8 82.4 74.3 72.3 55.0 61.1 42.9 39.2 36.2 21.8 62.3 50.4 57.0 103.5 55.8 55.4 81.2 56.3 60.1 44.5 115.7 67.1 59.6 14.0 15.0 97.9 71.0 27.5 34.1 54.0 67.9 54.8 29.4 16.4 95.9 57.5 46.6 35.8 67.2 23.9 114.5 63.7 17.2 160.5 47.8 36.1 48.6 41.7 108.8 38.2 31.5 3.1 6.9 1.5 10.3 8.8 10.5 10.4 9.5 10.9 13.3 5.3 9.7 11.1 0.3 13.7 11.9 5.3 12.6 8.5 22.7 24.9 23.8 34.2 25.2 24.5 25.3 26.0 26.0 21.0 26.1 28.5 12.2 28.9 29.0 13.4 9.3 6.8 17.6 11.1 6.2 13.1 10.7 12.2 44.9 8.6 23.5 3.7 20.9 13.4 7.9 12.4 7.9 18.2 186.1 14.5 14.6 14.0 18.0 10.7 18.4 29.2 20.0 14.7 16.8 23.1 14.5 18.0 7.1 16.3 14.8 6.7 17.9 12.7 20.3 10.1 6.3 98.7 17.1 10.0 19.6 6.5 9.9 7.1 4.1 11.1 14.7 34.8 10.0 14.7 13.7 23.9 10.6 8.5 19.1 19.7 6.6 16.9 15.3 28.1 21.6 17.0 5.7 13.5 10.1 30.4 12.9 17.7 KLF6 "BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9" ENSG00000067082 "Kruppel like factor 6" Q99612 10 3775996-3785281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 436.6" "Cell type enhanced" "Detected in all" "Squamous epithelial cells: 2075.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013529, HPA069585" Supported Supported Nucleoplasm,Nucleoli,Vesicles,Cytosol No No "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nucleoli, Vesicles, Cytosol" "CAB013529: AB_2533431, HPA069585: AB_2686157" "unprognostic (1.23e-1)" "unprognostic (1.53e-2)" "unprognostic (1.47e-3)" "unprognostic (4.53e-2)" "unprognostic (1.47e-1)" "unprognostic (7.55e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.83e-2)" "unprognostic (1.36e-2)" "unprognostic (2.35e-2)" "prognostic favorable (2.28e-4)" "unprognostic (8.07e-3)" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (1.37e-2)" 211.3 46.9 19.0 122.1 18.0 436.6 129.7 19.2 22.4 95.4 21.9 92.1 55.4 98.1 17.7 165.5 77.2 181.9 49.7 18.0 19.2 64.1 141.8 117.0 65.4 29.4 20.1 47.3 118.3 31.8 12.0 98.2 25.2 32.8 99.6 18.4 73.8 33.7 84.9 197.1 106.0 208.2 22.7 64.3 73.2 14.6 23.0 56.8 193.9 41.3 45.0 136.3 92.7 25.0 55.0 14.7 27.2 9.0 155.1 154.3 17.1 91.7 46.5 95.9 64.8 38.0 71.4 15.6 20.8 100.0 74.5 32.7 17.0 84.9 79.5 76.6 10.2 2.2 17.5 35.8 66.4 10.3 51.5 51.4 158.2 68.6 129.3 34.2 99.3 10.1 17.5 117.9 123.6 4.0 19.4 15.9 10.2 29.2 26.0 12.6 28.2 55.5 94.1 53.4 12.0 11.5 22.5 64.0 142.8 73.5 32.0 8.6 130.9 128.7 17.8 76.9 43.0 22.6 78.1 28.6 34.7 13.7 40.8 318.8 85.2 234.1 129.8 74.2 115.9 81.1 147.4 131.5 67.6 70.9 44.9 69.0 391.6 72.5 104.6 152.8 120.6 148.7 19.0 18.0 19.2 22.4 18.0 19.2 29.4 20.1 25.2 22.7 23.0 25.0 511.0 1246.8 489.4 14.0 716.9 585.5 1298.4 625.8 1227.0 39.6 985.9 630.0 63.6 544.7 451.9 138.0 33.3 163.1 518.3 1507.0 21.5 808.6 58.0 1065.6 618.9 469.9 397.3 77.9 18.5 553.0 473.8 545.5 1120.3 1905.9 626.7 195.9 248.4 309.9 583.6 37.0 10.0 746.7 429.3 968.7 885.1 53.2 130.5 992.1 483.8 58.1 609.8 42.9 150.4 7.5 4.3 857.9 949.9 133.9 1172.5 600.2 1009.9 97.4 342.0 90.1 138.1 194.8 441.8 9.0 19.4 2075.6 628.2 195.9 920.5 67.1 542.0 572.5 AKR1E2 "AKR1CL2, AKRDC1, htAKR, HTSP1, MGC10612" ENSG00000165568 "Aldo-keto reductase family 1 member E2" Q96JD6 10 4786629-4848062 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 19.0" "Group enriched" "Detected in some" 5 "Early spermatids: 153.8;Late spermatids: 174.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 12.3;RT4: 10.4;U-2197: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037821, HPA037822" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA037821: AB_2675687, HPA037822: AB_10671722" "unprognostic (2.33e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (8.27e-2)" "unprognostic (7.33e-2)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (7.42e-3)" "unprognostic (7.47e-2)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (3.06e-2)" "unprognostic (2.74e-1)" "unprognostic (2.04e-2)" "unprognostic (1.62e-4)" "unprognostic (5.62e-2)" 2.0 0.8 1.7 0.7 1.8 2.1 3.1 1.5 2.3 1.8 0.0 1.3 1.4 1.1 0.9 1.4 1.0 1.3 1.9 2.0 2.4 0.9 0.5 2.0 0.8 1.6 2.0 0.7 2.1 1.0 0.5 1.8 2.7 0.9 1.2 3.5 1.1 1.8 1.5 1.2 1.0 2.1 0.5 1.2 1.5 19.0 1.6 0.7 3.3 0.8 0.5 1.1 1.3 1.6 0.5 5.9 2.2 1.0 0.0 0.0 0.1 2.3 0.2 0.1 0.1 9.0 0.8 0.0 0.0 6.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 1.1 6.2 1.1 0.0 0.0 6.5 12.3 5.6 0.0 0.0 5.4 0.7 0.0 2.2 6.9 4.4 0.0 0.0 0.0 1.6 10.4 0.0 4.8 8.2 2.4 4.7 2.4 4.6 2.6 4.1 0.0 2.0 19.5 0.0 2.8 0.0 0.0 0.1 0.0 1.4 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.7 1.8 1.5 2.3 2.0 2.4 1.6 2.0 2.7 0.5 1.6 1.6 0.9 0.0 0.0 1.6 0.2 0.0 0.1 0.5 0.6 0.2 1.1 0.6 0.8 0.0 0.6 1.8 0.0 0.1 0.1 0.0 0.0 0.3 153.8 0.5 0.7 1.4 0.0 1.3 7.1 0.0 0.0 2.2 0.0 0.6 0.0 0.6 2.2 0.0 1.2 1.7 8.9 0.1 0.0 0.6 0.6 174.2 2.8 0.8 3.6 5.6 0.6 0.3 0.0 9.0 0.0 0.1 0.1 1.5 0.0 0.2 0.0 0.5 0.3 1.2 0.0 0.8 1.2 32.0 10.0 0.7 0.1 0.0 0.2 0.2 0.1 0.5 AKR1C1 "DD1, DDH, DDH1, HAKRC, MBAB" ENSG00000187134 "Aldo-keto reductase family 1 member C1" Q04828 10 4963253-4983283 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 623.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 253.8;Basal squamous epithelial cells: 262.4;Cholangiocytes: 284.5;Exocrine glandular cells: 328.0;Hepatocytes: 597.7;Squamous epithelial cells: 229.3;Urothelial cells: 306.0" "Cancer enhanced" "Detected in many" "liver cancer: 64.2;lung cancer: 53.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 8 "ASC diff: 2988.3;Hep G2: 5415.7;OE19: 2297.1" "CAB047303, HPA068265" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Endoplasmic reticulum, Cytosol" "CAB047303: , HPA068265: AB_2685966" "unprognostic (1.54e-2)" "prognostic favorable (3.05e-4)" "unprognostic (4.04e-2)" "unprognostic (8.38e-2)" "unprognostic (3.18e-2)" "unprognostic (7.05e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (8.38e-2)" "unprognostic (4.65e-1)" "unprognostic (1.82e-2)" "prognostic favorable (8.03e-9)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (6.30e-2)" 185.7 14.3 12.3 13.5 16.5 5.8 116.2 16.0 11.5 12.9 6.9 23.2 25.3 6.6 6.6 103.9 11.5 65.7 135.5 10.9 18.7 45.4 623.2 28.9 4.7 22.1 18.4 15.5 23.3 0.8 9.7 1.7 23.2 17.3 12.2 11.5 73.7 12.5 120.4 35.3 23.4 8.7 19.6 4.1 142.9 13.0 22.2 4.6 46.7 27.3 7.8 71.1 31.3 20.3 0.0 429.6 2.4 426.7 2988.3 358.2 0.2 13.7 95.9 5.4 4.1 8.4 0.5 0.0 6.1 97.7 72.5 3.6 1.6 22.4 2.5 0.1 0.2 12.6 65.6 5415.7 30.0 1.8 0.0 183.9 27.3 44.2 26.7 0.4 10.2 2.9 95.8 0.4 74.7 2.4 0.1 0.4 1.2 2297.1 1.5 0.1 0.8 4.2 24.3 81.4 0.4 1.7 23.8 0.7 0.8 1.3 0.5 7.8 85.3 36.0 2.3 97.6 4.5 1.6 0.5 0.3 129.3 12.1 0.9 1.5 0.0 0.3 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.4 0.3 0.1 0.0 0.2 0.1 0.2 12.3 16.5 16.0 11.5 10.9 18.7 22.1 18.4 23.2 19.6 22.2 20.3 21.6 67.3 34.4 2.0 2.4 21.2 27.8 253.8 262.4 3.1 7.6 1.0 3.2 284.5 144.5 62.5 0.0 0.1 0.2 5.9 13.7 67.0 24.0 3.3 1.7 17.1 1.8 52.6 3.4 328.0 0.1 176.3 139.1 4.6 4.5 0.8 21.0 597.7 0.4 0.0 3.1 6.8 20.3 16.1 15.6 9.9 151.6 3.3 106.7 13.1 4.6 51.5 0.0 4.5 0.5 120.2 3.6 147.4 0.4 41.3 20.2 61.9 72.2 4.5 0.0 16.4 24.3 1.9 1.1 229.3 20.5 0.1 2.1 6.4 20.3 306.0 AKR1C2 "BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD" ENSG00000151632 "Aldo-keto reductase family 1 member C2" P52895 10 4987400-5018031 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 341.5;liver: 481.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 141.7;Club cells: 128.8;Gastric mucus-secreting cells: 133.5;Hepatocytes: 397.4;Urothelial cells: 271.9" "Group enriched" "Detected in many" 6 "cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "A549: 2054.8;ASC diff: 2439.5;Hep G2: 3926.2;OE19: 2684.9;RT4: 1178.9" "CAB047304, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB047304: , HPA068265: AB_2685966" "unprognostic (6.77e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (2.86e-2)" "unprognostic (8.65e-2)" "unprognostic (5.03e-2)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.25e-3)" "unprognostic (8.58e-2)" "unprognostic (1.09e-2)" "unprognostic (8.60e-3)" "unprognostic (1.46e-2)" "unprognostic (8.30e-2)" 341.5 20.8 9.8 10.0 11.6 1.0 205.6 10.7 12.9 17.4 8.1 37.1 29.6 5.6 3.3 202.5 8.6 98.1 83.8 7.2 16.6 43.0 481.9 23.5 2.1 18.7 13.7 10.4 11.8 1.1 8.1 0.8 17.1 11.7 13.3 15.2 116.5 12.9 286.9 42.5 33.7 9.2 11.5 2.1 137.0 11.8 16.8 4.4 38.3 36.5 9.3 253.9 47.0 9.7 0.0 2054.8 2.4 214.1 2439.5 83.4 0.1 0.7 8.6 0.9 2.0 8.1 0.2 0.4 11.5 14.2 10.0 57.8 0.2 10.7 1.2 0.6 0.2 0.7 516.4 3926.2 4.6 0.4 0.9 218.3 126.4 10.5 10.4 0.7 0.9 0.3 81.9 0.3 20.4 3.3 0.2 0.0 0.7 2684.9 0.8 0.3 0.6 34.6 19.0 1178.9 1.2 0.4 21.2 0.3 0.1 0.4 0.5 4.0 8.6 5.1 1.8 74.6 0.8 0.6 0.6 0.3 25.9 30.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.8 11.6 10.7 12.9 7.2 16.6 18.7 13.7 17.1 11.5 16.8 9.7 15.2 12.8 2.8 0.0 0.9 11.9 9.5 141.7 20.5 1.9 0.8 1.4 5.5 102.9 128.8 0.0 0.0 0.0 0.0 10.3 0.0 18.3 17.3 0.7 0.5 7.5 1.8 8.0 2.6 103.3 0.1 44.2 133.5 0.8 0.0 0.1 10.8 397.4 0.1 3.3 4.2 5.4 46.8 12.0 7.8 7.8 79.2 1.0 8.8 19.7 0.6 39.6 0.0 5.5 0.3 90.0 6.6 78.6 0.8 23.7 15.9 3.6 40.3 3.0 0.0 5.3 13.9 0.2 0.3 112.9 13.5 0.0 1.3 0.4 8.5 271.9 AKR1C3 "DDX, HAKRB, HSD17B5, KIAA0119, PGFS" ENSG00000196139 "Aldo-keto reductase family 1 member C3" P42330 10 5035354-5107686 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 441.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 393.1;Exocrine glandular cells: 722.5;Proximal enterocytes: 576.9;Proximal tubular cells: 601.8" "Cancer enhanced" "Detected in all" "liver cancer: 83.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 244.0;gdT-cell: 102.6" "Group enriched" "Detected in many" 4 "granulocytes: 244.0;T-cells: 102.6" "Cell line enhanced" "Detected in many" "A549: 1615.1;ASC diff: 811.9;Hep G2: 699.6;OE19: 3025.3;RT4: 639.2" "CAB010874, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 19000000 "Cluster 38: Basophils - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB010874: AB_476751, HPA068265: AB_2685966" "unprognostic (4.20e-3)" "unprognostic (2.70e-2)" "unprognostic (8.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.41e-1)" "unprognostic (6.74e-2)" "unprognostic (5.08e-2)" "unprognostic (1.31e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (4.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.79e-3)" "unprognostic (4.24e-3)" 164.4 50.2 31.1 25.4 34.6 42.3 115.2 32.1 42.4 21.9 30.2 185.9 441.3 25.9 4.4 53.2 42.1 261.1 42.9 31.5 35.6 177.7 268.0 48.3 7.6 30.3 33.9 17.8 36.4 22.5 10.4 4.7 32.3 10.3 98.0 19.1 40.5 19.4 116.9 27.0 270.9 39.2 30.3 3.8 237.4 10.0 31.5 37.4 26.4 34.8 6.6 84.7 22.2 31.1 0.1 1615.1 1.1 413.0 811.9 292.2 1.0 0.0 21.4 0.4 1.4 47.6 24.5 0.2 78.7 19.4 45.0 11.5 1.5 28.8 1.1 3.0 0.5 3.2 438.4 699.6 4.3 0.7 0.2 160.9 57.1 20.0 0.7 25.8 28.1 3.4 10.8 0.0 42.6 3.8 9.8 2.6 0.7 3025.3 4.3 3.3 9.6 43.7 149.0 639.2 1.0 2.9 232.2 0.0 0.3 0.9 0.5 0.2 221.7 5.2 4.7 87.8 3.1 0.7 0.7 0.3 45.8 62.8 4.4 244.0 2.9 4.8 102.6 0.9 6.9 0.0 19.0 18.7 2.1 0.5 11.6 8.9 7.3 21.1 1.4 39.6 21.4 42.4 31.1 34.6 32.1 42.4 31.5 35.6 30.3 33.9 32.3 30.3 31.5 31.1 144.2 44.8 5.3 4.9 4.3 12.0 3.7 393.1 2.8 2.0 15.8 5.5 3.9 0.0 172.9 36.8 0.0 0.4 64.4 133.8 43.0 114.6 3.3 67.5 4.5 67.5 19.2 34.9 2.5 722.5 0.0 44.3 158.0 66.4 5.7 0.1 0.0 0.0 1.6 1.7 3.2 65.9 61.1 0.0 14.0 4.9 78.3 14.8 21.4 7.5 4.1 132.7 202.9 14.6 0.0 266.1 219.6 106.8 3.1 1.3 576.9 601.8 112.8 5.3 26.3 15.5 20.3 0.5 4.3 20.2 10.7 0.0 14.4 7.8 196.9 46.4 AKR1C8P AKR1CL1 ENSG00000264006 "Aldo-keto reductase family 1 member C8, pseudogene" Q5T2L2 10 5154140-5185187 "Predicted intracellular proteins" Oxidoreductase "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "choroid plexus: 3.3;epididymis: 3.4;liver: 8.1" "Cell type enhanced" "Detected in single" "Microglial cells: 1.0" "Cancer enriched" "Detected in single" 9 "liver cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 41 "HDLM-2: 19.5" NA NA "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (3.47e-1)" "unprognostic (2.14e-1)" "unprognostic (4.76e-1)" "unprognostic (4.20e-2)" "unprognostic (3.69e-1)" "unprognostic (3.07e-1)" "unprognostic (1.10e-1)" "unprognostic (1.92e-2)" "unprognostic (2.66e-2)" "unprognostic (6.28e-3)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 8.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 19.5 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AKR1C4 "3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581" ENSG00000198610 "Aldo-keto reductase family 1 member C4" P17516 10 5195462-5218949 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "liver: 717.5" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 613.3" "Cancer enriched" "Detected in some" 86 "liver cancer: 108.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 6.6;OE19: 2.9" "HPA044720, HPA068265" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 3800000 "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 2: Hepatocytes - Metabolism" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA044720: AB_2679058, HPA068265: AB_2685966" "unprognostic (2.21e-1)" "unprognostic (3.04e-1)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (5.99e-2)" "unprognostic (9.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (1.29e-1)" "unprognostic (3.31e-1)" "unprognostic (7.34e-2)" "unprognostic (1.45e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.2 0.0 0.4 41.8 0.0 0.0 0.0 0.3 717.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.3 0.2 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 37.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.2 0.0 0.8 0.0 13.5 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 13.6 613.3 0.0 0.0 0.0 0.6 0.0 14.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.2 1.0 1.5 0.0 0.0 0.1 0.0 2.1 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.1 UCN3 "SPC, UCNIII" ENSG00000178473 "Urocortin 3" Q969E3 10 5364966-5374692 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 8.8;pancreas: 5.8;stomach 1: 3.4" "Cell type enriched" "Detected in some" 29 "Enteroendocrine cells: 242.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 15.4" "Region enhanced" "Detected in some" "medulla oblongata: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SCLC-21H: 1.2" "Region enhanced" "Detected in some" "hypothalamus: 5.1" HPA038281 Uncertain "Secreted to blood" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "HPA038281: AB_10672408" "unprognostic (2.00e-2)" "unprognostic (2.31e-1)" "unprognostic (1.60e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-3)" "unprognostic (8.42e-2)" "unprognostic (3.55e-2)" "unprognostic (2.91e-2)" 0.0 0.8 1.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 2.3 8.8 0.0 0.0 0.0 1.0 1.0 0.0 0.0 0.8 0.7 0.0 0.6 0.0 1.9 0.5 0.0 5.8 0.0 2.7 0.1 0.1 0.3 2.3 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.0 0.8 1.9 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.1 242.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.3 0.0 0.0 0.3 0.6 2.9 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 TUBAL3 FLJ21665 ENSG00000178462 "Tubulin alpha like 3" A6NHL2 10 5393101-5404828 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 28.3" "Group enriched" "Detected in some" 4 "Distal enterocytes: 19.8;Proximal enterocytes: 19.7" "Cancer enriched" "Detected in some" 4 "colorectal cancer: 3.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEL: 13.3;JURKAT: 7.7;K-562: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA045900, HPA063394" Uncertain NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 36: HEL - Hemostasis" "Cluster 45: Enterocytes - Digestion" "HPA045900: AB_10961130, HPA063394: AB_2685003" "unprognostic (2.63e-1)" "unprognostic (1.69e-2)" "unprognostic (5.33e-2)" "unprognostic (1.09e-1)" "unprognostic (7.59e-2)" "unprognostic (2.13e-2)" "unprognostic (3.02e-2)" "unprognostic (4.02e-1)" "unprognostic (1.02e-1)" "unprognostic (2.68e-2)" "unprognostic (1.26e-1)" "unprognostic (3.44e-1)" "unprognostic (4.52e-2)" "unprognostic (2.75e-1)" "unprognostic (1.35e-4)" "unprognostic (7.93e-4)" 0.1 0.0 0.4 0.5 0.3 0.1 0.4 0.4 0.6 0.1 1.4 11.9 24.3 0.0 0.0 0.3 0.2 0.1 0.7 0.3 0.4 5.8 0.0 0.2 0.1 0.8 0.5 0.0 0.0 0.0 0.0 0.1 0.9 0.1 10.8 0.0 0.8 0.0 0.1 0.3 28.3 0.3 0.6 0.0 0.2 1.0 0.8 0.3 0.0 1.4 0.0 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.7 0.0 1.2 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 13.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.7 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.6 0.3 0.4 0.8 0.5 0.9 0.6 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 19.8 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.0 0.0 0.0 19.7 4.4 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.1 0.0 1.4 0.1 NET1 "ARHGEF8, NET1A" ENSG00000173848 "Neuroepithelial cell transforming 1" Q7Z628 10 5412557-5459056 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 242.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 8.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 252.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020068 Uncertain Approved Nucleoplasm,Vesicles Yes Yes "Cluster 32: T-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Vesicles "HPA020068: AB_2670348" "unprognostic (1.77e-2)" "unprognostic (1.87e-1)" "unprognostic (3.40e-1)" "unprognostic (4.05e-2)" "unprognostic (3.37e-3)" "unprognostic (2.15e-1)" "prognostic unfavorable (3.87e-5)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (8.27e-4)" "unprognostic (2.26e-1)" "unprognostic (5.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (2.46e-1)" 48.8 10.8 35.5 23.4 34.2 40.5 52.8 38.5 57.6 43.7 52.8 92.2 56.2 41.8 56.2 68.4 46.2 35.9 13.2 30.2 32.4 49.3 45.1 22.2 26.7 41.8 37.2 28.5 37.9 5.4 10.6 65.7 43.8 41.3 88.2 6.5 93.1 24.3 25.0 39.8 74.7 36.9 37.5 8.1 77.8 14.4 41.1 30.4 26.2 28.0 33.0 60.8 59.3 40.1 115.9 67.7 45.2 51.0 26.8 11.9 252.9 69.1 37.6 53.4 50.4 36.4 215.2 40.6 27.7 42.4 11.4 185.5 54.9 104.3 63.9 38.1 38.5 77.5 22.9 84.0 7.2 21.5 31.1 18.2 61.0 54.0 12.3 47.6 31.1 42.6 138.5 64.4 30.0 54.3 74.3 30.6 61.5 158.6 51.0 45.0 85.0 32.4 33.4 57.6 38.5 20.6 60.7 110.9 20.3 76.2 36.7 65.3 29.5 20.3 30.9 30.7 56.0 39.3 23.1 53.4 18.1 33.1 43.4 2.0 0.6 1.4 0.6 1.0 0.0 1.4 1.2 0.4 4.9 0.6 8.7 1.7 0.1 0.8 0.4 2.0 4.0 2.2 35.5 34.2 38.5 57.6 30.2 32.4 41.8 37.2 43.8 37.5 41.1 40.1 18.4 32.1 55.8 2.6 12.7 40.3 127.2 49.0 103.0 11.0 52.6 28.3 12.1 41.5 84.3 12.9 4.2 110.2 8.4 242.2 5.9 13.1 2.4 97.7 30.6 42.7 80.8 54.1 5.1 24.4 109.1 33.2 107.0 131.4 15.2 16.9 12.5 55.7 14.5 3.3 7.7 145.3 34.6 10.5 59.8 2.4 21.8 31.2 35.6 44.0 48.7 3.8 0.0 8.5 5.7 62.1 148.3 87.6 39.2 67.8 123.6 29.2 85.7 3.5 111.7 183.0 185.0 26.3 16.0 158.1 32.4 117.5 9.3 2.9 145.0 186.5 CALML5 CLSP ENSG00000178372 "Calmodulin like 5" Q9NZT1 10 5498697-5499570 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 3060.6" "Group enriched" "Detected in some" 4 "Breast glandular cells: 172.1;Breast myoepithelial cells: 156.1;Suprabasal keratinocytes: 390.7" "Group enriched" "Detected in many" 6 "breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "A-431: 400.3" "Not detected" "Not detected" HPA040725 Enhanced Approved "Plasma membrane,Cytosol" NA NA 48000000 "Cluster 61: Skin - Cornification" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 28: Keratinocytes - Keratinization" "Plasma membrane, Cytosol" "HPA040725: AB_10793863" "unprognostic (7.68e-3)" "unprognostic (5.06e-3)" "unprognostic (5.64e-2)" "prognostic favorable (2.59e-5)" "unprognostic (4.82e-2)" "unprognostic (2.67e-1)" "unprognostic (1.37e-1)" "unprognostic (8.27e-2)" "unprognostic (1.14e-1)" "unprognostic (2.79e-1)" "unprognostic (1.71e-1)" "unprognostic (4.99e-2)" 3.9 0.5 0.0 0.0 0.0 0.1 41.2 0.0 0.0 94.0 0.0 0.8 0.0 0.3 0.7 67.5 0.1 0.0 1.3 0.0 0.0 0.3 1.7 0.8 0.0 0.0 0.0 0.4 1.1 0.0 0.5 0.0 0.0 0.5 0.0 0.0 554.0 0.0 11.7 3060.6 0.6 0.0 0.0 0.4 0.8 1.0 0.0 9.2 0.6 0.0 13.4 0.1 306.6 0.0 400.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 7.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.8 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 27.3 0.3 2.2 0.0 0.0 172.1 156.1 0.2 0.0 1.8 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 11.1 0.0 0.0 0.4 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.2 0.3 6.8 390.7 0.0 1.2 0.0 0.0 3.3 CALML3 CLP ENSG00000178363 "Calmodulin like 3" P27482 10 5524961-5526771 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 507.1;skin 1: 179.0;vagina: 200.8" "Cell type enriched" "Detected in some" 8 "Squamous epithelial cells: 1257.1" "Cancer enhanced" "Detected in many" "cervical cancer: 150.9;head and neck cancer: 196.3" "Region enhanced" "Detected in single" "cerebellum: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 21.5;hTCEpi: 8.6;RPMI-8226: 6.0" "Not detected" "Not detected" "CAB010070, HPA044999" Approved NA NA 1200000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "CAB010070: , HPA044999: AB_2679177" "unprognostic (1.02e-3)" "unprognostic (1.18e-2)" "unprognostic (4.33e-2)" "unprognostic (1.37e-1)" "unprognostic (1.29e-2)" "unprognostic (2.16e-1)" "unprognostic (2.93e-1)" "unprognostic (3.11e-1)" "unprognostic (1.02e-2)" "unprognostic (9.64e-2)" "unprognostic (1.35e-1)" "unprognostic (2.73e-2)" "unprognostic (1.71e-1)" "unprognostic (2.56e-1)" "unprognostic (1.65e-1)" "unprognostic (4.43e-3)" 0.5 0.1 0.2 0.0 0.2 0.0 5.4 1.5 0.1 107.9 0.0 0.1 0.0 0.1 0.1 507.1 1.2 0.0 0.1 0.0 0.3 17.3 1.6 0.0 0.0 0.5 0.3 0.1 0.2 0.0 0.3 0.0 0.2 2.9 0.0 0.0 121.0 0.1 1.0 179.0 0.2 0.0 0.0 0.1 0.3 1.7 0.7 79.5 0.1 0.0 39.8 0.2 200.8 0.0 21.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.5 0.1 0.0 0.3 0.5 0.3 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 28.4 29.8 6.3 157.1 2.2 13.3 22.4 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 5.9 0.0 4.3 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 28.5 0.0 1.4 8.3 0.3 0.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 6.5 0.0 59.6 0.7 0.3 0.0 0.0 0.9 6.7 0.1 1257.1 55.0 0.0 0.7 0.0 0.2 30.6 ASB13 "FLJ13134, MGC19879" ENSG00000196372 "Ankyrin repeat and SOCS box containing 13" Q8WXK3 10 5638867-5666595 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 45.0;Hepatocytes: 55.9;Proximal enterocytes: 41.1;Proximal tubular cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 13.6;monocytes: 12.9;T-cells: 4.1" "Cell line enhanced" "Detected in many" "Daudi: 66.7;RPMI-8226: 68.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048293, HPA061742" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 2: Hepatocytes - Metabolism" "Nucleoplasm, Golgi apparatus" "HPA048293: AB_2680344, HPA061742: AB_2684599" "unprognostic (3.64e-2)" "unprognostic (3.60e-1)" "unprognostic (7.39e-2)" "unprognostic (2.21e-2)" "unprognostic (4.83e-2)" "unprognostic (2.77e-2)" "unprognostic (1.74e-1)" "unprognostic (2.47e-1)" "unprognostic (2.90e-2)" "unprognostic (2.87e-1)" "unprognostic (6.93e-2)" "unprognostic (3.42e-2)" "unprognostic (4.58e-3)" "unprognostic (1.16e-2)" "unprognostic (3.03e-1)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" 11.2 19.7 4.9 7.2 4.9 3.5 15.9 6.3 7.0 10.1 5.5 14.4 25.4 9.2 1.8 10.3 12.8 7.6 8.9 3.7 4.5 21.3 44.0 6.5 18.2 5.9 5.9 14.8 10.7 4.8 8.2 3.3 5.9 9.6 6.6 6.7 8.9 6.5 11.9 11.9 25.4 5.7 5.2 9.7 8.7 3.3 8.4 3.8 6.2 10.1 12.9 11.7 9.1 4.8 10.6 13.7 5.5 24.6 21.5 5.8 9.5 1.9 4.1 6.1 7.0 11.4 19.4 66.7 16.2 3.9 2.2 17.3 12.2 13.6 0.8 3.4 24.0 10.0 7.7 8.5 14.4 8.5 0.9 9.6 20.7 3.2 5.3 6.1 5.0 18.0 12.1 1.3 1.7 7.6 11.0 7.8 12.0 28.6 8.0 4.5 0.8 68.8 7.9 16.3 11.5 27.2 12.9 8.7 21.5 1.6 25.9 10.6 2.1 3.5 6.2 14.6 5.7 3.6 8.6 44.0 10.8 22.9 2.8 0.0 12.9 0.3 1.5 8.3 2.6 1.8 3.9 1.7 13.6 2.4 4.1 2.0 0.4 1.2 6.6 0.4 1.2 7.5 4.9 4.9 6.3 7.0 3.7 4.5 5.9 5.9 5.9 5.2 8.4 4.8 4.7 0.0 5.8 9.1 1.7 1.7 1.9 2.5 2.2 45.0 8.8 7.4 7.8 8.6 4.7 1.8 18.8 5.8 0.4 21.3 5.9 5.3 2.7 3.2 7.9 5.3 4.2 1.7 6.7 4.5 1.6 9.1 1.5 2.3 3.8 20.1 5.3 55.9 7.0 16.8 13.3 5.7 4.1 12.6 2.6 0.7 13.4 7.3 8.8 6.5 7.0 8.5 0.0 7.1 8.1 4.5 12.6 21.4 0.4 3.3 41.1 39.5 4.9 14.2 6.6 7.2 10.7 0.2 1.6 5.7 1.7 2.1 2.1 16.5 12.4 1.5 TASOR2 "bA318E3.2, C10orf18, FAM208B, FLJ20360, KIAA2006" ENSG00000108021 "Transcription activation suppressor family member 2" Q5VWN6 10 5684838-5763740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 19.0;Cardiomyocytes: 28.0;Cytotrophoblasts: 11.7;dendritic cells: 18.4;Extravillous trophoblasts: 10.5;Fibroblasts: 8.1;Hofbauer cells: 10.3;Plasma cells: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038042, HPA038043, HPA061547" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: AB_2684558" "unprognostic (3.69e-2)" "unprognostic (3.13e-2)" "unprognostic (9.25e-2)" "unprognostic (8.83e-2)" "unprognostic (8.12e-3)" "unprognostic (4.84e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.39e-1)" "unprognostic (9.21e-2)" "unprognostic (8.36e-2)" "unprognostic (8.85e-2)" "unprognostic (4.88e-3)" "unprognostic (2.90e-3)" "unprognostic (2.98e-1)" "unprognostic (3.50e-1)" "unprognostic (7.79e-3)" "unprognostic (5.23e-2)" 9.5 8.6 3.1 12.0 4.4 14.3 12.5 19.5 8.0 13.2 9.8 10.9 6.6 13.0 15.3 9.7 10.7 10.2 9.3 2.3 9.0 8.9 10.8 8.1 17.2 2.5 5.1 12.7 10.9 14.5 10.7 12.6 3.5 9.9 11.9 14.1 9.5 10.9 12.1 8.9 9.2 13.3 1.2 10.0 10.3 24.6 4.6 14.9 16.4 14.4 17.0 17.5 8.0 10.5 38.2 31.7 19.9 34.0 25.1 29.7 28.0 31.7 20.1 26.7 33.6 33.7 22.0 77.2 19.8 31.4 16.9 29.3 57.5 32.5 43.0 15.2 38.7 36.1 24.7 22.8 25.0 26.9 20.7 22.9 35.6 43.5 36.8 17.9 31.4 29.4 59.1 17.6 30.2 25.7 35.0 9.5 24.3 24.6 20.3 25.8 27.7 27.1 16.0 34.1 24.4 27.5 31.5 28.3 22.2 22.3 37.2 20.9 31.6 33.6 36.2 65.5 43.7 21.3 21.9 67.8 16.6 26.1 18.1 1.0 1.2 0.2 1.2 1.2 1.1 1.0 0.9 1.1 0.7 1.8 0.9 1.5 0.9 4.3 0.4 1.1 1.3 0.5 3.1 4.4 19.5 8.0 2.3 9.0 2.5 5.1 3.5 1.2 4.6 10.5 19.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 11.7 18.4 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 10.5 8.1 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 7.3 2.7 0.0 0.0 0.0 GDI2 RABGDIB ENSG00000057608 "GDP dissociation inhibitor 2" P50395 10 5765223-5842132 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049290, HPA057668" Supported Approved Cytosol NA NA 53000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 3: Monocytes - Immune response regulation" Cytosol "HPA049290: AB_2680700, HPA057668: AB_2683498" "unprognostic (1.08e-2)" "unprognostic (8.33e-3)" "unprognostic (5.25e-2)" "unprognostic (1.13e-1)" "prognostic favorable (9.26e-4)" "unprognostic (7.15e-2)" "prognostic unfavorable (7.56e-7)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.74e-2)" "unprognostic (6.97e-2)" "unprognostic (3.10e-1)" "unprognostic (4.09e-2)" "unprognostic (1.71e-2)" "unprognostic (5.33e-2)" "unprognostic (2.02e-1)" "unprognostic (5.68e-2)" 125.1 111.5 62.4 151.6 70.0 126.6 138.1 76.0 90.3 120.6 66.8 152.9 175.4 96.3 115.3 131.1 96.8 112.6 86.8 59.3 70.7 146.0 241.1 98.3 217.5 85.8 72.7 116.9 165.1 91.3 59.6 135.5 82.6 88.8 160.7 69.1 97.7 92.2 107.0 107.6 160.2 124.1 80.9 138.7 108.6 74.3 65.1 149.1 114.1 99.7 239.2 145.5 81.7 95.4 343.4 245.8 341.1 241.2 298.2 347.5 191.4 325.0 170.8 287.3 312.0 351.8 287.3 553.2 198.2 340.5 88.1 320.8 368.3 289.3 288.0 212.2 174.7 380.0 152.0 428.4 276.9 252.1 230.7 292.6 235.8 249.6 148.9 324.0 400.6 340.1 398.5 203.4 331.6 291.1 390.9 208.0 242.5 355.1 159.3 466.7 181.9 389.8 330.7 250.1 138.0 210.0 257.5 468.5 358.3 289.9 382.3 299.0 342.0 142.3 243.4 420.3 282.2 180.0 314.8 526.5 212.0 275.5 130.0 154.9 280.8 169.0 109.9 347.8 136.4 210.7 136.9 121.6 329.1 204.2 124.8 119.3 138.4 177.5 445.1 146.1 181.5 416.8 62.4 70.0 76.0 90.3 59.3 70.7 85.8 72.7 82.6 80.9 65.1 95.4 101.5 25.6 83.8 31.0 208.1 161.7 131.3 144.8 145.7 37.1 124.5 81.8 76.6 107.2 109.0 57.0 18.8 252.1 148.5 156.6 133.1 185.7 29.5 69.1 138.0 125.4 118.4 177.1 27.7 212.2 312.0 151.5 109.6 84.3 132.5 121.7 121.3 145.9 284.5 92.5 32.1 184.7 91.6 354.2 302.8 40.4 152.2 255.7 149.4 36.5 485.8 75.0 97.9 34.7 49.2 158.1 141.9 141.8 151.3 129.2 271.0 194.1 63.0 36.8 111.7 96.1 125.8 126.2 119.3 177.6 165.1 247.4 120.1 136.9 213.5 131.9 ANKRD16 DKFZP434N1511 ENSG00000134461 "Ankyrin repeat domain 16" Q6P6B7 10 5861616-5889906 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 26.9;Inhibitory neurons: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037920, HPA037921" Uncertain Approved "Endoplasmic reticulum" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Endoplasmic reticulum" "HPA037920: AB_10671381, HPA037921: AB_2675740" "unprognostic (1.90e-1)" "unprognostic (1.67e-1)" "unprognostic (5.94e-3)" "unprognostic (2.15e-1)" "unprognostic (1.73e-2)" "unprognostic (6.18e-3)" "unprognostic (9.96e-3)" "unprognostic (4.57e-2)" "unprognostic (3.05e-1)" "unprognostic (1.86e-2)" "prognostic favorable (1.98e-4)" "unprognostic (5.85e-2)" "prognostic unfavorable (4.31e-7)" "unprognostic (1.06e-2)" "unprognostic (7.64e-2)" "unprognostic (9.53e-2)" "unprognostic (3.93e-2)" 3.8 4.0 5.5 2.3 5.5 1.9 4.1 5.6 7.9 6.3 3.1 3.7 3.2 5.1 4.9 3.7 5.8 2.5 3.3 5.2 4.2 3.5 4.1 3.0 3.1 5.0 4.5 6.2 4.1 5.7 3.9 1.7 5.2 4.1 2.5 4.4 4.0 3.1 3.9 6.7 3.2 3.2 4.0 3.2 6.6 8.7 4.8 3.8 3.7 2.6 3.3 4.3 4.4 5.6 8.3 9.8 4.5 9.2 4.6 3.4 6.6 2.5 1.9 4.4 3.8 12.1 4.3 8.8 3.5 4.2 1.6 8.5 5.5 6.4 2.0 3.1 8.6 5.5 4.8 11.1 5.9 3.4 3.8 5.3 4.8 4.0 3.1 3.5 4.9 9.0 7.5 2.6 3.1 11.5 12.7 5.8 3.7 11.2 6.9 9.6 2.9 18.1 5.0 5.3 2.7 6.0 5.2 6.4 6.0 3.6 8.9 6.9 3.2 2.6 3.4 5.8 3.5 14.7 7.1 5.8 5.4 3.3 2.9 0.3 0.2 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.2 0.4 0.4 0.1 0.1 0.4 0.1 0.5 0.2 0.1 5.5 5.5 5.6 7.9 5.2 4.2 5.0 4.5 5.2 4.0 4.8 5.6 5.3 3.2 1.3 14.7 5.9 4.7 7.8 1.4 4.6 14.1 7.0 6.0 2.8 10.0 1.8 3.7 6.2 4.7 3.0 2.4 13.7 2.1 8.4 7.8 9.8 4.2 4.2 5.5 25.1 2.2 3.6 10.2 4.1 4.4 0.0 13.0 3.3 3.8 3.3 26.9 28.4 3.1 0.0 1.0 3.3 14.6 5.6 3.2 3.6 5.6 3.6 8.8 1.0 12.5 16.2 1.0 1.3 3.8 11.3 7.3 5.2 8.3 1.0 14.4 0.0 8.5 4.5 13.0 7.8 6.5 5.7 1.5 3.5 10.5 5.2 3.7 FBH1 "Fbx18, FBXO18, FLJ14590" ENSG00000134452 "F-box DNA helicase 1" Q8NFZ0 10 5890203-5937594 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 22.4;Distal tubular cells: 21.5;Granulosa cells: 23.6;Syncytiotrophoblasts: 32.0;Theca cells: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002844 Supported NA NA "Cluster 15: NK-cells - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "HPA002844: AB_1078829" "unprognostic (3.14e-2)" "unprognostic (1.55e-1)" "unprognostic (6.35e-3)" "unprognostic (4.42e-2)" "unprognostic (3.37e-2)" "unprognostic (8.98e-3)" "prognostic unfavorable (7.73e-7)" "unprognostic (1.89e-1)" "unprognostic (2.42e-1)" "unprognostic (3.37e-2)" "unprognostic (1.56e-2)" "unprognostic (2.23e-1)" "unprognostic (6.91e-3)" "unprognostic (3.69e-1)" "unprognostic (4.35e-2)" "unprognostic (1.24e-1)" "unprognostic (9.54e-2)" 28.7 38.8 17.5 22.8 20.3 24.6 26.8 17.7 19.1 32.4 25.7 30.4 24.6 34.3 21.3 24.0 36.4 23.0 44.5 17.2 18.0 25.2 28.8 27.6 27.6 17.7 18.2 30.7 21.9 28.5 26.1 26.6 18.0 28.6 24.2 14.8 24.3 25.8 30.3 30.4 29.7 30.1 17.8 35.3 27.6 24.7 19.2 40.2 25.2 27.4 27.2 28.8 27.1 19.0 31.8 34.0 31.3 34.4 70.4 46.3 28.1 35.9 24.6 34.8 38.8 40.4 28.3 29.6 23.0 52.5 16.7 46.3 42.6 38.2 31.3 32.2 31.5 28.6 27.3 34.8 48.2 14.2 26.4 58.2 36.4 44.2 19.4 44.0 59.7 39.7 50.9 30.4 37.3 48.1 34.5 20.9 14.3 54.7 18.9 37.6 14.8 49.9 34.0 25.5 17.7 26.6 36.8 33.1 50.8 35.7 33.7 28.5 37.9 22.1 24.7 59.1 28.1 30.9 26.1 16.3 29.8 20.7 15.8 0.0 2.1 3.3 1.9 1.7 1.3 3.0 2.0 2.5 2.0 4.1 2.5 1.8 1.3 4.6 1.3 4.0 6.2 1.7 17.5 20.3 17.7 19.1 17.2 18.0 17.7 18.2 18.0 17.8 19.2 19.0 22.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 15.6 16.1 0.0 0.0 0.0 7.3 0.0 20.3 9.3 0.0 21.5 16.8 0.0 11.4 19.0 7.1 0.0 0.0 0.0 15.1 19.4 9.8 0.0 14.9 0.0 23.6 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 10.3 0.0 0.0 0.0 0.0 18.3 0.0 0.0 3.2 0.0 0.0 20.9 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 32.0 4.4 27.9 0.0 0.0 IL15RA "CD215, IL-15RA" ENSG00000134470 "Interleukin 15 receptor subunit alpha" Q13261 10 5943639-5978187 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 39.1;Exocrine glandular cells: 55.2;Fibroblasts: 37.6;Hepatic stellate cells: 36.0;monocytes: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 70.8;EFO-21: 41.3;HDLM-2: 78.5;HHSteC: 42.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 8 "cerebellum: 7.1" CAB026215 Approved "Secreted to blood" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 19: Lung - Lung function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 50: Fibroblasts - ECM organization" "CAB026215: " "unprognostic (2.86e-2)" "unprognostic (8.41e-2)" "unprognostic (6.13e-2)" "unprognostic (4.45e-2)" "unprognostic (7.87e-2)" "unprognostic (5.49e-2)" "prognostic unfavorable (2.67e-6)" "unprognostic (5.09e-3)" "unprognostic (1.82e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (5.35e-4)" "unprognostic (6.18e-3)" "prognostic unfavorable (1.27e-12)" "unprognostic (4.43e-2)" "unprognostic (4.69e-2)" "unprognostic (4.08e-2)" "unprognostic (5.75e-2)" 19.3 7.5 3.3 20.4 3.7 11.7 18.3 3.0 4.6 21.5 3.6 12.3 16.2 15.0 4.6 11.5 18.8 23.2 17.8 2.8 4.4 14.1 19.5 44.5 21.3 5.7 3.9 3.7 11.5 2.2 4.6 16.1 4.6 10.4 10.9 0.3 8.0 5.3 7.1 11.2 15.7 12.1 4.8 15.1 16.3 3.2 4.6 5.7 12.1 10.2 11.6 25.7 12.7 3.5 16.8 2.4 0.0 0.7 21.5 4.9 4.3 8.6 18.4 10.7 11.4 0.3 70.8 1.9 41.3 16.0 6.0 15.6 2.0 12.1 2.4 78.5 3.5 2.0 4.9 1.2 42.7 0.9 0.6 4.1 4.2 6.0 0.2 4.4 29.1 1.3 20.5 23.5 0.3 9.3 3.6 8.9 0.4 6.7 6.8 10.0 0.0 13.4 2.8 1.3 0.1 0.1 12.9 1.4 0.6 0.2 6.1 8.0 10.8 0.5 1.3 30.1 11.2 20.5 6.2 0.4 4.9 12.4 0.7 10.2 26.0 6.6 18.9 32.8 29.1 10.8 14.7 19.7 7.1 6.4 6.1 11.0 7.5 11.5 21.0 0.1 17.7 12.8 3.3 3.7 3.0 4.6 2.8 4.4 5.7 3.9 4.6 4.8 4.6 3.5 25.2 6.4 5.0 1.3 6.0 5.7 5.7 9.9 4.6 0.0 4.4 3.0 5.8 22.8 3.3 0.0 0.0 0.6 4.2 5.8 0.0 39.1 1.7 5.1 23.0 21.0 5.4 19.8 3.3 55.2 1.6 37.6 9.7 6.7 3.8 0.1 36.0 8.7 6.6 0.0 0.9 6.8 2.0 14.7 5.5 2.1 5.0 7.3 3.6 12.2 55.0 0.0 4.1 1.0 0.3 35.5 13.3 0.7 22.2 20.1 9.3 0.1 3.4 0.0 0.0 7.1 6.4 0.2 0.4 4.6 6.5 0.1 7.8 0.0 9.3 6.8 IL2RA "CD25, IDDM10, IL2R" ENSG00000134460 "Interleukin 2 receptor subunit alpha" P01589 10 6010689-6062370 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.9;lymphoid tissue: 17.4;urinary bladder: 11.2" "Group enriched" "Detected in some" 6 "granulocytes: 80.8;monocytes: 177.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "basophil: 175.9;T-reg: 248.0" "Group enriched" "Detected in many" 14 "granulocytes: 175.9;T-cells: 248.0" "Cell line enriched" "Detected in some" 59 "HDLM-2: 1113.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB002419, HPA054622" Enhanced NA NA 410000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "CAB002419: AB_563538, HPA054622: AB_2682546" "unprognostic (2.82e-1)" "unprognostic (8.10e-3)" "unprognostic (1.75e-2)" "unprognostic (5.86e-2)" "unprognostic (1.50e-1)" "unprognostic (1.45e-3)" "unprognostic (2.78e-2)" "unprognostic (2.73e-1)" "unprognostic (5.03e-2)" "unprognostic (6.32e-2)" "unprognostic (7.21e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.08e-9)" "unprognostic (2.10e-2)" "unprognostic (4.66e-2)" "unprognostic (2.22e-1)" "unprognostic (5.10e-2)" 18.9 1.9 0.0 14.2 0.0 0.4 1.4 0.1 0.2 0.5 1.1 3.3 1.9 0.5 0.2 2.6 0.3 2.9 0.8 0.1 0.1 0.7 0.5 2.4 17.4 0.5 0.1 0.1 0.5 0.3 0.9 2.5 0.4 0.4 2.1 0.0 0.5 0.8 0.1 0.4 6.5 4.7 0.1 7.5 1.2 0.2 0.2 5.2 1.3 0.6 12.9 11.2 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1113.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.9 0.0 0.4 18.9 0.0 0.3 0.0 175.9 0.1 20.1 0.6 0.0 2.2 14.7 27.3 3.1 0.2 7.3 2.0 0.2 0.9 13.4 0.3 0.2 248.0 3.2 0.0 0.0 0.1 0.2 0.1 0.1 0.5 0.1 0.4 0.1 0.2 0.2 0.4 0.0 1.8 1.0 13.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.0 0.0 0.0 8.3 0.0 0.0 0.1 0.2 0.2 0.6 0.4 0.0 0.8 0.2 0.6 0.0 0.7 1.1 0.1 80.8 0.0 0.4 0.2 0.3 0.0 0.2 0.0 0.0 7.7 4.8 0.1 0.0 19.3 3.6 1.9 177.6 0.0 2.1 0.0 0.3 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.1 0.6 0.0 19.6 0.0 0.1 0.2 RBM17 "MGC14439, SPF45" ENSG00000134453 "RNA binding motif protein 17" Q96I25 10 6089034-6117457 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037477, HPA037478" Supported Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA037477: AB_10671372, HPA037478: AB_2675494" "unprognostic (8.55e-2)" "unprognostic (2.41e-1)" "unprognostic (3.11e-3)" "unprognostic (6.23e-2)" "unprognostic (1.05e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (4.57e-8)" "unprognostic (3.78e-2)" "unprognostic (6.39e-2)" "unprognostic (3.47e-3)" "unprognostic (1.44e-1)" "unprognostic (8.32e-2)" "prognostic unfavorable (4.31e-5)" "unprognostic (1.82e-1)" "unprognostic (5.53e-2)" "unprognostic (1.26e-2)" "unprognostic (3.01e-2)" 72.4 47.0 46.3 75.3 51.6 139.5 64.4 47.2 53.5 50.2 40.1 57.6 63.8 63.5 38.7 51.9 55.3 52.6 60.8 46.9 52.3 54.6 44.6 78.0 87.4 53.5 49.5 54.7 62.9 45.5 35.8 75.7 52.7 41.5 65.2 41.6 49.9 39.4 95.4 47.0 70.5 60.4 47.3 77.6 51.6 61.9 52.5 87.7 63.3 72.1 85.4 63.5 49.4 52.4 195.9 113.0 141.1 122.7 76.5 69.4 175.5 128.4 58.0 130.2 139.8 184.7 151.2 234.1 89.3 94.4 48.5 188.1 130.3 136.4 138.6 233.7 132.1 199.3 120.4 158.5 96.7 110.0 93.6 71.7 104.0 132.4 72.4 67.9 159.6 168.1 219.0 112.1 84.1 223.6 198.8 66.2 90.3 227.8 81.3 211.4 79.9 120.8 93.5 117.3 60.5 78.9 124.1 110.1 99.0 119.5 146.3 111.3 97.3 76.9 153.4 169.0 138.1 110.2 135.6 386.7 72.0 140.3 51.7 79.7 78.2 102.6 71.6 79.0 75.2 101.8 71.8 73.4 69.9 110.2 71.8 68.1 38.7 77.8 62.3 77.0 101.1 59.8 46.3 51.6 47.2 53.5 46.9 52.3 53.5 49.5 52.7 47.3 52.5 52.4 152.3 89.8 56.0 24.8 107.7 129.2 97.4 72.7 108.7 71.3 68.5 85.3 86.0 65.8 68.1 66.2 50.1 125.6 83.3 80.8 90.1 92.0 90.2 74.7 99.5 123.9 72.7 100.5 42.2 70.9 188.5 89.5 58.6 83.9 96.8 79.7 69.7 65.3 98.8 92.5 41.4 87.1 63.1 73.6 128.6 26.3 66.2 93.9 51.6 38.4 161.5 77.9 96.8 23.6 40.7 88.0 86.4 60.5 153.8 122.3 79.8 75.7 41.3 62.2 72.3 115.6 117.4 266.4 233.3 114.4 108.7 97.0 97.4 78.9 106.5 112.6 PFKFB3 ENSG00000170525 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3" Q16875 10 6144934-6254644 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 334.6;skeletal muscle: 621.3" "Cell type enhanced" "Detected in many" "Astrocytes: 153.8;Collecting duct cells: 195.0;Langerhans cells: 132.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 26.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 296.2;RPTEC TERT1: 181.8;T-47d: 192.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008266, CAB020795, HPA043889" Uncertain Enhanced Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 41: Macrophages - Immune response" Nucleoplasm "CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717" "unprognostic (1.61e-1)" "unprognostic (5.08e-3)" "unprognostic (2.89e-2)" "unprognostic (6.18e-2)" "unprognostic (2.29e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (1.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.04e-1)" "unprognostic (3.30e-2)" "unprognostic (7.34e-2)" "prognostic unfavorable (1.87e-7)" "unprognostic (1.89e-2)" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.74e-1)" 334.6 22.7 66.1 72.2 81.2 246.0 153.8 75.4 66.6 30.2 22.1 22.2 19.4 24.0 11.1 51.3 37.7 59.9 21.9 62.8 105.8 243.9 32.8 67.7 24.5 145.7 100.9 24.2 21.0 10.1 39.6 20.0 100.9 20.2 8.9 31.5 40.4 49.5 621.3 53.6 22.9 16.9 90.1 50.2 26.1 13.9 91.8 15.1 10.9 30.4 28.2 63.9 40.3 105.6 22.0 296.2 23.1 18.8 85.2 10.5 12.2 31.6 22.5 22.9 35.5 14.1 78.0 37.2 20.2 13.8 18.0 69.0 24.9 50.2 26.3 44.6 17.3 22.1 16.2 5.2 7.2 21.6 32.2 7.6 16.4 39.5 9.5 58.3 44.9 25.6 16.6 13.6 18.6 35.7 15.3 20.3 22.5 31.1 20.5 34.3 11.3 14.7 181.8 11.1 21.9 8.9 22.9 24.7 45.8 39.5 192.0 25.2 57.0 23.9 22.0 3.1 38.7 27.8 10.4 33.7 65.8 25.0 37.4 2.9 7.5 7.7 2.2 9.2 5.7 1.8 4.2 2.9 4.7 1.6 3.0 3.0 26.4 1.2 5.5 2.9 4.3 4.3 66.1 81.2 75.4 66.6 62.8 105.8 145.7 100.9 100.9 90.1 91.8 105.6 37.1 76.9 55.1 153.8 27.2 102.6 16.7 21.5 37.5 6.4 37.1 36.8 19.5 22.8 32.1 195.0 52.1 0.4 37.0 14.9 0.0 54.7 5.0 41.1 18.9 32.9 8.5 1.3 42.8 25.7 6.9 30.8 33.1 64.3 44.2 72.5 8.9 15.8 20.6 6.7 19.4 6.6 18.3 88.0 132.3 9.5 2.8 122.2 46.2 41.2 19.6 0.3 4.1 14.1 31.9 59.6 5.2 7.2 25.3 4.2 5.4 2.4 19.2 1.9 0.0 58.5 24.4 0.6 2.5 20.9 63.9 1.0 61.7 12.4 8.1 14.7 PRKCQ ENSG00000065675 "Protein kinase C theta" Q04759 10 6427143-6580301 "Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 33.6;skeletal muscle: 124.5;tongue: 112.6" "Cell type enhanced" "Detected in many" "Astrocytes: 22.9;dendritic cells: 22.4;NK-cells: 32.0;Oligodendrocyte precursor cells: 24.6;Oligodendrocytes: 75.2;T-cells: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 23.0;MAIT T-cell: 18.0;memory CD4 T-cell: 24.5;memory CD8 T-cell: 24.5;naive CD4 T-cell: 19.1;naive CD8 T-cell: 17.9;NK-cell: 13.3;T-reg: 39.7" "Group enriched" "Detected in many" 11 "NK-cells: 13.3;T-cells: 39.7" "Cell line enhanced" "Detected in many" "HEL: 57.8;JURKAT: 40.0;MOLT-4: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065279, HPA073098" Enhanced "Centriolar satellite" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Centriolar satellite" "HPA065279: AB_2685453, HPA073098: AB_2686571" "unprognostic (6.61e-3)" "unprognostic (2.12e-1)" "unprognostic (1.87e-1)" "unprognostic (1.48e-1)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (2.69e-3)" "unprognostic (2.46e-1)" "unprognostic (8.40e-2)" "unprognostic (2.66e-1)" "unprognostic (1.17e-1)" "unprognostic (3.22e-1)" "unprognostic (5.26e-2)" "unprognostic (7.74e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (3.51e-2)" 0.8 0.7 5.3 5.2 8.5 5.7 0.9 6.1 6.3 1.6 12.1 1.4 1.5 2.5 8.3 2.2 3.9 1.5 0.3 5.5 8.2 10.9 1.0 5.3 12.3 6.5 8.6 1.3 3.4 0.7 0.8 0.2 6.4 1.8 1.7 1.5 1.4 1.1 124.5 0.3 3.3 0.7 5.5 5.0 2.1 1.1 7.2 33.6 14.9 112.6 9.4 2.2 0.6 9.8 0.1 5.3 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.2 0.4 3.4 0.3 0.0 0.0 0.0 0.0 3.3 6.0 0.0 0.0 3.9 57.8 0.0 0.4 0.7 2.8 0.6 0.3 3.5 0.1 0.2 0.0 0.5 40.0 12.8 0.1 0.0 0.0 43.9 8.0 5.8 0.5 0.0 8.5 1.3 0.0 11.6 2.9 0.4 2.1 0.0 0.0 0.0 3.4 0.0 5.8 0.0 0.0 5.6 0.0 0.0 0.1 0.0 0.0 0.0 7.1 0.0 2.4 0.1 0.3 23.0 0.4 18.0 0.1 24.5 24.5 0.2 0.0 19.1 17.9 1.6 13.3 0.0 0.0 39.7 10.5 5.3 8.5 6.1 6.3 5.5 8.2 6.5 8.6 6.4 5.5 7.2 9.8 0.2 3.2 7.0 22.9 0.8 0.0 0.3 0.3 0.6 1.6 0.3 0.3 0.4 0.0 0.7 1.8 0.0 0.0 22.4 0.0 7.9 0.3 2.1 0.5 1.2 0.2 1.8 8.0 13.7 0.8 0.1 0.7 1.5 3.0 1.3 8.2 1.1 0.0 0.5 0.0 14.7 0.5 0.0 1.3 0.5 5.6 0.0 1.7 0.0 7.5 0.8 1.2 32.0 24.6 75.2 0.1 0.1 0.0 10.2 0.2 0.0 0.3 0.9 0.4 0.0 4.2 0.4 1.0 2.2 0.5 0.0 0.0 31.7 0.3 0.4 0.1 SFMBT2 KIAA1617 ENSG00000198879 "Scm like with four mbt domains 2" Q5VUG0 10 7158624-7411486 "Predicted intracellular proteins" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 27.7" "Cell type enriched" "Detected in many" 4 "Microglial cells: 618.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 23.0;REH: 21.0;RPMI-8226: 20.2;SH-SY5Y: 16.6;THP-1: 25.0;U-937: 16.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035447, HPA035448, HPA070388" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 43: THP-1 - Innate immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Nuclear speckles" "HPA035447: AB_2674628, HPA035448: AB_10669904, HPA070388: " "unprognostic (4.36e-2)" "unprognostic (2.29e-2)" "unprognostic (4.36e-2)" "unprognostic (1.42e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-3)" "unprognostic (4.65e-1)" "unprognostic (4.56e-1)" "unprognostic (1.03e-1)" "unprognostic (6.51e-2)" "unprognostic (5.57e-2)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (1.26e-1)" "unprognostic (9.17e-3)" "unprognostic (5.37e-3)" "unprognostic (7.29e-2)" 3.8 4.1 13.0 5.9 13.1 6.6 5.5 10.2 9.8 3.4 5.1 2.8 2.0 4.0 3.7 1.1 4.0 3.5 4.0 7.5 17.6 3.0 1.3 4.7 7.3 20.4 15.0 9.1 1.3 5.7 6.4 3.4 17.1 6.6 3.2 18.0 2.3 3.1 4.2 1.7 4.0 3.3 12.7 9.0 3.1 1.8 27.7 4.5 6.8 2.6 5.8 4.1 4.2 19.0 0.0 4.0 0.3 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 1.1 7.6 0.0 0.0 0.0 1.9 7.6 0.0 0.0 0.4 7.9 0.0 13.0 0.0 0.7 8.0 1.1 1.1 0.4 0.0 0.3 0.0 0.1 10.0 11.5 23.0 0.0 3.5 7.0 14.3 1.6 0.0 0.0 21.0 2.2 20.2 0.0 0.8 2.0 16.6 0.0 0.1 0.0 2.1 1.3 25.0 0.0 0.0 2.6 0.4 0.2 10.1 13.3 0.0 1.1 16.5 0.3 0.1 0.2 1.1 0.7 2.3 0.4 0.0 0.2 0.5 0.4 0.0 1.0 0.6 0.1 0.9 4.6 3.1 0.0 0.2 13.0 13.1 10.2 9.8 7.5 17.6 20.4 15.0 17.1 12.7 27.7 19.0 8.2 0.0 5.2 148.2 10.2 1.5 1.5 0.0 1.2 8.1 9.3 8.6 9.7 1.5 0.6 0.0 81.3 7.7 22.1 0.1 0.0 0.4 0.2 0.8 15.8 10.1 4.2 6.1 77.3 0.2 2.5 4.2 2.0 3.5 4.5 7.1 5.7 1.1 15.5 0.0 103.9 0.0 0.0 15.7 9.9 0.8 5.0 26.3 5.4 618.3 11.4 12.4 15.5 26.2 113.7 0.1 0.0 2.2 25.8 11.4 0.0 0.3 0.7 34.1 0.0 4.4 2.6 0.3 3.9 0.2 1.3 4.4 25.8 2.5 0.2 0.6 ITIH5 MGC10848 ENSG00000123243 "Inter-alpha-trypsin inhibitor heavy chain 5" 10 7559270-7666998 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 112.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 282.7;Fibroblasts: 111.3;Microglial cells: 160.2;Smooth muscle cells: 110.1;Syncytiotrophoblasts: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "WM-115: 102.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038305 Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Vesicles "HPA038305: AB_10670662" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "unprognostic (3.11e-3)" "unprognostic (6.80e-2)" "unprognostic (1.80e-1)" "unprognostic (5.84e-3)" "unprognostic (1.63e-1)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (2.90e-1)" "unprognostic (5.80e-3)" "unprognostic (6.11e-2)" "unprognostic (1.36e-1)" "unprognostic (6.79e-3)" "unprognostic (2.00e-2)" "unprognostic (4.50e-2)" "unprognostic (3.48e-2)" 112.7 3.7 17.9 19.4 18.6 0.2 53.3 19.7 23.2 17.4 28.6 62.7 13.9 24.3 6.3 21.4 10.5 27.7 16.8 14.7 18.0 16.4 1.6 22.4 12.5 18.9 18.1 21.2 15.0 6.3 5.4 86.9 19.7 24.0 16.8 3.5 9.5 46.6 17.8 12.0 21.6 28.8 15.7 3.4 24.0 6.2 22.5 3.8 24.5 22.5 13.4 51.4 15.3 15.2 0.0 0.0 0.0 0.1 0.0 0.0 7.0 18.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.5 14.8 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.2 0.1 0.0 0.0 0.0 102.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 18.6 19.7 23.2 14.7 18.0 18.9 18.1 19.7 15.7 22.5 15.2 74.9 3.2 2.7 1.3 0.2 11.3 3.0 0.1 6.8 2.7 1.6 17.3 8.7 8.6 3.7 0.0 2.1 282.7 0.8 0.1 0.0 25.7 2.0 18.7 1.5 58.8 0.0 0.0 0.5 0.4 70.2 111.3 0.0 34.1 2.5 0.5 1.8 0.1 20.7 0.0 0.7 0.0 8.2 1.2 19.6 2.2 5.3 3.6 14.2 160.2 1.1 21.9 0.0 1.5 1.0 0.3 0.0 15.4 0.9 1.8 0.2 2.1 0.7 3.2 78.9 32.3 110.1 1.7 7.7 0.7 8.8 221.9 3.0 0.3 0.0 1.6 ITIH2 H2P ENSG00000151655 "Inter-alpha-trypsin inhibitor heavy chain 2" P19823 10 7703316-7749520 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 668 "liver: 2156.1" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 489.6" "Cancer enriched" "Detected in many" 279 "liver cancer: 626.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 453 "Hep G2: 1103.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA059150 Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 32000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "HPA059150: AB_2683930" "unprognostic (4.82e-2)" "unprognostic (6.10e-2)" "unprognostic (2.48e-2)" "unprognostic (1.21e-2)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" "prognostic favorable (1.48e-4)" "unprognostic (1.37e-1)" "unprognostic (1.79e-1)" "unprognostic (1.47e-2)" "unprognostic (2.28e-1)" "unprognostic (2.02e-1)" "unprognostic (2.10e-8)" "unprognostic (9.91e-3)" "unprognostic (1.70e-1)" "unprognostic (2.35e-1)" "unprognostic (4.46e-4)" 0.1 0.2 0.3 0.1 1.1 0.1 3.0 1.6 3.2 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.1 0.6 1.0 0.8 2156.1 0.6 0.1 0.6 0.5 0.0 0.2 0.0 1.7 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.8 0.4 0.0 0.0 0.9 0.3 0.5 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 1103.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 2.4 0.0 0.1 0.7 0.0 0.4 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.1 1.6 3.2 0.6 1.0 0.6 0.5 0.6 0.9 0.9 0.7 0.1 0.0 2.2 0.7 1.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.4 117.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.1 0.0 0.0 0.6 0.0 2.7 3.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 8.2 489.6 0.1 0.0 1.4 0.0 0.0 9.4 0.0 2.1 0.0 0.0 0.0 18.7 0.0 0.0 0.0 1.5 1.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 KIN "KIN17, Rts2" ENSG00000151657 "Kin17 DNA and RNA binding protein" O60870 10 7750962-7787993 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication, Host-virus interaction, mRNA processing, Stress response" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016339, HPA038700" Enhanced Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB016339: AB_627860, HPA038700: AB_2676159" "unprognostic (4.33e-3)" "unprognostic (1.24e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-2)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "unprognostic (3.17e-3)" "unprognostic (1.30e-2)" "unprognostic (2.58e-1)" "unprognostic (5.59e-2)" "unprognostic (1.11e-1)" "unprognostic (5.40e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (3.98e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-1)" "prognostic favorable (3.23e-5)" 2.1 2.4 1.9 2.6 1.9 3.1 2.6 4.4 2.5 2.8 1.8 2.2 2.4 3.3 2.8 2.0 2.4 2.1 2.1 1.8 1.8 2.3 3.3 2.2 3.4 1.7 1.8 3.0 2.7 2.0 2.6 3.0 1.9 2.5 2.2 3.4 2.5 2.1 2.8 3.4 2.4 2.1 1.4 2.8 2.5 2.1 2.0 2.4 2.9 2.2 2.7 2.1 2.4 2.6 4.3 2.7 4.1 2.5 3.3 3.9 3.3 3.8 1.7 4.5 4.8 5.2 4.2 3.3 1.9 2.3 1.4 4.0 3.5 2.3 5.1 3.8 4.0 5.2 2.7 5.1 4.6 1.9 4.1 3.3 2.5 3.4 2.2 3.7 3.4 4.1 5.3 3.1 3.5 3.9 3.8 2.9 3.9 4.5 1.6 4.8 2.9 3.1 3.8 2.3 1.7 3.8 3.0 2.9 6.2 3.8 5.5 3.8 2.5 2.9 3.2 5.1 3.1 4.0 4.7 4.1 3.6 2.9 2.0 15.9 3.9 7.1 3.7 4.3 3.7 5.9 3.3 3.1 3.0 5.4 3.6 3.8 8.8 4.9 4.1 5.8 3.0 1.5 1.9 1.9 4.4 2.5 1.8 1.8 1.7 1.8 1.9 1.4 2.0 2.6 31.5 35.3 27.2 12.1 20.7 17.3 14.6 31.3 13.6 54.8 17.2 20.1 13.0 20.0 24.8 18.4 39.6 36.7 32.0 20.4 13.7 32.9 5.7 21.7 28.4 25.6 23.3 30.3 17.4 21.5 23.8 24.0 14.3 27.9 16.4 22.9 21.0 11.9 32.1 63.9 14.8 20.3 18.3 16.9 22.8 6.2 27.7 21.8 16.0 11.2 30.7 28.7 38.1 13.0 19.4 21.2 23.6 30.9 18.1 18.9 18.2 16.9 26.0 54.7 13.1 27.8 29.7 29.1 19.0 12.1 14.3 38.4 25.7 30.1 14.7 17.3 ATP5F1C "ATP5C, ATP5C1, ATP5CL1" ENSG00000165629 "ATP synthase F1 subunit gamma" P36542 10 7788147-7807815 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 895.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 517.1;Distal tubular cells: 890.2;Ductal cells: 453.9;Extravillous trophoblasts: 428.5;Hofbauer cells: 423.4;Proximal tubular cells: 938.6;Theca cells: 413.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060949 Approved NA NA 70000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 7: Non-specific - Mitochondria" "HPA060949: AB_2684395" "unprognostic (1.81e-2)" "unprognostic (8.34e-2)" "unprognostic (3.87e-2)" "unprognostic (1.69e-2)" "unprognostic (2.17e-2)" "unprognostic (1.64e-1)" "unprognostic (2.65e-2)" "unprognostic (8.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.31e-3)" "unprognostic (1.62e-1)" "unprognostic (4.12e-1)" "prognostic favorable (9.26e-4)" "unprognostic (2.47e-1)" "unprognostic (1.92e-1)" "unprognostic (8.30e-2)" "unprognostic (4.08e-2)" 123.7 265.0 82.8 103.2 82.4 149.0 164.8 111.3 111.0 122.5 102.6 240.9 254.7 100.9 150.1 145.9 114.7 112.6 710.9 81.5 94.3 399.9 368.6 93.5 133.0 85.4 83.2 86.8 182.2 411.4 76.7 147.5 86.4 117.5 274.7 161.6 168.3 136.2 537.8 110.7 205.7 146.1 88.8 96.4 174.3 71.1 89.1 192.5 161.7 895.1 175.3 163.8 91.0 90.9 301.2 266.8 255.2 219.3 212.5 276.7 241.2 211.1 176.1 365.7 351.6 511.4 293.8 323.8 163.3 248.0 95.3 337.9 318.3 342.8 325.5 222.3 381.6 351.7 169.3 479.8 172.2 193.6 249.6 222.9 234.1 224.7 134.5 315.7 426.7 321.8 283.4 230.1 352.6 419.0 451.9 217.7 173.3 623.4 201.8 301.9 179.1 460.6 637.5 301.0 141.3 168.2 186.0 417.5 417.1 287.3 437.9 315.9 202.7 151.7 205.3 349.2 229.8 159.2 194.7 265.5 224.7 286.2 127.3 373.0 273.8 241.9 158.5 363.1 185.3 199.2 180.7 174.5 370.4 158.6 146.4 159.6 88.5 226.9 428.2 237.8 261.4 349.3 82.8 82.4 111.3 111.0 81.5 94.3 85.4 83.2 86.4 88.8 89.1 90.9 196.2 118.6 95.4 0.0 30.4 0.0 0.0 0.0 0.0 0.0 156.2 239.3 0.0 0.0 60.7 215.2 0.0 517.1 85.3 0.0 890.2 453.9 0.0 160.9 125.4 76.7 0.0 0.0 0.0 381.8 428.5 89.5 0.0 170.4 97.1 163.2 0.0 0.0 423.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.6 0.0 0.0 140.6 0.0 0.0 0.0 0.0 304.4 0.0 0.0 12.0 0.0 0.0 938.6 64.8 0.0 0.0 0.0 102.0 0.0 0.0 0.0 0.0 371.9 49.1 413.9 0.0 0.0 TAF3 "TAF140, TAFII140" ENSG00000165632 "TATA-box binding protein associated factor 3" Q5VWG9 10 7818505-8016631 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066184 Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Nuclear membrane" "HPA066184: AB_2685631" "unprognostic (3.82e-2)" "unprognostic (2.87e-3)" "unprognostic (6.60e-2)" "unprognostic (4.23e-1)" "unprognostic (6.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (2.14e-7)" "unprognostic (2.97e-1)" "unprognostic (1.45e-1)" "unprognostic (2.71e-2)" "unprognostic (9.71e-2)" "unprognostic (6.30e-3)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.59e-2)" "unprognostic (3.44e-1)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" 5.4 4.9 7.1 4.8 7.9 6.9 4.5 9.9 9.0 4.7 4.8 5.1 2.8 5.2 2.2 3.0 4.3 3.3 5.9 6.1 7.6 4.0 3.7 3.9 6.1 7.9 9.0 7.0 4.3 5.2 3.1 4.5 7.9 3.5 3.5 5.3 3.6 4.4 10.7 5.2 3.8 4.2 7.2 5.5 3.7 7.5 8.2 7.0 4.3 7.6 4.6 5.0 4.2 7.2 7.9 7.2 8.0 4.3 9.0 6.2 11.1 9.2 3.5 6.8 7.7 15.6 5.8 13.4 6.9 5.4 2.8 8.4 8.9 7.9 8.5 10.9 9.8 11.5 5.0 10.0 7.7 7.8 10.1 4.2 7.8 9.5 4.6 4.3 6.5 14.5 13.0 13.5 7.8 14.9 17.7 5.5 6.1 11.5 4.2 14.2 7.6 9.0 3.9 4.9 4.3 6.1 10.0 7.2 9.4 7.8 13.1 8.1 8.1 6.1 10.7 16.3 9.1 8.0 10.3 14.4 5.9 8.8 5.6 5.8 3.9 5.7 6.0 3.4 7.1 5.2 5.4 5.9 3.2 5.6 6.7 5.8 1.5 6.2 6.6 3.1 4.9 3.9 7.1 7.9 9.9 9.0 6.1 7.6 7.9 9.0 7.9 7.2 8.2 7.2 26.2 28.9 29.5 41.1 45.2 32.0 20.7 13.3 23.3 28.6 15.3 16.5 40.1 14.3 10.5 27.6 35.5 26.6 32.0 18.0 0.0 17.0 39.6 16.7 22.9 29.9 18.7 25.2 45.1 14.7 36.8 23.2 19.9 16.7 22.1 18.0 19.6 14.5 19.8 26.9 54.4 14.6 8.2 21.3 24.2 22.0 27.4 25.3 24.9 71.2 25.7 27.0 53.5 43.2 63.9 15.0 5.9 28.6 37.7 14.1 20.5 4.5 16.3 47.8 26.3 39.3 31.0 58.9 46.2 16.4 43.0 20.0 48.6 16.4 16.5 17.6 GATA3 HDR ENSG00000107485 "GATA binding protein 3" P23771 10 8045378-8075198 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 109.9;skin 1: 172.9" "Cell type enhanced" "Detected in many" "Breast glandular cells: 267.1;Cytotrophoblasts: 323.5;Extravillous trophoblasts: 746.6;Suprabasal keratinocytes: 198.9;Syncytiotrophoblasts: 1134.9" "Group enriched" "Detected in many" 24 "breast cancer: 190.0;urothelial cancer: 87.0" "Group enriched" "Detected in many" 5 "midbrain: 28.3;pons: 12.6" "Group enriched" "Detected in many" 41 "gdT-cell: 19.9;MAIT T-cell: 26.9;memory CD4 T-cell: 36.7;memory CD8 T-cell: 28.8;naive CD4 T-cell: 19.9;naive CD8 T-cell: 18.3;NK-cell: 36.1;T-reg: 43.6" "Group enriched" "Detected in many" 57 "NK-cells: 36.1;T-cells: 43.6" "Cell line enhanced" "Detected in many" "BEWO: 190.2;MCF7: 473.4;RT4: 194.3;SH-SY5Y: 161.2;T-47d: 605.2" "Region enriched" "Detected in single" 6 "midbrain: 6.1" "Group enriched" "Detected in some" 11 "medulla oblongata: 5.2;midbrain: 14.0;pons: 11.8;thalamus: 13.1" "CAB016217, HPA029730" Enhanced Supported Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 6: T47d - Mammary gland" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "CAB016217: AB_2108591, HPA029730: AB_10601907" "unprognostic (1.70e-1)" "unprognostic (7.23e-2)" "unprognostic (3.58e-2)" "unprognostic (2.00e-1)" "unprognostic (7.03e-3)" "unprognostic (4.68e-3)" "unprognostic (4.23e-2)" "unprognostic (9.65e-2)" "unprognostic (2.06e-1)" "unprognostic (2.55e-1)" "unprognostic (3.83e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (6.31e-2)" "unprognostic (1.82e-3)" 6.7 6.4 0.9 3.8 0.2 4.1 34.2 0.2 0.2 3.4 0.8 0.7 1.0 0.6 8.6 0.6 0.5 1.2 2.5 0.1 0.6 24.9 1.0 3.4 7.8 3.9 28.3 0.1 0.3 109.9 5.0 32.2 12.6 11.2 0.7 0.0 19.9 24.9 2.1 172.9 2.4 0.3 0.5 7.2 1.5 0.2 4.1 25.0 3.0 1.0 3.8 38.8 10.8 0.2 33.8 8.1 0.0 0.4 0.0 0.0 190.2 0.7 0.0 0.0 0.1 12.4 29.9 0.0 0.1 0.0 0.0 28.9 3.2 0.6 0.1 95.8 10.2 0.2 0.3 0.1 2.1 0.1 0.5 0.0 6.9 0.1 1.8 1.0 15.3 45.8 0.4 0.0 0.1 473.4 54.2 0.5 3.5 6.5 4.5 2.8 2.6 0.8 0.0 194.3 9.8 161.2 0.5 26.8 0.0 34.1 605.2 0.1 0.0 2.4 5.9 1.4 4.3 0.9 0.0 0.0 1.3 0.0 1.7 0.1 0.1 0.0 19.9 0.0 26.9 0.4 36.7 28.8 0.0 0.1 19.9 18.3 0.7 36.1 0.0 0.0 43.6 7.0 0.9 0.2 0.2 0.2 0.1 0.6 3.9 28.3 12.6 0.5 4.1 0.2 14.6 0.0 6.0 0.0 3.4 94.8 69.6 1.6 0.0 0.0 267.1 167.3 1.3 0.0 1.5 178.4 0.0 323.5 49.2 0.0 0.0 0.2 0.2 0.5 0.4 12.6 0.0 2.1 0.0 0.4 746.6 5.3 2.6 0.7 2.5 0.0 6.8 0.6 30.7 0.0 0.0 0.0 0.0 3.5 9.9 0.1 0.0 3.8 8.8 1.0 1.5 0.0 51.5 0.0 0.0 4.1 1.1 0.0 12.2 45.8 0.0 0.6 0.3 0.0 0.0 1.1 2.8 0.0 1.4 1.0 198.9 1134.9 93.4 0.5 0.0 106.1 CELF2 "BRUNOL3, CUGBP2, Etr-3, NAPOR-2" ENSG00000048740 "CUGBP Elav-like family member 2" O95319 10 10798397-11336675 "Predicted intracellular proteins" "mRNA processing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 78.9" "Cell type enhanced" "Detected in many" "Astrocytes: 558.0;Excitatory neurons: 1676.4;Inhibitory neurons: 576.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 200.2;HMC-1: 186.2;REH: 86.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016395, HPA035813" Enhanced Supported "Nucleoplasm,Vesicles,Midbody ring" Yes No "Cluster 5: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 3: HMC-1 - Innate immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Vesicles, Midbody ring" "CAB016395: AB_2086271, HPA035813: AB_2674797" "unprognostic (1.62e-2)" "unprognostic (1.52e-2)" "unprognostic (1.90e-2)" "unprognostic (3.55e-2)" "unprognostic (9.00e-2)" "prognostic favorable (7.61e-4)" "unprognostic (1.57e-1)" "unprognostic (3.77e-2)" "unprognostic (4.20e-2)" "unprognostic (5.22e-2)" "unprognostic (2.60e-3)" "unprognostic (2.83e-2)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (2.31e-2)" "unprognostic (1.45e-1)" 39.6 5.7 33.7 30.7 42.7 78.9 17.7 0.2 42.0 14.2 0.0 16.5 9.2 15.0 5.0 21.4 13.3 17.2 37.5 42.5 7.2 3.0 4.3 28.2 42.4 0.9 13.9 46.8 4.4 3.5 6.5 8.6 0.4 14.1 17.9 35.4 9.6 12.2 17.6 8.6 23.4 23.2 8.6 31.1 10.3 7.6 23.7 60.7 8.5 15.0 29.4 16.2 8.0 21.0 0.1 0.0 47.6 0.0 7.4 2.7 5.3 7.0 0.2 1.1 0.2 0.1 0.0 0.1 5.3 6.1 0.0 0.1 6.8 0.2 0.4 40.4 11.9 200.2 0.7 0.0 1.7 58.0 186.2 3.0 0.3 0.4 0.0 0.7 6.7 70.6 9.3 80.7 59.6 0.0 71.9 42.0 19.3 0.0 0.0 86.7 50.8 18.0 3.4 0.0 7.1 0.5 0.1 0.2 51.1 15.2 0.0 39.0 0.1 8.9 2.5 29.9 0.1 30.7 30.1 9.3 2.9 68.8 21.6 68.0 43.2 90.8 54.8 57.5 69.2 48.1 54.1 60.5 53.4 51.0 56.1 52.7 115.1 73.5 67.8 37.9 60.9 63.5 33.7 42.7 0.2 42.0 42.5 7.2 0.9 13.9 0.4 8.6 23.7 21.0 20.4 160.3 147.3 558.0 165.6 19.9 3.4 5.8 12.5 68.2 18.8 13.7 122.7 5.7 22.4 12.9 102.2 1.1 233.5 11.8 15.6 1.6 135.9 5.3 11.3 34.7 59.3 45.2 1676.4 2.1 0.9 106.0 11.2 17.0 128.5 0.7 13.2 5.1 90.0 134.6 576.9 37.5 24.4 261.4 134.3 110.3 111.6 192.9 115.6 376.6 263.6 90.5 256.4 324.7 21.6 1.5 16.9 89.5 124.3 10.1 2.4 1.0 5.8 99.2 52.6 117.6 33.7 4.1 11.5 5.7 14.5 1.9 232.5 8.5 23.8 2.4 USP6NL "KIAA0019, RN-tre, RNTRE, TRE2NL, USP6NL-IT1" ENSG00000148429 "USP6 N-terminal like" Q92738 10 11453946-11611754 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 145.2;Oligodendrocyte precursor cells: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 4.0;naive B-cell: 3.4" "Lineage enriched" "Detected in single" 4 "B-cells: 4.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039196 Approved NA NA "Cluster 37: B-cells - Transcription" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" "HPA039196: AB_10795031" "unprognostic (1.64e-1)" "unprognostic (2.93e-1)" "unprognostic (6.84e-2)" "unprognostic (3.33e-2)" "unprognostic (1.35e-3)" "prognostic favorable (8.06e-4)" "unprognostic (2.39e-1)" "unprognostic (2.44e-2)" "unprognostic (4.22e-2)" "unprognostic (4.20e-2)" "unprognostic (1.86e-2)" "unprognostic (8.54e-2)" "unprognostic (1.96e-1)" "unprognostic (1.27e-2)" "unprognostic (3.58e-2)" "unprognostic (1.49e-1)" "unprognostic (8.54e-2)" 5.4 6.8 4.8 7.3 5.2 8.6 5.5 6.5 4.3 6.5 6.0 5.8 5.5 5.9 7.7 22.9 8.9 5.7 4.5 4.8 6.0 5.6 16.3 6.5 14.9 7.5 6.3 7.5 5.1 5.4 4.6 6.8 7.5 4.7 7.4 13.0 6.9 5.2 1.7 8.1 5.8 5.7 6.9 13.6 7.3 24.6 6.4 7.4 5.2 2.2 18.5 5.6 9.7 7.5 26.9 11.6 24.5 10.7 6.1 7.4 11.9 7.3 6.3 8.2 11.3 14.3 24.8 33.5 7.0 6.3 6.7 14.6 11.2 7.9 12.0 0.1 8.7 14.3 6.6 25.5 7.3 4.2 2.0 4.2 11.6 9.5 5.6 9.5 19.8 11.5 22.6 0.8 7.0 18.6 11.6 3.1 12.5 25.0 6.0 22.2 6.4 4.3 11.6 7.9 7.8 13.7 7.9 24.0 25.3 10.2 17.8 4.4 10.8 4.2 15.4 10.9 7.1 0.0 0.9 22.0 7.1 5.1 11.5 0.8 0.5 0.8 0.0 0.9 0.1 4.0 0.1 0.1 0.7 3.4 0.1 0.1 0.3 0.5 0.6 0.6 0.0 0.3 4.8 5.2 6.5 4.3 4.8 6.0 7.5 6.3 7.5 6.9 6.4 7.5 12.0 3.2 17.5 23.2 37.7 6.8 20.6 7.8 13.6 6.0 9.6 6.6 7.8 2.8 12.4 1.8 29.2 7.6 0.5 8.2 7.9 10.8 17.4 32.5 9.7 11.1 13.8 14.3 16.0 10.6 7.5 6.8 20.4 33.2 0.0 11.8 5.7 14.1 8.6 6.7 24.3 14.0 8.2 16.3 8.7 15.4 4.7 12.7 12.4 145.2 7.5 11.2 3.1 68.3 29.4 16.1 6.8 4.9 20.0 20.8 4.2 9.0 15.6 14.6 0.0 5.2 9.1 21.5 7.2 20.1 9.9 7.3 3.9 7.7 7.1 48.3 ECHDC3 FLJ20909 ENSG00000134463 "Enoyl-CoA hydratase domain containing 3" Q96DC8 10 11742366-11764070 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 161.6;skeletal muscle: 128.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 81.2;Distal tubular cells: 144.8;Hepatocytes: 152.0;Proximal tubular cells: 209.9" "Cancer enhanced" "Detected in all" "liver cancer: 35.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "eosinophil: 15.4" "Lineage enriched" "Detected in many" 9 "granulocytes: 15.4" "Cell line enhanced" "Detected in many" "A-431: 52.9;BEWO: 28.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038306 Enhanced NA NA 120000 "Cluster 52: Eosinophils - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 28: BEWO - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA038306: AB_10672586" "unprognostic (8.74e-2)" "unprognostic (1.69e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.92e-1)" "unprognostic (2.37e-2)" "unprognostic (1.09e-1)" "unprognostic (1.64e-1)" "unprognostic (5.07e-1)" "unprognostic (2.23e-1)" "unprognostic (2.04e-2)" "unprognostic (3.53e-1)" "prognostic favorable (3.43e-4)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (3.91e-4)" 71.7 29.3 2.6 3.2 2.4 7.0 52.8 2.5 2.5 15.9 17.5 6.7 1.8 11.0 2.2 22.9 11.1 1.8 67.0 2.6 4.3 63.0 161.6 17.5 3.7 3.0 2.7 10.5 29.7 1.8 10.8 7.9 2.9 13.7 3.6 2.0 28.6 13.7 128.4 21.7 6.0 4.4 2.9 15.7 26.6 14.3 3.8 2.8 17.9 60.1 5.5 9.3 17.8 3.3 52.9 7.6 0.1 0.0 0.0 0.0 28.7 6.3 0.0 4.6 4.0 19.1 0.4 0.0 5.8 14.1 1.3 12.5 11.9 1.9 2.0 0.1 0.5 0.0 7.6 0.0 20.5 0.0 7.4 14.1 11.8 4.8 0.0 0.4 9.3 0.0 19.6 0.0 1.4 7.3 0.0 0.2 13.3 0.1 0.0 16.3 0.0 0.0 3.6 0.0 5.5 8.4 0.0 13.1 0.0 16.5 20.5 2.6 2.8 0.0 5.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 3.6 2.9 1.7 15.4 0.0 0.6 0.0 0.2 0.1 0.5 1.7 1.7 0.3 0.0 3.6 0.5 0.7 0.6 0.0 0.3 2.6 2.4 2.5 2.5 2.6 4.3 3.0 2.7 2.9 2.9 3.8 3.3 2.7 19.2 11.8 0.0 3.6 4.5 13.8 2.7 0.0 0.9 16.7 27.2 42.2 17.2 6.4 16.5 2.1 81.2 0.1 1.3 144.8 33.6 4.0 2.3 5.9 3.5 0.0 1.7 0.3 29.8 32.9 6.0 16.3 4.6 0.0 49.5 4.6 152.0 13.1 0.0 0.2 0.6 6.1 14.1 2.2 6.3 2.8 10.6 8.8 1.0 6.8 13.1 0.0 0.0 0.5 13.6 1.2 3.4 6.4 26.1 0.9 209.9 0.4 2.7 19.7 12.0 12.0 22.1 9.6 0.4 5.7 28.9 1.5 4.9 1.9 6.8 PROSER2 "C10orf47, MGC35403" ENSG00000148426 "Proline and serine rich 2" Q86WR7 10 11823339-11872277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 41.0" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 28.4;Glandular and luminal cells: 28.4;Hepatocytes: 31.2;Prostatic glandular cells: 34.6;Urothelial cells: 69.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 86.5;CAPAN-2: 99.5;HBEC3-KT: 64.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 14.4" HPA041337 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA 220000 "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane, Cytosol" "HPA041337: AB_10794663" "unprognostic (2.36e-3)" "unprognostic (1.39e-1)" "unprognostic (3.55e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (7.60e-3)" "unprognostic (4.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (1.25e-3)" "unprognostic (1.61e-1)" "unprognostic (1.26e-2)" "unprognostic (4.04e-2)" "unprognostic (3.01e-1)" "unprognostic (5.06e-2)" "unprognostic (8.69e-2)" 4.5 1.6 1.9 1.0 2.0 10.4 4.1 1.4 1.6 3.6 4.8 3.1 1.2 3.4 0.5 9.9 3.8 1.7 1.8 1.7 1.8 14.0 41.0 9.8 0.3 1.9 2.3 2.4 7.5 0.5 1.9 7.2 2.0 9.1 1.8 0.1 6.9 2.2 2.0 5.1 1.7 1.0 1.7 7.3 6.6 6.1 3.1 1.9 6.7 0.4 2.8 4.0 6.0 1.3 86.5 12.1 0.7 0.3 2.5 3.1 4.9 3.8 1.8 3.0 1.5 28.1 99.5 0.0 15.1 0.3 1.3 22.1 8.4 64.2 1.5 0.1 20.3 9.8 4.8 18.4 14.2 0.0 5.9 3.6 13.6 17.8 19.9 0.3 9.2 1.6 15.0 0.1 4.3 11.7 0.0 3.2 5.3 11.3 6.9 13.9 11.3 0.0 6.6 4.2 0.1 1.1 6.5 24.9 11.1 4.1 13.1 5.3 6.8 0.1 19.7 33.2 0.4 0.0 0.2 0.1 0.1 3.4 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.9 2.0 1.4 1.6 1.7 1.8 1.9 2.3 2.0 1.7 3.1 1.3 3.0 9.6 5.9 1.3 0.0 5.7 28.4 8.2 8.6 0.0 5.5 5.2 1.1 18.6 6.5 5.5 0.0 5.5 0.2 3.2 5.9 11.6 3.0 18.6 2.8 3.7 1.8 2.5 0.7 3.8 18.3 3.6 6.1 28.4 0.0 1.9 1.1 31.2 0.8 0.0 0.7 1.3 2.0 0.3 0.7 3.0 1.8 3.7 3.6 6.5 0.1 0.1 0.0 0.5 0.4 20.0 1.5 4.5 0.0 34.6 0.2 0.8 6.8 0.1 0.0 0.6 1.3 3.7 5.6 4.6 4.7 0.7 0.5 0.7 2.6 69.4 UPF2 "DKFZP434D222, KIAA1408, RENT2, smg-3" ENSG00000151461 "UPF2 regulator of nonsense mediated mRNA decay" Q9HAU5 10 11920022-12043170 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067008 Supported "Cytosol,Cytoplasmic bodies" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 36: HEL - Hemostasis" "Cluster 41: Macrophages - Immune response" Cytosol "Cytoplasmic bodies" "HPA067008: AB_2685762" "unprognostic (1.99e-2)" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.61e-2)" "unprognostic (2.48e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (5.48e-2)" "unprognostic (5.68e-2)" "unprognostic (9.27e-2)" "unprognostic (1.68e-2)" "unprognostic (3.01e-2)" "unprognostic (4.65e-3)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-1)" "unprognostic (8.48e-2)" 12.8 8.1 12.4 14.1 13.7 21.0 12.7 15.8 15.1 12.0 12.5 16.2 10.0 14.9 10.7 10.9 11.0 8.9 10.6 12.5 13.6 10.9 16.7 10.4 18.9 11.8 12.2 16.2 13.7 14.8 7.9 14.1 11.6 13.5 12.9 14.8 11.1 12.2 22.0 12.9 11.4 12.1 11.9 14.8 11.3 19.5 12.7 21.5 12.8 21.4 17.7 13.4 11.8 13.2 35.9 22.3 18.8 23.5 14.0 17.9 21.2 27.5 12.7 19.2 23.0 21.2 28.6 51.4 9.1 23.0 15.8 29.4 27.2 24.9 27.4 32.5 15.7 61.6 18.2 19.4 15.8 28.1 39.8 13.5 19.0 24.3 16.4 18.2 23.8 27.1 37.1 25.7 22.2 17.7 34.8 16.4 18.0 27.1 11.8 30.4 22.5 25.3 18.2 14.2 12.1 13.0 21.6 23.1 23.8 18.7 27.9 37.1 25.5 15.0 31.4 31.1 21.1 23.4 19.8 41.4 24.0 26.9 12.1 13.7 4.2 10.2 4.3 4.2 4.2 10.7 4.9 4.5 3.0 10.6 5.4 4.5 29.5 5.4 2.9 11.5 3.8 1.8 12.4 13.7 15.8 15.1 12.5 13.6 11.8 12.2 11.6 11.9 12.7 13.2 74.8 25.6 34.6 32.0 133.3 71.9 35.0 46.9 64.3 66.3 53.8 38.6 69.6 52.9 39.4 49.7 102.2 47.0 79.6 97.7 39.2 47.7 70.1 99.3 86.2 62.6 66.3 108.4 36.1 44.8 51.7 48.2 58.1 88.7 58.9 71.8 64.2 89.5 41.1 52.2 31.6 90.2 48.8 71.4 125.3 116.9 86.3 56.0 53.4 31.9 89.0 45.5 98.9 37.2 45.4 53.7 78.9 59.0 121.2 38.7 70.6 34.1 41.5 97.2 98.6 54.3 60.1 182.9 149.8 47.3 81.8 56.5 73.6 35.9 65.5 36.3 DHTKD1 "CMT2Q, DKFZP762M115, KIAA1630, MGC3090" ENSG00000181192 "Dehydrogenase E1 and transketolase domain containing 1" Q96HY7 10 12068954-12123221 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Oxidoreductase "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 129.5" "Cell type enhanced" "Detected in all" "Hepatocytes: 227.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 102.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037949, HPA037950, HPA066098" Enhanced Supported Mitochondria NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617" "unprognostic (3.76e-2)" "unprognostic (8.08e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (3.04e-3)" "unprognostic (3.83e-3)" "unprognostic (5.01e-2)" "unprognostic (5.34e-2)" "unprognostic (3.02e-3)" "unprognostic (3.46e-1)" "unprognostic (1.56e-1)" "prognostic favorable (3.43e-4)" "unprognostic (2.12e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-2)" "unprognostic (2.88e-3)" 10.7 8.4 8.1 6.8 10.4 3.8 8.4 12.6 8.5 8.8 11.9 10.1 7.6 6.2 6.8 7.5 6.1 5.3 13.2 7.6 8.5 42.7 129.5 5.4 8.5 9.5 8.6 10.0 18.0 12.7 5.6 7.7 9.5 12.9 10.8 7.5 13.1 5.7 18.7 5.6 6.9 5.7 8.8 7.8 10.9 4.7 9.1 10.5 11.6 23.1 9.7 6.3 6.1 11.4 27.0 20.4 29.8 23.8 18.2 10.8 35.9 13.3 8.6 23.4 20.6 13.1 15.7 19.3 4.3 8.4 10.8 37.4 31.6 10.4 26.6 10.9 14.2 10.6 7.7 10.1 17.8 4.2 3.8 13.3 7.9 13.7 5.5 9.2 13.0 23.1 16.7 15.1 6.3 52.3 14.4 7.7 16.7 24.9 4.7 24.3 9.7 16.5 15.2 6.4 7.7 34.9 26.3 46.3 15.4 31.7 102.2 15.2 5.8 7.5 5.4 15.8 9.9 13.4 10.3 12.6 9.7 7.4 12.8 23.8 6.8 15.4 4.2 9.2 4.5 13.0 3.2 2.7 11.9 9.9 3.1 4.1 19.4 14.3 17.0 17.3 5.7 4.9 8.1 10.4 12.6 8.5 7.6 8.5 9.5 8.6 9.5 8.8 9.1 11.4 6.9 12.8 38.8 21.5 21.3 5.2 6.7 5.3 10.2 13.3 13.7 8.3 31.1 28.6 7.8 16.5 10.4 35.4 23.2 14.6 19.6 10.9 3.5 8.8 17.3 8.1 11.3 21.9 12.8 11.1 25.1 8.1 21.9 20.8 8.8 45.2 11.0 227.4 10.3 26.9 17.3 18.0 4.1 15.3 10.1 4.2 12.5 13.5 5.4 17.8 13.4 10.4 8.2 15.6 20.5 12.4 9.6 12.0 22.6 9.6 9.4 62.5 5.2 19.2 13.1 10.6 7.4 6.7 3.8 16.2 6.0 13.5 8.4 21.8 16.6 7.8 SEC61A2 FLJ10578 ENSG00000065665 "SEC61 translocon subunit alpha 2" Q9H9S3 10 12129637-12169961 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 41.2;Horizontal cells: 35.3;Inhibitory neurons: 42.4;Late spermatids: 31.1;Oligodendrocytes: 44.2;Spermatocytes: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (6.83e-2)" "unprognostic (2.76e-2)" "unprognostic (1.48e-2)" "unprognostic (1.01e-3)" "unprognostic (4.18e-2)" "unprognostic (1.84e-2)" "unprognostic (1.28e-3)" "unprognostic (1.55e-2)" "unprognostic (2.97e-1)" "unprognostic (3.95e-2)" "prognostic favorable (1.08e-5)" "unprognostic (3.14e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (6.41e-2)" "unprognostic (4.95e-2)" "unprognostic (6.18e-2)" "prognostic favorable (8.75e-4)" 4.2 4.8 24.0 4.9 23.2 15.1 4.5 18.3 27.6 8.2 8.0 7.0 3.4 6.9 7.9 4.1 6.6 4.5 9.9 24.1 25.9 5.8 12.6 5.2 5.6 21.1 24.1 7.1 4.2 3.8 13.1 4.0 24.4 7.5 5.0 18.9 4.5 5.1 7.8 8.2 5.9 5.0 18.8 7.2 4.9 15.2 22.5 6.2 5.9 7.1 5.4 6.2 6.5 28.9 8.4 13.2 19.2 12.0 7.3 5.0 6.3 8.6 4.6 15.4 16.1 13.3 5.7 3.4 4.4 12.3 20.1 7.2 24.9 10.4 13.2 9.7 10.2 4.0 19.7 9.7 7.6 2.5 9.1 7.2 6.4 27.2 4.5 7.2 4.1 18.7 4.7 9.1 12.9 7.2 8.1 4.2 18.4 6.9 4.4 8.7 7.2 2.0 9.8 8.8 8.6 13.2 11.7 6.3 6.1 14.3 12.3 4.1 7.9 13.5 15.3 17.8 5.9 8.4 12.4 5.2 10.6 3.2 4.1 0.0 0.1 0.1 0.8 0.0 0.7 0.2 0.5 0.5 0.3 0.5 1.0 0.7 1.7 0.9 0.2 2.5 0.7 0.1 24.0 23.2 18.3 27.6 24.1 25.9 21.1 24.1 24.4 18.8 22.5 28.9 2.4 3.2 2.8 19.2 6.3 1.8 2.6 2.5 2.2 14.6 2.8 1.9 7.3 1.5 3.3 9.2 8.4 3.4 7.5 3.7 0.0 2.8 19.8 6.2 5.8 2.6 1.2 3.6 41.2 2.3 2.3 4.9 3.1 4.2 2.5 5.6 3.9 14.1 2.9 35.3 42.4 2.2 6.1 1.9 2.3 31.1 6.8 2.6 5.4 15.0 1.4 5.8 2.1 26.2 44.2 2.0 2.8 4.5 5.0 3.0 1.3 1.4 4.2 15.9 0.0 2.7 4.8 35.2 14.3 1.7 1.4 3.4 4.9 2.8 1.0 2.0 NUDT5 "hYSAH1, YSA1H" ENSG00000165609 "Nudix hydrolase 5" Q9UKK9 10 12165330-12196144 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019827 Approved Approved Nucleoplasm,Vesicles,Centrosome NA NA 1500000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Vesicles "Nucleoplasm, Centrosome" "HPA019827: AB_1854704" "unprognostic (2.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (3.77e-3)" "unprognostic (4.91e-2)" "unprognostic (2.54e-2)" "unprognostic (4.60e-2)" "unprognostic (1.32e-1)" "unprognostic (6.39e-3)" "unprognostic (2.06e-1)" "unprognostic (9.97e-2)" "prognostic unfavorable (7.14e-12)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (3.68e-2)" 35.1 32.4 23.0 30.6 26.4 24.1 26.7 27.5 30.5 24.6 29.5 32.0 27.5 14.3 23.7 40.7 24.6 18.4 14.9 23.4 26.0 36.3 88.8 26.0 39.3 27.3 24.9 18.0 25.9 33.1 35.5 31.1 27.4 21.0 36.0 27.4 25.1 14.0 6.2 33.2 25.4 17.6 25.0 34.2 22.6 13.1 25.4 53.5 27.8 7.6 47.4 28.9 27.8 31.8 136.4 98.0 114.6 107.1 107.5 105.6 100.8 96.9 61.5 111.9 119.1 142.5 125.9 134.2 82.4 79.2 70.0 133.1 162.0 150.6 102.1 110.8 160.8 111.9 114.3 209.3 112.0 77.1 75.2 111.7 88.4 122.3 61.7 86.3 144.9 209.4 153.5 88.9 103.2 123.8 143.5 87.0 100.4 215.0 60.1 128.0 42.4 157.2 106.0 46.1 56.6 82.3 117.4 90.8 142.2 132.0 155.9 77.9 91.6 47.0 90.6 134.3 121.9 74.3 141.6 179.3 99.7 97.3 36.0 29.6 60.8 115.2 69.9 65.7 80.4 72.7 73.9 82.6 87.6 64.6 50.4 68.4 163.8 57.4 52.2 149.2 123.4 71.6 23.0 26.4 27.5 30.5 23.4 26.0 27.3 24.9 27.4 25.0 25.4 31.8 42.1 25.6 55.1 23.2 43.8 43.0 57.8 121.2 28.5 21.1 28.6 30.7 4.5 32.9 72.3 23.9 16.7 82.6 49.8 35.0 74.3 82.2 35.3 61.1 44.4 42.6 38.3 43.5 34.6 82.9 150.6 40.3 33.1 31.9 31.7 41.4 41.7 131.8 128.7 21.9 38.2 41.2 79.3 41.8 32.2 11.7 39.4 39.7 30.2 12.2 85.0 37.4 62.8 34.2 41.2 73.8 35.2 29.0 66.1 33.7 52.6 130.6 103.9 25.5 32.9 21.2 40.1 20.2 33.6 52.4 60.5 58.1 49.7 54.4 57.4 46.9 CDC123 "C10orf7, D123" ENSG00000151465 "Cell division cycle 123" O75794 10 12195965-12250589 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037830, HPA057540" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Golgi apparatus" Cytosol "HPA037830: AB_10671368, HPA057540: AB_2732614" "unprognostic (5.35e-3)" "unprognostic (9.06e-2)" "unprognostic (2.42e-1)" "unprognostic (5.09e-3)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "prognostic unfavorable (3.16e-7)" "unprognostic (2.63e-1)" "unprognostic (2.22e-1)" "unprognostic (3.20e-2)" "unprognostic (2.74e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (2.42e-6)" "unprognostic (5.35e-2)" "unprognostic (1.40e-1)" "unprognostic (3.88e-2)" "unprognostic (6.19e-2)" 44.9 40.0 38.1 53.8 44.3 73.5 45.9 40.6 46.1 43.5 39.1 54.1 37.1 39.0 46.9 50.1 42.3 34.0 61.0 41.7 41.5 42.6 55.6 35.8 69.1 40.3 38.4 31.4 29.4 42.3 33.0 50.8 40.5 35.4 58.3 29.7 31.5 39.3 49.7 44.3 39.1 53.4 41.3 45.3 35.4 35.7 40.1 65.2 41.5 52.5 81.1 63.6 34.7 43.7 155.4 187.4 148.3 157.1 125.4 136.3 117.7 137.0 94.2 194.8 205.5 274.0 186.5 259.7 123.5 153.6 116.1 157.7 237.0 223.3 172.0 176.8 206.6 199.3 142.8 266.6 162.1 151.6 159.0 131.3 118.9 214.0 126.5 98.0 206.3 320.6 224.2 114.5 178.6 135.0 208.3 133.8 221.4 223.1 76.3 195.7 111.9 234.0 173.2 86.3 72.3 140.8 139.6 165.4 152.6 120.4 180.7 179.2 200.9 107.7 127.6 167.9 166.6 112.5 233.5 320.7 135.4 155.3 69.7 133.8 99.2 242.2 103.6 117.0 108.1 158.6 114.8 115.0 139.0 170.5 93.5 99.9 233.4 121.1 129.4 116.0 143.5 167.3 38.1 44.3 40.6 46.1 41.7 41.5 40.3 38.4 40.5 41.3 40.1 43.7 48.6 32.1 35.9 18.3 51.5 54.2 49.2 162.1 39.9 28.5 28.0 32.3 56.4 24.3 75.8 35.0 6.2 120.8 55.3 25.1 86.1 91.1 7.9 26.8 39.5 49.7 20.9 36.8 33.2 82.6 138.2 46.3 26.5 26.1 49.4 36.6 34.2 37.6 101.3 26.9 27.9 31.9 105.8 25.9 34.0 10.1 41.7 37.2 46.2 21.5 79.3 43.3 45.3 19.6 23.5 84.3 34.3 45.9 44.2 46.5 30.7 73.0 62.5 29.9 39.5 32.3 59.8 50.2 41.5 46.5 74.0 77.6 51.3 72.4 47.0 50.7 CAMK1D CKLiK ENSG00000183049 "Calcium/calmodulin dependent protein kinase ID" Q8IU85 10 12349547-12835545 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Inflammatory response, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 57.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 167.4;Cone photoreceptor cells: 392.0;Excitatory neurons: 416.9;Inhibitory neurons: 233.6;Microglial cells: 168.6;Rod photoreceptor cells: 214.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 14.9;basal ganglia: 16.7;cerebral cortex: 35.6;hippocampal formation: 29.6;white matter: 14.5" "Immune cell enhanced" "Detected in all" "eosinophil: 75.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 75.1" "Cell line enhanced" "Detected in many" "HDLM-2: 113.8;U-266/70: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007266 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 58: Brain - Synaptic function" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Cytosol" "HPA007266: AB_1078389" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-3)" "unprognostic (4.23e-1)" "unprognostic (2.32e-2)" "unprognostic (6.90e-3)" "prognostic favorable (1.67e-4)" "unprognostic (1.06e-1)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (7.40e-2)" "unprognostic (1.35e-2)" "unprognostic (6.55e-2)" "unprognostic (1.65e-1)" "unprognostic (4.66e-2)" "unprognostic (2.56e-3)" 6.6 4.8 14.9 8.4 16.7 6.8 4.3 4.5 35.6 7.4 1.1 11.4 3.5 3.2 2.8 8.6 3.8 5.9 14.6 29.6 0.6 2.6 8.2 7.5 9.6 3.7 0.1 2.7 16.9 0.9 2.8 2.9 0.0 4.7 12.4 57.9 4.3 7.0 1.5 18.5 6.3 5.2 0.7 10.9 3.1 6.1 1.3 23.5 13.0 2.3 12.6 7.1 9.2 14.5 0.3 6.1 6.8 0.3 4.0 1.4 0.4 0.9 2.2 1.4 2.0 8.6 4.8 3.4 0.7 0.6 3.4 3.2 8.4 1.2 1.1 113.8 4.1 13.6 19.4 0.4 1.1 0.3 11.8 0.2 5.2 2.7 0.2 14.6 0.8 7.2 0.4 0.4 1.7 7.2 26.9 5.6 4.6 0.0 2.7 20.2 3.7 6.4 0.2 6.5 10.4 4.8 13.2 4.9 0.0 0.9 3.4 3.3 0.3 5.6 8.1 18.1 4.0 50.3 16.8 11.3 8.2 8.8 0.1 19.5 4.9 75.1 3.8 7.1 3.9 12.1 3.3 4.8 9.3 14.7 3.8 2.6 29.8 3.1 8.7 2.8 1.1 3.4 14.9 16.7 4.5 35.6 29.6 0.6 3.7 0.1 0.0 0.7 1.3 14.5 12.5 3.2 25.2 130.6 68.0 22.9 8.6 26.3 13.1 167.4 3.4 1.7 17.1 12.8 36.6 1.8 392.0 0.2 22.1 36.7 0.0 9.0 20.4 3.6 4.0 13.7 16.1 7.6 416.9 22.0 0.9 30.4 2.0 2.0 23.4 2.0 15.0 13.7 16.0 45.4 233.6 27.4 10.2 50.1 61.2 9.2 23.6 36.2 3.6 168.6 34.8 24.2 30.9 111.6 7.2 10.5 42.8 60.9 23.9 4.9 2.0 1.2 27.5 214.2 26.3 7.2 10.2 4.8 11.0 24.6 41.2 0.3 21.6 8.7 33.2 20.9 CCDC3 DKFZp761F241 ENSG00000151468 "Coiled-coil domain containing 3" Q9BQI4 10 12896625-13099652 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 132.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 50.1;Excitatory neurons: 100.2;Inhibitory neurons: 41.3;Peritubular cells: 60.5;Smooth muscle cells: 119.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 10.4;HAP1: 19.1;HDLM-2: 32.4;hTERT-RPE1: 14.8;U-2 OS: 20.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 20.8" HPA062425 Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 44: HDLM-2 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm Cytosol "HPA062425: AB_2684759" "unprognostic (2.26e-1)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (5.08e-2)" "unprognostic (3.11e-2)" "unprognostic (2.99e-2)" "unprognostic (5.56e-3)" "unprognostic (5.41e-2)" "unprognostic (4.25e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.54e-2)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.88e-2)" 91.8 11.0 32.9 5.9 35.2 0.1 37.2 17.9 40.2 48.1 17.8 10.1 6.6 25.0 41.3 60.4 56.7 70.7 21.9 37.1 20.1 19.0 20.6 21.0 12.4 18.6 19.1 86.2 6.5 4.9 10.2 22.2 19.6 35.2 7.4 1.6 7.1 22.0 30.7 132.2 14.3 24.2 19.8 24.7 13.1 11.6 21.7 42.0 20.0 13.3 4.2 23.2 27.4 30.5 0.0 0.2 1.7 9.4 0.0 0.0 0.1 0.0 0.0 0.7 0.0 2.5 0.0 0.0 0.7 0.0 10.4 1.9 19.1 3.6 0.6 32.4 8.1 0.0 0.2 0.0 0.7 0.0 0.0 2.3 2.3 0.4 0.0 14.8 0.9 0.8 0.0 0.2 1.0 0.2 0.0 5.4 1.5 0.0 0.1 0.0 4.1 0.3 0.0 0.0 3.6 1.6 7.0 1.0 0.0 4.4 0.0 0.0 0.0 0.0 20.0 1.2 0.3 0.0 0.0 0.0 0.1 0.0 6.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 32.9 35.2 17.9 40.2 37.1 20.1 18.6 19.1 19.6 19.8 21.7 30.5 12.4 0.0 0.0 10.1 0.1 50.1 6.4 26.3 13.6 1.2 0.9 4.7 7.9 1.5 2.1 0.0 0.0 0.3 1.3 0.1 1.9 0.0 0.2 0.1 0.7 27.2 0.0 0.0 100.2 0.0 0.2 16.0 0.5 0.4 0.0 16.4 8.2 0.2 0.3 0.0 41.3 0.1 0.0 0.0 6.4 1.5 22.4 0.6 14.2 3.7 0.0 0.3 0.0 22.6 23.2 0.1 2.5 60.5 0.0 3.0 0.3 0.4 1.1 2.1 32.9 7.9 119.4 0.0 5.7 2.1 37.2 0.3 1.0 6.0 0.3 1.3 OPTN "FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP" ENSG00000123240 Optineurin Q96CV9 10 13099449-13138308 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, Host-virus interaction, Immunity, Innate immunity" "Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "skeletal muscle: 879.4;tongue: 394.5" "Cell type enhanced" "Detected in all" "Late spermatids: 933.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003279, HPA003360, CAB019303" Approved Enhanced Cytosol NA NA 370000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528" "unprognostic (2.84e-2)" "unprognostic (3.37e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-3)" "unprognostic (5.58e-2)" "unprognostic (3.74e-2)" "unprognostic (5.15e-3)" "unprognostic (3.14e-2)" "unprognostic (2.68e-2)" "unprognostic (2.16e-1)" "unprognostic (1.40e-2)" "unprognostic (6.14e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (7.62e-2)" "unprognostic (5.67e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" 92.7 90.4 45.7 35.8 53.5 50.1 64.0 45.9 55.9 52.3 36.8 55.4 63.2 39.7 21.9 61.8 37.7 41.6 105.7 54.9 49.2 72.3 73.8 58.9 45.7 48.0 53.9 92.1 35.4 33.1 33.8 57.5 52.9 34.1 57.2 48.8 46.3 41.4 879.4 77.9 69.6 43.4 44.3 57.3 56.1 72.8 45.4 30.1 27.1 394.5 37.6 43.8 56.3 49.0 83.3 23.1 12.8 17.8 171.4 175.6 15.2 97.6 110.7 72.1 119.0 41.1 108.1 0.7 37.6 134.3 113.2 75.6 17.3 93.5 54.8 192.9 9.2 17.2 32.1 22.0 175.4 0.6 59.5 94.6 72.6 69.2 71.8 177.9 62.4 23.8 21.5 123.7 98.7 17.6 8.3 2.3 5.2 22.4 10.3 1.4 25.5 8.5 87.9 57.6 2.8 13.6 84.9 25.0 64.3 49.9 54.6 11.4 171.6 58.8 28.9 81.0 27.5 63.3 23.5 0.6 88.3 14.3 11.4 47.9 2.5 0.3 56.1 1.5 43.3 18.0 71.2 65.8 0.5 11.7 28.0 34.5 1.7 51.2 3.8 5.2 109.6 30.2 45.7 53.5 45.9 55.9 54.9 49.2 48.0 53.9 52.9 44.3 45.4 49.0 68.2 67.3 29.4 18.6 25.9 74.4 46.6 104.5 67.2 38.7 30.5 32.9 237.7 68.6 81.3 31.3 18.8 112.8 89.8 199.8 33.2 135.5 281.9 36.0 38.6 82.4 42.6 126.5 48.9 114.0 39.8 91.6 88.7 37.4 70.8 92.8 47.8 30.9 31.6 90.9 26.6 106.4 65.1 15.1 26.0 933.6 95.7 14.5 90.7 25.3 36.6 36.4 119.4 13.6 28.1 166.3 186.9 103.4 86.3 92.3 209.9 162.4 73.7 103.4 111.7 63.1 106.6 102.0 13.7 58.1 77.9 75.4 107.5 166.3 44.1 75.0 MCM10 "CNA43, DNA43, PRO2249" ENSG00000065328 "Minichromosome maintenance 10 replication initiation factor" Q7L590 10 13161558-13211110 "Predicted intracellular proteins" "DNA damage, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 9.2;lymphoid tissue: 8.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 11.8;Erythroid cells: 23.5;Extravillous trophoblasts: 20.9;Plasma cells: 15.3;Spermatocytes: 15.8;Spermatogonia: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045899, HPA071952" Approved Supported Nucleoplasm,Nucleoli Yes Yes "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli" "HPA045899: AB_10960529, HPA071952: AB_2686477" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-3)" "unprognostic (1.41e-1)" "unprognostic (6.58e-3)" "unprognostic (1.78e-8)" "unprognostic (2.42e-3)" "unprognostic (3.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.78e-4)" "unprognostic (7.81e-2)" "unprognostic (0.00e+0)" "unprognostic (8.87e-2)" "unprognostic (1.29e-1)" "unprognostic (9.73e-2)" "unprognostic (1.05e-1)" 1.2 0.1 0.0 3.3 0.1 9.2 0.8 0.1 0.2 0.4 0.1 1.7 1.5 0.4 0.1 1.9 0.2 0.2 0.1 0.0 0.0 0.1 0.7 0.3 4.8 0.0 0.1 0.2 0.1 0.2 0.1 2.1 0.1 0.1 2.2 0.1 0.3 0.0 0.5 1.1 1.2 0.8 0.0 1.0 0.8 1.5 0.2 8.1 0.3 0.1 4.5 0.6 0.6 0.1 38.0 42.0 48.6 36.9 1.6 2.9 21.2 38.7 5.9 42.7 44.0 41.3 26.4 56.7 17.1 9.9 15.7 43.3 69.0 22.8 39.2 29.7 32.9 70.9 17.6 27.7 0.0 36.6 30.8 0.6 0.8 43.3 4.0 3.5 14.0 45.0 85.2 37.6 23.4 34.0 87.7 15.7 28.9 36.3 10.3 68.3 43.0 34.6 9.8 13.7 9.7 36.6 31.3 22.0 5.9 25.2 27.7 24.9 8.6 27.0 50.3 41.0 42.4 11.7 49.0 74.3 17.2 39.6 21.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.9 0.3 0.1 0.1 0.7 0.4 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 1.7 0.0 0.0 0.0 1.8 1.7 0.4 0.8 0.0 0.0 0.8 0.5 2.4 0.0 0.8 0.0 0.0 11.8 0.8 2.4 0.0 0.4 1.0 0.3 1.2 1.4 0.0 23.5 0.4 0.2 20.9 1.8 1.1 1.0 0.0 7.2 0.0 0.2 5.3 0.0 0.4 1.2 2.0 0.6 0.4 1.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.4 15.3 0.2 0.2 0.0 0.0 0.0 0.0 0.4 6.4 15.8 12.9 3.6 0.4 3.4 1.2 0.8 3.1 0.4 UCMA "C10orf49, GRP" ENSG00000165623 "Upper zone of growth plate and cartilage matrix associated" Q8WVF2 10 13221766-13234374 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.2;ovary: 1.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Group enriched" "Detected in some" 6 "amygdala: 1.2;basal ganglia: 2.2;cerebral cortex: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046718 Uncertain "Secreted to extracellular matrix" NA NA 20000 "Cluster 10: Brain - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "HPA046718: AB_2679771" "unprognostic (4.25e-1)" 0.0 0.0 1.2 0.0 2.2 0.0 0.0 0.2 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.2 1.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.2 0.2 1.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 PHYH "PAHX, PHYH1, RD" ENSG00000107537 "Phytanoyl-CoA 2-hydroxylase" O14832 10 13277796-13302412 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 667.8;skeletal muscle: 483.6;tongue: 412.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 258.6;Proximal tubular cells: 414.6" "Cancer enhanced" "Detected in all" "liver cancer: 78.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007598, HPA011796" Enhanced NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA007598: AB_1855334, HPA011796: AB_1855335" "unprognostic (5.78e-2)" "unprognostic (3.83e-1)" "unprognostic (6.98e-2)" "unprognostic (3.62e-2)" "unprognostic (5.52e-2)" "unprognostic (1.61e-3)" "unprognostic (1.16e-1)" "unprognostic (1.95e-2)" "unprognostic (7.09e-2)" "unprognostic (6.15e-2)" "unprognostic (1.59e-1)" "unprognostic (3.24e-1)" "prognostic favorable (7.28e-12)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (1.07e-2)" "unprognostic (2.19e-1)" 57.9 66.5 22.9 9.5 23.7 8.2 32.2 23.5 28.3 28.8 31.7 46.5 58.7 22.1 16.7 22.9 16.7 28.2 126.5 21.7 24.1 191.4 667.8 17.3 7.5 21.6 24.4 36.8 48.2 56.7 20.9 19.3 22.8 22.5 37.2 28.2 33.7 25.4 483.6 17.5 55.8 23.2 22.7 12.8 44.2 15.1 26.0 5.6 56.0 412.7 5.4 27.0 14.8 23.6 17.2 35.2 15.6 22.5 110.7 69.9 12.4 17.2 23.9 19.4 19.1 9.1 30.3 0.9 12.9 29.0 47.0 7.8 20.5 20.2 11.8 41.4 10.7 14.9 9.3 36.6 54.8 2.5 26.8 50.3 28.9 21.0 8.4 22.7 18.7 16.8 8.4 32.2 45.5 16.3 9.2 12.1 14.4 49.4 12.6 15.7 24.1 5.8 40.6 21.9 5.3 16.8 64.8 1.4 32.9 12.5 64.8 44.2 6.4 29.5 10.6 36.4 11.8 36.6 26.3 3.3 38.3 18.9 11.6 16.3 18.7 8.2 8.0 14.2 17.6 11.0 9.9 10.4 15.8 5.6 12.5 12.7 0.8 4.4 11.2 14.4 10.5 12.3 22.9 23.7 23.5 28.3 21.7 24.1 21.6 24.4 22.8 22.7 26.0 23.6 53.6 12.8 19.2 8.5 14.5 11.9 27.6 19.1 6.2 47.0 22.6 24.5 258.6 77.2 19.7 35.0 22.9 137.8 20.5 72.9 144.8 40.6 33.1 18.5 29.0 29.7 31.8 15.2 7.1 19.6 34.3 41.3 41.8 26.8 30.4 28.3 25.0 145.5 55.4 21.9 5.6 57.4 46.8 21.0 22.0 45.4 25.4 25.3 17.8 4.7 10.3 69.3 7.2 2.5 2.4 16.7 46.0 37.6 15.1 11.9 141.9 414.6 19.6 41.8 19.7 30.2 37.5 12.5 1.6 7.3 13.4 83.9 25.2 103.3 46.9 18.1 SEPHS1 "SPS, SPS1" ENSG00000086475 "Selenophosphate synthetase 1" P49903 10 13317428-13348298 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037645, HPA062118" Enhanced Uncertain Nucleoplasm NA NA 21000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 5: NTERA-2 - Transcription" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA037645: AB_10671631, HPA062118: AB_2732676" "unprognostic (8.18e-3)" "unprognostic (1.79e-1)" "unprognostic (1.06e-3)" "unprognostic (2.07e-1)" "unprognostic (3.50e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.16e-7)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (2.61e-2)" "prognostic favorable (3.12e-4)" "unprognostic (1.09e-1)" "unprognostic (1.38e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (5.11e-2)" 27.8 28.6 23.2 23.6 23.9 25.3 33.5 25.3 22.3 25.6 28.1 31.2 23.2 32.3 35.9 24.6 35.3 23.8 30.8 21.7 24.1 56.5 48.6 24.3 29.3 26.7 28.4 35.7 33.6 48.1 23.5 27.8 23.1 26.4 32.7 25.0 26.9 24.7 33.3 20.9 24.6 33.2 25.9 21.8 25.6 22.1 24.6 64.3 55.4 36.6 34.3 24.8 17.4 24.4 127.7 90.8 182.4 176.3 59.4 45.1 85.8 55.4 42.6 115.6 97.9 103.5 116.4 123.1 67.2 65.0 55.9 79.6 195.2 91.4 120.5 186.7 80.9 67.4 66.8 132.9 61.4 92.0 41.4 39.6 64.6 67.7 39.5 53.9 95.0 255.9 90.7 97.5 83.2 168.1 228.8 39.3 301.8 119.8 40.9 176.3 88.8 73.7 62.2 51.0 64.5 119.5 169.6 74.1 75.7 157.7 93.8 96.1 64.1 51.1 96.3 67.6 117.6 71.3 143.4 228.1 41.2 67.6 41.9 10.2 11.6 8.8 7.7 17.1 9.5 9.5 7.8 8.9 13.6 6.4 10.0 9.4 1.7 15.4 24.8 15.4 13.3 8.3 23.2 23.9 25.3 22.3 21.7 24.1 26.7 28.4 23.1 25.9 24.6 24.4 24.1 12.8 13.1 8.1 12.3 17.2 16.5 19.3 9.6 17.1 23.8 19.4 14.1 20.0 18.0 22.0 0.0 31.6 27.1 17.6 33.2 26.4 13.5 16.9 15.4 26.1 16.7 19.3 8.2 30.1 45.2 18.0 11.7 16.1 15.8 27.7 19.6 32.7 21.1 21.9 8.3 13.7 20.3 10.1 11.7 14.1 14.9 13.1 16.0 4.7 8.0 35.2 9.2 4.0 12.9 34.1 15.3 18.4 18.7 17.5 16.4 44.6 13.4 15.6 6.6 14.2 26.1 17.6 21.2 15.0 16.9 25.6 13.2 25.9 18.0 15.1 BEND7 "C10orf30, FLJ40283" ENSG00000165626 "BEN domain containing 7" Q8N7W2 10 13438484-13528974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 167.3;Late spermatids: 268.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.5;hTERT-RPE1: 17.3" HPA037835 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" Yes No "Cluster 9: Neutrophils - Innate immune response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nucleoli fibrillar center, Vesicles" "HPA037835: AB_10669722" "unprognostic (6.22e-2)" "unprognostic (1.80e-1)" "unprognostic (1.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-2)" "unprognostic (4.62e-3)" "unprognostic (3.24e-3)" "unprognostic (3.52e-2)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.06e-1)" "unprognostic (4.19e-3)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (5.20e-3)" 8.0 6.0 4.7 2.4 4.9 0.7 9.4 6.5 4.7 7.4 4.9 11.2 16.5 7.3 13.6 2.2 12.4 6.5 7.4 5.0 4.9 18.5 9.0 9.1 1.1 5.1 5.9 8.3 12.1 14.8 10.3 4.3 5.9 5.7 6.6 15.4 15.1 6.5 16.4 3.2 19.3 6.1 4.7 3.0 11.2 16.3 5.6 0.5 23.5 13.3 1.0 6.8 4.4 4.4 9.9 5.9 6.0 2.2 0.1 0.0 8.7 3.8 0.1 9.3 5.6 2.4 17.5 0.0 5.1 7.3 5.2 0.4 9.8 2.1 8.3 0.0 8.7 0.0 0.0 11.4 3.9 0.0 0.0 0.2 5.7 1.2 0.0 17.3 10.3 1.4 4.3 0.0 9.3 4.0 0.1 0.0 1.8 0.0 1.0 0.0 4.4 0.0 8.0 1.3 0.4 4.7 10.7 0.0 0.1 9.1 0.1 4.7 9.2 1.1 13.8 11.6 4.8 0.0 0.0 0.0 3.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.7 4.9 6.5 4.7 5.0 4.9 5.1 5.9 5.9 4.7 5.6 4.4 33.6 22.4 11.6 23.5 1.9 3.4 23.6 1.1 1.8 14.4 15.4 11.4 11.0 22.8 9.8 20.2 8.4 3.0 2.6 13.2 3.9 13.0 167.3 25.0 5.8 16.7 7.8 0.0 7.5 16.5 2.9 8.0 9.7 36.2 6.3 14.7 22.5 9.6 3.0 1.7 10.2 8.5 6.1 9.4 1.9 268.7 5.0 2.5 3.6 24.4 4.5 20.3 12.3 47.7 0.7 21.8 9.5 6.0 0.5 23.9 45.2 52.0 9.7 32.2 0.0 14.1 8.4 21.5 20.0 3.3 1.8 2.5 3.5 3.4 10.3 36.1 PRPF18 hPrp18 ENSG00000165630 "Pre-mRNA processing factor 18" Q99633 10 13586939-13630859 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037599, HPA047950" Supported Approved "Nuclear speckles,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" Cytosol "HPA037599: AB_10795137, HPA047950: AB_2680221" "unprognostic (5.82e-2)" "unprognostic (7.86e-3)" "unprognostic (4.07e-2)" "unprognostic (1.20e-2)" "unprognostic (3.00e-2)" "unprognostic (6.36e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (6.12e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-3)" "unprognostic (2.82e-2)" "unprognostic (2.20e-1)" "unprognostic (8.09e-2)" "unprognostic (1.63e-1)" 14.6 15.9 8.4 14.4 9.7 43.0 19.6 12.2 10.4 12.8 8.9 16.0 16.9 14.0 28.1 15.8 11.7 15.5 14.3 8.5 10.8 20.7 21.9 14.9 18.2 8.7 8.7 12.9 17.0 18.7 10.7 17.4 8.7 14.3 18.1 10.1 14.3 13.0 23.2 14.3 16.5 15.1 8.6 13.6 15.0 18.8 9.1 25.0 23.6 22.2 19.7 16.4 12.3 10.1 29.5 21.7 18.9 16.4 25.9 24.7 23.5 33.6 16.6 35.9 34.2 20.8 43.8 24.4 18.3 31.1 16.3 23.8 25.1 27.8 41.3 36.3 24.9 28.4 18.5 16.3 30.7 22.6 32.9 19.4 44.3 31.3 15.4 21.9 35.3 35.0 29.9 32.1 33.1 30.5 42.2 15.6 17.8 29.0 10.7 29.8 22.8 30.6 23.9 12.6 13.2 32.7 26.6 18.8 29.1 23.0 29.0 36.6 30.2 22.2 26.1 36.5 25.5 31.2 35.8 34.8 32.8 27.9 15.4 27.2 27.3 36.5 27.7 25.1 24.0 26.9 24.8 23.9 27.4 25.8 26.4 32.6 40.3 39.7 37.4 23.3 33.5 16.8 8.4 9.7 12.2 10.4 8.5 10.8 8.7 8.7 8.7 8.6 9.1 10.1 24.5 19.2 22.4 14.7 32.8 45.6 24.0 35.7 25.0 13.5 22.6 15.0 9.4 30.0 32.9 22.0 10.4 30.5 28.7 21.1 41.1 30.9 29.8 27.5 22.8 21.1 12.6 25.9 27.0 29.1 40.4 18.9 19.4 22.0 27.1 10.5 16.4 28.4 26.0 21.9 25.3 21.8 46.8 20.7 18.0 16.5 17.7 19.4 24.9 18.7 29.7 20.2 36.0 28.1 29.3 33.7 28.9 13.2 27.1 16.2 30.2 50.6 31.8 21.7 19.7 20.8 18.3 105.8 41.1 17.1 46.9 41.7 33.2 11.6 19.0 25.8 AL157392.5 ENSG00000282246 "Novel protein" 10 13610047-13655929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 2.8;Collecting duct cells: 3.7;granulocytes: 2.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA047950 Uncertain NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "HPA047950: AB_2680221" 3.4 1.6 3.9 3.6 3.7 5.1 4.3 4.4 5.8 1.5 3.2 2.4 4.7 2.6 6.7 1.4 1.6 2.2 1.7 3.7 3.4 1.6 1.7 2.3 5.6 3.4 3.4 2.1 3.3 1.6 0.0 2.4 3.5 2.8 3.5 9.8 5.6 2.1 3.5 12.0 3.4 1.3 2.8 5.3 4.2 5.7 3.7 4.2 2.5 0.5 3.3 2.1 0.0 3.7 1.6 2.1 7.7 1.7 1.6 0.5 4.7 2.5 0.1 1.0 1.1 3.5 2.8 0.6 1.8 1.2 0.7 4.5 1.4 1.8 1.0 1.3 2.7 0.8 4.9 4.4 1.4 1.4 2.6 1.1 4.2 0.4 0.4 6.6 0.4 5.7 2.7 2.4 0.5 1.8 2.3 3.9 0.5 3.2 1.5 0.9 1.3 0.7 1.1 0.9 1.2 1.2 1.0 2.4 2.1 4.8 2.2 1.9 7.0 4.3 1.5 3.6 2.1 2.7 1.8 0.8 1.7 2.4 4.1 1.0 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.5 0.0 1.6 0.0 0.0 0.2 3.9 3.7 4.4 5.8 3.7 3.4 3.4 3.4 3.5 2.8 3.7 3.7 0.7 9.6 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.0 2.2 0.0 0.0 1.8 3.7 0.0 0.5 0.6 0.0 0.0 0.6 0.0 1.1 1.0 0.6 0.0 0.0 0.0 0.5 0.5 0.3 0.0 1.7 2.5 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.9 0.9 0.0 0.0 FRMD4A "bA295P9.4, FLJ10210, FRMD4, KIAA1294" ENSG00000151474 "FERM domain containing 4A" Q9P2Q2 10 13643706-14462142 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 60.8" "Group enriched" "Detected in many" 7 "Excitatory neurons: 1527.6;Inhibitory neurons: 1622.8;Microglial cells: 1329.4;Oligodendrocyte precursor cells: 442.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.3" "Lineage enriched" "Detected in single" 5 "B-cells: 2.3" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 134.0;HUVEC TERT2: 105.8;TIME: 191.6;WM-115: 163.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038449 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Nucleoplasm "HPA038449: AB_10669539" "unprognostic (6.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.51e-3)" "unprognostic (5.68e-2)" "unprognostic (1.55e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.21e-3)" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "unprognostic (1.74e-2)" "unprognostic (9.20e-2)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" "unprognostic (8.16e-2)" "unprognostic (1.84e-1)" 60.8 5.2 38.9 11.7 28.1 5.4 18.7 0.0 29.2 8.6 0.0 13.1 5.7 5.7 4.0 9.4 8.8 9.6 16.7 24.1 8.5 19.5 12.2 14.2 9.1 15.6 10.9 6.8 15.5 2.4 8.7 22.5 6.2 10.3 6.4 14.1 13.6 10.2 8.1 32.0 7.4 6.5 10.0 32.8 7.9 8.8 14.4 15.6 8.1 7.3 8.4 10.4 8.9 18.9 7.0 7.1 90.1 0.5 12.3 22.0 16.9 40.8 36.5 35.2 48.7 12.1 4.2 0.1 28.3 21.5 48.6 13.5 0.3 3.3 30.7 0.3 9.9 1.4 0.9 0.2 11.0 0.5 1.1 12.8 3.2 134.0 16.4 98.9 105.8 3.1 13.6 0.4 64.7 8.5 4.6 0.8 24.6 0.3 9.6 0.4 30.8 0.2 16.6 5.8 4.3 15.9 0.2 32.7 64.4 16.1 18.5 3.3 191.6 48.8 17.4 47.6 49.3 0.3 0.4 0.3 41.7 1.0 163.4 0.1 0.1 0.0 0.0 0.1 0.1 0.8 0.3 0.1 0.0 2.3 0.3 0.0 0.3 0.2 0.0 0.4 0.4 0.0 38.9 28.1 0.0 29.2 24.1 8.5 15.6 10.9 6.2 10.0 14.4 18.9 48.6 32.1 2.6 168.1 1.7 35.1 13.1 3.0 9.1 54.2 17.1 14.4 11.4 45.8 4.1 33.1 18.8 69.6 0.4 1.1 11.7 15.8 42.5 13.1 5.5 44.0 4.8 81.7 1527.6 4.0 42.1 14.9 4.6 26.9 15.2 58.1 44.3 6.2 35.9 80.8 1622.8 3.4 6.1 95.6 19.9 98.8 2.1 25.5 16.0 1329.4 2.7 46.0 0.0 442.3 61.0 1.8 1.4 1.9 0.9 8.0 0.3 2.7 2.5 12.9 13.1 41.2 45.5 1.3 2.1 20.6 32.7 28.7 3.0 5.3 5.4 4.3 FAM107B "C10orf45, FLJ45505, HITS, MGC11034" ENSG00000065809 "Family with sequence similarity 107 member B" Q9H098 10 14518557-14774897 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 526.5;Proximal tubular cells: 359.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 63.8;NK-cells: 53.8;T-cells: 106.2" "Cell line enhanced" "Detected in all" "Daudi: 373.0;HDLM-2: 449.6;Karpas-707: 309.6;THP-1: 294.4" "Low region specificity" "Detected in all" "HPA039661, HPA058814, HPA073195" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 15000 "Cluster 20: T-cells - T-cell receptor" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Golgi apparatus" "HPA039661: AB_10794751, HPA058814: AB_2683825, HPA073195: AB_2732221" "unprognostic (1.24e-1)" "unprognostic (1.91e-2)" "unprognostic (1.15e-1)" "unprognostic (1.80e-2)" "unprognostic (8.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.67e-1)" "unprognostic (1.50e-1)" "unprognostic (2.36e-1)" "unprognostic (6.82e-2)" "unprognostic (5.60e-2)" "unprognostic (4.63e-1)" "unprognostic (1.41e-1)" "unprognostic (1.80e-1)" "unprognostic (6.93e-2)" "unprognostic (7.01e-2)" "unprognostic (3.53e-2)" 48.4 44.7 82.3 90.2 150.8 171.5 44.3 112.4 112.5 42.2 90.8 64.2 32.7 48.2 11.4 22.8 20.6 66.1 11.1 84.2 102.1 119.6 147.3 64.8 152.3 136.8 125.9 7.3 70.6 70.0 21.3 22.2 130.7 27.6 42.5 15.2 68.6 113.7 3.5 22.2 55.9 31.4 95.5 50.6 122.8 37.3 118.7 48.0 12.6 9.3 134.0 66.7 17.1 223.6 60.8 129.1 50.3 3.4 7.6 1.7 21.3 59.7 85.8 35.9 25.6 79.9 49.9 373.0 52.8 27.5 13.4 18.6 16.1 36.4 63.5 449.6 13.9 10.3 55.6 95.0 26.7 136.6 23.3 4.2 28.0 14.9 7.2 42.4 154.6 72.5 1.1 309.6 28.2 15.6 33.6 39.5 12.5 72.7 28.2 240.8 39.1 140.2 81.9 39.0 18.7 53.5 23.6 12.4 39.0 44.7 46.0 294.4 50.8 37.0 31.2 118.3 20.3 136.2 131.7 241.3 6.5 117.5 10.1 52.3 6.0 63.8 100.2 7.1 97.7 12.4 79.4 85.0 5.2 12.6 105.7 106.2 25.2 53.8 14.9 3.5 78.0 74.8 82.3 150.8 112.4 112.5 84.2 102.1 136.8 125.9 130.7 95.5 118.7 223.6 12.8 105.8 44.4 7.2 203.6 89.7 147.1 25.4 16.5 4.8 94.6 30.4 4.1 134.4 52.5 286.9 2.1 18.1 194.7 65.9 223.0 44.3 27.0 234.9 98.7 37.8 14.3 22.7 1.6 106.8 38.2 49.7 175.3 268.2 119.2 32.7 72.8 177.4 37.1 201.9 7.3 110.5 36.7 53.9 120.9 53.2 2.5 110.7 51.6 15.0 68.8 13.6 198.8 11.1 526.5 90.3 44.3 4.9 176.6 139.6 25.9 359.9 85.3 15.0 0.0 5.4 64.6 56.2 35.7 8.3 82.3 62.5 237.7 3.8 39.9 240.2 CDNF ARMETL1 ENSG00000185267 "Cerebral dopamine neurotrophic factor" Q49AH0 10 14819245-14838575 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.9;tongue: 20.3" "Group enriched" "Detected in many" 9 "Early spermatids: 99.9;Late spermatids: 274.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "RPMI-8226: 8.4;U-266/70: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044587 Uncertain "Secreted in other tissues" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "HPA044587: AB_10795881" "unprognostic (2.80e-3)" "unprognostic (2.51e-2)" "unprognostic (6.20e-2)" "unprognostic (2.62e-1)" "unprognostic (4.47e-2)" "unprognostic (2.62e-1)" "unprognostic (5.32e-2)" "unprognostic (1.04e-1)" "unprognostic (1.41e-1)" "unprognostic (4.14e-2)" "unprognostic (1.25e-1)" "unprognostic (4.81e-2)" "unprognostic (1.08e-1)" "unprognostic (8.66e-2)" "unprognostic (6.93e-2)" "unprognostic (2.31e-2)" "unprognostic (3.62e-1)" 2.5 2.4 0.8 0.5 1.1 0.4 3.6 1.2 1.2 1.7 1.3 1.2 1.8 2.0 3.8 1.5 3.9 1.5 2.2 0.9 1.3 3.4 8.6 1.1 1.5 1.2 1.3 2.8 5.4 2.9 2.0 0.5 1.4 2.9 1.1 1.7 3.8 1.8 25.9 5.0 1.1 0.7 1.3 1.0 2.5 10.1 1.0 1.2 4.1 20.3 1.5 1.2 1.3 1.7 0.4 0.4 1.0 0.4 2.2 1.9 0.1 0.8 1.7 0.7 0.5 0.6 0.9 3.3 0.7 0.5 0.0 0.3 0.1 0.0 0.7 0.3 1.0 0.5 0.5 0.2 1.4 0.2 0.0 1.7 1.2 0.3 1.3 1.1 0.7 1.5 1.0 2.1 1.0 0.9 0.4 0.3 0.6 0.6 0.2 0.6 0.4 8.4 0.4 0.1 0.8 1.3 0.2 0.5 1.4 0.5 1.2 0.3 0.5 0.1 0.3 1.4 0.1 4.5 1.2 0.5 0.6 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.3 0.3 0.5 0.3 0.3 1.2 0.8 0.0 0.9 0.1 0.4 1.6 0.2 0.8 1.1 1.2 1.2 0.9 1.3 1.2 1.3 1.4 1.3 1.0 1.7 0.5 0.0 2.2 2.0 2.3 2.0 1.4 0.7 4.0 1.0 2.3 2.2 2.0 2.8 2.3 0.0 2.1 0.9 0.6 0.1 3.9 1.0 99.9 4.2 0.8 0.9 0.0 0.4 1.0 3.6 1.6 2.1 5.1 0.6 0.0 0.7 0.4 5.8 0.4 0.0 1.4 0.5 2.0 1.2 0.6 274.2 1.2 0.4 0.0 1.0 0.2 3.1 3.1 1.5 3.3 0.6 0.5 1.2 4.8 0.9 1.4 5.2 5.8 1.0 0.0 3.2 1.8 18.9 7.5 1.6 0.1 1.4 1.2 0.5 0.7 1.2 AC069544.1 ENSG00000284024 "Zinc finger and SCAN domain containing 29" 10 14838302-14846999 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.8;Breast myoepithelial cells: 1.5;Endometrial ciliated cells: 1.2;Endometrial stromal cells: 1.8;Glandular and luminal cells: 1.2;Granulosa cells: 2.3;Proximal tubular cells: 1.3;Theca cells: 4.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" 4.3 4.1 2.8 6.2 2.7 8.9 6.8 6.8 4.5 5.5 1.7 5.9 5.4 5.9 3.4 6.7 3.7 6.1 3.6 3.8 3.3 3.0 3.8 3.1 8.4 2.5 2.2 7.3 5.9 5.3 3.6 7.9 2.5 5.3 6.3 10.1 3.8 4.3 2.4 7.6 5.2 4.4 2.2 5.8 6.5 6.8 2.8 9.7 5.3 4.3 7.2 6.3 2.9 3.8 13.9 9.7 15.3 14.9 9.1 7.8 15.1 12.6 5.6 15.7 20.3 16.5 10.0 21.5 6.1 7.9 8.4 14.5 24.1 12.5 20.2 11.9 14.3 22.0 20.1 10.8 11.1 8.9 13.3 5.8 10.2 25.0 11.1 7.4 9.9 13.2 25.1 16.8 18.7 12.8 18.2 8.0 13.5 8.0 6.1 15.8 13.2 14.3 8.8 6.4 12.1 14.6 11.8 13.9 12.6 9.7 9.9 10.2 8.1 16.0 16.9 18.2 12.8 9.9 12.9 19.9 8.3 13.5 7.5 2.9 1.6 1.9 1.8 2.0 2.0 2.1 1.7 1.7 1.6 2.2 2.0 2.5 1.6 3.5 2.9 2.2 1.8 1.7 2.8 2.7 6.8 4.5 3.8 3.3 2.5 2.2 2.5 2.2 2.8 3.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 1.2 1.8 0.3 0.0 0.0 0.0 0.5 0.0 0.3 0.0 1.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 HSPA14 "HSP70-4, HSP70L1" ENSG00000187522 "Heat shock protein family A (Hsp70) member 14" Q0VDF9 10 14838306-14871741 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 223.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046180 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA046180: AB_2679571" "unprognostic (5.84e-3)" "unprognostic (5.85e-3)" "unprognostic (5.73e-2)" "unprognostic (6.40e-3)" "unprognostic (7.98e-3)" "prognostic favorable (5.73e-4)" "prognostic unfavorable (3.70e-8)" "unprognostic (2.20e-1)" "unprognostic (9.60e-2)" "prognostic favorable (9.16e-4)" "unprognostic (1.34e-1)" "unprognostic (1.17e-3)" "prognostic unfavorable (1.09e-5)" "unprognostic (7.27e-2)" "unprognostic (2.27e-1)" "unprognostic (5.42e-2)" "unprognostic (2.90e-1)" 8.9 9.2 9.2 14.7 9.5 42.8 13.3 13.5 12.4 8.5 7.8 14.7 13.1 9.2 11.1 11.0 7.1 8.9 11.4 10.0 9.5 10.2 11.8 8.8 19.4 8.3 8.2 7.9 11.5 8.2 8.8 10.1 8.6 8.8 17.8 10.3 10.1 8.9 21.4 13.3 12.5 9.7 8.6 12.0 9.4 30.9 9.1 18.6 10.3 16.6 19.1 13.0 8.0 10.2 54.0 38.9 33.7 30.7 15.7 21.7 43.6 27.8 14.6 47.5 37.9 52.1 38.9 66.8 21.6 25.7 23.5 43.1 55.3 32.8 49.7 28.2 56.0 62.1 33.0 30.4 13.4 43.6 39.9 15.9 15.0 38.9 11.4 11.8 24.3 53.8 54.3 53.6 35.4 37.3 65.7 30.4 34.9 55.2 20.7 50.3 43.8 53.9 24.7 27.2 19.1 23.5 31.3 43.1 35.8 32.0 49.0 57.6 13.6 19.8 27.7 77.8 45.1 36.6 85.4 67.8 39.6 56.3 11.4 15.8 12.3 13.3 13.7 18.0 14.9 15.1 14.0 17.2 13.4 14.5 11.7 14.6 6.1 17.8 15.8 14.7 20.3 10.7 9.2 9.5 13.5 12.4 10.0 9.5 8.3 8.2 8.6 8.6 9.1 10.2 8.2 6.4 3.3 7.2 18.7 26.3 20.5 37.9 30.7 16.6 7.8 5.8 19.3 14.3 21.2 3.7 6.2 36.2 17.5 16.2 1.9 4.2 53.9 6.7 8.7 12.1 6.0 20.4 21.8 3.9 65.6 16.2 18.3 8.9 10.2 7.4 11.7 12.6 22.8 6.7 19.5 17.0 26.4 11.6 20.3 14.6 14.0 12.1 14.2 10.3 9.0 17.6 23.7 14.6 15.9 4.7 19.9 12.4 33.3 24.4 15.2 2.0 12.5 13.7 13.1 23.3 33.1 223.8 71.4 25.7 26.1 48.7 21.5 8.0 21.2 22.2 SUV39H2 "FLJ23414, KMT1B" ENSG00000152455 "Suppressor of variegation 3-9 homolog 2" Q9H5I1 10 14878820-14904315 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 39.3" "Cell type enriched" "Detected in many" 4 "Early spermatids: 421.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045901, HPA057554" Enhanced Uncertain Mitochondria NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Mitochondria "HPA045901: AB_10960702, HPA057554: AB_2683466" "prognostic unfavorable (5.55e-4)" "unprognostic (1.45e-1)" "unprognostic (2.98e-2)" "unprognostic (8.78e-3)" "unprognostic (6.80e-2)" "unprognostic (1.23e-3)" "prognostic unfavorable (2.01e-6)" "unprognostic (1.06e-1)" "unprognostic (9.15e-2)" "unprognostic (3.59e-3)" "unprognostic (2.42e-1)" "unprognostic (4.13e-3)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" "unprognostic (5.55e-2)" "unprognostic (1.39e-1)" 2.1 1.5 1.4 2.4 1.8 4.7 3.8 8.3 3.5 1.6 1.4 2.9 2.0 2.0 1.5 3.1 2.1 1.7 1.0 1.5 1.2 2.4 3.1 1.3 2.5 1.2 1.4 2.5 1.8 1.9 1.3 3.8 1.2 2.7 3.4 3.4 1.7 2.3 1.4 1.9 2.6 2.3 1.2 1.5 1.8 39.3 1.3 6.1 1.4 1.2 3.1 3.1 1.4 3.1 28.6 20.8 40.8 24.1 7.5 10.7 16.9 14.8 8.1 24.1 34.6 29.5 15.2 22.4 13.4 5.8 22.6 21.3 27.7 16.4 31.6 22.9 15.1 29.4 14.0 21.5 4.3 14.8 16.2 4.1 5.3 24.2 5.4 6.4 19.0 37.4 41.9 15.2 20.3 19.3 31.3 4.4 28.8 26.6 5.9 38.4 28.1 20.7 10.9 11.0 13.8 16.8 23.9 16.6 11.1 23.8 24.6 11.0 11.6 21.4 31.7 22.9 23.1 9.5 36.1 47.9 12.1 14.8 13.5 0.2 0.3 0.2 1.5 1.1 1.9 0.4 1.1 1.7 1.1 0.3 1.8 1.8 0.3 3.0 0.4 1.8 2.0 0.5 1.4 1.8 8.3 3.5 1.5 1.2 1.2 1.4 1.2 1.2 1.3 3.1 2.0 0.0 1.5 4.2 2.6 8.3 10.2 6.7 9.1 7.5 4.0 3.7 2.9 2.8 7.5 1.8 10.4 13.9 1.7 1.1 5.9 4.4 421.0 3.4 5.1 4.3 3.5 16.2 8.0 2.2 25.6 5.1 4.1 4.0 2.5 7.8 1.8 3.0 5.0 11.8 7.9 3.1 6.1 1.6 2.8 104.4 4.7 1.8 1.8 2.8 0.7 4.2 3.1 4.5 4.5 2.1 1.7 2.6 7.1 14.5 1.0 7.4 3.5 10.2 6.6 5.8 6.6 47.5 46.6 8.3 8.8 8.9 3.4 8.7 4.5 10.9 DCLRE1C "A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C" ENSG00000152457 "DNA cross-link repair 1C" Q96SD1 10 14897359-14954432 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069295 Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Golgi apparatus" "HPA069295: AB_2686112" "unprognostic (8.42e-2)" "unprognostic (1.69e-2)" "unprognostic (2.66e-2)" "unprognostic (2.40e-2)" "unprognostic (1.36e-2)" "prognostic favorable (1.30e-4)" "unprognostic (8.02e-4)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic favorable (7.98e-4)" "unprognostic (1.91e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (9.03e-8)" "unprognostic (2.43e-2)" "unprognostic (2.32e-1)" "unprognostic (2.51e-1)" "unprognostic (5.45e-3)" 4.2 3.3 2.2 8.0 3.2 14.0 6.1 5.7 3.4 4.5 3.7 4.3 5.2 4.4 3.8 7.1 3.7 4.0 2.3 2.2 2.2 3.5 2.6 4.9 14.1 2.8 2.7 4.5 3.1 3.8 2.2 4.4 3.1 4.0 5.2 4.9 4.5 3.7 3.0 6.9 5.4 3.9 2.5 10.4 5.9 1.9 2.9 12.3 5.5 2.7 12.8 5.4 5.1 3.7 16.2 7.8 6.9 13.8 6.4 8.2 6.6 9.7 5.3 13.0 13.5 8.9 13.4 21.7 3.8 7.6 9.2 13.7 7.6 5.1 10.9 13.4 8.0 16.7 8.9 6.0 5.1 10.0 18.4 6.6 4.8 12.7 5.3 8.2 7.4 13.9 10.5 17.4 8.6 7.4 14.9 9.9 4.7 14.4 3.5 17.2 9.2 12.1 6.5 6.0 3.6 6.9 10.7 10.2 27.5 5.3 12.8 18.5 6.0 8.3 11.6 17.1 10.8 9.9 19.1 21.5 8.1 10.5 11.8 27.4 13.9 20.0 12.1 18.9 14.5 25.1 14.1 15.0 20.9 28.1 12.2 13.2 13.2 11.0 17.5 22.4 11.9 8.9 2.2 3.2 5.7 3.4 2.2 2.2 2.8 2.7 3.1 2.5 2.9 3.7 6.6 3.2 6.9 17.9 27.6 17.3 20.8 10.9 5.7 24.8 7.8 4.3 4.4 11.5 26.1 14.7 62.6 15.1 21.8 10.9 3.9 9.9 26.8 8.5 8.6 8.2 6.7 22.7 12.4 11.1 21.9 10.2 7.1 13.1 6.3 14.1 10.4 1.9 10.2 32.0 10.6 7.3 10.2 19.8 20.6 2.3 12.5 13.3 19.6 16.9 21.8 10.4 35.0 12.5 11.9 14.9 15.5 11.3 13.4 21.5 12.3 2.7 22.3 47.9 19.7 18.1 11.9 13.9 18.5 7.3 21.2 5.1 14.8 12.4 8.6 41.4 MEIG1 "bA2K17.3, SPATA39" ENSG00000197889 "Meiosis/spermiogenesis associated 1" Q5JSS6 10 14959388-14988050 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 3.7;testis: 10.2" "Cell type enhanced" "Detected in some" "Early spermatids: 128.5;Endometrial ciliated cells: 28.9;Late spermatids: 21.4;Respiratory ciliated cells: 31.7;Spermatocytes: 52.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 6.1;SK-MEL-30: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 37: B-cells - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.48e-2)" "unprognostic (1.20e-1)" "unprognostic (5.51e-2)" "unprognostic (4.05e-2)" "unprognostic (1.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.37e-1)" "unprognostic (2.85e-2)" "unprognostic (3.75e-6)" "unprognostic (6.89e-2)" "unprognostic (1.36e-5)" "unprognostic (2.97e-1)" "unprognostic (3.74e-3)" "unprognostic (8.40e-3)" "unprognostic (3.15e-1)" 0.2 0.3 1.3 0.0 1.4 0.0 0.0 1.4 1.9 0.2 1.6 0.1 0.0 0.1 0.0 0.1 3.7 0.0 0.1 1.4 1.4 0.3 0.2 0.4 0.2 1.6 1.7 0.0 0.2 0.2 0.8 0.1 1.4 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.0 1.5 0.2 0.1 10.2 1.4 0.3 0.1 0.0 0.1 0.1 0.0 1.6 0.8 0.7 1.2 0.6 0.3 0.2 0.0 0.2 0.3 0.4 0.4 0.0 1.1 0.2 0.0 0.2 0.6 0.1 0.8 0.1 0.1 6.1 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.4 0.1 0.3 0.6 0.6 1.2 0.2 0.0 0.6 0.6 0.9 1.2 0.2 0.4 0.6 0.0 0.9 1.6 0.3 0.3 3.3 0.2 0.6 0.1 0.0 0.0 0.0 0.3 0.0 1.9 1.7 1.7 0.7 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.2 1.4 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.4 0.3 0.2 0.7 0.0 1.3 1.4 1.4 1.9 1.4 1.4 1.6 1.7 1.4 1.5 1.4 1.6 0.2 0.0 0.5 1.3 0.2 0.0 0.5 2.8 0.0 0.2 0.8 1.0 0.8 0.0 3.2 1.8 0.0 0.8 0.1 0.1 1.9 0.4 128.5 28.9 0.3 0.1 0.0 0.0 1.3 0.9 0.4 0.2 0.0 0.8 0.0 0.3 0.0 1.4 0.6 0.0 1.4 0.5 4.1 0.3 0.3 21.4 2.1 0.5 0.0 0.0 0.3 2.6 1.0 0.5 1.4 0.2 0.0 0.0 0.1 0.5 0.0 0.7 31.7 0.3 0.0 0.2 0.7 52.2 3.7 0.0 0.4 0.3 0.5 0.1 0.3 0.4 OLAH "FLJ11106, SAST, THEDC1" ENSG00000152463 "Oleoyl-ACP hydrolase" Q9NV23 10 15032227-15073853 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 9.0;testis: 27.0" "Cell type enriched" "Detected in some" 4 "Early spermatids: 537.8" "Cancer enriched" "Detected in some" 4 "testis cancer: 3.6" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 2.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.6" "Cell line enhanced" "Detected in some" "HSkMC: 3.6;hTCEpi: 4.8;LHCN-M2: 3.6;SK-BR-3: 5.3;SuSa: 2.6;U-266/70: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037947, HPA037948" Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 83: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 30: Mammary glandular cells - Lactation" "HPA037947: AB_10795028, HPA037948: AB_10805352" "unprognostic (2.01e-1)" "unprognostic (6.12e-2)" "unprognostic (8.20e-3)" "unprognostic (4.04e-3)" "unprognostic (1.92e-1)" "unprognostic (8.09e-2)" "unprognostic (7.12e-2)" "unprognostic (5.12e-2)" "unprognostic (4.55e-1)" "unprognostic (3.74e-2)" "unprognostic (4.70e-1)" "unprognostic (1.69e-1)" "unprognostic (5.22e-10)" "unprognostic (4.55e-2)" "unprognostic (2.09e-1)" "unprognostic (5.11e-2)" "unprognostic (9.78e-2)" 1.5 0.9 1.1 0.2 0.8 1.1 5.5 0.6 1.5 0.8 0.8 0.2 0.1 0.4 0.4 3.0 1.7 1.0 0.2 1.1 0.3 1.1 0.3 1.7 0.3 0.5 0.3 0.2 0.1 0.3 1.0 3.2 0.3 0.3 0.0 0.7 2.7 0.1 0.2 0.7 0.5 0.2 0.2 9.0 0.3 27.0 0.7 0.1 0.4 0.3 0.0 0.2 0.8 1.2 0.0 0.0 0.1 0.2 0.2 0.7 1.2 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.1 0.1 0.2 0.1 0.0 0.5 0.0 0.4 3.6 4.8 0.5 0.0 0.0 0.4 0.1 0.2 0.1 3.6 0.0 0.3 0.2 0.2 0.0 0.3 0.4 0.7 0.2 0.0 0.0 0.0 0.1 0.1 5.3 0.0 2.6 0.1 0.1 0.2 0.0 1.8 0.1 0.1 3.1 0.7 0.2 1.1 0.2 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 2.6 0.4 0.0 0.5 0.2 0.0 1.1 0.8 0.6 1.5 1.1 0.3 0.5 0.3 0.3 0.2 0.7 1.2 0.7 3.2 0.6 0.3 0.1 0.3 0.5 0.0 0.0 0.1 131.3 0.9 0.4 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 2.7 537.8 0.1 0.2 0.3 0.0 0.0 0.1 0.0 1.7 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 2.2 0.3 66.1 4.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 8.2 0.0 0.4 0.0 0.0 0.8 0.7 6.6 0.5 1.0 2.8 1.9 0.0 0.3 11.4 0.9 0.1 0.0 0.1 ACBD7 "bA455B2.2, FLJ38219" ENSG00000176244 "Acyl-CoA binding domain containing 7" Q8N6N7 10 15075475-15088776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 37.8;choroid plexus: 17.1" "Cell type enriched" "Detected in some" 5 "Astrocytes: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 28.7;MOLT-4: 29.2;U-698: 21.8" "Region enriched" "Detected in all" 5 "olfactory bulb: 17.6" "Low region specificity" "Detected in all" "HPA043326, HPA062478" Approved Vesicles,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Vesicles, Cytosol" "HPA043326: AB_2678429, HPA062478: AB_2684777" "unprognostic (2.15e-1)" "unprognostic (8.94e-2)" "unprognostic (7.79e-3)" "unprognostic (6.53e-3)" "unprognostic (7.30e-2)" "unprognostic (6.89e-3)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.32e-1)" "unprognostic (6.34e-2)" "unprognostic (3.59e-3)" "unprognostic (3.06e-1)" "unprognostic (2.18e-4)" "unprognostic (9.72e-2)" "unprognostic (2.95e-1)" "unprognostic (2.14e-1)" "unprognostic (6.90e-2)" 0.3 0.3 34.9 0.4 36.0 1.4 4.2 28.8 37.8 0.2 17.1 0.4 0.9 0.3 0.8 0.4 1.9 0.4 0.2 31.6 29.7 0.4 0.4 0.4 0.7 33.7 37.1 0.4 0.4 0.3 0.6 0.3 26.3 0.4 0.4 7.7 2.3 0.5 0.9 1.3 0.5 0.2 27.2 0.4 0.5 3.0 35.1 6.7 1.7 0.0 0.5 0.3 0.1 23.2 3.4 0.8 12.7 7.0 1.0 0.6 1.8 0.8 0.7 1.9 3.0 3.8 4.2 2.9 4.3 2.5 2.6 0.6 6.9 1.8 2.9 6.0 10.2 3.4 1.1 2.3 0.1 0.4 1.3 0.3 0.1 1.0 0.1 3.2 2.9 28.7 2.4 3.6 2.5 10.5 29.2 4.5 6.3 1.0 2.0 16.4 4.3 6.9 1.6 1.0 9.7 6.6 2.7 8.6 1.1 4.7 10.9 0.6 1.6 0.7 6.6 1.3 2.8 10.4 19.1 21.8 2.1 0.5 0.7 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.8 0.3 0.1 0.3 0.1 0.0 34.9 36.0 28.8 37.8 31.6 29.7 33.7 37.1 26.3 27.2 35.1 23.2 0.1 0.0 0.6 28.1 0.1 0.1 0.1 0.0 0.6 0.2 0.5 0.6 0.0 0.0 0.0 0.0 2.1 0.0 0.5 0.2 0.0 0.0 5.3 2.6 0.1 0.4 1.8 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.1 0.0 1.0 0.0 0.6 0.0 1.5 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.1 1.6 0.8 0.0 0.3 0.3 2.9 0.4 0.5 0.0 0.1 0.2 0.1 0.1 0.1 RPP38 ENSG00000152464 "Ribonuclease P/MRP subunit p38" P78345 10 15097180-15139818 "Enzymes, Predicted intracellular proteins, Ribosomal proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 555.3;Late spermatids: 231.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045128, HPA050398" Approved Supported Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoli "HPA045128: AB_2797230, HPA050398: AB_2732560" "unprognostic (1.75e-1)" "unprognostic (3.91e-2)" "unprognostic (3.76e-2)" "unprognostic (1.51e-1)" "unprognostic (9.93e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.41e-2)" "unprognostic (4.86e-1)" "unprognostic (1.57e-3)" "unprognostic (3.42e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (6.13e-2)" "unprognostic (1.95e-1)" "unprognostic (5.11e-2)" "prognostic favorable (2.89e-6)" 14.0 12.9 9.1 12.3 9.4 12.4 19.8 12.4 11.7 14.0 15.1 16.3 15.8 15.0 16.7 16.2 19.3 11.2 13.0 9.4 9.5 17.2 19.4 13.8 20.1 8.9 9.0 14.6 15.2 14.2 13.4 11.5 8.9 13.9 16.7 13.4 14.4 12.1 19.0 17.2 16.6 12.5 8.8 17.7 15.4 48.1 9.3 15.6 16.2 14.8 18.0 17.6 13.3 10.1 40.6 29.4 15.6 20.3 20.7 21.2 27.9 18.7 14.0 29.0 29.3 29.6 40.3 33.2 19.3 17.6 23.7 36.2 31.8 32.4 26.2 26.0 28.6 34.3 17.3 26.2 44.4 19.5 27.5 25.3 43.8 23.4 20.5 21.9 23.2 33.0 40.1 22.7 22.0 32.6 34.9 20.9 18.0 49.0 14.0 28.3 15.9 41.5 37.0 15.3 14.7 18.5 25.7 44.4 53.6 25.6 39.7 30.8 18.8 13.1 22.8 28.3 25.2 31.6 36.5 44.9 25.8 23.3 12.6 21.9 48.5 49.7 49.1 49.0 48.6 58.7 49.7 60.8 51.9 66.0 57.2 52.4 16.2 41.5 40.8 52.3 47.3 43.4 9.1 9.4 12.4 11.7 9.4 9.5 8.9 9.0 8.9 8.8 9.3 10.1 15.5 16.0 22.0 4.2 24.0 31.5 41.9 34.7 14.2 14.2 22.5 26.0 7.1 11.5 40.3 9.2 6.2 30.2 18.6 18.6 27.4 34.2 555.3 54.4 18.7 19.2 13.2 15.2 3.3 33.2 42.1 15.7 16.8 16.0 12.7 15.5 19.6 32.4 24.7 8.4 3.5 25.4 36.7 18.8 12.6 231.1 23.6 13.4 8.8 5.6 21.6 17.7 33.0 4.5 5.5 29.6 16.8 19.9 14.5 46.8 26.9 33.9 89.2 31.0 13.1 14.9 14.6 68.0 34.6 17.2 36.1 32.2 21.5 23.6 24.0 43.8 NMT2 ENSG00000152465 "N-myristoyltransferase 2" O60551 10 15102584-15168693 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 93.6;Hepatocytes: 141.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 14.5;eosinophil: 13.6;gdT-cell: 11.0;MAIT T-cell: 19.8;memory CD4 T-cell: 17.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 21.8;naive CD8 T-cell: 14.5;NK-cell: 20.8;T-reg: 29.5" "Group enriched" "Detected in many" 8 "granulocytes: 14.5;NK-cells: 20.8;T-cells: 29.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 102.6;TIME: 147.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001303 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus, Plasma membrane, Cytosol" "HPA001303: AB_1079494" "unprognostic (1.08e-1)" "unprognostic (7.65e-2)" "unprognostic (8.78e-2)" "unprognostic (1.15e-3)" "unprognostic (6.97e-2)" "unprognostic (2.24e-1)" "unprognostic (7.11e-2)" "unprognostic (5.13e-2)" "unprognostic (3.20e-1)" "unprognostic (4.01e-3)" "unprognostic (3.31e-1)" "unprognostic (2.00e-1)" "unprognostic (7.06e-2)" "unprognostic (3.79e-3)" "unprognostic (2.00e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" 25.9 4.4 7.3 6.1 8.7 3.7 17.5 12.2 10.0 9.8 4.0 8.8 6.6 12.7 3.5 7.0 8.3 7.0 8.7 7.0 4.9 9.4 16.8 6.3 8.9 5.0 7.6 15.4 5.6 16.5 5.5 4.4 5.1 9.0 9.2 7.0 5.2 7.7 8.3 10.1 10.9 10.5 4.3 9.4 7.9 13.4 9.1 27.0 5.9 8.5 8.0 8.6 7.9 7.3 8.8 11.3 12.7 9.3 33.7 35.9 2.3 18.8 15.3 17.0 23.0 10.9 38.7 0.4 12.7 102.6 46.6 10.6 11.4 10.7 28.3 11.7 13.9 23.4 5.4 15.2 22.4 1.7 84.0 31.9 10.8 23.8 7.2 62.2 65.8 16.3 11.2 1.5 63.7 10.9 18.3 4.4 9.3 10.0 10.5 13.6 18.5 1.8 12.6 1.8 3.9 14.4 22.8 3.7 6.3 10.5 11.7 7.3 147.1 16.7 24.4 75.0 13.7 13.0 14.3 1.0 20.7 6.3 12.4 14.5 0.5 13.6 11.0 0.7 19.8 2.2 17.5 12.9 0.5 2.5 21.8 14.5 1.9 20.8 0.8 0.5 29.5 6.5 7.3 8.7 12.2 10.0 7.0 4.9 5.0 7.6 5.1 4.3 9.1 7.3 52.5 9.6 8.8 25.1 16.0 16.6 23.4 8.3 7.4 20.6 14.7 13.1 13.5 57.2 10.9 27.6 4.2 1.3 16.9 32.8 9.8 33.9 6.6 4.7 20.5 21.7 18.0 15.1 39.6 19.5 3.0 16.3 9.2 10.3 93.6 13.2 25.4 141.9 2.8 20.2 30.1 11.4 4.1 7.9 7.1 14.5 21.8 5.8 12.4 17.8 10.1 12.9 40.2 12.5 15.3 27.1 15.9 20.7 10.0 17.9 38.4 63.2 5.3 17.2 0.0 13.4 21.0 8.1 46.8 6.8 14.8 2.6 33.9 11.0 18.1 16.7 FAM171A1 "APCN, C10orf38, FLJ12884" ENSG00000148468 "Family with sequence similarity 171 member A1" Q5VUB5 10 15211643-15371289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 86.7" "Cell type enhanced" "Detected in many" "Astrocytes: 263.8;Cholangiocytes: 98.7;Excitatory neurons: 166.9;Oligodendrocytes: 214.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 1.7;MAIT T-cell: 4.4;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.2;naive CD4 T-cell: 4.7;naive CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 19 "T-cells: 4.7" "Cell line enhanced" "Detected in many" "TIME: 105.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051345 Approved Approved "Nucleoplasm,Plasma membrane" NA NA 130000 "Cluster 32: T-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane" Nucleoplasm "HPA051345: AB_2681449" "unprognostic (3.60e-2)" "unprognostic (7.15e-2)" "unprognostic (2.21e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (4.11e-2)" "unprognostic (9.84e-2)" "unprognostic (9.19e-2)" "unprognostic (2.28e-1)" "unprognostic (3.97e-2)" "unprognostic (3.09e-2)" "unprognostic (1.87e-1)" "prognostic favorable (2.71e-5)" "unprognostic (3.08e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (4.90e-6)" "unprognostic (3.28e-2)" 11.0 5.0 60.1 7.5 73.2 0.5 8.8 69.8 56.4 11.8 22.7 21.6 19.1 12.8 6.4 6.4 15.6 12.9 10.6 68.5 49.5 31.9 15.4 7.4 6.0 79.6 64.8 14.2 22.4 10.9 3.7 4.1 75.6 11.2 17.6 2.6 14.1 11.9 7.6 4.2 13.0 12.3 59.3 12.4 13.3 3.5 68.7 3.9 6.9 6.1 6.6 9.0 6.3 86.7 0.0 16.2 33.3 12.6 13.2 24.9 0.4 19.5 3.9 10.2 8.8 3.0 19.2 0.1 21.5 53.4 22.7 1.4 24.0 0.2 11.5 5.9 33.4 46.7 5.2 48.1 14.3 0.0 36.0 19.7 4.9 27.8 4.0 36.8 51.4 6.8 17.5 0.2 32.8 1.4 7.7 0.1 30.4 9.3 7.8 30.4 17.0 5.1 12.7 0.0 22.4 27.6 10.9 0.2 0.1 35.0 0.2 0.6 105.6 13.9 53.6 50.4 20.8 6.3 2.1 0.1 30.3 0.0 10.8 0.0 0.0 0.0 1.7 0.0 4.4 0.0 2.5 2.2 0.0 0.0 4.7 2.4 0.0 0.2 0.0 0.0 0.5 0.9 60.1 73.2 69.8 56.4 68.5 49.5 79.6 64.8 75.6 59.3 68.7 86.7 11.1 0.0 0.0 263.8 1.0 1.3 4.0 3.1 8.0 4.0 7.6 5.7 6.8 98.7 1.7 14.7 0.0 0.1 0.2 25.4 3.9 21.1 0.7 5.9 12.5 43.7 21.0 6.5 166.9 12.2 0.2 12.3 35.7 14.6 1.3 14.4 49.2 24.7 0.4 6.7 76.6 23.7 4.1 2.8 1.7 1.1 5.3 0.3 1.8 33.7 0.7 1.5 0.0 44.2 214.4 17.5 16.1 5.7 5.2 16.5 7.3 4.5 2.4 1.1 0.0 7.5 5.9 2.3 5.7 8.0 1.8 0.1 2.0 11.4 38.8 3.6 ITGA8 ENSG00000077943 "Integrin subunit alpha 8" P53708 10 15513954-15719922 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein, Integrin, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 37.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 82.8;Inhibitory neurons: 56.1;Microglial cells: 34.7;Oligodendrocyte precursor cells: 64.8;Plasma cells: 25.5;Sertoli cells: 52.6;Smooth muscle cells: 57.6" "Cancer enhanced" "Detected in many" "prostate cancer: 6.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 8.4;HMC-1: 19.8;HSkMC: 8.7;U-266/84: 9.7" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "basal ganglia: 14.1" HPA003432 Approved Approved "Plasma membrane" NA NA 200000 "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "HPA003432: AB_1851825" "unprognostic (2.15e-1)" "unprognostic (1.22e-3)" "unprognostic (1.05e-2)" "unprognostic (2.03e-1)" "unprognostic (1.25e-2)" "unprognostic (8.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.13e-3)" "unprognostic (6.82e-2)" "unprognostic (3.80e-1)" "unprognostic (2.54e-2)" "unprognostic (1.27e-1)" "unprognostic (4.10e-3)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.03e-2)" 8.6 10.5 1.6 2.1 2.1 0.1 2.7 1.9 5.0 23.8 8.0 6.1 6.7 9.7 5.5 9.8 8.8 6.7 7.7 7.0 0.9 10.0 0.7 20.8 3.2 1.5 2.8 5.7 0.8 4.7 3.2 0.2 1.1 37.4 6.1 1.6 1.8 30.8 2.9 3.3 6.8 9.1 1.5 19.9 19.3 0.6 1.5 1.0 5.6 6.9 4.4 15.7 9.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 8.4 2.5 0.0 0.0 0.0 0.0 19.8 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 9.7 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 1.9 5.0 7.0 0.9 1.5 2.8 1.1 1.5 1.5 2.2 1.2 0.0 1.3 0.7 2.4 1.0 1.9 0.0 0.6 6.3 0.1 0.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 4.0 11.4 0.0 0.0 82.8 0.0 0.0 10.1 0.0 0.2 0.0 0.0 4.2 0.0 0.1 0.0 56.1 0.0 0.0 0.0 1.8 0.1 0.9 0.5 1.8 34.7 0.0 13.6 0.0 64.8 4.0 0.0 0.0 0.0 25.5 1.5 0.0 0.0 0.0 0.3 52.6 11.3 57.6 0.0 0.2 0.4 1.1 0.0 1.2 0.1 0.1 1.4 MINDY3 "C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042" ENSG00000148481 "MINDY lysine 48 deubiquitinase 3" Q9H8M7 10 15778170-15860507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Hofbauer cells: 40.2;Syncytiotrophoblasts: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038400, HPA038406" Uncertain Supported "Nucleoplasm,Nuclear membrane" NA NA 23000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear membrane" "HPA038400: AB_10669724, HPA038406: AB_2676001" "unprognostic (9.20e-2)" "unprognostic (5.84e-2)" "unprognostic (3.09e-1)" "unprognostic (3.26e-1)" "unprognostic (1.99e-2)" "unprognostic (3.67e-1)" "unprognostic (8.29e-2)" "unprognostic (2.81e-2)" "unprognostic (3.85e-2)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (6.50e-2)" "unprognostic (1.32e-1)" "unprognostic (2.97e-1)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.19e-1)" 15.0 22.4 12.8 8.6 16.3 19.1 19.2 21.9 19.0 18.6 2.9 15.0 9.3 19.5 20.6 14.1 15.6 14.2 9.9 14.7 10.5 16.8 17.5 12.1 12.4 10.6 11.4 18.5 13.7 20.5 5.3 21.1 10.9 19.3 18.7 20.0 11.5 16.4 4.3 16.4 11.6 16.4 11.3 10.5 15.7 21.3 15.5 7.5 18.3 2.4 11.6 15.3 10.3 17.7 12.4 11.1 21.5 22.9 30.9 28.9 17.9 38.1 19.4 28.4 33.1 9.6 19.0 9.2 7.2 41.8 19.9 11.2 18.5 22.8 25.5 28.2 25.5 30.0 16.0 10.8 39.3 6.2 24.3 22.5 19.6 25.3 18.1 27.4 23.1 21.7 18.6 7.6 28.5 13.4 13.2 7.5 7.8 19.9 21.6 6.5 12.5 6.4 32.1 9.2 17.6 19.2 18.5 17.5 16.1 19.2 20.4 13.4 23.9 18.5 14.4 31.4 11.2 45.6 18.8 15.7 21.2 13.6 15.1 2.6 1.7 1.5 2.2 3.5 1.8 1.3 1.5 2.4 1.9 1.9 1.0 2.0 1.5 1.7 4.0 2.0 3.1 1.5 12.8 16.3 21.9 19.0 14.7 10.5 10.6 11.4 10.9 11.3 15.5 17.7 17.3 22.4 14.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 9.7 7.4 0.0 0.0 3.7 14.7 0.0 18.7 10.7 0.0 19.6 11.6 0.0 8.2 18.1 5.2 0.0 0.0 0.0 8.3 17.0 7.5 0.0 9.7 1.3 11.5 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 9.0 0.0 0.0 4.0 0.0 0.0 17.7 11.7 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 32.7 3.0 13.7 0.0 0.0 PTER ENSG00000165983 "Phosphotriesterase related" Q96BW5 10 16436943-16513745 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 31.5" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 190.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 9 "amygdala: 6.9;basal ganglia: 16.5;cerebral cortex: 8.7;hippocampal formation: 14.1" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038044, HPA038045" Approved Approved Nucleoplasm,Cytosol NA NA 8600 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Cytosol "HPA038044: AB_2675803, HPA038045: AB_10672616" "unprognostic (5.57e-2)" "unprognostic (1.04e-1)" "unprognostic (2.76e-2)" "unprognostic (3.14e-2)" "unprognostic (9.72e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.17e-1)" "unprognostic (4.51e-2)" "unprognostic (2.86e-1)" "unprognostic (2.05e-3)" "unprognostic (1.86e-1)" "prognostic favorable (6.52e-6)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (1.54e-2)" "unprognostic (5.36e-3)" 6.8 5.5 6.9 5.6 16.5 2.3 10.3 1.0 8.7 5.9 0.0 8.3 12.7 4.9 4.4 4.5 5.1 5.3 7.1 14.1 1.3 31.5 14.0 6.0 7.9 0.0 0.0 2.0 7.5 9.2 1.3 5.6 0.0 7.1 8.0 11.8 8.3 4.6 9.2 5.4 10.0 3.3 0.0 6.9 14.1 1.1 0.8 7.3 10.6 10.0 7.9 9.0 3.7 0.0 26.9 11.7 0.1 4.8 7.0 13.0 14.7 6.9 0.7 2.6 3.5 10.7 20.9 25.0 5.9 4.5 1.2 11.4 8.3 4.3 4.3 30.2 9.9 24.9 6.1 5.6 7.2 8.2 8.0 8.2 17.0 8.0 1.3 0.1 1.5 22.9 17.5 8.4 4.1 7.8 17.8 9.5 5.7 15.9 2.5 13.7 2.4 13.1 43.2 6.4 22.7 1.4 12.5 3.7 23.3 5.2 8.6 30.4 3.4 0.2 6.3 5.5 0.1 6.3 7.6 25.2 3.3 14.7 8.7 3.4 7.2 4.7 7.5 11.6 8.1 9.2 8.8 8.1 7.6 5.8 6.8 7.1 2.2 5.6 10.3 6.7 14.2 5.9 6.9 16.5 1.0 8.7 14.1 1.3 0.0 0.0 0.0 0.0 0.8 0.0 12.1 28.9 26.3 2.9 13.5 11.0 14.7 7.7 9.6 0.9 13.6 9.4 29.5 15.7 20.6 29.5 0.0 19.6 10.2 19.5 52.8 22.5 0.3 10.7 5.5 8.3 11.5 9.4 0.5 34.4 18.7 10.2 41.8 17.8 24.1 5.1 11.4 24.3 15.6 0.0 0.2 13.1 18.3 17.1 6.5 0.3 0.9 12.3 8.8 10.3 14.6 13.9 33.0 0.0 0.2 26.8 26.7 0.0 8.1 11.4 19.8 190.5 14.4 9.9 6.6 7.7 16.0 1.1 6.5 7.6 12.4 12.0 13.2 3.0 19.2 22.2 C1QL3 "C1ql, C1QTNF13, CTRP13, K100" ENSG00000165985 "Complement C1q like 3" Q5VWW1 10 16513734-16521879 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 45.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.5;Excitatory neurons: 4.8;Oligodendrocyte precursor cells: 1.0;Rod photoreceptor cells: 2.9" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 20 "amygdala: 26.8;basal ganglia: 39.1;cerebral cortex: 33.6;hippocampal formation: 45.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HDLM-2: 32.3;SCLC-21H: 19.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 72.1;cerebral cortex: 57.7;hippocampal formation: 51.2" "Secreted in brain" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (7.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.62e-1)" "unprognostic (1.16e-1)" "unprognostic (8.19e-3)" "unprognostic (6.31e-2)" "unprognostic (5.12e-2)" "unprognostic (3.89e-2)" "unprognostic (2.76e-2)" "unprognostic (2.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "prognostic favorable (6.29e-5)" "unprognostic (3.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.59e-2)" "unprognostic (6.12e-2)" 0.8 0.8 26.8 0.4 39.1 0.1 0.3 0.2 33.6 0.2 0.0 0.3 1.8 0.2 0.0 0.2 0.2 0.1 0.8 45.5 1.2 1.2 0.3 0.4 0.7 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.5 0.0 7.4 0.6 0.0 1.1 0.9 0.7 0.0 0.0 0.5 0.5 0.0 1.2 0.0 1.0 0.1 0.0 0.3 0.2 1.8 0.1 1.8 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 2.1 1.1 3.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 32.3 0.3 1.9 1.3 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.2 0.2 0.1 1.2 1.2 0.1 1.2 0.3 1.9 0.1 0.7 19.3 1.7 1.8 0.2 1.1 0.3 0.1 0.3 0.0 0.0 0.1 0.9 0.0 0.7 1.1 0.9 0.1 1.8 0.8 0.0 0.2 0.1 0.4 0.4 0.2 0.2 0.3 0.3 0.1 0.2 0.3 0.5 0.0 0.1 0.3 0.2 0.4 0.1 26.8 39.1 0.2 33.6 45.5 1.2 0.0 0.0 0.0 0.0 1.2 1.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RSU1 "FLJ31034, RSP-1" ENSG00000148484 "Ras suppressor protein 1" Q15404 10 16590611-16817463 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025927 Uncertain Approved Vesicles NA NA 33000000 "Cluster 27: Non-specific - Gene expression" "Cluster 46: Fibroblasts - ECM organization" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" Vesicles "HPA025927: AB_10610420" "unprognostic (7.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.08e-1)" "unprognostic (4.89e-1)" "unprognostic (9.56e-3)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (1.99e-1)" "unprognostic (3.83e-2)" "unprognostic (3.72e-2)" "unprognostic (3.30e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (9.32e-5)" "unprognostic (1.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.48e-1)" "unprognostic (4.53e-2)" 35.6 14.2 8.8 22.0 8.9 27.9 25.4 8.8 10.1 21.2 10.1 27.8 12.0 30.3 19.9 27.7 19.2 19.7 25.1 8.7 10.1 19.4 16.7 27.7 22.3 10.5 9.4 21.8 21.2 14.1 3.9 23.2 9.8 17.9 23.8 9.9 14.5 27.0 15.8 15.9 13.7 41.8 8.6 20.4 15.6 5.5 10.4 18.1 18.7 13.8 22.3 24.0 18.0 9.6 27.3 18.6 15.0 88.5 78.4 80.3 18.3 66.3 28.2 45.1 48.6 17.3 25.0 27.0 10.5 91.2 24.1 23.9 18.3 34.7 48.3 40.6 14.6 85.2 11.1 16.7 34.5 13.1 47.8 40.0 36.0 43.3 13.7 40.9 47.8 27.8 14.0 18.2 61.6 17.6 30.5 23.5 15.7 39.6 10.5 19.6 20.3 18.4 44.0 10.0 5.9 11.6 33.1 21.6 33.6 26.8 7.6 34.4 58.8 38.4 13.3 48.5 34.6 15.9 20.6 23.3 51.0 37.1 16.9 33.0 20.9 22.8 24.7 26.0 28.0 16.6 28.1 26.7 34.7 17.9 20.5 25.8 14.6 31.3 25.5 25.9 36.0 48.5 8.8 8.9 8.8 10.1 8.7 10.1 10.5 9.4 9.8 8.6 10.4 9.6 111.1 35.3 24.5 26.4 29.9 36.7 30.3 74.0 12.0 1.7 22.5 36.2 41.2 27.1 48.3 42.3 2.1 131.9 41.6 57.0 68.4 72.1 80.5 20.7 47.2 69.6 7.2 74.7 52.8 119.2 83.0 52.8 28.5 24.8 34.2 20.5 64.2 32.7 121.7 3.3 34.7 19.0 52.9 61.1 80.7 163.3 39.4 106.2 60.5 52.5 92.3 5.8 66.9 45.8 51.7 81.2 16.8 68.4 36.7 17.4 14.9 58.3 48.8 17.9 65.7 32.4 136.1 3.9 22.6 34.1 42.8 96.2 46.8 35.9 27.2 24.9 CUBN "gp280, IFCR, MGA1" ENSG00000107611 Cubilin O60494 10 16823966-17129811 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Protein transport, Steroid metabolism, Sterol metabolism, Transport" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 140.4" "Group enriched" "Detected in many" 7 "Proximal enterocytes: 257.7;Proximal tubular cells: 325.0" "Cancer enriched" "Detected in some" 15 "renal cancer: 24.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 14.8;ASC TERT1: 3.0;SK-MEL-30: 2.8;WM-115: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004133, HPA043854" Enhanced "Intracellular and membrane" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA004133: AB_2732398, HPA043854: AB_2732510" "unprognostic (1.75e-1)" "unprognostic (2.35e-1)" "unprognostic (2.12e-3)" "unprognostic (8.61e-4)" "unprognostic (9.54e-2)" "unprognostic (2.78e-2)" "unprognostic (2.88e-2)" "unprognostic (7.03e-2)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "unprognostic (1.98e-2)" "unprognostic (2.47e-1)" "prognostic favorable (1.12e-4)" "unprognostic (6.24e-3)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (1.93e-1)" 0.7 0.8 0.8 0.4 0.9 0.4 0.8 0.8 0.7 1.2 1.3 0.5 0.2 0.7 3.1 0.2 2.1 0.3 0.6 0.8 0.8 140.4 0.1 0.6 0.8 2.5 1.7 2.5 0.5 0.6 2.2 2.6 2.4 1.1 0.2 3.0 0.7 0.4 0.3 0.8 28.0 0.4 1.7 0.9 0.4 2.0 1.0 1.7 3.8 0.5 0.7 0.4 0.7 0.6 0.0 0.0 1.5 14.8 0.5 3.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.8 1.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.6 1.5 0.6 0.1 0.2 0.2 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.3 0.0 0.0 2.8 0.1 0.0 0.1 1.6 0.1 0.2 0.3 0.1 0.5 0.0 0.0 0.4 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.9 0.8 0.7 0.8 0.8 2.5 1.7 2.4 1.7 1.0 0.6 3.2 0.0 1.5 23.8 3.7 0.5 0.4 0.2 0.6 2.9 0.6 0.6 1.7 0.0 3.2 5.5 2.1 0.0 3.3 0.1 13.7 0.0 37.3 3.1 2.2 5.7 0.0 0.0 8.4 0.2 0.0 2.3 0.0 2.2 0.0 2.2 1.4 0.0 0.1 0.0 9.0 3.7 0.0 0.3 0.4 31.8 2.8 3.1 7.2 7.5 0.1 6.5 1.0 9.0 5.5 0.1 5.0 1.2 1.6 0.4 257.7 325.0 3.5 4.0 0.0 19.0 1.6 1.1 0.9 0.1 0.9 0.1 2.9 1.2 1.2 0.2 TRDMT1 "DNMT2, RNMT1" ENSG00000107614 "TRNA aspartic acid methyltransferase 1" O14717 10 17137336-17202054 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 29.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009468, HPA036945, HPA036946" Approved NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 21: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "CAB009468: AB_2208432, HPA036945: AB_2675398, HPA036946: AB_2675399" "unprognostic (4.55e-1)" "unprognostic (3.22e-2)" "unprognostic (4.49e-6)" "unprognostic (7.07e-2)" "unprognostic (3.87e-3)" "unprognostic (1.33e-1)" "unprognostic (3.27e-4)" "unprognostic (3.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.55e-1)" "unprognostic (2.65e-2)" "unprognostic (3.50e-2)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.40e-1)" "unprognostic (2.64e-2)" 1.8 1.5 1.4 1.3 2.3 1.5 1.8 4.5 1.6 1.7 1.9 1.2 0.8 2.7 4.6 1.2 2.0 2.0 1.4 1.5 1.1 2.1 0.7 1.4 2.2 2.5 2.0 3.0 1.5 2.6 1.3 1.5 3.2 1.3 1.0 5.8 1.5 0.9 1.2 1.6 1.3 1.1 1.6 1.3 1.5 1.2 1.5 3.3 3.7 0.2 1.9 1.1 1.5 1.4 3.6 1.3 7.7 1.3 2.3 1.1 0.0 4.0 2.0 4.0 4.0 3.2 3.5 2.1 0.5 1.5 5.7 1.9 3.7 2.0 2.6 5.4 1.6 2.4 3.3 1.8 0.6 2.8 3.1 2.0 1.6 1.7 1.6 2.6 2.6 6.1 3.8 2.7 4.6 0.8 14.6 0.9 4.1 1.1 1.3 2.6 5.3 1.3 0.7 2.4 1.7 2.3 0.0 1.7 2.1 3.3 2.9 2.3 0.9 1.9 5.1 4.7 3.0 3.1 4.1 7.0 2.5 3.2 1.9 4.9 2.5 1.2 2.2 1.7 4.2 3.4 3.8 2.8 3.2 3.5 4.9 3.4 1.6 2.6 0.9 7.0 1.3 2.0 1.4 2.3 4.5 1.6 1.5 1.1 2.5 2.0 3.2 1.6 1.5 1.4 6.5 6.4 4.8 29.4 9.1 3.3 2.1 3.5 4.6 12.2 2.6 2.8 5.5 2.8 6.1 3.7 4.2 2.1 7.1 2.1 5.9 4.4 6.7 8.1 5.9 6.2 0.0 6.9 21.8 4.9 2.5 5.8 5.6 5.9 12.7 10.2 4.2 1.7 5.1 16.8 23.2 1.2 4.1 5.0 7.0 6.7 6.5 5.8 0.0 8.4 5.4 12.1 7.2 23.6 14.9 2.5 1.7 6.4 10.2 1.1 2.5 5.0 7.5 17.3 0.0 7.7 7.6 12.5 6.1 4.8 3.1 1.8 10.4 7.6 3.1 1.2 VIM ENSG00000026025 Vimentin P08670 10 17228241-17237593 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 4879.0;Langerhans cells: 4893.1;Leydig cells: 5013.2;Muller glia cells: 8977.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 18287.8;fHDF/TERT166: 10084.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000080, HPA001762, CAB058687" Enhanced Supported "Intermediate filaments" NA NA 35000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 41: Macrophages - Immune response" "Intermediate filaments" "CAB000080: AB_2304493, CAB058687: AB_2665570, HPA001762: AB_1080568" "unprognostic (1.02e-1)" "unprognostic (2.58e-1)" "unprognostic (2.87e-2)" "prognostic favorable (9.75e-6)" "unprognostic (3.81e-2)" "unprognostic (2.52e-1)" "unprognostic (3.21e-1)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (2.05e-1)" "unprognostic (9.29e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (8.69e-8)" "unprognostic (1.87e-3)" "unprognostic (7.32e-2)" "unprognostic (1.82e-1)" "unprognostic (9.47e-3)" 3467.6 423.1 349.3 610.6 369.5 1455.5 2362.8 289.1 527.4 1816.3 568.1 923.2 218.4 1226.5 400.0 451.5 1458.7 960.2 1364.3 337.5 404.6 473.6 192.8 1133.2 806.2 667.4 328.2 3690.8 370.0 224.8 574.5 1030.0 443.7 570.0 400.8 731.0 628.5 551.8 363.7 1126.8 674.7 1109.3 414.6 819.9 522.8 251.7 472.7 412.2 1391.1 555.8 744.7 983.5 1366.6 425.5 21.2 1119.0 1981.0 3180.7 6407.4 18287.8 3.0 5238.5 3458.9 3859.2 3421.5 8.5 70.4 2.9 273.2 10084.4 1804.7 8.4 283.8 147.0 3734.1 3567.5 387.2 563.2 523.5 0.3 1967.3 301.1 222.8 6746.8 6.5 5712.0 3213.4 9020.8 6366.3 372.4 889.3 1575.4 6939.5 4.5 736.6 911.2 632.4 1.4 1394.0 564.8 2745.9 95.7 3925.3 0.8 8.1 946.6 1.4 6.9 5447.5 1133.1 8.6 341.8 5459.0 3819.8 1644.5 3244.7 6311.5 1754.4 953.7 130.4 5775.4 28.9 3726.3 667.8 751.8 215.2 219.5 469.3 278.7 176.3 357.0 285.0 866.0 117.5 217.1 217.2 409.3 99.2 471.2 342.3 481.5 615.4 349.3 369.5 289.1 527.4 337.5 404.6 667.4 328.2 443.7 414.6 472.7 425.5 3211.7 157.0 349.4 53.5 605.8 725.8 21.6 361.2 58.1 74.2 108.8 539.1 109.5 94.4 157.3 108.5 50.1 22.1 1110.1 9.1 5.9 198.8 58.1 922.9 2314.1 2923.2 309.1 236.5 0.4 569.0 45.8 3443.0 101.4 693.7 2776.4 4879.0 2195.6 19.2 3541.4 33.7 0.3 1.8 16.2 2841.2 4893.1 131.6 5013.2 3177.8 3082.5 85.3 3893.1 8977.0 259.5 1.0 0.4 525.9 1.5 2336.6 2097.2 79.5 3.1 181.6 90.7 284.1 1420.0 3171.9 3714.2 55.1 27.5 39.4 473.0 52.7 1566.3 1791.1 6.2 28.9 ST8SIA6 SIAT8F ENSG00000148488 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6" P61647 10 17315421-17454595 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.5;lung: 5.9" "Cell type enriched" "Detected in some" 5 "Microglial cells: 137.7" "Cancer enhanced" "Detected in some" "breast cancer: 5.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "HMC-1: 208.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011635, HPA072708" Uncertain Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 3: HMC-1 - Innate immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Endoplasmic reticulum" "HPA011635: AB_2194921, HPA072708: " "unprognostic (4.86e-3)" "unprognostic (7.01e-2)" "unprognostic (5.85e-3)" "unprognostic (2.21e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" "unprognostic (1.11e-2)" "unprognostic (6.81e-2)" "unprognostic (2.32e-1)" "unprognostic (3.23e-2)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (2.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.43e-1)" "unprognostic (2.22e-1)" "unprognostic (1.07e-3)" 0.7 0.3 5.8 0.4 4.1 1.8 5.2 3.2 3.6 0.3 2.4 0.6 0.3 0.4 4.6 0.5 0.3 0.5 3.4 2.9 3.3 0.8 1.0 5.9 0.2 5.4 10.5 0.4 0.2 0.0 0.3 1.1 4.6 1.5 0.4 0.4 0.6 0.2 0.2 1.0 0.4 0.3 3.6 0.6 0.3 0.3 8.0 0.3 0.4 0.8 0.4 0.2 0.4 4.3 0.2 0.2 0.1 1.7 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.6 0.6 0.0 0.1 0.3 0.3 0.5 0.1 0.0 0.0 0.4 0.2 25.9 0.4 0.5 0.0 0.0 208.0 0.1 0.0 0.2 0.1 1.8 0.0 0.3 4.6 0.4 2.5 1.9 1.1 0.4 2.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 9.3 0.2 1.1 0.0 3.6 0.1 0.3 0.0 0.1 0.1 0.2 0.1 0.1 0.4 0.1 1.7 0.5 0.5 0.5 0.1 0.2 0.1 0.3 0.3 0.2 0.3 0.3 0.4 1.0 0.7 0.3 0.2 0.8 0.2 5.8 4.1 3.2 3.6 2.9 3.3 5.4 10.5 4.6 3.6 8.0 4.3 0.6 0.0 0.0 2.6 0.1 0.6 0.1 0.2 0.0 0.0 10.0 3.9 0.8 0.0 0.2 0.0 0.0 0.0 5.5 1.2 0.0 0.0 0.5 0.1 0.0 10.9 0.0 25.5 3.0 0.0 0.0 0.3 0.0 0.8 10.2 2.8 26.7 0.0 0.1 0.0 4.4 0.0 0.0 0.9 0.0 0.6 0.0 0.2 8.8 137.7 0.2 0.0 8.2 1.5 1.1 0.1 0.1 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.8 0.3 0.0 0.0 0.0 2.4 0.1 0.0 0.1 HACD1 "CAP, PTPLA" ENSG00000165996 "3-hydroxyacyl-CoA dehydratase 1" B0YJ81 10 17589032-17617374 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Developmental protein, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 73.0" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 143.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 11 "T-reg: 55.7" "Lineage enriched" "Detected in many" 12 "T-cells: 55.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (2.73e-2)" "unprognostic (3.26e-2)" "unprognostic (3.54e-1)" "unprognostic (2.62e-2)" "unprognostic (4.10e-1)" "unprognostic (5.67e-3)" "unprognostic (4.21e-2)" "unprognostic (3.04e-2)" "unprognostic (2.38e-1)" "unprognostic (1.70e-2)" "unprognostic (2.61e-2)" "unprognostic (3.43e-1)" "unprognostic (2.46e-2)" "unprognostic (2.93e-2)" "unprognostic (3.40e-2)" "unprognostic (1.10e-1)" "unprognostic (6.49e-2)" 9.7 7.0 3.1 5.0 3.5 8.0 8.8 10.7 4.6 6.8 2.9 31.9 2.8 22.1 3.3 7.8 10.3 3.6 73.0 3.0 6.5 5.0 1.6 9.7 1.3 5.5 5.2 4.3 2.7 0.5 3.7 1.6 5.0 11.9 3.8 2.3 2.7 16.7 36.5 3.0 6.9 25.4 2.4 1.7 15.0 3.5 4.7 2.6 7.6 16.5 1.2 18.1 6.8 8.4 29.3 24.6 6.8 33.4 30.1 5.8 0.6 40.5 24.4 51.9 48.5 16.4 34.6 0.2 5.9 66.4 74.5 7.1 17.3 12.3 28.6 19.1 10.4 67.1 18.4 45.6 39.0 0.3 4.8 14.0 17.2 29.9 11.6 39.8 10.1 35.1 0.6 1.3 69.0 21.0 50.4 6.7 14.6 2.2 6.6 44.7 7.1 0.8 20.5 5.6 7.5 19.1 34.6 0.6 58.9 21.2 24.2 16.7 9.8 30.3 17.4 18.7 18.8 0.9 0.8 0.3 22.3 7.7 4.3 4.7 0.9 0.7 1.2 0.1 0.3 0.4 5.0 1.0 3.0 1.3 0.9 0.7 2.6 3.3 0.3 1.5 55.7 1.3 3.1 3.5 10.7 4.6 3.0 6.5 5.5 5.2 5.0 2.4 4.7 8.4 2.4 28.9 15.0 0.3 0.4 0.0 23.1 0.0 8.0 0.8 6.9 21.6 143.7 10.0 2.5 31.3 0.0 0.5 4.4 0.4 3.9 16.5 11.1 5.6 8.0 5.4 3.6 29.2 10.4 8.0 1.9 7.1 8.2 12.4 6.3 17.5 20.7 1.0 5.4 0.0 11.7 2.5 0.0 2.2 0.0 2.7 1.8 3.6 0.0 5.6 0.8 0.5 1.0 2.5 31.8 15.6 0.8 0.7 0.6 23.9 0.5 2.3 0.7 0.6 0.0 5.7 32.5 7.4 5.2 17.7 0.0 3.0 2.9 10.8 3.5 6.2 STAM STAM1 ENSG00000136738 "Signal transducing adaptor molecule" Q92783 10 17644151-17716824 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "T-reg: 76.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034399, HPA043882" Supported Supported Vesicles NA NA 82000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 36: HEL - Hemostasis" "Cluster 24: Non-specific - Transcription regulation" Vesicles "CAB034399: AB_2197486, HPA043882: AB_2678713" "unprognostic (1.09e-2)" "unprognostic (8.32e-2)" "unprognostic (1.10e-1)" "unprognostic (3.95e-2)" "unprognostic (9.11e-3)" "unprognostic (1.04e-1)" "prognostic unfavorable (3.44e-6)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (8.58e-2)" "unprognostic (1.37e-2)" "unprognostic (8.39e-2)" "unprognostic (1.02e-3)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.02e-1)" 10.8 13.3 7.7 6.9 9.7 53.1 8.9 14.0 11.8 10.7 3.4 8.0 8.2 9.0 5.8 12.2 7.8 9.1 18.0 9.2 8.7 10.2 6.9 10.9 7.5 9.8 9.5 11.4 10.4 10.3 7.4 8.5 9.8 8.7 7.7 11.2 8.5 6.1 24.5 10.0 7.3 8.5 9.6 6.8 11.4 8.1 9.1 13.1 10.8 10.1 7.5 10.9 9.0 14.7 34.8 19.8 30.8 14.2 30.1 21.9 10.3 45.1 19.8 41.0 33.1 25.9 31.7 9.1 7.2 33.9 31.7 18.2 27.6 21.1 35.0 10.9 12.7 86.3 15.3 43.1 31.8 6.5 43.7 22.7 27.0 33.6 28.3 26.6 19.8 56.3 30.1 10.5 43.8 10.4 35.7 5.6 14.7 19.7 10.2 18.0 29.0 11.9 17.5 11.2 13.0 19.2 24.6 16.7 34.6 24.1 27.5 9.4 26.6 23.9 24.5 42.7 21.1 6.6 11.5 15.6 25.6 9.6 15.6 47.5 7.5 12.5 5.9 8.2 5.6 5.4 12.8 6.2 9.6 3.1 8.8 7.1 5.9 17.3 7.5 5.5 76.5 6.4 7.7 9.7 14.0 11.8 9.2 8.7 9.8 9.5 9.8 9.6 9.1 14.7 13.2 12.8 23.4 15.7 14.1 22.9 5.3 16.2 23.9 19.7 9.4 8.9 30.0 5.7 14.0 16.5 10.4 10.2 24.3 6.4 5.9 15.1 3.5 16.3 22.3 11.0 11.4 56.8 31.7 13.4 10.5 23.5 15.8 25.9 31.6 13.0 10.4 7.8 15.5 10.1 36.9 7.8 2.0 10.4 16.3 3.5 9.6 15.6 19.6 39.4 8.4 13.7 10.3 31.7 59.4 29.9 8.0 6.0 20.8 10.1 5.7 15.6 14.0 14.5 26.3 22.3 12.6 22.1 14.6 21.8 21.0 24.6 27.6 18.4 8.1 8.5 TMEM236 "bA162I21.2, bA16O1.2, FAM23A, FAM23B" ENSG00000148483 "Transmembrane protein 236" Q5W0B7 10 17752201-17800868 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "intestine: 33.5" "Cell type enhanced" "Detected in some" "Distal enterocytes: 81.1;Enteroendocrine cells: 23.4;Intestinal goblet cells: 28.8;Paneth cells: 48.1;Proximal enterocytes: 96.5;Undifferentiated cells: 19.0" "Group enriched" "Detected in some" 4 "colorectal cancer: 1.7;pancreatic cancer: 0.5;stomach cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "MOLT-4: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045096 Enhanced NA NA "Cluster 17: Basophils - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 45: Enterocytes - Digestion" "HPA045096: AB_2732516" "unprognostic (4.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.88e-3)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (3.36e-2)" "unprognostic (2.52e-3)" "unprognostic (1.37e-1)" "unprognostic (3.98e-1)" "unprognostic (1.42e-1)" "unprognostic (5.06e-3)" "unprognostic (1.75e-1)" "unprognostic (1.62e-2)" "unprognostic (1.72e-1)" "unprognostic (3.43e-2)" "unprognostic (3.16e-2)" "unprognostic (1.54e-2)" 0.7 0.6 0.3 1.7 0.3 0.5 0.4 0.8 0.5 0.5 0.4 14.1 21.8 0.3 0.2 0.3 0.2 0.4 0.3 0.3 0.1 0.2 0.1 0.7 0.3 0.1 0.0 0.3 0.5 0.1 0.0 1.5 0.2 0.1 14.0 0.3 0.1 0.2 0.3 0.3 33.5 1.0 0.0 0.3 0.4 0.2 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.7 0.2 0.0 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.3 0.3 0.2 0.0 0.2 0.9 0.1 0.2 0.1 0.0 0.1 0.2 0.4 0.1 0.2 0.1 0.2 10.3 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.0 0.4 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.3 0.8 0.5 0.3 0.1 0.1 0.0 0.2 0.0 0.1 0.7 0.2 0.0 0.5 0.0 0.2 0.1 0.5 0.0 0.0 0.3 7.3 0.3 0.9 0.0 0.0 0.0 0.0 0.1 0.1 81.1 0.0 0.1 1.1 0.1 0.1 0.2 23.4 0.4 0.4 0.9 0.2 0.2 0.0 0.5 1.3 0.1 1.1 0.0 7.2 0.0 0.4 28.8 0.0 4.8 0.8 1.1 0.0 5.9 0.0 3.7 0.0 0.1 0.0 0.0 0.6 0.7 48.1 0.0 0.0 0.4 96.5 0.0 0.0 0.9 0.0 0.7 0.3 0.4 0.1 0.2 0.0 0.3 0.4 0.2 19.0 0.6 MRC1 "bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1" ENSG00000260314 "Mannose receptor C-type 1" P22897 10 17809348-17911164 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 122.3" "Group enriched" "Detected in many" 4 "Breast glandular cells: 128.9;Hepatic stellate cells: 397.7;Hofbauer cells: 176.1;Kupffer cells: 361.4;Macrophages: 316.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 16 "myeloid DC: 4.8" "Lineage enriched" "Detected in single" 16 "dendritic cells: 4.8" "Group enriched" "Detected in some" 19 "MOLT-4: 19.3;TIME: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004114, HPA045134, CAB068203" Enhanced NA NA 170000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 19: Lung - Lung function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 4: Macrophages - Innate immune response" "CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228" "unprognostic (2.20e-1)" "unprognostic (2.07e-1)" "unprognostic (1.03e-2)" "unprognostic (2.58e-1)" "unprognostic (5.62e-2)" "unprognostic (4.30e-1)" "unprognostic (6.36e-3)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (6.05e-2)" "unprognostic (5.61e-2)" "unprognostic (4.12e-1)" "unprognostic (2.94e-2)" "unprognostic (4.97e-2)" "unprognostic (3.05e-2)" "unprognostic (1.74e-2)" "unprognostic (7.02e-2)" 54.4 28.7 0.8 24.0 1.7 0.7 16.3 0.3 3.5 17.2 9.2 16.1 9.9 7.2 1.7 13.1 11.9 27.7 10.2 1.1 0.7 7.6 40.9 122.3 15.2 1.4 0.9 6.2 8.1 4.6 1.5 54.3 1.1 2.2 18.5 0.1 4.9 8.0 1.8 2.8 17.5 30.3 0.7 50.6 9.7 7.5 2.8 8.0 5.5 8.7 3.0 29.0 2.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 19.3 0.0 0.2 0.0 0.0 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.8 1.7 0.3 3.5 1.1 0.7 1.4 0.9 1.1 0.7 2.8 1.3 4.0 32.1 43.5 1.3 3.5 0.4 0.0 0.0 0.0 0.0 128.9 1.7 3.6 11.5 7.4 0.0 0.0 0.9 1.0 1.4 0.0 0.1 27.3 0.0 0.1 39.0 0.0 3.2 0.8 0.4 1.4 2.5 0.0 0.1 13.9 0.1 397.7 13.1 176.1 0.0 1.3 0.9 0.0 361.4 46.8 19.4 1.5 316.5 0.0 60.9 0.5 0.0 0.0 0.5 0.5 0.1 1.5 0.0 1.0 0.0 2.2 0.1 5.8 0.0 32.9 3.0 2.2 0.4 2.3 1.2 0.4 2.1 4.7 1.7 0.8 0.1 SLC39A12 FLJ30499 ENSG00000148482 "Solute carrier family 39 member 12" Q504Y0 10 17951839-18043292 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "choroid plexus: 353.4" "Group enriched" "Detected in some" 31 "Astrocytes: 133.5;Muller glia cells: 69.5" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 64: Astrocytes - Nervous system maintenance" "unprognostic (1.43e-2)" "unprognostic (2.67e-1)" "unprognostic (3.30e-1)" "unprognostic (8.70e-2)" "unprognostic (1.02e-1)" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.40e-6)" "unprognostic (1.94e-1)" "unprognostic (8.11e-2)" "unprognostic (3.76e-2)" 0.1 0.0 27.6 0.0 27.7 0.0 0.7 25.3 39.9 0.0 353.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.5 27.1 0.0 0.1 0.1 0.0 29.9 35.8 0.0 0.1 0.0 1.3 0.1 28.1 0.0 0.1 15.7 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.1 0.0 0.2 36.6 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.6 27.7 25.3 39.9 36.5 27.1 29.9 35.8 28.1 22.0 36.6 23.1 0.1 0.0 0.0 133.5 0.0 0.0 0.0 0.0 0.0 0.7 2.4 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.7 0.2 0.0 0.0 0.4 0.8 0.3 0.2 0.0 2.8 0.0 69.5 0.0 1.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CACNB2 "CACNLB2, MYSB" ENSG00000165995 "Calcium voltage-gated channel auxiliary subunit beta 2" Q08289 10 18140424-18543557 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Brugada syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 35.1" "Group enriched" "Detected in many" 5 "Astrocytes: 863.5;Excitatory neurons: 545.7;Inhibitory neurons: 357.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 6.4;HSkMC: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035326 Enhanced NA NA "Cluster 10: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA035326: AB_10669903" "unprognostic (3.03e-3)" "unprognostic (3.04e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (4.58e-3)" "unprognostic (4.67e-4)" "unprognostic (8.03e-2)" "unprognostic (3.76e-2)" "unprognostic (8.10e-2)" "unprognostic (1.70e-1)" "unprognostic (7.78e-4)" "unprognostic (1.40e-1)" "prognostic favorable (3.56e-5)" "unprognostic (3.48e-2)" "unprognostic (5.72e-2)" "unprognostic (1.03e-1)" "unprognostic (8.16e-2)" 2.8 9.4 1.3 2.1 3.9 1.3 3.8 5.4 12.9 7.4 0.1 17.6 1.1 12.8 2.7 5.0 10.1 2.2 17.8 5.4 7.4 3.2 10.7 3.9 0.9 0.0 0.1 13.6 7.5 0.6 19.3 0.5 0.0 8.5 3.2 35.1 3.9 8.8 1.1 4.2 11.4 5.3 0.0 1.5 7.7 2.1 2.2 0.7 2.5 0.7 0.2 16.8 4.6 1.5 0.2 1.0 0.7 0.5 0.3 0.3 0.5 0.3 0.0 0.0 0.3 0.4 0.5 0.9 0.2 0.2 0.3 0.7 6.4 0.0 0.0 0.3 2.4 0.8 1.7 1.5 1.6 0.5 1.5 8.1 0.0 0.0 0.0 0.3 0.0 1.4 0.9 1.6 0.0 0.7 0.8 1.0 2.4 0.0 0.0 0.7 0.7 0.8 0.0 0.8 2.9 0.8 0.1 0.0 0.4 0.8 0.1 0.9 0.0 0.6 1.5 0.3 0.6 1.6 1.8 1.7 0.2 1.2 0.3 1.4 0.1 0.2 0.2 0.2 0.4 0.4 0.3 0.1 0.0 0.5 0.5 0.8 0.1 0.3 0.2 0.2 1.1 0.0 1.3 3.9 5.4 12.9 5.4 7.4 0.0 0.1 0.0 0.0 2.2 1.5 2.1 0.0 0.6 863.5 0.1 3.3 1.3 0.0 1.8 31.9 1.1 1.3 22.4 0.0 0.0 0.0 108.4 0.4 0.7 2.8 1.9 0.4 0.9 1.1 13.9 1.5 37.1 0.8 545.7 0.2 0.0 3.0 0.0 2.6 0.0 3.8 0.0 0.9 0.1 8.4 357.8 9.4 0.0 0.0 1.1 0.8 0.9 0.5 1.8 96.5 0.0 15.9 0.0 95.5 13.7 0.2 2.4 4.5 0.3 2.1 5.9 0.8 0.0 75.7 6.6 2.6 14.2 0.1 0.1 0.0 4.1 0.3 1.0 5.3 5.7 1.3 NSUN6 "ARL5B-AS1, FLJ23743, NOPD1" ENSG00000241058 "NOP2/Sun RNA methyltransferase 6" Q8TEA1 10 18545561-18659285 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 61.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045902 Approved Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "HPA045902: AB_10962354" "unprognostic (7.34e-2)" "unprognostic (1.69e-2)" "unprognostic (3.10e-3)" "unprognostic (9.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.33e-3)" "unprognostic (1.63e-2)" "prognostic favorable (8.42e-4)" "unprognostic (1.60e-1)" "unprognostic (2.45e-1)" "unprognostic (9.96e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.55e-5)" "unprognostic (2.23e-1)" "unprognostic (7.53e-3)" "unprognostic (3.18e-2)" "unprognostic (2.00e-3)" 6.4 12.2 13.6 7.5 14.3 12.4 9.3 16.0 15.9 9.0 13.5 6.1 8.6 9.6 12.2 5.7 8.7 6.0 8.6 14.0 14.1 10.6 61.1 6.5 11.3 13.8 14.8 12.7 12.0 7.8 17.2 6.5 14.7 10.5 8.4 12.9 8.4 5.6 4.5 9.1 8.7 6.1 13.9 9.8 8.5 17.5 13.8 11.8 12.0 4.8 10.9 9.1 7.6 17.6 7.5 6.3 16.6 12.3 8.1 11.1 7.2 10.3 2.5 8.4 11.3 12.0 11.2 17.0 4.3 4.0 5.9 11.0 17.1 10.8 10.8 16.6 13.9 17.8 8.8 14.5 8.3 8.1 11.6 8.6 10.3 8.0 5.5 8.3 3.9 20.0 25.1 16.1 8.2 4.2 18.6 9.3 8.5 14.8 4.8 13.1 8.6 17.4 6.3 9.1 8.9 11.0 8.7 9.0 7.3 11.3 5.8 6.4 6.7 7.0 8.1 12.8 7.6 9.9 11.0 18.8 5.0 14.5 4.3 1.5 3.5 2.8 4.4 4.7 7.0 8.0 6.3 5.6 2.9 6.1 7.8 6.7 1.6 5.3 8.2 4.0 10.5 2.5 13.6 14.3 16.0 15.9 14.0 14.1 13.8 14.8 14.7 13.9 13.8 17.6 75.4 9.6 15.1 57.8 34.9 28.7 17.1 11.0 30.1 33.2 32.4 34.7 8.1 18.6 13.6 9.2 22.9 10.1 39.6 19.5 5.9 10.0 19.7 23.6 38.9 37.5 14.5 20.8 43.5 12.7 8.0 19.2 40.2 49.0 17.7 32.0 26.7 86.6 7.4 25.2 45.0 24.5 18.3 24.2 52.4 12.7 25.7 28.5 12.4 23.4 15.3 15.3 17.5 43.7 57.6 11.1 20.0 17.0 31.0 10.1 40.2 10.9 14.5 28.9 13.1 20.1 19.1 49.5 21.8 21.3 26.7 6.7 31.0 26.7 18.7 14.2 ARL5B ARL8 ENSG00000165997 "ADP ribosylation factor like GTPase 5B" Q96KC2 10 18659431-18681639 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 314.7;Langerhans cells: 304.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027002 Approved NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" "HPA027002: AB_10601685" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (4.04e-2)" "unprognostic (4.32e-2)" "unprognostic (1.77e-2)" "unprognostic (7.86e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "unprognostic (8.34e-2)" "unprognostic (6.54e-2)" "unprognostic (1.83e-1)" "unprognostic (7.54e-2)" "unprognostic (2.62e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (1.07e-1)" 11.1 20.8 3.2 7.8 3.5 19.6 6.5 6.0 5.6 8.1 4.5 7.5 9.3 9.3 3.7 8.5 4.7 14.1 6.8 3.6 4.0 5.7 29.8 9.7 7.1 3.4 3.9 7.9 9.0 6.1 6.8 13.1 3.6 6.3 8.4 5.7 7.2 3.6 4.3 6.6 10.0 6.7 4.0 5.6 6.4 5.7 3.9 13.5 8.2 6.2 7.1 12.6 5.9 4.3 14.8 8.1 36.5 14.2 10.4 11.9 22.1 12.5 6.0 11.8 19.9 26.7 12.4 18.3 5.0 6.5 7.6 14.2 25.5 9.1 15.0 5.9 19.5 18.4 9.5 38.2 26.7 8.8 10.3 11.9 12.4 11.3 12.3 11.5 18.7 13.8 23.7 19.0 9.4 7.0 21.1 6.4 25.2 15.4 3.5 26.1 23.8 12.0 10.5 12.7 4.7 30.4 9.6 10.0 17.9 27.9 5.9 10.1 12.7 6.7 20.5 12.9 10.6 10.1 13.8 24.9 6.7 7.3 6.2 1.2 0.7 0.5 0.5 0.8 0.7 0.5 0.5 0.6 0.9 0.5 0.8 0.6 0.9 1.0 0.5 0.5 0.7 0.5 3.2 3.5 6.0 5.6 3.6 4.0 3.4 3.9 3.6 4.0 3.9 4.3 70.1 38.5 26.0 10.4 36.1 152.3 76.0 42.9 122.9 9.9 84.3 50.4 16.7 21.5 36.9 9.2 6.2 26.7 53.5 96.8 5.9 25.9 74.5 117.1 52.1 54.5 65.4 16.4 12.4 15.8 39.1 44.9 72.9 314.7 101.1 26.6 15.7 44.8 13.4 10.1 12.1 65.2 14.2 25.3 304.3 15.8 6.8 94.1 58.7 12.2 8.0 9.1 7.2 19.1 14.7 20.8 81.6 5.7 49.0 63.8 58.5 8.1 34.5 7.4 6.6 41.9 50.8 27.8 15.5 134.6 167.1 43.2 47.1 21.5 43.5 153.1 MALRD1 "bA265G8.2, C10orf112, Diet1" ENSG00000204740 "MAM and LDL receptor class A domain containing 1" Q5VYJ5 10 19048801-19790401 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "intestine: 31.1" "Group enriched" "Detected in some" 4 "Astrocytes: 37.9;Oligodendrocyte precursor cells: 76.4;Proximal enterocytes: 69.3" "Cancer enhanced" "Detected in some" "breast cancer: 0.9;stomach cancer: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "Karpas-707: 44.2" "Not detected" "Not detected" "HPA035732, HPA038106, HPA046848" Uncertain Enhanced "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837" "unprognostic (9.03e-3)" "unprognostic (1.38e-1)" "unprognostic (2.40e-2)" "unprognostic (4.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (2.74e-2)" "unprognostic (5.57e-2)" "unprognostic (5.01e-1)" "unprognostic (1.00e-1)" "unprognostic (3.55e-1)" "unprognostic (7.69e-2)" "unprognostic (3.16e-2)" "unprognostic (9.80e-2)" "unprognostic (8.90e-2)" "unprognostic (3.13e-2)" "unprognostic (3.78e-4)" 0.5 0.7 1.9 0.2 1.9 0.4 0.6 1.0 1.6 0.7 1.3 0.5 30.6 0.6 2.2 0.2 0.2 0.4 1.4 1.8 2.1 1.5 0.1 0.9 0.1 1.5 1.7 1.2 0.1 0.0 1.5 0.4 1.5 0.6 0.1 0.3 0.1 0.3 0.6 0.2 31.1 0.4 1.7 0.2 0.3 2.1 1.9 1.9 0.5 0.1 0.0 0.6 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.8 0.0 2.6 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 44.2 0.0 4.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.9 1.9 1.0 1.6 1.8 2.1 1.5 1.7 1.5 1.7 1.9 1.5 0.0 0.0 1.8 37.9 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.6 1.6 0.0 0.0 0.0 0.0 0.8 1.3 0.0 1.9 0.1 7.9 0.1 0.3 0.1 0.0 4.2 11.6 0.0 0.8 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 11.0 9.5 0.0 0.0 0.3 1.8 0.0 0.0 0.0 5.6 0.0 1.4 0.0 76.4 4.9 0.0 13.8 0.7 0.0 0.2 69.3 0.2 0.0 0.0 0.0 0.1 0.2 9.0 4.1 0.1 0.1 0.3 0.0 1.9 9.7 0.0 PLXDC2 "FLJ14623, TEM7R" ENSG00000120594 "Plexin domain containing 2" Q6UX71 10 19816239-20289856 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Microglial cells: 1508.4;Oligodendrocytes: 470.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 57.5;intermediate monocyte: 33.4;myeloid DC: 36.0;neutrophil: 81.6;non-classical monocyte: 37.3" "Group enriched" "Detected in many" 13 "dendritic cells: 36.0;granulocytes: 81.6;monocytes: 57.5" "Cell line enhanced" "Detected in some" "HHSteC: 19.4;U-2197: 45.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017268, HPA070793" Approved Supported "Nuclear bodies" No No 720000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Nuclear bodies" "HPA017268: AB_10965928, HPA070793: AB_2686313" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (3.05e-1)" "unprognostic (3.31e-2)" "unprognostic (2.99e-1)" "unprognostic (1.94e-2)" "unprognostic (1.57e-1)" "unprognostic (5.32e-2)" "unprognostic (7.52e-2)" "unprognostic (1.89e-1)" "unprognostic (1.35e-1)" "unprognostic (5.44e-2)" "unprognostic (3.91e-3)" "unprognostic (8.71e-2)" "unprognostic (3.35e-1)" "unprognostic (2.66e-2)" 12.4 9.4 13.3 7.3 14.1 5.2 11.5 9.6 13.3 12.7 16.8 5.3 4.2 10.7 3.5 7.5 10.1 17.4 10.2 11.3 25.6 10.7 3.1 17.1 2.4 18.0 17.3 9.4 3.6 16.2 3.3 4.7 19.2 7.6 4.6 18.2 6.2 7.7 5.0 15.5 7.1 16.2 16.2 9.4 3.8 5.9 22.3 2.5 6.8 10.0 2.8 8.5 8.9 29.1 0.0 0.0 5.8 0.0 0.0 0.0 6.7 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 7.7 2.2 1.8 0.0 0.0 0.7 2.8 8.6 0.4 19.4 0.0 0.0 7.7 0.6 0.0 2.3 8.9 0.0 0.0 0.1 1.7 0.9 1.1 0.6 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.4 0.2 2.4 0.4 0.0 1.8 0.8 0.9 0.0 7.6 3.9 45.9 0.0 0.1 0.0 0.0 3.5 0.1 0.0 10.7 57.5 11.8 1.3 33.4 2.7 0.0 0.0 0.3 36.0 0.0 0.0 0.0 81.6 4.4 37.3 1.6 0.0 17.7 13.3 14.1 9.6 13.3 11.3 25.6 18.0 17.3 19.2 16.2 22.3 29.1 101.4 16.0 8.9 131.9 2.6 36.8 23.8 12.3 41.5 44.2 14.4 45.3 10.9 15.7 10.9 5.5 8.4 0.9 2.9 7.1 0.0 6.9 2.9 16.5 7.6 45.3 3.0 10.5 190.9 0.0 8.1 97.2 1.1 19.4 31.6 80.9 82.1 4.2 94.3 1.7 59.9 27.3 8.2 91.3 46.3 2.1 19.3 147.7 7.2 1508.4 94.5 25.5 5.2 158.3 470.2 1.0 16.6 57.2 3.8 5.5 16.0 22.2 3.0 73.6 19.7 110.1 12.7 1.6 1.2 35.5 38.1 1.2 4.2 71.4 8.8 11.7 NEBL "bA165O3.1, C10orf113, LASP2, LNEBL" ENSG00000078114 Nebulette O76041 10 20779973-21293011 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "heart muscle: 312.0" "Cell type enhanced" "Detected in many" "Astrocytes: 951.0;Cardiomyocytes: 2413.0;Excitatory neurons: 359.0;Inhibitory neurons: 436.6;Oligodendrocyte precursor cells: 352.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.4;SCLC-21H: 31.0;SH-SY5Y: 7.2;SK-BR-3: 8.0;TIME: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013994, HPA013995" Approved NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA013994: AB_1854359, HPA013995: AB_1854360" "unprognostic (3.79e-2)" "unprognostic (1.92e-3)" "unprognostic (3.44e-2)" "unprognostic (3.57e-3)" "unprognostic (1.50e-1)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.25e-2)" "unprognostic (1.05e-1)" "unprognostic (6.20e-3)" "unprognostic (2.36e-2)" "unprognostic (8.42e-2)" "prognostic favorable (2.77e-8)" "unprognostic (3.51e-1)" "unprognostic (8.11e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (5.56e-4)" 2.4 2.6 26.3 0.2 25.8 0.0 6.1 29.9 19.1 5.9 0.1 1.3 0.0 0.6 0.1 16.1 0.6 0.4 312.0 26.6 29.6 13.1 1.2 16.2 0.2 31.0 35.2 1.1 7.0 1.2 22.1 3.7 27.5 8.7 1.0 2.6 18.0 2.9 0.6 14.9 1.3 0.4 28.6 0.2 3.2 2.7 35.2 0.6 21.5 0.4 1.2 2.1 12.8 24.9 0.4 3.5 3.8 0.1 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.9 0.5 0.5 5.5 0.0 0.1 2.5 0.2 0.0 0.0 0.0 3.5 0.0 1.8 0.0 2.9 0.0 0.0 3.3 3.6 0.0 0.6 0.0 0.0 0.2 0.3 0.5 0.0 3.5 0.1 0.0 1.0 0.7 1.9 0.0 0.0 0.1 0.3 0.6 31.0 7.2 1.5 8.0 0.0 0.2 4.7 0.0 6.6 0.0 0.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 25.8 29.9 19.1 26.6 29.6 31.0 35.2 27.5 28.6 35.2 24.9 17.2 218.0 67.2 951.0 0.0 18.4 12.6 6.1 0.0 91.4 51.6 24.8 2413.0 15.7 19.9 33.1 39.6 15.3 1.0 7.5 29.4 2.9 331.4 17.4 3.9 20.8 18.0 0.0 359.0 7.1 11.1 61.0 8.6 47.3 0.0 1.0 0.7 0.2 2.1 146.4 436.6 19.5 14.2 0.6 2.3 61.7 3.7 1.2 12.4 206.1 5.9 4.0 0.0 352.3 9.0 12.9 25.7 4.9 0.0 17.3 5.5 7.7 39.1 10.3 0.0 0.8 14.8 2.8 1.1 33.8 46.2 36.8 1.8 4.5 13.7 33.9 SKIDA1 "C10orf140, FLJ45187" ENSG00000180592 "SKI/DACH domain containing 1" Q1XH10 10 21513475-21526368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Bipolar cells: 19.1;Early spermatids: 17.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 26.1;AN3-CA: 6.7;BEWO: 12.1;SH-SY5Y: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039208, HPA040439" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 45: Intestine - Brush border" "Cluster 12: NES - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA039208: AB_10795034, HPA040439: AB_10796122" "unprognostic (5.36e-2)" "unprognostic (1.84e-1)" "unprognostic (5.32e-3)" "unprognostic (6.45e-4)" "unprognostic (9.97e-2)" "unprognostic (3.23e-3)" "unprognostic (3.61e-2)" "unprognostic (1.12e-2)" "unprognostic (1.59e-2)" "unprognostic (4.23e-1)" "unprognostic (9.35e-3)" "unprognostic (5.93e-2)" "unprognostic (3.38e-6)" "unprognostic (8.13e-2)" "unprognostic (1.50e-1)" "unprognostic (8.20e-2)" "unprognostic (8.52e-3)" 0.3 0.6 0.4 0.1 0.6 0.6 0.2 0.4 2.3 0.5 0.0 0.6 0.1 0.2 0.2 0.2 0.5 0.1 1.2 0.5 0.0 1.3 1.4 0.3 0.1 0.1 0.0 1.3 0.5 1.1 0.5 0.8 0.0 0.3 0.2 1.5 0.5 0.6 0.2 1.0 0.2 0.3 0.0 0.1 0.2 1.7 0.0 0.2 1.2 0.2 0.1 0.3 0.3 0.9 0.5 1.1 26.1 6.7 0.5 0.3 12.1 0.5 0.4 0.0 0.1 2.5 0.2 0.2 1.0 0.4 0.2 1.6 2.4 0.5 0.0 0.0 2.9 0.1 1.3 0.3 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.7 0.2 0.4 0.2 0.2 0.1 1.1 0.9 0.1 1.6 0.0 0.0 0.4 0.8 0.0 0.5 0.7 2.9 6.0 0.9 4.5 0.1 2.1 0.4 5.4 0.4 0.2 0.8 0.2 0.6 0.1 0.0 0.3 1.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.4 2.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.0 0.0 1.5 5.2 0.2 1.5 1.0 0.6 6.8 19.1 1.8 2.2 6.9 4.3 1.4 1.8 0.0 5.3 0.0 0.1 7.9 0.1 17.9 0.4 1.3 4.3 0.0 0.0 2.8 0.6 3.4 2.1 0.0 0.3 1.3 3.3 4.6 10.3 3.2 1.7 2.2 0.0 0.0 2.2 0.3 10.2 1.5 0.6 0.0 1.0 0.0 6.1 0.0 3.5 2.1 0.3 0.0 2.2 0.1 0.7 0.0 8.5 0.6 4.7 6.6 1.5 1.2 6.5 5.1 4.2 1.8 3.4 0.1 5.2 0.0 0.2 MLLT10 AF10 ENSG00000078403 "MLLT10 histone lysine methyltransferase DOT1L cofactor" P55197 10 21524646-21743630 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 93.0" "Cell type enhanced" "Detected in all" "Excitatory neurons: 201.3;Spermatocytes: 233.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005736, HPA005747, HPA072790" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA005736: , HPA005747: AB_1079393, HPA072790: " "unprognostic (6.58e-2)" "unprognostic (1.57e-1)" "unprognostic (7.32e-2)" "unprognostic (1.47e-2)" "unprognostic (1.31e-2)" "prognostic favorable (8.75e-4)" "unprognostic (1.03e-3)" "unprognostic (9.56e-3)" "unprognostic (9.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.69e-2)" "unprognostic (7.85e-2)" "unprognostic (6.57e-2)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" 15.6 13.0 11.9 12.0 13.6 30.5 14.4 21.5 16.0 18.2 16.6 20.8 9.1 18.7 16.0 16.1 17.4 11.4 17.1 11.5 15.2 15.1 15.6 14.6 15.3 14.6 11.9 24.7 13.5 18.6 12.6 16.4 14.1 13.0 12.7 20.6 13.7 11.8 15.6 25.4 13.2 16.8 11.9 12.8 12.3 93.0 13.7 23.2 21.8 14.2 14.5 19.1 16.5 18.6 32.1 29.6 38.3 22.2 23.3 25.0 44.1 19.6 10.6 21.7 21.6 29.5 31.3 34.9 10.8 20.7 21.1 24.1 43.3 25.1 22.2 25.0 21.9 59.2 24.5 44.5 29.6 1.6 33.4 21.3 28.6 17.7 19.2 21.8 30.1 34.3 65.4 26.5 19.3 28.1 44.1 28.5 17.3 17.5 9.2 36.6 23.5 31.7 23.2 12.6 13.8 39.6 24.7 29.0 45.8 30.7 13.3 37.1 29.8 14.7 24.6 26.7 18.9 23.5 32.2 43.4 15.4 21.5 9.9 10.3 6.5 13.5 5.0 4.1 4.6 5.3 6.1 6.1 5.1 4.3 6.6 6.0 4.8 4.6 4.7 7.5 5.5 2.5 11.9 13.6 21.5 16.0 11.5 15.2 14.6 11.9 14.1 11.9 13.7 18.6 33.3 28.9 40.4 155.7 25.1 37.7 17.4 22.4 44.3 38.4 19.9 20.7 31.5 18.6 19.6 18.4 43.8 34.0 24.9 13.3 13.7 14.6 66.1 16.1 26.6 28.7 3.5 30.9 201.3 12.8 58.6 26.6 21.9 21.3 25.2 28.6 26.0 22.7 28.9 30.3 169.6 16.3 26.4 36.1 23.0 109.0 39.4 28.6 48.0 107.7 29.7 17.8 21.6 148.3 160.0 13.2 14.6 48.2 23.5 22.7 18.8 23.1 18.7 53.7 39.5 31.4 35.7 233.8 57.4 48.5 43.9 50.2 29.5 24.2 18.0 13.5 DNAJC1 "DNAJL1, ERdj1, MTJ1" ENSG00000136770 "DnaJ heat shock protein family (Hsp40) member C1" Q96KC8 10 21756548-22003769 "Predicted membrane proteins, Transcription factors" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013432 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Endoplasmic reticulum" "HPA013432: AB_1847797" "unprognostic (7.00e-2)" "unprognostic (9.81e-2)" "unprognostic (3.61e-1)" "unprognostic (5.12e-2)" "unprognostic (5.51e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (3.81e-2)" "unprognostic (1.21e-1)" "unprognostic (3.46e-2)" "unprognostic (1.09e-1)" "unprognostic (9.36e-2)" "prognostic favorable (2.33e-4)" "unprognostic (4.44e-3)" "unprognostic (4.88e-2)" "unprognostic (1.45e-2)" "unprognostic (2.22e-2)" 17.6 16.9 9.9 16.3 11.2 18.3 20.0 10.6 13.1 17.8 15.0 20.6 28.3 15.5 13.4 16.3 14.2 17.7 15.8 9.0 12.9 23.0 36.9 24.0 15.6 12.1 11.1 14.0 38.5 45.6 19.6 19.9 12.4 23.7 18.7 7.1 40.7 16.3 12.7 14.3 22.4 15.8 11.5 15.2 28.6 9.4 11.3 13.1 29.0 11.2 13.0 26.5 15.2 12.7 38.5 24.5 53.9 20.1 49.3 34.9 23.4 50.9 22.1 20.8 32.7 33.8 33.1 16.9 21.9 31.2 31.2 36.1 12.3 25.7 11.5 88.6 41.1 40.3 18.8 20.3 119.5 3.0 16.5 35.8 46.5 24.7 28.3 30.4 27.8 16.4 42.7 93.6 23.8 39.2 9.6 12.9 7.1 33.2 20.3 13.8 18.8 62.3 29.1 9.1 11.3 17.1 37.7 62.2 38.1 58.7 19.8 42.8 42.7 20.3 43.5 34.4 29.3 29.8 10.0 11.7 30.3 126.1 12.3 11.8 16.6 7.0 36.2 16.6 36.5 8.4 20.2 29.1 15.3 12.3 12.9 16.5 9.3 34.2 30.9 39.6 15.8 15.0 9.9 11.2 10.6 13.1 9.0 12.9 12.1 11.1 12.4 11.5 11.3 12.7 56.4 35.3 26.9 73.4 46.7 38.7 64.8 26.6 30.1 27.9 67.9 76.1 16.9 57.2 31.0 31.3 45.9 16.7 92.9 52.4 27.4 73.6 47.6 40.9 74.6 54.7 38.3 49.0 134.4 74.2 92.6 67.4 59.7 58.3 41.8 14.3 52.8 84.5 55.0 38.7 77.1 75.8 28.5 43.7 52.5 19.6 94.8 44.2 67.6 112.4 46.9 37.4 99.9 91.5 137.7 80.6 49.2 67.0 202.7 71.2 57.9 80.1 23.9 149.1 59.2 49.3 56.7 232.2 109.5 45.3 44.2 35.3 81.5 41.0 55.8 71.9 EBLN1 ENSG00000223601 "Endogenous Bornavirus like nucleoprotein 1" P0CF75 10 22208814-22210021 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 2.8" "Group enriched" "Detected in some" 10 "Early spermatids: 21.3;Late spermatids: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "GAMG: 1.0" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (1.39e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COMMD3 "BUP, C10orf8" ENSG00000148444 "COMM domain containing 3" Q9UBI1 10 22316386-22320306 "Predicted intracellular proteins" "Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 432.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 307.8;U-937: 403.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036584 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 32: U-937 - Innate immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA036584: AB_10670803" "unprognostic (3.11e-2)" "unprognostic (5.97e-3)" "unprognostic (6.43e-2)" "unprognostic (2.44e-1)" "unprognostic (7.42e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (5.46e-7)" "unprognostic (1.03e-3)" "unprognostic (1.57e-1)" "unprognostic (1.58e-1)" "unprognostic (2.20e-2)" "unprognostic (1.73e-1)" "unprognostic (2.68e-3)" "unprognostic (1.70e-1)" "unprognostic (3.35e-1)" "unprognostic (5.71e-2)" "unprognostic (2.88e-3)" 30.9 35.3 33.3 38.3 35.7 38.1 52.6 36.8 45.0 29.1 33.9 38.2 37.5 31.0 47.8 38.1 34.6 32.9 79.8 34.7 35.8 38.7 62.8 28.2 45.4 36.3 34.2 23.4 51.7 53.5 24.9 22.8 35.6 36.7 36.8 29.5 51.8 30.7 75.4 36.6 36.8 38.9 37.0 32.5 33.0 32.1 33.7 61.2 33.1 76.2 43.4 39.6 21.0 41.0 53.8 65.0 23.5 14.4 91.0 97.0 22.7 48.1 48.3 45.8 60.4 16.9 77.8 61.6 47.7 58.8 41.8 33.4 37.8 68.5 34.8 307.8 44.1 80.2 23.1 62.7 87.8 29.0 66.5 86.3 74.6 35.7 35.2 67.8 92.5 93.7 55.0 70.6 103.5 47.8 126.2 29.6 5.7 69.0 101.5 54.9 57.5 89.0 64.8 30.2 14.4 54.3 38.1 71.8 85.8 20.2 48.8 199.1 82.4 30.3 77.3 73.0 42.1 94.4 93.0 63.9 67.5 403.0 28.7 154.6 98.0 73.1 48.5 97.8 56.8 93.2 63.3 52.0 117.8 85.2 39.9 48.8 15.2 83.2 87.6 140.3 83.2 118.3 33.3 35.7 36.8 45.0 34.7 35.8 36.3 34.2 35.6 37.0 33.7 41.0 37.6 41.7 31.7 0.0 59.0 38.2 48.4 148.4 18.2 42.0 52.7 82.5 98.8 30.0 73.0 33.1 14.6 61.0 55.2 20.9 117.4 83.0 432.9 42.2 35.7 37.9 41.3 69.2 0.0 82.9 53.4 42.6 19.4 27.4 54.5 43.7 30.7 61.5 99.0 45.4 0.0 43.4 118.0 51.8 48.3 97.0 58.7 47.6 53.4 0.0 103.6 71.4 52.5 0.0 0.0 67.0 36.7 56.8 63.2 29.1 67.1 102.2 72.1 65.2 46.0 45.7 66.6 35.6 42.9 20.5 51.1 26.1 34.7 51.4 40.7 44.7 COMMD3-BMI1 ENSG00000269897 "COMMD3-BMI1 readthrough" 10 22316388-22329542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 10.1;testis: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 23.3;MOLT-4: 12.7;U-937: 23.8" "HPA030471, HPA030472, HPA036584" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 77: Retina - Visual perception" "Cluster 44: HDLM-2 - Immune response" "Nuclear bodies" "Nucleoplasm, Nucleoli, Cytosol" "HPA030471: AB_2673491, HPA030472: AB_10601090, HPA036584: AB_10670803" "unprognostic (8.63e-2)" "unprognostic (2.36e-2)" "unprognostic (1.83e-2)" 0.9 2.2 0.4 1.0 1.4 0.3 0.8 1.0 1.9 1.5 0.8 0.8 0.6 0.4 0.0 1.8 1.3 0.2 3.0 0.3 1.6 0.4 0.5 0.9 1.0 1.3 0.7 0.6 0.8 0.4 0.1 0.7 0.9 0.5 0.2 10.1 1.8 2.7 6.4 0.7 0.8 0.3 0.4 0.9 1.1 6.7 1.3 2.0 0.4 2.3 1.5 1.0 0.8 2.0 2.1 6.4 3.9 0.2 2.5 2.3 0.4 0.9 1.3 1.4 5.8 7.8 1.2 1.9 0.8 3.0 5.1 1.1 2.8 2.2 1.3 23.3 2.4 5.4 1.5 0.0 1.7 0.6 3.0 2.9 3.2 3.3 0.1 4.3 1.6 8.3 1.4 2.8 0.8 0.0 12.7 0.9 0.4 3.9 2.1 1.7 3.1 1.7 0.5 1.9 0.4 2.7 5.5 1.1 0.2 1.4 0.0 4.7 6.8 2.3 3.9 1.3 0.7 4.9 0.9 3.5 1.2 23.8 0.0 7.4 2.1 3.0 3.4 2.4 3.7 7.5 3.2 4.1 2.2 7.3 2.4 1.8 0.7 4.9 1.3 0.3 6.5 4.9 0.4 1.4 1.0 1.9 0.3 1.6 1.3 0.7 0.9 0.4 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BMI1 "PCGF4, RNF51" ENSG00000168283 "BMI1 proto-oncogene, polycomb ring finger" P35226 10 22321099-22331484 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 134.0;Late spermatids: 165.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 508.3;U-937: 583.9" "CAB011120, HPA030471, HPA030472" Supported Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 44: HDLM-2 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "Nucleoli, Cytosol" "CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090" "unprognostic (5.44e-1)" "unprognostic (2.98e-1)" "unprognostic (4.24e-2)" "unprognostic (4.37e-2)" "unprognostic (2.76e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (2.60e-8)" "unprognostic (9.43e-2)" "unprognostic (7.95e-2)" "unprognostic (7.84e-2)" "unprognostic (8.23e-2)" "unprognostic (1.56e-1)" "unprognostic (7.44e-2)" "unprognostic (9.73e-2)" "unprognostic (8.56e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-2)" 29.0 31.1 26.6 25.1 35.1 21.9 36.0 29.9 42.4 27.6 28.2 26.2 19.7 30.7 29.7 21.9 22.6 23.9 20.5 25.0 27.8 26.0 35.6 23.4 27.7 29.5 30.1 21.7 25.7 56.9 25.0 28.7 31.6 33.7 21.5 40.4 19.9 26.1 44.4 14.4 20.8 36.2 29.9 36.2 22.5 35.3 28.1 24.9 23.9 35.5 27.0 23.8 14.8 45.4 74.9 36.1 41.2 12.7 68.9 54.6 40.5 49.7 22.2 37.3 43.5 37.6 93.4 38.1 32.8 45.6 42.2 26.1 59.1 35.0 45.4 508.3 72.8 104.7 28.7 42.9 41.1 39.8 55.7 35.5 58.8 41.2 45.3 47.0 26.2 62.1 105.4 63.3 48.6 30.2 106.9 11.4 9.3 36.3 83.4 79.6 57.1 37.3 35.3 25.2 33.8 66.0 32.7 42.5 57.3 17.8 38.5 153.8 56.4 41.4 122.6 99.6 67.6 76.1 110.8 83.1 59.5 583.9 27.4 15.1 1.3 2.5 5.2 3.0 7.0 4.4 5.3 5.0 0.9 2.2 4.4 4.3 0.6 5.2 2.1 1.6 4.1 2.0 26.6 35.1 29.9 42.4 25.0 27.8 29.5 30.1 31.6 29.9 28.1 45.4 18.9 25.6 24.0 0.0 23.1 15.9 20.5 12.4 22.8 20.9 24.4 20.3 19.0 22.8 19.8 12.9 8.4 12.7 14.2 5.6 13.7 16.3 134.0 12.1 25.3 24.0 13.2 19.1 0.0 18.2 22.2 19.8 7.7 9.8 12.0 12.6 28.5 30.7 9.9 30.3 0.0 9.9 14.2 19.7 25.6 165.1 36.1 13.8 37.4 0.0 17.5 13.9 15.5 0.0 0.0 22.9 7.3 36.5 33.9 29.1 4.6 13.0 16.9 15.2 19.7 26.5 28.6 19.8 22.2 11.2 14.6 6.7 22.4 17.0 10.3 20.4 SPAG6 "CFAP194, CT141, FAP194, PF16, Repro-SA-1" ENSG00000077327 "Sperm associated antigen 6" O75602 10 22345445-22454224 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 63.5;fallopian tube: 49.0;testis: 96.3" "Cell type enhanced" "Detected in some" "Early spermatids: 228.6;Endometrial ciliated cells: 73.2;Respiratory ciliated cells: 266.4;Spermatocytes: 372.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 29 "U-937: 105.6" "Low region specificity" "Detected in single" "Region enhanced" "Detected in many" "midbrain: 11.1" HPA038440 Enhanced NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 32: U-937 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA038440: AB_10671742" "unprognostic (5.02e-2)" "unprognostic (9.52e-2)" "unprognostic (8.94e-6)" "unprognostic (2.21e-1)" "unprognostic (2.51e-2)" "unprognostic (4.91e-3)" "unprognostic (1.68e-1)" "unprognostic (2.38e-1)" "unprognostic (8.68e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.26e-1)" "unprognostic (2.71e-1)" "unprognostic (1.06e-3)" "unprognostic (3.10e-2)" "unprognostic (2.78e-4)" 0.0 0.0 4.2 0.0 4.0 0.4 1.7 1.9 1.4 1.7 63.5 0.0 0.0 0.2 0.4 0.0 49.0 0.0 0.1 3.3 5.0 0.3 0.1 7.0 0.1 17.6 16.1 0.1 0.3 1.8 14.6 0.0 9.9 1.0 0.0 5.8 0.0 0.0 0.0 0.3 0.0 0.0 16.3 0.0 0.0 96.3 6.4 0.4 0.1 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.9 2.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 3.6 0.0 0.0 0.0 0.3 0.0 2.5 0.0 0.0 0.0 0.0 0.1 1.7 0.8 0.2 0.0 105.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 4.2 4.0 1.9 1.4 3.3 5.0 17.6 16.1 9.9 16.3 6.4 10.1 0.0 0.0 4.8 0.0 0.1 0.1 0.1 14.0 0.0 0.2 0.5 0.3 0.6 0.0 24.5 0.0 0.0 0.1 0.2 0.1 1.9 0.3 228.6 73.2 0.4 0.2 0.0 0.0 7.1 0.0 0.0 0.7 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 3.1 0.0 16.2 0.0 0.2 51.4 5.0 0.5 1.8 4.7 0.0 0.3 0.0 0.5 6.0 0.4 0.0 4.9 0.3 1.8 0.0 1.4 266.4 1.2 0.0 0.0 3.7 372.6 4.8 0.0 0.1 0.0 0.5 0.1 0.0 0.1 PIP4K2A "PIP5K2A, PIP5KIIA, PIP5KIIalpha" ENSG00000150867 "Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha" P48426 10 22534854-22714578 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 498.1" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 1585.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065440, HPA068771" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 4900000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 2: Karpas-707 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "Plasma membrane, Cytosol" "HPA065440: AB_2685490, HPA068771: AB_2686030" "unprognostic (1.11e-1)" "unprognostic (2.71e-3)" "unprognostic (1.57e-3)" "unprognostic (4.20e-3)" "unprognostic (1.55e-1)" "unprognostic (8.80e-3)" "unprognostic (1.56e-3)" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (7.08e-2)" "unprognostic (1.29e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.52e-3)" "unprognostic (2.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.92e-3)" 28.4 15.5 162.5 47.8 329.4 44.8 15.0 239.0 239.9 26.5 49.8 17.8 13.2 21.1 11.8 19.8 15.2 32.9 13.5 169.7 193.6 16.5 18.6 25.9 81.2 260.6 273.4 8.8 10.9 24.8 8.5 23.7 271.7 9.3 19.1 15.3 7.8 13.0 5.1 8.3 20.6 31.5 171.8 62.6 19.3 12.5 233.3 60.4 12.8 10.9 88.5 24.1 10.5 498.1 30.2 29.2 33.4 10.8 52.3 70.6 25.3 55.0 58.1 29.1 35.7 27.6 47.2 63.2 19.4 111.0 63.7 10.4 29.2 15.4 29.2 140.5 30.4 118.7 21.6 60.9 92.5 23.1 89.1 35.6 13.7 39.7 38.2 44.6 43.7 83.5 67.4 119.1 54.5 12.5 92.3 20.5 13.7 14.5 20.7 36.9 47.8 86.3 43.0 5.8 6.1 13.9 17.7 9.0 86.4 37.6 7.6 39.1 53.0 22.3 32.8 41.7 33.9 75.1 46.3 45.0 60.5 68.3 17.6 72.6 32.6 104.0 119.5 57.9 164.0 52.1 94.2 139.9 43.7 33.1 62.8 118.2 40.5 144.2 67.3 44.8 75.9 183.4 162.5 329.4 239.0 239.9 169.7 193.6 260.6 273.4 271.7 171.8 233.3 498.1 22.5 3.2 6.7 84.9 43.2 17.6 4.0 2.0 3.4 5.7 12.9 5.5 8.1 14.3 5.6 18.4 2.1 8.6 196.9 3.4 11.7 9.7 22.9 7.4 15.7 29.2 4.9 236.9 65.6 10.7 5.4 19.6 6.6 24.8 22.8 13.4 62.4 8.7 31.8 13.5 62.0 2.9 0.0 98.6 80.0 34.5 16.8 82.8 104.9 142.4 81.3 5.0 159.6 167.9 1585.0 22.1 3.7 10.1 36.4 7.1 1.0 15.6 2.2 9.1 19.7 14.1 30.6 6.1 7.9 3.3 16.9 12.4 130.7 8.5 2.8 6.6 ARMC3 "CT81, FLJ32827" ENSG00000165309 "Armadillo repeat containing 3" Q5W041 10 22928024-23038523 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 12.9;choroid plexus: 34.5;fallopian tube: 44.6;testis: 33.6" "Cell type enhanced" "Detected in some" "Early spermatids: 364.4;Endometrial ciliated cells: 169.1;Late spermatids: 90.1;Respiratory ciliated cells: 204.6;Spermatocytes: 70.0" "Group enriched" "Detected in some" 5 "endometrial cancer: 4.0;ovarian cancer: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "CAPAN-2: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037823, HPA037824" Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA037823: AB_2675689, HPA037824: AB_10671634" "unprognostic (8.11e-3)" "unprognostic (5.78e-2)" "unprognostic (6.63e-2)" "unprognostic (7.81e-3)" "unprognostic (1.01e-1)" "unprognostic (2.28e-1)" "unprognostic (5.23e-1)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (7.37e-3)" "unprognostic (4.02e-1)" "unprognostic (3.61e-2)" "unprognostic (2.97e-1)" "unprognostic (6.21e-3)" "unprognostic (9.53e-4)" "unprognostic (1.40e-2)" 0.0 0.0 3.3 0.0 3.9 0.0 0.0 2.4 1.5 1.3 34.5 0.0 0.0 1.5 0.1 0.1 44.6 0.0 0.1 3.0 3.7 0.4 0.0 3.5 0.0 11.4 12.9 0.0 0.3 0.0 1.3 0.0 8.5 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 7.7 0.0 0.0 33.6 4.6 0.1 0.3 0.1 0.0 0.0 0.0 8.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.3 3.9 2.4 1.5 3.0 3.7 11.4 12.9 8.5 7.7 4.6 8.3 0.0 0.0 1.1 8.1 0.0 0.0 0.0 6.0 0.0 0.0 0.1 0.1 0.3 0.0 22.4 0.0 6.2 0.0 0.1 0.0 0.0 0.4 364.4 169.1 1.4 0.8 0.0 0.0 9.1 0.0 0.0 0.4 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 12.2 0.0 0.0 90.1 3.4 1.5 0.0 2.8 0.0 0.0 0.0 1.5 9.0 0.0 0.0 3.8 0.0 0.3 0.0 1.5 204.6 1.1 0.0 0.0 3.0 70.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MSRB2 "CBS-1, CBS1, CGI-131, MSRB, PILB" ENSG00000148450 "Methionine sulfoxide reductase B2" Q9Y3D2 10 23095579-23122013 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 269.1;Proximal tubular cells: 463.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027933 Enhanced "Intracellular and membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA027933: AB_10601867" "unprognostic (4.89e-2)" "unprognostic (2.76e-2)" "unprognostic (7.14e-3)" "unprognostic (3.47e-3)" "unprognostic (4.51e-1)" "unprognostic (9.26e-3)" "unprognostic (1.62e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-1)" "unprognostic (6.07e-3)" "unprognostic (3.47e-2)" "unprognostic (1.08e-2)" "unprognostic (2.03e-1)" "unprognostic (1.82e-2)" "unprognostic (6.74e-2)" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" 16.2 17.3 29.0 6.6 30.8 7.7 11.0 29.5 40.5 13.2 26.8 22.7 9.4 15.8 16.8 10.8 17.6 7.7 61.6 29.5 32.2 19.0 31.0 9.8 3.9 30.4 30.9 11.9 5.4 23.1 14.4 8.2 30.5 14.3 11.4 13.1 9.1 19.5 42.2 5.5 11.9 16.3 29.1 9.3 11.4 3.9 30.8 8.4 14.1 51.7 4.1 17.1 11.0 29.4 7.3 10.4 19.0 11.6 19.3 17.3 5.7 11.5 6.4 7.2 8.3 7.2 15.5 5.9 10.0 24.6 10.9 4.6 6.3 8.6 5.9 40.3 7.0 4.3 17.7 4.1 27.2 0.9 5.0 22.2 14.3 8.4 2.0 15.7 10.4 11.5 5.9 10.3 16.0 21.9 7.0 5.5 10.5 41.4 6.0 8.0 10.9 1.5 9.1 2.8 3.8 26.1 14.2 12.4 23.9 15.9 8.4 17.1 7.7 6.2 5.8 14.0 6.9 13.3 4.4 0.2 8.8 12.7 5.3 0.9 1.4 2.3 0.3 1.1 0.3 0.2 0.3 0.2 0.8 0.0 0.6 0.4 3.4 0.2 0.8 1.6 0.4 0.2 29.0 30.8 29.5 40.5 29.5 32.2 30.4 30.9 30.5 29.1 30.8 29.4 29.0 0.0 16.4 27.1 11.4 18.2 52.1 33.1 59.2 68.2 69.6 79.1 269.1 80.1 21.1 90.1 22.9 116.1 10.6 86.7 176.1 130.4 1.4 49.3 71.6 34.4 55.7 30.7 9.5 63.4 61.2 70.7 23.4 46.5 29.2 114.0 42.1 195.4 109.6 112.7 16.9 54.8 26.4 70.5 25.1 4.4 49.7 54.2 72.9 11.2 29.7 126.6 7.2 14.6 26.1 90.3 79.6 62.4 24.7 34.9 80.8 463.9 24.3 57.5 59.2 52.6 71.6 4.4 7.7 66.7 17.5 69.6 13.5 60.9 71.0 54.3 PTF1A "bHLHa29, p48, PTF1-p48" ENSG00000168267 "Pancreas associated transcription factor 1a" Q7RTS3 10 23192312-23194245 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "pancreas: 104.2" "Group enriched" "Detected in some" 4 "Early spermatids: 2.1;Exocrine glandular cells: 4.8;Spermatocytes: 3.8" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.6;pancreatic cancer: 1.2" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" CAB022612 Approved Nucleoplasm NA NA "Cluster 25: Pancreas - Digestion" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "CAB022612: " "unprognostic (2.02e-1)" "unprognostic (1.85e-1)" "unprognostic (4.49e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.6 1.4 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.6 0.4 0.0 0.0 0.0 0.0 0.8 0.6 0.1 104.2 0.0 0.2 0.0 0.8 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.5 0.0 1.9 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.6 1.4 0.6 0.4 0.8 0.6 0.8 0.5 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.0 0.4 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf67 "bA215C7.4, C10orf115, LINC01552, MGC46732" ENSG00000179133 "Chromosome 10 open reading frame 67" Q8IYJ2 10 23202696-23344845 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.1;fallopian tube: 4.8;testis: 12.4" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 38.5;Early spermatids: 40.2;Endometrial ciliated cells: 18.2;Late spermatids: 32.8;Proximal tubular cells: 17.9;Respiratory ciliated cells: 35.7;Spermatocytes: 70.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;SiHa: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA038131 Approved Approved Vesicles,Microtubules,Mitochondria NA No "Cluster 35: T-regs - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Vesicles, Microtubules, Mitochondria" "HPA038131: AB_10670658" "unprognostic (4.76e-4)" "unprognostic (2.38e-1)" "unprognostic (3.75e-2)" "unprognostic (2.92e-2)" "unprognostic (9.67e-3)" "unprognostic (1.91e-1)" "unprognostic (1.54e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (2.46e-3)" "unprognostic (3.98e-1)" "unprognostic (3.59e-2)" "unprognostic (3.84e-3)" "unprognostic (9.58e-2)" 0.0 0.2 1.5 0.2 1.4 0.3 0.1 0.9 1.6 0.1 5.1 0.1 0.5 0.2 1.4 0.1 4.8 0.2 0.7 1.7 1.3 3.5 0.4 2.9 0.3 2.0 2.2 0.5 0.2 0.4 1.2 0.1 1.5 0.0 0.0 0.9 0.1 0.1 0.5 1.3 0.3 0.0 1.3 0.2 0.1 12.4 1.9 0.0 0.6 0.1 0.1 0.0 0.0 2.0 0.7 0.1 0.9 0.1 0.0 0.2 0.3 0.1 0.0 0.9 0.8 0.2 1.3 0.1 0.1 0.8 0.1 3.0 0.1 0.3 0.8 0.3 0.2 0.3 0.7 0.2 0.5 0.1 0.2 0.2 1.0 0.3 0.4 0.1 0.0 0.1 0.3 0.5 0.0 0.3 0.1 0.2 0.5 0.0 0.1 0.1 0.1 0.1 0.7 0.2 0.5 0.2 3.9 0.1 0.0 0.1 0.2 0.2 0.2 0.2 0.8 0.2 0.1 0.5 0.1 0.0 1.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.3 0.2 0.0 0.3 0.2 0.2 0.0 0.2 0.1 0.2 1.2 0.0 1.5 1.4 0.9 1.6 1.7 1.3 2.0 2.2 1.5 1.3 1.9 2.0 0.0 38.5 2.4 0.3 0.0 2.8 0.1 1.9 0.0 0.4 0.0 0.0 1.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 1.9 0.2 40.2 18.2 0.2 0.1 0.0 0.0 4.7 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 32.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 2.2 0.2 0.0 0.7 0.0 0.0 0.0 17.9 35.7 1.6 6.6 0.0 0.1 70.1 5.2 0.0 1.3 0.0 0.3 0.5 0.1 0.0 OTUD1 "DUBA7, OTDC1" ENSG00000165312 "OTU deubiquitinase 1" Q5VV17 10 23439075-23442377 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 149.0;Langerhans cells: 219.1;Macrophages: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.1;HaCaT: 36.5;SiHa: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038503, HPA038504" Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA038503: AB_2676049, HPA038504: AB_10672712" "unprognostic (1.84e-1)" "unprognostic (2.80e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.56e-1)" "unprognostic (1.29e-2)" "unprognostic (3.18e-3)" "unprognostic (2.41e-1)" "unprognostic (7.77e-2)" "unprognostic (4.10e-2)" "unprognostic (1.80e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.61e-7)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-2)" 13.0 11.7 8.0 10.2 8.4 60.4 10.3 9.5 10.2 8.4 8.4 8.7 6.8 10.2 6.8 7.8 11.2 9.7 43.4 8.7 9.0 19.7 7.6 19.7 14.4 8.3 8.0 13.6 6.9 19.4 8.0 12.1 7.6 8.8 7.6 5.9 6.7 7.6 29.4 20.9 8.2 9.4 8.4 13.7 22.9 7.5 9.2 6.8 13.3 22.6 12.5 11.9 7.6 9.2 4.8 2.3 2.4 1.1 9.3 4.6 3.2 1.9 4.2 4.4 4.0 0.9 38.1 2.2 4.1 2.4 1.5 36.5 2.5 4.5 2.9 17.4 7.1 0.1 5.7 1.5 8.0 0.4 3.2 4.8 19.4 1.3 6.1 3.9 1.5 2.2 0.5 15.1 2.5 2.3 1.5 1.4 1.9 2.7 1.3 2.4 10.8 2.2 5.8 4.0 1.1 2.6 23.4 4.1 11.3 6.3 1.7 3.3 2.7 2.5 3.7 7.0 0.8 7.6 15.0 1.1 3.8 1.5 1.0 2.5 0.5 1.0 0.3 0.6 0.3 0.7 0.5 0.3 0.3 1.2 0.4 0.6 1.3 0.0 1.9 0.2 1.3 0.2 8.0 8.4 9.5 10.2 8.7 9.0 8.3 8.0 7.6 8.4 9.2 9.2 17.3 67.3 11.5 3.3 55.9 32.0 7.1 5.0 13.6 20.1 12.3 9.1 149.0 7.2 4.9 5.5 2.1 3.3 9.6 47.2 11.7 6.0 8.0 35.0 44.5 25.6 6.0 13.5 4.3 7.1 3.2 20.8 47.4 33.8 5.7 10.4 16.4 10.1 51.0 53.8 4.8 77.9 10.2 68.2 219.1 7.6 6.5 105.7 33.8 8.4 9.3 33.8 10.3 4.0 6.5 10.1 16.3 13.2 50.0 7.7 8.0 25.1 9.8 26.2 6.6 82.2 19.4 7.2 4.7 15.1 30.5 7.9 16.5 7.5 24.3 10.9 KIAA1217 "DKFZP761L0424, ETL4, SKT" ENSG00000120549 KIAA1217 Q5T5P2 10 23694746-24547848 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 108.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 609.1;Inhibitory neurons: 1251.8;Oligodendrocyte precursor cells: 255.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 82.6;Karpas-707: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004941 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Cytosol" "HPA004941: AB_2130659" "unprognostic (3.60e-2)" "unprognostic (7.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.73e-2)" "unprognostic (1.27e-1)" "unprognostic (4.45e-3)" "unprognostic (1.60e-3)" "unprognostic (2.03e-3)" "unprognostic (1.87e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.69e-1)" "unprognostic (1.84e-3)" "unprognostic (5.27e-2)" "unprognostic (2.44e-1)" "unprognostic (2.97e-1)" "unprognostic (1.22e-1)" 28.4 16.5 9.8 3.5 12.1 0.2 30.5 2.2 9.6 15.7 42.2 13.1 12.9 6.0 13.3 30.9 16.9 14.7 17.8 27.5 2.0 18.0 17.5 14.4 2.6 6.0 11.2 13.1 13.6 42.8 6.5 20.9 5.7 20.5 14.7 23.7 39.2 22.5 108.4 17.6 11.3 3.3 0.5 7.5 17.4 15.7 4.2 12.6 33.6 52.7 9.3 12.1 19.1 17.2 19.5 9.7 3.8 0.1 2.4 6.8 82.6 3.7 6.0 8.6 18.2 16.6 30.3 1.0 18.6 7.6 17.6 31.5 4.7 36.2 9.5 7.2 3.4 0.4 23.1 19.4 4.2 0.0 0.3 25.3 22.8 19.0 5.2 3.9 0.0 1.7 0.0 75.7 4.4 6.8 10.8 0.6 8.5 18.9 8.7 0.8 22.0 16.2 20.1 25.3 2.4 1.3 9.4 31.4 0.0 38.3 15.2 0.0 20.3 13.1 14.1 52.9 4.9 33.4 30.4 0.1 43.4 0.5 0.6 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.8 12.1 2.2 9.6 27.5 2.0 6.0 11.2 5.7 0.5 4.2 17.2 149.7 38.5 34.4 27.4 1.0 121.3 74.1 58.0 145.1 13.6 38.8 39.0 39.1 24.3 73.7 33.1 8.4 50.2 0.4 52.5 3.9 32.3 33.7 64.5 19.6 34.4 23.9 0.0 609.1 26.2 21.2 23.3 50.0 85.9 1.3 6.6 25.0 24.8 5.3 0.0 1251.8 22.8 26.4 14.6 7.8 11.3 17.7 1.3 1.8 30.0 0.0 93.6 0.0 255.9 10.3 24.1 22.7 33.1 3.1 36.8 15.4 6.3 36.9 3.1 13.1 19.6 20.4 0.8 1.1 96.4 51.0 65.1 2.2 14.2 19.4 43.7 ARHGAP21 "ARHGAP10, KIAA1424" ENSG00000107863 "Rho GTPase activating protein 21" Q5T5U3 10 24583609-24723887 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 111.2" "Cell type enhanced" "Detected in all" "Excitatory neurons: 266.5;Oligodendrocyte precursor cells: 336.7;Oligodendrocytes: 827.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036610, HPA057861" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 2: Karpas-707 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Cell Junctions, Actin filaments" "Plasma membrane" "HPA036610: AB_10669910, HPA057861: AB_2683546" "unprognostic (7.65e-2)" "unprognostic (1.61e-2)" "unprognostic (1.88e-1)" "unprognostic (5.84e-2)" "unprognostic (2.69e-1)" "unprognostic (3.59e-1)" "unprognostic (1.12e-3)" "unprognostic (5.35e-2)" "unprognostic (9.75e-2)" "unprognostic (3.34e-2)" "unprognostic (2.65e-3)" "unprognostic (3.23e-1)" "unprognostic (3.14e-2)" "unprognostic (1.53e-1)" "unprognostic (3.32e-1)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" 28.4 18.0 44.3 10.3 77.7 7.2 16.1 56.7 58.1 19.7 0.0 16.6 12.9 19.9 8.6 10.8 17.5 17.9 21.2 49.1 48.3 11.0 13.1 21.7 5.3 76.3 63.1 31.9 14.9 14.6 12.1 16.6 66.7 10.8 18.5 41.3 24.5 11.5 17.7 6.8 16.3 17.8 48.4 8.9 27.1 14.6 58.0 11.4 12.8 23.0 6.0 13.8 9.0 111.2 59.0 25.1 60.9 52.3 42.2 59.1 21.6 41.6 26.6 24.5 34.0 18.4 36.8 10.9 14.0 64.3 37.7 38.1 31.6 40.4 35.9 38.0 20.5 64.9 54.7 13.8 25.5 0.0 9.9 24.4 45.0 32.1 34.4 36.9 42.3 16.1 27.9 96.3 50.0 11.6 30.2 2.3 9.7 20.8 13.6 7.0 21.4 6.2 17.2 10.2 10.5 10.9 27.9 16.0 32.6 18.1 16.3 9.1 47.8 35.3 22.7 40.0 30.6 11.0 20.3 7.8 36.2 11.4 24.7 0.9 0.2 0.4 0.1 0.4 0.1 0.0 0.2 0.3 0.3 0.0 0.6 0.3 0.0 0.2 0.2 0.4 0.4 0.2 44.3 77.7 56.7 58.1 49.1 48.3 76.3 63.1 66.7 48.4 58.0 111.2 47.9 86.6 33.1 246.8 6.5 29.6 13.2 23.6 14.8 144.0 17.5 26.0 37.4 24.3 45.0 5.5 68.8 23.8 6.9 44.6 1.9 21.4 5.0 36.2 148.7 34.9 16.2 15.2 266.5 27.6 21.0 73.0 82.0 54.2 17.1 135.8 26.0 20.9 14.6 132.9 153.8 28.3 14.2 32.8 31.8 8.3 92.9 38.9 19.6 171.4 11.0 194.0 2.1 336.7 827.4 37.1 34.6 59.5 15.2 27.4 21.9 6.5 30.3 53.5 26.3 60.4 43.2 27.4 35.6 18.1 20.2 12.6 11.8 62.2 29.0 29.5 PRTFDC1 HHGP ENSG00000099256 "Phosphoribosyl transferase domain containing 1" Q9NRG1 10 24848614-24952606 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 136.1;Oligodendrocyte precursor cells: 111.6;Oligodendrocytes: 148.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "NK-cell: 4.4" "Lineage enriched" "Detected in single" 8 "NK-cells: 4.4" "Cell line enhanced" "Detected in many" "CACO-2: 75.9;CAPAN-2: 94.3;HEL: 56.2" "Low region specificity" "Detected in all" HPA021458 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 39: CACO-2 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "Golgi apparatus, Cytosol" "HPA021458: AB_1855793" "unprognostic (2.61e-1)" "unprognostic (3.47e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (9.49e-3)" "unprognostic (2.03e-1)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (2.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (7.66e-3)" "unprognostic (1.94e-2)" 5.4 22.2 21.7 4.5 28.7 0.9 7.6 24.9 27.2 12.9 16.1 9.9 17.7 15.8 7.4 5.5 9.8 14.8 10.9 22.4 24.6 4.8 2.8 4.3 4.2 26.7 24.0 20.2 4.6 13.4 11.4 2.9 28.0 7.8 11.3 16.5 9.7 8.2 1.3 1.8 17.1 9.8 25.8 3.2 17.5 2.2 23.7 6.8 5.3 2.8 3.2 7.4 6.3 37.1 19.5 41.3 30.2 12.4 4.9 24.4 0.0 20.2 15.1 14.2 19.3 75.9 94.3 0.0 3.1 23.7 1.2 10.7 34.7 0.0 22.0 0.0 1.4 56.2 7.6 0.1 14.6 0.0 0.0 7.1 0.2 7.7 0.0 13.3 22.6 2.2 18.6 10.5 6.8 0.5 8.8 0.1 20.9 3.3 0.7 9.7 0.1 0.2 12.7 0.5 21.5 0.9 19.3 0.1 0.0 0.6 1.1 4.3 12.2 6.3 15.5 23.1 12.2 0.9 0.0 0.0 16.8 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 4.4 0.0 0.1 0.0 0.9 21.7 28.7 24.9 27.2 22.4 24.6 26.7 24.0 28.0 25.8 23.7 37.1 3.5 0.0 0.5 136.1 0.7 2.7 4.6 5.4 2.8 10.2 1.1 5.8 8.6 7.2 3.9 3.7 2.1 1.0 0.8 3.8 5.9 5.8 1.4 1.5 27.3 2.8 5.4 3.0 38.2 0.5 4.9 20.6 12.2 2.2 0.0 25.1 7.5 0.1 7.2 6.7 43.0 7.3 0.0 0.9 3.1 1.0 12.2 7.8 3.6 24.4 1.5 45.8 0.0 111.6 148.2 2.3 2.1 9.8 1.3 1.1 12.2 0.1 1.1 15.9 0.0 16.4 10.4 3.4 6.3 0.4 2.8 0.8 1.0 22.7 11.6 1.5 ENKUR "C10orf63, CFAP106, enkurin, MGC26778" ENSG00000151023 "Enkurin, TRPC channel interacting protein" Q8TC29 10 24981979-25062279 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.4;choroid plexus: 13.6;fallopian tube: 43.6" "Group enriched" "Detected in many" 4 "Early spermatids: 73.9;Endometrial ciliated cells: 143.5;Respiratory ciliated cells: 288.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.1;glioma: 4.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 2.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "AN3-CA: 1.5;CAPAN-2: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037593, HPA037594, HPA061503" Enhanced NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA037593: AB_10672387, HPA037594: AB_2675568, HPA061503: AB_2684543" "unprognostic (2.33e-3)" "unprognostic (4.86e-2)" "unprognostic (1.13e-2)" "unprognostic (6.52e-3)" "unprognostic (3.31e-2)" "unprognostic (2.91e-2)" "unprognostic (1.38e-2)" "unprognostic (7.35e-2)" "unprognostic (1.18e-1)" "unprognostic (8.69e-2)" "unprognostic (6.85e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-6)" "unprognostic (3.94e-1)" "unprognostic (3.35e-2)" "unprognostic (3.45e-3)" "unprognostic (8.43e-3)" 0.1 0.4 8.7 0.5 8.3 0.4 0.1 9.8 9.1 1.4 13.6 0.3 1.3 1.6 0.2 0.0 43.6 0.3 0.1 9.1 12.6 0.4 0.7 4.4 0.0 14.2 14.4 0.2 0.0 0.0 5.5 0.6 13.8 0.1 0.1 1.9 0.1 0.0 0.2 0.1 1.5 0.2 12.0 0.3 0.3 6.9 9.7 0.1 0.5 0.1 0.1 0.0 0.0 12.4 0.1 0.4 0.4 1.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 2.7 0.2 0.3 0.0 0.4 0.2 0.0 0.3 0.0 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.8 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.4 0.2 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.1 0.3 0.0 6.2 8.7 8.3 9.8 9.1 9.1 12.6 14.2 14.4 13.8 12.0 9.7 12.4 0.2 0.0 1.1 19.2 0.6 0.0 0.7 10.7 0.0 0.3 0.1 0.4 0.3 0.0 27.3 1.8 0.0 0.4 0.2 4.0 0.0 2.5 73.9 143.5 2.3 1.0 2.4 0.0 8.1 5.1 1.8 1.4 3.6 1.8 1.3 0.3 0.0 0.2 0.0 0.0 3.3 0.6 8.2 0.0 0.0 12.6 1.2 25.0 0.0 2.8 2.0 18.7 4.1 2.0 3.1 11.2 0.1 0.7 0.0 0.7 2.0 0.9 288.8 1.6 0.0 0.7 2.9 35.8 4.9 0.0 0.1 0.3 0.3 0.7 0.5 0.2 THNSL1 "FLJ22002, TSH1" ENSG00000185875 "Threonine synthase like 1" Q8IYQ7 10 25016612-25026664 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 21.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 15.6;Early spermatids: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037585 Uncertain Approved "Nuclear bodies,Mitochondria,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 15: Liver - Metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear bodies, Cytosol" Mitochondria "HPA037585: AB_10696940" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (4.31e-2)" "unprognostic (5.26e-2)" "unprognostic (6.11e-2)" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (9.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.52e-1)" "unprognostic (1.71e-3)" "unprognostic (2.08e-1)" "unprognostic (3.21e-2)" "unprognostic (9.84e-3)" "unprognostic (3.06e-2)" 1.7 6.0 4.0 1.8 4.2 0.6 3.6 3.2 4.5 4.1 2.9 2.7 2.6 3.6 4.9 1.9 5.6 2.0 3.7 4.1 4.2 9.7 21.4 1.5 2.8 3.9 3.5 7.3 3.0 5.3 3.7 1.7 4.2 2.9 3.0 4.1 3.4 2.6 4.6 2.2 2.4 2.2 3.9 2.2 2.7 5.9 4.1 3.3 8.3 5.9 2.7 1.8 1.5 4.3 7.1 8.1 5.0 10.0 5.0 6.2 1.3 3.4 1.3 3.7 2.4 5.3 8.8 32.7 10.6 1.6 4.0 3.8 7.2 6.4 3.8 4.5 3.9 12.0 2.2 3.4 5.6 0.0 2.0 3.9 11.6 2.7 5.7 6.4 2.5 13.3 10.4 3.8 8.0 11.1 6.6 2.3 9.2 12.3 3.9 3.5 1.3 14.2 10.6 1.6 8.3 4.7 6.8 6.0 12.3 2.6 6.0 0.6 2.5 4.4 3.9 5.9 3.2 2.7 3.8 0.0 7.3 6.6 3.5 0.1 0.4 0.0 2.9 0.5 5.1 5.0 4.1 3.8 2.2 3.8 9.5 6.3 0.6 10.8 0.7 3.7 2.0 3.1 4.0 4.2 3.2 4.5 4.1 4.2 3.9 3.5 4.2 3.9 4.1 4.3 1.3 3.2 3.2 2.6 3.4 0.6 3.1 5.6 2.8 4.2 2.1 2.9 8.5 1.5 6.1 3.7 0.0 6.1 0.8 0.6 15.6 3.3 29.9 5.1 3.9 1.8 1.2 2.5 4.0 1.3 3.9 2.7 1.5 2.5 0.0 7.8 2.2 9.8 2.1 3.3 5.1 1.8 2.0 0.9 0.8 5.5 2.1 0.6 0.0 4.7 1.5 6.8 0.0 2.0 5.4 1.1 1.0 1.5 0.9 1.8 2.3 11.0 8.7 4.5 0.0 4.3 1.9 8.2 13.6 2.6 1.0 1.0 2.8 11.8 3.5 1.1 GPR158 KIAA1136 ENSG00000151025 "G protein-coupled receptor 158" Q5T848 10 25174802-25602229 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 24.9" "Cell type enhanced" "Detected in some" "Excitatory neurons: 367.4;Horizontal cells: 144.7;Inhibitory neurons: 301.9;Oligodendrocyte precursor cells: 419.7;Oligodendrocytes: 101.6" "Cancer enhanced" "Detected in many" "glioma: 2.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 21.3;T-47d: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013185 Uncertain NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 36: HEL - Hemostasis" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA013185: AB_2113957" "unprognostic (4.43e-2)" "unprognostic (3.14e-2)" "unprognostic (7.42e-2)" "unprognostic (2.66e-5)" "unprognostic (5.67e-2)" "unprognostic (9.37e-2)" "unprognostic (4.73e-2)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (4.37e-2)" "unprognostic (8.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.60e-6)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (1.21e-3)" "unprognostic (3.90e-1)" 0.0 0.7 2.6 0.1 12.7 0.0 0.0 24.9 8.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 2.4 0.0 0.0 0.0 0.0 8.5 4.7 0.0 0.0 0.2 1.4 0.3 8.8 0.1 0.1 4.5 0.0 0.2 0.0 0.0 0.2 0.0 2.3 0.0 0.1 0.5 7.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 21.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.2 0.0 0.0 1.2 0.0 0.5 1.1 1.9 0.0 5.6 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 12.7 24.9 8.6 3.5 2.4 8.5 4.7 8.8 2.3 7.0 4.3 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 19.9 0.0 0.1 0.1 0.0 0.0 367.4 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 144.7 301.9 0.0 0.0 0.0 0.0 12.0 0.0 0.1 0.0 10.3 0.0 26.2 0.0 419.7 101.6 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 3.8 0.0 0.1 0.1 1.8 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MYO3A DFNB30 ENSG00000095777 "Myosin IIIA" Q8NEV4 10 25934229-26212532 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 15.5;testis: 5.2" "Cell type enhanced" "Detected in some" "Early spermatids: 156.6;Late spermatids: 58.2;Muller glia cells: 74.8;Spermatocytes: 31.7" "Cancer enhanced" "Detected in many" "cervical cancer: 1.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.3;CAPAN-2: 1.2;HEK 293: 1.5;SCLC-21H: 1.4;U-2 OS: 2.4;U-698: 6.3" "Not detected" "Not detected" "HPA051893, HPA075413" Enhanced Supported "Plasma membrane,Actin filaments,Cytoplasmic bodies" No No "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 5: Muller glia cells - Visual perception" "Actin filaments, Cytoplasmic bodies" "Plasma membrane" "HPA051893: , HPA075413: " "unprognostic (5.00e-3)" "unprognostic (3.36e-2)" "unprognostic (1.53e-1)" "unprognostic (3.20e-3)" "unprognostic (2.96e-1)" "unprognostic (4.37e-2)" "unprognostic (5.29e-2)" "unprognostic (2.74e-1)" "unprognostic (4.31e-2)" "unprognostic (1.03e-1)" "unprognostic (5.66e-3)" "unprognostic (7.96e-3)" "unprognostic (6.34e-2)" "unprognostic (1.46e-2)" "unprognostic (6.62e-2)" "unprognostic (9.69e-2)" 0.1 0.1 0.4 0.0 1.8 0.1 0.1 0.0 0.8 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.6 0.3 0.0 0.1 0.0 0.6 0.5 0.0 0.7 0.0 0.5 0.0 0.5 0.1 0.3 15.5 0.0 0.1 0.0 0.7 0.1 0.0 0.2 0.0 0.2 5.2 0.3 0.2 0.2 0.1 0.2 0.0 0.3 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.8 0.0 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.8 0.1 0.6 0.6 0.5 0.5 0.2 0.3 0.3 0.2 0.0 0.5 2.0 0.1 1.8 0.3 0.0 0.0 0.9 0.6 0.3 0.6 0.0 2.5 0.0 0.0 0.0 0.0 0.2 1.9 0.8 156.6 0.6 0.1 0.3 1.8 0.0 2.2 0.0 0.4 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 5.9 0.4 0.0 0.0 0.0 58.2 1.2 0.1 0.0 1.9 0.0 74.8 0.0 1.0 0.4 0.2 0.0 1.2 0.0 0.3 0.0 1.0 0.0 3.9 0.0 0.0 2.4 31.7 14.2 2.4 1.0 0.0 0.0 0.0 0.4 0.3 GAD2 GAD65 ENSG00000136750 "Glutamate decarboxylase 2" Q05329 10 26216665-26304558 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 37.6;retina: 9.5" "Cell type enriched" "Detected in some" 13 "Inhibitory neurons: 293.9" "Cancer enhanced" "Detected in some" "pancreatic cancer: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "SCLC-21H: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044637, CAB078177" Enhanced NA NA "Cluster 65: Brain - Ion transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB078177: AB_2665779, HPA044637: AB_10794053" "unprognostic (8.67e-2)" "unprognostic (1.11e-1)" "unprognostic (4.93e-2)" "unprognostic (2.52e-5)" "unprognostic (5.44e-2)" "unprognostic (8.08e-2)" 0.0 0.0 13.1 0.0 37.3 0.0 0.0 6.9 16.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.0 37.6 0.0 0.0 0.0 0.0 6.6 14.8 0.0 3.6 0.0 0.4 0.0 7.7 0.0 0.0 9.5 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.1 0.4 11.9 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 37.3 6.9 16.2 6.0 37.6 6.6 14.8 7.7 3.1 11.9 3.6 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 1.8 0.0 1.6 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 293.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.6 0.0 0.3 0.0 2.0 6.1 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APBB1IP "INAG1, RIAM" ENSG00000077420 "Amyloid beta precursor protein binding family B member 1 interacting protein" Q7Z5R6 10 26438341-26567803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 145.4" "Cell type enhanced" "Detected in many" "B-cells: 88.2;dendritic cells: 149.1;Kupffer cells: 117.7;Macrophages: 93.4;Microglial cells: 381.3;NK-cells: 134.9;T-cells: 125.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 182.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 101.0;MOLT-4: 87.7;REH: 195.4;U-698: 204.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017009, HPA063903" Enhanced Enhanced "Plasma membrane,Cytosol" No NA "Cluster 1: Neutrophils - Mixed function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane, Cytosol" "HPA017009: AB_2669505, HPA063903: AB_2685147" "unprognostic (1.31e-2)" "unprognostic (3.26e-2)" "unprognostic (2.79e-3)" "prognostic favorable (7.48e-4)" "unprognostic (3.06e-1)" "unprognostic (1.07e-2)" "unprognostic (3.83e-2)" "unprognostic (3.05e-1)" "unprognostic (1.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.72e-2)" "unprognostic (9.75e-2)" "unprognostic (1.71e-1)" "unprognostic (7.77e-3)" "unprognostic (2.68e-2)" "unprognostic (6.00e-2)" "unprognostic (2.38e-2)" 30.7 4.7 7.0 47.8 8.0 45.5 14.5 10.4 7.6 3.5 5.7 6.1 7.1 2.2 1.6 3.4 5.9 11.6 5.7 7.6 10.4 5.0 38.3 15.5 50.0 16.4 12.5 1.5 4.3 1.6 2.8 8.8 18.0 2.6 6.7 0.6 5.1 2.1 1.4 3.4 17.8 7.5 16.0 56.6 9.2 0.8 15.5 145.4 3.5 2.7 44.3 10.5 3.6 27.3 0.1 1.8 0.0 0.0 12.8 21.2 11.3 37.0 7.2 20.8 19.8 0.0 0.0 101.0 0.5 24.9 22.2 0.1 0.0 0.0 28.6 0.0 0.0 73.3 0.2 0.0 0.0 13.9 0.1 30.3 0.0 0.7 0.0 2.6 0.0 40.5 0.1 62.0 0.0 0.0 87.7 19.5 0.1 7.9 0.0 195.4 0.1 72.4 5.8 0.0 0.1 0.0 3.4 0.3 0.1 0.3 0.1 47.6 0.1 0.0 0.5 6.8 0.1 16.8 0.0 204.7 16.9 71.0 0.0 81.5 23.8 58.5 30.2 23.6 24.9 32.6 25.8 25.9 15.4 39.5 29.3 28.8 182.9 19.1 38.9 50.3 27.2 13.4 7.0 8.0 10.4 7.6 7.6 10.4 16.4 12.5 18.0 16.0 15.5 27.3 3.2 0.0 25.3 1.6 88.2 1.1 0.1 0.1 0.6 0.1 1.6 3.2 1.0 8.6 2.6 3.7 0.0 2.2 149.1 0.1 0.0 3.9 0.4 0.7 12.8 4.7 0.0 28.2 1.1 0.0 20.7 15.0 3.6 0.4 23.4 0.1 6.8 28.9 59.9 0.0 2.9 0.2 0.0 117.7 18.4 0.3 0.0 93.4 3.6 381.3 65.2 0.0 134.9 4.0 1.5 0.1 0.1 0.0 41.7 0.1 0.0 5.1 3.7 0.2 0.0 0.9 11.3 0.1 1.1 0.4 0.1 1.4 125.9 0.4 0.1 0.1 PDSS1 "COQ1, COQ1A, TPRT, TPT" ENSG00000148459 "Decaprenyl diphosphate synthase subunit 1" Q5T2R2 10 26697701-26746798 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.1;lymphoid tissue: 13.8" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 32.5;Proximal enterocytes: 29.8;Undifferentiated cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038032, HPA042741" Uncertain Approved Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA038032: AB_10670650, HPA042741: AB_2678139" "unprognostic (1.41e-2)" "unprognostic (3.92e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (1.66e-4)" "unprognostic (6.79e-3)" "unprognostic (5.43e-2)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.47e-2)" "unprognostic (9.43e-2)" "unprognostic (2.33e-2)" "unprognostic (2.20e-1)" "unprognostic (4.11e-2)" "unprognostic (2.99e-3)" "unprognostic (2.93e-3)" "unprognostic (8.85e-2)" "unprognostic (9.83e-2)" "unprognostic (6.36e-2)" 2.1 1.4 0.8 5.3 0.9 5.8 2.3 2.6 1.4 1.8 0.6 14.1 19.1 1.9 1.3 4.3 1.5 1.6 2.8 0.8 0.8 6.2 3.6 2.2 4.0 0.8 0.9 1.7 1.3 2.2 0.8 2.4 0.9 1.5 15.1 1.9 1.8 1.3 5.7 1.4 15.3 2.9 0.8 1.8 2.8 2.8 0.9 13.8 1.2 9.5 4.7 3.1 2.2 1.1 15.6 11.8 8.9 16.3 2.9 5.4 12.2 14.0 3.6 20.0 13.7 18.3 8.4 35.0 7.2 7.0 7.6 19.2 28.6 21.8 16.7 14.7 23.6 30.4 9.9 13.6 4.3 20.3 11.6 6.8 9.2 19.0 5.0 3.5 10.7 22.8 28.4 9.3 14.4 24.9 64.6 14.7 17.9 24.9 11.3 29.6 25.1 25.5 12.0 7.3 25.7 15.8 13.5 27.6 15.9 9.2 9.9 23.7 6.8 11.1 17.9 22.9 22.5 3.6 14.1 25.6 10.9 51.3 8.7 0.0 2.8 0.5 0.4 2.3 1.0 0.2 0.8 0.6 2.6 2.4 1.6 0.7 0.1 0.4 1.2 0.7 0.0 0.7 0.8 0.9 2.6 1.4 0.8 0.8 0.8 0.9 0.9 0.8 0.9 1.1 3.6 0.0 0.0 18.9 4.8 6.9 3.6 5.7 8.0 2.9 4.4 5.1 2.2 5.7 3.9 3.7 4.2 7.7 4.9 11.7 7.9 6.1 12.0 2.1 3.8 2.7 10.8 8.4 16.9 3.9 12.4 3.4 10.2 3.3 0.0 3.7 1.8 4.5 8.8 1.7 32.5 13.0 6.1 5.3 2.7 4.1 2.1 7.7 1.8 5.6 6.2 1.2 1.0 6.6 6.5 5.6 9.8 2.6 9.1 3.7 29.8 26.3 2.1 4.9 0.0 4.1 6.5 12.5 9.4 13.6 3.1 6.3 4.8 4.6 29.8 3.3 ABI1 "ABI-1, E3B1, SSH3BP1" ENSG00000136754 "Abl interactor 1" Q8IZP0 10 26746593-26861087 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 278.2;Suprabasal keratinocytes: 270.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008375, HPA068407" Approved Approved "Plasma membrane,Cell Junctions" NA NA 440000 "Cluster 5: Granulocytes - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane, Cell Junctions" "CAB008375: AB_592744, HPA068407: AB_2685983" "unprognostic (2.83e-3)" "unprognostic (8.69e-2)" "unprognostic (1.12e-1)" "unprognostic (3.96e-1)" "unprognostic (2.51e-2)" "unprognostic (9.24e-3)" "unprognostic (1.88e-3)" "unprognostic (2.03e-1)" "unprognostic (6.04e-2)" "unprognostic (4.38e-1)" "unprognostic (2.40e-2)" "unprognostic (5.48e-2)" "unprognostic (1.98e-1)" "unprognostic (1.07e-1)" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" 28.9 16.2 28.5 35.0 29.2 83.8 29.8 28.3 38.9 30.4 20.9 32.0 32.4 23.6 19.2 53.0 23.8 24.9 16.3 37.4 28.8 27.6 24.9 28.1 48.1 24.7 26.8 26.6 19.9 20.1 12.9 28.3 25.4 20.8 33.0 18.9 32.9 19.1 20.0 42.9 34.1 23.8 26.2 32.3 31.8 14.2 28.0 44.5 22.6 19.6 53.7 34.7 36.5 27.1 55.0 28.6 21.1 21.9 34.4 39.5 34.1 50.9 31.2 35.0 37.5 33.7 61.7 101.1 23.2 51.7 23.0 57.7 28.0 37.0 41.0 65.2 24.2 44.5 18.0 29.0 23.6 23.2 43.9 28.1 54.6 35.3 21.8 41.5 43.7 33.5 30.7 67.2 40.5 25.4 49.8 26.0 18.8 37.5 13.5 51.4 41.2 69.2 48.0 22.9 17.1 18.5 41.3 44.5 46.8 29.4 27.7 35.5 50.6 27.3 33.2 34.4 25.5 15.0 24.0 108.7 38.7 61.1 17.4 77.3 35.5 91.4 42.1 43.2 40.8 57.2 40.9 48.5 39.4 47.7 37.7 41.7 64.3 35.8 45.4 34.1 76.5 57.2 28.5 29.2 28.3 38.9 37.4 28.8 24.7 26.8 25.4 26.2 28.0 27.1 44.4 41.7 37.7 278.2 89.3 246.2 127.9 74.0 123.5 9.6 40.5 26.5 23.2 38.6 73.5 25.8 2.1 36.4 75.7 69.7 13.7 56.3 11.3 72.1 41.3 41.9 44.9 43.8 81.6 52.1 46.9 45.9 42.3 111.5 57.7 22.3 32.9 25.6 75.8 16.8 133.7 54.9 83.4 80.5 116.3 5.7 22.1 92.1 92.5 106.8 89.8 48.2 73.2 128.7 47.4 82.2 52.1 22.2 56.8 132.5 52.7 39.0 86.2 10.0 32.9 29.8 40.3 14.7 10.8 109.6 270.6 77.2 71.0 27.2 41.3 195.4 ANKRD26 "KIAA1074, THC2" ENSG00000107890 "Ankyrin repeat domain 26" Q9UPS8 10 26973793-27100494 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 130.6;Cone photoreceptor cells: 200.1;Excitatory neurons: 136.8;Inhibitory neurons: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA040654, HPA041460" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 37: B-cells - Transcription" "Cluster 54: Non-specific - Microtubule organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus, Vesicles" "HPA040654: AB_10795370, HPA041460: AB_10795120" "unprognostic (1.92e-1)" "unprognostic (3.41e-1)" "unprognostic (2.99e-1)" "unprognostic (1.46e-1)" "unprognostic (1.02e-1)" "unprognostic (2.09e-2)" "unprognostic (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (1.01e-1)" "unprognostic (4.08e-2)" "unprognostic (1.53e-2)" "unprognostic (1.03e-2)" "unprognostic (2.53e-3)" "unprognostic (5.35e-2)" "unprognostic (1.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.99e-1)" 2.3 2.6 4.7 1.6 5.4 1.5 3.8 5.9 8.6 3.9 5.0 2.5 1.7 3.3 3.0 2.0 3.0 2.0 4.1 4.4 4.0 2.7 2.8 1.9 3.5 4.7 3.8 4.0 2.6 4.0 4.6 3.2 2.7 2.6 2.8 10.0 2.3 2.5 6.7 2.5 2.0 2.5 2.8 2.5 2.2 4.0 4.9 3.1 2.7 7.5 2.2 2.2 2.7 5.8 7.7 5.4 9.8 3.7 6.1 6.7 3.4 10.1 3.7 9.2 8.5 5.2 5.1 17.9 3.1 4.7 6.5 8.1 9.6 4.7 11.0 7.4 7.2 1.1 7.9 7.9 4.5 4.5 1.2 4.7 2.9 9.5 3.2 7.5 8.4 5.5 14.8 4.8 9.3 4.3 5.5 2.8 3.9 2.8 3.5 6.6 13.8 4.3 5.7 3.1 8.5 4.7 9.6 2.0 8.1 7.1 8.5 3.1 7.6 7.7 5.2 9.9 5.7 1.9 2.6 11.7 7.3 9.9 3.5 1.0 0.2 0.2 0.2 0.1 0.7 1.2 0.4 0.4 0.3 0.6 1.6 0.5 0.1 1.6 0.1 2.1 0.4 0.2 4.7 5.4 5.9 8.6 4.4 4.0 4.7 3.8 2.7 2.8 4.9 5.8 19.5 22.4 28.8 130.6 14.3 4.2 7.6 9.0 8.6 77.8 13.5 17.7 70.9 7.2 19.4 3.7 200.1 24.8 8.6 8.3 5.9 14.5 19.0 47.7 38.6 20.4 20.9 6.3 136.8 13.1 13.1 21.3 8.2 16.5 5.1 43.5 13.6 8.3 11.9 79.1 185.9 9.3 10.2 5.7 5.4 6.4 30.4 11.8 3.6 45.0 12.4 45.0 18.6 87.0 67.2 11.3 4.2 27.1 7.8 5.3 12.1 5.6 49.5 117.9 32.9 30.1 15.6 60.7 57.2 8.9 8.0 13.7 12.9 46.1 14.6 5.0 YME1L1 YME1L ENSG00000136758 "YME1 like 1 ATPase" Q96TA2 10 27110111-27155266 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066953 Approved Supported "Nuclear bodies,Mitochondria" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nuclear bodies" "HPA066953: AB_2685753" "unprognostic (2.28e-3)" "unprognostic (3.00e-2)" "unprognostic (1.34e-1)" "unprognostic (7.19e-2)" "unprognostic (8.12e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (8.25e-6)" "unprognostic (7.08e-2)" "unprognostic (2.91e-1)" "unprognostic (9.24e-2)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (1.44e-2)" "unprognostic (7.09e-2)" 48.8 52.6 17.7 51.7 18.4 95.1 47.5 23.3 21.7 52.4 36.4 52.2 46.0 50.3 53.3 59.1 43.7 46.0 61.4 17.8 22.7 54.0 65.5 39.8 56.6 18.2 22.1 50.8 52.0 54.5 33.3 61.1 19.9 48.4 52.4 42.0 44.7 44.5 111.4 40.1 46.3 49.2 16.6 46.4 48.8 51.2 19.7 65.9 62.2 97.7 62.5 56.8 35.0 24.4 146.6 105.3 125.5 62.0 118.3 123.9 100.7 143.3 79.7 139.7 157.6 143.3 171.9 152.1 90.8 154.8 100.5 135.6 152.8 122.6 152.9 143.4 89.0 144.4 91.0 98.3 124.6 100.4 114.5 104.7 143.3 123.4 121.6 122.5 146.7 138.8 173.8 150.5 154.4 95.1 189.1 53.7 97.4 119.3 49.4 160.4 199.7 143.0 107.7 68.2 95.6 121.9 138.4 105.2 138.9 102.8 101.5 115.1 146.9 83.4 117.3 140.8 126.7 75.1 121.9 196.1 119.4 178.8 65.8 195.0 146.4 165.4 147.5 128.5 149.4 143.0 142.4 138.8 121.9 149.7 129.3 136.8 204.0 135.6 143.1 222.6 156.7 155.5 17.7 18.4 23.3 21.7 17.8 22.7 18.2 22.1 19.9 16.6 19.7 24.4 105.4 67.3 81.8 40.5 108.3 70.1 96.7 55.6 92.2 53.1 76.8 90.9 103.6 32.9 66.4 29.5 83.4 61.2 121.0 179.4 15.6 52.2 62.3 141.4 152.5 86.1 50.3 63.1 67.0 48.6 74.4 101.1 136.6 224.3 110.8 75.0 58.5 70.0 73.2 50.5 68.1 121.2 32.6 98.9 133.2 27.0 57.8 125.4 56.9 41.2 63.7 63.8 47.4 66.9 75.2 66.8 109.3 43.2 93.8 83.7 156.5 47.3 70.1 65.7 72.3 156.6 94.5 143.4 57.4 92.5 64.9 94.8 122.1 102.2 104.4 75.0 MASTL "FLJ14813, Gwl, THC2" ENSG00000120539 "Microtubule associated serine/threonine kinase like" Q96GX5 10 27154824-27187953 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 24.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027175, HPA054273" Approved Enhanced Nucleoplasm NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA027175: AB_1853591, HPA054273: AB_2682433" "unprognostic (4.10e-2)" "unprognostic (6.89e-2)" "unprognostic (1.22e-2)" "unprognostic (3.14e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (2.19e-2)" "unprognostic (4.00e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (4.81e-5)" "unprognostic (3.78e-2)" "prognostic unfavorable (1.71e-6)" "unprognostic (1.55e-3)" "unprognostic (2.27e-1)" "unprognostic (2.66e-1)" "unprognostic (1.79e-1)" 5.0 3.9 1.7 6.2 1.9 18.7 5.3 2.3 2.3 3.8 2.1 4.1 4.4 3.9 4.5 5.9 3.0 3.9 2.5 1.9 2.0 3.9 4.9 4.0 8.9 2.0 2.0 3.4 3.3 6.0 3.1 6.5 2.1 3.1 5.2 2.7 4.1 3.0 2.3 6.0 4.3 4.5 1.6 4.6 4.7 6.5 2.0 10.4 4.7 2.2 7.1 4.5 4.3 2.3 29.4 22.0 43.8 15.5 6.2 9.1 25.4 43.3 18.0 68.4 83.8 26.7 27.2 22.4 16.1 18.4 33.5 26.8 27.9 16.0 48.2 20.2 26.5 26.9 14.5 15.5 3.8 10.4 19.8 5.6 7.5 41.6 7.9 9.0 14.7 18.2 21.1 49.9 41.5 17.9 34.8 11.2 32.0 15.9 8.9 22.2 71.9 18.9 17.4 10.6 19.2 26.8 26.0 17.6 19.1 28.1 17.2 21.4 12.6 17.0 36.3 44.0 37.4 5.9 10.3 34.7 18.3 31.1 14.8 0.2 1.8 1.7 0.7 1.7 1.1 1.1 0.9 0.7 1.0 1.6 0.9 0.8 2.3 1.0 1.8 1.1 1.6 0.8 1.7 1.9 2.3 2.3 1.9 2.0 2.0 2.0 2.1 1.6 2.0 2.3 4.3 6.4 7.8 2.6 7.4 11.0 4.9 4.4 4.0 1.7 4.2 4.8 3.0 2.8 7.0 1.8 0.0 8.6 10.1 7.0 0.0 4.0 3.0 9.7 5.3 4.6 4.2 7.8 4.3 2.5 24.9 7.3 6.1 17.9 12.7 6.9 2.5 2.5 5.8 3.3 4.3 3.7 4.1 7.8 19.3 1.7 3.1 11.3 0.0 3.7 5.1 1.8 3.1 3.5 4.9 4.4 2.9 2.6 7.1 5.0 2.8 1.9 4.0 1.0 0.0 3.8 5.3 14.9 14.1 10.9 9.9 6.2 11.6 5.4 4.5 6.6 ACBD5 "DKFZp434A2417, KIAA1996" ENSG00000107897 "Acyl-CoA binding domain containing 5" Q5T8D3 10 27168135-27243046 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Transport" Leukodystrophy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011861, HPA012145" Enhanced Enhanced Peroxisomes NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 45: Enterocytes - Digestion" Peroxisomes "HPA011861: AB_1844493, HPA012145: AB_1844494" "prognostic unfavorable (3.33e-4)" "unprognostic (4.93e-1)" "unprognostic (3.68e-1)" "unprognostic (1.34e-1)" "unprognostic (6.21e-2)" "unprognostic (5.98e-3)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (2.69e-1)" "unprognostic (3.66e-1)" "unprognostic (1.11e-1)" "unprognostic (4.46e-2)" "prognostic favorable (4.68e-5)" "unprognostic (7.91e-3)" "unprognostic (1.71e-1)" "unprognostic (3.63e-2)" "unprognostic (3.37e-3)" 14.6 25.1 31.0 13.5 37.0 18.2 12.3 36.2 37.1 13.2 24.2 20.3 39.8 9.4 9.7 12.0 12.0 15.4 40.4 27.6 33.1 37.3 73.8 14.7 14.7 37.2 34.0 9.9 11.1 31.2 6.4 13.4 38.1 15.2 20.9 36.2 10.3 11.4 31.0 17.3 39.2 8.8 36.7 14.7 21.0 19.3 36.1 12.2 27.8 36.6 12.7 13.5 7.5 38.8 25.8 76.5 17.1 18.0 19.1 17.3 20.1 32.3 12.1 28.1 33.5 19.4 39.9 10.7 27.0 22.4 23.4 21.1 23.2 16.3 23.0 26.2 23.9 16.5 23.1 15.2 20.6 11.0 20.9 16.7 17.7 23.5 12.8 24.9 20.5 16.7 13.6 19.5 35.7 20.0 21.1 9.4 13.1 35.2 10.0 17.4 42.5 20.2 44.1 22.4 21.3 45.5 35.4 38.3 17.9 18.9 18.8 11.5 30.4 27.2 15.2 43.7 25.9 19.4 28.1 20.7 27.4 24.6 12.0 12.5 13.0 10.2 15.3 12.7 15.2 6.4 7.5 12.4 13.0 7.0 5.0 11.0 11.1 10.3 15.1 8.5 7.4 8.0 31.0 37.0 36.2 37.1 27.6 33.1 37.2 34.0 38.1 36.7 36.1 38.8 23.3 25.6 29.9 17.9 16.0 9.7 4.1 14.5 7.4 30.8 14.5 10.8 83.0 15.7 25.2 31.3 25.0 9.6 27.4 22.4 33.2 22.1 43.1 33.7 20.2 18.7 10.2 8.6 20.6 16.2 12.6 16.4 19.4 41.1 12.6 11.5 12.8 56.9 19.0 23.5 26.9 30.4 10.2 25.5 12.5 16.9 16.4 22.4 21.4 15.9 22.4 47.7 29.9 17.6 24.8 17.8 26.1 16.6 14.2 11.7 64.4 48.2 32.7 47.2 19.7 20.9 16.1 41.0 8.3 16.5 15.5 10.4 22.3 27.1 26.5 9.2 RAB18 ENSG00000099246 "RAB18, member RAS oncogene family" Q9NP72 10 27504174-27542239 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Protein transport, Transport" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025928 Uncertain NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 6: T47d - Mammary gland" "Cluster 30: Mammary glandular cells - Lactation" "HPA025928: AB_1855997" "unprognostic (9.45e-3)" "unprognostic (7.71e-2)" "unprognostic (2.95e-1)" "unprognostic (6.71e-2)" "unprognostic (3.37e-2)" "unprognostic (1.28e-2)" "unprognostic (8.59e-3)" "unprognostic (1.17e-1)" "unprognostic (3.64e-1)" "unprognostic (1.27e-2)" "unprognostic (8.97e-2)" "unprognostic (3.22e-1)" "unprognostic (1.71e-3)" "unprognostic (9.55e-2)" "unprognostic (1.01e-1)" "unprognostic (1.39e-1)" "unprognostic (8.48e-2)" 40.8 55.5 26.3 29.0 26.8 88.9 50.7 28.9 32.1 32.3 26.5 34.3 33.5 30.5 41.0 44.5 25.4 26.7 48.0 26.4 33.4 47.5 52.3 30.0 26.2 28.5 30.2 30.8 31.5 53.2 20.4 36.7 31.8 41.2 35.2 70.6 28.0 34.1 51.2 35.7 30.9 37.4 30.9 30.0 32.0 34.3 30.1 34.9 41.1 50.5 32.9 39.7 31.0 33.5 68.1 47.5 56.8 41.0 94.1 53.3 37.9 102.6 47.0 87.6 83.4 46.2 44.6 27.7 42.7 88.8 44.2 44.9 37.4 65.6 72.0 42.3 34.1 39.2 44.2 59.3 68.0 16.9 45.4 70.5 122.2 55.0 31.4 62.3 68.5 25.7 22.6 55.2 75.0 44.1 37.8 11.6 24.8 38.7 22.1 27.3 93.8 33.7 83.5 37.6 30.5 36.9 50.6 57.1 67.5 59.6 115.6 35.0 68.5 40.0 49.9 76.8 60.1 24.0 47.5 34.7 68.6 97.6 22.6 212.9 54.4 137.4 41.7 50.7 91.5 25.6 35.7 45.1 40.6 26.5 30.1 35.9 193.2 45.2 60.9 26.7 42.7 49.8 26.3 26.8 28.9 32.1 26.4 33.4 28.5 30.2 31.8 30.9 30.1 33.5 50.3 73.7 44.5 37.5 51.4 186.0 105.3 145.9 68.9 74.1 131.7 51.2 131.4 48.6 92.9 90.1 41.7 90.5 64.9 82.3 213.2 105.0 46.7 46.7 55.4 62.1 65.4 41.2 53.9 90.4 114.9 78.7 31.6 51.8 34.9 63.6 62.8 85.1 84.5 48.8 51.2 47.5 152.5 81.0 83.4 33.8 63.0 62.4 99.6 42.2 115.6 117.6 53.5 43.7 54.8 120.5 57.8 69.2 51.3 127.6 73.1 208.6 72.8 91.0 26.3 45.9 76.9 138.7 81.0 80.7 199.0 149.1 60.9 79.1 40.9 132.6 MKX "C10orf48, IRXL1, MGC39616" ENSG00000150051 "Mohawk homeobox" Q8IYA7 10 27672874-27746060 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 11.1;prostate: 15.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 39.1;Granulosa cells: 11.1;Inhibitory neurons: 15.7;Peritubular cells: 7.2;Respiratory ciliated cells: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 51.3;BJ hTERT+: 29.4;BJ hTERT+ SV40 Large T+: 33.1;BJ hTERT+ SV40 Large T+ RasG12V: 22.6;fHDF/TERT166: 148.4;SiHa: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA006927 Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Nuclear speckles" "HPA006927: AB_1853981" "unprognostic (2.04e-1)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.23e-2)" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (8.37e-2)" "unprognostic (2.16e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (7.62e-2)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (6.38e-3)" 2.7 2.2 1.1 0.7 1.5 0.0 1.1 5.1 8.5 2.8 0.0 3.3 0.2 1.2 2.3 1.0 5.2 1.3 0.4 1.0 3.9 0.2 1.2 0.7 0.2 5.0 3.8 11.1 0.5 1.3 4.9 0.0 4.9 15.7 0.9 0.3 0.3 5.3 0.3 0.6 0.3 0.6 4.4 0.4 2.0 0.8 0.9 0.0 3.3 0.0 0.0 4.2 0.9 3.6 0.0 0.0 0.3 0.1 0.0 0.0 0.0 51.3 29.4 33.1 22.6 0.2 0.1 0.0 0.1 148.4 1.3 0.0 0.4 0.0 8.8 0.0 3.3 0.0 9.1 0.1 1.3 0.0 0.0 1.4 2.2 0.0 0.1 0.0 0.0 3.3 0.0 6.3 0.8 0.0 0.2 0.0 0.7 0.0 4.3 0.0 0.7 0.0 0.0 0.0 0.5 0.0 21.4 0.0 0.0 0.2 3.6 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.5 5.1 8.5 1.0 3.9 5.0 3.8 4.9 4.4 0.9 3.6 0.0 0.0 1.9 4.6 0.1 0.0 0.0 0.2 0.6 0.3 0.0 0.1 1.9 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.5 0.1 0.1 0.0 0.0 39.1 0.2 0.0 2.2 0.0 0.1 0.0 11.1 0.0 0.8 0.0 0.0 15.7 0.0 0.0 0.0 0.8 2.1 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.5 1.2 0.1 0.0 7.2 0.1 0.1 0.0 0.1 7.3 0.1 0.0 0.0 1.0 0.1 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 ARMC4 "CILD23, DKFZP434P1735, FLJ10376, FLJ10817, gudu" ENSG00000169126 "Armadillo repeat containing 4" Q5T2S8 10 27775186-27999079 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 23.1;testis: 40.7" "Cell type enhanced" "Detected in some" "Early spermatids: 277.5;Endometrial ciliated cells: 45.3;Late spermatids: 85.1;Respiratory ciliated cells: 128.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 7.8;BJ: 8.2;fHDF/TERT166: 9.4;RH-30: 25.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037829 Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 49: Ciliated cells - Cilium organization" "HPA037829: AB_10670960" "unprognostic (1.03e-2)" "unprognostic (2.87e-1)" "unprognostic (3.48e-2)" "unprognostic (4.43e-3)" "unprognostic (1.64e-1)" "unprognostic (4.28e-2)" "unprognostic (6.23e-2)" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (1.65e-1)" "unprognostic (1.11e-3)" "unprognostic (7.72e-2)" "unprognostic (2.76e-2)" "unprognostic (1.75e-2)" "unprognostic (6.15e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" 0.3 0.9 1.4 0.3 1.4 0.6 0.2 0.9 1.7 1.2 9.5 1.0 0.2 1.0 0.6 0.4 23.1 0.3 0.2 1.3 1.8 0.3 0.7 2.6 0.1 4.5 4.7 1.6 0.0 0.3 3.2 0.0 3.5 2.4 0.3 0.3 0.0 1.8 0.1 0.1 0.2 0.5 3.5 0.2 0.3 40.7 1.4 0.6 0.4 0.0 0.0 0.6 0.3 2.8 0.1 0.2 7.8 0.0 0.0 0.0 0.1 8.2 2.7 6.0 3.6 0.0 0.3 0.1 0.0 9.4 1.8 0.0 1.2 0.6 4.7 0.3 4.9 0.0 4.6 0.0 0.9 0.0 0.0 1.1 0.0 0.0 0.0 2.2 2.2 1.8 0.0 0.0 1.3 0.0 4.9 0.6 6.8 0.0 5.4 0.1 25.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.4 0.7 1.7 1.0 0.0 3.6 0.4 4.3 0.2 0.0 0.1 1.2 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.4 0.9 1.7 1.3 1.8 4.5 4.7 3.5 3.5 1.4 2.8 0.2 3.2 3.9 8.8 0.0 0.0 0.1 2.1 0.0 0.0 0.1 0.4 2.7 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 277.5 45.3 0.9 0.6 0.0 0.0 2.2 0.4 0.0 1.1 0.0 0.7 0.0 1.1 0.0 0.0 0.1 0.0 1.2 0.0 2.0 0.0 0.3 85.1 1.2 0.3 0.0 5.6 0.0 0.0 0.0 7.1 0.3 0.0 1.1 1.9 0.0 0.1 0.0 0.1 128.4 0.0 0.0 0.2 1.4 32.4 2.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 MPP7 FLJ32798 ENSG00000150054 "Membrane palmitoylated protein 7" Q5T2T1 10 28050993-28334486 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.1" "Cell type enhanced" "Detected in many" "Early spermatids: 82.3;Excitatory neurons: 76.7;Suprabasal keratinocytes: 61.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 4.7" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 23.3;CACO-2: 45.2;CAPAN-2: 27.9;T-47d: 89.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037597, HPA037598" Approved Supported "Nucleoplasm,Cell Junctions" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 6: T47d - Mammary gland" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Cell Junctions" Nucleoplasm "HPA037597: AB_2675569, HPA037598: AB_10696941" "unprognostic (1.12e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "unprognostic (6.64e-2)" "unprognostic (7.78e-2)" "unprognostic (9.31e-3)" "prognostic favorable (5.88e-4)" "unprognostic (2.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.88e-1)" "unprognostic (2.26e-1)" "prognostic favorable (2.79e-14)" "unprognostic (2.46e-1)" "unprognostic (1.88e-1)" "unprognostic (4.66e-2)" "unprognostic (1.03e-2)" 3.8 2.7 0.1 5.7 1.0 8.8 9.7 4.7 2.2 6.4 0.1 10.7 6.0 5.1 1.9 37.1 11.8 6.4 6.6 0.4 0.0 12.2 1.9 10.1 2.6 0.0 0.0 3.4 12.1 11.8 2.2 11.7 0.1 8.0 9.3 9.7 7.6 4.8 13.8 24.8 7.2 8.7 0.0 2.4 8.8 9.0 0.0 3.2 14.4 14.3 6.9 9.7 9.6 1.1 5.9 0.1 0.6 0.0 0.1 0.1 23.3 1.2 0.9 4.7 7.4 45.2 27.9 0.0 0.3 3.4 3.4 10.4 3.9 7.5 10.9 0.0 7.5 0.0 1.3 2.8 0.0 0.0 0.0 0.3 11.6 0.7 0.4 0.0 0.0 2.2 1.1 0.0 6.2 10.9 2.3 0.0 1.4 8.9 2.1 1.2 13.3 0.0 0.4 19.0 1.1 0.0 2.3 11.3 0.0 3.6 89.3 1.1 0.0 1.8 12.5 0.0 1.0 0.2 0.0 0.1 0.1 10.7 0.0 0.0 7.7 9.0 3.8 2.5 5.6 0.6 4.2 2.6 7.8 0.5 7.9 5.7 3.1 5.0 1.5 0.1 1.1 5.1 0.1 1.0 4.7 2.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.1 1.6 44.8 48.3 10.4 5.5 23.1 10.9 9.5 7.4 1.1 14.7 8.6 12.1 10.0 24.3 14.7 16.7 50.0 9.8 15.3 9.8 5.5 82.3 9.3 0.6 11.7 6.7 4.2 76.7 12.9 3.5 2.6 11.2 6.6 1.3 0.7 2.9 3.2 5.4 3.3 30.3 10.4 8.2 4.7 5.3 20.3 0.9 8.1 7.2 12.2 16.2 24.0 4.1 4.5 2.5 6.6 7.8 0.4 5.1 7.5 12.1 9.5 19.3 8.5 0.0 1.5 7.6 5.4 9.5 48.0 61.1 46.5 16.3 0.1 11.3 17.4 WAC "BM-016, FLJ31290, MGC10753, PRO1741, Wwp4" ENSG00000095787 "WW domain containing adaptor with coiled-coil" Q9BTA9 10 28532493-28623112 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036528, HPA042609, HPA074604" Approved Enhanced Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 72: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA036528: AB_10670839, HPA042609: AB_2678076, HPA074604: " "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.80e-1)" "unprognostic (4.53e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (9.27e-6)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.07e-1)" "unprognostic (2.90e-1)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (3.13e-2)" "unprognostic (6.63e-2)" "unprognostic (1.36e-1)" 53.2 39.9 18.4 30.8 24.3 51.6 48.9 45.2 22.0 49.4 17.9 66.3 27.3 50.3 16.7 45.9 47.1 23.7 44.8 19.6 20.5 38.1 35.9 50.4 31.6 19.2 21.9 53.1 39.5 34.0 36.9 31.6 19.6 40.6 23.2 34.5 44.2 25.6 55.1 50.2 47.4 25.0 19.1 45.6 45.8 37.3 21.8 45.8 43.7 34.0 28.4 54.9 46.7 26.3 72.4 45.2 65.5 51.1 40.7 31.4 59.9 58.2 33.1 60.9 50.5 68.7 73.2 71.8 42.8 46.6 44.6 63.1 51.5 46.8 55.1 92.1 54.0 89.0 40.6 41.2 51.2 39.9 66.7 33.0 57.7 65.6 46.7 38.4 44.4 65.8 76.8 69.9 38.4 60.0 87.8 24.6 41.9 48.1 21.4 71.8 109.3 56.2 29.3 36.1 60.1 56.8 50.7 57.4 78.2 40.6 45.8 56.1 47.9 38.5 64.3 40.1 52.8 40.8 44.4 82.6 47.8 70.5 38.8 13.7 10.7 9.2 10.5 15.0 10.5 12.7 8.7 12.7 11.2 12.3 10.3 9.2 13.0 13.4 14.3 7.3 9.2 8.5 18.4 24.3 45.2 22.0 19.6 20.5 19.2 21.9 19.6 19.1 21.8 26.3 110.8 93.0 75.1 114.6 94.1 176.0 94.6 44.2 105.9 114.5 95.8 78.9 109.6 81.5 52.9 40.5 95.9 59.2 115.7 77.1 31.3 47.0 99.8 92.9 107.4 92.8 69.5 97.8 117.8 47.6 61.5 86.4 58.6 142.4 55.8 94.1 75.3 61.4 53.6 107.7 107.1 86.2 44.7 111.5 154.8 123.6 83.0 107.2 76.5 138.7 92.1 68.4 87.6 142.7 180.9 55.0 68.5 82.8 86.0 128.5 73.2 59.4 45.5 92.4 59.2 113.5 85.1 85.9 59.2 80.5 184.1 99.1 100.4 83.4 71.6 134.5 BAMBI NMA ENSG00000095739 "BMP and activin membrane bound inhibitor" Q13145 10 28677510-28682932 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 81.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 174.7;Breast myoepithelial cells: 163.2;Granulosa cells: 334.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 166.7;SK-MEL-30: 199.0;SuSa: 357.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010819, HPA010866" Approved Approved "Nucleoli fibrillar center,Vesicles,Lipid droplets" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Nucleoli fibrillar center, Lipid droplets" "HPA010819: AB_2668371, HPA010866: AB_10601686" "unprognostic (7.02e-3)" "unprognostic (4.52e-2)" "unprognostic (1.28e-2)" "unprognostic (3.17e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (9.42e-6)" "unprognostic (1.09e-1)" "unprognostic (6.45e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-3)" "unprognostic (9.29e-2)" "prognostic favorable (5.25e-4)" "unprognostic (1.01e-1)" "unprognostic (3.24e-1)" "unprognostic (2.38e-2)" "unprognostic (2.10e-2)" 4.4 44.1 13.8 2.3 16.3 6.0 23.7 18.4 17.6 5.7 20.7 3.8 1.6 17.9 2.9 2.1 6.3 5.4 43.5 13.6 15.9 19.9 23.9 12.0 2.0 19.9 16.9 81.6 6.9 8.2 8.5 39.3 21.1 7.4 4.7 13.4 6.4 16.7 1.8 5.4 2.1 12.2 16.6 18.0 3.8 8.7 14.8 0.4 1.2 1.9 1.4 30.0 5.4 22.7 1.0 41.0 4.2 2.2 4.8 0.1 24.5 9.7 3.5 15.4 10.0 166.7 17.3 0.5 5.7 7.4 8.8 12.2 10.2 1.6 7.2 10.1 21.0 39.5 6.2 63.7 5.9 2.4 51.5 3.7 2.3 10.4 1.6 96.7 2.4 2.1 22.1 18.7 3.1 70.1 0.2 3.3 71.6 34.5 9.9 0.3 7.8 3.6 12.9 40.4 6.8 5.2 13.2 78.5 199.0 357.8 23.2 3.0 0.3 10.4 7.3 17.0 4.7 0.5 15.0 0.0 1.0 8.9 67.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 16.3 18.4 17.6 13.6 15.9 19.9 16.9 21.1 16.6 14.8 22.7 6.6 9.6 5.9 15.0 5.7 4.0 7.6 0.6 13.1 14.3 174.7 163.2 34.9 58.6 3.5 11.0 4.2 12.0 9.3 33.8 1.9 20.8 0.1 14.3 15.3 7.3 26.8 0.0 0.5 0.2 22.2 46.1 58.6 21.1 1.3 334.8 14.6 16.0 6.7 6.7 0.2 3.8 0.0 1.6 4.2 1.2 3.4 5.4 16.0 15.9 0.7 50.2 0.0 46.3 21.2 12.1 34.6 2.2 4.3 10.8 1.1 16.1 1.4 5.9 0.0 4.2 42.7 1.9 15.5 13.5 1.3 8.5 7.8 6.2 3.8 14.1 LYZL1 "LYC2, MGC33408" ENSG00000120563 "Lysozyme like 1" Q6UWQ5 10 29289061-29318328 "Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 429 "testis: 51.0" "Group enriched" "Detected in some" 37 "Early spermatids: 600.3;Late spermatids: 201.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (1.88e-1)" "unprognostic (8.40e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 600.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 201.8 5.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.0 10.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SVIL ENSG00000197321 Supervillin O95425 10 29457338-29736959 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 808.1;tongue: 581.5" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 204.9;Cardiomyocytes: 469.6;Peritubular cells: 260.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 259.3" "Lineage enriched" "Detected in all" 9 "granulocytes: 259.3" "Cell line enhanced" "Detected in many" "HaCaT: 146.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010878, HPA020095, HPA020138" Approved Supported "Plasma membrane,Actin filaments,Cytosol" NA NA 210000 "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane" "Actin filaments, Cytosol" "CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.06e-2)" "unprognostic (1.15e-2)" "unprognostic (3.47e-3)" "unprognostic (2.26e-2)" "unprognostic (4.12e-1)" "unprognostic (1.49e-1)" "unprognostic (4.28e-1)" "unprognostic (3.42e-3)" "unprognostic (1.55e-1)" "unprognostic (9.20e-2)" "unprognostic (2.38e-3)" "unprognostic (7.11e-3)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (5.70e-5)" 26.4 13.4 3.7 22.7 3.9 37.2 22.6 1.3 8.9 45.8 2.5 314.5 14.8 116.2 24.1 92.1 55.5 52.0 165.0 2.2 2.7 15.4 10.4 22.9 12.6 7.0 4.1 83.3 18.5 31.8 8.5 17.9 4.4 70.3 37.1 10.3 40.6 100.0 808.1 26.9 60.1 107.0 4.4 7.6 77.6 11.7 4.9 19.1 35.0 581.5 10.8 173.2 40.3 5.2 71.4 27.9 12.4 5.4 32.1 84.4 22.1 12.6 24.1 4.3 4.7 34.4 63.1 2.4 43.0 4.9 31.9 146.8 8.6 25.6 5.2 1.4 17.6 0.1 33.6 19.9 21.4 8.0 1.5 72.7 24.5 44.2 19.1 71.9 69.6 14.7 0.1 0.4 6.7 19.9 7.7 4.0 7.0 27.8 15.1 15.5 32.1 0.9 40.2 20.1 18.1 14.1 12.3 1.4 34.3 39.8 12.9 7.9 46.3 21.9 23.4 94.4 34.4 0.6 0.8 0.3 64.5 14.0 65.4 43.4 12.1 58.2 11.1 14.0 10.9 0.6 11.2 7.6 7.3 1.0 17.1 10.9 259.3 14.6 29.6 3.0 4.3 3.7 3.7 3.9 1.3 8.9 2.2 2.7 7.0 4.1 4.4 4.4 4.9 5.2 31.3 48.1 30.5 2.3 3.7 70.2 108.0 41.1 204.9 11.7 36.6 67.1 469.6 18.6 53.5 38.6 25.0 29.7 11.3 39.7 7.9 94.1 4.0 26.3 65.8 61.1 23.9 1.7 8.3 42.3 18.5 68.1 7.7 43.6 10.1 35.7 32.2 11.8 10.4 5.0 43.9 31.3 28.5 7.5 45.7 6.8 109.6 25.3 28.4 146.1 16.7 30.6 13.4 28.1 6.6 63.4 40.2 260.7 3.3 131.8 18.4 10.8 42.2 15.0 46.0 90.6 92.9 6.5 11.1 103.8 60.0 24.8 14.6 27.9 39.2 98.3 JCAD KIAA1462 ENSG00000165757 "Junctional cadherin 5 associated" Q9P266 10 30012803-30115494 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Adipocytes: 106.8;Endothelial cells: 30.3;Granulosa cells: 72.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 29.3;HUVEC TERT2: 29.9;LHCN-M2: 24.9;TIME: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017956 Enhanced Approved "Vesicles,Cell Junctions" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cell Junctions" "HPA017956: AB_1852408" "unprognostic (1.78e-1)" "unprognostic (8.33e-2)" "unprognostic (5.37e-2)" "unprognostic (8.07e-2)" "unprognostic (6.32e-2)" "unprognostic (7.09e-2)" "unprognostic (9.36e-2)" "unprognostic (1.28e-1)" "unprognostic (1.16e-1)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (3.08e-2)" "prognostic unfavorable (2.54e-4)" "prognostic unfavorable (2.01e-4)" "unprognostic (1.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.34e-2)" 31.2 7.5 13.5 5.2 21.2 0.1 13.0 5.1 13.0 6.5 3.1 36.0 1.4 17.3 7.5 5.9 12.5 10.4 18.3 10.8 7.2 6.7 1.8 24.2 3.5 12.5 8.4 10.9 16.9 4.9 4.5 33.6 10.1 7.8 3.9 13.1 2.4 9.5 9.9 3.7 3.7 17.3 7.3 0.9 4.5 14.0 13.3 6.1 13.6 14.8 1.8 18.3 4.4 8.1 15.3 6.7 5.9 0.0 3.7 0.9 8.6 8.1 8.5 1.2 2.0 2.6 0.1 0.0 0.6 29.3 1.7 0.3 1.6 0.5 3.3 1.7 3.6 0.0 0.0 0.1 16.0 0.0 1.0 9.1 0.2 19.9 1.5 0.5 29.9 0.4 0.0 0.0 24.9 0.5 0.0 0.7 1.2 0.9 10.2 0.0 3.3 0.0 1.2 0.3 0.8 0.1 0.3 0.1 0.0 8.4 0.0 1.4 67.8 14.9 3.6 4.7 0.7 6.2 0.8 0.0 3.5 10.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 21.2 5.1 13.0 10.8 7.2 12.5 8.4 10.1 7.3 13.3 8.1 106.8 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 16.4 0.0 1.3 8.5 30.3 0.0 0.0 0.0 0.4 0.9 2.2 0.0 0.8 1.3 72.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 2.9 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.4 0.2 7.1 0.0 0.0 MTPAP "FLJ10486, PAPD1, SPAX4, TENT6" ENSG00000107951 "Mitochondrial poly(A) polymerase" Q9NVV4 10 30309801-30374448 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transcription" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 36.8" "Cell type enriched" "Detected in many" 7 "Early spermatids: 240.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038620, HPA058232" Approved Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Mitochondria "HPA038620: AB_10673015, HPA058232: AB_2683646" "unprognostic (2.76e-2)" "unprognostic (2.04e-1)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (3.05e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.20e-6)" "unprognostic (1.16e-1)" "unprognostic (2.04e-1)" "unprognostic (4.78e-2)" "unprognostic (1.77e-1)" "unprognostic (3.56e-2)" "unprognostic (9.02e-2)" "unprognostic (6.28e-3)" "unprognostic (3.77e-1)" "unprognostic (1.14e-2)" "unprognostic (4.39e-2)" 8.9 7.4 4.9 10.3 4.8 36.8 9.7 12.6 6.7 6.1 3.1 9.6 10.6 9.0 6.2 8.3 6.6 5.2 8.8 4.8 4.3 9.6 10.6 6.3 10.7 3.4 3.5 8.2 10.0 8.4 2.7 9.6 3.9 7.2 11.0 7.1 8.0 4.9 13.2 8.4 9.0 9.1 3.2 9.3 7.1 5.1 3.6 9.2 10.2 12.0 10.3 8.1 5.2 6.2 26.0 25.3 15.8 23.0 15.2 14.2 20.6 17.6 6.2 17.7 18.4 27.0 35.4 36.9 12.3 11.7 16.3 29.7 31.1 20.7 21.6 18.7 24.0 37.3 23.7 27.5 16.0 24.6 28.2 14.3 19.0 19.9 11.7 9.8 19.6 34.0 41.2 28.1 13.5 21.8 29.8 21.8 10.8 19.5 13.3 29.6 27.9 34.4 16.2 17.1 25.9 20.8 16.0 16.4 24.7 14.8 15.8 15.6 18.7 18.4 23.8 26.0 19.8 6.2 16.3 50.8 15.9 44.5 6.6 27.4 25.2 27.3 21.7 35.0 23.0 20.8 20.4 21.1 33.0 17.1 21.6 22.0 4.2 25.1 27.9 17.3 23.1 13.1 4.9 4.8 12.6 6.7 4.8 4.3 3.4 3.5 3.9 3.2 3.6 6.2 12.2 9.6 7.4 9.1 11.2 25.2 13.9 7.4 4.6 0.0 9.8 9.8 16.7 15.7 9.2 3.7 0.0 13.1 13.9 8.1 19.6 9.6 240.7 9.9 14.8 12.9 4.2 16.6 12.7 9.1 12.0 12.7 7.7 12.5 5.1 18.8 12.5 14.6 14.7 0.0 14.5 15.6 6.1 15.8 13.6 34.3 12.2 10.8 8.8 8.4 14.8 0.0 5.2 4.5 14.4 8.9 5.2 16.6 5.3 14.1 8.7 14.2 8.6 0.0 13.1 14.7 10.8 25.3 19.5 11.4 24.9 11.5 8.8 12.6 18.4 16.6 MAP3K8 "c-COT, COT, EST, ESTF, MEKK8, Tpl-2" ENSG00000107968 "Mitogen-activated protein kinase kinase kinase 8" P41279 10 30434021-30461833 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 332.1" "Cell type enhanced" "Detected in many" "Macrophages: 225.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 44.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB005120, HPA017962" Supported Supported Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 41: Macrophages - Immune response" Cytosol "CAB005120: AB_2140669, HPA017962: AB_1853776" "unprognostic (1.91e-2)" "unprognostic (2.94e-1)" "unprognostic (3.07e-1)" "unprognostic (9.29e-2)" "unprognostic (6.73e-2)" "unprognostic (1.00e-2)" "unprognostic (1.44e-1)" "unprognostic (3.36e-2)" "unprognostic (1.41e-2)" "unprognostic (8.04e-3)" "unprognostic (8.23e-2)" "unprognostic (2.96e-1)" "prognostic unfavorable (8.76e-7)" "unprognostic (1.88e-1)" "unprognostic (1.49e-1)" "unprognostic (1.63e-2)" "unprognostic (5.98e-3)" 69.1 18.8 7.2 39.9 5.8 332.1 31.8 5.9 8.0 15.1 22.1 19.6 8.3 18.3 5.9 23.2 38.0 37.4 18.5 6.7 13.5 12.7 16.2 64.5 33.7 10.7 8.1 12.0 7.4 6.9 8.4 46.5 8.8 11.1 16.4 10.9 12.5 11.2 6.6 36.0 21.1 35.6 9.3 41.7 20.3 3.0 15.9 9.3 14.7 6.1 28.8 49.4 20.4 7.9 15.5 13.7 3.6 7.7 18.3 15.4 17.3 3.8 20.3 8.2 9.6 9.4 34.2 10.3 9.2 8.1 8.1 28.2 8.4 3.7 3.0 23.3 4.4 19.2 25.6 30.8 16.0 6.0 44.2 19.5 2.1 7.4 1.6 7.7 3.6 0.2 8.8 14.7 1.4 8.8 0.2 22.3 1.4 8.3 4.9 1.3 3.0 5.8 7.9 30.8 0.3 1.6 13.7 11.3 1.9 10.0 3.7 12.7 0.1 4.8 4.3 18.0 0.6 22.4 22.7 3.2 6.9 25.3 0.2 45.8 14.7 53.1 15.7 26.4 8.7 20.8 3.3 10.3 14.5 38.0 0.2 6.0 35.5 28.3 38.7 30.0 1.0 10.3 7.2 5.8 5.9 8.0 6.7 13.5 10.7 8.1 8.8 9.3 15.9 7.9 51.0 38.5 49.6 11.8 147.3 116.9 50.0 91.1 109.8 19.0 51.7 24.3 10.1 11.5 67.5 3.7 0.0 29.3 203.6 13.6 1.9 31.4 0.5 149.3 51.4 55.7 12.0 21.2 7.7 11.3 86.8 66.2 33.1 205.6 71.1 1.1 25.0 3.1 128.2 0.0 7.1 6.3 83.4 113.8 205.5 1.1 8.4 225.1 42.7 30.9 64.7 6.1 36.0 2.0 0.7 23.4 20.7 4.1 107.8 46.8 3.9 3.5 78.8 1.6 6.6 23.6 62.3 0.3 0.8 129.1 84.8 159.4 97.8 1.5 6.5 195.6 LYZL2 ENSG00000151033 "Lysozyme like 2" Q7Z4W2 10 30611779-30629762 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 712 "testis: 71.1" "Group enriched" "Detected in some" 43 "Early spermatids: 786.1;Late spermatids: 204.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SK-BR-3: 3.0" "Secreted in male reproductive system" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (2.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 786.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 204.1 7.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF438 bA330O11.1 ENSG00000183621 "Zinc finger protein 438" Q7Z4V0 10 30820207-31031937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 111.3;Excitatory neurons: 55.3;Inhibitory neurons: 74.7;Microglial cells: 76.8;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 86.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 19.0;U-937: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039843 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 32: U-937 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm Cytosol "HPA039843: AB_10795159" "unprognostic (1.69e-1)" "unprognostic (9.49e-3)" "unprognostic (3.72e-2)" "unprognostic (9.21e-2)" "unprognostic (4.75e-2)" "unprognostic (1.22e-2)" "unprognostic (3.98e-3)" "unprognostic (1.30e-1)" "unprognostic (4.65e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-2)" "unprognostic (4.85e-2)" "unprognostic (1.08e-2)" "unprognostic (9.96e-2)" "unprognostic (1.52e-1)" "unprognostic (8.52e-3)" "unprognostic (9.50e-2)" 11.9 3.6 5.5 6.4 5.7 5.5 7.4 5.1 7.3 8.5 5.7 11.3 3.8 9.2 6.6 4.6 8.2 5.6 11.0 5.6 5.8 4.4 5.4 8.4 4.0 5.3 5.2 5.9 3.1 3.7 4.9 4.0 5.5 5.4 4.1 4.5 6.2 5.6 24.6 6.8 5.3 8.7 5.3 10.3 6.0 8.4 6.3 7.8 9.7 17.4 3.1 9.3 6.8 6.5 3.7 3.7 3.1 2.7 18.0 12.5 1.7 2.9 4.2 4.5 5.6 0.2 4.4 5.0 3.3 5.2 4.2 1.0 1.6 2.2 6.3 11.6 1.2 2.2 2.0 0.2 10.1 1.7 2.3 6.0 3.7 6.4 3.6 4.1 19.0 5.8 4.3 3.5 6.2 2.7 5.9 9.7 0.3 2.7 1.5 2.6 4.5 2.9 6.4 0.9 2.3 2.5 1.4 0.6 2.1 2.0 1.4 16.2 7.9 2.0 3.5 6.1 3.6 0.8 1.5 0.1 4.0 25.3 1.5 1.3 7.2 3.3 2.0 6.9 1.5 1.0 1.5 2.7 2.2 3.7 3.1 1.7 13.1 3.9 4.3 2.8 3.6 3.5 5.5 5.7 5.1 7.3 5.6 5.8 5.3 5.2 5.5 5.3 6.3 6.5 7.8 3.2 4.8 111.3 3.2 1.0 2.0 1.7 5.2 5.5 2.1 2.2 13.0 5.7 4.2 3.7 6.2 3.5 2.0 1.8 7.9 3.6 25.2 2.7 5.6 6.1 0.0 2.5 55.3 4.2 4.6 9.1 7.1 2.4 12.6 4.1 6.4 1.8 6.9 3.3 74.7 2.6 0.0 12.9 3.5 9.6 4.1 36.3 0.0 76.8 7.3 2.4 7.2 137.2 86.9 3.7 0.8 8.2 3.6 1.3 2.5 3.9 3.9 5.3 6.6 17.0 6.7 12.8 8.0 6.0 2.4 1.6 4.2 2.4 2.3 1.8 ZEB1 "AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a" ENSG00000148516 "Zinc finger E-box binding homeobox 1" P37275 10 31318495-31529814 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 287.8;Excitatory neurons: 276.1;Inhibitory neurons: 261.9;Microglial cells: 479.7;Oligodendrocyte precursor cells: 968.6" "Cancer enhanced" "Detected in all" "glioma: 15.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 113.1;TIME: 87.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027524, CAB058686, CAB079943" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm Nucleoli "CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977" "unprognostic (1.54e-1)" "unprognostic (3.08e-1)" "unprognostic (3.42e-2)" "unprognostic (1.04e-1)" "unprognostic (4.85e-2)" "unprognostic (7.40e-2)" "unprognostic (1.34e-2)" "unprognostic (5.59e-2)" "unprognostic (1.30e-1)" "unprognostic (2.96e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (7.34e-6)" "unprognostic (5.59e-3)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" "unprognostic (1.66e-2)" 26.6 8.6 16.4 12.9 16.2 8.6 16.8 14.0 20.1 33.2 9.9 49.2 6.0 38.7 13.4 11.7 18.6 20.0 34.8 15.2 22.8 7.5 10.4 16.0 9.6 21.1 19.2 9.3 3.8 3.4 7.9 17.5 21.2 14.5 12.3 14.8 8.0 26.9 54.4 7.0 11.8 39.9 16.8 8.1 18.1 10.1 18.2 29.9 11.2 60.5 9.7 24.4 16.4 18.5 0.1 11.1 35.1 43.9 58.4 113.1 0.0 32.7 44.9 6.6 9.3 0.2 0.1 11.3 15.6 39.6 9.3 0.0 14.9 0.0 11.8 19.1 7.9 0.0 7.0 6.3 44.4 9.8 0.3 53.4 0.1 19.6 17.6 21.4 54.9 9.5 7.5 14.4 42.7 0.1 33.7 6.2 2.3 0.0 6.6 11.6 66.0 5.1 12.9 0.0 0.9 15.6 11.1 0.0 0.0 7.2 0.0 6.7 87.7 40.8 9.4 10.0 16.7 9.1 6.3 12.8 10.9 0.0 4.2 4.9 0.0 5.4 2.4 0.0 3.2 4.1 3.2 1.7 1.3 3.1 6.8 3.5 8.5 6.6 0.0 3.1 5.0 1.6 16.4 16.2 14.0 20.1 15.2 22.8 21.1 19.2 21.2 16.8 18.2 18.5 104.4 0.0 7.7 212.9 34.6 11.2 3.0 2.0 0.6 42.7 1.4 2.8 106.3 1.5 3.6 1.8 45.9 0.3 22.0 0.0 0.0 2.1 110.1 7.2 287.8 110.6 0.0 12.2 276.1 2.7 0.5 66.1 2.0 6.5 1.3 17.0 49.6 13.4 1.2 10.1 261.9 0.0 0.0 3.8 25.6 141.8 30.7 6.3 26.6 479.7 10.7 7.2 7.2 968.6 7.3 2.5 0.0 102.0 33.2 3.7 0.0 1.6 1.5 43.4 78.9 99.2 74.2 17.4 15.7 1.1 8.7 0.7 36.2 12.0 0.0 3.8 ARHGAP12 "FLJ10971, FLJ20737, FLJ21785" ENSG00000165322 "Rho GTPase activating protein 12" Q8IWW6 10 31805398-31928876 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 156.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000412 Enhanced NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA000412: AB_10964051" "unprognostic (1.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.52e-1)" "unprognostic (3.42e-1)" "prognostic favorable (1.36e-4)" "unprognostic (5.88e-3)" "unprognostic (6.44e-2)" "unprognostic (6.60e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-1)" "unprognostic (5.68e-3)" "unprognostic (1.04e-1)" "prognostic favorable (4.64e-5)" "unprognostic (1.45e-2)" "unprognostic (1.29e-1)" "unprognostic (9.01e-2)" "unprognostic (5.48e-3)" 8.6 12.5 9.3 8.5 13.0 4.2 16.4 18.5 7.6 13.2 15.8 15.7 15.4 9.3 10.8 9.3 7.8 15.2 11.8 8.0 15.7 14.6 16.3 12.3 7.2 22.1 17.8 14.9 21.3 19.5 6.6 10.8 20.5 11.6 14.7 17.8 16.6 8.0 7.9 8.1 15.8 8.0 17.9 17.8 29.4 6.6 15.0 5.9 16.1 9.6 8.0 10.8 6.9 27.0 23.3 30.8 18.8 16.6 28.0 31.3 12.4 14.4 19.3 11.0 16.1 16.5 56.6 6.8 8.6 23.6 18.9 13.1 9.1 16.6 19.3 3.0 8.8 1.3 5.5 31.5 17.7 1.2 1.3 19.9 14.0 16.7 12.0 18.2 11.7 6.3 14.0 2.1 25.1 16.5 4.4 2.5 6.6 31.0 4.7 6.0 22.1 5.7 19.7 22.2 10.2 9.8 7.4 7.1 37.0 16.9 4.8 4.7 17.3 12.6 18.8 29.2 11.0 2.0 2.7 7.5 18.9 9.4 16.4 0.0 1.2 0.0 3.0 2.7 2.4 2.5 2.5 3.3 0.7 2.2 3.1 3.2 1.7 4.2 2.5 1.0 3.1 1.6 9.3 13.0 18.5 7.6 8.0 15.7 22.1 17.8 20.5 17.9 15.0 27.0 19.0 48.1 45.3 54.5 17.8 24.6 14.9 17.1 37.5 14.5 34.2 19.3 33.5 34.3 29.4 22.0 29.2 9.1 20.0 32.9 11.7 28.5 1.3 21.2 24.2 14.9 33.0 3.8 39.1 29.6 5.4 34.0 69.8 28.6 3.8 24.5 13.6 19.4 19.2 58.9 103.2 38.1 8.2 18.7 12.6 3.3 18.0 13.4 21.4 156.4 6.5 20.7 22.6 94.0 81.5 34.3 28.3 22.2 12.9 22.1 26.9 21.3 27.1 25.1 13.1 49.5 17.8 12.6 24.5 16.5 20.6 9.7 17.3 37.4 24.1 22.9 KIF5B "KNS, KNS1" ENSG00000170759 "Kinesin family member 5B" P33176 10 32009015-32056425 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009846, HPA037589, HPA037590" Approved Enhanced "Centriolar satellite,Cytosol" NA Yes 97000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 10: Non-specific - Unknown function" "Centriolar satellite, Cytosol" "CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (4.00e-2)" "unprognostic (6.21e-2)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.70e-1)" "unprognostic (6.37e-3)" "unprognostic (2.03e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-1)" "unprognostic (2.43e-2)" "unprognostic (2.39e-1)" "unprognostic (8.06e-2)" "unprognostic (1.76e-1)" 59.7 41.8 110.0 46.7 128.2 84.9 45.3 107.7 149.7 47.3 75.6 66.4 52.0 54.1 30.3 52.7 39.2 59.8 87.4 85.8 100.2 44.7 31.9 52.5 39.9 121.9 123.8 27.6 41.8 91.6 22.9 54.4 120.6 65.9 63.6 45.1 39.1 52.0 65.0 38.9 54.7 81.3 128.1 48.1 51.4 64.4 116.8 44.0 50.5 67.3 36.6 60.8 29.8 143.4 115.8 96.4 127.3 89.9 89.2 97.7 54.4 155.6 73.3 117.6 99.6 106.6 124.0 78.7 65.8 185.8 66.9 93.3 117.6 99.4 156.4 68.4 64.1 100.2 87.9 104.5 102.5 70.5 105.6 79.9 138.0 135.8 94.0 93.4 152.8 68.2 122.9 80.5 164.7 69.7 74.0 39.7 20.7 110.1 43.4 95.7 237.2 32.6 90.6 79.5 123.3 89.9 120.4 47.5 117.3 88.0 57.5 99.4 128.4 118.7 111.0 139.3 117.2 24.2 29.8 90.9 113.2 142.2 114.1 41.8 25.9 44.0 19.1 33.0 18.7 23.7 24.0 20.6 24.7 24.3 21.1 20.8 51.1 24.3 35.7 47.9 29.4 18.4 110.0 128.2 107.7 149.7 85.8 100.2 121.9 123.8 120.6 128.1 116.8 143.4 160.3 182.7 206.8 49.3 86.3 213.1 177.7 200.6 66.0 181.9 119.0 103.8 396.0 115.8 198.4 104.8 100.1 121.0 125.5 145.0 45.0 209.4 185.5 167.8 171.4 181.0 132.3 69.2 44.6 176.0 134.9 141.2 85.6 158.9 91.2 159.7 88.5 46.2 132.7 151.4 56.0 227.3 213.6 111.8 129.1 51.8 59.0 137.2 101.4 84.3 169.3 160.5 82.4 61.9 83.3 202.2 164.9 130.9 84.2 254.1 120.2 59.5 206.1 123.8 85.5 176.0 244.8 566.0 195.6 87.6 236.7 331.9 116.0 137.4 208.1 246.8 EPC1 Epl1 ENSG00000120616 "Enhancer of polycomb homolog 1" Q9H2F5 10 32267751-32378798 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 149.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028931 Approved Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Vesicles" "HPA028931: " "unprognostic (6.94e-2)" "unprognostic (3.03e-2)" "unprognostic (9.93e-2)" "unprognostic (9.43e-2)" "unprognostic (5.73e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.80e-2)" "unprognostic (3.83e-3)" "unprognostic (7.43e-2)" "unprognostic (5.55e-2)" "prognostic favorable (6.02e-4)" "unprognostic (4.40e-2)" "unprognostic (1.59e-3)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-3)" 14.4 9.6 12.5 13.9 13.7 149.7 19.4 21.2 14.5 17.5 12.0 15.9 11.5 20.6 15.8 11.1 14.8 12.8 11.9 12.4 12.0 11.9 13.8 14.7 21.5 12.4 12.7 23.4 14.4 14.6 10.3 11.7 13.0 15.0 16.1 19.3 15.0 10.3 22.7 13.8 12.9 16.8 12.5 18.6 13.9 14.4 12.4 31.9 16.8 23.4 17.6 15.2 14.1 16.2 12.0 9.6 21.4 17.9 10.6 14.1 12.4 12.2 6.9 15.6 12.8 10.7 15.1 21.8 8.0 13.6 8.2 12.1 12.1 10.4 10.8 15.9 19.4 18.0 13.5 19.2 11.4 14.1 24.7 12.9 15.8 9.3 7.3 13.9 12.8 18.3 18.8 27.7 12.6 12.9 21.5 10.1 5.3 11.4 8.4 27.7 18.3 11.2 12.1 10.9 18.7 17.8 11.4 8.3 20.1 11.8 8.6 18.7 11.6 9.3 22.7 7.8 10.6 11.3 12.2 35.6 10.0 21.1 8.4 65.8 15.3 36.3 18.9 10.2 16.0 27.4 16.9 15.0 9.1 30.9 17.5 16.1 46.8 13.4 13.2 27.4 21.1 7.7 12.5 13.7 21.2 14.5 12.4 12.0 12.4 12.7 13.0 12.5 12.4 16.2 103.8 41.7 50.9 133.2 166.8 28.6 85.0 54.0 78.6 101.4 69.6 84.3 32.4 52.9 49.2 40.5 68.8 34.9 182.6 55.5 9.8 51.5 11.8 54.1 86.7 70.1 98.6 74.9 108.0 43.6 40.7 71.8 58.1 65.8 85.4 74.9 58.5 35.8 35.2 114.4 106.7 63.9 50.8 55.7 46.8 13.1 94.8 84.4 40.9 134.0 75.4 57.3 148.3 161.9 131.8 49.9 52.3 68.1 139.4 71.6 50.4 20.5 44.1 85.8 98.6 134.9 82.5 77.8 58.3 62.9 24.9 46.1 175.3 56.5 51.0 72.4 CCDC7 "BIOT2, C10orf68, FLJ13031, FLJ32762" ENSG00000216937 "Coiled-coil domain containing 7" Q96M83 10 32446140-32882874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 17 "brain: 28.1;testis: 78.0" "Cell type enhanced" "Detected in many" "Early spermatids: 489.6;Late spermatids: 914.3;Oligodendrocytes: 161.0;Spermatocytes: 176.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075536 Approved "Nucleoli,Mitotic spindle,Cytosol" Yes No "Cluster 20: T-cells - T-cell receptor" "Cluster 78: Testis - Spermatogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" Nucleoli "Mitotic spindle, Cytosol" "HPA075536: AB_2686755" "unprognostic (3.43e-3)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "unprognostic (1.01e-2)" "unprognostic (2.69e-2)" "unprognostic (3.75e-3)" "unprognostic (2.65e-5)" "unprognostic (6.95e-2)" "unprognostic (7.57e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-3)" "unprognostic (2.84e-2)" "unprognostic (2.95e-5)" "unprognostic (7.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" 1.0 1.2 10.9 0.9 20.3 2.4 1.3 28.1 14.5 1.4 0.0 1.1 1.2 1.3 1.5 1.2 0.8 1.1 1.1 3.1 8.9 1.1 0.7 1.2 1.6 13.7 9.1 1.5 1.5 0.8 1.7 0.9 17.0 1.1 1.5 3.0 0.8 1.3 0.7 0.7 1.0 1.2 10.7 1.1 1.2 78.0 15.6 0.8 1.9 0.6 1.4 0.8 1.0 23.7 1.4 1.5 0.4 1.8 1.2 0.9 0.6 1.2 0.4 0.4 1.2 0.3 2.0 1.0 0.6 0.8 1.1 0.6 0.7 0.7 1.6 3.6 0.2 0.5 1.3 0.4 2.1 0.6 0.9 0.8 0.3 0.8 0.3 0.8 0.5 1.6 0.8 3.4 1.5 0.2 0.4 0.3 0.4 0.7 1.4 0.9 1.9 0.1 1.2 0.3 0.9 1.0 0.2 0.2 0.9 0.5 1.0 0.8 2.0 1.0 1.2 1.3 0.7 1.1 0.8 1.0 1.3 4.0 0.6 0.0 0.3 0.0 1.7 0.2 1.7 1.2 2.7 1.5 0.1 0.6 2.9 2.0 0.0 1.8 0.1 1.0 2.0 0.3 10.9 20.3 28.1 14.5 3.1 8.9 13.7 9.1 17.0 10.7 15.6 23.7 7.4 6.4 8.6 87.8 4.8 1.9 1.1 0.5 2.2 8.9 4.1 3.9 7.2 0.0 3.0 1.8 4.2 0.7 6.2 2.0 1.9 4.6 489.6 5.0 6.1 3.5 3.0 2.1 84.3 3.4 1.1 3.7 4.1 5.4 12.6 7.0 0.0 0.0 1.7 0.0 103.3 2.8 0.0 0.0 1.2 914.3 9.6 3.1 1.8 93.7 2.4 3.5 4.1 96.0 161.0 2.8 0.5 7.2 3.8 0.5 2.4 1.1 1.1 23.1 13.1 6.0 3.6 176.0 9.4 1.3 1.1 0.1 8.6 4.6 2.1 0.6 ITGB1 "CD29, FNRB, GPIIA, MDF2, MSK12" ENSG00000150093 "Integrin subunit beta 1" P05556 10 32887273-33005792 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 1206.9;Pancreatic endocrine cells: 1393.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 2711.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003434, HPA059297, HPA069003" Enhanced Supported "Endoplasmic reticulum,Plasma membrane,Focal adhesion sites" NA NA 270000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane, Focal adhesion sites" "Endoplasmic reticulum" "CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125" "unprognostic (3.07e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.67e-2)" "unprognostic (4.36e-1)" "unprognostic (1.20e-2)" "unprognostic (3.87e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (3.36e-6)" "unprognostic (3.22e-1)" "unprognostic (2.36e-3)" "unprognostic (3.68e-3)" "unprognostic (2.42e-1)" "unprognostic (1.02e-3)" "unprognostic (1.25e-2)" "unprognostic (2.23e-1)" "unprognostic (2.48e-1)" "unprognostic (3.08e-2)" 491.9 179.3 61.5 241.5 78.2 81.5 216.2 75.0 90.9 259.2 68.3 265.3 147.4 330.4 171.7 168.6 172.0 347.4 390.3 60.2 74.3 180.4 287.1 233.6 118.0 88.4 80.6 157.1 135.3 145.4 59.8 459.5 88.9 248.1 223.6 27.7 130.7 427.7 157.9 92.2 150.8 710.0 76.6 204.7 160.1 91.2 86.4 77.5 161.5 194.5 106.2 357.4 119.1 88.9 638.0 907.0 495.4 559.6 1183.4 1019.5 398.1 2063.9 1239.6 999.0 903.9 215.9 1478.2 164.5 354.1 1830.9 638.0 438.9 149.1 1204.1 1122.0 163.1 112.7 195.8 416.3 253.6 826.4 48.3 195.5 1027.7 658.2 1040.8 426.0 2711.1 1263.6 81.0 136.6 76.5 1700.8 109.0 80.1 46.7 107.4 200.6 428.2 52.0 357.0 30.9 1454.8 186.2 108.0 271.4 649.9 114.6 498.2 813.7 153.9 175.0 1362.6 1280.0 712.2 904.2 719.7 64.7 14.8 91.2 956.6 198.2 518.5 7.5 35.1 16.1 83.4 69.8 22.8 109.6 191.8 138.7 33.9 40.3 24.9 68.4 9.0 90.3 108.2 11.4 266.8 117.2 61.5 78.2 75.0 90.9 60.2 74.3 88.4 80.6 88.9 76.6 86.4 88.9 631.5 342.9 143.8 26.4 118.0 546.7 435.5 531.6 208.3 32.8 147.1 307.5 210.8 241.6 268.1 226.2 31.3 210.3 217.8 179.8 13.7 1206.9 6.6 194.6 437.9 421.1 193.3 153.0 37.2 411.3 515.2 374.7 95.8 406.5 88.7 561.8 375.9 268.1 179.8 38.7 52.4 97.4 213.6 170.1 206.7 18.3 254.5 217.8 343.3 67.5 119.4 72.0 111.2 42.7 66.8 1393.7 128.5 601.8 181.2 412.5 75.6 68.7 171.5 45.5 637.7 236.3 724.0 10.1 76.0 84.4 170.5 219.7 211.3 225.6 127.0 296.1 NRP1 "CD304, NRP, VEGF165R" ENSG00000099250 "Neuropilin 1" O14786 10 33177492-33336262 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 366.0;Endothelial cells: 174.4;Hepatic stellate cells: 184.6;Sertoli cells: 282.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "hippocampal formation: 48.6" "Immune cell enriched" "Detected in some" 16 "plasmacytoid DC: 39.3" "Lineage enriched" "Detected in many" 16 "dendritic cells: 39.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 444.6;hTERT-RPE1: 371.6;TIME: 369.5;U-87 MG: 425.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004511, HPA030278" Approved "Secreted in other tissues" NA NA 780000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "CAB004511: AB_2282634, HPA030278: AB_10601976" "unprognostic (3.19e-1)" "prognostic unfavorable (7.10e-5)" "unprognostic (1.50e-2)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (6.17e-2)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (6.66e-2)" "unprognostic (2.52e-1)" "unprognostic (1.82e-1)" "unprognostic (4.78e-2)" "prognostic unfavorable (3.87e-4)" "prognostic unfavorable (1.22e-5)" "unprognostic (3.83e-2)" "unprognostic (5.48e-2)" "unprognostic (7.79e-2)" 125.2 42.3 9.3 43.3 9.4 3.7 62.2 0.0 26.0 36.9 13.3 26.6 21.3 51.6 35.7 19.7 34.5 54.1 80.8 48.6 9.1 52.7 53.1 63.7 23.7 4.0 3.9 43.0 33.0 24.4 9.0 133.7 2.1 21.3 23.6 11.6 19.3 38.4 55.9 22.1 21.0 55.9 5.7 66.7 18.6 12.9 13.4 18.2 49.7 46.6 12.4 35.3 20.0 10.7 57.4 217.8 11.1 1.1 204.8 224.7 1.3 224.4 216.2 109.6 118.2 28.9 132.4 1.1 26.6 444.6 116.8 15.8 13.8 65.2 89.3 0.7 11.2 0.6 24.5 48.7 74.3 20.8 1.6 277.3 11.2 261.7 116.8 371.6 304.0 1.4 0.7 1.4 221.3 96.8 1.4 3.9 5.5 11.9 204.2 9.6 24.8 1.2 109.7 1.3 5.1 2.7 23.0 17.5 0.9 9.2 1.0 3.3 369.5 156.4 36.9 193.0 153.8 0.7 1.1 0.7 425.2 26.4 143.5 0.4 2.5 0.5 0.6 0.4 1.0 0.7 0.7 0.6 2.3 0.6 0.6 0.6 0.4 1.2 0.3 39.3 0.6 0.9 9.3 9.4 0.0 26.0 48.6 9.1 4.0 3.9 2.1 5.7 13.4 10.7 366.0 0.0 20.2 80.3 4.3 15.7 10.6 5.5 7.4 10.5 4.2 5.5 67.6 28.6 13.0 18.4 4.2 61.5 29.4 0.6 1.9 57.9 1.3 11.3 116.9 174.4 4.2 3.2 105.4 18.9 13.4 58.5 6.6 11.0 7.6 62.3 184.6 12.5 135.4 0.0 14.4 1.8 16.2 62.7 33.3 5.5 42.3 46.0 12.4 78.7 5.8 3.4 0.0 11.6 2.3 15.4 0.0 21.1 1.6 4.1 3.0 59.8 5.4 0.9 282.7 13.1 117.9 0.2 1.3 2.7 10.5 67.2 3.8 61.1 1.5 3.3 PARD3 "ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118" ENSG00000148498 "Par-3 family cell polarity regulator" Q8TEW0 10 34109560-34815325 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Astrocytes: 455.4;Inhibitory neurons: 147.0;Microglial cells: 193.0;Oligodendrocyte precursor cells: 367.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 50 "basophil: 9.6" "Lineage enriched" "Detected in single" 97 "granulocytes: 9.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030443 Approved Supported "Plasma membrane,Cell Junctions" NA NA 21000 "Cluster 34: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane, Cell Junctions" "HPA030443: AB_10600926" "unprognostic (9.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.62e-1)" "unprognostic (2.83e-2)" "unprognostic (1.81e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (3.48e-1)" "unprognostic (3.49e-1)" "unprognostic (8.07e-2)" "unprognostic (5.82e-3)" "unprognostic (1.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-2)" "unprognostic (3.54e-1)" "unprognostic (9.20e-2)" "prognostic unfavorable (4.41e-4)" 13.1 15.9 19.6 4.8 17.0 0.5 21.5 10.9 12.4 25.9 16.0 30.4 10.6 20.7 12.2 47.8 20.6 14.9 14.6 17.8 20.6 25.1 22.1 15.2 2.6 15.7 22.1 38.5 34.2 20.7 7.3 21.7 15.9 17.0 21.7 13.6 20.1 23.9 40.5 52.1 13.4 21.8 16.0 4.2 17.7 14.0 24.0 13.5 15.2 30.9 12.4 21.3 30.8 13.9 50.6 121.1 40.1 28.6 28.5 24.2 59.1 22.2 25.4 37.3 40.0 44.3 43.3 0.3 31.4 44.6 30.4 35.8 34.7 56.7 46.1 0.4 26.8 0.0 14.9 44.1 36.2 5.7 0.1 28.7 54.9 50.9 38.1 35.9 23.3 32.4 34.7 14.9 44.8 35.4 59.3 4.2 18.0 32.7 41.4 44.9 39.0 21.9 80.9 38.4 20.1 20.9 26.8 37.3 42.9 49.6 21.1 6.7 28.4 18.7 56.1 35.5 24.2 13.2 17.1 0.1 21.0 0.2 22.3 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 19.6 17.0 10.9 12.4 17.8 20.6 15.7 22.1 15.9 16.0 24.0 13.9 6.4 35.3 35.3 455.4 0.2 34.0 42.3 19.8 19.9 8.7 17.1 24.9 39.0 21.5 24.3 14.7 29.2 24.9 0.2 25.6 0.0 34.1 19.9 22.3 29.9 9.4 24.0 2.7 5.4 36.4 25.0 22.3 13.3 33.4 1.3 33.1 8.9 24.8 3.4 11.8 147.0 30.1 14.2 0.6 4.7 20.3 30.4 7.7 5.4 193.0 0.8 28.8 1.0 367.9 13.9 38.8 23.8 38.4 1.4 31.4 13.7 25.6 29.3 19.7 26.3 23.4 26.1 6.2 27.6 40.4 61.5 40.1 1.5 32.1 22.0 47.2 CUL2 ENSG00000108094 "Cullin 2" Q13617 10 35008551-35090642 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 319.6;Late spermatids: 181.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002677, HPA024578" Approved Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "CAB002677: , HPA024578: AB_1847338" "unprognostic (8.11e-3)" "unprognostic (1.12e-1)" "unprognostic (9.77e-2)" "unprognostic (1.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (8.24e-6)" "unprognostic (2.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (4.70e-2)" "unprognostic (6.94e-2)" "prognostic unfavorable (9.32e-5)" "unprognostic (2.26e-2)" "unprognostic (2.31e-1)" "unprognostic (3.70e-1)" "unprognostic (2.29e-1)" 15.3 13.3 10.5 16.2 11.7 20.1 15.5 11.9 13.1 13.0 9.8 14.7 14.5 14.8 10.4 16.8 11.0 12.0 19.2 12.2 12.2 14.3 21.0 13.4 19.8 10.8 11.2 12.7 13.4 22.1 8.8 18.8 11.4 15.3 15.2 13.2 11.5 15.7 45.2 13.4 13.9 19.1 11.5 15.0 14.0 35.8 12.3 18.2 16.2 37.6 20.8 17.0 10.1 12.2 50.4 29.2 37.7 32.5 42.0 46.0 39.8 57.8 32.1 56.1 56.2 38.7 47.0 39.9 31.0 61.6 41.1 45.3 55.4 53.4 63.9 46.9 35.9 51.8 29.0 34.8 46.0 28.6 32.6 44.5 43.7 61.6 21.4 43.3 63.6 41.5 60.5 35.2 62.2 34.4 47.7 15.9 13.8 34.4 117.3 39.4 61.0 25.0 51.3 38.9 18.4 24.4 32.4 40.3 47.0 41.6 30.7 32.4 58.6 34.5 38.3 59.6 38.4 14.7 21.2 47.4 66.4 63.2 24.8 12.8 9.9 11.6 12.3 14.9 17.4 10.9 13.5 14.6 12.6 12.6 16.1 15.2 4.8 13.3 15.3 5.7 17.8 8.5 10.5 11.7 11.9 13.1 12.2 12.2 10.8 11.2 11.4 11.5 12.3 12.2 24.8 22.4 12.6 21.9 23.0 12.0 8.6 13.1 9.6 13.1 12.0 12.4 26.4 5.7 20.7 9.2 10.4 24.7 27.8 9.9 15.6 18.4 319.6 17.5 25.4 22.3 10.7 9.4 39.7 17.8 20.1 15.7 9.2 20.5 20.3 19.2 16.4 18.2 20.1 23.5 35.6 10.6 14.2 17.2 12.3 181.0 14.0 20.3 10.6 27.2 23.0 16.0 27.8 30.7 41.7 17.5 6.9 11.7 17.3 8.3 15.2 15.0 19.9 13.7 0.0 16.1 26.9 40.1 32.8 14.4 13.1 37.1 25.3 23.0 13.1 9.9 CREM hCREM-2 ENSG00000095794 "CAMP responsive element modulator" Q03060 10 35126791-35212958 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 216.6" "Cell type enhanced" "Detected in all" "dendritic cells: 819.1;Early spermatids: 2013.6;Langerhans cells: 1094.0;Late spermatids: 814.3;T-cells: 612.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 103.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001818, CAB018352" Enhanced Supported Nucleoplasm,Vesicles NA NA "Cluster 13: T-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "CAB018352: AB_673599, HPA001818: AB_1078566" "unprognostic (1.78e-1)" "unprognostic (6.26e-3)" "unprognostic (7.09e-2)" "unprognostic (2.51e-2)" "unprognostic (6.22e-3)" "unprognostic (9.27e-3)" "unprognostic (1.16e-1)" "unprognostic (2.41e-2)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" "unprognostic (8.98e-2)" "unprognostic (3.42e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (4.44e-2)" "unprognostic (4.19e-1)" "unprognostic (1.66e-2)" "unprognostic (1.52e-1)" 54.9 137.4 31.9 51.0 34.3 22.0 27.1 31.3 39.2 26.4 38.6 24.5 8.9 30.3 11.4 17.6 29.2 44.5 50.5 33.6 42.9 58.8 60.5 30.5 17.6 36.7 35.5 60.6 16.0 24.5 59.5 100.3 36.0 32.0 13.6 23.5 13.4 23.3 30.0 9.0 15.9 24.5 34.1 25.3 20.7 216.6 35.8 29.3 22.3 31.3 16.9 60.5 19.1 33.5 24.8 39.0 32.3 33.2 22.2 23.0 32.2 31.8 24.8 19.6 27.0 4.6 10.2 42.0 30.2 18.7 21.2 5.6 28.0 20.8 28.5 103.8 20.6 14.9 25.7 18.6 26.5 3.6 15.2 20.4 25.9 38.3 11.7 17.2 55.3 31.1 44.3 16.9 30.4 20.0 26.1 10.8 9.6 9.2 88.6 16.0 16.9 7.8 34.8 9.7 7.5 20.4 15.1 13.1 88.7 36.5 7.2 11.0 74.0 14.9 19.1 41.4 21.3 7.4 10.9 14.6 35.6 33.1 13.0 5.3 3.5 11.5 11.5 5.5 14.6 7.0 12.6 10.4 4.1 6.8 9.0 10.4 9.7 10.2 4.2 12.4 16.2 8.5 31.9 34.3 31.3 39.2 33.6 42.9 36.7 35.5 36.0 34.1 35.8 33.5 98.7 19.2 47.9 42.7 301.8 143.4 58.0 30.9 18.8 18.3 32.1 32.4 62.3 20.0 33.2 165.5 6.2 98.7 819.1 16.8 97.8 40.6 2013.6 32.6 27.6 118.7 69.0 5.7 50.1 44.4 109.1 140.6 29.0 44.2 347.7 14.5 17.9 37.6 120.6 10.1 34.3 17.9 32.6 61.4 1094.0 814.3 26.1 286.1 247.3 30.0 187.4 39.0 65.9 113.1 34.9 30.6 19.7 32.7 109.4 49.5 15.3 64.2 46.1 19.5 46.0 45.5 232.8 464.7 156.8 15.9 108.4 230.0 612.4 46.4 13.6 52.7 CCNY "C10orf9, CBCP1, CFP1" ENSG00000108100 "Cyclin Y" Q8ND76 10 35247025-35572669 "Predicted intracellular proteins" "Cell cycle, Cell division, Wnt signaling pathway" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Late spermatids: 3651.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 26.4" "Group enriched" "Detected in all" 5 "dendritic cells: 7.8;granulocytes: 26.4;monocytes: 23.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036290 Approved NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "HPA036290: AB_10600860" "unprognostic (1.25e-2)" "unprognostic (1.48e-1)" "unprognostic (4.30e-2)" "unprognostic (2.23e-3)" "unprognostic (1.30e-1)" "unprognostic (4.65e-1)" "prognostic unfavorable (6.75e-5)" "unprognostic (3.37e-2)" "unprognostic (6.15e-3)" "unprognostic (4.06e-2)" "unprognostic (2.94e-1)" "unprognostic (1.10e-1)" "unprognostic (2.74e-2)" "unprognostic (1.31e-1)" "unprognostic (3.77e-2)" "unprognostic (1.98e-1)" "unprognostic (1.80e-1)" 28.6 21.9 35.1 21.2 37.1 35.9 23.7 31.6 35.1 21.8 24.8 28.4 21.5 28.4 26.9 20.5 22.2 22.7 33.1 37.0 32.4 24.8 31.0 25.9 23.4 32.0 33.6 25.2 20.6 17.9 15.5 38.7 31.9 18.3 20.0 19.3 17.0 20.1 25.5 19.3 22.2 25.7 32.3 24.4 26.3 81.2 35.5 22.5 29.6 22.9 21.0 25.4 17.3 33.4 52.3 22.2 29.3 28.2 41.6 56.5 38.2 27.4 27.7 26.0 24.9 32.4 51.7 33.2 38.1 44.1 22.7 27.1 26.3 34.6 27.7 105.0 17.3 62.0 16.0 42.4 45.8 22.7 28.3 40.3 48.1 39.9 27.1 57.6 63.3 38.3 49.1 27.3 51.6 33.2 39.9 19.6 11.2 29.6 46.2 33.0 54.4 20.7 33.2 24.6 25.8 39.3 21.5 42.7 38.6 25.4 36.9 41.8 75.5 32.1 38.6 49.4 23.9 18.3 16.6 24.4 56.0 46.6 15.1 1.7 23.4 5.2 3.3 6.5 3.6 3.1 3.2 3.5 7.8 2.4 3.2 3.6 26.4 2.9 3.4 4.0 2.3 7.6 35.1 37.1 31.6 35.1 37.0 32.4 32.0 33.6 31.9 32.3 35.5 33.4 102.2 32.1 25.9 91.1 23.4 26.9 14.1 29.0 13.6 43.5 30.2 28.7 33.1 41.5 32.1 38.6 20.9 12.0 35.2 25.8 5.9 16.5 709.0 29.5 37.2 59.8 52.8 12.4 205.5 27.8 18.1 34.4 20.4 33.4 16.5 35.3 32.5 85.3 28.9 48.8 130.0 29.0 26.4 80.4 46.9 3651.5 41.3 56.6 16.0 192.0 89.3 62.4 24.7 167.9 445.2 27.9 19.2 38.7 11.7 27.7 31.5 23.1 28.5 39.6 6.6 56.0 26.5 33.8 40.2 17.1 29.5 9.4 26.2 43.2 28.6 20.9 GJD4 "CX40.1, FLJ90023" ENSG00000177291 "Gap junction protein delta 4" Q96KN9 10 35605341-35608935 "Predicted membrane proteins, Transporters" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Paneth cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.7" "Cell line enhanced" "Detected in single" "RH-30: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA038266 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 22: Epithelial cell types - Mixed function" "HPA038266: AB_10672741" "unprognostic (2.05e-1)" "unprognostic (2.58e-1)" "unprognostic (5.74e-6)" "unprognostic (2.00e-1)" "unprognostic (8.96e-2)" "unprognostic (3.92e-2)" "unprognostic (8.49e-2)" "unprognostic (7.70e-2)" "unprognostic (1.67e-2)" "unprognostic (2.44e-1)" "unprognostic (1.19e-10)" "unprognostic (3.06e-1)" "unprognostic (1.43e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-1)" 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.2 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.5 0.0 0.3 0.2 0.2 0.2 0.1 0.5 0.2 1.4 0.0 0.0 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.2 0.4 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.2 0.6 0.2 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 1.7 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 FZD8 ENSG00000177283 "Frizzled class receptor 8" Q9H461 10 35638247-35642296 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 39.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Gastric mucus-secreting cells: 13.7;Muller glia cells: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 15.6;PC-3: 40.3;U-138 MG: 14.8;U-251 MG: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045025, HPA071142" Approved Approved "Endoplasmic reticulum" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 5: Muller glia cells - Visual perception" "Endoplasmic reticulum" "HPA045025: AB_10795888, HPA071142: AB_2686349" "unprognostic (1.20e-1)" "unprognostic (4.42e-3)" "unprognostic (1.85e-2)" "unprognostic (1.97e-1)" "unprognostic (2.21e-2)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (1.08e-3)" "unprognostic (1.11e-1)" "unprognostic (1.53e-1)" "prognostic favorable (8.21e-4)" "unprognostic (4.92e-2)" "unprognostic (2.25e-1)" "unprognostic (4.85e-2)" "unprognostic (1.68e-1)" "unprognostic (7.34e-3)" "unprognostic (1.19e-1)" 5.6 1.4 5.2 1.2 5.8 0.1 3.7 1.8 6.1 2.3 39.4 8.7 0.6 2.5 0.5 0.9 5.4 1.3 9.7 5.9 2.1 6.9 3.1 4.4 1.3 1.8 3.3 1.8 4.7 2.4 2.7 0.4 2.0 1.3 2.0 3.9 3.3 1.4 3.1 3.7 2.0 1.6 1.5 11.7 7.2 2.5 4.3 1.4 6.7 2.5 0.6 1.8 1.6 5.0 0.0 4.4 0.7 0.0 1.7 0.1 2.6 4.8 0.2 0.2 0.2 0.5 0.7 0.0 0.7 2.1 4.8 1.5 0.5 1.5 0.0 0.0 12.4 0.0 0.5 0.2 0.8 0.0 0.3 1.5 6.0 9.7 3.8 15.6 3.4 0.0 0.3 0.0 1.3 1.9 0.0 0.0 4.0 0.3 40.3 4.1 2.5 0.0 7.7 0.3 12.0 0.4 0.9 0.2 0.0 5.5 0.1 0.7 8.1 14.8 2.2 7.3 13.4 0.0 0.0 0.0 8.5 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 5.8 1.8 6.1 5.9 2.1 1.8 3.3 2.0 1.5 4.3 5.0 12.2 19.2 3.3 12.4 0.0 0.3 1.0 4.2 2.2 0.6 4.1 10.8 10.2 1.5 3.1 0.0 2.1 0.1 0.5 11.2 0.0 3.4 0.0 4.2 2.7 7.2 1.2 0.0 0.4 3.1 0.3 6.1 13.7 9.3 0.0 1.6 10.4 4.5 0.6 0.0 0.5 2.7 0.0 0.8 1.3 0.1 1.2 1.2 0.0 1.9 0.2 27.2 0.0 1.0 0.3 3.5 1.5 2.2 0.1 0.8 0.5 4.2 2.1 1.3 6.6 2.7 5.8 0.2 1.4 1.2 1.1 0.1 0.4 0.7 4.8 0.2 ANKRD30A NY-BR-1 ENSG00000148513 "Ankyrin repeat domain 30A" Q9BXX3 10 37125725-37384111 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "breast: 38.1" "Group enriched" "Detected in some" 4 "Breast glandular cells: 295.9;Breast myoepithelial cells: 84.8" "Cancer enriched" "Detected in single" 37 "breast cancer: 11.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "A549: 2.7;U-266/70: 10.4" HPA071849 Uncertain Nucleoli NA NA "Cluster 5: Breast - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 35: Glandular cells - Unknown function" Nucleoli "HPA071849: " "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (1.01e-7)" "unprognostic (1.41e-1)" "unprognostic (5.93e-1)" 1.0 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 295.9 84.8 0.3 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 16.3 0.0 0.4 1.0 0.0 0.0 1.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 8.5 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 45.8 1.7 0.0 0.0 0.3 0.3 0.1 0.0 0.0 MTRNR2L7 ENSG00000256892 "MT-RNR2 like 7" P0CJ74 10 37601440-37602974 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 2.1" "Cell type enriched" "Detected in some" 26 "Cardiomyocytes: 188.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (2.28e-1)" "unprognostic (5.87e-2)" 0.0 0.1 0.4 0.0 0.5 0.1 0.0 0.4 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.1 0.1 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 2.1 0.4 0.5 0.5 0.4 0.5 0.4 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 188.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.6 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 ZNF248 bA162G10.3 ENSG00000198105 "Zinc finger protein 248" Q8NDW4 10 37776526-37858106 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 110.0;Excitatory neurons: 145.0;Inhibitory neurons: 135.1;Oligodendrocyte precursor cells: 101.6;Oligodendrocytes: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018237, HPA018287, HPA018455" Uncertain Approved Nucleoplasm NA NA "Cluster 30: Non-specific - Translation" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "HPA018237: AB_2669815, HPA018287: AB_2669829, HPA018455: AB_2669869" "unprognostic (6.25e-3)" "unprognostic (1.16e-2)" "unprognostic (3.75e-2)" "unprognostic (3.15e-2)" "unprognostic (3.20e-2)" "unprognostic (6.51e-3)" "unprognostic (2.50e-4)" "prognostic favorable (1.04e-4)" "unprognostic (6.37e-3)" "unprognostic (2.05e-2)" "prognostic favorable (1.22e-4)" "prognostic unfavorable (6.71e-4)" "prognostic unfavorable (2.25e-4)" "unprognostic (2.70e-1)" "unprognostic (1.62e-1)" "unprognostic (9.51e-2)" "unprognostic (8.68e-3)" 5.2 7.1 12.8 6.7 12.8 0.8 7.8 21.0 16.7 15.9 7.6 17.6 5.5 15.2 14.1 5.8 12.2 6.6 7.9 12.7 11.7 8.2 6.0 6.2 6.7 10.3 10.9 15.5 6.8 12.3 18.9 6.5 10.7 12.2 8.9 17.1 6.8 16.1 8.5 7.3 7.9 10.8 8.5 7.9 7.7 7.0 12.8 5.5 13.4 9.7 6.5 9.5 9.7 17.5 7.0 5.8 1.2 16.1 11.3 9.4 7.0 7.1 3.6 7.2 7.7 7.2 8.7 9.2 6.1 5.0 5.5 8.7 9.4 5.0 6.2 16.2 10.3 11.5 12.9 8.8 5.6 9.6 7.5 3.8 9.4 3.8 3.1 14.3 6.6 9.9 5.1 6.5 10.7 3.4 9.7 6.2 4.9 4.6 31.1 8.9 16.2 6.6 8.9 3.4 6.7 12.7 6.1 3.3 4.2 9.8 8.8 2.7 6.5 6.5 6.8 5.2 4.3 10.1 11.6 7.7 8.7 12.5 3.2 0.8 1.3 1.2 4.0 0.9 4.5 4.2 3.5 3.5 2.9 5.1 6.0 5.3 0.2 3.4 1.2 2.6 2.0 2.2 12.8 12.8 21.0 16.7 12.7 11.7 10.3 10.9 10.7 8.5 12.8 17.5 7.1 12.8 14.4 110.0 10.0 2.0 7.6 4.4 10.2 47.4 6.7 7.6 24.4 8.6 7.2 5.5 47.9 6.3 7.7 4.0 7.9 4.1 1.0 15.7 15.4 8.3 5.4 7.2 145.0 1.6 3.1 11.1 6.1 24.7 5.1 26.3 5.0 4.1 4.3 42.1 135.1 4.4 0.0 1.6 2.9 1.8 9.9 3.3 1.8 52.5 4.0 16.1 6.2 101.6 106.8 3.8 5.9 12.0 8.2 4.8 4.2 4.4 5.2 36.9 0.0 17.0 14.2 9.0 10.5 5.9 2.7 2.6 6.4 17.1 5.1 4.2 ZNF25 "FLJ31890, KOX19, Zfp9" ENSG00000175395 "Zinc finger protein 25" P17030 10 37949573-37976647 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 46.7;Inhibitory neurons: 44.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030190 Uncertain Approved "Nucleoplasm,Golgi apparatus" No No "Cluster 14: Monocytes - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA030190: AB_10602687" "unprognostic (9.42e-2)" "unprognostic (6.18e-2)" "unprognostic (5.64e-2)" "unprognostic (2.93e-1)" "unprognostic (4.67e-2)" "unprognostic (1.44e-2)" "unprognostic (2.64e-2)" "unprognostic (3.85e-3)" "unprognostic (1.15e-1)" "unprognostic (5.32e-2)" "unprognostic (1.40e-3)" "unprognostic (1.45e-1)" "unprognostic (2.01e-3)" "unprognostic (1.21e-2)" "unprognostic (1.29e-1)" "unprognostic (9.30e-3)" "unprognostic (2.61e-1)" 10.2 10.1 12.3 3.5 12.5 2.6 8.2 12.5 19.1 9.7 4.1 12.3 2.2 9.9 6.1 5.4 9.2 6.1 10.0 12.5 15.9 5.7 3.0 6.4 4.8 11.9 10.9 11.1 5.4 7.6 14.3 4.7 12.4 7.3 4.4 10.6 4.6 8.9 22.3 4.8 5.3 8.9 9.8 6.5 5.8 4.7 14.6 4.6 6.0 21.5 4.3 8.8 7.1 12.6 1.6 3.0 3.3 6.7 12.1 9.2 0.6 3.6 4.9 2.8 4.2 0.5 2.3 3.1 1.0 6.4 1.0 0.4 0.9 1.5 4.5 7.3 1.6 5.0 0.0 1.0 7.7 3.3 3.1 6.5 6.6 3.1 3.6 11.1 4.9 4.0 0.4 2.3 6.9 1.0 1.1 2.6 0.6 0.6 2.2 1.2 3.7 0.6 3.3 0.6 1.2 7.6 1.2 0.2 4.7 1.2 2.9 5.3 7.1 4.3 0.8 7.1 2.2 2.8 1.4 1.3 8.2 6.3 2.9 1.3 1.5 3.4 1.6 2.5 1.7 1.0 1.4 1.3 1.9 1.3 1.8 1.5 0.2 1.0 5.2 0.3 1.2 1.2 12.3 12.5 12.5 19.1 12.5 15.9 11.9 10.9 12.4 9.8 14.6 12.6 10.0 3.2 3.2 17.9 4.8 3.4 2.5 2.5 3.4 17.3 3.8 3.6 23.6 4.3 2.9 7.3 6.2 1.2 3.5 1.0 1.9 2.0 27.9 2.4 7.0 7.6 0.0 2.1 46.7 2.5 0.5 10.6 4.1 2.7 8.2 8.2 10.4 2.9 5.7 16.8 44.6 1.2 4.1 13.2 6.8 41.9 12.2 9.5 3.6 14.0 8.1 13.7 5.2 38.2 36.7 1.8 0.3 16.1 1.5 2.6 1.3 3.1 8.1 7.1 0.0 11.4 10.4 4.4 6.4 2.4 4.0 0.3 5.2 4.8 0.8 1.3 ZNF33A "FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK" ENSG00000189180 "Zinc finger protein 33A" Q06730 10 38010650-38065088 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA005538, HPA056638" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoli fibrillar center, Endoplasmic reticulum" Vesicles "HPA005538: , HPA056638: AB_2683199" "unprognostic (1.85e-2)" "unprognostic (1.19e-1)" "unprognostic (7.68e-3)" "unprognostic (1.48e-1)" "unprognostic (3.42e-2)" "unprognostic (1.69e-3)" "unprognostic (7.96e-3)" "unprognostic (4.89e-3)" "unprognostic (6.73e-2)" "unprognostic (9.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.75e-2)" "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (6.83e-2)" "unprognostic (7.39e-3)" 9.2 12.6 5.8 12.2 7.0 12.2 17.9 17.1 7.6 14.5 9.6 12.2 13.4 15.1 10.9 9.3 14.9 11.8 9.0 5.0 7.8 15.3 16.3 10.1 14.8 9.5 7.1 14.8 16.9 17.1 14.0 11.4 9.9 15.1 15.8 20.6 14.9 14.3 13.9 13.9 13.7 10.3 6.7 14.2 16.7 4.3 6.8 14.0 15.7 15.8 16.2 11.0 10.3 8.4 16.3 9.1 16.2 14.1 7.8 9.8 12.8 7.3 7.1 9.1 10.2 9.7 14.5 31.5 7.7 9.8 5.2 10.6 19.3 12.6 8.5 18.9 22.0 25.2 18.6 13.2 7.9 36.0 20.2 8.6 22.5 6.9 10.1 17.0 7.5 17.7 13.5 16.5 9.3 10.6 15.0 8.2 16.4 8.2 10.5 12.9 11.2 14.8 12.8 15.0 12.6 19.8 11.3 12.3 6.4 11.2 14.8 9.5 7.3 8.0 11.7 9.0 5.8 13.0 17.1 18.5 7.4 19.7 3.7 12.7 3.6 6.1 5.4 5.0 4.7 6.4 4.7 3.6 3.4 6.2 5.8 4.6 15.9 4.7 6.6 6.3 3.6 3.1 5.8 7.0 17.1 7.6 5.0 7.8 9.5 7.1 9.9 6.7 6.8 8.4 28.4 60.9 73.0 39.8 47.5 11.9 33.0 25.6 19.4 38.2 33.4 28.6 70.6 31.5 49.0 27.6 33.3 28.4 43.1 27.1 25.4 34.9 4.6 62.8 19.3 31.6 34.1 30.3 47.4 29.2 20.0 23.5 25.5 37.7 33.6 47.6 21.4 39.6 19.4 30.3 63.9 28.2 18.3 22.8 16.8 6.7 23.9 26.1 10.6 58.1 46.9 21.1 38.1 56.3 81.5 32.0 29.6 24.0 32.1 38.9 22.0 39.3 80.8 31.8 26.3 32.7 22.7 15.3 18.9 18.7 12.8 35.6 34.6 33.2 27.5 38.4 ZNF37A "KOX21, ZNF37" ENSG00000075407 "Zinc finger protein 37A" P17032 10 38094334-38150293 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003172 Approved Approved Vesicles NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Vesicles "HPA003172: AB_1080709" "unprognostic (8.64e-2)" "unprognostic (1.24e-1)" "unprognostic (3.22e-1)" "unprognostic (6.87e-2)" "unprognostic (1.17e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (2.83e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (4.39e-2)" "unprognostic (1.29e-1)" "unprognostic (3.43e-2)" "unprognostic (3.09e-2)" 4.9 5.6 5.9 6.2 6.0 3.1 5.7 11.3 7.8 6.3 4.3 5.6 4.8 7.2 5.8 3.7 5.2 4.5 4.3 6.3 8.0 5.8 4.9 4.8 5.9 5.5 5.0 7.5 8.7 9.7 8.6 4.8 5.9 5.7 4.8 16.6 7.6 5.6 3.7 6.3 4.6 5.6 3.6 6.0 5.6 2.4 6.7 5.8 8.1 5.1 6.0 4.4 4.2 8.8 15.8 7.9 7.0 13.2 10.5 10.2 7.6 11.9 4.5 5.4 7.2 6.4 4.5 23.1 3.5 6.6 7.4 6.3 13.2 10.0 8.4 14.9 12.5 23.3 9.7 9.1 9.0 24.7 14.4 7.8 16.4 9.3 7.7 10.8 7.2 10.8 15.4 15.9 11.7 3.7 14.0 3.7 6.1 5.5 13.0 10.0 19.0 4.6 5.7 6.1 5.6 9.6 8.2 6.6 6.7 7.4 12.1 7.6 12.4 10.1 10.9 9.8 11.6 17.8 20.5 8.9 6.7 17.3 6.5 1.3 1.0 1.0 1.5 0.8 2.0 1.5 1.8 1.6 1.0 2.6 2.1 1.8 0.7 2.7 2.3 1.2 1.1 0.7 5.9 6.0 11.3 7.8 6.3 8.0 5.5 5.0 5.9 3.6 6.7 8.8 21.8 25.6 43.6 31.6 26.0 8.2 14.7 11.0 18.8 66.1 14.4 16.4 29.6 15.7 18.8 11.0 54.2 10.2 23.2 7.6 1.9 18.1 3.7 15.0 30.0 26.3 41.9 26.3 46.7 11.8 6.8 27.0 16.3 14.9 40.5 56.9 22.9 10.4 7.1 42.1 57.7 10.4 10.2 11.3 6.4 1.4 28.3 13.8 5.4 40.3 16.6 27.4 30.9 64.3 85.5 11.9 8.3 28.2 34.4 17.0 12.6 7.3 12.6 55.1 13.1 53.5 25.7 22.2 15.2 14.7 6.0 3.8 18.5 48.5 12.5 9.3 ZNF33B "KOX2, KOX31, ZNF11B" ENSG00000196693 "Zinc finger protein 33B" Q06732 10 42574185-42638570 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 80.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA005538, HPA056638" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoli fibrillar center, Endoplasmic reticulum" Vesicles "HPA005538: , HPA056638: AB_2683199" "unprognostic (3.01e-3)" "unprognostic (2.20e-1)" "unprognostic (2.93e-2)" "unprognostic (8.34e-2)" "unprognostic (5.15e-2)" "unprognostic (1.16e-1)" "unprognostic (1.01e-2)" "unprognostic (2.19e-2)" "unprognostic (1.43e-2)" "unprognostic (1.18e-1)" "unprognostic (3.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.90e-3)" "unprognostic (3.71e-1)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (1.61e-2)" 4.7 9.8 3.9 5.9 4.9 3.1 20.6 9.8 5.1 9.5 9.5 9.1 8.9 11.7 7.6 7.4 18.6 8.6 5.3 4.8 6.6 18.5 10.3 8.9 9.4 4.9 4.0 23.5 34.1 15.2 10.0 7.2 5.1 12.6 10.4 10.4 18.6 10.4 3.9 12.2 9.7 5.2 2.5 10.3 14.3 4.7 5.3 8.0 18.3 4.9 8.9 9.0 9.0 3.7 13.2 3.3 8.5 8.8 3.1 0.4 10.6 8.1 6.2 5.1 7.1 7.3 14.9 19.9 4.8 3.1 7.7 10.9 16.5 5.6 5.7 11.8 12.4 7.9 12.7 11.9 3.6 18.8 6.2 5.1 20.1 3.1 17.0 13.4 4.4 10.8 10.9 14.7 3.1 5.7 7.5 4.5 9.3 6.5 7.7 8.0 8.5 8.5 13.4 17.2 15.3 14.9 5.1 10.5 5.1 7.7 13.4 5.7 5.3 2.6 12.3 4.5 8.6 9.5 15.5 6.1 1.8 13.9 2.4 19.4 7.5 7.1 10.7 6.7 15.1 20.1 15.4 10.8 6.7 15.4 19.5 13.7 2.4 8.3 5.5 11.1 13.4 9.0 3.9 4.9 9.8 5.1 4.8 6.6 4.9 4.0 5.1 2.5 5.3 3.7 10.0 80.1 37.8 14.0 17.7 4.8 18.0 5.5 18.2 15.4 26.0 27.8 31.5 34.3 30.0 20.2 10.4 18.6 13.4 9.7 21.5 27.0 2.4 37.2 6.0 14.1 25.3 17.1 25.6 36.1 16.8 10.0 14.8 14.5 8.2 23.8 16.4 10.8 8.4 10.1 48.2 17.6 4.1 13.6 3.6 3.8 20.5 9.3 7.2 36.5 17.9 10.2 21.6 30.7 14.1 25.8 21.4 11.7 15.2 13.0 21.2 27.0 47.6 9.6 0.0 9.0 8.5 9.0 11.3 11.8 4.0 11.5 17.0 22.6 18.5 12.8 BMS1 "BMS1L, KIAA0187" ENSG00000165733 "BMS1 ribosome biogenesis factor" Q14692 10 42782795-42834937 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036589, HPA043081" Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli, Mitotic chromosome" "HPA036589: AB_10601460, HPA043081: AB_2678305" "unprognostic (1.46e-2)" "unprognostic (4.31e-1)" "unprognostic (7.09e-2)" "unprognostic (3.56e-2)" "unprognostic (3.11e-2)" "unprognostic (7.25e-3)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (3.81e-3)" "unprognostic (1.32e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.43e-1)" "unprognostic (4.82e-2)" 8.1 8.3 6.5 8.9 7.2 10.7 8.5 8.6 8.2 8.2 8.5 7.7 6.3 8.2 6.8 9.6 7.3 5.1 9.0 6.1 7.8 8.1 8.1 7.6 10.0 7.4 7.8 8.4 8.8 11.4 7.6 8.2 7.7 7.3 7.9 6.5 8.8 6.9 17.7 10.2 7.8 7.7 6.5 8.7 7.4 8.1 7.0 9.6 7.2 13.4 10.8 10.1 8.3 7.2 32.0 26.7 25.3 29.0 18.8 15.5 24.5 26.1 27.5 30.3 25.9 37.1 24.4 16.9 18.1 22.7 17.0 27.3 42.0 33.8 39.4 24.7 29.3 22.7 20.7 31.9 16.2 61.7 20.4 13.9 16.9 32.7 31.5 16.9 23.2 19.4 40.4 17.7 21.8 27.1 34.6 20.3 32.3 22.0 28.0 31.3 26.7 18.1 16.8 27.7 19.3 20.4 22.9 25.1 21.7 26.2 30.6 17.6 28.3 14.0 50.7 28.4 43.2 14.1 18.7 48.5 20.5 44.9 11.0 3.8 4.6 2.7 7.2 8.2 8.5 8.7 8.9 7.9 7.5 6.1 9.6 8.3 0.6 6.1 7.1 3.9 6.9 5.3 6.5 7.2 8.6 8.2 6.1 7.8 7.4 7.8 7.7 6.5 7.0 7.2 25.6 32.1 33.1 19.6 29.7 22.9 33.9 28.4 14.2 20.7 18.8 17.1 48.0 20.0 37.4 23.9 10.4 27.7 23.6 10.2 21.5 32.3 14.6 28.8 34.5 31.3 16.8 19.5 31.4 34.9 30.0 26.4 16.3 30.0 22.1 36.8 21.4 18.6 19.7 21.9 28.8 11.5 22.4 15.3 22.6 12.1 23.6 19.9 33.8 10.3 35.2 12.8 24.7 20.1 24.0 38.2 8.9 16.6 31.3 32.2 8.8 30.1 49.5 28.7 19.7 35.3 31.4 40.3 56.1 17.1 25.4 24.9 25.3 33.5 18.7 41.4 RET "CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51" ENSG00000165731 "Ret proto-oncogene" P07949 10 43077064-43130351 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 20.8;brain: 27.3;parathyroid gland: 31.8" "Group enriched" "Detected in some" 4 "Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1" "Cancer enhanced" "Detected in many" "breast cancer: 11.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "midbrain: 53.3;spinal cord: 19.4" "CAB002581, HPA008356, HPA008495" Approved Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" No NA 2100000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Cytosol" "Plasma membrane" "CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: " "unprognostic (7.94e-2)" "unprognostic (3.68e-2)" "unprognostic (4.49e-1)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (9.13e-4)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (2.86e-1)" "unprognostic (2.01e-1)" "unprognostic (1.54e-3)" "unprognostic (4.43e-1)" "unprognostic (9.35e-5)" "unprognostic (1.64e-3)" "unprognostic (8.28e-2)" "unprognostic (3.67e-3)" "unprognostic (2.02e-2)" 1.8 20.8 1.0 1.3 0.9 0.4 1.1 5.1 5.6 1.0 0.2 3.4 1.4 0.6 0.3 0.4 0.5 0.6 2.2 0.3 5.5 0.9 3.0 0.4 0.6 14.4 27.3 0.4 1.3 31.8 5.3 0.5 12.0 1.8 1.4 4.7 5.1 2.0 5.9 0.9 1.4 1.0 4.8 0.2 2.2 2.7 7.6 1.6 0.8 3.1 0.2 0.6 1.4 5.8 0.1 0.4 0.1 1.7 0.0 0.0 0.1 0.7 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 5.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.6 0.0 42.2 7.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.7 329.3 0.1 0.0 0.1 0.5 4.1 95.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.0 1.0 0.9 5.1 5.6 0.3 5.5 14.4 27.3 12.0 4.8 7.6 5.8 0.4 0.0 0.5 1.6 0.0 0.3 0.8 0.0 0.0 1.7 6.0 0.5 2.1 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 1.5 0.0 0.3 1.1 0.0 0.0 4.2 0.2 2.3 6.8 0.0 0.0 1.3 0.5 0.0 1.2 0.1 79.1 8.6 1.9 26.4 0.0 0.6 1.5 0.3 0.5 0.0 1.0 0.0 0.8 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 1.7 0.0 23.1 1.2 1.1 4.7 0.0 0.6 0.0 0.2 0.3 0.2 0.1 CSGALNACT2 "GALNACT-2, GALNACT2, MGC40204, PRO0082" ENSG00000169826 "Chondroitin sulfate N-acetylgalactosaminyltransferase 2" Q8N6G5 10 43138445-43185302 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 133.9" "Cell type enhanced" "Detected in many" "Langerhans cells: 121.6;Macrophages: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031540 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 41: Macrophages - Immune response" "Endoplasmic reticulum" "HPA031540: AB_10599943" "unprognostic (1.65e-1)" "unprognostic (2.70e-2)" "unprognostic (9.10e-2)" "unprognostic (6.41e-2)" "unprognostic (1.95e-1)" "unprognostic (8.28e-3)" "unprognostic (2.85e-3)" "unprognostic (4.95e-2)" "unprognostic (2.96e-1)" "unprognostic (3.43e-3)" "unprognostic (7.65e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (3.53e-7)" "unprognostic (2.68e-2)" "unprognostic (1.40e-1)" "unprognostic (2.47e-1)" "unprognostic (4.05e-3)" 19.7 10.6 8.8 24.1 10.8 133.9 12.9 15.1 13.3 15.1 12.6 15.1 9.2 19.5 8.4 10.5 15.5 25.4 12.8 8.5 10.8 8.8 13.9 26.8 22.5 10.7 9.7 17.0 7.8 8.0 11.6 26.4 11.1 13.4 11.6 9.8 7.9 10.9 14.6 11.0 11.5 20.8 9.4 26.5 10.1 9.2 9.9 27.9 9.9 17.2 17.4 24.0 12.1 13.5 12.6 8.2 15.1 14.4 23.0 38.5 3.7 44.7 59.8 19.3 30.0 2.9 12.7 20.8 10.8 40.6 9.2 11.4 12.6 16.8 31.3 24.9 9.3 10.8 7.9 8.6 50.0 25.3 21.8 38.6 18.1 43.1 89.3 24.3 25.0 30.7 4.6 60.1 39.9 6.5 19.3 15.1 6.5 4.2 10.7 11.9 15.0 8.8 17.1 6.6 13.6 26.8 11.6 11.9 28.8 13.0 15.7 20.5 37.3 16.5 26.2 52.3 30.4 15.4 23.2 10.9 35.1 60.8 7.9 14.7 11.9 19.4 7.3 14.2 6.4 3.0 5.5 5.7 14.4 3.0 6.4 5.4 11.2 11.3 21.8 4.1 7.1 6.9 8.8 10.8 15.1 13.3 8.5 10.8 10.7 9.7 11.1 9.4 9.9 13.5 16.3 16.0 18.7 23.8 20.5 17.7 13.3 7.0 6.2 13.1 10.7 8.5 10.9 5.7 9.6 11.0 10.4 2.1 47.8 1.7 0.0 5.9 2.1 12.0 22.0 16.8 9.0 18.5 42.5 6.9 6.1 31.4 4.6 11.3 48.1 23.5 11.4 11.9 16.4 8.4 41.1 1.6 4.1 68.6 121.6 1.4 17.1 82.6 8.8 16.9 41.5 4.1 35.0 45.2 54.5 13.7 3.1 12.4 33.8 12.7 1.5 4.4 5.8 8.5 26.3 27.7 25.3 17.8 18.3 3.6 12.1 1.5 37.4 7.2 1.6 7.0 RASGEF1A "CG4853, FLJ37817" ENSG00000198915 "RasGEF domain family member 1A" Q8N9B8 10 43194535-43267065 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.6;brain: 19.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 22.1;Inhibitory neurons: 16.3;NK-cells: 8.2;Spermatogonia: 7.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 17.2;SCLC-21H: 15.6;SK-BR-3: 14.1;T-47d: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035593 Enhanced Approved "Golgi apparatus" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA035593: AB_10602083" "prognostic favorable (1.86e-5)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.28e-4)" "unprognostic (1.86e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (5.73e-2)" "unprognostic (8.53e-2)" "unprognostic (9.00e-2)" "unprognostic (2.86e-1)" "unprognostic (3.52e-1)" "prognostic unfavorable (4.11e-7)" "unprognostic (2.88e-2)" "unprognostic (2.32e-1)" "unprognostic (1.89e-2)" "unprognostic (3.83e-2)" 0.8 1.6 18.8 1.3 17.0 14.6 3.3 11.6 19.3 1.7 5.2 0.8 0.9 1.2 0.4 1.1 2.5 2.3 1.5 19.2 14.6 2.6 0.4 1.6 5.3 15.0 15.2 1.2 3.7 4.3 4.4 0.7 13.6 1.4 0.4 1.3 3.4 1.7 0.8 0.8 1.3 1.2 13.1 3.8 0.7 2.3 18.4 1.0 0.8 0.7 3.7 1.2 2.6 17.0 9.7 8.2 0.0 0.1 0.0 0.2 4.8 0.1 0.0 0.0 0.0 0.2 5.2 8.4 8.6 0.8 0.0 0.1 1.3 7.7 0.0 0.0 6.3 0.0 0.1 0.4 3.7 0.0 3.0 2.0 8.7 0.7 0.0 0.0 0.0 0.4 17.2 0.0 0.0 1.9 0.0 0.2 0.8 4.3 0.0 0.0 0.0 0.2 0.6 4.5 15.6 0.0 0.0 14.1 0.1 7.1 15.6 0.1 0.1 0.0 3.5 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 6.1 2.9 0.5 1.1 0.2 0.7 2.2 2.9 2.6 0.2 1.4 9.4 6.3 0.4 5.1 0.0 1.2 18.8 17.0 11.6 19.3 19.2 14.6 15.0 15.2 13.6 13.1 18.4 17.0 0.2 0.0 0.0 3.6 1.1 0.5 0.3 2.4 0.6 2.0 4.3 4.1 2.2 0.0 0.2 3.7 0.0 0.4 6.7 0.2 0.0 0.3 1.3 1.8 0.5 1.0 0.0 0.0 22.1 1.3 1.1 1.0 0.5 2.3 0.0 1.9 1.1 0.1 0.9 1.7 16.3 0.3 0.0 0.9 1.7 0.7 0.0 1.4 0.0 1.0 1.4 0.3 8.2 1.5 1.0 2.1 0.1 0.0 0.7 1.2 0.2 0.6 0.6 0.3 0.0 0.9 0.4 0.7 7.7 0.5 0.3 0.3 5.0 0.5 0.6 0.1 FXYD4 CHIF ENSG00000150201 "FXYD domain containing ion transport regulator 4" P59646 10 43371636-43376335 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 43 "kidney: 297.7" "Cell type enriched" "Detected in some" 107 "Collecting duct cells: 5039.3" "Group enriched" "Detected in many" 5 "renal cancer: 10.7;urothelial cancer: 20.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "SuSa: 10.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA058421 Enhanced Uncertain Cytosol NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 12: NES - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA058421: AB_2683714" "unprognostic (2.92e-3)" "unprognostic (5.25e-1)" "unprognostic (9.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (5.17e-2)" "unprognostic (2.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-1)" "unprognostic (2.09e-2)" 0.1 0.0 1.5 0.0 2.6 0.0 0.0 1.5 2.7 0.0 1.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 1.4 2.0 297.7 0.0 1.1 0.0 1.6 2.2 0.0 0.0 0.0 0.1 0.0 1.7 0.1 0.0 0.0 5.6 2.7 1.3 0.0 0.0 0.0 1.4 0.0 6.9 0.8 2.2 0.0 0.0 0.4 0.0 1.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.6 1.5 2.7 1.4 2.0 1.6 2.2 1.7 1.4 2.2 2.7 0.0 6.4 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 5039.3 0.0 0.5 0.0 0.5 46.9 0.0 2.6 6.4 2.6 0.0 0.0 0.0 0.0 0.2 0.1 0.4 9.2 15.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 11.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.2 0.1 0.1 8.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.4 0.3 0.1 1.0 1.4 HNRNPF HNRPF ENSG00000169813 "Heterogeneous nuclear ribonucleoprotein F" P52597 10 43385617-43409166 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA016884, HPA069667" Supported Enhanced Nucleoplasm NA Yes 2500000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 6: T47d - Mammary gland" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA016884: AB_1856444, HPA069667: AB_2686166" "unprognostic (9.93e-2)" "unprognostic (2.26e-2)" "unprognostic (1.81e-1)" "unprognostic (3.65e-2)" "unprognostic (6.39e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (1.51e-2)" "unprognostic (6.37e-2)" "unprognostic (6.33e-3)" "unprognostic (4.89e-3)" "unprognostic (1.07e-2)" "unprognostic (1.95e-2)" "unprognostic (3.77e-3)" "unprognostic (3.35e-1)" "unprognostic (3.71e-1)" "unprognostic (2.22e-1)" 114.6 77.7 43.3 133.9 48.6 161.3 102.9 49.8 47.9 86.8 65.2 124.5 134.2 78.3 58.9 114.9 119.4 88.9 63.7 40.2 45.9 94.4 173.2 97.6 181.4 52.4 51.4 87.3 87.5 73.1 50.5 113.6 51.5 90.8 118.9 80.4 85.2 74.8 93.6 104.5 130.7 89.1 49.2 123.5 118.0 84.0 49.4 193.3 72.7 79.6 182.8 160.0 81.8 58.3 292.1 302.9 184.2 280.7 220.5 239.5 269.1 222.5 371.0 305.6 358.2 285.5 394.7 581.8 139.2 242.0 179.3 401.7 496.8 363.6 249.5 245.6 297.2 371.2 178.6 370.9 271.4 550.5 360.9 293.2 282.4 237.6 434.6 177.1 266.4 281.3 382.0 256.2 234.2 453.4 542.5 300.5 139.5 439.1 252.4 449.0 172.7 276.8 314.9 442.7 226.1 226.8 226.6 410.4 344.3 199.2 457.4 265.3 200.4 140.1 264.4 231.8 356.8 228.5 415.8 352.6 227.1 520.0 139.7 205.5 234.9 227.2 247.0 269.2 301.0 238.9 256.6 273.3 251.8 200.7 213.8 204.0 152.2 287.9 253.6 140.6 315.8 460.5 43.3 48.6 49.8 47.9 40.2 45.9 52.4 51.4 51.5 49.2 49.4 58.3 223.8 134.6 102.8 13.4 206.9 336.0 336.5 204.9 189.5 51.4 156.8 126.4 66.3 157.3 147.9 112.2 47.9 292.9 201.7 164.7 176.1 218.6 360.1 203.8 153.3 176.6 126.8 199.6 10.8 142.2 414.8 157.0 154.9 147.0 116.1 106.9 127.5 222.3 226.0 48.8 12.0 230.1 164.8 193.3 181.7 92.7 146.0 178.5 99.6 24.4 213.0 116.9 219.4 16.6 32.7 161.4 152.1 117.8 163.3 280.8 189.7 233.1 242.0 163.6 98.6 179.7 278.1 184.5 167.3 210.2 330.5 210.4 229.9 126.3 238.8 314.0 ZNF487 "KRBO1, ZNF487P" ENSG00000243660 "Zinc finger protein 487" 10 43436841-43483181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.2" "Cell type enhanced" "Detected in many" "Early spermatids: 191.2;Endometrial ciliated cells: 65.7;Late spermatids: 289.9;Respiratory ciliated cells: 73.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA037820 Approved "Nucleoplasm,Nuclear membrane,Cytosol" Yes No "Cluster 5: Granulocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA037820: AB_10697083" "unprognostic (1.97e-1)" "unprognostic (1.69e-3)" "unprognostic (1.49e-1)" "unprognostic (3.42e-3)" "unprognostic (7.40e-2)" "unprognostic (1.42e-2)" "unprognostic (7.10e-2)" "unprognostic (4.84e-1)" "unprognostic (4.00e-2)" "unprognostic (1.05e-2)" "unprognostic (6.97e-4)" "unprognostic (5.85e-2)" "unprognostic (3.97e-4)" "unprognostic (2.91e-1)" "unprognostic (4.42e-2)" "unprognostic (2.52e-2)" "unprognostic (5.92e-2)" 2.9 2.1 2.1 2.0 2.1 4.3 2.8 2.0 6.3 3.2 4.5 2.6 2.4 3.8 2.1 2.1 6.0 3.7 2.1 2.3 1.9 2.3 2.2 3.0 2.4 7.5 6.0 4.2 1.6 3.6 2.4 1.9 5.0 2.3 1.9 8.9 1.5 2.7 1.2 2.1 2.5 3.0 4.7 2.4 2.3 28.2 2.2 3.6 3.3 1.6 2.2 3.3 2.1 3.8 1.7 1.6 2.0 2.1 2.4 4.8 0.6 2.7 4.7 2.5 2.7 2.6 4.7 4.3 0.4 3.4 2.4 2.7 0.6 1.0 2.4 0.5 0.9 1.4 0.4 1.5 3.1 1.4 1.7 5.0 2.3 4.2 3.0 5.2 0.9 0.9 0.7 0.6 1.9 3.0 2.9 1.1 0.4 0.8 0.9 1.5 0.7 1.8 5.7 1.9 1.7 1.3 2.4 1.3 1.1 1.2 2.2 1.6 1.5 2.4 1.5 1.4 0.7 0.3 1.1 4.7 5.6 2.0 0.9 1.8 3.0 4.5 3.3 2.2 2.6 1.9 2.4 2.9 3.9 2.5 1.9 2.3 10.4 2.9 1.2 2.9 1.6 2.1 2.1 2.1 2.0 6.3 2.3 1.9 7.5 6.0 5.0 4.7 2.2 3.8 4.0 22.4 4.8 11.8 6.2 1.8 6.3 6.6 3.4 5.4 6.6 7.7 3.3 7.2 8.3 5.5 8.4 1.4 9.8 6.1 11.7 4.5 191.2 65.7 6.5 5.3 7.8 1.3 19.4 2.1 4.0 5.4 5.6 6.3 0.0 3.4 3.3 2.7 3.3 6.7 21.1 4.4 10.2 5.6 3.1 289.9 4.7 6.3 1.8 0.0 7.3 12.6 2.1 6.0 7.1 2.1 3.9 6.8 3.6 3.2 13.0 12.7 73.5 18.7 0.0 6.3 5.1 16.7 7.5 1.9 2.8 1.6 5.6 3.8 3.5 6.1 ZNF239 "HOK-2, MOK2" ENSG00000196793 "Zinc finger protein 239" Q16600 10 43556344-43574618 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 49.2;Late spermatids: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 2.8;T-cells: 6.4" "Cell line enhanced" "Detected in many" "NTERA-2: 24.4;T-47d: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030843, HPA046679" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear bodies" "HPA030843: AB_2673632, HPA046679: AB_10960498" "unprognostic (1.74e-2)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (1.45e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.05e-7)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.90e-3)" "unprognostic (4.13e-2)" "unprognostic (5.59e-3)" "prognostic unfavorable (4.70e-7)" "unprognostic (2.62e-2)" "unprognostic (3.64e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" 2.5 2.3 4.3 1.9 4.3 0.3 5.3 4.1 4.9 3.8 3.1 3.3 1.3 4.4 2.1 1.1 4.3 1.4 1.4 4.1 4.0 6.2 1.5 1.4 2.9 3.8 3.8 3.9 5.0 4.3 4.5 0.9 3.7 5.2 2.7 1.5 1.9 4.5 2.9 0.7 2.0 4.9 3.9 1.5 2.5 8.2 4.2 1.7 3.2 2.7 2.6 4.3 1.7 4.3 0.0 4.3 5.0 4.9 6.8 5.2 0.0 8.9 1.0 10.6 9.3 11.1 9.7 0.0 3.3 4.9 3.9 0.3 0.0 0.5 13.5 0.1 7.2 0.0 8.0 0.0 5.3 0.0 3.2 5.7 0.2 8.3 0.0 3.2 0.4 0.0 14.7 0.0 8.8 4.9 1.4 1.5 24.4 4.8 5.0 0.0 0.0 0.3 8.8 3.9 9.3 12.7 4.0 0.1 0.6 6.9 19.1 6.1 1.1 0.0 10.8 0.3 11.6 1.2 8.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.5 0.0 3.7 2.6 3.5 2.4 0.0 2.8 6.4 3.8 0.0 0.4 0.0 0.0 2.0 1.4 4.3 4.3 4.1 4.9 4.1 4.0 3.8 3.8 3.7 3.9 4.2 4.3 0.5 0.0 0.5 3.6 1.4 0.0 1.7 0.3 4.0 3.1 1.8 2.4 0.7 0.0 1.3 3.7 0.0 0.3 0.2 0.2 1.9 2.0 49.2 0.5 2.2 0.3 0.0 0.4 5.6 0.4 1.2 1.6 1.5 0.7 0.0 2.1 0.4 0.2 0.4 0.0 6.7 0.9 0.0 0.0 0.3 16.4 0.3 0.2 0.0 1.0 0.6 1.3 3.1 7.5 4.3 0.9 0.2 1.5 0.1 0.9 0.0 1.5 0.0 0.5 0.0 1.9 1.6 6.1 8.2 0.4 0.0 0.1 0.8 2.8 1.1 0.2 ZNF485 ENSG00000198298 "Zinc finger protein 485" Q8NCK3 10 43606419-43617904 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 8.9;Spermatocytes: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA059356 Uncertain NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA059356: AB_2683988" "prognostic unfavorable (5.24e-4)" "unprognostic (1.34e-1)" "unprognostic (4.18e-1)" "unprognostic (1.08e-1)" "unprognostic (5.12e-3)" "unprognostic (3.21e-1)" "unprognostic (1.40e-4)" "unprognostic (1.32e-1)" "unprognostic (1.04e-1)" "unprognostic (4.56e-3)" "unprognostic (4.12e-2)" "unprognostic (2.40e-2)" "unprognostic (3.46e-6)" "unprognostic (8.45e-2)" "unprognostic (1.61e-1)" "unprognostic (1.30e-1)" "unprognostic (1.41e-2)" 1.4 1.7 2.1 2.2 2.6 0.7 3.7 2.2 2.8 1.7 1.6 2.1 1.7 2.3 1.7 1.9 2.7 1.0 1.3 2.0 2.8 2.1 1.8 1.3 3.3 2.5 2.6 3.9 4.1 1.5 1.0 1.0 2.6 2.6 2.0 1.8 1.8 1.8 3.1 3.9 1.6 1.5 2.0 2.2 2.4 4.0 2.5 2.1 1.9 2.5 3.4 1.7 1.6 3.4 3.3 2.4 1.9 7.1 3.7 4.3 0.1 3.6 1.0 4.0 5.6 6.8 5.1 11.1 3.7 1.4 1.6 3.3 4.2 3.5 6.5 4.9 3.3 0.1 3.0 3.1 2.8 1.8 5.2 3.1 5.8 2.5 4.7 1.8 1.6 1.9 10.4 0.2 7.9 5.4 5.8 5.4 9.7 5.2 3.0 3.1 1.3 2.6 3.6 3.1 7.0 5.5 1.7 5.9 2.2 2.9 9.7 3.8 2.2 2.9 4.3 4.4 5.8 7.3 8.5 2.2 0.6 2.7 2.8 0.1 1.9 0.9 4.3 3.8 6.7 6.0 5.5 4.8 2.6 4.8 9.2 5.7 0.3 13.8 1.3 1.5 4.8 3.3 2.1 2.6 2.2 2.8 2.0 2.8 2.5 2.6 2.6 2.0 2.5 3.4 1.2 0.0 1.1 0.3 2.4 0.6 1.8 1.7 2.8 1.7 2.0 2.3 2.6 1.5 1.8 0.0 0.0 0.9 1.5 0.7 3.9 2.0 8.9 0.6 2.2 1.0 0.0 2.5 2.1 2.0 0.9 1.3 0.5 0.6 0.0 2.5 1.4 1.3 1.5 1.7 2.7 1.9 0.0 0.6 0.4 4.6 0.6 1.1 0.0 1.0 1.0 0.6 2.1 2.0 3.4 1.7 2.1 1.2 0.6 1.6 0.2 1.6 0.2 0.6 0.0 2.4 1.1 19.9 4.7 2.6 0.6 0.3 2.1 2.6 2.4 0.9 ZNF32 "KOX30, Zfp637, ZNF637" ENSG00000169740 "Zinc finger protein 32" P17041 10 43643860-43648881 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039148 Approved "Nucleoplasm,Nuclear bodies" Yes No "Cluster 22: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear bodies" Nucleoplasm "HPA039148: AB_2676365" "unprognostic (1.05e-2)" "unprognostic (2.04e-3)" "unprognostic (1.15e-3)" "unprognostic (9.76e-2)" "unprognostic (1.04e-2)" "unprognostic (5.26e-2)" "prognostic unfavorable (7.08e-4)" "unprognostic (7.39e-2)" "unprognostic (9.94e-3)" "unprognostic (2.90e-3)" "prognostic favorable (3.02e-4)" "unprognostic (1.39e-1)" "unprognostic (5.73e-3)" "unprognostic (6.66e-2)" "unprognostic (4.57e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" 33.2 33.2 69.4 13.2 71.9 8.3 45.9 71.0 101.5 46.0 69.0 56.7 12.7 42.9 57.5 23.1 40.0 23.4 60.0 69.0 70.8 49.9 32.4 26.5 22.1 71.3 71.0 52.8 48.1 47.7 45.1 16.6 70.4 48.5 23.4 40.8 31.0 38.1 84.3 31.5 29.6 36.8 70.1 36.0 37.8 16.2 70.9 32.8 41.9 72.9 25.9 41.2 32.9 73.3 25.0 21.8 32.3 48.9 58.1 62.1 10.6 21.9 65.5 39.9 35.8 14.8 12.5 0.1 37.7 46.7 18.8 14.5 20.7 21.2 29.2 27.5 23.0 6.6 13.2 17.2 54.4 0.7 19.7 64.1 48.0 24.7 29.7 38.2 30.6 86.8 19.5 0.0 50.9 22.8 25.2 22.8 25.2 25.2 11.3 38.5 36.3 5.7 40.8 9.7 41.2 36.7 18.1 13.3 35.4 35.3 49.0 23.0 13.1 22.3 26.8 16.4 5.4 14.3 40.2 0.1 8.0 15.9 21.1 14.0 13.9 18.2 36.5 12.9 36.8 26.0 29.2 41.1 22.9 27.2 37.0 41.6 1.1 50.4 11.6 19.3 22.8 20.7 69.4 71.9 71.0 101.5 69.0 70.8 71.3 71.0 70.4 70.1 70.9 73.3 26.1 9.6 14.3 14.0 18.8 11.0 24.4 28.6 33.0 23.2 41.4 57.8 11.7 22.8 16.9 18.4 8.4 18.0 31.9 7.5 105.7 44.7 2.3 16.2 25.6 23.8 27.7 16.8 9.7 47.4 17.1 27.3 16.3 11.5 30.4 34.1 25.7 25.5 29.4 16.8 11.1 16.0 22.4 22.3 10.1 2.1 42.3 19.0 17.8 9.4 15.8 52.7 58.7 16.6 23.0 28.4 10.3 54.5 9.5 36.2 10.0 53.1 12.6 24.1 32.9 38.3 34.2 17.0 14.3 26.4 15.3 6.7 27.1 33.0 17.9 17.9 CXCL12 "PBSF, SCYB12, SDF-1a, SDF-1b, SDF1, SDF1A, SDF1B, TLSF-a, TLSF-b, TPAR1" ENSG00000107562 "C-X-C motif chemokine ligand 12" P48061 10 44370165-44386493 "Predicted secreted proteins" "Chemotaxis, Host-virus interaction" "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 347.2;Distal tubular cells: 172.1;Fibroblasts: 566.4;Kupffer cells: 191.8;Smooth muscle cells: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 509.6;BJ hTERT+: 303.5;BJ hTERT+ SV40 Large T+: 294.9;BJ hTERT+ SV40 Large T+ RasG12V: 441.2;fHDF/TERT166: 501.8;HSkMC: 1293.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017564 Approved "Secreted to blood" NA NA 1030000 560000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "CAB017564: AB_2088170" "unprognostic (2.41e-1)" "unprognostic (2.95e-2)" "unprognostic (1.48e-1)" "unprognostic (3.38e-1)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "unprognostic (3.14e-2)" "unprognostic (1.28e-1)" "unprognostic (2.28e-1)" "unprognostic (3.28e-3)" "unprognostic (2.55e-1)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (2.91e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-1)" "unprognostic (5.95e-3)" 366.8 82.6 19.4 143.8 20.2 35.1 237.4 19.1 28.1 268.4 24.5 124.3 53.6 360.7 54.3 138.5 122.1 263.3 190.3 19.4 18.6 124.8 252.8 71.0 215.8 22.3 21.1 112.3 131.2 126.7 21.3 8.5 19.1 47.8 115.5 2.1 116.3 66.2 158.9 99.4 96.5 343.5 19.9 356.6 45.4 19.4 21.0 142.6 103.4 181.3 119.7 107.0 174.3 17.7 0.0 0.0 0.4 0.6 509.6 78.9 0.4 187.7 303.5 294.9 441.2 0.0 0.1 0.2 1.9 501.8 0.0 0.1 0.8 0.2 97.1 187.2 2.4 0.0 0.0 0.0 172.8 0.4 0.9 1293.8 0.0 63.8 0.1 0.0 0.2 0.1 0.1 0.0 1.0 0.4 0.7 0.6 32.2 0.0 0.6 0.8 0.3 224.3 0.2 0.0 0.6 0.6 0.3 0.7 0.0 63.6 272.2 0.4 0.4 0.4 0.5 205.0 0.2 0.2 0.1 0.1 0.6 0.3 3.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 20.2 19.1 28.1 19.4 18.6 22.3 21.1 19.1 19.9 21.0 17.7 347.2 0.0 1.1 1.3 1.4 76.3 0.3 0.0 9.6 1.5 8.1 14.0 25.0 10.0 0.6 5.5 0.0 0.3 2.1 0.0 172.1 0.8 2.2 1.7 46.8 134.1 0.0 0.0 0.6 20.5 0.3 566.4 1.5 1.0 0.0 0.4 55.6 2.5 2.6 0.0 6.6 3.9 0.0 191.8 110.1 3.7 70.2 27.9 135.2 74.0 0.0 1.9 0.0 12.1 0.1 3.0 0.0 8.6 1.0 1.0 0.1 25.5 0.0 0.8 85.5 43.7 146.1 1.8 5.9 6.3 62.7 0.7 9.6 33.2 0.5 0.5 TMEM72 "bA285G1.3, C10orf127, KSP37" ENSG00000187783 "Transmembrane protein 72" A0PK05 10 44911316-44937010 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "choroid plexus: 51.2;kidney: 74.4" "Cell type enhanced" "Detected in some" "Collecting duct cells: 27.6;Distal enterocytes: 21.1;Distal tubular cells: 33.2;Late spermatids: 15.9;Paneth cells: 8.9" "Cancer enriched" "Detected in some" 8 "renal cancer: 8.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 123 "RPMI-8226: 44.0;U-937: 26.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA039894, HPA062907" Enhanced NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA039894: AB_10795261, HPA062907: AB_2684900" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (1.08e-1)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (8.58e-2)" "unprognostic (5.45e-2)" "prognostic favorable (1.01e-4)" "unprognostic (4.99e-3)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" 0.0 0.0 0.6 0.0 0.4 0.4 0.0 0.7 0.5 0.0 51.2 6.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 3.5 1.5 74.4 0.1 0.0 0.0 1.7 1.5 0.0 9.1 0.5 0.2 0.0 1.4 0.0 7.7 0.2 2.4 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.2 2.8 2.2 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.7 0.5 3.5 1.5 1.7 1.5 1.4 0.2 2.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 27.6 0.0 0.0 0.0 21.1 33.2 0.1 5.5 0.7 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 RASSF4 "AD037, MGC44914" ENSG00000107551 "Ras association domain family member 4" Q9H2L5 10 44959407-44995891 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 77.3" "Cell type enhanced" "Detected in many" "Hofbauer cells: 157.0;monocytes: 258.7;Muller glia cells: 260.3;Proximal tubular cells: 128.0;Skeletal myocytes: 186.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 84.8;intermediate monocyte: 63.9;myeloid DC: 84.2;non-classical monocyte: 37.9" "Group enriched" "Detected in many" 10 "dendritic cells: 84.2;monocytes: 84.8" "Cell line enhanced" "Detected in many" "Karpas-707: 64.3;RH-30: 162.7;RPMI-8226: 54.9;U-937: 85.4;WM-115: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038834, HPA077069" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 5: Muller glia cells - Visual perception" "Nucleoplasm, Nucleoli" "Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA038834: AB_10795576, HPA077069: " "unprognostic (1.83e-1)" "unprognostic (8.21e-3)" "unprognostic (1.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (5.14e-2)" "unprognostic (3.15e-2)" "unprognostic (2.18e-2)" "unprognostic (8.81e-2)" "unprognostic (4.83e-2)" "unprognostic (8.75e-3)" "unprognostic (4.20e-1)" "unprognostic (4.11e-3)" "unprognostic (4.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.42e-1)" "unprognostic (6.20e-2)" 35.3 7.1 57.4 21.7 67.9 8.3 22.7 64.3 58.6 6.5 43.8 18.5 13.6 3.0 8.6 4.7 6.0 10.8 44.8 53.9 58.9 77.3 17.1 11.9 19.7 63.4 64.0 3.6 39.5 5.0 13.0 12.7 65.9 7.9 6.0 26.9 16.7 10.9 14.8 4.8 13.8 8.7 55.8 20.1 9.4 9.0 65.3 10.4 40.7 17.6 9.1 11.4 7.0 69.7 1.4 0.3 6.0 11.4 17.9 1.0 4.1 0.7 1.1 2.0 3.5 5.0 0.6 0.1 2.3 0.8 3.9 0.0 2.6 2.8 2.8 37.8 0.0 0.1 0.2 39.7 19.0 2.6 0.0 13.1 0.0 1.9 0.2 10.9 3.0 1.6 0.0 64.3 2.9 0.0 3.0 43.1 1.2 0.2 1.2 8.1 162.7 54.9 0.4 1.2 1.0 0.8 0.0 0.5 2.0 10.7 1.1 32.4 0.0 0.4 3.6 3.0 6.5 0.7 0.7 0.1 18.9 85.4 54.8 0.0 84.8 0.1 8.7 63.9 0.2 0.0 0.6 3.7 84.2 0.0 0.6 2.6 3.0 6.9 37.9 2.2 0.3 48.9 57.4 67.9 64.3 58.6 53.9 58.9 63.4 64.0 65.9 55.8 65.3 69.7 8.9 19.2 17.2 77.4 3.7 3.7 1.4 3.2 1.2 22.5 9.7 7.0 47.9 37.1 13.1 16.5 4.2 1.2 20.3 10.1 17.6 45.3 1.4 6.4 13.7 9.2 11.5 0.0 17.0 3.8 1.2 28.6 1.5 14.8 1.3 4.2 6.1 20.1 157.0 37.0 33.6 7.4 12.2 84.7 94.3 4.4 10.5 91.0 8.8 35.6 258.7 260.3 54.6 37.7 38.2 4.0 11.3 2.2 4.1 1.0 45.0 128.0 5.9 13.3 26.3 186.4 25.9 0.6 1.9 0.8 1.7 2.6 8.0 4.9 15.0 0.7 DEPP1 "C10orf10, DEPP, FIG, Fseg" ENSG00000165507 "DEPP1 autophagy regulator" Q9NTK1 10 44970981-44978809 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 889.5;breast: 697.2" "Cell type enhanced" "Detected in many" "Adipocytes: 192.0;Ductal cells: 146.3;Exocrine glandular cells: 113.0;Glandular and luminal cells: 87.1;Syncytiotrophoblasts: 300.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 143.2;HDLM-2: 106.7;HHSteC: 258.2;HSkMC: 201.6;HUVEC TERT2: 165.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013687, HPA037818, HPA037819" Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Mitochondria Vesicles "CAB013687: , HPA037818: , HPA037819: AB_2675685" "unprognostic (3.99e-2)" "unprognostic (4.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-3)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (4.25e-1)" "unprognostic (5.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.89e-2)" "prognostic unfavorable (2.29e-6)" "unprognostic (2.30e-3)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.74e-1)" 889.5 48.4 62.3 19.4 71.4 4.5 697.2 59.5 71.8 153.0 50.3 145.7 16.7 168.5 16.5 65.7 334.2 68.5 260.6 55.5 71.9 95.4 131.6 508.6 63.0 175.9 72.3 297.8 349.7 23.0 85.2 76.5 93.4 82.6 12.0 28.2 119.7 22.8 165.8 165.0 94.8 68.8 101.6 32.8 104.6 19.3 87.4 25.2 200.5 52.2 47.6 177.6 139.1 90.6 30.2 0.2 0.5 0.4 143.2 69.5 7.4 0.2 10.2 0.4 1.8 1.1 11.2 0.0 1.6 13.5 7.1 1.2 1.2 9.1 0.7 106.7 4.0 0.1 0.1 11.0 258.2 0.1 0.1 201.6 0.4 0.1 1.4 24.9 165.0 0.0 0.2 63.2 0.6 0.0 0.1 1.7 0.2 0.6 0.9 5.1 1.7 25.7 0.5 10.9 5.6 0.3 0.0 1.3 5.8 17.0 0.2 7.0 1.6 7.8 5.6 0.5 7.3 1.7 2.8 0.4 44.2 2.6 4.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.4 62.3 71.4 59.5 71.8 55.5 71.9 175.9 72.3 93.4 101.6 87.4 90.6 192.0 0.0 24.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 47.0 27.8 0.0 0.0 6.2 31.3 0.0 53.8 1.4 0.0 37.2 146.3 0.0 61.3 33.2 60.0 0.0 0.0 0.0 113.0 14.7 79.3 0.0 87.1 0.0 8.4 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 65.0 0.0 0.0 0.5 0.0 0.0 25.5 5.8 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 300.2 1.8 0.8 0.0 0.0 ZNF22 "HKR-T1, KOX15, Zfp422, ZNF422" ENSG00000165512 "Zinc finger protein 22" P17026 10 45000923-45005326 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 184.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016736, HPA054893" Approved Enhanced Nucleoplasm NA NA "Cluster 24: B-cells - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 32: Non-specific - Translation" Nucleoplasm "HPA016736: AB_1859133, HPA054893: AB_2682632" "unprognostic (2.87e-2)" "unprognostic (1.10e-1)" "unprognostic (2.65e-1)" "unprognostic (5.77e-2)" "unprognostic (3.50e-3)" "unprognostic (3.42e-2)" "unprognostic (4.77e-2)" "unprognostic (2.01e-1)" "unprognostic (1.01e-3)" "unprognostic (9.31e-3)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.11e-5)" "prognostic unfavorable (8.06e-4)" "unprognostic (1.39e-1)" "unprognostic (9.96e-2)" "unprognostic (4.58e-2)" 28.3 13.5 19.8 21.9 21.3 25.7 41.1 20.5 26.1 22.8 18.1 21.0 18.9 30.6 23.5 10.9 25.7 17.6 23.9 19.1 21.0 25.2 38.7 23.1 36.1 25.1 20.7 35.8 39.6 13.3 8.6 40.0 21.5 22.8 21.6 19.2 22.7 19.6 21.1 8.4 18.2 23.9 21.4 27.1 22.8 9.0 20.9 70.4 23.9 25.7 35.1 18.1 10.9 22.9 46.7 7.4 63.3 39.3 32.1 23.2 0.5 21.6 44.5 54.7 58.8 25.5 38.6 48.4 33.5 32.5 12.0 7.8 62.1 23.2 77.3 30.3 1.1 50.3 11.3 0.3 68.8 98.5 17.0 41.6 33.3 22.3 0.9 0.5 87.7 127.8 67.8 84.9 43.7 1.4 184.0 148.5 38.0 26.8 12.9 133.8 87.8 69.4 43.0 39.2 60.5 52.7 19.3 38.8 32.3 57.5 8.4 96.7 48.4 39.2 72.2 27.2 73.3 48.0 51.0 46.4 24.4 3.6 42.6 28.2 28.1 37.6 51.7 27.5 62.5 42.2 33.6 53.8 37.8 54.4 45.3 56.6 2.9 70.8 18.3 64.7 21.1 38.1 19.8 21.3 20.5 26.1 19.1 21.0 25.1 20.7 21.5 21.4 20.9 22.9 69.3 28.9 27.4 5.9 45.7 19.2 65.5 34.1 42.1 33.6 51.2 68.6 9.9 68.6 25.2 33.1 10.4 71.7 48.0 7.0 56.7 58.7 6.3 22.1 48.7 72.9 40.0 67.5 5.0 43.3 55.8 49.5 21.4 25.4 33.5 59.1 91.8 58.6 49.3 38.7 7.6 37.2 38.7 28.7 28.4 3.6 44.4 32.7 19.6 4.7 61.4 57.2 89.6 7.5 11.3 35.7 15.1 51.1 31.9 57.9 6.9 54.6 28.4 32.7 32.9 77.1 48.4 40.1 37.1 23.9 13.2 53.2 36.4 58.7 34.7 27.6 OR13A1 ENSG00000256574 "Olfactory receptor family 13 subfamily A member 1" Q8NGR1 10 45302298-45315608 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "urinary bladder: 1.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "Daudi: 10.4;U-698: 9.3" "Not detected" "Not detected" HPA057237 Uncertain NA NA "Cluster 37: B-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA057237: AB_2683378" "unprognostic (7.88e-2)" "unprognostic (1.90e-1)" "unprognostic (5.52e-2)" "unprognostic (2.33e-5)" "unprognostic (6.43e-3)" "unprognostic (6.04e-2)" "unprognostic (8.65e-2)" "unprognostic (3.59e-1)" "unprognostic (2.45e-1)" "unprognostic (2.54e-2)" "unprognostic (1.31e-1)" "unprognostic (1.67e-15)" "unprognostic (6.54e-2)" "unprognostic (2.87e-1)" "unprognostic (8.55e-2)" "unprognostic (4.09e-3)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.2 0.1 0.7 0.0 0.0 0.3 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 ALOX5 5-LOX ENSG00000012779 "Arachidonate 5-lipoxygenase" P09917 10 45374176-45446119 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Leukotriene biosynthesis" "Dioxygenase, Hydrolase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 72.8;lymphoid tissue: 93.9" "Cell type enhanced" "Detected in many" "B-cells: 63.7;granulocytes: 201.3;Hofbauer cells: 85.0;Kupffer cells: 78.5;Macrophages: 86.5;monocytes: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 13.9;Daudi: 40.9;HMC-1: 24.0;U-266/70: 30.8;U-698: 11.0" "Region enriched" "Detected in single" 4 "white matter: 2.9" "Low region specificity" "Detected in all" HPA071285 Enhanced Supported Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm "HPA071285: AB_2686379" "unprognostic (2.57e-2)" "unprognostic (2.81e-1)" "unprognostic (4.82e-2)" "unprognostic (1.75e-2)" "unprognostic (7.98e-3)" "unprognostic (1.26e-1)" "unprognostic (5.32e-2)" "unprognostic (8.69e-2)" "unprognostic (1.86e-2)" "unprognostic (6.91e-2)" "unprognostic (5.04e-2)" "unprognostic (3.42e-1)" "prognostic unfavorable (1.80e-5)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.53e-1)" "prognostic favorable (7.18e-4)" 16.8 8.4 1.4 8.4 1.1 31.1 12.7 2.8 2.9 6.1 1.0 11.0 3.0 6.9 0.3 10.7 11.1 3.4 6.7 1.2 1.8 8.3 5.5 72.8 6.7 4.1 2.5 2.6 23.2 0.9 3.2 3.6 2.7 11.8 2.3 0.1 14.1 1.5 2.1 5.6 35.8 4.9 2.5 93.9 9.3 2.1 2.2 2.6 4.7 3.7 8.9 40.0 7.9 4.2 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 7.4 40.9 0.7 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.1 8.6 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 2.7 0.0 5.2 0.7 0.0 0.0 0.2 0.0 0.1 0.1 0.6 0.0 0.0 2.2 0.0 0.0 30.8 2.8 11.0 0.0 0.1 0.0 462.5 225.6 317.6 0.3 198.4 0.6 133.9 5.3 1.7 119.7 98.5 0.7 0.5 457.8 0.2 210.5 2.4 1.2 136.1 1.4 1.1 2.8 2.9 1.2 1.8 4.1 2.5 2.7 2.5 2.2 4.2 0.7 16.0 38.4 1.3 63.7 1.1 7.3 0.2 1.2 1.3 7.3 4.3 2.2 12.8 9.5 9.2 2.1 0.7 1.7 1.7 0.0 20.9 0.5 0.7 0.5 3.0 7.1 1.7 2.8 21.6 2.0 1.7 13.7 4.4 201.3 2.2 3.6 1.1 85.0 0.0 1.1 2.0 14.2 78.5 17.8 1.1 0.3 86.5 0.0 47.8 59.5 0.7 4.1 4.0 1.4 18.4 0.6 0.0 13.8 4.0 9.4 0.2 2.6 0.3 13.1 0.3 1.1 0.3 1.1 9.2 1.4 4.1 5.9 0.7 3.2 45.3 MARCHF8 "c-MIR, CMIR, MARCH-VIII, MARCH8, MIR, RNF178" ENSG00000165406 "Membrane associated ring-CH-type finger 8" Q5T0T0 10 45454585-45594906 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014597 Approved NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA014597: AB_1853580" "unprognostic (1.38e-1)" "unprognostic (3.69e-2)" "unprognostic (1.74e-1)" "unprognostic (1.68e-3)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (3.51e-1)" "unprognostic (2.58e-1)" "unprognostic (1.56e-2)" "unprognostic (2.04e-1)" "prognostic favorable (2.71e-4)" "unprognostic (1.28e-1)" "prognostic favorable (6.64e-4)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (1.85e-1)" "unprognostic (3.12e-2)" 14.3 19.2 11.8 12.4 18.5 49.1 16.8 19.3 13.1 13.8 11.7 21.3 14.2 14.4 10.4 10.6 15.3 13.4 20.5 11.1 13.1 15.5 16.9 15.0 16.9 18.8 14.2 19.5 26.5 19.8 16.0 12.2 17.3 11.5 18.3 18.2 14.8 15.2 14.7 10.5 22.4 13.8 14.7 18.7 14.4 57.1 16.1 17.8 16.3 15.4 20.3 11.4 9.0 26.7 16.6 16.4 13.7 12.4 19.4 24.2 10.1 7.5 35.0 13.6 14.8 4.2 16.8 23.8 12.6 21.9 12.3 3.0 15.2 12.4 12.6 36.3 16.7 9.2 7.4 10.0 13.6 11.3 39.1 19.8 16.3 6.8 17.9 13.4 22.5 22.4 26.5 23.2 10.5 5.8 11.5 7.1 4.5 2.4 5.3 12.7 13.7 7.0 10.2 9.5 12.2 17.0 14.7 3.5 14.0 13.3 21.2 5.2 15.1 10.6 13.6 15.6 12.0 39.8 34.2 10.5 21.0 15.5 2.9 13.9 1.1 10.8 3.0 1.9 4.5 3.5 3.4 3.3 1.6 5.4 2.5 3.2 14.1 8.5 0.9 1.6 3.6 2.5 11.8 18.5 19.3 13.1 11.1 13.1 18.8 14.2 17.3 14.7 16.1 26.7 6.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 2.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.6 1.3 0.0 0.0 0.0 ZFAND4 "ANUBL1, FLJ40185" ENSG00000172671 "Zinc finger AN1-type containing 4" Q86XD8 10 45615500-45672780 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "testis: 37.4" "Group enriched" "Detected in many" 6 "Early spermatids: 414.6;Late spermatids: 689.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "Daudi: 34.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057543, HPA074103" Enhanced Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 83: Testis - Spermatogenesis" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA057543: AB_2683461, HPA074103: " "unprognostic (1.57e-1)" "unprognostic (1.53e-2)" "unprognostic (6.90e-2)" "unprognostic (3.57e-2)" "unprognostic (2.27e-2)" "unprognostic (5.31e-2)" "unprognostic (1.62e-1)" "unprognostic (1.46e-3)" "unprognostic (2.55e-1)" "unprognostic (3.16e-1)" "unprognostic (8.85e-5)" "unprognostic (3.23e-1)" "unprognostic (9.15e-3)" "unprognostic (1.18e-1)" "unprognostic (6.19e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-3)" 2.2 3.3 1.8 2.0 1.9 2.2 3.0 4.0 2.1 2.6 1.9 2.1 2.1 2.4 1.5 1.6 2.7 1.4 2.5 1.5 2.4 2.1 3.8 2.2 4.9 2.3 2.4 2.4 2.4 1.4 3.0 1.2 2.3 2.6 2.2 2.2 2.3 1.7 2.2 3.2 2.0 1.8 2.1 2.5 1.9 37.4 2.3 3.2 3.4 1.6 4.7 2.1 2.2 2.4 1.0 0.7 1.4 2.1 3.2 2.5 0.0 1.4 2.4 1.3 1.4 0.0 1.0 34.6 1.7 0.9 1.9 0.3 1.1 0.9 1.6 5.6 1.7 1.0 1.1 0.8 2.4 0.0 6.8 2.2 1.7 0.5 1.3 1.0 1.2 4.5 0.9 5.8 1.5 0.1 3.3 0.7 1.4 1.1 0.9 0.5 1.1 0.0 1.1 0.9 2.7 1.8 1.1 1.3 1.1 1.5 2.9 1.9 1.1 0.5 2.5 2.1 1.7 4.6 8.2 0.0 1.0 3.4 0.6 0.3 0.2 0.0 0.4 0.1 0.5 0.4 0.3 0.3 0.1 0.3 0.3 0.4 0.0 0.7 0.4 0.1 0.3 0.1 1.8 1.9 4.0 2.1 1.5 2.4 2.3 2.4 2.3 2.1 2.3 2.4 2.5 6.4 3.1 22.5 7.6 0.8 3.3 1.0 5.7 7.9 4.0 2.2 3.9 4.3 0.7 1.8 27.1 0.3 7.1 3.7 1.9 1.1 414.6 6.5 3.4 2.8 1.8 5.7 3.3 1.8 0.4 3.1 4.6 1.8 2.5 3.0 3.3 5.6 2.2 3.3 23.2 2.5 0.0 2.5 1.0 689.8 6.5 2.3 3.6 13.1 2.2 4.1 1.0 47.3 39.7 1.3 0.5 3.0 10.3 3.9 1.6 3.7 8.9 8.7 6.6 4.5 2.2 86.3 13.5 3.2 2.3 0.1 7.0 4.0 2.7 1.9 WASHC2C "Em:AC012044.3, FAM21C, KIAA0592" ENSG00000172661 "WASH complex subunit 2C" Q9Y4E1 10 45727200-45792964 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 35.3;Alveolar cells type 2: 35.2;Collecting duct cells: 23.9;granulocytes: 30.3;Respiratory ciliated cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (7.50e-2)" "unprognostic (2.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-2)" "unprognostic (5.98e-3)" "prognostic unfavorable (1.35e-5)" "prognostic favorable (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.00e-3)" "unprognostic (1.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-2)" 19.4 15.7 10.9 17.3 11.8 42.5 17.5 14.8 14.9 19.1 13.5 20.3 15.2 16.8 12.4 13.5 14.9 16.5 22.0 11.3 11.4 18.0 15.9 17.7 20.2 12.5 12.2 21.6 11.6 21.4 13.9 13.7 12.7 15.6 22.0 14.2 15.3 14.6 17.1 17.6 19.7 19.0 9.6 19.3 15.0 12.9 14.1 21.2 17.1 9.8 18.7 17.7 14.6 14.0 24.5 25.9 20.7 23.5 52.1 45.8 12.4 28.4 45.8 32.4 30.8 16.0 23.3 20.1 18.8 41.7 30.8 21.6 23.2 13.0 32.6 18.9 19.2 20.9 32.3 12.3 55.0 21.4 24.6 43.4 30.4 35.4 26.1 31.6 33.7 16.5 33.9 15.7 40.1 12.8 14.0 35.9 14.8 14.7 3.9 17.4 30.5 10.5 23.8 38.2 10.0 22.3 32.8 16.1 39.4 21.0 22.1 20.6 58.1 16.8 18.0 44.7 19.1 21.5 36.3 19.6 23.5 49.4 9.2 14.1 17.1 11.7 12.2 17.9 11.8 9.9 10.1 12.7 11.7 9.2 10.0 8.9 16.8 12.5 22.8 8.1 10.4 13.3 10.9 11.8 14.8 14.9 11.3 11.4 12.5 12.2 12.7 9.6 14.1 14.0 16.2 35.3 35.2 0.0 3.0 0.0 0.0 0.0 0.0 0.0 11.3 8.8 0.0 0.0 11.8 23.9 0.0 6.8 11.8 0.0 3.9 13.5 0.0 11.3 17.9 6.1 0.0 0.0 0.0 14.0 6.4 7.9 0.0 13.9 30.3 13.7 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 10.3 0.0 0.0 0.0 0.0 11.9 0.0 0.0 3.8 0.0 0.0 12.8 24.8 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 7.8 7.0 12.1 0.0 0.0 AGAP4 "AGAP8, CTGLF1, CTGLF5, Em:AC012044.1, MRIP2" ENSG00000188234 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 4" Q96P64 10 45825613-45853875 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 141.3;Late spermatids: 52.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NB-4: 21.6" HPA042490 Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA042490: AB_2678022" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.05e-1)" "unprognostic (7.50e-2)" "unprognostic (2.50e-2)" "unprognostic (4.10e-4)" "unprognostic (4.13e-3)" "unprognostic (5.72e-2)" "unprognostic (3.68e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (2.81e-3)" "unprognostic (3.76e-5)" "unprognostic (7.49e-2)" "unprognostic (3.19e-1)" "unprognostic (8.58e-2)" "unprognostic (5.28e-4)" 5.0 6.8 11.9 5.1 12.2 5.9 5.3 14.6 13.7 7.5 11.2 6.0 7.5 5.0 5.8 4.9 6.1 3.0 6.0 12.0 11.8 8.9 9.3 5.1 7.1 11.5 11.0 7.3 7.4 2.5 9.0 3.6 11.7 9.1 3.7 9.8 4.6 4.2 7.2 9.6 6.8 2.7 10.4 10.2 5.8 7.1 12.1 5.3 6.3 2.8 3.5 5.8 5.9 12.9 2.8 3.2 9.3 5.6 3.8 4.5 7.0 3.2 3.0 3.4 3.5 7.3 7.3 4.1 4.7 2.6 1.9 7.8 1.8 4.5 2.4 5.2 5.8 0.3 8.1 9.2 3.7 4.8 3.1 3.0 3.9 3.9 4.1 2.6 1.8 8.5 6.1 4.8 1.9 4.5 4.0 21.6 4.3 2.7 1.2 5.7 3.1 4.5 3.3 3.5 6.5 5.3 1.5 5.7 5.5 4.8 5.1 5.8 5.3 1.5 4.4 3.3 6.8 8.5 5.0 3.6 3.1 6.9 1.7 2.0 0.2 0.7 0.4 0.2 0.3 0.1 0.1 0.4 0.3 0.5 0.2 0.2 1.0 0.4 0.1 0.3 0.1 0.1 11.9 12.2 14.6 13.7 12.0 11.8 11.5 11.0 11.7 10.4 12.1 12.9 5.4 19.2 8.2 6.2 2.4 0.4 1.6 0.1 0.0 4.2 4.3 4.7 5.2 5.7 5.1 1.8 10.4 4.6 4.3 4.7 0.0 2.0 141.3 4.2 2.7 4.4 1.2 2.1 15.1 1.8 1.4 2.9 10.2 3.0 12.7 6.5 5.7 2.5 2.3 0.0 14.3 4.9 2.0 4.1 0.6 52.9 2.1 2.6 0.0 2.8 4.4 1.8 3.1 8.0 9.9 1.5 1.0 5.3 2.9 2.8 5.5 1.0 6.4 5.5 6.6 3.3 4.8 6.6 5.3 2.1 0.1 1.9 3.4 3.9 5.6 2.1 TIMM23 TIM23 ENSG00000265354 "Translocase of inner mitochondrial membrane 23" O14925 10 45972489-46003742 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 148.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA031408 Approved Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria "HPA031408: AB_10600828" "unprognostic (4.09e-2)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (1.15e-2)" "prognostic unfavorable (2.77e-5)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "prognostic favorable (6.79e-4)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (3.24e-1)" "unprognostic (7.78e-2)" "unprognostic (5.54e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" 39.0 50.1 47.1 35.5 48.7 66.4 38.3 50.3 62.9 28.2 55.6 40.1 56.5 26.8 61.9 43.1 28.0 31.7 84.9 49.1 51.6 59.5 74.2 26.6 36.4 50.7 51.5 20.6 32.2 50.5 35.0 35.2 52.3 34.6 39.9 42.9 32.5 36.9 128.5 35.7 37.7 37.6 49.9 25.6 32.8 80.6 50.5 40.0 43.3 134.5 45.4 53.0 27.1 49.0 162.6 167.5 108.7 110.3 88.5 82.4 106.1 130.6 156.1 155.6 164.0 212.8 125.4 144.1 105.7 138.6 111.3 136.1 168.0 139.9 153.3 108.0 165.6 92.1 120.8 231.7 142.2 173.1 98.7 99.4 122.3 133.4 188.0 64.7 146.1 123.0 166.0 78.8 138.7 162.7 155.5 239.0 131.7 119.0 51.8 118.6 105.0 105.5 177.6 111.8 127.3 117.0 72.8 159.4 132.8 83.8 168.7 102.1 108.1 74.8 130.6 96.8 188.9 83.6 148.9 203.2 139.3 246.7 63.9 54.8 98.1 54.3 73.1 131.1 75.7 82.1 70.0 79.1 111.2 79.8 62.5 69.5 22.8 79.1 118.6 92.2 85.8 129.5 47.1 48.7 50.3 62.9 49.1 51.6 50.7 51.5 52.3 49.9 50.5 49.0 13.3 9.6 22.2 10.7 19.4 21.9 18.1 32.7 15.9 14.3 16.0 11.9 97.5 30.0 24.4 12.9 8.4 42.1 17.0 16.1 45.0 40.4 101.5 26.6 20.8 18.3 10.2 43.3 19.1 30.1 47.7 24.8 20.9 23.8 27.8 14.2 13.2 27.3 34.5 0.0 18.6 16.5 36.7 16.0 15.8 35.0 17.7 18.9 23.2 12.2 29.3 23.0 20.6 14.6 19.6 36.7 14.7 11.7 36.0 20.3 22.3 61.0 26.9 10.4 6.6 13.1 26.0 148.7 48.4 38.7 21.6 35.6 16.6 17.0 25.6 22.4 NCOA4 "ARA70, DKFZp762E1112, ELE1, PTC3, RFG" ENSG00000266412 "Nuclear receptor coactivator 4" Q13772 10 46005088-46030623 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 476.2;Macrophages: 316.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 251.9;granulocytes: 839.6;monocytes: 363.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051260, HPA065208" Uncertain Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 51: Myeloid cells - Hemostasis" Nucleoli "Golgi apparatus, Cytosol" "HPA051260: AB_2681412, HPA065208: AB_2685432" "unprognostic (4.23e-2)" "unprognostic (1.50e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.34e-1)" "unprognostic (1.80e-1)" "unprognostic (9.34e-2)" "unprognostic (4.67e-2)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.04e-2)" "prognostic favorable (8.04e-6)" "unprognostic (1.35e-1)" "unprognostic (4.71e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" 117.1 67.8 45.6 91.5 52.5 189.5 96.9 56.1 50.9 85.1 50.7 110.3 249.7 70.2 74.6 110.3 62.6 87.8 156.8 40.6 55.8 159.7 372.9 108.3 102.6 52.4 53.5 65.5 64.6 97.9 25.2 131.3 53.6 132.2 115.7 33.7 79.2 78.7 163.5 71.1 155.9 98.3 52.6 148.1 90.3 43.6 51.6 124.4 87.0 193.6 150.3 104.6 46.8 60.0 142.7 58.5 68.0 70.4 176.9 159.4 170.3 128.3 204.8 122.1 119.6 91.0 102.3 161.2 149.2 211.2 69.1 141.8 72.6 142.3 137.1 114.4 74.1 108.4 74.3 263.5 124.0 279.9 229.7 156.1 139.2 104.2 175.7 131.6 185.5 79.5 119.7 93.5 171.9 64.0 136.1 104.3 41.4 110.2 34.8 79.5 99.3 96.7 148.9 119.4 68.2 46.1 128.9 146.2 131.5 133.5 105.7 135.3 171.6 75.8 89.9 81.3 87.5 69.3 79.1 156.9 94.6 231.2 41.2 692.1 363.6 611.8 78.9 223.6 86.2 57.6 73.3 74.9 251.9 53.8 78.2 66.4 839.6 119.0 275.3 77.4 92.8 559.4 45.6 52.5 56.1 50.9 40.6 55.8 52.4 53.5 53.6 52.6 51.6 60.0 44.5 51.3 95.2 13.4 44.6 49.5 39.3 126.2 50.7 14.3 49.6 38.5 161.3 45.8 96.2 44.1 29.2 104.7 58.2 108.8 80.3 45.3 105.4 45.1 37.7 52.9 26.9 476.2 17.4 51.8 107.2 45.3 42.3 56.9 195.2 28.2 55.3 166.7 181.4 20.2 20.5 45.4 59.0 254.5 74.2 72.4 37.3 316.1 51.6 16.9 158.4 38.2 44.3 18.6 22.9 47.8 63.9 47.4 37.6 62.0 162.5 128.8 59.7 13.0 13.1 36.7 46.7 24.5 16.5 71.9 56.7 158.2 41.3 60.7 71.3 52.0 MSMB "IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94" ENSG00000263639 "Microseminoprotein beta" P08118 10 46033307-46048180 "Cancer-related genes, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "prostate: 9384.0" "Cell type enriched" "Detected in many" 4 "Prostatic glandular cells: 10715.4" "Cancer enriched" "Detected in many" 42 "prostate cancer: 3435.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 25.6;NB-4: 21.6;RPMI-8226: 11.3;SH-SY5Y: 6.1;SK-BR-3: 5.9;U-2197: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB026357, HPA051257" Enhanced "Secreted in male reproductive system" NA NA 6000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 51: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 35: Glandular cells - Unknown function" "CAB026357: , HPA051257: AB_2681410" "unprognostic (6.47e-2)" "unprognostic (7.21e-3)" "unprognostic (1.37e-2)" "unprognostic (8.18e-3)" "unprognostic (4.28e-3)" "unprognostic (9.24e-3)" "unprognostic (1.66e-1)" "unprognostic (8.66e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (2.01e-1)" "unprognostic (7.04e-2)" "unprognostic (1.39e-1)" "prognostic favorable (7.19e-4)" 5.1 4.5 0.0 3.0 0.0 0.1 20.5 0.0 0.0 3.2 0.0 2.8 10.3 0.3 45.1 12.3 4.6 3.0 0.5 0.0 0.0 1.8 1.8 29.9 0.2 0.0 0.0 0.3 2.3 0.2 0.5 0.6 0.0 9384.0 0.1 0.0 31.9 0.6 0.4 39.7 2.3 0.0 0.0 0.7 552.3 10.1 0.0 1.0 0.7 0.0 10.0 7.2 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 25.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 21.6 0.2 0.0 0.0 0.0 0.0 11.3 0.0 1.6 1.0 6.1 0.0 5.9 0.0 0.2 0.4 0.0 0.0 0.0 0.0 12.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.3 0.0 195.9 586.4 0.0 0.0 6.4 1.3 0.0 4.3 2203.2 0.0 0.0 2.1 0.1 0.3 0.0 0.1 48.9 0.6 0.0 10.7 0.0 0.0 0.1 0.2 0.4 9.5 404.2 0.2 1.3 0.0 0.0 1.2 0.2 0.0 0.0 0.8 419.1 0.0 0.0 78.8 0.3 30.5 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 29.6 0.0 0.8 10715.4 0.3 0.0 570.6 0.0 0.0 0.0 271.0 0.5 1.4 0.0 0.4 1.5 14.3 0.0 0.1 192.4 ANTXRL ENSG00000274209 "ANTXR like" A6NF34 10 46286345-46330207 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 12.7" "Group enriched" "Detected in some" 27 "Early spermatids: 58.5;Late spermatids: 28.8" "Cancer enriched" "Detected in single" 6 "ovarian cancer: 0.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 83: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (1.09e-1)" "unprognostic (2.67e-2)" "unprognostic (3.65e-3)" "unprognostic (2.59e-2)" "unprognostic (3.40e-1)" "unprognostic (8.11e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.61e-1)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (1.53e-2)" 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 12.7 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANXA8L1 "ANXA8L2, bA145E20.2, bA301J7.3" ENSG00000264230 "Annexin A8 like 1" Q5VT79 10 46375627-46391784 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 195.2;skin 1: 325.4;vagina: 100.5" "Cell type enriched" "Detected in many" 4 "Squamous epithelial cells: 118.7" "Cancer enhanced" "Detected in many" "cervical cancer: 5.2;head and neck cancer: 5.6" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.2;myeloid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 374.5;HBEC3-KT: 485.0;hTCEpi: 140.1;SiHa: 116.6" "HPA045246, HPA047451" Approved Nucleoplasm NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "HPA045246: AB_2679271, HPA047451: AB_2680052" "unprognostic (3.67e-3)" "unprognostic (4.56e-3)" "unprognostic (9.14e-3)" "unprognostic (3.92e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.27e-2)" "unprognostic (1.08e-2)" "unprognostic (8.05e-2)" "unprognostic (6.94e-3)" "unprognostic (8.33e-5)" "unprognostic (3.43e-1)" "unprognostic (8.26e-10)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" 39.8 0.2 0.0 0.0 0.0 1.2 21.9 0.0 0.1 45.2 0.0 0.3 0.0 0.1 0.0 195.2 6.1 0.1 2.9 0.0 0.0 0.0 1.1 16.5 0.0 0.0 0.0 0.9 0.3 0.0 0.2 24.1 0.0 6.8 0.0 0.0 40.8 4.5 1.1 325.4 0.1 0.0 0.0 0.1 0.3 0.8 0.0 4.3 0.1 0.0 35.1 37.4 100.5 0.0 70.1 18.2 0.0 0.0 0.0 0.0 24.8 0.9 0.1 0.0 0.0 1.9 12.6 0.0 0.6 0.3 0.5 374.5 0.0 485.0 0.0 28.9 0.0 0.0 33.3 0.0 9.3 0.0 0.7 0.0 140.1 0.2 58.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 70.2 0.2 0.7 0.0 0.0 0.8 0.0 0.0 76.0 0.1 0.0 116.6 12.0 0.0 7.2 0.0 0.7 0.0 0.1 12.2 0.1 0.3 0.0 0.1 0.0 2.8 0.1 0.2 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.9 1.1 0.0 0.0 0.0 3.0 0.2 11.4 1.6 2.3 2.4 3.7 18.6 19.9 0.0 0.0 14.8 0.0 3.0 0.0 0.7 0.4 1.0 0.0 0.9 0.0 0.0 0.0 0.2 11.4 12.8 5.6 0.1 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.7 1.4 0.0 1.2 2.5 5.2 0.0 10.9 0.2 13.1 0.0 1.5 0.3 2.4 118.7 1.1 6.3 0.6 0.0 0.2 5.9 NPY4R "PP1, PPYR1, Y4" ENSG00000204174 "Neuropeptide Y receptor Y4" P50391 10 46461099-46465958 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.3;intestine: 6.0;skin 1: 3.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "prostate cancer: 0.8" "Region enhanced" "Detected in single" "thalamus: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "A549: 28.6" HPA027863 Approved NA NA "Cluster 37: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "HPA027863: AB_10602819" "unprognostic (2.26e-6)" "unprognostic (2.94e-1)" "unprognostic (8.17e-2)" "unprognostic (1.20e-1)" "unprognostic (1.30e-1)" "unprognostic (1.77e-3)" "unprognostic (1.98e-1)" "unprognostic (2.64e-3)" "unprognostic (6.58e-2)" "unprognostic (9.79e-2)" 0.5 0.0 0.3 0.7 0.1 0.0 0.2 0.6 0.2 0.1 0.0 4.9 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.7 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.6 1.3 6.0 0.0 0.0 0.0 0.0 3.0 1.2 1.0 0.3 0.0 1.9 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 28.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.8 0.0 0.0 5.9 0.0 0.4 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.2 0.2 0.4 0.5 0.5 0.6 0.3 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPRIN2 "KIAA0514, MGC15171" ENSG00000204175 "G protein regulated inducer of neurite outgrowth 2" O60269 10 46549044-46555530 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 10.5;skin 1: 17.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Distal enterocytes: 30.4;Exocrine glandular cells: 20.2;Intestinal goblet cells: 30.8;Late spermatids: 20.6;Proximal enterocytes: 21.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 10.2;A549: 13.1;SiHa: 3.7;SK-BR-3: 12.0" "Low region specificity" "Detected in many" "HPA038129, HPA070760" Approved Approved "Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Plasma membrane, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA038129: AB_2675846, HPA070760: " "unprognostic (1.00e-2)" "unprognostic (1.91e-1)" "unprognostic (1.77e-2)" "prognostic unfavorable (8.60e-8)" "unprognostic (5.77e-2)" "prognostic favorable (3.47e-4)" "unprognostic (2.23e-1)" "unprognostic (2.67e-2)" "unprognostic (2.54e-1)" "unprognostic (1.27e-1)" "unprognostic (1.52e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.98e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.67e-3)" 0.1 0.0 1.7 0.6 1.6 0.0 0.9 5.9 2.1 0.9 0.4 6.2 3.6 0.0 0.0 4.4 0.3 0.2 0.0 0.6 6.7 5.7 0.3 10.5 0.0 5.5 4.9 0.1 5.7 2.1 4.2 0.0 5.7 1.9 3.4 0.1 2.8 1.1 0.1 17.4 8.0 0.1 1.8 0.0 5.1 3.0 9.7 0.0 3.4 0.0 0.5 0.6 2.0 1.0 10.2 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.2 0.0 0.7 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.0 0.0 1.7 0.3 0.3 0.1 3.7 12.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 5.9 2.1 0.6 6.7 5.5 4.9 5.7 1.8 9.7 1.0 0.0 19.2 3.7 0.0 0.0 1.7 2.8 1.9 2.8 0.3 1.4 1.0 0.2 7.2 2.1 3.7 0.0 0.0 0.0 30.4 0.0 11.3 9.3 0.0 0.0 0.1 6.6 0.0 0.7 20.2 0.0 0.1 3.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.9 30.8 0.0 0.0 0.3 20.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 13.1 0.4 0.0 2.1 21.7 4.0 1.8 0.1 0.0 0.0 0.2 2.9 0.8 2.4 6.1 0.0 0.1 0.0 7.3 1.3 SYT15 CHR10SYT ENSG00000204176 "Synaptotagmin 15" Q9BQS2 10 46578217-46594173 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 54.5;Alveolar cells type 2: 49.5;Endothelial cells: 20.4;Hepatic stellate cells: 26.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-BR-3: 14.6" "HPA036971, HPA036972, HPA064559" Uncertain Approved "Golgi apparatus" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (1.64e-2)" "unprognostic (9.28e-3)" "unprognostic (1.54e-1)" "unprognostic (6.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.31e-2)" "unprognostic (5.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.02e-2)" "unprognostic (1.49e-2)" "unprognostic (3.19e-4)" "unprognostic (4.03e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-2)" "unprognostic (1.15e-3)" 3.7 2.3 3.5 3.4 3.8 0.8 3.2 1.9 9.3 4.5 0.0 1.6 1.8 2.9 3.9 3.3 4.5 2.7 4.1 7.6 1.8 2.1 1.4 9.6 5.4 6.9 1.7 2.6 4.8 2.3 0.9 5.1 6.7 2.5 2.1 3.4 3.6 3.5 2.2 11.6 1.5 3.7 0.2 3.5 1.2 1.5 4.3 1.8 2.6 4.1 4.0 2.9 3.4 3.9 2.8 2.9 1.5 0.7 1.7 1.6 2.1 2.9 5.3 2.2 2.5 6.8 5.2 0.6 2.2 2.5 2.1 9.4 0.0 0.8 2.9 1.4 3.2 1.7 2.8 4.5 4.4 3.0 2.1 3.2 0.9 1.4 4.2 2.7 1.2 2.2 0.7 1.7 1.0 4.6 1.5 4.7 1.2 0.5 1.2 1.9 0.0 1.9 3.3 1.3 0.9 1.4 2.4 14.6 1.3 1.4 4.3 1.3 3.8 0.8 3.3 2.0 2.1 2.6 2.9 2.3 1.8 1.9 0.6 0.0 0.6 0.3 0.7 1.4 0.6 0.4 0.6 0.3 0.6 0.2 0.4 0.5 0.0 0.5 1.1 0.4 0.1 0.3 3.5 3.8 1.9 9.3 7.6 1.8 6.9 1.7 6.7 0.2 4.3 3.9 8.0 54.5 49.5 0.7 0.3 6.1 2.2 2.0 0.6 2.2 2.8 1.5 3.6 0.0 3.0 1.8 2.1 1.1 0.6 0.9 1.9 2.0 0.4 0.8 1.2 20.4 1.2 2.7 0.7 5.8 1.4 2.7 0.0 1.0 2.5 1.1 26.4 1.5 0.1 0.0 0.8 1.6 0.0 2.2 3.5 0.6 3.7 0.6 3.6 1.9 0.5 0.6 1.0 1.0 1.1 4.5 0.9 3.8 0.4 5.6 1.1 2.5 1.5 1.8 6.6 3.6 2.7 1.3 1.4 0.5 5.5 1.2 0.8 0.4 1.4 2.4 PTPN20 "bA142I17.1, bA42B19.1, CT126, DKFZP566K0524, PTPN20A, PTPN20B" ENSG00000204179 "Protein tyrosine phosphatase non-receptor type 20" Q4JDL3 10 46911396-47002488 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 16.3;Distal tubular cells: 21.5;Early spermatids: 44.2;Late spermatids: 34.9;Proximal tubular cells: 17.7;Spermatocytes: 24.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HDLM-2: 50.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043337, HPA046896, HPA048310, HPA069148" Enhanced Supported "Centriolar satellite" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Centriolar satellite" "HPA043337: AB_2678436, HPA046896: , HPA048310: AB_2680350, HPA069148: " "unprognostic (1.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.04e-2)" "unprognostic (2.82e-3)" "unprognostic (6.78e-2)" "unprognostic (1.85e-1)" "unprognostic (8.44e-2)" "unprognostic (1.92e-1)" "unprognostic (1.53e-1)" "unprognostic (2.22e-2)" "unprognostic (2.83e-1)" "unprognostic (1.24e-1)" "unprognostic (1.06e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-2)" "unprognostic (1.75e-1)" "unprognostic (8.34e-2)" 1.6 9.1 3.4 0.2 4.4 0.2 3.5 9.2 5.1 0.8 8.9 0.9 1.3 0.9 0.3 3.4 1.4 0.7 9.1 3.9 5.2 4.4 0.8 0.8 0.4 18.5 9.0 1.9 4.1 0.0 3.1 0.2 19.6 1.2 1.6 2.9 2.4 1.4 12.3 5.7 0.6 0.8 4.6 1.2 1.1 14.0 5.3 0.3 2.0 14.7 0.6 0.9 1.1 4.8 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 2.9 0.0 3.7 0.0 0.0 0.0 50.2 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 2.2 1.3 9.0 5.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.1 0.3 0.1 0.6 0.9 0.0 0.8 0.0 0.7 0.4 0.2 3.4 4.4 9.2 5.1 3.9 5.2 18.5 9.0 19.6 4.6 5.3 4.8 0.5 0.0 1.5 0.0 0.7 0.0 2.0 0.0 5.7 6.0 5.9 3.7 16.3 0.0 2.5 9.2 6.2 0.1 0.3 0.7 21.5 1.8 44.2 5.0 0.1 0.5 1.2 1.7 0.0 0.9 0.2 1.9 3.1 0.2 0.0 4.9 1.4 0.9 0.4 11.8 0.0 0.4 0.0 0.0 0.0 34.9 0.0 0.4 0.0 0.0 0.7 7.3 0.0 0.0 0.0 2.2 0.2 7.2 1.5 0.9 0.2 17.7 3.6 3.1 0.0 2.7 0.8 24.8 12.2 5.2 0.0 0.1 0.4 8.4 0.8 0.9 GDF10 BMP-3b ENSG00000266524 "Growth differentiation factor 10" P55107 10 47300197-47313577 "Plasma proteins, Predicted secreted proteins" Osteogenesis "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 19.6;retina: 18.4" "Group enriched" "Detected in some" 5 "Bipolar cells: 20.9;Cone photoreceptor cells: 16.7;Fibroblasts: 25.7;Rod photoreceptor cells: 34.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 13.5;MOLT-4: 3.0;SH-SY5Y: 5.5" "Region enriched" "Detected in all" 8 "cerebellum: 42.5" "Low region specificity" "Detected in all" HPA015498 Uncertain Approved Vesicles "Secreted in other tissues" NA NA "Cluster 77: Retina - Visual perception" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA015498: AB_1849584" "unprognostic (4.34e-2)" "unprognostic (3.10e-1)" "unprognostic (1.41e-1)" "unprognostic (5.09e-1)" "unprognostic (3.17e-1)" "unprognostic (9.84e-3)" "unprognostic (1.37e-2)" "unprognostic (2.26e-2)" "unprognostic (1.55e-1)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-7)" "unprognostic (3.49e-2)" "unprognostic (1.48e-1)" "unprognostic (2.59e-3)" "unprognostic (2.63e-1)" 12.4 3.2 5.4 0.3 5.4 0.0 9.7 5.1 4.0 2.6 0.6 2.5 0.0 4.2 0.2 2.4 1.6 2.2 4.4 5.9 3.3 0.1 0.1 19.6 0.8 2.6 5.8 0.3 13.3 0.0 0.7 0.0 1.4 2.2 0.3 18.4 8.8 0.2 2.2 3.1 0.6 0.4 2.5 0.1 1.8 7.1 5.5 0.4 9.7 10.4 1.0 1.3 1.7 3.7 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 5.4 5.1 4.0 5.9 3.3 2.6 5.8 1.4 2.5 5.5 3.7 2.4 0.0 0.6 0.0 0.0 0.4 0.1 0.0 0.0 20.9 0.1 0.0 0.8 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.6 0.2 25.7 0.0 0.0 1.3 0.0 0.0 0.0 0.1 1.7 0.0 0.2 0.0 0.0 2.6 0.7 0.9 0.2 1.8 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 0.0 0.6 1.6 0.4 1.3 0.0 0.9 0.0 0.4 0.0 0.0 0.0 GDF2 "BMP-9, BMP9" ENSG00000263761 "Growth differentiation factor 2" Q9UK05 10 47322454-47327588 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Angiogenesis "Cytokine, Growth factor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "liver: 18.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB023357 Uncertain "Secreted to blood" NA NA 2210000 740000 "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 43: Cardiomyocytes - Nuclear processes" "CAB023357: AB_2111086" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBP3 "D10S64, D10S65, D10S66, RP66" ENSG00000265203 "Retinol binding protein 3" P10745 10 47348363-47357881 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins" Transport "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 335 "retina: 542.3" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 2070.4;Rod photoreceptor cells: 1610.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hippocampal formation: 1.3" "Low region specificity" "Detected in many" "HPA041301, HPA044239" Enhanced "Secreted in other tissues" NA NA "Cluster 79: Retina - Phototransduction" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA041301: AB_2677398, HPA044239: AB_2678868" "unprognostic (3.48e-2)" "unprognostic (4.78e-3)" "unprognostic (1.36e-2)" "unprognostic (4.02e-2)" "unprognostic (1.40e-1)" "unprognostic (1.58e-2)" "unprognostic (5.09e-2)" "unprognostic (5.14e-3)" "unprognostic (7.44e-2)" "unprognostic (1.23e-1)" "unprognostic (4.68e-3)" 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.3 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 542.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.3 1.2 1.6 0.5 0.3 0.6 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.7 0.0 0.0 0.5 0.0 0.0 0.0 2070.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1610.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ZNF488 FLJ32104 ENSG00000265763 "Zinc finger protein 488" Q96MN9 10 47365496-47384293 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 34.4;intestine: 22.4" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 7.0;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 20.1;Proximal enterocytes: 21.5;Syncytiotrophoblasts: 36.1" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 46.9;HDLM-2: 70.1;RT4: 38.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035957, HPA035958" Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 45: Intestine - Brush border" "Cluster 44: HDLM-2 - Immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nucleoplasm, Cytosol" "HPA035957: AB_10672234, HPA035958: AB_2674887" "unprognostic (3.29e-2)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (1.49e-4)" "unprognostic (1.16e-1)" "unprognostic (8.85e-2)" "unprognostic (1.60e-3)" "unprognostic (2.13e-2)" "unprognostic (3.11e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (4.02e-7)" "unprognostic (3.60e-1)" "unprognostic (6.62e-5)" "unprognostic (2.76e-1)" "unprognostic (4.47e-1)" "unprognostic (8.10e-2)" "unprognostic (3.18e-2)" 0.2 0.1 10.2 0.1 22.2 0.0 0.8 23.6 18.1 0.3 3.1 0.6 22.4 0.1 1.6 0.9 0.1 0.2 0.1 18.0 14.8 1.1 0.0 0.2 0.0 29.4 26.4 0.3 0.0 0.0 0.8 3.4 26.8 0.3 0.6 2.6 0.4 0.1 0.0 1.7 11.2 0.1 20.4 0.0 0.3 0.8 23.2 0.3 0.1 0.1 0.6 0.5 0.5 34.4 4.9 13.7 2.3 0.7 0.0 0.0 0.2 0.5 0.6 0.8 0.8 5.3 12.7 0.3 0.8 0.0 5.3 46.9 1.2 5.2 0.7 70.1 1.4 0.2 1.5 0.4 0.0 0.1 0.7 0.0 12.2 0.5 1.3 0.2 0.0 2.7 0.0 0.0 0.0 0.2 0.5 0.2 3.5 10.3 1.3 0.0 5.8 0.0 0.3 38.2 11.1 2.0 3.3 0.5 0.0 5.1 1.1 0.1 0.0 0.0 3.5 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 22.2 23.6 18.1 18.0 14.8 29.4 26.4 26.8 20.4 23.2 34.4 0.2 0.0 0.0 1.0 0.0 0.6 0.9 0.4 0.0 1.8 0.2 0.4 0.6 0.0 0.2 0.0 0.0 7.0 0.0 0.8 5.9 0.2 0.0 0.1 0.0 0.1 0.0 0.0 1.9 0.2 0.5 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 10.1 20.1 0.6 0.0 0.0 0.0 1.1 21.5 0.2 0.0 0.5 0.0 0.2 0.6 0.1 1.5 0.0 0.1 36.1 0.0 0.1 1.5 0.4 ANXA8 ANX8 ENSG00000265190 "Annexin A8" P13928 10 47460162-47484158 "Predicted intracellular proteins" "Blood coagulation, Hemostasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 217.6;skin 1: 266.2;vagina: 110.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 99.3;Astrocytes: 38.8;Club cells: 40.7;Excitatory neurons: 47.8;Fibroblasts: 34.5;Inhibitory neurons: 41.0;Microglial cells: 35.6;Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 48.1;Squamous epithelial cells: 63.6" "Group enriched" "Detected in many" 4 "cervical cancer: 14.3;head and neck cancer: 16.1;lung cancer: 4.3;urothelial cancer: 11.1" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 394.3;HBEC3-KT: 622.3;hTCEpi: 357.6;hTERT-HME1: 134.2;RT4: 159.6" "HPA045246, HPA047451" Approved Nucleoplasm NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "HPA045246: AB_2679271, HPA047451: AB_2680052" "unprognostic (8.32e-4)" "unprognostic (2.52e-1)" "unprognostic (2.44e-1)" "unprognostic (6.15e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (5.94e-2)" "unprognostic (2.88e-2)" "unprognostic (2.40e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (2.68e-4)" "unprognostic (1.19e-1)" "unprognostic (7.55e-15)" "unprognostic (1.04e-2)" "unprognostic (9.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.39e-1)" 73.3 0.7 0.5 0.1 0.5 0.7 11.7 0.7 1.1 49.6 0.6 0.5 0.0 0.1 1.0 217.6 3.7 0.4 4.4 0.6 0.3 0.0 1.8 13.1 0.0 1.0 0.8 1.3 0.3 0.0 0.3 30.9 0.8 12.4 0.1 0.0 47.3 9.8 0.4 266.2 0.2 0.0 0.6 0.2 0.4 0.8 1.5 4.8 0.2 0.2 46.6 66.4 110.7 0.9 123.4 16.2 0.0 0.0 0.0 0.0 33.7 2.3 0.3 0.0 0.0 8.7 35.0 0.0 2.5 1.0 1.8 394.3 0.0 622.3 0.0 27.9 0.0 0.0 39.6 0.0 26.2 0.0 1.3 0.2 357.6 0.2 134.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 37.2 0.1 4.0 0.0 0.0 0.5 0.0 0.0 159.6 0.0 0.0 56.4 16.4 0.3 8.7 0.1 3.5 0.0 0.0 39.5 0.7 2.4 0.2 0.1 0.2 4.4 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.5 0.7 1.1 0.6 0.3 1.0 0.8 0.8 0.6 1.5 0.9 0.1 99.3 7.3 38.8 0.0 1.1 10.3 1.6 2.8 0.0 4.9 3.4 2.6 7.2 40.7 3.7 0.0 14.7 0.1 1.0 0.0 3.1 0.6 2.1 0.0 0.5 0.0 0.0 47.8 0.4 6.7 34.5 0.0 0.2 1.3 0.1 0.0 0.0 0.6 0.0 41.0 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.0 35.6 0.1 0.0 0.0 50.8 48.1 17.3 0.0 0.0 0.0 8.5 1.5 0.0 14.2 0.0 0.0 0.0 0.6 0.2 1.4 63.6 2.0 6.2 0.3 0.1 0.2 17.2 FAM25G bA301J7.4 ENSG00000189090 "Family with sequence similarity 25 member G" B3EWG6 10 47487219-47491693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 18.6;skin 1: 43.3" "Group enriched" "Detected in some" 4 "Pancreatic endocrine cells: 57.1;Spermatogonia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 13.8" HPA044808 Uncertain NA NA "Cluster 31: Skin - Epidermis development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA044808: AB_2679096" "unprognostic (1.97e-2)" 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 10.4 0.0 0.2 0.2 0.0 0.0 18.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.9 0.0 0.7 43.3 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 10.0 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.1 0.0 0.0 0.0 7.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 19.8 3.9 0.0 0.4 0.0 0.0 0.1 0.1 AGAP9 "bA301J7.2, CTGLF6, FLJ00312" ENSG00000204172 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 9" Q5VTM2 10 47501854-47523638 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA042490 Uncertain NA NA "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA042490: AB_2678022" "unprognostic (6.26e-2)" "unprognostic (5.74e-2)" "prognostic unfavorable (9.98e-5)" "unprognostic (1.85e-1)" "unprognostic (6.80e-2)" "unprognostic (9.89e-4)" "unprognostic (1.13e-2)" "unprognostic (3.71e-2)" "unprognostic (1.13e-1)" "unprognostic (5.85e-2)" "unprognostic (4.51e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.02e-5)" "unprognostic (9.44e-2)" "unprognostic (3.42e-2)" "unprognostic (2.70e-3)" "prognostic favorable (7.04e-4)" 12.7 14.5 7.8 5.2 8.6 8.5 14.4 9.7 9.4 17.9 9.4 14.1 15.6 12.2 6.7 13.5 14.9 5.6 13.0 7.7 8.1 22.1 39.8 12.2 5.4 8.7 8.4 18.6 32.1 3.0 26.1 2.3 9.0 18.0 3.4 11.9 14.2 4.7 9.9 19.7 19.2 3.5 7.1 14.6 18.4 27.3 9.0 4.9 19.8 2.3 3.2 12.3 14.8 10.0 4.4 6.6 5.7 5.8 5.1 4.2 6.8 4.2 1.9 2.0 1.5 7.9 6.9 0.9 5.2 2.9 1.2 12.9 2.3 3.0 1.5 8.5 12.4 2.5 2.6 9.4 4.5 9.3 7.4 2.9 5.8 5.1 14.2 2.2 1.0 0.5 4.0 3.5 1.3 7.3 1.6 11.9 3.1 3.2 1.3 3.4 3.2 2.8 4.1 5.0 0.7 4.1 3.4 7.0 0.9 5.4 9.3 5.1 5.3 4.3 7.1 5.0 7.8 4.8 3.7 4.3 4.3 9.7 1.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 7.8 8.6 9.7 9.4 7.7 8.1 8.7 8.4 9.0 7.1 9.0 10.0 3.8 3.2 9.9 0.0 1.6 0.0 1.6 0.0 2.8 6.6 5.3 5.0 1.6 7.2 3.1 11.0 18.8 3.1 3.0 0.2 1.9 1.8 109.7 12.3 4.7 2.7 1.2 2.7 0.0 2.2 0.7 3.6 20.4 4.1 7.6 7.1 2.2 7.2 2.1 11.8 0.0 1.5 0.0 3.0 0.0 21.5 3.4 3.3 0.0 0.0 1.7 4.3 1.0 0.0 0.0 6.0 0.8 6.0 2.1 2.6 6.7 1.0 6.6 8.7 0.0 3.2 2.9 12.4 4.8 1.8 0.0 1.0 2.3 4.0 2.0 1.8 FO681492.1 ENSG00000277758 Synaptotagmin-15 10 47749758-47763592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.3;lung: 12.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 11.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-BR-3: 68.9" "HPA036971, HPA036972, HPA064559" Approved Approved "Golgi apparatus" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (2.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-2)" "unprognostic (5.70e-2)" "unprognostic (4.59e-1)" "unprognostic (2.51e-1)" "unprognostic (2.06e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (2.69e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-5)" "unprognostic (4.52e-2)" "unprognostic (5.13e-2)" "unprognostic (6.35e-2)" "unprognostic (1.11e-2)" 2.7 0.7 2.1 1.2 2.4 0.1 2.2 0.0 11.3 2.3 0.0 0.8 0.3 1.3 0.5 2.5 2.1 1.1 1.3 5.0 0.0 0.5 0.4 12.2 3.7 0.0 0.0 0.7 4.1 0.8 0.3 2.5 0.0 1.1 0.6 0.5 1.8 1.3 0.6 3.2 0.8 0.9 0.2 0.9 0.6 0.3 0.2 0.8 1.1 0.6 1.9 1.1 2.0 1.0 0.4 4.1 0.4 0.5 0.2 0.3 0.2 2.8 0.4 0.3 0.3 4.5 4.0 0.1 0.3 2.2 1.3 0.5 0.0 0.1 0.4 0.1 1.6 0.0 0.8 0.4 3.9 0.3 0.8 0.4 0.2 0.3 0.7 0.4 0.3 1.9 0.1 0.4 0.2 7.6 0.2 0.6 0.1 0.0 0.0 0.2 0.1 0.2 0.3 0.2 0.6 0.2 5.2 68.9 0.2 0.2 5.4 0.3 0.5 0.3 0.7 0.3 0.2 0.3 0.3 0.2 0.4 0.1 0.9 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 11.3 5.0 0.0 0.0 0.0 0.0 0.2 0.2 1.0 0.1 3.2 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPY4R2 CH17-360D5.1 ENSG00000264717 "Neuropeptide Y receptor Y4-2" P0DQD5 10 47918739-47923524 "Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "intestine: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "A549: 10.2" HPA027863 Uncertain NA NA "Cluster 37: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "HPA027863: AB_10602819" "unprognostic (1.74e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-1)" "unprognostic (7.78e-2)" "unprognostic (6.72e-3)" "unprognostic (1.23e-1)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.0 1.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.1 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 10.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM25C bA164N7.4 ENSG00000276430 "Family with sequence similarity 25 member C" B3EWG5 10 47995322-47999791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "cervix: 14.8;esophagus: 30.1;salivary gland: 15.4;skin 1: 43.6;vagina: 13.4" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 1.3;Basal respiratory cells: 3.0;Suprabasal keratinocytes: 3.1" "Cancer enriched" "Detected in single" 5 "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 10.7" HPA044808 Uncertain NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA044808: AB_2679096" "unprognostic (2.93e-1)" "unprognostic (2.21e-1)" 0.1 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.1 14.8 0.0 0.3 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 43.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.4 0.0 13.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 3.1 0.0 0.0 0.0 0.0 0.0 FRMPD2 "MGC35285, PDZD5C, PDZK5C" ENSG00000170324 "FERM and PDZ domain containing 2" Q68DX3 10 48153088-48274696 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.7;choroid plexus: 5.2;retina: 24.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 50.0;Cone photoreceptor cells: 287.7;Early spermatids: 97.7;Endometrial ciliated cells: 70.6;Late spermatids: 118.5;Respiratory ciliated cells: 62.9;Rod photoreceptor cells: 90.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.4;HBEC3-KT: 1.0;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 77: Retina - Visual perception" "Cluster 28: BEWO - Transcription regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "unprognostic (1.53e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-4)" "unprognostic (7.59e-2)" "unprognostic (2.37e-1)" "unprognostic (2.06e-1)" "unprognostic (6.54e-3)" "unprognostic (1.85e-1)" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (3.25e-12)" "unprognostic (3.48e-2)" "unprognostic (5.43e-2)" "unprognostic (1.54e-1)" "unprognostic (7.43e-5)" 0.0 0.0 2.4 0.0 2.0 0.0 0.4 2.7 1.3 0.2 5.2 0.0 0.0 0.1 0.1 0.0 3.0 0.0 0.9 2.1 2.7 0.1 0.0 0.2 0.0 4.7 6.7 0.0 0.0 0.0 0.1 0.0 4.1 0.3 0.1 24.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.3 3.5 0.0 0.5 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.0 2.7 1.3 2.1 2.7 4.7 6.7 4.1 4.0 3.5 3.4 0.0 0.0 0.5 36.6 0.0 0.1 0.4 1.6 0.0 50.0 1.1 0.4 5.0 0.0 4.6 3.7 287.7 0.2 0.0 0.1 0.0 0.1 97.7 70.6 0.5 0.3 3.0 0.0 2.0 0.0 0.3 0.8 0.0 1.6 0.0 0.0 0.0 0.2 0.1 3.3 0.9 0.6 6.1 0.0 0.0 118.5 0.3 0.2 0.0 0.0 0.0 5.2 0.0 0.5 0.3 0.2 0.1 0.4 0.0 0.4 4.2 0.5 62.9 90.8 0.0 0.2 0.6 2.1 1.0 0.0 0.3 0.0 0.1 0.1 0.7 0.4 MAPK8 "JNK, JNK1, PRKM8, SAPK1" ENSG00000107643 "Mitogen-activated protein kinase 8" P45983 10 48306639-48439360 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 160.5;Excitatory neurons: 199.1;Inhibitory neurons: 218.2;Oligodendrocyte precursor cells: 233.7;Oligodendrocytes: 163.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004463, CAB069396" Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "CAB004463: AB_675868, CAB069396: AB_1619977" "unprognostic (7.49e-2)" "unprognostic (1.47e-1)" "unprognostic (2.74e-2)" "unprognostic (1.46e-1)" "unprognostic (3.07e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (8.66e-4)" "unprognostic (4.23e-2)" "unprognostic (5.98e-2)" "unprognostic (4.31e-3)" "unprognostic (2.33e-1)" "unprognostic (6.06e-2)" "prognostic favorable (8.66e-4)" "unprognostic (1.58e-1)" "unprognostic (9.95e-2)" "unprognostic (1.85e-2)" "unprognostic (1.01e-3)" 7.2 6.7 11.3 7.0 12.6 11.3 13.8 18.3 12.8 8.8 4.5 9.0 10.4 11.0 7.7 9.4 7.5 9.2 7.2 12.5 9.4 13.6 15.6 6.7 7.8 11.6 9.7 11.0 7.5 8.6 7.9 8.3 13.1 8.3 9.9 21.9 9.6 8.2 11.7 6.5 11.2 9.6 8.8 6.7 8.1 13.1 10.9 13.8 14.1 9.6 9.6 8.3 7.0 12.8 29.2 7.2 21.8 12.8 11.3 10.4 16.5 37.9 23.6 20.0 17.8 7.7 19.2 10.9 10.5 21.3 10.7 13.1 10.2 15.2 31.2 45.4 16.5 15.9 6.8 12.7 16.0 24.2 13.2 9.5 18.5 14.4 21.8 12.5 22.0 22.4 25.1 14.5 13.2 8.6 22.1 15.4 14.4 10.0 4.7 17.8 25.8 12.6 17.1 11.1 38.3 34.8 13.5 11.9 16.1 14.8 12.4 11.4 16.7 14.4 31.9 14.6 30.4 6.2 18.0 16.4 14.3 24.9 8.7 0.0 1.1 1.4 1.1 1.1 2.1 0.6 1.7 1.3 1.0 0.8 1.7 1.0 0.8 1.3 1.4 1.8 1.1 1.0 11.3 12.6 18.3 12.8 12.5 9.4 11.6 9.7 13.1 8.8 10.9 12.8 21.2 3.2 17.1 145.3 21.9 44.7 50.6 19.3 20.5 56.2 34.4 17.7 10.0 22.8 18.0 7.3 31.3 15.5 22.3 19.1 11.7 28.9 160.5 25.7 21.9 22.0 31.0 12.4 199.1 25.3 7.4 21.8 16.3 42.9 12.0 25.8 10.4 22.3 9.8 70.7 218.2 16.5 28.5 11.0 34.9 99.2 14.6 18.4 21.4 93.7 25.4 18.9 11.3 233.7 163.0 35.9 22.5 10.1 31.2 39.3 25.4 24.3 16.6 34.6 6.6 23.0 24.5 28.1 28.1 17.5 36.7 15.7 21.6 41.0 11.9 45.5 ARHGAP22 RhoGAP2 ENSG00000128805 "Rho GTPase activating protein 22" Q7Z5H3 10 48446036-48656265 "Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6" "Cell type enhanced" "Detected in many" "Late spermatids: 122.7;Microglial cells: 227.7;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 200.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 68.8;LHCN-M2: 64.8;TIME: 66.2;U-87 MG: 82.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020696, HPA040391, HPA064439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266" "unprognostic (1.87e-1)" "unprognostic (3.98e-2)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.07e-1)" "unprognostic (6.74e-3)" "unprognostic (4.81e-3)" "unprognostic (2.78e-1)" "unprognostic (1.66e-1)" "unprognostic (3.03e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.16e-8)" "unprognostic (7.40e-2)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (3.66e-2)" 2.6 1.9 12.0 3.0 15.7 1.4 1.6 17.6 14.5 1.6 7.7 2.0 0.6 1.1 0.7 1.4 1.8 1.8 4.4 11.9 12.7 1.3 0.8 2.0 2.7 22.6 17.0 4.8 1.7 0.9 2.0 0.8 20.1 3.3 1.0 0.4 2.0 1.1 1.9 2.2 1.6 1.4 16.9 2.8 1.2 4.8 17.0 2.8 6.6 1.6 2.2 2.1 2.2 22.2 6.2 1.4 0.4 0.0 5.1 20.8 4.3 31.9 15.1 3.0 4.1 7.0 0.9 0.0 1.2 13.1 2.1 12.4 0.4 11.2 5.4 0.6 11.5 18.2 0.2 0.1 2.7 2.0 2.0 5.0 11.2 37.1 3.0 68.8 20.6 0.0 17.4 3.0 64.8 0.2 0.2 0.1 7.2 0.0 0.5 0.1 0.0 7.9 6.5 0.7 1.1 6.4 1.5 0.1 0.6 0.6 0.4 0.3 66.2 30.1 0.4 3.8 23.8 0.0 0.0 0.0 82.5 0.3 4.9 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 12.0 15.7 17.6 14.5 11.9 12.7 22.6 17.0 20.1 16.9 17.0 22.2 0.9 0.0 1.7 4.2 2.9 3.4 4.1 6.8 4.6 1.1 0.8 3.0 2.9 1.5 2.9 0.0 2.1 11.6 3.2 0.2 0.0 2.8 53.6 0.7 1.6 2.4 0.0 10.9 51.7 4.4 0.7 6.5 0.5 1.0 0.0 4.4 1.8 0.0 10.3 0.0 29.8 0.3 2.0 7.6 14.2 122.7 2.8 15.6 1.8 227.7 14.8 1.8 0.0 141.8 200.8 2.5 0.0 6.0 0.5 1.9 0.0 0.2 3.8 1.4 0.0 1.6 4.2 1.6 4.3 0.4 0.6 1.0 0.7 10.6 0.1 0.6 WDFY4 "C10orf64, Em:AC060234.3, FLJ45748, KIAA1607" ENSG00000128815 "WDFY family member 4" Q6ZS81 10 48684876-48982956 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.7;lymphoid tissue: 28.5" "Cell type enhanced" "Detected in some" "B-cells: 44.7;dendritic cells: 29.9;Early spermatids: 47.2;Langerhans cells: 30.6;Macrophages: 24.6;Microglial cells: 81.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 14.3;myeloid DC: 11.3;naive B-cell: 21.2;neutrophil: 10.2;plasmacytoid DC: 32.5" "Group enriched" "Detected in many" 7 "B-cells: 21.2;dendritic cells: 32.5;granulocytes: 10.2" "Cell line enhanced" "Detected in some" "Daudi: 61.0;HDLM-2: 56.3;HL-60: 21.5;THP-1: 18.9;U-698: 25.6;U-937: 25.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040634 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm Cytosol "HPA040634: AB_10795491" "unprognostic (6.20e-2)" "unprognostic (6.60e-3)" "unprognostic (1.87e-1)" "unprognostic (3.31e-2)" "unprognostic (1.87e-1)" "unprognostic (9.38e-4)" "unprognostic (9.41e-2)" "unprognostic (3.89e-3)" "unprognostic (2.15e-2)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" "unprognostic (9.64e-2)" "unprognostic (3.21e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-2)" "unprognostic (1.97e-1)" "unprognostic (3.76e-2)" 1.9 0.7 3.2 12.1 3.4 11.7 1.4 4.2 4.8 1.1 3.2 1.9 1.5 0.8 1.9 1.4 0.7 3.2 0.6 3.2 4.2 0.8 1.3 5.2 28.5 6.0 4.9 0.6 1.0 0.4 0.3 1.2 6.2 0.8 1.9 0.1 1.3 0.6 0.7 2.6 7.4 1.7 5.9 17.3 2.3 3.7 6.3 12.3 0.6 0.4 23.9 3.1 0.3 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 56.3 0.0 6.5 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 6.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 25.0 0.0 0.0 3.0 0.0 0.0 2.8 0.0 14.3 0.0 0.1 11.3 21.2 0.0 0.0 10.2 0.0 1.3 32.5 0.0 1.1 3.2 3.4 4.2 4.8 3.2 4.2 6.0 4.9 6.2 5.9 6.3 9.3 0.2 0.0 1.1 2.0 44.7 0.4 0.1 0.0 0.0 0.0 0.1 0.4 1.3 0.0 0.6 1.8 0.0 0.1 29.9 0.0 1.9 0.0 47.2 0.0 0.1 0.3 0.0 0.4 0.7 0.0 0.2 1.1 0.0 0.0 5.7 0.0 0.0 0.0 13.0 0.0 0.4 0.1 0.0 12.9 30.6 17.7 0.3 24.6 1.8 81.5 16.4 0.0 0.0 1.0 0.5 0.0 0.0 0.4 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 2.9 0.5 0.2 0.3 0.3 1.5 0.0 0.3 0.1 LRRC18 "MGC34773, UNQ933, UNQ9338, VKGE9338" ENSG00000165383 "Leucine rich repeat containing 18" Q8N456 10 48909483-48914232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "choroid plexus: 12.1;fallopian tube: 7.6;testis: 14.0" "Group enriched" "Detected in some" 8 "Early spermatids: 222.0;Late spermatids: 64.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039256, HPA076699" Enhanced Approved Cytosol NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "HPA039256: AB_10671873, HPA076699: " "unprognostic (1.31e-2)" "unprognostic (3.66e-2)" "unprognostic (9.83e-4)" "unprognostic (3.10e-1)" "unprognostic (4.82e-2)" "unprognostic (1.98e-1)" "unprognostic (2.00e-1)" "unprognostic (8.11e-2)" "unprognostic (1.11e-1)" "unprognostic (3.16e-2)" "unprognostic (8.57e-3)" "unprognostic (4.08e-1)" "unprognostic (1.13e-1)" 0.0 0.0 0.3 0.4 0.2 0.4 0.3 0.5 0.3 0.6 12.1 0.4 0.2 0.2 0.0 0.1 7.6 0.3 0.3 0.8 0.3 0.0 0.0 1.5 0.2 1.0 0.9 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.7 0.0 0.1 0.0 0.0 0.8 0.4 0.2 0.6 0.1 0.2 14.0 0.6 0.0 0.0 0.0 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.5 0.3 0.8 0.3 1.0 0.9 0.8 0.6 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.0 6.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 64.1 1.8 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.2 2.8 0.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 VSTM4 "C10orf72, FLJ31737" ENSG00000165633 "V-set and transmembrane domain containing 4" Q8IW00 10 49014236-49115522 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 88.5;Granulosa cells: 96.9;Late spermatids: 140.6;Sertoli cells: 59.2;Theca cells: 44.7" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 22.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 8.6;RH-30: 9.3;SH-SY5Y: 7.9;U-138 MG: 10.6;U-2197: 24.0;U-87 MG: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017279 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Vesicles" "HPA017279: AB_10959519" "unprognostic (8.46e-2)" "unprognostic (5.41e-1)" "unprognostic (1.89e-1)" "unprognostic (2.07e-1)" "unprognostic (1.80e-1)" "unprognostic (2.84e-2)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" "unprognostic (3.03e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.25e-4)" 18.7 41.5 7.1 3.2 9.0 0.3 9.8 8.0 6.6 22.3 7.7 7.8 2.5 12.3 7.4 7.8 8.5 10.5 12.3 6.2 7.6 12.3 3.9 10.9 3.5 8.9 9.3 35.2 1.5 26.8 5.1 10.4 9.2 13.5 5.6 2.3 3.4 11.7 5.6 4.9 4.9 11.4 8.6 2.3 5.6 9.4 8.4 6.5 27.8 5.9 4.6 12.0 7.5 9.4 0.0 0.0 3.1 0.1 1.3 0.7 0.1 2.6 4.1 0.9 0.2 0.0 0.1 0.1 0.1 6.1 3.4 0.1 0.2 0.0 0.4 3.2 1.4 0.2 0.1 0.1 0.1 0.1 0.0 4.7 0.0 4.2 0.0 0.0 0.0 0.8 8.6 0.1 0.8 0.1 0.0 0.2 0.6 0.0 0.0 0.0 9.3 5.0 0.0 0.1 0.1 7.9 0.1 0.0 0.0 0.4 0.1 0.3 0.0 10.6 1.2 24.0 0.1 0.0 6.8 0.0 11.6 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.3 0.1 0.1 0.0 0.0 7.1 9.0 8.0 6.6 6.2 7.6 8.9 9.3 9.2 8.6 8.4 9.4 9.4 3.2 17.5 17.3 1.3 6.5 1.6 0.1 0.6 5.4 1.2 1.1 16.7 0.0 9.4 0.0 2.1 0.4 3.7 0.2 1.9 0.1 88.5 0.8 10.7 6.2 0.0 0.0 11.1 0.0 0.3 29.7 0.0 0.7 12.6 96.9 5.3 5.0 0.7 5.0 7.0 0.0 0.0 2.2 11.1 140.6 9.6 2.9 7.2 4.7 1.0 9.1 2.1 20.1 33.3 0.2 0.1 14.7 0.7 0.8 0.0 9.4 3.8 2.9 59.2 20.6 37.7 1.3 4.4 0.4 4.3 0.4 2.0 44.7 0.0 0.7 FAM170B "AC084727.4, C10orf73" ENSG00000172538 "Family with sequence similarity 170 member B" A6NMN3 10 49131154-49134021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 6.4" "Cell type enriched" "Detected in some" 4 "Early spermatids: 80.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 20 "eosinophil: 1.9" "Lineage enriched" "Detected in single" 20 "granulocytes: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043899, HPA050610" Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 78: Testis - Spermatogenesis" "Cluster 29: Early spermatids - Spermatogenesis" "HPA043899: AB_2678721, HPA050610: AB_2681189" "unprognostic (8.01e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 19.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM273 "C10orf128, Em:AC084727.5" ENSG00000204161 "Transmembrane protein 273" Q5T292 10 49154725-49188585 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 37.8;dendritic cells: 10.1;Hofbauer cells: 82.9;Macrophages: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "eosinophil: 269.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 269.0" "Cell line enhanced" "Detected in some" "HDLM-2: 214.8;HEL: 51.7;K-562: 101.4;U-266/84: 38.3;U-87 MG: 102.2;U-937: 91.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA058166 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 4: Macrophages - Innate immune response" "HPA058166: AB_2683627" "unprognostic (1.33e-1)" "unprognostic (5.67e-4)" "unprognostic (1.34e-2)" "unprognostic (1.21e-1)" "unprognostic (4.50e-2)" "unprognostic (4.13e-2)" "unprognostic (5.86e-3)" "unprognostic (9.13e-3)" "unprognostic (2.61e-1)" "unprognostic (1.25e-1)" "unprognostic (5.11e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (2.86e-5)" "unprognostic (2.45e-2)" "unprognostic (2.22e-2)" "unprognostic (8.69e-3)" "unprognostic (1.24e-1)" 31.5 3.0 15.1 17.2 22.1 4.0 27.5 23.0 27.1 15.1 13.4 12.8 8.8 13.7 6.1 8.4 12.8 18.3 28.0 15.2 18.2 6.0 9.5 27.1 22.2 25.0 22.8 3.9 4.0 14.4 3.3 10.9 25.0 8.2 14.2 1.1 9.8 7.8 8.5 7.3 24.3 20.9 18.9 29.8 8.9 1.9 20.5 7.8 10.2 16.5 23.4 14.4 12.7 30.7 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 214.8 0.0 51.7 0.0 0.0 0.0 0.5 21.9 0.0 0.0 0.0 0.0 0.0 1.4 0.2 101.4 6.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.3 0.0 0.0 0.0 0.1 0.0 38.3 0.1 102.2 91.6 0.0 24.9 4.2 269.0 22.9 1.4 36.5 35.9 13.8 22.0 19.8 18.5 0.7 6.1 19.4 0.2 0.7 0.6 11.2 11.5 15.1 22.1 23.0 27.1 15.2 18.2 25.0 22.8 25.0 18.9 20.5 30.7 37.8 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 1.8 0.0 0.8 10.1 0.0 0.0 0.1 0.0 1.1 0.2 9.4 0.0 0.0 0.0 0.0 0.7 0.5 0.0 2.0 0.0 0.0 0.0 0.0 82.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 2.9 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.1 5.6 0.0 0.0 0.0 C10orf71 FLJ45913 ENSG00000177354 "Chromosome 10 open reading frame 71" Q711Q0 10 49299170-49327492 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 280.2;tongue: 81.9" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 56.0" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "K-562: 6.9;RH-30: 9.9" "Not detected" "Not detected" HPA057556 Approved Nucleoplasm,Mitochondria NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 1: K-562 - Erythropoiesis" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm Mitochondria "HPA057556: AB_2683467" "unprognostic (1.25e-2)" "unprognostic (3.97e-2)" "unprognostic (4.16e-2)" "unprognostic (5.58e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 44.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.3 21.9 0.0 0.0 0.1 1.3 0.0 0.0 1.2 0.0 280.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364066-49396089 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "adrenal gland: 5.4;brain: 10.4" "Cell type enhanced" "Detected in some" "Langerhans cells: 1.2;Melanocytes: 1.8" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 12 "medulla oblongata: 10.1;pons: 10.4;spinal cord: 8.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "RH-30: 11.6;SH-SY5Y: 46.2;U-2197: 17.7" "Region enriched" "Detected in single" 6 "pons and medulla: 3.9" "Group enriched" "Detected in some" 10 "cerebral cortex: 4.0;hippocampal formation: 1.6;medulla oblongata: 2.4;spinal cord: 3.7" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.1 5.4 0.0 0.2 0.1 0.1 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 10.1 0.7 0.0 0.0 0.0 0.2 0.0 10.4 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 8.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 17.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 0.3 10.1 0.7 10.4 8.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.2 0.8 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 ERCC6 "ARMD5, CKN2, CSB, RAD26" ENSG00000225830 "ERCC excision repair 6, chromatin remodeling factor" "P0DP91, Q03468" 10 49454168-49539538 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 53.8;hTERT-RPE1: 123.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071297 Approved "Nucleoplasm,Nuclear bodies" Yes No "Cluster 6: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies" "HPA071297: AB_2732177" "unprognostic (1.92e-2)" "unprognostic (1.85e-1)" "unprognostic (9.79e-3)" "unprognostic (7.26e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-2)" "unprognostic (3.03e-2)" "unprognostic (2.99e-2)" "unprognostic (1.71e-2)" "unprognostic (1.13e-1)" "unprognostic (1.80e-1)" "unprognostic (4.57e-2)" "unprognostic (1.04e-1)" "unprognostic (8.61e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" 2.7 2.1 1.6 1.9 1.5 4.6 3.8 3.0 2.3 3.1 7.7 2.4 2.0 3.0 1.5 3.8 2.9 2.7 3.4 1.2 1.1 3.2 3.3 2.7 2.9 2.4 1.9 4.5 3.1 5.9 2.8 3.4 2.1 3.3 2.7 3.1 3.2 2.2 3.5 4.6 2.5 2.3 2.2 2.9 2.4 3.1 2.1 3.3 5.1 3.6 3.4 2.6 3.3 1.9 11.2 5.5 4.1 2.1 6.6 10.5 3.4 21.2 27.1 14.1 9.9 6.2 5.6 4.9 3.7 18.7 6.7 9.5 6.3 16.6 13.5 8.4 4.1 3.9 21.7 3.4 3.9 5.0 3.7 4.3 17.2 12.9 53.8 123.4 19.8 2.9 6.8 0.8 16.8 8.3 3.4 2.0 4.0 3.5 10.2 2.3 5.8 2.6 4.1 7.1 5.9 4.7 15.4 3.6 8.2 9.4 7.1 2.7 38.9 7.0 5.5 8.6 5.2 3.3 4.5 4.1 7.3 5.0 5.1 13.1 3.0 7.5 4.1 2.6 3.0 6.8 2.3 2.2 3.9 5.2 2.8 1.4 7.2 1.2 5.3 2.2 3.1 1.8 1.6 1.5 3.0 2.3 1.2 1.1 2.4 1.9 2.1 2.2 2.1 1.9 6.9 16.0 13.2 14.7 6.0 3.6 1.4 1.5 5.2 0.0 7.1 7.1 7.1 5.7 8.2 9.2 0.0 2.5 10.9 4.8 5.9 5.2 11.3 8.1 8.7 5.1 1.2 1.3 24.3 6.0 2.1 4.9 2.0 10.1 7.6 8.9 5.3 4.3 2.6 0.0 21.7 5.3 0.0 4.4 2.6 15.3 2.8 8.0 1.8 23.4 11.2 0.0 4.1 17.6 16.6 5.2 2.6 2.2 3.6 2.5 5.0 3.6 9.0 0.0 6.6 4.4 4.2 5.3 5.0 3.5 4.1 1.8 7.4 11.4 2.8 1.9 CHAT ENSG00000070748 "Choline O-acetyltransferase" P28329 10 49609095-49667942 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Acyltransferase, Transferase" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 13.0;placenta: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "NB-4: 20.9" "Region enhanced" "Detected in many" "basal ganglia: 20.6" "Group enriched" "Detected in some" 7 "basal ganglia: 6.5;pons: 7.0;spinal cord: 12.0" "CAB002313, HPA048547, CAB079053" Supported Supported NA NA "Cluster 65: Brain - Ion transport" "Cluster 24: NB-4 - Immune response" "Cluster 33: Fibroblasts - ECM organization" "CAB002313: AB_563661, CAB079053: , HPA048547: AB_2680437" "unprognostic (2.34e-2)" "unprognostic (6.10e-2)" "unprognostic (5.28e-2)" "unprognostic (6.96e-2)" "unprognostic (2.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.6 0.2 2.8 0.0 0.0 0.3 13.0 0.0 0.3 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 7.9 5.1 0.0 0.3 0.0 0.0 5.5 9.4 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.8 20.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 2.8 0.3 13.0 0.1 3.1 7.9 5.1 9.4 1.3 0.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC18A3 VACHT ENSG00000187714 "Solute carrier family 18 member A3" Q16572 10 49610310-49612720 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 25.6" "Cell type enriched" "Detected in some" 4 "Fibroblasts: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 7.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "spinal cord: 78.1" CAB079011 Supported NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" "CAB079011: " "unprognostic (2.14e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (9.39e-2)" "unprognostic (4.55e-2)" "unprognostic (3.00e-1)" "unprognostic (5.85e-3)" "unprognostic (7.56e-2)" "unprognostic (1.16e-1)" 0.0 0.0 0.7 0.3 2.0 0.0 0.0 0.0 19.7 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 18.9 8.0 0.0 0.0 0.0 1.2 0.4 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 3.6 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 6.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.0 0.0 19.7 0.1 4.9 18.9 8.0 25.6 3.6 0.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 C10orf53 Em:AC069546.1 ENSG00000178645 "Chromosome 10 open reading frame 53" Q8N6V4 10 49679651-49710261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 39.6" "Group enriched" "Detected in some" 10 "Early spermatids: 499.3;Late spermatids: 1522.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA037951 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "HPA037951: AB_10671382" "unprognostic (9.09e-2)" 0.0 0.0 0.4 0.0 0.3 0.3 0.0 1.8 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 39.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.3 1.8 0.8 0.2 0.4 0.7 0.6 0.4 0.1 0.5 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 499.3 2.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1522.4 4.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 98.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OGDHL FLJ10851 ENSG00000197444 "Oxoglutarate dehydrogenase L" Q9ULD0 10 49734641-49762379 "Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 98.5;kidney: 121.8;liver: 80.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 30.4;Collecting duct cells: 29.5;Cone photoreceptor cells: 31.3;Distal tubular cells: 92.0;Hepatocytes: 55.3;Horizontal cells: 30.3;Proximal tubular cells: 84.7" "Group enriched" "Detected in many" 5 "liver cancer: 14.7;renal cancer: 44.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 21.3;RPTEC TERT1: 43.4;SH-SY5Y: 16.3;SK-BR-3: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043716, HPA052497" Enhanced Approved "Nucleoli fibrillar center" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoli fibrillar center" "HPA043716: , HPA052497: AB_2681853" "unprognostic (9.05e-2)" "unprognostic (3.93e-3)" "unprognostic (5.30e-2)" "unprognostic (2.50e-1)" "unprognostic (3.70e-3)" "unprognostic (2.03e-1)" "unprognostic (1.46e-3)" "unprognostic (4.19e-1)" "unprognostic (2.07e-1)" "unprognostic (1.46e-2)" "unprognostic (1.52e-3)" "unprognostic (4.60e-1)" "prognostic favorable (1.21e-14)" "unprognostic (3.25e-2)" "unprognostic (1.85e-1)" "unprognostic (1.59e-3)" "unprognostic (8.38e-2)" 0.2 11.6 23.1 0.3 23.4 0.0 0.0 23.7 41.1 0.7 98.5 1.4 1.0 2.2 0.5 0.1 1.0 0.4 5.8 24.4 36.9 121.8 80.0 0.0 0.2 38.4 25.6 1.6 4.3 50.5 29.3 0.1 38.9 1.6 0.3 18.7 17.1 6.3 0.1 0.1 1.1 0.7 15.4 0.3 1.0 2.3 33.8 0.5 23.0 0.8 0.6 0.5 0.5 24.3 0.0 0.0 4.7 21.3 0.0 0.0 2.7 0.1 0.1 1.1 0.2 10.5 2.3 0.0 11.4 0.0 3.4 0.4 7.4 0.2 0.4 0.0 0.4 0.0 0.2 5.3 0.2 0.0 1.6 0.3 0.0 0.0 0.0 0.6 0.0 5.4 0.5 0.0 0.0 3.2 8.2 7.3 2.0 0.8 1.0 0.0 0.0 0.0 43.4 0.7 12.0 16.3 0.1 16.2 1.1 6.1 4.5 2.9 0.0 0.0 10.6 0.0 0.7 0.2 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 23.4 23.7 41.1 24.4 36.9 38.4 25.6 38.9 15.4 33.8 24.3 0.0 0.0 0.0 20.2 0.8 0.0 0.9 0.4 0.0 30.4 0.1 0.1 4.4 2.8 0.1 29.5 31.3 0.0 0.0 0.4 92.0 1.1 0.2 0.9 0.2 0.3 4.8 0.0 16.8 0.0 0.1 0.3 0.0 1.6 0.0 0.7 1.4 55.3 0.1 30.3 21.4 0.5 2.0 1.3 0.0 0.5 0.0 0.5 0.0 1.0 0.0 5.4 0.0 3.5 1.8 0.1 1.1 0.0 0.0 0.3 0.0 84.7 0.0 18.1 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.1 0.6 0.4 0.3 0.3 PARG ENSG00000227345 "Poly(ADP-ribose) glycohydrolase" Q86W56 10 49818279-49970203 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021819, HPA053007" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Vesicles, Cytosol" "HPA021819: AB_1854974, HPA053007: AB_2682014" "unprognostic (5.77e-3)" "unprognostic (6.74e-2)" "unprognostic (3.06e-2)" "unprognostic (9.90e-2)" "unprognostic (1.22e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.57e-5)" "unprognostic (1.21e-1)" "unprognostic (3.97e-1)" "unprognostic (8.34e-2)" "unprognostic (1.47e-1)" "unprognostic (4.06e-2)" "unprognostic (5.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (8.54e-2)" "unprognostic (1.13e-1)" 5.3 6.5 3.7 6.2 3.8 3.2 7.1 7.5 4.8 6.1 1.4 7.3 8.8 6.1 4.7 7.0 5.8 5.4 8.5 4.0 4.3 12.7 6.9 5.2 9.1 3.6 3.2 5.4 4.0 8.9 4.3 7.7 4.0 6.7 7.8 5.8 5.3 6.3 12.0 7.3 7.0 6.3 3.0 6.9 6.4 7.8 3.7 9.1 6.7 9.0 9.0 6.2 5.2 4.3 15.3 9.5 20.0 17.8 11.2 13.6 14.9 13.6 17.2 17.0 16.1 9.8 15.2 10.5 10.7 13.3 7.8 17.7 17.3 10.2 19.8 15.5 16.6 11.6 7.7 13.2 13.8 16.5 8.9 8.4 21.0 12.3 22.4 13.4 10.6 14.0 18.8 11.1 14.9 9.2 18.0 20.0 22.4 10.5 26.8 21.1 20.7 13.9 16.1 8.4 16.0 19.7 10.6 21.6 17.1 21.2 23.8 10.9 10.0 11.5 12.4 11.8 15.9 10.4 16.2 21.9 18.9 18.8 8.8 6.1 2.5 1.4 2.3 2.2 3.2 3.0 3.0 2.8 2.7 2.9 3.7 3.5 1.3 3.9 3.5 2.9 2.8 2.3 3.7 3.8 7.5 4.8 4.0 4.3 3.6 3.2 4.0 3.0 3.7 4.3 8.2 9.6 15.3 22.2 12.2 6.1 5.2 4.3 12.0 13.9 9.5 7.4 28.6 14.3 9.2 12.9 27.1 7.7 8.9 10.4 9.8 7.3 6.1 17.7 14.8 11.1 6.6 12.8 42.5 6.5 6.2 12.0 11.2 11.8 14.5 17.0 6.8 13.6 9.7 5.0 37.9 10.0 2.0 12.0 4.3 4.6 7.5 11.6 3.6 35.6 12.4 7.3 24.7 26.7 41.4 8.1 3.7 8.2 9.9 5.3 8.7 40.3 21.5 20.7 0.0 11.3 12.0 17.1 13.3 13.8 6.0 4.7 12.0 20.0 11.2 4.4 TIMM23B bA592B15.7 ENSG00000204152 "Translocase of inner mitochondrial membrane 23 homolog B" Q5SRD1 10 49942049-49974850 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "unprognostic (8.84e-2)" "unprognostic (2.67e-2)" "unprognostic (5.92e-2)" "unprognostic (4.19e-3)" "unprognostic (9.37e-2)" "unprognostic (7.64e-2)" "unprognostic (2.04e-1)" "unprognostic (1.34e-1)" "unprognostic (3.11e-1)" "unprognostic (1.43e-3)" "unprognostic (4.03e-2)" "unprognostic (3.30e-3)" "unprognostic (5.39e-2)" "unprognostic (9.66e-2)" "unprognostic (1.62e-1)" "unprognostic (4.90e-3)" "unprognostic (1.18e-1)" 5.0 4.4 3.4 4.2 3.9 15.1 5.9 4.1 4.4 3.1 1.8 3.9 6.0 4.6 4.5 4.2 3.1 2.7 9.0 3.0 4.6 3.2 5.5 3.9 3.8 5.2 4.3 3.9 5.1 3.2 4.0 3.6 5.2 4.3 3.8 5.9 3.8 3.6 18.3 6.4 3.9 4.4 4.3 3.5 4.1 3.8 4.6 3.5 3.9 14.7 3.5 5.2 2.9 5.0 4.0 2.2 2.1 4.6 5.1 7.7 2.2 4.8 10.9 4.0 2.2 3.2 5.6 5.8 2.9 14.6 4.0 3.3 1.8 4.8 8.2 6.8 0.3 0.7 0.0 5.8 8.3 11.6 1.0 11.7 2.6 5.4 13.5 3.6 5.7 5.0 5.3 4.4 7.8 0.6 4.9 4.0 5.3 1.2 3.4 3.7 4.4 4.5 3.7 4.4 4.6 10.6 2.5 7.2 5.6 5.0 5.1 4.1 4.9 3.8 3.5 7.5 8.6 5.4 2.6 13.4 9.1 2.6 3.0 1.5 0.9 1.2 1.2 1.1 2.0 1.5 1.1 1.2 1.4 1.0 1.9 1.3 0.3 2.6 2.4 1.2 0.6 1.3 3.4 3.9 4.1 4.4 3.0 4.6 5.2 4.3 5.2 4.3 4.6 5.0 8.2 19.2 10.9 27.4 11.4 0.0 10.1 0.0 10.2 15.2 5.0 4.3 7.1 7.2 5.6 5.5 29.2 5.0 7.7 2.5 1.9 6.1 1.1 9.2 10.8 6.1 0.0 10.3 30.5 8.2 5.4 7.5 10.7 8.3 7.0 8.7 5.3 10.5 5.6 20.2 39.8 2.8 0.0 3.2 0.0 2.3 5.6 5.8 0.0 19.7 9.2 8.0 7.2 24.6 33.3 9.8 1.1 8.6 13.4 9.1 2.9 3.5 2.9 17.5 6.6 9.4 6.7 15.5 9.1 8.0 0.0 5.9 9.3 9.1 3.7 9.7 TIMM23B-AGAP6 LINC00843 ENSG00000178440 "TIMM23B-AGAP6 readthrough (NMD candidate)" 10 49942056-50011654 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" NA NA "Cluster 24: NB-4 - Immune response" "unprognostic (1.42e-1)" "unprognostic (6.27e-3)" "unprognostic (3.47e-2)" "unprognostic (2.15e-1)" "unprognostic (4.82e-2)" "unprognostic (1.69e-2)" "unprognostic (3.65e-1)" "unprognostic (1.33e-1)" "unprognostic (7.28e-2)" "unprognostic (2.86e-2)" "unprognostic (1.41e-1)" "unprognostic (5.84e-4)" "unprognostic (6.36e-4)" "unprognostic (6.62e-2)" "unprognostic (1.46e-1)" "unprognostic (4.84e-2)" "unprognostic (1.60e-2)" 0.4 0.2 0.9 0.6 0.9 1.1 0.2 1.3 1.1 0.2 1.3 0.1 0.6 0.3 0.2 0.2 0.1 0.1 0.3 0.9 0.9 0.1 0.3 0.2 0.8 1.0 0.9 0.3 0.3 0.1 0.0 0.9 0.4 0.3 0.5 0.4 0.3 0.8 0.4 0.1 0.3 0.8 0.5 0.2 0.9 1.0 0.7 0.1 0.8 0.5 0.2 1.1 1.0 0.5 1.4 2.6 0.5 0.3 1.8 0.9 0.6 1.0 1.0 1.9 0.5 1.3 1.5 0.9 0.8 1.9 1.4 0.5 0.9 0.6 1.2 0.6 1.7 1.7 0.7 0.8 2.4 0.8 1.1 2.4 1.1 0.8 1.1 2.9 2.5 1.4 0.0 2.0 4.1 5.6 1.7 1.0 3.8 1.5 0.7 1.9 0.4 0.4 1.6 1.7 0.4 1.4 0.9 1.6 0.9 2.3 0.7 0.9 2.2 0.3 2.0 1.6 2.3 1.9 1.1 2.2 0.8 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.9 0.9 1.3 1.1 0.9 0.9 1.0 0.9 0.9 0.8 1.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGAP6 "bA324H6.1, CTGLF3" ENSG00000204149 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 6" Q5VW22 10 49982190-50011654 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 84.8;Late spermatids: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NB-4: 9.0" HPA042490 Uncertain NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA042490: AB_2678022" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (3.07e-3)" "unprognostic (2.96e-1)" "unprognostic (1.71e-1)" "unprognostic (7.60e-3)" "unprognostic (1.34e-2)" "unprognostic (7.48e-2)" "unprognostic (5.51e-2)" "unprognostic (1.91e-2)" "prognostic favorable (2.66e-4)" "unprognostic (9.93e-3)" "prognostic unfavorable (9.70e-10)" "unprognostic (8.04e-2)" "unprognostic (2.12e-1)" "unprognostic (1.85e-2)" "prognostic favorable (1.83e-7)" 20.3 21.7 1.9 1.1 2.0 0.4 20.2 2.3 2.7 23.6 2.7 23.8 1.4 18.6 0.2 16.0 20.7 0.3 17.4 1.8 1.7 28.8 38.7 22.6 2.3 1.8 1.7 22.6 31.4 0.4 38.6 0.8 1.8 28.4 1.0 0.7 18.5 1.3 20.1 18.9 24.0 1.1 1.5 35.0 20.8 29.3 1.9 3.2 29.0 0.6 0.7 19.2 19.5 2.1 1.0 1.4 0.8 2.1 2.7 1.5 1.8 3.0 0.5 1.0 1.6 2.9 1.1 2.3 1.0 0.6 0.6 1.5 1.0 1.0 1.4 1.4 4.3 3.8 3.0 1.2 1.2 3.1 4.6 1.8 3.4 1.2 3.7 1.6 1.2 2.3 3.9 3.1 1.8 1.4 3.5 9.0 0.6 0.8 3.6 2.6 0.9 1.2 2.0 2.3 2.1 2.6 0.7 2.3 1.1 0.7 1.8 1.6 3.1 1.4 1.4 0.4 2.4 4.9 2.1 1.5 0.3 3.3 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 1.9 2.0 2.3 2.7 1.8 1.7 1.8 1.7 1.8 1.5 1.9 2.1 6.0 19.2 10.9 19.2 2.9 3.3 1.8 1.3 1.2 6.2 5.6 7.4 8.3 2.8 7.8 0.0 4.2 2.6 6.0 4.5 0.0 2.4 84.8 4.3 5.0 5.8 7.3 2.5 22.6 2.5 1.5 3.9 6.6 5.1 7.6 5.1 5.0 5.4 2.2 3.3 17.8 6.4 0.0 5.0 1.5 44.0 5.6 4.5 0.0 10.3 5.1 2.8 3.1 14.6 17.4 2.6 3.3 4.5 6.2 3.2 4.0 0.7 7.5 7.0 0.0 4.3 4.8 10.7 7.8 1.3 5.3 1.4 5.9 3.8 8.4 2.0 WASHC2A "bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824" ENSG00000099290 "WASH complex subunit 2A" Q641Q2 10 50067888-50133509 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Alveolar cells type 2: 28.5;Endometrial ciliated cells: 45.7;Respiratory ciliated cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (2.46e-1)" "unprognostic (1.11e-3)" "unprognostic (8.82e-2)" "unprognostic (3.28e-1)" "unprognostic (2.75e-1)" "unprognostic (6.51e-3)" "prognostic unfavorable (6.75e-5)" "unprognostic (4.60e-2)" "unprognostic (2.85e-2)" "unprognostic (2.37e-2)" "unprognostic (9.04e-2)" "unprognostic (2.73e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (4.40e-2)" 25.3 25.9 19.9 22.1 20.7 37.5 24.0 23.4 24.8 24.7 18.3 28.9 25.2 22.5 19.2 20.2 19.7 18.0 58.6 19.9 19.9 22.9 15.5 26.0 28.8 21.1 21.2 26.7 17.7 23.3 21.5 22.9 21.1 20.6 28.9 19.9 21.9 20.0 22.3 25.7 28.9 21.2 18.6 26.6 21.5 12.5 22.6 24.2 23.3 15.6 26.9 23.8 22.1 23.9 26.1 12.5 21.1 24.3 83.2 46.0 16.9 29.8 64.0 43.7 46.6 28.8 37.8 22.5 18.1 44.8 41.3 28.0 31.2 25.3 43.2 22.2 22.0 15.9 25.6 29.7 58.6 28.0 27.2 47.8 31.2 47.6 30.5 46.2 33.1 19.2 26.6 22.2 53.9 19.1 15.5 48.0 17.1 16.7 58.4 23.1 30.1 13.7 30.5 29.3 7.3 22.4 27.8 25.9 40.9 30.9 31.6 19.2 49.4 22.0 18.5 62.7 25.0 23.4 48.3 19.1 48.9 51.4 9.0 1.0 9.1 9.9 9.1 11.6 10.1 5.1 8.0 8.8 7.3 4.9 7.7 6.0 4.1 8.2 6.9 4.6 9.2 7.9 19.9 20.7 23.4 24.8 19.9 19.9 21.1 21.2 21.1 18.6 22.6 23.9 16.2 38.5 28.5 0.0 3.3 0.0 0.0 0.0 0.0 0.0 10.6 11.0 0.0 0.0 22.9 14.7 0.0 7.4 10.0 0.0 0.0 16.7 0.0 45.7 19.9 7.9 0.0 0.0 0.0 15.6 6.9 8.9 0.0 20.3 15.2 13.5 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 15.1 0.0 0.0 2.6 0.0 0.0 11.7 41.5 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 7.7 7.8 9.4 0.0 0.0 ASAH2 ENSG00000188611 "N-acylsphingosine amidohydrolase 2" Q9NR71 10 50182778-50279720 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 81.5" "Cell type enhanced" "Detected in some" "Late spermatids: 12.5;Muller glia cells: 9.0;Proximal enterocytes: 17.1;Sertoli cells: 6.6" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "cerebellum: 8.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061171 Supported Approved "Focal adhesion sites" "Intracellular and membrane" NA NA 2200000 "Cluster 32: T-cells - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 45: Enterocytes - Digestion" "Focal adhesion sites" "HPA061171: AB_2684442" "unprognostic (3.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.66e-1)" "unprognostic (3.84e-2)" "unprognostic (3.66e-1)" "unprognostic (4.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-2)" "unprognostic (4.33e-2)" "unprognostic (2.17e-1)" "unprognostic (1.14e-1)" "unprognostic (8.29e-2)" "unprognostic (1.86e-2)" "unprognostic (5.64e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" 0.4 0.8 0.0 0.2 1.1 0.0 0.5 8.1 0.4 0.7 0.1 0.8 81.5 0.8 0.5 0.7 0.8 0.3 0.8 0.1 0.4 0.5 2.9 0.6 0.3 3.2 2.9 0.8 1.4 0.6 0.6 0.6 2.2 0.4 0.4 7.3 0.6 0.2 0.8 0.7 64.6 1.2 1.5 0.2 5.0 0.8 0.6 0.5 0.7 0.4 0.1 0.5 0.4 0.6 1.2 0.9 1.0 1.4 1.8 0.7 1.3 1.2 0.9 2.5 2.2 0.7 3.0 0.0 1.4 1.9 2.0 1.1 1.4 0.4 3.0 1.6 2.5 0.9 2.2 1.9 1.1 0.3 0.1 0.2 1.7 4.3 4.8 0.3 0.5 0.0 1.7 0.8 1.7 1.1 1.0 0.0 3.2 0.0 2.7 0.0 4.2 1.1 1.3 0.2 1.8 4.8 1.7 1.2 2.1 2.4 1.0 0.7 1.4 1.2 2.8 3.2 4.0 1.2 0.1 0.0 3.5 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.1 8.1 0.4 0.1 0.4 3.2 2.9 2.2 1.5 0.6 0.6 0.1 0.0 0.0 0.7 0.0 0.4 0.3 0.4 0.0 2.8 0.4 0.3 3.8 0.0 0.9 0.0 2.1 0.4 1.4 0.5 0.0 0.9 4.8 0.1 0.2 0.5 0.0 3.2 1.1 1.6 0.3 0.6 0.0 0.2 0.0 0.2 0.4 2.1 0.2 1.7 1.5 1.8 0.0 0.0 0.0 12.5 1.2 0.0 0.0 0.0 0.0 9.0 1.0 0.0 0.2 1.6 0.1 1.5 0.0 0.3 17.1 1.0 0.7 2.1 6.6 0.6 0.9 1.9 0.9 0.0 0.1 0.3 0.5 0.2 1.2 0.2 SGMS1 "MGC17342, MOB, SMS1, TMEM23" ENSG00000198964 "Sphingomyelin synthase 1" Q86VZ5 10 50305586-50625163 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 153.1;Microglial cells: 229.5;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 422.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045191 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA045191: AB_10959605" "unprognostic (1.13e-1)" "unprognostic (5.75e-2)" "unprognostic (1.87e-1)" "unprognostic (9.08e-2)" "unprognostic (8.69e-3)" "unprognostic (8.34e-2)" "unprognostic (7.98e-2)" "unprognostic (2.29e-1)" "unprognostic (1.30e-2)" "unprognostic (5.75e-2)" "unprognostic (9.20e-2)" "unprognostic (2.05e-1)" "prognostic favorable (1.95e-7)" "unprognostic (8.38e-2)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" "unprognostic (3.05e-1)" 15.8 19.3 19.8 10.7 27.4 24.0 14.5 21.5 20.3 16.9 33.9 10.1 13.5 11.9 19.9 15.3 16.6 15.4 13.2 17.2 23.0 20.2 27.9 21.9 14.9 29.5 24.1 18.6 13.3 52.9 6.4 24.6 28.5 19.5 11.7 20.2 18.0 16.8 9.9 25.3 16.0 15.8 23.6 11.7 14.3 11.3 23.4 12.0 24.7 10.5 14.5 20.9 13.1 41.3 30.2 14.0 4.0 9.0 14.2 18.6 18.8 19.6 19.7 13.5 12.6 11.7 30.3 22.1 11.3 25.9 12.2 18.7 9.5 20.6 14.0 19.4 10.2 32.7 17.9 9.0 16.5 7.5 7.6 12.1 23.6 18.0 21.7 8.7 19.3 7.9 62.6 32.2 14.6 12.7 3.3 4.2 9.2 13.7 13.7 5.5 18.4 8.8 19.7 31.2 6.2 4.9 14.4 14.2 7.5 11.3 21.4 2.7 27.1 14.6 17.8 14.1 14.6 11.0 9.5 6.3 18.2 12.0 12.1 3.4 9.3 28.4 4.6 4.9 10.3 7.0 6.2 6.8 5.2 6.5 8.2 5.4 16.7 10.1 4.0 3.2 15.6 6.3 19.8 27.4 21.5 20.3 17.2 23.0 29.5 24.1 28.5 23.6 23.4 41.3 17.1 44.8 40.0 106.7 19.9 54.4 28.9 15.6 23.9 20.1 15.8 8.9 26.3 10.0 30.0 29.5 4.2 10.9 15.6 6.2 15.6 17.6 17.0 20.9 10.5 19.6 14.9 32.0 153.1 21.6 7.7 19.8 30.5 32.4 20.8 12.1 17.9 16.0 29.0 5.0 117.2 11.1 4.1 46.5 17.6 30.6 16.1 34.5 12.4 229.5 12.4 17.4 10.3 313.1 422.0 10.7 6.4 10.5 13.7 32.3 18.4 9.3 25.1 36.4 0.0 20.5 27.1 12.8 2.3 18.7 83.4 4.9 20.0 11.8 12.4 25.4 ASAH2B "ASAH2C, ASAH2L, bA449O16.3, bA98I6.3" ENSG00000204147 "N-acylsphingosine amidohydrolase 2B" P0C7U1 10 50739318-50816495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "intestine: 17.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 25.8" "Low region specificity" "Detected in many" HPA061171 Supported Approved "Focal adhesion sites" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 56: Bipolar cells - Visual perception" "Focal adhesion sites" "HPA061171: AB_2684442" "unprognostic (6.86e-3)" "unprognostic (1.91e-2)" "unprognostic (7.22e-2)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "unprognostic (1.18e-2)" "unprognostic (5.42e-3)" "unprognostic (5.03e-3)" "unprognostic (2.21e-2)" "unprognostic (1.11e-1)" "unprognostic (3.79e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-3)" "unprognostic (2.80e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" 1.5 3.7 1.9 1.9 1.8 1.3 2.8 2.0 2.3 2.1 1.7 2.8 17.2 1.6 3.4 2.6 2.6 2.4 5.2 1.9 2.5 4.4 6.4 2.0 1.7 2.4 2.2 3.0 3.5 4.6 3.3 1.0 2.1 3.6 3.2 7.0 2.6 2.4 3.7 1.8 11.1 2.6 1.6 0.9 3.9 3.0 2.6 1.6 3.7 4.0 1.7 1.8 1.7 2.7 2.5 3.7 3.9 6.3 1.4 3.1 3.0 12.9 7.1 7.5 6.1 8.3 7.4 0.1 4.5 3.4 2.4 2.4 4.3 5.4 6.1 4.6 5.4 1.6 10.5 6.4 5.1 2.2 2.3 3.9 5.6 7.1 10.4 2.3 1.7 0.0 8.0 3.0 5.9 6.0 3.7 0.2 5.0 7.6 25.8 0.1 8.9 3.1 4.2 9.7 7.2 14.7 4.1 5.0 4.3 4.0 8.5 1.4 8.0 3.0 14.0 6.3 16.2 3.9 0.5 0.0 15.5 0.0 5.7 0.3 0.0 0.0 1.1 0.0 3.2 0.4 1.9 1.3 0.0 0.7 2.6 2.5 0.2 0.3 0.0 1.8 2.4 0.8 1.9 1.8 2.0 2.3 1.9 2.5 2.4 2.2 2.1 1.6 2.6 2.7 0.6 3.2 1.1 1.0 1.1 1.7 1.0 1.5 3.4 7.0 2.9 1.7 5.1 5.7 2.1 5.5 8.4 1.7 0.6 1.4 5.9 4.4 0.2 1.6 1.4 1.3 6.7 0.8 6.4 4.8 1.5 2.0 3.6 1.0 0.0 2.3 1.8 7.3 0.3 0.0 6.4 4.2 2.0 0.0 0.0 1.0 1.8 0.1 1.8 2.8 0.2 4.1 2.1 7.1 0.5 4.4 2.5 1.2 2.2 1.3 3.5 6.0 2.0 4.6 0.0 1.0 2.4 4.3 3.0 3.4 0.4 0.5 2.2 2.3 3.9 1.0 A1CF "ACF, ACF64, ACF65, APOBEC1CF, ASP" ENSG00000148584 "APOBEC1 complementation factor" Q9NQ94 10 50799409-50885675 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 144.0" "Cell type enhanced" "Detected in some" "Cholangiocytes: 150.2;Distal enterocytes: 71.3;Enteroendocrine cells: 116.5;Hepatocytes: 337.9;Paneth cells: 83.8;Proximal enterocytes: 147.5;Proximal tubular cells: 118.4" "Cancer enriched" "Detected in some" 6 "liver cancer: 18.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "CACO-2: 23.5;Hep G2: 60.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA037779, HPA044079" Enhanced Supported Nucleoplasm NA NA "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm "HPA037779: AB_10670529, HPA044079: AB_2678800" "unprognostic (3.87e-3)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (2.21e-3)" "unprognostic (2.73e-1)" "unprognostic (4.61e-3)" "unprognostic (1.71e-1)" "unprognostic (7.38e-3)" "unprognostic (1.30e-2)" "unprognostic (2.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-3)" "unprognostic (1.97e-2)" "unprognostic (2.77e-1)" "unprognostic (2.19e-2)" "unprognostic (8.50e-4)" 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.1 23.4 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 12.5 144.0 0.0 0.0 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 10.3 0.1 0.0 0.0 0.0 0.0 26.8 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 60.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.6 150.2 0.0 3.7 2.1 0.0 0.0 71.3 9.8 1.2 0.0 0.0 0.0 0.6 116.5 5.3 0.4 11.4 0.0 0.0 0.0 0.0 0.0 0.0 6.1 337.9 0.0 0.0 0.3 52.0 0.0 8.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.1 83.8 0.0 0.0 0.1 147.5 118.4 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 35.1 0.1 PRKG1 "PGK, PKG, PKG1, PRKG1B, PRKGR1B" ENSG00000185532 "Protein kinase cGMP-dependent 1" Q13976 10 50990888-52298423 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 36.1" "Cell type enhanced" "Detected in many" "Astrocytes: 778.3;Excitatory neurons: 244.9;Inhibitory neurons: 473.0;Microglial cells: 188.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 36 "basophil: 7.3" "Lineage enriched" "Detected in single" 49 "granulocytes: 7.3" "Cell line enhanced" "Detected in many" "AN3-CA: 14.3;BJ hTERT+: 19.2;fHDF/TERT166: 16.1;U-138 MG: 11.2;U-87 MG: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007699, CAB009629" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Vesicles, Cytosol" "CAB009629: AB_2170663, HPA007699: AB_1079677" "unprognostic (3.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.44e-2)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-1)" "unprognostic (5.54e-1)" "unprognostic (2.23e-1)" "unprognostic (4.94e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (3.40e-1)" "unprognostic (9.26e-2)" "unprognostic (5.50e-3)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (3.78e-4)" 7.0 8.3 6.4 2.7 7.2 0.6 3.1 1.4 6.9 10.3 12.4 5.5 2.4 10.3 3.5 5.2 5.2 7.0 14.1 6.6 10.7 3.8 1.7 6.8 1.2 5.1 4.6 4.2 1.7 9.6 1.3 10.1 3.2 6.4 5.3 3.6 4.0 8.1 25.8 1.0 3.4 14.6 5.3 2.5 3.3 1.8 12.2 1.5 7.0 36.1 0.9 5.4 4.2 2.7 0.1 0.2 1.7 14.3 6.5 6.0 0.1 5.4 19.2 2.1 2.6 0.1 0.9 0.3 0.0 16.1 2.0 0.1 0.0 0.1 1.7 0.0 5.0 1.0 0.3 0.0 5.5 0.0 0.1 8.1 0.1 4.8 0.1 0.6 0.0 0.0 0.0 0.1 5.3 0.1 0.0 0.0 4.1 0.0 2.5 0.0 3.9 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.1 2.0 0.1 0.0 0.0 11.2 1.9 5.9 3.7 1.5 0.8 0.0 10.0 0.0 2.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 6.4 7.2 1.4 6.9 6.6 10.7 5.1 4.6 3.2 5.3 12.2 2.7 10.5 16.0 10.8 778.3 0.3 0.9 1.7 0.0 7.4 5.9 2.8 9.4 31.4 0.0 0.0 3.7 0.0 1.0 0.3 2.9 0.0 2.4 56.0 0.4 14.7 7.1 0.0 3.4 244.9 3.6 1.2 24.2 0.5 0.5 4.5 0.1 5.0 0.0 0.4 0.0 473.0 4.2 0.0 0.0 2.2 53.0 32.6 5.3 3.6 188.3 0.0 23.6 0.0 24.6 8.0 4.8 14.1 39.5 0.1 0.5 3.2 0.2 0.9 1.3 39.5 3.9 69.9 0.9 0.9 1.6 0.6 2.2 0.2 7.9 3.6 1.0 CSTF2T "CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64" ENSG00000177613 "Cleavage stimulation factor subunit 2 tau variant" Q9H0L4 10 51695486-51699595 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039216, HPA062021" Approved Enhanced Nucleoplasm,Vesicles No No "Cluster 15: NK-cells - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Vesicles "HPA039216: AB_10795462, HPA062021: AB_2684662" "unprognostic (2.60e-2)" "unprognostic (3.75e-2)" "unprognostic (2.93e-2)" "unprognostic (2.17e-1)" "unprognostic (8.59e-2)" "unprognostic (1.06e-1)" "unprognostic (4.06e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (5.92e-2)" "unprognostic (5.36e-2)" "unprognostic (7.63e-2)" "unprognostic (5.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.31e-1)" "unprognostic (1.96e-1)" 13.5 13.2 10.6 17.4 13.1 13.6 11.7 13.4 13.4 11.0 11.2 10.4 11.7 11.7 10.3 9.0 14.8 10.2 14.4 10.4 11.5 11.9 12.6 9.6 19.6 13.3 12.6 17.9 12.3 18.0 6.0 11.9 13.1 11.9 10.6 13.8 10.7 9.3 22.2 10.9 11.6 12.2 13.9 17.6 11.1 9.5 12.0 21.5 11.5 22.8 19.4 12.4 6.3 18.4 16.2 18.9 27.9 29.4 38.5 26.2 1.9 22.5 20.7 25.4 24.7 25.3 23.2 46.5 12.7 19.7 15.4 24.8 21.2 23.6 22.9 27.1 24.0 26.8 19.9 4.7 18.6 10.5 23.6 38.0 18.0 22.4 25.8 16.1 19.3 26.9 29.3 25.6 22.2 13.9 42.9 16.8 10.3 19.7 40.3 33.7 56.2 9.9 19.6 13.4 23.3 30.1 18.8 19.4 20.4 28.9 36.2 19.2 20.7 16.2 22.1 15.1 28.5 32.5 13.0 32.9 33.7 24.1 14.3 2.8 4.1 4.5 3.5 3.8 4.9 1.7 2.6 2.8 4.3 3.0 4.4 4.0 1.1 10.9 2.8 2.7 4.6 2.9 10.6 13.1 13.4 13.4 10.4 11.5 13.3 12.6 13.1 13.9 12.0 18.4 13.4 9.6 7.5 2.9 15.8 9.1 7.1 15.7 12.5 18.2 8.7 5.6 14.3 8.6 11.1 9.2 8.4 24.1 13.7 7.5 23.5 16.4 1.7 9.2 13.5 17.7 6.1 17.7 4.6 15.3 14.6 12.4 9.7 7.8 20.3 10.9 17.9 16.7 15.4 20.2 5.7 8.7 10.2 14.8 8.3 2.7 23.9 8.9 0.0 3.7 22.5 13.2 33.0 3.0 19.3 13.9 6.1 19.9 7.1 4.1 9.3 13.6 17.8 13.7 6.6 16.1 9.1 37.0 15.7 8.5 6.5 6.2 17.2 12.0 11.2 5.1 DKK1 "DKK-1, SK" ENSG00000107984 "Dickkopf WNT signaling pathway inhibitor 1" O94907 10 52314281-52318042 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 34.0;placenta: 48.9" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 486.2;Endometrial stromal cells: 337.6;Pancreatic endocrine cells: 194.6;Prostatic glandular cells: 992.9;Urothelial cells: 320.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 1141.1;BJ hTERT+: 620.0;CACO-2: 1011.3;fHDF/TERT166: 1590.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted in other tissues" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (5.65e-2)" "unprognostic (4.21e-2)" "unprognostic (7.09e-2)" "unprognostic (7.99e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.35e-8)" "unprognostic (7.93e-2)" "prognostic unfavorable (7.80e-6)" "unprognostic (1.54e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.81e-1)" "unprognostic (1.68e-1)" "unprognostic (7.47e-3)" "unprognostic (4.05e-1)" "unprognostic (1.19e-1)" "unprognostic (2.06e-2)" 22.0 0.3 0.6 0.3 0.8 0.0 5.6 1.1 0.9 34.0 0.4 0.3 0.1 1.8 0.0 7.9 0.4 3.9 0.7 0.5 1.5 0.6 0.2 1.2 0.4 0.6 1.6 1.0 0.2 0.1 0.1 48.9 0.8 4.8 0.1 7.0 2.3 1.9 0.3 16.5 0.2 0.2 0.7 0.8 1.2 0.2 1.7 0.0 0.3 0.0 0.5 21.9 10.6 0.6 315.3 215.8 0.1 32.4 149.6 30.4 0.1 1141.1 620.0 383.8 202.5 1011.3 64.2 0.0 1.6 1590.5 93.5 245.1 0.3 130.7 361.3 0.1 0.7 0.0 4.4 26.2 31.8 0.0 0.1 30.3 16.0 83.0 488.3 19.8 35.8 0.0 0.0 0.1 255.8 135.7 0.0 0.1 0.2 13.7 543.9 0.2 34.8 0.0 148.6 25.6 0.2 342.4 102.8 1.1 17.7 0.4 1.1 0.9 78.9 0.2 0.2 338.5 211.9 0.1 0.3 0.1 4.6 0.1 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.1 0.9 0.5 1.5 0.6 1.6 0.8 0.7 1.7 0.6 1.9 25.6 0.0 0.0 1.0 5.4 486.2 28.5 0.0 0.2 0.8 6.9 1.1 0.0 15.2 0.0 0.0 4.6 0.0 0.9 0.0 10.7 1.2 11.0 337.6 8.5 0.0 0.0 1.2 4.1 4.0 91.5 2.6 8.1 4.5 0.0 1.1 0.0 9.3 0.0 2.2 2.4 6.1 0.0 1.6 0.6 0.0 4.9 0.0 1.0 0.0 6.1 0.0 1.5 0.2 194.6 5.0 0.0 1.3 992.9 0.4 0.0 9.8 0.4 0.0 0.0 10.6 0.4 2.2 1.4 3.1 8.3 2.8 0.0 1.0 320.0 MBL2 "COLEC1, MBL" ENSG00000165471 "Mannose binding lectin 2" P11226 10 52765380-52772784 "Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2810 "liver: 280.9" "Cell type enriched" "Detected in some" 66 "Hepatocytes: 238.5" "Cancer enriched" "Detected in single" 275 "liver cancer: 22.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "Hep G2: 2.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "basal ganglia: 1.1" "HPA002027, CAB016782" Enhanced "Secreted to blood" NA NA 1220000000 1900000000 "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "CAB016782: , HPA002027: AB_1079324" "unprognostic (1.72e-2)" "unprognostic (3.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 280.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 238.5 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 PCDH15 "CDHR15, DFNB23, USH1F" ENSG00000150275 "Protocadherin related 15" Q96QU1 10 53802771-55627942 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Hearing" "Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 19.0;brain: 21.2;retina: 61.7" "Cell type enriched" "Detected in some" 13 "Oligodendrocyte precursor cells: 2965.2" "Cancer enriched" "Detected in single" 9 "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.1;U-266/70: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074437 Supported "Intracellular and membrane" NA NA 22000 "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 68: Oligodendrocytes - Mixed function" "HPA074437: " "unprognostic (1.38e-1)" "unprognostic (3.39e-1)" "unprognostic (8.15e-5)" "unprognostic (3.07e-3)" "unprognostic (2.79e-1)" "unprognostic (9.15e-4)" "unprognostic (2.02e-1)" "unprognostic (3.89e-2)" "unprognostic (1.12e-3)" "unprognostic (1.31e-3)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (7.66e-3)" 0.2 19.0 13.4 0.3 9.5 0.1 0.0 3.1 10.3 0.2 0.0 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.5 16.6 19.6 8.0 0.0 2.5 0.4 13.8 13.7 0.0 0.0 0.5 4.7 0.2 12.6 0.2 0.0 61.7 0.1 0.0 0.0 0.1 0.2 0.0 9.7 0.7 0.3 3.3 21.2 0.1 0.0 0.0 0.5 0.5 0.0 6.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.1 0.0 0.0 3.3 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 9.5 3.1 10.3 16.6 19.6 13.8 13.7 12.6 9.7 21.2 6.2 0.0 0.0 0.0 14.4 0.0 0.3 0.0 0.0 0.0 5.1 0.6 0.0 4.8 0.0 0.0 0.0 87.6 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.1 0.3 0.0 0.0 27.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 216.2 0.1 0.0 0.0 0.0 7.5 0.0 0.1 0.0 3.7 0.0 4.4 0.0 2965.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 92.8 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 MTRNR2L5 ENSG00000249860 "MT-RNR2 like 5" P0CJ72 10 55599042-55600728 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.3" "Cell type enriched" "Detected in some" 18 "Cardiomyocytes: 27.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 1.2;neutrophil: 1.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.2" "Not detected" "Not detected" "Secreted - unknown location" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (2.11e-2)" "unprognostic (1.20e-1)" 0.0 0.1 1.2 0.1 0.9 0.3 0.0 0.5 1.5 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 1.3 1.7 0.1 0.1 0.0 0.2 1.3 1.4 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.1 0.0 0.6 0.2 0.1 0.0 0.6 0.2 0.1 0.0 2.3 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.1 1.2 0.2 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 1.2 0.2 0.1 0.1 0.0 0.1 1.2 0.9 0.5 1.5 1.3 1.7 1.3 1.4 1.0 0.6 2.3 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 ZWINT "KNTC2AP, SIP30, Zwint1" ENSG00000122952 "ZW10 interacting kinetochore protein" O95229 10 56357227-56361273 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 41.6;lymphoid tissue: 43.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 133.0;Extravillous trophoblasts: 108.6;Late spermatids: 208.8;Spermatocytes: 121.0;Spermatogonia: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 17.0" "Lineage enriched" "Detected in many" 5 "T-cells: 17.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA005757, HPA022264" Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nuclear bodies" Cytosol "HPA005757: AB_10600224, HPA022264: AB_10600995" "unprognostic (5.59e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (9.38e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.77e-8)" "unprognostic (6.36e-3)" "unprognostic (5.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.58e-3)" "unprognostic (1.86e-2)" "prognostic unfavorable (3.72e-12)" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (5.47e-2)" "unprognostic (3.46e-1)" 2.6 2.5 1.2 15.7 1.3 41.6 6.5 1.1 1.8 3.9 1.0 18.8 13.7 3.2 1.7 12.4 2.8 2.4 1.5 1.5 1.2 4.4 4.8 2.9 26.5 1.2 1.3 1.5 2.4 5.4 0.8 10.8 1.2 2.5 22.4 0.5 3.3 1.4 0.3 10.8 14.8 6.8 1.2 5.0 12.5 26.1 1.6 43.5 3.9 0.7 33.0 5.0 4.3 1.4 199.8 154.8 107.9 120.9 7.5 10.8 88.1 143.1 108.0 169.6 153.4 275.4 116.1 102.0 53.2 49.6 79.1 99.9 153.2 108.3 156.7 259.9 80.2 101.6 120.8 129.4 0.7 169.6 131.0 5.1 6.8 157.7 64.9 20.8 86.8 134.2 140.2 121.4 151.1 160.1 150.7 108.3 77.0 135.9 188.7 151.7 209.5 54.0 53.5 87.5 99.8 61.2 135.2 304.2 35.3 62.2 197.3 163.4 47.4 73.6 189.4 76.9 223.2 105.8 55.3 176.0 103.8 210.0 94.7 0.0 0.8 0.7 2.4 3.0 0.3 1.6 5.3 3.6 1.4 0.3 6.3 3.6 0.0 3.5 2.3 1.1 17.0 3.1 1.2 1.3 1.1 1.8 1.5 1.2 1.2 1.3 1.2 1.2 1.6 1.4 0.9 3.2 1.7 0.3 11.1 18.4 6.0 20.2 4.6 2.0 9.4 5.5 1.4 2.8 7.3 5.5 0.0 73.7 3.3 17.9 0.0 9.7 74.0 7.0 4.3 5.7 0.0 133.0 1.3 13.3 108.6 10.3 16.8 8.0 0.0 27.6 7.9 3.5 49.4 0.0 0.3 22.8 14.2 8.5 8.8 208.8 5.0 9.2 7.2 0.0 2.6 1.3 0.0 0.0 0.6 8.6 16.4 2.6 42.4 1.9 8.7 6.0 2.5 0.9 0.0 1.4 10.6 121.0 100.3 24.5 8.2 23.1 7.9 6.5 39.4 8.4 IPMK ENSG00000151151 "Inositol polyphosphate multikinase" Q8NFU5 10 58191517-58267894 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.0" "Group enriched" "Detected in many" 4 "granulocytes: 3.0;monocytes: 1.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037837, HPA057542" Uncertain Enhanced Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "HPA037837: AB_10670166, HPA057542: AB_2683460" "unprognostic (4.52e-2)" "unprognostic (3.29e-2)" "unprognostic (4.22e-3)" "unprognostic (6.85e-2)" "unprognostic (2.41e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-3)" "unprognostic (2.10e-1)" "unprognostic (9.39e-2)" "unprognostic (2.23e-1)" "unprognostic (1.55e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (9.96e-7)" "unprognostic (1.79e-1)" "unprognostic (4.33e-1)" "unprognostic (1.27e-3)" "unprognostic (9.02e-3)" 4.9 3.1 3.1 5.8 3.1 2.4 4.7 4.1 4.5 4.4 2.3 7.1 7.9 2.3 3.4 5.2 2.9 6.9 1.8 2.9 3.2 4.1 18.1 3.3 4.6 3.6 3.6 1.8 3.8 12.1 1.9 8.7 3.2 3.4 6.0 4.7 2.7 1.7 2.7 5.1 10.4 1.9 3.2 6.4 3.5 2.2 3.5 4.5 4.1 3.2 4.4 5.2 2.5 3.2 16.3 4.1 5.9 5.8 5.7 6.6 5.1 4.2 9.0 3.5 7.1 8.3 10.1 13.0 8.3 5.0 3.4 4.9 5.0 5.6 11.2 5.9 3.8 3.2 3.9 7.9 3.4 5.1 7.1 7.3 4.9 6.0 12.0 4.0 7.7 3.7 2.1 6.5 6.3 4.1 7.0 9.8 3.8 6.6 3.8 0.5 12.8 6.0 6.6 4.1 4.1 7.1 5.5 14.4 4.3 9.6 12.0 6.1 6.7 3.8 7.4 8.1 5.4 13.8 8.7 10.1 7.2 5.3 1.5 1.7 0.7 1.6 0.1 0.7 0.1 0.3 0.1 0.1 0.4 0.2 0.4 0.1 3.0 0.2 1.0 0.2 0.0 0.1 3.1 3.1 4.1 4.5 2.9 3.2 3.6 3.6 3.2 3.2 3.5 3.2 8.9 6.4 4.2 16.6 16.9 54.0 10.0 8.4 26.2 10.0 11.6 8.3 2.8 4.3 13.3 1.8 6.2 10.5 8.1 29.3 3.9 4.2 3.0 24.3 9.7 9.9 8.4 3.0 21.8 4.9 22.5 15.7 8.2 22.8 7.0 2.5 8.2 13.2 10.0 13.5 27.8 10.6 10.2 22.8 40.7 1.4 2.8 29.1 26.6 24.4 16.6 5.4 2.1 30.7 23.6 6.2 21.7 1.9 8.5 9.6 28.6 9.1 29.1 5.8 6.6 10.2 8.5 10.0 5.1 20.1 58.1 9.4 10.1 4.1 11.1 17.5 CISD1 "C10orf70, MDS029, mitoNEET, ZCD1" ENSG00000122873 "CDGSH iron sulfur domain 1" Q9NZ45 10 58269162-58289586 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 82.3" "Cell type enhanced" "Detected in all" "Distal tubular cells: 716.1;Proximal enterocytes: 539.1;Proximal tubular cells: 726.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074383 Supported Supported Mitochondria NA NA 13000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA074383: AB_2686684" "prognostic unfavorable (1.11e-4)" "unprognostic (8.60e-3)" "unprognostic (1.07e-1)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (3.22e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (1.87e-2)" "unprognostic (2.35e-1)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "unprognostic (7.23e-2)" "unprognostic (1.34e-3)" "unprognostic (4.19e-2)" "unprognostic (7.20e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (6.69e-4)" 5.2 10.1 10.0 6.3 9.8 0.9 5.9 10.4 13.6 6.6 11.8 9.7 22.7 5.6 3.4 11.2 6.1 7.2 43.0 10.1 12.7 26.4 16.6 4.3 6.1 10.1 9.9 6.8 5.3 82.3 5.8 5.5 11.2 7.6 8.8 8.2 9.9 7.1 46.4 8.4 21.8 8.0 9.5 4.6 7.2 2.8 9.6 6.5 10.1 49.9 5.9 7.8 3.0 8.9 20.5 10.2 8.0 14.6 10.5 11.6 4.7 16.9 19.2 16.4 22.5 24.1 18.8 36.1 13.9 17.5 9.6 12.9 21.7 15.1 14.7 16.2 29.4 9.5 16.4 19.6 11.9 17.0 7.1 14.6 12.1 15.7 23.9 13.9 19.5 17.9 21.2 16.5 11.6 6.8 14.6 18.2 8.5 15.5 31.4 11.0 29.3 19.0 22.1 7.1 25.0 9.0 12.9 34.1 12.4 7.0 22.7 9.0 19.3 7.1 12.8 20.5 20.4 16.6 29.0 27.2 18.9 16.6 7.0 0.0 4.5 0.2 4.3 3.4 5.3 6.3 4.9 5.0 7.6 5.4 5.7 5.7 2.3 5.4 2.3 5.0 6.8 4.2 10.0 9.8 10.4 13.6 10.1 12.7 10.1 9.9 11.2 9.5 9.6 8.9 31.4 60.9 45.7 27.4 33.0 128.7 87.3 309.4 78.0 84.6 46.4 61.1 321.6 97.2 180.2 134.3 43.8 174.8 22.7 71.1 716.1 98.0 240.9 42.8 30.4 61.6 225.4 24.8 47.2 82.1 78.5 52.7 38.2 43.8 34.3 23.0 63.9 249.6 68.6 42.1 53.1 141.9 272.6 37.0 37.9 366.1 42.3 31.0 183.2 21.5 34.0 47.2 44.3 36.7 30.9 83.2 121.9 40.3 31.7 109.1 539.1 726.8 138.6 56.3 32.9 50.1 55.6 159.4 65.6 94.9 114.2 72.7 26.2 65.0 147.3 69.4 UBE2D1 "E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A" ENSG00000072401 "Ubiquitin conjugating enzyme E2 D1" P51668 10 58334979-58370751 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 138.7;tongue: 65.3" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 194.4;Suprabasal keratinocytes: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 112.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (4.23e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.03e-1)" "unprognostic (2.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.04e-6)" "unprognostic (9.71e-3)" "unprognostic (4.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.66e-2)" 13.0 11.8 5.3 16.7 5.7 32.4 7.8 6.6 8.1 8.9 4.4 11.4 7.0 12.6 7.5 11.6 7.1 9.5 33.3 6.1 6.2 8.1 8.3 8.9 13.8 6.6 6.4 8.4 5.5 8.9 3.9 8.9 6.6 9.5 12.0 5.4 5.5 6.7 138.7 5.9 8.3 13.6 6.4 13.4 6.4 4.5 6.3 7.8 8.4 65.3 11.4 15.1 5.6 6.7 19.1 10.2 18.8 24.4 37.5 30.0 12.1 12.4 21.2 13.9 20.3 20.9 16.4 0.0 19.0 18.6 10.3 17.1 36.6 18.0 19.5 19.8 21.2 4.9 3.7 12.2 24.4 15.3 11.8 34.8 19.9 14.4 26.8 18.7 28.1 13.1 10.0 7.8 19.1 6.1 16.5 17.1 23.0 11.7 15.7 13.8 16.9 10.6 21.2 11.2 14.0 18.8 24.2 40.3 20.6 28.5 14.8 10.2 22.8 5.3 18.6 18.2 13.7 19.7 16.4 16.8 16.7 31.3 6.2 10.1 38.5 17.8 6.2 27.1 7.2 8.9 7.3 7.9 20.0 9.8 7.5 6.2 112.3 8.2 23.4 8.3 9.8 23.4 5.3 5.7 6.6 8.1 6.1 6.2 6.6 6.4 6.6 6.4 6.3 6.7 41.6 12.8 11.2 5.5 54.3 194.4 94.1 60.6 46.1 23.7 45.6 45.5 92.4 17.2 39.0 27.6 18.8 29.9 41.7 27.4 76.3 62.3 5.0 32.6 46.9 42.5 41.7 12.0 18.5 42.0 50.4 51.9 38.7 51.2 22.9 19.6 27.5 15.6 73.7 16.8 17.1 40.1 69.2 90.6 104.0 3.0 33.2 147.7 53.4 4.7 94.6 17.9 22.6 12.5 21.2 81.2 52.7 32.4 26.4 108.4 16.1 54.3 33.6 16.1 6.6 51.4 59.1 33.5 19.9 47.1 190.2 149.0 42.8 14.9 28.5 118.2 TFAM "TCF6, TCF6L2" ENSG00000108064 "Transcription factor A, mitochondrial" Q00059 10 58385345-58399220 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 631.4;Late spermatids: 933.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040648, HPA063684" Supported Enhanced Mitochondria "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" Mitochondria "HPA040648: AB_10795635, HPA063684: AB_2685089" "unprognostic (5.30e-2)" "unprognostic (1.14e-1)" "unprognostic (6.34e-3)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.10e-2)" "unprognostic (3.40e-2)" "unprognostic (1.54e-2)" "unprognostic (3.23e-2)" "unprognostic (1.24e-2)" "prognostic favorable (2.74e-4)" "unprognostic (1.99e-2)" "unprognostic (5.39e-2)" "prognostic favorable (2.22e-5)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (6.76e-2)" 16.5 20.1 5.7 21.6 6.1 38.1 17.3 10.8 8.4 11.4 6.8 20.0 21.0 13.7 9.5 14.7 12.6 10.7 18.5 5.5 7.3 21.5 22.6 10.9 27.7 5.8 6.1 17.8 13.9 16.2 6.3 20.4 6.5 14.5 17.3 9.8 17.3 11.4 17.7 9.0 17.8 11.6 7.0 17.3 16.1 33.0 6.4 24.9 19.6 16.1 23.0 16.7 7.5 8.8 85.7 47.7 52.8 54.7 15.3 19.4 59.8 37.9 37.3 46.8 51.1 170.0 88.6 170.1 53.9 17.6 34.8 65.2 97.6 53.5 73.4 73.4 85.7 64.1 33.4 64.5 23.3 164.7 49.4 19.2 24.4 57.0 51.6 22.2 41.1 49.9 153.4 74.8 33.2 46.4 130.2 65.1 100.0 39.2 49.9 102.9 113.0 76.0 28.3 57.0 69.8 48.1 75.1 103.7 97.0 42.9 112.8 47.9 32.0 34.4 109.5 39.5 102.5 75.6 125.8 214.2 44.1 125.1 26.4 1.0 9.5 4.0 8.3 9.5 10.8 12.8 10.0 8.8 12.1 12.5 12.4 10.1 7.1 15.0 8.3 14.7 9.0 6.9 5.7 6.1 10.8 8.4 5.5 7.3 5.8 6.1 6.5 7.0 6.4 8.8 46.4 54.5 27.9 6.2 52.5 50.1 44.0 52.4 59.2 25.1 48.6 62.9 35.0 38.6 51.0 20.2 16.7 98.1 56.8 17.1 88.0 41.0 631.4 36.8 44.5 39.5 15.5 46.7 10.1 44.7 77.4 38.8 25.0 41.2 29.7 34.1 26.0 64.1 44.0 38.7 11.5 37.5 18.3 21.9 19.3 933.1 41.3 32.3 23.2 2.8 36.3 38.2 48.4 10.6 11.7 35.2 23.0 30.9 35.8 47.3 14.1 72.0 31.4 21.4 26.3 74.8 40.5 55.3 63.9 48.6 54.7 52.5 38.3 69.1 48.1 31.8 BICC1 ENSG00000122870 "BicC family RNA binding protein 1" Q9H694 10 58512872-58831435 "Disease related genes, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 28.6" "Cell type enhanced" "Detected in many" "Astrocytes: 120.5;Cholangiocytes: 158.7;Collecting duct cells: 86.5;Ductal cells: 98.5;Fibroblasts: 79.6;Microglial cells: 165.8;Proximal tubular cells: 148.2" "Group enriched" "Detected in all" 4 "pancreatic cancer: 9.2;renal cancer: 25.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 10 "basophil: 6.2" "Lineage enriched" "Detected in single" 10 "granulocytes: 6.2" "Cell line enhanced" "Detected in many" "A549: 59.1;BJ hTERT+: 61.4;CACO-2: 93.1;RPTEC TERT1: 140.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070797 Approved Centrosome,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 50: Fibroblasts - ECM organization" Cytosol Centrosome "HPA070797: " "unprognostic (1.27e-1)" "unprognostic (1.57e-3)" "unprognostic (3.61e-1)" "unprognostic (1.96e-1)" "unprognostic (6.09e-3)" "unprognostic (1.72e-1)" "unprognostic (9.98e-3)" "unprognostic (1.79e-2)" "unprognostic (6.69e-2)" "unprognostic (4.56e-2)" "unprognostic (4.40e-3)" "unprognostic (7.16e-2)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (6.23e-2)" "unprognostic (2.94e-2)" 10.6 6.1 0.3 4.0 0.5 0.3 8.7 0.0 1.6 5.8 1.9 4.5 1.2 4.9 4.0 3.5 7.5 11.6 10.5 0.6 1.0 28.6 2.4 5.8 2.4 1.2 0.6 13.9 16.9 0.8 3.6 3.6 0.2 3.8 4.1 1.4 4.3 4.2 7.6 6.1 2.7 4.7 1.2 2.9 2.7 3.1 0.7 1.4 4.6 6.2 2.7 5.5 5.6 0.7 0.0 59.1 0.8 0.0 17.9 23.0 0.0 38.5 61.4 34.4 40.4 93.1 12.3 0.0 39.8 39.3 8.8 0.8 6.1 7.0 47.4 0.1 5.9 0.0 7.4 0.1 11.5 0.0 0.0 36.0 2.2 26.9 28.6 42.3 0.1 0.0 0.0 0.2 13.4 0.1 0.0 0.0 0.5 0.0 3.8 0.0 14.3 0.0 140.8 7.1 0.2 7.3 0.1 0.4 3.4 2.4 0.0 0.6 0.0 8.2 7.7 1.4 5.0 0.0 0.0 0.1 23.8 0.0 7.8 6.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.5 0.2 0.5 0.1 0.0 0.3 0.5 0.0 1.6 0.6 1.0 1.2 0.6 0.2 1.2 0.7 0.7 4.1 0.0 0.5 120.5 1.5 7.1 1.3 1.3 0.6 0.6 1.1 4.3 3.3 158.7 1.7 86.5 0.0 0.4 0.1 0.3 78.2 98.5 5.2 43.8 14.4 1.4 3.6 0.0 70.4 3.5 0.2 79.6 0.5 7.2 0.0 4.2 3.3 1.4 3.5 0.0 37.2 1.2 0.0 0.6 18.5 3.2 71.1 1.7 21.4 165.8 1.1 10.1 0.0 25.6 2.7 35.3 1.2 50.0 0.3 2.4 0.0 148.2 14.1 0.2 6.6 40.0 9.8 0.1 3.9 0.3 4.7 4.1 1.5 8.7 1.6 0.1 PHYHIPL "Em:AC025038.1, KIAA1796" ENSG00000165443 "Phytanoyl-CoA 2-hydroxylase interacting protein like" Q96FC7 10 59176643-59247774 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 18.4;brain: 45.5;retina: 30.5" "Cell type enhanced" "Detected in many" "Astrocytes: 210.6;Early spermatids: 208.4;Horizontal cells: 144.7;Inhibitory neurons: 170.2;Late spermatids: 241.4;Muller glia cells: 246.1;Oligodendrocyte precursor cells: 264.9;Oligodendrocytes: 357.1" "Group enriched" "Detected in many" 5 "glioma: 21.1;renal cancer: 8.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 5.3;Hep G2: 34.3;SCLC-21H: 6.1;SH-SY5Y: 19.4;SK-BR-3: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038746 Uncertain Approved Cytosol NA NA "Cluster 77: Retina - Visual perception" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 5: Muller glia cells - Visual perception" Cytosol "HPA038746: AB_10673293" "unprognostic (6.34e-3)" "unprognostic (2.40e-1)" "unprognostic (1.04e-1)" "unprognostic (3.76e-3)" "unprognostic (7.06e-2)" "unprognostic (3.37e-1)" "unprognostic (5.63e-2)" "unprognostic (3.78e-2)" "unprognostic (1.06e-1)" "unprognostic (4.00e-3)" "unprognostic (2.67e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.60e-7)" "unprognostic (1.29e-3)" "unprognostic (1.30e-1)" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" 0.3 18.4 22.5 0.4 30.1 0.0 0.4 31.6 36.9 1.6 0.3 2.1 8.5 0.7 1.8 0.3 1.1 0.1 0.3 21.2 36.1 11.0 1.1 0.2 0.0 41.3 32.1 0.8 5.4 0.0 6.7 1.8 32.8 2.8 0.3 30.5 0.7 2.6 0.6 0.3 8.9 0.1 42.4 0.1 0.6 6.5 26.2 0.0 0.2 0.0 0.0 0.1 1.2 45.5 0.0 0.6 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 19.4 0.0 8.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 30.1 31.6 36.9 21.2 36.1 41.3 32.1 32.8 42.4 26.2 45.5 3.1 0.0 0.0 210.6 0.0 0.0 14.0 0.0 0.0 135.2 0.2 1.0 0.5 2.8 0.0 3.7 12.5 1.0 0.0 0.1 13.7 0.6 208.4 24.1 8.0 1.6 0.0 2.7 97.3 6.5 0.3 1.2 0.0 71.9 0.0 0.8 0.7 1.8 0.5 144.7 170.2 3.0 0.0 0.0 0.0 241.4 13.1 1.3 1.8 11.2 0.0 246.1 0.0 264.9 357.1 1.7 6.3 0.4 0.0 4.0 24.0 80.3 0.0 53.9 0.0 3.0 2.4 137.1 27.2 0.1 0.0 49.0 0.6 0.3 9.6 2.8 FAM13C FAM13C1 ENSG00000148541 "Family with sequence similarity 13 member C" Q8NE31 10 59246130-59363181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.0" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 477.1" "Cancer enhanced" "Detected in some" "prostate cancer: 3.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 4.1;HSkMC: 5.1;hTERT-RPE1: 3.4;NTERA-2: 4.5;SCLC-21H: 8.6;SH-SY5Y: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037888 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 70: Brain - Nervous system development" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Cytosol" "HPA037888: AB_10962981" "unprognostic (3.68e-1)" "unprognostic (6.10e-2)" "unprognostic (2.46e-1)" "unprognostic (6.69e-5)" "unprognostic (8.54e-2)" "unprognostic (4.56e-2)" "unprognostic (3.30e-2)" "unprognostic (1.06e-2)" "unprognostic (6.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-3)" "unprognostic (3.27e-1)" "unprognostic (4.51e-6)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (1.94e-3)" "unprognostic (4.66e-3)" 13.5 16.2 20.8 3.9 45.8 0.0 9.3 33.2 32.4 8.7 3.7 7.7 4.2 8.7 8.0 13.8 14.5 11.5 8.1 21.3 34.3 3.4 2.1 9.9 4.7 49.3 36.3 21.2 2.2 4.7 4.7 2.6 40.9 17.2 6.2 9.9 5.6 7.9 17.1 7.2 5.9 12.2 35.5 5.1 3.8 5.2 37.6 5.2 6.3 22.9 2.3 4.4 7.9 68.0 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 1.3 0.2 0.1 0.0 1.2 0.0 4.1 1.9 0.1 0.0 0.0 5.1 0.6 0.2 0.0 3.4 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 4.5 0.0 0.4 0.0 0.8 0.0 0.0 1.3 8.6 5.0 0.0 0.2 0.0 0.3 0.7 0.0 0.0 2.5 2.2 0.1 2.1 0.0 0.0 0.1 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 45.8 33.2 32.4 21.3 34.3 49.3 36.3 40.9 35.5 37.6 68.0 47.8 0.0 0.0 33.6 0.1 4.8 9.3 0.3 8.0 10.5 0.7 2.7 2.5 0.0 0.7 0.0 6.2 0.0 0.4 0.1 7.9 0.0 49.0 18.6 1.5 35.2 0.0 0.0 66.8 0.0 0.0 19.8 0.5 5.3 0.0 26.9 3.9 0.5 0.0 3.3 73.2 0.2 20.3 0.0 2.5 22.1 23.0 0.7 3.6 7.5 0.0 8.8 0.0 56.8 477.1 0.0 0.0 21.1 0.1 5.4 0.0 0.6 20.7 13.6 39.5 23.4 36.2 1.4 0.7 2.4 6.3 0.0 1.2 17.4 0.2 1.1 SLC16A9 "C10orf36, FLJ43803, MCT9" ENSG00000165449 "Solute carrier family 16 member 9" Q7RTY1 10 59650764-59736002 "Metabolic proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 151.3;kidney: 191.1" "Group enriched" "Detected in many" 4 "Astrocytes: 83.9;Distal enterocytes: 108.6;Proximal tubular cells: 252.6;Theca cells: 99.4" "Cancer enhanced" "Detected in many" "renal cancer: 21.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 10.8;NTERA-2: 20.1;SuSa: 10.1;U-251 MG: 10.6;U-937: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049286 Approved Approved "Nucleoplasm,Cell Junctions" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Cell Junctions" "HPA049286: AB_2680699" "unprognostic (3.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-3)" "unprognostic (1.76e-2)" "unprognostic (5.96e-2)" "unprognostic (3.50e-3)" "unprognostic (5.01e-2)" "unprognostic (2.11e-3)" "unprognostic (5.99e-2)" "unprognostic (4.60e-2)" "prognostic favorable (2.56e-6)" "unprognostic (7.57e-3)" "unprognostic (1.27e-2)" "unprognostic (3.72e-1)" "unprognostic (1.94e-1)" 1.2 151.3 12.8 1.2 12.8 1.7 1.7 11.9 14.8 18.5 18.4 12.5 0.4 16.2 5.2 10.9 22.0 3.1 3.4 12.9 16.6 191.1 2.5 1.1 1.7 14.0 13.7 34.1 3.0 29.2 6.9 0.1 12.0 7.8 16.7 5.6 2.9 10.2 4.3 0.4 1.2 7.2 13.3 40.8 6.0 8.9 12.3 1.2 13.9 2.8 2.8 2.2 9.0 15.0 0.0 0.3 5.2 6.8 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.7 0.0 0.0 0.9 10.8 0.0 0.0 0.0 1.8 0.1 0.3 0.1 0.1 2.3 0.0 0.5 0.2 0.0 2.8 0.1 0.4 5.4 8.0 0.1 0.6 4.2 3.0 0.0 20.1 2.0 9.3 3.6 0.2 7.2 0.0 0.3 3.4 9.6 0.1 0.4 0.0 10.1 3.4 4.5 3.2 0.5 1.1 0.1 10.6 0.0 0.0 0.0 0.0 18.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 12.8 11.9 14.8 12.9 16.6 14.0 13.7 12.0 13.3 12.3 15.0 0.3 0.0 0.0 83.9 1.0 0.1 2.1 9.4 0.6 4.3 3.1 1.5 3.9 0.0 26.2 7.3 0.0 0.0 0.0 108.6 25.4 1.0 0.2 2.3 2.0 1.5 20.0 4.2 2.5 0.0 1.7 4.1 3.6 2.4 0.0 28.4 0.4 0.0 0.1 3.3 4.8 19.1 4.1 18.8 0.7 1.5 13.7 1.5 3.6 1.9 0.6 11.8 0.0 14.6 1.0 0.1 23.2 12.0 0.0 17.7 2.2 252.6 7.4 1.0 0.0 2.4 3.4 0.3 0.2 17.0 0.1 0.0 0.7 99.4 11.9 6.5 MRLN "Linc-RAM, LINC00948, M1, MLN, MUSER1" ENSG00000227877 Myoregulin P0DMT0 10 59736692-59756041 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "skeletal muscle: 269.3;tongue: 147.3" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 118.8;Proximal tubular cells: 25.8;Respiratory ciliated cells: 35.7;Rod photoreceptor cells: 37.8" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.4" "Region enriched" "Detected in some" 4 "cerebellum: 4.5" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "RH-30: 13.3" "Region enriched" "Detected in many" 11 "cerebellum: 21.6" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (2.27e-1)" "unprognostic (4.54e-1)" "unprognostic (3.17e-3)" "unprognostic (9.77e-2)" "unprognostic (1.09e-2)" "unprognostic (8.49e-2)" "unprognostic (1.23e-1)" "unprognostic (2.79e-2)" "unprognostic (1.12e-2)" "unprognostic (6.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.46e-1)" 0.1 0.2 0.4 0.1 0.4 0.3 0.2 4.5 0.7 0.5 0.4 0.2 1.0 0.5 0.8 1.2 5.1 0.7 0.1 0.4 0.2 8.1 0.2 0.7 0.1 0.5 0.3 0.3 2.8 0.0 12.0 0.1 1.0 1.3 0.1 30.6 7.0 0.1 269.3 0.6 1.1 0.1 0.1 0.5 1.0 0.8 0.3 0.3 0.3 147.3 0.1 0.0 0.1 0.6 0.0 0.8 0.4 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.6 1.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.7 0.2 1.8 1.1 0.1 0.0 0.6 1.0 0.0 0.6 0.0 0.1 0.0 0.1 0.1 1.0 0.0 1.1 0.0 1.0 0.2 0.2 0.8 0.5 13.3 0.0 0.0 0.2 0.6 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.3 0.3 0.6 0.2 0.5 0.1 0.1 0.4 0.3 0.0 1.7 0.3 0.4 0.6 0.1 0.4 0.5 0.3 0.3 0.2 0.6 0.2 0.5 1.2 0.3 0.3 0.4 0.3 0.0 0.4 0.4 4.5 0.7 0.4 0.2 0.5 0.3 1.0 0.1 0.3 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.1 1.0 0.0 1.8 0.0 2.1 0.0 0.1 1.5 0.0 0.2 5.6 118.8 0.8 0.7 0.0 0.0 1.3 0.2 6.4 0.4 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.5 0.6 0.3 0.0 0.4 0.0 0.1 0.0 25.8 35.7 37.8 0.0 10.1 0.2 2.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 CCDC6 "D10S170, H4, PTC, TPC, TST1" ENSG00000108091 "Coiled-coil domain containing 6" Q16204 10 59788747-59906556 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019049, HPA019051" Enhanced Supported Cytosol No No 12000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 41: Macrophages - Immune response" Cytosol "HPA019049: AB_1846163, HPA019051: AB_1846164" "unprognostic (1.88e-2)" "unprognostic (1.72e-2)" "unprognostic (4.41e-2)" "unprognostic (1.25e-3)" "unprognostic (5.98e-3)" "prognostic favorable (5.48e-4)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.39e-2)" "unprognostic (2.45e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.95e-4)" "unprognostic (4.08e-1)" "unprognostic (4.69e-2)" "unprognostic (2.23e-1)" "unprognostic (2.56e-1)" "unprognostic (9.95e-2)" "unprognostic (4.19e-2)" 11.9 12.2 21.1 13.9 23.4 16.8 22.4 10.2 20.0 23.4 8.5 23.5 22.8 24.9 16.7 34.1 25.3 16.7 10.0 24.9 21.4 21.2 12.1 17.3 21.4 12.4 15.8 15.7 25.2 17.9 11.5 13.2 17.4 19.4 19.8 18.3 29.0 14.3 17.3 28.6 16.2 30.8 11.9 14.7 18.6 11.4 20.8 12.1 18.3 12.2 21.6 17.3 23.1 12.6 42.9 38.0 18.7 41.9 27.8 41.6 37.9 20.6 27.2 20.2 23.7 74.4 81.8 36.5 30.2 34.6 11.7 61.7 37.7 37.5 30.0 55.1 18.7 29.8 29.1 45.5 33.5 34.5 26.9 30.3 48.7 33.7 81.8 28.3 30.2 20.4 22.6 22.7 26.6 57.6 14.5 19.8 29.9 40.1 25.6 19.2 30.5 23.0 33.9 36.2 19.0 16.6 26.1 107.8 23.1 24.1 68.7 18.4 31.1 18.8 33.9 29.3 34.9 12.0 14.9 16.3 29.6 64.6 11.9 0.0 2.0 0.0 1.0 2.3 1.1 4.3 1.5 1.3 5.0 4.9 1.3 1.0 0.1 0.8 1.3 1.3 1.4 1.0 21.1 23.4 10.2 20.0 24.9 21.4 12.4 15.8 17.4 11.9 20.8 12.6 24.0 99.3 25.9 45.1 41.6 95.0 51.7 25.3 70.0 15.1 51.2 38.7 16.5 28.6 46.3 25.8 41.7 37.8 31.4 42.6 29.4 50.2 27.6 105.2 54.6 22.4 27.0 25.7 83.2 65.3 18.8 27.8 39.8 134.5 29.1 45.2 17.2 20.1 23.1 16.8 58.4 38.9 30.5 40.7 35.3 80.6 24.5 36.4 16.0 32.8 23.0 11.5 13.4 55.3 34.2 50.2 25.0 19.5 26.4 52.2 47.1 48.4 28.1 49.8 19.7 31.4 27.0 2.3 22.4 92.3 80.1 27.0 24.3 32.5 46.3 46.1 ANK3 ENSG00000151150 "Ankyrin 3" Q12955 10 60026298-60733490 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism spectrum disorder, Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 490.2;Excitatory neurons: 859.2;Inhibitory neurons: 881.3;Oligodendrocyte precursor cells: 592.6;Oligodendrocytes: 1579.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 50.3;SK-BR-3: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013249, CAB015179, HPA038455" Enhanced Supported "Plasma membrane" NA NA "Cluster 30: Non-specific - Translation" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" "CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: AB_2676020" "unprognostic (1.91e-1)" "unprognostic (5.33e-3)" "unprognostic (6.76e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (1.89e-1)" "unprognostic (1.21e-2)" "unprognostic (3.83e-1)" "unprognostic (2.28e-2)" "prognostic favorable (8.88e-16)" "unprognostic (5.75e-2)" "unprognostic (2.59e-1)" "unprognostic (1.00e-1)" "unprognostic (2.83e-2)" 6.3 6.7 45.5 6.5 86.5 2.1 21.5 144.9 82.3 12.0 0.0 26.0 39.3 23.0 125.2 16.9 19.1 21.5 81.1 60.8 86.1 95.4 16.6 24.6 6.1 82.7 61.3 11.6 11.2 131.8 14.5 15.6 97.0 20.0 20.9 123.2 42.6 40.5 80.5 39.9 27.2 13.2 21.2 10.8 15.5 8.0 87.3 9.1 41.6 94.1 7.4 10.8 14.1 114.4 8.7 4.9 30.3 0.4 0.0 1.8 23.3 0.6 0.4 0.1 0.6 22.2 16.6 0.5 9.8 0.6 0.9 12.1 16.4 14.9 0.5 0.5 11.0 0.2 9.7 0.1 6.2 0.1 0.4 14.6 9.3 7.8 0.4 26.1 3.6 0.0 4.3 20.6 6.9 29.0 0.2 1.0 13.8 23.3 26.6 0.1 21.7 4.3 5.4 50.3 15.6 2.8 0.6 49.4 0.0 33.6 28.7 0.1 10.0 0.9 2.9 13.3 1.5 0.9 0.2 0.2 5.5 0.2 18.9 1.6 0.2 0.5 2.7 0.2 2.4 4.1 4.6 1.5 0.1 1.1 5.0 1.2 0.7 1.5 0.3 2.5 0.8 1.0 45.5 86.5 144.9 82.3 60.8 86.1 82.7 61.3 97.0 21.2 87.3 114.4 0.9 44.8 174.3 20.2 14.5 19.1 21.9 17.8 38.7 490.2 26.8 20.6 189.3 12.8 42.5 53.3 225.2 38.8 3.4 62.9 19.6 10.6 28.3 139.8 26.2 3.9 30.6 0.0 859.2 8.6 9.9 13.2 15.8 153.3 12.6 66.9 7.9 0.5 4.7 43.7 881.3 12.1 14.2 4.8 1.4 11.5 28.0 3.3 8.8 23.4 4.4 41.4 0.0 592.6 1579.5 4.8 41.8 5.7 3.4 12.2 62.5 51.3 66.7 216.6 0.0 30.2 11.7 1.1 2.3 35.9 18.2 25.0 18.5 4.5 17.8 18.4 CDK1 "CDC2, CDC28A" ENSG00000170312 "Cyclin dependent kinase 1" P06493 10 60778331-60794852 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis" "Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 53.2;lymphoid tissue: 74.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 80.9;Erythroid cells: 209.6;Extravillous trophoblasts: 144.6;Spermatocytes: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "NK-cell: 3.2;T-reg: 3.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003387, CAB003799, CAB079974" Enhanced Supported Nucleoplasm,Cytosol NA Yes 51000 "Cluster 15: NK-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Cytosol" "CAB003799: AB_344898, CAB079974: , HPA003387: AB_1846356" "unprognostic (6.34e-2)" "prognostic favorable (8.81e-4)" "unprognostic (1.90e-1)" "unprognostic (6.82e-2)" "unprognostic (6.67e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (1.10e-6)" "prognostic unfavorable (7.88e-4)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.15e-6)" "unprognostic (1.80e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.27e-1)" "unprognostic (2.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" 3.8 1.8 0.9 17.0 1.0 53.2 7.4 0.9 1.5 5.2 0.9 17.6 16.3 7.1 12.2 17.5 3.7 4.3 1.4 0.9 1.0 3.1 3.2 4.7 40.6 1.2 1.2 2.3 0.8 2.5 4.1 19.4 1.1 1.7 20.8 1.3 3.2 5.2 1.4 13.2 14.5 8.0 0.9 9.0 10.1 25.1 1.4 74.0 3.6 2.2 47.5 7.1 6.9 1.0 249.9 93.5 241.1 96.0 15.4 23.6 99.0 183.8 132.7 218.8 209.0 218.9 213.7 226.2 69.6 50.6 79.6 149.9 166.2 106.8 225.8 162.3 121.1 119.4 84.4 128.1 2.8 184.5 117.6 4.7 10.4 142.1 137.0 49.6 133.3 146.2 185.1 270.3 246.9 66.3 234.0 131.1 106.6 149.3 193.1 199.7 224.5 111.3 84.3 81.4 112.7 98.7 123.5 184.9 96.3 130.0 199.9 111.5 55.4 92.8 197.9 99.1 255.8 104.9 180.8 205.6 79.9 203.5 117.6 0.0 0.0 0.0 0.3 0.1 0.2 0.5 0.7 1.3 0.3 0.4 0.2 0.7 0.0 3.2 0.1 0.9 3.4 0.9 0.9 1.0 0.9 1.5 0.9 1.0 1.2 1.2 1.1 0.9 1.4 1.0 7.7 0.0 3.2 0.3 7.1 39.8 5.4 29.9 2.8 1.1 5.3 6.1 0.8 0.0 10.2 18.4 0.0 80.9 3.6 8.9 3.9 0.8 18.7 10.8 6.2 10.5 3.0 209.6 0.4 0.0 144.6 13.3 13.3 9.4 0.0 51.5 7.5 1.3 57.2 0.0 0.2 14.6 30.5 20.5 18.1 10.4 2.1 16.5 1.8 1.9 1.0 1.0 3.1 0.0 0.1 0.4 0.7 0.7 32.1 4.3 2.2 3.0 17.6 0.7 0.0 0.5 24.6 110.0 39.6 33.8 18.6 22.0 10.3 2.1 26.6 10.4 RHOBTB1 KIAA0740 ENSG00000072422 "Rho related BTB domain containing 1" O94844 10 60869438-61001440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 144.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 135.5;Horizontal cells: 334.8;Oligodendrocytes: 155.5;Syncytiotrophoblasts: 302.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 67.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040205, HPA040226" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Cytosol "HPA040205: AB_2676883, HPA040226: AB_10795377" "unprognostic (1.25e-1)" "unprognostic (2.72e-2)" "unprognostic (6.69e-3)" "unprognostic (2.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-3)" "unprognostic (1.64e-1)" "unprognostic (2.25e-1)" "unprognostic (4.31e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-2)" "unprognostic (8.54e-3)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (7.16e-2)" "unprognostic (2.57e-2)" 7.8 13.9 5.6 4.1 6.6 0.9 7.1 5.2 7.8 15.7 5.3 8.1 6.6 14.5 2.4 3.0 10.9 11.5 13.5 4.6 4.7 30.8 6.8 10.6 2.8 6.1 6.1 10.2 9.2 8.6 3.2 37.1 6.3 7.7 4.8 24.3 2.1 9.9 144.2 3.6 5.6 12.1 4.9 14.9 20.8 15.1 7.6 1.9 3.3 19.6 1.2 7.4 7.5 7.8 0.2 12.0 17.8 0.0 8.3 7.3 0.0 5.3 4.8 4.3 6.4 0.6 0.2 0.0 21.9 28.0 2.0 0.3 5.3 1.6 5.0 0.0 4.8 1.1 8.8 67.3 9.0 1.4 0.4 10.6 3.0 2.6 2.7 16.5 20.6 3.8 10.2 0.0 19.1 0.4 5.2 0.0 7.7 0.2 7.9 4.5 24.9 6.4 14.1 0.7 4.9 19.0 6.3 6.9 6.9 11.1 1.4 2.4 18.5 8.2 21.1 0.2 5.9 0.0 0.0 0.0 4.1 3.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 5.6 6.6 5.2 7.8 4.6 4.7 6.1 6.1 6.3 4.9 7.6 7.8 13.7 16.0 8.7 3.6 1.0 1.8 1.0 0.5 0.6 3.4 3.7 2.5 29.5 1.5 2.3 1.8 135.5 66.1 0.2 0.7 1.9 3.8 75.2 11.0 14.7 13.6 8.3 3.8 74.3 16.0 3.4 8.6 34.1 4.5 0.0 59.0 17.9 9.6 11.3 334.8 23.1 7.7 4.1 21.5 1.4 35.3 8.1 14.1 1.8 57.1 0.4 16.0 0.0 14.1 155.5 16.4 2.5 4.9 0.1 1.2 1.5 36.4 10.2 25.1 6.6 16.7 11.8 2.8 1.4 0.6 1.4 302.4 0.8 15.2 4.3 0.4 TMEM26 "Em:AC068892.1, MGC35010" ENSG00000196932 "Transmembrane protein 26" Q6ZUK4 10 61406642-61453381 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.8" "Cell type enhanced" "Detected in some" "Breast glandular cells: 8.2;Endometrial stromal cells: 5.4;Excitatory neurons: 5.3;Hepatic stellate cells: 4.6;Inhibitory neurons: 4.8;Kupffer cells: 12.2;Late spermatids: 5.6;Theca cells: 15.0" "Group enriched" "Detected in some" 4 "breast cancer: 2.5;endometrial cancer: 1.0;prostate cancer: 1.8;renal cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.7;fHDF/TERT166: 1.1;HSkMC: 2.0;HUVEC TERT2: 1.5;MOLT-4: 2.3" "Region enhanced" "Detected in some" "hypothalamus: 2.3" "Low region specificity" "Detected in all" NA NA "Cluster 64: Macrophages - Immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 35: Glandular cells - Unknown function" "unprognostic (1.21e-3)" "unprognostic (2.84e-1)" "unprognostic (7.34e-2)" "unprognostic (7.83e-2)" "unprognostic (1.38e-3)" "unprognostic (1.30e-1)" "unprognostic (7.56e-2)" "unprognostic (3.69e-2)" "unprognostic (3.13e-1)" "unprognostic (9.41e-2)" "unprognostic (5.38e-2)" "unprognostic (5.24e-2)" "unprognostic (2.29e-5)" "unprognostic (2.55e-2)" "unprognostic (1.51e-2)" "unprognostic (8.53e-2)" "unprognostic (1.95e-1)" 0.5 0.5 1.3 0.9 1.4 0.1 5.2 0.3 1.1 2.3 0.2 0.7 1.4 4.0 0.1 0.5 0.4 1.0 0.2 1.1 0.8 2.2 2.5 1.4 0.7 0.8 1.0 0.5 0.0 1.4 0.2 1.5 0.4 2.6 0.9 0.0 0.0 2.4 0.8 0.0 0.8 2.0 0.5 8.8 0.2 3.6 1.5 2.1 0.4 0.2 0.2 0.7 0.5 0.7 0.0 0.0 0.1 0.0 0.1 0.8 0.1 0.0 4.7 0.4 0.6 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.0 0.0 0.5 0.0 0.5 1.5 0.5 0.0 0.0 0.1 0.0 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.4 0.3 1.1 1.1 0.8 0.8 1.0 0.4 0.5 1.5 0.7 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 2.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.7 5.4 1.7 0.0 0.0 5.3 0.0 0.0 1.4 0.0 1.6 0.0 0.1 4.6 0.2 0.3 0.0 4.8 0.0 0.0 12.2 0.0 5.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.1 1.2 0.5 0.2 0.0 0.1 0.0 0.1 15.0 0.0 0.0 CABCOCO1 "bA63A2.1, C10orf107, Em:AC022398.2, MGC44593" ENSG00000183346 "Ciliary associated calcium binding coiled-coil 1" Q8IVU9 10 61662929-61766766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.6;testis: 15.5" "Group enriched" "Detected in some" 10 "Endometrial ciliated cells: 60.4;Respiratory ciliated cells: 88.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "MOLT-4: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041398 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Centrosome "Nucleoplasm, Cytosol" "HPA041398: AB_10794374" "unprognostic (1.89e-3)" "unprognostic (7.37e-2)" "unprognostic (2.23e-1)" "prognostic favorable (1.79e-4)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (5.52e-2)" "unprognostic (4.43e-2)" "unprognostic (3.31e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.52e-3)" "unprognostic (2.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.33e-2)" 1.0 0.5 4.2 0.2 4.2 0.0 1.2 3.5 3.9 4.2 5.9 1.2 0.3 3.5 0.5 0.3 26.6 0.8 0.2 4.4 4.6 1.8 0.3 4.1 0.0 6.8 8.9 0.2 0.5 2.9 4.2 0.8 7.2 4.1 0.6 0.9 1.0 2.5 0.1 0.3 0.5 0.7 8.3 1.0 0.5 15.5 4.0 0.1 0.7 0.0 0.1 0.4 0.6 7.8 0.0 0.2 0.1 0.0 0.0 2.5 0.0 0.4 1.7 0.3 0.6 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.1 1.0 0.9 0.5 0.1 0.0 0.1 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 5.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 4.2 3.5 3.9 4.4 4.6 6.8 8.9 7.2 8.3 4.0 7.8 1.9 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.0 0.0 7.4 3.7 0.0 0.3 0.0 0.0 0.0 0.8 0.0 60.4 4.1 0.4 0.0 0.0 0.0 0.2 0.2 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 88.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.2 1.2 0.0 0.0 ARID5B "FLJ21150, MRF2" ENSG00000150347 "AT-rich interaction domain 5B" Q14865 10 61901684-62096944 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 968.2;Syncytiotrophoblasts: 920.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 115.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015037 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Cytosol" "HPA015037: AB_1845015" "unprognostic (3.31e-1)" "unprognostic (1.99e-2)" "unprognostic (2.94e-2)" "unprognostic (1.86e-1)" "unprognostic (1.17e-1)" "unprognostic (5.60e-2)" "unprognostic (1.50e-2)" "unprognostic (4.90e-2)" "unprognostic (3.90e-1)" "unprognostic (6.03e-2)" "unprognostic (1.97e-1)" "unprognostic (5.75e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (2.58e-1)" "unprognostic (1.94e-1)" "unprognostic (3.93e-2)" 50.0 8.1 2.9 21.2 5.8 6.9 34.3 3.2 11.3 37.2 20.7 17.5 10.2 39.0 4.6 20.2 20.6 39.3 18.3 4.4 1.6 21.4 8.3 18.3 18.8 7.8 6.9 17.5 6.2 13.3 10.0 21.0 11.4 18.3 11.7 4.1 15.8 10.2 87.2 18.1 14.2 42.5 0.9 16.9 11.5 6.9 9.0 13.1 7.8 11.9 16.7 30.9 19.6 9.7 2.2 0.9 6.0 14.7 13.0 34.0 1.2 42.9 115.2 29.9 23.3 52.7 2.3 3.9 10.1 41.4 4.3 14.3 20.6 6.5 36.0 13.7 6.1 2.1 10.4 13.5 23.9 0.6 25.2 43.3 3.4 17.6 20.2 26.2 3.9 7.5 1.9 5.7 9.9 7.7 14.4 1.1 1.1 10.2 13.5 17.7 9.8 1.1 20.1 23.9 3.3 4.4 19.2 10.6 12.8 13.1 8.7 0.7 3.3 16.5 22.0 25.1 10.9 0.4 0.0 11.4 14.3 0.8 5.4 9.6 1.2 0.8 13.3 2.8 1.8 37.5 19.7 11.8 2.2 41.2 12.8 8.4 2.2 12.3 8.2 1.0 30.9 5.4 2.9 5.8 3.2 11.3 4.4 1.6 7.8 6.9 11.4 0.9 9.0 9.7 86.2 131.4 70.7 54.5 199.8 968.2 453.9 111.3 105.9 54.4 112.8 96.6 72.8 27.1 96.3 51.5 0.0 187.8 89.1 7.5 99.7 56.1 31.7 164.7 231.0 134.1 36.4 5.2 167.8 14.6 150.7 343.6 21.4 457.7 24.6 37.6 119.2 7.4 51.0 74.0 181.9 18.7 22.4 44.1 162.4 20.1 151.6 43.6 138.7 34.7 39.0 17.2 58.7 74.4 155.8 41.1 25.2 60.5 234.5 193.7 5.4 304.8 38.4 3.6 131.5 496.3 463.9 8.2 5.8 65.7 477.8 920.4 178.2 24.3 41.7 233.9 RTKN2 "bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1" ENSG00000182010 "Rhotekin 2" Q8IZC4 10 62183035-62268844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lung: 77.5" "Group enriched" "Detected in many" 10 "Alveolar cells type 1: 1753.2;Early spermatids: 480.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.6" "Immune cell enriched" "Detected in some" 8 "T-reg: 16.7" "Lineage enriched" "Detected in single" 72 "T-cells: 16.7" "Cell line enhanced" "Detected in many" "A-431: 45.2;HaCaT: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037946, HPA038446" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 19: Lung - Lung function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm Mitochondria "HPA037946: AB_10795398, HPA038446: AB_10796218" "unprognostic (2.33e-1)" "unprognostic (2.59e-1)" "unprognostic (2.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.26e-1)" "unprognostic (8.92e-3)" "unprognostic (6.66e-5)" "unprognostic (7.81e-3)" "unprognostic (2.33e-2)" "unprognostic (3.24e-1)" "unprognostic (3.72e-2)" "unprognostic (9.48e-4)" "unprognostic (3.70e-11)" "unprognostic (3.95e-2)" "unprognostic (9.34e-3)" "unprognostic (4.68e-3)" "unprognostic (1.55e-1)" 0.2 0.1 0.1 1.7 0.4 0.8 1.1 0.6 1.6 1.5 0.0 1.6 1.3 0.9 0.1 7.1 0.2 0.7 0.1 0.2 0.0 0.4 0.2 77.5 3.5 0.0 0.0 0.2 0.1 0.4 0.8 1.3 0.0 1.1 2.0 0.9 1.4 0.2 0.0 1.2 1.5 0.4 0.0 1.4 1.2 7.6 0.1 3.9 0.6 0.0 3.4 1.2 3.1 0.5 45.2 2.6 23.2 10.8 0.0 0.1 5.6 6.4 7.4 7.2 11.2 18.7 8.9 0.1 2.8 2.6 7.3 35.3 13.1 1.0 7.4 6.4 8.9 7.5 5.4 7.8 0.1 9.9 5.6 0.3 0.6 8.8 0.9 3.8 1.1 11.8 0.5 0.2 9.7 5.6 19.8 13.1 9.8 6.7 8.7 16.9 24.9 0.1 4.6 19.5 12.6 14.5 4.3 14.8 6.0 6.8 13.4 5.6 0.1 3.3 20.8 0.2 16.5 0.1 0.1 17.2 4.2 0.0 5.2 0.1 0.0 0.0 1.1 0.0 0.0 0.0 2.0 0.4 0.1 0.1 0.6 0.3 0.2 0.1 0.0 0.1 16.7 0.2 0.1 0.4 0.6 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.4 1753.2 45.8 0.3 1.5 4.7 10.2 3.0 0.0 0.7 5.0 3.6 0.5 1.5 10.9 0.0 0.0 9.0 2.0 1.9 0.0 1.6 480.3 5.6 1.4 0.7 1.8 1.7 21.5 1.6 7.2 2.9 7.1 10.8 3.8 12.9 1.1 0.0 2.4 0.0 2.5 8.5 6.1 0.6 2.9 102.8 2.1 2.1 1.8 1.0 0.4 0.3 0.0 0.5 1.0 15.4 0.7 1.9 3.3 9.7 0.5 1.9 2.8 0.5 0.0 0.6 3.4 23.5 24.6 26.2 1.8 2.1 17.4 2.9 7.0 97.3 ZNF365 "KIAA0844, UAN" ENSG00000138311 "Zinc finger protein 365" Q70YC5 10 62374192-62480288 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.7;esophagus: 10.2" "Group enriched" "Detected in some" 6 "Excitatory neurons: 112.7;Oligodendrocyte precursor cells: 113.6;Oligodendrocytes: 195.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 22.7;hippocampal formation: 8.3;thalamus: 8.0;white matter: 16.6" "Group enriched" "Detected in many" 9 "gdT-cell: 2.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.7;naive CD8 T-cell: 2.7;NK-cell: 6.4;T-reg: 5.9" "Group enriched" "Detected in many" 62 "NK-cells: 6.4;T-cells: 5.9" "Cell line enhanced" "Detected in many" "HaCaT: 22.3;PC-3: 13.9;U-251 MG: 18.6;U-87 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052446 Supported Approved Vesicles,Centrosome NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Centrosome" "HPA052446: AB_2681836" "unprognostic (7.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.36e-1)" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (4.05e-3)" "unprognostic (1.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.15e-2)" "unprognostic (3.11e-3)" "unprognostic (3.06e-2)" "unprognostic (7.90e-2)" "unprognostic (1.12e-6)" "unprognostic (2.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-4)" "unprognostic (2.89e-2)" 0.1 1.3 1.0 0.1 2.8 0.0 0.3 1.5 22.7 0.9 0.0 0.0 0.1 0.1 0.2 10.2 0.1 0.3 1.0 8.3 0.0 0.1 0.0 0.7 0.0 0.0 3.2 0.0 0.4 5.6 1.6 0.1 0.0 1.8 0.1 5.1 1.1 2.0 0.0 0.8 0.1 0.1 0.0 0.3 0.0 0.5 8.0 0.5 0.6 0.1 1.4 0.8 1.1 16.6 6.3 0.6 0.1 0.0 0.1 0.0 0.0 5.5 5.8 2.6 2.1 0.0 1.0 0.0 0.2 3.1 8.4 22.3 0.0 0.4 3.5 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.9 6.6 0.9 0.0 0.0 0.0 5.5 2.1 0.7 0.0 0.9 0.0 13.9 0.0 0.2 0.0 0.3 2.8 0.1 1.2 1.1 0.2 0.6 0.0 0.0 0.0 0.0 1.1 6.1 0.0 18.6 0.0 0.0 0.0 12.9 0.0 1.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.1 2.7 0.0 0.0 0.4 2.7 0.0 6.4 0.0 0.0 5.9 0.8 1.0 2.8 1.5 22.7 8.3 0.0 0.0 3.2 0.0 0.0 8.0 16.6 0.0 0.0 0.0 15.3 0.2 0.5 3.7 0.6 0.0 13.5 0.3 0.3 2.6 1.5 0.1 3.7 2.1 0.0 2.8 0.0 0.0 0.2 0.5 0.3 0.2 0.2 0.0 0.0 112.7 0.0 0.0 0.9 0.0 0.6 0.0 0.1 0.0 0.0 0.1 18.5 23.4 0.0 0.0 0.3 1.1 0.3 0.0 0.4 0.0 6.5 0.0 2.7 0.0 113.6 195.5 0.9 0.0 0.0 1.9 1.2 0.0 0.7 0.1 5.3 0.0 0.8 0.8 0.1 0.7 0.0 0.4 0.0 3.9 0.2 0.0 6.0 AC024598.1 ENSG00000285837 "Novel protein" 10 62374192-62672011 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "gallbladder: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.1;TIME: 2.5" HPA052446 Uncertain Approved Vesicles,Centrosome NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Vesicles, Centrosome" "HPA052446: AB_2681836" 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.7 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.3 0.7 0.1 0.4 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADO "C10orf22, FLJ14547" ENSG00000181915 "2-aminoethanethiol dioxygenase" Q96SZ5 10 62804720-62808479 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 186.2;Late spermatids: 317.6;Spermatocytes: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "PC-3: 99.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039194, HPA040437" Approved NA NA "Cluster 37: B-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "HPA039194: AB_10794994, HPA040437: AB_10795633" "unprognostic (4.41e-2)" "unprognostic (1.44e-1)" "unprognostic (9.25e-2)" "unprognostic (1.73e-2)" "unprognostic (1.54e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (8.01e-5)" "unprognostic (4.48e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-1)" "unprognostic (4.24e-2)" "unprognostic (8.64e-2)" "unprognostic (8.68e-2)" "unprognostic (4.11e-2)" "unprognostic (7.46e-2)" "unprognostic (2.64e-1)" "unprognostic (4.59e-2)" 8.9 8.4 12.8 7.6 17.8 5.1 9.2 20.5 17.0 8.4 7.5 7.2 7.0 8.7 13.1 6.7 7.0 7.4 14.5 11.8 14.6 11.3 7.4 7.7 10.0 19.7 17.7 10.5 7.9 12.4 4.0 7.2 18.3 9.7 6.3 10.5 6.4 8.8 11.7 6.1 6.5 9.3 19.0 8.5 7.4 37.6 16.3 8.9 11.9 17.4 9.9 8.6 4.9 28.0 14.3 10.3 20.1 33.2 21.6 16.3 11.9 17.3 20.5 18.2 19.7 16.2 11.2 13.3 8.9 17.8 14.4 21.6 21.0 13.3 19.3 18.3 15.8 9.1 10.8 13.7 22.3 31.3 22.8 14.0 25.3 19.1 30.7 27.8 14.0 17.3 16.8 12.5 24.4 13.6 20.5 30.5 18.7 13.7 99.1 23.9 16.1 8.2 17.6 9.0 20.9 34.3 17.4 23.8 36.4 16.1 15.5 21.5 12.1 18.3 18.9 15.0 29.0 22.8 44.8 21.1 22.2 32.8 12.0 0.8 0.8 0.2 0.4 1.3 0.8 1.3 0.5 0.6 0.9 0.8 0.4 0.8 0.0 0.8 0.9 0.6 0.3 0.4 12.8 17.8 20.5 17.0 11.8 14.6 19.7 17.7 18.3 19.0 16.3 28.0 7.6 9.6 7.3 3.9 7.2 15.9 11.9 4.3 9.6 23.4 9.9 7.1 32.2 5.7 4.3 14.7 6.2 9.1 8.5 5.3 19.6 6.6 186.2 2.7 13.2 9.0 4.9 4.0 9.5 5.3 7.9 11.5 8.2 4.4 2.5 9.2 10.8 3.7 12.7 32.0 7.8 6.8 0.0 11.9 13.3 317.6 10.5 10.9 12.4 3.7 11.3 12.5 7.2 6.0 22.4 7.5 3.4 26.7 3.2 12.1 4.8 15.8 5.6 17.7 13.1 13.0 11.7 90.5 8.4 9.4 21.7 3.8 8.9 12.5 8.4 10.8 EGR2 KROX20 ENSG00000122877 "Early growth response 2" P11161 10 62811996-62919900 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 59.9;thyroid gland: 136.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 55.5;Breast myoepithelial cells: 68.1;Enteroendocrine cells: 73.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 19.7" "Group enriched" "Detected in many" 5 "cerebral cortex: 10.2;hippocampal formation: 5.2" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.5;non-classical monocyte: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "U-87 MG: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031165 Supported Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA031165: AB_2673768" "prognostic favorable (7.30e-5)" "unprognostic (1.86e-3)" "unprognostic (1.45e-2)" "unprognostic (8.72e-2)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (2.70e-1)" "unprognostic (1.75e-1)" "unprognostic (9.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (2.47e-3)" "unprognostic (6.54e-2)" "unprognostic (1.74e-2)" "unprognostic (3.46e-1)" "unprognostic (1.11e-3)" 13.7 10.6 0.4 9.8 1.2 8.2 8.6 1.3 10.2 18.5 2.0 3.3 1.9 6.0 59.9 8.8 4.5 31.9 14.9 5.2 0.2 7.9 5.4 15.2 14.4 0.3 0.3 9.4 4.2 7.0 8.7 3.0 0.7 17.5 3.7 1.4 2.9 1.9 0.9 14.2 4.6 16.8 0.1 4.5 2.3 4.1 0.6 26.4 136.4 9.1 7.1 15.7 1.7 1.5 0.0 0.2 2.5 1.0 1.8 2.4 0.4 0.5 0.2 0.6 0.8 0.0 0.3 0.6 0.0 0.6 0.7 0.3 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.6 3.8 0.3 0.6 1.3 0.2 0.8 0.1 0.3 0.2 0.8 0.1 1.2 0.0 1.8 0.2 0.1 1.1 0.1 0.3 0.4 0.0 0.2 0.1 0.3 0.2 0.5 4.2 0.5 0.0 0.5 0.1 0.5 0.4 0.2 0.3 1.3 0.7 0.3 22.5 0.5 0.4 0.0 0.5 0.2 0.1 2.5 0.0 0.4 0.0 0.1 0.5 0.4 0.0 0.1 0.7 0.2 2.3 0.0 0.0 0.4 0.4 1.2 1.3 10.2 5.2 0.2 0.3 0.3 0.7 0.1 0.6 1.5 15.9 0.0 12.6 0.0 14.0 21.3 30.1 36.0 33.0 1.4 55.5 68.1 7.8 0.0 9.4 0.0 0.0 1.1 9.9 9.5 0.0 1.4 8.9 13.9 14.0 16.7 73.1 0.0 1.7 0.6 1.6 30.4 13.3 26.1 20.8 2.3 5.3 2.4 25.2 0.0 0.5 29.4 14.2 28.1 39.5 4.3 1.8 40.5 8.8 0.0 0.8 4.1 0.0 0.0 0.1 1.0 4.4 7.2 6.4 5.5 7.7 0.0 7.1 0.7 6.6 20.7 12.0 0.1 2.0 14.8 12.5 1.1 13.6 5.1 25.8 3.1 NRBF2 "COPR1, COPR2, DKFZp564C1664, FLJ30395" ENSG00000148572 "Nuclear receptor binding factor 2" Q96F24 10 63133247-63155031 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 285.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "neutrophil: 687.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 687.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021670, HPA059477" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nucleoplasm, Cytosol" "HPA021670: AB_2670803, HPA059477: AB_2684032" "unprognostic (7.71e-2)" "unprognostic (2.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.05e-2)" "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-2)" "unprognostic (2.42e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (2.36e-4)" "unprognostic (2.38e-1)" "unprognostic (3.21e-2)" "unprognostic (2.44e-2)" "unprognostic (1.59e-2)" 18.8 12.6 8.7 20.9 9.2 33.8 17.8 10.5 12.1 15.0 8.6 16.6 16.8 13.1 11.1 14.9 9.5 17.2 12.6 9.5 10.2 14.1 45.1 16.4 21.2 11.0 13.0 11.4 10.4 10.8 9.7 22.0 13.1 10.3 16.7 7.2 14.5 8.6 24.7 15.3 15.7 14.2 10.3 22.6 13.4 11.9 10.5 22.5 18.5 26.3 20.2 19.8 10.7 10.7 23.9 20.8 20.7 19.3 48.5 74.5 20.7 33.2 56.4 26.0 36.7 44.5 24.9 30.8 15.8 37.6 26.1 18.3 20.3 28.0 35.7 27.7 19.6 22.9 10.3 36.0 61.4 30.6 25.5 69.1 59.0 42.5 103.4 48.8 27.1 19.7 23.4 34.8 33.6 17.4 25.9 54.1 24.3 19.4 84.8 25.0 18.8 18.2 30.2 13.4 11.9 20.3 19.9 38.4 61.7 33.8 23.8 30.0 28.2 18.1 26.7 28.3 36.2 43.5 35.6 37.2 50.6 48.2 14.8 124.6 79.5 162.1 28.8 92.3 30.4 47.9 29.4 32.2 68.7 42.5 35.9 33.1 687.6 32.6 93.4 34.1 36.6 55.2 8.7 9.2 10.5 12.1 9.5 10.2 11.0 13.0 13.1 10.3 10.5 10.7 29.7 3.2 30.6 3.9 45.7 28.8 41.8 42.8 20.5 12.2 30.1 40.0 8.9 14.3 30.6 12.9 4.2 53.1 44.0 31.5 23.5 31.6 10.3 30.6 49.9 26.0 15.6 13.2 9.4 35.0 76.8 34.8 16.8 37.7 14.0 15.2 17.9 53.2 48.9 20.2 8.4 41.1 32.6 49.7 34.9 6.3 23.3 56.0 46.2 10.3 56.6 15.4 35.0 5.5 9.3 40.0 32.0 21.4 43.1 40.0 31.9 31.4 24.7 9.0 19.7 26.0 30.6 55.4 71.1 29.4 31.8 285.3 43.3 25.2 29.6 68.6 JMJD1C "DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8" ENSG00000171988 "Jumonji domain containing 1C" Q15652 10 63167221-63521850 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 590.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 49.7" "Immune cell enhanced" "Detected in many" "neutrophil: 14.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056175, HPA066195" Approved Supported Nucleoplasm,Cytosol No No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "HPA056175: AB_2683057, HPA066195: AB_2685634" "unprognostic (7.72e-2)" "unprognostic (5.57e-2)" "unprognostic (9.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.87e-2)" "unprognostic (6.91e-2)" "unprognostic (3.85e-1)" "unprognostic (2.54e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (2.22e-3)" "unprognostic (1.27e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-2)" "unprognostic (2.53e-1)" "unprognostic (4.18e-2)" "unprognostic (1.13e-1)" 16.3 12.5 3.7 18.9 5.4 40.2 22.3 49.7 6.6 19.9 6.4 11.3 16.9 24.0 11.3 12.8 12.5 24.6 12.1 4.0 4.5 15.6 22.3 16.0 22.1 5.0 5.0 24.7 13.1 21.9 6.8 14.4 6.2 14.1 12.3 41.4 13.1 11.5 11.0 11.1 18.9 15.6 3.1 20.9 14.5 15.7 4.8 20.4 20.8 13.8 21.3 16.0 9.4 7.7 23.2 11.5 26.5 20.4 13.8 25.2 9.3 15.8 32.5 13.9 19.0 19.8 24.2 31.3 9.4 14.9 12.6 18.6 7.6 15.2 24.7 8.5 9.6 11.9 11.9 14.4 16.8 25.8 4.3 25.3 15.3 24.7 71.3 31.5 25.4 22.0 21.4 23.0 33.1 6.2 19.8 13.8 28.3 5.2 40.0 34.0 57.5 15.0 14.1 16.5 14.4 23.5 23.8 14.7 22.8 19.3 14.6 46.0 30.6 12.9 18.1 11.3 20.0 20.4 17.4 29.1 15.7 15.1 11.7 0.6 2.7 3.2 1.8 1.8 2.7 4.4 1.9 1.9 2.3 4.2 2.7 2.3 14.1 1.7 1.6 4.0 1.8 1.1 3.7 5.4 49.7 6.6 4.0 4.5 5.0 5.0 6.2 3.1 4.8 7.7 256.1 112.2 93.3 214.5 184.4 151.9 369.2 46.6 93.9 88.7 106.7 92.7 69.4 55.8 96.9 55.2 152.2 34.7 117.4 80.7 13.7 63.3 38.3 155.8 179.7 176.7 86.0 75.3 590.1 47.0 27.7 141.1 119.8 210.1 93.1 79.1 118.2 37.2 57.9 117.8 416.5 66.8 38.7 89.8 185.0 42.3 103.8 206.8 76.5 355.1 96.6 61.2 58.7 419.2 378.8 76.7 88.4 89.5 124.8 161.0 90.6 32.4 104.1 170.9 72.3 214.4 112.6 158.6 146.5 56.4 134.0 33.2 145.6 76.0 52.3 286.7 REEP3 "C10orf74, Yip2b" ENSG00000165476 "Receptor accessory protein 3" Q6NUK4 10 63521401-63625128 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 346.0;Urothelial cells: 270.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (4.85e-2)" "unprognostic (7.07e-3)" "unprognostic (2.89e-2)" "unprognostic (6.25e-2)" "unprognostic (3.50e-3)" "prognostic unfavorable (7.83e-4)" "prognostic unfavorable (3.19e-4)" "unprognostic (1.13e-2)" "unprognostic (9.33e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.89e-2)" "unprognostic (6.82e-2)" "unprognostic (2.18e-1)" "unprognostic (4.06e-2)" 26.5 16.0 10.9 10.3 21.8 2.1 15.9 20.0 12.9 23.5 19.4 16.3 28.3 19.9 16.2 17.1 10.6 15.6 10.5 9.8 15.0 14.0 21.0 17.2 8.8 23.9 20.2 7.4 9.1 29.1 7.0 20.7 23.8 21.6 17.1 6.7 19.8 19.1 6.9 15.5 29.0 25.7 17.8 11.3 13.3 9.2 17.9 6.2 21.0 8.1 9.1 23.6 9.9 35.4 53.6 23.7 21.6 20.7 77.9 76.9 24.3 40.0 66.0 29.9 42.2 33.5 81.2 4.9 14.9 58.5 9.9 61.7 8.7 56.1 52.6 16.3 17.8 11.2 9.7 21.5 50.4 12.5 0.2 65.0 43.2 42.0 63.3 74.2 52.6 6.4 5.5 23.4 54.9 16.3 9.0 19.3 7.5 10.2 50.0 16.0 14.5 10.1 43.1 31.0 6.4 21.7 37.1 36.1 34.7 30.5 35.7 28.6 39.9 28.6 8.6 26.0 31.2 20.0 32.6 7.5 25.8 0.1 30.6 0.1 3.3 2.1 1.6 4.6 3.4 2.0 3.5 2.4 2.9 1.5 1.3 1.9 1.5 1.7 3.0 3.1 5.1 1.6 10.9 21.8 20.0 12.9 9.8 15.0 23.9 20.2 23.8 17.8 17.9 35.4 96.6 28.9 30.4 46.0 25.4 64.5 108.2 46.8 31.9 13.6 76.4 57.1 24.5 34.3 65.9 82.8 27.1 66.7 23.1 113.8 29.4 71.5 346.0 28.9 56.1 64.2 43.0 21.0 96.7 72.1 97.4 56.2 37.8 34.4 9.5 10.7 65.3 71.8 44.2 20.2 37.5 47.0 54.9 38.5 45.4 107.5 105.9 47.6 39.2 65.6 47.1 16.9 13.4 75.9 145.3 156.4 88.3 124.8 47.2 190.8 179.2 46.5 52.1 22.5 98.6 32.0 72.0 133.6 8.8 38.6 73.2 117.5 30.4 42.7 29.4 270.2 CTNNA3 "MGC26194, VR22" ENSG00000183230 "Catenin alpha 3" Q9UI47 10 65912523-67696195 "Disease related genes, Predicted intracellular proteins" "Cell adhesion" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 176.3" "Cell type enriched" "Detected in some" 14 "Oligodendrocytes: 4054.6" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.4;Karpas-707: 1.5;NTERA-2: 1.7;RPMI-8226: 2.4;SCLC-21H: 1.5;U-266/70: 6.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061818 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA061818: AB_2684618" "unprognostic (2.19e-1)" "unprognostic (1.57e-1)" "unprognostic (8.64e-4)" "unprognostic (8.13e-3)" "unprognostic (6.43e-3)" "unprognostic (9.90e-2)" "unprognostic (2.60e-4)" "unprognostic (8.27e-2)" "unprognostic (5.10e-2)" "unprognostic (2.55e-1)" "unprognostic (9.09e-3)" "unprognostic (1.15e-1)" "unprognostic (2.67e-3)" "unprognostic (7.93e-5)" "unprognostic (6.43e-2)" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" 0.7 0.5 31.8 0.6 96.9 0.1 0.5 49.3 49.7 1.4 0.0 2.0 0.3 1.3 0.1 1.4 0.7 0.6 18.7 30.3 51.6 0.5 8.5 0.1 0.2 90.9 66.8 1.7 0.1 0.2 0.2 0.4 95.3 0.4 0.6 0.4 0.3 0.2 12.0 0.2 0.8 2.6 52.4 0.3 1.2 2.2 69.7 0.1 0.3 23.4 0.3 0.6 0.6 176.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.6 0.7 0.1 0.0 2.4 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.4 0.0 0.0 6.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 31.8 96.9 49.3 49.7 30.3 51.6 90.9 66.8 95.3 52.4 69.7 176.3 0.4 0.0 0.0 24.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 75.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 217.8 0.0 1.5 1.2 0.0 0.0 49.8 0.0 0.0 2.5 0.0 0.1 0.0 2.6 0.4 5.7 0.0 0.0 50.6 0.0 0.0 0.8 0.3 275.5 4.4 0.3 0.0 30.0 0.0 1.4 0.0 50.3 4054.6 0.0 0.1 4.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 9.3 4.0 1.6 0.0 0.1 0.0 0.1 4.6 0.1 0.0 LRRTM3 ENSG00000198739 "Leucine rich repeat transmembrane neuronal 3" Q86VH5 10 66926036-67101551 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.6;brain: 4.8;ovary: 2.7;pituitary gland: 3.4" "Group enriched" "Detected in some" 22 "Early spermatids: 164.0;Excitatory neurons: 485.6;Inhibitory neurons: 577.7;Late spermatids: 178.7;Oligodendrocyte precursor cells: 601.7;Oligodendrocytes: 253.5" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.4;HAP1: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA070444, HPA078598" Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear bodies" "HPA070444: , HPA078598: " "unprognostic (1.21e-2)" "unprognostic (4.85e-2)" "unprognostic (1.12e-1)" "unprognostic (4.02e-2)" "unprognostic (1.15e-4)" "unprognostic (8.11e-2)" "unprognostic (4.77e-1)" 0.1 2.6 2.7 0.0 3.1 0.0 0.0 1.0 4.8 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.9 0.7 0.0 0.0 0.2 0.0 0.0 0.6 2.7 1.0 0.0 3.4 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.1 1.0 4.8 3.9 0.7 0.0 0.6 0.0 0.1 1.0 3.4 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.0 0.0 0.2 0.2 0.0 0.0 485.6 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 577.7 0.0 0.0 0.0 0.0 178.7 8.7 0.1 0.0 8.4 0.0 0.4 0.0 601.7 253.5 0.1 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.3 2.5 1.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 DNAJC12 JDP1 ENSG00000108176 "DnaJ heat shock protein family (Hsp40) member C12" Q9UKB3 10 67796669-67838188 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 70.3;liver: 67.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 75.9;Enteroendocrine cells: 166.2;Hepatocytes: 74.5;Intestinal goblet cells: 98.0;Proximal tubular cells: 163.2" "Cancer enhanced" "Detected in many" "breast cancer: 22.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "plasmacytoid DC: 7.7" "Lineage enriched" "Detected in single" 24 "dendritic cells: 7.7" "Cell line enhanced" "Detected in many" "Daudi: 91.5;NB-4: 76.0;SCLC-21H: 72.0;U-698: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036289 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 22: Non-specific - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 30: Mammary glandular cells - Lactation" "HPA036289: AB_10670794" "unprognostic (1.52e-2)" "unprognostic (3.65e-3)" "unprognostic (4.12e-2)" "unprognostic (2.28e-2)" "unprognostic (5.28e-2)" "unprognostic (6.59e-3)" "unprognostic (6.35e-2)" "unprognostic (3.46e-2)" "unprognostic (7.14e-2)" "unprognostic (5.05e-2)" "unprognostic (3.97e-2)" "unprognostic (7.31e-3)" "prognostic unfavorable (1.97e-10)" "unprognostic (7.35e-3)" "unprognostic (1.37e-1)" "unprognostic (5.81e-3)" "unprognostic (7.99e-2)" 2.0 70.3 23.3 2.3 26.3 1.5 30.2 36.5 28.5 6.0 12.8 9.1 3.2 7.3 5.9 1.2 3.4 5.4 6.6 26.3 29.1 29.5 67.5 1.6 0.6 22.5 50.1 15.0 37.0 6.6 41.1 0.1 29.0 7.6 14.2 13.6 5.4 4.8 10.9 0.3 4.7 6.0 19.7 1.2 6.6 7.0 23.2 2.1 1.5 9.9 0.7 4.4 3.3 23.4 0.0 32.9 5.3 0.9 7.5 6.1 0.1 0.1 2.0 1.1 6.8 0.5 0.0 91.5 13.4 0.1 0.4 0.0 0.9 1.2 0.3 4.4 36.9 21.9 26.9 8.5 7.9 41.7 0.5 19.3 7.6 3.2 1.9 0.1 11.4 2.6 40.5 1.2 3.2 1.8 2.0 76.0 1.5 0.4 36.4 1.2 3.0 48.2 0.8 0.0 72.0 41.1 0.5 14.4 1.3 0.3 0.7 0.4 0.0 3.5 1.0 0.8 1.0 8.6 1.0 68.2 6.6 49.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.1 0.3 0.0 0.0 0.0 7.7 0.0 0.0 23.3 26.3 36.5 28.5 26.3 29.1 22.5 50.1 29.0 19.7 23.2 23.4 1.5 0.0 1.1 2.9 2.1 0.3 2.2 1.4 0.6 31.9 75.9 35.6 9.3 1.5 13.0 5.5 6.2 0.1 0.6 7.2 9.8 1.5 5.6 2.2 24.8 2.3 166.2 9.1 12.3 55.9 0.1 8.7 6.1 1.6 0.0 2.0 1.4 74.5 0.6 38.7 14.8 98.0 8.2 2.6 0.4 4.2 16.1 3.1 0.0 1.0 3.7 13.5 0.0 11.6 13.6 43.4 4.1 21.4 0.4 26.3 1.1 163.2 20.3 5.5 0.0 4.6 5.3 2.8 0.7 0.2 0.1 0.0 0.9 21.6 4.4 1.3 SIRT1 SIR2L1 ENSG00000096717 "Sirtuin 1" Q96EB6 10 67884656-67918390 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 292.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003855, HPA006295, HPA052351" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nucleoli fibrillar center, Mitochondria, Cytosol" "CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796" "unprognostic (1.55e-1)" "unprognostic (2.78e-1)" "unprognostic (9.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-2)" "unprognostic (2.48e-1)" "unprognostic (4.95e-2)" "unprognostic (1.41e-1)" "unprognostic (4.64e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (2.18e-2)" "unprognostic (2.83e-2)" "unprognostic (9.67e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" 16.4 30.2 8.9 11.0 10.4 19.8 17.5 15.6 11.9 17.1 7.8 12.5 9.2 18.5 11.9 10.9 11.9 14.0 10.6 8.5 9.9 13.4 17.3 12.6 17.7 9.3 9.2 25.1 12.1 14.0 6.9 12.7 10.0 14.0 12.0 13.5 9.9 11.2 14.6 9.6 9.7 13.7 8.8 14.3 10.3 26.8 9.4 19.2 14.7 18.5 15.1 15.5 9.5 12.9 15.1 16.8 26.2 29.4 24.4 18.7 16.3 20.4 21.0 27.4 24.3 18.7 12.6 31.4 10.8 13.7 17.1 11.7 32.8 6.9 29.3 16.9 19.0 16.7 12.1 14.7 22.3 18.1 12.3 17.3 16.2 16.6 28.3 29.4 11.2 17.6 21.6 16.7 20.3 12.1 17.0 25.0 32.5 9.6 26.6 30.3 20.6 12.4 13.1 9.1 16.8 23.0 37.4 24.4 26.8 22.5 17.7 16.6 9.4 21.2 19.8 19.0 20.1 13.9 17.7 61.8 10.9 27.2 8.9 1.3 0.8 1.1 1.1 1.0 1.6 1.8 1.2 1.5 1.3 1.0 2.2 1.3 1.0 1.2 1.3 1.2 1.0 0.6 8.9 10.4 15.6 11.9 8.5 9.9 9.3 9.2 10.0 8.8 9.4 12.9 35.7 19.2 7.4 17.0 27.6 39.1 20.9 7.2 22.8 12.5 48.3 33.4 34.8 11.5 8.7 5.5 27.1 7.1 42.5 31.2 5.9 4.3 292.2 38.4 26.2 20.6 42.9 10.3 16.0 5.6 5.4 28.0 23.4 57.1 12.0 14.8 15.4 15.8 9.1 11.8 18.4 21.0 10.2 23.4 28.7 45.6 17.7 34.1 16.0 30.9 14.8 7.1 9.2 18.6 30.7 6.2 20.6 19.5 15.8 26.0 11.2 8.4 4.1 14.0 0.0 43.4 28.8 24.2 16.3 21.1 47.5 12.4 29.1 8.9 18.7 17.2 HERC4 "DKFZP564G092, KIAA1593" ENSG00000148634 "HECT and RLD domain containing E3 ubiquitin protein ligase 4" Q5GLZ8 10 67921899-68075301 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 174.9;Oligodendrocytes: 209.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 201.4;fHDF/TERT166: 226.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045453, HPA070301" Uncertain Supported "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Nucleoli fibrillar center" "HPA045453: AB_10961917, HPA070301: AB_2686247" "unprognostic (3.66e-2)" "unprognostic (6.31e-2)" "unprognostic (1.58e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-1)" "unprognostic (4.23e-2)" "unprognostic (3.51e-2)" "unprognostic (1.01e-3)" "unprognostic (3.54e-1)" "unprognostic (8.57e-2)" "unprognostic (4.94e-3)" "unprognostic (2.25e-2)" "prognostic unfavorable (3.86e-5)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "unprognostic (3.98e-1)" "unprognostic (2.31e-2)" 13.9 19.6 18.2 14.4 18.9 10.9 14.3 19.5 23.5 15.2 15.3 14.1 13.8 14.9 14.0 14.5 13.4 13.3 13.6 20.6 22.4 13.7 16.6 13.9 21.0 19.4 19.7 15.3 11.1 12.0 14.1 16.5 19.4 12.2 15.9 13.9 11.5 11.4 13.5 13.4 14.6 15.6 18.1 18.2 11.6 14.2 21.1 15.2 13.1 12.3 19.4 16.2 14.3 26.7 75.4 30.4 16.7 28.5 47.5 63.9 15.5 201.4 125.5 75.5 47.6 17.5 35.3 29.7 14.3 226.7 40.6 40.9 21.1 28.9 102.0 17.6 9.2 13.7 51.3 12.2 22.6 17.3 21.3 30.2 33.8 39.3 34.4 89.1 47.5 15.0 14.9 14.3 117.4 35.2 11.3 19.9 9.9 15.8 49.0 15.3 7.6 8.2 32.3 23.7 8.7 9.4 66.1 26.4 26.5 37.6 15.4 20.1 65.0 38.2 17.5 94.7 31.9 8.7 11.2 17.8 67.7 32.3 13.6 10.8 5.0 6.6 3.9 4.1 5.0 3.4 4.1 4.5 5.7 3.4 4.1 4.2 6.7 5.2 4.1 1.6 5.6 3.7 18.2 18.9 19.5 23.5 20.6 22.4 19.4 19.7 19.4 18.1 21.1 26.7 29.8 48.1 29.3 127.0 41.0 50.3 33.7 27.2 26.2 50.1 29.1 16.6 23.0 14.3 24.1 18.4 43.8 29.3 38.7 78.7 7.9 19.5 66.4 44.3 45.4 30.9 22.1 32.4 170.2 12.2 40.8 30.3 34.1 70.9 30.4 31.3 28.5 24.5 23.6 53.8 148.8 29.9 26.4 42.9 23.3 47.4 26.8 30.9 17.8 149.9 36.0 18.9 40.2 174.9 209.2 38.6 52.3 19.2 17.4 42.6 37.8 24.9 25.5 45.8 6.6 33.2 28.1 25.2 12.4 23.4 60.9 15.6 40.9 38.5 21.9 48.5 MYPN MYOP ENSG00000138347 Myopalladin Q86TC9 10 68106117-68212017 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 64.1;skeletal muscle: 283.6;tongue: 172.8" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 114.2" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 0.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "basophil: 1.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "BJ: 39.8;fHDF/TERT166: 112.3;HBF TERT88: 25.6;LHCN-M2: 47.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA036299, HPA061494" Enhanced Approved Nucleoplasm,Vesicles,Cytosol No No "Cluster 41: Basophils - Cellular respiration" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Vesicles" Cytosol "HPA036299: , HPA061494: AB_2684539" "unprognostic (4.75e-2)" "unprognostic (2.20e-1)" "unprognostic (8.14e-3)" "unprognostic (8.62e-3)" "unprognostic (3.91e-1)" "unprognostic (3.36e-3)" "unprognostic (4.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "unprognostic (2.26e-3)" "unprognostic (3.94e-3)" "unprognostic (3.10e-1)" "unprognostic (2.88e-8)" "unprognostic (4.63e-5)" "unprognostic (9.94e-2)" "unprognostic (2.01e-1)" "unprognostic (3.47e-1)" 0.1 0.3 0.2 0.2 0.1 0.6 0.1 0.5 0.2 0.0 0.0 0.3 0.1 0.1 0.1 2.2 0.0 0.1 64.1 0.8 0.8 0.0 0.0 0.0 0.2 0.6 0.2 0.1 0.6 0.0 0.0 0.1 0.1 1.7 0.1 1.7 2.7 0.0 283.6 0.1 0.1 0.2 0.0 0.1 0.8 0.9 0.0 0.1 0.0 172.8 0.0 0.1 0.0 0.3 2.9 1.3 0.0 0.0 0.7 4.1 0.1 39.8 19.7 14.4 5.4 0.0 0.1 0.1 0.0 112.3 20.5 0.7 0.0 0.2 25.6 0.4 0.0 0.0 14.6 0.0 0.3 0.0 0.1 1.6 0.0 7.9 0.9 3.6 0.4 0.0 0.0 0.2 47.6 8.6 0.0 0.1 0.0 0.0 1.3 0.0 2.2 0.0 0.1 0.1 0.1 0.0 5.7 0.9 0.2 0.1 0.0 0.0 1.1 0.7 0.2 4.1 0.1 0.1 0.0 0.0 4.6 0.1 4.2 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.2 0.8 0.8 0.6 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.2 0.0 114.2 0.0 0.0 0.0 25.0 0.0 0.0 1.8 0.0 0.0 1.0 1.5 0.1 0.7 0.0 0.0 0.5 0.2 0.0 1.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.4 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.1 ATOH7 "bHLHa13, Math5" ENSG00000179774 "Atonal bHLH transcription factor 7" Q8N100 10 68230595-68232113 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.0;liver: 3.0" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Excitatory neurons: 1.7;Hepatocytes: 1.1;Spermatogonia: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SCLC-21H: 7.5" "Region enriched" "Detected in some" 9 "cerebellum: 28.7" "Low region specificity" "Detected in some" HPA027008 Uncertain NA NA "Cluster 15: Liver - Metabolism" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA027008: AB_10600783" "unprognostic (7.17e-2)" "unprognostic (2.81e-1)" "unprognostic (7.66e-2)" "unprognostic (1.86e-2)" "unprognostic (2.20e-3)" "unprognostic (7.40e-2)" "unprognostic (7.76e-2)" "unprognostic (6.16e-2)" "unprognostic (2.46e-1)" "unprognostic (9.28e-4)" "unprognostic (4.96e-3)" "unprognostic (1.17e-1)" "unprognostic (5.06e-4)" "unprognostic (1.72e-1)" "unprognostic (2.52e-2)" "unprognostic (1.36e-1)" "unprognostic (7.18e-2)" 0.1 0.2 1.4 0.0 1.5 0.0 0.1 3.0 2.0 0.1 0.7 0.2 0.2 0.2 0.1 0.0 0.1 0.0 0.0 2.0 1.0 1.2 3.0 0.0 0.0 0.8 0.8 0.1 0.4 0.0 0.2 0.0 0.8 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.3 0.2 0.8 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 7.5 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.5 3.0 2.0 2.0 1.0 0.8 0.8 0.8 0.8 0.8 1.2 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.2 0.3 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.9 0.1 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 1.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.3 0.5 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 PBLD "FLJ14767, MAWBP, MAWDBP" ENSG00000108187 "Phenazine biosynthesis like protein domain containing" P30039 10 68282660-68333049 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "intestine: 171.5;kidney: 270.0;liver: 335.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 97.5;Distal tubular cells: 109.5;Hepatocytes: 216.9;Proximal enterocytes: 380.2;Proximal tubular cells: 426.5" "Cancer enhanced" "Detected in all" "liver cancer: 16.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA038035, HPA038036" Enhanced Approved Vesicles NA NA 1100000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 6: T47d - Mammary gland" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "HPA038035: AB_10672470, HPA038036: AB_10675625" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (6.14e-2)" "unprognostic (8.83e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" "prognostic favorable (1.44e-4)" "unprognostic (8.25e-2)" "unprognostic (3.62e-2)" "unprognostic (3.36e-3)" "unprognostic (1.19e-1)" "unprognostic (6.26e-3)" "unprognostic (3.40e-2)" "unprognostic (1.17e-1)" "unprognostic (2.07e-2)" "unprognostic (8.28e-2)" "unprognostic (6.68e-2)" 8.9 11.2 2.9 8.4 5.5 9.3 4.5 5.3 5.3 3.9 4.2 33.2 171.5 5.9 3.8 3.4 7.2 9.4 6.2 3.0 4.6 270.0 335.2 3.9 5.5 4.9 4.1 3.6 63.0 5.6 2.3 4.2 4.2 5.6 27.6 8.7 4.5 5.1 5.6 5.6 146.4 5.0 3.0 4.6 54.8 3.8 4.4 2.1 5.5 3.1 2.2 5.4 2.1 8.9 3.8 7.5 7.1 4.9 6.4 3.6 3.3 15.1 9.5 5.6 5.8 6.9 9.5 4.2 5.6 10.6 2.3 5.8 3.3 3.9 4.8 2.0 5.4 3.3 9.3 6.4 3.0 5.0 3.3 6.4 4.0 3.4 4.2 10.1 3.5 4.0 3.1 9.2 8.9 5.9 4.7 8.7 2.1 3.0 3.2 8.0 9.4 7.1 11.3 5.4 4.1 5.5 10.1 5.8 7.0 2.0 20.0 5.9 10.9 5.5 3.9 2.7 2.5 5.5 4.3 6.3 6.6 2.7 1.4 2.6 2.8 1.5 0.4 1.4 0.8 0.8 0.6 0.4 2.8 0.6 1.1 0.7 3.3 1.8 0.9 1.2 1.1 1.2 2.9 5.5 5.3 5.3 3.0 4.6 4.9 4.1 4.2 3.0 4.4 8.9 1.6 3.2 4.2 3.6 4.5 1.9 1.7 2.2 1.2 5.0 6.2 2.8 3.5 24.3 4.3 55.2 10.4 3.9 3.7 97.5 109.5 8.8 1.2 17.9 5.7 3.4 7.2 6.6 1.8 31.8 2.0 3.2 33.1 6.5 1.3 8.2 6.4 216.9 3.1 10.1 2.8 42.6 2.0 10.4 4.4 0.4 4.1 5.5 1.8 3.7 5.0 5.5 3.1 3.0 7.5 12.5 46.4 3.0 1.5 2.0 380.2 426.5 12.9 17.2 0.0 2.0 6.6 1.6 1.4 1.8 0.6 3.1 2.8 9.6 57.3 3.0 HNRNPH3 "2H9, HNRPH3" ENSG00000096746 "Heterogeneous nuclear ribonucleoprotein H3" P31942 10 68331174-68343193 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038264 Supported Nucleoplasm NA NA 650000 "Cluster 49: Eosinophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "HPA038264: AB_10697246" "unprognostic (1.72e-1)" "unprognostic (3.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.85e-1)" "unprognostic (7.25e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (6.17e-2)" "unprognostic (8.29e-2)" "unprognostic (1.75e-1)" "unprognostic (2.32e-1)" "unprognostic (9.81e-3)" "unprognostic (2.75e-3)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-1)" "unprognostic (1.06e-3)" 71.8 65.3 80.6 65.7 82.6 101.8 58.8 81.2 96.6 79.4 69.1 74.4 56.4 92.5 44.5 55.1 72.1 44.1 67.2 76.4 82.4 84.2 56.7 63.5 79.1 85.8 83.7 109.7 44.7 54.4 55.0 83.2 87.2 59.9 63.7 81.1 47.7 60.2 92.2 63.2 64.6 68.0 86.4 63.9 59.2 69.1 81.4 98.1 75.1 66.9 78.2 68.6 69.2 87.5 233.2 220.5 343.4 107.6 131.8 81.0 221.6 199.1 104.2 183.2 150.0 379.3 200.7 364.7 106.8 132.5 145.2 151.9 280.2 192.8 280.9 226.4 148.2 282.9 194.1 231.7 115.4 326.9 149.4 53.6 172.7 209.0 368.0 151.0 142.8 191.2 356.8 122.7 205.2 323.6 291.3 350.6 229.2 169.0 258.6 239.6 288.2 119.0 148.3 189.7 155.0 168.5 211.9 144.2 221.7 195.4 153.7 164.5 154.6 170.9 284.8 89.8 273.4 147.6 213.7 368.2 94.1 159.0 135.1 22.7 18.6 37.6 17.0 21.2 18.1 16.2 20.4 20.2 21.6 16.2 25.7 21.6 23.8 22.3 26.0 17.6 20.2 13.4 80.6 82.6 81.2 96.6 76.4 82.4 85.8 83.7 87.2 86.4 81.4 87.5 133.6 102.5 117.3 33.6 111.1 325.8 275.5 99.9 113.3 114.2 83.2 102.6 115.5 64.3 114.5 73.5 95.9 149.6 111.7 71.6 60.7 89.6 29.0 108.2 138.9 125.7 107.7 127.9 39.8 83.8 202.2 143.6 69.3 162.5 141.1 111.5 75.0 39.6 95.5 87.5 41.9 80.2 73.2 69.5 153.2 21.1 96.3 97.1 129.9 50.6 105.7 107.8 75.2 51.8 84.6 76.8 99.7 120.4 97.9 214.3 84.6 72.0 115.2 146.7 131.5 150.0 174.6 277.3 164.5 89.7 266.8 191.8 128.5 90.8 84.4 215.1 RUFY2 "FLJ10063, KIAA1537, RABIP4R, ZFYVE13" ENSG00000204130 "RUN and FYVE domain containing 2" Q8WXA3 10 68341107-68407294 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 93.1;Oligodendrocytes: 153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039792 Approved Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 70: Brain - Nervous system development" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA039792: AB_10673363" "unprognostic (1.23e-1)" "unprognostic (3.37e-1)" "unprognostic (1.91e-1)" "unprognostic (2.19e-1)" "unprognostic (2.48e-3)" "unprognostic (2.22e-2)" "unprognostic (4.36e-3)" "unprognostic (1.96e-1)" "unprognostic (2.13e-2)" "unprognostic (2.08e-2)" "unprognostic (1.92e-1)" "unprognostic (1.28e-2)" "unprognostic (2.00e-3)" "unprognostic (3.23e-1)" "unprognostic (3.82e-1)" "unprognostic (7.74e-2)" "unprognostic (3.40e-2)" 5.8 4.7 8.4 3.8 12.7 1.9 6.5 13.5 18.7 5.9 3.7 4.9 3.3 8.4 4.6 4.9 5.7 5.0 4.5 9.6 10.5 5.6 1.8 5.4 4.1 13.7 10.9 9.8 4.4 6.9 3.6 5.5 12.9 6.3 5.4 10.0 4.7 4.9 5.1 5.0 4.0 7.0 11.3 4.9 4.9 4.2 12.3 5.6 6.4 4.4 4.2 5.7 5.2 19.0 11.7 4.5 7.3 9.8 9.2 13.5 4.5 9.8 12.1 10.2 10.2 6.9 10.8 3.8 7.2 16.0 4.5 8.3 3.2 10.9 10.2 1.6 8.2 2.6 3.6 3.7 9.7 3.7 1.7 12.0 11.4 12.1 12.4 16.2 11.5 3.2 4.9 5.6 10.9 4.8 3.1 5.0 3.2 3.6 13.1 4.3 5.9 2.3 10.8 7.1 8.4 7.9 7.0 9.3 6.0 9.1 13.8 4.6 13.2 12.7 9.6 7.6 13.8 5.6 3.2 1.9 12.0 3.6 5.6 0.6 0.5 1.1 0.8 0.6 0.8 0.8 1.1 1.1 0.3 0.9 1.1 1.4 0.5 2.6 0.8 0.5 0.4 0.3 8.4 12.7 13.5 18.7 9.6 10.5 13.7 10.9 12.9 11.3 12.3 19.0 22.8 32.1 15.1 40.1 15.9 6.6 15.2 14.8 8.0 47.7 11.7 11.2 11.4 4.3 20.7 25.8 60.5 9.3 13.0 7.2 1.9 16.1 8.5 24.1 30.2 20.3 10.2 13.5 93.1 12.9 6.0 24.8 14.3 20.2 7.6 24.2 22.5 6.5 6.5 32.0 84.7 12.0 10.2 10.0 7.7 5.5 24.2 11.2 12.4 45.0 13.1 20.2 12.3 58.8 153.7 17.9 5.4 17.7 12.0 15.6 6.3 10.1 21.7 62.0 13.1 31.7 24.7 11.1 24.4 15.9 8.1 9.6 11.8 22.8 7.7 10.7 DNA2 "DNA2L, KIAA0083" ENSG00000138346 "DNA replication helicase/nuclease 2" P51530 10 68414064-68472121 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Disease variant, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 33.2;Excitatory neurons: 14.1;Inhibitory neurons: 15.5;Oligodendrocytes: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "NK-cell: 1.8" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA037487, HPA057526" Approved Supported Mitochondria No Yes "Cluster 15: NK-cells - Transcription" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Mitochondria "HPA037487: AB_10672493, HPA057526: AB_2683456" "unprognostic (1.79e-1)" "unprognostic (1.35e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (4.50e-5)" "unprognostic (3.36e-2)" "unprognostic (4.70e-2)" "unprognostic (3.72e-2)" "unprognostic (1.30e-2)" "unprognostic (3.29e-4)" "unprognostic (1.09e-10)" "unprognostic (3.43e-2)" "unprognostic (1.98e-1)" "unprognostic (9.36e-2)" "unprognostic (1.23e-2)" 1.3 0.9 1.9 2.8 2.1 4.6 1.8 2.5 3.6 1.4 1.0 2.3 2.1 1.1 0.9 1.9 0.9 0.9 1.8 1.8 1.9 2.6 4.2 1.8 5.2 2.3 1.9 1.2 1.6 0.4 1.5 1.6 2.4 1.9 2.8 5.3 1.6 0.4 1.6 1.8 3.2 1.1 1.6 2.1 1.9 2.9 2.1 8.1 1.0 0.9 4.2 1.4 1.4 3.2 25.6 13.0 29.0 20.7 3.2 2.2 20.4 12.4 10.3 17.4 21.2 31.1 16.1 26.1 4.6 3.8 6.7 15.2 16.8 6.5 20.7 16.2 12.6 15.8 8.5 12.3 0.9 27.7 16.4 1.8 2.6 12.3 3.6 4.5 7.9 17.0 23.6 22.8 10.1 9.0 42.8 19.8 20.5 10.9 24.0 33.1 20.0 8.4 7.5 11.7 13.1 15.7 16.9 21.4 4.2 20.1 16.5 11.6 3.4 6.6 20.5 8.5 23.8 11.5 13.9 38.3 5.7 26.1 8.9 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 1.8 0.0 0.0 0.1 0.0 1.9 2.1 2.5 3.6 1.8 1.9 2.3 1.9 2.4 1.6 2.1 3.2 1.0 6.4 1.1 4.9 1.3 2.3 0.9 1.7 2.8 2.5 2.3 1.4 10.5 2.8 1.1 1.8 6.2 3.9 2.2 1.7 0.0 0.8 2.2 2.0 1.4 2.0 1.2 33.2 14.1 0.9 4.8 2.0 2.6 2.8 0.0 6.0 0.7 4.6 2.2 0.0 15.5 1.8 0.0 1.3 0.7 3.7 0.6 1.5 0.0 4.7 0.5 0.5 2.1 5.5 18.4 0.7 0.1 0.7 7.4 2.5 2.4 0.6 0.8 4.3 0.0 2.4 1.1 9.1 12.2 4.7 1.7 1.2 1.6 0.7 3.7 1.0 SLC25A16 "D10S105E, GDA, HGT.1, ML7" ENSG00000122912 "Solute carrier family 25 member 16" P16260 10 68477998-68527523 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036243, HPA044580" Uncertain Approved Mitochondria NA NA "Cluster 17: Basophils - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria "HPA036243: AB_2675019, HPA044580: AB_10962723" "unprognostic (1.71e-1)" "unprognostic (1.54e-1)" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (6.75e-2)" "unprognostic (2.68e-2)" "unprognostic (1.23e-2)" "unprognostic (9.13e-3)" "unprognostic (1.92e-1)" "unprognostic (4.13e-2)" "unprognostic (8.65e-2)" "unprognostic (1.17e-1)" "unprognostic (8.37e-3)" "unprognostic (2.10e-1)" "unprognostic (2.79e-1)" "unprognostic (2.06e-2)" "unprognostic (1.44e-3)" 10.3 3.6 5.1 2.1 5.3 3.7 4.1 7.1 7.9 2.1 0.0 3.2 3.8 3.5 3.2 2.6 2.1 2.3 2.8 5.0 5.6 5.8 11.4 3.1 2.7 2.7 3.5 2.3 5.1 3.5 2.6 2.8 3.4 8.2 2.8 4.7 4.5 2.8 4.9 3.0 3.8 2.6 2.2 2.4 4.5 1.5 7.0 2.0 3.5 2.3 2.0 2.7 2.1 6.1 2.8 1.1 3.2 4.4 4.2 5.0 3.4 3.8 4.2 2.4 2.6 6.6 1.9 3.0 2.7 7.6 1.3 1.6 10.2 1.9 6.1 2.2 6.3 1.6 3.5 2.9 5.1 5.2 3.4 4.3 4.9 4.6 6.4 3.6 2.0 2.6 1.8 4.8 5.2 2.6 2.9 3.7 0.7 0.8 14.8 1.6 2.3 1.0 6.8 9.2 2.2 1.8 5.4 5.2 4.4 2.2 2.9 2.1 8.9 3.6 4.8 6.1 4.5 4.9 2.8 4.9 3.5 4.2 1.6 1.4 0.7 0.7 0.4 0.5 0.4 0.4 0.4 0.3 0.5 0.8 0.4 0.6 1.3 0.6 0.4 0.8 0.4 0.3 5.1 5.3 7.1 7.9 5.0 5.6 2.7 3.5 3.4 2.2 7.0 6.1 9.6 44.8 20.7 23.5 9.9 6.4 6.3 4.9 4.6 19.2 11.0 6.7 10.4 12.8 7.4 12.9 39.6 19.0 12.4 12.9 11.7 8.1 9.9 9.6 9.3 7.8 15.0 9.9 44.0 19.2 32.3 8.8 20.9 14.1 8.2 6.1 13.9 37.7 10.6 20.2 53.7 9.4 8.2 10.3 6.5 13.0 3.1 7.9 1.8 13.1 8.2 9.5 15.5 29.7 48.0 14.4 7.8 7.9 16.4 13.5 17.7 21.4 9.9 31.2 0.0 13.4 11.3 4.5 2.5 10.5 6.8 59.8 9.4 9.4 9.0 10.6 TET1 "bA119F7.1, CXXC6, KIAA1676, LCX" ENSG00000138336 "Tet methylcytosine dioxygenase 1" Q8NFU7 10 68560337-68694487 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.9" "Cell type enhanced" "Detected in many" "Astrocytes: 54.5;Extravillous trophoblasts: 79.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 45.3;Theca cells: 43.7" "Cancer enriched" "Detected in some" 15 "testis cancer: 10.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 17.7;HAP1: 20.4;K-562: 12.0;NTERA-2: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019032, HPA057273" Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Nuclear membrane" "HPA019032: AB_1847363, HPA057273: AB_2683391" "unprognostic (1.60e-1)" "unprognostic (8.30e-2)" "unprognostic (9.85e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (8.15e-2)" "unprognostic (3.60e-3)" "unprognostic (1.12e-1)" "unprognostic (2.00e-1)" "unprognostic (7.90e-3)" "unprognostic (1.83e-1)" "unprognostic (1.71e-1)" "unprognostic (1.18e-3)" "unprognostic (2.88e-4)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (9.52e-3)" 0.4 0.2 0.6 0.2 1.2 0.3 0.4 4.9 0.7 0.7 0.8 0.4 0.1 0.9 0.6 0.2 0.5 0.3 0.3 0.3 0.9 0.3 0.2 0.2 0.3 0.9 1.3 0.8 0.2 0.7 0.3 1.2 1.1 0.6 0.3 1.5 1.0 0.3 0.9 0.3 0.2 0.5 1.0 0.3 0.4 0.2 1.1 2.0 0.5 0.3 0.3 0.2 0.4 2.2 0.7 0.8 8.0 9.0 0.8 0.7 17.7 0.4 1.0 0.7 1.2 5.5 0.3 0.0 0.3 0.8 0.1 0.0 20.4 0.0 0.8 0.3 3.3 2.1 0.0 4.9 1.2 1.9 1.0 1.0 0.1 0.5 0.1 1.6 0.1 3.5 12.0 1.4 0.7 0.6 3.3 1.4 11.9 0.0 1.1 3.2 2.5 0.2 0.4 0.8 2.2 3.5 0.4 0.5 1.6 7.9 1.0 1.5 0.3 0.7 1.6 0.0 0.6 0.5 0.6 3.2 0.2 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.4 0.3 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.5 0.0 0.6 1.2 4.9 0.7 0.3 0.9 0.9 1.3 1.1 1.0 1.1 2.2 6.3 3.2 6.2 54.5 2.5 1.1 1.8 0.4 5.2 2.5 7.0 9.5 7.2 1.5 2.6 0.0 10.4 21.0 3.0 0.2 0.0 2.7 0.8 3.6 34.2 4.8 13.8 2.5 15.6 0.4 79.9 15.4 1.5 2.9 0.0 13.6 5.7 2.5 3.9 35.3 20.6 0.3 4.1 0.0 0.3 1.7 25.7 0.8 1.8 12.2 0.4 16.1 5.2 44.7 45.3 0.6 0.0 20.7 7.3 1.4 0.0 0.9 0.8 12.5 6.6 21.9 10.7 0.5 1.5 0.8 1.1 27.9 2.6 43.7 0.6 0.4 CCAR1 "CARP-1, CARP1, FLJ10590" ENSG00000060339 "Cell division cycle and apoptosis regulator 1" Q8IX12 10 68721012-68792377 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007856, HPA048513" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Golgi apparatus" "HPA007856: AB_1078415, HPA048513: AB_2680424" "unprognostic (1.71e-1)" "unprognostic (1.22e-1)" "unprognostic (2.34e-2)" "unprognostic (1.86e-1)" "unprognostic (5.15e-3)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.41e-5)" "unprognostic (1.10e-1)" "unprognostic (3.25e-2)" "prognostic favorable (4.05e-5)" "unprognostic (2.89e-2)" "unprognostic (3.21e-3)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.67e-1)" "unprognostic (2.36e-1)" "unprognostic (2.24e-1)" "unprognostic (1.41e-2)" 17.4 21.4 14.4 20.2 16.0 23.4 17.2 21.1 25.4 15.9 15.2 17.9 16.8 16.7 16.1 20.1 14.5 16.5 15.6 13.6 17.0 18.4 19.1 15.9 30.3 16.9 14.9 19.9 20.4 15.9 14.5 21.7 16.4 17.3 22.2 20.9 18.5 13.5 20.6 23.9 19.4 16.0 13.2 21.5 17.8 14.3 16.8 29.8 18.2 17.9 28.7 21.7 17.0 19.2 64.0 64.8 73.9 49.7 31.4 30.3 57.7 56.0 47.4 59.3 40.0 87.2 50.8 74.7 29.9 39.1 29.8 49.3 78.4 44.3 64.8 51.5 48.2 60.1 46.1 54.5 35.7 96.2 67.5 30.5 54.2 50.1 61.7 36.7 48.5 37.5 83.5 46.8 58.8 46.5 64.2 60.7 74.1 49.7 58.4 74.2 44.1 44.7 52.5 48.6 42.7 36.9 55.1 89.1 57.1 57.6 60.6 58.9 48.1 36.8 46.3 40.1 61.4 32.2 45.5 78.5 30.8 63.8 35.6 6.1 14.6 14.3 16.3 13.0 14.6 14.2 11.3 15.8 21.0 17.3 13.5 14.3 3.3 10.6 15.5 13.1 18.4 11.3 14.4 16.0 21.1 25.4 13.6 17.0 16.9 14.9 16.4 13.2 16.8 19.2 50.5 35.3 85.5 61.4 69.2 37.0 49.6 54.7 66.0 51.0 36.1 40.0 65.5 41.5 49.0 46.0 58.4 73.1 62.9 44.1 23.5 68.0 28.8 55.2 68.5 54.0 46.1 61.2 49.7 78.1 83.8 49.2 45.3 62.2 67.2 76.8 39.3 40.4 49.2 55.5 51.2 55.1 30.5 47.4 36.3 14.5 53.7 49.8 21.4 41.2 65.4 36.5 66.9 47.7 66.1 77.7 34.2 50.4 61.0 45.3 36.0 18.3 49.1 68.7 65.7 53.2 62.3 128.7 77.2 50.4 37.4 109.5 61.3 83.2 67.2 49.4 STOX1 "C10orf24, FLJ25162" ENSG00000165730 "Storkhead box 1" Q6ZVD7 10 68827531-68895432 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2;choroid plexus: 30.8" "Group enriched" "Detected in many" 5 "Astrocytes: 85.2;Endometrial ciliated cells: 67.4;Respiratory ciliated cells: 42.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 8.6;HAP1: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037844, HPA037845" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Intracellular and membrane" No NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA037844: AB_2675700, HPA037845: AB_10671369" "prognostic favorable (3.37e-5)" "unprognostic (5.53e-3)" "unprognostic (6.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.63e-3)" "unprognostic (1.95e-2)" "unprognostic (2.24e-3)" "prognostic favorable (2.08e-4)" "unprognostic (1.52e-1)" "unprognostic (2.45e-3)" "unprognostic (5.33e-3)" "unprognostic (5.29e-2)" "unprognostic (3.87e-2)" "unprognostic (8.77e-2)" "unprognostic (3.06e-2)" "unprognostic (2.33e-1)" "unprognostic (3.46e-2)" 6.3 5.1 26.4 0.5 23.6 0.2 4.2 14.9 33.2 1.9 30.8 1.6 1.1 1.6 7.4 1.4 12.5 0.9 0.4 23.9 22.4 2.8 0.3 1.3 1.2 16.5 24.9 1.1 1.4 6.5 7.2 0.8 17.4 1.2 1.6 0.7 1.6 1.1 1.3 0.9 2.1 0.8 16.3 0.4 3.4 2.5 26.2 6.7 3.1 0.8 1.0 2.5 0.7 20.5 1.8 2.0 4.2 8.6 1.8 0.0 2.5 0.2 0.1 1.2 1.3 1.8 2.6 1.7 2.4 0.0 3.3 0.5 8.1 0.0 0.6 2.0 3.4 0.1 0.4 2.6 0.2 2.3 3.1 0.2 0.1 0.2 0.0 0.2 0.1 4.5 0.4 0.2 0.1 1.8 3.9 2.8 1.4 0.4 1.2 2.8 0.1 0.0 2.6 4.6 1.3 3.9 3.1 0.8 0.6 2.7 1.9 1.8 0.0 0.0 0.2 0.0 1.3 0.7 1.6 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.1 0.8 0.4 0.0 0.0 0.0 1.0 0.0 0.0 26.4 23.6 14.9 33.2 23.9 22.4 16.5 24.9 17.4 16.3 26.2 20.5 0.3 0.0 0.5 85.2 0.3 1.5 4.5 0.9 1.2 0.7 5.1 4.1 0.5 0.0 5.6 1.8 0.0 1.6 3.1 0.4 3.9 0.1 0.3 67.4 1.7 0.4 0.0 1.7 11.4 0.4 0.5 0.6 0.5 4.2 2.5 0.8 0.0 0.2 0.1 0.0 9.9 2.5 2.0 0.3 0.7 0.7 1.2 0.2 0.0 1.9 0.1 1.9 2.1 6.0 2.1 0.1 0.3 0.0 0.6 1.7 0.8 1.8 42.8 0.4 6.6 1.5 5.0 1.4 8.8 0.4 0.4 1.2 0.7 6.9 5.3 1.8 DDX50 "GU2, GUB, MGC3199, RH-II/GuB" ENSG00000107625 "DExD-box helicase 50" Q9BQ39 10 68901286-68946847 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037388, HPA037389, HPA058196" Approved Enhanced Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoli "HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635" "unprognostic (2.05e-1)" "unprognostic (3.36e-1)" "unprognostic (9.90e-2)" "unprognostic (9.75e-2)" "unprognostic (1.29e-1)" "unprognostic (1.23e-1)" "unprognostic (1.47e-3)" "unprognostic (2.62e-1)" "unprognostic (1.97e-1)" "unprognostic (8.78e-2)" "unprognostic (4.57e-2)" "unprognostic (1.44e-1)" "unprognostic (4.22e-3)" "unprognostic (1.22e-2)" "unprognostic (2.38e-2)" "unprognostic (4.91e-2)" "unprognostic (1.02e-1)" 21.5 16.9 12.3 19.0 12.4 17.3 25.5 14.6 13.9 24.5 14.2 25.1 13.1 27.3 18.1 19.9 22.5 17.4 18.6 12.5 13.5 19.1 16.3 15.9 27.7 12.1 12.2 30.4 20.9 23.1 21.9 22.1 12.3 19.7 17.9 23.3 15.8 22.5 20.9 17.7 16.3 27.3 12.5 19.7 17.5 25.8 13.3 30.6 25.7 20.7 27.4 23.7 20.0 14.0 48.3 30.6 53.8 67.0 45.4 58.6 33.5 50.2 56.7 45.7 42.5 69.3 41.3 62.4 29.4 45.7 27.9 41.5 53.4 38.0 58.0 54.6 38.5 33.6 30.0 31.0 45.6 71.7 40.5 45.9 38.2 43.7 120.7 79.3 37.3 52.8 60.8 37.5 57.0 39.7 67.6 67.7 31.3 46.7 67.3 58.0 60.6 11.4 35.5 28.7 36.9 50.2 36.5 43.0 57.1 50.2 50.6 45.3 32.0 35.1 40.0 39.5 69.5 49.7 47.6 52.8 37.6 72.8 20.9 9.2 10.6 15.0 18.5 16.7 22.9 16.8 22.8 19.4 14.0 17.1 24.1 21.9 3.4 20.6 13.6 12.4 21.8 15.0 12.3 12.4 14.6 13.9 12.5 13.5 12.1 12.2 12.3 12.5 13.3 14.0 27.8 19.2 21.7 21.2 50.5 11.9 35.4 34.6 36.5 44.2 21.1 23.1 27.4 30.0 31.5 20.2 39.6 40.6 36.0 11.4 56.7 28.7 80.3 25.2 41.6 30.3 16.2 29.5 37.5 25.1 39.3 32.2 22.4 22.8 43.0 30.3 23.2 16.2 23.2 37.0 36.4 19.2 26.4 21.6 9.1 20.0 36.4 21.3 12.4 22.5 41.2 22.7 51.5 28.1 29.5 22.8 14.3 39.1 46.3 30.1 11.1 41.3 26.7 55.1 19.7 35.8 53.5 72.8 58.4 31.7 14.3 41.2 40.8 35.4 21.4 20.7 DDX21 "GURDB, RH-II/GU" ENSG00000165732 "DExD-box helicase 21" Q9NR30 10 68956170-68985068 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 589.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036592, HPA036593" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No 40000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA036592: AB_10673625, HPA036593: AB_2675208" "unprognostic (3.04e-1)" "unprognostic (6.81e-3)" "unprognostic (1.13e-2)" "unprognostic (1.21e-2)" "unprognostic (1.75e-2)" "unprognostic (6.71e-3)" "unprognostic (1.34e-2)" "unprognostic (1.99e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (3.12e-4)" "unprognostic (1.64e-1)" "unprognostic (1.39e-2)" "unprognostic (9.33e-2)" "unprognostic (5.41e-2)" "unprognostic (1.24e-2)" "unprognostic (5.74e-3)" 55.9 27.9 7.9 52.7 8.8 103.5 36.2 8.9 9.3 22.0 7.7 26.5 25.5 25.2 13.4 40.3 24.0 32.4 21.9 7.4 9.7 30.0 42.1 31.5 50.0 10.8 10.1 20.1 45.7 24.5 12.9 38.0 11.0 19.0 32.0 8.1 20.5 17.5 47.9 30.1 21.8 28.4 10.7 30.2 26.4 22.5 8.8 33.6 25.1 26.9 51.0 81.7 23.5 11.3 194.4 112.5 64.5 199.7 56.7 74.4 135.6 129.8 104.3 163.8 138.3 366.7 128.8 289.5 77.8 108.2 77.2 168.1 250.4 161.8 217.5 90.7 176.1 203.2 76.9 153.3 121.2 488.9 184.7 76.8 205.2 196.2 324.5 76.1 121.3 106.8 393.8 140.5 116.8 88.1 192.9 106.1 176.3 91.8 236.8 170.1 105.3 143.0 108.2 102.7 132.5 141.6 116.6 254.8 155.5 76.8 144.9 101.1 125.6 95.5 136.0 129.8 230.7 160.4 228.2 418.2 79.3 362.4 66.5 7.6 10.9 20.4 8.7 17.1 15.9 14.0 11.4 11.8 13.0 12.3 10.6 11.8 4.9 9.4 21.2 12.1 9.2 7.5 7.9 8.8 8.9 9.3 7.4 9.7 10.8 10.1 11.0 10.7 8.8 11.3 199.4 102.5 141.6 8.1 243.7 550.2 346.2 103.8 174.2 25.9 159.9 113.7 74.2 94.4 144.1 71.7 41.7 80.8 139.5 134.0 72.4 141.2 50.8 116.7 260.7 196.7 86.7 98.6 18.5 187.8 151.8 162.2 120.8 201.8 168.5 57.1 104.2 215.3 112.4 25.2 16.0 202.7 67.1 154.5 266.8 19.7 89.5 199.1 124.5 12.2 138.1 25.8 64.9 13.6 18.2 222.9 77.7 77.1 148.9 465.3 59.9 128.2 72.8 29.8 26.3 302.6 174.9 105.5 114.8 224.8 589.7 137.5 159.6 99.4 210.7 375.5 KIFBP "DKFZP586B0923, KBP, KIAA1279, KIF1BP, TTC20" ENSG00000198954 "Kinesin family binding protein" Q96EK5 10 68988803-69043544 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 9.5;Cardiomyocytes: 40.7;Cytotrophoblasts: 21.7;Extravillous trophoblasts: 19.5;Fibroblasts: 8.7;Hofbauer cells: 16.7;Syncytiotrophoblasts: 8.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035538, HPA035539" Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "HPA035538: AB_10601130, HPA035539: AB_2674676" "unprognostic (4.28e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (4.19e-1)" "unprognostic (1.96e-1)" "unprognostic (2.13e-3)" "unprognostic (4.23e-3)" "unprognostic (3.72e-2)" "unprognostic (3.52e-2)" "unprognostic (7.74e-2)" "unprognostic (6.23e-3)" "unprognostic (8.74e-2)" "prognostic favorable (2.60e-4)" "unprognostic (5.19e-2)" "unprognostic (9.45e-2)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" 19.9 22.1 21.3 6.7 24.4 1.3 11.2 24.4 32.5 14.0 19.7 11.9 6.4 12.5 15.9 12.2 11.8 12.6 37.3 24.6 23.8 19.5 13.8 9.9 6.7 23.9 22.2 12.3 8.5 33.8 13.6 14.8 24.5 16.6 10.3 25.7 9.8 17.3 30.4 8.7 8.1 15.3 25.7 7.5 11.4 16.2 22.7 7.6 19.2 43.3 9.2 15.2 9.3 28.1 49.1 36.9 33.3 36.1 48.3 42.5 0.2 63.2 58.0 63.4 71.9 40.4 24.7 0.1 20.7 57.3 39.5 40.2 57.0 37.9 63.6 27.5 48.8 9.5 22.0 24.0 32.4 13.3 11.5 26.4 30.4 42.3 37.7 60.5 46.6 15.1 13.1 14.0 78.4 23.3 13.0 15.8 20.7 25.4 84.1 15.5 27.7 7.2 67.4 12.4 25.0 18.1 36.0 48.9 34.8 32.2 60.3 10.2 46.3 28.0 25.7 24.6 64.0 2.8 0.3 9.0 35.9 19.8 15.7 1.8 4.3 2.4 7.3 7.5 8.8 5.1 8.4 7.2 5.5 4.1 9.6 7.8 1.6 6.9 12.9 2.8 8.0 5.0 21.3 24.4 24.4 32.5 24.6 23.8 23.9 22.2 24.5 25.7 22.7 28.1 9.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 0.0 0.0 0.0 21.7 3.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 19.5 8.7 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 8.3 0.9 0.0 0.0 0.0 SRGN "PPG, PRG, PRG1" ENSG00000122862 Serglycin P10124 10 69088103-69104805 "Plasma proteins, Predicted secreted proteins" "Apoptosis, Biomineralization" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "bone marrow: 8096.7" "Cell type enhanced" "Detected in many" "dendritic cells: 2922.2;granulocytes: 2343.1;Kupffer cells: 1789.9;Langerhans cells: 6618.2;Macrophages: 3639.1;monocytes: 3188.2;Plasma cells: 1740.9;T-cells: 2235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 5714.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 5714.1" "Cell line enhanced" "Detected in many" "HL-60: 4442.1;NB-4: 2549.7;THP-1: 4346.8;TIME: 2609.1;U-937: 3546.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000759 Enhanced Supported "Golgi apparatus" "Secreted to blood" NA NA 100000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA000759: AB_1079675" "unprognostic (3.61e-2)" "unprognostic (1.62e-2)" "unprognostic (2.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (4.50e-2)" "unprognostic (1.30e-1)" "unprognostic (1.70e-2)" "unprognostic (1.63e-1)" "unprognostic (8.22e-2)" "unprognostic (5.80e-2)" "unprognostic (9.82e-2)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.65e-1)" "unprognostic (2.32e-2)" "unprognostic (4.07e-2)" "unprognostic (4.08e-2)" 404.6 114.9 48.8 799.8 50.5 8096.7 136.4 55.5 99.6 93.2 70.1 101.8 77.9 63.5 25.9 91.0 96.8 316.4 111.9 48.2 67.8 98.3 239.4 347.3 437.2 82.4 59.3 30.7 68.4 131.6 62.1 355.6 67.8 58.9 118.9 15.5 40.1 57.4 37.5 18.9 111.4 219.4 65.5 362.8 95.0 18.3 64.7 228.9 72.7 117.1 314.6 508.3 46.1 71.0 5.3 43.0 0.2 0.4 768.1 749.7 1.2 94.9 63.9 235.1 283.5 0.1 18.2 9.1 117.4 4.1 134.4 1.1 0.0 20.6 799.9 535.7 0.4 87.1 29.8 0.3 312.7 4442.1 914.9 306.8 1.1 641.5 39.2 223.8 1227.8 13.3 82.5 419.9 1239.9 0.2 18.7 2549.7 0.7 0.1 84.6 2.4 2.3 446.7 0.6 6.0 0.3 0.8 2.3 0.6 16.0 0.0 2.2 4346.8 2609.1 187.9 12.9 3.8 20.1 486.4 508.4 57.3 112.2 3546.9 1.2 2349.8 1105.3 2730.6 474.9 774.6 313.4 73.5 228.5 362.8 583.0 39.0 125.5 268.4 5714.1 962.8 693.6 631.9 392.6 1590.5 48.8 50.5 55.5 99.6 48.2 67.8 82.4 59.3 67.8 65.5 64.7 71.0 1081.4 112.2 198.1 0.7 592.0 175.9 12.5 38.3 8.6 1.1 16.0 28.2 21.2 21.5 57.5 33.1 0.0 10.2 2922.2 2.9 0.0 4.2 4.1 4.6 15.0 566.8 1.8 277.8 0.2 9.8 10.2 87.9 70.3 6.6 2343.1 0.4 636.1 22.1 847.1 0.0 0.5 1.7 0.0 1789.9 6618.2 8.4 7.5 3639.1 556.7 80.6 3188.2 1.4 1292.5 0.0 0.2 1.3 1.2 18.0 1740.9 12.2 0.3 4.7 45.6 5.0 72.3 22.8 97.5 0.9 2.2 8.7 141.8 14.2 2235.9 1.2 5.5 18.1 VPS26A "Hbeta58, PEP8A, VPS26" ENSG00000122958 "VPS26, retromer complex component A" O75436 10 69123512-69174412 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 243.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011602, HPA057498, CAB075733" Supported Enhanced Endosomes,Lysosomes NA NA 41000 "Cluster 7: Monocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Endosomes, Lysosomes" "CAB011602: AB_2215043, CAB075733: AB_2665739, HPA057498: AB_2683448" "unprognostic (1.17e-2)" "unprognostic (6.94e-2)" "unprognostic (5.58e-2)" "unprognostic (9.35e-2)" "unprognostic (5.95e-2)" "prognostic unfavorable (1.72e-4)" "prognostic unfavorable (1.70e-6)" "unprognostic (1.17e-1)" "unprognostic (1.35e-1)" "unprognostic (7.88e-2)" "prognostic unfavorable (9.18e-6)" "unprognostic (4.63e-2)" "unprognostic (2.15e-2)" "unprognostic (7.14e-2)" "unprognostic (6.68e-2)" "unprognostic (4.33e-2)" "unprognostic (1.72e-1)" 37.0 27.1 23.6 24.4 25.9 36.2 32.9 27.6 32.3 26.9 23.7 32.1 24.8 26.8 22.1 41.7 22.7 22.7 22.0 24.3 25.9 34.0 30.4 27.5 23.3 26.0 25.9 25.8 23.8 38.1 12.0 39.9 25.6 24.6 32.3 19.6 26.1 20.9 33.4 37.3 25.5 25.7 26.7 23.1 24.1 42.7 24.9 27.8 29.9 31.3 27.9 33.0 29.9 29.0 113.1 42.5 51.7 87.1 80.8 73.8 46.1 66.3 106.0 79.7 90.1 91.8 110.9 34.3 53.1 72.3 78.2 75.9 73.1 63.5 108.5 31.3 38.7 54.0 36.7 52.2 104.9 80.6 39.4 66.3 90.8 79.8 161.5 99.8 81.9 40.8 104.7 46.0 119.2 35.8 35.8 86.4 34.0 51.9 97.9 44.2 85.0 40.4 86.6 68.3 30.5 45.5 89.3 119.5 117.6 44.5 50.3 62.9 97.9 53.0 69.7 91.7 83.8 28.0 74.4 57.4 71.2 123.6 27.8 54.6 39.6 38.6 40.8 46.6 37.4 26.3 30.7 42.2 44.8 20.0 26.7 37.7 38.1 54.6 40.9 17.7 38.3 44.4 23.6 25.9 27.6 32.3 24.3 25.9 26.0 25.9 25.6 26.7 24.9 29.0 49.0 73.7 56.6 21.5 40.6 120.7 83.4 79.6 60.3 24.4 43.0 34.8 44.2 40.0 75.2 40.5 14.6 117.1 59.2 47.3 80.3 69.3 59.4 29.8 42.2 52.7 16.2 58.3 29.4 53.4 87.8 57.4 30.5 42.0 45.5 32.4 35.3 29.4 85.8 20.2 30.3 38.3 85.5 53.2 108.7 29.6 42.3 66.0 62.2 28.1 62.4 63.2 52.5 21.6 39.8 65.7 43.3 44.8 28.2 65.2 30.5 80.6 45.5 27.4 13.1 48.0 61.9 89.3 73.7 57.5 107.0 243.7 59.5 38.2 44.4 77.6 SUPV3L1 SUV3 ENSG00000156502 "Suv3 like RNA helicase" Q8IYB8 10 69180234-69209099 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038380, HPA038405" Supported Supported Mitochondria NA NA "Cluster 44: Non-specific - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Mitochondria "HPA038380: AB_2675983, HPA038405: AB_10675797" "unprognostic (4.70e-2)" "unprognostic (1.85e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.74e-2)" "unprognostic (3.32e-2)" "unprognostic (1.44e-2)" "unprognostic (1.78e-1)" "unprognostic (1.57e-1)" "unprognostic (9.47e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (5.48e-3)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (5.27e-2)" "unprognostic (1.33e-1)" 10.1 10.9 7.9 8.7 8.2 24.2 11.5 10.2 10.3 7.7 7.6 11.6 8.9 9.3 7.9 8.8 8.3 6.0 15.8 8.5 8.2 12.9 17.9 6.1 12.0 7.9 7.4 10.6 9.3 16.5 7.5 8.7 7.9 8.0 12.7 11.1 8.9 8.6 25.9 10.6 8.6 9.3 7.2 9.9 8.9 15.8 7.8 11.0 10.9 29.1 12.2 9.5 7.7 8.5 28.9 19.9 17.4 53.5 19.1 16.1 22.7 17.5 27.1 34.7 32.6 51.4 23.8 51.5 14.0 17.6 24.8 32.3 42.2 27.4 33.1 21.5 33.1 22.6 14.9 27.2 48.1 54.3 16.5 20.5 33.7 31.9 72.6 23.6 20.3 32.2 59.6 26.1 19.2 18.7 33.1 33.5 20.8 27.2 106.7 30.1 24.7 22.6 15.6 13.9 24.7 18.7 24.2 49.7 46.7 19.1 15.5 23.5 12.7 13.7 24.7 21.1 34.3 20.5 25.4 47.5 22.6 56.4 8.9 8.9 5.1 4.7 11.1 7.3 12.5 9.0 7.9 9.5 7.1 7.3 8.7 9.6 0.9 7.7 5.4 3.9 8.8 6.2 7.9 8.2 10.2 10.3 8.5 8.2 7.9 7.4 7.9 7.2 7.8 8.5 11.2 6.4 7.4 15.3 21.7 23.8 11.6 16.6 21.6 21.6 10.8 9.5 22.5 5.7 15.1 7.3 4.2 17.8 49.3 11.7 11.7 11.6 13.4 17.2 17.6 10.1 9.0 10.3 29.6 8.6 11.4 12.6 14.8 28.8 7.6 15.1 5.7 12.0 9.6 11.8 28.2 9.0 16.2 6.0 10.0 4.5 6.8 9.4 5.4 15.0 7.2 11.3 19.6 14.1 17.6 8.5 8.1 9.1 37.0 10.8 8.5 14.3 12.6 12.5 6.6 17.2 14.6 38.6 26.6 23.6 22.3 22.4 28.8 16.1 14.1 10.7 HKDC1 "FLJ22761, FLJ37767" ENSG00000156510 "Hexokinase domain containing 1" Q2TB90 10 69220332-69267552 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 53.5;retina: 46.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 31.5;Distal enterocytes: 29.0;Ductal cells: 32.6;Endometrial ciliated cells: 50.0;Glandular and luminal cells: 55.2;Muller glia cells: 126.9;Proximal enterocytes: 56.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 3.1;naive CD4 T-cell: 5.8;naive CD8 T-cell: 2.3;T-reg: 5.4" "Lineage enriched" "Detected in single" 23 "T-cells: 5.8" "Cell line enhanced" "Detected in some" "A549: 40.1;CACO-2: 57.5;CAPAN-2: 111.4;EFO-21: 33.9;GAMG: 45.4;Hep G2: 33.6;RPTEC TERT1: 81.9" "Region enhanced" "Detected in many" "cerebral cortex: 11.9" "Low region specificity" "Detected in all" "HPA064198, HPA064230" Enhanced Enhanced Mitochondria No No "Cluster 20: T-cells - T-cell receptor" "Cluster 56: Intestine - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 5: Muller glia cells - Visual perception" Mitochondria "HPA064198: AB_2685210, HPA064230: AB_2685219" "unprognostic (1.29e-2)" "unprognostic (2.26e-2)" "unprognostic (1.86e-1)" "unprognostic (8.47e-2)" "unprognostic (1.55e-1)" "unprognostic (3.05e-1)" "unprognostic (6.31e-3)" "unprognostic (5.03e-2)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (3.11e-1)" "unprognostic (1.04e-3)" "unprognostic (1.35e-1)" "unprognostic (2.24e-1)" "unprognostic (2.10e-3)" "unprognostic (2.19e-1)" 0.1 0.0 1.1 2.7 1.3 0.0 0.0 1.4 1.0 1.1 1.4 6.8 53.5 0.9 0.0 0.1 4.6 6.8 0.0 1.0 1.1 13.3 4.6 1.5 1.0 1.3 2.1 0.0 6.2 0.0 0.3 0.0 1.7 0.0 4.2 46.8 0.1 0.0 0.0 0.1 48.0 0.5 1.4 0.3 1.1 1.0 1.0 5.2 9.3 0.0 0.2 0.0 0.1 1.2 1.2 40.1 0.2 0.1 0.0 0.0 0.2 0.0 0.3 0.1 0.1 57.5 111.4 0.0 33.9 0.3 45.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 33.6 2.7 0.0 0.0 0.0 0.3 0.4 3.2 0.6 0.0 11.3 0.0 0.0 0.7 0.1 0.2 0.1 0.0 11.9 1.3 0.0 1.2 0.1 81.9 0.1 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.4 1.6 0.2 0.8 0.0 0.1 0.0 8.1 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.5 0.0 3.1 1.0 0.0 0.0 5.8 2.3 0.0 0.2 0.0 0.0 5.4 1.0 1.1 1.3 1.4 1.0 1.0 1.1 1.3 2.1 1.7 1.4 1.0 1.2 0.0 3.2 4.8 11.8 0.7 0.0 0.0 0.3 0.0 1.9 0.0 0.0 1.0 31.5 1.0 16.5 0.0 0.0 0.2 29.0 1.9 32.6 0.6 50.0 4.5 0.5 0.0 0.0 0.4 7.3 0.0 0.2 1.5 55.2 0.0 0.0 0.0 0.4 0.1 3.3 0.5 5.6 0.0 0.3 0.0 0.2 0.3 0.4 0.0 0.0 0.0 126.9 0.0 0.0 0.5 25.5 12.7 0.0 0.3 0.0 56.3 15.7 0.3 5.1 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 1.3 0.1 5.6 0.3 HK1 ENSG00000156515 "Hexokinase 1" P19367 10 69269984-69401884 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycolysis, Immunity, Inflammatory response, Innate immunity" "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 374.0;Horizontal cells: 304.5;Late spermatids: 1034.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007043, HPA007044, CAB010052" Supported Supported Mitochondria NA NA 560000 "Cluster 51: Monocytes - Innate immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 25: Spermatids - Spermatogenesis" Mitochondria "CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049" "unprognostic (8.80e-2)" "unprognostic (1.78e-1)" "unprognostic (2.03e-1)" "unprognostic (2.00e-3)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (4.29e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-3)" "unprognostic (1.12e-1)" "unprognostic (1.37e-3)" "unprognostic (7.25e-2)" "unprognostic (1.40e-2)" "unprognostic (2.00e-3)" "unprognostic (3.86e-2)" 47.0 24.4 61.0 45.0 65.7 60.3 40.6 58.0 76.6 54.7 64.2 60.1 13.1 41.3 11.2 129.9 37.0 25.7 150.8 69.1 62.7 49.2 8.5 48.1 34.1 56.7 59.8 19.9 12.3 25.0 44.9 49.3 71.1 52.9 31.9 147.6 67.1 53.1 193.5 102.6 29.2 49.8 40.0 40.3 61.6 77.2 53.5 44.9 71.0 146.7 47.6 74.3 80.9 54.1 101.6 56.6 74.2 71.1 81.0 60.4 47.1 98.3 256.5 128.5 138.0 16.3 11.0 7.3 75.8 165.9 92.9 86.2 69.9 220.0 122.0 67.5 54.5 250.0 58.3 1.1 91.7 5.1 181.2 91.5 125.8 184.5 407.6 160.8 135.4 36.8 424.5 51.3 178.7 167.7 29.7 13.1 113.8 51.7 247.0 44.8 45.0 0.6 88.7 117.4 75.7 88.7 112.6 215.4 65.2 104.3 117.7 16.5 140.4 190.5 86.4 106.5 139.6 61.1 42.8 17.4 247.3 130.4 56.1 68.7 88.8 44.6 41.5 125.2 69.0 33.5 47.9 47.6 81.0 19.9 41.7 33.9 20.9 31.2 135.4 9.1 58.1 110.4 61.0 65.7 58.0 76.6 69.1 62.7 56.7 59.8 71.1 40.0 53.5 54.1 26.1 25.6 32.4 38.2 26.5 48.3 50.5 37.8 43.9 83.9 33.1 21.7 130.6 4.3 34.2 27.6 54.2 70.6 14.6 30.3 13.7 28.6 374.0 32.6 28.0 37.9 18.7 104.8 53.8 30.6 93.3 30.3 41.3 34.5 23.4 72.6 26.7 1.1 49.4 304.5 49.8 28.7 44.7 41.7 21.9 1034.1 15.2 51.3 37.4 29.0 35.3 32.9 20.6 14.1 3.5 54.6 11.1 18.4 19.1 29.1 0.7 1.1 30.7 95.5 19.7 22.2 43.1 5.3 6.2 86.0 51.7 118.9 30.5 28.3 19.3 43.5 TACR2 "NK2R, NKNAR, SKR, TAC2R" ENSG00000075073 "Tachykinin receptor 2" P21452 10 69403903-69416918 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 184.0" "Cell type enhanced" "Detected in some" "Horizontal cells: 6.7;Kupffer cells: 2.4;Leydig cells: 2.8" "Cancer enriched" "Detected in many" 4 "stomach cancer: 6.7" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SK-MEL-30: 4.2;U-87 MG: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076573 Approved "Plasma membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane" "HPA076573: AB_2732313" "unprognostic (2.83e-1)" "unprognostic (1.58e-3)" "unprognostic (2.48e-2)" "unprognostic (1.67e-1)" "unprognostic (4.22e-1)" "unprognostic (2.30e-1)" "unprognostic (1.30e-2)" "unprognostic (1.96e-2)" "unprognostic (3.72e-1)" "unprognostic (6.14e-2)" "unprognostic (2.45e-2)" "unprognostic (3.16e-2)" "unprognostic (9.88e-4)" "unprognostic (5.59e-3)" "unprognostic (4.31e-3)" "unprognostic (1.25e-3)" "unprognostic (1.32e-1)" 0.9 0.3 1.3 2.5 1.2 0.4 0.8 1.5 1.7 10.3 0.2 184.0 5.0 25.2 0.2 14.7 20.4 0.5 3.2 1.7 0.1 0.3 0.5 0.7 0.3 0.0 0.2 1.8 0.3 0.0 0.2 0.2 0.1 6.2 9.1 4.1 0.5 1.1 2.8 1.1 31.4 33.1 0.0 0.3 37.9 0.7 0.0 0.1 0.4 0.2 0.1 32.3 8.5 0.4 0.9 0.6 0.2 0.3 1.4 0.1 0.1 0.2 0.1 0.2 0.3 0.3 0.1 0.1 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.2 0.8 0.3 0.8 0.1 0.0 1.4 0.2 0.3 0.0 0.0 0.4 0.0 0.0 0.2 1.2 0.0 0.3 0.0 0.2 0.2 0.8 0.9 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.6 1.2 4.2 0.1 0.5 0.1 0.3 1.4 0.2 0.6 0.5 0.5 0.6 0.1 2.3 0.1 0.8 0.2 0.4 0.0 0.1 1.3 0.1 0.3 0.2 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.1 1.3 1.2 1.5 1.7 1.7 0.1 0.0 0.2 0.1 0.0 0.0 0.4 0.5 0.0 0.5 0.3 0.1 0.6 0.2 0.2 0.0 0.2 1.1 1.4 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.3 0.6 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.6 0.0 0.2 1.4 0.1 1.2 6.7 0.1 0.3 0.0 2.4 0.4 0.1 2.8 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.4 0.1 1.5 0.2 0.0 1.1 0.7 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.4 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451465-69507666 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 125.8;Ductal cells: 125.2;Exocrine glandular cells: 189.3;Pancreatic endocrine cells: 193.4;Paneth cells: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "MAIT T-cell: 19.5" "Lineage enriched" "Detected in many" 6 "T-cells: 19.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 154.7;EFO-21: 211.3;MCF7: 168.0;OE19: 153.2;PC-3: 266.8;SK-BR-3: 134.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044657, HPA071160" Approved Approved "Nuclear bodies,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Nuclear bodies, Plasma membrane" "Vesicles, Cytosol" "HPA044657: AB_10967927, HPA071160: " "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavorable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 70.1 5.3 22.8 15.3 37.6 1.0 61.0 35.0 34.1 16.4 14.9 62.5 38.8 32.6 8.5 10.8 24.6 27.4 16.9 23.6 25.4 25.9 4.6 34.4 8.7 36.9 33.4 3.4 20.0 3.2 6.6 28.1 33.7 34.5 39.4 3.1 26.6 24.7 17.9 10.6 38.8 31.3 30.0 26.7 75.3 9.5 34.5 3.6 14.5 5.6 7.5 46.0 14.9 62.4 51.3 103.9 2.1 0.3 2.3 0.0 12.0 0.2 1.9 2.6 6.8 45.1 154.7 0.0 211.3 2.3 9.2 101.2 7.2 11.5 3.0 42.1 20.4 2.9 3.5 10.0 1.1 0.1 1.8 2.2 3.1 1.4 1.5 7.5 39.4 20.5 1.1 0.0 1.2 168.0 0.6 0.9 2.6 153.2 266.8 4.0 2.1 2.0 29.7 92.9 34.5 13.2 0.6 134.8 17.9 17.3 59.3 2.2 34.5 0.2 0.8 0.1 17.5 1.2 6.1 1.0 1.1 0.1 0.2 0.0 0.0 0.0 2.3 0.0 19.5 0.0 3.1 2.8 3.3 0.0 1.0 0.2 0.0 0.1 0.0 0.2 1.1 0.5 22.8 37.6 35.0 34.1 23.6 25.4 36.9 33.4 33.7 30.0 34.5 62.4 108.8 32.1 6.9 4.9 1.5 3.6 10.9 59.6 2.2 2.9 45.1 15.6 1.7 31.5 29.5 29.5 6.2 2.0 1.6 125.8 3.9 125.2 27.9 25.5 3.8 48.4 40.2 8.0 1.7 189.3 11.9 8.2 71.4 36.6 1.3 2.5 10.4 0.1 25.3 1.7 1.0 106.7 36.7 8.5 16.1 6.6 0.6 9.8 28.4 15.0 15.6 44.7 0.0 11.1 75.3 193.4 120.9 0.0 0.2 50.4 68.3 1.8 27.6 1.5 13.1 39.7 26.8 4.3 18.5 2.9 3.1 3.0 3.9 7.5 66.3 29.6 NEUROG3 "Atoh5, bHLHa7, Math4B, ngn3" ENSG00000122859 "Neurogenin 3" Q9Y4Z2 10 69571698-69573422 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 5.4;intestine: 2.6" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 9.5;Enteroendocrine cells: 5.3" "Cancer enhanced" "Detected in some" "stomach cancer: 1.4" "Group enriched" "Detected in some" 20 "cerebral cortex: 4.5;hippocampal formation: 5.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "THP-1: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA039785 Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 43: THP-1 - Innate immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear speckles" Nucleoplasm "HPA039785: AB_10795114" "unprognostic (1.22e-2)" "unprognostic (7.33e-2)" "unprognostic (3.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (5.85e-5)" "unprognostic (4.58e-2)" "unprognostic (4.19e-1)" 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 4.5 0.0 0.0 0.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 4.5 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630247-69633596 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.3" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 19.4;Collecting duct cells: 16.5;Distal tubular cells: 11.7;Ductal cells: 24.3;Exocrine glandular cells: 18.4;Pancreatic endocrine cells: 20.7;Proximal tubular cells: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 13 "gdT-cell: 4.3;MAIT T-cell: 10.9;memory CD4 T-cell: 10.5;memory CD8 T-cell: 7.0;naive CD4 T-cell: 17.2;naive CD8 T-cell: 5.7;T-reg: 7.8" "Lineage enriched" "Detected in single" 25 "T-cells: 17.2" "Cell line enhanced" "Detected in many" "PC-3: 57.5" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavorable (8.64e-4)" "prognostic unfavorable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favorable (9.72e-4)" 1.6 3.0 26.3 1.9 27.3 1.1 4.7 30.4 40.3 2.2 19.2 6.6 2.7 3.2 11.1 4.8 4.3 2.0 6.6 35.5 31.7 10.7 3.7 4.0 2.9 21.7 24.2 2.1 8.2 8.2 12.7 1.2 28.2 7.8 2.3 11.3 5.5 4.7 4.7 3.4 3.5 3.8 21.5 1.4 5.8 22.2 26.4 2.8 5.8 1.2 2.3 5.8 3.0 22.2 29.4 31.9 3.9 31.8 0.0 0.0 13.6 2.9 0.8 5.1 5.6 23.4 23.6 0.0 42.8 0.6 18.6 11.8 16.6 9.6 7.1 29.4 22.8 0.0 6.7 8.8 8.1 0.0 10.0 0.0 9.4 0.2 4.8 3.8 0.0 43.8 11.1 0.1 0.5 39.9 0.3 0.0 19.1 11.8 57.5 0.0 0.0 0.4 10.9 16.6 16.0 22.2 12.1 29.6 19.0 7.8 20.5 5.1 1.4 0.8 19.4 0.1 8.5 5.1 15.2 0.1 0.4 0.0 0.8 0.0 0.0 0.0 4.3 0.0 10.9 0.1 10.5 7.0 0.1 0.4 17.2 5.7 0.6 0.2 0.0 0.1 7.8 3.1 26.3 27.3 30.4 40.3 35.5 31.7 21.7 24.2 28.2 21.5 26.4 22.2 1.4 0.0 4.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 8.3 19.4 0.0 0.0 3.1 16.5 0.0 7.5 0.6 0.0 11.7 24.3 0.0 5.7 0.4 0.7 0.0 0.0 0.0 18.4 5.6 0.6 0.0 5.0 0.0 8.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.3 0.0 0.0 13.5 4.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.9 2.8 3.7 0.0 0.0 COL13A1 ENSG00000197467 "Collagen type XIII alpha 1 chain" Q5TAT6 10 69801880-69964275 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Osteogenesis" "Developmental protein, Heparin-binding" "Congenital myasthenic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 30.4" "Cell type enhanced" "Detected in some" "Fibroblasts: 10.1;granulocytes: 20.3;Melanocytes: 5.4;Microglial cells: 6.5;NK-cells: 9.2;Smooth muscle cells: 5.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 63.6;BJ hTERT+: 61.6;hTERT-RPE1: 83.7;HUVEC TERT2: 102.2;PC-3: 93.1;TIME: 137.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA050392 Approved NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" "HPA050392: AB_2681110" "unprognostic (2.79e-2)" "unprognostic (2.82e-3)" "unprognostic (1.38e-1)" "unprognostic (3.86e-1)" "unprognostic (4.67e-4)" "unprognostic (3.13e-1)" "unprognostic (1.69e-1)" "unprognostic (7.43e-2)" "unprognostic (6.16e-3)" "unprognostic (1.22e-1)" "unprognostic (2.60e-1)" "unprognostic (2.53e-2)" "unprognostic (1.36e-5)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.52e-2)" "unprognostic (3.93e-2)" 1.2 1.9 1.5 2.6 1.7 0.3 2.0 9.5 3.3 5.7 1.9 4.6 2.9 1.8 30.4 1.9 2.8 2.4 3.4 1.4 1.5 2.0 0.8 10.9 0.9 1.6 1.6 0.9 2.1 0.8 3.7 1.7 1.8 13.6 3.4 0.0 0.7 8.0 0.9 5.2 3.8 2.9 1.6 8.0 6.2 0.7 1.7 0.3 1.5 1.4 0.8 3.8 1.8 1.5 1.5 0.6 22.1 0.0 0.1 4.3 0.1 63.6 61.6 10.9 5.5 0.0 1.4 0.2 10.5 30.1 1.0 2.3 0.0 0.2 18.9 0.0 1.6 0.0 0.0 0.0 2.9 0.0 0.1 9.8 0.1 27.5 9.0 83.7 102.2 0.0 0.0 0.1 10.4 0.4 0.0 0.2 5.3 0.0 93.1 0.1 0.0 10.3 0.4 0.0 2.4 0.0 0.0 0.2 3.4 0.9 0.0 0.2 137.4 0.3 17.1 5.7 45.7 13.4 0.0 0.1 37.2 0.1 51.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.5 1.7 9.5 3.3 1.4 1.5 1.6 1.6 1.8 1.6 1.7 1.5 0.9 0.0 0.6 0.3 0.0 3.4 0.3 0.3 0.6 0.2 0.1 2.0 2.1 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 1.3 0.0 0.0 0.2 3.4 0.0 0.0 1.4 0.0 0.0 10.1 0.0 0.1 20.3 1.8 1.1 0.0 0.1 0.0 0.3 0.0 0.0 0.3 2.3 0.0 0.0 0.3 5.4 6.5 0.0 0.1 9.2 0.0 0.3 0.1 0.0 0.4 0.3 0.5 0.9 0.0 0.1 0.0 0.0 1.1 5.6 0.5 0.5 0.2 3.0 0.1 0.6 0.5 0.1 0.1 MACROH2A2 H2AFY2 ENSG00000099284 "MacroH2A.2 histone" Q9P0M6 10 70052544-70112282 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 7.1;Fibroblasts: 1.7;Hofbauer cells: 4.9;Syncytiotrophoblasts: 1.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 12.6" "Group enriched" "Detected in many" 5 "dendritic cells: 12.6;monocytes: 5.4" "Cell line enhanced" "Detected in many" "AF22: 173.9;AN3-CA: 111.5;SCLC-21H: 137.0;SH-SY5Y: 132.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035865, HPA041189" Enhanced Supported Nucleoplasm No No "Cluster 28: Myeloid DCs - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 12: NES - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" Nucleoplasm "HPA035865: AB_10672099, HPA041189: AB_2677357" "unprognostic (1.62e-2)" "unprognostic (9.62e-2)" "unprognostic (1.46e-2)" "unprognostic (1.46e-2)" "unprognostic (7.71e-3)" "unprognostic (1.85e-1)" "unprognostic (3.44e-2)" "unprognostic (5.37e-2)" "unprognostic (1.67e-1)" "unprognostic (9.17e-2)" "unprognostic (7.32e-2)" "unprognostic (1.80e-2)" "unprognostic (1.31e-2)" "unprognostic (3.27e-2)" "unprognostic (4.58e-2)" "unprognostic (8.78e-2)" "unprognostic (4.66e-2)" 3.8 3.2 5.3 5.6 4.5 1.9 10.2 7.3 6.3 14.7 3.3 10.8 9.5 18.3 11.6 17.4 16.5 8.7 13.5 4.1 4.9 15.2 5.2 5.6 4.9 3.8 3.9 13.3 7.8 14.9 14.0 2.1 3.7 13.1 10.5 3.2 10.9 14.4 6.5 10.7 10.1 15.3 3.6 2.7 8.6 11.8 4.2 7.4 10.2 8.6 7.2 13.2 11.8 4.4 4.7 31.1 173.9 111.5 2.5 5.1 0.1 8.6 0.3 16.2 11.0 0.5 55.8 0.0 23.5 2.8 9.1 27.4 15.3 44.8 5.1 81.1 63.4 0.0 0.2 59.1 11.2 1.9 0.8 8.1 30.4 6.4 8.5 23.4 0.0 6.3 0.1 0.6 15.7 37.5 0.2 0.9 74.8 0.2 44.9 0.4 0.5 0.6 30.7 34.0 137.0 132.4 28.6 0.2 0.0 35.2 41.5 20.3 0.0 0.3 32.3 12.4 6.2 0.4 0.1 0.3 0.0 0.2 0.3 1.6 2.4 0.8 0.6 5.4 1.1 0.3 0.9 0.8 12.6 0.3 0.8 0.9 1.4 1.1 3.0 0.2 0.5 1.6 5.3 4.5 7.3 6.3 4.1 4.9 3.8 3.9 3.7 3.6 4.2 4.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 AIFM2 "AMID, FLJ14497, PRG3" ENSG00000042286 "Apoptosis inducing factor mitochondria associated 2" Q9BRQ8 10 70098223-70132934 "Predicted intracellular proteins" "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 173.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028961, HPA042309, HPA075576" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 82: Adipose tissue - ECM organization" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "Plasma membrane, Cytosol" "HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: " "unprognostic (6.62e-2)" "unprognostic (2.73e-1)" "unprognostic (4.29e-1)" "prognostic favorable (2.80e-4)" "unprognostic (7.26e-3)" "unprognostic (2.57e-2)" "unprognostic (7.95e-3)" "unprognostic (2.80e-1)" "unprognostic (5.31e-2)" "unprognostic (8.90e-2)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.49e-1)" "unprognostic (4.59e-3)" "unprognostic (2.17e-1)" "unprognostic (1.11e-1)" "prognostic favorable (2.92e-4)" 39.6 13.5 7.5 6.3 8.1 1.9 31.2 7.3 8.0 6.9 8.6 12.9 9.3 7.8 9.0 13.3 6.8 5.0 17.0 6.9 7.7 10.4 21.9 9.3 5.1 8.2 7.3 7.9 5.0 3.2 5.6 4.1 6.9 9.9 7.1 2.4 7.6 7.7 9.8 5.6 11.5 5.0 6.2 7.7 9.9 3.9 8.3 2.4 14.6 7.3 3.6 12.0 6.3 6.5 26.5 45.2 1.1 11.3 26.2 9.8 0.3 10.4 25.5 21.0 23.6 35.3 49.8 3.8 25.8 14.5 27.5 27.9 12.7 3.8 5.9 50.8 1.9 0.2 27.3 173.3 56.1 0.3 6.4 13.3 8.4 33.8 7.2 13.2 9.5 1.7 20.5 21.9 11.0 33.5 1.2 1.3 4.5 21.2 14.6 0.8 4.2 12.4 11.4 19.2 3.6 0.8 19.1 16.6 29.8 1.8 0.7 7.2 12.0 0.5 25.3 15.6 30.8 16.2 32.7 7.3 14.0 0.9 13.9 1.0 0.5 0.5 1.8 0.5 1.5 1.7 0.6 1.5 0.4 1.5 0.8 1.3 0.5 4.0 0.5 0.2 1.3 0.7 7.5 8.1 7.3 8.0 6.9 7.7 8.2 7.3 6.9 6.2 8.3 6.5 11.6 6.4 14.1 7.2 5.0 2.3 15.0 8.4 2.8 5.7 5.5 4.7 13.8 8.6 10.5 18.4 0.0 13.9 1.4 53.1 3.9 40.7 24.1 6.0 7.7 4.8 12.0 7.0 8.2 21.9 3.0 11.2 14.3 6.2 11.4 22.3 1.8 25.0 10.2 1.7 5.2 7.1 14.2 3.3 3.3 47.0 5.3 6.7 8.8 4.7 34.4 4.8 1.0 5.5 3.5 40.8 22.7 4.5 17.0 14.6 28.7 22.6 9.5 2.1 19.7 11.8 12.8 6.2 3.9 5.1 1.4 18.6 3.8 8.8 13.7 20.4 TYSND1 "MGC34695, NET41" ENSG00000156521 "Trypsin like peroxisomal matrix peptidase 1" Q2T9J0 10 70137981-70146700 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 120.7;Late spermatids: 227.4;Spermatocytes: 124.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 27.5;PC-3: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030304 Approved Uncertain Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Centrosome" Cytosol "HPA030304: AB_10670560" "unprognostic (4.75e-3)" "unprognostic (4.30e-2)" "unprognostic (2.44e-2)" "unprognostic (7.69e-2)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.02e-2)" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-1)" "unprognostic (1.59e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-1)" "unprognostic (9.26e-3)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" 5.7 6.0 1.4 1.9 1.3 0.9 5.4 1.7 1.8 5.8 1.1 4.9 3.3 4.1 0.6 11.8 4.5 0.6 2.9 1.0 0.9 5.2 6.4 2.8 1.8 2.1 0.7 4.2 6.2 1.3 3.4 1.3 0.8 5.7 0.6 0.2 5.7 1.5 3.2 11.4 5.0 0.3 0.6 5.4 3.9 14.2 0.9 1.2 4.6 0.5 0.9 4.8 6.5 1.4 16.0 10.2 0.8 6.2 1.0 0.9 3.7 2.2 1.4 2.0 1.8 6.2 9.6 13.8 6.0 0.5 0.6 27.5 1.0 3.9 0.4 8.9 9.5 0.7 2.9 3.3 2.4 1.2 0.1 2.0 7.6 1.7 3.1 1.2 1.4 4.9 0.1 4.3 0.8 6.3 5.3 5.6 3.3 3.5 41.7 8.9 2.6 6.2 0.9 2.6 7.4 3.8 6.7 14.8 6.1 0.2 9.4 1.1 2.6 2.5 1.7 4.8 8.7 14.9 9.9 7.0 2.9 6.2 1.8 0.0 0.8 0.7 3.8 1.2 2.4 3.0 2.2 2.8 0.9 3.3 3.0 2.6 0.3 2.0 0.7 0.7 2.6 1.4 1.4 1.3 1.7 1.8 1.0 0.9 2.1 0.7 0.8 0.6 0.9 1.4 6.1 9.6 5.3 4.9 12.6 14.3 14.5 13.3 14.8 6.9 14.8 16.9 4.2 27.1 7.8 11.0 0.0 35.2 15.5 14.6 17.6 7.8 120.7 5.5 6.8 6.3 14.3 5.0 6.7 9.5 9.8 7.5 5.1 6.3 13.4 9.3 6.8 16.5 12.1 0.0 6.0 12.1 16.2 10.7 6.6 227.4 9.3 8.2 12.4 6.5 6.1 7.0 12.3 11.6 5.5 5.5 11.6 7.9 7.5 14.5 19.2 16.5 3.9 4.4 6.6 6.9 6.1 124.7 12.5 22.4 18.5 16.7 14.0 10.6 21.0 8.8 SAR1A "SAR1, Sara, SARA1" ENSG00000079332 "Secretion associated Ras related GTPase 1A" Q9NR31 10 70147289-70170523 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006923, CAB022545, HPA048368" Supported Supported "Endoplasmic reticulum" NA NA 660000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 10: Non-specific - Unknown function" "Endoplasmic reticulum" "CAB022545: , HPA006923: AB_1856577, HPA048368: AB_2680373" "unprognostic (3.77e-2)" "unprognostic (7.13e-2)" "unprognostic (3.08e-3)" "unprognostic (3.13e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (7.00e-5)" "prognostic unfavorable (4.04e-4)" "unprognostic (1.60e-2)" "unprognostic (1.00e-1)" "unprognostic (1.02e-2)" "unprognostic (4.06e-2)" "unprognostic (2.06e-1)" "unprognostic (2.38e-3)" "unprognostic (1.76e-1)" "unprognostic (4.80e-2)" "unprognostic (1.10e-2)" "unprognostic (7.13e-2)" 77.1 52.8 41.8 38.4 43.5 163.2 48.1 45.1 45.7 43.1 53.3 39.1 26.6 41.0 47.0 41.4 37.3 35.0 44.8 43.8 48.3 43.3 70.2 51.4 36.7 42.8 44.9 41.0 33.9 44.2 37.9 76.0 44.0 38.9 35.5 42.0 39.9 38.9 51.1 38.5 34.5 49.7 47.3 40.7 37.9 23.5 48.4 33.2 39.8 56.3 38.4 45.8 36.2 52.1 85.8 56.3 75.7 131.9 246.1 143.1 61.1 128.3 154.4 115.6 140.0 169.7 78.2 74.4 67.1 153.7 52.8 96.6 94.5 75.9 111.6 103.9 44.3 54.1 65.8 82.5 112.4 86.7 56.6 155.9 68.4 76.4 133.2 119.0 63.8 55.9 68.7 105.9 110.0 60.0 73.8 72.6 65.2 55.6 141.3 70.8 84.4 42.5 88.7 69.7 42.6 73.8 98.0 134.6 72.2 66.8 65.8 59.7 88.6 63.7 94.3 92.2 91.3 72.3 141.3 114.0 84.9 111.7 48.7 75.5 63.5 74.0 88.0 80.9 94.8 47.7 68.5 85.9 58.5 38.6 65.7 88.7 67.9 103.3 72.9 44.8 53.2 95.9 41.8 43.5 45.1 45.7 43.8 48.3 42.8 44.9 44.0 47.3 48.4 52.1 88.4 128.2 110.2 6.8 53.5 235.7 138.0 120.2 25.0 38.6 99.2 62.4 74.7 57.2 105.3 49.7 33.3 120.6 109.8 51.6 54.8 78.4 3.0 52.3 85.8 85.2 42.7 46.1 21.2 77.3 199.0 127.8 23.9 89.7 53.2 46.3 69.7 114.1 101.0 26.9 22.2 72.1 65.1 51.2 208.9 5.6 54.7 68.1 113.8 21.5 58.4 61.9 75.2 16.1 26.4 78.8 56.2 58.6 97.7 141.4 59.1 95.9 67.1 33.4 78.9 73.7 158.8 64.1 51.8 37.2 248.8 238.9 86.3 45.2 53.2 175.2 PPA1 "IOPPP, PP, PP1, Ppase, SID6-8061" ENSG00000180817 "Inorganic pyrophosphatase 1" Q15181 10 70202835-70233911 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 1239.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019878, HPA020096" Supported Supported Vesicles NA NA 1000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 30: Epithelial cell lines - Translation" "Cluster 5: Muller glia cells - Visual perception" Vesicles "HPA019878: AB_1855601, HPA020096: AB_1855600" "unprognostic (1.50e-1)" "unprognostic (2.85e-1)" "unprognostic (4.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.42e-1)" "unprognostic (4.47e-2)" "unprognostic (2.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-1)" "unprognostic (2.13e-2)" "unprognostic (3.60e-2)" "unprognostic (1.82e-3)" "unprognostic (5.36e-2)" "unprognostic (2.37e-1)" "unprognostic (3.53e-2)" "unprognostic (2.74e-1)" 176.7 198.5 124.3 116.0 138.8 85.0 186.7 166.7 163.0 96.5 123.0 137.3 99.4 85.8 166.7 157.7 110.2 90.3 100.1 125.8 148.5 123.2 150.2 129.0 132.6 153.1 142.3 56.5 188.5 68.5 92.1 103.7 165.4 68.7 152.5 332.0 116.1 78.7 133.0 85.9 125.1 96.8 159.3 64.2 97.5 73.5 141.6 103.5 126.3 137.3 137.3 167.1 140.0 167.0 446.9 181.2 158.8 471.2 421.6 368.8 148.2 163.5 305.3 250.1 261.8 556.7 230.6 641.0 144.5 164.0 162.8 351.2 470.7 318.4 253.8 599.1 443.5 176.1 169.1 321.7 265.8 439.0 106.9 244.2 372.9 201.3 530.7 273.8 307.9 319.2 416.9 336.4 239.4 262.3 426.5 408.7 165.9 614.2 494.8 256.9 181.7 378.2 527.0 276.3 474.4 159.6 179.3 694.5 148.0 110.8 174.3 194.2 141.0 69.0 262.2 229.4 315.2 110.1 259.2 469.8 106.7 605.2 62.0 0.4 68.8 1.7 48.9 55.2 131.1 83.6 112.3 85.6 190.0 59.4 122.7 106.8 4.1 65.8 63.1 44.4 120.4 105.3 124.3 138.8 166.7 163.0 125.8 148.5 153.1 142.3 165.4 159.3 141.6 167.0 207.0 224.4 165.9 17.0 122.7 267.9 366.2 427.3 158.2 184.9 347.8 363.7 93.3 218.8 275.7 108.5 173.0 313.2 63.4 203.3 201.5 540.1 31.7 278.8 196.1 182.1 162.7 88.4 36.8 776.1 298.3 156.9 114.2 512.1 36.8 208.2 38.2 141.8 96.5 85.8 41.2 254.9 160.7 80.1 148.1 31.7 109.6 120.3 181.5 29.0 612.7 1239.0 65.9 21.6 98.4 532.9 213.5 117.4 161.2 512.4 444.5 551.2 92.1 278.4 65.7 97.2 136.8 173.7 170.7 245.8 257.1 245.7 120.9 203.0 347.6 613.9 NPFFR1 "GPR147, NPFF1R1, OT7T022" ENSG00000148734 "Neuropeptide FF receptor 1" Q9GZQ6 10 70247329-70284004 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 9.5;retina: 3.1" "Cell type enhanced" "Detected in some" "Astrocytes: 6.5;Muller glia cells: 10.4" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "basal ganglia: 15.7;hypothalamus: 6.3" "Low region specificity" "Detected in single" HPA037521 Uncertain NA NA "Cluster 11: Basophils - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 5: Muller glia cells - Visual perception" "HPA037521: AB_2675520" "unprognostic (1.73e-3)" "unprognostic (7.29e-4)" "unprognostic (2.12e-1)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (8.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.48e-1)" "unprognostic (4.14e-2)" "unprognostic (3.51e-1)" "unprognostic (9.62e-2)" "unprognostic (6.78e-2)" "unprognostic (5.84e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" 0.2 0.0 1.6 0.4 2.5 0.3 0.1 9.5 1.8 0.1 0.9 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.0 1.6 2.8 0.0 0.0 0.2 0.6 2.5 2.8 0.1 0.0 0.0 0.1 0.0 2.7 0.1 0.1 3.1 0.0 0.2 0.2 0.1 0.1 0.0 1.8 0.2 0.2 1.0 3.2 0.0 0.0 0.1 0.3 0.1 0.2 2.9 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.3 0.2 0.0 0.1 0.0 0.7 1.6 2.5 9.5 1.8 1.6 2.8 2.5 2.8 2.7 1.8 3.2 2.9 0.2 0.0 2.0 6.5 0.2 1.7 1.8 0.3 0.0 0.7 0.1 0.3 1.0 1.5 0.0 1.8 0.0 0.2 1.5 0.4 0.0 0.0 0.3 0.6 0.2 0.5 0.0 0.0 0.2 0.2 0.2 0.8 0.0 0.8 2.5 0.1 0.4 0.2 0.1 0.0 1.4 0.1 0.0 0.3 2.8 1.6 0.6 0.8 0.0 0.0 0.4 10.4 1.0 1.0 1.0 0.1 0.1 0.4 0.0 1.1 0.0 0.1 0.1 1.6 0.0 1.7 0.6 0.6 1.2 0.0 2.0 1.1 0.3 0.0 0.2 0.9 LRRC20 "FLJ10751, FLJ10844" ENSG00000172731 "Leucine rich repeat containing 20" Q8TCA0 10 70298970-70382650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 305.6;tongue: 125.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 31.0;Early spermatids: 25.4;Hepatocytes: 17.5;Late spermatids: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-2 OS: 64.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039630 Approved Nucleoplasm,Cytosol No No "Cluster 22: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm Cytosol "HPA039630: AB_10795467" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-2)" "unprognostic (3.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.50e-3)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.30e-1)" 2.8 5.9 17.1 2.6 17.7 3.3 2.3 13.6 21.5 15.1 10.0 14.1 2.7 6.5 3.1 14.7 4.3 3.1 40.7 18.3 14.8 3.7 32.0 4.5 3.1 17.3 15.5 4.3 3.4 3.2 13.2 1.4 18.1 4.6 4.0 4.4 6.3 4.2 305.6 3.5 4.1 6.9 14.4 3.3 5.0 12.5 18.0 7.3 4.4 125.0 5.3 6.2 19.9 17.5 26.1 18.1 16.2 29.7 9.3 6.5 0.1 4.0 14.5 9.2 8.6 17.2 27.7 5.9 13.2 2.4 31.1 9.8 14.3 18.1 8.1 14.7 3.6 3.2 4.6 53.3 8.6 8.2 2.7 2.6 7.0 11.3 5.4 11.2 18.7 34.6 4.0 7.6 8.4 3.6 31.0 8.4 5.3 26.0 46.3 23.8 8.2 14.8 15.1 2.7 32.4 16.2 2.0 2.5 10.9 4.1 3.4 9.2 10.6 6.3 64.7 10.7 8.9 13.6 22.3 9.3 12.6 32.7 1.7 0.0 0.2 0.0 0.4 0.3 0.4 0.1 0.3 0.4 0.6 0.0 1.0 0.4 0.0 0.4 0.1 0.1 0.0 0.3 17.1 17.7 13.6 21.5 18.3 14.8 17.3 15.5 18.1 14.4 18.0 17.5 1.9 0.0 4.6 9.4 1.1 1.5 0.5 0.6 0.0 8.5 1.5 0.6 31.0 2.8 1.3 0.0 4.2 0.1 0.8 0.8 0.0 3.9 25.4 1.1 1.3 2.4 5.4 1.7 10.0 4.7 0.2 2.8 1.5 0.7 0.0 2.5 2.2 17.5 0.5 1.7 10.1 2.0 0.0 0.6 0.7 50.1 3.1 0.8 1.8 1.9 1.2 7.5 1.0 6.6 3.9 5.8 3.1 1.5 1.7 0.8 0.3 1.6 0.6 2.0 0.0 5.2 1.9 8.5 4.8 0.1 0.6 0.0 1.3 1.8 2.1 0.6 EIF4EBP2 ENSG00000148730 "Eukaryotic translation initiation factor 4E binding protein 2" Q13542 10 70404145-70428618 "Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019415, HPA037410, HPA061665" Approved Approved Nucleoplasm,Mitochondria NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Mitochondria" "CAB019415: AB_10699019, HPA037410: AB_2675461, HPA061665: AB_2684580" "unprognostic (9.57e-2)" "unprognostic (3.22e-2)" "unprognostic (2.27e-1)" "unprognostic (1.45e-2)" "unprognostic (1.05e-1)" "unprognostic (3.51e-1)" "unprognostic (3.84e-1)" "unprognostic (7.24e-2)" "unprognostic (8.24e-2)" "unprognostic (8.19e-2)" "unprognostic (2.87e-1)" "unprognostic (1.46e-1)" "prognostic favorable (6.69e-6)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (1.53e-1)" "unprognostic (4.61e-2)" 67.7 27.6 27.8 23.2 25.2 30.4 44.8 21.8 23.6 29.0 28.9 41.2 40.4 25.1 16.5 31.9 25.8 23.8 40.8 21.0 23.9 57.3 50.5 30.5 26.2 28.9 26.6 34.9 30.2 27.5 11.2 43.8 21.7 24.7 39.6 34.9 28.2 33.6 64.2 35.0 47.3 27.2 23.6 26.7 30.9 18.2 34.7 34.5 23.2 67.4 29.2 36.2 28.2 20.1 56.3 17.8 93.7 92.0 176.9 66.8 51.8 33.5 40.5 24.0 25.9 77.5 48.1 57.2 20.1 48.6 14.9 35.6 46.2 30.4 26.9 63.6 24.0 41.4 21.1 30.8 41.5 74.4 28.4 74.8 30.8 29.4 26.4 48.4 36.8 46.0 69.0 50.7 37.5 31.5 64.3 76.3 80.7 54.2 31.8 66.3 37.6 37.4 30.7 56.3 51.1 77.6 45.7 103.0 44.5 63.8 47.2 65.3 40.6 15.6 20.0 25.8 30.2 35.5 73.2 66.5 18.1 108.2 16.3 20.8 19.2 28.7 16.4 16.8 13.2 9.0 13.1 13.8 17.2 8.2 10.9 11.4 21.1 11.6 23.0 5.7 15.7 19.2 27.8 25.2 21.8 23.6 21.0 23.9 28.9 26.6 21.7 23.6 34.7 20.1 72.5 25.6 37.6 21.9 31.9 52.9 53.5 25.4 27.9 46.8 42.9 32.5 147.0 68.6 29.1 36.8 20.9 47.3 45.2 196.7 43.0 43.9 25.9 33.1 52.1 41.4 26.5 70.5 13.0 59.3 119.1 49.9 34.7 57.8 11.4 39.0 61.8 157.4 46.0 23.5 17.5 73.6 34.6 95.4 45.1 59.0 65.9 50.9 21.4 24.4 92.9 73.1 76.2 22.1 9.1 59.5 94.7 61.3 33.8 63.4 195.2 137.0 23.4 17.2 78.9 46.4 37.1 43.7 47.1 39.1 70.0 57.3 43.0 47.0 73.1 109.4 NODAL ENSG00000156574 "Nodal growth differentiation factor" Q96S42 10 70431936-70447951 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Developmental protein, Growth factor" "Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.3;skeletal muscle: 2.3" "Group enriched" "Detected in some" 26 "Early spermatids: 15.4;Late spermatids: 38.5" "Cancer enriched" "Detected in some" 10 "testis cancer: 20.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.9;SH-SY5Y: 1.4;SuSa: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA045201 Uncertain "Secreted to blood" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 25: Spermatids - Spermatogenesis" "HPA045201: AB_2679252" "unprognostic (3.07e-2)" "unprognostic (2.10e-1)" "unprognostic (1.51e-2)" "unprognostic (2.41e-1)" "unprognostic (1.70e-1)" "unprognostic (4.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.65e-1)" "unprognostic (5.66e-3)" "unprognostic (3.12e-2)" "unprognostic (8.77e-2)" "unprognostic (1.61e-1)" "unprognostic (1.63e-5)" "unprognostic (4.37e-1)" "unprognostic (6.98e-2)" "unprognostic (1.19e-1)" "unprognostic (2.02e-1)" 0.7 0.0 0.7 0.0 0.6 0.6 0.5 2.3 0.6 0.6 0.0 0.4 0.2 0.3 0.0 0.3 0.3 0.2 0.3 0.5 0.6 0.1 0.1 0.4 0.2 0.7 0.6 0.3 0.1 0.0 0.1 0.2 0.7 0.2 0.0 1.3 0.2 0.0 2.3 1.0 0.2 0.0 0.5 0.2 0.2 1.9 0.6 0.2 0.1 0.0 0.0 0.4 0.4 0.6 0.3 0.2 0.8 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.9 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.2 0.5 0.2 0.0 0.2 0.2 0.5 0.0 0.1 0.1 1.4 0.4 0.1 0.0 3.5 0.4 0.1 0.0 0.0 0.2 0.1 0.1 0.5 1.1 1.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.6 2.3 0.6 0.5 0.6 0.7 0.6 0.7 0.5 0.6 0.6 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 38.5 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PALD1 "KIAA1274, PALD" ENSG00000107719 "Phosphatase domain containing paladin 1" Q9ULE6 10 70478767-70568450 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Microglial cells: 129.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 15 "plasmacytoid DC: 5.0" "Lineage enriched" "Detected in single" 27 "dendritic cells: 5.0" "Cell line enhanced" "Detected in many" "AN3-CA: 21.5;Daudi: 26.7;NB-4: 25.7;RPMI-8226: 32.8;U-698: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015696, HPA017343" Uncertain NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA015696: AB_1852399, HPA017343: AB_1852397" "unprognostic (1.11e-1)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.51e-1)" "unprognostic (7.94e-2)" "unprognostic (2.52e-3)" "unprognostic (4.52e-3)" "unprognostic (3.55e-2)" "unprognostic (4.96e-2)" "unprognostic (3.34e-2)" "unprognostic (6.56e-2)" "unprognostic (2.48e-1)" "unprognostic (8.20e-3)" "unprognostic (2.73e-2)" "unprognostic (9.27e-2)" "unprognostic (2.46e-1)" "unprognostic (8.81e-3)" 6.9 4.5 16.3 5.1 15.0 2.5 5.3 16.1 18.1 5.5 10.6 14.3 2.7 4.8 1.2 4.7 5.8 4.6 7.4 15.4 16.4 5.3 1.6 19.9 9.2 23.6 17.5 5.5 7.2 1.6 5.4 7.6 20.7 6.0 2.2 1.0 4.0 2.1 5.6 5.5 8.1 4.8 22.1 14.7 7.5 3.6 21.4 4.6 8.2 3.0 8.0 5.2 3.7 19.9 0.0 6.4 7.2 21.5 0.0 0.0 0.0 0.0 0.0 1.8 0.4 2.7 0.2 26.7 5.5 0.0 0.3 0.1 11.9 0.0 0.5 0.1 13.6 0.0 0.9 0.5 2.2 9.0 0.0 0.0 0.0 0.7 0.0 1.9 3.1 8.2 1.4 3.6 0.2 2.2 4.6 25.7 7.6 0.0 0.0 13.5 0.1 32.8 1.9 0.0 7.1 5.3 0.3 0.1 0.6 0.9 0.0 1.9 0.6 0.0 9.7 0.0 0.8 0.3 0.0 26.3 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 16.3 15.0 16.1 18.1 15.4 16.4 23.6 17.5 20.7 22.1 21.4 19.9 15.0 0.0 1.1 4.6 3.2 1.3 0.1 0.1 4.0 0.5 1.3 2.2 3.6 1.5 0.0 1.8 0.0 0.0 11.4 0.0 0.0 1.7 0.9 1.1 0.6 20.3 0.0 0.0 4.9 0.2 0.1 3.5 0.0 1.8 1.3 0.7 12.5 0.2 7.4 0.0 2.2 0.0 0.0 10.8 3.3 0.5 1.8 12.2 1.8 129.3 0.3 3.0 0.0 6.6 0.9 0.1 0.0 0.7 5.1 0.3 0.0 0.1 0.0 0.4 0.0 3.0 5.1 0.2 2.7 0.5 1.3 0.0 0.6 1.2 0.0 0.0 PRF1 "HPLH2, P1, PFP" ENSG00000180644 "Perforin 1" P14222 10 70597348-70602759 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Cytolysis "Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 28.6;lung: 16.5;lymphoid tissue: 49.4" "Cell type enhanced" "Detected in some" "dendritic cells: 542.1;NK-cells: 1231.7;T-cells: 265.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 900.4;MAIT T-cell: 628.8;memory CD8 T-cell: 499.1;naive CD8 T-cell: 313.0;NK-cell: 656.8" "Group enriched" "Detected in all" 50 "NK-cells: 656.8;T-cells: 900.4" "Cell line enriched" "Detected in some" 11 "HDLM-2: 240.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002436, HPA037940" Approved Approved Cytosol "Intracellular and membrane" NA NA 2100000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 2: Immune cells - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "CAB002436: AB_563955, HPA037940: AB_2675747" "unprognostic (6.11e-3)" "unprognostic (1.26e-2)" "unprognostic (1.71e-1)" "prognostic favorable (2.09e-4)" "unprognostic (1.87e-2)" "prognostic favorable (3.54e-4)" "unprognostic (6.98e-3)" "unprognostic (2.62e-1)" "unprognostic (1.44e-3)" "unprognostic (1.69e-2)" "unprognostic (5.22e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.08e-5)" "unprognostic (7.38e-2)" "unprognostic (2.70e-1)" "unprognostic (7.97e-3)" "unprognostic (5.22e-3)" 5.0 2.0 0.7 7.6 0.7 28.6 2.7 0.7 1.3 1.3 1.3 2.2 2.3 3.5 1.1 1.9 1.9 4.2 2.2 0.6 0.6 1.7 6.3 16.5 20.3 1.4 0.7 1.0 1.0 0.5 0.9 2.7 1.0 1.5 1.4 0.0 2.3 1.2 2.6 0.9 5.2 2.0 1.3 49.4 4.7 0.6 1.0 5.8 2.6 1.5 4.9 3.8 1.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 240.1 0.0 1.4 0.0 7.4 0.0 0.3 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 22.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 5.2 1.9 0.9 900.4 1.7 628.8 4.0 125.8 499.1 2.0 3.5 52.1 313.0 15.4 656.8 2.6 2.9 108.8 587.5 0.7 0.7 0.7 1.3 0.6 0.6 1.4 0.7 1.0 1.3 1.0 1.0 3.1 3.2 13.6 0.0 4.4 0.4 0.1 0.0 0.6 0.0 0.5 0.5 0.8 1.5 2.5 0.0 0.0 0.2 542.1 0.1 0.0 0.3 0.0 0.2 0.3 1.9 0.0 19.0 0.0 0.0 0.1 2.1 7.7 0.4 8.8 0.0 10.8 2.7 0.1 0.0 0.0 0.0 0.0 7.8 2.3 0.0 0.0 5.7 0.0 1.9 7.4 0.0 1231.7 0.0 0.1 0.0 0.0 0.0 88.5 0.1 0.1 1.6 1.5 0.0 0.0 1.1 0.8 0.0 0.0 0.5 0.9 0.7 265.4 0.0 0.1 0.0 ADAMTS14 ENSG00000138316 "ADAM metallopeptidase with thrombospondin type 1 motif 14" Q8WXS8 10 70672506-70762441 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.9;gallbladder: 6.7;placenta: 7.6" "Group enriched" "Detected in some" 5 "Oligodendrocytes: 44.8;Paneth cells: 14.6;Theca cells: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.1;K-562: 10.4;RH-30: 5.4;U-138 MG: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" "unprognostic (1.30e-1)" "unprognostic (1.04e-2)" "unprognostic (5.98e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-3)" "unprognostic (2.40e-1)" "unprognostic (5.33e-3)" "unprognostic (2.35e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.98e-2)" "unprognostic (6.81e-2)" "unprognostic (3.84e-13)" "unprognostic (3.90e-2)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" "unprognostic (2.16e-2)" 0.8 0.2 2.6 3.2 5.9 0.6 0.3 2.0 5.4 1.0 0.4 2.7 2.3 0.7 0.4 1.0 0.5 6.7 0.7 2.9 3.7 0.5 0.3 1.7 1.1 3.2 4.3 0.2 0.2 0.0 0.1 7.6 3.2 0.6 1.8 0.0 0.8 0.1 0.1 1.3 3.2 2.2 1.4 0.4 1.4 0.5 10.9 0.4 0.2 0.3 0.7 2.5 0.4 9.9 0.0 0.0 0.1 0.3 0.2 4.0 0.0 1.0 3.2 0.3 1.7 0.0 9.1 0.0 0.7 1.7 0.4 0.7 0.0 0.0 0.1 3.6 0.0 0.3 0.0 0.2 0.0 0.0 2.4 0.3 0.1 0.8 0.2 1.0 0.0 0.0 10.4 0.0 1.3 0.0 0.0 0.9 0.3 0.1 0.0 0.0 5.4 0.2 0.0 0.0 3.4 0.5 0.0 0.1 0.3 0.1 0.0 0.0 0.0 8.9 0.1 0.7 0.5 0.8 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 5.9 2.0 5.4 2.9 3.7 3.2 4.3 3.2 1.4 10.9 9.9 0.1 0.0 0.0 0.3 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.1 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.1 0.5 0.1 0.3 0.0 2.1 0.3 0.0 0.1 2.1 0.0 0.2 4.5 0.1 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 0.8 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 2.0 44.8 0.1 14.6 0.0 0.1 0.0 0.7 0.0 1.4 0.0 0.0 1.8 1.1 0.0 0.0 0.2 0.1 0.4 0.0 17.9 0.5 0.1 TBATA "C10orf27, FLJ32820, spatial" ENSG00000166220 "Thymus, brain and testes associated" Q96M53 10 70771239-70785401 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "lymphoid tissue: 376.5" "Group enriched" "Detected in some" 20 "Early spermatids: 119.6;Late spermatids: 291.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "SK-BR-3: 4.0" "Region enhanced" "Detected in many" "cerebellum: 21.0" "Low region specificity" "Detected in all" NA NA "Cluster 63: T-cells - Adaptive immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (2.54e-1)" "unprognostic (2.97e-1)" "unprognostic (1.93e-2)" "unprognostic (2.14e-1)" "unprognostic (6.24e-2)" "unprognostic (1.45e-1)" "unprognostic (4.88e-1)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 20.9 0.1 376.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 119.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 291.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SGPL1 SPL ENSG00000166224 "Sphingosine-1-phosphate lyase 1" O95470 10 70815948-70881184 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 112.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021125, HPA023086" Enhanced Supported "Endoplasmic reticulum" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" "Endoplasmic reticulum" "HPA021125: AB_1856803, HPA023086: AB_1856804" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (3.07e-2)" "unprognostic (2.13e-1)" "unprognostic (2.34e-1)" "unprognostic (7.60e-2)" "unprognostic (2.98e-2)" "unprognostic (2.88e-1)" "unprognostic (1.06e-1)" "unprognostic (1.70e-2)" "unprognostic (2.12e-1)" "unprognostic (9.52e-2)" "unprognostic (3.42e-1)" "unprognostic (2.14e-1)" "unprognostic (9.21e-2)" "unprognostic (4.68e-3)" 12.0 12.7 15.8 18.0 17.4 6.8 13.0 15.2 16.3 17.6 11.0 16.7 16.0 14.4 18.8 27.9 15.3 12.6 6.4 14.7 16.4 15.5 22.9 10.7 18.1 18.6 16.7 9.0 18.5 21.0 9.4 10.0 17.4 17.5 17.9 10.8 14.3 12.4 9.6 30.4 22.8 13.9 17.4 16.1 12.3 14.0 17.7 17.9 20.1 6.0 20.1 25.0 14.7 19.8 26.9 35.2 33.2 38.1 8.9 11.5 22.1 15.5 16.4 16.5 21.4 38.4 57.8 24.2 18.0 15.8 15.9 44.1 28.8 31.0 23.5 39.1 15.6 2.5 17.5 46.2 33.6 10.6 20.9 21.8 51.4 22.1 57.6 34.6 10.4 22.3 7.2 20.4 23.6 29.6 13.2 7.1 15.0 35.4 19.5 16.6 25.2 9.1 26.3 112.1 22.6 27.5 30.9 46.6 28.5 25.9 24.3 7.5 20.3 14.8 38.7 11.6 30.1 8.4 12.6 11.0 14.7 19.3 10.7 1.1 18.2 14.0 18.0 34.6 16.5 7.2 11.5 14.7 16.2 8.7 8.5 13.5 15.0 18.8 44.9 8.9 11.8 12.4 15.8 17.4 15.2 16.3 14.7 16.4 18.6 16.7 17.4 17.4 17.7 19.8 3.8 16.0 6.4 32.3 11.0 12.2 17.8 21.4 8.0 6.3 15.8 9.8 6.3 27.1 23.2 46.0 20.9 7.3 16.0 41.5 3.9 36.2 2.9 30.2 13.3 7.3 25.1 4.4 48.7 37.6 13.8 10.1 6.6 46.1 14.7 23.1 7.1 44.5 27.6 15.2 38.8 21.2 22.4 43.1 16.1 5.2 11.5 25.7 7.2 35.6 22.7 9.8 25.7 41.7 43.8 55.6 18.8 20.3 5.9 26.0 53.5 12.0 26.6 9.7 6.6 13.3 19.0 20.0 34.0 15.9 22.7 6.3 11.1 18.2 20.9 25.3 PCBD1 "DCOH, PCBD, PCD" ENSG00000166228 "Pterin-4 alpha-carbinolamine dehydratase 1" P61457 10 70882280-70888565 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation" "Activator, Lyase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 429.5" "Cell type enhanced" "Detected in all" "Distal tubular cells: 453.9;Hepatocytes: 603.7;Proximal tubular cells: 877.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 527.8;Hep G2: 527.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037575, HPA061723" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 170000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 15: Liver - Metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Cytosol "HPA037575: AB_10671761, HPA061723: AB_2684594" "unprognostic (1.02e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (3.69e-1)" "unprognostic (5.39e-2)" "unprognostic (4.80e-3)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "unprognostic (2.40e-2)" "unprognostic (2.95e-1)" "unprognostic (5.63e-2)" "unprognostic (3.38e-2)" "unprognostic (9.26e-2)" "unprognostic (1.74e-1)" "unprognostic (5.76e-2)" "unprognostic (7.43e-3)" 77.3 102.9 115.0 31.0 111.8 21.8 67.9 111.9 140.7 58.0 114.1 83.9 54.4 48.2 91.2 54.3 111.5 47.4 152.3 109.3 136.9 165.1 429.5 57.9 31.1 125.4 138.5 64.2 174.9 135.1 61.5 33.4 139.4 73.8 88.3 48.6 49.9 78.4 109.7 25.7 64.0 75.6 119.7 25.6 84.8 20.0 131.8 25.8 86.3 109.1 35.8 69.3 39.2 118.9 158.3 374.3 21.4 223.8 80.9 76.0 29.4 50.0 84.5 77.7 61.6 527.8 270.3 32.2 141.4 56.3 57.9 101.7 138.9 81.3 53.2 86.2 251.9 28.6 57.5 527.1 84.9 28.5 99.2 74.1 88.5 76.5 35.8 114.1 212.3 19.9 57.1 2.8 55.2 270.2 3.5 94.7 30.1 420.5 346.0 15.1 29.7 103.6 328.6 164.7 94.0 158.8 41.5 277.1 111.5 59.9 81.1 53.8 86.2 12.7 102.9 18.9 123.8 1.1 6.7 1.1 68.3 93.1 19.5 0.2 24.8 8.7 19.6 47.1 15.3 25.7 25.8 28.3 49.6 10.9 8.4 17.1 1.6 19.6 34.4 35.8 41.1 18.7 115.0 111.8 111.9 140.7 109.3 136.9 125.4 138.5 139.4 119.7 131.8 118.9 25.5 41.7 91.5 8.5 25.9 49.8 169.1 88.2 103.0 39.0 197.9 249.6 151.5 138.7 86.0 187.6 6.2 124.6 18.5 113.8 453.9 185.0 2.3 138.7 49.3 40.8 176.4 36.2 4.9 169.9 81.6 82.2 86.6 175.3 31.1 64.6 37.9 603.7 180.3 35.3 8.5 313.3 65.1 79.9 55.7 11.2 67.4 73.1 78.2 5.6 68.0 153.0 22.6 9.0 4.6 154.8 164.7 95.5 35.1 212.7 232.1 877.7 78.4 33.2 85.5 57.2 63.3 4.4 12.3 147.8 45.7 77.6 32.6 95.9 230.2 187.5 UNC5B "p53RDL1, UNC5H2" ENSG00000107731 "Unc-5 netrin receptor B" Q8IZJ1 10 71212570-71302864 "Plasma proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.3" "Cell type enhanced" "Detected in many" "Horizontal cells: 112.7;Muller glia cells: 54.1;Oligodendrocytes: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 46.2;HHSteC: 146.3;hTCEpi: 132.1;SH-SY5Y: 123.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076687 Approved NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 62: Horizontal cells - Visual perception" "HPA076687: " "unprognostic (3.98e-2)" "unprognostic (3.14e-2)" "unprognostic (9.28e-2)" "unprognostic (2.71e-1)" "unprognostic (5.64e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.01e-5)" "unprognostic (8.82e-3)" "unprognostic (6.79e-3)" "prognostic unfavorable (3.80e-5)" "unprognostic (7.70e-3)" "unprognostic (6.67e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.17e-2)" "unprognostic (4.62e-2)" "unprognostic (9.89e-3)" "unprognostic (2.25e-1)" 3.2 10.2 17.5 4.0 28.4 0.1 2.3 26.8 19.2 6.0 15.4 7.2 2.6 5.9 6.0 18.6 7.4 8.8 15.6 15.1 17.3 7.9 2.4 9.5 3.5 34.1 28.8 3.6 4.3 2.2 5.8 5.0 25.3 9.8 4.9 7.8 5.3 27.0 2.6 8.0 5.2 4.4 19.1 7.8 8.7 5.6 32.3 2.9 3.7 4.1 2.9 9.0 12.2 48.3 0.0 0.2 0.8 3.9 11.6 18.9 0.3 6.6 19.3 0.2 0.6 3.8 17.9 0.0 6.7 41.6 0.4 46.2 1.4 2.7 0.0 0.1 4.3 10.7 0.7 0.2 146.3 0.2 1.1 16.4 132.1 1.6 8.4 1.7 2.8 0.2 0.4 0.1 0.2 1.5 0.0 0.0 10.3 9.6 0.3 0.0 4.5 0.1 0.1 20.5 20.3 123.7 1.4 1.6 1.0 18.2 1.9 0.6 8.0 1.4 5.9 2.5 2.7 0.0 0.0 0.0 42.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 28.4 26.8 19.2 15.1 17.3 34.1 28.8 25.3 19.1 32.3 48.3 18.6 0.0 3.3 5.5 0.0 3.1 19.3 21.8 2.8 13.1 1.6 3.0 7.6 0.0 11.3 5.5 0.0 0.4 0.0 34.3 0.0 5.7 0.4 12.7 4.8 22.7 3.0 0.0 8.9 1.6 0.4 6.5 12.2 25.8 22.9 27.0 7.5 0.0 1.2 112.7 11.3 6.3 32.6 8.5 2.4 1.0 0.6 5.9 1.8 29.0 0.6 54.1 0.0 11.6 89.0 12.1 20.1 0.7 0.0 14.7 8.1 0.2 14.4 3.5 0.0 2.7 12.7 0.8 5.4 20.3 4.3 0.3 0.8 0.7 4.7 44.8 SLC29A3 "ENT3, FLJ11160" ENSG00000198246 "Solute carrier family 29 member 3" Q9BZD2 10 71319259-71381423 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 31.8;Hep G2: 35.9;RT4: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046085, HPA054976, HPA057905" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus, Vesicles" "HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550" "unprognostic (1.73e-1)" "unprognostic (2.38e-3)" "unprognostic (3.23e-3)" "unprognostic (1.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.07e-6)" "unprognostic (1.28e-1)" "unprognostic (4.71e-1)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (3.37e-1)" "unprognostic (1.36e-1)" "prognostic favorable (1.16e-4)" "unprognostic (3.43e-3)" 4.7 2.6 3.1 4.1 3.9 1.1 4.8 3.7 3.7 7.3 2.7 4.4 2.1 6.8 2.5 2.2 5.8 4.4 2.4 3.0 3.6 2.5 9.4 6.7 7.1 4.7 3.7 9.7 5.2 3.5 1.7 11.2 4.2 5.1 3.5 0.3 4.9 2.9 1.4 2.6 3.7 5.1 4.2 6.5 6.1 3.7 4.4 3.7 3.8 0.6 3.8 9.8 4.4 5.0 2.1 12.3 1.8 7.8 6.8 5.3 31.8 2.3 2.2 0.7 0.4 13.8 8.8 7.4 6.4 4.7 3.2 18.3 5.7 2.9 0.1 5.6 5.6 2.2 1.0 35.9 3.3 1.8 4.5 5.2 12.9 0.3 0.6 1.5 3.2 8.5 6.5 6.8 0.9 19.1 4.2 3.8 4.2 19.2 4.5 5.7 0.6 5.9 2.3 29.5 8.5 9.6 6.4 20.3 1.7 5.2 3.2 4.0 5.2 0.2 3.8 2.3 0.1 1.8 3.1 4.0 7.6 24.0 1.3 4.2 19.3 2.2 5.4 15.3 4.6 4.9 4.5 5.1 29.1 1.9 3.5 5.0 1.5 9.4 10.3 20.2 5.5 9.5 3.1 3.9 3.7 3.7 3.0 3.6 4.7 3.7 4.2 4.2 4.4 5.0 2.0 3.2 1.1 2.0 3.1 0.3 1.5 4.0 1.8 2.3 2.7 3.8 0.8 1.5 3.8 0.0 0.0 46.1 6.3 2.6 0.0 6.1 3.6 1.8 3.2 1.8 1.8 4.2 2.4 8.9 45.3 4.7 7.1 2.4 2.5 10.2 3.3 5.4 34.7 0.0 1.3 2.5 8.2 11.8 4.4 15.2 2.8 10.9 1.8 16.9 8.5 3.0 3.1 2.5 2.7 7.9 13.1 1.5 6.0 3.2 0.1 2.0 2.6 0.4 0.0 0.2 2.5 0.6 5.0 0.7 0.0 31.7 2.9 10.0 2.5 1.7 CDH23 "CDHR23, DFNB12, USH1D" ENSG00000107736 "Cadherin related 23" Q9H251 10 71396920-71815947 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Hearing, Sensory transduction, Vision" "Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.6;ovary: 35.3" "Cell type enhanced" "Detected in many" "Early spermatids: 78.4;Late spermatids: 67.7;Microglial cells: 33.7;Muller glia cells: 90.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 26.8;non-classical monocyte: 38.1;plasmacytoid DC: 9.5" "Lineage enhanced" "Detected in many" "monocytes: 38.1" "Group enriched" "Detected in some" 4 "RT4: 13.4;SCLC-21H: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA017232 Approved NA NA 950000 "Cluster 51: Monocytes - Innate immune response" "Cluster 21: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 5: Muller glia cells - Visual perception" "HPA017232: AB_1845903" "unprognostic (6.76e-2)" "unprognostic (2.86e-3)" "unprognostic (3.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.07e-1)" "unprognostic (5.52e-2)" "unprognostic (7.93e-2)" "unprognostic (2.88e-1)" "unprognostic (6.44e-3)" "unprognostic (4.67e-2)" "unprognostic (2.05e-1)" "unprognostic (9.23e-3)" "unprognostic (2.14e-3)" "unprognostic (2.33e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "prognostic favorable (3.40e-4)" 11.3 3.3 9.6 2.1 11.6 2.2 6.2 10.6 7.9 3.3 10.2 1.7 1.1 4.9 1.6 1.8 8.9 2.2 5.4 6.3 16.2 0.9 14.4 7.8 1.7 35.6 18.5 35.3 8.4 9.9 1.2 0.5 34.7 3.7 1.2 14.4 1.2 0.7 2.7 1.6 2.3 2.1 8.6 7.0 1.7 11.0 23.6 5.3 1.8 2.5 1.4 4.2 2.6 8.8 0.0 0.7 0.8 1.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.9 0.4 1.3 0.0 0.0 0.1 1.2 1.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.1 1.5 0.4 0.0 1.1 0.0 0.1 0.0 13.4 5.3 1.1 0.8 0.2 0.1 1.1 0.1 2.2 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.2 1.5 1.0 0.0 0.0 6.0 5.1 0.1 26.8 0.4 0.0 0.2 0.1 4.9 0.0 0.2 0.6 6.1 0.0 38.1 9.5 0.0 2.9 9.6 11.6 10.6 7.9 6.3 16.2 35.6 18.5 34.7 8.6 23.6 8.8 8.2 0.0 0.6 9.4 1.1 0.8 4.1 0.3 0.6 1.9 0.2 1.1 4.7 0.0 1.0 1.8 0.0 1.5 11.5 0.9 0.0 0.4 78.4 1.9 0.7 10.0 7.2 0.0 1.1 0.4 4.4 3.4 1.1 0.3 0.0 0.4 7.9 20.4 2.2 0.0 2.7 1.1 0.0 12.2 11.6 67.7 2.5 15.0 7.2 33.7 10.6 90.7 3.1 1.5 8.5 0.2 7.5 0.7 0.4 2.6 1.6 0.8 0.7 4.2 6.6 5.1 1.7 3.4 1.0 0.0 1.1 0.3 1.0 0.2 0.7 3.6 C10orf105 FLJ00245 ENSG00000214688 "Chromosome 10 open reading frame 105" Q8TEF2 10 71711701-71737824 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 34.6" "Group enriched" "Detected in some" 4 "Early spermatids: 8.7;Langerhans cells: 2.4;Late spermatids: 5.1;Melanocytes: 3.6" "Cancer enriched" "Detected in single" 9 "glioma: 0.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.8;non-classical monocyte: 2.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 5 "BJ hTERT+: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (2.60e-3)" "unprognostic (6.76e-3)" "unprognostic (5.45e-1)" "unprognostic (4.14e-1)" "unprognostic (1.17e-1)" "unprognostic (1.37e-6)" "unprognostic (5.25e-2)" "unprognostic (2.10e-3)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (3.87e-2)" "unprognostic (1.35e-1)" "unprognostic (7.37e-2)" "unprognostic (4.64e-1)" "unprognostic (1.53e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" 0.6 0.0 14.4 0.7 15.0 0.5 0.1 13.8 7.7 0.2 4.2 0.1 0.2 0.1 0.0 0.1 0.4 0.2 0.2 9.2 19.4 0.0 0.1 0.5 1.1 27.3 34.6 0.5 0.0 0.0 0.1 0.1 19.2 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.2 0.0 17.3 2.8 0.1 1.4 22.5 0.5 0.0 0.1 0.4 0.1 0.2 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.1 14.4 15.0 13.8 7.7 9.2 19.4 27.3 34.6 19.2 17.3 22.5 13.6 0.4 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.4 5.1 0.0 0.7 3.6 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 VSIR "B7-H5, B7H5, C10orf54, Dies1, GI24, PD-1H, SISP1, VISTA" ENSG00000107738 "V-set immunoregulatory receptor" Q9H7M9 10 71747556-71773520 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 90.3" "Cell type enhanced" "Detected in many" "Adipocytes: 217.1;Cytotrophoblasts: 324.4;Extravillous trophoblasts: 293.4;Syncytiotrophoblasts: 677.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1006.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 63.1;HaCaT: 48.0;HMC-1: 78.6;U-937: 71.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007968 Approved Nucleoplasm NA NA 320000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "HPA007968: AB_1845518" "unprognostic (1.19e-1)" "unprognostic (1.76e-3)" "unprognostic (1.64e-1)" "unprognostic (6.67e-2)" "unprognostic (9.29e-2)" "unprognostic (2.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (1.02e-2)" "unprognostic (6.82e-2)" "unprognostic (8.70e-2)" "unprognostic (2.57e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.37e-3)" "unprognostic (3.29e-1)" 40.8 8.0 32.9 31.6 33.6 81.4 28.6 31.4 38.3 18.7 25.0 18.9 21.2 23.8 3.5 23.7 24.5 12.7 28.2 29.9 33.6 8.3 4.8 34.7 25.7 39.3 34.4 17.6 6.3 2.8 5.5 23.6 33.4 15.5 8.3 0.7 12.2 9.7 7.6 15.3 25.3 15.9 33.0 90.3 14.5 3.6 36.7 10.7 12.3 12.9 20.6 19.6 20.7 30.4 8.2 15.7 0.0 0.2 8.1 6.7 7.4 2.9 18.8 3.7 6.1 6.5 63.1 0.5 3.9 27.1 0.0 48.0 0.0 1.8 1.0 0.3 0.1 10.7 3.1 0.6 11.2 1.8 78.6 5.6 1.8 0.5 0.3 5.3 1.3 1.4 0.2 5.9 2.3 0.3 1.9 13.5 0.0 12.3 3.1 0.1 0.8 3.8 0.0 3.8 0.0 0.3 4.1 3.0 3.0 0.9 0.2 23.0 4.2 0.0 0.0 12.7 0.0 4.4 2.3 0.1 0.4 71.5 0.2 237.3 400.9 768.1 75.4 371.8 99.5 15.0 75.2 71.7 220.3 16.8 68.6 69.2 1006.0 56.8 435.5 58.0 82.9 472.3 32.9 33.6 31.4 38.3 29.9 33.6 39.3 34.4 33.4 33.0 36.7 30.4 217.1 28.9 6.8 0.0 15.6 0.0 0.0 0.0 0.0 0.0 10.5 15.5 0.0 0.0 6.2 11.0 0.0 324.4 51.6 0.0 0.0 41.3 0.0 1.9 8.1 33.0 0.0 0.0 0.0 10.6 293.4 32.5 0.0 1.7 31.5 0.3 0.0 0.0 71.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.5 0.0 0.0 67.7 0.0 0.0 0.0 0.0 59.8 0.0 0.0 12.6 0.0 0.0 14.5 3.6 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 677.7 34.7 5.1 0.0 0.0 PSAP "GLBA, SAP1, SAP2" ENSG00000197746 Prosaposin P07602 10 71816298-71851325 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Lipid metabolism, Sphingolipid metabolism" "Disease variant, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 2792.8;Kupffer cells: 2427.0;Macrophages: 1916.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "intermediate monocyte: 11615.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 5104.0;hTERT-RPE1: 6978.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004426, CAB004647" Supported Supported Vesicles "Intracellular and membrane" NA NA 88000000 "Cluster 7: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" Vesicles "CAB004647: AB_425625, HPA004426: AB_1079701" "unprognostic (4.43e-3)" "unprognostic (2.69e-1)" "unprognostic (1.64e-2)" "unprognostic (8.00e-2)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (8.36e-3)" "unprognostic (2.79e-1)" "unprognostic (3.31e-2)" "unprognostic (3.25e-2)" "unprognostic (2.30e-3)" "unprognostic (2.00e-2)" "unprognostic (3.62e-3)" "unprognostic (6.47e-2)" "unprognostic (4.42e-2)" "unprognostic (2.34e-1)" "unprognostic (2.06e-1)" 1068.6 1192.2 831.4 874.2 946.7 834.2 683.8 873.7 831.7 1073.9 1023.0 667.1 475.6 879.3 951.2 605.5 724.7 1115.6 1413.3 830.5 1081.8 860.4 906.4 1118.6 956.1 957.6 894.0 1106.9 544.7 1167.5 563.5 869.3 885.3 773.9 625.5 665.2 580.9 936.8 1409.5 544.4 487.7 1138.6 1025.9 1045.9 664.0 489.1 1048.8 672.3 875.9 987.5 560.4 941.2 578.3 1325.1 455.9 847.4 540.4 1121.0 5104.0 2910.1 1900.2 799.9 2368.3 620.8 735.9 795.4 1131.9 245.6 1608.1 1321.6 1038.9 964.1 207.5 659.1 434.8 481.4 381.8 288.9 352.3 459.6 1970.7 188.8 1596.0 1871.8 1479.1 625.7 1177.6 6978.9 1128.1 345.8 420.5 1158.1 777.0 294.9 843.8 290.1 249.5 575.4 404.0 172.9 301.3 696.7 730.3 764.4 584.4 515.8 751.1 2248.3 3122.2 700.4 454.4 431.1 1467.0 861.8 610.0 587.1 670.5 1289.0 1038.7 435.4 1375.5 374.4 650.0 863.2 10095.9 1127.5 424.2 11615.6 349.8 466.7 342.9 368.8 3481.1 425.5 370.1 350.6 2890.4 365.8 10148.2 1758.2 422.8 15009.0 831.4 946.7 873.7 831.7 830.5 1081.8 957.6 894.0 885.3 1025.9 1048.8 1325.1 263.2 253.2 339.0 136.8 173.9 228.3 253.4 487.0 108.1 193.8 254.6 158.7 664.1 253.1 318.9 476.3 127.2 891.6 260.2 434.8 70.5 1043.6 19.3 147.0 246.6 311.4 261.9 160.5 86.1 456.1 872.6 623.8 187.6 195.2 398.1 210.8 426.9 509.2 2792.8 333.1 93.7 242.2 343.8 2427.0 779.7 54.1 458.6 1916.9 663.5 105.9 1528.9 495.6 182.3 92.5 117.6 357.7 298.3 551.8 503.0 244.8 370.6 311.6 297.2 164.3 276.1 273.6 263.8 55.2 126.3 137.2 198.0 1073.2 138.9 624.1 228.3 223.9 CHST3 "C6ST, C6ST1" ENSG00000122863 "Carbohydrate sulfotransferase 3" Q7LGC8 10 71964395-72013558 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 26.9;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 27.1;Skeletal myocytes: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 65.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047523, HPA055704" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 690000 "Cluster 21: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus, Cytosol" "HPA047523: AB_2680075, HPA055704: AB_2682891" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.13e-3)" "unprognostic (1.16e-3)" "unprognostic (2.44e-1)" "unprognostic (4.67e-2)" "unprognostic (4.79e-2)" "unprognostic (7.53e-2)" "unprognostic (7.99e-2)" "unprognostic (3.71e-2)" "unprognostic (2.83e-3)" "unprognostic (5.99e-2)" "unprognostic (1.40e-2)" "unprognostic (2.65e-2)" "unprognostic (7.77e-2)" "unprognostic (2.56e-2)" "unprognostic (2.54e-3)" 18.4 13.4 10.7 5.5 17.9 0.0 11.4 16.8 11.5 10.7 6.2 11.9 0.9 16.0 3.7 6.4 12.9 4.7 14.3 9.9 12.9 7.9 1.2 7.9 1.6 27.9 18.2 20.6 4.6 1.2 4.6 8.0 19.8 11.1 2.1 2.1 6.4 14.8 17.7 8.7 5.4 17.1 14.0 2.5 14.7 18.1 17.3 4.2 5.5 9.0 1.4 9.4 8.4 25.3 15.4 16.4 8.2 20.3 36.6 14.4 0.3 32.0 30.4 19.3 12.8 14.4 30.1 0.0 21.4 37.9 15.5 19.7 7.4 21.9 15.3 0.4 5.5 0.1 27.8 13.8 18.7 0.0 0.1 19.8 24.9 19.0 25.9 37.3 5.7 0.7 4.7 0.0 20.6 0.4 0.0 0.1 3.5 0.5 5.3 0.2 9.9 0.0 26.9 15.7 0.5 8.1 24.2 0.6 24.1 9.9 1.8 3.1 11.9 23.6 27.1 39.6 65.1 0.0 0.1 0.1 17.2 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 17.9 16.8 11.5 9.9 12.9 27.9 18.2 19.8 14.0 17.3 25.3 23.9 0.0 1.9 14.0 0.1 2.8 4.9 6.1 13.6 0.1 4.3 8.0 10.4 5.7 2.5 7.3 0.0 4.6 0.0 0.1 3.9 9.7 0.8 20.1 24.7 5.6 0.0 0.0 0.2 2.7 2.2 9.3 2.6 17.9 1.3 26.9 13.6 0.3 0.8 0.0 0.3 0.0 2.0 0.6 1.9 3.2 20.5 0.7 8.8 4.7 0.7 6.6 0.0 26.7 27.1 12.7 0.0 21.8 0.0 4.2 0.0 3.6 2.0 0.2 6.6 26.8 13.9 1.0 2.1 7.5 2.4 1.1 0.4 5.5 0.1 1.3 SPOCK2 "KIAA0275, testican-2" ENSG00000107742 "SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2" Q92563 10 72059034-72089032 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 220.1;lymphoid tissue: 114.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 288.4;Bipolar cells: 116.5;dendritic cells: 86.4;Inhibitory neurons: 81.1;Microglial cells: 75.9;NK-cells: 90.6;T-cells: 195.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 117.5;MAIT T-cell: 198.8;memory CD4 T-cell: 115.9;memory CD8 T-cell: 93.5;naive CD4 T-cell: 87.8;naive CD8 T-cell: 89.4;T-reg: 174.3" "Lineage enriched" "Detected in all" 8 "T-cells: 198.8" "Group enriched" "Detected in some" 7 "Hep G2: 50.2;SCLC-21H: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044605 Enhanced "Secreted to blood" NA NA 34000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 24: Non-specific - Transcription regulation" "HPA044605: AB_10965991" "prognostic favorable (4.05e-4)" "unprognostic (3.11e-3)" "unprognostic (2.92e-2)" "unprognostic (2.29e-1)" "unprognostic (2.77e-2)" "prognostic favorable (1.95e-5)" "unprognostic (4.18e-2)" "unprognostic (9.04e-2)" "prognostic favorable (4.72e-4)" "prognostic unfavorable (7.19e-4)" "unprognostic (4.53e-3)" "unprognostic (2.29e-1)" "unprognostic (1.46e-3)" "unprognostic (5.59e-2)" "unprognostic (5.49e-2)" "unprognostic (3.19e-3)" "unprognostic (2.24e-2)" 9.4 46.6 152.6 44.5 108.0 58.1 3.8 160.4 143.2 4.2 2.8 7.6 9.2 4.0 3.1 3.3 6.2 15.3 10.0 117.4 150.1 68.0 2.7 86.5 67.3 212.1 157.7 7.1 1.6 2.0 44.0 3.4 220.1 4.7 5.4 33.4 3.3 5.6 5.1 1.8 32.3 4.4 127.9 29.1 13.6 25.1 207.3 114.4 10.4 6.7 45.3 9.9 3.8 95.6 0.2 0.4 0.3 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 8.2 0.3 1.4 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.8 0.2 1.4 50.2 1.6 0.4 1.2 0.1 0.4 0.0 0.0 0.2 0.1 2.7 0.1 0.8 0.0 0.3 0.9 0.3 0.1 0.0 0.2 0.2 0.3 0.1 0.0 0.3 68.2 4.1 0.1 1.5 0.4 0.3 0.0 1.9 0.2 0.0 0.3 0.3 0.1 0.7 1.7 7.3 0.3 0.1 0.2 0.6 0.4 0.2 117.5 1.2 198.8 23.6 115.9 93.5 0.3 18.3 87.8 89.4 13.5 14.4 0.4 3.5 174.3 48.4 152.6 108.0 160.4 143.2 117.4 150.1 212.1 157.7 220.1 127.9 207.3 95.6 17.3 288.4 10.0 51.9 54.6 3.8 0.4 2.1 0.0 116.5 1.9 2.0 3.1 1.5 4.1 14.7 6.2 0.1 86.4 2.4 0.0 3.6 8.1 2.5 1.0 29.9 4.9 3.6 39.6 0.8 0.1 8.4 3.6 1.0 3.8 0.2 7.9 0.4 0.2 3.3 81.1 1.3 2.0 1.6 7.9 10.5 5.3 5.5 5.4 75.9 4.1 5.0 90.6 28.6 8.3 0.0 4.4 6.0 34.2 0.5 0.1 0.5 2.4 17.6 0.0 17.9 2.4 6.3 1.1 0.5 4.4 0.4 195.1 0.8 0.7 0.3 ASCC1 "ASC1p50, CGI-18, Em:AC022392.3, p50" ENSG00000138303 "Activating signal cointegrator 1 complex subunit 1" Q8N9N2 10 72096032-72217134 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038038, HPA057567" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA038038: AB_10674544, HPA057567: " "unprognostic (1.96e-1)" "unprognostic (2.79e-2)" "unprognostic (5.36e-2)" "unprognostic (1.03e-2)" "unprognostic (2.92e-3)" "unprognostic (2.34e-2)" "prognostic unfavorable (3.52e-4)" "unprognostic (1.22e-2)" "unprognostic (8.30e-3)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.66e-1)" "unprognostic (6.64e-2)" 19.0 24.9 18.3 13.9 23.5 7.3 16.4 22.4 24.5 16.1 18.8 14.4 9.0 17.1 16.4 14.3 15.3 13.7 24.8 17.2 20.7 15.2 21.6 13.5 18.5 23.4 20.6 17.9 22.7 14.2 11.9 13.0 23.6 11.9 9.9 15.7 12.8 14.5 29.7 17.1 14.6 12.4 21.7 17.1 14.4 18.4 20.4 22.3 13.4 17.3 16.8 15.7 13.6 30.4 29.3 40.3 25.8 58.1 34.0 37.9 21.1 18.0 33.5 26.5 30.7 31.4 105.3 37.0 35.6 26.3 17.9 38.4 21.1 30.6 26.5 27.2 20.1 24.1 29.1 36.4 32.7 25.2 24.1 33.3 68.9 26.7 45.0 38.1 36.4 40.4 34.8 51.8 35.0 25.7 34.2 36.1 15.7 18.8 8.8 20.1 21.1 27.4 49.8 21.0 27.1 16.9 26.1 65.7 49.4 23.9 21.7 18.5 32.0 15.2 27.1 11.6 19.4 28.4 40.4 45.5 24.6 55.9 10.8 20.4 19.0 35.0 16.5 20.3 17.0 31.4 19.4 17.7 21.0 32.5 27.2 25.8 12.5 26.6 15.4 28.9 29.2 19.0 18.3 23.5 22.4 24.5 17.2 20.7 23.4 20.6 23.6 21.7 20.4 30.4 16.7 9.6 5.8 25.5 20.5 6.2 14.0 22.8 9.6 12.9 9.0 6.3 23.6 10.0 13.4 12.9 14.6 17.7 18.6 4.7 23.5 20.4 27.5 12.1 13.8 13.9 3.6 11.1 33.1 20.0 19.5 16.5 6.6 12.1 12.7 12.6 10.4 22.0 18.2 25.2 42.9 5.2 16.2 24.1 8.7 14.2 20.5 12.7 19.6 27.2 21.4 19.9 16.5 35.7 52.8 14.7 8.4 20.7 14.5 8.0 9.5 11.4 9.8 14.3 13.1 10.8 15.9 27.8 28.2 10.9 7.0 15.2 17.9 18.9 6.5 9.2 ANAPC16 "APC16, bA570G20.3, C10orf104, CENP-27, FLJ33728" ENSG00000166295 "Anaphase promoting complex subunit 16" Q96DE5 10 72216000-72235860 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 93.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037815 Approved Supported Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA037815: AB_10672288" "unprognostic (2.87e-1)" "unprognostic (4.35e-3)" "unprognostic (2.01e-2)" "unprognostic (7.12e-3)" "unprognostic (2.16e-1)" "unprognostic (6.20e-3)" "unprognostic (1.51e-2)" "unprognostic (2.00e-1)" "unprognostic (1.82e-1)" "unprognostic (3.10e-2)" "unprognostic (1.90e-2)" "unprognostic (2.11e-1)" "unprognostic (2.75e-3)" "unprognostic (7.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.03e-1)" "unprognostic (1.35e-3)" 20.5 25.2 12.4 15.0 13.4 14.1 21.9 16.6 15.2 19.7 15.5 23.6 15.7 18.2 22.3 14.9 23.5 12.6 43.6 12.5 12.8 24.2 27.2 18.9 25.4 13.6 12.8 24.3 33.7 33.1 15.9 11.9 13.4 21.5 17.9 20.6 32.3 21.8 62.7 15.0 19.6 17.8 12.4 22.7 25.8 8.4 13.1 32.3 23.5 43.2 25.7 19.5 15.1 14.6 24.9 12.1 12.1 14.3 33.0 15.7 9.3 8.5 17.3 11.7 11.0 14.6 31.1 24.3 13.6 12.7 14.1 19.0 10.9 21.9 11.0 29.0 18.0 12.5 10.6 14.4 39.6 21.0 14.7 20.5 93.9 10.6 34.8 25.8 14.3 35.1 18.4 28.1 13.6 15.0 17.9 21.1 9.3 18.2 6.8 10.2 10.8 24.2 29.4 10.4 17.4 16.0 14.8 37.9 29.5 15.2 12.2 21.9 18.6 5.9 13.8 9.5 13.1 28.6 26.8 25.1 16.4 40.3 7.0 41.1 21.5 38.8 31.4 23.1 35.2 60.5 35.2 31.3 18.1 66.1 48.6 38.6 19.7 34.4 24.9 45.7 34.7 36.3 12.4 13.4 16.6 15.2 12.5 12.8 13.6 12.8 13.4 12.4 13.1 14.6 191.0 157.0 209.5 41.8 303.7 111.7 246.7 322.0 150.8 81.0 288.6 316.5 435.4 280.2 234.9 222.5 37.5 198.4 240.1 166.8 684.8 239.8 91.9 188.9 98.9 179.8 161.8 155.0 47.8 291.9 191.2 142.0 108.1 145.9 202.0 110.1 203.1 481.3 226.5 33.7 57.2 258.0 254.3 310.0 111.9 53.4 233.6 160.4 193.9 36.5 322.4 192.4 363.5 43.2 75.9 196.9 239.9 250.1 208.2 218.1 262.6 548.7 217.0 144.5 230.1 162.0 219.9 158.7 126.2 189.9 140.9 149.3 268.6 145.6 214.1 240.9 DDIT4 "Dig2, FLJ20500, REDD-1, REDD1, RTP801" ENSG00000168209 "DNA damage inducible transcript 4" Q9NX09 10 72273919-72276036 "Predicted intracellular proteins" "Antiviral defense, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 776.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 657.6;hTCEpi: 2252.5;hTERT-HME1: 877.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034507, HPA034508" Approved Supported Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "HPA034507: AB_2674199, HPA034508: AB_10601206" "unprognostic (2.84e-3)" "unprognostic (1.05e-3)" "unprognostic (1.06e-1)" "unprognostic (2.59e-1)" "unprognostic (7.91e-3)" "prognostic unfavorable (5.42e-4)" "unprognostic (7.65e-2)" "unprognostic (1.62e-3)" "unprognostic (2.90e-1)" "unprognostic (4.96e-3)" "prognostic unfavorable (2.78e-4)" "unprognostic (9.72e-2)" "prognostic unfavorable (2.54e-6)" "unprognostic (8.52e-2)" "unprognostic (1.12e-1)" "unprognostic (5.92e-2)" "unprognostic (1.66e-1)" 313.5 280.9 88.9 83.7 89.3 123.7 287.3 92.5 106.4 415.9 103.4 93.5 20.8 98.6 12.6 425.0 118.6 47.8 237.2 82.4 87.7 179.9 337.1 197.8 90.1 102.9 92.0 741.5 675.4 94.4 169.5 51.8 90.0 171.1 13.3 86.7 224.9 68.3 278.1 231.6 111.7 25.4 88.0 166.3 121.2 32.0 95.8 102.5 105.1 60.0 114.3 315.3 597.5 98.2 139.2 95.2 20.0 179.3 124.0 74.3 52.1 40.3 45.6 13.5 56.7 11.1 280.5 14.3 113.7 6.5 19.1 143.0 28.9 657.6 33.7 213.9 35.8 15.1 115.4 74.0 501.2 47.7 57.7 291.1 2252.5 59.2 877.9 127.1 60.1 33.9 135.3 347.2 51.5 58.7 28.5 62.1 4.2 67.6 22.2 15.2 22.4 265.7 115.9 30.9 33.2 46.2 98.3 152.0 583.9 43.0 20.9 104.4 118.7 4.6 35.4 8.7 22.3 234.3 135.1 42.3 252.9 99.9 29.8 68.8 7.6 51.1 236.4 14.5 249.6 97.4 163.8 141.3 40.3 122.4 274.5 213.7 17.1 408.1 13.0 197.4 136.9 215.0 88.9 89.3 92.5 106.4 82.4 87.7 102.9 92.0 90.0 88.0 95.8 98.2 366.5 12.8 27.1 136.1 290.6 228.5 383.5 534.1 290.8 87.8 129.8 112.5 16.1 77.2 226.6 60.7 79.2 9.9 680.2 109.2 60.7 310.7 3.1 46.4 101.8 177.9 75.1 129.0 2.1 165.3 141.1 203.8 116.2 69.2 415.0 30.8 249.1 83.8 89.7 30.3 3.8 105.6 173.0 102.4 485.9 7.0 88.3 280.5 396.6 5.6 38.9 682.8 249.3 7.1 5.5 131.5 177.7 128.2 776.1 143.5 41.6 19.3 100.6 143.3 72.3 124.2 338.3 2.1 5.7 519.6 251.5 19.0 537.4 126.0 70.6 359.6 DNAJB12 "DJ10, FLJ20027" ENSG00000148719 "DnaJ heat shock protein family (Hsp40) member B12" Q9NXW2 10 72332830-72355149 "Predicted membrane proteins, Transporters" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 235.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010642, HPA072702" Approved Supported "Nuclear membrane,Endoplasmic reticulum" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "Nuclear membrane" "HPA010642: AB_1078692, HPA072702: " "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (4.79e-4)" "unprognostic (6.01e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.17e-4)" "unprognostic (5.73e-2)" "unprognostic (5.60e-2)" "unprognostic (8.85e-3)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (4.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.87e-1)" 24.1 29.8 18.3 18.1 19.5 27.6 24.5 20.0 20.4 21.6 19.5 23.3 21.4 24.0 23.4 23.2 20.8 17.5 26.8 19.0 18.1 23.9 28.0 21.1 16.4 20.0 18.8 22.6 26.9 32.9 23.7 20.3 19.1 23.4 14.7 16.6 28.4 17.7 37.5 28.5 20.7 19.0 18.4 24.8 23.9 21.4 18.9 17.3 23.5 23.5 16.0 21.6 20.6 20.0 37.4 38.3 23.4 39.3 30.5 31.1 29.6 36.6 63.8 49.5 45.9 44.7 64.3 27.2 28.8 45.1 31.3 61.4 22.2 33.0 26.9 29.9 29.4 14.7 23.0 29.6 68.5 30.1 54.2 39.6 67.6 44.1 55.8 45.0 35.1 25.6 23.2 40.2 43.3 36.7 26.0 26.3 10.8 29.1 11.1 23.4 17.8 18.9 37.7 21.7 16.1 23.0 20.0 74.0 36.8 12.9 28.2 34.2 39.1 24.6 33.4 28.0 46.7 33.8 27.3 16.0 40.6 32.6 17.1 18.7 29.2 18.7 12.8 31.5 11.4 11.5 12.5 9.6 24.6 11.1 10.3 10.2 36.6 13.9 28.9 16.4 13.8 17.5 18.3 19.5 20.0 20.4 19.0 18.1 20.0 18.8 19.1 18.4 18.9 20.0 30.3 28.9 29.3 10.1 30.1 13.4 30.6 38.6 25.6 33.3 36.1 29.6 23.3 50.1 44.3 23.9 22.9 41.1 37.7 38.1 11.7 34.2 122.2 25.1 26.1 25.3 29.4 31.2 12.7 64.3 41.1 28.6 23.4 29.3 40.0 26.4 21.0 29.6 38.1 30.3 13.0 28.8 12.2 36.0 16.0 235.7 36.4 37.6 10.6 7.5 39.6 33.6 35.0 12.1 15.2 34.9 38.1 35.0 34.2 27.4 62.2 34.4 26.8 35.6 52.6 27.4 34.4 32.4 10.9 28.1 15.5 68.0 22.8 37.0 25.9 35.2 MICU1 "CALC, CBARA1, EFHA3, FLJ12684" ENSG00000107745 "Mitochondrial calcium uptake 1" Q9BPX6 10 72367327-72626191 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" Allergen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 185.5;Inhibitory neurons: 205.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037479, HPA037480" Approved Supported Mitochondria NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria "HPA037479: AB_2675495, HPA037480: AB_10696934" "unprognostic (8.18e-2)" "unprognostic (6.98e-3)" "unprognostic (6.71e-2)" "unprognostic (8.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (8.91e-2)" "unprognostic (3.60e-2)" "unprognostic (2.96e-3)" "unprognostic (3.38e-2)" "unprognostic (7.43e-2)" "unprognostic (2.23e-2)" "prognostic favorable (4.66e-7)" "unprognostic (1.70e-1)" "unprognostic (1.55e-1)" "unprognostic (5.35e-2)" "unprognostic (6.70e-2)" 30.9 55.3 34.4 21.2 37.2 34.2 26.4 51.4 47.1 28.8 27.8 30.1 37.4 36.5 23.8 20.7 34.6 32.3 43.9 37.8 32.2 105.3 116.7 29.6 20.1 32.2 30.7 41.6 20.0 43.3 24.4 23.6 33.7 24.8 32.9 31.5 20.8 22.3 72.2 29.0 32.7 38.4 29.0 27.0 43.3 20.2 30.4 26.1 22.9 76.9 21.6 30.8 21.7 34.1 42.2 71.8 45.4 53.3 70.8 66.6 20.6 45.8 101.6 65.7 89.8 42.2 77.2 56.8 37.3 63.5 54.0 49.1 57.7 40.7 76.9 51.9 46.6 38.3 37.1 61.2 56.4 53.3 40.1 66.6 36.2 72.4 66.5 90.4 57.7 53.4 60.0 64.5 77.6 37.9 46.7 49.9 19.0 45.0 17.3 50.5 60.9 37.4 80.8 31.0 34.8 49.8 54.2 65.9 42.0 45.2 39.3 50.5 36.2 32.6 50.1 65.7 38.4 33.9 62.6 39.2 65.1 69.6 22.5 21.5 60.0 110.8 16.8 49.8 14.7 15.1 14.7 15.5 26.0 17.5 14.4 12.0 48.8 15.2 54.5 16.5 15.3 35.4 34.4 37.2 51.4 47.1 37.8 32.2 32.2 30.7 33.7 29.0 30.4 34.1 30.4 54.5 36.0 47.7 23.4 9.9 16.0 22.6 14.2 31.9 25.3 19.6 35.8 25.8 38.3 35.0 20.9 20.7 16.9 25.9 80.3 35.6 10.7 42.0 43.0 22.7 14.4 25.0 185.5 26.7 18.8 31.1 45.9 48.2 18.3 31.5 23.9 60.4 34.8 16.8 205.9 24.4 16.2 36.9 13.4 12.5 26.8 40.1 12.4 64.6 38.0 51.3 10.3 146.8 97.5 51.4 24.9 25.9 25.0 10.7 29.3 110.7 34.0 33.8 6.6 29.0 27.2 54.5 40.0 14.2 14.2 21.5 19.0 73.4 23.6 14.2 MCU "C10orf42, CCDC109A, FLJ46135" ENSG00000156026 "Mitochondrial calcium uniporter" Q8NE86 10 72692131-72887694 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 53.7" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 68.3;Inhibitory neurons: 65.6;Oligodendrocyte precursor cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016480 Approved Supported Mitochondria No No 17000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria "HPA016480: AB_2071893" "unprognostic (2.42e-2)" "unprognostic (1.58e-2)" "unprognostic (3.01e-2)" "unprognostic (5.37e-2)" "unprognostic (7.84e-2)" "unprognostic (3.05e-1)" "prognostic unfavorable (6.06e-5)" "unprognostic (1.23e-1)" "unprognostic (2.28e-1)" "unprognostic (2.33e-1)" "unprognostic (5.12e-3)" "unprognostic (1.73e-1)" "prognostic favorable (5.07e-4)" "unprognostic (4.51e-2)" "unprognostic (3.79e-1)" "unprognostic (2.74e-2)" "unprognostic (2.48e-2)" 6.1 3.8 2.8 7.4 2.5 19.9 5.7 10.4 3.6 8.3 6.4 28.7 27.8 8.9 3.0 14.2 10.8 12.7 7.8 3.9 2.8 10.6 7.0 10.2 4.9 3.4 3.2 4.9 5.5 10.0 1.9 12.8 3.2 5.8 30.8 2.3 6.7 5.7 41.8 6.8 24.5 13.5 3.0 5.0 43.2 4.3 3.3 5.7 6.4 53.7 7.7 14.9 5.1 2.8 41.7 66.1 16.8 12.2 25.0 28.0 17.1 25.0 35.5 24.5 26.0 39.6 38.6 17.7 19.6 30.8 13.3 36.9 22.2 29.8 32.5 19.5 20.8 22.1 23.5 22.1 19.5 56.0 17.9 28.7 24.9 22.0 46.6 38.4 29.8 18.5 14.0 12.9 23.0 24.3 15.2 12.0 18.5 45.2 13.6 15.7 35.8 4.7 32.7 22.4 17.8 7.9 30.8 34.1 7.5 20.2 6.8 14.5 24.3 11.8 19.9 25.7 16.9 9.4 12.8 12.1 15.8 27.5 9.2 1.8 6.7 18.6 3.0 7.3 3.1 3.5 2.9 3.6 5.8 1.7 2.3 2.6 8.8 2.2 8.9 2.0 5.2 4.2 2.8 2.5 10.4 3.6 3.9 2.8 3.4 3.2 3.2 3.0 3.3 2.8 13.7 35.3 17.0 21.2 4.2 11.7 14.4 8.9 10.8 3.0 5.9 3.9 6.6 8.6 22.0 18.4 2.1 7.3 4.8 38.2 1.9 11.1 14.5 23.3 9.9 9.7 8.4 10.8 58.2 25.2 10.1 7.2 68.3 26.4 8.2 3.4 8.9 5.8 6.7 0.0 65.6 28.2 12.2 6.0 2.9 7.2 5.3 6.7 8.8 37.5 5.7 5.4 2.1 72.4 40.3 40.7 15.6 4.1 5.7 9.7 19.8 8.6 22.6 3.9 13.1 6.8 12.1 5.1 5.2 6.2 12.4 9.3 5.0 12.7 24.5 26.8 OIT3 "FLJ39116, LZP" ENSG00000138315 "Oncoprotein induced transcript 3" Q8WWZ8 10 72893584-72933036 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "liver: 110.8" "Cell type enriched" "Detected in some" 11 "Hepatic stellate cells: 372.3" "Cancer enriched" "Detected in many" 4 "liver cancer: 4.6" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 2.3;Hep G2: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 52000000 "Cluster 62: Liver - Hemostasis" "Cluster 39: CACO-2 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "unprognostic (2.42e-2)" "unprognostic (6.76e-2)" "unprognostic (7.98e-4)" "unprognostic (9.26e-2)" "unprognostic (9.47e-4)" "unprognostic (3.05e-1)" "unprognostic (4.33e-2)" "unprognostic (1.99e-2)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (8.50e-3)" "unprognostic (1.41e-1)" "unprognostic (4.11e-2)" "unprognostic (1.35e-1)" "unprognostic (2.44e-1)" "unprognostic (3.68e-3)" "unprognostic (1.19e-1)" 0.0 0.0 0.1 0.3 0.1 0.0 0.0 1.3 0.5 0.0 0.1 0.3 5.3 0.0 0.0 0.0 0.0 0.3 2.8 0.1 0.0 1.5 110.8 0.3 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 6.1 0.0 0.0 7.8 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 10.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.0 14.6 0.0 10.7 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 372.3 10.6 0.0 0.0 0.9 0.0 0.0 31.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 PLA2G12B PLA2G13 ENSG00000138308 "Phospholipase A2 group XIIB" Q9BX93 10 72934762-72954806 "Metabolic proteins, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 33.1;kidney: 14.4;liver: 71.0" "Group enriched" "Detected in some" 4 "Hepatocytes: 52.2;Proximal enterocytes: 70.0" "Cancer enriched" "Detected in many" 8 "liver cancer: 35.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "CACO-2: 9.1;Hep G2: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA057745, HPA059562" Approved "Secreted to blood" NA NA 2300000 "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" "HPA057745: AB_2683514, HPA059562: AB_2684064" "unprognostic (1.11e-2)" "unprognostic (2.66e-2)" "unprognostic (2.02e-3)" "unprognostic (3.41e-1)" "unprognostic (1.68e-1)" "unprognostic (1.89e-1)" "unprognostic (1.26e-1)" "unprognostic (3.14e-2)" 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.0 2.2 27.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 14.4 71.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.0 0.0 0.0 33.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.3 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 3.1 1.5 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.8 52.2 0.0 0.0 0.3 2.4 0.0 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 6.3 0.0 0.0 0.0 70.0 13.4 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 6.3 0.0 P4HA1 "C-P4Halpha(I), P4HA" ENSG00000122884 "Prolyl 4-hydroxylase subunit alpha 1" P13674 10 73007217-73096974 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 494.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007599, HPA026593" Enhanced Supported "Endoplasmic reticulum,Vesicles,Mitochondria" "Intracellular and membrane" Yes No 60000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Endoplasmic reticulum" "Vesicles, Mitochondria" "HPA007599: AB_1854891, HPA026593: AB_1854892" "prognostic unfavorable (9.01e-4)" "prognostic unfavorable (3.19e-5)" "unprognostic (2.76e-3)" "unprognostic (3.04e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (2.30e-1)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.28e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.15e-2)" "prognostic unfavorable (9.40e-9)" "unprognostic (3.14e-1)" "unprognostic (4.22e-2)" "unprognostic (1.02e-2)" "unprognostic (5.75e-2)" 28.1 26.0 25.7 20.8 26.4 15.5 26.3 29.6 58.5 31.9 34.7 16.3 11.0 27.0 18.9 10.1 41.1 26.3 38.7 26.5 27.1 35.8 72.8 27.8 16.2 32.9 30.0 34.9 17.5 17.0 11.6 65.3 33.0 20.0 17.4 33.3 13.0 18.4 110.9 17.4 14.4 28.5 30.2 19.6 19.8 19.3 30.1 12.9 13.9 54.0 14.6 29.6 18.2 39.0 84.0 21.2 60.1 117.6 181.2 138.3 50.1 239.9 215.8 90.8 215.8 35.6 63.6 28.4 89.7 239.0 55.1 92.5 38.3 87.7 197.1 36.5 14.5 24.4 18.6 42.5 75.3 45.1 16.4 84.5 50.3 77.7 101.6 494.2 43.5 23.8 38.3 14.7 79.3 22.4 17.9 42.9 21.6 38.9 92.3 16.4 40.2 52.4 51.0 35.6 5.5 33.7 49.2 143.2 58.3 135.0 21.9 41.9 41.9 110.5 44.8 31.3 56.9 81.8 31.3 13.7 198.1 64.5 54.9 1.1 18.8 14.9 6.7 23.5 8.7 8.2 8.1 7.9 20.7 9.2 5.9 6.1 10.4 5.2 25.7 16.6 10.7 9.1 25.7 26.4 29.6 58.5 26.5 27.1 32.9 30.0 33.0 30.2 30.1 39.0 29.0 6.4 28.4 87.1 31.7 36.3 33.0 138.0 22.2 13.5 23.8 15.7 42.0 7.2 69.2 23.9 27.1 31.5 24.9 25.1 0.0 33.1 16.8 85.6 89.2 25.9 10.3 7.2 48.8 19.5 116.4 67.7 14.3 131.4 40.5 16.9 20.0 29.8 43.9 11.8 41.6 9.5 46.8 54.1 75.7 8.1 51.9 51.5 44.4 62.8 39.0 34.0 6.2 86.5 44.8 36.6 27.1 47.0 32.9 24.9 13.5 25.1 94.6 17.2 39.5 37.0 44.7 61.7 34.0 9.8 23.9 33.2 27.7 31.1 7.0 17.6 NUDT13 DKFZp586P2219 ENSG00000166321 "Nudix hydrolase 13" Q86X67 10 73110375-73131828 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040636 Approved NA No "Cluster 24: B-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA040636: AB_10960360" "unprognostic (3.75e-1)" "unprognostic (3.85e-1)" "unprognostic (1.07e-1)" "unprognostic (2.48e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.33e-1)" "unprognostic (2.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.60e-1)" "unprognostic (9.40e-2)" "unprognostic (5.07e-4)" "unprognostic (1.91e-1)" "unprognostic (3.82e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (5.96e-2)" 1.9 3.2 1.4 1.9 1.7 2.4 2.0 3.4 2.0 1.7 1.3 2.6 2.9 1.7 3.9 1.6 1.9 1.8 4.3 1.6 1.3 4.3 6.2 1.5 2.4 1.4 1.4 1.8 3.1 3.0 1.7 1.5 1.8 2.0 1.8 2.9 2.1 1.0 4.2 3.0 2.5 1.1 1.0 2.5 2.9 2.4 1.8 1.5 1.9 2.1 1.5 2.4 1.7 2.2 4.7 3.3 5.3 6.6 3.2 2.7 1.1 4.1 3.6 2.1 2.3 8.7 9.6 2.3 2.0 2.5 3.4 5.4 0.5 3.8 2.1 1.7 9.3 6.4 5.9 4.9 0.3 3.5 2.5 2.0 4.1 2.7 1.5 5.6 1.6 4.1 5.5 3.5 2.1 2.2 2.1 5.0 2.0 3.0 10.5 4.7 0.9 0.1 2.9 2.1 2.3 3.4 2.0 5.4 1.9 2.2 3.0 2.3 3.1 1.8 7.1 0.7 1.6 2.5 3.1 3.1 5.0 6.5 1.7 0.0 1.1 1.1 0.7 1.1 0.8 1.3 0.5 0.6 0.8 3.7 0.9 1.0 0.4 2.2 1.6 0.3 1.7 0.4 1.4 1.7 3.4 2.0 1.6 1.3 1.4 1.4 1.8 1.0 1.8 2.2 1.9 6.4 2.0 2.6 1.9 0.9 1.9 2.8 0.6 1.1 1.6 1.7 6.2 1.5 2.2 3.7 4.2 3.6 0.4 1.1 3.9 1.8 5.5 2.9 1.3 1.8 1.2 1.3 4.7 0.7 0.9 1.1 1.5 2.7 0.0 1.8 0.4 3.7 1.7 0.0 5.1 1.7 2.0 2.9 1.0 5.0 0.9 1.8 0.0 5.6 2.8 0.9 2.1 4.5 8.1 1.6 3.3 0.7 0.7 1.2 2.5 6.2 5.3 1.9 0.0 2.3 1.4 2.9 0.9 1.4 1.4 1.1 0.8 2.3 1.3 1.1 ECD "GCR2, hSGT1" ENSG00000122882 "Ecdysoneless cell cycle regulator" O95905 10 73130155-73169055 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006465 Approved Supported Nucleoplasm,Cytosol Yes No "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Cytosol" "HPA006465: AB_2667595" "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (6.46e-2)" "unprognostic (2.19e-1)" "unprognostic (2.75e-2)" "unprognostic (4.71e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (1.22e-1)" "unprognostic (3.55e-2)" "unprognostic (6.61e-2)" "unprognostic (3.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (7.05e-2)" "unprognostic (3.84e-2)" 13.8 17.2 8.0 14.6 11.2 31.9 17.9 12.7 10.7 14.8 10.2 13.1 12.1 16.0 16.2 15.2 11.9 15.9 12.8 8.5 7.7 17.4 18.9 12.6 17.7 7.4 7.1 13.9 16.7 22.8 11.3 17.8 7.5 16.5 13.9 17.0 14.4 14.3 13.8 15.3 11.7 14.7 7.2 14.4 13.1 19.2 7.6 21.0 19.0 14.3 18.4 20.0 12.5 12.5 41.0 28.8 32.0 48.1 28.8 28.2 26.3 31.1 48.5 49.9 57.8 52.0 41.4 31.8 29.9 30.5 36.7 33.0 34.6 36.9 50.3 26.1 33.5 39.9 21.2 38.0 43.7 48.3 25.3 31.5 30.9 41.6 51.7 37.9 53.3 29.3 42.1 21.4 47.6 34.8 44.5 28.6 33.0 37.7 81.8 32.1 35.6 17.6 40.4 29.5 13.9 26.5 28.4 62.5 40.3 32.6 36.1 23.0 33.3 21.1 42.8 23.3 36.2 25.2 18.1 54.5 40.1 40.4 18.5 21.0 23.3 26.3 24.7 24.9 26.4 24.3 23.0 24.4 20.3 21.2 29.9 21.5 27.5 32.5 34.7 13.8 24.8 20.3 8.0 11.2 12.7 10.7 8.5 7.7 7.4 7.1 7.5 7.2 7.6 12.5 21.2 28.9 12.1 13.1 22.7 11.0 27.9 16.6 24.5 13.9 11.9 10.3 12.5 8.6 23.0 7.3 25.0 22.7 22.7 9.0 7.9 15.8 39.4 15.3 15.5 17.4 10.8 21.8 17.3 12.2 15.7 15.7 23.4 24.8 19.6 12.2 15.0 8.8 16.6 20.2 16.3 11.8 8.2 12.4 10.1 11.5 15.8 16.0 14.2 9.4 10.8 10.3 14.4 11.6 18.6 14.7 5.7 13.2 16.7 13.1 9.8 12.2 10.5 13.1 6.6 17.8 18.2 32.9 16.0 19.2 10.9 33.2 22.1 11.6 9.2 24.7 FAM149B1 KIAA0974 ENSG00000138286 "Family with sequence similarity 149 member B1" Q96BN6 10 73168119-73244504 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039189, HPA039859" Uncertain Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA039189: AB_10805355, HPA039859: AB_2676712" "unprognostic (2.23e-1)" "unprognostic (7.04e-2)" "unprognostic (1.52e-1)" "unprognostic (4.88e-2)" "unprognostic (6.21e-2)" "unprognostic (1.45e-1)" "unprognostic (2.34e-1)" "unprognostic (4.66e-2)" "unprognostic (3.01e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (5.13e-2)" "unprognostic (1.96e-3)" "unprognostic (1.22e-1)" "unprognostic (9.21e-3)" "unprognostic (2.68e-1)" "unprognostic (5.24e-2)" 12.3 10.6 20.7 6.4 23.1 5.2 12.4 22.8 22.9 14.1 18.9 9.2 7.7 11.5 12.6 11.7 13.6 12.6 12.6 19.2 21.3 21.8 19.1 10.4 9.4 21.6 22.1 15.0 12.2 13.9 6.2 13.3 22.8 10.9 9.9 11.8 11.3 10.6 13.6 7.8 8.9 11.5 21.1 8.0 9.9 21.9 21.3 12.4 12.3 17.2 9.7 10.6 7.6 25.3 8.7 8.4 19.8 19.0 45.9 28.5 13.9 12.5 28.6 9.8 17.1 2.5 23.6 8.1 5.8 25.8 10.8 10.1 12.6 18.4 11.7 11.1 4.7 6.3 5.6 7.4 23.8 10.2 6.1 24.6 13.4 12.6 48.6 44.5 24.9 11.7 5.8 15.2 18.0 10.4 7.7 12.9 8.7 29.8 19.7 4.3 11.2 9.9 26.4 12.1 3.3 20.1 11.1 30.1 19.6 17.8 18.6 9.9 12.7 8.2 6.6 8.2 12.6 20.0 8.8 4.4 15.9 11.3 7.0 0.7 0.2 0.6 0.3 0.6 0.2 0.3 0.1 0.2 0.4 0.4 0.5 0.4 0.5 1.0 0.2 0.6 0.1 0.1 20.7 23.1 22.8 22.9 19.2 21.3 21.6 22.1 22.8 21.1 21.3 25.3 5.4 3.2 3.1 24.8 3.9 2.0 3.5 4.6 6.8 6.7 5.3 5.2 12.2 5.7 5.4 1.8 6.2 7.4 2.4 4.6 1.9 3.9 21.8 6.1 7.0 6.2 7.7 3.0 19.7 3.6 5.8 7.2 5.1 6.1 2.5 8.2 7.1 4.0 5.4 3.3 24.9 5.0 6.1 6.3 3.1 27.6 8.4 4.0 1.8 12.2 4.1 4.6 1.0 23.6 41.3 4.2 2.2 4.5 1.8 4.6 6.6 6.9 9.8 11.4 13.1 5.9 5.0 13.4 5.1 5.3 3.7 8.2 3.4 7.2 5.4 4.3 DNAJC9 "JDD1, SB73" ENSG00000213551 "DnaJ heat shock protein family (Hsp40) member C9" Q8WXX5 10 73183362-73247255 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 91.9" "Cell type enhanced" "Detected in all" "Erythroid cells: 173.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035215, HPA035216" Supported Supported "Nucleoplasm,Plasma membrane" NA NA 39000 "Cluster 44: Non-specific - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Plasma membrane" "HPA035215: AB_10603663, HPA035216: AB_2674522" "unprognostic (4.18e-2)" "unprognostic (1.61e-2)" "unprognostic (7.63e-2)" "unprognostic (2.67e-3)" "unprognostic (3.45e-1)" "unprognostic (6.83e-3)" "unprognostic (2.43e-3)" "prognostic unfavorable (3.26e-4)" "unprognostic (6.20e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-1)" "prognostic unfavorable (7.07e-5)" "unprognostic (5.61e-2)" "unprognostic (3.08e-3)" "unprognostic (6.49e-2)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" 9.2 10.6 17.1 17.6 17.5 91.9 15.4 19.2 21.5 11.2 15.4 16.0 14.6 12.8 12.4 16.9 9.7 6.9 8.6 16.9 17.0 10.0 13.4 9.6 28.2 16.4 16.5 15.3 8.7 10.2 10.6 17.6 16.9 11.4 18.0 25.1 11.3 11.2 11.5 17.7 13.9 11.8 15.7 14.8 12.2 12.4 17.0 35.8 8.4 13.1 32.3 11.5 11.9 17.6 135.0 77.3 93.8 68.4 16.1 19.3 45.7 101.5 59.4 101.1 106.1 130.8 89.4 86.9 33.5 43.6 43.7 83.1 92.9 67.5 118.1 98.5 63.8 188.3 79.4 93.4 14.8 173.1 71.0 14.8 33.2 107.1 93.4 36.4 66.2 112.1 168.3 103.0 81.4 118.4 155.0 124.7 36.3 64.4 215.1 114.2 85.1 47.6 52.9 61.5 44.3 73.4 73.5 114.5 52.9 43.7 62.1 76.8 48.0 65.2 118.3 71.3 168.0 45.0 70.6 141.8 64.8 162.9 45.9 23.9 3.7 29.1 25.5 10.7 29.2 32.8 31.3 28.2 6.5 28.3 30.3 26.9 4.5 24.8 10.9 20.3 36.8 18.0 17.1 17.5 19.2 21.5 16.9 17.0 16.4 16.5 16.9 15.7 17.0 17.6 17.3 9.6 12.3 11.1 39.5 47.7 34.1 31.9 33.0 26.1 21.5 24.8 2.7 17.2 24.8 9.2 8.4 107.8 44.6 18.3 21.5 31.5 80.4 15.9 14.0 20.6 12.0 173.8 11.8 31.4 111.4 17.6 12.2 19.0 42.3 26.0 13.9 9.8 61.9 15.2 12.8 25.6 54.9 10.9 19.6 43.3 14.0 17.4 32.0 6.5 23.0 29.5 32.0 7.5 6.5 44.1 16.7 20.3 49.7 27.6 18.2 16.3 21.9 43.2 26.3 17.7 28.3 28.7 65.4 38.2 43.5 58.0 45.2 19.7 38.0 37.5 MRPS16 CGI-132 ENSG00000182180 "Mitochondrial ribosomal protein S16" Q9Y3D3 10 73248843-73252693 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050081, HPA054538" Supported Supported Mitochondria,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "Mitochondria, Cytosol" "HPA050081: AB_2681007, HPA054538: AB_2682519" "unprognostic (9.19e-2)" "unprognostic (5.19e-2)" "unprognostic (2.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.23e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (4.57e-5)" "unprognostic (1.68e-2)" "unprognostic (6.44e-2)" "unprognostic (2.98e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (1.20e-1)" "unprognostic (5.84e-2)" 24.0 37.8 12.0 18.3 12.7 20.2 22.6 13.3 13.8 18.7 15.8 27.5 24.8 21.6 14.5 32.1 19.1 12.6 47.2 12.3 12.3 32.0 39.5 17.5 22.3 13.0 12.3 18.5 27.4 21.8 20.5 12.9 12.4 19.6 22.0 8.3 23.7 15.3 76.1 25.3 22.4 16.7 12.6 23.3 27.3 21.0 12.8 21.4 17.7 46.3 22.5 20.8 20.2 14.8 84.5 120.5 40.7 55.6 29.1 27.2 65.7 36.7 62.7 49.6 50.5 147.1 78.4 97.8 40.3 36.9 45.2 74.5 43.1 73.2 30.6 54.6 50.4 59.6 61.0 108.5 58.4 79.3 51.4 40.5 54.5 51.4 120.4 37.9 54.2 83.3 92.4 52.2 49.7 92.3 83.4 70.1 52.7 53.7 211.1 75.1 56.1 69.4 48.4 51.3 26.9 49.8 43.5 164.2 83.7 22.5 121.1 38.1 44.8 46.9 83.3 50.3 74.6 79.0 91.4 75.0 50.5 89.5 32.1 31.3 33.0 26.3 26.1 37.3 28.2 42.9 28.4 24.8 27.3 47.5 29.9 26.9 15.0 28.1 30.1 41.8 31.4 39.5 12.0 12.7 13.3 13.8 12.3 12.3 13.0 12.3 12.4 12.6 12.8 14.8 38.0 6.4 32.4 13.7 59.9 35.1 73.9 103.1 42.7 28.0 76.5 87.6 101.1 58.6 71.4 47.8 31.3 118.0 34.0 77.4 248.4 103.7 68.1 54.6 57.8 56.3 54.5 79.8 18.2 119.7 160.7 45.0 52.0 48.4 30.4 52.5 46.8 157.2 154.5 20.2 19.3 102.8 75.3 64.5 36.0 37.8 62.1 57.2 65.8 13.1 78.3 47.9 52.5 9.0 10.7 127.5 55.9 41.8 88.8 126.6 88.6 239.2 51.1 36.2 0.0 38.7 69.0 124.5 70.8 92.8 44.2 106.9 42.6 87.5 114.9 99.0 CFAP70 "FLJ25765, TTC18" ENSG00000156042 "Cilia and flagella associated protein 70" Q5T0N1 10 73253759-73358859 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 24.4;testis: 20.9" "Cell type enhanced" "Detected in many" "Astrocytes: 68.6;Early spermatids: 61.9;Endometrial ciliated cells: 153.6;Respiratory ciliated cells: 179.3;Spermatocytes: 60.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "PC-3: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037582, HPA070304" Enhanced NA NA "Cluster 32: T-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" "HPA037582: AB_2675560, HPA070304: AB_2732153" "unprognostic (2.29e-3)" "unprognostic (4.42e-2)" "unprognostic (1.12e-1)" "unprognostic (1.43e-2)" "unprognostic (2.41e-1)" "unprognostic (9.94e-2)" "unprognostic (2.81e-1)" "unprognostic (4.60e-2)" "unprognostic (2.97e-2)" "unprognostic (1.32e-2)" "unprognostic (1.67e-3)" "unprognostic (5.95e-3)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.16e-1)" 1.3 4.5 4.3 0.5 4.4 0.3 3.1 3.9 4.9 2.8 24.4 0.7 1.2 1.6 11.3 0.6 14.7 1.4 1.3 4.9 5.5 7.8 2.3 3.1 0.7 10.0 12.5 3.2 2.9 4.7 13.5 0.5 8.4 4.3 0.6 10.5 2.3 1.9 0.9 2.9 0.7 0.5 8.4 1.4 1.3 20.9 5.0 0.6 6.3 0.6 0.8 0.9 1.1 6.2 1.1 1.3 1.4 1.2 2.4 2.1 0.4 0.5 0.1 0.3 0.4 1.0 4.6 0.5 0.7 0.2 0.9 0.7 0.8 1.0 0.5 1.0 2.3 1.0 1.0 1.1 0.2 0.5 0.6 1.3 2.3 0.7 0.6 1.7 0.0 3.1 0.4 2.9 0.4 1.8 1.3 1.0 0.5 1.1 5.4 0.8 1.2 2.4 2.3 0.3 1.9 0.2 0.4 0.9 0.9 0.8 1.8 0.8 0.8 0.3 1.2 0.5 1.3 3.0 1.8 1.5 1.7 1.0 0.4 0.0 0.0 0.4 0.3 0.1 0.7 0.5 0.6 0.5 0.2 0.8 1.3 1.1 0.1 0.5 0.1 0.4 0.6 0.2 4.3 4.4 3.9 4.9 4.9 5.5 10.0 12.5 8.4 8.4 5.0 6.2 2.0 9.6 8.4 68.6 2.2 0.0 3.6 0.0 2.8 15.3 6.7 3.9 2.1 1.5 36.5 5.5 29.2 1.4 0.3 0.3 3.9 1.9 61.9 153.6 3.3 1.8 4.9 0.4 29.5 0.6 0.2 3.2 3.1 7.4 2.5 3.2 4.6 2.6 0.5 6.7 37.6 0.5 0.0 0.3 0.0 39.0 4.7 1.1 0.0 5.6 0.1 16.0 0.0 12.1 22.4 0.2 0.1 3.0 1.3 5.5 0.5 2.8 179.3 28.0 6.6 5.3 1.1 60.4 14.8 2.0 0.0 0.3 1.3 8.1 0.8 2.5 ANXA7 ANX7 ENSG00000138279 "Annexin A7" P20073 10 73375101-73414076 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 693.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004312, HPA064290" Approved Uncertain Nucleoplasm,Cytosol NA NA 290000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 3: Monocytes - Immune response regulation" Nucleoplasm Cytosol "CAB004312: AB_626681, HPA064290: AB_2685233" "unprognostic (1.48e-1)" "unprognostic (4.70e-2)" "unprognostic (1.90e-1)" "unprognostic (2.23e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (2.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.47e-1)" "unprognostic (2.67e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (6.93e-2)" "unprognostic (3.06e-2)" 79.0 72.1 60.1 58.6 61.1 85.2 75.5 55.9 67.8 69.9 57.1 64.3 39.4 57.6 80.5 69.3 57.0 51.8 113.4 62.6 64.8 116.4 126.0 60.4 60.8 55.4 57.0 67.1 55.9 240.7 55.6 57.2 58.1 69.2 74.4 32.3 70.2 70.6 200.1 61.2 44.9 68.4 60.8 53.4 51.7 26.3 62.5 55.4 83.1 139.6 84.1 75.2 57.4 63.9 143.4 101.4 38.8 95.3 148.9 145.2 84.3 93.2 244.7 119.9 100.6 149.2 164.8 56.6 92.2 177.2 78.8 116.9 73.2 110.9 118.1 140.8 54.5 80.4 46.5 133.9 130.6 115.7 35.4 90.8 105.7 149.2 265.1 104.7 108.0 60.8 106.2 156.4 154.4 114.5 66.1 74.4 43.5 85.1 693.9 53.9 110.1 103.4 209.3 86.5 30.9 42.8 105.1 239.4 90.3 54.3 149.7 61.0 100.8 48.5 87.9 148.1 122.5 100.5 153.2 79.5 114.4 147.4 38.4 188.6 98.1 129.8 57.5 74.9 78.9 96.5 88.8 72.2 101.3 75.1 80.0 71.4 98.0 97.2 77.5 43.2 127.8 137.2 60.1 61.1 55.9 67.8 62.6 64.8 55.4 57.0 58.1 60.8 62.5 63.9 85.0 67.3 61.8 24.8 68.4 86.2 137.9 189.8 40.9 33.0 56.7 40.9 131.9 62.9 120.6 93.8 14.6 210.6 61.2 76.2 193.7 167.2 9.7 82.9 43.8 82.4 191.8 119.3 44.8 150.9 112.0 85.3 51.5 60.4 108.3 69.0 56.4 122.7 119.9 10.1 50.7 82.8 193.3 83.0 87.3 6.5 137.0 91.4 85.4 15.0 301.5 66.4 36.0 26.7 46.2 133.1 47.5 174.5 73.0 125.3 57.9 262.8 161.1 26.3 26.3 82.1 92.9 24.0 42.3 72.5 92.5 177.3 78.4 46.9 76.9 146.1 MSS51 "FLJ39565, ZMYND17" ENSG00000166343 "MSS51 mitochondrial translational activator" Q4VC12 10 73423579-73433561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 261.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 5.3;Excitatory neurons: 11.9;Inhibitory neurons: 9.7;Oligodendrocyte precursor cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038564 Uncertain Vesicles,Cytosol NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 37: Myocytes - Muscle contraction" Vesicles Cytosol "HPA038564: AB_10674687" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.40e-3)" "unprognostic (2.06e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-3)" "unprognostic (3.05e-3)" "unprognostic (7.88e-3)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (1.50e-4)" "unprognostic (1.22e-1)" "unprognostic (1.78e-7)" "unprognostic (1.51e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-2)" 1.9 1.5 1.5 1.5 1.8 1.6 1.7 4.3 2.0 3.2 1.6 2.3 1.2 2.1 1.7 1.4 2.2 1.2 10.9 1.5 0.6 1.7 1.6 2.2 1.8 0.2 0.3 3.0 1.9 56.2 2.3 0.6 0.2 2.5 1.3 2.5 1.7 0.8 261.3 3.7 2.7 1.1 0.0 3.9 1.8 1.4 0.7 1.5 1.5 5.9 1.5 2.2 2.2 1.3 0.9 0.6 1.5 2.7 2.1 2.8 1.2 0.7 0.5 0.3 0.6 0.3 0.7 2.1 0.2 0.7 0.1 1.1 1.0 0.2 0.8 1.1 0.9 1.7 1.3 0.5 0.7 1.1 1.7 2.4 0.7 0.6 1.7 2.1 0.2 0.8 0.6 1.0 1.2 0.2 0.9 1.6 0.4 0.5 0.7 0.5 4.1 0.1 0.8 0.9 0.3 0.8 0.5 1.0 0.9 1.4 0.9 0.9 1.3 1.2 0.7 0.4 1.7 0.6 2.1 1.1 0.5 1.9 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.8 4.3 2.0 1.5 0.6 0.2 0.3 0.2 0.0 0.7 1.3 0.9 0.0 3.6 4.6 1.0 0.5 0.1 0.6 0.0 1.4 0.4 0.5 5.3 0.0 0.2 0.0 0.0 0.3 0.4 0.4 0.0 0.4 0.3 0.4 0.7 1.2 0.0 1.3 11.9 0.4 0.2 0.8 1.1 0.8 5.1 1.8 1.4 0.2 0.2 0.0 9.7 0.4 0.0 0.8 0.6 0.3 3.1 0.5 0.0 4.7 1.1 0.5 1.0 6.0 3.4 0.2 3.9 1.5 0.4 0.5 0.6 0.2 0.3 1.2 0.0 4.0 0.6 0.7 0.3 0.0 0.0 0.1 1.1 1.4 0.6 0.2 PPP3CB "CALNA2, CALNB, CNA2, PP2Bbeta" ENSG00000107758 "Protein phosphatase 3 catalytic subunit beta" P16298 10 73436433-73496024 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 379.3;tongue: 179.7" "Cell type enhanced" "Detected in all" "Excitatory neurons: 119.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008233, HPA008823" Uncertain Approved Mitochondria NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 10: Non-specific - Unknown function" Mitochondria "HPA008233: AB_1855661, HPA008823: AB_2668148" "unprognostic (3.05e-1)" "unprognostic (2.54e-1)" "unprognostic (1.50e-1)" "unprognostic (4.93e-2)" "unprognostic (8.93e-2)" "unprognostic (4.28e-2)" "prognostic unfavorable (9.59e-4)" "unprognostic (1.14e-1)" "unprognostic (1.34e-1)" "unprognostic (2.12e-2)" "prognostic favorable (6.96e-5)" "unprognostic (4.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (2.66e-1)" "unprognostic (1.68e-2)" 44.8 37.5 40.5 29.8 51.1 19.8 32.1 49.5 63.1 30.3 26.7 41.4 24.2 40.3 34.5 33.1 30.9 28.3 41.3 56.9 29.5 28.1 21.8 23.5 34.9 25.4 25.2 39.6 25.3 39.2 30.6 25.5 28.7 39.1 29.6 57.0 26.6 39.8 379.3 26.3 22.6 48.2 27.2 25.3 24.3 29.0 29.1 32.9 23.5 179.7 36.1 34.3 24.3 44.9 53.7 29.0 50.9 53.0 71.4 98.3 24.5 48.0 65.7 46.1 45.4 18.6 26.8 47.1 15.3 70.0 21.8 28.1 41.6 36.9 64.5 66.6 34.0 20.3 25.0 35.5 42.7 45.2 40.2 70.1 43.5 43.6 58.1 84.7 32.3 40.6 25.6 54.0 94.1 16.9 40.7 41.6 20.7 23.3 83.8 26.9 27.7 22.4 45.1 25.6 27.2 31.5 28.1 69.5 36.4 42.1 52.4 43.2 35.6 36.6 33.7 29.5 66.1 35.8 105.3 33.0 45.3 64.0 21.3 2.2 2.0 3.5 4.0 2.7 4.8 2.7 4.3 4.4 2.1 2.3 3.4 5.1 1.1 3.5 1.7 4.0 7.8 1.9 40.5 51.1 49.5 63.1 56.9 29.5 25.4 25.2 28.7 27.2 29.1 44.9 23.0 3.2 14.3 72.5 31.6 25.6 29.8 13.2 27.3 54.8 25.7 16.9 48.9 14.3 12.8 18.4 20.9 21.0 23.7 11.1 62.6 18.1 11.8 20.0 24.2 21.5 42.6 30.7 119.5 19.4 16.8 32.6 20.4 18.8 21.0 35.4 18.9 14.2 20.3 38.7 111.0 13.2 18.3 31.7 24.2 9.9 33.5 25.2 26.6 51.5 29.6 34.8 18.6 79.4 54.4 16.7 12.9 29.0 34.1 27.1 13.4 34.2 17.6 30.1 6.6 41.8 36.4 43.8 49.2 32.1 31.5 22.2 27.3 28.4 13.1 22.1 USP54 "bA137L10.3, bA137L10.4, C10orf29, FLJ37318" ENSG00000166348 "Ubiquitin specific peptidase 54" Q70EL1 10 73497538-73625994 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 134.8" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 476.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "OE19: 33.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047663, HPA063665" Approved Approved Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 70: Brain - Nervous system development" "Cluster 21: OE19 - Mitochondria" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Mitochondria "HPA047663: AB_2680116, HPA063665: " "unprognostic (2.46e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-2)" "unprognostic (1.89e-2)" "unprognostic (2.48e-2)" "unprognostic (4.89e-3)" "unprognostic (6.63e-4)" "prognostic favorable (7.00e-4)" "unprognostic (6.24e-2)" "unprognostic (4.35e-2)" "unprognostic (8.91e-3)" "unprognostic (3.49e-1)" "unprognostic (1.95e-3)" "unprognostic (8.18e-2)" "unprognostic (6.88e-2)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" 4.6 3.1 61.5 5.5 103.5 2.1 16.3 85.5 72.4 14.5 32.2 15.0 4.9 9.3 13.2 13.9 12.0 5.6 7.0 60.5 71.9 5.2 1.5 17.9 2.8 99.8 97.5 6.8 10.8 8.9 2.9 2.8 94.0 12.1 19.7 14.8 16.8 7.6 49.7 15.2 6.7 7.1 70.4 2.9 20.7 9.1 85.0 8.4 40.7 17.0 7.1 6.6 4.9 134.8 10.0 8.4 15.9 13.7 4.4 4.8 4.7 4.7 11.2 7.9 8.6 8.1 16.7 6.6 6.5 3.7 6.1 14.2 10.7 4.3 10.2 2.8 8.6 5.0 6.3 8.0 4.1 5.6 2.3 3.9 3.8 9.0 10.9 20.6 3.4 5.7 7.5 3.0 6.3 5.6 4.5 6.8 8.0 33.4 30.2 7.0 11.9 3.0 8.7 7.6 4.8 5.4 10.1 11.7 15.8 10.2 15.8 5.8 4.9 3.5 11.2 6.6 6.8 2.4 4.3 4.1 8.3 5.3 3.1 0.2 0.4 0.5 0.6 0.4 0.7 0.4 0.5 0.4 0.4 0.3 0.7 0.4 0.0 0.3 0.5 0.4 0.6 0.4 61.5 103.5 85.5 72.4 60.5 71.9 99.8 97.5 94.0 70.4 85.0 134.8 5.9 48.1 34.3 33.0 1.7 2.7 8.5 11.0 4.0 7.7 15.3 8.4 7.2 5.7 18.9 12.9 16.7 1.0 1.2 19.6 0.0 4.7 2.4 25.8 12.9 6.3 10.3 2.1 23.1 8.0 1.0 7.6 40.2 44.3 3.8 3.5 2.5 3.0 1.4 5.0 33.4 23.4 2.0 1.3 1.4 2.2 3.4 1.8 8.8 76.8 0.8 12.5 0.0 116.1 476.0 12.2 9.7 10.9 2.3 52.6 10.5 1.9 21.7 12.2 6.6 19.6 3.8 9.2 6.0 7.7 4.0 1.4 3.0 2.9 11.2 15.2 MYOZ1 "CS-2, FATZ, MYOZ" ENSG00000177791 "Myozenin 1" Q9NP98 10 73631612-73641474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 82 "skeletal muscle: 7134.0;tongue: 3308.1" "Cell type enriched" "Detected in some" 11 "Skeletal myocytes: 144.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "BEWO: 44.6" "Region enriched" "Detected in single" 17 "olfactory bulb: 3.9" "Low region specificity" "Detected in all" "HPA037848, HPA038437" Enhanced NA NA 71000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 37: Myocytes - Muscle contraction" "HPA037848: AB_10670156, HPA038437: AB_2676009" "unprognostic (4.55e-2)" "unprognostic (2.23e-1)" "unprognostic (4.90e-2)" "unprognostic (3.91e-2)" "unprognostic (1.14e-1)" "unprognostic (5.08e-2)" "unprognostic (2.76e-2)" "unprognostic (1.22e-4)" "unprognostic (1.18e-1)" "unprognostic (9.25e-2)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (5.14e-2)" "unprognostic (2.64e-2)" "unprognostic (6.78e-2)" "unprognostic (7.17e-2)" "unprognostic (1.09e-1)" 3.0 0.7 2.9 0.2 3.1 0.0 2.6 2.8 3.9 1.4 2.6 0.7 0.0 1.0 23.2 63.9 1.5 1.4 45.2 2.6 3.4 2.9 0.6 5.0 0.4 3.0 2.8 1.8 0.6 0.2 2.7 2.2 3.0 22.1 0.3 1.1 36.9 3.4 7134.0 2.1 0.5 0.9 2.9 1.6 0.6 2.1 3.0 0.9 4.4 3308.1 0.4 0.9 1.6 3.0 0.0 0.0 0.3 0.0 0.0 0.0 44.6 0.3 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.3 0.2 7.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.1 2.8 3.9 2.6 3.4 3.0 2.8 3.0 2.9 3.0 3.0 0.2 0.0 0.0 0.3 0.0 0.3 1.6 0.3 0.6 2.7 1.0 1.9 9.3 0.0 1.3 5.5 0.0 0.4 0.0 0.0 7.9 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.1 0.2 2.5 1.5 0.0 0.0 0.0 0.9 0.0 0.0 6.3 0.0 0.1 0.0 2.0 0.0 0.8 1.2 0.9 0.7 0.0 0.0 0.0 6.1 0.0 0.5 0.1 0.0 0.0 7.5 0.0 0.3 0.0 0.4 0.1 0.6 13.1 144.4 11.6 0.4 2.2 0.1 0.3 0.1 0.6 3.0 0.0 0.3 SYNPO2L FLJ12921 ENSG00000166317 "Synaptopodin 2 like" Q9H987 10 73644881-73663803 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "heart muscle: 262.3;skeletal muscle: 279.2;tongue: 87.2" "Cell type enriched" "Detected in some" 52 "Cardiomyocytes: 665.1" "Group enriched" "Detected in some" 6 "breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 4.1;HSkMC: 3.2;RH-30: 3.0;SK-BR-3: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055192, HPA057142" Enhanced Supported "Nuclear speckles,Cell Junctions,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nuclear speckles" "Cell Junctions, Cytosol" "HPA055192: AB_2682732, HPA057142: AB_2683348" "unprognostic (2.75e-1)" "unprognostic (1.58e-1)" "unprognostic (1.20e-3)" "unprognostic (3.65e-3)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (4.54e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-2)" "unprognostic (4.50e-2)" "unprognostic (2.32e-1)" "unprognostic (7.44e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-1)" 0.1 0.5 0.7 0.1 0.7 0.3 3.6 0.8 0.9 0.4 0.1 0.0 0.1 0.1 0.1 11.8 0.1 0.1 262.3 0.7 0.5 0.1 0.1 1.2 0.2 0.7 0.6 0.2 0.4 0.0 0.1 0.6 0.5 3.1 0.0 0.4 4.8 0.0 279.2 0.3 0.0 0.0 0.5 0.2 0.1 0.3 0.6 0.1 0.2 87.2 0.2 0.0 1.1 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.5 0.6 0.1 0.0 4.1 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.0 3.2 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.1 0.1 0.1 0.0 3.2 0.0 0.1 0.1 0.1 0.0 0.2 0.4 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.2 0.0 0.0 0.7 0.7 0.8 0.9 0.7 0.5 0.7 0.6 0.5 0.5 0.6 0.7 0.5 3.2 0.0 0.3 0.9 1.5 1.4 0.0 2.2 1.9 1.0 0.8 665.1 0.0 0.7 0.0 2.1 0.2 0.5 0.0 0.0 0.0 2.6 0.1 0.4 5.0 0.0 0.0 0.3 0.0 0.2 12.6 0.0 0.3 1.3 0.3 0.0 0.4 0.2 0.0 0.9 0.0 0.0 0.6 2.1 1.1 0.9 0.8 1.8 1.0 0.3 0.4 0.0 1.5 1.1 0.0 0.0 0.4 0.3 0.9 0.0 0.2 0.7 1.2 0.0 12.0 5.2 0.8 1.3 0.4 0.4 0.0 0.7 0.2 0.0 1.0 AGAP5 "CTGLF2, Em:AC073389.1" ENSG00000172650 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 5" A6NIR3 10 73674287-73697881 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 79.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA042490 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA042490: AB_2678022" "unprognostic (1.84e-1)" "unprognostic (3.59e-2)" "unprognostic (1.27e-2)" "unprognostic (1.07e-1)" "unprognostic (1.61e-1)" "unprognostic (4.45e-3)" "unprognostic (1.40e-1)" "unprognostic (4.52e-1)" "unprognostic (1.41e-1)" "unprognostic (1.98e-2)" "unprognostic (4.04e-3)" "unprognostic (4.33e-3)" "unprognostic (5.83e-5)" "unprognostic (3.33e-2)" "unprognostic (2.87e-1)" "unprognostic (7.29e-2)" "unprognostic (1.17e-2)" 3.2 5.1 2.7 3.8 3.1 3.2 4.3 4.2 3.7 3.9 4.4 3.5 3.5 3.3 4.2 3.2 3.3 2.6 5.5 2.7 3.2 4.4 6.9 3.6 4.4 3.0 2.8 4.8 9.9 1.9 4.7 2.6 3.2 4.7 3.1 5.3 6.3 2.5 8.7 6.5 4.0 2.2 2.1 5.0 4.3 8.4 3.4 3.1 4.0 2.1 2.8 3.3 3.5 4.6 2.4 2.9 3.8 4.2 3.0 2.3 5.7 2.9 2.1 2.0 1.7 3.9 3.3 2.9 2.4 2.3 0.8 5.9 2.8 2.4 1.3 3.4 3.3 2.3 6.7 4.5 2.5 5.9 3.7 2.4 2.6 2.3 6.2 5.2 1.6 4.2 3.0 5.8 1.8 2.3 2.3 7.7 1.1 2.6 7.9 3.1 1.6 2.2 2.0 2.3 1.7 1.5 1.7 6.2 3.5 2.7 3.5 4.7 2.9 2.5 3.4 2.5 3.8 6.9 3.7 1.7 2.6 6.7 1.1 0.6 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 2.7 3.1 4.2 3.7 2.7 3.2 3.0 2.8 3.2 2.1 3.4 4.6 2.1 0.0 9.0 4.2 1.5 1.9 0.3 0.8 0.0 2.4 2.4 1.7 0.0 1.5 3.7 3.7 6.2 1.7 2.1 1.0 0.0 1.6 79.9 2.6 2.3 2.1 0.0 2.7 6.4 2.2 0.7 1.7 4.6 1.5 3.8 2.5 3.9 3.5 1.5 3.3 6.3 2.0 0.0 1.3 2.2 18.9 1.2 1.9 1.8 1.9 2.4 1.7 2.1 4.5 8.4 2.7 0.5 3.8 1.6 1.1 3.2 0.6 6.6 2.7 0.0 0.9 0.9 4.2 2.4 0.9 1.3 0.7 1.8 1.3 2.1 0.7 SEC24C KIAA0079 ENSG00000176986 "SEC24 homolog C, COPII coat complex component" P53992 10 73744372-73772161 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040196, HPA040213" Supported Supported Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA040196: AB_10796449, HPA040213: AB_10796451" "unprognostic (5.06e-2)" "unprognostic (1.00e-2)" "unprognostic (2.17e-1)" "unprognostic (3.54e-1)" "unprognostic (8.46e-2)" "unprognostic (7.23e-2)" "unprognostic (9.06e-2)" "unprognostic (4.55e-2)" "unprognostic (1.64e-1)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-1)" "unprognostic (7.71e-2)" "unprognostic (8.34e-3)" "unprognostic (2.11e-1)" "unprognostic (3.35e-2)" "unprognostic (1.77e-2)" 27.8 42.9 20.1 31.6 21.2 16.2 27.4 23.1 26.8 42.5 20.7 34.2 27.4 36.4 33.2 69.0 30.7 24.0 34.5 20.4 21.2 29.8 45.8 30.5 31.4 21.4 20.1 33.2 34.9 50.5 45.4 36.4 20.9 37.7 27.6 29.1 36.9 31.1 49.7 35.8 31.7 32.1 18.3 37.1 34.1 27.7 22.7 35.2 34.0 33.9 43.3 35.5 38.8 23.0 72.7 71.8 55.6 99.9 59.2 48.3 45.6 53.6 90.4 70.4 65.7 67.2 47.9 57.3 43.3 72.0 48.1 61.4 78.3 70.7 60.4 76.6 55.6 53.1 50.5 71.2 47.0 80.7 71.1 41.5 76.8 61.8 76.4 89.2 73.6 44.6 64.1 80.8 69.9 64.7 60.4 55.3 34.8 68.3 259.2 65.2 45.0 47.0 46.5 40.8 20.0 51.7 41.9 144.6 60.1 51.7 106.3 70.6 72.7 29.5 53.1 57.7 62.5 82.0 85.9 84.0 84.0 80.8 35.0 28.2 15.8 13.6 27.4 21.4 35.5 12.6 16.2 21.6 18.1 9.4 11.7 15.8 11.5 22.4 19.1 14.8 10.9 22.7 20.1 21.2 23.1 26.8 20.4 21.2 21.4 20.1 20.9 18.3 22.7 23.0 12.1 35.3 28.6 16.3 11.6 8.7 4.7 11.5 6.2 15.1 17.0 14.9 2.3 14.3 17.6 14.7 16.7 17.8 18.6 24.7 3.9 15.1 8.8 10.9 13.0 11.0 19.2 5.9 14.6 19.4 16.4 9.7 19.9 17.0 22.2 20.1 16.4 19.9 17.1 15.2 15.7 18.4 8.2 11.7 8.4 6.0 11.8 12.4 5.4 6.5 12.3 10.3 17.5 14.1 16.8 23.8 14.4 11.7 21.9 10.8 20.0 10.4 8.2 14.7 6.6 10.0 9.7 10.3 8.3 11.5 11.4 25.2 16.9 14.7 16.1 10.9 FUT11 MGC33202 ENSG00000196968 "Fucosyltransferase 11" Q495W5 10 73772276-73780251 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 171.6;Late spermatids: 234.7;NK-cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014033 Approved Approved "Nuclear membrane,Golgi apparatus" "Intracellular and membrane" NA NA 1200000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 34: Spermatids - Unknown function" "Nuclear membrane" "Golgi apparatus" "HPA014033: AB_1849192" "prognostic unfavorable (6.78e-4)" "prognostic unfavorable (2.39e-6)" "unprognostic (1.47e-2)" "unprognostic (2.42e-3)" "unprognostic (3.27e-1)" "unprognostic (7.64e-2)" "unprognostic (2.29e-2)" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (9.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (2.59e-2)" "unprognostic (1.71e-1)" "unprognostic (3.61e-1)" "unprognostic (2.66e-2)" 9.4 5.1 2.5 6.8 3.2 6.4 5.2 4.4 2.8 8.9 1.8 4.5 3.1 6.0 3.2 7.0 4.7 9.0 9.4 2.1 3.8 4.7 5.1 8.7 6.4 4.9 4.8 6.3 4.1 3.7 3.1 17.4 4.1 4.3 3.8 10.0 4.1 6.4 4.1 4.5 3.7 8.3 4.1 10.2 4.9 10.2 5.0 4.3 7.0 4.8 6.2 7.0 4.8 4.9 26.4 14.2 9.9 20.8 19.2 22.2 2.9 13.1 31.3 16.3 31.7 4.7 13.8 6.1 9.3 21.7 5.5 10.9 5.2 13.3 18.1 14.4 10.9 8.1 11.4 7.6 7.5 11.6 24.5 14.8 3.0 15.5 15.9 50.3 30.1 2.7 8.1 10.5 16.4 3.2 2.0 6.0 4.7 2.5 35.1 2.8 6.1 7.2 5.9 4.7 3.0 9.6 11.5 12.0 7.5 8.4 8.2 5.0 31.3 21.1 9.0 10.6 16.4 13.8 5.1 1.4 29.6 10.2 7.0 5.4 1.4 1.4 20.0 1.6 14.2 2.1 5.9 14.3 1.7 1.8 4.3 8.9 0.3 10.9 1.8 3.5 2.6 6.9 2.5 3.2 4.4 2.8 2.1 3.8 4.9 4.8 4.1 4.1 5.0 4.9 22.4 16.0 13.1 6.2 12.1 13.6 5.6 22.7 5.2 14.6 6.1 6.1 12.2 7.2 9.8 11.0 14.6 10.7 23.1 4.9 0.0 13.3 171.6 6.7 12.0 28.0 4.8 15.8 6.0 6.8 25.2 15.8 2.6 10.5 14.0 7.1 38.2 5.2 12.5 20.2 5.7 4.6 2.0 18.1 16.7 234.7 16.1 11.0 17.8 11.2 11.4 8.3 69.0 5.0 6.5 10.3 5.2 14.7 10.2 8.9 2.6 3.4 9.8 13.0 6.6 14.3 11.7 20.7 19.0 5.5 11.5 9.7 19.9 6.8 3.1 6.4 CHCHD1 "C10orf34, FLJ25854" ENSG00000172586 "Coiled-coil-helix-coiled-coil-helix domain containing 1" Q96BP2 10 73782047-73783652 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 561.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039046 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Mitochondria" "Nucleoli fibrillar center" "HPA039046: AB_10673234" "unprognostic (4.97e-2)" "unprognostic (1.90e-3)" "unprognostic (2.96e-1)" "unprognostic (1.31e-3)" "unprognostic (1.80e-1)" "unprognostic (9.85e-2)" "unprognostic (1.75e-2)" "unprognostic (3.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.24e-2)" "unprognostic (4.53e-1)" "unprognostic (1.91e-2)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (1.54e-1)" "unprognostic (5.58e-2)" "prognostic favorable (5.42e-4)" 30.1 53.2 38.7 29.3 39.1 26.7 34.4 40.0 45.1 25.4 41.9 38.1 40.0 25.9 52.0 49.8 25.6 18.5 52.9 38.9 39.6 55.9 54.7 25.6 36.4 38.8 38.5 24.1 31.3 42.8 31.0 29.2 39.2 36.7 29.0 21.9 45.6 21.9 64.2 29.9 35.1 19.1 39.3 40.3 37.6 24.8 39.4 34.6 31.9 50.6 30.8 27.7 30.1 40.1 115.8 87.6 70.8 98.3 57.0 56.6 71.1 58.3 70.7 59.8 80.0 78.6 99.3 56.9 63.3 52.9 60.1 77.9 69.8 79.8 46.9 87.6 132.4 42.7 73.2 119.6 68.6 65.8 65.7 52.3 96.3 51.5 33.0 87.4 83.9 78.8 67.0 61.7 78.3 117.3 82.1 146.5 66.3 109.6 561.7 77.3 53.9 72.6 97.5 63.0 34.2 67.4 36.0 246.2 127.3 56.8 138.0 92.5 47.2 35.7 79.7 60.2 102.4 61.5 70.7 91.2 83.4 133.7 28.5 44.2 51.3 32.5 36.1 54.9 43.9 62.6 43.7 43.5 52.5 50.8 36.1 36.9 21.2 36.6 45.6 75.1 65.2 35.8 38.7 39.1 40.0 45.1 38.9 39.6 38.8 38.5 39.2 39.3 39.4 40.1 45.0 41.7 48.4 5.2 50.7 35.1 34.4 117.2 29.0 27.0 68.7 74.4 77.3 47.1 84.4 60.7 22.9 151.6 49.3 112.1 199.6 80.8 73.3 99.0 64.1 44.5 61.8 61.2 8.6 88.3 166.3 38.2 41.8 75.8 29.8 63.9 51.4 132.5 139.7 20.2 8.0 106.2 122.1 61.2 35.6 16.3 56.5 52.7 40.9 5.6 82.5 76.8 51.5 5.5 9.6 96.4 96.4 55.3 53.3 55.3 101.0 243.3 99.0 35.3 52.6 36.1 52.4 70.1 48.7 71.2 43.5 128.1 41.6 83.9 98.4 54.9 ZSWIM8 "4832404P21Rik, KIAA0913" ENSG00000214655 "Zinc finger SWIM-type containing 8" A7E2V4 10 73785606-73801797 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041244 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA041244: AB_10794269" "unprognostic (8.83e-2)" "unprognostic (2.86e-1)" "unprognostic (2.89e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-2)" "prognostic favorable (5.61e-4)" "unprognostic (3.11e-1)" "unprognostic (1.64e-1)" "unprognostic (2.97e-1)" "unprognostic (1.69e-1)" "unprognostic (2.24e-3)" "unprognostic (1.31e-1)" "unprognostic (1.52e-1)" "unprognostic (2.41e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-1)" "unprognostic (2.52e-1)" 60.4 97.0 86.7 19.7 88.1 42.8 59.3 85.1 110.5 77.1 88.3 77.7 27.2 63.8 43.4 105.6 62.5 24.9 65.1 87.5 85.5 97.3 143.6 68.9 25.1 87.9 86.4 69.8 64.4 35.4 145.0 24.8 87.1 91.1 17.8 27.5 70.9 28.4 62.2 88.9 70.1 28.1 83.7 109.8 68.1 96.4 87.8 25.1 87.6 22.4 21.6 74.5 77.1 90.4 14.0 23.3 28.4 46.9 65.6 31.2 16.3 17.5 48.1 24.3 29.1 20.7 11.3 7.9 12.3 28.6 23.6 20.6 10.1 19.9 12.2 12.6 21.3 11.2 26.1 27.7 49.2 7.7 41.4 51.4 36.2 30.2 35.0 66.0 28.5 16.4 16.0 14.9 28.3 21.2 11.7 22.8 8.4 11.2 72.8 13.9 13.5 4.7 34.9 29.6 6.8 30.9 14.5 42.1 25.9 24.5 28.5 15.8 29.6 26.7 16.0 12.2 18.1 37.6 21.6 5.1 29.5 11.3 14.1 2.4 2.2 1.9 3.0 1.5 1.7 1.8 1.3 1.3 1.8 1.2 0.6 1.9 4.9 1.1 2.5 3.8 1.8 1.0 86.7 88.1 85.1 110.5 87.5 85.5 87.9 86.4 87.1 83.7 87.8 90.4 17.2 3.2 11.5 49.6 7.2 12.4 7.4 15.1 11.4 32.8 20.2 17.7 1.4 20.0 12.8 20.2 68.8 13.4 27.2 21.7 1.9 13.7 5.5 14.0 19.0 17.1 20.4 11.4 34.0 14.8 8.4 13.2 24.5 22.2 0.0 18.8 29.6 35.0 19.0 35.3 30.2 18.3 14.2 24.2 15.7 2.2 22.1 17.1 16.0 21.5 19.2 19.6 15.5 26.7 36.5 17.5 19.5 24.0 8.2 17.7 41.3 11.7 15.4 45.3 13.1 21.1 18.3 35.8 15.9 14.9 14.2 28.7 13.9 19.3 12.1 17.9 NDST2 "HSST2, NST2" ENSG00000166507 "N-deacetylase and N-sulfotransferase 2" P52849 10 73801911-73811798 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 13.7;granulocytes: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 110.2" HPA051515 Approved Approved Cytosol NA NA 130000 "Cluster 32: T-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 3: HMC-1 - Innate immune response" "Cluster 59: Non-specific - Transcription" Cytosol "HPA051515: AB_2681517" "unprognostic (8.84e-2)" "unprognostic (7.57e-2)" "unprognostic (2.53e-2)" "unprognostic (9.43e-3)" "unprognostic (5.69e-1)" "unprognostic (1.07e-2)" "unprognostic (5.83e-3)" "unprognostic (2.16e-2)" "unprognostic (8.19e-2)" "unprognostic (1.61e-2)" "unprognostic (2.23e-5)" "unprognostic (1.49e-2)" "unprognostic (4.08e-7)" "unprognostic (3.71e-2)" "unprognostic (3.69e-2)" "unprognostic (5.93e-2)" "unprognostic (9.06e-2)" 14.9 16.7 11.6 19.6 11.6 53.6 13.3 15.7 14.2 15.7 10.6 13.6 10.7 15.7 11.6 16.8 15.0 15.1 11.4 11.6 11.7 14.4 10.9 17.0 24.6 12.6 11.4 15.8 14.1 18.4 15.8 12.5 11.2 15.6 12.1 14.9 17.7 14.2 8.9 18.8 17.4 15.8 10.4 35.3 13.6 13.6 12.5 31.9 13.3 8.5 23.9 15.3 15.4 11.5 10.0 7.9 16.7 26.2 20.9 23.0 9.1 12.3 24.5 13.4 13.3 4.6 12.4 9.5 7.1 21.8 13.6 11.6 8.1 11.8 9.6 23.4 8.5 9.3 7.0 7.3 36.7 11.8 110.2 22.9 14.5 21.4 22.4 41.1 17.5 17.9 9.2 33.8 16.6 8.1 12.7 13.4 4.5 6.4 36.4 8.5 8.2 5.9 11.5 7.2 5.5 9.0 9.9 23.5 7.5 11.3 18.6 18.6 29.5 6.3 7.8 9.1 8.4 17.4 8.0 11.8 7.2 17.0 5.5 0.7 2.7 1.1 2.7 1.9 3.1 1.2 2.3 2.3 2.0 1.3 2.6 3.4 2.8 1.1 1.7 3.4 1.6 1.8 11.6 11.6 15.7 14.2 11.6 11.7 12.6 11.4 11.2 10.4 12.5 11.5 1.5 0.0 3.0 13.7 5.4 1.3 0.8 0.6 1.2 0.7 4.1 2.3 1.8 0.0 1.8 0.0 0.0 1.4 3.6 4.7 0.0 5.4 7.5 0.8 1.2 1.1 2.4 7.8 7.5 9.6 1.5 1.9 4.6 0.7 14.5 0.3 1.4 4.2 5.2 1.7 7.6 2.6 2.0 8.5 3.1 10.4 0.0 10.8 1.8 2.8 5.4 0.8 0.0 5.0 5.0 7.0 3.2 0.0 10.6 1.3 2.4 7.4 2.7 0.8 0.0 1.4 1.5 2.3 1.7 4.7 1.6 6.2 5.3 0.3 2.2 1.9 CAMK2G CAMKG ENSG00000148660 "Calcium/calmodulin dependent protein kinase II gamma" Q13555 10 73812501-73874591 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Neurogenesis" "Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 154.3" "Cell type enhanced" "Detected in many" "Astrocytes: 410.7;Cytotrophoblasts: 163.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 133.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 154.8;SK-BR-3: 177.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040656, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 200000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Plasma membrane" "Cell Junctions, Cytosol" "HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (8.63e-3)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (3.46e-3)" "unprognostic (4.27e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-2)" "unprognostic (2.36e-1)" "unprognostic (2.48e-1)" "unprognostic (6.25e-2)" "unprognostic (2.92e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (2.48e-1)" "unprognostic (8.28e-2)" "unprognostic (9.64e-2)" "unprognostic (4.62e-2)" 22.0 14.0 86.1 17.0 92.6 34.5 15.2 79.9 137.8 24.1 44.1 101.1 34.2 45.2 14.5 34.7 30.6 17.8 11.8 91.3 79.0 19.3 14.5 18.8 16.2 96.1 96.5 12.7 10.3 12.3 14.1 27.3 94.1 31.1 26.1 42.4 22.9 49.6 154.3 17.3 41.5 43.9 91.4 24.9 30.4 6.5 102.5 15.7 13.6 84.8 14.9 58.4 25.8 91.9 35.7 24.6 22.5 43.9 16.7 26.1 26.3 25.8 41.0 31.9 26.1 39.8 37.2 27.4 25.7 32.4 12.4 54.9 17.5 20.5 25.3 24.0 22.2 18.2 20.4 17.8 8.1 24.7 29.1 14.4 17.7 32.5 22.1 50.4 28.3 32.5 19.5 37.9 19.0 25.2 41.7 37.5 16.5 21.3 154.8 36.5 25.3 13.7 17.2 51.5 11.5 28.4 15.0 177.4 11.9 16.5 33.2 15.0 36.7 24.9 40.0 13.4 33.3 11.9 14.9 24.8 26.5 69.2 8.8 31.0 17.9 133.9 23.1 7.9 28.5 13.9 26.3 25.0 23.0 12.7 24.5 24.1 115.8 34.0 15.1 7.9 27.7 17.5 86.1 92.6 79.9 137.8 91.3 79.0 96.1 96.5 94.1 91.4 102.5 91.9 19.3 16.0 11.7 410.7 22.2 9.4 8.7 9.2 14.2 63.3 14.8 16.3 6.7 12.8 15.5 7.3 100.1 163.6 21.3 46.2 13.7 13.3 2.0 6.3 6.4 20.2 23.9 13.3 107.9 19.6 45.2 12.0 14.8 7.5 16.5 20.2 16.4 9.6 27.2 26.9 89.7 24.8 10.2 18.9 16.3 3.1 12.8 15.8 12.4 43.1 18.3 17.7 26.8 61.9 16.9 22.0 65.5 18.8 13.6 8.2 77.1 26.9 10.4 77.0 46.0 11.2 50.8 0.8 13.5 26.5 12.6 81.1 30.3 5.2 32.1 13.7 PLAU "UPA, URK" ENSG00000122861 "Plasminogen activator, urokinase" P00749 10 73909177-73917496 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 103.8;urinary bladder: 128.5" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 635.9;Basal respiratory cells: 237.3;Pancreatic endocrine cells: 613.9;Prostatic glandular cells: 695.0;Urothelial cells: 869.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "myeloid DC: 1.1;neutrophil: 2.1;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 11 "dendritic cells: 2.0;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 856.0;LHCN-M2: 822.4;RPTEC TERT1: 3100.7;U-251 MG: 869.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070796 Supported Uncertain "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 647000 88000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus, Vesicles" "HPA070796: " "unprognostic (1.96e-2)" "unprognostic (2.99e-2)" "unprognostic (7.40e-2)" "prognostic favorable (3.38e-4)" "unprognostic (4.73e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (1.39e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (2.26e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (2.83e-1)" "unprognostic (3.37e-2)" "unprognostic (1.51e-2)" "unprognostic (1.77e-2)" 57.6 4.8 2.5 41.7 2.7 36.2 17.6 2.7 8.9 9.3 4.4 13.1 11.9 22.0 16.7 14.4 10.3 28.5 23.1 2.4 2.9 103.8 5.0 22.0 14.3 3.8 2.9 2.3 10.1 8.3 2.9 36.5 5.4 9.1 18.2 0.3 17.3 13.7 10.8 25.5 13.7 23.4 3.3 40.6 15.7 3.7 4.7 5.9 17.9 18.9 7.2 128.5 16.2 4.7 171.1 88.9 36.8 1.7 3.1 59.5 2.0 101.9 461.6 40.0 62.2 2.3 856.0 0.1 184.0 14.5 416.9 114.1 0.9 165.8 44.8 9.9 0.0 0.1 4.4 1.7 72.6 15.6 32.3 158.7 20.2 271.4 103.7 447.0 114.7 1.0 1.1 0.9 822.4 0.2 0.2 22.7 10.8 0.3 244.5 0.4 112.6 0.9 3100.7 130.6 0.1 0.2 0.3 4.0 2.4 25.4 1.2 22.9 300.6 3.5 20.3 21.6 869.8 0.2 1.3 1.6 216.0 25.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.1 0.0 0.0 2.0 0.0 0.1 2.5 2.7 2.7 8.9 2.4 2.9 3.8 2.9 5.4 3.3 4.7 4.7 29.0 3.2 4.6 0.3 1.4 37.3 635.9 237.3 19.9 0.0 3.0 24.4 2.5 0.0 103.6 29.5 0.0 28.0 1.6 0.6 68.4 62.7 0.5 50.7 22.2 46.4 3.5 0.0 0.2 21.3 21.7 69.7 0.0 68.9 31.1 0.1 3.9 0.0 39.8 0.0 0.3 0.1 140.4 4.0 33.1 1.3 2.5 53.4 7.2 4.7 23.8 0.0 0.0 0.5 0.2 613.9 0.3 0.0 0.5 695.0 0.0 1.4 35.4 0.0 6.6 27.6 65.2 0.0 0.2 60.6 29.5 17.5 4.7 0.6 1.7 869.6 VCL ENSG00000035403 Vinculin P18206 10 73995193-74121363 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" Actin-binding "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 339.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 568.3;hTERT-RPE1: 547.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002131, CAB002453, HPA063777" Enhanced Enhanced "Focal adhesion sites" NA NA 750000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 44: Endometrium - Transcription" "Focal adhesion sites" "CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121" "unprognostic (8.49e-2)" "unprognostic (1.61e-2)" "unprognostic (3.14e-1)" "unprognostic (6.31e-2)" "unprognostic (3.34e-1)" "unprognostic (9.62e-3)" "unprognostic (2.72e-3)" "unprognostic (2.67e-3)" "unprognostic (3.42e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.29e-1)" "unprognostic (3.68e-2)" "unprognostic (4.03e-2)" "unprognostic (4.02e-2)" "unprognostic (1.89e-1)" "unprognostic (1.37e-3)" 85.8 19.1 9.9 52.2 10.6 41.5 45.3 8.4 11.3 73.9 33.4 180.3 35.3 167.6 45.9 92.2 75.9 69.4 132.2 10.5 11.3 37.2 24.1 68.7 18.7 10.3 10.3 45.2 40.3 51.3 13.8 88.6 13.3 131.7 73.1 12.5 31.6 151.9 136.9 37.9 52.7 224.7 9.9 41.9 63.5 41.3 12.1 12.8 39.6 144.1 23.9 135.7 56.3 8.4 147.2 97.0 174.2 123.8 213.2 246.2 95.8 188.5 568.3 126.3 141.9 88.4 124.0 6.5 153.1 331.6 86.3 183.3 115.7 95.0 132.5 12.3 49.6 69.4 92.2 37.2 116.5 14.1 101.8 205.0 25.0 171.5 154.8 547.4 171.0 11.6 50.7 14.3 213.1 25.2 2.0 16.6 82.8 69.9 342.4 24.0 90.9 18.6 180.4 185.8 6.5 25.8 104.7 117.2 53.9 152.8 54.5 21.2 230.9 136.9 57.0 67.0 179.4 2.6 6.0 28.4 160.0 38.9 39.7 15.0 13.6 36.2 14.9 17.1 10.4 5.6 7.1 7.8 20.7 2.3 2.6 5.3 11.2 4.4 19.0 8.0 1.9 28.3 9.9 10.6 8.4 11.3 10.5 11.3 10.3 10.3 13.3 9.9 12.1 8.4 68.0 99.3 39.7 56.5 13.4 114.7 161.4 68.4 30.7 13.4 39.4 58.5 339.5 37.1 79.8 42.3 85.5 51.5 46.7 91.2 3.9 60.8 5.0 98.2 152.6 60.4 38.3 5.9 63.2 61.6 78.6 74.4 66.3 149.1 35.4 45.5 56.7 34.4 23.6 16.8 47.5 44.5 22.4 31.9 51.0 7.5 50.1 77.9 26.6 55.3 44.7 9.7 61.8 18.6 4.6 125.5 48.3 76.8 8.0 100.1 13.7 14.8 37.7 34.5 105.2 49.6 179.9 18.6 13.7 45.6 93.1 39.7 18.3 44.5 48.7 94.8 AP3M1 ENSG00000185009 "Adaptor related protein complex 3 subunit mu 1" Q9Y2T2 10 74120255-74150842 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 266.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045591, HPA048380" Uncertain NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 10: Non-specific - Unknown function" "HPA045591: AB_2679377, HPA048380: AB_2680379" "unprognostic (1.83e-3)" "unprognostic (1.26e-1)" "unprognostic (6.69e-2)" "unprognostic (7.52e-2)" "unprognostic (3.40e-2)" "unprognostic (1.61e-1)" "unprognostic (4.92e-3)" "unprognostic (1.04e-1)" "unprognostic (1.07e-1)" "unprognostic (2.10e-1)" "unprognostic (2.24e-1)" "unprognostic (6.99e-2)" "unprognostic (9.64e-2)" "unprognostic (1.55e-1)" "unprognostic (1.68e-1)" "unprognostic (3.84e-1)" "unprognostic (3.43e-2)" 24.6 23.3 9.8 22.6 11.2 16.3 22.5 13.2 13.6 21.3 11.9 21.8 20.7 23.2 16.5 25.6 20.0 18.0 21.5 9.9 13.6 19.7 27.1 19.2 25.6 12.8 15.1 20.0 24.1 36.0 9.0 32.4 13.6 26.1 27.5 17.6 19.0 22.7 14.3 17.3 19.1 29.0 12.3 21.8 20.4 17.6 11.2 30.5 24.5 20.6 32.8 25.7 14.5 14.5 51.8 52.3 64.8 74.3 41.9 56.3 44.1 50.9 65.1 61.1 67.8 60.1 45.9 52.2 34.0 49.2 35.2 55.0 76.7 48.3 74.6 51.8 55.4 43.6 39.4 35.8 34.9 72.9 43.5 40.0 27.5 52.7 43.6 66.9 81.8 43.5 84.9 63.2 55.2 28.2 70.0 34.0 28.2 56.6 266.0 61.9 52.4 41.7 46.1 40.4 30.5 47.5 40.2 102.5 57.3 52.5 97.6 41.3 60.5 31.0 44.5 40.1 60.4 33.3 62.2 75.0 51.1 80.7 31.3 38.1 22.5 16.9 20.5 24.4 23.6 19.9 18.1 21.5 24.5 18.6 18.9 20.1 13.8 23.5 29.3 15.6 19.3 23.2 9.8 11.2 13.2 13.6 9.9 13.6 12.8 15.1 13.6 12.3 11.2 14.5 11.5 28.9 12.1 8.8 19.7 11.0 13.3 10.6 18.8 8.2 17.8 12.2 8.6 11.5 17.3 11.0 33.3 38.3 27.8 15.4 7.9 14.1 2.0 16.8 15.1 15.9 12.0 12.4 16.7 15.7 16.8 15.3 18.3 23.6 12.7 20.9 14.3 19.5 21.1 21.9 15.2 17.6 8.2 19.8 8.2 2.0 17.4 17.4 10.6 8.4 23.1 17.3 17.5 18.6 13.7 15.8 10.2 13.9 18.6 13.6 12.3 10.6 5.8 14.5 19.7 12.7 19.4 19.9 14.7 23.6 13.5 34.2 19.2 20.1 15.4 12.9 ADK AK ENSG00000156110 "Adenosine kinase" P55263 10 74151202-74709963 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Purine salvage" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 151.2" "Cell type enhanced" "Detected in all" "Excitatory neurons: 245.3;Inhibitory neurons: 287.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032876, HPA038391, HPA038409, HPA075222" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 920000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: " "unprognostic (1.55e-3)" "unprognostic (1.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.62e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.93e-4)" "prognostic favorable (9.91e-4)" "unprognostic (2.64e-1)" "unprognostic (2.88e-1)" "unprognostic (1.55e-1)" "unprognostic (8.15e-3)" "unprognostic (2.51e-1)" "unprognostic (1.89e-3)" "unprognostic (2.03e-1)" "unprognostic (2.88e-2)" "unprognostic (4.97e-3)" "unprognostic (2.95e-2)" 23.9 15.5 13.0 16.9 18.7 28.6 27.4 13.5 17.7 17.5 11.6 17.9 16.9 10.8 16.5 47.3 16.5 11.4 27.2 13.9 15.2 35.8 151.2 24.4 22.8 14.0 15.0 8.3 18.8 44.2 14.9 26.6 16.5 14.9 19.5 16.1 20.0 16.0 41.5 33.9 12.4 14.8 14.2 15.0 12.1 15.5 14.1 27.0 38.2 47.1 34.5 24.5 24.7 15.8 177.3 37.4 37.2 50.5 37.1 54.7 88.2 140.8 105.4 103.8 114.5 114.0 172.6 86.3 34.2 57.7 51.3 151.1 44.1 150.1 167.0 59.1 51.3 55.6 59.8 122.8 41.7 87.6 22.5 51.1 95.5 77.4 191.7 79.0 91.2 38.7 41.8 28.4 78.8 101.7 102.5 129.0 9.9 80.0 276.3 100.6 63.7 69.4 117.1 92.7 29.5 33.8 63.6 239.7 49.5 34.7 159.7 69.3 82.8 34.3 67.0 93.2 123.0 40.5 48.3 98.1 65.0 127.6 22.1 2.3 34.2 4.1 12.9 65.5 29.9 103.7 28.2 24.1 83.1 155.0 21.3 19.2 11.1 20.7 80.4 57.6 55.7 36.3 13.0 18.7 13.5 17.7 13.9 15.2 14.0 15.0 16.5 14.2 14.1 15.8 9.8 83.3 75.8 136.5 84.2 94.2 73.5 102.0 105.9 16.3 26.2 26.0 67.8 38.6 72.4 31.3 56.3 136.7 25.9 11.0 92.0 83.2 80.7 40.6 18.8 14.9 10.8 27.7 245.3 67.5 139.5 27.0 23.0 55.6 21.5 9.7 17.2 130.1 39.3 11.8 287.7 12.1 44.7 25.2 50.0 26.9 16.8 33.7 48.0 198.6 44.1 14.1 11.3 140.8 165.4 62.7 10.4 12.0 39.1 92.1 5.0 64.5 33.5 25.0 6.6 20.4 26.0 17.4 14.3 96.7 97.0 107.3 32.7 17.0 20.5 66.3 KAT6B "Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B" ENSG00000156650 "Lysine acetyltransferase 6B" Q8WYB5 10 74824927-75032624 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006104 Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies" "HPA006104: AB_1079445" "unprognostic (4.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.82e-1)" "unprognostic (2.32e-2)" "unprognostic (7.83e-2)" "unprognostic (2.85e-2)" "unprognostic (3.56e-1)" "unprognostic (2.62e-1)" "unprognostic (2.54e-1)" "unprognostic (1.09e-1)" "unprognostic (9.47e-2)" "unprognostic (8.78e-2)" "prognostic favorable (4.82e-4)" "unprognostic (2.52e-1)" "unprognostic (3.70e-1)" "unprognostic (2.59e-2)" "unprognostic (3.15e-1)" 7.6 6.3 5.0 3.1 5.6 8.8 7.3 5.6 5.3 10.5 2.0 9.6 3.2 9.2 5.2 6.9 8.3 3.8 7.5 5.7 4.0 4.3 4.6 6.5 4.4 3.1 3.5 12.2 8.6 10.5 7.4 4.4 3.0 6.5 4.1 6.4 7.3 4.3 11.8 8.0 8.1 6.0 3.0 5.4 9.3 7.8 5.6 9.8 7.3 6.0 4.1 9.1 8.9 4.9 4.7 4.4 8.0 6.9 6.2 9.2 4.1 4.1 7.5 3.4 3.6 3.4 5.3 9.8 2.1 7.1 3.5 3.8 4.2 3.3 5.6 4.2 6.8 3.6 3.9 4.5 4.5 8.6 2.4 5.9 5.3 4.5 6.9 10.5 3.8 7.7 3.9 9.0 4.2 4.7 8.2 4.3 5.0 4.9 25.7 12.7 4.3 2.4 2.3 2.3 4.2 6.9 4.1 7.4 3.7 2.8 4.5 3.2 4.7 4.6 5.5 3.1 3.8 6.4 8.1 6.4 5.0 8.9 1.3 1.7 1.3 1.6 2.3 1.0 2.6 2.2 1.9 2.1 1.1 2.8 2.9 2.6 1.8 4.4 1.1 1.7 1.7 1.0 5.0 5.6 5.6 5.3 5.7 4.0 3.1 3.5 3.0 3.0 5.6 4.9 34.5 44.8 53.7 90.1 48.1 19.9 20.8 16.3 74.6 52.8 36.7 27.3 53.9 12.8 29.3 9.2 68.8 10.4 51.8 22.5 9.8 12.7 6.2 41.1 72.7 24.9 23.8 32.0 130.2 18.0 10.6 44.4 57.6 50.8 41.7 68.0 18.9 16.0 11.0 43.7 131.2 21.7 12.2 12.3 15.0 8.3 42.3 24.1 14.2 41.2 13.6 45.5 42.2 101.0 92.1 10.5 19.4 40.3 62.5 21.0 17.8 10.2 28.6 52.5 26.3 55.3 44.1 33.1 32.2 46.6 17.5 22.7 59.7 27.1 17.5 23.5 DUSP29 "DUPD1, DUSP27" ENSG00000188716 "Dual specificity phosphatase 29" Q68J44 10 75037836-75058514 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 71.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042964 Uncertain NA NA "Cluster 33: Striated muscle - Muscle contraction" "HPA042964: AB_10795764" "unprognostic (1.05e-2)" "unprognostic (1.77e-1)" "unprognostic (2.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.9 0.0 71.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUSP13 "BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP" ENSG00000079393 "Dual specificity phosphatase 13" "Q6B8I1, Q9UII6" 10 75094432-75109221 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 247.2;testis: 53.7;tongue: 122.5" "Cell type enriched" "Detected in some" 4 "Early spermatids: 428.1" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.0" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 10 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "BEWO: 4.3;EFO-21: 5.0;Hep G2: 11.0;K-562: 4.3;LHCN-M2: 9.5;RH-30: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.79e-1)" "unprognostic (2.39e-2)" "unprognostic (2.39e-1)" "unprognostic (7.07e-2)" "unprognostic (1.66e-3)" "unprognostic (2.47e-3)" "unprognostic (8.63e-2)" "unprognostic (1.97e-1)" "unprognostic (2.63e-2)" "unprognostic (1.27e-1)" "unprognostic (3.92e-1)" "unprognostic (2.22e-7)" "unprognostic (1.93e-2)" "unprognostic (1.54e-1)" "unprognostic (4.81e-1)" "unprognostic (2.09e-2)" 0.1 0.0 0.1 0.0 0.1 5.8 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.3 3.7 0.1 0.0 17.3 0.1 0.5 0.1 0.1 0.3 0.0 0.2 0.7 0.0 0.0 0.2 0.1 0.0 1.3 1.0 0.0 0.0 3.5 0.0 247.2 0.5 0.0 0.0 0.1 0.5 0.0 53.7 0.1 0.2 0.1 122.5 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 11.0 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 4.3 0.0 9.5 0.5 0.0 0.0 0.6 0.1 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.5 0.2 0.7 1.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.3 1.1 3.4 0.0 0.0 0.1 12.2 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 428.1 0.0 0.0 0.6 0.0 0.0 0.1 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 94.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.1 0.1 0.0 0.0 0.2 0.0 0.0 21.7 0.6 10.4 3.3 6.3 2.0 3.0 0.1 0.0 0.0 0.2 SAMD8 "FLJ25082, SMSr" ENSG00000156671 "Sterile alpha motif domain containing 8" Q96LT4 10 75099586-75182123 "Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 19.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044402 Supported "Endoplasmic reticulum" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA044402: " "unprognostic (4.32e-1)" "unprognostic (3.14e-1)" "unprognostic (3.24e-2)" "unprognostic (7.87e-2)" "unprognostic (3.37e-2)" "unprognostic (2.77e-2)" "unprognostic (1.61e-2)" "unprognostic (1.39e-1)" "unprognostic (5.29e-1)" "unprognostic (3.12e-2)" "unprognostic (2.70e-1)" "unprognostic (4.69e-2)" "unprognostic (4.16e-3)" "unprognostic (3.89e-2)" "unprognostic (3.76e-1)" "unprognostic (2.53e-1)" "unprognostic (9.26e-3)" 14.0 10.8 17.1 7.2 22.8 17.0 10.4 20.8 18.7 14.8 10.3 7.2 6.1 11.1 7.2 15.6 10.7 9.2 11.3 17.1 17.8 7.3 7.5 10.1 6.9 23.4 24.9 13.6 5.1 9.6 9.2 11.5 22.5 8.1 4.9 22.6 7.7 8.0 27.1 7.1 6.8 10.1 23.6 7.9 5.6 15.2 21.0 6.3 7.8 14.7 6.1 9.5 12.9 29.7 8.7 7.8 12.7 10.0 28.1 25.8 15.1 14.8 29.9 9.1 11.7 12.8 12.4 5.9 9.4 14.3 10.5 15.3 6.8 11.3 15.9 7.2 8.3 2.6 8.0 8.6 15.6 2.7 6.8 24.4 11.2 18.0 24.8 24.6 14.1 6.7 5.6 10.4 21.0 6.1 5.1 4.1 5.7 6.4 23.9 4.4 10.6 2.8 10.3 7.8 1.8 8.7 13.9 17.8 15.1 13.6 7.4 3.1 22.6 10.5 13.7 12.6 10.4 6.9 6.9 6.0 16.4 7.0 6.7 3.1 3.7 2.5 2.9 4.8 1.8 5.5 3.2 3.4 3.4 5.9 2.7 3.1 19.2 4.0 6.6 3.8 3.0 1.3 17.1 22.8 20.8 18.7 17.1 17.8 23.4 24.9 22.5 23.6 21.0 29.7 24.6 9.6 12.5 25.1 25.0 42.3 28.1 34.2 23.9 20.9 21.4 11.3 26.7 10.0 26.5 14.7 14.6 10.4 18.1 10.0 0.0 10.9 47.6 17.3 29.8 24.3 23.4 4.4 50.9 10.2 12.5 29.4 10.2 23.1 12.7 18.5 23.2 10.9 13.2 18.5 37.2 3.3 26.4 16.3 48.4 10.9 25.1 27.8 12.4 35.6 27.8 20.5 12.3 38.2 77.1 16.3 11.4 25.2 22.2 22.3 11.8 7.7 35.4 32.7 32.9 30.9 23.9 54.7 24.3 42.9 42.9 68.0 20.2 12.4 5.2 40.3 VDAC2 ENSG00000165637 "Voltage dependent anion channel 2" P45880 10 75210154-75231448 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043475 Enhanced Supported Mitochondria NA NA 490000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" Mitochondria "HPA043475: AB_10795615" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (9.47e-2)" "unprognostic (9.00e-3)" "unprognostic (5.74e-2)" "prognostic unfavorable (4.51e-4)" "prognostic unfavorable (4.55e-4)" "unprognostic (1.83e-3)" "unprognostic (5.89e-2)" "unprognostic (2.45e-1)" "unprognostic (2.02e-2)" "unprognostic (1.56e-2)" "unprognostic (4.27e-2)" "unprognostic (1.40e-1)" "unprognostic (1.65e-1)" "unprognostic (6.28e-2)" "unprognostic (1.34e-2)" 138.2 150.3 95.5 93.3 97.4 138.5 116.2 116.2 115.0 165.5 117.1 209.1 151.3 116.6 90.7 322.1 117.4 85.4 420.5 99.0 109.0 177.5 115.9 112.0 83.5 105.7 107.1 132.8 150.6 192.7 85.3 115.6 110.1 108.8 184.4 198.4 151.4 134.0 539.4 171.6 148.4 149.2 105.0 77.7 159.4 104.6 107.1 92.7 111.0 565.9 148.3 163.6 207.1 110.4 304.4 245.0 291.0 370.5 253.3 342.1 305.2 384.9 430.4 412.7 386.6 367.5 281.8 358.6 210.9 324.3 228.6 398.2 539.2 382.2 402.1 196.0 313.5 209.4 191.4 425.2 252.6 402.0 223.4 305.6 441.7 352.8 747.3 578.2 310.0 222.9 359.9 283.7 439.4 222.6 262.6 325.7 250.7 341.2 937.6 308.2 230.0 228.3 408.9 187.5 183.4 216.5 212.4 701.7 467.4 337.8 409.7 177.4 241.4 204.4 279.8 305.7 419.8 226.7 333.1 369.0 296.3 390.4 178.1 168.2 179.0 138.9 106.7 193.1 130.8 154.2 144.3 119.4 220.4 127.9 144.2 134.5 61.5 135.5 238.4 107.3 178.6 221.6 95.5 97.4 116.2 115.0 99.0 109.0 105.7 107.1 110.1 105.0 107.1 110.4 130.3 96.1 54.9 30.3 135.5 381.4 417.8 575.6 280.6 149.6 149.5 159.1 325.1 128.7 246.3 112.2 43.8 315.0 128.0 583.7 669.1 413.3 257.6 172.2 110.9 146.5 149.7 148.5 22.1 345.7 437.6 142.6 158.0 199.9 112.3 197.5 165.9 79.2 266.1 129.5 30.7 305.1 284.8 164.8 220.3 110.8 169.9 180.2 224.1 16.9 264.3 275.5 92.7 23.1 26.0 443.5 497.2 166.3 172.2 386.3 610.9 324.3 119.5 161.1 177.5 170.3 289.0 359.7 149.7 493.3 420.4 396.5 129.6 210.5 355.7 568.1 COMTD1 FLJ23841 ENSG00000165644 "Catechol-O-methyltransferase domain containing 1" Q86VU5 10 75233641-75236030 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 128.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 334.8;Exocrine glandular cells: 249.5;Paneth cells: 272.5;Proximal enterocytes: 435.9;Squamous epithelial cells: 285.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.2;PC-3: 38.3;RPMI-8226: 24.5;U-266/70: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042165 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "Plasma membrane, Cytosol" "HPA042165: AB_10794042" "unprognostic (2.53e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (9.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.23e-2)" "unprognostic (8.08e-3)" "unprognostic (9.35e-2)" "unprognostic (6.74e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.12e-1)" "unprognostic (2.35e-1)" 11.0 17.9 1.1 1.0 1.5 1.5 9.8 1.2 1.8 18.3 5.8 23.3 7.4 7.5 0.4 70.6 7.2 0.4 33.5 1.3 1.7 29.1 37.5 11.7 0.6 1.7 2.0 8.0 128.6 3.4 17.1 0.9 1.7 11.8 1.0 1.1 23.9 1.0 28.2 25.3 25.2 0.5 1.1 12.4 27.8 3.4 1.6 0.5 18.5 0.7 0.7 8.3 29.0 0.9 6.9 2.2 0.5 1.3 0.1 0.7 19.0 2.1 1.0 0.3 0.6 1.6 6.0 20.0 3.5 0.4 1.1 9.0 0.9 1.9 0.1 3.2 30.2 0.8 4.8 3.3 1.1 3.5 3.3 0.6 3.2 0.1 2.9 1.3 0.3 3.6 7.8 4.7 0.1 6.2 5.3 11.0 1.2 5.1 38.3 10.6 1.3 24.5 1.8 0.6 8.4 2.3 2.4 16.0 4.8 0.5 8.9 0.5 1.4 0.6 5.9 1.2 2.1 21.5 4.5 9.8 0.7 3.4 0.6 0.0 7.1 3.9 10.6 10.0 11.6 7.1 10.6 11.0 8.5 5.6 3.5 6.1 1.4 7.3 9.4 15.3 8.9 6.8 1.1 1.5 1.2 1.8 1.3 1.7 1.7 2.0 1.7 1.1 1.6 0.9 23.6 19.2 11.5 1.6 18.2 29.4 40.5 54.1 133.1 6.0 29.3 37.1 31.1 57.2 33.8 53.3 10.4 33.4 30.8 334.8 144.8 162.8 1.6 10.5 7.7 13.5 40.2 16.0 3.4 249.5 79.1 13.4 148.8 33.4 12.7 10.3 25.4 84.0 35.1 1.7 3.9 206.0 42.7 24.2 21.3 3.5 9.6 21.8 37.4 6.5 31.8 10.7 24.7 1.5 0.5 109.2 272.5 7.2 50.8 38.7 435.9 140.3 11.3 34.5 32.9 6.2 25.6 2.6 3.4 285.3 38.2 30.4 29.2 10.7 143.8 56.7 ZNF503 "FLJ45745, MGC2555, Nlz2" ENSG00000165655 "Zinc finger protein 503" Q96F45 10 75397830-75401764 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 255.0;Squamous epithelial cells: 189.3" "Cancer enhanced" "Detected in all" "ovarian cancer: 62.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 115.1;PC-3: 149.2;U-87 MG: 44.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026848 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 61: Squamous epithelial cells - Keratinization" "Plasma membrane, Cytosol" Nucleoplasm "HPA026848: AB_10610704" "unprognostic (1.18e-1)" "unprognostic (8.56e-2)" "unprognostic (8.63e-3)" "unprognostic (7.41e-2)" "unprognostic (2.82e-1)" "unprognostic (3.57e-2)" "unprognostic (9.63e-2)" "unprognostic (7.42e-2)" "unprognostic (3.42e-2)" "unprognostic (3.22e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (3.50e-4)" "prognostic favorable (1.97e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" 14.5 39.9 6.1 3.1 10.1 2.0 9.2 3.8 5.2 34.5 1.0 17.7 8.1 44.1 10.3 20.1 23.8 2.4 9.0 7.4 5.5 25.6 7.1 14.2 1.5 12.0 9.2 46.3 25.4 4.6 4.8 3.3 7.6 17.5 1.8 1.4 9.5 17.6 3.6 5.3 8.5 7.7 10.0 8.0 16.3 2.4 8.1 1.1 7.8 2.1 1.0 13.8 18.2 6.5 5.2 4.9 1.1 6.3 10.6 7.1 1.6 4.6 2.8 1.9 1.7 7.5 20.4 0.0 13.4 4.6 1.1 9.4 0.7 4.9 1.4 0.0 115.1 0.0 12.4 24.8 8.5 6.1 12.9 19.1 4.8 3.5 2.0 16.6 0.5 0.5 0.1 0.2 2.6 2.7 0.2 18.8 0.1 3.8 149.2 0.0 5.6 0.1 2.8 4.1 4.1 5.2 8.5 0.6 27.1 1.0 1.0 4.2 3.9 14.6 16.3 30.7 13.0 0.0 0.0 0.0 44.9 27.2 11.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 10.1 3.8 5.2 7.4 5.5 12.0 9.2 7.6 10.0 8.1 6.5 27.2 38.5 11.6 2.3 1.7 27.1 35.6 15.0 255.0 23.7 7.7 42.3 20.4 10.0 10.1 40.5 20.9 0.5 2.1 0.8 58.7 45.9 0.1 53.2 72.2 41.0 3.6 5.3 12.6 34.7 0.3 60.1 18.3 48.1 6.3 2.7 44.6 10.3 13.5 6.7 3.2 6.7 10.2 27.4 30.5 2.0 59.7 30.7 24.9 13.1 8.2 7.7 0.0 4.0 0.7 33.2 1.5 49.2 3.9 19.7 13.4 32.5 1.7 26.3 39.5 10.2 78.1 0.2 6.0 189.3 13.9 0.3 4.0 24.5 9.7 14.3 LRMDA "C10orf11, CDA017, OCA7" ENSG00000148655 "Leucine rich melanocyte differentiation associated" Q9H2I8 10 75431624-76560168 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation Albinism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 61.5;epididymis: 59.5" "Cell type enhanced" "Detected in many" "Adipocytes: 42.4;Distal tubular cells: 33.2;Endometrial ciliated cells: 27.8;Hofbauer cells: 56.9;Proximal tubular cells: 113.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 57.6;eosinophil: 22.1;intermediate monocyte: 28.8;myeloid DC: 67.5;non-classical monocyte: 17.1" "Group enriched" "Detected in many" 7 "dendritic cells: 67.5;granulocytes: 22.1;monocytes: 57.6" "Cell line enhanced" "Detected in many" "Hep G2: 46.3;HMC-1: 34.0;NB-4: 65.6;SK-MEL-30: 93.0;THP-1: 48.7;U-937: 43.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047446, HPA050419" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA047446: AB_2680050, HPA050419: AB_2756316" "unprognostic (1.04e-1)" "unprognostic (8.03e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (8.57e-3)" "unprognostic (5.86e-2)" "unprognostic (6.80e-2)" "unprognostic (8.34e-2)" "unprognostic (1.26e-1)" "unprognostic (7.34e-3)" "unprognostic (7.26e-2)" "unprognostic (6.50e-2)" "unprognostic (4.98e-3)" "unprognostic (3.64e-2)" 16.1 61.5 8.0 5.4 8.6 27.5 10.3 7.7 7.7 12.0 4.7 8.1 5.8 6.4 59.5 7.5 9.7 10.2 13.3 7.8 8.4 20.6 35.8 12.8 5.2 11.5 9.6 13.0 24.9 20.6 10.1 12.7 11.8 10.7 7.2 2.4 9.2 10.0 2.7 3.1 4.5 9.0 10.2 10.5 16.8 3.7 10.9 4.1 18.6 4.8 5.1 11.4 4.5 11.5 0.3 5.7 0.2 0.1 2.9 3.5 0.1 0.7 0.0 0.3 0.5 7.6 13.4 0.0 25.8 0.0 0.1 0.3 0.0 0.0 0.1 0.5 1.6 1.6 2.9 46.3 1.1 9.4 34.0 1.4 1.0 0.6 0.1 5.5 0.8 0.1 0.0 1.4 0.1 1.0 0.1 65.6 0.3 3.9 2.2 0.1 0.2 0.1 0.6 8.3 0.3 0.4 8.1 0.0 93.0 0.2 0.5 48.7 0.9 0.3 3.1 2.4 5.3 0.4 0.2 0.2 22.6 43.6 11.3 6.4 57.6 22.1 0.1 28.8 0.3 0.1 0.0 0.0 67.5 0.1 0.1 0.1 3.2 7.1 17.1 0.5 0.2 18.9 8.0 8.6 7.7 7.7 7.8 8.4 11.5 9.6 11.8 10.2 10.9 11.5 42.4 22.4 19.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.1 5.7 0.0 0.0 3.7 12.9 0.0 1.1 0.8 0.0 33.2 16.6 0.0 27.8 2.5 13.2 0.0 0.0 0.0 15.8 0.8 4.5 0.0 10.0 7.6 16.1 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 6.7 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.1 0.0 0.0 113.4 6.6 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 1.2 0.6 25.7 0.0 0.0 KCNMA1 "KCa1.1, mSLO1, SLO" ENSG00000156113 "Potassium calcium-activated channel subfamily M alpha 1" Q12791 10 76869601-77638369 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 138.7" "Cell type enhanced" "Detected in many" "Astrocytes: 471.1;Bipolar cells: 409.8;Excitatory neurons: 1023.7;Inhibitory neurons: 635.9;Oligodendrocyte precursor cells: 708.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.4;non-classical monocyte: 1.7" "Lineage enhanced" "Detected in single" "monocytes: 2.4" "Cell line enhanced" "Detected in many" "BJ: 100.8;hTERT-HME1: 115.3;PC-3: 159.6;U-138 MG: 112.6;U-87 MG: 109.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054648 Approved NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA054648: AB_2682556" "unprognostic (1.25e-1)" "unprognostic (2.23e-2)" "unprognostic (1.86e-2)" "unprognostic (5.29e-2)" "unprognostic (9.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.77e-1)" "unprognostic (2.81e-2)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (4.12e-3)" "unprognostic (1.20e-1)" "unprognostic (2.26e-2)" "unprognostic (1.42e-2)" "unprognostic (5.19e-2)" "unprognostic (1.42e-2)" "unprognostic (3.99e-3)" 10.9 12.6 36.2 8.9 38.0 1.0 15.8 1.0 45.0 54.4 4.2 118.2 7.3 138.7 31.4 33.7 47.8 22.4 3.7 36.4 10.1 11.4 19.2 9.6 7.8 4.8 15.2 13.9 8.0 0.2 26.9 4.8 5.7 48.3 21.1 40.2 42.8 76.1 96.6 5.0 23.3 92.8 1.0 24.1 33.6 5.8 15.6 2.1 3.0 18.7 3.5 44.3 24.6 28.4 0.3 30.3 0.1 0.3 4.6 24.8 0.3 100.8 89.2 23.9 11.8 6.7 0.6 0.0 0.7 75.9 56.8 0.2 0.0 59.0 14.6 60.9 0.6 0.0 0.0 0.0 45.0 0.0 0.4 17.4 10.7 38.3 115.3 84.0 9.8 0.5 0.0 0.0 42.6 1.2 1.9 0.2 1.8 0.2 159.6 0.1 3.6 0.1 15.3 0.2 9.1 1.1 0.0 2.5 0.1 11.9 12.2 0.1 65.4 112.6 12.7 20.6 90.0 0.0 0.2 0.0 109.8 0.1 45.1 0.0 0.1 0.0 0.0 2.4 0.0 0.7 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.1 36.2 38.0 1.0 45.0 36.4 10.1 4.8 15.2 5.7 1.0 15.6 28.4 0.9 0.0 4.3 471.1 2.8 2.0 71.7 5.7 17.6 409.8 30.4 43.9 3.5 5.7 4.8 1.8 60.5 0.3 0.5 2.8 29.4 3.3 74.4 20.9 17.9 3.4 4.9 0.0 1023.7 10.7 0.2 16.2 0.5 29.7 0.0 1.9 2.5 27.3 10.8 6.7 635.9 59.6 46.8 106.0 3.9 63.1 3.7 36.7 48.0 133.0 4.0 52.3 0.0 708.2 33.9 8.7 1.4 1.2 8.7 64.0 1.4 0.9 0.1 17.2 6.6 20.6 19.2 3.4 2.5 7.7 0.3 0.3 0.7 177.2 1.7 2.4 DLG5 "KIAA0583, P-dlg" ENSG00000151208 "Discs large MAGUK scaffold protein 5" Q8TDM6 10 77790791-77926755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 112.5;Glandular and luminal cells: 139.6;Horizontal cells: 186.7;Syncytiotrophoblasts: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "PC-3: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001746 Supported "Cell Junctions" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 44: Endometrium - Transcription" "Cell Junctions" "HPA001746: AB_2666418" "unprognostic (1.36e-1)" "unprognostic (2.30e-1)" "unprognostic (1.07e-1)" "unprognostic (6.48e-2)" "unprognostic (1.13e-1)" "unprognostic (2.94e-2)" "prognostic unfavorable (5.38e-4)" "unprognostic (8.48e-2)" "unprognostic (6.41e-2)" "unprognostic (1.68e-2)" "unprognostic (2.02e-2)" "unprognostic (2.60e-1)" "unprognostic (8.00e-2)" "unprognostic (3.06e-1)" "unprognostic (5.13e-1)" "unprognostic (6.00e-2)" "unprognostic (2.74e-2)" 11.9 51.8 8.3 0.5 8.1 0.2 19.4 7.7 8.5 24.4 9.4 28.6 0.3 25.1 16.3 19.7 17.7 1.1 7.4 8.1 8.6 8.8 4.6 8.6 0.4 17.2 9.6 19.5 11.1 6.1 33.9 2.4 10.2 31.2 1.7 4.2 16.8 2.9 26.3 36.3 12.5 2.2 10.1 4.1 16.4 6.2 8.6 1.2 22.3 0.9 1.4 20.3 22.2 10.3 5.7 0.1 4.5 4.9 6.8 2.9 2.9 6.3 3.7 1.1 1.1 0.0 3.8 0.0 6.0 3.2 1.9 6.0 2.3 3.4 4.2 2.0 7.5 1.1 0.0 7.0 6.5 0.4 1.5 3.3 8.1 0.2 9.8 8.2 0.4 0.1 3.0 0.0 3.4 2.0 0.6 1.8 4.3 7.0 20.0 4.1 1.4 0.3 4.8 0.0 1.5 4.2 2.7 5.7 2.2 6.1 2.3 1.1 1.9 1.2 9.2 1.2 5.7 0.0 0.7 0.5 1.2 1.2 0.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.3 8.1 7.7 8.5 8.1 8.6 17.2 9.6 10.2 10.1 8.6 10.3 5.2 6.4 5.4 21.2 0.5 29.6 24.2 20.2 12.0 18.3 41.9 28.3 2.8 12.8 13.6 20.2 16.7 112.5 12.1 12.2 0.0 6.7 16.4 55.6 41.7 4.9 2.4 0.0 24.0 5.9 23.6 12.5 8.2 139.6 1.3 49.4 3.3 3.3 13.1 186.7 28.3 10.4 8.2 0.0 3.9 10.2 18.6 1.8 8.8 10.3 0.8 46.4 9.2 19.1 13.6 12.4 7.6 18.4 6.8 25.4 15.2 2.1 34.6 15.3 26.3 24.2 15.1 1.6 7.6 10.8 24.2 171.6 5.5 10.4 10.1 23.5 POLR3A "C160, hRPC155, RPC1, RPC155" ENSG00000148606 "RNA polymerase III subunit A" O14802 10 77969251-78029515 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Nucleotidyltransferase, Transferase" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 75.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037926 Uncertain Supported Nucleoplasm NA NA "Cluster 42: Non-specific - Transcription" "Cluster 58: Brain - Synaptic function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA037926: AB_10672400" "unprognostic (6.83e-2)" "unprognostic (3.41e-2)" "unprognostic (4.54e-2)" "unprognostic (2.76e-2)" "unprognostic (6.41e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.64e-6)" "unprognostic (3.25e-1)" "unprognostic (1.07e-1)" "unprognostic (1.73e-1)" "unprognostic (6.64e-2)" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (1.34e-1)" "unprognostic (3.19e-1)" "unprognostic (1.30e-1)" "unprognostic (4.11e-2)" 4.3 6.0 6.6 5.2 7.1 3.9 6.2 6.7 7.9 5.1 4.7 4.8 5.1 5.5 7.5 5.0 4.8 3.7 4.9 8.1 3.7 5.2 5.6 4.0 5.7 5.5 3.4 6.5 5.4 6.8 10.4 6.1 5.5 5.8 5.7 12.8 5.0 4.5 11.5 6.7 4.7 5.6 2.2 5.1 4.7 6.0 4.0 7.6 5.6 8.7 6.3 5.0 4.8 6.5 14.2 16.3 17.4 28.8 11.2 14.2 11.6 16.0 20.7 20.2 19.8 22.1 10.0 17.6 9.7 14.0 11.5 15.7 30.3 17.5 24.4 13.0 22.2 14.2 13.6 26.6 10.5 24.6 11.5 12.2 12.3 35.9 33.0 19.4 18.0 14.1 26.8 10.6 19.9 10.6 18.7 15.6 19.0 11.0 75.1 17.5 11.0 11.5 10.0 8.6 15.5 20.0 15.4 28.3 16.6 15.5 21.0 12.7 19.8 12.9 12.5 14.2 32.0 16.4 18.6 21.0 23.0 25.4 6.4 5.4 2.6 1.5 3.5 3.1 3.5 2.6 2.8 3.4 2.4 3.2 2.5 3.0 1.5 3.4 2.9 2.6 4.6 1.9 6.6 7.1 6.7 7.9 8.1 3.7 5.5 3.4 5.5 2.2 4.0 6.5 8.5 0.0 9.1 17.0 8.7 9.9 5.1 5.3 11.4 28.3 9.6 8.3 11.7 8.6 9.5 0.0 64.6 8.0 12.6 6.1 1.9 7.0 1.6 8.3 14.4 8.1 7.2 11.6 26.4 6.2 6.9 8.2 8.2 8.9 6.3 15.7 5.3 9.5 5.5 15.2 26.3 10.2 0.0 6.9 3.7 1.2 13.1 5.9 1.8 10.3 7.8 13.0 12.3 16.1 18.7 8.1 8.3 8.2 11.2 4.7 8.0 5.0 10.4 31.5 6.6 13.6 8.3 12.5 18.0 10.1 9.1 4.1 7.8 13.7 8.6 3.6 RPS24 "eS24, S24" ENSG00000138326 "Ribosomal protein S24" P62847 10 78033760-78056813 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003364, HPA073508" Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 90000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "HPA003364: AB_1079847, HPA073508: " "prognostic favorable (1.50e-4)" "unprognostic (1.58e-1)" "unprognostic (4.95e-2)" "unprognostic (1.09e-1)" "unprognostic (6.95e-2)" "unprognostic (8.01e-3)" "unprognostic (3.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.25e-1)" "unprognostic (9.48e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.10e-10)" "unprognostic (3.18e-2)" "unprognostic (1.38e-1)" "unprognostic (6.65e-2)" "unprognostic (8.22e-2)" 2458.4 1993.8 1538.1 1424.8 1549.0 4673.1 4757.9 1530.6 2756.8 3012.3 1536.9 2576.1 1756.5 2519.4 2811.2 2293.7 2474.3 1606.6 1604.1 1488.8 1645.6 1754.0 2209.3 1458.8 2669.4 1576.3 1569.3 5844.6 2955.3 1438.5 1178.1 1754.5 1586.4 1958.8 2573.9 964.5 2512.4 1637.4 3019.3 3045.0 1693.7 1946.0 1586.5 1916.9 1651.7 776.1 1538.2 2798.0 2252.7 2553.7 2707.5 2652.8 2547.2 1623.3 3390.5 1308.2 3303.3 5221.9 4021.6 7048.4 2884.3 3654.6 5055.0 3773.7 3323.4 1878.5 2339.0 7039.0 1940.5 3205.9 1303.4 2612.8 3847.7 4674.9 3460.7 2403.0 4325.8 2868.1 822.8 1879.0 4533.9 6943.1 1575.6 6732.0 6867.2 2652.4 9675.7 7591.6 4592.2 2981.8 4007.0 1455.6 4191.8 1388.2 3770.5 11229.0 2318.2 5976.0 12085.6 2567.9 3934.7 3482.3 4773.4 1608.2 1658.6 3234.9 1805.2 6010.8 4716.9 3414.2 3356.5 7559.6 3894.3 1175.5 2712.7 1570.9 4896.7 1774.5 3875.7 5354.8 1459.5 9444.0 970.5 1058.0 2124.4 809.3 1585.0 2036.3 2627.9 2796.4 2178.6 2037.5 2932.4 2380.3 2861.9 2644.0 276.9 2801.9 1626.7 2569.0 1916.3 4390.5 1538.1 1549.0 1530.6 2756.8 1488.8 1645.6 1576.3 1569.3 1586.4 1586.5 1538.2 1623.3 2643.8 743.6 1535.6 44.1 4070.7 4105.7 5007.7 2774.6 5333.8 344.3 4139.9 6421.4 617.1 2051.8 1719.2 801.9 108.4 3406.3 3424.5 1200.3 3279.1 2335.3 1414.9 1799.8 4602.7 2194.2 2090.5 3250.6 40.4 4508.1 6260.1 2099.8 2310.4 2451.6 1237.2 3541.5 2346.6 2252.0 3311.9 151.4 42.6 3944.5 880.9 4754.9 4734.0 5440.1 5670.8 3861.9 2031.3 49.6 5590.7 1395.6 3262.7 23.1 45.9 2886.9 3231.4 2588.2 3109.6 4622.7 2703.3 3770.5 768.5 465.7 1268.8 3609.7 2661.0 653.8 709.0 7289.7 4590.1 3541.8 3518.7 4105.6 4384.9 4943.2 ZMIZ1 "FLJ13541, hZIMP10, KIAA1224, MIZ, RAI17, RP11-519K18.1, Zimp10" ENSG00000108175 "Zinc finger MIZ-type containing 1" Q9ULJ6 10 79068966-79316519 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 259.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 176.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045144, HPA071156" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA045144: AB_10962360, HPA071156: " "unprognostic (4.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.63e-1)" "unprognostic (5.59e-2)" "unprognostic (2.02e-1)" "unprognostic (2.86e-2)" "unprognostic (3.64e-3)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (1.16e-1)" "unprognostic (3.13e-2)" "unprognostic (7.90e-2)" "prognostic favorable (3.64e-7)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (8.22e-2)" "unprognostic (1.34e-2)" 34.0 24.4 24.5 19.2 27.1 26.6 27.7 25.1 30.1 44.7 5.2 28.1 19.2 51.5 18.8 37.5 26.5 25.9 31.8 25.8 27.5 17.2 8.7 26.5 17.5 34.5 36.0 48.5 23.3 19.2 12.5 21.7 29.9 19.5 14.5 14.6 28.4 28.8 34.6 33.7 22.2 26.9 27.2 44.8 27.6 4.5 33.9 16.4 37.3 17.0 18.2 28.4 31.0 23.1 24.0 29.3 54.8 23.6 55.8 16.0 19.1 22.4 40.2 15.6 8.8 8.7 10.8 12.2 17.8 52.8 40.9 33.0 9.2 16.6 8.4 26.5 5.1 43.5 11.1 25.9 39.2 24.3 88.1 21.0 18.2 22.3 15.9 98.4 25.3 10.2 16.9 62.9 13.3 45.4 24.4 37.6 16.2 13.8 44.0 107.5 10.3 12.3 11.6 20.0 56.8 82.8 14.8 176.2 46.8 19.4 56.5 23.4 35.5 58.7 23.5 29.9 29.2 11.5 21.9 0.2 77.0 42.7 11.5 1.3 2.1 1.6 1.2 3.6 0.8 0.5 0.8 0.7 2.6 0.2 0.3 0.6 3.0 3.4 3.0 2.5 1.0 1.2 24.5 27.1 25.1 30.1 25.8 27.5 34.5 36.0 29.9 27.2 33.9 23.1 49.3 38.5 26.0 64.9 14.5 22.8 8.4 14.9 15.4 49.8 27.1 18.0 54.4 20.0 15.8 16.5 0.0 7.1 14.7 39.1 7.9 22.1 47.2 17.9 75.3 49.9 13.8 25.7 23.1 24.1 5.6 36.2 38.7 33.2 50.6 16.8 56.4 9.6 37.9 63.9 16.4 14.5 14.2 34.9 86.0 259.7 28.3 52.4 24.9 46.9 27.2 12.9 4.1 92.5 45.5 19.3 22.5 23.7 14.2 13.0 19.7 8.1 14.7 3.4 19.7 24.7 32.6 1.8 3.2 40.8 23.7 3.6 12.1 14.3 14.8 12.7 PPIF "Cyp-D, hCyP3" ENSG00000108179 "Peptidylprolyl isomerase F" P30405 10 79347469-79355334 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Necrosis" "Isomerase, Rotamase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 370.9;Macrophages: 160.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 75.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077416 Supported Mitochondria NA NA 320000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 1: K-562 - Erythropoiesis" "Cluster 41: Macrophages - Immune response" Mitochondria "HPA077416: AB_2686840" "unprognostic (2.21e-1)" "unprognostic (5.48e-2)" "unprognostic (1.68e-1)" "unprognostic (1.72e-3)" "unprognostic (1.69e-1)" "unprognostic (3.16e-3)" "unprognostic (3.45e-1)" "unprognostic (4.33e-3)" "unprognostic (1.66e-1)" "unprognostic (1.97e-1)" "unprognostic (2.82e-1)" "unprognostic (9.37e-3)" "unprognostic (1.02e-3)" "unprognostic (1.23e-1)" "unprognostic (1.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.88e-2)" 62.7 227.7 42.7 42.8 48.4 168.8 42.4 57.9 69.6 27.6 63.7 50.0 36.3 14.0 7.2 66.0 22.9 19.5 119.1 38.1 45.2 63.3 174.9 29.1 32.3 49.0 56.2 19.3 86.9 77.6 18.3 27.1 48.8 18.8 52.4 8.9 39.5 45.5 99.5 71.9 31.3 21.0 50.6 58.7 98.2 35.0 57.1 28.3 26.0 133.6 55.5 60.0 35.1 60.8 220.4 90.6 62.3 123.5 57.0 73.6 79.8 124.2 161.2 265.7 249.6 213.5 102.7 224.8 68.0 87.4 188.6 127.8 195.3 115.4 410.5 72.2 186.4 352.8 87.5 380.7 96.4 245.7 80.4 173.2 81.3 264.5 262.3 86.5 47.5 86.4 351.6 268.3 91.6 111.7 64.1 204.2 53.0 99.6 500.6 109.8 96.4 114.7 103.9 200.0 124.1 92.0 63.6 253.8 97.9 40.5 111.4 187.2 43.5 116.1 106.3 137.9 242.0 124.7 137.7 181.9 114.5 313.9 32.0 15.2 34.3 18.0 10.4 27.5 10.9 19.1 9.1 9.6 43.3 7.7 8.1 7.9 75.0 9.0 10.4 5.4 10.0 16.6 42.7 48.4 57.9 69.6 38.1 45.2 49.0 56.2 48.8 50.6 57.1 60.8 8.4 6.4 6.8 7.2 32.7 42.6 30.2 23.8 31.3 4.0 41.8 40.8 124.6 14.3 14.4 12.9 6.2 99.4 26.4 39.9 92.0 42.1 14.5 12.4 24.0 10.1 21.6 37.0 4.1 28.0 127.1 25.1 78.0 15.5 13.4 73.4 6.1 98.5 91.1 8.4 5.7 69.5 18.3 40.3 370.9 14.1 6.2 160.8 35.6 4.7 32.0 13.0 5.2 5.5 15.0 39.8 26.6 6.0 48.7 41.4 21.3 41.2 12.6 5.2 19.7 18.2 28.6 14.8 22.5 52.9 37.6 142.3 23.9 60.2 81.1 34.2 ZCCHC24 "C10orf56, FLJ90798, Z3CXXC8" ENSG00000165424 "Zinc finger CCHC-type containing 24" Q8N2G6 10 79382325-79445624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 148.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 66.0;Hepatic stellate cells: 64.2;Hepatocytes: 59.2;Leydig cells: 68.6;Oligodendrocyte precursor cells: 184.5;Oligodendrocytes: 130.6;Peritubular cells: 65.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 135.0;ASC TERT1: 115.1;BJ hTERT+: 91.6;HSkMC: 120.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038348 Approved Approved Nucleoplasm,Mitochondria NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 68: Oligodendrocytes - Mixed function" Mitochondria Nucleoplasm "HPA038348: AB_10669538" "unprognostic (3.47e-3)" "unprognostic (8.70e-3)" "unprognostic (3.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (7.28e-2)" "unprognostic (2.17e-2)" "unprognostic (2.25e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (3.76e-4)" "unprognostic (4.77e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (5.35e-6)" "unprognostic (1.84e-2)" "unprognostic (5.52e-2)" "unprognostic (2.85e-2)" "unprognostic (2.95e-3)" 40.4 11.9 119.7 13.8 147.7 2.6 32.5 112.0 109.7 42.3 44.8 67.7 6.2 42.8 8.9 14.0 34.1 23.8 35.7 89.4 101.0 8.7 33.1 22.7 7.5 134.9 145.8 26.4 8.4 4.0 9.4 16.1 120.3 32.2 8.9 3.7 12.0 27.2 58.0 13.7 18.2 36.1 119.7 10.9 25.5 8.9 136.8 2.7 18.4 26.5 4.3 43.2 22.9 148.0 3.3 3.1 10.4 9.0 135.0 115.1 2.5 24.6 91.6 14.2 16.5 2.6 0.1 0.1 13.1 49.5 5.0 0.3 1.7 0.6 11.9 6.2 6.5 1.3 7.2 3.1 35.1 3.8 2.0 120.5 1.3 12.8 3.5 42.1 2.9 0.9 4.8 5.3 12.3 1.1 0.1 14.9 2.5 0.6 30.1 0.6 12.3 2.2 1.7 4.0 0.3 12.9 7.7 0.9 31.5 9.7 3.5 7.0 2.0 13.6 12.4 37.4 8.5 9.2 6.5 0.1 27.9 4.9 49.4 0.0 0.6 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.1 0.1 119.7 147.7 112.0 109.7 89.4 101.0 134.9 145.8 120.3 119.7 136.8 148.0 36.2 0.0 2.6 29.0 1.4 7.6 1.4 1.5 1.8 0.1 5.6 5.7 20.2 5.7 1.2 0.0 0.0 0.6 4.5 0.3 0.0 0.8 2.0 2.3 66.0 29.5 0.0 4.4 0.3 0.8 0.9 40.9 5.1 2.6 1.3 4.1 64.2 59.2 10.7 0.0 0.5 0.4 0.0 17.1 14.5 4.8 68.6 7.4 16.0 30.0 5.6 16.7 1.0 184.5 130.6 0.9 0.1 65.5 5.0 2.9 0.0 1.8 1.2 1.1 13.1 38.7 24.0 0.7 1.7 1.4 4.5 1.5 3.6 8.9 0.1 1.3 EIF5AL1 "bA342M3.3, EIF5AP1" ENSG00000253626 "Eukaryotic translation initiation factor 5A like 1" Q6IS14 10 79512533-79516440 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 10.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 79.2;Intestinal goblet cells: 96.7;Spermatocytes: 76.5;Undifferentiated cells: 121.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "U-251 MG: 2.2" HPA074052 Approved "Plasma membrane,Cytosol" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Plasma membrane" "HPA074052: " "unprognostic (2.16e-2)" "prognostic favorable (4.23e-4)" "unprognostic (2.55e-1)" "unprognostic (4.14e-3)" "unprognostic (1.50e-1)" "unprognostic (3.48e-2)" "unprognostic (4.25e-2)" "unprognostic (2.50e-3)" "unprognostic (2.04e-2)" "unprognostic (3.57e-1)" "unprognostic (1.01e-1)" "unprognostic (8.79e-3)" "unprognostic (1.56e-1)" "unprognostic (8.63e-2)" "unprognostic (1.87e-1)" "unprognostic (6.68e-2)" "unprognostic (1.81e-1)" 0.8 0.8 0.1 0.2 0.1 0.2 0.6 0.5 0.3 0.4 0.0 0.6 0.2 0.5 0.2 1.4 0.4 0.0 0.9 0.1 0.0 0.5 1.3 0.6 0.3 0.0 0.0 0.3 0.7 0.2 0.4 0.0 0.0 0.5 0.2 0.8 0.5 0.0 1.5 1.0 0.5 0.0 0.0 0.5 0.5 10.6 0.0 0.0 0.5 0.0 0.3 0.5 0.7 0.1 0.4 0.8 0.3 1.7 0.0 0.2 0.3 0.3 0.1 0.3 0.2 0.6 0.3 0.9 0.3 0.0 0.2 0.5 0.1 0.0 0.2 0.2 0.7 0.2 1.0 0.4 0.1 0.3 0.6 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.3 0.1 0.6 1.0 0.9 1.2 0.1 0.1 0.3 0.7 0.6 0.5 0.8 0.2 0.5 0.5 0.4 0.6 0.1 0.8 0.7 0.2 0.4 1.0 1.1 2.2 0.4 0.5 0.8 0.7 0.2 0.6 1.1 0.8 0.6 1.2 2.0 1.4 1.3 1.2 1.3 1.6 1.3 0.9 1.3 0.7 1.7 1.3 2.5 1.0 0.8 0.1 0.1 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 16.0 30.0 1.3 10.4 33.8 3.0 7.8 0.0 0.6 5.1 2.4 43.1 2.8 16.1 0.0 0.0 20.8 2.4 79.2 11.7 64.5 14.7 2.9 4.4 12.9 60.0 10.7 0.6 47.8 35.1 15.5 0.0 3.2 48.2 0.9 4.2 5.1 17.5 1.7 0.6 96.7 8.2 8.7 27.9 8.7 5.0 7.2 19.6 0.0 41.9 1.2 13.4 0.0 1.0 65.6 61.2 3.0 0.5 10.3 66.5 11.1 6.1 0.5 0.0 6.9 25.9 76.5 4.3 0.0 34.5 27.6 8.9 3.3 121.3 5.0 SFTPA2 "COLEC5, SP-A2" ENSG00000185303 "Surfactant protein A2" Q8IWL1 10 79555852-79560407 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Gaseous exchange" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 404 "lung: 10798.8" "Cell type enriched" "Detected in some" 10 "Alveolar cells type 2: 16905.3" "Cancer enriched" "Detected in many" 21 "lung cancer: 863.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "BEWO: 7.3;NB-4: 8.3;RPMI-8226: 26.1;U-2197: 14.7" "CAB002439, HPA042638, HPA045752, HPA049368" Enhanced "Secreted in other tissues" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 19: Lung - Lung function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 11: Alveolar cells - Smell perception" "CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" "unprognostic (4.99e-2)" "unprognostic (4.38e-2)" "unprognostic (4.29e-2)" "unprognostic (1.05e-1)" "unprognostic (5.78e-2)" "unprognostic (5.08e-1)" "unprognostic (4.94e-2)" "unprognostic (1.68e-3)" "unprognostic (3.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-1)" "unprognostic (4.69e-3)" 0.7 12.1 0.4 4.6 0.6 0.0 1.0 3.1 0.9 1.4 0.0 1.4 0.0 0.2 0.1 0.4 0.2 0.0 1.1 0.5 0.4 0.4 1.1 10798.8 0.0 1.2 0.0 6.5 1.3 0.0 0.4 2.3 1.3 26.7 2.6 0.2 0.4 8.3 1.0 1.1 0.5 0.1 0.0 6.7 10.5 0.5 0.3 2.7 0.8 0.0 0.1 0.4 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.3 0.4 0.0 0.0 0.2 0.0 26.1 0.0 0.3 0.3 0.3 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.2 14.7 0.1 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.6 3.1 0.9 0.5 0.4 1.2 0.0 1.3 0.0 0.3 0.6 0.0 1593.0 16905.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 329.9 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.2 0.0 0.0 22.3 1.8 0.0 0.3 3.1 0.0 22.0 0.0 0.2 431.4 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.2 2.0 0.0 0.0 1.0 0.0 0.1 135.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.7 0.0 2.4 0.1 SFTPA1 "COLEC4, SFTP1, SP-A, SP-A1" ENSG00000122852 "Surfactant protein A1" Q8IWL2 10 79610939-79615455 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Gaseous exchange" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1048 "lung: 7084.8" "Cell type enriched" "Detected in some" 11 "Alveolar cells type 2: 13480.7" "Cancer enriched" "Detected in some" 25 "lung cancer: 706.4" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 27 "plasmacytoid DC: 2.7" "Lineage enriched" "Detected in single" 27 "dendritic cells: 2.7" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 43.2" "CAB016793, HPA042638, HPA045752, HPA049368" Supported "Secreted in other tissues" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 19: Lung - Lung function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 11: Alveolar cells - Smell perception" "CAB016793: , HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731" "unprognostic (5.83e-4)" "unprognostic (1.17e-1)" "unprognostic (3.38e-2)" "unprognostic (4.24e-1)" "unprognostic (3.47e-2)" "unprognostic (9.09e-2)" 0.5 6.7 0.1 2.6 0.1 0.0 0.5 0.3 0.3 0.9 0.0 0.3 0.0 0.1 0.0 0.2 0.2 0.0 0.8 0.2 0.0 0.2 0.9 7084.8 0.0 0.0 0.0 6.3 0.7 0.0 0.3 1.4 0.0 1.0 0.0 0.0 0.2 4.8 0.8 0.8 0.4 0.0 0.0 4.9 3.8 0.3 0.0 1.5 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.1 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 7.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.1 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1160.3 13480.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 183.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 454.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.2 0.0 0.0 0.0 NUTM2B "bA119F19.1, FAM22B" ENSG00000188199 "NUT family member 2B" A6NNL0 10 79703227-79714681 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" HPA064635 Approved "Nuclear bodies" NA NA "Cluster 43: Testis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 27: Mucus-secreting cells - Mucin production" "Nuclear bodies" "HPA064635: " "unprognostic (9.51e-2)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.10e-1)" "unprognostic (3.63e-1)" "unprognostic (6.60e-2)" "unprognostic (2.47e-2)" "unprognostic (7.66e-2)" "unprognostic (1.33e-2)" "unprognostic (1.95e-1)" "unprognostic (7.79e-3)" "unprognostic (1.15e-1)" "unprognostic (9.70e-2)" "unprognostic (9.97e-2)" "unprognostic (5.72e-2)" "unprognostic (5.37e-2)" "unprognostic (2.32e-2)" 0.6 0.7 1.6 0.7 1.3 1.4 0.6 3.1 1.9 0.6 0.0 0.8 0.2 0.8 0.5 0.6 0.9 0.2 1.5 1.7 0.9 1.6 1.1 0.8 0.7 1.6 0.9 0.9 1.4 0.7 1.8 0.3 1.5 1.1 0.2 0.8 1.0 0.3 1.0 1.1 0.9 0.1 0.3 1.3 0.9 3.4 1.8 0.7 0.9 0.1 0.7 0.5 0.8 1.8 0.7 0.8 1.7 1.0 0.4 0.4 0.7 0.3 0.5 0.4 0.4 0.1 1.5 1.7 0.2 0.4 0.6 0.7 0.1 0.8 0.3 1.1 0.6 1.3 0.2 0.5 0.7 1.2 2.9 1.1 0.4 0.2 0.3 1.5 0.0 2.4 1.9 0.8 0.3 1.4 0.3 2.3 1.6 0.0 0.8 0.4 0.2 0.2 0.5 0.2 0.7 1.8 1.0 1.3 1.7 0.8 0.4 1.4 1.0 0.2 0.3 0.2 0.6 0.3 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.3 3.1 1.9 1.7 0.9 1.6 0.9 1.5 0.3 1.8 1.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 NUTM2E FAM22E ENSG00000228570 "NUT family member 2E" B1AL46 10 79841358-79850878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 1.2;Exocrine glandular cells: 1.0;Pancreatic endocrine cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.0;NB-4: 1.6;U-266/84: 1.2" HPA064635 Approved "Nuclear bodies" NA NA "Cluster 43: Testis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Nuclear bodies" "HPA064635: " "unprognostic (2.82e-1)" "unprognostic (3.95e-1)" "unprognostic (1.90e-1)" "unprognostic (1.00e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-1)" "unprognostic (1.96e-2)" "unprognostic (2.51e-1)" "unprognostic (2.33e-1)" "unprognostic (1.03e-1)" "unprognostic (2.58e-1)" "unprognostic (3.66e-1)" "unprognostic (4.35e-1)" "unprognostic (4.09e-1)" 0.1 0.1 0.6 0.0 0.5 0.1 0.1 1.0 0.6 0.2 0.1 0.1 0.2 0.2 0.6 0.1 0.2 0.1 0.2 0.6 0.4 0.3 0.2 0.2 0.3 0.5 0.5 0.2 0.3 0.0 0.5 0.1 0.4 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.3 0.3 0.1 0.7 0.5 0.5 0.3 0.3 0.0 0.1 0.1 0.6 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.5 0.2 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.5 2.0 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.6 1.6 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.7 1.2 0.1 0.3 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 1.0 0.6 0.6 0.4 0.5 0.5 0.4 0.3 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 SFTPD "COLEC7, SFTP4, SP-D" ENSG00000133661 "Surfactant protein D" P35247 10 79937467-79982614 "Predicted secreted proteins" "Gaseous exchange, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "lung: 507.9" "Cell type enriched" "Detected in many" 4 "Alveolar cells type 2: 1863.1" "Cancer enriched" "Detected in many" 16 "lung cancer: 106.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "intermediate monocyte: 10.0;non-classical monocyte: 36.3" "Lineage enriched" "Detected in many" 18 "monocytes: 36.3" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HaCaT: 1.0;hTCEpi: 3.2;MCF7: 1.3;U-2197: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB004578, HPA044582, HPA056768" Enhanced "Secreted in other tissues" NA NA 8200000 "Cluster 51: Monocytes - Innate immune response" "Cluster 19: Lung - Lung function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 11: Alveolar cells - Smell perception" "CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232" "unprognostic (3.81e-5)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (1.41e-2)" "unprognostic (4.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.66e-3)" "unprognostic (6.83e-2)" "unprognostic (3.85e-1)" "unprognostic (2.23e-1)" "unprognostic (5.29e-2)" "unprognostic (2.57e-1)" "unprognostic (4.70e-2)" "unprognostic (2.57e-2)" "unprognostic (2.38e-1)" "unprognostic (1.45e-1)" "unprognostic (8.86e-2)" 1.1 1.8 2.2 0.4 2.4 19.7 0.9 1.7 2.5 1.3 2.3 1.0 0.1 0.5 1.3 1.8 1.8 0.9 1.1 2.2 2.4 1.6 1.0 507.9 0.0 1.7 2.0 1.1 4.2 2.0 3.4 0.7 1.8 1.4 0.1 0.3 1.0 1.2 0.2 5.0 0.4 0.4 1.4 0.6 1.1 1.3 2.6 0.5 5.8 0.2 0.2 0.3 2.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.3 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 10.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 36.3 0.0 0.0 0.9 2.2 2.4 1.7 2.5 2.2 2.4 1.7 2.0 1.8 1.4 2.6 1.7 0.3 439.1 1863.1 1.0 0.2 0.9 1.3 7.8 1.2 1.7 1.4 1.8 0.7 0.0 38.0 5.5 0.0 0.1 0.0 0.0 1.9 1.4 7.4 0.6 0.1 1.5 0.0 0.0 4.9 5.8 3.0 4.4 0.0 0.9 20.2 1.6 0.4 0.7 0.1 0.0 3.5 0.0 0.0 0.0 2.7 12.2 1.2 2.9 0.0 1.9 0.6 2.8 0.0 0.0 0.6 2.0 0.1 0.4 0.0 0.8 0.0 0.2 9.6 0.5 0.0 1.8 0.4 0.4 0.3 0.6 1.8 0.1 4.3 0.1 0.1 0.6 TMEM254 "bA369J21.6, C10orf57, FLJ13263" ENSG00000133678 "Transmembrane protein 254" Q8TBM7 10 80078646-80092557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029105, HPA072613" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" Nucleoplasm "HPA029105: AB_2672909, HPA072613: AB_2732205" "unprognostic (9.40e-2)" "unprognostic (1.76e-1)" "unprognostic (9.52e-2)" "unprognostic (5.74e-3)" "unprognostic (5.39e-2)" "unprognostic (6.04e-2)" "unprognostic (3.66e-1)" "unprognostic (3.90e-1)" "unprognostic (1.64e-2)" "unprognostic (1.87e-3)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (7.65e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (3.45e-3)" "unprognostic (5.96e-2)" 15.2 11.9 7.9 11.1 8.3 9.4 26.5 7.3 8.3 16.0 7.0 22.6 16.3 10.7 62.1 39.5 28.0 14.0 5.7 8.0 7.0 14.8 52.8 9.4 10.4 8.0 8.7 13.0 19.0 16.5 4.4 15.6 8.5 43.1 22.3 11.2 16.6 14.2 4.4 72.3 15.4 10.4 8.3 7.8 15.0 15.5 7.5 15.4 14.8 2.9 14.6 12.4 22.7 9.3 14.4 13.8 20.0 17.2 27.1 29.7 33.4 13.5 9.3 9.0 9.7 10.6 43.5 11.0 22.1 16.9 9.3 15.2 8.9 11.5 10.0 17.5 16.5 3.0 3.8 14.3 11.2 12.8 13.0 20.3 48.6 8.9 7.3 20.6 7.7 9.1 7.9 22.9 9.4 29.8 10.7 9.9 11.0 12.6 43.2 13.2 2.8 9.7 13.5 11.9 8.0 12.1 12.6 31.4 13.3 14.8 45.1 9.1 12.1 7.8 12.8 12.0 8.0 15.8 24.7 0.8 17.8 13.6 6.6 57.3 25.0 13.0 18.1 28.6 22.3 21.3 20.2 18.8 20.7 14.3 33.8 22.6 2.8 17.5 31.5 23.1 27.2 20.5 7.9 8.3 7.3 8.3 8.0 7.0 8.0 8.7 8.5 8.3 7.5 9.3 4.6 9.6 9.6 17.6 7.3 8.2 5.9 9.7 5.2 7.9 22.6 17.5 4.4 12.8 13.7 9.2 16.7 40.9 3.8 9.0 21.5 15.7 10.5 37.6 10.0 5.4 8.4 5.9 17.2 8.7 37.2 7.6 11.2 10.5 5.7 12.9 5.7 33.4 19.4 16.8 16.4 23.7 8.2 10.3 5.8 7.5 9.3 8.5 3.6 4.7 15.2 15.7 12.3 8.5 14.8 10.3 15.3 11.7 5.2 15.6 19.6 23.1 40.2 13.3 13.1 2.6 7.1 36.8 8.7 20.9 24.0 22.7 6.9 11.2 18.1 8.4 PLAC9 ENSG00000189129 "Placenta associated 9" Q5JTB6 10 80131682-80145359 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 124.3" "Cell type enhanced" "Detected in many" "Fibroblasts: 926.5;Leydig cells: 873.5;Peritubular cells: 659.7;Sertoli cells: 295.9;Smooth muscle cells: 446.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.0" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.0" "Cell line enhanced" "Detected in many" "ASC diff: 98.5;ASC TERT1: 85.3;BEWO: 32.1;HSkMC: 28.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "spinal cord: 37.9" HPA043469 Uncertain "Secreted - unknown location" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA043469: AB_10795770" "unprognostic (1.72e-1)" "unprognostic (4.22e-2)" "unprognostic (5.01e-3)" "unprognostic (1.78e-2)" "unprognostic (2.76e-1)" "unprognostic (3.93e-1)" "unprognostic (5.57e-3)" "unprognostic (5.88e-3)" "unprognostic (8.45e-2)" "prognostic unfavorable (6.60e-4)" "unprognostic (1.30e-2)" "unprognostic (1.09e-1)" "unprognostic (4.23e-3)" "unprognostic (4.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.14e-1)" "unprognostic (2.82e-3)" 112.3 18.4 10.2 6.6 9.2 1.2 85.7 10.3 15.5 77.3 53.3 22.1 4.0 26.9 5.0 21.4 30.4 9.0 124.3 14.3 5.9 17.9 6.4 56.1 2.7 5.9 5.8 11.5 5.7 4.1 4.9 12.5 6.4 35.9 4.6 0.6 20.1 7.6 16.9 47.8 19.7 6.5 6.5 5.0 21.4 14.9 6.9 2.2 44.6 19.2 1.9 54.0 75.7 8.5 0.2 0.0 0.8 0.0 98.5 85.3 32.1 10.3 8.7 0.9 1.2 0.0 0.7 0.0 0.2 6.0 0.1 0.8 0.1 0.0 0.0 0.8 0.3 0.0 0.5 0.0 16.4 0.0 2.3 28.7 0.0 2.1 1.2 10.6 3.4 0.4 0.0 0.4 0.0 0.3 0.1 0.6 1.9 0.4 1.5 0.0 0.1 1.5 0.0 0.6 0.0 1.8 0.0 1.2 0.7 0.2 0.1 0.2 3.6 6.6 3.6 21.0 0.2 0.7 0.9 0.1 1.9 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 10.2 9.2 10.3 15.5 14.3 5.9 5.9 5.8 6.4 6.5 6.9 8.5 246.2 3.2 1.8 0.0 1.6 126.4 0.7 1.1 8.0 0.4 7.4 14.0 24.4 0.0 0.3 0.0 0.0 7.0 3.6 0.1 0.0 0.3 4.6 3.1 75.7 102.5 1.8 0.0 0.5 0.2 17.7 926.5 5.6 4.4 1.3 0.1 115.6 0.3 14.1 0.0 0.5 0.0 0.0 0.0 191.3 26.7 873.5 7.9 136.9 7.5 0.0 50.2 0.0 0.0 0.2 0.7 0.0 659.7 2.1 1.0 0.0 0.2 0.9 1.7 295.9 89.7 446.6 2.6 2.9 4.6 126.3 11.5 14.1 1.1 0.0 1.8 ANXA11 ANX11 ENSG00000122359 "Annexin A11" P50995 10 80150889-80205572 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 443.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004851, HPA027545" Supported Supported Nucleoplasm,Cytosol NA NA 210000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Cytosol "CAB004851: AB_626682, HPA027545: AB_1844851" "unprognostic (1.85e-2)" "unprognostic (2.85e-2)" "unprognostic (5.35e-3)" "unprognostic (5.06e-2)" "unprognostic (8.18e-3)" "unprognostic (1.99e-1)" "unprognostic (4.01e-3)" "unprognostic (6.28e-2)" "unprognostic (2.32e-2)" "unprognostic (4.88e-2)" "unprognostic (3.46e-2)" "unprognostic (2.56e-2)" "prognostic favorable (6.69e-8)" "unprognostic (2.69e-3)" "unprognostic (1.84e-1)" "unprognostic (6.79e-2)" "unprognostic (2.02e-1)" 139.9 29.5 39.0 99.4 40.6 192.9 107.6 27.5 46.8 86.6 52.8 130.3 138.0 74.3 107.5 210.2 109.0 84.8 236.2 47.3 29.0 144.7 47.7 109.5 81.2 26.4 26.6 78.2 95.4 81.8 27.2 91.1 23.9 100.3 120.7 4.8 94.1 81.8 188.9 75.6 137.2 86.0 25.4 76.2 139.3 24.5 24.6 100.2 61.4 166.2 101.7 148.1 102.8 30.4 221.7 195.7 10.4 53.9 220.2 201.1 119.6 149.5 397.3 95.7 98.8 168.7 338.2 13.1 113.6 236.7 8.1 277.7 44.6 136.2 54.2 384.3 76.0 84.4 98.9 131.5 129.4 92.0 212.3 222.9 74.6 57.8 39.4 178.9 143.9 117.9 82.1 163.7 76.8 127.3 119.8 200.9 19.6 211.5 367.7 91.7 14.9 344.0 155.1 191.8 5.1 37.9 65.0 269.9 156.4 83.4 80.6 120.6 160.0 68.7 101.4 157.6 84.4 91.7 145.6 96.0 66.6 155.4 47.4 130.8 66.8 443.8 72.9 52.4 75.0 64.9 92.5 100.5 49.4 54.2 83.7 74.4 231.8 61.3 59.1 78.5 126.5 85.4 39.0 40.6 27.5 46.8 47.3 29.0 26.4 26.6 23.9 25.4 24.6 30.4 150.5 96.1 78.4 17.3 101.4 51.2 266.4 219.4 92.8 1.6 58.8 50.4 293.3 203.0 227.1 220.7 0.0 271.7 137.1 457.7 332.6 429.2 4.5 180.6 49.7 82.7 77.5 29.9 29.5 352.5 309.8 113.1 175.8 265.7 116.1 81.4 91.4 40.8 228.1 3.3 15.5 186.9 97.6 149.7 167.4 9.6 92.9 155.0 90.7 24.4 208.2 38.9 159.6 3.0 2.3 420.6 461.0 92.6 98.2 414.9 367.7 156.8 229.0 2.8 92.1 56.4 137.9 2.8 51.5 98.4 42.1 185.5 131.9 50.8 227.8 581.4 MAT1A "MAT, MATA1, SAMS, SAMS1" ENSG00000151224 "Methionine adenosyltransferase 1A" Q00266 10 80271820-80289658 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "liver: 1346.5" "Cell type enriched" "Detected in some" 55 "Hepatocytes: 5534.4" "Cancer enriched" "Detected in many" 54 "liver cancer: 209.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "Hep G2: 94.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048627 Supported NA NA 1900000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "HPA048627: AB_2680465" "unprognostic (6.92e-2)" "unprognostic (2.63e-1)" "unprognostic (2.88e-2)" "unprognostic (9.43e-2)" "unprognostic (3.79e-2)" "unprognostic (2.49e-2)" "unprognostic (2.03e-3)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.66e-2)" "unprognostic (1.11e-16)" "unprognostic (8.59e-3)" "unprognostic (9.90e-2)" "unprognostic (3.58e-1)" "unprognostic (5.98e-2)" 0.5 0.5 0.4 0.1 0.8 0.0 0.4 0.1 0.5 0.2 0.9 0.2 0.2 0.1 57.5 0.1 1.2 0.0 0.2 0.2 0.2 0.9 1346.5 0.4 0.1 0.6 0.8 6.3 43.8 0.1 0.8 0.1 0.4 0.0 0.0 0.0 0.3 1.9 0.0 4.2 0.0 0.2 0.8 0.5 0.2 3.7 0.2 0.4 0.4 0.0 0.0 0.5 0.1 0.2 6.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.0 3.2 0.1 0.0 0.0 0.0 0.3 0.5 1.6 0.0 94.9 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 2.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 1.0 0.2 0.0 0.5 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.1 0.5 0.2 0.2 0.6 0.8 0.4 0.8 0.2 0.2 0.0 0.0 0.5 0.0 8.8 2.0 0.1 0.4 0.0 0.0 0.2 0.6 0.7 67.2 0.9 1.8 0.0 0.0 0.0 0.0 1.9 0.1 23.9 3.0 0.0 5.3 0.0 69.5 0.1 4.6 0.0 0.0 0.0 0.2 0.0 7.6 76.8 5534.4 0.1 0.0 0.0 0.0 0.0 100.4 0.6 5.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.4 0.0 0.1 0.0 0.6 10.2 0.0 0.0 0.0 0.2 2.7 0.3 0.0 2.7 0.0 6.0 1.0 0.0 0.0 DYDC1 "bA36D19.5, DPY30D1" ENSG00000170788 "DPY30 domain containing 1" Q8WWB3 10 80336105-80356755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 126.6" "Cell type enhanced" "Detected in some" "Early spermatids: 222.4;Late spermatids: 83.5;Spermatocytes: 349.2" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "basophil: 2.0" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037790, HPA037791" Uncertain NA NA "Cluster 17: Basophils - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA037790: AB_10805351, HPA037791: AB_10796215" "unprognostic (8.95e-2)" "unprognostic (8.28e-3)" "unprognostic (7.11e-2)" "unprognostic (3.12e-1)" "unprognostic (1.87e-1)" "unprognostic (1.90e-1)" "unprognostic (9.96e-2)" "unprognostic (7.95e-2)" 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.1 0.1 0.2 2.2 0.0 0.0 0.2 1.5 0.0 5.6 0.0 0.0 0.2 0.2 0.0 0.0 1.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 126.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.2 0.5 0.1 0.1 0.2 0.2 0.5 0.7 0.2 0.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.4 15.1 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 1.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 83.5 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.1 0.0 0.0 36.3 0.0 6.6 0.0 0.3 349.2 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DYDC2 "bA36D19.6, MGC16186" ENSG00000133665 "DPY30 domain containing 2" Q96IM9 10 80344745-80368073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "fallopian tube: 97.4" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 182.5;Respiratory ciliated cells: 324.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.2;NTERA-2: 3.2;SCLC-21H: 2.9;SH-SY5Y: 1.9;U-2197: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038006, HPA038007" Enhanced NA NA "Cluster 34: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "HPA038006: AB_10672734, HPA038007: AB_2675783" "unprognostic (1.60e-3)" "unprognostic (7.35e-2)" "unprognostic (1.89e-2)" "unprognostic (9.26e-3)" "unprognostic (8.85e-2)" "unprognostic (3.26e-1)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.55e-1)" "prognostic favorable (3.54e-4)" "unprognostic (1.87e-2)" "unprognostic (2.43e-1)" "unprognostic (2.34e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-4)" "unprognostic (9.86e-2)" "unprognostic (5.40e-2)" 0.1 0.1 1.6 0.1 2.6 0.8 0.3 1.7 2.1 2.2 5.3 0.3 0.1 1.8 4.5 0.5 97.4 0.3 0.0 2.1 2.4 0.3 0.6 4.6 0.0 5.5 5.7 0.1 0.8 0.3 0.8 0.3 3.7 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.1 5.9 0.0 0.3 10.8 3.7 0.2 0.2 0.0 0.1 0.0 0.1 3.6 0.1 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.3 0.0 0.4 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.8 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.4 0.0 3.2 0.0 0.0 0.9 0.2 0.8 0.0 0.0 2.9 1.9 0.0 0.0 0.3 0.8 0.0 1.4 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.6 2.6 1.7 2.1 2.1 2.4 5.5 5.7 3.7 5.9 3.7 3.6 0.0 0.0 3.1 0.3 0.0 0.0 0.1 20.6 0.0 0.0 0.3 0.1 0.2 0.0 29.6 0.0 0.0 0.0 0.1 0.1 1.9 0.5 61.4 182.5 1.6 0.1 0.0 0.0 0.8 0.5 0.0 0.9 0.0 2.4 0.0 1.3 0.0 0.6 0.1 0.0 0.3 0.0 14.2 0.0 0.3 30.4 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.3 0.0 0.1 324.1 0.0 0.0 0.2 4.3 8.5 3.1 0.1 0.0 0.0 0.4 0.2 0.0 0.1 PRXL2A "Adrx, C10orf58, FAM213A, MGC4248, PAMM" ENSG00000122378 "Peroxiredoxin like 2A" Q9BRX8 10 80407829-80437115 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Antioxidant "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 405.6" "Group enriched" "Detected in some" 7 "Adipocytes: 161.4;Cardiomyocytes: 161.5;Hofbauer cells: 75.1;Smooth muscle cells: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 11 "plasmacytoid DC: 166.0" "Lineage enriched" "Detected in all" 11 "dendritic cells: 166.0" "Cell line enhanced" "Detected in many" "ASC diff: 947.9;HaCaT: 276.4;HUVEC TERT2: 436.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009025, HPA024565" Enhanced "Secreted in other tissues" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 24: Non-specific - Transcription regulation" "HPA009025: AB_1078312, HPA024565: AB_1845519" "unprognostic (1.73e-2)" "unprognostic (2.96e-2)" "unprognostic (6.96e-3)" "unprognostic (2.15e-2)" "unprognostic (3.02e-2)" "unprognostic (4.31e-2)" "unprognostic (3.14e-1)" "unprognostic (6.68e-2)" "unprognostic (2.58e-1)" "unprognostic (7.01e-2)" "unprognostic (3.54e-2)" "unprognostic (2.83e-3)" "unprognostic (3.32e-3)" "unprognostic (3.55e-1)" "unprognostic (6.78e-2)" "unprognostic (1.80e-1)" "prognostic favorable (6.11e-4)" 405.6 25.1 112.4 15.9 110.4 3.6 210.2 97.4 119.8 92.0 122.6 51.8 84.0 52.5 212.8 83.9 30.9 30.8 76.3 121.8 104.3 110.9 197.3 20.9 18.0 108.2 111.3 30.7 66.0 69.0 59.1 45.2 108.5 70.4 43.2 42.9 50.6 44.3 49.7 81.1 59.8 19.9 103.1 12.3 24.8 51.5 131.1 34.7 55.1 75.8 26.9 71.4 51.9 101.5 26.0 62.9 105.3 0.4 947.9 0.1 7.2 4.0 22.0 2.0 0.5 60.1 76.3 16.6 82.1 0.3 47.1 276.4 9.5 10.9 0.5 1.1 17.6 32.5 23.8 89.0 91.9 0.3 9.0 71.1 20.2 6.7 0.3 250.1 436.7 95.1 26.9 0.6 0.0 89.6 41.9 4.7 51.2 39.1 0.3 117.5 48.5 0.8 223.1 106.2 107.6 76.6 11.0 147.7 168.4 78.9 66.2 46.2 119.1 0.6 1.0 0.5 0.6 9.3 22.0 0.4 66.0 0.6 7.6 1.3 3.5 11.6 6.6 0.8 5.1 15.8 3.7 5.5 3.3 11.1 13.4 13.9 2.2 6.2 0.2 166.0 0.2 4.8 112.4 110.4 97.4 119.8 121.8 104.3 108.2 111.3 108.5 103.1 131.1 101.5 161.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.5 0.0 0.0 0.0 0.0 13.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 7.4 13.4 0.0 0.0 0.0 0.0 0.0 0.0 75.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.6 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.0 TSPAN14 "DC-TM4F2, MGC11352, TM4SF14" ENSG00000108219 "Tetraspanin 14" Q8NG11 10 80454166-80533124 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatic stellate cells: 156.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 276.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014773, HPA057174" Uncertain Supported Vesicles NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles "HPA014773: AB_2208670, HPA057174: " "unprognostic (7.52e-2)" "prognostic favorable (3.56e-4)" "unprognostic (6.55e-3)" "unprognostic (1.56e-1)" "unprognostic (4.40e-2)" "unprognostic (1.18e-1)" "unprognostic (2.11e-2)" "unprognostic (8.90e-2)" "unprognostic (5.21e-2)" "unprognostic (3.13e-1)" "unprognostic (5.15e-3)" "unprognostic (4.12e-3)" "prognostic favorable (4.20e-4)" "unprognostic (2.52e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (2.57e-3)" 97.9 20.7 29.1 43.1 24.2 57.2 80.1 25.1 29.7 63.1 19.4 33.4 30.9 38.4 44.1 92.1 47.1 32.9 51.2 26.2 21.4 45.7 21.1 70.8 54.2 31.7 32.2 47.2 33.1 35.7 15.7 81.9 29.7 34.8 27.1 7.9 47.7 34.1 24.9 74.3 34.8 33.3 31.2 48.5 24.7 23.2 32.8 40.1 46.5 42.1 44.6 55.0 56.1 31.4 96.2 135.6 128.3 44.5 186.6 59.3 59.6 49.3 91.8 51.1 38.0 134.8 54.6 31.5 93.2 26.4 18.9 97.0 35.9 88.5 41.4 55.9 13.9 88.9 15.8 118.2 63.5 31.8 20.3 58.8 77.2 52.8 92.1 94.8 191.5 31.8 48.8 23.0 15.0 83.3 50.0 23.3 29.5 61.2 0.1 167.9 14.9 5.3 203.9 131.9 27.5 42.3 19.7 133.7 149.5 43.7 54.1 79.8 276.3 13.0 52.8 12.4 35.1 10.7 42.0 11.8 42.2 65.4 57.5 16.2 51.5 56.3 92.1 102.1 41.3 13.8 70.7 81.1 33.9 13.7 82.3 79.3 54.7 95.2 172.8 13.6 61.8 84.3 29.1 24.2 25.1 29.7 26.2 21.4 31.7 32.2 29.7 31.2 32.8 31.4 141.9 16.0 55.1 13.1 18.5 34.9 40.3 54.6 35.3 2.1 29.5 23.2 11.3 25.8 39.0 33.1 77.2 7.8 38.4 32.8 7.9 43.8 2.4 44.7 38.9 95.3 64.2 35.6 12.9 24.8 74.4 18.8 18.3 75.1 7.6 41.2 156.7 21.1 50.5 3.3 7.4 37.0 34.6 129.3 12.9 4.1 39.1 66.5 14.2 35.6 51.8 23.7 89.6 4.5 13.5 64.2 21.6 41.0 18.4 55.7 23.4 8.0 29.6 7.1 98.6 10.2 43.1 5.0 19.0 80.2 36.4 7.7 55.7 10.4 30.6 69.7 SH2D4B ENSG00000178217 "SH2 domain containing 4B" Q5SQS7 10 80537902-80646560 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.8;Inhibitory neurons: 1.0;Spermatogonia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 87 "REH: 27.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040022 Uncertain NA NA "Cluster 14: REH - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA040022: AB_10805601" "unprognostic (1.19e-2)" "unprognostic (4.51e-3)" "unprognostic (4.45e-2)" "unprognostic (2.94e-2)" "unprognostic (3.31e-1)" "unprognostic (1.09e-1)" "unprognostic (2.36e-1)" "unprognostic (2.87e-2)" "unprognostic (3.80e-1)" "unprognostic (1.24e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-1)" "unprognostic (2.65e-6)" "unprognostic (9.37e-2)" "unprognostic (4.41e-2)" "unprognostic (1.26e-3)" "unprognostic (3.81e-1)" 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 NRG3 ENSG00000185737 "Neuregulin 3" P56975 10 81875194-82987179 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.3;retina: 5.2" "Group enriched" "Detected in some" 18 "Astrocytes: 2921.6;Excitatory neurons: 3761.0;Inhibitory neurons: 3088.3;Oligodendrocyte precursor cells: 1175.2" "Cancer enhanced" "Detected in many" "melanoma: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;SK-MEL-30: 2.7;U-2 OS: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075789 Uncertain Vesicles "Secreted in brain" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "HPA075789: " "unprognostic (6.15e-3)" "unprognostic (2.43e-2)" "unprognostic (1.65e-5)" "unprognostic (1.89e-1)" "unprognostic (7.03e-4)" "unprognostic (1.85e-2)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" "unprognostic (9.33e-2)" "unprognostic (1.82e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-2)" "unprognostic (3.31e-4)" "unprognostic (1.04e-1)" "unprognostic (7.68e-3)" "unprognostic (7.27e-4)" 0.1 0.4 16.4 0.3 11.4 0.0 1.3 0.0 17.3 0.1 0.0 0.4 0.1 0.0 0.0 0.1 4.7 2.8 0.4 16.1 2.6 0.7 0.5 0.7 0.1 1.2 6.3 0.0 0.1 0.1 2.0 0.3 0.4 0.1 0.1 5.2 2.6 0.2 0.0 0.6 0.1 0.1 2.5 0.1 0.3 1.8 9.9 0.0 0.2 0.1 0.0 0.1 0.0 3.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 11.4 0.0 17.3 16.1 2.6 1.2 6.3 0.4 2.5 9.9 3.5 0.1 0.0 0.0 2921.6 0.1 0.0 0.0 0.0 0.0 15.9 0.7 0.6 0.8 2.8 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.9 31.4 0.0 0.0 0.7 0.0 0.0 3761.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 3088.3 0.0 0.0 0.0 0.0 12.8 0.6 0.1 0.0 148.0 0.0 6.7 0.0 1175.2 50.2 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 GHITM "DERP2, HSPC282, My021, PTD010, TMBIM5" ENSG00000165678 "Growth hormone inducible transmembrane protein" Q9H3K2 10 84139509-84153568 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 1114.2;Late spermatids: 2559.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016464, HPA061664" Approved Supported Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA016464: AB_1849656, HPA061664: AB_2684579" "unprognostic (6.26e-3)" "unprognostic (1.85e-1)" "unprognostic (2.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.61e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (5.71e-2)" "unprognostic (4.56e-2)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (8.14e-2)" "unprognostic (5.71e-2)" "prognostic favorable (2.32e-10)" "unprognostic (2.46e-2)" "unprognostic (2.09e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" 113.9 179.5 124.3 87.0 133.3 110.6 93.8 138.6 147.7 73.1 150.6 171.2 163.5 76.8 86.1 114.4 71.4 68.9 365.3 136.1 146.1 300.7 271.1 74.1 87.3 136.6 128.1 72.7 77.7 197.3 88.8 70.3 138.5 80.6 166.4 144.3 94.4 84.2 369.3 79.7 137.1 85.7 125.4 73.8 123.1 115.7 137.5 86.5 105.9 456.6 103.3 92.3 76.5 123.1 228.2 230.8 97.1 223.5 162.6 143.3 171.6 153.3 267.4 193.7 180.2 283.1 183.8 178.9 167.7 203.2 170.9 199.9 208.4 200.0 185.9 179.8 157.4 127.7 227.3 281.0 306.5 402.0 200.0 162.7 384.1 200.4 577.8 201.8 169.9 150.5 299.9 324.3 180.4 197.4 143.6 318.9 98.3 184.8 203.2 128.3 89.4 270.5 271.4 179.2 79.4 92.4 154.7 134.1 325.1 111.2 273.7 254.2 145.3 94.0 126.5 138.5 251.1 227.9 265.7 199.9 246.8 364.4 67.1 293.7 284.9 276.5 173.9 304.7 194.2 211.0 178.9 186.0 279.9 177.9 166.6 178.8 223.7 206.7 281.3 145.3 235.3 578.0 124.3 133.3 138.6 147.7 136.1 146.1 136.6 128.1 138.5 125.4 137.5 123.1 94.1 96.1 87.6 23.2 138.0 170.3 185.1 440.9 87.0 135.9 102.2 71.8 689.3 140.2 235.8 158.2 70.9 260.4 134.0 376.0 579.2 295.3 1114.2 58.7 68.6 120.7 125.6 242.9 33.6 232.3 234.9 119.6 107.6 67.1 102.0 79.3 88.5 326.1 267.7 101.0 34.5 206.0 443.5 156.2 169.2 2559.1 110.3 153.0 163.7 16.9 228.3 269.0 114.4 14.6 24.3 223.3 276.3 136.9 167.3 180.1 343.7 802.9 173.4 159.9 144.7 114.5 219.8 263.1 153.2 150.4 170.3 386.0 141.6 158.4 281.4 212.9 C10orf99 "AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833" ENSG00000188373 "Chromosome 10 open reading frame 99" Q6UWK7 10 84173801-84185294 "Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Cytokine" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 193.2;intestine: 274.9;vagina: 115.3" "Group enriched" "Detected in some" 11 "Distal enterocytes: 853.2;Intestinal goblet cells: 267.6;Paneth cells: 815.9;Proximal enterocytes: 364.8;Undifferentiated cells: 402.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 91.5;head and neck cancer: 102.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 52.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050920 Enhanced "Secreted in other tissues" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA050920: AB_2681274" "unprognostic (3.13e-2)" "unprognostic (1.43e-1)" "unprognostic (6.04e-2)" "unprognostic (1.78e-2)" "unprognostic (7.46e-3)" "unprognostic (2.05e-1)" "unprognostic (7.98e-2)" "unprognostic (2.04e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (3.70e-1)" "unprognostic (4.67e-2)" 0.4 0.0 0.0 16.8 0.0 0.0 0.5 0.0 0.0 46.7 0.0 268.5 0.0 0.6 0.0 193.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 274.9 0.1 21.7 2.6 0.0 38.5 21.5 13.1 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.0 17.4 33.5 115.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 52.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 6.8 1.2 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.1 853.2 0.0 0.0 0.4 3.3 0.8 0.1 28.9 0.0 0.0 0.0 0.0 0.0 0.0 4.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 267.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 815.9 0.0 0.0 1.0 364.8 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 46.0 2.3 0.0 1.4 0.0 402.8 46.4 CDHR1 "CORD15, KIAA1775, PCDH21, RP65" ENSG00000148600 "Cadherin related family member 1" Q96JP9 10 84194537-84219621 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cone-rod dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "retina: 313.8;skin 1: 214.0" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 379.5;Rod photoreceptor cells: 240.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 13.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 12 "NK-cell: 7.5" "Lineage enriched" "Detected in single" 12 "NK-cells: 7.5" "Cell line enhanced" "Detected in some" "HAP1: 10.2;HEK 293: 5.2;HEL: 6.3;K-562: 4.6;NTERA-2: 4.4;RPTEC TERT1: 16.3" "Region enriched" "Detected in many" 21 "olfactory bulb: 333.0" "Low region specificity" "Detected in all" HPA036819 Enhanced "Intracellular and membrane" NA NA 55000 "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA036819: AB_10671750" "unprognostic (8.91e-4)" "unprognostic (5.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.71e-2)" "unprognostic (2.63e-2)" "unprognostic (3.03e-2)" "unprognostic (6.40e-2)" "unprognostic (7.77e-2)" "unprognostic (1.41e-1)" "unprognostic (2.67e-1)" "unprognostic (6.69e-4)" "unprognostic (1.90e-1)" "unprognostic (5.51e-3)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" "unprognostic (4.56e-3)" "unprognostic (5.07e-2)" 0.2 1.9 7.4 1.0 18.3 0.4 4.5 2.3 8.7 5.3 46.2 29.2 0.1 0.6 4.4 10.7 0.5 0.4 1.2 6.6 7.5 0.4 0.5 0.2 0.9 13.4 2.3 1.1 0.1 0.0 3.0 0.2 13.9 1.4 53.2 313.8 1.5 4.2 1.0 214.0 12.2 1.2 0.1 7.0 0.2 0.3 3.2 3.3 0.2 0.0 1.1 0.1 3.5 3.5 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 10.2 2.0 0.0 0.0 5.2 6.3 0.0 0.0 0.2 0.0 0.2 0.0 2.2 0.0 0.7 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 1.5 4.4 0.0 0.0 0.0 0.0 1.4 16.3 0.0 3.4 0.8 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.1 7.4 18.3 2.3 8.7 6.6 7.5 13.4 2.3 13.9 0.1 3.2 3.5 0.0 0.0 0.5 1.3 0.1 51.2 0.3 1.4 3.4 24.1 0.0 0.1 1.8 0.0 0.7 0.0 379.5 0.0 2.1 47.9 0.0 0.1 0.0 2.7 0.7 1.8 12.7 0.0 4.9 0.0 0.0 0.6 0.0 3.1 0.0 3.7 0.4 0.4 0.0 5.0 7.7 46.9 0.0 0.3 5.2 0.2 0.0 0.1 3.6 1.0 0.0 26.3 1.0 7.5 4.4 0.0 31.2 0.0 0.7 0.3 23.0 0.2 0.1 240.4 0.0 0.2 0.3 0.6 0.3 3.0 67.5 0.0 3.0 0.3 52.9 0.2 LRIT2 "AC022389.4, LRRC22" ENSG00000204033 "Leucine rich repeat, Ig-like and transmembrane domains 2" A6NDA9 10 84220571-84225544 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "retina: 59.0" "Group enriched" "Detected in some" 4 "Bipolar cells: 7.5;Cone photoreceptor cells: 8.4;Rod photoreceptor cells: 24.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037788 Enhanced NA NA "Cluster 79: Retina - Phototransduction" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA037788: AB_10672393" "unprognostic (3.12e-1)" "unprognostic (1.09e-3)" "unprognostic (3.99e-1)" "unprognostic (9.44e-2)" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.5 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 59.0 0.0 0.0 0.0 3.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.3 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RGR RP44 ENSG00000148604 "Retinal G protein coupled receptor" P47804 10 84230666-84259960 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 139.0" "Cell type enriched" "Detected in some" 29 "Muller glia cells: 1475.8" "Cancer enriched" "Detected in single" 4 "glioma: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "midbrain: 23.4;olfactory bulb: 49.7;thalamus: 27.3" HPA059149 Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 77: Retina - Visual perception" "Cluster 5: Muller glia cells - Visual perception" Vesicles "Plasma membrane, Cytosol" "HPA059149: " "unprognostic (9.28e-2)" "unprognostic (1.05e-1)" "unprognostic (1.37e-1)" "unprognostic (9.53e-2)" "unprognostic (4.57e-2)" "unprognostic (1.57e-1)" "unprognostic (1.59e-1)" "unprognostic (1.97e-1)" 0.2 0.0 11.9 0.0 11.9 0.0 0.1 4.4 14.6 0.0 14.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.5 7.4 8.5 0.0 0.0 0.2 0.0 5.2 8.2 0.0 0.0 0.0 0.4 0.0 5.4 0.0 0.0 139.0 0.1 0.0 0.0 0.1 0.1 0.0 3.1 0.0 0.2 0.9 10.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 11.9 4.4 14.6 7.4 8.5 5.2 8.2 5.4 3.1 10.1 6.2 0.0 0.0 0.0 6.8 0.0 0.0 0.1 0.0 0.0 20.6 0.1 0.1 0.4 0.0 0.0 0.0 31.3 0.0 0.0 0.1 0.0 0.0 8.6 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 10.6 0.3 0.0 0.0 0.0 0.0 1475.8 0.0 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.6 0.0 2.8 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRIT1 "DKFZP434K091, FIGLER9, LRRC21, PAL" ENSG00000148602 "Leucine rich repeat, Ig-like and transmembrane domains 1" Q9P2V4 10 84231520-84241546 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 25.7" "Group enriched" "Detected in some" 4 "Bipolar cells: 13.6;Early spermatids: 31.2;Late spermatids: 38.5;Spermatocytes: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 77: Retina - Visual perception" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (2.13e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 31.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 38.5 0.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 13.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCSER2 "FAM190B, KIAA1128" ENSG00000107771 "Coiled-coil serine rich protein 2" Q9H7U1 10 84328586-84518521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 16 "Early spermatids: 1945.3;Late spermatids: 5466.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037481, HPA037482" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA037481: AB_10672385, HPA037482: AB_10671501" "unprognostic (4.06e-3)" "unprognostic (4.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.71e-2)" "unprognostic (4.16e-3)" "unprognostic (2.43e-1)" "unprognostic (5.60e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-1)" "unprognostic (3.02e-2)" "unprognostic (1.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.83e-2)" "unprognostic (8.56e-2)" "unprognostic (1.33e-1)" "unprognostic (5.74e-2)" 20.1 10.0 22.4 9.4 22.1 9.6 13.7 28.6 23.1 18.4 15.8 20.7 11.5 18.9 15.3 27.8 10.2 12.2 55.7 22.4 28.3 11.6 12.7 16.5 12.1 31.0 25.1 13.6 11.8 11.4 6.6 10.7 32.2 14.6 12.2 18.5 9.5 15.5 66.2 13.3 11.3 24.7 25.4 10.3 10.8 63.1 31.0 16.3 24.5 62.9 11.3 16.5 11.0 26.8 17.1 13.0 15.2 33.7 21.4 35.1 10.7 20.2 33.1 12.3 23.8 7.4 17.7 11.4 12.9 37.1 19.7 14.2 11.5 12.8 18.4 37.5 7.2 4.1 5.8 9.3 20.1 6.1 8.3 17.4 18.1 19.8 62.2 31.5 33.7 21.0 5.4 33.6 22.2 10.6 10.6 4.3 6.6 5.9 10.3 10.6 7.8 4.2 11.0 17.8 4.6 8.4 11.1 7.3 34.7 20.9 13.4 3.0 30.5 36.7 16.6 18.2 21.5 33.5 12.2 9.0 23.7 7.7 16.2 4.9 4.3 7.7 19.4 3.9 19.8 7.5 14.3 18.2 4.1 6.9 12.8 13.8 5.9 20.3 3.2 6.2 9.6 8.5 22.4 22.1 28.6 23.1 22.4 28.3 31.0 25.1 32.2 25.4 31.0 26.8 50.9 41.7 40.8 120.2 28.8 35.3 57.8 28.1 22.8 87.0 43.7 43.1 218.6 12.8 32.6 16.5 31.3 24.9 101.2 16.1 37.2 31.3 1945.3 21.2 33.9 54.1 16.3 3.0 146.7 45.8 19.3 52.2 21.4 28.8 14.5 28.5 37.1 24.0 20.9 62.2 142.5 28.9 22.4 21.4 66.2 5466.2 51.6 29.2 26.6 124.6 39.5 58.5 81.4 209.6 222.3 34.1 13.8 59.8 42.1 55.4 49.6 26.1 22.0 55.9 13.1 61.8 65.3 103.6 84.0 36.4 47.0 68.4 90.4 30.0 21.4 67.2 GRID1 "GluD1, KIAA1220" ENSG00000182771 "Glutamate ionotropic receptor delta type subunit 1" Q9ULK0 10 85599552-86366795 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.4" "Group enriched" "Detected in some" 19 "Astrocytes: 149.8;Excitatory neurons: 284.5;Inhibitory neurons: 301.2;Oligodendrocyte precursor cells: 316.2;Oligodendrocytes: 534.1" "Group enriched" "Detected in many" 5 "glioma: 3.6;thyroid cancer: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.4;HEL: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 36: HEL - Hemostasis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "unprognostic (7.60e-2)" "unprognostic (2.75e-2)" "unprognostic (5.92e-2)" "unprognostic (4.31e-2)" "unprognostic (4.24e-1)" "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (4.21e-2)" "unprognostic (5.09e-2)" "unprognostic (1.49e-3)" "unprognostic (8.30e-2)" "unprognostic (8.26e-2)" "unprognostic (4.58e-9)" "unprognostic (3.15e-3)" "unprognostic (5.91e-2)" "unprognostic (2.21e-1)" "unprognostic (8.65e-3)" 0.6 0.9 5.3 0.1 5.7 0.0 0.8 3.9 6.9 1.5 0.1 0.3 0.3 1.0 0.7 0.2 1.2 0.2 0.2 5.5 5.4 0.1 0.1 0.4 0.3 5.4 5.4 0.3 0.2 0.2 0.2 0.7 4.8 0.4 0.1 0.7 0.1 0.9 0.2 0.4 0.3 0.4 5.6 0.0 0.4 0.9 5.7 0.1 2.0 0.0 0.2 0.1 0.6 7.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.6 2.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.7 3.9 6.9 5.5 5.4 5.4 5.4 4.8 5.6 5.7 7.4 1.1 3.2 0.5 149.8 0.0 0.5 0.1 0.1 2.2 10.5 0.0 0.1 1.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.0 0.0 0.3 0.3 0.0 0.0 284.5 0.2 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 301.2 0.0 0.0 0.0 0.4 3.0 2.1 0.2 5.4 15.9 0.0 0.8 0.0 316.2 534.1 0.0 0.0 4.5 0.0 0.2 0.0 0.0 0.0 0.5 13.1 0.2 5.7 0.1 0.9 0.2 0.0 0.1 0.1 0.0 0.0 0.0 WAPL "FOE, KIAA0261, WAPAL" ENSG00000062650 "WAPL cohesin release factor" Q7Z5K2 10 86435256-86521792 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037874, HPA037875, HPA066141" Enhanced Supported Nucleoplasm NA NA "Cluster 42: Non-specific - Transcription" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: " "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (3.03e-2)" "unprognostic (2.91e-2)" "unprognostic (6.63e-2)" "unprognostic (3.51e-1)" "unprognostic (3.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (5.78e-2)" "unprognostic (5.56e-2)" "unprognostic (7.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (4.56e-1)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" 15.4 13.2 8.4 19.6 9.9 27.1 16.6 11.9 9.2 12.8 7.8 15.4 15.2 14.8 8.7 15.9 11.7 13.1 10.3 7.5 8.3 16.8 22.6 16.5 25.0 8.2 8.5 13.7 14.4 16.9 4.9 18.4 8.3 13.0 15.2 36.0 11.2 11.7 20.9 17.9 16.0 14.8 8.9 19.0 16.5 35.1 9.0 33.7 17.9 22.5 27.7 17.9 9.2 10.4 42.6 19.6 33.5 44.4 26.1 27.6 29.6 36.4 44.2 30.3 32.4 42.9 36.6 64.3 24.1 32.5 26.7 39.1 38.3 31.3 46.3 42.1 25.3 38.9 30.9 47.4 29.7 79.8 43.1 21.9 35.7 38.9 64.9 34.5 34.6 36.8 41.7 37.6 35.2 36.3 49.9 29.6 29.9 26.4 19.5 35.2 27.1 25.6 26.3 37.2 13.1 25.2 32.3 21.4 40.9 33.2 47.1 41.9 33.5 29.1 34.4 25.8 48.6 36.8 54.9 66.9 26.7 55.8 20.9 15.0 3.5 7.7 3.4 4.1 4.9 3.9 4.5 4.7 4.8 4.0 5.1 4.0 5.5 3.2 7.4 3.6 6.1 2.4 8.4 9.9 11.9 9.2 7.5 8.3 8.2 8.5 8.3 8.9 9.0 10.4 38.3 83.3 54.8 0.0 48.3 0.0 57.4 0.0 35.3 49.1 41.3 27.9 0.0 20.0 21.1 16.5 20.9 42.8 62.4 17.4 21.5 60.8 86.8 36.7 44.4 33.9 18.2 94.1 0.0 52.5 28.3 30.0 37.8 52.2 25.2 40.3 32.5 47.6 40.4 55.5 0.0 21.5 0.0 56.5 0.0 42.0 32.0 58.3 0.0 0.0 81.0 48.7 55.6 0.0 0.0 52.1 27.5 32.4 50.5 56.6 25.0 35.5 13.8 113.4 65.7 70.3 33.6 153.4 90.2 48.4 0.0 76.1 51.4 35.2 24.8 74.1 OPN4 "melanopsin, MOP" ENSG00000122375 "Opsin 4" Q9UHM6 10 86654547-86666848 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Biological rhythms, Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.9;skeletal muscle: 2.5" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 4.6;Excitatory neurons: 2.8;Inhibitory neurons: 1.9;Smooth muscle cells: 2.6" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 7.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039147 Approved NA NA "Cluster 47: Non-specific - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "HPA039147: AB_10673304" "unprognostic (3.67e-3)" "unprognostic (1.40e-2)" "unprognostic (3.02e-2)" "unprognostic (1.62e-1)" "unprognostic (7.03e-3)" "unprognostic (2.89e-2)" "unprognostic (3.26e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (8.88e-3)" "unprognostic (1.93e-6)" "unprognostic (4.10e-2)" "unprognostic (5.58e-2)" "unprognostic (6.76e-2)" 2.0 0.1 1.5 0.0 7.9 0.0 0.7 0.0 3.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.3 0.0 0.2 0.0 0.1 1.1 0.6 0.0 2.5 0.7 0.4 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.8 0.4 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 7.9 0.0 3.0 1.6 0.0 0.1 0.1 0.2 0.1 1.4 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LDB3 "CMD1C, KIAA0613, PDLIM6, ZASP" ENSG00000122367 "LIM domain binding 3" O75112 10 86668507-86736072 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cardiomyopathy, Disease variant, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 26 "heart muscle: 1423.0;skeletal muscle: 2945.6;tongue: 1809.4" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 1825.0" "Group enriched" "Detected in some" 4 "head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 3.0;hTERT-RPE1: 3.3;SCLC-21H: 4.9;SK-MEL-30: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048955 Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 750000 "Cluster 13: Striated muscle - Muscle contraction" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 54: Cardiomyocytes - Muscle contraction" "Focal adhesion sites, Cytosol" Nucleoplasm "HPA048955: AB_2680568" "unprognostic (1.60e-1)" "unprognostic (9.01e-2)" "unprognostic (4.87e-2)" "unprognostic (6.92e-2)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (2.57e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-2)" "unprognostic (7.61e-2)" "unprognostic (2.54e-3)" "unprognostic (3.55e-2)" "unprognostic (4.72e-4)" "unprognostic (3.07e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-2)" "unprognostic (3.16e-1)" 11.1 1.4 12.8 2.8 39.6 0.4 6.5 29.8 29.0 10.1 0.1 36.2 2.4 15.1 4.9 54.5 17.3 3.1 1423.0 14.7 23.3 2.0 0.8 5.1 0.5 55.5 36.9 6.4 1.3 0.5 2.4 2.7 46.2 38.1 5.3 0.7 20.8 25.2 2945.6 4.8 8.8 23.7 26.4 0.6 9.0 4.7 38.4 0.7 5.2 1809.4 0.3 7.0 10.3 78.4 0.1 0.1 0.2 1.7 0.2 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.5 0.4 0.4 0.7 0.0 0.0 0.0 0.9 3.0 0.2 0.0 0.0 3.3 0.0 0.3 0.1 1.0 0.0 0.8 0.2 0.1 0.2 0.2 0.2 0.0 1.1 0.0 0.0 0.6 4.9 0.9 0.2 0.1 2.4 0.7 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.3 0.2 0.4 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.8 39.6 29.8 29.0 14.7 23.3 55.5 36.9 46.2 26.4 38.4 78.4 1.5 0.0 0.0 1.0 0.0 1.0 0.5 0.2 0.0 1.5 0.2 0.3 1825.0 0.0 0.2 1.8 0.0 0.1 0.0 0.0 0.0 0.0 23.4 0.1 0.4 15.5 0.0 0.0 4.5 1.1 0.0 31.5 0.0 0.2 0.0 0.9 0.0 0.0 0.1 0.0 2.6 0.0 4.1 0.0 1.2 19.6 11.1 0.5 1.8 1.9 0.0 0.7 0.0 1.5 245.1 0.1 0.0 6.8 0.0 0.3 0.0 0.1 0.1 4.1 39.5 48.0 54.9 1.0 1.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 BMPR1A "ACVRLK3, ALK3, CD292" ENSG00000107779 "Bone morphogenetic protein receptor type 1A" P36894 10 86756601-86932825 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 142.7;Inhibitory neurons: 79.9;Oligodendrocyte precursor cells: 122.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB019398 Approved Approved Cytosol NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 68: Oligodendrocytes - Mixed function" Cytosol "CAB019398: " "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (3.34e-1)" "unprognostic (9.61e-2)" "unprognostic (1.05e-3)" "unprognostic (9.34e-2)" "prognostic unfavorable (8.93e-4)" "unprognostic (3.64e-1)" "unprognostic (2.38e-2)" "unprognostic (1.53e-1)" "unprognostic (9.24e-2)" "unprognostic (9.42e-2)" "unprognostic (4.32e-2)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "unprognostic (1.01e-2)" "unprognostic (1.07e-1)" 9.1 6.4 4.3 4.5 5.2 0.0 10.3 5.4 5.5 8.1 4.9 9.9 5.4 12.9 11.9 7.8 7.4 9.6 7.8 4.7 6.1 7.0 4.3 7.3 2.9 6.8 5.8 11.6 5.8 9.9 2.6 6.5 6.3 12.5 8.2 4.8 12.1 13.0 7.9 9.3 8.6 12.5 6.2 2.9 7.3 5.2 4.6 2.9 19.1 4.8 3.0 7.9 4.1 6.5 14.6 7.8 27.6 26.8 15.0 10.6 5.5 14.5 18.3 9.4 11.3 11.0 13.1 4.7 6.1 19.2 5.9 15.0 15.8 14.3 14.1 5.5 8.2 5.9 6.9 19.0 10.2 7.4 37.7 10.7 8.5 11.2 9.5 13.9 0.0 8.1 7.6 2.7 12.3 7.0 6.7 7.8 17.6 5.2 4.2 0.0 12.3 0.1 18.9 12.1 3.7 12.8 17.8 8.4 12.6 34.1 15.0 4.1 6.2 7.0 9.8 12.7 13.3 0.3 12.3 5.3 6.5 5.6 6.0 0.3 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.0 4.3 5.2 5.4 5.5 4.7 6.1 6.8 5.8 6.3 6.2 4.6 6.5 3.5 35.3 22.4 142.7 3.5 12.1 7.1 9.9 17.6 7.5 10.2 10.2 22.6 18.6 10.5 11.0 20.9 14.1 2.3 10.7 1.9 10.6 0.7 10.7 19.7 4.5 18.0 0.0 63.8 9.5 1.0 20.6 19.4 13.9 15.2 22.9 9.3 7.2 3.4 11.8 79.9 13.9 8.2 4.8 6.1 4.1 33.5 2.3 8.8 34.7 0.8 12.9 2.1 122.2 64.3 8.9 4.9 31.2 3.2 13.7 10.6 5.5 16.5 20.4 6.6 20.3 19.2 2.1 6.6 11.5 9.8 5.1 4.3 11.9 11.1 6.7 MMRN2 "EMILIN3, EndoGlyx-1, FLJ13465" ENSG00000173269 "Multimerin 2" Q9H8L6 10 86935540-86969481 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 11 "Adipocytes: 229.3;Endothelial cells: 127.1;Hepatic stellate cells: 182.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "CAPAN-2: 89.2;HUVEC TERT2: 196.6;TIME: 237.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020741 Approved Vesicles "Secreted to extracellular matrix" NA NA 84000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "HPA020741: AB_1848154" "unprognostic (4.17e-1)" "unprognostic (7.87e-2)" "unprognostic (6.67e-3)" "unprognostic (3.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.08e-2)" "unprognostic (1.75e-3)" "unprognostic (1.43e-1)" "unprognostic (2.09e-2)" "unprognostic (3.11e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (6.17e-3)" "unprognostic (1.54e-3)" "unprognostic (1.25e-1)" "unprognostic (6.44e-2)" "unprognostic (1.66e-1)" 63.2 13.9 14.0 10.1 12.7 1.5 54.5 11.5 12.5 20.6 11.0 14.2 10.5 28.1 13.8 16.9 22.7 16.6 38.8 11.4 11.9 22.0 8.6 32.1 9.7 13.6 12.4 23.1 10.5 10.6 7.6 73.8 13.7 14.1 8.9 3.0 26.6 28.7 26.8 38.9 13.8 27.3 13.2 34.6 11.9 15.3 15.8 6.5 25.8 32.5 13.3 32.3 19.1 12.0 11.4 2.9 0.4 0.2 1.2 6.3 7.1 4.1 11.1 4.8 6.8 6.4 89.2 0.1 39.5 7.6 11.6 21.9 0.0 5.2 6.4 8.1 0.0 2.3 10.2 0.2 0.9 0.0 4.6 1.5 26.4 5.7 38.6 13.0 196.6 2.4 2.1 35.0 1.8 7.1 0.4 4.4 2.0 0.4 4.9 0.2 0.1 0.1 2.0 17.5 4.8 0.0 3.1 3.7 1.4 0.9 14.9 1.2 237.1 1.9 11.0 1.9 0.1 2.6 4.0 0.1 5.8 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.0 12.7 11.5 12.5 11.4 11.9 13.6 12.4 13.7 13.2 15.8 12.0 229.3 0.0 5.8 1.6 0.3 9.4 0.9 0.0 4.6 0.2 1.4 2.0 13.2 5.7 0.7 1.8 0.0 0.7 0.4 0.0 0.0 0.1 1.0 0.3 0.4 127.1 0.0 2.7 0.9 0.0 0.1 8.1 0.0 0.5 0.0 0.2 182.0 4.1 1.7 0.0 1.2 0.0 0.0 6.5 4.4 2.8 2.5 0.7 3.6 15.9 0.0 0.7 0.0 1.0 0.1 0.0 0.0 3.0 0.1 0.6 0.5 0.2 0.0 0.6 6.6 3.9 9.4 1.8 2.3 2.2 7.7 0.3 0.8 3.6 0.2 1.0 SNCG "BCSG1, persyn, SR" ENSG00000173267 "Synuclein gamma" O76070 10 86958599-86963258 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 268.3;brain: 411.2" "Cell type enhanced" "Detected in many" "Adipocytes: 164.9;Breast myoepithelial cells: 156.1;Endothelial cells: 143.3;Hepatic stellate cells: 206.0;Smooth muscle cells: 234.3;Urothelial cells: 358.3" "Group enriched" "Detected in all" 8 "ovarian cancer: 84.1;urothelial cancer: 301.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 748.2;RT4: 483.5;T-47d: 151.7;TIME: 160.9" "Region enhanced" "Detected in all" "pons and medulla: 279.9" "Low region specificity" "Detected in many" "CAB001452, HPA014404, CAB040581, CAB080022" Enhanced Supported NA NA 23000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" "CAB001452: AB_564020, CAB040581: , CAB080022: , HPA014404: AB_1857715" "unprognostic (2.06e-1)" "unprognostic (2.58e-1)" "unprognostic (6.87e-3)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (4.76e-3)" "unprognostic (8.99e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-3)" "unprognostic (3.75e-1)" "prognostic unfavorable (2.29e-8)" "prognostic unfavorable (7.15e-4)" "unprognostic (2.35e-1)" "unprognostic (2.36e-2)" "unprognostic (3.77e-3)" 208.2 268.3 215.6 11.9 150.8 0.0 98.1 199.9 313.3 33.3 44.0 27.0 9.2 22.9 15.1 25.4 64.5 12.7 31.7 190.2 387.7 22.3 4.3 13.9 11.6 411.2 276.4 42.1 5.3 3.3 11.1 11.9 357.8 36.6 4.9 52.7 22.9 101.6 14.6 28.6 18.8 10.1 155.3 64.2 16.4 5.4 304.7 9.0 20.3 13.7 25.6 204.8 38.9 148.8 2.6 6.8 0.7 1.1 0.3 3.9 0.7 0.8 0.0 0.0 0.0 1.1 748.2 0.0 22.6 1.4 0.0 71.0 0.0 3.4 0.0 0.1 1.4 3.6 109.6 2.0 1.4 0.0 1.8 2.8 55.5 0.0 0.6 0.2 49.8 0.0 5.3 0.0 0.0 0.6 0.2 0.4 11.3 0.0 0.4 0.0 0.4 0.3 0.2 483.5 0.1 0.0 6.5 8.7 0.9 1.0 151.7 0.3 160.9 1.1 3.7 0.3 0.0 0.2 0.0 0.0 0.8 3.6 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 215.6 150.8 199.9 313.3 190.2 387.7 411.2 276.4 357.8 155.3 304.7 148.8 164.9 0.0 0.0 7.5 1.5 28.8 65.9 16.3 11.4 32.2 61.1 156.1 1.9 8.6 14.6 55.2 6.2 19.4 2.8 0.1 125.2 3.6 0.6 0.4 0.8 143.3 0.0 2.7 9.9 1.1 0.6 14.2 0.5 0.6 0.0 0.1 206.0 0.8 5.5 87.5 28.0 0.0 20.3 1.8 27.3 3.7 59.0 2.2 23.2 6.5 0.9 66.4 0.0 4.5 7.5 4.7 2.2 9.8 0.0 14.2 0.3 1.3 2.4 109.3 92.1 2.5 234.3 0.6 0.7 2.6 19.7 6.2 2.7 16.9 0.0 358.3 ADIRF "AFRO, APM2, C10orf116" ENSG00000148671 "Adipogenesis regulatory factor" Q15847 10 86968432-86983934 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 1238.9" "Cell type enriched" "Detected in many" 4 "Proximal enterocytes: 12067.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 2.5;naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 8 "T-cells: 2.5" "Cell line enhanced" "Detected in many" "HaCaT: 847.5;PC-3: 680.7;RT4: 1035.2" "Low region specificity" "Detected in all" HPA026810 Approved Supported Nucleoplasm,Cytosol NA NA 760000 "Cluster 32: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 15: RT4 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Cytosol" "HPA026810: AB_2672003" 1238.9 58.8 253.4 50.9 238.3 1.0 246.1 221.8 380.1 201.9 226.1 114.2 476.9 114.1 49.1 114.2 235.9 46.7 90.6 251.6 278.5 147.2 82.5 209.5 15.5 259.4 237.0 252.6 73.2 26.9 55.1 28.4 241.8 312.5 48.1 29.0 296.8 233.8 87.5 115.6 491.6 75.8 239.8 73.6 75.2 27.2 242.7 25.8 116.6 131.9 44.7 242.9 171.1 247.4 259.8 4.9 0.1 0.1 123.3 224.9 16.1 97.0 166.9 1.7 0.4 6.5 29.5 0.0 3.4 209.9 8.4 847.5 0.0 39.7 1.0 9.1 0.0 0.0 22.5 1.8 19.9 0.2 3.4 1.9 132.0 0.6 70.1 6.7 50.4 3.6 0.3 36.3 4.0 130.4 0.6 6.5 0.0 6.4 680.7 0.5 0.0 3.4 14.6 1035.2 11.8 3.0 36.0 222.0 1.7 0.0 270.7 2.7 132.6 3.4 17.4 13.2 0.6 4.0 3.3 0.4 6.3 0.0 5.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.3 0.0 2.5 1.9 0.0 0.0 0.0 0.0 0.5 0.3 253.4 238.3 221.8 380.1 251.6 278.5 259.4 237.0 241.8 239.8 242.7 247.4 1215.2 1842.9 476.5 3.9 15.0 528.4 141.9 309.7 39.9 5.4 651.4 253.2 0.0 58.6 614.4 187.6 2.1 299.2 14.3 658.7 1352.0 29.9 9.6 55.7 63.9 944.9 30.0 37.5 0.1 272.1 16.9 508.0 121.3 195.1 48.9 11.7 1691.7 257.4 26.4 0.0 0.3 418.7 128.1 17.3 492.0 48.4 1309.5 25.3 610.1 10.3 99.9 703.9 0.0 1.0 0.2 336.8 1115.3 469.8 3.4 481.9 12067.2 1144.8 88.2 16.5 1472.6 705.4 2422.0 3.2 6.2 35.0 438.6 166.8 40.7 2.4 443.5 1160.7 FAM25A bA96C23.5 ENSG00000188100 "Family with sequence similarity 25 member A" B3EWG3 10 87020294-87024730 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 143.3;esophagus: 519.5;salivary gland: 140.0;skin 1: 175.0;vagina: 193.1" "Group enriched" "Detected in some" 4 "Suprabasal keratinocytes: 49.6;Syncytiotrophoblasts: 16.1" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 53.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A-431: 30.3;SK-BR-3: 70.0" "Low region specificity" "Detected in single" HPA044808 Uncertain NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA044808: AB_2679096" "unprognostic (9.94e-2)" "unprognostic (2.57e-1)" "unprognostic (7.62e-2)" "unprognostic (1.03e-1)" "unprognostic (2.02e-1)" "unprognostic (1.05e-5)" "unprognostic (1.21e-1)" 0.3 2.0 0.0 0.0 0.0 0.0 5.7 0.0 0.1 143.3 0.0 0.1 0.0 0.1 0.0 519.5 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.1 1.5 0.0 0.1 0.0 0.0 140.0 0.0 1.2 175.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 1.4 0.0 0.0 63.6 0.1 193.1 0.1 30.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.3 0.0 0.0 0.2 0.0 0.0 9.0 0.1 0.0 0.0 0.2 2.0 0.0 0.3 0.0 1.6 1.2 0.0 0.0 0.0 70.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.8 2.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 49.6 16.1 0.0 0.0 0.0 1.9 GLUD1 "GDH, GLUD" ENSG00000148672 "Glutamate dehydrogenase 1" P00367 10 87050202-87094843 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 816.4" "Cell type enhanced" "Detected in all" "Astrocytes: 294.1;Hepatocytes: 402.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 555.0" "Low region specificity" "Detected in all" "HPA042492, HPA044839, HPA061369" Approved Supported Mitochondria "Intracellular and membrane" NA NA 23000000 "Cluster 26: Non-specific - Mitochondria" "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 41: Macrophages - Immune response" Mitochondria "HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494" "unprognostic (1.48e-1)" "unprognostic (1.26e-2)" "unprognostic (3.55e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.81e-4)" "unprognostic (1.31e-1)" "unprognostic (1.91e-2)" "unprognostic (5.50e-2)" "unprognostic (2.06e-1)" "unprognostic (4.57e-3)" "prognostic unfavorable (1.76e-5)" "unprognostic (1.13e-1)" "prognostic favorable (1.44e-6)" "unprognostic (2.29e-1)" "unprognostic (4.23e-2)" "unprognostic (7.19e-2)" "unprognostic (4.27e-2)" 70.1 93.0 217.2 44.8 219.0 29.2 96.4 180.4 216.8 50.2 135.8 63.4 80.9 48.1 30.0 77.0 47.4 53.3 75.6 193.3 223.2 249.2 816.4 57.7 42.9 220.9 222.9 71.6 66.2 39.0 37.1 58.8 202.3 110.5 61.5 90.2 55.6 53.2 51.1 84.2 88.6 53.3 223.2 46.4 57.0 22.3 254.6 44.8 68.1 64.4 59.2 68.1 55.6 202.3 127.1 100.3 77.1 131.5 143.0 174.5 84.0 97.7 167.8 92.4 100.5 233.0 120.6 141.5 77.8 143.4 53.0 194.7 101.4 98.5 98.0 102.7 79.8 69.0 55.9 555.0 318.1 163.2 95.5 121.3 181.5 103.2 304.9 140.3 112.0 109.3 70.7 124.0 101.0 92.1 148.1 145.7 88.2 136.9 79.8 110.4 98.3 93.1 267.4 101.8 39.7 73.9 87.8 68.8 126.1 73.9 94.3 112.8 112.4 47.8 42.5 98.2 101.0 73.6 81.4 167.5 115.3 182.8 29.3 9.1 14.2 9.7 8.3 11.1 10.3 9.8 11.2 10.1 15.9 11.3 9.9 8.0 1.2 13.6 16.0 5.9 12.6 6.5 217.2 219.0 180.4 216.8 193.3 223.2 220.9 222.9 202.3 223.2 254.6 202.3 49.3 22.4 23.9 294.1 56.6 106.0 57.5 32.2 105.3 22.5 83.3 38.2 60.2 57.2 47.3 60.7 37.5 95.7 45.6 56.1 156.5 32.5 14.2 37.3 44.0 54.1 39.4 52.6 35.8 33.8 63.8 89.0 86.2 59.7 43.2 33.6 50.7 402.3 69.1 15.2 38.0 49.5 36.7 74.1 184.5 26.0 88.0 81.4 104.9 42.2 50.6 140.0 39.1 48.7 42.9 50.2 38.3 90.7 75.7 103.4 124.2 175.5 21.6 68.9 65.7 41.3 55.9 11.4 8.6 189.5 122.3 47.6 84.6 70.9 49.6 107.3 SHLD2 "bA163M19.1, FAM35A, FAM35A1, MGC5560, RINN2" ENSG00000122376 "Shieldin complex subunit 2" Q86V20 10 87094161-87191465 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 31.3;Endometrial stromal cells: 28.6;Glandular and luminal cells: 29.0;Proximal tubular cells: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036582 Uncertain Approved "Nucleoplasm,Actin filaments" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Actin filaments" "HPA036582: AB_10670233" "unprognostic (1.08e-1)" "unprognostic (2.72e-1)" "prognostic favorable (6.06e-4)" "unprognostic (1.77e-1)" "prognostic favorable (3.09e-4)" "unprognostic (5.34e-2)" "unprognostic (2.68e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (8.20e-2)" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (1.29e-3)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" "unprognostic (6.44e-3)" "unprognostic (3.61e-2)" 15.6 20.1 10.8 12.6 8.4 9.6 17.3 7.3 10.0 11.9 10.2 15.7 22.3 11.4 7.0 12.8 11.2 10.7 10.3 8.6 10.5 32.1 37.2 11.6 13.1 27.5 10.9 12.7 12.4 6.1 10.9 9.7 8.8 14.9 16.5 15.6 14.3 9.5 10.6 12.0 24.8 12.2 9.3 11.9 12.0 8.0 10.1 10.4 23.3 11.7 14.4 13.3 11.2 8.7 33.6 26.7 14.9 34.4 16.4 15.8 21.7 22.1 31.0 29.0 31.8 30.8 25.2 24.4 12.1 30.2 17.0 21.9 37.2 16.9 29.8 35.1 24.6 33.9 24.3 29.1 25.4 53.4 28.5 14.5 30.4 26.6 45.4 25.6 19.6 26.3 43.7 42.7 27.2 19.2 43.7 37.8 17.2 24.2 18.4 26.8 29.6 27.0 26.6 27.7 7.4 30.6 17.1 19.9 29.8 13.7 44.0 29.6 19.4 16.5 15.0 24.8 44.7 23.9 55.8 58.5 27.8 65.4 9.1 7.1 7.3 2.8 6.7 11.8 13.7 9.2 10.0 10.0 11.3 8.8 10.0 10.1 0.1 12.5 9.5 3.9 10.4 8.7 10.8 8.4 7.3 10.0 8.6 10.5 27.5 10.9 8.8 9.3 10.1 8.7 21.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 20.9 13.2 0.0 0.0 0.0 5.5 0.0 7.2 17.4 0.0 31.3 12.6 0.0 16.7 28.6 4.2 0.0 0.0 0.0 13.7 15.1 7.9 0.0 29.0 0.0 20.2 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 8.8 0.0 0.0 0.0 0.0 14.7 0.0 0.0 7.6 0.0 0.0 48.2 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 2.2 7.8 19.1 0.0 0.0 NUTM2A FAM22A ENSG00000184923 "NUT family member 2A" Q8IVF1 10 87225448-87236908 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 10.2" HPA064635 Approved "Nuclear bodies" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear bodies" "HPA064635: " "unprognostic (1.75e-2)" "unprognostic (1.33e-2)" "unprognostic (1.03e-1)" "unprognostic (8.29e-2)" "unprognostic (5.67e-2)" "unprognostic (8.08e-2)" "unprognostic (1.75e-2)" "unprognostic (6.84e-2)" "unprognostic (2.46e-3)" "unprognostic (1.75e-2)" "unprognostic (7.24e-2)" "unprognostic (1.40e-1)" "unprognostic (4.24e-3)" "unprognostic (1.35e-1)" "unprognostic (1.11e-1)" "unprognostic (1.96e-2)" "unprognostic (2.65e-1)" 1.4 1.1 1.8 0.5 2.6 0.9 1.1 0.8 2.8 0.9 0.0 1.3 0.7 1.4 0.9 0.9 1.0 0.5 2.2 1.2 1.7 1.3 1.3 1.1 0.6 3.2 2.2 1.3 1.7 1.4 1.5 0.7 2.5 1.6 0.5 0.6 2.4 0.4 1.3 1.8 1.2 0.4 1.1 1.3 1.5 2.0 2.9 1.0 1.5 1.6 0.3 1.1 1.2 4.4 1.4 0.1 0.8 0.0 1.3 0.6 0.7 0.6 1.3 0.6 0.4 0.3 0.6 1.2 0.1 0.0 0.2 1.1 0.0 0.9 0.1 0.4 1.0 2.0 0.3 0.3 0.6 0.8 10.2 0.4 3.2 1.0 1.0 1.2 0.0 1.9 1.9 0.3 0.1 1.0 1.0 2.0 2.3 0.0 0.3 1.5 0.1 0.0 0.4 0.1 1.2 2.0 0.6 0.5 0.5 0.1 0.6 0.8 1.4 0.0 0.3 0.6 0.2 0.0 0.2 0.6 0.6 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.6 0.8 2.8 1.2 1.7 3.2 2.2 2.5 1.1 2.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 NUTM2D FAM22D ENSG00000214562 "NUT family member 2D" Q5VT03 10 87357720-87370695 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.2;Cone photoreceptor cells: 4.2;Gastric mucus-secreting cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 12.4;hTCEpi: 11.7" HPA064635 Approved "Nuclear bodies" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear bodies" "HPA064635: " "unprognostic (2.13e-1)" "unprognostic (7.95e-2)" "unprognostic (3.94e-2)" "unprognostic (2.16e-1)" "unprognostic (9.69e-2)" "unprognostic (2.29e-1)" "unprognostic (7.35e-4)" "unprognostic (1.87e-1)" "unprognostic (2.62e-2)" "unprognostic (2.45e-1)" "unprognostic (2.46e-1)" "unprognostic (3.57e-1)" "unprognostic (7.76e-3)" "unprognostic (1.00e-2)" "unprognostic (1.16e-1)" "unprognostic (1.80e-1)" "unprognostic (2.32e-1)" 3.1 3.0 5.3 1.4 7.2 2.4 3.1 4.5 8.4 2.4 0.2 3.6 2.1 3.0 3.4 2.8 3.1 2.6 5.6 4.5 4.9 4.8 4.2 3.3 2.1 8.1 7.0 3.7 4.7 4.1 4.8 2.5 7.0 4.5 2.0 2.7 3.9 2.0 3.8 4.7 3.2 1.3 3.6 3.7 4.0 4.9 7.1 2.5 4.5 2.9 1.6 3.1 3.1 10.5 3.9 2.8 6.1 0.0 1.6 2.3 1.4 1.0 5.0 2.2 2.5 1.8 1.9 3.3 0.9 1.7 1.0 1.8 0.1 2.0 1.0 2.2 2.7 4.9 0.2 2.8 3.8 3.1 12.4 3.7 11.7 2.5 1.9 3.4 2.2 4.3 5.2 0.8 0.5 3.5 2.4 5.2 3.4 0.8 0.3 3.3 0.4 0.1 2.2 0.8 2.4 3.7 1.1 2.6 1.2 2.3 4.9 2.4 5.5 1.5 1.0 1.4 1.8 4.0 2.4 0.9 0.9 1.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.2 4.5 8.4 4.5 4.9 8.1 7.0 7.0 3.6 7.1 10.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 0.3 0.3 1.2 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.1 0.0 0.0 0.2 1.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 MINPP1 MIPP ENSG00000107789 "Multiple inositol-polyphosphate phosphatase 1" Q9UNW1 10 87504875-87553461 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 288.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026859 Approved "Intracellular and membrane" NA NA 370000000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 6: Erythroid cells - Oxygen transport" "HPA026859: AB_1853961" "unprognostic (9.15e-2)" "unprognostic (8.76e-3)" "unprognostic (2.08e-2)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (5.20e-3)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (4.55e-1)" "unprognostic (2.07e-2)" "unprognostic (6.54e-2)" "unprognostic (6.50e-3)" "prognostic unfavorable (6.98e-5)" "unprognostic (2.43e-1)" "unprognostic (2.09e-1)" "unprognostic (2.07e-1)" "unprognostic (7.01e-2)" 8.5 21.3 6.6 7.2 6.7 31.1 9.4 6.9 9.1 8.8 9.4 12.6 17.6 7.0 10.0 3.6 8.5 8.4 5.8 6.8 8.0 17.5 29.1 8.3 7.7 6.4 6.8 8.8 11.9 9.0 8.1 18.9 6.4 11.7 12.9 11.9 6.9 7.6 4.9 9.1 13.6 7.6 6.9 6.9 8.5 7.9 7.7 8.1 11.6 5.7 7.0 8.6 5.7 7.4 18.6 28.1 28.1 40.9 46.4 38.1 23.2 29.5 51.1 28.8 38.3 15.0 35.5 16.4 27.0 35.9 19.4 28.2 29.9 27.1 33.2 37.1 35.7 41.1 10.4 55.7 34.6 18.0 36.0 33.7 34.7 32.6 19.5 52.5 37.0 14.3 24.5 75.9 34.4 13.8 11.9 25.6 20.0 14.2 20.2 0.0 15.8 11.0 38.5 10.4 10.2 31.5 28.1 5.9 51.5 31.5 16.7 14.7 32.4 18.3 21.9 22.1 28.7 24.5 27.1 4.2 29.3 26.8 13.7 10.5 10.8 4.9 11.5 13.8 10.1 8.7 10.8 13.0 14.3 8.2 10.2 11.4 0.7 11.7 12.5 8.2 17.3 10.5 6.6 6.7 6.9 9.1 6.8 8.0 6.4 6.8 6.4 6.9 7.7 7.4 11.7 6.4 12.8 9.1 8.1 2.8 8.3 25.5 8.0 14.4 9.0 4.3 4.9 15.7 16.2 7.3 2.1 20.4 4.9 14.0 5.9 17.2 15.9 7.1 13.4 10.5 13.1 288.9 18.3 16.7 19.2 17.9 7.1 6.7 24.7 17.8 16.4 58.3 12.9 10.1 20.8 25.5 20.3 16.0 5.8 4.0 9.3 8.7 10.6 7.5 11.7 11.1 10.3 25.6 19.1 10.5 17.2 8.2 18.6 6.8 17.1 26.0 19.0 14.8 0.0 4.8 11.1 10.6 12.1 4.0 3.4 8.1 8.2 13.7 11.6 4.4 PAPSS2 ATPSK2 ENSG00000198682 "3'-phosphoadenosine 5'-phosphosulfate synthase 2" O95340 10 87659613-87747705 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 135.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 240.4;Distal enterocytes: 202.4;Hepatocytes: 111.5;Proximal enterocytes: 181.3;Theca cells: 96.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 4.0;myeloid DC: 2.1;non-classical monocyte: 7.7" "Group enriched" "Detected in many" 7 "dendritic cells: 2.1;monocytes: 7.7" "Cell line enhanced" "Detected in many" "BJ: 189.8;fHDF/TERT166: 473.2;HHSteC: 196.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071224, HPA075267" Enhanced Approved Mitochondria No No 16000 "Cluster 7: Monocytes - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 41: Macrophages - Immune response" Mitochondria "HPA071224: AB_2686366, HPA075267: " "unprognostic (3.98e-3)" "unprognostic (7.06e-2)" "unprognostic (4.95e-3)" "unprognostic (1.02e-1)" "unprognostic (2.67e-1)" "unprognostic (1.61e-2)" "unprognostic (4.96e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.33e-6)" "unprognostic (3.50e-2)" "prognostic favorable (6.58e-4)" "unprognostic (1.14e-1)" "unprognostic (4.90e-2)" "unprognostic (6.72e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.21e-5)" "unprognostic (3.46e-3)" 33.3 135.2 6.3 26.6 7.0 2.0 20.9 6.2 9.5 17.8 6.2 79.9 29.5 8.5 3.1 10.2 12.4 20.7 11.6 5.8 6.2 23.8 77.0 70.4 11.0 6.9 6.6 27.5 26.1 2.1 3.0 58.5 7.5 6.7 64.3 2.3 16.4 3.4 4.7 3.5 61.8 16.7 6.8 8.5 9.2 11.7 8.0 3.0 21.3 8.7 14.8 16.6 11.5 7.2 19.9 20.0 6.4 0.3 129.4 164.8 0.3 189.8 157.7 110.4 79.9 1.0 4.1 0.1 9.8 473.2 3.5 8.5 13.9 13.3 125.2 0.2 10.0 8.8 13.4 0.1 196.5 0.2 3.8 58.7 0.3 63.7 5.2 135.6 94.2 1.4 0.0 89.4 79.2 74.1 0.1 0.7 7.4 4.8 24.1 0.4 0.1 0.4 117.5 8.7 0.9 1.6 92.5 3.3 1.1 12.6 13.5 5.3 120.0 38.2 22.5 131.5 13.9 0.3 1.0 0.3 18.3 0.2 0.2 0.0 1.1 0.0 0.0 4.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.6 0.0 7.7 0.0 0.0 0.8 6.3 7.0 6.2 9.5 5.8 6.2 6.9 6.6 7.5 6.8 8.0 7.2 49.5 240.4 38.2 3.6 2.6 2.3 0.9 18.0 1.8 0.2 11.5 4.7 4.4 8.6 13.8 9.2 0.0 0.5 0.8 202.4 13.7 6.4 1.2 2.6 18.7 23.2 12.6 5.2 22.2 30.2 0.8 36.1 15.3 11.6 0.0 20.3 36.0 111.5 11.5 0.0 27.6 26.5 4.1 29.8 50.7 0.8 17.4 51.0 1.8 30.0 5.2 1.3 0.0 21.6 1.0 19.4 46.1 5.3 3.1 2.1 181.3 9.8 3.4 0.0 13.1 1.0 20.4 1.2 0.7 1.1 1.3 1.4 1.7 96.4 74.3 1.1 ATAD1 "FLJ14600, Msp1" ENSG00000138138 "ATPase family AAA domain containing 1" Q8NBU5 10 87751512-87841361 "Disease related genes, Human disease related genes, Predicted membrane proteins" Translocase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 16 "Early spermatids: 987.5;Late spermatids: 1846.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037569 Uncertain Approved "Nucleoli rim,Mitochondria" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 34: Spermatids - Unknown function" "Nucleoli rim" Mitochondria "HPA037569: AB_10672496" "unprognostic (9.92e-2)" "unprognostic (2.90e-1)" "unprognostic (4.05e-2)" "unprognostic (2.68e-1)" "unprognostic (3.24e-2)" "unprognostic (6.60e-3)" "unprognostic (3.38e-1)" "unprognostic (1.40e-1)" "unprognostic (2.35e-1)" "unprognostic (8.45e-2)" "unprognostic (1.35e-3)" "unprognostic (1.67e-2)" "prognostic favorable (3.98e-6)" "unprognostic (2.35e-1)" "unprognostic (3.29e-1)" "unprognostic (3.45e-2)" "unprognostic (4.22e-2)" 15.7 17.4 9.9 9.0 10.3 4.9 16.3 11.3 12.6 16.0 10.7 18.2 10.9 16.8 13.7 16.2 13.8 10.5 36.1 10.4 11.5 16.7 18.0 14.5 11.8 10.7 11.5 15.9 12.7 28.5 13.4 15.2 11.1 18.7 14.5 28.0 14.9 16.1 37.2 15.1 12.5 13.6 10.0 10.0 13.6 26.4 11.0 13.8 17.4 31.8 12.1 15.5 16.0 10.2 18.8 18.2 20.8 18.2 27.4 29.5 14.4 19.7 33.4 19.6 20.6 14.6 53.8 17.6 15.4 17.3 9.8 31.3 18.9 14.4 21.2 18.6 26.4 15.3 24.0 18.8 30.5 41.7 8.0 23.0 45.4 20.7 42.1 37.2 12.7 14.1 15.9 20.7 22.7 11.2 23.1 22.9 16.4 13.9 10.0 15.8 13.2 19.2 28.9 13.4 14.2 31.5 20.3 12.3 32.0 21.0 29.1 18.0 19.3 16.2 13.9 11.2 24.5 25.4 39.4 22.5 20.8 23.7 11.5 8.4 2.8 4.9 6.3 4.9 10.3 7.2 7.3 8.3 5.4 5.7 9.1 8.6 1.7 8.6 6.9 4.6 7.6 5.7 9.9 10.3 11.3 12.6 10.4 11.5 10.7 11.5 11.1 10.0 11.0 10.2 31.0 54.5 28.0 46.4 41.4 26.8 42.9 46.2 44.3 50.4 29.8 20.8 81.3 27.1 44.9 22.0 35.5 37.7 35.2 33.8 23.5 37.0 987.5 22.3 38.3 21.7 22.8 24.6 69.0 28.0 33.2 35.6 32.6 28.7 29.2 23.1 20.0 28.9 27.3 70.7 73.1 22.9 50.8 18.0 20.1 1846.8 35.8 25.1 32.0 37.5 16.1 59.6 23.7 58.8 52.7 39.0 25.2 47.0 32.3 42.3 20.5 29.5 44.8 54.8 59.2 29.5 43.8 77.2 29.8 34.6 30.1 88.4 40.0 34.8 23.7 54.6 KLLN killin ENSG00000227268 "Killin, p53 regulated DNA replication inhibitor" B2CW77 10 87859158-87863533 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.5" "Cell type enhanced" "Detected in many" "granulocytes: 5.7;Sertoli cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 5.0;Karpas-707: 5.1" HPA074502 Supported Nucleoplasm,Nucleoli No No "Cluster 42: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Nucleoli "HPA074502: AB_2686695" "unprognostic (4.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (3.71e-1)" "unprognostic (6.53e-2)" "unprognostic (1.37e-1)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (3.12e-3)" "unprognostic (1.57e-2)" "unprognostic (4.79e-4)" "unprognostic (1.38e-2)" "unprognostic (1.00e-1)" "unprognostic (9.02e-4)" "unprognostic (1.60e-1)" 1.0 0.7 1.0 0.6 0.7 0.5 0.6 1.5 1.6 0.7 0.6 0.9 0.4 0.5 1.0 0.4 1.4 0.4 0.5 0.7 0.9 0.9 0.9 0.4 0.8 0.5 0.6 0.4 0.2 0.5 0.5 0.6 0.6 0.4 0.8 1.0 0.3 0.5 4.5 0.4 0.4 0.5 0.3 0.8 0.6 1.0 0.6 1.0 0.7 0.5 0.8 0.3 0.3 1.5 0.8 1.0 1.1 0.7 0.5 0.3 0.8 0.7 0.9 0.5 0.7 0.6 2.6 2.0 0.3 0.2 0.5 0.9 0.7 0.8 0.4 0.5 0.3 0.7 1.5 0.6 0.6 1.4 0.5 0.6 0.8 0.7 0.8 0.9 0.3 5.0 0.4 5.1 0.5 1.8 4.1 1.6 0.4 0.6 0.5 2.6 0.1 2.6 0.4 0.8 0.4 1.0 0.9 0.6 0.1 0.7 1.6 1.2 0.3 0.5 0.3 0.9 0.3 2.9 3.3 2.9 0.9 2.9 0.6 1.6 0.3 0.6 0.2 0.5 0.4 0.4 0.3 0.3 0.3 0.5 0.4 0.3 2.5 0.6 0.8 0.5 0.2 0.2 1.0 0.7 1.5 1.6 0.7 0.9 0.5 0.6 0.6 0.3 0.6 1.5 0.6 0.0 0.0 0.3 0.5 0.1 0.3 0.2 0.6 1.7 1.0 1.3 2.7 1.5 1.3 0.0 0.0 0.7 2.0 3.0 0.0 0.2 3.9 0.8 0.9 0.6 0.0 0.8 0.4 0.2 0.4 1.1 3.6 0.4 5.7 0.3 0.7 0.4 0.3 3.3 0.5 1.8 0.0 1.3 0.0 2.0 0.0 0.6 0.0 0.0 0.3 1.6 0.0 0.0 0.1 0.3 2.5 0.0 0.2 0.3 1.8 1.9 2.3 1.0 6.6 1.1 2.9 0.3 1.2 0.6 0.4 0.5 0.7 0.3 1.3 0.2 PTEN "BZS, MHAM, MMAC1, PTEN1, TEP1" ENSG00000171862 "Phosphatase and tensin homolog" P60484 10 87863625-87971930 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Lipid metabolism, Neurogenesis" "Hydrolase, Protein phosphatase" "Autism spectrum disorder, Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 60.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004076, HPA031335" Approved Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 24: NB-4 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm Cytosol "CAB004076: AB_390810, HPA031335: AB_2797221" "unprognostic (8.72e-2)" "unprognostic (2.45e-1)" "unprognostic (5.43e-1)" "unprognostic (1.50e-2)" "unprognostic (3.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.18e-1)" "unprognostic (2.08e-1)" "unprognostic (2.07e-1)" "unprognostic (6.87e-2)" "unprognostic (9.77e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (7.35e-4)" "unprognostic (1.57e-1)" "unprognostic (2.73e-1)" "unprognostic (6.54e-3)" "unprognostic (2.41e-1)" 64.0 25.4 17.8 18.6 19.3 12.9 47.6 34.5 23.4 54.8 15.6 28.1 12.9 27.4 18.6 28.3 35.2 15.6 29.7 20.4 18.4 22.6 39.2 39.5 21.4 16.6 17.8 28.0 33.2 11.9 17.3 30.5 16.4 26.3 14.6 30.0 19.6 16.5 23.7 25.9 24.5 22.2 14.5 40.0 25.6 28.2 19.7 31.8 26.1 14.0 16.5 28.1 38.4 17.6 23.5 10.8 12.3 11.2 28.5 19.7 10.9 12.5 28.0 14.5 20.4 10.9 28.0 28.1 8.0 20.9 8.3 14.1 16.6 14.3 22.8 14.1 4.7 9.3 28.5 13.8 30.1 31.9 15.3 13.5 38.7 18.0 23.7 60.3 20.8 17.7 7.0 72.6 13.5 18.1 17.8 56.3 4.6 19.9 0.0 27.6 6.4 20.8 22.9 13.4 4.5 19.9 16.6 7.9 23.0 9.7 21.9 45.2 17.9 44.6 10.8 18.3 10.1 23.9 32.9 30.7 14.6 29.2 2.9 21.3 14.2 25.8 6.8 21.8 7.2 7.9 7.2 6.6 10.3 6.8 8.3 8.3 60.5 8.9 15.6 8.2 7.0 4.5 17.8 19.3 34.5 23.4 20.4 18.4 16.6 17.8 16.4 14.5 19.7 17.6 67.2 35.3 63.3 83.6 48.3 56.1 57.4 31.5 47.3 113.0 49.4 41.9 46.5 57.2 31.2 29.5 39.6 25.8 64.4 57.7 33.2 24.7 70.1 40.0 114.5 56.0 31.2 52.0 141.0 30.0 62.2 79.3 39.8 33.6 25.4 39.6 53.9 64.1 35.0 45.4 132.4 44.7 12.2 206.1 97.2 92.1 56.8 105.2 62.2 196.8 101.5 61.6 44.3 139.2 95.7 30.6 39.7 54.5 39.3 45.1 50.1 38.0 31.2 61.2 92.1 66.4 170.7 33.5 25.4 45.2 60.1 57.3 46.3 44.7 46.1 64.0 RNLS "C10orf59, FLJ11218, renalase" ENSG00000184719 "Renalase, FAD dependent amine oxidase" Q5VYX0 10 88273864-88584530 "Enzymes, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 103.0;Inhibitory neurons: 101.1;Oligodendrocyte precursor cells: 51.8;Oligodendrocytes: 61.8;Proximal tubular cells: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 18.3;fHDF/TERT166: 17.1;HSkMC: 19.5" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 10500000000 "Cluster 7: Monocytes - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (3.27e-2)" "unprognostic (9.16e-2)" "unprognostic (1.27e-1)" "unprognostic (2.58e-1)" "unprognostic (1.46e-3)" "unprognostic (1.99e-1)" "unprognostic (2.01e-1)" "unprognostic (2.29e-1)" "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (3.98e-1)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "unprognostic (7.74e-3)" "unprognostic (1.37e-2)" "unprognostic (9.80e-2)" "unprognostic (1.71e-1)" 7.1 13.4 2.0 2.8 2.4 2.2 6.7 6.1 3.5 7.4 7.2 7.6 5.5 5.0 5.3 4.9 6.1 5.5 11.8 2.0 2.9 16.6 8.7 3.0 3.8 5.0 6.6 5.8 8.2 9.0 5.3 2.0 5.2 7.0 8.3 4.8 6.0 3.9 11.8 4.3 5.6 3.5 3.4 2.8 6.7 5.3 2.7 2.5 9.1 9.8 4.0 4.7 4.4 3.2 18.3 8.2 0.3 0.1 2.4 2.8 0.0 5.1 0.5 2.7 2.3 1.0 5.2 0.0 8.0 17.1 0.0 2.4 0.0 0.9 2.2 3.8 0.1 2.9 5.1 0.2 11.2 0.0 0.5 19.5 1.4 10.2 0.1 0.3 5.7 0.1 1.4 9.2 0.1 6.3 0.0 3.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.1 4.3 0.1 0.1 4.0 12.4 4.9 2.2 8.9 1.3 2.5 4.1 6.3 3.9 5.3 8.4 0.2 0.0 9.8 0.0 0.0 2.1 1.2 2.3 3.6 1.7 2.4 1.7 1.6 3.1 2.2 1.8 1.4 0.1 2.7 2.3 2.7 0.9 1.8 2.0 2.4 6.1 3.5 2.0 2.9 5.0 6.6 5.2 3.4 2.7 3.2 1.2 3.2 1.5 32.0 5.5 3.2 6.8 5.7 4.0 6.5 5.5 3.9 16.7 4.3 5.8 1.8 2.1 2.0 3.2 6.2 23.5 6.4 8.9 3.8 3.1 1.3 5.4 4.6 103.0 9.6 0.5 6.2 7.1 3.2 1.3 2.2 2.5 10.1 6.5 5.0 101.1 5.5 2.0 4.7 3.8 4.3 1.5 3.8 3.6 40.3 3.7 6.8 3.1 51.8 61.8 4.2 8.9 6.4 3.9 4.4 8.5 43.1 1.6 5.7 0.0 4.6 4.6 4.7 8.2 10.4 5.5 1.6 3.0 2.9 7.2 6.9 LIPJ "bA425M17.2, LIPL1" ENSG00000204022 "Lipase family member J" Q5W064 10 88586753-88606976 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 7.0" "Cell type enriched" "Detected in some" 7 "Early spermatids: 67.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048594 Uncertain Approved "Plasma membrane" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Plasma membrane" "HPA048594: AB_2680456" "unprognostic (4.79e-3)" "unprognostic (6.77e-2)" "unprognostic (4.80e-2)" "unprognostic (2.36e-1)" "unprognostic (2.70e-2)" "unprognostic (9.33e-2)" "unprognostic (2.90e-3)" "unprognostic (7.50e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.73e-2)" "unprognostic (1.73e-2)" "unprognostic (6.21e-4)" "unprognostic (9.87e-2)" "unprognostic (9.57e-2)" "unprognostic (1.85e-1)" "unprognostic (1.88e-1)" 0.2 0.0 0.2 0.1 0.2 0.0 0.2 1.0 0.3 0.1 0.3 0.1 0.3 0.1 0.9 0.0 0.7 0.1 0.1 0.3 0.3 0.2 0.5 0.1 0.3 1.2 0.5 0.1 0.4 0.0 0.1 0.0 0.5 0.3 0.2 0.1 0.3 0.1 0.3 0.1 0.1 0.2 0.4 0.1 0.2 7.0 0.3 0.4 0.6 0.0 0.3 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.0 0.3 0.3 0.3 1.2 0.5 0.5 0.4 0.3 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.1 67.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.5 0.0 0.0 0.6 0.0 9.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 LIPF "HGL, HLAL" ENSG00000182333 "Lipase F, gastric type" P07098 10 88664441-88678814 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 142 "stomach 1: 37213.5" "Cell type enriched" "Detected in some" 444 "Gastric mucus-secreting cells: 1509.7" "Cancer enriched" "Detected in some" 75 "stomach cancer: 278.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 4.1;MOLT-4: 3.4;NTERA-2: 3.4;REH: 2.1;RPMI-8226: 1.8;THP-1: 6.8;U-2 OS: 2.2;U-266/70: 3.1" "Region enriched" "Detected in single" 77 "olfactory bulb: 7.6" HPA045930 Enhanced "Secreted to digestive system" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 4: Stomach - Digestion" "Cluster 3: HMC-1 - Innate immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA045930: AB_10959518" "unprognostic (1.53e-1)" "unprognostic (1.83e-1)" 6.3 2.8 0.0 0.0 0.0 0.0 4.6 0.1 0.0 3.9 0.0 13.0 262.0 1.9 0.0 117.9 5.4 0.0 3.2 0.0 0.0 11.4 4.9 7.3 0.0 0.3 0.1 2.2 4.5 0.0 7.3 0.5 0.1 6.7 0.0 0.0 2.6 0.0 1.6 2.0 1.9 0.0 0.0 2.6 37213.5 2.9 0.0 0.0 1.3 0.0 0.1 2.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 3.4 0.0 0.0 2.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 2.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1509.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LIPK "bA186O14.2, LIPL2" ENSG00000204021 "Lipase family member K" Q5VXJ0 10 88724544-88752756 "Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 32.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SK-BR-3: 2.6" "Not detected" "Not detected" "Secreted in other tissues" NA NA "Cluster 61: Skin - Cornification" "Cluster 8: SK-BR-3 - Unknown function" "unprognostic (7.65e-2)" "unprognostic (8.64e-2)" "unprognostic (3.57e-2)" "unprognostic (3.19e-7)" "unprognostic (1.25e-1)" "unprognostic (1.60e-2)" "unprognostic (2.13e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 32.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 LIPN "bA186O14.3, LIPL4" ENSG00000204020 "Lipase family member N" Q5VXI9 10 88759982-88779626 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase Ichthyosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "skin 1: 26.7" "Group enriched" "Detected in some" 4 "Macrophages: 7.5;monocytes: 2.5" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "classical monocyte: 2.9;eosinophil: 10.3;intermediate monocyte: 7.5;neutrophil: 5.4;non-classical monocyte: 8.5" "Group enriched" "Detected in many" 8 "granulocytes: 10.3;monocytes: 8.5" "Cell line enhanced" "Detected in single" "HL-60: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 61: Skin - Cornification" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" "unprognostic (2.01e-1)" "unprognostic (3.48e-1)" "unprognostic (1.13e-1)" "unprognostic (2.99e-1)" "unprognostic (1.08e-1)" "unprognostic (3.27e-1)" "unprognostic (1.07e-1)" "unprognostic (2.03e-2)" "unprognostic (9.75e-2)" "unprognostic (2.54e-2)" "unprognostic (4.40e-2)" "unprognostic (5.77e-3)" "unprognostic (1.65e-1)" 1.3 0.3 0.0 2.8 0.0 2.8 1.7 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 26.7 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 2.9 10.3 0.0 7.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 5.4 0.0 8.5 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 7.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 LIPM "bA304I5.1, LIPL3" ENSG00000173239 "Lipase family member M" Q5VYY2 10 88802730-88820546 "Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 28.0" "Cell type enriched" "Detected in single" 11 "Suprabasal keratinocytes: 1.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071276 Approved "Endoplasmic reticulum" "Secreted in other tissues" NA NA "Cluster 61: Skin - Cornification" "Cluster 28: Keratinocytes - Keratinization" "Endoplasmic reticulum" "HPA071276: " "unprognostic (7.72e-2)" "unprognostic (8.49e-4)" "unprognostic (1.42e-2)" "unprognostic (2.23e-4)" "unprognostic (6.70e-3)" "unprognostic (3.01e-3)" "unprognostic (5.75e-2)" "unprognostic (6.63e-2)" "unprognostic (5.61e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.59e-2)" "unprognostic (5.93e-2)" "unprognostic (7.05e-3)" "unprognostic (4.17e-2)" "unprognostic (9.02e-2)" "unprognostic (9.70e-6)" 0.1 0.0 0.0 0.2 0.0 0.1 1.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 28.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 ANKRD22 MGC22805 ENSG00000152766 "Ankyrin repeat domain 22" Q5VYY1 10 88819896-88851844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 33.8;skin 1: 30.9;stomach 1: 46.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 37.2;Distal enterocytes: 38.2;Gastric mucus-secreting cells: 49.5;Paneth cells: 51.5;Squamous epithelial cells: 35.8;Suprabasal keratinocytes: 102.9;Urothelial cells: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "neutrophil: 6.4" "Group enriched" "Detected in many" 14 "granulocytes: 6.4;monocytes: 3.1" "Cell line enhanced" "Detected in some" "A-431: 8.6;CAPAN-2: 26.1;HL-60: 9.4;NB-4: 8.7;OE19: 20.9;RT4: 16.4;T-47d: 12.2;U-937: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA012922 Approved Approved Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA012922: AB_1844838" "unprognostic (1.86e-1)" "unprognostic (1.48e-3)" "unprognostic (9.73e-3)" "prognostic favorable (8.73e-6)" "unprognostic (1.18e-1)" "unprognostic (2.81e-2)" "unprognostic (2.39e-2)" "unprognostic (1.50e-1)" "unprognostic (4.57e-2)" "unprognostic (7.21e-3)" "prognostic unfavorable (6.15e-4)" "unprognostic (1.09e-3)" "unprognostic (1.05e-2)" "unprognostic (4.87e-3)" "unprognostic (4.17e-2)" "unprognostic (3.18e-3)" "unprognostic (1.01e-3)" 0.2 0.3 0.6 9.5 0.7 5.4 2.6 0.5 0.9 7.6 0.4 7.2 2.7 0.2 0.3 33.8 0.3 3.2 0.1 0.5 0.7 4.7 2.0 1.5 4.2 1.3 0.8 0.3 12.9 0.8 0.3 0.2 1.1 2.5 7.1 0.1 4.9 0.1 0.1 30.9 2.1 1.6 0.6 6.4 46.3 0.1 0.7 5.5 0.1 0.0 7.8 4.8 13.9 0.9 8.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.1 0.0 0.0 6.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.4 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.6 8.7 0.0 20.9 0.1 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 1.3 0.0 0.0 12.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 7.9 0.0 0.0 2.1 1.1 0.0 3.1 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 6.4 0.2 0.6 0.2 0.0 0.6 0.6 0.7 0.5 0.9 0.5 0.7 1.3 0.8 1.1 0.6 0.7 0.9 0.0 0.0 3.7 0.0 1.0 37.2 18.6 7.6 1.8 0.0 1.5 0.9 0.2 5.7 4.5 7.3 0.0 0.0 0.0 38.2 0.0 3.2 0.0 0.9 0.5 0.3 1.8 0.4 0.0 5.9 0.0 0.6 49.5 4.8 0.0 0.0 0.0 0.6 2.2 0.0 0.0 14.9 16.2 9.3 3.1 0.2 0.3 8.5 1.8 0.0 2.2 0.0 0.0 0.0 0.0 5.7 51.5 0.0 0.2 10.1 0.6 0.0 1.7 0.0 0.0 0.1 0.3 0.1 0.2 35.8 102.9 0.0 0.8 0.1 25.7 30.3 STAMBPL1 "ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373" ENSG00000138134 "STAM binding protein like 1" Q96FJ0 10 88879734-88975153 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.8" "Cell type enhanced" "Detected in many" "Early spermatids: 54.3;Excitatory neurons: 60.5;Microglial cells: 32.8;Spermatocytes: 40.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040202 Uncertain Approved "Plasma membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "HPA040202: AB_10805708" "unprognostic (2.73e-1)" "unprognostic (1.95e-1)" "unprognostic (7.56e-2)" "unprognostic (4.25e-2)" "unprognostic (6.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-2)" "unprognostic (4.67e-2)" "unprognostic (8.20e-2)" "unprognostic (2.78e-1)" "unprognostic (6.57e-2)" "prognostic unfavorable (1.08e-5)" "unprognostic (4.41e-2)" "unprognostic (4.06e-2)" "unprognostic (1.50e-1)" "unprognostic (4.40e-3)" 3.9 23.8 5.5 10.4 6.5 5.3 2.5 2.6 9.0 2.7 0.0 8.7 6.4 4.2 0.9 4.4 2.2 4.1 8.0 6.2 1.4 1.8 1.8 3.6 16.2 1.1 0.5 12.7 2.3 3.4 5.5 1.2 2.6 1.7 9.7 4.4 1.4 1.1 0.7 3.7 7.3 3.0 1.9 7.2 5.1 18.0 0.5 7.1 1.2 1.5 12.2 6.4 2.5 5.6 14.8 16.5 1.0 0.6 14.4 27.7 0.0 31.5 28.9 19.0 16.3 0.3 25.6 18.6 2.3 15.6 12.3 6.4 4.1 4.5 17.9 16.3 10.8 4.6 10.4 0.9 10.3 20.2 5.7 10.6 1.4 31.6 9.6 18.4 0.6 20.9 0.0 7.3 50.0 3.0 34.2 21.5 6.6 13.3 14.1 3.4 13.0 3.8 6.5 4.7 9.6 11.9 3.7 1.1 37.5 3.6 2.3 4.1 4.9 17.0 12.4 20.7 19.9 17.7 19.7 17.2 18.2 19.4 16.9 9.5 1.0 8.1 10.7 1.1 14.1 17.7 15.5 13.7 1.7 14.9 16.6 10.0 1.4 23.6 0.5 27.9 28.3 8.0 5.5 6.5 2.6 9.0 6.2 1.4 1.1 0.5 2.6 1.9 0.5 5.6 2.3 0.0 4.5 10.7 16.7 9.6 5.3 1.4 1.2 3.6 2.3 1.4 8.6 0.0 0.2 5.5 0.0 0.1 18.8 7.6 0.0 1.3 54.3 1.9 6.5 1.8 9.1 3.4 60.5 1.8 0.1 7.7 3.1 1.4 5.1 7.4 1.8 2.4 3.7 6.7 26.2 9.3 4.1 1.3 9.6 20.7 7.2 3.1 0.0 32.8 1.0 9.3 12.3 26.2 1.9 1.9 2.8 1.5 14.2 1.9 7.9 0.8 5.0 0.4 0.0 20.4 6.4 40.2 2.5 5.9 11.4 0.1 17.6 14.9 14.2 2.9 ACTA2 ACTSA ENSG00000107796 "Actin alpha 2, smooth muscle" P62736 10 88935074-88991339 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Aortic aneurysm, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 6678.8;seminal vesicle: 5920.3;smooth muscle: 8099.9" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 1007.7;Peritubular cells: 5290.7;Sertoli cells: 3030.6;Smooth muscle cells: 2394.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 58.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 390.6;fHDF/TERT166: 641.1;HHSteC: 625.8;HSkMC: 345.1;hTERT-RPE1: 743.4;SuSa: 296.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "midbrain: 101.0" "CAB000002, CAB003761, CAB013531, HPA041264, HPA041271" Enhanced Supported "Actin filaments" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Actin filaments" "CAB000002: AB_2223500, CAB003761: AB_562031, CAB013531: , HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (7.05e-2)" "unprognostic (2.54e-1)" "unprognostic (2.30e-3)" "unprognostic (3.18e-2)" "unprognostic (3.33e-2)" "unprognostic (6.19e-2)" "unprognostic (2.36e-2)" "unprognostic (1.71e-2)" "unprognostic (4.25e-2)" "unprognostic (1.20e-1)" "unprognostic (1.44e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (1.37e-8)" "unprognostic (1.87e-3)" "unprognostic (2.30e-1)" "unprognostic (7.91e-2)" "unprognostic (2.09e-3)" 1035.2 241.6 54.0 728.1 61.4 3.9 838.4 52.7 121.1 2000.3 61.4 2755.1 248.9 6678.8 1360.1 1509.9 3104.3 906.1 1069.2 53.4 54.6 312.2 161.8 732.8 173.7 59.0 55.9 798.0 91.4 80.6 60.8 771.3 55.3 2642.8 866.4 8.2 414.7 5920.3 202.1 355.7 701.6 8099.9 54.1 452.1 1427.1 263.9 56.1 56.5 312.0 214.0 48.4 3002.5 1367.0 52.9 3.9 19.0 49.3 102.7 198.1 390.6 9.5 109.8 136.8 11.9 45.4 0.0 8.8 7.2 11.5 641.1 8.6 1.4 1.8 25.4 11.3 60.6 11.3 0.4 5.6 119.3 625.8 0.8 3.2 345.1 44.9 73.9 28.5 743.4 11.3 3.0 0.0 7.1 128.8 10.8 1.0 28.3 2.5 0.2 1.2 1.4 0.2 4.6 27.1 5.0 0.7 7.6 10.2 7.9 1.0 296.8 32.4 1.0 27.9 24.0 4.0 30.2 9.3 21.1 1.6 0.6 29.6 10.2 26.1 28.1 12.3 17.5 17.6 8.7 13.8 6.0 14.1 19.8 10.8 1.8 1.5 10.7 11.1 4.0 14.2 0.4 58.7 10.7 54.0 61.4 52.7 121.1 53.4 54.6 59.0 55.9 55.3 54.1 56.1 52.9 65.4 9.6 6.1 5.5 4.4 43.2 23.4 16.5 22.8 1.1 22.7 1007.7 25.1 2.8 5.2 0.0 6.2 16.3 7.3 1.9 1.9 1.8 11.1 11.1 225.4 41.1 0.0 4.0 3.6 0.9 16.8 316.3 10.7 8.2 5.7 448.9 474.0 4.6 37.7 0.0 1.1 2.7 4.1 5.4 67.6 48.8 141.4 12.6 55.2 61.8 4.2 13.4 4.1 1.0 0.3 2.0 3.0 5290.7 3.7 17.5 3.4 9.5 10.9 1.4 3030.6 72.0 2394.6 4.0 13.8 11.1 40.5 23.7 16.5 36.0 5.7 10.4 FAS "APO-1, APT1, CD95, FAS1, TNFRSF6" ENSG00000026103 "Fas cell surface death receptor" P25445 10 88990531-89017059 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis "Calmodulin-binding, Receptor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 114.7" "Group enriched" "Detected in all" 5 "granulocytes: 114.7;T-cells: 96.2" "Cell line enhanced" "Detected in many" "HDLM-2: 83.4;Karpas-707: 109.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027444 Uncertain Supported "Nuclear bodies,Plasma membrane,Cytosol" "Secreted to blood" NA NA 11900000 420000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" "Nuclear bodies, Cytosol" "HPA027444: AB_10601378" "unprognostic (6.84e-2)" "unprognostic (2.88e-3)" "unprognostic (8.38e-3)" "unprognostic (1.94e-1)" "unprognostic (2.35e-2)" "unprognostic (9.56e-2)" "unprognostic (7.00e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (7.70e-2)" "unprognostic (1.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.52e-3)" "unprognostic (2.10e-1)" "unprognostic (2.32e-2)" "unprognostic (4.95e-3)" "unprognostic (1.65e-1)" 14.1 26.3 3.6 17.0 3.6 20.8 10.9 2.9 4.7 12.7 2.8 16.4 7.0 12.8 10.3 10.8 14.8 15.7 7.5 3.6 3.7 7.2 23.3 21.7 18.9 4.6 3.1 20.1 3.7 2.7 3.7 10.4 4.0 8.9 23.3 3.3 6.5 9.3 2.3 9.4 9.2 15.0 3.5 11.2 4.4 2.6 3.9 14.4 7.3 2.6 15.6 12.9 10.2 4.3 22.7 8.2 5.4 13.9 37.0 51.3 0.0 51.8 50.2 1.7 9.1 0.1 23.4 4.7 19.0 52.1 9.6 4.0 1.0 44.8 3.2 83.4 8.7 0.4 5.2 14.7 31.6 3.4 1.6 69.2 38.7 31.4 66.0 24.5 4.7 17.8 0.0 109.0 44.0 1.4 6.4 3.4 0.6 0.2 1.8 1.4 0.5 5.0 60.7 7.3 0.4 0.2 7.7 0.0 0.8 7.0 13.9 1.0 9.5 15.8 9.0 15.2 12.3 45.3 5.3 0.4 11.8 10.2 4.5 43.1 9.4 30.9 9.9 12.3 13.8 7.5 27.6 19.6 11.5 4.0 3.1 10.0 114.7 3.1 22.1 0.2 96.2 12.8 3.6 3.6 2.9 4.7 3.6 3.7 4.6 3.1 4.0 3.5 3.9 4.3 10.3 57.7 13.8 40.1 12.8 45.9 109.7 53.1 39.9 0.0 5.5 9.5 3.5 12.8 27.5 9.2 0.0 0.4 16.3 24.9 0.0 6.3 11.3 9.2 22.3 8.9 8.4 9.5 8.8 4.3 0.2 35.4 8.6 15.5 3.8 4.9 2.2 19.3 5.5 1.7 2.8 14.4 8.2 7.0 31.7 4.9 19.0 17.7 12.4 17.8 20.9 14.5 10.3 8.0 0.7 6.5 8.7 13.9 32.2 46.0 15.6 14.4 26.3 0.7 6.6 26.8 29.1 11.3 1.1 28.5 43.9 0.4 48.4 11.8 24.4 30.0 CH25H ENSG00000138135 "Cholesterol 25-hydroxylase" O95992 10 89205629-89207317 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.3" "Cell type enhanced" "Detected in many" "Adipocytes: 125.9;Basal squamous epithelial cells: 224.3;Macrophages: 47.3;Microglial cells: 40.3;Smooth muscle cells: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 8.8;ASC TERT1: 4.4;fHDF/TERT166: 32.8;HSkMC: 8.2" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "spinal cord: 6.3" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 41: Macrophages - Immune response" "unprognostic (6.07e-3)" "unprognostic (2.96e-3)" "unprognostic (1.57e-1)" "unprognostic (5.11e-2)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "unprognostic (3.15e-2)" "unprognostic (2.13e-1)" "unprognostic (2.54e-1)" "unprognostic (8.65e-3)" "unprognostic (7.74e-2)" "unprognostic (4.76e-2)" "unprognostic (2.62e-5)" "unprognostic (2.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.32e-2)" "unprognostic (2.29e-2)" 21.5 5.1 4.3 7.0 5.0 3.1 7.4 6.5 6.6 3.5 4.4 3.6 3.2 1.3 12.6 14.7 6.0 14.6 4.5 4.2 8.4 7.8 3.6 17.2 4.0 18.4 9.5 2.1 1.6 1.1 9.0 4.2 11.4 4.1 5.5 0.4 2.1 1.3 1.8 3.0 5.6 5.5 8.6 2.0 5.8 0.1 6.0 35.3 2.8 1.0 3.7 18.5 2.1 8.2 0.0 0.0 0.0 0.0 8.8 4.4 0.0 0.1 3.1 0.8 0.9 0.0 0.0 0.0 1.1 32.8 0.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.8 0.0 0.0 8.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 4.2 0.0 0.2 0.0 0.1 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 5.0 6.5 6.6 4.2 8.4 18.4 9.5 11.4 8.6 6.0 8.2 125.9 3.2 3.4 0.3 1.8 6.9 4.4 11.7 224.3 0.0 6.4 1.0 0.6 0.0 10.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 1.5 0.9 23.6 0.0 0.0 2.9 0.0 0.2 33.4 2.0 3.1 1.3 0.0 2.5 0.0 10.2 1.7 0.5 0.0 2.0 12.9 8.2 0.0 0.3 47.3 7.2 40.3 0.0 0.6 0.0 0.0 0.4 0.1 0.0 0.7 4.4 1.0 0.0 0.0 4.5 0.5 6.6 3.6 59.3 0.0 0.0 30.8 6.7 0.1 11.6 0.5 0.0 6.2 LIPA "CESD, LAL" ENSG00000107798 "Lipase A, lysosomal acid type" P38571 10 89213569-89414557 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 398.4" "Cell type enhanced" "Detected in many" "Hofbauer cells: 515.0;Kupffer cells: 714.8;Macrophages: 303.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 167.3;intermediate monocyte: 355.1;myeloid DC: 123.6;non-classical monocyte: 198.5" "Group enriched" "Detected in all" 6 "dendritic cells: 123.6;monocytes: 355.1" "Cell line enhanced" "Detected in many" "A-431: 354.4;AN3-CA: 367.8;ASC TERT1: 450.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034892, HPA057052" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Intracellular and membrane" NA NA 280000 "Cluster 7: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Vesicles, Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "CAB034892: AB_784329, HPA057052: AB_2683322" "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (7.14e-2)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (4.28e-2)" "unprognostic (1.08e-1)" "unprognostic (7.30e-3)" "unprognostic (1.39e-2)" "unprognostic (1.40e-1)" "unprognostic (4.42e-2)" "unprognostic (3.42e-2)" "unprognostic (5.71e-2)" 76.0 46.3 43.5 66.7 65.2 39.8 47.8 64.1 74.4 54.0 39.0 67.7 167.6 38.8 21.7 28.6 37.8 83.5 24.2 43.5 53.1 44.9 218.9 169.5 159.3 74.7 55.5 32.7 21.4 68.9 12.7 79.1 82.2 30.7 72.0 12.6 22.5 33.8 11.8 18.7 227.5 47.7 65.4 398.4 34.3 13.4 57.0 44.5 31.6 22.5 45.5 58.4 19.3 115.5 354.4 49.4 30.7 367.8 343.5 450.8 10.0 171.4 194.8 65.5 121.5 18.6 176.6 63.9 34.0 264.4 73.7 338.7 13.8 92.8 53.6 86.1 34.7 25.1 19.1 81.5 87.6 48.8 48.9 190.4 69.2 72.9 40.6 88.2 14.9 45.4 0.3 108.5 58.3 28.2 45.7 34.6 22.7 62.4 60.0 26.4 39.0 60.5 69.2 50.9 10.5 21.8 41.4 49.9 133.9 20.4 64.4 65.8 26.2 58.8 15.5 132.1 44.6 60.0 65.7 25.8 71.4 112.9 82.1 4.2 167.3 16.9 40.0 355.1 40.6 31.9 35.8 38.8 123.6 33.4 36.7 40.4 7.1 29.8 198.5 25.0 38.2 159.6 43.5 65.2 64.1 74.4 43.5 53.1 74.7 55.5 82.2 65.4 57.0 115.5 75.5 41.7 33.8 11.1 35.9 17.7 30.3 58.1 25.6 5.4 16.1 14.1 9.6 45.8 31.9 33.1 0.0 34.8 31.4 2.8 21.5 35.1 6.8 11.4 20.4 56.7 21.8 27.4 34.4 36.2 32.9 34.6 21.4 15.5 28.5 10.8 54.7 66.7 515.0 16.8 15.1 8.9 40.7 714.8 69.0 2.7 11.5 303.1 48.0 30.0 71.7 33.1 29.9 15.1 143.0 19.3 12.0 21.8 15.4 11.3 161.0 14.0 28.8 2.2 6.6 19.7 21.0 5.1 13.8 31.9 12.5 20.0 33.1 17.6 9.1 24.0 IFIT2 "cig42, G10P2, GARG-39, IFI-54, IFI54, ISG-54K" ENSG00000119922 "Interferon induced protein with tetratricopeptide repeats 2" P09913 10 89283694-89309271 "Predicted intracellular proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.4" "Cell type enhanced" "Detected in many" "Adipocytes: 53.5;Glandular and luminal cells: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 420.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 420.2" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 141.0;BJ hTERT+ SV40 Large T+ RasG12V: 113.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003408 Approved Approved Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA003408: AB_1079100" "unprognostic (1.77e-1)" "unprognostic (2.10e-1)" "unprognostic (2.42e-2)" "unprognostic (2.25e-3)" "unprognostic (1.75e-2)" "unprognostic (9.28e-2)" "unprognostic (6.71e-3)" "unprognostic (2.22e-1)" "unprognostic (5.40e-1)" "unprognostic (1.36e-1)" "unprognostic (7.03e-3)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.99e-4)" "unprognostic (2.92e-2)" "unprognostic (1.03e-2)" "unprognostic (5.33e-3)" "unprognostic (6.46e-2)" 7.7 6.7 12.6 13.1 17.3 48.4 5.4 14.7 16.2 6.1 8.2 5.4 6.7 5.0 6.2 2.8 9.3 13.6 7.5 11.7 14.1 10.2 21.8 21.0 7.9 19.5 16.6 9.2 3.1 10.0 2.5 16.4 18.9 4.1 4.5 1.7 8.8 6.5 2.3 3.7 5.7 6.5 30.1 27.5 3.6 2.2 15.9 12.6 3.4 6.8 5.7 6.3 2.9 20.8 29.3 1.1 0.3 14.5 13.0 14.4 5.2 10.7 32.4 141.0 113.0 0.1 20.0 3.2 5.9 7.8 20.6 28.9 0.6 1.5 15.4 11.6 0.1 5.3 14.3 0.0 22.2 0.7 2.3 8.2 0.7 10.7 1.6 8.6 0.7 2.8 0.1 0.5 2.2 0.1 3.4 6.6 3.5 0.0 6.1 2.1 3.7 0.8 4.8 5.6 0.1 0.2 3.8 0.6 24.7 1.8 0.7 1.6 0.9 1.5 0.3 3.9 1.1 1.4 5.1 0.5 2.3 2.4 2.9 97.6 32.6 107.8 9.5 75.9 5.1 19.2 8.0 6.5 10.6 17.7 7.6 6.8 420.2 8.9 92.3 12.7 3.9 17.6 12.6 17.3 14.7 16.2 11.7 14.1 19.5 16.6 18.9 30.1 15.9 20.8 53.5 41.7 6.7 1.6 12.3 1.5 5.3 6.6 1.2 1.3 5.6 9.5 7.4 11.5 9.4 12.9 0.0 2.9 27.6 23.5 9.8 35.0 0.2 34.9 9.1 34.9 3.5 0.8 1.0 4.2 1.6 10.9 2.0 67.0 5.1 3.8 16.4 6.1 26.0 25.2 2.1 5.9 4.1 25.5 3.3 0.2 8.1 29.5 7.2 4.7 20.9 13.3 12.3 2.0 20.3 6.3 11.5 11.7 2.4 19.1 18.9 30.8 4.7 0.9 0.0 8.3 14.3 0.2 0.2 3.2 0.6 1.4 13.1 6.2 2.1 5.8 IFIT3 "CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G" ENSG00000119917 "Interferon induced protein with tetratricopeptide repeats 3" O14879 10 89327307-89377473 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 89.5;Ductal cells: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 488.1" "Group enriched" "Detected in all" 19 "granulocytes: 488.1;monocytes: 125.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 198.8;BJ hTERT+ SV40 Large T+: 468.4;BJ hTERT+ SV40 Large T+ RasG12V: 540.2" "Low region specificity" "Detected in all" HPA059914 Approved Supported Mitochondria,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Mitochondria, Cytosol" "HPA059914: AB_2684159" "unprognostic (2.81e-1)" "unprognostic (5.62e-2)" "unprognostic (4.94e-2)" "unprognostic (5.25e-3)" "unprognostic (3.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (5.18e-3)" "unprognostic (2.99e-3)" "unprognostic (5.72e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (1.36e-1)" "unprognostic (4.69e-2)" "unprognostic (9.80e-3)" "unprognostic (5.09e-2)" 21.3 20.1 10.5 20.4 22.7 42.9 14.3 15.9 14.8 11.5 1.5 11.2 25.4 12.9 11.7 6.8 17.7 24.6 15.5 11.8 15.9 19.3 28.6 44.2 9.0 24.7 17.0 18.1 7.4 5.4 6.1 31.1 25.0 6.0 9.0 3.8 34.6 12.5 7.1 6.4 18.7 18.1 37.2 47.6 12.6 6.8 15.7 33.1 7.4 14.8 5.3 13.5 7.8 35.0 38.7 2.7 0.9 10.3 41.7 43.9 0.5 25.4 198.8 468.4 540.2 2.0 54.3 3.3 11.2 39.0 112.0 33.6 0.6 4.9 34.0 5.6 0.7 15.9 10.1 1.2 23.8 4.5 13.8 27.8 0.6 40.6 3.4 17.9 2.8 1.5 1.1 8.3 12.7 0.3 10.7 11.7 0.7 0.1 12.1 10.2 3.3 2.4 13.3 19.1 0.4 0.2 5.9 0.7 96.8 1.4 1.4 5.7 4.0 8.2 1.9 14.7 7.4 13.8 11.3 0.9 12.0 19.9 7.9 105.7 45.8 172.5 4.6 101.9 1.0 9.7 6.6 3.0 15.6 10.9 3.7 4.5 488.1 2.1 125.0 3.5 16.3 19.4 10.5 22.7 15.9 14.8 11.8 15.9 24.7 17.0 25.0 37.2 15.7 35.0 89.5 51.3 10.1 5.9 8.0 3.2 6.7 13.0 4.0 10.7 3.1 5.5 32.5 10.0 12.5 9.2 4.2 5.2 8.3 6.8 21.5 70.6 0.9 26.0 16.6 66.4 0.0 10.3 9.1 36.3 12.8 20.1 4.6 39.3 13.9 19.8 20.0 13.6 34.6 60.6 8.4 4.0 4.1 21.7 4.4 0.5 30.4 26.8 3.6 17.8 22.0 20.8 8.2 6.0 50.2 23.3 9.4 28.2 2.5 10.0 34.6 14.5 12.3 2.1 46.0 16.0 22.2 1.2 1.6 2.9 1.8 1.9 6.3 14.4 3.7 6.2 IFIT1B "bA149I23.6, IFIT1L" ENSG00000204010 "Interferon induced protein with tetratricopeptide repeats 1B" Q5T764 10 89378056-89385205 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 25.7" "Cell type enriched" "Detected in single" 320 "Erythroid cells: 96.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062924 Approved NA NA "Cluster 67: Neutrophils - Humoral immune response" "Cluster 6: Erythroid cells - Oxygen transport" "HPA062924: AB_2684906" "unprognostic (2.59e-1)" "unprognostic (3.13e-1)" "unprognostic (6.62e-3)" "unprognostic (4.55e-2)" "unprognostic (4.11e-2)" "unprognostic (9.34e-2)" "unprognostic (1.76e-1)" "unprognostic (6.86e-2)" 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFIT1 "G10P1, GARG-16, IFI56, IFNAI1" ENSG00000185745 "Interferon induced protein with tetratricopeptide repeats 1" P09914 10 89392546-89406487 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 63.3;Distal tubular cells: 64.6;Muller glia cells: 77.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 66.7" "Group enriched" "Detected in all" 8 "granulocytes: 66.7;monocytes: 21.7" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 325.3;BJ hTERT+ SV40 Large T+ RasG12V: 318.1" "CAB045980, HPA053890, HPA055380" Approved Enhanced Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "CAB045980: AB_11125836, HPA053890: , HPA055380: AB_2682800" "unprognostic (1.16e-1)" "unprognostic (2.77e-1)" "unprognostic (1.80e-1)" "unprognostic (7.96e-3)" "unprognostic (1.35e-3)" "unprognostic (2.02e-2)" "unprognostic (6.45e-2)" "unprognostic (3.66e-1)" "unprognostic (3.34e-1)" "unprognostic (8.65e-3)" "unprognostic (1.82e-2)" "unprognostic (7.68e-2)" "unprognostic (2.21e-2)" "unprognostic (2.03e-2)" "unprognostic (5.95e-2)" "unprognostic (9.75e-3)" "unprognostic (6.40e-3)" 17.5 38.0 12.6 4.5 12.4 9.9 14.3 15.2 17.8 17.2 13.0 14.6 3.9 6.9 6.6 5.0 9.5 13.8 22.7 12.4 12.7 23.7 24.9 14.1 3.4 15.1 14.2 9.1 6.1 11.9 20.3 9.9 13.5 6.7 5.0 8.0 42.0 6.2 17.4 4.9 7.5 7.9 29.4 18.7 6.9 5.4 13.9 13.3 9.1 20.6 2.4 7.6 9.4 14.4 10.0 1.2 2.6 17.2 8.1 16.5 0.2 11.7 68.9 325.3 318.1 1.0 10.4 0.7 3.8 14.6 63.4 8.2 1.0 1.0 15.6 0.6 1.1 1.7 8.4 0.9 9.2 1.4 1.7 13.5 0.3 6.2 0.1 6.4 0.4 1.7 0.2 7.7 3.5 0.3 2.3 6.8 0.3 0.1 6.3 3.1 0.8 2.0 7.9 1.2 0.1 0.6 3.1 2.4 69.6 2.4 1.3 1.5 0.5 1.7 1.9 2.5 1.4 1.0 1.3 0.6 2.2 2.3 0.9 9.9 12.6 15.4 1.6 15.6 2.9 3.0 4.1 2.9 3.7 3.2 5.7 3.5 66.7 1.9 21.7 0.2 4.9 6.6 12.6 12.4 15.2 17.8 12.4 12.7 15.1 14.2 13.5 29.4 13.9 14.4 63.3 35.3 5.8 7.2 2.5 2.9 3.3 12.9 3.4 26.4 2.4 5.2 19.1 4.3 7.6 9.2 18.8 4.8 4.7 6.3 64.6 12.6 0.4 21.1 3.2 41.4 0.0 4.0 13.8 5.1 20.8 22.8 0.5 7.2 2.5 11.0 9.3 12.1 36.9 32.0 13.3 1.4 4.1 14.5 3.3 3.0 19.3 13.3 1.8 16.9 13.5 77.9 1.0 12.1 14.4 3.6 4.7 43.6 0.7 1.1 9.8 26.7 17.8 13.4 39.5 18.1 11.4 0.5 3.0 1.0 1.7 1.4 3.1 15.4 0.2 1.2 IFIT5 RI58 ENSG00000152778 "Interferon induced protein with tetratricopeptide repeats 5" Q13325 10 89414568-89421605 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 109.1;BJ hTERT+ SV40 Large T+ RasG12V: 128.0" "Low region specificity" "Detected in all" "HPA037957, HPA062180" Uncertain Supported "Plasma membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "HPA037957: AB_10672499, HPA062180: AB_2684705" "unprognostic (2.17e-1)" "unprognostic (1.85e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-1)" "unprognostic (1.67e-3)" "unprognostic (4.19e-2)" "unprognostic (2.88e-2)" "unprognostic (2.80e-1)" "unprognostic (1.45e-1)" "unprognostic (8.89e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" "unprognostic (3.24e-2)" "unprognostic (1.48e-1)" "unprognostic (3.42e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-1)" 13.3 11.6 11.9 11.1 14.3 16.1 9.7 18.7 13.5 11.4 25.0 9.4 9.4 10.2 9.1 7.4 11.2 12.6 14.6 10.8 14.5 14.2 14.1 17.1 13.2 14.7 13.0 14.1 9.2 22.8 3.7 14.6 14.4 9.7 8.9 9.0 12.2 10.5 3.7 5.5 11.1 14.2 19.2 18.6 9.1 6.3 12.5 10.5 10.8 6.4 11.3 12.3 4.6 16.8 41.8 12.5 17.3 56.9 46.7 43.4 3.7 33.2 59.5 109.1 128.0 1.0 19.0 1.8 12.1 38.7 42.8 34.8 20.9 19.3 26.0 17.8 13.1 5.0 8.9 7.8 52.4 0.4 3.1 34.9 7.4 32.0 23.7 30.8 6.2 10.8 0.0 29.4 30.8 7.7 12.6 3.8 2.2 0.0 21.9 11.0 20.0 4.6 23.7 5.1 1.9 11.1 18.2 6.6 51.6 4.7 6.2 3.5 15.5 14.0 10.3 23.2 20.0 3.8 0.6 0.2 24.2 3.3 11.6 24.7 15.7 19.3 13.9 25.6 16.4 21.4 14.7 13.0 14.2 18.1 16.8 14.1 45.2 8.3 32.1 1.3 14.1 12.3 11.9 14.3 18.7 13.5 10.8 14.5 14.7 13.0 14.4 19.2 12.5 16.8 24.8 6.4 14.8 3.6 12.8 8.5 35.7 15.2 13.6 8.3 4.4 4.3 8.9 11.5 12.4 9.2 0.0 6.3 7.5 7.2 11.7 13.7 0.1 11.2 17.1 23.1 4.9 2.1 3.6 9.1 11.5 17.9 6.1 13.3 15.2 6.2 12.1 16.5 11.0 35.3 7.2 5.5 6.1 8.9 6.0 1.0 21.1 10.8 7.2 4.7 12.3 14.6 7.2 4.5 10.2 10.5 5.9 17.3 6.8 21.0 7.5 17.0 9.6 5.3 19.7 15.4 14.2 17.2 14.4 7.7 3.8 4.5 9.3 4.7 2.5 29.1 SLC16A12 MCT12 ENSG00000152779 "Solute carrier family 16 member 12" Q6ZSM3 10 89430299-89556641 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" Cataract "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "choroid plexus: 92.2;epididymis: 51.8;kidney: 85.2;pancreas: 25.3" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 18.1;Leydig cells: 27.1;Peritubular cells: 26.7;Proximal tubular cells: 69.2" "Cancer enriched" "Detected in many" 10 "renal cancer: 18.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC TERT1: 23.0;HSkMC: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037587 Approved Mitochondria NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA037587: AB_2732475" "unprognostic (5.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.79e-2)" "unprognostic (2.28e-2)" "unprognostic (3.51e-1)" "unprognostic (5.35e-2)" "unprognostic (2.45e-1)" "unprognostic (1.32e-1)" "unprognostic (1.78e-2)" "unprognostic (2.42e-1)" "unprognostic (9.60e-2)" "unprognostic (2.31e-1)" "prognostic favorable (4.50e-12)" "unprognostic (3.84e-2)" "unprognostic (7.91e-2)" "unprognostic (8.29e-2)" "unprognostic (1.84e-3)" 1.8 2.5 0.8 0.1 1.1 0.0 1.9 1.0 2.7 9.2 92.2 0.8 0.1 1.4 51.8 0.3 4.1 0.1 4.9 2.9 0.3 85.2 2.0 2.5 0.1 0.5 1.6 1.3 25.3 0.1 3.4 11.6 0.6 0.6 0.2 0.0 0.4 14.1 1.6 0.5 0.3 0.3 1.2 0.0 1.0 3.3 1.0 0.4 6.2 2.5 0.0 0.4 0.7 0.6 0.2 0.0 0.0 0.0 3.0 23.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.3 0.5 0.0 0.0 0.0 0.5 0.0 3.7 0.0 0.0 8.2 0.2 1.2 1.5 2.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 2.8 0.0 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 1.0 2.7 2.9 0.3 0.5 1.6 0.6 1.2 1.0 0.6 0.8 3.2 3.9 3.3 0.6 0.0 2.2 0.1 0.0 0.1 4.6 0.1 3.3 1.5 2.9 14.7 0.0 16.4 0.1 0.0 15.6 0.0 8.3 11.5 0.8 1.3 18.1 0.0 0.3 4.1 1.1 2.2 0.0 1.0 1.3 0.0 0.4 2.2 1.2 3.3 0.4 0.2 0.0 0.0 0.9 4.8 27.1 1.0 0.0 11.2 0.1 0.0 0.0 0.0 0.4 2.1 0.1 26.7 0.0 0.7 0.0 69.2 6.2 0.6 13.1 3.4 7.8 0.2 0.5 0.0 0.3 9.0 0.9 0.1 0.0 1.8 PANK1 "MGC24596, PANK, PANK1a, PANK1b" ENSG00000152782 "Pantothenate kinase 1" Q8TE04 10 89579497-89645572 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 45.2;liver: 109.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 37.5;Distal tubular cells: 70.5;Hepatocytes: 149.8;Proximal tubular cells: 53.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 12: NES - Nervous system development" "Cluster 2: Hepatocytes - Metabolism" "unprognostic (1.00e-1)" "unprognostic (2.19e-1)" "unprognostic (2.02e-2)" "unprognostic (1.09e-2)" "unprognostic (6.71e-2)" "unprognostic (6.97e-2)" "prognostic favorable (1.50e-4)" "unprognostic (1.59e-1)" "unprognostic (1.38e-2)" "unprognostic (1.61e-1)" "unprognostic (4.55e-4)" "unprognostic (4.61e-2)" "prognostic favorable (1.55e-10)" "unprognostic (3.49e-2)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" "unprognostic (6.64e-2)" 2.1 4.6 2.8 2.1 3.1 0.5 2.5 7.2 4.2 5.3 9.7 13.9 20.4 1.8 3.8 5.3 3.0 1.7 8.6 3.1 2.7 45.2 109.7 2.2 1.8 3.5 3.4 2.3 1.8 6.5 1.5 2.7 3.8 1.9 17.3 2.0 2.1 2.3 11.4 9.6 17.2 2.3 2.0 1.6 4.6 2.8 4.0 5.2 10.4 28.0 2.6 1.9 3.5 2.8 8.0 5.2 28.1 19.4 14.9 10.8 14.2 4.6 5.0 4.3 5.7 8.2 8.1 5.8 3.0 3.6 3.2 7.9 12.9 2.9 4.6 2.0 5.7 3.9 5.6 16.2 4.4 12.3 2.1 6.6 12.7 6.5 5.1 9.2 5.1 4.9 6.8 0.7 6.3 6.2 13.6 12.5 22.1 21.0 3.1 11.9 5.6 3.8 13.2 3.8 8.7 10.4 5.8 6.9 4.6 16.6 7.5 8.9 2.2 2.6 2.5 5.2 5.7 6.5 12.7 7.2 3.4 9.7 1.8 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.1 2.8 3.1 7.2 4.2 3.1 2.7 3.5 3.4 3.8 2.0 4.0 2.8 0.6 6.4 3.7 7.8 1.6 2.3 0.7 2.2 1.8 4.7 2.1 2.0 12.9 10.0 2.5 11.0 2.1 4.7 0.5 37.5 70.5 1.1 0.5 2.5 2.6 1.7 11.4 7.8 21.1 0.7 4.5 1.8 2.0 3.3 0.0 8.4 3.3 149.8 2.4 13.5 32.1 14.8 0.0 3.8 0.7 0.7 1.2 2.2 0.0 7.5 0.4 1.0 0.0 12.1 3.0 0.1 17.9 2.2 1.4 0.5 31.4 53.2 1.5 1.3 0.0 2.2 5.1 0.7 0.8 5.6 2.8 1.8 1.8 1.4 25.1 0.5 KIF20B "CT90, KRMP1, MPHOSPH1, MPP1" ENSG00000138182 "Kinesin family member 20B" Q96Q89 10 89701590-89774939 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.2;lymphoid tissue: 9.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 89.2;Spermatocytes: 165.4;Spermatogonia: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA050214 Supported Supported "Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol" Yes Yes "Cluster 6: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Cytokinetic bridge" "Midbody, Cytosol" "HPA050214: AB_2681053" "unprognostic (2.13e-1)" "unprognostic (3.01e-2)" "unprognostic (1.72e-2)" "unprognostic (3.20e-2)" "unprognostic (2.65e-1)" "unprognostic (7.39e-2)" "unprognostic (8.95e-5)" "unprognostic (3.32e-3)" "unprognostic (2.01e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (3.06e-6)" "unprognostic (4.22e-3)" "unprognostic (2.70e-1)" "unprognostic (2.51e-2)" "unprognostic (6.43e-2)" 1.3 0.7 0.3 4.5 1.0 10.2 2.5 2.4 0.4 1.5 0.1 3.2 3.6 2.3 0.4 3.3 1.2 1.3 0.9 0.3 0.3 1.3 1.3 1.5 8.0 0.5 0.3 2.7 0.7 1.1 0.2 2.4 0.6 1.3 4.0 1.1 1.0 0.9 0.4 2.5 3.4 2.2 0.4 3.3 2.5 6.9 0.6 9.8 1.8 0.7 7.5 1.6 0.7 0.6 84.8 17.0 24.3 21.7 4.7 8.0 20.2 33.8 30.9 34.8 36.3 22.6 38.1 32.5 10.4 17.3 13.0 41.8 27.3 18.9 46.4 39.5 18.6 33.1 30.5 19.5 1.4 57.1 26.3 3.4 2.8 33.7 33.9 12.2 22.8 17.0 32.2 36.5 31.3 14.6 33.6 10.8 25.0 13.8 16.1 23.1 47.8 14.3 10.7 11.2 7.7 13.9 24.4 11.0 12.2 17.3 28.5 16.3 17.9 22.2 22.1 29.1 55.3 10.1 29.5 43.2 21.1 49.4 16.8 13.1 2.4 4.2 5.5 4.1 6.8 13.0 7.4 6.1 1.3 16.0 8.6 8.0 0.2 3.0 4.5 5.2 9.5 2.2 0.3 1.0 2.4 0.4 0.3 0.3 0.5 0.3 0.6 0.4 0.6 0.6 11.5 3.2 13.5 2.3 36.4 17.7 6.2 20.8 6.8 14.3 8.3 8.5 8.7 1.5 10.7 0.0 10.4 21.4 32.3 8.8 3.9 6.9 13.1 10.6 13.2 11.0 1.2 89.2 8.1 4.7 38.1 13.2 14.8 12.9 44.4 37.2 9.3 4.4 20.7 13.5 9.5 8.6 16.2 21.0 17.9 10.5 8.1 17.1 5.4 23.4 11.3 7.5 24.7 9.0 9.1 4.1 5.7 8.6 51.4 3.7 8.9 3.2 6.6 9.8 6.6 16.9 17.1 165.4 96.7 26.1 14.1 5.2 34.2 12.9 25.5 5.2 HTR7 5-HT7 ENSG00000148680 "5-hydroxytryptamine receptor 7" P34969 10 90740823-90858039 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.6;parathyroid gland: 13.1;testis: 8.7" "Cell type enhanced" "Detected in some" "Early spermatids: 7.0;Excitatory neurons: 5.9;Inhibitory neurons: 24.2;Spermatocytes: 13.1" "Group enriched" "Detected in some" 5 "cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 12 "myeloid DC: 1.4" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 11.3;hTCEpi: 10.1;hTERT-HME1: 33.4;LHCN-M2: 13.5;U-251 MG: 9.6;U-87 MG: 10.2;WM-115: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022708, HPA073617" Approved Supported Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 30: Epithelial cell lines - Translation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "Nuclear speckles, Cytosol" "CAB022708: , HPA073617: AB_2732228" "unprognostic (1.17e-1)" "unprognostic (1.24e-2)" "unprognostic (4.72e-2)" "unprognostic (1.33e-1)" "unprognostic (5.51e-3)" "unprognostic (1.71e-2)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (1.15e-1)" "unprognostic (4.58e-3)" "unprognostic (3.32e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-1)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" 0.5 0.2 2.4 0.9 1.4 0.3 0.3 0.0 2.5 0.4 0.4 0.6 0.5 0.2 0.1 0.7 0.2 0.9 0.1 2.7 7.1 0.1 0.4 0.2 0.6 1.5 3.2 0.1 0.2 13.1 0.1 0.3 1.9 0.2 0.9 0.1 0.3 0.1 0.9 0.5 1.4 0.3 0.5 1.1 0.7 8.7 7.6 0.2 0.1 0.5 0.3 2.3 0.6 0.8 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.7 0.3 0.7 1.0 0.0 1.2 0.0 0.0 0.1 2.0 4.7 1.3 11.3 2.8 0.0 0.2 0.0 0.0 0.0 5.1 0.0 0.6 7.8 10.1 3.3 33.4 6.3 0.0 0.0 0.1 0.0 13.5 0.0 0.0 0.2 1.2 0.0 1.6 1.0 0.1 0.0 0.0 1.2 0.4 0.0 0.5 0.0 5.4 0.6 0.0 0.2 0.3 6.1 0.0 0.1 9.6 0.0 0.0 0.0 10.2 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 1.4 0.0 2.5 2.7 7.1 1.5 3.2 1.9 0.5 7.6 0.8 0.1 0.0 0.0 0.7 0.3 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.3 0.0 0.0 0.4 5.9 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.4 0.0 1.7 0.0 24.2 0.0 2.0 2.2 0.0 2.7 0.0 2.5 0.0 0.0 0.4 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.1 13.1 1.3 0.0 0.1 0.1 0.2 0.0 0.0 0.3 RPP30 TSG15 ENSG00000148688 "Ribonuclease P/MRP subunit p30" P78346 10 90871952-90908553 "Enzymes, Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037578 Approved Approved "Nucleoplasm,Nucleoli,Microtubule ends,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli" "Microtubule ends, Cytosol" "HPA037578: AB_10696939" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" "unprognostic (2.35e-1)" "unprognostic (4.08e-1)" "unprognostic (5.64e-2)" "unprognostic (3.05e-2)" "unprognostic (3.80e-3)" "unprognostic (1.27e-1)" "unprognostic (2.73e-1)" "unprognostic (1.03e-1)" "unprognostic (2.27e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.01e-6)" "unprognostic (1.98e-1)" "unprognostic (9.84e-3)" "unprognostic (3.43e-2)" "unprognostic (2.10e-2)" 19.2 13.9 7.8 12.9 8.8 25.9 17.3 8.2 10.6 14.1 7.3 15.3 9.3 15.8 14.1 18.0 14.9 12.7 22.6 8.8 8.4 16.3 15.1 13.1 21.0 7.1 7.3 18.1 11.0 23.0 8.0 18.5 7.6 12.1 15.1 13.2 14.5 12.2 31.1 17.9 12.4 16.4 8.3 15.0 14.3 28.6 7.7 21.7 12.2 22.2 22.4 17.0 14.2 10.6 82.2 53.2 55.0 66.5 34.4 37.6 19.4 57.0 51.1 93.3 98.3 90.6 64.1 48.1 42.6 36.4 60.9 56.0 73.9 50.5 95.3 77.2 51.3 32.7 31.1 73.0 33.0 66.7 39.1 30.9 32.4 70.5 79.1 39.6 54.1 43.5 65.7 42.6 62.6 50.8 77.4 89.8 33.9 46.4 59.8 42.9 46.7 50.4 35.6 38.2 29.9 29.9 33.1 23.8 68.2 50.0 64.8 41.3 31.2 46.3 46.3 26.5 119.6 28.7 79.4 104.4 57.9 35.4 36.4 9.2 30.0 27.1 25.2 30.7 27.5 31.7 28.7 28.0 35.1 28.1 24.6 27.0 3.5 25.4 26.2 32.8 33.0 27.6 7.8 8.8 8.2 10.6 8.8 8.4 7.1 7.3 7.6 8.3 7.7 10.6 31.4 32.1 16.9 14.0 28.7 34.4 27.5 51.8 23.9 19.2 16.7 28.2 45.7 27.1 31.4 14.7 18.8 60.6 33.7 9.4 31.3 41.9 95.9 18.9 26.1 25.2 19.8 38.5 18.0 35.0 68.1 28.0 13.3 17.9 23.5 33.3 21.4 14.3 58.1 16.8 19.4 21.0 30.5 23.9 29.3 49.9 28.9 24.7 23.2 11.2 32.2 23.3 15.5 17.6 19.6 31.3 12.5 29.3 20.6 18.8 12.5 36.5 21.6 24.3 39.5 30.1 36.9 77.9 54.2 20.2 34.0 33.8 23.7 28.6 17.6 27.6 ANKRD1 "ALRP, C-193, CARP, CVARP, MCARP" ENSG00000148677 "Ankyrin repeat domain 1" Q15327 10 90912096-90921087 "Metabolic proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "heart muscle: 6540.8" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 13820.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 474.5;EFO-21: 1248.9;hTERT-RPE1: 679.8;LHCN-M2: 1573.6;SuSa: 469.1;TIME: 2206.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA038736 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoli fibrillar center" Nucleoplasm "HPA038736: AB_2676184" "unprognostic (2.45e-1)" "unprognostic (6.14e-3)" "unprognostic (2.24e-1)" "unprognostic (4.39e-1)" "unprognostic (9.14e-3)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.28e-2)" "unprognostic (6.63e-3)" "unprognostic (2.19e-1)" "unprognostic (3.27e-1)" "unprognostic (4.51e-2)" "unprognostic (3.40e-1)" "unprognostic (2.72e-5)" "unprognostic (3.40e-2)" "unprognostic (2.79e-1)" "unprognostic (7.22e-2)" "unprognostic (3.16e-3)" 0.9 0.7 0.0 0.4 0.0 0.0 1.8 0.2 0.3 0.6 0.6 0.7 0.0 0.4 0.0 0.6 0.1 1.3 6540.8 0.0 0.2 0.7 1.6 48.6 2.5 0.0 0.2 0.7 4.8 0.2 1.1 4.2 0.0 6.8 0.0 0.0 8.7 0.1 571.0 2.3 0.6 2.1 0.0 0.5 1.0 0.9 0.8 1.5 1.7 20.5 0.0 1.2 0.5 0.1 37.2 10.8 6.6 0.3 5.8 6.7 0.5 21.5 2.2 6.0 10.8 474.5 17.9 0.3 1248.9 1.8 48.5 13.3 2.3 3.1 15.7 1.4 1.2 0.2 2.9 148.5 27.7 0.0 0.0 44.2 0.1 9.5 21.6 679.8 437.8 0.0 0.3 0.0 1573.6 0.4 0.0 0.0 1.3 2.7 0.3 0.0 104.3 0.0 3.9 0.5 0.1 0.0 0.3 0.4 1.2 469.1 0.3 1.9 2206.7 4.1 163.9 3.2 175.0 0.0 1.2 3.0 0.9 0.6 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.1 0.0 913.5 42.0 0.0 0.0 0.0 3.5 18.5 0.0 0.0 0.0 0.0 13820.4 7.2 6.6 0.0 0.0 0.6 0.0 0.0 0.0 66.3 5.7 9.4 0.2 83.6 0.0 0.0 0.0 0.2 0.2 243.5 0.0 4.6 3.8 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.4 0.0 0.1 1.0 0.0 0.0 74.5 100.9 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.1 PCGF5 "MGC16202, RNF159" ENSG00000180628 "Polycomb group ring finger 5" Q86SE9 10 91163012-91284337 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 345.7;Oligodendrocytes: 252.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038349, HPA059071" Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA038349: AB_10669523, HPA059071: " "unprognostic (1.34e-2)" "unprognostic (8.22e-2)" "unprognostic (1.25e-2)" "unprognostic (7.41e-2)" "unprognostic (1.15e-1)" "unprognostic (8.35e-2)" "unprognostic (6.53e-2)" "unprognostic (6.43e-2)" "unprognostic (3.89e-1)" "unprognostic (3.24e-2)" "unprognostic (3.75e-2)" "unprognostic (1.49e-1)" "prognostic favorable (4.98e-4)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (2.56e-2)" "prognostic favorable (6.90e-4)" 13.7 21.8 17.8 13.1 18.9 5.8 11.9 17.4 20.0 12.0 10.9 15.3 17.6 12.5 10.7 12.8 12.1 12.7 28.3 14.2 25.2 23.4 26.2 13.1 16.9 21.8 21.2 14.9 16.2 19.9 7.2 15.9 17.7 13.7 14.1 16.3 17.6 14.0 15.2 11.2 21.0 11.9 17.6 17.8 14.7 11.4 21.1 19.4 24.2 16.7 15.7 12.2 8.5 23.0 32.9 14.2 11.6 5.0 16.5 25.7 8.3 18.2 37.3 16.2 22.5 2.2 18.7 43.2 8.3 22.9 13.3 6.3 12.6 12.5 28.4 50.1 9.5 20.4 9.0 22.2 21.8 16.0 31.0 11.7 22.6 12.1 16.8 33.2 13.7 19.0 11.1 23.5 25.4 6.1 36.2 4.1 1.7 7.5 8.1 17.8 21.5 11.7 29.6 5.1 5.5 7.8 8.9 9.4 15.6 4.1 7.6 7.1 35.9 19.0 13.4 11.8 21.8 40.8 26.9 38.2 26.7 11.4 6.0 6.4 1.6 2.7 2.6 4.0 4.7 4.0 3.9 2.7 2.1 3.9 3.9 3.9 2.1 5.1 7.7 0.5 2.4 2.6 17.8 18.9 17.4 20.0 14.2 25.2 21.8 21.2 17.7 17.6 21.1 23.0 35.8 6.4 24.0 135.8 60.1 34.4 48.7 34.8 38.7 20.2 26.8 30.6 81.2 28.6 28.3 29.5 16.7 16.5 49.7 82.8 49.0 33.9 127.8 25.2 38.7 33.8 21.6 124.8 99.0 63.9 5.0 32.7 33.1 29.0 23.4 14.0 35.3 58.6 50.5 50.5 159.5 65.4 20.3 73.1 64.9 345.7 19.6 65.9 42.7 56.2 74.0 79.9 40.2 107.1 252.6 54.3 55.1 29.7 72.3 61.2 83.7 59.0 27.9 19.3 13.1 59.1 39.4 78.2 14.4 34.4 31.3 5.6 55.9 10.9 49.0 67.2 HECTD2 FLJ37306 ENSG00000165338 "HECT domain E3 ubiquitin protein ligase 2" Q5U5R9 10 91409280-91514829 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 127.5;Inhibitory neurons: 99.4;Microglial cells: 60.0;Oligodendrocyte precursor cells: 87.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "NK-cell: 2.8" "Lineage enriched" "Detected in single" 6 "NK-cells: 2.8" "Cell line enhanced" "Detected in many" "AF22: 29.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 56.1" HPA037767 Approved Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "HPA037767: AB_10671378" "unprognostic (6.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.26e-2)" "unprognostic (3.34e-1)" "unprognostic (6.65e-3)" "unprognostic (1.10e-2)" "unprognostic (9.37e-4)" "unprognostic (1.42e-1)" "unprognostic (1.59e-1)" "unprognostic (2.31e-1)" "unprognostic (2.54e-3)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.67e-5)" "unprognostic (6.98e-3)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.84e-2)" 6.6 5.8 6.9 3.7 7.7 1.6 7.3 8.1 8.7 9.0 2.2 8.3 3.0 12.0 11.3 5.3 9.4 7.9 6.0 7.2 5.2 7.1 3.2 6.9 3.4 3.5 3.6 11.8 5.3 7.5 6.9 7.3 1.9 16.8 5.0 11.7 5.7 16.4 5.8 4.6 4.6 12.6 3.3 3.8 5.5 7.0 5.3 3.8 6.7 7.2 2.3 8.2 7.4 6.8 5.8 2.9 29.0 12.0 6.2 6.8 5.2 4.7 6.2 9.2 8.5 0.3 5.4 0.0 3.9 4.8 5.4 0.4 7.9 3.3 11.3 6.3 9.8 3.4 23.1 1.8 3.1 0.7 2.1 7.0 2.9 6.7 5.7 13.0 7.0 7.1 4.5 14.6 14.5 2.7 3.6 1.8 12.1 0.5 2.9 9.0 19.1 3.5 6.5 1.6 6.8 7.2 9.1 2.0 9.4 8.8 13.2 2.0 7.3 9.2 6.3 0.6 8.9 1.0 2.0 8.2 8.1 0.1 5.4 0.0 0.0 0.0 0.4 0.4 0.3 0.1 0.2 0.3 0.2 0.2 0.2 0.2 0.0 2.8 0.1 0.0 0.0 0.2 6.9 7.7 8.1 8.7 7.2 5.2 3.5 3.6 1.9 3.3 5.3 6.8 9.4 0.0 5.1 45.4 3.5 6.1 8.8 3.6 8.6 20.6 6.3 8.4 7.9 4.3 6.0 5.5 27.1 0.4 1.2 1.1 21.5 2.7 2.8 6.8 14.2 8.9 9.0 1.3 127.5 3.7 0.4 12.8 7.1 7.3 3.8 7.8 8.2 1.2 6.5 28.6 99.4 2.7 4.1 7.0 6.5 2.0 12.2 7.0 7.2 60.0 2.3 13.1 0.0 87.0 21.2 2.5 1.4 14.3 4.5 4.9 0.5 1.4 7.2 9.1 13.1 15.8 10.5 9.5 9.5 8.4 4.4 0.4 3.0 4.5 1.2 4.3 PPP1R3C "PPP1R5, PTG" ENSG00000119938 "Protein phosphatase 1 regulatory subunit 3C" Q9UQK1 10 91628442-91633071 "Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 908.0;tongue: 448.5" "Group enriched" "Detected in many" 8 "Astrocytes: 201.8;Cardiomyocytes: 232.0;Hepatocytes: 64.2;Muller glia cells: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 41.9;HHSteC: 51.7;hTERT-RPE1: 85.4;LHCN-M2: 102.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027041 Uncertain NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA027041: AB_1855649" "unprognostic (2.11e-1)" "unprognostic (1.86e-3)" "unprognostic (1.01e-1)" "unprognostic (2.44e-1)" "unprognostic (7.15e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-2)" "unprognostic (6.38e-2)" "unprognostic (1.85e-2)" "unprognostic (1.75e-3)" "unprognostic (5.63e-3)" "unprognostic (1.59e-2)" "unprognostic (5.48e-3)" "unprognostic (8.44e-3)" "unprognostic (4.86e-2)" "unprognostic (2.49e-1)" "unprognostic (4.61e-3)" 14.1 12.2 39.3 3.4 51.5 0.0 9.9 39.8 44.6 97.1 21.4 16.2 4.0 10.3 12.0 106.8 10.2 14.4 170.5 40.1 42.9 11.6 164.2 12.3 1.4 44.1 55.1 10.2 18.7 4.5 5.7 15.6 43.9 29.1 4.1 83.2 28.4 35.7 908.0 17.0 5.8 15.4 39.6 3.0 17.5 2.5 42.4 0.5 2.7 448.5 6.2 19.8 136.7 38.0 0.0 6.6 1.8 26.8 11.9 5.6 0.0 29.8 23.2 12.0 12.8 0.0 2.2 0.0 1.2 28.0 4.8 1.6 0.7 3.2 22.0 0.0 0.1 0.4 41.9 4.8 51.7 0.0 0.0 19.1 5.2 7.6 0.4 85.4 3.0 0.0 14.4 0.0 102.5 1.0 0.0 0.0 1.7 0.0 0.0 0.0 6.4 0.0 1.1 26.2 0.9 1.8 0.0 0.0 0.0 0.0 0.2 4.5 20.3 5.3 5.2 7.0 4.3 0.2 0.6 0.0 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.3 51.5 39.8 44.6 40.1 42.9 44.1 55.1 43.9 39.6 42.4 38.0 2.4 0.0 0.0 201.8 0.4 4.6 9.3 0.8 0.6 9.7 4.8 2.5 232.0 1.5 0.2 3.7 0.0 0.2 0.0 0.3 7.9 3.1 0.1 0.3 0.7 3.5 10.1 0.0 1.7 11.4 0.5 11.9 0.0 0.6 0.0 0.4 2.5 64.2 1.4 18.5 3.0 0.5 2.0 1.6 1.5 0.1 2.8 0.6 12.4 5.6 0.0 133.1 0.0 3.5 0.5 4.0 0.1 7.5 0.0 2.5 0.0 1.8 0.4 12.8 0.0 9.4 18.6 0.7 1.7 5.4 4.0 0.3 0.7 0.1 0.1 0.7 TNKS2 "ARTD6, PARP-5b, PARP-5c, PARP5B, PARP5C, pART6, TANK2, TNKL" ENSG00000107854 "Tankyrase 2" Q9H2K2 10 91798426-91865475 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036606 Approved Microtubules NA NA "Cluster 24: B-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" Microtubules "HPA036606: AB_10673470" "unprognostic (1.12e-1)" "unprognostic (2.66e-1)" "unprognostic (4.16e-1)" "unprognostic (1.61e-2)" "unprognostic (3.07e-2)" "unprognostic (1.51e-2)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "unprognostic (2.93e-1)" "unprognostic (2.59e-2)" "unprognostic (1.50e-1)" "unprognostic (2.26e-2)" "unprognostic (1.00e-1)" "unprognostic (2.35e-1)" "unprognostic (1.69e-1)" "unprognostic (7.97e-2)" "unprognostic (2.53e-1)" 18.4 19.3 14.7 21.2 16.1 38.5 22.2 18.0 17.0 21.1 25.0 14.8 14.9 22.5 19.8 22.8 17.8 20.8 11.1 14.3 14.9 17.4 21.2 19.7 28.1 14.6 15.1 30.3 22.0 21.8 14.4 31.2 15.8 19.6 17.1 31.2 18.5 16.6 55.6 27.3 15.3 20.7 16.0 30.0 19.8 11.8 17.4 37.7 29.6 40.5 29.4 24.1 17.1 19.7 29.1 24.3 48.9 41.7 33.8 30.6 54.5 30.6 55.5 36.5 44.5 21.7 23.2 27.2 14.3 40.0 24.6 30.6 31.0 23.6 51.3 27.7 29.9 22.6 22.9 24.3 32.9 44.0 32.3 31.4 30.6 37.0 65.3 54.8 34.8 24.1 16.9 29.4 38.5 15.6 38.1 29.9 24.6 13.2 16.1 35.2 30.5 20.9 25.0 30.9 12.8 22.9 30.8 13.4 38.7 39.2 32.5 30.3 37.8 19.6 16.5 26.1 29.5 36.7 32.1 34.8 25.9 32.4 17.9 0.2 0.7 1.2 0.9 0.6 0.8 1.0 0.9 0.8 1.0 1.0 0.7 0.6 0.7 1.0 0.6 1.5 0.5 0.4 14.7 16.1 18.0 17.0 14.3 14.9 14.6 15.1 15.8 16.0 17.4 19.7 39.1 41.7 22.3 63.3 51.6 74.6 32.5 23.8 56.9 41.7 38.8 24.0 23.2 8.6 31.0 44.1 47.9 45.2 48.7 19.2 7.9 16.0 4.7 41.1 29.3 37.1 33.0 27.5 77.5 24.5 55.1 30.9 50.4 52.1 2.5 34.8 35.7 35.9 26.1 42.1 78.5 19.3 26.4 55.3 49.4 8.1 31.1 48.4 33.8 67.5 46.5 24.9 37.0 66.9 68.0 29.0 12.3 35.3 45.7 44.7 16.1 16.6 47.4 34.8 46.0 40.5 28.0 19.1 21.7 75.9 109.1 101.0 49.1 30.5 14.9 61.7 FGFBP3 "C10orf13, MGC39320" ENSG00000174721 "Fibroblast growth factor binding protein 3" Q8TAT2 10 91906584-91909486 "Predicted secreted proteins" "Growth factor binding, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 19.6;Enteroendocrine cells: 46.2;Muller glia cells: 28.2" "Cancer enhanced" "Detected in many" "glioma: 4.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 9 "AF22: 315.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA053943 Uncertain "Secreted in brain" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 12: NES - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "HPA053943: AB_2682318" "unprognostic (8.66e-2)" "unprognostic (6.00e-2)" "unprognostic (4.47e-2)" "unprognostic (2.88e-1)" "unprognostic (9.98e-3)" "unprognostic (7.76e-2)" "unprognostic (1.43e-1)" "unprognostic (1.96e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.39e-3)" "unprognostic (2.61e-1)" "unprognostic (3.90e-1)" "unprognostic (6.95e-2)" "unprognostic (2.85e-1)" "unprognostic (2.63e-1)" "unprognostic (6.76e-3)" 1.0 1.4 3.9 0.8 3.6 0.6 1.1 3.0 4.4 1.5 2.0 1.0 0.6 1.4 1.5 0.9 1.1 0.2 0.9 3.3 4.3 1.6 0.6 0.7 0.8 4.1 3.7 1.4 1.9 0.9 2.2 0.4 3.7 1.7 1.0 4.5 1.5 0.6 2.0 1.3 1.1 0.4 3.3 1.3 1.2 0.5 4.0 0.8 2.3 0.6 0.6 1.5 1.1 4.0 0.3 2.5 315.8 4.7 1.3 0.4 1.1 0.2 0.2 0.6 1.0 0.8 1.2 0.4 0.4 0.6 0.1 1.3 2.2 0.3 0.8 1.2 3.4 6.5 2.6 3.8 0.7 35.5 0.9 0.9 0.4 1.6 1.5 1.0 0.2 4.1 3.4 1.2 0.1 2.7 4.1 14.2 23.4 1.3 1.1 10.5 2.0 0.5 0.5 0.8 3.3 4.3 0.8 0.1 5.7 1.8 1.3 0.7 0.3 0.3 2.3 0.4 1.1 0.8 2.0 1.3 0.3 4.1 0.6 0.6 0.1 0.0 0.5 0.0 0.1 0.8 0.3 0.2 0.1 1.7 0.5 0.4 0.0 0.3 0.0 0.1 0.0 0.0 3.9 3.6 3.0 4.4 3.3 4.3 4.1 3.7 3.7 3.3 4.0 4.0 2.8 0.0 2.0 2.6 2.9 1.3 5.1 0.3 1.2 13.0 5.4 5.1 3.2 4.3 2.9 5.5 2.1 2.9 4.4 1.7 19.6 2.0 0.3 1.4 1.9 2.6 46.2 2.1 1.9 3.4 1.1 3.8 5.1 1.3 0.0 3.2 3.3 1.5 1.4 6.7 2.7 7.6 0.0 3.4 2.6 0.5 5.9 2.5 3.6 1.0 2.5 28.2 10.3 5.5 2.6 0.6 2.4 3.8 3.1 3.2 1.0 3.2 4.9 15.9 0.0 4.6 3.1 0.3 1.0 4.7 2.7 1.0 6.4 2.6 3.8 4.3 BTAF1 "MOT1, TAF-172, TAF(II)170, TAF172, TAFII170" ENSG00000095564 "B-TFIID TATA-box binding protein associated factor 1" O14981 10 91923770-92030325 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 91.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070682 Supported Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm Vesicles "HPA070682: AB_2686294" "unprognostic (2.41e-1)" "unprognostic (1.29e-1)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-1)" "prognostic favorable (5.07e-4)" "unprognostic (2.72e-1)" "unprognostic (9.28e-2)" "unprognostic (1.16e-1)" "unprognostic (7.34e-2)" "unprognostic (9.70e-3)" "unprognostic (4.27e-2)" "prognostic unfavorable (4.04e-5)" "unprognostic (6.45e-2)" "unprognostic (1.10e-1)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" 20.4 13.2 5.2 20.1 7.3 32.1 19.2 8.5 8.6 18.4 5.9 20.4 16.2 20.7 21.1 17.2 23.4 15.2 14.4 6.1 5.5 11.8 15.4 19.1 32.0 6.1 5.3 25.4 18.1 14.7 13.3 13.7 6.0 16.8 15.9 34.3 19.2 12.7 14.8 50.4 22.0 14.0 5.9 22.0 18.4 17.9 5.8 21.7 17.3 9.2 25.5 20.1 19.9 10.4 28.9 13.8 31.7 38.7 16.5 25.8 15.8 16.5 19.6 16.0 23.7 19.1 17.2 30.8 10.3 16.3 9.9 30.4 21.5 14.6 23.8 21.2 23.2 21.9 35.7 20.0 16.8 33.3 22.0 18.4 18.5 24.3 35.1 34.3 15.6 25.9 18.2 34.5 16.6 12.6 25.8 21.0 14.4 8.3 10.8 20.6 19.7 14.5 14.9 17.5 12.2 14.3 15.8 8.0 20.3 20.8 16.2 21.9 16.9 14.3 11.4 19.5 23.7 39.7 19.6 24.9 22.4 30.1 3.8 4.4 2.7 1.5 2.5 1.9 2.2 2.5 1.9 1.8 2.1 3.1 2.3 1.8 1.9 2.2 3.6 4.9 1.6 1.4 5.2 7.3 8.5 8.6 6.1 5.5 6.1 5.3 6.0 5.9 5.8 10.4 18.3 19.2 31.5 58.4 29.5 21.7 12.1 7.3 21.6 26.7 16.2 11.9 13.6 7.2 14.6 20.2 45.9 6.6 34.8 7.9 1.9 6.8 12.9 33.3 28.0 15.6 16.2 13.9 78.5 6.6 9.8 17.3 35.2 46.6 24.1 22.4 8.9 8.7 7.1 18.5 66.4 7.1 6.1 9.7 19.8 5.1 11.8 27.1 5.4 67.5 16.4 13.9 14.4 68.3 91.5 6.7 6.3 11.7 52.1 15.7 9.6 3.3 24.9 35.5 6.6 25.7 22.8 24.7 12.2 20.4 29.8 14.6 24.7 11.4 9.3 16.4 CPEB3 KIAA0940 ENSG00000107864 "Cytoplasmic polyadenylation element binding protein 3" Q8NE35 10 92046692-92291078 "Predicted intracellular proteins" "Translation regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 32.2" "Cell type enhanced" "Detected in many" "Astrocytes: 176.0;Early spermatids: 226.2;Excitatory neurons: 233.7;Inhibitory neurons: 286.9;Late spermatids: 408.9;Oligodendrocyte precursor cells: 148.8;Oligodendrocytes: 128.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 12.1;U-266/70: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070942 Approved "Nucleoplasm,Plasma membrane,Midbody,Cytosol" Yes No "Cluster 10: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "Nucleoplasm, Plasma membrane, Midbody" "HPA070942: " "unprognostic (4.90e-2)" "unprognostic (2.12e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-1)" "unprognostic (2.95e-5)" "prognostic favorable (5.06e-5)" "unprognostic (4.09e-4)" "unprognostic (2.73e-1)" "unprognostic (2.40e-1)" "unprognostic (1.47e-2)" "unprognostic (2.42e-2)" "prognostic favorable (3.84e-9)" "unprognostic (3.33e-2)" "unprognostic (7.42e-2)" "unprognostic (1.36e-2)" "unprognostic (1.40e-1)" 1.9 3.9 6.1 1.8 7.2 1.7 3.2 6.2 17.3 2.5 2.1 2.3 3.1 1.9 4.5 4.6 1.8 2.0 5.1 6.4 4.3 4.6 32.2 2.2 1.9 10.4 5.6 3.5 3.5 3.2 4.0 1.6 11.0 4.2 2.6 7.1 7.5 2.4 19.7 4.0 3.0 2.0 1.4 2.6 2.8 12.9 4.4 1.5 6.5 9.5 2.1 1.9 3.1 7.0 0.9 0.2 0.3 1.9 0.5 0.5 0.7 0.8 0.6 1.2 0.9 0.6 1.9 1.1 1.0 0.3 0.5 2.5 0.9 0.6 0.7 1.1 0.9 1.4 1.3 0.8 1.4 0.6 1.4 0.4 1.5 0.6 2.4 1.0 1.1 1.3 0.9 12.1 0.5 0.7 0.9 0.8 0.2 1.3 0.9 1.1 1.6 2.1 1.2 0.4 1.4 0.5 0.8 2.2 1.6 1.0 2.7 1.6 0.8 0.6 0.6 0.4 0.7 6.3 1.7 1.1 0.3 2.2 0.1 2.6 0.4 0.8 0.2 0.5 0.2 0.7 0.1 0.3 0.3 0.1 0.1 0.1 0.5 0.2 0.6 0.2 0.1 0.2 6.1 7.2 6.2 17.3 6.4 4.3 10.4 5.6 11.0 1.4 4.4 7.0 6.1 6.4 7.0 176.0 6.2 8.8 4.0 4.0 7.4 26.0 20.5 10.7 25.3 5.7 4.4 12.9 50.1 2.1 3.0 11.3 5.9 3.2 226.2 9.0 3.0 7.1 19.8 3.6 233.7 2.6 1.6 5.5 4.1 10.8 3.8 4.1 12.5 75.2 4.8 30.3 286.9 9.9 8.2 23.9 3.4 408.9 5.9 10.3 5.4 87.1 8.9 3.2 4.1 148.8 128.6 3.2 4.0 7.9 4.2 10.7 10.1 5.0 8.7 24.7 0.0 4.4 4.1 13.2 7.2 22.0 13.9 1.2 3.3 3.4 5.9 6.5 MARCHF5 "FLJ20445, MARCH-V, MARCH5, MITOL, RNF153" ENSG00000198060 "Membrane associated ring-CH-type finger 5" Q9NX47 10 92291167-92353964 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 23.8;Cardiomyocytes: 28.6;Cytotrophoblasts: 39.2;Extravillous trophoblasts: 44.0;Hofbauer cells: 34.9;Syncytiotrophoblasts: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056596 Supported Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Mitochondria "HPA056596: AB_2683181" "unprognostic (4.00e-2)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (4.10e-2)" "unprognostic (5.47e-3)" "unprognostic (2.33e-3)" "unprognostic (4.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.24e-2)" "unprognostic (9.77e-2)" "unprognostic (5.50e-3)" "unprognostic (4.02e-3)" "unprognostic (6.14e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (4.53e-1)" "unprognostic (2.85e-2)" 13.6 14.0 9.1 7.7 9.6 17.3 15.0 9.1 11.9 12.2 10.4 9.8 11.3 13.3 12.6 19.3 10.1 10.7 12.8 9.6 9.4 15.1 20.1 10.4 9.0 9.0 9.4 14.0 9.2 12.5 7.0 7.8 8.8 15.1 10.1 8.8 13.7 7.8 18.2 9.8 11.6 10.7 9.6 8.9 10.5 8.8 9.3 12.5 17.2 16.1 9.8 10.7 12.2 9.7 28.0 14.8 28.7 33.1 19.2 19.8 14.8 24.5 26.7 29.8 30.4 10.0 19.6 16.2 16.5 24.1 13.0 22.4 20.3 20.5 42.5 12.3 23.9 13.1 13.6 23.7 23.2 21.1 12.4 20.4 27.0 19.7 40.9 39.6 26.6 17.0 14.5 19.7 24.2 17.7 18.7 24.1 6.7 18.1 22.1 20.0 29.4 9.8 30.8 17.8 13.3 24.5 21.3 15.5 26.7 13.7 27.1 16.1 26.0 13.9 15.3 15.3 34.0 19.9 16.2 14.2 12.7 28.7 9.5 4.2 6.0 7.0 5.1 7.5 5.2 5.2 5.7 5.5 6.9 4.5 5.7 5.5 12.2 5.0 6.7 4.6 5.9 5.0 9.1 9.6 9.1 11.9 9.6 9.4 9.0 9.4 8.8 9.6 9.3 9.7 23.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.0 0.0 39.2 12.9 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 44.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 65.3 2.8 0.0 0.0 0.0 IDE ENSG00000119912 "Insulin degrading enzyme" P14735 10 92451684-92574096 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063478 Approved "Secreted in other tissues" NA NA 310000 "Cluster 27: Non-specific - Gene expression" "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA063478: AB_2685020" "unprognostic (1.70e-1)" "unprognostic (6.40e-2)" "prognostic favorable (3.69e-4)" "prognostic favorable (3.53e-4)" "unprognostic (2.54e-1)" "unprognostic (1.78e-1)" "unprognostic (2.51e-1)" "unprognostic (3.79e-1)" "unprognostic (8.88e-2)" "unprognostic (2.57e-1)" "unprognostic (6.58e-2)" "unprognostic (7.79e-2)" "unprognostic (6.81e-2)" "unprognostic (9.24e-3)" "unprognostic (6.13e-2)" "unprognostic (3.89e-2)" "unprognostic (3.91e-1)" 6.7 10.1 3.4 2.8 3.6 3.5 6.1 3.7 4.2 8.1 5.9 8.6 3.3 7.4 9.7 9.8 6.5 2.9 11.7 3.4 3.7 5.9 11.4 5.9 3.4 3.8 3.7 5.4 12.3 9.5 4.7 2.7 3.9 9.1 3.8 10.3 7.8 4.2 28.8 36.4 6.8 3.7 3.6 6.3 8.2 25.8 3.6 2.4 6.7 9.7 4.1 8.9 7.9 3.8 12.1 22.9 6.2 15.1 10.5 5.8 8.5 10.4 13.3 6.1 5.2 19.4 9.5 12.5 16.4 14.3 7.2 16.3 14.6 10.0 3.9 14.7 8.8 5.1 13.7 25.9 11.5 14.9 6.5 5.4 6.6 9.1 14.0 7.8 8.6 3.3 10.0 8.1 5.4 18.0 6.6 8.8 10.2 10.4 5.2 10.2 10.8 9.0 10.9 19.3 2.2 5.6 14.3 6.4 6.7 6.8 12.6 6.3 15.3 4.4 8.2 5.0 10.4 11.2 12.2 14.5 6.9 10.9 4.4 0.3 3.5 1.4 2.0 4.2 2.2 2.9 2.6 2.9 4.6 2.1 1.9 2.0 0.0 3.7 5.9 1.3 3.9 2.3 3.4 3.6 3.7 4.2 3.4 3.7 3.8 3.7 3.9 3.6 3.6 3.8 12.9 9.6 14.1 20.9 11.1 5.2 6.1 10.5 5.2 15.0 8.7 4.3 45.7 7.2 10.6 7.3 47.9 11.2 10.0 14.0 1.9 14.0 46.4 14.9 19.3 10.8 10.8 19.6 43.3 20.2 5.7 9.1 22.4 16.5 1.3 9.9 11.7 24.1 11.9 6.7 42.6 12.7 18.3 16.6 5.4 12.0 6.5 12.5 8.8 23.4 7.8 7.8 4.1 20.6 24.0 16.5 5.7 10.1 24.2 12.2 9.0 10.7 23.3 26.9 6.6 7.6 13.2 51.5 11.0 19.6 16.3 3.8 8.5 9.8 9.8 9.6 KIF11 "Eg5, HKSP, KNSL1, TRIP5" ENSG00000138160 "Kinesin family member 11" P52732 10 92574105-92655395 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.4;lymphoid tissue: 37.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 39.1;Granulosa cells: 20.7;Spermatocytes: 38.0;Spermatogonia: 23.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA006916, HPA010093, HPA010568, CAB017617" Enhanced Supported "Mitotic spindle,Cytosol" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Mitotic spindle" "CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (1.59e-2)" "unprognostic (3.35e-2)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (8.19e-7)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.30e-4)" "unprognostic (6.59e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.35e-3)" "unprognostic (7.23e-2)" "unprognostic (9.08e-2)" "unprognostic (2.01e-1)" 1.1 0.7 0.5 8.5 0.7 19.4 2.5 0.4 0.6 1.4 0.5 6.3 5.5 1.8 1.0 6.7 1.0 1.2 0.6 0.5 0.5 1.0 1.1 1.3 17.5 0.6 0.6 0.6 0.5 0.7 0.3 3.9 0.6 1.0 7.4 0.8 1.3 0.7 0.2 6.0 5.3 2.5 0.5 2.9 3.9 11.6 0.4 37.9 1.6 0.3 18.5 2.3 2.3 0.6 103.1 45.2 100.6 94.5 7.3 10.5 24.2 72.6 62.8 78.8 78.1 39.6 67.2 111.1 36.5 34.4 32.9 72.0 72.1 36.5 92.4 68.3 41.3 70.5 41.4 42.4 1.4 116.0 63.0 3.6 3.3 61.4 55.9 18.3 50.0 46.1 51.2 126.4 61.1 41.4 99.3 65.8 40.3 42.5 30.7 106.6 98.8 40.2 21.0 30.1 30.0 42.9 56.4 25.9 29.2 34.1 67.9 37.6 28.6 35.7 51.3 37.1 96.9 35.4 58.3 113.4 29.5 82.3 50.3 0.8 0.0 0.1 0.0 0.3 0.3 0.6 0.4 0.4 0.2 0.1 0.1 0.2 0.2 1.0 0.1 0.1 1.1 0.2 0.5 0.7 0.4 0.6 0.5 0.5 0.6 0.6 0.6 0.5 0.4 0.6 0.4 0.0 2.0 1.3 3.5 2.9 1.1 1.6 3.4 1.0 1.8 1.8 1.7 1.5 2.5 1.8 0.0 6.7 2.3 2.9 1.9 0.5 16.3 3.4 4.3 2.0 0.0 39.1 2.1 0.6 11.4 4.7 9.2 4.9 0.0 20.7 2.2 0.4 8.2 0.0 1.8 4.3 4.1 4.6 3.4 4.4 0.9 4.0 0.0 0.0 1.0 0.7 2.1 2.5 1.1 0.2 0.4 0.7 15.2 0.8 0.5 0.6 3.7 0.4 0.0 1.7 3.7 38.0 23.4 12.6 3.3 1.5 4.5 2.5 8.0 1.7 HHEX "HEX, HOX11L-PEN, PRHX" ENSG00000152804 "Hematopoietically expressed homeobox" Q03014 10 92689955-92695647 "Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 84.7;liver: 91.2;thyroid gland: 102.1" "Cell type enhanced" "Detected in many" "B-cells: 77.2;Cholangiocytes: 125.8;dendritic cells: 57.6;Ductal cells: 107.9;Endothelial cells: 80.0;Hepatic stellate cells: 88.9;Hepatocytes: 58.3;Hofbauer cells: 72.6;Kupffer cells: 63.5" "Group enriched" "Detected in all" 5 "liver cancer: 20.1;thyroid cancer: 56.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 43 "basophil: 28.0;classical monocyte: 41.5;eosinophil: 61.8;intermediate monocyte: 45.7;memory B-cell: 59.3;myeloid DC: 30.8;naive B-cell: 65.8;neutrophil: 31.4;non-classical monocyte: 50.7;plasmacytoid DC: 36.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 87.7;HEL: 99.9;HMC-1: 105.6;HUVEC TERT2: 106.1;K-562: 154.8;NB-4: 101.8;U-937: 79.7" "Low region specificity" "Detected in many" "HPA003257, HPA051894" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Nuclear bodies" "HPA003257: , HPA051894: AB_2681653" "prognostic favorable (8.83e-4)" "prognostic favorable (3.91e-5)" "unprognostic (2.98e-2)" "unprognostic (7.92e-2)" "unprognostic (6.46e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.23e-4)" "unprognostic (1.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.96e-2)" "unprognostic (5.27e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.25e-5)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.50e-2)" 16.2 18.5 5.0 22.2 5.4 84.7 11.2 5.6 8.8 7.1 5.1 7.8 6.4 6.4 3.5 4.1 6.1 27.4 6.1 4.8 5.2 7.0 91.2 16.9 39.1 6.3 5.4 3.0 38.1 1.9 2.2 14.6 6.4 4.7 6.5 0.3 3.5 4.0 2.9 4.6 19.0 5.8 6.2 39.9 5.2 2.4 6.0 4.4 102.1 6.3 30.4 12.7 5.0 6.7 11.2 20.6 10.5 0.1 0.9 0.7 0.2 5.6 46.4 7.4 6.6 4.0 2.6 10.7 87.7 0.7 0.0 2.1 9.5 0.3 9.1 0.1 11.1 99.9 8.8 67.4 21.0 58.6 105.6 0.3 0.2 6.5 0.0 3.7 106.1 0.3 154.8 0.1 0.5 3.2 0.4 101.8 0.2 30.2 11.8 34.0 3.0 0.1 0.9 4.3 4.9 1.0 6.2 0.0 0.1 0.5 3.3 30.6 37.2 0.0 0.6 0.1 0.1 2.6 1.8 21.2 0.0 79.7 51.4 28.0 41.5 61.8 0.8 45.7 0.3 59.3 0.0 0.1 30.8 65.8 0.1 0.1 31.4 1.0 50.7 36.3 0.4 15.5 5.0 5.4 5.6 8.8 4.8 5.2 6.3 5.4 6.4 6.2 6.0 6.7 31.9 0.0 3.0 0.0 77.2 6.4 2.1 0.9 2.2 0.0 3.0 3.2 3.6 125.8 1.6 0.0 0.0 0.7 57.6 0.4 0.0 107.9 0.3 0.8 0.5 80.0 5.3 28.2 0.0 12.0 0.7 2.2 0.5 1.0 7.0 0.0 88.9 58.3 72.6 0.0 0.0 1.6 0.0 63.5 29.1 1.1 0.3 51.7 7.2 5.6 50.4 0.0 9.2 0.5 0.0 10.5 0.0 1.2 1.6 3.2 0.0 0.2 0.9 0.2 0.0 1.9 2.1 0.3 6.3 1.0 3.7 1.1 8.3 3.4 0.7 1.3 EXOC6 "DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p" ENSG00000138190 "Exocyst complex component 6" Q8TAG9 10 92826831-93059493 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "retina: 164.2" "Cell type enhanced" "Detected in all" "Excitatory neurons: 181.7;Microglial cells: 146.1;Oligodendrocyte precursor cells: 157.3;Rod photoreceptor cells: 177.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 30.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036285, HPA059111" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 77: Retina - Visual perception" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 46: Photoreceptor cells - Phototransduction" Vesicles Nucleoplasm "HPA036285: AB_10673617, HPA059111: AB_2683907" "unprognostic (1.41e-1)" "unprognostic (1.39e-3)" "unprognostic (5.20e-2)" "unprognostic (2.65e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-1)" "unprognostic (1.16e-3)" "unprognostic (7.21e-3)" "unprognostic (3.84e-1)" "unprognostic (2.70e-1)" "unprognostic (1.66e-1)" "unprognostic (8.13e-2)" "prognostic favorable (4.66e-4)" "unprognostic (2.12e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (6.41e-2)" 8.7 14.4 5.9 8.2 7.5 12.9 8.0 7.7 8.6 6.5 8.0 9.6 8.1 6.1 5.7 4.2 5.8 10.1 7.1 8.2 6.0 6.4 10.1 10.7 9.5 3.4 2.4 3.9 10.0 6.3 6.1 37.4 3.7 8.6 10.2 164.2 5.6 4.3 31.8 5.0 9.5 7.7 3.3 9.1 7.0 9.9 6.1 8.5 28.4 19.7 8.2 10.1 3.5 7.1 19.8 24.3 25.7 16.8 1.3 1.6 9.1 9.0 24.9 8.1 9.7 9.1 16.5 22.5 19.0 4.3 6.6 12.3 20.8 5.7 10.1 20.1 20.9 35.1 8.3 11.7 9.6 36.4 30.6 2.2 3.0 7.2 4.8 14.6 113.8 14.6 29.2 14.5 4.0 10.7 15.3 23.2 3.5 40.2 7.0 22.5 11.2 11.6 17.4 13.2 8.5 11.9 9.2 9.2 11.8 6.4 18.2 18.8 22.4 0.6 8.2 7.5 14.7 10.8 12.4 18.1 2.8 41.6 9.3 6.2 4.9 15.2 3.0 3.9 3.0 6.7 3.4 2.8 5.1 6.6 2.7 3.2 30.6 2.8 3.9 11.1 3.3 2.4 5.9 7.5 7.7 8.6 8.2 6.0 3.4 2.4 3.7 3.3 6.1 7.1 28.3 16.0 16.7 33.6 27.6 3.3 10.7 8.6 3.4 40.2 9.8 6.5 12.0 20.0 15.0 16.5 39.6 22.9 24.1 14.3 5.9 28.3 5.4 8.8 3.0 53.1 25.6 39.2 181.7 15.4 7.8 7.8 13.7 16.5 10.8 24.3 77.1 14.2 21.4 23.5 100.3 16.6 14.2 18.2 12.5 12.6 4.4 18.9 5.4 146.1 22.8 27.1 19.6 157.3 84.7 14.1 10.3 14.7 13.8 14.1 10.8 8.4 10.0 177.8 13.1 13.6 9.0 25.0 25.5 4.9 4.8 20.5 18.4 29.8 11.9 15.8 CYP26C1 ENSG00000187553 "Cytochrome P450 family 26 subfamily C member 1" Q6V0L0 10 93060798-93069540 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Ectodermal dysplasia" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.2;Microglial cells: 2.8;Rod photoreceptor cells: 1.0;Theca cells: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (8.39e-2)" "unprognostic (3.41e-2)" "unprognostic (3.88e-1)" "unprognostic (5.05e-2)" "unprognostic (3.25e-2)" "unprognostic (3.43e-2)" "unprognostic (4.97e-2)" "unprognostic (1.70e-1)" "unprognostic (8.85e-2)" "unprognostic (5.29e-2)" "unprognostic (2.47e-1)" "unprognostic (1.10e-1)" "unprognostic (2.02e-2)" "unprognostic (1.74e-4)" "unprognostic (8.59e-3)" "unprognostic (3.10e-3)" "unprognostic (1.17e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 6.9 0.0 0.0 CYP26A1 "CP26, CYP26, P450RAI, P450RAI1" ENSG00000095596 "Cytochrome P450 family 26 subfamily A member 1" O43174 10 93073475-93077885 "Metabolic proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "liver: 17.9" "Group enriched" "Detected in some" 4 "Basal respiratory cells: 48.0;Endometrial ciliated cells: 46.3;Glandular and luminal cells: 86.7;Muller glia cells: 62.1" "Cancer enhanced" "Detected in many" "testis cancer: 5.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "AF22: 62.1" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 6.9" NA NA "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 12: NES - Nervous system development" "Cluster 44: Endometrium - Transcription" "unprognostic (2.80e-1)" "unprognostic (4.21e-3)" "unprognostic (5.65e-2)" "unprognostic (2.94e-1)" "unprognostic (2.16e-1)" "unprognostic (4.90e-1)" "unprognostic (4.17e-2)" "unprognostic (6.22e-2)" "unprognostic (3.35e-1)" "unprognostic (4.89e-1)" "unprognostic (1.11e-2)" "unprognostic (6.24e-2)" "unprognostic (2.04e-11)" "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (4.11e-1)" 0.0 0.1 0.4 0.0 0.4 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.5 0.0 17.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 62.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.6 0.4 0.5 0.3 0.1 0.2 0.1 0.5 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 48.0 0.0 1.1 0.4 8.1 0.3 0.0 13.1 0.0 2.1 0.3 0.1 0.0 0.0 0.2 0.2 46.3 10.6 1.0 0.0 0.0 0.9 0.0 1.1 0.2 0.0 86.7 0.0 0.0 0.0 8.2 0.1 0.0 4.9 0.0 6.1 0.0 0.0 0.2 0.0 0.2 0.0 1.0 0.0 62.1 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 2.7 0.0 0.0 0.4 2.1 2.6 0.0 0.0 7.7 0.6 1.9 0.0 0.0 MYOF "FER1L3, KIAA1207" ENSG00000138119 Myoferlin Q9NZM1 10 93306429-93482334 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 123.4;Pancreatic endocrine cells: 153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 20.4;non-classical monocyte: 26.6" "Group enriched" "Detected in many" 57 "dendritic cells: 8.1;monocytes: 26.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 452.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014245 Enhanced Supported "Vesicles,Plasma membrane" NA NA 190000 "Cluster 51: Monocytes - Innate immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles "Plasma membrane" "HPA014245: AB_1848495" "unprognostic (3.41e-2)" "unprognostic (3.85e-1)" "unprognostic (2.88e-2)" "unprognostic (7.44e-2)" "unprognostic (3.50e-2)" "unprognostic (8.57e-3)" "unprognostic (3.48e-2)" "unprognostic (7.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.55e-1)" "unprognostic (5.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.94e-2)" "unprognostic (9.17e-2)" "unprognostic (9.18e-2)" 31.7 8.1 2.9 20.6 4.1 1.5 43.3 5.0 2.5 56.4 37.4 22.4 5.3 27.5 7.1 36.4 36.9 26.6 13.8 3.4 4.1 10.9 2.9 32.2 4.4 8.9 6.8 9.8 5.9 23.8 3.8 55.2 8.1 27.5 29.3 0.9 19.7 31.4 3.6 56.1 9.0 44.3 6.2 6.5 13.4 2.2 5.4 5.1 35.7 6.2 9.1 62.0 29.4 6.2 228.9 206.3 21.4 14.6 159.4 318.4 62.0 190.3 452.7 110.1 109.2 51.1 177.1 0.0 76.9 353.7 116.2 350.0 1.8 204.7 82.6 1.4 0.9 0.0 80.8 2.1 55.2 0.0 0.2 183.0 71.6 77.7 323.8 289.4 299.7 0.0 0.0 0.5 275.6 39.4 0.1 0.9 1.6 72.0 171.6 0.0 15.8 0.1 314.3 281.5 0.1 0.0 130.4 29.7 46.1 83.1 141.5 4.7 378.5 167.3 11.8 111.3 113.9 0.2 0.3 0.3 128.2 2.6 201.0 0.0 5.4 0.0 0.0 20.4 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.3 0.0 26.6 2.8 0.2 1.6 2.9 4.1 5.0 2.5 3.4 4.1 8.9 6.8 8.1 6.2 5.4 6.2 42.5 60.9 52.5 1.6 1.2 23.7 63.0 101.4 39.3 0.1 48.4 34.3 9.2 14.3 91.5 22.0 0.0 56.6 3.8 74.1 1.9 54.8 0.6 50.9 45.9 28.8 1.8 0.0 2.7 33.7 23.7 38.1 23.0 123.4 1.3 1.7 35.7 0.4 22.9 0.0 0.8 29.6 42.7 29.2 20.2 0.6 5.9 28.5 8.8 60.0 12.8 0.1 0.0 2.0 0.7 153.7 22.2 9.1 0.8 86.7 0.6 1.5 60.7 0.8 6.6 15.9 39.6 0.1 0.3 53.4 30.7 51.2 1.9 8.3 18.7 100.7 CEP55 "C10orf3, CT111, FLJ10540" ENSG00000138180 "Centrosomal protein 55" Q53EZ4 10 93496612-93529092 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.4;testis: 21.7" "Cell type enhanced" "Detected in many" "Early spermatids: 29.4;Extravillous trophoblasts: 17.1;Granulosa cells: 19.8;Spermatocytes: 77.3;Spermatogonia: 17.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 8 "T-reg: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA023430 Approved Approved "Plasma membrane,Midbody,Centriolar satellite" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Centriolar satellite" Midbody "HPA023430: AB_10960212" "unprognostic (9.85e-2)" "unprognostic (1.12e-2)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavorable (3.20e-9)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.50e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (3.99e-2)" "prognostic unfavorable (0.00e+0)" "prognostic favorable (3.15e-4)" "unprognostic (7.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" 1.3 0.6 0.0 7.6 0.0 5.0 1.4 0.0 0.2 1.7 0.0 7.0 6.7 1.4 0.1 7.3 0.4 1.4 0.3 0.0 0.1 0.3 0.6 1.3 14.7 0.1 0.3 0.2 0.2 0.2 0.3 3.5 0.2 0.3 8.8 0.0 1.2 0.3 0.1 4.5 6.3 5.2 0.0 2.4 4.6 21.7 0.4 27.4 0.5 0.2 15.5 3.1 2.3 0.1 208.5 81.5 53.0 67.7 5.8 12.0 29.6 112.4 78.2 103.5 106.4 87.2 108.6 55.4 48.2 72.8 69.6 115.4 64.8 54.8 123.4 167.2 33.7 21.0 49.2 29.9 0.6 36.3 46.3 2.8 3.8 110.6 133.5 30.7 97.1 89.9 19.3 101.8 118.5 48.3 96.3 54.8 20.9 64.2 58.8 41.3 86.9 30.3 47.1 25.5 21.7 30.7 86.3 26.3 64.9 40.1 68.9 36.4 61.4 65.3 90.6 90.5 186.7 45.1 66.1 66.8 51.0 134.8 59.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.2 0.0 0.4 0.1 0.2 0.0 1.3 0.0 2.7 3.6 0.9 1.9 0.0 0.0 1.8 2.0 0.4 2.8 0.2 0.0 0.0 7.7 0.9 3.3 0.0 0.6 29.4 1.7 2.0 1.5 0.0 2.5 0.5 0.2 17.1 2.3 8.2 3.6 0.0 19.8 2.2 0.3 12.9 0.0 0.3 4.5 4.1 7.0 5.1 8.2 0.3 5.1 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.3 0.0 0.4 14.8 1.1 0.4 0.0 0.2 0.0 0.0 0.5 4.5 77.3 17.3 16.1 1.3 1.5 4.3 1.6 7.9 1.7 FFAR4 "GPR120, GPR129, O3FAR1, PGR4" ENSG00000186188 "Free fatty acid receptor 4" Q5NUL3 10 93566665-93604480 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "Differentiation, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 11.4;pituitary gland: 11.0" "Cell type enriched" "Detected in some" 4 "Intestinal goblet cells: 125.7" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 12.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042563 Uncertain "Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Plasma membrane" "HPA042563: AB_10794762" "unprognostic (1.96e-1)" "unprognostic (1.06e-2)" "unprognostic (1.14e-2)" "unprognostic (4.21e-2)" "unprognostic (2.12e-1)" "unprognostic (4.98e-4)" "unprognostic (1.41e-3)" "unprognostic (1.20e-2)" "unprognostic (2.34e-2)" "unprognostic (7.87e-2)" "unprognostic (9.51e-2)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (5.32e-2)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" 4.1 0.4 1.2 0.7 1.3 0.1 1.3 0.6 1.2 0.1 0.3 8.3 0.5 0.0 0.0 0.2 1.0 0.5 0.3 1.0 1.8 0.1 0.4 3.6 0.2 0.6 0.8 0.0 0.6 0.1 11.0 0.1 0.5 0.1 11.4 0.2 0.1 0.0 0.3 0.9 0.6 0.2 0.3 0.1 0.5 1.5 2.6 0.3 0.1 0.1 0.1 0.1 0.0 0.7 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 12.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.2 1.2 1.3 0.6 1.2 1.0 1.8 0.6 0.8 0.5 0.3 2.6 0.7 0.2 0.0 0.5 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.2 0.8 0.4 7.2 0.6 0.0 0.0 0.2 0.0 28.1 0.0 0.8 27.8 0.1 0.0 0.3 20.9 0.0 3.2 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 7.4 0.0 2.0 125.7 0.0 7.2 4.4 16.7 0.6 7.6 1.8 3.7 0.5 0.0 0.0 0.0 0.3 0.9 23.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.3 RBP4 ENSG00000138207 "Retinol binding protein 4" P02753 10 93591687-93601744 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Transport, Vision" "Cancer-related genes, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "liver: 11920.3" "Cell type enriched" "Detected in many" 12 "Hepatocytes: 12711.6" "Cancer enriched" "Detected in all" 27 "liver cancer: 3135.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Hep G2: 1117.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001641, CAB004555" Supported "Secreted to blood" NA NA 46100000000 210000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "CAB004555: AB_670938, HPA001641: AB_1079795" "unprognostic (9.42e-3)" "unprognostic (3.40e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.60e-2)" "unprognostic (6.69e-4)" "prognostic favorable (1.74e-8)" "unprognostic (2.39e-1)" "unprognostic (5.76e-2)" "unprognostic (3.26e-2)" "unprognostic (3.26e-1)" "unprognostic (3.44e-1)" "unprognostic (7.14e-3)" "unprognostic (9.88e-3)" "unprognostic (2.31e-1)" "unprognostic (1.03e-1)" "unprognostic (8.60e-2)" 730.7 32.4 30.2 6.2 34.4 1.1 394.2 12.4 48.1 5.8 12.4 11.2 4.8 2.3 0.9 1.1 2.1 7.5 16.7 32.2 113.0 142.8 11920.3 24.5 0.6 21.5 19.3 4.1 82.4 0.1 519.9 12.4 21.3 8.6 6.7 3.0 13.7 4.6 6.2 16.4 19.2 0.8 14.9 5.5 11.9 4.7 46.2 1.5 7.9 5.3 0.1 19.0 8.8 18.0 0.0 14.7 0.0 0.0 2.9 0.0 0.1 0.3 0.1 2.5 0.4 264.9 0.5 1.5 2.7 0.3 0.2 0.8 0.0 0.0 0.3 0.2 0.2 2.2 1.1 1117.2 0.2 9.2 0.2 18.7 0.5 0.7 0.0 0.0 0.0 0.0 1.4 0.2 1.2 0.0 0.1 7.3 1.3 2.4 121.7 0.4 7.0 0.0 0.0 0.6 0.9 0.2 9.6 0.0 0.0 0.6 0.5 0.8 0.4 0.0 7.8 0.2 0.3 0.9 0.3 3.7 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.2 34.4 12.4 48.1 32.2 113.0 21.5 19.3 21.3 14.9 46.2 18.0 9.1 0.0 4.2 0.3 17.2 0.8 0.5 0.0 0.0 0.0 2.1 6.7 0.7 999.4 0.6 23.9 6.2 0.3 0.2 21.9 97.8 7.8 2.8 1.6 3.1 10.8 62.5 152.4 5.8 0.2 22.6 10.5 0.0 22.1 0.0 0.0 158.1 12711.6 17.8 0.0 7.2 40.7 0.0 210.4 3.0 2.4 3.1 7.8 1.8 1.0 0.0 0.8 0.0 1.0 1.1 29.2 28.0 5.7 0.3 2.1 0.8 785.3 0.7 0.5 0.0 7.3 3.8 3.1 13.9 0.0 0.9 1.4 12.3 0.0 1.7 1.4 PDE6C "ACHM5, COD4, PDEA2" ENSG00000095464 "Phosphodiesterase 6C" P51160 10 93612537-93666010 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "retina: 23.1" "Cell type enriched" "Detected in some" 13 "Cone photoreceptor cells: 56.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 79: Retina - Phototransduction" "Cluster 9: Photoreceptor cells - Phototransduction" "unprognostic (1.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.61e-2)" "unprognostic (2.24e-1)" "unprognostic (3.17e-2)" "unprognostic (5.23e-3)" "unprognostic (2.46e-3)" "unprognostic (2.81e-3)" "unprognostic (9.68e-2)" "unprognostic (2.64e-1)" "unprognostic (1.51e-2)" "unprognostic (2.96e-3)" "unprognostic (2.19e-7)" "unprognostic (1.19e-1)" "unprognostic (6.61e-2)" "unprognostic (1.81e-1)" "unprognostic (1.80e-3)" 0.1 0.1 0.2 0.0 0.2 0.2 0.1 0.8 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.2 0.2 0.0 23.1 0.1 0.0 0.5 0.5 0.1 0.0 0.0 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.2 0.2 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.3 0.2 0.2 0.2 0.0 0.2 0.0 0.4 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 56.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 FRA10AC1 C10orf4 ENSG00000148690 "FRA10A associated CGG repeat 1" Q70Z53 10 93667883-93702592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 151.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039204 Approved NA NA "Cluster 44: Non-specific - Transcription" "Cluster 70: Brain - Nervous system development" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA039204: AB_10794426" "unprognostic (3.21e-3)" "unprognostic (1.61e-1)" "unprognostic (5.03e-2)" "unprognostic (9.91e-2)" "unprognostic (9.24e-2)" "unprognostic (8.30e-2)" "unprognostic (4.38e-2)" "unprognostic (2.89e-3)" "unprognostic (1.63e-1)" "unprognostic (2.34e-2)" "unprognostic (2.28e-2)" "unprognostic (3.64e-2)" "unprognostic (3.42e-2)" "unprognostic (1.27e-2)" "unprognostic (3.06e-2)" "unprognostic (2.20e-1)" "unprognostic (1.13e-1)" 9.2 8.6 18.4 6.3 20.0 7.0 8.6 19.6 24.5 10.5 14.1 10.2 5.9 10.7 8.4 6.5 10.1 5.3 11.8 17.8 19.1 8.4 8.3 6.4 8.3 18.8 18.6 12.2 10.3 8.3 10.2 5.9 19.2 9.0 6.4 12.3 12.4 7.5 12.2 9.8 6.6 6.8 18.6 7.2 7.8 10.5 19.5 7.3 9.1 12.7 7.3 8.9 8.5 20.5 15.9 11.6 10.7 29.4 14.3 17.1 6.9 13.4 9.5 7.3 8.4 5.3 12.9 11.9 9.7 8.9 11.6 19.1 13.0 10.0 11.5 22.4 14.4 8.9 9.0 12.0 20.1 17.5 5.8 11.7 5.9 7.9 18.8 23.1 15.3 13.6 13.0 14.3 13.1 7.6 16.2 17.9 8.5 8.3 11.1 10.6 13.4 5.1 8.8 5.5 10.5 10.0 6.8 6.1 28.1 11.1 24.2 14.2 15.9 5.3 9.5 4.4 15.6 11.5 16.2 11.6 13.5 28.4 3.9 4.7 2.7 5.6 4.4 3.1 6.0 5.7 6.5 5.9 2.2 6.3 7.8 6.7 2.0 4.0 4.1 3.6 5.5 1.4 18.4 20.0 19.6 24.5 17.8 19.1 18.8 18.6 19.2 18.6 19.5 20.5 39.6 16.0 45.4 28.1 25.5 20.6 29.6 37.7 32.5 36.2 24.1 43.6 109.7 34.3 28.9 14.7 22.9 29.0 18.7 13.4 37.2 35.2 75.8 29.0 35.8 35.1 43.0 24.6 44.2 43.7 21.0 37.1 21.4 24.6 25.3 34.5 29.6 77.1 19.6 50.5 45.6 51.7 20.3 20.0 14.6 26.2 30.7 18.4 16.0 34.7 26.9 47.9 29.9 44.7 48.2 36.0 16.1 28.2 19.0 32.5 14.8 43.1 23.7 33.0 13.1 57.2 43.0 151.3 69.0 20.3 22.3 14.1 23.1 33.6 25.3 21.8 LGI1 "EPITEMPIN, EPT, ETL1, IB1099" ENSG00000108231 "Leucine rich glioma inactivated 1" O95970 10 93757840-93806272 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 39.7;choroid plexus: 44.7" "Cell type enhanced" "Detected in some" "Astrocytes: 242.9;Excitatory neurons: 57.1;Inhibitory neurons: 74.7;Oligodendrocyte precursor cells: 28.6" "Group enriched" "Detected in some" 7 "glioma: 1.8;testis cancer: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.4;CACO-2: 2.0;NTERA-2: 6.1;SuSa: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 12: NES - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "unprognostic (1.26e-1)" "unprognostic (4.68e-2)" "unprognostic (2.45e-2)" "unprognostic (1.01e-1)" "unprognostic (8.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.24e-3)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" "unprognostic (8.71e-2)" "unprognostic (2.21e-1)" "unprognostic (5.93e-2)" "unprognostic (4.65e-1)" 0.5 1.8 26.8 0.1 31.5 0.0 0.2 23.8 39.7 0.1 44.7 4.0 0.5 0.1 0.0 4.3 0.1 1.0 0.5 29.2 22.6 0.0 2.7 0.0 0.0 29.9 24.2 0.0 0.2 0.0 7.6 0.0 32.9 0.7 2.6 0.4 0.1 0.5 5.9 0.3 1.5 0.6 23.7 0.0 1.8 0.4 26.7 0.0 0.2 3.6 0.1 0.9 0.3 25.2 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 31.5 23.8 39.7 29.2 22.6 29.9 24.2 32.9 23.7 26.7 25.2 0.2 0.0 0.0 242.9 0.0 0.3 0.4 0.0 0.0 0.5 0.4 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.4 0.0 0.0 57.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 6.0 0.0 0.0 74.7 0.0 0.0 0.0 0.4 1.6 1.5 0.0 0.0 10.3 0.0 0.1 0.0 28.6 3.9 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.5 0.6 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.2 SLC35G1 "C10orf60, FLJ33990, TMEM20" ENSG00000176273 "Solute carrier family 35 member G1" Q2M3R5 10 93893973-93956062 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 68.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 26.9;Peritubular cells: 36.5;Proximal enterocytes: 47.4;Theca cells: 59.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 56: Intestine - Transmembrane transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "unprognostic (1.94e-2)" "unprognostic (1.90e-1)" "unprognostic (9.48e-2)" "unprognostic (1.65e-1)" "unprognostic (7.90e-4)" "unprognostic (8.89e-2)" "unprognostic (9.01e-3)" "unprognostic (1.15e-2)" "unprognostic (9.47e-2)" "unprognostic (7.90e-2)" "unprognostic (2.09e-1)" "unprognostic (4.30e-2)" "unprognostic (1.65e-2)" "unprognostic (2.29e-3)" "unprognostic (3.28e-1)" "unprognostic (3.02e-1)" "unprognostic (2.30e-1)" 0.8 0.8 0.1 1.0 0.1 0.3 0.7 0.2 0.1 0.4 1.0 6.0 68.4 0.8 0.8 1.1 0.4 0.6 1.4 0.1 0.2 0.5 3.7 0.8 0.8 0.3 0.2 1.0 9.5 2.1 1.1 0.8 0.4 0.7 5.8 0.2 1.4 0.8 0.6 1.5 33.4 0.9 0.1 0.6 2.0 3.4 0.2 0.4 1.4 0.2 0.6 1.1 0.7 0.1 6.2 6.1 2.9 3.3 0.9 2.5 3.8 5.4 6.2 5.2 6.5 4.8 4.2 3.9 2.1 3.6 3.4 11.1 6.7 2.1 7.9 4.8 7.0 3.2 3.7 3.6 1.3 6.1 6.1 2.4 2.1 3.9 2.3 1.7 2.3 3.5 3.0 2.2 3.1 2.2 2.9 1.3 3.7 2.2 7.1 0.0 4.6 1.5 2.5 5.3 3.7 3.4 7.2 3.5 4.6 2.4 3.7 2.0 2.9 3.8 6.1 6.8 5.6 2.5 2.4 1.3 2.8 0.0 2.7 0.0 0.1 0.7 0.1 0.1 0.4 0.1 0.8 0.5 0.1 0.1 0.8 0.5 0.0 0.0 0.0 0.1 1.1 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.3 0.2 0.4 0.1 0.2 0.1 3.2 3.2 3.9 1.0 2.4 3.1 2.1 2.2 2.2 4.3 1.5 2.7 4.7 5.7 1.6 7.3 4.2 3.0 0.6 26.9 3.9 2.3 20.3 1.8 5.0 4.7 4.2 3.0 2.6 9.7 6.1 4.4 3.1 1.3 0.0 19.9 5.0 5.8 2.3 1.7 6.4 5.0 2.0 3.3 1.2 9.2 17.1 0.9 5.4 1.0 3.1 4.8 0.0 5.0 0.9 3.1 18.3 36.5 2.2 1.3 47.4 1.2 1.3 2.7 0.0 3.6 2.4 19.1 9.2 4.1 1.8 0.8 3.6 59.2 8.3 2.3 PLCE1 "KIAA1516, NPHS3, PLCE" ENSG00000138193 "Phospholipase C epsilon 1" Q9P212 10 93993931-94332823 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Guanine-nucleotide releasing factor, Hydrolase, Transducer" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 70.5;Astrocytes: 69.5;Distal enterocytes: 79.6;Inhibitory neurons: 83.9;Muller glia cells: 82.7;Oligodendrocyte precursor cells: 123.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RT4: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015597, HPA015598" Enhanced Supported Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 21: OE19 - Mitochondria" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA015597: AB_1855321, HPA015598: AB_1855322" "unprognostic (4.73e-2)" "unprognostic (1.16e-1)" "unprognostic (4.03e-2)" "unprognostic (3.59e-3)" "unprognostic (3.01e-1)" "unprognostic (2.96e-1)" "unprognostic (1.73e-2)" "unprognostic (4.76e-3)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-3)" "unprognostic (3.56e-1)" "unprognostic (3.92e-2)" "unprognostic (3.54e-2)" "unprognostic (4.30e-2)" 3.8 2.6 4.5 2.8 4.1 0.2 2.7 3.1 5.6 8.0 7.0 12.6 4.0 9.0 5.3 1.7 4.4 2.5 12.4 3.9 4.7 8.4 0.7 7.3 0.7 3.9 4.8 3.9 14.7 0.8 4.4 2.9 4.0 3.8 7.5 7.3 2.3 5.4 4.1 1.1 5.2 4.2 3.2 6.2 8.3 2.0 5.4 0.5 9.8 6.3 0.6 5.6 5.6 4.2 4.0 6.7 1.8 1.1 0.7 3.2 1.9 2.8 0.6 0.3 0.4 5.3 1.3 0.8 1.3 2.3 1.3 2.6 2.2 0.4 0.6 0.4 2.3 0.5 4.0 0.5 0.0 0.9 0.3 1.8 0.0 1.1 0.0 6.8 0.0 0.4 0.5 0.3 4.2 0.3 0.8 0.9 0.7 7.9 5.0 0.1 3.9 0.2 0.2 10.3 0.9 1.5 3.3 3.6 0.7 4.1 3.5 0.6 0.6 3.0 5.9 2.0 4.4 0.6 0.3 0.4 3.5 1.1 2.2 0.1 0.1 0.0 0.3 0.2 0.2 0.5 0.3 0.2 0.1 0.7 0.5 0.4 0.1 0.2 0.2 0.2 0.1 0.1 4.5 4.1 3.1 5.6 3.9 4.7 3.9 4.8 4.0 3.2 5.4 4.2 8.2 70.5 5.4 69.5 7.0 8.2 9.7 6.8 2.2 12.2 3.6 3.6 34.7 4.3 12.3 0.0 0.0 3.7 2.9 79.6 1.9 1.1 20.7 26.7 18.4 9.7 1.8 0.0 3.1 6.4 2.5 15.3 29.6 10.6 0.0 7.2 4.2 1.6 0.7 6.7 83.9 9.7 4.1 2.4 5.2 5.3 12.2 1.3 7.2 5.6 1.2 82.7 4.1 123.1 2.4 4.2 54.8 23.3 0.9 7.5 11.0 2.5 10.6 18.7 6.6 30.8 37.7 3.7 8.0 1.7 7.4 1.9 4.3 3.7 41.1 10.5 NOC3L "AD24, C10orf117, FAD24, FLJ12820" ENSG00000173145 "NOC3 like DNA replication regulator" Q8WTT2 10 94333226-94362959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063958, HPA067638, HPA070981" Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331" "unprognostic (1.29e-1)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.49e-1)" "unprognostic (1.27e-3)" "unprognostic (4.58e-2)" "unprognostic (6.49e-3)" "unprognostic (3.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.34e-1)" "unprognostic (9.93e-2)" "unprognostic (5.50e-2)" "unprognostic (1.47e-2)" "unprognostic (3.24e-2)" "unprognostic (2.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.30e-1)" 8.6 9.0 5.1 9.5 6.5 3.6 11.2 5.9 5.9 6.7 5.9 5.2 5.4 8.5 6.4 9.0 6.2 5.7 5.3 4.6 5.8 7.2 9.9 5.2 13.1 6.5 6.4 8.2 5.3 9.1 4.3 8.9 6.5 7.4 6.3 6.2 5.3 6.5 9.4 9.3 5.4 7.1 6.4 11.4 5.5 10.4 5.8 7.5 11.1 10.4 13.2 10.3 6.4 7.1 38.4 20.6 13.6 44.1 13.9 22.4 16.1 29.9 23.6 40.2 46.3 35.1 26.4 41.3 21.4 15.0 20.6 26.9 39.2 18.0 64.6 28.3 29.3 28.1 16.6 22.6 27.8 45.0 12.2 13.0 17.3 42.5 42.2 26.2 18.1 15.1 44.2 20.3 40.0 12.9 28.5 33.2 28.9 22.3 22.4 12.5 31.3 22.8 23.7 11.7 9.7 24.1 21.4 10.7 33.9 15.2 27.6 17.1 17.7 25.6 25.9 23.4 50.9 19.1 40.8 56.8 23.4 42.6 19.5 0.1 2.6 0.6 4.3 4.3 5.4 14.4 4.4 5.5 4.6 12.8 5.7 5.2 0.1 8.2 5.0 4.1 4.3 3.3 5.1 6.5 5.9 5.9 4.6 5.8 6.5 6.4 6.5 6.4 5.8 7.1 33.5 19.2 13.7 11.4 38.0 23.7 32.7 17.0 33.0 20.7 16.4 20.7 22.5 14.3 31.8 22.0 8.4 21.1 17.7 5.1 25.4 20.6 3.9 20.3 50.1 26.1 5.4 26.7 11.7 13.8 15.1 27.0 10.2 17.0 29.2 26.9 11.7 12.9 13.2 13.5 15.5 8.1 12.2 17.0 11.9 5.0 18.3 15.0 12.4 11.2 23.3 20.5 20.6 19.6 23.6 15.3 3.4 24.8 26.3 34.1 1.7 22.7 21.1 20.9 13.1 37.8 23.7 64.0 64.5 25.5 21.7 15.2 17.3 44.5 10.7 19.1 TBC1D12 KIAA0608 ENSG00000108239 "TBC1 domain family member 12" O60347 10 94402541-94536332 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.1" "Cell type enhanced" "Detected in many" "Microglial cells: 110.5;Oligodendrocytes: 397.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038277, HPA038645" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 39: CACO-2 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Nuclear speckles" "HPA038277: AB_10672584, HPA038645: AB_10672650" "unprognostic (7.23e-3)" "unprognostic (1.58e-2)" "prognostic favorable (1.79e-5)" "unprognostic (7.83e-2)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" "unprognostic (1.21e-2)" "unprognostic (7.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-1)" "unprognostic (2.27e-2)" "unprognostic (9.43e-2)" "unprognostic (3.71e-1)" "unprognostic (1.29e-1)" "unprognostic (1.12e-1)" 5.8 3.6 13.5 3.1 26.5 1.1 5.6 28.3 16.0 4.6 8.2 6.1 4.5 4.1 2.8 3.3 3.8 3.6 3.8 12.4 17.8 4.0 3.7 4.7 2.5 40.2 26.7 3.9 4.6 13.3 2.6 5.7 35.8 4.1 6.8 7.0 3.2 4.3 4.1 4.9 5.1 4.3 25.1 4.9 3.6 8.4 23.0 1.3 3.3 4.1 2.6 4.6 4.1 46.1 7.3 3.2 4.1 6.1 5.6 6.8 5.4 4.6 9.5 5.1 4.7 12.8 3.1 0.0 2.7 6.8 4.9 4.0 4.9 3.4 6.5 0.0 5.7 2.3 2.9 4.1 4.2 0.0 1.8 4.6 4.3 5.3 6.9 8.6 5.5 0.0 3.4 7.4 8.2 4.0 0.0 0.0 1.3 5.2 3.3 0.0 5.3 3.9 4.6 3.2 1.7 4.1 4.6 4.0 3.9 3.7 8.6 4.4 5.4 3.5 4.8 5.7 3.7 5.1 5.3 0.0 3.5 0.0 1.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 26.5 28.3 16.0 12.4 17.8 40.2 26.7 35.8 25.1 23.0 46.1 11.0 9.6 5.3 34.9 7.6 19.5 6.5 2.9 10.8 17.5 10.6 9.1 6.5 4.3 4.3 9.2 10.4 19.4 0.6 18.1 0.0 5.8 22.6 7.6 9.5 13.7 8.4 5.2 46.8 5.1 13.4 23.8 13.7 10.3 5.7 3.5 8.9 4.8 19.1 8.4 66.7 8.7 4.1 23.6 25.9 9.2 8.4 20.9 16.0 110.5 11.7 8.9 1.0 60.8 397.2 7.6 13.2 10.5 12.0 11.7 11.7 5.9 4.0 28.0 13.1 11.7 12.0 64.3 13.5 11.4 19.2 24.4 1.5 6.3 11.8 10.3 HELLS "LSH, Nbla10143, PASG, SMARCA6" ENSG00000119969 "Helicase, lymphoid specific" Q9NRZ9 10 94501434-94613905 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Developmental protein, Helicase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.3;lymphoid tissue: 15.9" "Cell type enhanced" "Detected in many" "Spermatocytes: 182.0;Spermatogonia: 173.9" "Cancer enhanced" "Detected in all" "testis cancer: 16.1" "Region enhanced" "Detected in many" "cerebellum: 5.5" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 36.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004491, HPA063242" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" No Yes "Cluster 35: T-regs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Golgi apparatus, Vesicles" "CAB004491: AB_627895, HPA063242: AB_2684968" "unprognostic (1.94e-1)" "prognostic favorable (1.36e-4)" "unprognostic (9.85e-2)" "unprognostic (3.38e-2)" "unprognostic (8.65e-2)" "unprognostic (4.85e-3)" "unprognostic (1.76e-5)" "unprognostic (7.59e-3)" "unprognostic (7.03e-3)" "unprognostic (6.49e-2)" "unprognostic (2.05e-2)" "unprognostic (9.45e-5)" "unprognostic (9.93e-13)" "unprognostic (2.25e-2)" "unprognostic (1.72e-1)" "unprognostic (6.24e-2)" "unprognostic (3.03e-2)" 1.1 1.2 0.8 6.4 0.3 16.3 3.0 5.5 1.2 3.2 1.3 4.3 2.9 2.9 1.4 5.9 1.7 2.0 0.7 0.4 1.3 2.5 1.8 1.7 12.4 0.8 0.8 2.6 1.2 1.4 3.0 4.1 1.0 2.1 5.1 1.1 1.9 1.0 0.3 5.3 3.9 2.2 0.9 4.3 3.7 12.8 0.9 15.9 1.1 0.2 12.6 3.6 3.2 1.5 57.7 55.4 70.6 90.1 2.9 6.4 37.4 42.9 27.8 34.4 54.6 70.3 45.5 70.0 16.7 15.5 29.1 56.3 40.9 34.9 50.7 68.5 45.5 37.3 56.3 58.0 1.7 71.2 31.6 3.6 2.0 42.1 20.0 9.4 24.0 46.0 20.7 43.5 43.1 54.9 75.2 35.6 73.4 42.3 24.1 70.3 62.1 16.3 24.2 72.2 28.4 22.8 50.3 14.5 7.8 59.0 60.9 23.1 17.2 38.4 19.4 35.4 52.4 22.3 47.6 74.5 19.0 42.8 17.9 0.3 0.7 0.0 7.0 1.5 2.4 18.8 11.4 9.4 2.3 23.2 5.2 7.7 1.0 10.2 1.0 36.8 19.7 2.3 0.8 0.3 5.5 1.2 0.4 1.3 0.8 0.8 1.0 0.9 0.9 1.5 4.7 9.6 3.9 0.0 19.7 21.5 11.5 12.6 13.1 16.4 10.0 15.0 1.0 12.8 12.6 22.0 0.0 46.3 13.2 26.2 3.9 9.0 2.0 9.3 16.4 8.1 10.8 50.5 3.3 6.2 43.4 13.0 17.9 16.3 5.7 60.6 5.7 3.6 15.1 6.7 5.4 17.8 8.2 2.2 10.3 5.3 9.0 7.3 1.8 9.4 5.7 4.3 1.0 4.5 6.6 4.7 1.8 5.7 37.5 3.7 1.7 1.6 6.3 11.4 19.7 10.5 16.4 182.0 173.9 22.9 9.9 11.1 15.7 16.5 30.9 11.7 CYP2C18 "CPCI, CYP2C, CYP2C17, P450IIC17" ENSG00000108242 "Cytochrome P450 family 2 subfamily C member 18" P33260 10 94683729-94736190 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 102.8;liver: 197.0;stomach 1: 67.2" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 68.8;Hepatocytes: 124.0;Proximal enterocytes: 62.5;Squamous epithelial cells: 22.8" "Cancer enhanced" "Detected in many" "liver cancer: 18.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.2;OE19: 1.9" "Not detected" "Not detected" HPA074424 Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Plasma membrane" "HPA074424: " "unprognostic (2.40e-1)" "unprognostic (1.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.10e-2)" "unprognostic (1.32e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-1)" "unprognostic (9.78e-2)" "unprognostic (2.28e-1)" "unprognostic (4.22e-3)" "unprognostic (1.62e-3)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (6.81e-3)" 0.3 0.0 0.0 1.6 0.1 0.0 0.3 0.2 0.1 5.3 0.0 5.9 102.8 0.1 0.0 30.9 0.0 16.3 0.0 0.1 0.0 0.3 197.0 0.8 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 2.5 0.0 5.4 0.0 0.0 4.4 83.1 0.1 0.1 0.0 67.2 0.1 0.1 0.3 0.0 0.0 7.1 0.2 9.5 0.2 0.0 0.1 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.4 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.0 3.3 0.0 0.3 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.1 17.2 3.2 0.0 0.0 0.1 0.0 6.7 0.0 1.5 0.0 0.6 0.1 0.0 0.0 2.7 0.5 6.9 0.2 0.1 68.8 1.3 0.0 0.0 1.8 124.0 0.0 0.0 0.8 2.1 2.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 9.1 3.9 0.0 0.3 0.0 62.5 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.3 22.8 1.7 1.5 0.1 0.1 5.7 0.0 CYP2C19 "CPCJ, CYP2C, P450IIC19" ENSG00000165841 "Cytochrome P450 family 2 subfamily C member 19" P33261 10 94762681-94855547 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 190.2" "Group enriched" "Detected in some" 11 "Gastric mucus-secreting cells: 3.1;Hepatocytes: 9.5;Proximal enterocytes: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015066, HPA074424" Supported Uncertain Vesicles "Intracellular and membrane" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 2: Hepatocytes - Metabolism" Vesicles "HPA015066: AB_1847433, HPA074424: " "unprognostic (3.15e-2)" "unprognostic (2.13e-1)" "unprognostic (2.48e-1)" "unprognostic (1.83e-2)" "unprognostic (1.53e-1)" 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.3 0.2 0.2 0.1 0.2 32.4 0.0 0.1 1.6 0.0 1.7 0.0 0.1 0.0 0.0 190.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.6 13.9 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 3.1 0.0 0.0 0.0 0.4 9.5 0.0 0.0 0.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 CYP2C9 "CYP2C10, P450IIC9" ENSG00000138109 "Cytochrome P450 family 2 subfamily C member 9" P11712 10 94938658-94990091 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 1719.9" "Cell type enriched" "Detected in some" 26 "Hepatocytes: 1704.9" "Cancer enriched" "Detected in some" 41 "liver cancer: 118.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015066, CAB016123, HPA074424" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Plasma membrane" "CAB016123: AB_629363, HPA015066: AB_1847433, HPA074424: " "unprognostic (3.37e-1)" "unprognostic (5.68e-2)" "unprognostic (9.67e-2)" "unprognostic (4.16e-2)" "unprognostic (1.83e-2)" "prognostic favorable (2.83e-6)" "unprognostic (2.37e-1)" "unprognostic (2.05e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-4)" "unprognostic (7.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.45e-2)" "unprognostic (1.24e-2)" 0.2 0.0 0.0 0.4 0.0 0.2 0.1 0.1 0.0 1.2 0.0 2.7 87.8 0.0 0.0 7.7 0.0 7.9 0.0 0.0 0.0 4.3 1719.9 0.2 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.0 0.0 0.0 2.3 46.2 0.1 0.0 0.5 18.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.6 0.2 1.8 0.0 0.0 0.0 1.5 0.0 7.6 0.0 0.8 0.7 1.1 0.0 16.0 0.0 0.7 0.0 0.2 44.4 7.4 0.0 0.0 26.7 1704.9 0.0 0.0 0.1 1.4 0.0 34.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.6 0.0 0.1 0.0 65.3 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.1 1.9 0.0 2.7 0.0 CYP2C8 CPC8 ENSG00000138115 "Cytochrome P450 family 2 subfamily C member 8" P10632 10 95036772-95069497 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 359 "liver: 2156.6" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 1834.2" "Cancer enriched" "Detected in some" 82 "liver cancer: 102.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013547, HPA013970, HPA015066, HPA074424" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 62: Liver - Hemostasis" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Plasma membrane" "HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433, HPA074424: " "unprognostic (3.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (1.09e-2)" "unprognostic (1.80e-3)" "unprognostic (4.29e-2)" "unprognostic (1.03e-1)" "unprognostic (3.38e-1)" "prognostic favorable (9.82e-4)" "unprognostic (2.85e-1)" "unprognostic (1.44e-3)" "unprognostic (2.63e-1)" "unprognostic (7.88e-2)" "unprognostic (1.39e-1)" "unprognostic (4.05e-4)" 0.3 1.8 1.7 0.0 1.9 0.2 0.3 1.4 2.1 0.3 1.4 0.4 0.2 0.1 0.3 0.1 1.1 4.6 0.3 1.8 2.2 1.4 2156.6 0.4 0.1 1.7 2.2 0.1 1.7 0.5 3.1 0.1 1.8 0.6 0.0 3.1 0.2 0.3 0.2 0.1 1.1 0.0 1.4 1.0 6.0 4.0 2.1 0.2 0.9 0.0 0.1 0.2 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.9 1.4 2.1 1.8 2.2 1.7 2.2 1.8 1.4 2.1 1.8 0.0 0.0 0.0 1.6 8.9 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.2 147.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 7.3 0.9 0.1 2.0 1.8 57.5 4.5 0.2 0.0 0.1 0.0 0.2 0.0 0.6 52.8 1834.2 0.0 5.0 3.7 0.1 0.0 70.9 0.0 7.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 1.2 0.5 1.2 0.0 0.0 0.1 1.0 0.8 0.9 1.7 0.0 0.0 0.3 2.1 0.6 0.0 0.0 0.0 3.3 0.0 0.2 0.2 ACSM6 "bA310E22.3, C10orf129" ENSG00000173124 "Acyl-CoA synthetase medium chain family member 6" Q6P461 10 95194200-95228928 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 3.6;pancreas: 4.0;skin 1: 1.9;stomach 1: 1.9;urinary bladder: 1.0" "Cell type enhanced" "Detected in some" "Astrocytes: 2.0;Cone photoreceptor cells: 2.1;Early spermatids: 2.4;Excitatory neurons: 3.8;Inhibitory neurons: 3.4;Oligodendrocytes: 2.1;Rod photoreceptor cells: 5.3" "Cancer enriched" "Detected in single" 7 "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "RT4: 3.7" HPA044593 Uncertain NA NA "Cluster 25: Pancreas - Digestion" "Cluster 15: RT4 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA044593: AB_10960261" "unprognostic (2.91e-2)" "unprognostic (2.87e-1)" "unprognostic (3.64e-2)" "unprognostic (5.73e-2)" "unprognostic (2.48e-2)" "unprognostic (6.34e-2)" "unprognostic (1.41e-2)" "unprognostic (1.91e-1)" "unprognostic (3.75e-3)" "unprognostic (2.25e-1)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.71e-4)" 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.9 0.1 0.1 3.6 0.4 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 2.0 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.4 0.6 1.2 0.6 0.0 0.0 3.8 0.0 0.0 0.1 1.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 5.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 PDLIM1 "CLIM1, CLP-36, CLP36, hCLIM1" ENSG00000107438 "PDZ and LIM domain 1" O00151 10 95237572-95291012 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 675.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 805.9;Basal respiratory cells: 763.8;Paneth cells: 769.2;Proximal enterocytes: 1059.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "eosinophil: 189.7;memory B-cell: 223.8;naive B-cell: 213.0" "Group enriched" "Detected in all" 7 "B-cells: 223.8;granulocytes: 189.7" "Cell line enhanced" "Detected in many" "HaCaT: 766.3;Hep G2: 635.3;HHSteC: 731.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017010, CAB072838, CAB072840" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" NA NA 93000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Actin filaments" "Plasma membrane, Cell Junctions" "CAB072838: , CAB072840: , HPA017010: AB_1855147" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.58e-2)" "prognostic favorable (1.14e-5)" "unprognostic (3.18e-2)" "unprognostic (7.54e-2)" "unprognostic (2.07e-1)" "unprognostic (8.99e-2)" "unprognostic (2.26e-1)" "unprognostic (2.82e-3)" "unprognostic (5.77e-2)" "unprognostic (6.56e-2)" "unprognostic (1.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.97e-1)" "unprognostic (4.21e-3)" "unprognostic (1.11e-1)" 301.7 32.4 10.7 91.5 10.8 25.0 236.0 10.2 18.5 133.1 30.2 220.0 179.4 115.0 91.8 182.3 155.3 114.9 393.2 11.7 10.9 82.8 160.3 337.2 104.5 20.4 12.7 35.6 98.3 65.9 29.5 141.1 14.1 116.9 218.5 36.9 166.1 114.7 675.1 136.8 249.0 146.0 14.0 148.3 148.3 13.7 13.8 105.9 194.7 290.0 123.7 276.3 165.3 11.2 274.4 181.8 12.4 0.4 64.1 43.3 277.1 82.6 266.4 218.8 356.5 387.0 429.8 0.3 21.9 233.8 110.4 766.3 91.5 498.1 220.6 0.2 132.0 277.9 50.1 635.3 731.0 0.1 13.2 125.5 257.0 111.9 400.6 233.2 396.8 24.2 60.0 70.3 52.7 51.4 0.8 4.9 24.6 137.7 137.2 234.1 10.0 98.4 114.4 268.9 48.3 18.9 91.2 84.6 0.9 293.8 68.2 125.7 345.1 84.5 19.7 0.7 0.7 31.2 0.1 91.6 92.5 0.2 41.0 0.4 2.4 189.7 11.9 0.8 0.1 223.8 2.3 14.1 31.0 213.0 0.5 8.1 7.5 8.9 1.5 3.2 2.2 44.5 10.7 10.8 10.2 18.5 11.7 10.9 20.4 12.7 14.1 14.0 13.8 11.2 435.0 76.9 123.5 0.0 145.6 366.3 805.9 763.8 244.7 10.1 100.6 131.4 266.2 223.1 250.2 51.5 29.2 538.2 20.5 657.0 15.6 420.1 8.4 218.6 319.3 359.3 101.3 41.6 0.9 172.5 116.7 149.2 100.9 113.0 12.6 47.2 459.7 100.4 50.0 1.7 0.4 488.9 152.5 19.4 105.2 8.0 5.0 88.8 40.9 2.8 8.8 11.6 32.0 0.0 0.0 227.0 769.2 0.7 103.5 256.5 1059.7 109.0 316.4 59.5 315.5 21.0 213.1 4.3 35.7 170.4 197.9 117.0 25.8 1.9 419.2 554.3 SORBS1 "CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12" ENSG00000095637 "Sorbin and SH3 domain containing 1" Q9BX66 10 95311771-95561414 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 800.2;Cardiomyocytes: 612.3;Excitatory neurons: 401.1;Inhibitory neurons: 295.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 6.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 6.1" "Cell line enhanced" "Detected in many" "CACO-2: 28.0;Hep G2: 19.5;HMC-1: 48.3;SK-MEL-30: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027559, CAB032850, HPA043084" Enhanced Supported "Plasma membrane,Focal adhesion sites,Centrosome" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "Focal adhesion sites" "Plasma membrane, Centrosome" "CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307" "prognostic favorable (2.84e-4)" "unprognostic (3.53e-1)" "unprognostic (1.89e-1)" "unprognostic (7.85e-2)" "unprognostic (3.43e-1)" "unprognostic (1.41e-1)" "unprognostic (2.98e-2)" "unprognostic (5.30e-2)" "unprognostic (1.95e-2)" "unprognostic (1.65e-2)" "unprognostic (3.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.40e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.55e-2)" "unprognostic (5.01e-3)" 370.8 21.6 128.5 53.3 153.3 4.7 78.3 101.7 144.1 46.0 42.6 312.8 25.6 169.4 32.1 155.5 99.2 81.3 351.6 127.0 165.4 17.6 49.3 34.4 3.1 164.0 161.5 19.0 22.0 26.4 11.5 30.3 126.7 140.6 67.0 39.0 24.5 217.4 190.5 24.5 62.7 151.0 138.9 8.1 143.1 14.4 127.0 3.7 14.8 155.9 1.5 235.3 47.1 139.9 1.6 1.2 12.4 3.1 4.2 0.2 2.4 0.4 0.1 0.4 0.1 28.0 10.9 0.0 2.2 0.2 4.2 0.6 2.4 0.6 0.4 3.2 4.5 7.2 0.4 19.5 1.5 0.0 48.3 0.9 0.4 0.5 0.3 0.2 4.9 1.9 11.7 2.3 1.3 0.8 0.1 0.8 5.7 6.2 2.6 1.0 4.0 0.4 15.1 18.3 4.9 3.7 1.8 0.6 45.2 8.9 2.1 0.4 0.3 0.1 4.0 0.1 2.4 1.8 0.5 0.2 4.8 0.5 11.7 6.1 0.1 1.2 0.4 0.6 0.5 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.3 0.1 128.5 153.3 101.7 144.1 127.0 165.4 164.0 161.5 126.7 138.9 127.0 139.9 42.2 22.4 20.9 800.2 0.8 11.6 8.7 0.0 5.2 7.5 6.5 19.3 612.3 12.8 1.3 1.8 2.1 20.2 1.0 4.0 3.9 7.2 70.4 1.4 15.8 25.7 6.0 16.0 401.1 3.1 2.4 21.4 8.6 1.6 16.4 8.2 30.4 50.5 3.1 6.7 295.1 10.9 0.0 3.8 12.0 48.6 7.5 1.1 14.2 163.9 0.7 22.1 1.0 155.3 22.6 2.3 2.8 76.8 1.1 4.7 1.2 6.1 0.1 5.5 0.0 11.8 51.6 3.4 3.7 1.9 12.5 29.6 1.6 0.1 5.1 5.9 ALDH18A1 "GSAS, P5CS, PYCS, SPG9" ENSG00000059573 "Aldehyde dehydrogenase 18 family member A1" P54886 10 95605941-95656711 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" "Kinase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 120.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 80.5;Granulosa cells: 81.6;Proximal enterocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008333, HPA012604" Approved Enhanced Mitochondria NA NA 48000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA008333: AB_1078125, HPA012604: AB_1844721" "unprognostic (5.97e-3)" "unprognostic (2.08e-2)" "unprognostic (5.75e-2)" "prognostic favorable (4.20e-4)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (8.30e-3)" "unprognostic (7.08e-2)" "unprognostic (4.06e-2)" "unprognostic (8.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.60e-9)" "unprognostic (1.02e-3)" "unprognostic (6.57e-2)" "unprognostic (1.29e-3)" "unprognostic (6.43e-2)" 15.3 16.1 12.2 21.2 12.6 16.7 20.2 12.4 13.1 33.4 21.0 51.9 89.3 18.5 30.9 21.0 21.9 25.2 11.5 12.2 13.6 17.7 24.3 10.8 22.0 12.4 14.7 16.7 61.8 33.5 28.2 26.3 13.1 24.2 49.3 11.4 120.1 24.9 4.3 22.4 73.1 26.3 12.7 12.1 40.5 11.7 14.0 17.2 37.5 5.5 26.9 25.2 14.3 13.1 66.5 61.6 57.9 152.7 76.0 72.9 62.2 75.6 112.8 75.1 93.7 124.4 51.6 223.7 68.9 119.7 36.2 85.6 117.1 77.8 84.6 64.0 92.0 71.2 40.5 177.9 49.7 125.6 76.1 77.0 46.8 61.5 119.1 124.5 79.9 82.6 67.5 46.0 57.1 95.0 114.5 80.5 68.6 109.2 60.7 105.9 66.3 76.9 88.3 49.7 57.5 56.9 60.1 47.1 56.9 66.0 70.5 57.9 66.7 31.1 49.0 80.9 88.2 52.4 41.7 135.8 60.4 142.8 40.7 0.1 2.6 0.2 27.3 5.2 28.7 23.0 24.5 28.3 9.6 16.1 20.7 23.1 0.5 26.3 8.3 5.9 25.8 15.5 12.2 12.6 12.4 13.1 12.2 13.6 12.4 14.7 13.1 12.7 14.0 13.1 4.6 6.4 9.2 7.2 12.6 11.2 8.3 8.9 14.2 6.3 15.6 12.4 4.6 11.5 14.3 20.2 0.0 43.9 6.7 80.5 1.9 13.7 1.3 12.7 18.1 8.0 19.8 17.9 15.7 21.1 31.6 16.2 18.8 16.9 8.2 81.6 5.3 27.3 11.5 10.1 13.6 41.3 8.2 3.5 3.8 1.6 9.3 3.5 16.0 11.2 2.6 7.1 8.2 17.6 12.8 11.7 56.4 12.0 30.1 18.4 79.4 8.4 15.2 3.4 0.0 10.5 10.1 8.2 9.9 17.6 8.1 30.2 9.0 10.8 38.7 9.4 TCTN3 "C10orf61, DKFZP564D116, JBTS18, TECT3" ENSG00000119977 "Tectonic family member 3" Q6NUS6 10 95659823-95694143 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026987 Approved Approved Microtubules "Intracellular and membrane" NA NA 4400000 "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 41: Macrophages - Immune response" Microtubules "HPA026987: AB_10600911" "unprognostic (1.58e-1)" "unprognostic (1.54e-1)" "unprognostic (9.78e-2)" "prognostic favorable (5.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.50e-2)" "unprognostic (8.88e-3)" "unprognostic (1.08e-1)" "unprognostic (3.03e-2)" "unprognostic (9.25e-3)" "unprognostic (3.78e-3)" "unprognostic (7.29e-2)" "unprognostic (4.60e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (9.30e-3)" "unprognostic (1.59e-1)" 21.3 25.3 8.6 15.7 9.0 5.1 25.2 9.1 11.3 26.3 24.0 22.1 17.6 24.8 65.0 17.0 35.4 22.7 18.4 8.8 9.8 32.5 26.8 19.4 14.3 9.7 9.5 30.6 27.1 69.9 22.8 26.9 9.5 25.6 25.6 22.2 25.4 27.7 9.5 20.5 15.4 26.8 9.2 17.3 19.1 19.4 9.6 14.0 70.6 11.5 18.0 23.9 18.6 9.2 34.0 54.1 44.1 89.3 93.6 74.6 25.7 45.3 94.8 46.9 55.3 35.4 57.3 31.3 40.1 60.4 49.8 46.7 43.9 54.5 56.5 33.6 36.4 10.9 21.6 49.2 46.9 37.4 22.8 65.2 49.2 46.6 72.4 88.0 80.7 27.7 21.0 40.3 63.4 32.5 23.4 27.9 12.1 49.7 38.1 25.3 33.9 38.3 67.8 23.3 11.5 24.5 37.7 18.5 52.6 40.8 71.0 35.1 37.9 35.6 24.9 23.9 49.5 18.9 37.9 20.7 57.5 47.1 19.0 6.8 14.2 4.9 25.8 21.9 32.0 28.3 23.1 25.2 45.2 19.4 24.2 20.0 1.6 26.8 24.3 23.6 22.2 21.3 8.6 9.0 9.1 11.3 8.8 9.8 9.7 9.5 9.5 9.2 9.6 9.2 14.8 19.2 16.2 16.6 29.3 14.4 23.7 33.8 31.3 24.0 18.2 15.0 8.5 27.1 20.3 31.3 37.5 50.3 18.8 20.2 7.9 27.2 18.6 25.5 25.7 20.4 13.8 11.6 17.3 20.3 44.2 27.3 11.7 18.3 8.2 29.8 21.4 16.8 28.5 25.2 17.7 12.5 26.4 14.1 59.1 14.1 20.8 18.7 16.0 16.9 14.8 36.7 15.5 20.6 13.7 14.1 12.7 25.2 35.9 19.8 16.2 16.1 27.5 44.4 13.1 23.9 19.8 39.8 34.1 15.3 11.5 31.5 23.0 34.2 23.7 14.6 ENTPD1 "ATPDase, CD39, NTPDase-1, SPG64" ENSG00000138185 "Ectonucleoside triphosphate diphosphohydrolase 1" P49961 10 95711779-95877266 "CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Hydrolase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 74.1;Kupffer cells: 110.4;Langerhans cells: 161.3;Microglial cells: 217.4;monocytes: 112.2;Plasma cells: 80.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 17.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 102.2" "Group enriched" "Detected in all" 4 "dendritic cells: 31.9;granulocytes: 102.2;monocytes: 41.0" "Group enriched" "Detected in many" 7 "HDLM-2: 147.5;Karpas-707: 135.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002494, HPA014067, CAB079986" Enhanced Uncertain Microtubules NA NA 19000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 2: Karpas-707 - Immune response" "Cluster 41: Macrophages - Immune response" Microtubules "CAB002494: AB_563557, CAB079986: , HPA014067: AB_1848178" "unprognostic (1.14e-1)" "unprognostic (1.01e-2)" "unprognostic (3.11e-1)" "unprognostic (5.67e-2)" "unprognostic (9.68e-3)" "unprognostic (3.45e-3)" "unprognostic (6.31e-2)" "unprognostic (5.26e-3)" "unprognostic (2.73e-1)" "unprognostic (1.28e-2)" "unprognostic (6.40e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.33e-5)" "unprognostic (9.79e-2)" "unprognostic (2.30e-1)" "prognostic favorable (7.89e-4)" "unprognostic (5.09e-2)" 11.8 8.3 5.9 24.7 5.5 27.5 10.8 5.0 6.3 17.5 5.0 14.3 9.3 28.0 19.3 19.2 14.0 27.7 8.5 5.3 6.3 7.6 5.4 16.1 20.2 7.1 6.5 5.5 2.8 3.4 3.9 11.4 7.7 11.2 12.8 6.8 6.0 18.1 4.0 6.3 11.7 49.7 6.2 21.5 7.3 4.5 7.5 6.8 20.0 8.7 25.6 30.6 11.0 6.3 1.4 2.7 5.4 7.1 0.1 0.1 5.0 4.5 1.2 0.0 0.0 4.0 1.6 8.2 3.1 0.0 5.3 2.2 0.0 0.0 0.0 147.5 5.2 7.2 4.0 4.3 0.0 12.5 4.1 0.1 0.0 0.6 0.0 2.4 18.2 2.0 5.3 135.4 0.1 4.4 4.7 5.8 5.9 3.6 2.8 15.3 2.4 4.4 1.7 2.2 5.1 6.2 3.6 3.7 3.9 3.6 5.5 5.9 3.9 3.9 2.8 3.8 5.3 21.6 7.2 0.6 4.3 13.9 2.7 0.7 41.0 102.2 0.6 27.2 1.1 13.7 1.6 1.1 31.9 11.4 0.6 0.6 49.4 1.5 6.7 2.1 13.1 15.5 5.9 5.5 5.0 6.3 5.3 6.3 7.1 6.5 7.7 6.2 7.5 6.3 19.6 0.0 1.1 74.1 40.9 8.9 0.3 0.0 0.6 1.4 0.8 1.5 10.1 0.0 0.7 1.8 2.1 0.6 3.7 0.3 1.9 0.0 10.3 0.6 3.6 60.6 0.0 4.4 2.8 2.0 1.9 15.7 6.1 0.6 3.8 0.3 31.4 0.8 26.6 0.0 5.2 0.1 0.0 110.4 161.3 7.3 0.6 62.1 16.0 217.4 112.2 0.4 0.0 20.6 5.0 0.2 1.2 3.0 80.1 0.5 0.1 0.3 0.8 0.8 6.6 1.0 22.7 10.1 4.4 0.8 11.2 15.7 26.9 15.1 1.0 0.5 CC2D2B "bA248J23.4, bA690P14.3, C10orf130, C10orf131" ENSG00000188649 "Coiled-coil and C2 domain containing 2B" Q6DHV5 10 95907603-96033745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 8.7" "Cell type enhanced" "Detected in some" "Astrocytes: 25.8;Early spermatids: 10.8;Microglial cells: 15.0;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044091, HPA072122" Enhanced Approved "Nucleoli,Nucleoli rim" NA NA "Cluster 37: B-cells - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoli, Nucleoli rim" "HPA044091: AB_2732514, HPA072122: AB_2686489" "unprognostic (6.38e-2)" "unprognostic (5.95e-2)" "unprognostic (1.47e-1)" "unprognostic (5.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.39e-3)" "unprognostic (1.21e-1)" "unprognostic (3.63e-1)" "unprognostic (8.18e-3)" "unprognostic (2.11e-3)" "unprognostic (9.11e-4)" "unprognostic (1.93e-2)" "unprognostic (4.34e-1)" "unprognostic (5.45e-3)" "unprognostic (1.41e-1)" 0.7 1.9 0.9 1.9 2.7 2.5 0.5 1.2 1.6 0.8 3.4 0.9 1.0 1.5 0.4 0.8 0.9 1.5 1.1 0.5 3.5 0.9 0.6 0.8 1.3 2.1 0.9 1.1 0.4 0.7 0.3 1.1 2.6 0.6 0.3 2.8 1.0 0.4 2.2 2.4 0.6 1.2 1.0 1.2 1.0 8.7 2.2 0.2 3.0 0.2 0.2 0.8 0.8 5.4 1.1 4.4 3.7 7.4 0.2 0.4 4.1 3.8 0.4 0.7 0.1 3.3 0.8 4.4 3.0 0.0 3.8 3.0 0.3 0.3 0.0 4.9 8.5 9.7 3.5 2.8 0.0 9.8 0.7 0.7 0.0 0.4 0.1 1.3 0.3 1.4 7.8 2.9 0.9 2.6 4.6 3.1 7.9 3.3 6.8 12.1 3.4 3.8 0.7 0.8 6.5 3.2 3.9 1.0 2.5 4.4 6.8 4.9 3.7 4.3 4.5 3.0 5.7 2.6 11.7 0.2 3.3 8.4 2.8 0.0 0.3 0.0 0.5 0.1 0.9 1.2 0.4 0.3 0.3 1.2 0.4 0.1 0.3 0.2 0.2 0.3 0.2 0.1 0.9 2.7 1.2 1.6 0.5 3.5 2.1 0.9 2.6 1.0 2.2 5.4 1.1 0.0 0.0 25.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.8 0.2 0.4 1.1 0.0 0.0 3.2 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 15.0 0.2 0.0 0.0 13.6 7.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 CCNJ "bA690P14.1, FLJ10895" ENSG00000107443 "Cyclin J" Q5T5M9 10 96043394-96060870 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 42.1;AN3-CA: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036531, HPA058151" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 56: Bipolar cells - Visual perception" "Nucleoplasm, Golgi apparatus" "HPA036531: AB_10696656, HPA058151: AB_2683623" "unprognostic (1.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.30e-2)" "unprognostic (4.37e-2)" "unprognostic (1.14e-1)" "unprognostic (8.61e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (6.65e-2)" "unprognostic (4.88e-2)" "unprognostic (1.77e-3)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" 3.6 4.5 1.9 4.2 2.4 11.5 3.9 2.9 2.1 3.3 1.7 3.3 4.4 4.3 3.1 2.7 2.8 3.8 2.2 1.7 2.5 2.6 2.5 3.1 4.9 2.5 2.2 2.8 4.3 5.0 2.1 3.5 2.4 3.3 3.6 4.0 2.7 3.1 3.8 2.9 3.6 3.4 2.1 5.0 2.8 4.2 2.4 4.0 3.2 4.0 3.9 4.4 1.8 2.6 9.0 6.6 42.1 42.2 4.2 3.1 6.1 5.6 5.9 7.7 6.9 17.2 3.7 12.3 6.4 5.4 6.5 5.2 27.4 5.9 10.0 6.1 11.8 12.0 5.2 26.0 9.7 12.0 5.4 5.7 8.2 7.5 17.3 7.6 18.8 11.0 17.6 0.2 4.9 8.6 20.9 14.8 23.6 0.8 6.0 24.3 2.0 0.9 9.4 8.1 6.4 22.2 6.2 1.8 12.6 14.1 10.1 13.7 9.1 4.8 11.1 5.6 13.1 2.5 1.0 11.5 5.8 20.5 3.3 0.1 1.7 0.5 0.9 1.4 1.2 0.7 0.8 0.4 2.9 0.7 1.1 1.1 0.1 0.4 1.3 0.6 0.7 0.9 1.9 2.4 2.9 2.1 1.7 2.5 2.5 2.2 2.4 2.1 2.4 2.6 2.6 6.4 3.1 2.3 3.3 1.9 3.1 1.3 2.8 5.1 3.1 2.0 4.0 1.5 2.4 5.5 14.6 1.5 2.1 3.4 3.9 2.9 3.7 2.6 4.8 4.8 4.2 4.2 4.2 2.7 3.0 3.2 2.0 2.5 0.0 4.6 10.4 1.4 3.6 1.7 5.8 3.5 2.0 6.5 4.6 7.6 1.8 5.0 1.8 1.9 2.8 3.1 1.0 5.5 3.7 4.0 1.5 1.9 1.9 4.0 1.4 2.1 4.3 3.2 0.0 4.1 4.0 10.1 6.9 2.3 1.4 1.1 2.2 3.1 3.2 2.9 ZNF518A "KIAA0335, ZNF518" ENSG00000177853 "Zinc finger protein 518A" Q6AHZ1 10 96129715-96205288 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029049 Approved Nucleoplasm Yes No "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA029049: AB_2672885" "unprognostic (1.48e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-2)" "unprognostic (4.66e-2)" "unprognostic (7.61e-2)" "unprognostic (3.38e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-2)" "unprognostic (6.02e-1)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" "unprognostic (8.38e-3)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (3.09e-2)" "unprognostic (1.16e-3)" 4.1 3.2 3.8 4.4 4.5 7.6 7.3 5.7 4.7 4.3 2.1 7.1 5.0 5.6 7.8 4.3 4.3 4.1 3.4 3.5 5.1 5.1 4.6 4.5 6.1 5.0 4.5 7.4 4.5 4.0 4.1 4.4 5.4 4.8 7.0 9.3 4.1 4.2 1.9 6.0 6.4 4.4 4.5 5.4 6.7 16.1 4.7 8.1 7.7 2.3 6.1 3.8 2.8 6.8 4.2 9.4 10.3 0.0 5.1 5.8 12.4 4.4 2.5 4.7 4.8 8.9 10.0 15.5 4.1 2.8 6.7 5.9 11.8 4.2 4.3 7.1 6.3 23.2 3.2 14.5 4.5 25.3 13.5 3.8 10.1 4.9 7.8 3.4 5.7 17.8 20.1 10.1 4.7 4.2 15.0 15.3 15.9 4.7 0.6 16.7 11.8 6.2 5.6 8.5 3.0 7.2 6.2 5.8 4.5 17.0 6.9 16.0 3.7 2.2 8.5 3.0 4.8 9.3 24.9 8.8 1.5 19.0 2.4 9.8 2.6 3.2 1.8 2.8 2.7 2.5 2.1 1.8 1.7 2.2 3.0 2.1 2.5 2.3 5.3 2.9 2.5 1.4 3.8 4.5 5.7 4.7 3.5 5.1 5.0 4.5 5.4 4.5 4.7 6.8 31.1 57.7 28.2 136.8 26.1 0.0 17.1 0.0 13.1 65.0 32.5 21.2 26.5 30.0 14.9 40.5 43.8 49.1 31.6 51.0 19.6 24.1 23.6 42.6 38.8 24.0 61.2 17.1 63.9 25.5 30.8 21.6 32.6 41.3 9.5 57.9 35.3 28.3 28.1 75.7 90.5 35.8 0.0 32.8 0.0 15.0 35.1 31.3 0.0 81.5 48.7 29.1 47.4 150.3 173.0 32.9 52.4 25.2 18.3 20.8 39.5 20.4 10.2 56.9 19.7 33.8 23.2 73.1 131.2 16.2 0.0 43.8 23.3 40.9 35.2 17.6 BLNK "BASH, bca, BLNK-s, Ly57, SLP-65, SLP65" ENSG00000095585 "B cell linker" Q8WV28 10 96189171-96271587 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 70.5" "Cell type enhanced" "Detected in many" "B-cells: 94.2;dendritic cells: 64.0;Microglial cells: 157.4;Plasma cells: 80.4;Proximal enterocytes: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "memory B-cell: 161.2;naive B-cell: 140.5;plasmacytoid DC: 231.5" "Group enriched" "Detected in many" 101 "B-cells: 161.2;dendritic cells: 231.5" "Group enriched" "Detected in some" 6 "Daudi: 68.7;REH: 168.4;RPMI-8226: 94.4;U-698: 251.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009333, CAB016291, HPA038309, HPA038310" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane" Vesicles "CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: AB_2675946" "unprognostic (4.86e-2)" "unprognostic (6.05e-3)" "unprognostic (1.00e-2)" "unprognostic (2.73e-2)" "unprognostic (2.29e-1)" "unprognostic (1.63e-3)" "unprognostic (1.08e-2)" "unprognostic (5.19e-2)" "unprognostic (2.97e-1)" "unprognostic (1.02e-1)" "unprognostic (8.94e-2)" "unprognostic (3.73e-1)" "unprognostic (1.84e-2)" "unprognostic (5.23e-2)" "unprognostic (9.76e-2)" "unprognostic (1.46e-3)" "prognostic favorable (2.67e-6)" 2.2 3.2 3.8 27.5 3.4 10.1 6.3 2.4 4.1 7.1 13.9 16.9 38.9 2.4 30.1 39.9 6.1 10.8 1.0 3.5 5.1 28.5 39.2 6.6 57.6 4.7 4.0 1.5 12.1 17.4 1.8 6.4 5.0 7.3 18.2 1.4 10.9 13.2 0.5 8.0 34.0 3.0 3.8 54.0 29.2 1.3 4.9 10.6 11.6 1.1 70.5 9.9 15.8 5.2 0.3 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.2 0.2 68.7 0.4 0.0 0.3 0.6 0.1 0.8 0.1 5.5 0.2 0.3 0.3 0.1 0.0 0.1 1.4 0.1 8.7 0.0 0.0 0.1 0.0 0.8 0.3 6.4 0.0 0.7 0.4 0.2 0.2 0.2 0.0 168.4 0.3 94.4 0.9 13.0 0.3 0.3 0.2 15.1 0.1 0.2 23.7 1.1 0.2 0.2 0.8 0.1 0.2 5.4 0.4 251.4 0.1 0.5 0.1 0.3 1.6 0.2 0.3 1.3 0.1 161.2 0.3 0.2 20.6 140.5 0.1 0.1 1.1 1.9 0.1 231.5 0.6 8.1 3.8 3.4 2.4 4.1 3.5 5.1 4.7 4.0 5.0 3.8 4.9 5.2 0.4 6.4 7.7 0.7 94.2 1.1 21.0 13.1 21.1 0.0 4.1 3.4 1.2 30.0 7.3 40.5 0.0 23.0 64.0 9.2 27.4 14.6 3.1 14.4 1.9 0.3 4.9 5.3 1.0 13.8 17.5 0.7 35.7 22.9 1.3 0.0 2.9 27.8 22.8 0.0 1.3 19.4 30.5 9.0 13.8 1.1 0.3 18.2 1.8 157.4 4.8 0.0 0.0 2.5 0.9 4.4 22.4 0.0 80.4 5.1 64.6 2.3 3.4 0.0 6.6 0.3 0.7 1.6 0.1 34.7 1.4 41.5 3.6 0.5 22.5 23.8 DNTT TDT ENSG00000107447 "DNA nucleotidylexotransferase" P04053 10 96304409-96338564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Terminal addition" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 329.1" "Group enriched" "Detected in some" 5 "Early spermatids: 11.3;Late spermatids: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "MOLT-4: 416.0;REH: 1415.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036532, HPA044194" Supported Nucleoplasm,Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 14: REH - Unknown function" "Cluster 34: Spermatids - Unknown function" Nucleoplasm Cytosol "HPA036532: , HPA044194: AB_10960525" "unprognostic (4.24e-1)" "unprognostic (1.00e-1)" "unprognostic (2.60e-2)" "unprognostic (1.86e-2)" 0.0 0.0 0.0 0.2 0.1 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.0 329.1 0.4 0.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 195.3 0.0 0.0 0.0 0.0 416.0 0.0 0.1 0.0 0.0 1415.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.3 0.4 0.0 0.0 0.0 0.4 0.7 0.0 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OPALIN "HTMP10, TMEM10, TMP10" ENSG00000197430 "Oligodendrocytic myelin paranodal and inner loop protein" Q96PE5 10 96343221-96359365 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 654 "brain: 166.5;choroid plexus: 47.8" "Cell type enriched" "Detected in some" 304 "Oligodendrocytes: 304.5" "Cancer enriched" "Detected in single" 36 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "REH: 1.0" "Region enhanced" "Detected in all" "white matter: 240.1" "Low region specificity" "Detected in all" HPA014372 Supported NA NA "Cluster 65: Brain - Ion transport" "Cluster 14: REH - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA014372: AB_2158172" "unprognostic (1.18e-1)" 0.0 0.0 112.6 0.0 135.3 0.0 0.0 58.9 166.5 0.0 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.9 86.6 0.0 0.0 0.0 0.0 101.3 106.0 0.0 0.0 0.0 0.1 0.0 83.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.4 0.0 0.0 0.0 94.9 0.0 0.0 0.0 0.0 0.0 0.0 149.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.6 135.3 58.9 166.5 104.9 86.6 101.3 106.0 83.4 72.4 94.9 149.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 304.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TLL2 ENSG00000095587 "Tolloid like 2" Q9Y6L7 10 96364608-96513926 "Predicted secreted proteins" Differentiation "Developmental protein, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.7;heart muscle: 3.6;tongue: 1.9" "Cell type enriched" "Detected in some" 4 "Granulosa cells: 82.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "RPTEC TERT1: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.28e-2)" "unprognostic (7.54e-4)" "unprognostic (1.50e-1)" "unprognostic (3.31e-3)" "unprognostic (2.67e-1)" "unprognostic (2.14e-3)" "unprognostic (1.31e-2)" "unprognostic (3.52e-4)" "unprognostic (7.08e-2)" "unprognostic (2.50e-1)" "unprognostic (6.71e-2)" "unprognostic (3.37e-2)" "unprognostic (4.98e-4)" "unprognostic (2.90e-1)" "unprognostic (8.41e-2)" "unprognostic (1.95e-4)" "unprognostic (2.30e-1)" 0.0 0.1 1.3 0.1 1.5 0.2 0.0 0.6 1.7 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.3 3.6 1.2 1.3 0.0 0.0 0.0 0.1 2.6 1.0 0.1 0.2 0.0 0.4 0.1 2.9 0.1 0.1 0.2 0.2 0.0 0.9 0.0 0.3 0.1 2.2 0.1 0.3 0.1 4.7 0.0 0.1 1.9 0.0 0.0 0.0 2.0 0.2 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 1.0 0.1 0.2 0.1 0.2 0.1 0.0 2.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.6 0.1 0.1 0.4 0.0 20.1 0.0 0.7 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.5 0.6 1.7 1.2 1.3 2.6 1.0 2.9 2.2 4.7 2.0 0.4 0.0 1.1 0.3 0.7 0.1 0.5 1.9 0.0 0.0 0.0 0.0 5.5 1.5 1.0 0.0 0.0 2.4 0.1 0.0 0.0 0.2 6.9 0.2 0.1 1.4 0.0 0.0 1.9 0.6 0.1 2.4 1.5 0.5 0.0 82.4 0.0 0.0 0.3 0.0 5.6 1.7 2.0 0.3 1.4 5.5 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 18.6 0.7 0.0 0.0 1.4 0.8 1.0 0.2 0.2 0.0 0.0 0.7 0.4 0.2 2.6 0.0 0.4 3.4 0.3 0.1 0.2 0.6 TM9SF3 SMBP ENSG00000077147 "Transmembrane 9 superfamily member 3" Q9HD45 10 96518110-96587452 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039609 Approved Approved "Golgi apparatus,Vesicles" NA NA 240000 "Cluster 46: Basophils - DNA binding" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" Vesicles "Golgi apparatus" "HPA039609: AB_10673535" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (1.43e-2)" "unprognostic (5.11e-2)" "unprognostic (4.95e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-2)" "unprognostic (3.09e-2)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (4.14e-3)" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (8.28e-3)" "unprognostic (6.18e-2)" 57.0 53.4 28.5 54.6 33.0 36.7 58.4 33.2 34.8 65.3 34.9 111.8 116.9 62.5 69.2 57.5 46.0 89.9 39.7 27.7 34.4 68.0 75.0 43.2 42.0 33.8 31.2 62.9 73.3 70.1 22.5 67.8 35.2 91.7 94.5 43.4 83.2 56.4 26.6 38.5 112.4 50.8 35.7 41.8 183.5 34.6 30.7 44.7 87.4 41.1 44.9 72.8 34.8 43.6 146.8 97.2 106.5 149.3 151.4 112.4 127.7 197.8 146.7 84.0 67.5 116.4 281.6 107.3 107.0 175.8 105.5 135.3 97.6 108.1 156.8 121.3 83.6 95.3 81.8 92.0 114.5 197.7 107.2 105.0 108.6 118.6 203.7 253.2 94.7 96.4 97.0 119.9 132.2 66.4 77.1 76.2 68.9 237.9 59.6 94.6 134.4 84.8 120.1 106.8 49.6 110.3 104.1 98.6 103.0 126.2 171.0 73.7 165.3 103.5 87.1 104.6 183.1 123.7 152.3 98.4 140.9 134.9 73.5 5.7 2.2 3.8 3.5 2.3 4.0 2.1 3.6 3.9 2.7 1.5 2.7 3.6 2.4 3.9 2.4 7.1 4.0 1.3 28.5 33.0 33.2 34.8 27.7 34.4 33.8 31.2 35.2 35.7 30.7 43.6 115.7 51.3 43.0 43.1 53.2 116.8 118.8 63.2 51.8 57.8 103.1 73.0 65.0 121.5 88.2 141.6 56.3 77.5 89.5 238.7 21.5 80.7 27.6 93.0 162.0 99.8 123.9 68.8 59.9 146.1 97.6 98.7 212.0 192.2 40.6 75.0 78.9 126.9 60.0 58.9 64.0 368.3 69.2 85.6 125.3 12.8 93.2 73.5 103.2 49.6 56.8 58.1 54.6 69.9 79.2 132.1 140.6 82.4 88.9 196.1 141.5 59.3 65.9 54.7 65.7 89.2 121.0 45.8 38.4 73.2 120.6 140.9 63.0 74.5 246.7 156.2 PIK3AP1 "BCAP, FLJ35564" ENSG00000155629 "Phosphoinositide-3-kinase adaptor protein 1" Q6ZUJ8 10 96593315-96720514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 83.2;lymphoid tissue: 62.3;salivary gland: 73.6" "Cell type enhanced" "Detected in many" "B-cells: 53.7;Hepatocytes: 70.7;Kupffer cells: 127.0;Macrophages: 89.8;Microglial cells: 60.9;monocytes: 57.4;NK-cells: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 44.7;memory B-cell: 48.3;naive B-cell: 44.5;non-classical monocyte: 123.0" "Group enriched" "Detected in all" 6 "B-cells: 48.3;monocytes: 123.0" "Cell line enhanced" "Detected in many" "Daudi: 85.3;NB-4: 62.1;REH: 183.5;THP-1: 92.9;U-698: 114.7;U-937: 95.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026136, HPA038452" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" No No "Cluster 51: Monocytes - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 14: REH - Unknown function" "Cluster 57: B-cells - Immune response" Cytosol "Nucleoplasm, Plasma membrane" "CAB026136: , HPA038452: AB_2676019" "unprognostic (2.83e-2)" "unprognostic (4.61e-3)" "unprognostic (7.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.79e-1)" "unprognostic (1.49e-1)" "unprognostic (4.60e-2)" "unprognostic (1.10e-1)" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" "unprognostic (2.10e-1)" "unprognostic (5.11e-2)" "unprognostic (1.28e-1)" "unprognostic (4.69e-2)" "unprognostic (5.45e-1)" "unprognostic (1.13e-1)" 8.1 4.5 2.1 51.1 2.0 47.5 4.7 2.4 3.2 2.8 2.7 7.3 6.8 2.1 1.7 2.4 2.2 24.8 2.5 1.9 2.9 11.8 83.2 16.7 61.2 6.5 4.6 6.0 22.8 2.0 1.4 14.1 5.3 2.8 8.6 3.1 73.6 2.4 0.7 1.0 7.7 8.3 4.7 62.3 6.9 3.0 5.7 8.7 4.1 3.1 57.8 15.2 0.6 7.6 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.9 1.2 2.8 1.5 85.3 8.5 0.0 1.3 0.1 17.7 0.0 0.6 48.0 3.0 13.0 0.0 1.7 0.1 36.1 6.7 0.0 0.0 0.1 0.0 0.1 0.0 3.1 0.9 0.1 0.1 0.4 1.1 62.1 0.8 24.3 1.0 183.5 4.3 20.0 0.2 0.1 3.6 2.0 0.2 0.2 1.1 0.3 0.2 92.9 0.0 0.0 2.8 0.1 0.7 0.7 0.2 114.7 0.0 95.2 0.0 6.1 16.0 10.5 13.3 44.7 4.7 48.3 0.3 4.1 12.9 44.5 0.1 3.3 13.5 14.0 123.0 11.3 0.5 14.4 2.1 2.0 2.4 3.2 1.9 2.9 6.5 4.6 5.3 4.7 5.7 7.6 0.5 3.2 3.9 1.3 53.7 1.5 0.1 0.1 0.6 0.6 2.2 2.3 2.6 32.9 2.2 1.8 2.1 0.5 41.5 8.1 1.9 40.0 4.3 0.3 0.1 1.8 1.8 10.3 0.8 29.1 0.9 0.7 0.0 0.2 14.0 0.2 5.7 70.7 47.7 0.0 0.8 2.8 4.1 127.0 32.5 1.0 1.2 89.8 5.4 60.9 57.4 0.2 58.7 1.0 0.3 16.4 21.2 2.2 9.4 0.4 1.6 18.3 1.1 3.4 0.0 0.6 0.8 0.8 0.2 0.3 1.1 2.3 18.3 0.4 3.8 0.3 LCOR "C10orf12, DKFZP564P1916, FLJ13022, FLJ38026, KIAA1795, MLR2" ENSG00000196233 "Ligand dependent nuclear receptor corepressor" Q96JN0 10 96832254-96995956 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 264.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031429, HPA057621, HPA077000" Approved Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 6: Brain - Smell perception" "Cluster 15: RT4 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA031429: AB_2673879, HPA057621: AB_2732616, HPA077000: AB_2686824" "unprognostic (5.61e-2)" "unprognostic (1.59e-1)" "unprognostic (2.11e-1)" "unprognostic (2.23e-1)" "unprognostic (1.49e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (2.19e-1)" "unprognostic (2.40e-1)" "unprognostic (1.54e-1)" "unprognostic (4.93e-2)" "unprognostic (5.61e-3)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (4.40e-2)" "unprognostic (1.24e-1)" "prognostic favorable (2.16e-4)" 3.7 3.1 7.1 6.2 6.4 25.5 5.0 21.8 6.6 4.3 3.3 8.7 11.2 4.2 4.6 7.0 3.9 3.9 3.7 4.8 15.6 5.3 5.9 4.8 6.3 6.9 5.6 6.4 8.2 4.3 5.3 4.9 6.7 4.7 8.5 15.8 5.6 3.5 9.2 4.1 10.7 3.4 4.8 5.5 8.3 4.6 7.5 6.0 5.4 5.1 6.0 6.8 4.7 15.8 14.7 9.3 16.5 8.9 4.4 6.2 7.9 6.2 6.0 7.5 8.5 12.0 10.0 15.4 7.3 6.4 7.0 12.2 16.5 8.6 13.3 7.4 8.0 17.7 6.0 15.2 8.4 22.1 8.8 4.9 7.5 11.5 20.4 7.7 8.1 7.8 12.7 7.2 11.9 6.7 9.2 8.4 6.3 7.9 4.0 11.2 12.7 4.3 8.6 30.7 7.5 6.6 7.0 4.4 8.8 7.1 8.3 6.9 12.5 5.8 13.0 5.2 11.6 9.4 6.7 17.9 6.1 13.9 3.1 1.7 5.0 8.0 5.8 4.1 4.7 4.6 4.4 5.3 3.7 8.6 4.7 3.7 16.7 5.0 2.0 5.4 3.6 2.5 7.1 6.4 21.8 6.6 4.8 15.6 6.9 5.6 6.7 4.8 7.5 15.8 26.4 19.2 26.8 72.1 36.1 15.4 16.7 31.3 25.6 45.2 37.0 20.3 17.8 37.1 38.2 31.3 77.2 18.8 46.5 85.3 11.7 27.0 0.8 34.6 26.8 23.1 46.9 17.7 138.3 33.9 8.2 17.1 28.1 35.9 26.6 67.1 20.3 22.2 14.1 40.4 151.6 31.2 52.9 30.5 29.7 2.3 10.2 40.0 21.4 103.0 28.1 11.7 24.7 143.2 264.9 41.5 62.0 13.9 36.8 26.9 67.1 25.4 54.1 58.9 19.7 21.6 26.8 21.7 26.3 29.2 12.9 38.6 34.0 22.0 33.6 34.4 SLIT1 "MEGF4, SLIL1, Slit-1, SLIT3" ENSG00000187122 "Slit guidance ligand 1" O75093 10 96998038-97185959 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 32.5;pituitary gland: 13.5" "Group enriched" "Detected in some" 6 "Early spermatids: 27.0;Excitatory neurons: 96.2;Inhibitory neurons: 34.6;Late spermatids: 25.5;Oligodendrocyte precursor cells: 25.1" "Group enriched" "Detected in many" 4 "glioma: 9.2;thyroid cancer: 10.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "JURKAT: 23.2;MOLT-4: 81.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006879 Approved "Plasma membrane" "Secreted in brain" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "HPA006879: AB_1078197" "unprognostic (2.72e-1)" "unprognostic (2.25e-2)" "unprognostic (5.67e-3)" "unprognostic (1.43e-5)" "unprognostic (8.40e-2)" "unprognostic (2.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.06e-2)" "unprognostic (2.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.66e-1)" "unprognostic (2.18e-1)" "unprognostic (1.21e-1)" "unprognostic (4.39e-3)" 0.4 0.1 28.6 0.2 32.5 0.2 0.1 0.0 29.8 0.1 0.0 0.5 0.1 0.1 0.0 0.0 0.2 0.0 0.1 28.7 5.2 0.1 0.1 0.2 0.1 0.0 2.1 0.1 0.6 0.1 13.5 0.0 0.0 0.3 0.1 0.8 0.1 0.0 0.1 0.0 0.2 0.1 1.6 0.3 0.3 1.8 14.1 2.4 2.5 0.0 0.1 0.1 0.1 7.4 0.0 0.1 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.1 0.3 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 23.2 0.0 0.6 0.0 0.2 81.0 0.3 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 4.9 2.1 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 1.7 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 28.6 32.5 0.0 29.8 28.7 5.2 0.0 2.1 0.0 1.6 14.1 7.4 0.2 0.0 0.0 6.5 0.5 0.0 0.1 0.0 0.0 3.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 27.0 0.5 0.1 0.1 1.8 0.0 96.2 0.0 0.0 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.5 0.0 34.6 0.0 0.0 0.3 0.0 25.5 0.0 0.3 0.0 2.8 0.2 0.1 0.0 25.1 3.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.1 0.2 3.4 2.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 ARHGAP19 "FLJ00194, MGC14258" ENSG00000213390 "Rho GTPase activating protein 19" Q14CB8 10 97222173-97292673 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.3" "Cell type enhanced" "Detected in many" "Spermatocytes: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA035777, HPA043231" Uncertain Enhanced "Plasma membrane" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane" "HPA035777: AB_2674777, HPA043231: AB_10796791" "unprognostic (5.88e-2)" "unprognostic (2.39e-2)" "unprognostic (2.47e-2)" "unprognostic (1.91e-2)" "unprognostic (1.68e-1)" "unprognostic (8.79e-3)" "unprognostic (1.60e-3)" "unprognostic (2.00e-2)" "unprognostic (9.89e-2)" "unprognostic (1.97e-2)" "unprognostic (6.76e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (7.47e-5)" "unprognostic (1.12e-2)" "unprognostic (1.56e-1)" "unprognostic (2.23e-2)" "unprognostic (4.29e-2)" 3.2 2.1 2.4 7.1 3.9 18.8 7.6 2.9 2.0 3.7 0.6 4.3 3.6 5.5 2.6 4.0 4.7 3.4 3.3 1.6 3.2 3.9 2.4 4.7 13.3 4.3 3.2 9.3 1.6 5.5 0.5 5.3 4.4 3.6 4.5 3.2 3.2 3.0 1.8 3.6 5.3 4.5 3.3 7.9 3.6 18.5 2.9 21.3 3.2 4.2 13.2 2.9 2.0 5.9 18.5 6.0 31.9 56.0 2.1 8.3 9.8 9.0 9.1 13.9 9.9 11.2 16.1 40.9 7.4 6.2 8.3 12.3 27.1 11.2 17.8 20.4 14.7 27.0 7.8 7.8 2.1 42.1 27.8 4.2 3.9 9.8 22.3 4.7 19.6 57.3 27.1 21.0 12.1 8.9 39.3 9.1 16.9 12.2 5.5 45.5 27.1 11.4 4.2 7.8 2.5 14.5 6.7 3.1 14.5 11.9 19.4 22.2 9.1 5.7 6.8 8.9 23.6 18.6 20.7 54.3 7.0 48.7 6.4 21.5 7.2 11.1 5.0 6.8 4.7 5.5 4.9 4.7 5.4 5.3 5.6 5.0 15.8 4.4 6.1 3.0 6.3 5.5 2.4 3.9 2.9 2.0 1.6 3.2 4.3 3.2 4.4 3.3 2.9 5.9 5.8 3.2 3.2 0.0 4.1 0.9 1.4 2.8 3.4 2.8 3.6 8.8 1.9 2.8 1.6 0.0 0.0 2.0 3.6 2.2 0.0 1.3 9.1 2.4 2.6 5.4 0.0 6.7 0.0 1.6 3.5 3.9 1.5 3.6 5.1 5.6 11.7 2.6 3.5 6.7 0.0 1.9 2.0 9.3 1.9 6.3 3.4 6.1 1.8 0.0 5.4 1.7 5.2 0.0 0.0 1.4 2.9 4.1 5.8 2.6 2.6 0.7 4.8 1.3 0.0 3.1 2.2 13.7 10.4 5.3 2.4 1.0 3.5 3.4 3.5 1.6 FRAT1 ENSG00000165879 "FRAT regulator of WNT signaling pathway 1" Q92837 10 97319271-97321915 "Predicted intracellular proteins" "Wnt signaling pathway" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 25.2;Early spermatids: 31.3;Kupffer cells: 26.1;Late spermatids: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 8.7;neutrophil: 10.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB046472, HPA055258" Approved Approved Vesicles,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 6: T47d - Mammary gland" "Cluster 31: Spermatids - Spermatogenesis" "Vesicles, Cytosol" "CAB046472: AB_1849131, HPA055258: AB_2682763" "unprognostic (1.48e-2)" "prognostic favorable (5.92e-4)" "unprognostic (3.54e-1)" "unprognostic (1.13e-2)" "unprognostic (1.45e-1)" "prognostic favorable (2.75e-4)" "unprognostic (1.11e-2)" "unprognostic (4.44e-3)" "unprognostic (5.73e-2)" "unprognostic (2.50e-2)" "unprognostic (6.36e-3)" "unprognostic (1.89e-1)" "prognostic favorable (6.36e-5)" "unprognostic (6.38e-2)" "unprognostic (5.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.43e-2)" 3.2 2.9 2.6 5.0 2.6 10.6 2.4 3.8 3.5 2.5 1.8 3.2 4.4 2.6 1.0 2.4 3.0 1.2 3.1 2.8 3.1 2.1 11.8 3.3 3.8 3.6 3.4 2.4 3.9 2.0 2.1 1.2 3.1 4.0 1.9 1.9 3.7 1.6 3.8 4.2 4.5 1.5 2.9 12.6 4.8 10.9 3.9 4.1 2.0 2.6 2.4 2.3 2.1 2.6 0.7 1.3 1.4 6.7 1.8 0.9 1.5 0.8 2.9 0.5 0.6 0.2 0.8 4.5 1.5 0.5 1.0 2.0 1.1 1.4 0.1 4.0 2.0 3.8 0.8 1.8 0.6 1.4 4.0 0.8 2.0 0.2 0.9 2.7 1.2 6.1 1.6 3.1 0.4 4.2 4.0 7.9 1.9 4.8 5.5 3.3 0.3 2.9 0.5 1.0 0.7 2.2 1.0 2.1 1.5 1.4 7.7 5.4 1.1 0.3 0.4 1.0 0.3 2.9 1.7 1.5 0.5 7.0 0.0 0.9 2.0 8.7 0.5 1.3 0.4 0.5 0.4 0.7 1.0 0.5 0.7 0.5 10.1 0.2 1.5 0.6 0.3 0.5 2.6 2.6 3.8 3.5 2.8 3.1 3.6 3.4 3.1 2.9 3.9 2.6 4.1 3.2 5.8 1.0 5.8 1.1 1.1 0.9 1.2 25.2 2.9 1.9 3.3 5.7 0.9 1.8 0.0 0.6 16.8 6.0 0.0 1.4 31.3 5.8 1.6 4.0 4.2 4.2 0.7 2.0 1.7 1.5 2.0 4.1 0.0 5.0 3.3 15.6 3.9 3.3 1.6 4.9 4.1 26.1 1.8 85.2 1.2 15.5 3.6 0.0 12.5 4.9 13.4 0.5 0.7 1.1 2.3 1.9 1.1 2.5 3.8 1.0 3.3 8.4 0.0 3.4 1.7 1.2 0.6 1.6 1.6 2.3 9.0 4.7 2.8 2.2 FRAT2 ENSG00000181274 "FRAT regulator of WNT signaling pathway 2" O75474 10 97332497-97334729 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 4 "testis cancer: 70.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 15.0;neutrophil: 58.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 58.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049763 Uncertain Approved Nucleoplasm,Mitochondria No No "Cluster 9: Neutrophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Mitochondria "HPA049763: AB_2680868" "unprognostic (4.93e-2)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (1.46e-1)" "unprognostic (4.04e-3)" "unprognostic (1.87e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.17e-3)" "unprognostic (2.60e-1)" "unprognostic (8.02e-2)" "unprognostic (4.60e-2)" "unprognostic (3.25e-2)" "prognostic favorable (2.55e-4)" "unprognostic (7.87e-3)" "unprognostic (4.83e-2)" "unprognostic (2.34e-1)" "unprognostic (9.08e-2)" 5.3 3.6 7.2 10.4 7.1 31.0 8.0 7.7 7.4 6.0 9.8 17.1 25.1 4.1 6.2 14.4 7.1 4.0 6.0 6.3 6.8 7.8 18.3 9.7 8.7 7.7 7.6 2.8 14.0 5.2 3.0 7.4 6.8 7.9 15.5 3.3 15.1 4.3 10.1 20.4 15.9 4.1 7.0 28.9 13.2 14.6 7.5 8.9 5.3 9.1 10.8 6.7 8.1 6.0 10.9 4.3 6.9 31.2 4.9 4.0 25.7 2.4 8.9 3.7 3.7 6.8 12.5 13.3 8.4 2.5 2.2 20.3 18.3 9.5 2.9 20.0 28.0 17.9 9.2 15.0 2.8 28.9 20.6 3.2 20.0 3.6 11.4 7.9 9.3 11.7 15.8 4.2 1.8 17.9 12.6 36.5 42.9 36.2 17.5 12.8 2.9 19.1 8.9 9.8 12.5 10.2 3.1 19.1 12.6 28.0 28.8 44.8 4.2 2.2 2.7 1.7 6.4 11.4 12.5 6.6 2.6 49.3 0.8 8.3 7.2 15.0 1.1 4.8 0.6 1.1 1.3 1.8 3.8 3.2 2.2 1.3 58.2 1.6 7.9 1.0 0.7 2.3 7.2 7.1 7.7 7.4 6.3 6.8 7.7 7.6 6.8 7.0 7.5 6.0 18.2 0.0 3.9 2.9 15.7 31.7 25.3 6.6 46.1 19.7 24.7 19.6 6.4 20.0 5.0 14.7 4.2 6.1 26.1 31.0 11.7 2.2 40.7 39.6 9.7 10.3 13.8 14.5 2.0 5.3 18.5 6.4 37.2 46.3 1.3 16.7 8.6 11.3 8.6 11.8 2.8 30.6 4.1 28.3 9.0 42.3 2.1 25.2 10.6 7.5 24.7 5.0 14.4 2.0 1.1 3.4 21.6 2.6 8.4 30.0 13.5 3.7 4.5 18.1 0.0 14.9 8.7 2.3 4.4 37.7 52.7 7.8 18.8 20.1 31.6 32.3 RRP12 KIAA0690 ENSG00000052749 "Ribosomal RNA processing 12 homolog" Q5JTH9 10 97356358-97426076 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 90.9;skeletal muscle: 38.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 26.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049945, HPA074403" Supported "Nucleoli,Vesicles,Plasma membrane,Cytosol" No No "Cluster 51: Monocytes - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 41: Macrophages - Immune response" Nucleoli "Vesicles, Plasma membrane, Cytosol" "HPA049945: AB_2680965, HPA074403: " "unprognostic (2.79e-1)" "unprognostic (7.65e-2)" "unprognostic (5.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.42e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.12e-8)" "unprognostic (2.64e-1)" "unprognostic (1.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.94e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (2.54e-5)" "unprognostic (2.58e-2)" "unprognostic (3.32e-1)" "unprognostic (4.81e-2)" "unprognostic (6.99e-3)" 8.1 10.2 2.6 9.2 3.4 90.9 5.6 1.1 7.6 5.6 2.4 4.9 6.0 7.4 3.6 8.5 7.3 7.2 11.4 3.2 2.7 6.8 5.7 6.7 6.7 4.3 4.4 6.1 16.0 9.3 10.2 4.3 4.1 6.3 3.8 3.4 8.3 4.0 38.5 10.3 4.7 6.0 0.2 7.6 6.3 10.9 3.7 4.7 5.5 9.7 6.1 9.3 5.7 4.6 38.9 50.8 13.2 28.6 10.0 11.6 28.9 24.2 14.4 24.2 18.7 55.6 35.0 42.3 30.4 15.1 21.6 48.7 36.3 28.0 16.3 23.1 44.2 32.8 19.5 43.6 16.5 51.7 41.5 12.2 38.6 59.9 54.6 27.0 13.7 23.5 47.7 27.4 14.0 50.8 35.0 33.0 57.0 20.4 34.0 38.1 18.0 42.1 16.8 21.4 17.7 37.9 19.2 18.1 24.1 10.4 43.7 26.5 18.2 16.1 27.9 36.5 76.4 55.7 52.7 48.6 23.2 64.9 17.9 0.4 11.2 6.9 2.7 13.6 3.3 3.9 1.6 2.2 6.2 4.2 2.5 2.8 26.7 1.9 16.9 5.0 1.2 6.0 2.6 3.4 1.1 7.6 3.2 2.7 4.3 4.4 4.1 0.2 3.7 4.6 8.8 35.3 31.1 5.9 18.5 23.5 14.2 5.1 25.0 5.8 12.7 9.9 11.6 7.2 21.5 14.7 41.7 5.2 7.7 10.6 0.0 8.7 7.2 17.1 10.6 10.6 21.5 7.2 15.1 8.7 7.5 13.5 27.0 20.1 41.7 12.9 3.9 8.9 11.5 5.0 9.5 13.8 4.1 12.5 7.1 4.8 3.7 30.3 7.2 2.8 12.3 1.9 3.1 5.0 4.4 8.5 6.4 2.6 31.8 17.1 3.7 6.8 24.6 12.7 0.0 19.4 6.7 10.6 20.6 22.7 19.6 9.2 11.0 13.5 11.5 13.6 PGAM1 "PGAM-B, PGAMA" ENSG00000171314 "Phosphoglycerate mutase 1" P18669 10 97426191-97433444 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 791.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042528, HPA060483" Approved Supported Nucleoplasm NA NA 120000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm "HPA042528: AB_2678039, HPA060483: AB_2684292" "prognostic unfavorable (2.04e-4)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.64e-1)" "unprognostic (5.64e-2)" "unprognostic (1.16e-1)" "unprognostic (9.47e-3)" "unprognostic (7.60e-3)" "unprognostic (1.74e-3)" "unprognostic (3.22e-1)" "unprognostic (1.05e-1)" "unprognostic (4.37e-3)" "unprognostic (2.48e-2)" "unprognostic (1.48e-1)" "unprognostic (5.74e-2)" "unprognostic (4.94e-2)" "unprognostic (1.19e-1)" "unprognostic (2.61e-3)" 149.0 294.7 228.7 153.6 249.7 180.0 122.1 252.9 265.0 184.3 275.1 162.9 151.5 153.7 98.6 436.7 117.2 106.6 275.7 256.1 266.0 167.6 182.5 121.7 165.7 241.7 242.7 133.3 81.8 191.3 150.8 156.6 280.9 107.3 141.9 420.7 164.7 156.5 56.5 206.9 141.4 177.9 228.3 139.6 133.2 87.5 278.8 124.9 86.9 70.2 229.7 186.6 233.3 224.7 1160.6 538.9 364.0 697.9 336.7 307.7 494.1 722.4 938.4 830.2 1148.3 589.4 335.4 609.1 482.7 619.2 333.4 706.8 639.8 1051.4 998.1 567.2 611.7 393.6 386.4 667.5 248.4 570.0 503.9 303.2 422.5 552.7 408.7 1118.9 610.8 447.2 262.0 334.0 884.8 478.3 514.7 697.8 559.0 331.8 637.8 384.2 333.6 484.0 646.0 431.1 79.1 370.1 388.6 229.2 381.2 564.9 625.0 472.9 463.8 441.5 385.2 394.8 844.0 499.0 593.1 556.1 1023.3 937.5 209.3 242.5 433.5 572.7 217.0 366.6 192.3 134.8 183.8 216.9 309.7 114.7 117.5 164.9 312.6 149.4 422.7 110.5 265.6 580.2 228.7 249.7 252.9 265.0 256.1 266.0 241.7 242.7 280.9 228.3 278.8 224.7 92.9 44.8 44.4 23.8 122.2 187.0 173.1 394.2 124.1 403.5 77.8 76.7 22.9 85.8 140.8 106.7 77.2 495.8 122.3 233.9 358.1 321.8 15.1 50.2 113.7 145.9 48.1 71.1 29.4 205.8 791.9 146.0 68.8 72.0 103.4 109.5 96.8 193.7 395.1 387.0 35.7 116.7 152.5 170.0 129.1 27.0 149.5 174.6 131.6 16.9 376.9 404.4 174.0 14.1 19.9 295.7 132.9 234.3 254.9 175.2 283.0 274.8 72.1 300.5 203.8 73.1 199.9 38.0 114.7 253.3 204.7 372.6 138.0 257.8 176.4 269.6 EXOSC1 "CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p" ENSG00000171311 "Exosome component 1" Q9Y3B2 10 97435909-97446017 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038370 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 22: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" Nucleoplasm "HPA038370: AB_10672515" "unprognostic (1.77e-2)" "unprognostic (1.08e-2)" "unprognostic (1.32e-2)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (1.10e-2)" "unprognostic (3.27e-3)" "unprognostic (2.33e-2)" "unprognostic (1.62e-2)" "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.88e-9)" "unprognostic (9.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (4.41e-2)" 21.9 25.4 31.4 23.5 34.3 28.7 22.4 50.4 39.9 25.5 27.7 25.6 24.3 24.0 42.6 28.4 22.2 17.0 23.5 29.7 33.6 25.3 26.9 20.5 32.3 33.3 32.2 23.6 38.8 21.1 24.2 17.6 32.6 24.5 23.5 21.2 26.6 17.3 29.0 23.5 22.3 22.1 32.6 30.3 31.2 15.2 32.8 32.5 21.6 14.8 31.9 25.3 22.9 36.3 62.9 49.6 34.8 61.7 42.1 44.3 47.0 52.2 73.9 57.2 64.4 86.5 62.1 60.4 59.0 50.2 44.1 64.0 52.5 58.9 56.6 77.3 61.3 39.5 48.0 68.9 74.5 94.2 46.1 45.8 77.9 69.6 101.3 70.2 66.3 90.5 45.6 108.0 43.2 70.3 88.0 153.3 58.1 64.7 43.2 65.8 43.4 106.4 39.4 32.8 20.4 38.3 38.6 30.0 87.6 44.1 71.2 113.2 43.6 31.9 40.1 50.4 117.6 72.5 103.1 119.5 54.3 113.2 26.3 79.0 91.0 93.5 75.5 132.8 96.5 109.6 93.1 87.9 96.4 94.7 89.4 78.1 35.7 57.9 121.7 82.9 144.0 86.4 31.4 34.3 50.4 39.9 29.7 33.6 33.3 32.2 32.6 32.6 32.8 36.3 22.5 25.6 24.6 15.0 42.4 19.1 35.7 59.3 18.2 31.0 22.5 27.3 20.5 27.1 35.8 44.1 27.1 48.6 41.2 15.4 39.2 36.0 17.4 22.6 24.1 27.7 14.3 23.8 24.7 41.8 58.1 27.0 21.9 16.7 25.3 31.0 34.6 25.3 50.9 30.3 22.2 28.1 36.7 31.4 20.7 17.0 32.6 28.7 30.2 17.8 61.0 29.1 61.8 12.1 25.5 35.9 20.0 24.0 43.6 24.9 30.1 53.8 47.1 48.1 26.3 20.7 35.2 35.8 39.1 27.6 24.4 41.2 44.3 26.4 25.7 31.7 ZDHHC16 APH2 ENSG00000171307 "Zinc finger DHHC-type palmitoyltransferase 16" Q969W1 10 97446170-97457370 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Apoptosis, DNA damage" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039893, HPA040214" Uncertain Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Nuclear membrane, Cytosol" "HPA039893: AB_10794757, HPA040214: AB_2676886" "unprognostic (4.44e-2)" "unprognostic (3.14e-2)" "unprognostic (3.34e-1)" "unprognostic (1.20e-2)" "unprognostic (8.75e-2)" "unprognostic (8.35e-3)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (1.57e-1)" "unprognostic (2.31e-1)" "unprognostic (6.34e-2)" "unprognostic (1.93e-3)" "unprognostic (1.34e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-1)" 15.6 14.9 17.8 10.2 18.5 6.8 16.3 20.3 21.9 15.0 16.4 17.1 14.3 16.4 18.5 19.9 12.2 9.9 22.1 18.1 16.5 25.1 30.3 20.8 11.3 17.2 17.8 15.9 22.8 25.5 16.7 21.6 16.4 18.3 17.3 17.4 24.2 12.1 25.8 13.1 14.7 16.6 16.1 14.5 24.1 17.3 18.8 12.6 16.0 27.9 15.1 17.1 15.3 16.7 50.7 57.4 37.9 47.1 58.7 40.4 38.7 54.6 72.1 61.2 58.4 45.7 43.6 44.4 60.1 79.8 53.4 58.0 48.2 76.7 54.2 43.7 56.0 28.5 39.8 44.3 47.4 34.0 39.7 45.7 49.8 71.6 51.3 66.3 63.9 40.4 23.1 32.8 79.0 48.4 51.8 46.0 29.9 45.8 49.5 34.0 38.6 40.9 51.9 23.2 18.4 25.9 33.2 33.7 30.6 37.7 44.6 32.9 39.6 38.2 35.0 25.0 64.7 29.2 53.0 26.9 44.1 51.7 20.7 0.3 11.1 11.1 7.2 11.9 8.1 9.0 12.5 11.5 15.7 10.6 10.0 10.1 0.5 14.5 11.8 12.0 11.1 6.8 17.8 18.5 20.3 21.9 18.1 16.5 17.2 17.8 16.4 16.1 18.8 16.7 6.2 19.2 23.1 3.9 9.0 5.2 18.9 31.8 14.8 15.8 13.6 9.3 10.1 14.3 27.6 12.9 4.2 39.8 10.3 11.5 25.4 35.5 24.8 7.0 13.3 11.3 7.2 11.6 8.2 32.3 67.2 13.7 10.2 10.9 7.0 13.3 7.5 19.5 24.6 13.5 9.2 18.9 28.5 7.3 5.9 7.6 8.7 9.3 3.6 9.4 18.4 14.9 15.5 11.1 8.4 31.5 12.1 3.8 17.1 20.0 18.9 22.2 8.3 13.0 6.6 5.2 12.2 20.1 12.9 13.8 4.3 37.9 7.2 10.9 20.9 19.3 MMS19 "CIAO4, hMMS19, MET18, MMS19L" ENSG00000155229 "MMS19 homolog, cytosolic iron-sulfur assembly component" Q96T76 10 97458324-97498794 "Predicted intracellular proteins" "Chromosome partition, DNA damage, DNA repair, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051936, HPA056299" Approved Enhanced Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA051936: AB_2681668, HPA056299: AB_2683091" "unprognostic (8.57e-2)" "unprognostic (2.38e-3)" "unprognostic (9.34e-3)" "unprognostic (1.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (4.40e-1)" "unprognostic (1.99e-2)" "unprognostic (4.90e-2)" "unprognostic (1.17e-1)" "unprognostic (9.06e-3)" "unprognostic (6.79e-2)" "unprognostic (6.49e-2)" "unprognostic (4.06e-1)" "unprognostic (3.51e-2)" "prognostic unfavorable (3.39e-4)" 25.9 23.3 45.1 14.9 47.1 16.4 27.0 45.7 66.4 27.7 45.3 26.1 14.2 24.6 18.3 32.8 24.8 13.1 39.3 47.6 44.0 37.3 24.0 25.1 22.3 44.7 44.2 30.3 30.6 17.1 35.7 20.6 45.2 23.5 17.5 28.8 26.7 15.8 38.0 44.4 28.4 17.8 43.4 33.4 27.9 47.2 45.8 25.8 23.5 29.2 22.7 25.6 30.3 44.9 39.1 36.5 43.3 61.1 41.4 49.9 26.3 30.7 61.6 45.8 53.5 48.9 49.7 59.9 32.5 42.1 30.4 43.5 71.5 82.7 43.1 26.3 54.5 32.0 30.5 51.8 31.3 42.7 29.9 41.5 35.7 40.7 86.3 88.8 78.2 44.7 45.5 32.8 45.1 35.1 40.5 77.3 24.6 39.0 29.8 32.1 33.0 27.1 55.0 27.9 17.8 29.5 17.8 23.4 48.3 53.7 47.9 37.8 45.0 21.1 26.0 14.2 35.6 29.5 35.0 34.6 31.5 62.3 17.3 10.5 6.1 4.6 5.4 6.6 9.3 6.0 7.2 6.8 8.5 5.0 8.7 7.1 1.2 5.7 5.2 6.3 7.2 6.3 45.1 47.1 45.7 66.4 47.6 44.0 44.7 44.2 45.2 43.4 45.8 44.9 9.4 22.4 16.0 21.2 10.0 10.5 6.2 11.3 12.5 10.6 9.2 11.2 18.0 12.8 8.2 5.5 18.8 13.7 13.4 8.7 11.7 11.1 9.6 5.6 12.1 13.0 10.2 11.6 32.8 8.1 18.8 9.9 16.8 9.0 3.8 12.8 15.4 14.4 12.4 10.1 29.7 14.6 4.1 12.6 9.6 7.4 15.5 9.0 14.2 7.5 15.6 6.4 6.2 27.6 38.6 9.7 4.1 11.3 10.7 6.1 9.1 6.7 7.6 22.2 13.1 9.1 8.8 22.2 28.5 12.7 11.5 8.8 9.7 9.7 13.1 4.9 UBTD1 FLJ11807 ENSG00000165886 "Ubiquitin domain containing 1" Q9HAC8 10 97498924-97571206 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 53.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 6.4;neutrophil: 6.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034825 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "Plasma membrane, Cytosol" "HPA034825: AB_10602254" "unprognostic (1.52e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.54e-4)" "unprognostic (2.43e-1)" "unprognostic (1.78e-1)" "unprognostic (3.90e-2)" "unprognostic (3.63e-3)" "unprognostic (1.43e-2)" "unprognostic (1.66e-3)" "unprognostic (9.25e-3)" "unprognostic (2.45e-1)" "unprognostic (4.78e-1)" "unprognostic (6.62e-3)" "unprognostic (8.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-3)" "unprognostic (3.50e-3)" 18.8 11.1 14.9 5.7 15.2 8.8 14.7 16.8 17.0 16.5 12.6 10.3 1.8 13.5 4.0 9.5 13.6 7.0 35.1 13.5 15.8 29.2 18.6 29.8 3.1 17.7 17.1 8.7 9.6 3.6 15.9 3.8 16.2 13.4 0.6 6.0 11.2 7.5 34.2 49.5 5.5 3.6 16.1 11.0 9.4 60.3 18.9 1.6 14.6 11.2 1.1 12.4 16.3 14.6 18.1 17.7 4.6 23.0 18.9 17.8 5.4 20.3 29.4 21.3 16.3 12.0 15.4 2.2 24.1 13.8 13.4 21.4 4.6 27.2 3.0 5.6 9.1 2.2 5.5 15.2 27.2 2.0 5.9 24.6 9.0 23.3 5.7 32.8 34.3 4.7 1.2 3.3 13.9 8.6 0.9 18.5 7.5 3.4 32.1 1.8 8.1 2.1 16.7 6.7 1.5 4.8 9.2 5.6 27.1 4.0 20.8 13.6 37.5 26.9 16.4 28.4 26.8 4.2 5.1 0.9 22.7 12.3 14.3 1.0 2.6 6.4 0.1 0.7 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 6.6 0.0 0.7 0.9 0.3 0.5 14.9 15.2 16.8 17.0 13.5 15.8 17.7 17.1 16.2 16.1 18.9 14.6 5.0 41.7 28.6 13.1 1.1 26.0 8.8 32.2 19.4 3.8 10.0 4.8 15.5 8.6 21.2 7.3 4.2 3.5 0.6 1.5 11.7 18.9 53.5 8.2 8.7 23.8 0.0 0.4 5.6 12.8 12.8 11.6 2.6 4.0 0.0 0.8 7.9 7.0 25.8 6.7 5.9 0.2 10.2 10.1 18.9 33.8 12.8 10.3 10.6 12.2 8.4 16.5 2.1 2.0 14.5 22.1 0.1 9.4 3.0 14.0 0.0 10.4 19.1 18.6 13.1 8.5 10.3 7.5 7.9 8.2 29.7 2.9 1.9 1.5 0.4 7.6 ANKRD2 ARPP ENSG00000165887 "Ankyrin repeat domain 2" Q9GZV1 10 97572499-97583884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 63 "heart muscle: 437.1;skeletal muscle: 981.2;tongue: 823.8" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 218.3" "Cancer enhanced" "Detected in many" "renal cancer: 4.9;testis cancer: 5.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 17.6;BJ hTERT+ SV40 Large T+: 7.3;HaCaT: 13.0;RPTEC TERT1: 17.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040842, HPA040884" Enhanced Enhanced Vesicles NA NA 110000 "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" Vesicles "HPA040842: AB_10963794, HPA040884: AB_10969453" "unprognostic (1.27e-2)" "unprognostic (9.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.39e-2)" "unprognostic (1.37e-1)" "unprognostic (1.61e-2)" "unprognostic (2.53e-1)" "unprognostic (5.60e-3)" "unprognostic (2.17e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.22e-1)" "unprognostic (1.05e-2)" "unprognostic (3.69e-3)" "unprognostic (4.56e-2)" "unprognostic (1.39e-1)" "unprognostic (2.13e-1)" 0.4 0.8 2.5 0.1 2.3 0.0 0.5 2.5 3.7 0.2 2.0 0.3 0.0 0.3 0.3 1.0 0.1 0.3 437.1 2.5 2.7 11.8 0.3 0.8 0.2 2.5 2.4 0.1 0.9 0.0 0.6 0.0 2.5 2.9 0.0 0.3 3.4 0.9 981.2 2.7 0.2 0.2 1.9 0.1 0.2 0.5 2.7 0.0 0.5 823.8 0.1 0.1 0.4 2.5 17.6 5.4 0.0 0.0 0.2 0.0 0.4 0.9 0.0 7.3 4.7 0.3 5.3 0.0 0.6 0.2 0.4 13.0 0.0 4.7 5.0 0.2 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.8 2.1 4.3 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 17.4 0.8 0.0 0.0 0.0 4.4 0.0 0.4 2.1 0.3 0.0 0.1 1.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 2.3 2.5 3.7 2.5 2.7 2.5 2.4 2.5 1.9 2.7 2.5 0.1 0.0 0.0 1.3 0.0 0.1 0.7 1.7 1.2 0.0 0.2 0.4 218.3 2.8 0.2 3.7 0.0 0.2 0.0 0.0 31.3 1.2 0.6 0.1 0.3 1.6 0.0 0.0 1.3 0.2 0.4 1.0 0.0 0.1 0.0 0.7 0.4 0.2 0.1 0.0 1.5 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.5 0.4 0.9 0.0 1.9 0.0 0.1 0.0 19.1 0.0 0.1 0.0 13.6 1.1 2.5 3.5 0.6 0.3 0.3 0.2 0.1 0.0 0.5 HOGA1 "C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2" ENSG00000241935 "4-hydroxy-2-oxoglutarate aldolase 1" Q86XE5 10 97584323-97612802 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 51.8;liver: 54.8" "Cell type enhanced" "Detected in some" "Cholangiocytes: 35.8;Distal tubular cells: 29.4;Hepatocytes: 43.3;Late spermatids: 18.4;Proximal tubular cells: 98.0" "Group enriched" "Detected in many" 5 "liver cancer: 4.5;renal cancer: 9.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 7.8;EFO-21: 9.7;Hep G2: 26.1;RPTEC TERT1: 31.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039466 Approved NA NA 16000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA039466: AB_2676522" "unprognostic (6.44e-2)" "unprognostic (3.64e-2)" "unprognostic (7.50e-2)" "unprognostic (2.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.29e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-3)" "unprognostic (4.72e-1)" "unprognostic (2.37e-1)" "unprognostic (1.28e-1)" "unprognostic (6.80e-2)" "prognostic favorable (9.08e-4)" "unprognostic (2.20e-1)" "unprognostic (1.80e-1)" "unprognostic (2.94e-3)" "unprognostic (7.20e-4)" 4.1 8.3 5.8 0.2 7.4 0.4 1.9 9.3 5.0 0.7 11.4 0.2 0.3 1.1 3.7 1.0 2.0 2.5 21.1 4.4 6.5 51.8 54.8 1.4 0.3 8.2 9.2 0.2 15.3 5.7 3.6 0.1 8.3 1.1 0.1 0.8 1.7 2.1 3.4 1.5 0.3 0.5 7.3 0.4 0.2 0.9 7.9 0.3 1.8 12.1 0.2 0.4 0.9 10.3 0.3 3.7 0.1 7.8 1.5 0.3 0.1 0.1 0.2 0.0 0.0 3.0 0.2 0.3 9.7 0.2 0.5 2.6 0.0 0.2 0.1 0.1 4.0 0.1 1.4 26.1 1.1 0.2 0.1 0.3 0.7 0.1 0.1 1.9 0.4 0.1 0.0 0.4 0.6 1.6 0.1 0.1 0.2 0.2 0.0 0.1 0.6 0.4 31.5 0.6 0.6 1.0 0.1 1.3 0.5 0.2 2.8 0.0 0.2 0.8 0.2 0.3 0.2 0.5 0.9 0.1 2.0 0.1 0.1 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.1 0.4 0.2 0.2 1.0 0.2 0.2 0.3 0.2 0.1 5.8 7.4 9.3 5.0 4.4 6.5 8.2 9.2 8.3 7.3 7.9 10.3 0.0 0.0 0.0 7.2 1.5 0.1 0.7 0.5 1.8 0.4 0.1 0.4 6.0 35.8 0.2 9.2 0.0 0.1 0.0 0.1 29.4 5.9 3.8 1.8 0.1 0.0 0.0 0.0 1.3 0.2 0.0 0.2 0.0 0.5 0.0 0.1 0.4 43.3 0.1 1.7 1.2 0.0 0.0 1.3 0.0 18.4 0.0 0.8 1.8 1.0 0.0 2.0 0.0 1.5 12.3 0.5 0.1 0.0 0.0 0.1 0.0 98.0 3.2 0.3 0.0 4.5 0.9 0.0 0.1 0.7 0.0 0.0 0.5 0.0 0.0 0.2 AL355315.1 ENSG00000249967 "Novel protein" 10 97584374-97673910 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "tongue: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;EFO-21: 1.3;GAMG: 1.0;HBEC3-KT: 1.1;hTERT-RPE1: 1.9" HPA076857 Uncertain "Plasma membrane" NA NA "Cluster 8: Non-specific - Mitochondria" "Cluster 38: EFO-21 - Unknown function" "Plasma membrane" "HPA076857: AB_2686817" 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.2 0.0 0.4 0.8 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.6 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.2 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 1.3 0.2 1.0 0.7 0.0 1.1 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.2 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf62 bA548K23.1 ENSG00000203942 "Chromosome 10 open reading frame 62" Q5T681 10 97589721-97590934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 155 "testis: 277.9" "Cell type enriched" "Detected in some" 5 "Late spermatids: 9848.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA072947 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "Nucleoplasm, Vesicles" "HPA072947: AB_2686562" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (2.81e-1)" "unprognostic (5.36e-2)" "unprognostic (3.62e-1)" "unprognostic (1.20e-1)" "unprognostic (3.63e-2)" "unprognostic (2.53e-2)" "unprognostic (2.04e-2)" 0.0 0.2 0.3 0.0 0.8 0.0 0.2 1.4 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.5 0.7 0.7 0.0 0.0 0.9 1.0 0.0 0.3 0.1 0.2 0.0 0.9 0.3 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.5 0.0 0.0 277.9 0.8 0.0 0.1 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 1.4 0.4 0.3 0.5 0.9 1.0 0.9 0.5 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1711.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9848.3 39.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.3 0.0 0.0 6.6 0.0 0.0 40.7 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MORN4 "bA548K23.4, C10orf83, FLJ25925, rtp" ENSG00000171160 "MORN repeat containing 4" Q8NDC4 10 97614553-97633500 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 51.5;Distal tubular cells: 90.1;Proximal tubular cells: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052718 Uncertain NA NA "Cluster 35: T-regs - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "HPA052718: AB_2681926" "unprognostic (7.24e-2)" "unprognostic (6.27e-2)" "unprognostic (1.78e-2)" "unprognostic (1.80e-2)" "unprognostic (3.71e-1)" "unprognostic (2.13e-2)" "unprognostic (1.11e-2)" "unprognostic (4.32e-1)" "unprognostic (3.14e-3)" "unprognostic (2.50e-1)" "unprognostic (6.15e-3)" "unprognostic (9.82e-2)" "unprognostic (1.07e-3)" "unprognostic (4.10e-1)" "unprognostic (1.89e-1)" "unprognostic (3.87e-1)" "unprognostic (1.32e-1)" 4.0 8.9 24.2 1.7 26.0 1.8 6.6 18.2 27.2 9.4 18.5 7.3 0.9 7.6 11.6 2.5 9.6 5.0 16.9 24.2 31.0 15.8 5.4 4.6 1.9 20.5 23.3 12.3 10.0 24.3 26.7 3.4 23.2 10.1 3.0 15.4 4.9 9.2 6.1 5.3 2.9 5.6 18.5 3.9 6.6 8.8 28.1 2.2 10.3 5.7 1.6 6.4 5.6 20.9 12.0 13.6 17.1 41.5 6.2 18.5 1.5 9.4 14.0 9.8 13.9 6.1 16.4 0.0 14.2 6.8 28.9 8.1 0.0 11.1 10.4 9.7 13.5 2.0 6.9 14.2 16.6 2.8 1.0 10.0 34.3 14.9 19.2 34.9 14.1 12.0 7.6 7.1 9.9 8.7 0.0 0.2 12.2 7.2 15.6 0.0 1.6 0.0 10.4 5.1 12.0 25.4 13.6 3.7 25.5 9.3 16.0 2.2 3.9 10.5 9.1 11.6 11.2 15.1 20.0 0.1 18.8 0.1 5.5 0.6 0.2 0.4 2.0 0.2 2.3 2.5 1.7 1.5 0.1 0.6 2.7 1.9 0.4 0.5 0.1 1.0 2.2 0.6 24.2 26.0 18.2 27.2 24.2 31.0 20.5 23.3 23.2 18.5 28.1 20.9 1.7 6.4 2.0 10.1 2.5 4.2 3.9 7.5 8.6 5.5 5.2 7.1 51.5 5.7 7.3 11.0 0.0 2.1 0.3 1.0 90.1 5.9 13.0 8.9 5.4 2.9 9.0 3.4 22.9 8.0 1.4 7.8 5.1 6.6 5.7 8.3 3.3 2.5 2.7 1.7 23.8 2.4 6.1 0.3 2.3 16.3 7.5 0.8 5.4 4.7 1.8 9.1 1.0 18.6 9.7 6.9 0.4 9.1 2.4 3.7 0.4 51.9 16.1 4.9 0.0 3.7 5.8 7.7 2.2 3.3 3.1 2.1 1.8 5.4 2.3 2.8 PI4K2A "DKFZP761G1923, PI4KII, PIK42A" ENSG00000155252 "Phosphatidylinositol 4-kinase type 2 alpha" Q9BTU6 10 97640686-97676434 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB030649, HPA076857" Approved Approved "Plasma membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane" "CAB030649: , HPA076857: AB_2686817" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (4.21e-5)" "unprognostic (1.80e-2)" "unprognostic (2.12e-1)" "unprognostic (1.75e-2)" "unprognostic (2.84e-3)" "unprognostic (1.60e-2)" "unprognostic (1.39e-3)" "unprognostic (1.38e-2)" "unprognostic (1.02e-2)" "unprognostic (1.65e-1)" "unprognostic (9.92e-2)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" 12.0 25.7 15.5 10.0 15.1 24.1 9.3 15.1 18.9 12.6 13.4 10.7 9.8 12.7 13.0 20.7 9.6 14.0 14.2 15.5 17.8 12.6 15.0 14.2 11.2 20.2 18.8 10.0 8.4 16.6 15.8 18.0 22.0 10.9 8.7 12.9 10.5 10.4 12.7 17.4 10.8 13.0 15.8 14.6 9.4 10.8 17.3 9.8 9.5 13.0 10.6 14.5 12.7 15.2 28.7 21.3 17.2 30.7 36.0 25.8 13.8 28.0 61.5 43.3 45.7 19.4 27.7 10.4 16.2 35.8 31.8 27.1 19.3 55.9 35.8 12.6 16.4 9.3 14.6 17.7 34.5 8.4 12.7 27.3 46.9 45.4 80.1 47.4 22.4 19.9 14.7 16.5 30.4 14.6 18.4 6.4 11.1 14.7 19.8 8.6 17.8 10.3 29.7 26.6 5.8 18.9 23.9 5.9 35.5 24.0 16.4 13.2 25.0 20.6 15.2 24.6 22.1 14.6 18.4 16.9 38.1 5.0 6.8 0.0 1.2 0.0 1.3 0.8 1.0 1.4 0.5 1.1 1.3 0.6 0.4 0.9 0.4 0.7 0.6 0.6 1.2 0.6 15.5 15.1 15.1 18.9 15.5 17.8 20.2 18.8 22.0 15.8 17.3 15.2 4.9 3.2 5.4 9.8 12.0 13.4 4.5 6.5 8.0 14.7 10.7 8.9 10.4 10.0 4.3 5.5 12.5 14.0 12.5 8.6 3.9 4.9 2.4 6.8 15.4 6.9 3.0 8.2 10.9 4.9 6.4 12.0 7.1 7.6 1.3 5.7 3.6 9.9 38.1 11.8 10.9 4.0 6.1 15.0 24.7 2.2 4.4 19.0 10.6 12.2 15.0 8.0 18.6 5.5 6.0 7.2 0.8 9.1 9.4 5.8 9.0 7.3 4.8 15.1 6.6 11.9 8.0 11.0 6.1 6.3 14.3 27.1 9.7 12.4 3.6 7.8 AVPI1 "PP5395, VIP32, VIT32" ENSG00000119986 "Arginine vasopressin induced 1" Q5T686 10 97677424-97687241 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 100.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 246.7;Granulosa cells: 385.5;Langerhans cells: 326.1;Late spermatids: 278.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 119.7;HHSteC: 119.1;hTCEpi: 230.5;SK-MEL-30: 194.5;U-2197: 134.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037649 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Plasma membrane" "HPA037649: AB_10671879" "unprognostic (4.57e-2)" "unprognostic (3.28e-2)" "unprognostic (3.04e-2)" "unprognostic (4.79e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-2)" "unprognostic (7.34e-3)" "unprognostic (8.56e-3)" "unprognostic (2.29e-3)" "unprognostic (1.23e-1)" "unprognostic (3.91e-3)" "unprognostic (4.04e-1)" "unprognostic (2.03e-1)" "unprognostic (8.66e-2)" "unprognostic (3.83e-3)" 32.1 41.5 18.5 6.5 25.4 5.0 21.2 21.9 23.2 38.1 16.2 24.6 14.0 11.2 4.7 26.2 18.9 10.4 22.4 18.3 19.8 12.1 46.9 22.5 2.4 23.7 20.2 85.6 9.4 5.6 19.2 16.9 21.9 26.3 18.9 25.5 22.7 16.6 12.5 100.7 15.6 5.3 22.4 20.8 30.5 16.0 20.8 2.0 9.1 3.9 4.4 25.5 46.0 29.5 38.8 99.8 0.5 14.3 20.2 9.1 20.0 18.5 100.7 25.0 37.5 18.8 47.2 0.8 13.0 10.5 18.0 40.0 7.6 32.3 9.4 1.0 8.9 2.6 119.7 52.6 119.1 2.6 3.0 14.6 230.5 18.7 49.1 22.8 3.4 3.6 5.7 2.0 14.0 33.4 1.7 3.1 3.5 10.6 9.3 1.3 11.3 1.5 24.9 20.9 1.7 4.0 63.9 22.7 194.5 3.2 17.2 3.1 5.5 5.9 11.7 134.4 4.6 4.4 3.3 0.8 22.2 8.1 3.8 0.0 6.2 2.3 4.2 5.7 2.0 2.8 2.8 3.1 11.1 2.0 3.0 3.7 0.5 2.0 0.5 2.3 2.6 2.9 18.5 25.4 21.9 23.2 18.3 19.8 23.7 20.2 21.9 22.4 20.8 29.5 6.3 19.2 19.0 0.7 8.0 96.0 87.6 246.7 145.1 9.6 13.6 16.8 9.7 52.9 63.4 38.6 6.2 149.6 15.4 137.5 43.0 18.8 60.9 33.2 17.1 11.4 31.8 2.1 3.6 24.1 64.8 23.4 58.1 57.9 6.3 385.5 34.2 42.4 41.8 13.5 4.3 70.4 48.8 21.7 326.1 278.5 10.2 49.6 83.6 0.0 6.4 128.2 2.1 0.5 4.4 43.3 100.6 14.7 5.9 55.2 109.0 11.2 16.7 14.6 6.6 10.2 19.3 3.5 4.9 68.0 108.4 194.7 19.0 10.9 100.6 106.3 MARVELD1 "bA548K23.8, FLJ22343, FLJ23440, GB14, MGC4415, MRVLDC1" ENSG00000155254 "MARVEL domain containing 1" Q9BSK0 10 97713173-97718150 "Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 86.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 3.2;intermediate monocyte: 2.7;myeloid DC: 3.1" "Group enriched" "Detected in many" 18 "dendritic cells: 3.1;monocytes: 3.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 141.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (3.28e-2)" "unprognostic (2.11e-2)" "unprognostic (1.26e-3)" "unprognostic (3.05e-2)" "unprognostic (1.36e-3)" "unprognostic (8.82e-2)" "unprognostic (7.40e-3)" "prognostic unfavorable (5.85e-5)" "unprognostic (1.54e-2)" "unprognostic (7.44e-3)" "unprognostic (3.40e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (8.89e-7)" "unprognostic (3.92e-3)" "unprognostic (7.02e-2)" "unprognostic (1.50e-1)" "unprognostic (3.86e-3)" 35.9 8.9 4.7 12.6 5.4 5.2 26.7 4.5 5.5 56.8 24.5 57.1 7.7 60.0 16.7 19.7 48.1 20.4 24.8 4.6 7.5 12.4 5.6 29.7 6.9 6.4 5.7 40.5 7.0 11.3 20.0 25.0 5.5 44.3 24.5 2.0 19.1 48.5 6.1 30.8 22.3 47.7 5.8 16.0 23.7 6.8 6.6 5.3 15.9 7.0 6.0 46.5 41.3 5.9 42.0 30.7 26.1 99.9 97.8 94.0 27.0 56.4 141.3 51.6 34.5 13.5 70.4 0.0 44.5 105.1 7.3 50.3 22.4 53.5 25.9 3.2 28.0 20.3 24.6 0.0 40.9 28.6 0.0 82.7 137.5 33.2 38.3 95.3 65.0 17.6 5.7 0.1 57.7 24.1 3.8 9.9 19.5 4.5 30.6 26.1 22.4 7.0 27.4 8.9 16.9 17.8 34.0 0.3 59.7 16.0 13.4 33.7 65.8 51.9 21.2 50.7 21.4 0.0 3.1 0.1 26.5 0.1 40.2 0.0 3.2 0.0 0.0 2.7 0.1 0.0 0.0 0.1 3.1 0.0 0.0 0.1 0.0 0.0 0.7 0.8 0.0 1.0 4.7 5.4 4.5 5.5 4.6 7.5 6.4 5.7 5.5 5.8 6.6 5.9 7.0 9.6 6.3 10.7 0.9 7.6 31.4 13.4 9.6 2.5 7.1 21.0 4.4 11.5 5.7 12.9 6.2 10.5 0.1 31.9 0.0 8.3 0.7 3.1 32.3 10.5 3.0 4.6 2.3 0.9 21.0 29.9 2.0 6.3 2.5 86.6 12.8 0.6 12.9 0.0 2.8 28.9 4.1 32.6 13.4 2.9 23.0 15.6 12.4 7.5 11.7 13.7 0.0 2.5 0.6 1.9 7.0 38.7 0.3 4.0 2.0 0.2 0.7 3.2 0.0 10.0 31.9 0.3 1.6 1.0 5.4 3.4 1.2 13.1 9.4 6.9 ZFYVE27 "FLJ32919, SPG33" ENSG00000155256 "Zinc finger FYVE-type containing 27" Q5T4F4 10 97737121-97760907 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037523, HPA069876" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Vesicles" Cytosol "HPA037523: AB_10672351, HPA069876: AB_2686218" "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.30e-2)" "unprognostic (2.48e-2)" "unprognostic (7.15e-2)" "unprognostic (2.05e-3)" "unprognostic (5.24e-2)" "unprognostic (3.38e-3)" "prognostic favorable (7.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.26e-2)" "prognostic favorable (7.80e-4)" 14.4 27.9 33.1 12.9 32.1 23.2 15.8 29.2 35.9 20.6 34.8 25.6 24.8 16.5 22.9 16.5 20.3 12.1 17.8 35.5 33.6 28.3 32.6 17.7 16.1 32.6 31.4 25.9 23.7 19.2 38.3 9.5 33.2 22.0 16.3 28.4 18.9 10.3 12.8 18.2 30.6 8.5 29.1 29.1 19.8 23.0 33.5 12.7 20.4 5.9 13.1 16.8 17.0 32.4 17.7 21.4 12.6 28.1 14.1 9.8 17.2 17.7 18.5 20.3 19.7 19.1 35.9 27.2 19.8 12.8 25.9 38.8 18.4 17.2 10.6 28.3 18.6 12.9 23.1 18.1 18.1 20.9 24.9 16.0 20.4 19.9 15.2 32.4 11.5 22.5 19.6 17.9 15.3 13.8 16.9 39.4 10.3 15.3 16.4 19.2 12.7 13.0 19.5 10.8 10.1 19.7 11.9 9.9 47.2 11.5 21.8 20.5 12.4 10.2 11.9 15.6 34.2 20.6 18.6 14.3 25.3 26.5 11.9 4.8 5.8 9.3 9.6 6.2 8.2 7.1 6.6 7.9 5.4 6.7 7.5 8.3 8.2 6.8 9.2 5.6 9.5 8.3 33.1 32.1 29.2 35.9 35.5 33.6 32.6 31.4 33.2 29.1 33.5 32.4 10.0 3.2 11.4 14.0 22.1 8.2 12.8 11.3 18.8 29.9 11.1 8.9 7.2 14.3 9.7 14.7 58.4 7.4 21.2 33.9 7.9 14.9 5.2 14.3 7.8 11.0 20.3 14.3 33.6 16.0 5.7 10.1 19.4 11.4 14.0 17.3 10.8 10.9 8.2 37.0 35.2 15.6 14.2 8.8 5.7 1.5 9.6 11.0 10.6 16.9 11.2 14.8 15.5 12.5 20.2 13.9 26.1 9.1 13.4 13.8 35.5 8.6 16.6 43.7 19.7 6.7 9.9 8.9 7.6 10.4 5.5 13.5 17.9 10.9 14.7 17.7 SFRP5 SARP3 ENSG00000120057 "Secreted frizzled related protein 5" Q5T4F7 10 97766751-97771999 "Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "choroid plexus: 98.7;heart muscle: 78.7;intestine: 36.4;pancreas: 143.2" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 273.1" "Cancer enriched" "Detected in many" 4 "pancreatic cancer: 30.4" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 4 "naive CD8 T-cell: 3.6" "Lineage enriched" "Detected in single" 4 "T-cells: 3.6" "Cell line enhanced" "Detected in some" "A549: 2.5;CACO-2: 12.4;RPMI-8226: 4.5;SCLC-21H: 2.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 8 "spinal cord: 120.7" "Secreted in other tissues" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 39: CACO-2 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (2.63e-4)" "unprognostic (3.03e-3)" "unprognostic (6.74e-2)" "unprognostic (3.43e-2)" "unprognostic (9.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" "unprognostic (3.19e-1)" "unprognostic (2.85e-1)" "unprognostic (8.83e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (4.51e-9)" "unprognostic (1.67e-2)" "unprognostic (1.57e-1)" "unprognostic (9.17e-2)" "unprognostic (1.62e-1)" 2.9 9.6 2.8 0.3 3.9 0.3 2.4 1.6 0.6 3.5 98.7 36.4 29.8 1.8 2.2 2.0 2.2 4.1 78.7 5.6 7.5 0.4 8.8 3.4 0.3 3.6 8.3 0.6 143.2 0.0 0.9 0.0 3.6 6.8 0.5 0.2 2.8 4.0 1.3 3.1 26.3 0.4 1.6 0.1 10.5 0.8 14.7 0.1 1.0 2.9 0.1 3.2 4.9 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 4.5 0.0 0.0 2.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.8 0.0 0.2 2.8 3.9 1.6 0.6 5.6 7.5 3.6 8.3 3.6 1.6 14.7 0.2 0.0 3.2 3.6 0.3 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 7.8 273.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.1 0.6 0.0 0.0 0.2 16.8 0.0 3.2 0.0 0.0 0.0 0.0 2.2 0.7 0.0 0.0 0.3 1.3 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.2 3.3 2.5 0.0 0.0 0.0 37.8 0.0 0.0 0.2 0.0 1.2 0.4 0.1 5.9 0.0 0.0 0.0 0.1 0.0 0.5 0.0 GOLGA7B "bA451M19.3, bA459F3.4, C10orf132, C10orf133" ENSG00000155265 "Golgin A7 family member B" Q2TAP0 10 97849843-97871580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.0;choroid plexus: 26.2;epididymis: 23.4" "Cell type enhanced" "Detected in many" "Astrocytes: 25.5;Excitatory neurons: 33.6;Inhibitory neurons: 21.2;Late spermatids: 16.6;Rod photoreceptor cells: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.3;GAMG: 14.5;HDLM-2: 5.7;SK-MEL-30: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046878 Uncertain NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA046878: AB_2679854" "unprognostic (7.90e-2)" "unprognostic (1.70e-3)" "unprognostic (7.10e-3)" "unprognostic (1.06e-2)" "unprognostic (8.97e-2)" "unprognostic (1.54e-1)" "unprognostic (6.20e-4)" "unprognostic (1.95e-1)" "unprognostic (4.45e-1)" "unprognostic (2.49e-1)" "unprognostic (8.89e-2)" "unprognostic (4.13e-2)" "unprognostic (1.15e-7)" "unprognostic (2.12e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-3)" "unprognostic (5.90e-3)" 1.2 2.3 28.7 0.8 30.7 0.2 1.1 33.9 36.0 1.0 26.2 1.1 1.5 0.2 23.4 2.6 0.4 0.4 5.6 32.9 28.0 0.2 0.6 0.7 1.4 29.2 29.2 0.1 8.0 0.0 9.3 0.2 27.5 0.5 0.5 16.9 0.7 0.5 4.6 14.5 2.0 0.1 25.1 0.5 1.0 1.3 29.8 0.3 0.9 3.2 1.1 0.6 2.0 30.0 5.3 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.1 0.0 14.5 1.9 0.0 0.4 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 1.0 0.3 0.0 1.8 0.1 0.1 0.3 0.8 1.4 0.0 1.0 22.6 0.0 2.1 0.1 0.1 0.1 0.0 0.0 0.2 1.7 0.8 0.0 3.9 2.3 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 28.7 30.7 33.9 36.0 32.9 28.0 29.2 29.2 27.5 25.1 29.8 30.0 0.2 0.0 0.5 25.5 0.0 12.5 0.1 0.7 0.0 6.4 0.6 4.4 2.3 12.8 0.2 1.8 2.1 0.0 3.2 0.3 0.0 6.4 5.4 0.3 0.4 0.5 12.0 0.0 33.6 4.3 0.0 0.6 0.0 0.4 0.0 0.0 0.4 0.0 5.1 3.3 21.2 1.1 0.0 0.0 1.2 16.6 0.3 0.2 7.2 5.6 0.6 3.2 3.1 2.5 1.9 7.4 0.1 0.4 0.0 0.3 1.2 0.0 0.0 18.7 0.0 1.5 0.3 3.9 2.3 0.0 5.1 0.0 2.9 0.0 0.4 0.3 CRTAC1 "ASPIC1, CEP-68, FLJ10320" ENSG00000095713 "Cartilage acidic protein 1" Q9NQ79 10 97865000-98030828 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.6;fallopian tube: 38.2;lung: 50.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 119.5;Club cells: 36.4;Inhibitory neurons: 63.6;Oligodendrocyte precursor cells: 54.8" "Cancer enhanced" "Detected in many" "melanoma: 43.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 3.0;HMC-1: 2.5;HUVEC TERT2: 7.1;SCLC-21H: 4.7;SK-MEL-30: 7.7;TIME: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008175 Enhanced "Secreted to extracellular matrix" NA NA 550000000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 11: Alveolar cells - Smell perception" "HPA008175: AB_1847254" "unprognostic (2.55e-1)" "unprognostic (6.41e-3)" "unprognostic (4.90e-3)" "prognostic unfavorable (5.01e-6)" "unprognostic (2.54e-1)" "unprognostic (6.96e-3)" "unprognostic (9.30e-2)" "unprognostic (9.13e-2)" "unprognostic (1.02e-2)" "unprognostic (3.01e-1)" "unprognostic (7.66e-2)" "unprognostic (1.69e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.70e-4)" "unprognostic (1.05e-2)" "unprognostic (3.29e-3)" "prognostic favorable (1.51e-4)" 4.4 0.8 8.7 1.1 23.7 0.0 2.4 10.9 20.1 6.4 0.9 11.5 0.5 1.3 3.8 8.3 38.2 0.3 10.6 9.1 8.1 4.3 0.4 50.0 0.4 45.1 10.2 0.7 1.3 0.8 5.3 0.0 45.6 2.3 0.4 11.3 3.4 33.6 1.1 4.1 2.3 0.8 12.6 0.1 1.8 3.9 18.5 0.2 4.7 1.5 0.3 30.2 4.9 15.5 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.7 0.0 3.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 4.7 1.1 0.5 0.0 7.7 0.3 0.0 0.0 9.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 23.7 10.9 20.1 9.1 8.1 45.1 10.2 45.6 12.6 18.5 15.5 1.9 22.4 119.5 2.9 0.0 1.5 2.7 1.3 5.7 10.1 2.6 2.8 7.1 1.5 36.4 9.2 0.0 0.0 0.1 0.0 0.0 4.6 0.1 0.5 0.1 8.8 1.8 0.0 22.9 0.7 0.0 2.3 0.0 0.6 5.1 0.0 5.7 0.1 0.0 0.0 63.6 0.0 0.0 0.6 0.9 0.6 0.0 0.2 8.8 2.8 0.0 14.1 0.0 54.8 6.2 0.6 0.0 0.4 1.2 1.3 0.0 0.0 0.9 5.3 0.0 3.5 0.3 1.5 1.9 13.1 0.4 0.0 0.4 0.0 0.0 1.7 R3HCC1L "C10orf28, GIDRP86, PSORT" ENSG00000166024 "R3H domain and coiled-coil containing 1 like" Q7Z5L2 10 98134624-98244897 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 51.5;Oligodendrocytes: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037367 Enhanced Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear speckles" "HPA037367: AB_10696930" "unprognostic (3.00e-1)" "unprognostic (2.55e-2)" "unprognostic (1.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.67e-2)" "unprognostic (7.04e-2)" "unprognostic (1.15e-3)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (6.00e-2)" "unprognostic (1.55e-1)" "unprognostic (1.74e-3)" "unprognostic (7.39e-2)" "unprognostic (3.12e-1)" "unprognostic (1.49e-1)" "unprognostic (1.43e-2)" 12.8 8.5 8.8 7.8 10.0 17.4 11.6 10.9 11.1 14.2 9.1 12.1 6.4 8.9 9.7 13.1 9.2 5.9 8.3 8.5 8.9 11.8 13.5 10.9 12.2 9.7 9.3 8.7 11.0 10.5 8.6 8.3 9.7 12.7 10.1 10.0 11.8 6.6 9.9 15.1 12.3 6.5 9.4 15.3 9.5 31.1 9.5 13.7 10.1 8.0 13.0 12.4 13.1 10.9 14.6 9.4 13.9 12.4 11.7 12.4 11.5 16.1 22.4 15.4 17.0 12.8 10.0 20.4 8.5 9.6 8.7 16.0 14.2 9.7 17.4 15.4 9.6 12.1 7.3 14.4 14.4 16.7 14.1 11.4 10.9 13.6 20.0 13.6 10.1 12.6 10.6 12.4 12.2 14.0 13.2 17.3 10.1 6.9 12.1 13.4 15.9 8.2 11.2 8.5 4.8 10.2 8.3 6.0 32.9 17.7 10.8 10.4 11.2 10.3 11.0 11.6 12.2 12.5 14.1 34.4 14.8 17.1 7.7 12.2 6.3 17.8 8.6 8.8 7.8 9.2 8.9 8.9 5.0 8.6 7.7 7.7 7.6 10.4 13.4 5.5 13.4 5.5 8.8 10.0 10.9 11.1 8.5 8.9 9.7 9.3 9.7 9.4 9.5 10.9 11.8 16.0 15.1 30.0 13.2 3.3 4.8 3.9 6.8 6.7 5.9 5.0 8.9 10.0 6.5 7.3 6.2 9.8 15.6 13.5 5.9 7.8 28.4 10.8 10.5 9.5 6.0 11.8 39.9 6.9 9.8 8.3 14.3 10.1 17.1 9.7 6.1 4.5 6.9 5.0 35.8 12.2 2.0 8.7 5.1 13.1 5.3 13.5 12.4 51.5 9.5 6.5 13.4 34.2 59.8 10.5 5.4 5.7 11.9 5.4 9.6 3.4 13.0 14.2 0.0 7.6 7.1 36.6 23.9 6.3 3.8 13.0 12.8 8.7 9.5 7.5 LOXL4 "FLJ21889, LOXC" ENSG00000138131 "Lysyl oxidase like 4" Q96JB6 10 98247690-98268194 "Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Basal respiratory cells: 141.0" "Cancer enhanced" "Detected in all" "melanoma: 44.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "BJ hTERT+: 249.7;CAPAN-2: 301.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033876, HPA037609" Approved Approved Vesicles "Secreted to extracellular matrix" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles "CAB033876: AB_2135101, HPA037609: AB_2675579" "unprognostic (9.91e-3)" "unprognostic (3.97e-2)" "unprognostic (1.81e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (7.71e-2)" "unprognostic (1.75e-2)" "unprognostic (8.38e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (9.57e-4)" "unprognostic (2.51e-1)" "unprognostic (4.97e-2)" "unprognostic (5.25e-2)" "unprognostic (5.77e-3)" "unprognostic (1.28e-1)" "unprognostic (6.10e-2)" "unprognostic (7.40e-3)" 8.2 2.4 0.7 1.6 0.9 0.5 11.9 1.1 0.7 11.8 2.3 10.4 1.9 7.0 3.0 2.0 7.8 1.8 3.0 0.8 1.2 6.6 6.0 4.4 0.4 1.3 1.3 7.1 6.6 1.2 1.9 5.8 1.3 6.6 1.8 2.6 19.6 10.8 8.3 4.0 3.2 7.6 1.0 2.7 2.9 5.5 1.0 1.4 7.0 1.5 0.7 5.0 7.4 1.0 0.0 1.6 0.1 0.3 6.9 29.5 0.9 32.1 249.7 2.6 26.6 5.4 301.6 0.1 28.4 25.1 1.1 0.3 0.1 0.0 2.2 0.0 0.2 0.0 4.4 13.3 6.7 0.0 0.0 3.3 0.0 4.4 0.0 0.4 0.1 0.0 0.3 0.0 0.4 0.0 0.0 2.3 0.6 0.1 0.5 0.1 2.9 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 8.7 0.2 0.7 0.7 0.2 53.7 3.2 1.1 0.0 0.0 0.2 0.5 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.7 0.9 1.1 0.7 0.8 1.2 1.3 1.3 1.3 1.0 1.0 1.0 0.3 6.4 1.5 0.7 0.3 0.9 2.1 141.0 0.0 0.4 6.5 6.5 1.6 4.3 17.5 31.3 0.0 0.2 1.7 0.1 0.0 11.1 0.3 1.5 1.2 0.9 0.0 0.0 0.1 0.5 0.4 6.0 0.0 4.2 1.3 1.1 2.2 0.4 0.2 0.0 0.1 0.2 8.2 0.0 2.1 0.4 4.1 0.2 0.0 9.4 0.0 5.4 0.0 0.0 0.0 3.0 0.0 1.5 0.3 7.9 0.0 0.4 6.3 0.1 0.0 5.2 2.2 0.1 0.2 0.1 0.9 0.4 0.2 0.7 0.0 3.4 PYROXD2 "C10orf33, FLJ23849" ENSG00000119943 "Pyridine nucleotide-disulphide oxidoreductase domain 2" Q8N2H3 10 98383565-98415182 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "eosinophil: 189.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 189.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 46.1;U-937: 31.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037566, HPA037567, HPA067394" Approved Approved Mitochondria NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA037566: AB_10670385, HPA037567: AB_2675550, HPA067394: AB_2685832" "unprognostic (2.35e-2)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.41e-2)" "unprognostic (1.10e-3)" "unprognostic (6.76e-2)" "unprognostic (1.27e-2)" "unprognostic (3.38e-2)" "unprognostic (2.69e-1)" "unprognostic (3.34e-1)" "unprognostic (2.20e-1)" "unprognostic (1.63e-1)" "unprognostic (9.05e-2)" "unprognostic (2.74e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-2)" "prognostic favorable (3.37e-4)" 10.2 14.5 6.4 2.2 6.9 2.6 8.4 6.7 7.8 9.1 9.6 7.2 2.0 5.5 8.3 2.5 9.4 4.2 10.7 6.3 6.4 6.3 12.2 4.3 2.6 7.3 7.1 9.2 3.5 2.8 4.7 4.2 7.4 10.5 4.7 0.7 22.4 4.1 9.3 2.9 3.7 5.7 7.0 5.1 5.3 3.7 7.1 2.3 8.6 10.4 1.4 9.7 6.3 8.0 3.6 8.9 4.9 0.2 7.6 15.1 1.9 5.8 18.0 3.2 6.1 0.0 12.3 0.0 10.2 6.2 0.9 1.8 1.5 2.0 3.3 0.3 1.4 7.3 16.1 0.8 9.7 0.1 16.2 8.9 2.6 2.6 3.1 46.1 2.5 3.4 0.2 0.2 4.9 11.1 0.2 17.2 1.4 7.0 3.0 2.3 1.9 0.1 4.7 5.5 0.3 0.1 6.4 0.8 4.6 6.7 5.1 8.1 3.3 0.0 3.6 1.1 5.9 1.2 0.8 0.0 5.7 31.5 0.5 5.4 0.3 189.8 6.1 0.0 1.3 0.0 2.1 5.2 1.9 0.2 1.2 3.6 0.3 44.5 0.0 0.3 0.6 1.8 6.4 6.9 6.7 7.8 6.3 6.4 7.3 7.1 7.4 7.0 7.1 8.0 3.8 9.6 5.1 19.9 1.3 0.5 6.1 9.7 4.0 0.4 15.0 18.4 11.2 5.7 9.5 1.8 0.0 5.6 6.5 3.5 7.9 3.8 0.2 4.1 4.9 4.6 1.2 1.7 3.4 2.4 3.8 7.2 11.2 3.2 2.5 11.2 4.6 2.9 9.8 0.0 4.3 4.9 8.2 3.2 6.6 0.9 3.4 2.0 1.8 5.6 1.8 2.3 19.6 1.5 9.5 1.7 1.6 3.8 0.5 2.7 2.2 12.1 12.2 0.8 6.6 9.7 5.9 2.9 1.5 0.8 0.6 1.8 5.4 17.8 6.3 10.0 HPS1 "BLOC3S1, HPS" ENSG00000107521 "HPS1 biogenesis of lysosomal organelles complex 3 subunit 1" Q92902 10 98416198-98446935 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Guanine-nucleotide releasing factor" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061260 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 18: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA061260: AB_2684459" "unprognostic (1.31e-1)" "prognostic favorable (3.37e-5)" "unprognostic (8.95e-2)" "prognostic favorable (2.93e-5)" "prognostic unfavorable (6.54e-4)" "unprognostic (2.19e-1)" "unprognostic (9.38e-3)" "prognostic favorable (1.26e-4)" "unprognostic (2.39e-1)" "unprognostic (2.44e-3)" "unprognostic (5.64e-3)" "unprognostic (2.24e-1)" "unprognostic (1.76e-1)" "unprognostic (4.74e-2)" "unprognostic (1.84e-1)" "unprognostic (3.06e-2)" "unprognostic (8.30e-3)" 16.8 22.2 12.9 13.4 12.7 37.2 15.3 12.0 15.2 15.6 14.5 18.7 18.4 14.1 6.2 14.1 13.9 13.9 13.2 13.4 12.7 16.3 19.9 16.4 21.3 13.5 12.9 12.3 21.8 6.2 13.4 8.9 13.3 16.1 9.1 2.1 20.4 10.4 7.3 16.2 24.4 7.9 12.6 25.2 18.4 12.8 14.2 10.7 12.7 3.3 12.1 16.3 14.1 12.4 16.9 15.3 1.2 20.6 16.6 19.6 9.4 13.4 43.4 14.3 22.0 10.5 14.7 17.4 16.6 16.3 19.8 20.1 7.7 7.6 6.5 31.4 17.4 27.1 10.0 20.5 37.7 22.0 50.6 21.9 21.1 15.3 19.5 16.7 18.1 11.3 12.0 29.5 15.1 24.0 8.0 18.4 4.2 11.8 9.4 12.8 0.0 12.7 16.6 19.0 3.2 12.3 9.7 7.2 27.6 7.9 16.9 23.5 28.9 10.8 13.8 23.8 14.5 17.3 12.3 12.9 33.0 35.4 12.6 20.2 19.3 36.5 11.3 27.5 11.4 12.4 8.9 10.3 22.6 12.4 6.1 7.4 13.5 16.9 27.4 16.0 14.6 13.6 12.9 12.7 12.0 15.2 13.4 12.7 13.5 12.9 13.3 12.6 14.2 12.4 16.8 19.2 23.8 17.6 49.9 22.3 48.2 40.8 46.1 3.7 40.5 43.9 24.2 28.6 30.2 23.9 2.1 28.3 33.7 72.0 19.6 50.7 33.5 12.4 18.3 18.5 27.1 83.9 11.4 50.3 29.7 27.9 43.8 14.1 29.8 11.6 28.9 26.6 80.6 0.0 14.1 37.5 22.4 62.6 48.7 56.8 27.7 57.4 35.6 12.2 78.6 17.8 60.8 5.5 18.1 60.5 83.0 26.7 43.7 47.7 80.7 59.3 14.7 3.1 13.1 22.3 22.4 28.6 9.5 33.3 18.0 24.6 39.7 41.3 33.1 69.2 HPSE2 "HPA2, HPR2, UFS" ENSG00000172987 "Heparanase 2 (inactive)" Q8WWQ2 10 98457077-99235862 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.6;cervix: 36.7;vagina: 27.6" "Cell type enriched" "Detected in some" 9 "Astrocytes: 900.7" "Cancer enhanced" "Detected in some" "prostate cancer: 4.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "BJ hTERT+: 10.2;HEL: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA044603 Uncertain "Secreted to extracellular matrix" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 57: Non-specific - Angiogenesis" "Cluster 36: HEL - Hemostasis" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA044603: AB_10794051" "unprognostic (2.44e-1)" "unprognostic (4.28e-3)" "unprognostic (4.83e-3)" "unprognostic (6.00e-2)" "unprognostic (1.15e-1)" "unprognostic (1.59e-1)" "unprognostic (3.05e-2)" "unprognostic (1.82e-2)" "unprognostic (4.03e-2)" "unprognostic (7.94e-2)" "unprognostic (1.38e-1)" "unprognostic (2.02e-1)" "unprognostic (1.86e-4)" "unprognostic (5.79e-2)" "unprognostic (2.51e-1)" "unprognostic (9.39e-3)" "unprognostic (6.13e-3)" 2.0 0.0 9.9 2.0 20.9 0.0 5.2 15.4 7.6 36.7 3.6 2.9 2.7 4.5 0.0 14.3 1.8 1.4 0.1 5.8 21.1 3.5 0.0 2.2 0.0 23.2 29.6 0.2 0.0 0.0 0.3 1.5 21.5 11.1 3.0 0.0 2.4 4.2 0.3 3.2 5.2 1.7 16.5 0.0 4.6 2.7 28.5 0.1 0.1 3.0 0.4 18.3 27.6 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 10.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 20.9 15.4 7.6 5.8 21.1 23.2 29.6 21.5 16.5 28.5 11.9 0.3 0.0 0.0 900.7 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.4 24.8 0.3 0.0 0.0 6.4 0.0 0.0 4.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 97.3 0.2 0.0 0.0 0.0 48.6 0.3 0.0 0.0 40.3 0.0 0.0 0.0 16.6 4.6 0.0 0.0 0.4 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.9 1.9 11.5 2.1 0.0 0.1 0.0 0.2 0.8 0.0 0.7 CNNM1 ACDP1 ENSG00000119946 "Cyclin and CBS domain divalent metal cation transport mediator 1" Q9NRU3 10 99329356-99394330 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7;testis: 9.8" "Cell type enhanced" "Detected in many" "Early spermatids: 103.1;Excitatory neurons: 69.9;Horizontal cells: 50.5;Inhibitory neurons: 89.5;Late spermatids: 88.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 19.6;BJ hTERT+: 7.4;BJ hTERT+ SV40 Large T+ RasG12V: 11.3;HAP1: 8.7;OE19: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040408 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane, Cytosol" "HPA040408: AB_10793963" "unprognostic (9.04e-4)" "unprognostic (2.93e-1)" "unprognostic (1.70e-1)" "unprognostic (7.60e-4)" "unprognostic (4.08e-3)" "unprognostic (9.51e-2)" "unprognostic (6.01e-2)" "unprognostic (2.27e-2)" "unprognostic (6.03e-2)" "unprognostic (1.94e-1)" "unprognostic (3.09e-2)" "unprognostic (2.45e-1)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (4.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.03e-1)" 0.2 1.1 9.9 0.2 9.9 0.0 0.5 5.4 16.7 1.8 0.0 0.7 0.4 0.9 1.7 0.8 1.0 0.3 0.1 7.3 7.3 1.7 0.2 0.1 0.0 3.6 2.9 2.6 1.1 0.6 3.6 0.0 3.5 1.7 0.4 5.2 0.8 0.8 0.0 1.2 0.6 0.4 2.0 0.1 0.6 9.8 4.7 0.1 0.1 0.1 0.1 1.7 1.4 10.1 0.0 19.6 0.0 0.0 0.0 0.0 0.0 2.8 7.4 6.7 11.3 0.0 4.4 0.0 0.0 1.4 0.1 1.7 8.7 0.0 4.8 0.0 0.9 1.9 2.8 3.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.4 2.7 0.3 0.0 0.9 7.7 0.8 0.0 0.0 0.0 0.9 0.0 2.2 6.1 2.0 0.4 1.0 0.5 0.0 0.0 0.0 0.6 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 9.9 5.4 16.7 7.3 7.3 3.6 2.9 3.5 2.0 4.7 10.1 0.6 0.0 0.0 4.6 0.0 2.3 3.3 0.1 5.2 25.3 0.7 2.8 1.4 0.0 0.2 1.8 14.6 0.0 0.0 0.0 0.0 0.6 103.1 0.5 1.0 0.4 0.0 0.8 69.9 1.5 0.0 1.0 0.0 0.3 0.0 0.2 1.8 0.0 0.0 50.5 89.5 0.1 0.0 0.0 0.8 88.0 2.1 0.3 1.8 4.7 0.1 1.3 0.0 10.6 2.2 2.0 0.3 2.6 0.0 5.9 0.1 0.7 0.6 3.4 0.0 2.0 0.5 1.9 1.6 1.5 1.0 0.0 0.2 1.2 0.1 2.4 GOT1 AST1 ENSG00000120053 "Glutamic-oxaloacetic transaminase 1" P17174 10 99396870-99430624 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Amino-acid biosynthesis" "Aminotransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 511.1;liver: 369.5;skeletal muscle: 489.9;tongue: 1011.6" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 449.0;Distal tubular cells: 240.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064532, HPA072629" Enhanced Supported Nucleoplasm,Cytosol NA Yes 100000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "HPA064532: AB_2685279, HPA072629: AB_2686540" "unprognostic (6.40e-2)" "prognostic favorable (6.23e-4)" "unprognostic (5.99e-2)" "unprognostic (2.84e-2)" "unprognostic (2.82e-1)" "unprognostic (2.96e-2)" "unprognostic (5.25e-2)" "unprognostic (1.08e-3)" "unprognostic (6.67e-2)" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (1.79e-1)" "prognostic favorable (3.72e-13)" "unprognostic (1.93e-2)" "unprognostic (4.23e-1)" "unprognostic (6.85e-2)" "unprognostic (1.00e-1)" 14.7 54.9 67.8 14.7 71.1 8.0 22.7 70.3 119.1 53.1 82.6 50.9 62.0 13.1 25.9 42.7 17.9 49.0 511.1 70.0 77.6 143.1 369.5 15.5 14.1 83.5 55.0 18.1 34.0 142.4 22.5 14.4 83.7 22.7 59.2 106.2 48.6 27.4 489.9 23.9 45.8 21.4 48.4 16.9 58.9 33.6 69.1 17.7 47.7 1011.6 30.3 22.3 21.0 70.1 73.7 40.3 46.0 114.4 35.1 30.7 127.1 58.9 108.7 101.8 109.8 89.9 56.4 71.9 20.4 50.2 89.2 88.6 107.1 78.9 105.8 25.7 46.7 28.1 46.7 114.3 184.9 77.9 44.0 47.3 82.5 86.9 228.4 69.5 49.5 48.6 71.1 106.2 65.4 64.9 42.5 56.5 29.2 118.7 56.1 45.5 44.4 72.8 173.7 37.5 19.6 28.7 44.8 59.3 222.6 66.8 115.7 27.1 23.3 25.4 56.3 28.0 68.7 76.8 99.7 74.3 65.4 40.8 34.1 4.0 8.7 6.8 19.7 25.8 18.4 17.6 21.5 20.7 21.9 21.2 15.6 22.7 0.8 20.5 31.5 36.4 27.6 15.6 67.8 71.1 70.3 119.1 70.0 77.6 83.5 55.0 83.7 48.4 69.1 70.1 10.3 16.0 16.2 26.1 38.8 11.9 41.8 82.7 24.5 95.6 18.8 21.2 449.0 72.9 34.4 73.5 62.6 35.9 10.7 62.1 240.7 51.9 166.7 17.8 9.3 16.7 19.7 39.5 47.4 30.8 18.1 23.5 76.9 21.5 31.8 20.2 17.2 191.8 31.6 75.7 63.3 45.3 54.9 12.4 6.9 24.1 11.1 13.0 49.8 13.1 10.5 36.6 6.2 21.1 37.2 27.6 34.4 14.3 22.4 13.1 97.0 163.3 27.9 76.5 13.1 15.2 20.5 116.7 10.4 40.9 10.4 55.1 14.6 47.0 66.4 42.3 NKX2-3 "CSX3, NKX2.3, NKX2C, NKX4-3" ENSG00000119919 "NK2 homeobox 3" Q8TAU0 10 99532942-99536524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 38.9;lymphoid tissue: 31.4;salivary gland: 15.7" "Group enriched" "Detected in some" 4 "Endothelial cells: 2.2;Hepatic stellate cells: 4.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.7;REH: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA047561 Uncertain Uncertain Nucleoli,Cytosol NA NA "Cluster 14: B-cells - Humoral immune response" "Cluster 14: REH - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoli, Cytosol" "HPA047561: AB_2680088" "unprognostic (5.70e-2)" "unprognostic (2.95e-1)" "unprognostic (2.70e-4)" "unprognostic (6.34e-3)" "unprognostic (3.92e-2)" "unprognostic (7.40e-2)" "unprognostic (1.20e-1)" "unprognostic (4.91e-2)" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" 1.4 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 38.9 11.5 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 4.9 0.0 15.7 0.0 0.0 0.0 22.4 3.6 0.0 31.4 2.5 0.1 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 SLC25A28 "MRS3/4, MRS4L" ENSG00000155287 "Solute carrier family 25 member 28" Q96A46 10 99610522-99620609 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 148.9;Late spermatids: 390.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (2.87e-3)" "prognostic favorable (2.18e-6)" "unprognostic (8.59e-3)" "unprognostic (6.86e-2)" "unprognostic (4.29e-1)" "unprognostic (1.43e-2)" "unprognostic (3.39e-2)" "unprognostic (9.90e-2)" "unprognostic (1.47e-1)" "unprognostic (1.40e-2)" "unprognostic (9.80e-3)" "unprognostic (2.77e-2)" "prognostic unfavorable (7.28e-5)" "unprognostic (1.12e-1)" "unprognostic (2.68e-1)" "unprognostic (1.11e-1)" "unprognostic (7.62e-3)" 55.6 74.0 107.1 32.8 110.6 86.0 51.1 104.4 125.4 60.1 98.7 82.0 22.9 46.9 46.4 70.5 59.0 24.9 69.2 106.6 108.9 53.6 96.7 73.4 41.6 108.5 112.8 60.9 66.0 32.4 55.7 28.2 109.0 78.6 33.7 54.4 51.7 45.7 100.3 58.8 56.3 35.8 105.8 80.4 58.5 90.2 107.8 30.9 48.6 45.4 37.8 89.8 62.9 111.9 28.7 28.5 17.8 42.8 32.3 40.1 18.1 33.8 40.4 45.2 37.0 22.4 35.2 36.9 19.9 30.8 20.5 47.6 22.1 31.6 27.8 27.5 28.3 16.3 46.4 23.9 31.8 29.3 21.6 33.9 46.0 29.4 58.1 58.9 32.4 32.1 11.7 27.9 23.5 39.6 25.4 66.1 4.2 23.1 21.9 31.9 21.2 20.6 30.0 31.1 11.9 14.9 19.2 20.7 25.4 23.1 37.3 28.8 19.9 27.6 19.0 36.9 41.0 22.8 15.5 18.3 26.5 55.8 11.7 0.0 1.4 4.0 2.7 1.3 1.2 1.7 1.9 1.6 2.1 1.6 1.4 1.2 1.2 1.6 1.3 5.8 2.4 0.7 107.1 110.6 104.4 125.4 106.6 108.9 108.5 112.8 109.0 105.8 107.8 111.9 30.4 12.8 11.0 37.2 11.8 25.4 16.4 17.5 4.6 30.7 12.5 14.1 19.7 15.7 7.3 5.5 20.9 21.0 18.3 9.2 7.9 3.8 148.9 11.1 13.6 17.1 4.2 4.8 34.1 8.0 8.7 15.8 4.1 13.2 6.3 36.2 9.7 19.1 9.8 43.7 34.0 11.9 6.1 9.2 20.0 390.1 12.8 16.2 19.6 20.6 10.6 29.0 8.2 28.6 36.3 6.3 9.6 18.0 10.6 31.1 7.2 8.3 4.0 29.2 13.1 20.5 15.6 63.4 9.2 13.6 27.4 14.5 12.2 58.2 11.4 20.6 ENTPD7 "FLJ30978, LALP1" ENSG00000198018 "Ectonucleoside triphosphate diphosphohydrolase 7" Q9NQZ7 10 99659509-99711241 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 14.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 17.5;Urothelial cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014351 Uncertain Approved Nucleoplasm NA NA 65000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA014351: AB_1848183" "unprognostic (1.82e-1)" "unprognostic (7.26e-2)" "unprognostic (1.11e-2)" "unprognostic (6.01e-3)" "unprognostic (6.22e-2)" "unprognostic (3.32e-3)" "unprognostic (9.35e-2)" "unprognostic (3.77e-3)" "unprognostic (3.83e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "unprognostic (1.22e-1)" "unprognostic (2.99e-2)" "unprognostic (3.39e-1)" 1.8 3.7 0.4 4.2 0.5 7.0 2.2 1.7 0.7 3.2 3.9 3.7 14.6 2.1 2.2 4.4 1.8 4.5 1.3 0.7 0.2 2.7 6.3 1.9 2.2 0.3 0.4 1.0 6.9 2.9 1.7 6.5 0.2 2.7 3.8 2.7 2.9 2.3 0.5 2.9 14.6 2.7 0.3 2.1 3.9 1.4 0.3 1.6 2.2 0.4 2.7 10.2 2.6 0.5 5.4 5.9 8.0 14.4 4.0 3.6 8.4 10.0 19.1 11.4 9.2 11.1 5.2 4.8 5.4 14.0 3.6 13.6 6.0 4.0 9.6 2.3 5.6 4.0 4.4 11.2 5.8 13.4 7.8 3.5 6.7 14.1 15.3 14.1 11.8 5.1 6.1 4.7 4.8 4.6 2.6 3.9 4.7 6.0 2.4 0.3 6.2 2.4 15.8 16.7 3.4 6.9 6.7 2.7 9.5 5.4 7.1 5.9 8.5 11.0 6.2 7.0 8.4 4.7 7.3 4.1 11.0 4.4 2.7 0.3 0.6 0.9 0.6 0.7 0.5 0.2 0.3 0.5 1.3 0.1 0.4 0.3 0.5 0.8 0.4 2.3 0.2 0.3 0.4 0.5 1.7 0.7 0.7 0.2 0.3 0.4 0.2 0.3 0.3 0.5 1.2 0.0 0.0 2.9 1.3 8.2 17.5 4.6 10.8 0.7 2.0 1.1 0.8 1.5 2.2 5.5 2.1 6.3 3.2 3.7 0.0 2.3 1.5 6.0 2.8 1.7 5.4 1.3 9.5 5.0 5.3 2.4 9.2 5.3 0.0 0.7 0.7 4.7 1.9 0.0 7.9 4.2 0.0 0.6 2.7 2.7 0.9 2.6 0.0 6.5 4.9 0.4 0.0 10.1 3.2 4.5 3.1 0.7 7.6 2.6 11.4 1.3 3.6 1.9 0.0 1.1 1.7 1.2 0.8 6.9 7.4 5.1 1.2 3.9 2.4 23.6 CUTC CGI-32 ENSG00000119929 "CutC copper transporter" Q9NTM9 10 99702558-99756134 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "skeletal muscle: 385.5;tongue: 204.2" "Cell type enriched" "Detected in all" 4 "Spermatocytes: 163.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038619, HPA058231" Enhanced Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Cluster 5: Granulocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 32: U-937 - Innate immune response" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Cytosol" Nucleoli "HPA038619: AB_10672649, HPA058231: " "unprognostic (1.25e-2)" "unprognostic (5.92e-2)" "unprognostic (2.70e-1)" "unprognostic (8.66e-2)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (3.55e-3)" "unprognostic (8.67e-2)" "unprognostic (5.36e-2)" "unprognostic (1.81e-1)" "unprognostic (5.87e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.81e-7)" "unprognostic (1.00e-1)" "unprognostic (3.42e-2)" "unprognostic (2.41e-1)" "unprognostic (3.97e-1)" 38.7 15.5 19.3 14.6 21.9 23.6 27.3 20.8 25.9 17.3 17.3 19.4 11.1 14.7 11.0 16.0 17.1 12.1 41.7 18.7 20.7 13.5 30.2 15.1 22.3 21.0 20.6 12.6 14.2 8.6 7.8 11.3 21.3 16.1 15.9 28.3 16.9 11.2 385.5 18.6 20.9 14.4 20.1 28.6 18.6 43.4 20.3 23.9 13.2 204.2 19.7 43.8 16.7 25.0 27.4 57.7 19.9 60.7 71.8 32.8 10.8 22.0 28.0 21.6 24.2 26.7 20.5 98.9 19.1 37.5 10.6 22.9 40.8 36.6 23.9 29.5 39.0 32.9 26.1 42.7 33.2 61.5 15.5 34.0 22.3 34.5 71.1 26.8 37.8 56.2 29.6 21.4 16.4 19.4 55.7 63.2 20.0 27.7 21.4 37.5 23.3 38.3 22.8 11.2 6.5 14.8 10.1 15.9 28.9 27.1 25.3 34.7 21.2 9.0 12.2 9.9 29.5 34.7 48.5 69.6 29.4 130.0 8.2 70.6 42.6 111.7 56.9 35.2 60.0 73.4 53.9 54.9 47.1 66.5 74.4 57.2 68.6 63.1 46.0 54.2 57.0 45.3 19.3 21.9 20.8 25.9 18.7 20.7 21.0 20.6 21.3 20.1 20.3 25.0 26.3 9.6 12.5 15.3 32.8 12.1 14.7 23.1 5.7 18.7 12.6 15.2 40.6 14.3 14.9 5.5 8.4 18.6 23.2 4.6 21.5 16.9 12.6 11.4 12.0 19.8 12.1 28.2 8.5 17.4 13.5 32.8 10.7 8.3 30.4 14.4 27.5 23.4 20.9 11.8 9.0 7.4 12.2 17.0 11.7 10.8 13.1 16.6 30.2 7.5 28.0 25.9 21.6 8.0 26.9 10.5 7.4 16.1 27.2 16.1 19.2 34.8 21.5 33.0 19.7 27.1 15.5 163.3 36.7 14.3 10.9 13.5 25.6 36.3 9.6 11.6 COX15 CEMCOX2 ENSG00000014919 "Cytochrome c oxidase assembly homolog COX15" Q7KZN9 10 99710868-99732127 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037727, HPA037728, HPA066096" Uncertain Supported Nucleoplasm,Mitochondria NA NA "Cluster 38: Basophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Nucleoplasm "HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: AB_2685616" "unprognostic (9.74e-2)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (6.55e-3)" "unprognostic (1.50e-2)" "unprognostic (1.34e-1)" "unprognostic (5.36e-2)" "unprognostic (2.96e-1)" "unprognostic (6.84e-2)" "unprognostic (1.76e-1)" "unprognostic (3.40e-2)" "unprognostic (8.34e-2)" "prognostic favorable (9.21e-6)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-2)" "unprognostic (3.40e-2)" 15.0 31.2 12.9 9.7 13.3 6.6 13.8 12.9 16.4 16.7 14.3 17.1 12.6 15.6 14.2 18.8 15.2 10.4 21.3 12.7 12.7 21.1 23.4 11.4 13.7 12.4 12.9 19.0 16.2 14.6 16.2 10.8 13.0 14.5 16.0 15.3 14.2 11.0 34.5 14.7 15.6 10.9 12.7 17.8 16.2 12.0 13.6 13.4 13.6 27.2 16.1 19.6 15.0 14.1 22.7 50.3 19.6 42.9 28.4 22.4 15.9 16.9 22.1 25.0 23.9 37.6 30.2 42.8 26.6 15.4 15.6 32.1 44.2 25.7 26.5 19.2 21.0 25.1 23.5 39.6 30.0 33.5 22.3 23.3 23.9 27.7 40.9 36.6 26.3 36.1 27.3 29.6 24.2 24.8 24.7 27.6 21.0 22.1 22.0 30.2 29.5 27.9 24.8 16.6 16.7 26.4 29.9 16.6 29.5 15.7 61.2 13.2 22.1 12.4 17.1 18.7 25.6 25.2 36.2 28.5 22.7 53.2 10.7 19.6 12.8 12.4 7.4 15.2 8.8 12.7 8.6 8.4 13.9 11.3 8.6 8.9 7.9 8.7 18.5 5.7 9.9 9.7 12.9 13.3 12.9 16.4 12.7 12.7 12.4 12.9 13.0 12.7 13.6 14.1 11.4 22.4 8.4 32.0 14.1 6.1 10.3 13.2 12.0 14.7 14.2 11.2 25.2 14.3 15.9 14.7 10.4 23.7 9.0 16.5 29.4 17.6 1.9 14.0 15.4 10.8 17.5 9.4 18.7 15.8 20.7 9.6 11.7 14.6 2.5 21.5 7.9 27.2 17.4 13.5 23.7 13.4 6.1 27.4 8.6 1.9 10.5 14.7 12.4 12.2 18.5 13.4 13.4 16.6 26.1 13.2 11.9 10.1 9.0 7.5 16.5 24.5 27.7 15.5 0.0 11.0 9.4 10.1 9.5 12.2 9.2 22.7 10.3 35.8 16.6 9.3 ABCC2 "CMOAT, cMRP, DJS, MRP2" ENSG00000023839 "ATP binding cassette subfamily C member 2" Q92887 10 99782640-99852594 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.2;liver: 121.7" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 70.7" "Cancer enriched" "Detected in many" 5 "liver cancer: 24.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "A549: 204.4;Hep G2: 208.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071145 Enhanced NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "HPA071145: " "unprognostic (1.49e-3)" "unprognostic (5.92e-2)" "unprognostic (1.59e-1)" "unprognostic (3.67e-1)" "unprognostic (1.93e-2)" "unprognostic (2.33e-1)" "unprognostic (2.51e-1)" "unprognostic (7.15e-3)" "unprognostic (5.68e-2)" "unprognostic (2.01e-1)" "unprognostic (4.30e-1)" "unprognostic (1.40e-3)" "prognostic unfavorable (1.93e-5)" "unprognostic (1.31e-1)" "unprognostic (3.22e-2)" "unprognostic (2.95e-1)" "unprognostic (1.26e-2)" 1.6 0.4 0.2 0.7 0.4 0.8 3.0 0.5 0.3 0.5 0.1 0.6 39.1 0.4 0.2 0.3 0.7 24.4 0.2 0.3 0.2 18.5 121.7 0.5 0.7 0.4 0.3 0.3 1.1 0.1 0.1 0.5 0.4 0.4 0.4 3.9 0.5 0.2 1.1 1.7 40.2 0.2 0.2 1.4 0.7 0.7 0.3 0.8 0.4 0.7 0.5 1.3 0.5 0.6 0.3 204.4 3.5 10.2 15.3 12.0 3.4 0.5 1.3 0.5 0.6 44.6 0.3 0.4 0.3 0.7 0.5 1.3 0.3 0.4 0.6 0.5 0.3 0.0 1.0 208.7 0.5 0.3 0.7 1.9 13.9 1.5 1.4 0.2 0.4 0.6 0.0 0.3 0.2 1.0 0.2 1.4 0.3 39.8 0.3 0.3 0.2 0.4 1.4 0.3 0.1 0.2 0.5 3.4 25.9 0.4 0.1 0.4 0.7 0.6 0.6 0.9 0.6 0.8 0.1 0.2 16.1 1.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.3 0.3 0.2 0.4 0.3 0.4 0.2 0.3 0.6 0.7 0.0 0.0 2.3 0.4 0.0 0.2 0.2 0.0 0.3 0.1 0.0 0.5 1.5 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 2.6 2.9 0.2 0.3 0.0 0.4 1.0 0.4 0.0 1.7 0.0 0.6 1.3 0.1 1.4 70.7 0.2 0.0 1.3 0.6 0.0 1.0 0.0 1.1 0.3 0.4 5.4 1.9 0.3 0.1 0.0 1.0 2.2 0.1 0.0 0.0 0.1 0.2 15.5 10.7 2.8 1.5 0.0 0.4 0.5 1.2 0.7 0.1 0.0 1.6 0.4 0.1 0.4 0.0 DNMBP "ARHGEF36, KIAA1010, Tuba" ENSG00000107554 "Dynamin binding protein" Q6XZF7 10 99875577-100009947 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 75.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037878, HPA058216" Uncertain Approved "Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 41: Macrophages - Immune response" "Nucleoli, Golgi apparatus, Cytosol" "Nuclear bodies" "HPA037878: AB_10675622, HPA058216: AB_2683640" "unprognostic (3.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.95e-6)" "unprognostic (3.92e-2)" "unprognostic (4.13e-1)" "unprognostic (9.79e-2)" "unprognostic (4.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.02e-1)" "unprognostic (8.67e-3)" "unprognostic (4.03e-2)" "unprognostic (5.07e-3)" "unprognostic (6.52e-2)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "prognostic favorable (6.15e-4)" 13.6 6.0 3.6 5.5 3.7 10.3 10.2 6.2 5.3 15.8 8.6 17.7 22.5 9.6 12.5 10.2 11.3 11.0 7.5 4.7 4.2 20.6 13.1 8.4 4.6 3.7 3.6 11.5 17.6 31.7 3.9 10.5 3.8 8.9 20.7 15.8 8.4 12.8 13.4 27.4 27.2 8.8 3.0 7.7 23.8 6.9 5.2 20.1 8.1 11.1 5.2 19.8 17.7 3.1 25.7 20.7 18.4 29.2 32.9 27.4 4.4 45.2 43.6 21.5 20.7 14.2 38.0 26.6 18.9 34.9 11.8 19.9 21.6 26.1 29.9 1.4 6.7 3.8 23.7 10.0 17.1 2.6 1.8 13.0 5.7 26.6 23.4 75.5 52.1 8.5 3.6 0.0 44.1 3.2 4.5 5.1 17.7 18.0 12.3 5.5 18.7 1.4 36.6 21.9 3.1 4.2 7.4 1.9 5.7 25.3 1.5 2.4 63.4 16.0 15.3 13.1 29.8 2.1 1.7 36.3 15.2 8.4 12.2 0.0 0.8 0.2 0.7 1.2 0.7 1.2 0.1 0.4 0.3 1.9 0.1 0.3 0.7 2.1 1.2 0.3 0.0 0.6 3.6 3.7 6.2 5.3 4.7 4.2 3.7 3.6 3.8 3.0 5.2 3.1 6.8 9.6 11.0 11.1 14.8 35.1 7.2 5.0 5.2 6.3 9.3 6.3 6.1 12.8 11.2 12.9 35.5 7.7 4.4 36.7 3.9 7.5 1.0 27.0 11.0 12.6 3.6 0.0 15.9 14.3 1.4 17.6 26.0 43.9 2.5 4.1 11.4 12.8 4.7 13.5 24.8 25.0 6.1 10.7 9.6 3.2 13.7 20.5 3.6 23.4 3.3 4.3 0.0 10.6 2.6 19.3 23.6 9.1 6.1 4.0 36.5 3.7 19.9 26.6 0.0 4.3 6.9 4.2 9.3 9.0 45.6 3.7 4.3 15.0 28.4 21.8 CPN1 ENSG00000120054 "Carboxypeptidase N subunit 1" P15169 10 100042193-100081869 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "liver: 81.6" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 37.2" "Group enriched" "Detected in some" 12 "liver cancer: 26.6;melanoma: 7.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 17 "SK-MEL-30: 141.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted to blood" NA NA 13000000000 "Cluster 62: Liver - Hemostasis" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 15: Hepatocytes - Hemostasis" "unprognostic (2.97e-2)" "unprognostic (2.23e-2)" "unprognostic (3.93e-2)" "unprognostic (1.64e-1)" "unprognostic (6.75e-2)" "unprognostic (2.93e-2)" "unprognostic (5.26e-2)" "unprognostic (2.63e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 81.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 141.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 37.2 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.6 4.4 0.0 0.0 0.1 0.1 0.0 0.2 0.0 ERLIN1 "C10orf69, Erlin-1, KE04, SPFH1, SPG62" ENSG00000107566 "ER lipid raft associated 1" O75477 10 100150094-100186033 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 114.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011252 Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 32: U-937 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Endoplasmic reticulum" "HPA011252: AB_1853965" "unprognostic (3.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.57e-1)" "unprognostic (6.98e-3)" "unprognostic (2.69e-1)" "unprognostic (1.70e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (7.63e-4)" "unprognostic (1.26e-1)" "unprognostic (9.68e-2)" "unprognostic (1.99e-3)" "unprognostic (9.09e-2)" "unprognostic (1.32e-3)" "unprognostic (6.10e-3)" "unprognostic (1.76e-1)" "unprognostic (2.97e-1)" "unprognostic (1.93e-1)" 29.4 14.2 8.6 21.4 10.5 76.2 21.4 9.5 10.1 27.5 10.3 37.0 40.4 21.8 17.6 32.8 31.6 16.3 11.0 9.6 9.4 27.2 114.1 19.1 14.5 8.6 8.2 30.4 19.2 19.4 5.4 42.2 9.0 17.7 38.2 10.8 15.1 16.4 8.6 22.5 30.2 22.4 8.8 16.6 36.8 28.0 9.0 15.6 26.2 13.6 21.2 28.6 19.1 9.7 97.4 95.3 46.9 86.3 113.5 107.9 96.8 148.7 138.3 120.2 137.5 64.0 109.9 42.6 59.7 139.9 100.5 98.5 42.6 90.0 164.1 26.1 38.8 36.7 38.5 83.5 47.6 128.4 39.4 62.6 53.6 105.8 129.2 114.9 90.1 43.5 36.8 25.2 130.2 40.7 33.5 65.9 33.8 66.2 40.4 28.3 77.2 31.6 53.9 37.6 19.1 31.1 85.6 23.6 56.0 53.8 59.3 109.0 101.7 118.7 92.4 72.4 160.8 19.6 35.2 57.1 105.6 204.8 60.6 8.1 20.4 24.4 10.5 15.1 9.3 7.4 7.9 8.6 16.3 6.7 8.1 10.9 15.0 9.9 11.9 4.1 5.6 9.7 8.6 10.5 9.5 10.1 9.6 9.4 8.6 8.2 9.0 8.8 9.0 9.7 28.2 0.0 11.5 5.2 6.4 15.8 11.3 16.1 12.5 4.6 13.4 12.3 4.8 5.7 14.6 14.7 6.2 20.6 6.4 31.5 0.0 9.9 28.9 16.3 19.5 18.8 13.2 19.1 16.2 10.9 62.7 17.1 20.4 20.9 8.2 19.7 13.6 77.6 14.3 3.3 14.8 27.5 0.0 14.4 7.2 12.9 15.2 12.9 10.6 12.2 13.3 5.9 6.2 15.6 21.0 9.5 19.8 7.9 4.7 12.7 25.6 12.6 30.2 6.2 0.0 14.3 11.8 50.9 15.4 20.6 20.3 24.8 6.6 19.6 27.6 15.6 CHUK "IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16" ENSG00000213341 "Component of inhibitor of nuclear factor kappa B kinase complex" O15111 10 100188300-100229596 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001402, CAB004240, CAB018564" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (3.74e-2)" "unprognostic (3.01e-1)" "unprognostic (3.02e-2)" "unprognostic (5.93e-2)" "unprognostic (4.02e-2)" "unprognostic (2.09e-1)" "unprognostic (8.58e-2)" "unprognostic (8.39e-2)" "unprognostic (6.73e-2)" "unprognostic (1.49e-1)" "prognostic favorable (1.27e-4)" "unprognostic (2.48e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-3)" "unprognostic (2.22e-1)" 13.5 10.3 6.6 11.7 7.6 19.6 10.8 7.1 8.3 8.4 8.3 11.9 12.8 8.8 9.1 9.7 7.5 9.0 6.8 6.4 9.2 21.0 17.0 10.2 12.7 7.3 7.5 5.6 11.5 14.0 6.5 10.5 7.6 9.6 13.3 8.0 8.8 9.0 14.2 6.9 10.8 11.8 7.7 9.9 11.2 8.3 8.7 14.3 11.1 11.7 12.6 13.6 6.4 8.7 27.7 22.9 23.0 34.4 21.6 19.3 17.6 34.3 33.5 31.3 38.0 25.9 15.9 37.2 19.7 23.5 21.8 26.7 38.7 18.2 34.9 39.8 33.5 24.7 18.0 28.7 18.4 46.2 34.8 15.5 19.1 36.2 35.0 21.8 22.7 30.1 28.5 29.9 34.6 16.7 36.9 28.4 15.0 21.8 16.5 23.7 25.5 17.0 19.9 17.6 13.7 20.3 18.6 14.2 30.9 18.0 28.5 27.8 23.9 19.6 21.9 21.5 39.7 34.9 33.7 35.7 21.3 36.9 15.8 1.0 1.2 2.1 0.9 1.9 1.5 1.6 1.1 1.6 1.4 1.0 1.3 1.5 2.8 1.8 1.3 0.8 1.2 0.5 6.6 7.6 7.1 8.3 6.4 9.2 7.3 7.5 7.6 7.7 8.7 8.7 11.4 12.8 11.5 17.9 10.8 19.8 7.1 5.1 8.0 6.3 7.3 4.8 9.2 7.2 5.9 5.5 2.1 6.5 14.1 12.2 11.7 7.1 7.6 8.9 8.6 8.4 6.0 12.0 22.7 11.8 7.8 6.5 7.7 12.7 8.2 6.2 7.1 14.4 10.6 13.5 21.3 8.0 8.2 16.9 12.7 8.0 6.2 11.7 7.2 19.7 15.6 4.5 9.2 20.6 27.7 10.4 6.0 6.0 18.5 9.6 9.5 20.0 6.4 5.0 19.7 7.8 12.0 16.4 12.9 13.2 19.0 13.8 11.1 10.1 6.6 10.6 CWF19L1 "FLJ10998, hDrn1" ENSG00000095485 "CWF19 like cell cycle control factor 1" Q69YN2 10 100232298-100267680 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036889, HPA036890" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Golgi apparatus" "HPA036889: AB_10670928, HPA036890: AB_10696789" "unprognostic (2.76e-2)" "unprognostic (1.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.39e-1)" "unprognostic (3.66e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.90e-4)" "unprognostic (3.04e-1)" "unprognostic (9.17e-3)" "unprognostic (3.61e-1)" "unprognostic (2.70e-2)" "unprognostic (6.50e-3)" "unprognostic (5.61e-3)" "unprognostic (6.16e-2)" "unprognostic (2.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" 8.1 6.9 5.9 11.4 6.3 18.8 11.6 7.5 7.6 7.9 5.1 7.2 6.8 8.2 5.7 6.9 8.7 6.7 7.4 5.9 6.5 7.8 8.2 7.5 16.4 6.0 5.8 10.3 8.0 9.0 6.1 9.0 6.3 6.8 8.6 10.3 8.6 6.5 10.1 11.2 8.1 9.3 6.3 11.8 6.6 14.3 6.0 14.8 8.1 10.2 16.9 8.5 6.6 8.4 29.1 18.8 18.7 29.2 9.1 10.8 20.7 17.2 23.8 37.5 30.6 21.5 22.6 30.5 19.4 16.6 16.3 27.9 42.2 24.9 39.6 19.4 20.8 17.5 15.8 20.6 15.8 44.7 19.6 15.2 10.4 28.0 26.2 14.2 26.6 30.8 20.7 26.8 21.9 18.3 36.2 32.4 14.7 15.0 23.2 12.6 29.2 21.2 15.0 16.5 9.4 16.8 20.6 10.3 26.0 12.6 37.3 19.1 18.6 15.8 21.5 18.3 32.8 23.9 29.6 17.9 20.1 39.1 11.4 10.0 17.0 22.7 12.8 15.9 16.3 14.0 13.3 14.4 14.9 13.0 14.9 15.0 9.6 18.1 14.7 6.8 17.7 13.8 5.9 6.3 7.5 7.6 5.9 6.5 6.0 5.8 6.3 6.3 6.0 8.4 8.0 19.2 10.8 14.0 16.2 4.5 7.7 6.8 4.6 9.5 4.8 3.9 8.0 5.7 11.3 5.5 4.2 10.4 13.5 4.3 7.9 6.0 23.6 6.8 6.4 8.3 4.2 11.2 26.8 7.7 11.0 6.7 4.6 6.3 17.7 8.3 7.5 5.9 9.5 10.1 24.3 4.2 10.2 13.1 5.7 5.3 6.8 11.3 8.8 14.0 15.5 5.1 19.6 18.6 24.0 7.2 6.7 4.1 11.3 5.3 4.5 6.2 12.5 12.3 0.0 8.4 6.9 18.4 12.2 5.8 7.7 10.9 12.8 6.7 5.3 4.4 BLOC1S2 "BLOS2, BORCS2, FLJ30135, MGC10120" ENSG00000196072 "Biogenesis of lysosomal organelles complex 1 subunit 2" Q6QNY1 10 100273280-100286680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048088, HPA055010" Approved NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA048088: AB_2680259, HPA055010: AB_2682670" "unprognostic (3.64e-2)" "unprognostic (1.16e-2)" "unprognostic (2.01e-2)" "unprognostic (1.71e-1)" "unprognostic (8.75e-2)" "unprognostic (4.37e-2)" "unprognostic (8.64e-3)" "unprognostic (3.10e-1)" "unprognostic (8.44e-2)" "unprognostic (1.39e-1)" "unprognostic (2.79e-1)" "unprognostic (1.21e-1)" "unprognostic (7.57e-2)" "unprognostic (2.90e-1)" "unprognostic (2.44e-1)" "unprognostic (2.08e-2)" "unprognostic (3.53e-1)" 26.3 34.7 33.0 25.9 34.3 73.4 24.4 32.7 42.9 25.3 27.5 18.1 15.5 14.6 22.7 57.9 15.9 14.5 25.1 34.1 38.5 35.3 40.9 30.7 38.2 35.3 35.8 18.1 25.9 25.4 36.1 16.0 37.3 23.5 18.4 18.9 27.9 9.8 74.5 42.1 23.4 11.5 35.4 44.1 22.3 21.0 34.6 23.0 22.9 22.9 34.5 19.9 33.4 38.5 36.5 36.5 49.2 56.1 52.3 47.8 44.5 62.0 60.5 31.4 39.6 24.9 30.6 34.4 34.1 38.0 25.2 37.2 25.0 78.9 31.7 53.9 36.9 20.4 33.3 62.5 45.9 59.9 62.3 37.2 86.7 30.6 98.9 51.7 55.0 42.7 28.2 56.7 68.3 44.2 50.5 36.6 26.6 38.4 29.2 13.6 45.1 30.0 47.9 49.2 23.5 31.4 27.9 15.6 68.2 47.7 57.3 33.4 43.7 19.0 37.1 33.3 57.9 56.0 69.1 67.0 56.6 61.4 19.7 63.1 51.6 81.1 26.5 70.6 39.3 74.7 33.3 30.2 59.7 94.0 28.9 32.5 106.8 35.0 70.7 38.4 47.3 44.6 33.0 34.3 32.7 42.9 34.1 38.5 35.3 35.8 37.3 35.4 34.6 38.5 33.4 25.6 31.4 10.1 103.6 66.4 45.0 171.3 57.5 27.3 40.3 39.0 22.6 18.6 50.9 35.0 12.5 85.1 68.1 19.5 92.0 61.8 33.3 20.8 26.5 36.7 28.8 42.5 16.8 70.9 71.6 38.9 27.5 25.4 86.3 21.5 30.4 30.3 133.3 21.9 14.8 19.7 85.5 108.0 71.9 36.2 22.7 82.3 40.9 14.0 127.1 29.1 74.2 14.1 17.4 94.4 23.1 17.7 32.3 38.9 26.3 72.5 38.0 24.0 6.6 51.1 29.4 84.4 54.7 102.4 77.3 45.7 68.3 27.3 26.1 31.4 PKD2L1 "PCL, PKD2L, PKDL, TRPP3" ENSG00000107593 "Polycystin 2 like 1, transient receptor potential cation channel" Q9P0L9 10 100288149-100330264 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;lymphoid tissue: 7.9;retina: 13.3" "Cell type enhanced" "Detected in some" "Early spermatids: 14.6;Hofbauer cells: 13.6;Horizontal cells: 60.6;Kupffer cells: 14.4;Late spermatids: 20.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB022621, HPA070002" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane" "Actin filaments, Cytosol" "CAB022621: , HPA070002: " "unprognostic (2.67e-1)" "unprognostic (3.66e-7)" "unprognostic (8.07e-3)" "unprognostic (4.38e-2)" "unprognostic (4.70e-2)" "unprognostic (5.31e-2)" "unprognostic (2.19e-1)" "unprognostic (2.85e-2)" "unprognostic (2.01e-1)" "unprognostic (9.25e-2)" "unprognostic (1.55e-1)" "unprognostic (9.37e-2)" "unprognostic (1.49e-4)" "unprognostic (3.00e-1)" "unprognostic (2.05e-2)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" 0.2 0.1 5.4 0.4 5.6 0.9 0.7 4.8 10.8 0.1 4.8 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.4 4.9 0.3 1.6 2.3 1.5 4.9 5.2 0.1 0.1 0.0 0.1 0.5 5.1 0.3 1.2 13.3 0.1 0.0 0.1 0.0 0.6 0.0 5.0 7.9 0.0 2.3 5.0 0.9 0.0 0.0 1.7 0.2 0.0 5.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.1 5.4 5.6 4.8 10.8 5.4 4.9 4.9 5.2 5.1 5.0 5.0 5.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.6 0.0 0.0 0.1 0.0 0.0 2.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 13.6 60.6 0.4 0.0 0.0 14.4 0.0 20.1 0.3 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SCD "FADS5, SCDOS" ENSG00000099194 "Stearoyl-CoA desaturase" O00767 10 100347233-100364826 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 1233.7;brain: 839.9;liver: 583.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 389.6;Granulosa cells: 187.3;Hepatocytes: 840.3;Oligodendrocytes: 451.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 2534.2;CAPAN-2: 1824.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012107, HPA063921" Approved Enhanced "Endoplasmic reticulum" No Yes "Cluster 7: Monocytes - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 15: Hepatocytes - Hemostasis" "Endoplasmic reticulum" "HPA012107: AB_1856610, HPA063921: AB_2685154" "unprognostic (2.10e-1)" "unprognostic (2.62e-3)" "unprognostic (7.86e-2)" "unprognostic (5.19e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (6.53e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (7.18e-2)" "unprognostic (3.27e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (7.79e-5)" 1233.7 131.2 408.7 25.7 525.8 23.0 261.5 535.7 522.1 43.2 156.6 42.9 93.1 15.4 25.5 107.8 5.0 28.7 47.1 349.1 457.5 18.5 583.8 142.8 17.2 775.0 508.9 49.6 22.6 79.5 10.3 19.9 637.8 100.1 39.7 17.9 112.6 11.2 6.1 27.0 36.0 15.9 574.4 15.3 25.2 51.8 538.7 18.4 13.0 7.2 21.0 22.5 41.9 839.9 411.2 373.3 777.6 536.4 2534.2 1449.4 158.2 43.4 948.3 101.6 536.6 323.8 1824.4 173.3 33.7 102.2 461.8 716.4 433.7 1549.5 88.9 59.4 179.6 97.5 219.3 653.4 488.4 136.9 100.9 795.5 459.4 395.0 688.9 273.1 196.2 375.3 275.4 513.3 41.7 646.8 155.9 163.3 270.7 120.7 106.3 72.6 287.4 550.4 443.8 455.3 48.9 185.3 85.8 399.7 834.9 224.2 447.7 291.3 79.0 10.0 115.9 9.1 89.8 141.4 81.5 262.9 184.4 416.0 65.9 0.0 0.8 0.0 1.4 1.6 2.3 0.6 0.5 0.7 2.7 0.9 0.4 1.3 0.1 1.4 0.0 1.5 0.0 1.2 408.7 525.8 535.7 522.1 349.1 457.5 775.0 508.9 637.8 574.4 538.7 839.9 3.8 54.5 389.6 34.0 15.7 3.7 4.5 121.8 0.6 6.5 16.1 6.2 11.2 28.6 66.2 0.0 6.2 3.0 4.7 21.5 0.0 14.6 52.6 13.9 9.0 12.5 25.8 15.8 4.8 67.9 71.7 15.9 25.0 26.9 6.3 187.3 32.9 840.3 34.1 26.9 5.2 16.4 52.9 113.5 4.2 93.0 3.7 21.2 58.7 8.4 10.2 11.9 2.1 18.6 451.5 29.6 2.7 1.5 3.7 31.4 16.2 4.9 31.0 6.2 0.0 3.6 25.7 2.0 1.2 26.7 2.3 17.4 6.6 97.8 38.9 8.2 WNT8B ENSG00000075290 "Wnt family member 8B" Q93098 10 100463009-100483744 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "parathyroid gland: 1.2" "Cell type enhanced" "Detected in single" "Oligodendrocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.3;JURKAT: 3.1;RPMI-8226: 1.0;SCLC-21H: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA036570 Uncertain "Secreted to extracellular matrix" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA036570: AB_10670113" "unprognostic (6.92e-2)" "unprognostic (1.57e-1)" "unprognostic (7.13e-2)" "unprognostic (6.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.90e-1)" "unprognostic (2.64e-1)" "unprognostic (9.16e-4)" "unprognostic (1.95e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "unprognostic (7.83e-2)" "unprognostic (2.42e-3)" "unprognostic (5.02e-2)" "unprognostic (1.63e-1)" "unprognostic (2.68e-2)" "unprognostic (1.24e-2)" 0.0 0.8 0.1 0.0 0.4 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.4 1.2 0.1 0.0 0.0 0.2 0.0 0.9 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.2 0.0 0.6 0.8 0.0 0.0 0.0 0.1 0.2 0.0 1.0 0.0 0.7 1.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SEC31B "DKFZP434M183, SEC31B-1, SEC31L2" ENSG00000075826 "SEC31 homolog B, COPII coat complex component" Q9NQW1 10 100486646-100519864 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 28.7;Bipolar cells: 32.2;Cone photoreceptor cells: 39.6;Excitatory neurons: 38.1;Horizontal cells: 40.4;Inhibitory neurons: 40.7;Oligodendrocyte precursor cells: 32.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 9.1;JURKAT: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035882, HPA040819, HPA060052" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 59: Non-specific - Translation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Vesicles, Cytosol" "HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: " "unprognostic (1.23e-1)" "unprognostic (3.13e-3)" "unprognostic (3.39e-3)" "unprognostic (1.03e-2)" "unprognostic (4.85e-2)" "unprognostic (1.42e-3)" "unprognostic (1.97e-3)" "unprognostic (6.63e-2)" "unprognostic (2.22e-1)" "unprognostic (2.25e-2)" "unprognostic (1.10e-4)" "unprognostic (8.23e-3)" "prognostic unfavorable (6.41e-7)" "unprognostic (2.31e-2)" "unprognostic (2.54e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-4)" 2.2 1.5 2.0 1.1 2.0 2.5 2.0 2.3 2.9 2.6 1.2 2.5 0.3 2.1 1.0 0.8 2.6 0.8 2.8 1.8 1.9 2.2 2.0 1.7 1.6 1.9 1.7 2.8 0.6 1.7 3.7 0.7 1.8 2.3 0.8 1.5 1.6 0.8 5.9 1.3 2.3 0.8 1.5 3.0 1.7 2.7 1.9 2.9 2.0 8.3 1.3 1.8 1.5 2.2 0.1 0.0 2.0 0.5 0.6 1.0 0.1 0.4 0.9 0.2 0.6 0.1 0.0 0.4 0.6 0.0 0.1 0.0 1.1 0.2 0.5 2.5 0.5 1.0 1.5 0.2 0.9 0.8 0.8 1.8 1.0 0.1 1.2 9.1 0.3 8.9 0.1 1.3 0.0 0.0 1.4 2.3 0.0 0.2 0.4 2.0 0.0 0.9 0.6 0.0 0.1 0.7 0.2 0.0 0.4 1.5 0.4 0.2 0.0 0.1 0.2 0.1 0.1 0.9 0.5 0.6 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.0 2.3 2.9 1.8 1.9 1.9 1.7 1.8 1.5 1.9 2.2 2.5 6.4 4.5 28.7 2.4 1.1 0.9 1.7 1.2 32.2 2.9 2.0 8.0 4.3 2.3 11.0 39.6 1.2 4.5 3.8 0.0 0.4 2.3 1.3 3.4 2.6 5.4 0.4 38.1 0.2 0.3 2.4 3.1 1.6 1.3 7.7 2.9 6.1 2.2 40.4 40.7 3.3 0.0 4.8 1.7 1.7 3.4 3.5 1.8 7.5 5.2 3.6 1.0 32.6 21.5 0.2 2.0 4.1 2.5 1.2 2.4 1.0 2.2 5.8 0.0 1.9 2.2 7.7 3.2 1.8 1.1 0.8 4.6 4.7 4.0 1.1 NDUFB8 "ASHI, CI-ASHI" ENSG00000166136 "NADH:ubiquinone oxidoreductase subunit B8" O95169 10 100523740-100530000 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 876.5;Proximal tubular cells: 881.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003886, HPA065549" Supported Enhanced Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA003886: AB_1079463, HPA065549: " "unprognostic (4.07e-2)" "unprognostic (1.95e-3)" "unprognostic (2.28e-1)" "unprognostic (7.33e-2)" "unprognostic (4.88e-2)" "unprognostic (5.78e-2)" "unprognostic (3.02e-1)" "unprognostic (6.46e-2)" "unprognostic (8.33e-2)" "unprognostic (9.09e-2)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-2)" 152.6 199.3 431.2 103.4 439.3 171.5 135.8 427.1 606.3 127.3 416.7 237.8 161.0 145.8 163.0 170.2 132.4 88.0 482.4 444.8 441.9 249.9 262.0 108.6 132.0 438.5 439.4 130.4 115.5 331.0 186.7 83.0 441.9 132.2 145.0 127.1 163.6 135.8 408.9 128.2 147.8 125.5 411.8 133.3 201.0 66.2 442.5 140.6 130.1 512.8 119.9 162.9 132.9 448.3 250.2 419.6 222.3 383.1 159.6 158.8 238.5 168.1 370.9 259.3 278.8 575.4 278.1 260.7 146.4 185.6 189.1 289.5 162.9 269.7 194.5 172.9 417.8 183.9 350.3 465.7 217.6 379.3 302.6 191.6 240.7 249.2 329.3 180.4 283.7 361.1 194.5 159.3 218.4 304.1 369.7 472.9 144.7 324.3 377.9 252.4 237.6 346.1 298.8 281.3 147.9 209.7 122.0 227.4 250.9 147.3 338.2 332.8 185.5 139.5 158.7 151.5 296.8 288.4 286.4 334.8 277.6 398.2 159.3 299.4 530.8 478.1 406.0 558.8 483.1 616.1 498.0 468.1 589.7 546.7 538.1 514.0 122.7 478.0 489.6 655.0 817.6 1113.4 431.2 439.3 427.1 606.3 444.8 441.9 438.5 439.4 441.9 411.8 442.5 448.3 184.8 76.9 132.7 41.8 107.6 0.0 187.1 0.0 12.5 186.4 162.2 210.2 392.9 204.5 48.3 198.6 58.4 333.1 175.8 109.0 876.5 268.1 24.9 105.8 86.3 142.7 105.6 114.3 72.6 264.7 305.1 128.8 35.2 87.1 109.7 112.0 153.8 346.5 399.1 153.1 82.6 171.6 0.0 184.4 0.0 56.0 218.1 142.2 0.0 33.7 231.0 219.5 158.6 40.2 62.3 250.6 191.7 217.4 59.3 203.2 560.2 881.6 85.2 183.5 170.9 117.2 176.0 85.5 83.1 31.5 0.0 307.7 112.9 225.5 237.6 221.5 HIF1AN "DKFZp762F1811, FIH1, FLJ20615, FLJ22027" ENSG00000166135 "Hypoxia inducible factor 1 subunit alpha inhibitor" Q9NWT6 10 100529072-100559998 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 41.6;tongue: 40.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048742, HPA065302, CAB069903" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458" "unprognostic (4.07e-2)" "unprognostic (7.75e-2)" "unprognostic (2.35e-2)" "unprognostic (3.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.21e-1)" "unprognostic (8.07e-3)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-3)" "unprognostic (1.54e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-2)" "unprognostic (3.09e-2)" "unprognostic (9.92e-2)" "unprognostic (1.41e-1)" "unprognostic (3.24e-2)" 6.5 8.1 6.9 7.8 6.5 6.2 6.5 6.1 7.3 6.2 5.7 7.5 7.2 7.3 7.2 7.5 6.8 6.3 12.3 6.6 6.0 7.5 5.4 5.7 7.8 6.7 7.5 10.3 8.1 12.1 6.5 6.0 6.5 7.5 6.6 9.8 6.5 8.3 41.6 10.1 7.2 7.4 6.0 6.8 6.5 13.9 7.0 9.3 5.5 40.8 9.6 7.1 5.4 6.5 13.8 14.4 19.0 19.1 28.8 11.9 16.3 14.4 34.4 20.9 24.5 22.3 11.5 14.8 12.8 21.7 15.4 15.9 16.9 13.0 22.6 16.5 10.2 14.2 12.8 17.2 14.9 17.1 17.9 11.7 12.9 20.4 22.2 29.4 11.9 19.5 6.3 8.1 23.9 14.4 18.3 11.2 6.2 11.6 6.9 13.2 23.4 7.2 14.6 18.2 7.2 11.9 12.4 7.6 13.7 15.8 25.7 9.2 10.1 10.6 13.8 10.6 14.7 10.9 11.8 11.1 17.6 13.8 8.1 13.7 7.6 15.3 7.7 10.7 7.7 7.9 8.0 7.3 7.2 6.4 7.6 7.8 8.0 9.1 13.0 2.6 9.8 8.4 6.9 6.5 6.1 7.3 6.6 6.0 6.7 7.5 6.5 6.0 7.0 6.5 7.9 0.0 6.5 11.8 16.7 11.0 11.5 16.4 13.1 17.9 12.3 8.9 40.7 14.3 11.7 11.0 16.7 27.8 16.5 15.5 9.8 17.3 21.5 9.0 11.3 12.1 13.2 16.0 12.2 13.9 17.6 10.9 11.2 8.7 6.3 20.0 8.2 10.9 14.3 25.2 11.2 12.0 8.2 18.5 6.8 49.3 11.1 10.1 3.6 11.2 23.4 15.0 27.8 11.1 12.8 17.7 11.3 12.0 11.2 11.4 20.1 20.5 11.6 23.1 6.6 12.0 16.1 48.2 26.6 11.4 11.6 32.7 14.0 14.8 13.3 10.3 PAX2 ENSG00000075891 "Paired box 2" Q02962 10 100735396-100829944 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 29.6;kidney: 85.3" "Cell type enhanced" "Detected in some" "Collecting duct cells: 145.3;Distal tubular cells: 49.0;Endometrial ciliated cells: 129.5;Glandular and luminal cells: 246.0" "Group enriched" "Detected in some" 19 "endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "AN3-CA: 14.4;EFO-21: 22.6;RPTEC TERT1: 16.0" "Group enriched" "Detected in some" 9 "cerebellum: 1.3;pons and medulla: 3.4" "Group enriched" "Detected in some" 7 "cerebellum: 3.6;medulla oblongata: 5.6;spinal cord: 4.9" "CAB013024, HPA047704, HPA070751" Enhanced Supported Nucleoplasm "Intracellular and membrane" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305" "unprognostic (3.98e-2)" "unprognostic (9.55e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (4.56e-4)" "unprognostic (4.85e-2)" "unprognostic (5.54e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.24e-2)" "unprognostic (6.59e-2)" "unprognostic (9.18e-2)" "unprognostic (3.30e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-1)" "unprognostic (6.34e-2)" "unprognostic (8.26e-2)" 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 0.4 5.4 0.2 0.0 0.0 1.8 29.6 0.0 8.4 0.0 0.0 0.5 0.4 85.3 0.1 0.0 0.0 6.8 1.6 0.2 0.4 5.9 0.8 0.0 3.3 0.2 0.0 1.2 0.0 11.5 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 14.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.6 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 16.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.2 0.4 0.5 0.4 6.8 1.6 3.3 6.3 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 5.9 0.0 0.0 145.3 0.0 0.0 0.0 0.0 49.0 0.0 9.4 129.5 14.8 0.6 0.0 0.0 0.5 0.2 0.0 0.2 0.0 246.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 1.5 0.0 1.1 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 27.6 0.0 0.5 0.0 0.0 0.6 1.1 1.2 0.0 0.0 0.0 1.2 0.0 0.1 0.0 SLF2 "C10orf6, FAM178A, FLJ10512, FLJ25012" ENSG00000119906 "SMC5-SMC6 complex localization factor 2" Q8IX21 10 100912963-100965134 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 108.1;Peritubular cells: 105.7;Theca cells: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 145.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038499, HPA057568" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA038499: AB_10672520, HPA057568: AB_2683471" "unprognostic (9.05e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-2)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (2.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.66e-2)" "unprognostic (1.54e-2)" "unprognostic (1.16e-3)" "unprognostic (2.85e-1)" "unprognostic (4.90e-2)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" 9.1 17.2 17.3 10.9 29.2 11.8 8.8 20.4 23.1 14.0 9.3 12.6 7.9 20.8 48.6 8.9 17.6 8.0 10.8 17.0 24.9 11.3 11.6 10.8 14.7 24.5 24.7 25.1 13.1 7.9 23.8 15.4 25.7 15.2 10.1 11.7 9.4 12.9 17.8 13.4 12.7 10.7 19.1 23.1 10.4 25.8 25.3 12.2 11.3 13.3 11.5 11.3 11.2 46.2 25.7 20.6 29.6 31.4 16.1 20.9 11.3 26.3 18.5 24.1 29.0 15.2 17.5 24.1 15.8 11.3 17.9 25.3 20.4 8.8 29.1 26.6 16.6 21.7 14.2 31.0 11.7 28.0 24.9 10.0 13.2 18.6 19.9 25.1 15.7 14.7 15.6 22.5 37.3 17.7 19.1 16.0 13.7 9.9 15.2 18.5 145.7 8.3 10.1 12.8 6.6 12.9 16.5 4.6 30.6 14.1 26.3 10.7 20.6 28.2 23.4 18.0 31.1 18.1 28.5 19.1 20.0 32.9 15.1 6.1 6.6 7.0 9.8 6.7 8.9 8.6 7.8 8.5 5.2 11.0 8.5 7.8 3.6 9.1 7.5 7.5 8.0 4.6 17.3 29.2 20.4 23.1 17.0 24.9 24.5 24.7 25.7 19.1 25.3 46.2 18.4 25.6 18.9 0.0 18.2 0.0 8.4 0.0 12.5 33.8 13.8 12.6 0.0 5.7 8.6 25.8 25.0 17.4 29.4 9.0 13.7 11.0 8.4 22.7 64.8 20.8 12.2 11.3 0.0 8.0 7.1 20.2 10.7 25.0 24.0 32.3 26.7 12.8 17.9 38.7 0.0 10.5 0.0 18.2 0.0 10.4 108.1 18.6 0.0 0.0 19.2 19.7 46.4 0.0 0.0 7.0 8.4 105.7 12.3 9.4 9.3 8.9 13.8 31.4 19.7 44.5 12.8 33.5 43.0 10.4 0.0 5.1 19.7 77.6 8.2 6.0 MRPL43 bMRP36a ENSG00000055950 "Mitochondrial ribosomal protein L43" Q8N983 10 100969458-100987515 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073022 Approved Nucleoplasm,Mitochondria NA NA "Cluster 44: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Mitochondria" "HPA073022: " "unprognostic (2.65e-1)" "unprognostic (1.10e-2)" "unprognostic (2.01e-2)" "unprognostic (4.11e-3)" "unprognostic (6.07e-2)" "unprognostic (3.74e-1)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.03e-1)" "unprognostic (6.04e-3)" "unprognostic (3.02e-1)" "unprognostic (3.53e-2)" "unprognostic (7.29e-2)" "unprognostic (2.53e-2)" 58.5 84.9 26.4 21.0 30.2 25.4 61.6 34.0 37.7 63.3 27.6 69.2 28.6 56.3 7.4 63.7 57.7 18.9 65.2 25.0 27.9 79.4 82.8 45.0 23.6 30.1 29.0 71.4 76.3 27.5 51.7 21.7 30.4 62.5 6.9 9.2 65.7 30.8 117.9 71.8 50.7 7.5 30.5 50.7 68.1 41.1 27.7 12.5 65.3 18.2 7.4 66.5 57.5 34.3 102.5 113.6 23.3 41.5 24.0 30.6 72.4 69.7 62.2 52.9 53.4 65.1 78.0 87.1 92.8 29.3 28.9 62.8 8.5 58.1 7.0 66.4 146.1 68.9 76.6 102.6 51.1 55.1 53.2 47.8 44.6 45.1 19.8 25.2 50.0 54.7 34.9 43.3 16.3 107.7 51.4 124.5 37.9 27.7 105.8 54.7 77.8 59.4 29.4 51.9 26.1 67.6 51.0 24.5 80.7 7.5 130.9 26.1 62.4 49.4 65.9 53.4 74.4 89.9 73.5 44.5 63.1 101.5 36.4 100.4 62.2 70.8 58.0 58.8 59.4 67.1 63.5 57.7 69.7 62.8 59.9 54.9 20.9 72.3 58.7 54.3 77.0 68.0 26.4 30.2 34.0 37.7 25.0 27.9 30.1 29.0 30.4 30.5 27.7 34.3 84.3 44.8 49.6 9.8 64.5 55.7 70.6 97.2 60.3 44.0 93.6 130.8 34.3 88.6 74.7 75.4 41.7 135.3 63.7 47.2 180.0 101.1 114.1 74.3 53.2 58.8 61.1 52.6 8.9 127.2 140.6 68.9 53.5 44.5 46.9 64.8 69.3 75.7 98.4 18.5 13.4 77.7 67.1 51.5 43.6 51.5 85.4 47.6 64.0 7.5 67.6 91.5 71.1 12.1 31.0 91.0 77.4 73.7 70.8 72.0 94.3 221.0 79.7 62.4 52.6 66.1 82.2 277.1 76.6 82.6 68.5 103.7 61.6 98.1 80.6 79.2 SEMA4G "FLJ20590, KIAA1619" ENSG00000095539 "Semaphorin 4G" Q9NTN9 10 100969518-100985871 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 84.6;liver: 102.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 66.4;Gastric mucus-secreting cells: 27.0;Hepatocytes: 60.5;Intestinal goblet cells: 34.6;Paneth cells: 38.5;Proximal enterocytes: 47.6;Undifferentiated cells: 45.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 31.7;CACO-2: 30.5;Hep G2: 113.8;OE19: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038362, HPA077752" Uncertain Uncertain "Vesicles,Lipid droplets" "Intracellular and membrane" NA NA 1300000 "Cluster 37: B-cells - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Vesicles, Lipid droplets" "HPA038362: AB_10669524, HPA077752: " "unprognostic (3.90e-3)" "unprognostic (9.43e-3)" "unprognostic (2.84e-1)" "unprognostic (1.13e-2)" "unprognostic (5.55e-2)" "unprognostic (8.11e-2)" "unprognostic (3.28e-1)" "unprognostic (3.71e-2)" "unprognostic (3.63e-1)" "unprognostic (1.41e-2)" "unprognostic (3.09e-2)" "unprognostic (3.14e-1)" "unprognostic (3.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.05e-2)" 2.4 12.7 13.1 5.9 10.9 0.4 3.6 18.9 12.3 6.9 12.8 53.6 53.4 3.5 32.1 3.6 5.9 9.0 3.0 10.0 11.6 19.1 102.4 5.8 2.5 11.2 14.4 18.9 31.3 7.3 9.9 3.9 11.5 20.2 84.6 7.3 8.5 3.0 2.6 18.3 41.2 4.6 9.6 3.1 20.9 3.7 17.0 0.8 15.3 0.8 0.9 4.0 5.0 9.9 0.2 31.7 8.0 3.4 5.0 1.6 6.8 1.2 3.4 1.7 1.7 30.5 5.2 0.5 4.2 1.5 0.6 2.1 8.0 1.4 1.4 0.7 4.9 1.7 3.0 113.8 12.5 1.2 1.0 8.3 1.8 1.6 0.9 22.2 4.4 3.5 3.3 0.4 2.5 2.0 0.5 1.2 1.3 69.1 1.8 3.1 0.7 1.5 7.4 1.0 2.5 12.5 1.1 2.1 3.2 8.7 8.7 1.5 3.0 1.0 3.7 0.8 0.3 1.1 0.6 0.5 0.9 1.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 10.9 18.9 12.3 10.0 11.6 11.2 14.4 11.5 9.6 17.0 9.9 0.3 3.2 1.1 3.9 1.2 0.0 0.6 0.7 0.6 3.5 2.5 2.0 1.2 20.0 0.2 0.0 0.0 8.8 0.0 66.4 0.0 2.7 0.2 1.6 0.7 0.6 8.5 0.8 3.0 2.6 1.9 2.0 27.0 0.3 0.0 3.4 2.2 60.5 0.9 11.8 14.1 34.6 2.0 3.3 0.0 0.2 2.1 0.2 1.8 0.0 0.0 0.9 0.0 3.5 5.5 2.4 38.5 1.2 0.2 3.0 47.6 6.4 2.4 1.6 0.0 0.1 0.4 1.1 1.9 0.5 0.1 2.9 0.2 12.7 45.9 0.9 TWNK "C10orf2, FLJ21832, IOSCA, PEO, PEO1, TWINKLE, TWINL" ENSG00000107815 "Twinkle mtDNA helicase" Q96RR1 10 100987367-100994403 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA replication" "Helicase, Hydrolase" "Deafness, Disease variant, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 6.8;Breast myoepithelial cells: 6.6;Ductal cells: 5.4;Endometrial stromal cells: 7.2;Granulosa cells: 7.1;Theca cells: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002532 Uncertain NA NA "Cluster 44: Non-specific - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "HPA002532: AB_1078311" "unprognostic (8.10e-2)" "unprognostic (9.65e-2)" "unprognostic (1.16e-1)" "unprognostic (2.19e-2)" "unprognostic (2.81e-2)" "unprognostic (1.19e-1)" "unprognostic (7.82e-3)" "unprognostic (7.99e-2)" "unprognostic (1.22e-1)" "unprognostic (7.95e-2)" "unprognostic (7.52e-2)" "unprognostic (1.96e-2)" "unprognostic (9.46e-2)" "unprognostic (9.82e-3)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" "unprognostic (1.45e-1)" 4.9 7.0 3.7 5.5 3.7 3.0 7.5 3.6 3.5 3.8 3.2 4.4 3.3 4.6 5.3 5.5 6.6 2.6 5.0 3.4 3.6 5.9 6.0 2.1 6.1 3.9 4.0 5.1 5.2 4.8 2.4 3.8 3.8 4.0 4.8 1.6 4.0 3.4 11.6 5.5 3.8 4.5 3.7 4.6 3.9 8.3 4.0 8.1 4.1 12.6 8.3 6.6 3.5 3.5 15.5 32.0 12.5 39.7 11.1 7.2 14.7 11.4 14.8 17.3 16.6 52.6 13.1 55.4 21.1 7.0 10.4 25.0 52.2 27.7 21.1 25.5 31.0 42.1 17.4 40.2 19.1 54.8 16.7 14.9 30.7 25.5 77.6 15.8 10.6 26.3 45.9 15.0 12.3 21.2 37.0 18.8 35.8 28.2 25.9 35.5 27.5 33.2 10.7 15.4 20.1 38.5 12.0 16.0 37.8 13.8 20.9 16.0 12.4 8.6 17.4 10.6 32.5 28.0 31.3 46.0 10.6 47.8 9.8 1.2 0.6 0.1 1.2 0.5 3.7 2.4 1.8 2.7 1.2 2.1 2.0 2.2 0.0 2.5 0.8 1.3 0.4 1.4 3.7 3.7 3.6 3.5 3.4 3.6 3.9 4.0 3.8 3.7 4.0 3.5 3.5 0.0 2.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 6.8 6.6 0.0 0.0 3.1 1.8 0.0 4.2 1.9 0.0 3.9 5.4 0.0 2.3 7.2 2.0 0.0 0.0 0.0 3.0 3.7 1.3 0.0 2.8 1.3 7.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.6 1.1 9.1 0.0 0.0 LZTS2 "KIAA1813, LAPSER1" ENSG00000107816 "Leucine zipper tumor suppressor 2" Q9BRK4 10 100996618-101007836 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044956 Approved Approved "Plasma membrane,Cytosol" No Yes "Cluster 39: Non-specific - mRNA processing" "Cluster 35: Non-specific - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "Plasma membrane, Cytosol" "HPA044956: AB_10795989" "unprognostic (1.42e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (8.18e-2)" "unprognostic (4.64e-2)" "unprognostic (1.56e-1)" "unprognostic (5.49e-3)" "unprognostic (3.56e-1)" "unprognostic (7.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (3.39e-4)" "unprognostic (7.63e-2)" "unprognostic (1.86e-1)" "unprognostic (5.46e-3)" "unprognostic (1.76e-3)" 69.9 66.0 46.8 14.9 65.5 14.4 63.3 58.0 54.1 74.3 25.8 96.3 17.5 90.3 17.7 41.0 69.2 19.8 58.9 41.2 45.8 51.8 18.0 57.1 12.1 63.7 64.3 78.6 29.5 29.1 43.6 28.5 58.5 69.5 8.9 5.9 44.3 40.6 37.8 48.9 43.0 26.6 49.0 44.4 54.9 36.2 64.1 10.8 57.6 18.0 8.1 84.1 54.4 78.9 32.9 43.1 34.6 59.7 45.0 36.3 70.8 38.7 72.8 31.9 36.0 50.5 26.6 13.1 35.1 52.5 23.0 54.6 21.5 28.2 7.8 12.8 31.9 12.1 46.4 66.3 63.6 6.4 15.2 66.1 20.2 25.1 30.1 67.3 32.8 15.6 38.7 7.3 28.7 31.6 5.8 15.8 38.8 12.6 35.2 74.7 101.3 13.5 24.4 39.3 8.4 62.8 26.3 11.9 99.9 18.6 61.0 51.6 42.1 37.9 42.6 40.5 20.7 14.0 10.2 3.3 64.0 17.7 19.4 0.0 0.7 0.4 2.7 0.4 3.7 2.3 3.4 3.0 1.1 2.9 3.5 3.0 0.3 2.9 0.1 1.8 3.0 1.5 46.8 65.5 58.0 54.1 41.2 45.8 63.7 64.3 58.5 49.0 64.1 78.9 34.7 16.0 10.5 20.2 5.3 13.4 9.0 12.4 19.4 14.4 21.7 20.3 5.2 11.5 9.4 5.5 6.2 18.6 1.9 8.0 7.9 19.1 6.8 7.9 20.5 22.9 16.7 5.0 6.8 12.6 13.2 21.8 14.8 13.0 1.3 38.9 18.5 2.6 22.2 18.5 7.7 17.8 16.2 7.2 9.2 4.1 25.7 8.4 16.0 13.1 4.8 18.9 4.1 9.0 70.3 13.3 7.9 29.3 5.4 18.1 6.5 8.3 6.1 4.0 26.3 21.1 40.7 3.8 15.0 10.8 12.1 47.1 6.0 26.9 15.1 9.7 PDZD7 "bA108L7.8, DFNB57, FLJ23209, PDZK7" ENSG00000186862 "PDZ domain containing 7" Q9H5P4 10 101007679-101032295 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 21.5;intestine: 20.0;pituitary gland: 6.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 15.9;Cone photoreceptor cells: 22.9;Excitatory neurons: 32.3;Inhibitory neurons: 16.5;Proximal enterocytes: 56.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 7.5;SCLC-21H: 11.7;THP-1: 18.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074542 Supported Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 43: THP-1 - Innate immune response" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "HPA074542: " "unprognostic (1.46e-1)" "unprognostic (2.85e-3)" "unprognostic (3.96e-2)" "unprognostic (2.10e-1)" "unprognostic (2.15e-2)" "unprognostic (2.83e-2)" "unprognostic (1.38e-2)" "unprognostic (5.31e-2)" "unprognostic (2.52e-2)" "unprognostic (2.95e-2)" "unprognostic (2.45e-1)" "unprognostic (1.87e-3)" "unprognostic (3.54e-3)" "unprognostic (3.89e-1)" "unprognostic (1.79e-1)" "unprognostic (3.51e-2)" "unprognostic (2.80e-1)" 1.5 1.3 5.8 1.0 8.0 1.3 0.5 10.2 15.4 0.7 0.7 0.4 12.8 1.4 0.9 0.3 0.4 1.9 0.6 5.7 4.5 1.5 0.1 1.0 0.9 21.5 7.7 0.6 0.9 1.1 6.0 1.0 21.0 0.7 0.2 2.3 1.1 0.5 0.9 2.4 20.0 1.0 2.7 1.6 1.0 1.2 8.8 0.7 1.2 0.2 0.1 0.4 0.8 9.9 7.5 0.9 0.5 0.7 0.9 0.1 2.3 1.2 0.6 0.0 0.3 1.5 1.7 3.7 3.5 0.3 1.0 2.2 0.2 0.7 0.0 1.0 2.5 0.2 3.8 2.3 0.6 0.5 3.1 0.3 0.1 0.2 0.1 4.2 0.2 3.3 0.6 0.7 0.1 1.8 0.5 1.2 0.6 1.5 2.4 1.6 1.0 0.4 1.8 0.6 11.7 5.4 0.8 0.3 1.2 1.0 2.4 18.2 0.5 1.1 2.4 1.4 1.0 1.5 0.1 0.2 6.4 1.2 0.6 0.6 0.4 0.5 0.3 0.4 0.3 0.3 0.2 0.4 0.1 0.3 0.4 0.2 1.6 0.8 0.3 0.1 0.1 0.3 5.8 8.0 10.2 15.4 5.7 4.5 21.5 7.7 21.0 2.7 8.8 9.9 0.8 0.0 0.0 1.3 0.1 0.5 0.5 0.2 0.0 15.9 0.5 0.9 1.4 2.8 0.2 1.8 22.9 0.2 0.1 0.2 1.9 0.7 1.7 2.1 0.3 0.7 0.0 0.0 32.3 0.4 5.2 0.8 1.1 0.3 0.0 1.6 0.7 0.0 2.1 1.7 16.5 1.5 0.0 1.3 2.7 2.6 0.3 1.0 0.0 5.6 0.3 0.9 1.0 0.5 6.9 1.3 1.2 1.2 0.3 0.4 56.7 1.6 1.3 8.3 0.0 1.4 1.7 2.9 3.7 0.2 0.4 1.9 0.8 0.1 1.0 0.2 SFXN3 "SFX3, SLC56A3" ENSG00000107819 "Sideroflexin 3" Q9BWM7 10 101031234-101041244 "Metabolic proteins, Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 177.5;Proximal enterocytes: 119.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008028, HPA048105" Approved Enhanced Mitochondria NA NA "Cluster 46: Basophils - DNA binding" "Cluster 45: Intestine - Brush border" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 31: Spermatids - Spermatogenesis" Mitochondria "HPA008028: AB_1079938, HPA048105: AB_2680265" "unprognostic (2.55e-1)" "unprognostic (3.32e-2)" "unprognostic (4.94e-2)" "unprognostic (2.82e-2)" "unprognostic (4.94e-3)" "prognostic unfavorable (3.79e-4)" "unprognostic (3.84e-3)" "unprognostic (8.46e-2)" "unprognostic (1.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.04e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (3.56e-1)" "unprognostic (3.05e-2)" "unprognostic (3.70e-2)" "unprognostic (1.71e-1)" 20.1 10.7 16.2 11.8 19.0 6.2 14.9 19.4 21.2 17.9 15.7 13.9 31.7 18.0 21.5 8.1 18.3 16.4 15.1 19.7 12.9 12.0 4.3 21.3 7.9 18.5 15.8 12.7 9.1 18.3 9.0 21.0 19.2 12.0 10.4 23.4 11.1 16.5 3.6 22.2 37.5 25.4 12.7 10.7 11.0 7.2 18.2 6.4 9.9 7.9 7.1 14.9 14.7 19.3 44.4 16.9 1.7 5.2 43.5 46.0 4.4 26.4 92.7 33.0 26.4 28.1 47.4 1.9 24.8 62.1 27.7 31.8 7.9 57.7 14.4 12.3 10.2 5.3 27.1 20.4 29.8 4.2 41.2 31.8 8.3 29.1 27.3 91.8 73.5 12.5 0.4 1.4 54.4 7.3 1.9 6.4 2.1 16.2 40.3 4.3 32.5 12.0 48.5 6.8 9.0 44.1 14.4 1.7 39.3 11.8 13.8 31.2 60.9 29.0 22.7 26.0 13.1 6.6 2.7 0.2 70.7 23.7 23.7 10.6 18.1 9.1 11.0 13.4 8.5 2.4 7.4 7.6 19.1 1.1 4.5 5.6 3.2 5.5 7.8 2.9 8.7 11.7 16.2 19.0 19.4 21.2 19.7 12.9 18.5 15.8 19.2 12.7 18.2 19.3 17.1 12.8 5.3 7.5 3.9 13.9 5.0 6.3 2.8 60.2 6.9 7.0 3.2 18.6 4.6 5.5 47.9 1.2 21.2 7.3 1.9 31.7 51.9 25.2 13.4 17.5 5.4 4.8 14.2 15.3 40.9 17.4 7.7 5.6 14.5 55.5 20.0 0.9 37.4 10.1 12.2 7.8 4.1 21.3 29.9 177.5 17.4 24.3 33.8 1.0 12.0 7.7 9.2 5.0 16.0 38.5 10.8 14.7 10.4 2.9 119.1 14.3 38.8 24.0 13.1 6.7 12.0 1.4 0.7 1.3 10.9 10.9 19.7 2.7 5.6 3.4 KAZALD1 "FKSG28, FKSG40" ENSG00000107821 "Kazal type serine peptidase inhibitor domain 1" Q96I82 10 101061989-101068131 "Predicted secreted proteins" "Differentiation, Osteogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 23.0;Gastric mucus-secreting cells: 44.4;Intestinal goblet cells: 53.5;Proximal enterocytes: 78.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 30.8;T-47d: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA011800 Uncertain "Secreted to extracellular matrix" NA NA 65000 "Cluster 64: Macrophages - Immune response" "Cluster 6: T47d - Mammary gland" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA011800: AB_1852082" "unprognostic (3.34e-1)" "unprognostic (8.86e-3)" "unprognostic (1.16e-2)" "unprognostic (4.43e-3)" "unprognostic (4.88e-2)" "unprognostic (1.35e-2)" "unprognostic (6.68e-3)" "unprognostic (2.62e-1)" "unprognostic (1.39e-2)" "unprognostic (1.70e-2)" "unprognostic (1.35e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-1)" "unprognostic (3.44e-3)" "unprognostic (6.35e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (2.11e-1)" 2.9 0.6 0.3 0.6 0.2 0.3 2.8 0.3 0.4 7.1 0.1 1.9 2.8 2.0 1.3 0.6 2.1 0.6 8.1 0.5 0.2 2.0 0.5 1.2 0.7 0.4 0.3 0.5 0.9 0.8 3.6 0.8 0.4 5.2 1.6 0.4 6.9 2.2 4.1 1.7 3.2 1.5 0.2 18.0 6.6 1.9 0.4 1.0 2.5 3.1 0.3 3.6 2.9 0.2 3.3 1.6 1.8 30.8 1.8 7.4 2.0 5.2 5.6 1.0 1.0 6.2 2.0 0.2 2.8 4.6 0.5 0.7 1.9 0.1 0.3 3.1 0.8 0.4 6.5 6.7 0.5 0.4 2.3 1.1 0.4 0.1 0.9 0.4 0.0 0.9 0.7 3.2 0.9 5.3 0.1 1.9 0.5 7.2 11.7 12.4 9.1 0.4 0.6 1.6 0.3 1.2 0.5 0.8 1.7 0.7 36.7 0.5 0.1 0.7 2.1 0.5 1.2 0.9 2.6 2.5 1.3 3.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.4 0.5 0.2 0.4 0.3 0.4 0.2 0.4 0.2 8.3 0.0 1.5 0.7 0.3 2.0 0.9 1.6 0.6 1.5 2.5 3.0 3.4 1.5 1.6 0.0 2.1 0.3 0.3 23.0 1.9 0.5 0.1 4.1 1.3 5.1 2.4 2.7 0.1 2.1 0.6 16.9 44.4 7.2 0.0 0.2 3.6 0.3 0.8 0.0 0.1 53.5 4.1 4.8 1.9 0.1 9.9 0.9 1.8 0.0 0.0 0.8 0.0 0.0 0.1 1.5 12.8 0.4 0.2 5.0 78.1 0.4 0.7 2.2 0.0 10.4 6.1 3.9 1.4 0.7 2.8 0.5 0.6 0.2 8.1 0.4 TLX1 "HOX11, TCL3" ENSG00000107807 "T cell leukemia homeobox 1" P31314 10 101131300-101137789 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 29 "lymphoid tissue: 43.9;salivary gland: 16.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "medulla oblongata: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.5;HEK 293: 2.5;K-562: 13.8;SCLC-21H: 2.2;SH-SY5Y: 3.3;SiHa: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 64: Macrophages - Immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (8.67e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.06e-5)" "unprognostic (1.06e-1)" "unprognostic (1.60e-1)" "unprognostic (5.07e-1)" "unprognostic (1.57e-2)" "unprognostic (2.12e-2)" "unprognostic (2.69e-2)" "unprognostic (2.52e-3)" "unprognostic (1.81e-1)" "unprognostic (2.63e-1)" "unprognostic (3.26e-1)" "unprognostic (3.06e-1)" "unprognostic (7.35e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.1 0.3 0.0 0.1 0.7 0.0 0.1 0.0 16.5 0.0 0.0 0.0 0.8 0.0 0.0 43.9 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 3.3 2.7 0.0 0.0 0.2 0.1 0.4 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 LBX1 "HPX6, LBX1H" ENSG00000138136 "Ladybird homeobox 1" P52954 10 101226195-101229794 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 26.5" "Cell type enriched" "Detected in single" 5 "Skeletal myocytes: 3.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebellum: 1.9;medulla oblongata: 3.5;pons: 2.5;spinal cord: 4.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 3.4;RH-30: 4.3;SCLC-21H: 9.1" "Group enriched" "Detected in some" 24 "cerebellum: 1.6;pons and medulla: 3.0" "Group enriched" "Detected in some" 18 "cerebellum: 1.2;medulla oblongata: 2.0;spinal cord: 2.0" "HPA002016, HPA002086, CAB079927" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242" "unprognostic (4.13e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" "unprognostic (2.29e-1)" "unprognostic (7.28e-3)" "unprognostic (3.31e-1)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.3 0.0 0.0 0.0 9.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 3.5 0.4 2.5 4.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BTRC "beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1" ENSG00000166167 "Beta-transducin repeat containing E3 ubiquitin protein ligase" Q9Y297 10 101354033-101557321 "Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 109.7;Excitatory neurons: 154.0;Inhibitory neurons: 144.4;Oligodendrocyte precursor cells: 183.5;Oligodendrocytes: 148.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031156, CAB032986" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 58: Brain - Synaptic function" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "Plasma membrane, Cytosol" "CAB032986: AB_2243598, HPA031156: AB_2673764" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (8.88e-2)" "unprognostic (2.09e-1)" "unprognostic (3.55e-1)" "unprognostic (2.73e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-2)" "unprognostic (8.80e-3)" "unprognostic (5.05e-1)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (3.07e-2)" "unprognostic (2.23e-1)" 5.2 9.2 16.3 3.8 19.3 2.8 8.5 8.9 17.4 6.8 7.8 6.3 3.9 6.1 10.5 8.4 7.7 5.8 14.6 18.9 16.3 8.0 6.4 4.9 4.2 10.7 12.6 11.0 6.5 13.1 9.4 7.9 13.7 8.8 4.7 21.6 6.9 5.9 12.2 6.8 4.7 7.1 10.0 6.5 5.7 13.8 16.3 6.4 8.5 12.1 5.6 6.4 6.7 13.7 8.7 13.0 17.2 20.0 16.1 14.1 6.3 12.0 18.4 11.8 10.0 9.0 6.5 13.8 11.8 9.9 12.3 12.9 14.1 13.0 11.7 9.5 11.5 10.1 8.0 11.5 8.9 14.9 5.7 9.0 14.7 10.4 18.4 22.4 15.3 12.7 11.0 4.5 12.0 7.2 9.8 7.5 7.8 9.0 9.9 12.4 24.6 2.8 10.3 5.4 12.9 11.2 8.1 3.5 11.3 19.2 9.2 5.1 12.7 6.1 10.3 8.6 8.5 7.5 18.2 8.7 6.4 7.3 3.9 1.8 1.7 1.8 2.9 1.5 2.8 2.5 3.0 2.5 2.3 2.1 3.4 2.8 1.1 2.5 1.6 1.1 2.8 1.6 16.3 19.3 8.9 17.4 18.9 16.3 10.7 12.6 13.7 10.0 16.3 13.7 8.6 3.2 9.4 109.7 6.9 5.6 4.1 6.9 12.5 32.5 10.0 7.4 28.0 8.6 10.6 3.7 29.2 11.5 6.1 5.0 7.9 9.7 41.9 11.7 12.4 9.0 3.0 20.6 154.0 7.2 7.2 10.3 3.6 10.6 13.9 10.1 6.4 6.7 5.9 16.8 144.4 4.9 6.1 3.5 2.5 21.6 9.0 5.0 1.8 69.3 4.6 13.6 8.2 183.5 148.0 7.9 3.2 10.5 6.3 6.6 5.5 9.4 13.0 26.0 6.6 8.3 7.6 33.8 18.3 7.4 7.1 12.4 8.2 5.9 4.8 6.2 DPCD "DKFZP566F084, RP11-529I10.4" ENSG00000166171 "Deleted in primary ciliary dyskinesia homolog (mouse)" Q9BVM2 10 101570560-101609662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 132.4" "Group enriched" "Detected in many" 4 "Early spermatids: 579.4;Late spermatids: 1068.7;Respiratory ciliated cells: 329.7;Spermatocytes: 313.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 20.2;intermediate monocyte: 22.2;myeloid DC: 29.6;non-classical monocyte: 9.5" "Group enriched" "Detected in all" 14 "dendritic cells: 29.6;monocytes: 22.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036603, HPA036604" Enhanced Approved "Nuclear speckles" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" "HPA036603: AB_2675212, HPA036604: AB_10673503" "unprognostic (1.22e-2)" "unprognostic (1.73e-3)" "unprognostic (4.66e-1)" "prognostic favorable (6.57e-4)" "unprognostic (1.90e-1)" "unprognostic (9.13e-2)" "unprognostic (4.00e-3)" "unprognostic (1.71e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (1.64e-1)" "unprognostic (4.55e-2)" "unprognostic (2.70e-1)" "unprognostic (5.04e-2)" "unprognostic (3.83e-2)" "unprognostic (7.54e-2)" 10.5 18.7 35.1 8.7 37.2 11.8 19.4 31.5 42.0 21.8 55.1 17.3 6.8 16.7 41.3 20.4 73.3 15.5 29.6 37.4 39.1 30.9 10.4 14.0 6.2 36.2 37.1 23.5 14.7 49.3 49.5 10.6 36.5 16.1 13.5 55.8 21.2 15.7 19.2 13.2 7.1 18.0 33.3 4.5 14.4 132.4 39.7 6.6 33.0 18.3 8.2 14.4 14.9 33.4 97.1 53.4 37.9 77.2 35.2 61.7 15.6 44.5 53.6 59.4 55.1 38.8 51.4 9.0 74.6 42.7 25.2 54.0 55.4 65.3 61.2 23.0 57.5 11.3 49.8 56.7 20.3 58.8 8.1 42.3 54.8 72.0 56.1 153.7 50.8 14.0 32.4 12.6 45.1 122.9 0.0 48.1 28.7 26.9 41.6 0.0 51.8 20.5 92.6 25.3 37.1 63.3 36.5 23.4 31.3 34.1 71.2 23.9 35.5 27.3 24.9 55.7 62.3 37.9 45.9 16.9 94.7 13.7 11.7 0.0 20.2 1.0 1.8 22.2 1.7 1.3 1.4 1.4 29.6 0.7 1.5 1.8 0.9 1.6 9.5 4.1 0.6 8.1 35.1 37.2 31.5 42.0 37.4 39.1 36.2 37.1 36.5 33.3 39.7 33.4 6.9 35.3 12.4 4.9 2.1 9.7 29.5 89.2 9.6 16.4 25.4 29.5 33.7 30.0 56.6 49.7 18.8 24.6 0.9 10.5 95.9 63.3 579.4 136.5 23.5 11.1 23.9 14.1 7.7 27.5 16.7 21.2 10.2 20.2 1.3 19.2 11.4 10.9 24.0 11.8 6.2 12.5 52.9 4.4 14.6 1068.7 23.6 8.7 16.0 3.7 6.9 27.8 2.1 4.0 1.4 33.9 12.4 27.8 5.6 18.6 3.5 117.3 329.7 49.1 0.0 12.4 29.0 313.8 77.4 8.7 14.2 10.7 2.9 25.3 22.1 23.9 POLL ENSG00000166169 "DNA polymerase lambda" Q9UGP5 10 101578882-101588270 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076828 Supported Nucleoplasm "Intracellular and membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 22: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA076828: " "unprognostic (3.71e-3)" "unprognostic (6.93e-3)" "unprognostic (1.73e-2)" "unprognostic (2.47e-2)" "unprognostic (9.52e-2)" "unprognostic (1.80e-2)" "unprognostic (2.11e-2)" "unprognostic (1.24e-1)" "unprognostic (8.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.12e-2)" "unprognostic (7.19e-2)" "unprognostic (4.74e-2)" "unprognostic (1.06e-2)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" "unprognostic (1.64e-3)" 17.4 22.4 17.3 12.4 18.0 12.8 19.6 15.9 19.0 21.1 18.2 21.8 16.8 19.4 22.6 18.1 22.1 15.6 19.9 17.5 16.0 24.8 26.9 15.6 17.0 16.3 16.3 26.3 45.6 21.3 28.5 13.7 17.2 26.0 17.1 17.4 20.8 15.4 34.4 16.1 18.7 14.2 14.1 22.7 27.6 41.4 17.1 7.4 26.1 18.2 17.1 20.9 17.7 17.4 23.5 21.0 16.2 23.0 16.2 30.0 22.7 15.3 26.4 22.9 23.9 15.5 27.8 5.7 23.5 13.9 12.6 28.8 18.4 22.6 18.4 20.8 24.8 18.1 23.1 17.7 29.8 19.0 16.2 27.5 30.3 25.0 51.8 64.1 24.7 11.1 20.4 19.2 14.7 18.8 0.0 20.8 8.6 13.0 12.4 0.1 14.6 9.9 19.2 14.1 11.2 16.6 9.4 15.7 26.5 23.8 47.3 11.0 13.5 8.1 16.4 9.8 16.8 28.4 15.3 8.9 17.5 16.6 6.3 0.6 9.2 1.3 6.5 6.6 10.6 8.4 7.4 6.8 11.6 6.8 11.7 8.0 1.0 9.5 6.7 0.2 10.2 7.6 17.3 18.0 15.9 19.0 17.5 16.0 16.3 16.3 17.2 14.1 17.1 17.4 7.5 6.4 12.9 13.7 11.4 3.7 6.7 9.7 7.4 16.9 14.7 19.0 8.6 11.5 7.4 7.3 47.9 16.9 7.5 9.1 5.9 9.6 25.2 7.3 7.5 7.6 13.1 25.9 10.4 21.5 9.8 9.6 20.9 6.6 14.0 20.9 8.6 10.9 11.2 21.9 7.9 13.6 18.3 17.7 6.0 51.6 14.0 9.6 10.6 2.8 18.0 10.1 13.4 8.5 9.9 13.7 9.2 11.3 10.9 6.5 13.7 11.6 7.2 24.0 13.1 10.8 9.6 35.5 11.0 8.4 2.0 11.5 9.4 14.4 15.6 5.6 FBXW4 "dactylin, Fbw4, SHFM3" ENSG00000107829 "F-box and WD repeat domain containing 4" P57775 10 101610664-101695295 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043496 Approved Approved "Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA043496: AB_2678514" "unprognostic (4.31e-2)" "unprognostic (5.43e-3)" "unprognostic (8.40e-3)" "prognostic favorable (4.91e-4)" "unprognostic (2.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-1)" "unprognostic (9.96e-3)" "unprognostic (1.87e-1)" "unprognostic (3.96e-1)" "prognostic favorable (4.67e-4)" "unprognostic (1.13e-2)" "prognostic favorable (3.41e-5)" "unprognostic (2.94e-3)" "unprognostic (1.81e-1)" "unprognostic (4.99e-2)" "unprognostic (1.85e-2)" 38.4 30.4 89.9 10.4 96.6 16.0 34.8 83.5 96.3 33.2 71.3 59.9 16.5 26.7 29.6 38.7 28.9 12.9 62.4 80.9 81.1 36.4 34.9 35.8 18.0 92.3 92.1 30.2 44.2 47.0 46.7 16.4 87.8 49.1 16.5 14.2 41.4 26.8 80.0 49.7 31.5 14.7 94.8 30.1 40.8 22.8 94.2 18.1 40.2 44.4 17.9 49.0 32.9 98.0 22.1 25.7 4.0 28.9 20.1 16.5 18.9 11.3 31.1 12.8 10.0 12.0 22.9 25.1 17.5 23.4 13.1 13.4 11.0 16.7 4.3 26.8 15.2 6.0 9.1 26.1 35.7 10.0 7.6 15.2 52.0 6.9 42.8 29.8 11.0 17.6 6.2 15.3 14.2 45.9 11.4 14.2 11.3 11.4 12.3 9.4 29.6 10.7 25.1 14.7 12.3 21.6 21.8 8.1 20.7 6.0 33.6 17.8 11.8 13.8 1.8 5.8 11.5 31.9 15.4 11.1 11.3 12.7 8.1 1.3 1.4 2.2 4.3 0.8 2.6 3.8 4.3 4.2 1.1 4.8 4.5 3.7 0.2 4.2 1.4 4.1 1.4 1.2 89.9 96.6 83.5 96.3 80.9 81.1 92.3 92.1 87.8 94.8 94.2 98.0 13.6 3.2 36.9 45.4 14.0 11.2 16.4 11.9 6.8 28.5 25.7 21.8 35.8 12.8 11.1 11.0 18.8 17.0 24.4 29.1 3.9 15.2 50.2 15.3 16.3 10.0 20.4 7.0 57.5 26.1 9.2 11.3 17.3 27.2 5.1 32.3 8.9 24.7 8.8 37.0 55.7 27.8 14.2 8.6 7.4 28.9 14.3 8.7 14.2 55.3 10.7 29.9 15.5 54.8 70.3 19.4 24.4 17.0 14.1 22.2 21.1 13.3 7.5 22.7 13.1 15.4 14.7 4.9 6.0 11.3 12.5 15.6 16.9 10.9 21.7 18.7 FGF8 AIGF ENSG00000107831 "Fibroblast growth factor 8" P55075 10 101770130-101780369 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "skeletal muscle: 48.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.1;testis cancer: 3.3" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 17 "RH-30: 37.8" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (1.56e-1)" "unprognostic (3.90e-3)" "unprognostic (1.12e-2)" "unprognostic (4.88e-1)" "unprognostic (2.47e-2)" "unprognostic (9.09e-2)" "unprognostic (8.75e-3)" "unprognostic (8.12e-2)" "unprognostic (1.75e-1)" "unprognostic (2.95e-2)" "unprognostic (1.17e-2)" "unprognostic (2.35e-9)" "unprognostic (6.17e-3)" "unprognostic (9.01e-2)" "unprognostic (1.97e-1)" 0.5 0.0 0.7 0.0 0.7 0.2 0.2 0.6 1.2 0.1 0.8 0.2 0.3 0.2 0.2 0.9 0.1 0.3 0.3 0.9 1.1 0.1 0.1 0.3 0.3 0.5 0.7 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.1 0.5 0.0 0.1 48.7 0.2 0.0 0.0 0.4 0.6 0.1 1.1 0.7 0.0 0.2 0.0 0.0 0.2 0.0 1.0 0.6 0.1 0.3 1.4 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.6 0.7 0.4 0.6 0.0 0.0 0.5 0.3 0.0 0.0 1.1 1.0 0.4 0.3 0.5 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.0 1.0 0.3 0.9 0.0 0.4 0.6 2.2 0.2 0.0 0.1 0.6 37.8 0.8 0.0 0.2 0.9 0.9 0.0 0.6 0.5 0.0 0.6 0.1 0.6 0.6 1.1 0.8 0.2 0.2 0.8 1.3 0.8 0.7 0.8 1.9 0.4 0.5 0.3 0.5 0.6 0.4 0.4 0.4 0.4 0.5 0.6 0.5 1.1 0.7 0.9 0.4 0.5 0.3 0.7 0.7 0.6 1.2 0.9 1.1 0.5 0.7 0.6 0.4 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NPM3 ENSG00000107833 "Nucleophosmin/nucleoplasmin 3" O75607 10 101781325-101783413 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036295, HPA036296" Approved Approved "Nucleoli,Actin filaments,Cytosol" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 32: Non-specific - Translation" "Nucleoli, Actin filaments, Cytosol" "HPA036295: AB_10671244, HPA036296: AB_10672083" "unprognostic (3.41e-2)" "unprognostic (3.70e-2)" "unprognostic (4.33e-2)" "unprognostic (1.75e-1)" "unprognostic (8.06e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (1.00e-2)" "unprognostic (1.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.75e-1)" "unprognostic (2.45e-2)" "unprognostic (1.35e-2)" "unprognostic (2.86e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (5.69e-2)" "unprognostic (9.58e-2)" 12.7 19.5 9.9 18.5 10.2 27.2 19.0 7.8 10.4 19.6 9.6 15.5 8.3 17.2 10.1 26.6 15.3 9.8 8.4 9.6 11.6 16.4 12.3 10.2 23.3 8.4 8.5 20.6 30.3 16.4 12.4 16.3 8.6 13.4 19.3 1.1 15.1 8.2 13.3 16.7 10.7 19.9 8.5 14.8 13.1 17.1 11.6 20.3 11.1 10.1 25.9 20.9 16.7 9.3 94.8 117.2 34.2 226.2 76.5 80.0 36.1 50.0 75.7 75.8 64.4 126.5 117.1 154.8 91.0 56.0 41.6 99.2 192.6 211.8 59.3 66.1 199.8 124.5 50.5 206.0 86.1 286.6 87.4 69.6 100.8 105.2 417.0 39.0 100.6 187.1 156.9 83.7 63.3 173.8 121.0 371.8 60.7 131.1 89.1 93.3 179.2 158.0 75.0 45.8 70.0 45.1 31.2 72.5 144.7 41.8 94.4 59.0 40.1 30.0 95.8 44.8 94.1 36.0 39.9 179.7 41.9 263.4 31.8 0.0 2.8 0.0 3.6 4.0 6.5 4.0 5.9 6.9 6.4 4.8 9.5 9.8 0.1 8.1 0.8 8.3 2.6 5.1 9.9 10.2 7.8 10.4 9.6 11.6 8.4 8.5 8.6 8.5 11.6 9.3 5.1 3.2 5.0 1.0 15.3 62.7 79.6 121.4 28.5 1.4 55.5 54.4 2.9 28.6 32.0 36.8 0.0 91.4 15.6 16.3 78.2 54.0 8.9 7.3 22.1 21.6 24.2 17.9 2.7 41.2 90.6 29.7 13.7 10.5 16.5 19.6 15.0 19.0 68.6 0.0 2.0 33.1 46.8 21.1 69.9 10.9 28.0 18.0 30.2 1.9 14.7 2.5 18.6 1.5 1.0 34.2 12.7 23.7 19.1 118.5 3.1 61.6 16.4 2.0 6.6 47.9 21.6 46.5 91.3 21.3 49.9 60.7 18.5 29.0 46.9 62.8 OGA "MEA5, MGEA5, NCOAT" ENSG00000198408 O-GlcNAcase O60502 10 101784443-101818465 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 86.5;dendritic cells: 89.3;Glandular and luminal cells: 83.7;Granulosa cells: 69.4;Pancreatic endocrine cells: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036141, HPA076501" Approved Supported Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 6: Brain - Smell perception" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA036141: AB_10672079, HPA076501: AB_2686802" "unprognostic (4.34e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (8.69e-5)" "unprognostic (4.63e-1)" "unprognostic (2.06e-1)" "unprognostic (2.57e-2)" "unprognostic (2.65e-1)" "unprognostic (1.79e-2)" "unprognostic (2.44e-1)" "unprognostic (1.21e-3)" "unprognostic (6.00e-2)" "unprognostic (7.81e-2)" "unprognostic (1.68e-1)" "unprognostic (3.01e-1)" "unprognostic (3.21e-2)" "unprognostic (1.90e-1)" "unprognostic (9.23e-3)" 65.3 34.1 77.3 46.7 80.3 89.0 59.2 99.3 82.8 62.2 54.3 64.8 28.1 50.0 55.5 57.4 52.9 29.8 60.7 82.2 74.0 45.6 46.0 52.9 69.8 66.8 70.3 66.8 42.9 60.6 44.9 41.0 67.7 52.7 40.7 99.8 50.5 38.9 56.6 72.7 62.8 35.4 68.6 74.4 46.4 38.6 84.3 67.6 51.7 29.5 64.8 57.0 58.6 77.6 89.8 44.7 63.7 124.6 40.0 96.6 44.4 61.7 61.8 28.1 48.0 33.1 56.0 59.6 43.7 73.7 48.2 62.9 60.3 77.5 59.2 87.9 41.2 59.6 65.0 26.0 43.1 44.4 32.3 93.9 85.1 48.1 113.7 80.0 53.0 53.1 42.8 107.3 48.3 45.6 47.2 46.1 35.4 19.4 44.8 64.8 70.5 44.0 47.2 80.0 27.7 48.8 55.2 29.4 78.2 58.0 77.9 47.7 80.9 43.0 41.6 63.0 71.6 53.1 91.0 47.2 54.0 74.6 24.0 14.4 2.1 7.2 6.4 2.0 5.1 6.6 4.5 5.8 1.3 7.5 6.1 5.2 14.1 6.6 6.3 3.3 4.6 1.5 77.3 80.3 99.3 82.8 82.2 74.0 66.8 70.3 67.7 68.6 84.3 77.6 66.3 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 66.5 47.0 0.0 0.0 0.0 86.5 0.0 41.9 89.3 0.0 13.7 38.0 0.0 61.6 68.3 18.1 0.0 0.0 0.0 40.9 34.3 20.3 0.0 83.7 0.0 69.4 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 48.6 0.0 0.0 0.0 0.0 82.4 0.0 0.0 44.3 0.0 0.0 34.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 50.9 34.6 44.8 0.0 0.0 KCNIP2 KCHIP2 ENSG00000120049 "Potassium voltage-gated channel interacting protein 2" Q9NS61 10 101825974-101843920 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 227.4;brain: 139.6;heart muscle: 307.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 54.3;Cardiomyocytes: 135.7;Cone photoreceptor cells: 25.0;Excitatory neurons: 23.3;Horizontal cells: 48.8;Inhibitory neurons: 41.9" "Cancer enhanced" "Detected in many" "glioma: 3.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 21.3;HMC-1: 12.7" "Group enriched" "Detected in all" 4 "amygdala: 96.8;basal ganglia: 234.9;cerebral cortex: 106.9;hippocampal formation: 142.6;olfactory bulb: 144.0" "Low region specificity" "Detected in all" HPA066717 Approved Vesicles NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 56: Bipolar cells - Visual perception" Vesicles "HPA066717: " "unprognostic (5.92e-2)" "unprognostic (2.16e-1)" "unprognostic (3.48e-3)" "unprognostic (5.77e-4)" "unprognostic (1.34e-1)" "unprognostic (1.31e-3)" "unprognostic (8.80e-2)" "unprognostic (9.11e-3)" "unprognostic (1.14e-1)" "unprognostic (5.34e-2)" "unprognostic (3.18e-2)" "unprognostic (7.20e-2)" "unprognostic (1.49e-9)" "unprognostic (9.85e-2)" "unprognostic (1.81e-1)" "unprognostic (3.27e-1)" "unprognostic (8.37e-4)" 227.4 6.8 74.5 3.5 139.6 0.9 67.1 48.8 84.5 7.4 40.5 5.0 1.8 4.1 4.1 2.5 4.9 3.1 307.5 98.8 50.6 2.8 2.3 2.5 8.1 47.5 51.6 11.5 2.4 1.7 19.7 2.9 48.1 5.2 4.7 52.6 9.9 3.5 8.0 5.9 5.3 2.6 50.3 5.7 2.7 8.5 57.1 2.3 3.5 5.4 8.3 4.8 4.4 60.8 1.7 2.6 2.5 3.2 1.0 1.1 0.6 1.2 1.0 0.6 0.9 3.6 3.4 1.6 0.9 0.8 0.7 1.7 0.9 0.4 0.6 2.4 2.0 21.3 3.0 1.9 0.9 1.4 12.7 2.6 1.7 1.0 1.4 3.7 1.0 4.7 6.3 1.8 1.0 1.2 0.8 4.0 0.8 0.7 0.6 1.0 0.2 1.4 1.0 1.1 7.4 1.2 0.8 0.6 2.4 1.5 2.2 0.9 2.3 1.3 2.0 0.6 1.2 1.7 1.9 1.7 1.4 5.3 0.2 0.0 0.0 0.7 0.0 0.5 0.1 0.9 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 74.5 139.6 48.8 84.5 98.8 50.6 47.5 51.6 48.1 50.3 57.1 60.8 0.4 0.0 0.0 8.5 2.3 0.4 0.1 0.3 0.0 54.3 0.3 0.5 135.7 0.0 0.1 1.8 25.0 0.2 0.0 0.8 0.0 0.2 6.6 0.0 0.2 1.6 0.0 0.0 23.3 0.0 0.2 5.8 0.0 0.0 0.0 0.8 0.4 0.1 2.2 48.8 41.9 0.4 0.0 0.6 0.8 5.2 1.8 0.3 0.0 1.0 0.5 8.3 0.0 5.5 3.7 0.3 0.2 0.7 0.3 0.1 0.5 0.1 0.2 4.7 0.0 0.1 1.3 2.5 5.5 0.5 0.0 0.3 0.1 0.5 0.3 0.1 ARMH3 "C10orf76, FLJ13114" ENSG00000120029 "Armadillo like helical domain containing 3" Q5T2E6 10 101845599-102056193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 11.2;dendritic cells: 10.5;Extravillous trophoblasts: 14.8;Granulosa cells: 11.5;Hofbauer cells: 12.6;Syncytiotrophoblasts: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050913, HPA053580" Approved Approved Vesicles NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 23: Testis - Cell cycle regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA050913: AB_2681270, HPA053580: AB_2682198" "unprognostic (5.88e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "unprognostic (3.41e-2)" "unprognostic (9.41e-2)" "unprognostic (9.55e-2)" "unprognostic (5.28e-2)" "unprognostic (1.92e-2)" "unprognostic (1.18e-1)" "unprognostic (6.03e-3)" "unprognostic (1.40e-3)" "unprognostic (2.76e-1)" "unprognostic (1.86e-2)" "unprognostic (1.16e-1)" "unprognostic (2.48e-1)" "unprognostic (3.85e-1)" "unprognostic (4.87e-2)" 10.4 9.1 5.9 12.0 7.6 21.8 9.9 10.2 7.3 11.2 8.0 12.5 12.8 10.5 9.4 14.3 10.5 9.2 16.6 5.7 7.3 10.0 12.0 11.8 12.7 7.1 8.2 11.2 10.1 16.4 7.9 11.0 6.1 10.8 13.2 16.3 9.5 10.5 19.7 12.2 12.2 12.9 6.0 13.6 10.3 8.9 6.7 13.1 10.0 19.8 13.3 10.8 10.1 7.9 23.2 17.7 15.5 19.1 12.9 17.3 13.9 20.3 24.0 20.0 16.9 12.2 18.6 17.0 13.5 22.9 14.5 17.7 20.4 22.4 18.3 17.9 18.9 30.3 15.9 14.6 15.2 21.3 26.4 16.0 17.7 22.6 19.9 23.4 15.3 15.3 0.9 15.9 16.6 14.4 16.5 13.8 8.5 18.8 11.6 16.0 28.1 11.0 16.4 18.6 7.3 12.1 15.8 10.9 21.0 15.8 28.8 12.4 15.1 10.5 17.1 9.8 14.7 15.4 17.0 17.1 16.9 23.7 7.9 19.4 7.3 7.4 5.9 8.7 5.5 6.1 6.2 4.5 7.7 7.0 4.8 4.9 1.9 5.2 10.7 7.4 6.0 4.7 5.9 7.6 10.2 7.3 5.7 7.3 7.1 8.2 6.1 6.0 6.7 7.9 8.8 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 7.4 6.0 0.0 0.0 0.0 0.0 0.0 11.2 10.5 0.0 1.9 7.8 0.0 6.9 6.8 1.9 0.0 0.0 0.0 9.7 14.8 2.7 0.0 7.7 0.0 11.5 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 9.9 0.0 0.0 2.2 0.0 0.0 7.6 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 16.3 3.9 5.7 0.0 0.0 HPS6 "BLOC2S3, FLJ22501" ENSG00000166189 "HPS6 biogenesis of lysosomal organelles complex 2 subunit 3" Q86YV9 10 102065349-102068036 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040687 Approved NA NA "Cluster 15: NK-cells - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA040687: AB_2677078" "unprognostic (4.15e-1)" "unprognostic (2.23e-1)" "unprognostic (8.74e-2)" "unprognostic (1.38e-2)" "unprognostic (3.30e-1)" "unprognostic (2.07e-1)" "unprognostic (1.14e-2)" "unprognostic (9.21e-2)" "unprognostic (3.04e-2)" "unprognostic (2.39e-1)" "unprognostic (1.23e-2)" "unprognostic (4.23e-1)" "unprognostic (5.86e-3)" "unprognostic (5.53e-2)" "unprognostic (1.66e-1)" "unprognostic (2.88e-1)" "unprognostic (5.50e-2)" 6.2 8.0 4.3 6.5 4.4 7.5 6.0 4.0 5.3 6.1 3.3 8.1 7.8 9.0 3.5 10.3 7.2 4.1 7.1 4.6 4.4 5.6 6.6 6.5 7.7 5.4 4.2 5.5 9.2 6.7 4.4 5.6 4.4 5.0 4.7 1.9 7.6 5.6 8.1 9.0 8.3 5.1 4.1 9.2 8.5 3.6 5.1 5.6 4.9 5.9 6.5 7.0 5.8 4.1 26.0 21.5 6.3 17.3 19.4 14.0 13.5 16.8 25.0 20.0 16.3 11.5 17.4 13.6 16.7 18.8 11.4 25.9 11.9 27.4 5.3 19.8 16.4 14.1 10.1 8.4 12.2 16.5 17.0 15.6 28.0 12.7 16.1 20.2 14.6 11.8 9.6 7.4 15.9 17.5 12.2 21.8 6.2 12.1 17.5 16.7 2.2 11.8 17.3 11.8 4.6 13.0 9.8 11.9 13.1 8.1 23.4 20.9 19.0 7.6 9.3 7.6 17.3 12.7 10.5 9.8 15.4 19.3 6.1 0.0 1.9 2.5 3.1 2.9 2.7 2.3 2.6 2.6 1.8 1.6 1.2 1.5 2.1 3.9 1.4 3.0 2.0 1.2 4.3 4.4 4.0 5.3 4.6 4.4 5.4 4.2 4.4 4.1 5.1 4.1 4.2 9.6 2.6 1.3 6.9 1.9 7.7 4.5 3.4 8.1 2.8 2.8 6.2 4.3 4.3 5.5 12.5 12.4 4.7 9.2 7.9 12.4 0.1 3.0 3.7 4.8 2.4 6.1 1.2 14.9 9.5 4.5 4.6 3.2 0.0 4.6 6.1 6.7 10.6 10.1 1.2 5.8 0.0 6.3 2.7 0.9 7.5 4.8 5.4 1.0 10.5 10.1 10.3 1.5 0.6 12.6 5.8 5.3 4.2 6.3 8.7 6.2 3.7 5.1 0.0 4.3 5.6 2.4 4.2 6.0 2.4 10.1 5.9 5.3 9.0 6.3 LDB1 "CLIM2, NLI" ENSG00000198728 "LIM domain binding 1" Q86U70 10 102106489-102120368 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034488 Approved Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 36: HEL - Hemostasis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA034488: AB_10669783" "unprognostic (8.83e-2)" "unprognostic (3.71e-2)" "unprognostic (1.97e-3)" "unprognostic (4.54e-2)" "unprognostic (1.35e-1)" "unprognostic (5.01e-3)" "unprognostic (1.55e-2)" "unprognostic (1.04e-3)" "unprognostic (2.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-3)" "unprognostic (8.25e-2)" "unprognostic (2.54e-1)" "unprognostic (3.19e-1)" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (1.26e-2)" 41.3 38.0 48.0 42.9 51.2 122.4 44.0 42.8 57.4 89.1 55.8 73.8 31.1 81.5 38.1 54.1 68.9 49.1 60.6 49.4 47.0 40.5 20.5 46.6 61.5 42.1 42.2 117.9 29.4 55.6 52.3 49.1 40.0 58.4 27.5 41.6 65.6 71.6 52.5 149.9 51.7 52.8 38.2 60.8 44.4 30.6 45.8 59.3 49.5 31.6 55.3 65.4 72.4 48.5 42.6 53.5 105.8 128.0 41.3 44.6 52.7 43.8 70.2 48.7 42.3 38.3 36.3 64.8 60.8 56.7 23.0 85.8 48.9 87.3 25.9 55.7 46.9 208.2 62.7 38.6 49.0 56.1 67.8 97.4 70.0 40.2 46.3 177.3 52.0 59.7 128.3 69.1 38.6 41.9 101.1 89.5 52.1 20.4 26.4 112.0 68.4 46.9 46.7 47.3 42.6 103.8 30.9 34.1 51.6 69.0 162.5 36.3 53.8 29.5 60.0 26.8 37.3 58.7 54.4 44.3 49.7 125.7 27.2 2.9 2.0 1.9 2.1 2.9 1.3 2.0 1.5 2.1 1.3 2.4 2.0 1.6 4.8 2.0 4.9 1.4 1.6 1.3 48.0 51.2 42.8 57.4 49.4 47.0 42.1 42.2 40.0 38.2 45.8 48.5 6.4 32.1 11.0 5.2 8.1 22.8 2.8 4.6 17.6 18.5 8.4 7.9 9.1 2.8 6.9 3.7 4.2 4.8 11.7 3.2 0.0 7.7 2.1 7.7 11.1 6.9 8.3 17.0 9.8 5.6 6.3 7.0 5.6 9.3 9.5 9.5 5.3 2.2 8.9 15.2 10.4 1.4 4.1 5.4 7.5 3.0 6.2 7.3 3.6 12.2 4.0 11.8 6.2 5.5 6.6 7.5 2.0 6.4 7.7 2.7 1.9 1.4 3.5 6.1 0.0 6.9 8.2 7.6 7.3 10.7 21.2 7.8 10.0 10.3 2.6 2.0 PPRC1 "KIAA0595, MGC74642, PRC" ENSG00000148840 "PPARG related coactivator 1" Q5VV67 10 102132994-102150333 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038511, HPA057571" Approved Enhanced Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA038511: AB_10672521, HPA057571: AB_2683472" "unprognostic (2.27e-1)" "unprognostic (7.66e-2)" "unprognostic (2.35e-2)" "unprognostic (4.77e-2)" "unprognostic (1.63e-1)" "unprognostic (4.96e-2)" "unprognostic (4.29e-3)" "unprognostic (6.31e-2)" "unprognostic (3.95e-2)" "unprognostic (1.26e-1)" "unprognostic (2.33e-1)" "unprognostic (2.86e-1)" "prognostic unfavorable (6.71e-7)" "unprognostic (8.65e-2)" "unprognostic (4.22e-1)" "unprognostic (1.12e-1)" "unprognostic (4.93e-2)" 31.0 19.2 10.3 13.1 10.9 19.0 19.3 9.8 10.7 20.3 12.0 23.2 8.1 21.8 8.1 25.2 21.7 11.9 19.2 10.2 12.0 21.2 19.4 26.3 13.7 11.7 11.4 25.0 24.9 9.4 17.9 13.4 11.2 19.2 8.2 5.1 16.3 8.0 28.8 29.2 16.1 14.2 10.3 19.8 20.4 14.2 11.2 11.0 16.0 12.1 13.7 21.0 20.2 11.5 30.7 44.3 27.0 54.5 23.6 24.2 34.7 26.7 35.9 37.9 31.2 51.1 34.1 66.4 21.8 40.5 23.8 56.7 55.4 52.8 32.6 27.5 43.4 63.5 33.9 48.7 31.4 50.6 26.3 31.9 46.9 44.3 82.8 24.9 23.9 26.5 48.0 38.4 29.9 52.4 40.5 70.0 46.6 29.0 26.7 55.9 38.6 28.2 32.7 30.1 18.6 26.9 23.3 25.2 32.7 25.9 40.8 26.4 26.1 30.1 38.0 30.9 61.2 31.8 24.3 59.6 33.8 61.7 15.4 0.0 1.2 0.1 1.8 1.3 2.3 1.5 1.4 2.3 2.6 1.8 1.7 2.1 0.0 4.1 1.3 1.0 0.9 1.3 10.3 10.9 9.8 10.7 10.2 12.0 11.7 11.4 11.2 10.3 11.2 11.5 16.4 28.9 13.2 6.5 13.4 44.4 33.1 6.1 48.9 4.7 17.5 12.4 9.1 8.6 9.5 5.5 4.2 7.6 9.2 7.9 1.9 8.0 1.1 16.3 16.1 15.6 8.4 10.7 6.8 9.6 12.9 13.7 32.1 31.3 10.8 9.5 6.8 7.2 8.7 1.7 6.2 11.2 6.1 5.3 15.9 2.4 6.2 9.7 8.8 2.8 3.9 2.2 9.2 5.5 5.3 14.0 5.8 6.4 21.4 26.0 2.8 2.4 3.8 4.1 6.6 35.6 18.2 6.3 14.8 36.0 43.5 5.1 10.8 7.8 11.4 30.0 NOLC1 "KIAA0035, NOPP130, NOPP140, P130, Srp40" ENSG00000166197 "Nucleolar and coiled-body phosphoprotein 1" Q14978 10 102152176-102163871 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032654, HPA037366, HPA050388" Supported Enhanced "Nucleoli fibrillar center" No Yes 44000 "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli fibrillar center" "CAB032654: AB_2152006, HPA037366: AB_10670930, HPA050388: AB_2681109" "unprognostic (3.23e-1)" "unprognostic (5.58e-2)" "unprognostic (9.44e-2)" "unprognostic (9.13e-2)" "unprognostic (8.89e-2)" "unprognostic (7.03e-3)" "unprognostic (2.36e-3)" "unprognostic (7.34e-3)" "unprognostic (3.43e-1)" "unprognostic (3.74e-1)" "unprognostic (5.64e-3)" "unprognostic (3.73e-2)" "prognostic unfavorable (9.19e-5)" "unprognostic (3.15e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (8.25e-5)" "unprognostic (7.68e-2)" 36.5 23.9 10.7 41.9 12.3 37.2 32.3 14.6 20.5 27.1 4.5 31.8 21.8 30.3 18.7 33.3 34.4 29.0 24.0 12.6 18.2 21.4 37.5 24.9 43.1 10.9 14.4 34.4 38.4 42.9 14.6 38.3 11.9 31.5 39.1 38.0 26.3 26.6 45.3 21.9 22.8 33.8 10.8 27.6 27.4 19.3 12.2 54.2 37.6 46.4 55.7 64.2 19.6 18.3 202.1 175.1 98.2 209.0 84.7 66.0 166.6 108.5 87.8 150.1 130.5 302.1 132.4 401.5 118.1 69.5 73.9 225.1 285.0 236.1 173.3 127.0 194.8 267.9 143.6 200.3 112.0 389.8 122.8 86.3 169.8 158.3 328.7 94.5 96.5 194.3 286.6 172.6 102.6 170.3 373.7 95.0 196.5 150.7 137.1 277.3 261.6 233.3 100.2 123.5 148.3 141.9 103.5 124.1 144.5 95.6 207.5 99.3 79.3 67.7 93.5 81.3 256.9 165.5 254.4 442.4 110.5 422.7 60.7 2.4 12.5 11.6 20.4 14.4 24.9 16.6 16.1 19.2 16.2 12.1 18.5 22.6 1.3 17.3 17.2 12.4 13.0 17.9 10.7 12.3 14.6 20.5 12.6 18.2 10.9 14.4 11.9 10.8 12.2 18.3 47.8 60.9 74.7 6.2 47.6 120.4 112.6 37.7 101.9 20.8 52.6 48.0 35.3 20.0 68.2 16.5 14.6 49.2 29.1 28.3 25.4 42.2 29.0 38.5 56.3 47.3 27.6 56.8 8.8 23.1 62.7 63.9 43.3 73.1 44.2 28.6 16.8 23.4 27.1 10.1 7.9 38.3 18.3 11.2 46.0 9.7 23.0 26.8 26.6 4.7 22.9 15.1 32.0 2.5 6.8 48.8 21.0 21.1 62.3 89.5 10.2 19.9 56.6 20.0 6.6 85.8 58.9 32.1 53.5 103.3 117.5 48.6 44.5 40.1 49.1 100.5 ELOVL3 CIG-30 ENSG00000119915 "ELOVL fatty acid elongase 3" Q9HB03 10 102226299-102229589 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 30.5" "Cell type enhanced" "Detected in some" "Adipocytes: 2.5;Breast myoepithelial cells: 3.2;Skeletal myocytes: 5.0;Spermatogonia: 3.4;Theca cells: 2.2" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 10 "classical monocyte: 7.1;intermediate monocyte: 2.4;myeloid DC: 2.0;non-classical monocyte: 5.9" "Group enriched" "Detected in many" 10 "dendritic cells: 2.0;monocytes: 7.1" "Cell line enhanced" "Detected in many" "ASC diff: 9.5;ASC TERT1: 9.4;HSkMC: 13.9;NB-4: 11.6;SiHa: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA036236 Enhanced Approved Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Cytosol" "HPA036236: AB_10601550" "unprognostic (1.52e-2)" "unprognostic (6.76e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (6.25e-5)" "unprognostic (8.23e-3)" "unprognostic (9.82e-2)" "unprognostic (2.17e-4)" "unprognostic (4.27e-2)" "unprognostic (2.28e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (5.36e-3)" "unprognostic (2.66e-9)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" 3.2 0.7 1.0 0.3 0.8 1.8 3.5 0.5 1.3 0.1 0.3 0.1 0.0 0.1 0.2 0.2 0.2 0.2 0.2 1.0 0.4 0.8 0.0 1.0 0.1 0.4 0.9 0.1 0.0 0.1 0.0 0.9 0.4 0.2 0.1 0.1 0.3 0.1 0.2 30.5 0.2 0.0 0.4 0.8 0.1 1.2 0.4 0.0 0.0 0.3 0.0 0.2 0.3 0.5 3.2 0.2 0.2 7.8 9.5 9.4 2.8 0.1 0.3 0.4 0.5 0.5 3.0 0.0 0.3 0.0 0.0 0.1 5.9 0.1 0.5 0.0 0.0 0.2 0.4 0.8 0.3 0.0 0.1 13.9 1.6 3.6 0.0 0.0 0.0 0.9 0.1 3.5 0.8 0.0 0.0 11.6 0.1 1.1 1.0 0.0 5.1 0.0 2.0 0.1 0.0 0.4 22.6 0.9 0.7 0.6 8.1 2.7 0.0 1.5 0.0 0.3 0.3 0.5 7.2 0.0 3.4 6.5 0.0 0.0 7.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 5.9 0.0 0.0 1.7 1.0 0.8 0.5 1.3 1.0 0.4 0.4 0.9 0.4 0.4 0.4 0.5 2.5 0.0 1.1 0.0 0.2 0.4 0.5 0.6 0.6 0.0 1.1 3.2 0.3 0.0 0.5 0.0 0.0 0.0 1.1 0.2 0.0 0.1 0.0 0.0 1.3 1.9 0.0 0.0 0.3 0.0 0.7 1.3 0.0 0.2 0.0 0.0 1.4 0.4 0.2 0.0 0.0 0.2 0.0 1.5 0.8 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 5.0 1.2 0.1 3.4 0.6 0.1 0.3 0.3 2.2 0.2 0.1 PITX3 ASMD ENSG00000107859 "Paired like homeodomain 3" O75364 10 102230186-102241512 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 5.5;skeletal muscle: 16.5;tongue: 6.0" "Cell type enriched" "Detected in some" 4 "Skeletal myocytes: 22.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 14 "midbrain: 5.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "RH-30: 30.3" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 9.1" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (8.13e-2)" "unprognostic (4.07e-1)" "unprognostic (5.15e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (6.04e-5)" "unprognostic (6.30e-3)" "unprognostic (2.02e-1)" "unprognostic (6.36e-2)" "unprognostic (2.67e-2)" "unprognostic (3.73e-2)" "unprognostic (1.76e-2)" "unprognostic (6.76e-3)" "unprognostic (4.13e-2)" 1.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.1 0.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 16.5 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.2 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 30.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.0 5.5 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 22.1 0.3 1.4 1.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 GBF1 "ARF1GEF, KIAA0248" ENSG00000107862 "Golgi brefeldin A resistant guanine nucleotide exchange factor 1" Q92538 10 102245371-102382899 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 28.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037759, HPA037760" Uncertain Supported "Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA037759: AB_10671884, HPA037760: AB_2675651" "unprognostic (5.97e-2)" "unprognostic (3.33e-1)" "unprognostic (2.74e-3)" "unprognostic (7.02e-2)" "unprognostic (2.03e-1)" "unprognostic (6.72e-2)" "unprognostic (3.78e-2)" "unprognostic (8.28e-2)" "unprognostic (1.12e-2)" "unprognostic (5.34e-3)" "unprognostic (2.04e-2)" "unprognostic (6.06e-2)" "unprognostic (1.87e-1)" "unprognostic (2.10e-1)" "unprognostic (2.24e-1)" "unprognostic (3.02e-1)" "unprognostic (3.09e-2)" 19.4 21.1 31.5 16.0 31.7 25.0 19.3 28.7 47.2 21.7 34.9 24.6 20.6 23.5 12.7 21.9 19.7 9.8 30.0 32.2 27.7 21.7 23.2 20.5 14.6 28.5 37.3 21.6 25.6 24.4 31.5 11.5 30.6 24.2 13.9 19.2 24.5 15.2 48.1 24.9 25.8 16.4 27.1 21.7 21.2 20.5 29.8 11.8 25.4 30.1 13.8 21.7 20.5 29.1 19.4 49.7 23.3 25.1 62.9 40.7 28.1 37.7 56.0 45.3 48.1 52.7 35.1 21.7 29.7 59.6 33.8 38.6 45.9 52.8 33.8 35.4 36.9 33.3 38.1 44.6 26.4 35.2 46.8 37.3 28.0 60.7 57.5 77.2 45.2 22.5 20.7 53.7 41.8 36.9 24.2 38.9 15.4 29.5 35.6 33.6 72.1 18.8 39.3 30.9 15.0 16.3 30.2 22.3 26.5 33.1 50.4 30.8 60.5 29.1 29.6 37.7 55.6 32.4 36.3 26.5 30.0 36.3 22.1 28.6 4.5 4.3 4.9 5.0 5.9 6.5 3.6 6.5 5.0 3.9 5.7 5.3 4.6 4.6 4.1 4.2 7.4 3.9 31.5 31.7 28.7 47.2 32.2 27.7 28.5 37.3 30.6 27.1 29.8 29.1 12.5 12.8 10.1 56.5 15.5 9.8 5.5 10.6 17.6 24.7 15.7 12.8 17.0 15.7 10.9 12.9 56.3 12.2 15.1 31.4 3.9 12.5 4.9 14.3 18.1 12.3 12.0 13.9 72.1 16.7 16.3 14.6 31.1 15.6 7.6 10.3 8.2 17.6 12.2 52.2 73.0 21.9 12.2 11.0 5.0 4.7 10.2 13.4 12.4 66.5 9.5 11.1 9.2 80.9 71.1 18.6 20.7 11.3 46.0 7.7 27.1 9.0 12.3 41.0 6.6 21.7 12.3 36.0 25.4 20.7 13.1 17.6 16.0 19.1 19.4 6.7 NFKB2 "LYT-10, NF-kB2, p105, p49/p100, p52" ENSG00000077150 "Nuclear factor kappa B subunit 2" Q00653 10 102394110-102402524 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 168.0;Karpas-707: 157.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008422, CAB022098, HPA023900" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 41: Macrophages - Immune response" Cytosol Nucleoplasm "CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435" "unprognostic (1.10e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.86e-4)" "unprognostic (1.53e-2)" "unprognostic (8.08e-3)" "unprognostic (2.15e-1)" "unprognostic (2.38e-3)" "unprognostic (3.98e-2)" "prognostic favorable (8.45e-5)" "unprognostic (4.04e-1)" "unprognostic (8.34e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (6.69e-12)" "unprognostic (2.37e-3)" "unprognostic (1.63e-1)" "unprognostic (4.90e-2)" "unprognostic (1.56e-1)" 26.5 21.0 7.6 44.4 7.4 69.3 19.6 7.1 9.2 22.9 8.5 39.1 15.5 21.6 2.3 17.7 20.4 18.5 20.6 7.2 7.2 34.6 28.2 41.0 40.7 8.5 7.5 21.4 24.1 6.1 10.8 14.7 8.0 29.0 6.8 1.1 21.3 9.1 18.4 20.0 26.5 12.2 7.5 50.6 22.7 10.0 8.4 16.9 20.1 7.6 25.7 37.0 19.1 8.0 67.9 48.6 7.7 31.7 11.1 16.6 19.3 18.5 61.0 19.6 25.9 28.6 55.2 32.9 43.5 11.9 48.8 40.9 20.5 28.2 6.8 168.0 11.2 7.0 11.7 15.9 30.1 5.1 45.5 22.0 14.6 34.1 32.3 26.5 7.8 16.1 7.6 157.8 7.4 26.4 7.1 22.7 10.3 15.7 16.6 16.8 24.5 27.0 34.3 22.1 1.7 8.2 16.2 36.7 26.3 7.2 29.3 16.4 21.2 19.0 28.9 25.4 47.0 113.1 105.0 32.6 31.1 14.8 10.9 0.0 1.3 0.0 0.7 0.9 0.7 2.6 0.8 0.7 0.7 2.1 0.8 0.8 5.6 0.8 2.1 0.6 1.1 0.5 7.6 7.4 7.1 9.2 7.2 7.2 8.5 7.5 8.0 7.5 8.4 8.0 20.8 9.6 8.8 3.3 88.3 43.5 59.3 41.2 34.7 2.2 17.1 14.5 3.1 25.8 29.9 18.4 16.7 6.3 39.0 33.3 5.9 33.2 1.1 33.7 14.4 26.1 16.3 0.4 0.1 21.0 15.8 26.0 80.0 52.0 71.8 5.5 11.7 3.7 20.9 0.0 0.1 30.4 22.4 19.4 122.9 1.7 7.5 52.5 30.2 1.9 75.1 3.9 12.3 1.5 0.7 44.9 37.4 4.9 49.1 49.3 33.2 8.6 19.9 5.3 0.0 36.4 43.6 4.7 11.1 17.5 44.6 23.1 54.6 8.8 17.9 45.6 PSD "EFA6, EFA6A, KIAA2011, PSD1, TYL" ENSG00000059915 "Pleckstrin and Sec7 domain containing" A5PKW4 10 102402617-102421539 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 233.9;intestine: 261.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 50.7;Cone photoreceptor cells: 95.9;Endometrial stromal cells: 47.7;Excitatory neurons: 41.1;Inhibitory neurons: 29.9;Rod photoreceptor cells: 70.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 7.7;MOLT-4: 4.4;SCLC-21H: 7.4;SH-SY5Y: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059237 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "Plasma membrane, Cytosol" "HPA059237: AB_2683954" "unprognostic (2.43e-1)" "unprognostic (1.74e-1)" "unprognostic (5.62e-3)" "unprognostic (1.53e-1)" "unprognostic (3.16e-2)" "unprognostic (2.90e-2)" "unprognostic (7.73e-3)" "unprognostic (1.75e-1)" "unprognostic (9.59e-2)" "unprognostic (7.59e-2)" "unprognostic (2.24e-3)" "unprognostic (4.71e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (8.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" 1.2 9.1 159.5 3.8 151.7 0.7 1.5 7.8 233.9 53.8 0.0 261.8 6.1 78.3 1.4 1.6 46.2 8.9 4.4 220.9 63.9 2.8 2.4 1.2 0.9 23.8 25.4 15.3 5.0 1.5 99.4 0.8 27.3 4.3 3.5 36.8 1.0 1.2 0.4 1.6 41.4 17.7 14.9 1.5 44.2 12.4 70.2 1.4 1.1 0.0 0.4 105.7 14.7 87.6 0.2 0.0 3.0 2.7 1.1 0.6 0.3 0.2 0.0 0.1 0.0 2.1 0.3 0.2 1.8 0.0 0.2 0.2 0.1 0.0 0.0 0.3 0.2 0.1 0.1 0.1 1.6 0.0 0.1 7.7 0.2 0.5 0.1 1.2 0.0 1.0 0.4 0.7 0.0 1.7 4.4 0.2 0.4 0.3 0.0 1.2 0.0 0.1 0.0 0.1 7.4 6.4 0.1 0.1 0.2 0.2 0.5 0.4 0.0 2.2 3.5 0.2 0.0 1.9 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 159.5 151.7 7.8 233.9 220.9 63.9 23.8 25.4 27.3 14.9 70.2 87.6 0.7 3.2 0.5 6.8 1.0 0.6 0.3 0.3 0.0 50.7 1.1 0.5 1.5 2.8 1.5 0.0 95.9 0.2 0.6 0.8 1.9 0.2 6.6 4.8 47.7 1.0 18.0 0.0 41.1 1.9 0.2 4.0 2.6 1.8 0.0 0.4 0.0 1.3 0.7 13.5 29.9 0.9 0.0 0.6 0.7 2.7 3.7 0.5 0.0 3.7 0.1 13.2 0.0 9.0 2.4 0.7 1.4 4.1 0.1 0.4 1.3 1.2 0.5 70.8 0.0 2.0 1.1 4.0 3.7 0.7 0.1 0.7 1.9 8.8 1.3 0.1 FBXL15 "Fbl15, FBXO37, MGC11279" ENSG00000107872 "F-box and leucine rich repeat protein 15" Q9H469 10 102419189-102423136 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8" "Cell type enhanced" "Detected in all" "Distal tubular cells: 211.3;Proximal enterocytes: 176.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 65: Brain - Ion transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "unprognostic (1.08e-1)" "unprognostic (3.96e-1)" "unprognostic (7.35e-2)" "unprognostic (1.19e-2)" "unprognostic (1.91e-1)" "unprognostic (8.39e-2)" "unprognostic (3.65e-2)" "unprognostic (1.70e-1)" "unprognostic (3.17e-2)" "unprognostic (2.33e-2)" "unprognostic (1.38e-3)" "unprognostic (1.72e-1)" "prognostic favorable (7.82e-4)" "unprognostic (3.99e-2)" "unprognostic (2.62e-1)" "unprognostic (9.97e-2)" "prognostic favorable (7.92e-4)" 6.3 7.0 12.9 2.7 13.6 4.6 3.2 11.8 21.8 3.6 8.3 8.6 9.1 5.9 0.3 4.1 4.1 0.7 4.3 13.6 13.4 5.7 4.2 3.8 2.1 17.2 13.0 3.8 4.6 3.8 16.3 1.4 15.1 3.7 1.1 4.7 5.2 2.3 9.1 3.4 8.0 1.4 10.0 6.6 8.5 8.0 13.7 1.0 3.1 1.4 1.1 5.5 3.6 13.8 19.9 3.5 3.8 3.6 2.2 2.5 13.4 6.4 4.3 2.4 2.0 5.0 4.9 7.4 16.4 1.9 2.1 9.7 1.8 2.3 0.3 13.0 24.4 10.7 6.8 8.2 3.2 7.8 11.2 1.9 5.2 1.7 3.0 4.5 2.8 3.7 15.1 4.5 0.4 7.2 5.2 44.7 5.2 4.3 14.3 13.8 4.6 8.6 2.4 3.5 15.1 18.6 4.7 4.1 20.5 0.8 8.6 6.2 8.3 1.9 6.9 7.4 5.4 15.4 8.8 8.2 4.7 7.5 0.7 43.9 51.6 60.2 39.0 40.2 31.3 33.2 37.0 32.7 50.1 37.5 36.5 31.3 23.8 33.0 47.7 44.5 43.1 39.7 12.9 13.6 11.8 21.8 13.6 13.4 17.2 13.0 15.1 10.0 13.7 13.8 34.7 16.0 16.0 4.9 29.6 25.0 28.8 47.5 21.1 60.2 31.6 35.9 21.5 51.5 34.3 31.3 20.9 24.6 38.3 75.3 211.3 52.7 44.3 21.5 13.3 30.7 84.9 12.0 16.7 77.2 20.7 23.8 30.1 22.0 32.4 20.4 43.5 48.5 66.7 26.9 17.2 59.3 57.0 44.0 49.7 21.0 29.8 36.8 39.2 6.5 84.1 54.1 61.8 4.5 6.6 47.4 76.7 30.5 19.6 34.3 176.2 139.0 22.3 53.3 13.1 18.2 40.3 20.6 23.2 24.3 31.4 30.0 31.1 37.2 59.9 24.8 CUEDC2 "C10orf66, MGC2491" ENSG00000107874 "CUE domain containing 2" Q9H467 10 102423245-102432584 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036544, HPA041829" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "HPA036544: AB_10670111, HPA041829: AB_2677694" "unprognostic (2.10e-1)" "unprognostic (2.80e-2)" "unprognostic (7.31e-2)" "unprognostic (4.24e-2)" "unprognostic (9.78e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" "unprognostic (1.88e-1)" "unprognostic (2.24e-2)" "unprognostic (1.32e-1)" "unprognostic (3.48e-3)" "unprognostic (4.34e-1)" "unprognostic (1.67e-1)" "unprognostic (8.38e-2)" "unprognostic (1.58e-2)" 45.6 66.6 84.3 28.3 86.0 29.8 42.3 89.4 91.2 49.5 80.5 64.7 19.8 53.4 33.7 30.7 48.3 31.5 91.8 84.4 89.0 55.8 44.9 38.1 33.2 85.1 84.1 56.3 41.0 58.9 45.5 27.8 86.2 48.1 23.3 31.1 40.8 37.3 119.4 37.5 34.2 42.5 83.8 42.8 48.0 38.4 88.1 43.2 42.2 119.2 30.4 48.2 37.7 87.2 53.8 58.2 98.3 120.0 77.3 95.8 35.8 42.4 147.8 95.6 71.6 18.9 56.5 94.4 91.7 76.3 41.7 54.7 65.0 97.3 50.5 75.5 66.4 58.7 50.1 20.8 130.4 45.2 38.0 116.2 89.9 93.6 95.3 187.0 100.1 108.5 46.6 96.5 109.4 58.8 110.2 101.6 35.4 44.1 37.9 124.6 115.0 49.9 101.9 24.8 49.7 113.0 29.6 31.6 96.8 41.5 94.3 71.7 59.5 48.2 45.4 60.6 62.9 112.3 93.2 63.3 84.4 154.2 41.4 98.9 111.5 84.4 69.2 91.5 77.3 80.5 66.9 72.4 112.0 89.5 66.2 63.2 43.0 93.0 58.0 97.9 84.3 86.7 84.3 86.0 89.4 91.2 84.4 89.0 85.1 84.1 86.2 83.8 88.1 87.2 56.6 32.1 21.9 10.7 36.1 31.7 49.0 73.1 44.9 54.7 58.8 81.0 56.8 40.0 37.4 46.0 25.0 66.9 40.6 24.0 80.3 70.0 21.0 28.3 52.9 46.4 55.7 35.7 12.2 46.6 33.2 58.5 31.6 26.6 51.4 89.6 59.3 49.9 75.1 67.3 16.0 36.4 63.1 49.1 47.7 42.2 57.2 44.3 51.6 3.7 97.0 94.7 44.3 13.6 23.4 40.0 32.0 60.2 45.4 38.3 34.5 151.7 28.1 47.5 39.5 46.5 164.9 56.6 31.3 42.6 33.8 45.6 38.7 92.5 39.3 41.9 C10orf95 FLJ14280 ENSG00000120055 "Chromosome 10 open reading frame 95" 10 102449837-102451543 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 9.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 30.1;Rod photoreceptor cells: 18.4;Syncytiotrophoblasts: 38.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 11.8;JURKAT: 11.7" "Low region specificity" "Detected in single" "Secreted - unknown location" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 51: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (2.31e-1)" "unprognostic (7.76e-3)" "unprognostic (3.19e-1)" "unprognostic (5.62e-3)" "unprognostic (4.02e-1)" "unprognostic (5.03e-2)" "unprognostic (1.08e-1)" "unprognostic (5.98e-2)" "unprognostic (1.50e-2)" "unprognostic (1.01e-1)" "unprognostic (4.42e-2)" "unprognostic (2.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.66e-1)" "unprognostic (2.14e-1)" "unprognostic (1.22e-2)" "unprognostic (4.80e-3)" 0.5 1.5 0.7 1.8 0.6 2.0 0.2 2.8 1.1 1.1 0.9 1.2 2.5 1.2 0.4 1.3 9.7 1.4 0.6 0.6 0.8 1.4 0.4 3.5 2.9 0.3 0.2 1.1 4.7 0.1 1.3 0.7 0.1 1.6 0.4 4.7 4.0 0.1 0.7 4.1 2.3 0.0 0.0 2.6 3.6 0.7 0.9 0.0 5.3 0.0 0.5 0.6 0.5 0.1 5.7 1.1 0.1 2.3 0.0 0.0 4.9 0.2 0.0 0.0 0.0 4.4 9.8 5.0 2.2 0.0 0.7 9.8 0.0 0.4 0.0 4.3 11.8 3.2 4.7 3.7 0.0 4.4 3.0 0.1 1.8 0.0 0.1 3.1 0.0 11.7 5.6 4.1 0.0 4.5 2.4 4.2 2.2 2.0 3.3 7.0 0.1 5.4 1.1 2.0 8.8 1.3 2.4 1.5 3.1 1.7 4.8 0.3 0.4 0.2 1.0 0.2 0.5 3.5 2.9 3.3 0.2 6.5 0.1 2.1 1.2 1.7 7.8 0.6 7.4 10.7 8.4 7.9 3.6 8.3 11.7 9.9 0.9 10.1 0.3 6.3 9.6 4.9 0.7 0.6 2.8 1.1 0.6 0.8 0.3 0.2 0.1 0.0 0.9 0.1 0.3 0.0 3.2 0.7 3.1 1.5 4.3 0.5 0.0 4.6 2.4 2.5 0.1 2.8 4.2 5.5 10.4 2.3 6.4 2.5 3.9 1.5 0.1 30.1 0.7 1.0 1.2 1.3 0.7 1.1 1.7 0.3 1.5 4.0 0.0 0.8 0.4 0.3 2.3 3.3 0.7 3.7 4.1 1.0 1.0 0.5 0.6 1.4 0.0 0.0 2.2 2.7 6.2 0.0 0.0 0.7 0.4 0.7 2.5 3.3 2.0 4.2 8.7 18.4 0.0 0.9 0.5 0.7 1.4 1.9 1.6 38.0 3.2 0.7 3.2 2.9 MFSD13A "bA18I14.8, C10orf77, FLJ22529, TMEM180" ENSG00000138111 "Major facilitator superfamily domain containing 13A" Q14CX5 10 102461395-102477045 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.4;Hofbauer cells: 15.7;Horizontal cells: 21.9;Syncytiotrophoblasts: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018031 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 6: Brain - Smell perception" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Cytosol" "HPA018031: AB_2204891" "unprognostic (2.24e-2)" "prognostic favorable (8.29e-4)" "unprognostic (7.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.79e-1)" "unprognostic (2.11e-1)" "unprognostic (9.16e-3)" "unprognostic (4.70e-2)" "unprognostic (4.03e-2)" "unprognostic (8.10e-2)" "unprognostic (2.04e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.66e-3)" "unprognostic (2.44e-1)" "unprognostic (2.74e-1)" "unprognostic (4.02e-2)" 2.3 2.5 10.0 3.2 13.0 5.2 2.1 14.1 12.8 2.4 2.3 5.0 5.5 3.1 0.7 3.0 2.3 2.3 3.2 10.8 7.2 2.5 6.3 9.0 3.2 7.7 7.7 1.4 3.8 1.7 4.1 2.3 7.8 3.1 3.2 4.9 1.8 0.9 2.3 11.7 4.4 2.5 6.5 6.9 4.0 3.7 9.2 1.8 5.4 1.4 3.6 2.2 2.6 9.4 12.0 5.4 4.0 9.6 0.4 0.4 6.2 2.3 6.0 4.6 10.5 10.7 16.0 10.6 11.8 0.9 4.4 14.6 7.4 6.3 1.7 13.5 6.8 13.1 8.2 5.6 10.1 6.7 12.3 5.2 2.6 2.6 4.6 3.7 5.3 14.2 3.0 5.7 0.4 2.4 11.3 4.3 6.8 10.5 5.2 13.6 0.6 1.8 2.0 3.1 10.0 9.5 2.2 1.2 5.2 1.4 6.0 4.0 1.6 2.1 2.5 2.6 3.3 1.9 5.5 14.0 11.6 10.9 2.9 0.4 4.3 3.5 2.9 3.2 2.8 3.4 2.7 2.3 4.5 1.4 2.8 3.2 2.5 1.2 1.8 0.4 0.8 2.6 10.0 13.0 14.1 12.8 10.8 7.2 7.7 7.7 7.8 6.5 9.2 9.4 4.1 19.2 15.4 0.0 1.1 0.0 1.5 0.0 0.6 8.2 1.5 1.9 0.0 1.5 0.6 1.8 4.2 1.8 5.7 2.6 0.0 2.8 1.8 1.0 1.0 3.8 2.4 3.6 0.0 3.6 2.6 1.6 5.6 1.6 1.3 2.8 6.4 4.0 15.7 21.9 0.0 3.8 0.0 4.8 0.0 1.0 0.9 8.7 0.0 0.0 5.6 3.2 2.1 0.0 0.0 3.2 4.6 2.2 0.8 1.4 5.6 1.5 0.7 13.8 0.0 2.8 1.1 4.5 3.0 2.4 0.0 28.5 3.2 4.0 4.5 1.4 ACTR1A "ARP1, Arp1A" ENSG00000138107 "Actin related protein 1A" P61163 10 102461881-102502712 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037193, HPA047443" Approved Approved Microtubules NA NA 560000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 1: Pancreatic cells - Digestion" Microtubules "CAB037193: AB_258253, HPA047443: AB_2680049" "unprognostic (9.64e-3)" "unprognostic (1.92e-2)" "unprognostic (8.34e-2)" "unprognostic (4.05e-2)" "unprognostic (2.57e-1)" "unprognostic (3.48e-1)" "unprognostic (2.20e-3)" "unprognostic (2.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.66e-2)" "unprognostic (7.77e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-1)" "unprognostic (3.10e-1)" "unprognostic (4.13e-1)" 59.4 58.8 98.3 39.4 100.6 36.8 51.5 101.9 108.4 50.9 78.4 90.0 37.8 61.8 37.5 61.6 47.4 36.1 93.0 101.9 108.0 49.0 40.4 58.5 33.7 116.3 105.9 36.9 41.9 56.5 54.7 45.3 116.9 53.0 41.7 41.9 46.4 51.9 174.3 65.1 49.1 69.0 97.4 48.7 56.2 40.4 104.0 56.8 41.2 127.0 42.2 74.8 51.2 104.4 80.5 95.8 113.5 117.1 138.0 109.2 45.5 100.3 177.3 154.4 142.4 52.7 63.3 54.4 75.2 149.5 76.2 78.3 109.9 123.7 106.5 70.7 75.8 72.9 53.4 77.9 99.6 56.9 65.0 112.4 89.6 141.2 100.7 155.7 201.6 88.7 60.5 53.5 154.6 67.1 103.5 97.9 45.4 62.5 86.2 78.5 146.0 35.0 125.2 43.9 40.5 88.8 60.1 35.4 75.1 98.3 130.0 38.9 147.0 74.7 71.5 83.6 102.1 54.0 58.8 63.3 78.7 98.3 45.9 32.2 40.7 44.3 31.1 51.8 25.5 18.8 22.0 30.4 40.6 17.6 18.0 20.7 31.2 23.9 57.0 20.8 33.6 39.2 98.3 100.6 101.9 108.4 101.9 108.0 116.3 105.9 116.9 97.4 104.0 104.4 40.0 57.7 41.0 10.1 23.4 33.8 24.0 42.3 13.1 26.6 22.1 17.1 51.6 14.3 34.8 27.6 16.7 54.9 23.8 52.4 54.8 75.5 53.0 15.3 21.0 45.2 39.6 45.9 14.9 77.5 63.3 36.9 23.4 19.3 32.3 27.3 34.6 24.1 73.9 26.9 15.5 24.4 46.8 37.6 38.2 53.9 33.2 44.5 51.6 5.6 70.3 31.5 38.1 10.1 15.3 92.0 36.8 36.1 30.0 26.7 40.9 45.6 26.5 24.5 46.0 17.1 48.5 61.9 14.0 27.3 32.4 104.7 28.2 32.9 24.2 26.6 SUFU "PRO1280, SUFUH, SUFUXL" ENSG00000107882 "SUFU negative regulator of hedgehog signaling" Q9UMX1 10 102503972-102633535 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Ciliopathy, Disease variant, Joubert syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 129.2;Late spermatids: 115.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008700 Supported Supported Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA008700: AB_1080125" "unprognostic (1.55e-1)" "unprognostic (4.00e-2)" "unprognostic (5.14e-2)" "unprognostic (1.33e-1)" "unprognostic (4.69e-2)" "unprognostic (5.68e-2)" "unprognostic (3.69e-2)" "unprognostic (5.99e-2)" "unprognostic (1.64e-1)" "unprognostic (3.15e-3)" "unprognostic (9.60e-2)" "unprognostic (2.13e-1)" "unprognostic (3.72e-3)" "unprognostic (1.82e-1)" "unprognostic (1.44e-1)" "unprognostic (5.10e-2)" "unprognostic (3.82e-3)" 6.6 7.2 8.8 7.1 8.5 2.0 6.1 8.9 8.0 8.6 5.5 6.8 3.9 7.4 4.9 9.2 7.1 6.6 6.3 7.8 7.3 6.1 6.2 5.8 7.2 8.3 8.2 8.9 4.1 11.1 4.3 7.4 7.8 8.5 4.4 4.6 7.1 5.2 8.6 14.4 5.7 7.3 6.7 7.4 4.6 11.5 8.0 7.8 3.4 7.3 8.1 8.8 9.2 7.3 8.7 9.1 14.4 20.8 14.5 12.1 7.0 8.8 17.0 12.5 11.3 8.5 6.3 8.9 24.5 9.9 5.0 6.0 17.8 9.8 8.2 5.5 13.8 21.2 5.2 8.0 6.9 7.7 14.6 13.9 7.5 9.3 7.5 22.9 16.3 8.5 4.8 7.9 7.8 7.2 14.8 11.6 4.1 5.6 6.7 15.8 15.5 4.7 8.3 12.8 4.8 7.8 7.0 6.4 8.1 13.1 14.2 5.0 18.1 5.5 7.8 6.0 9.8 6.4 4.5 6.4 6.9 14.9 3.8 2.0 2.0 2.9 1.0 2.4 0.8 0.9 1.2 1.1 1.9 0.8 0.8 1.0 0.4 1.1 2.5 1.1 0.8 1.4 8.8 8.5 8.9 8.0 7.8 7.3 8.3 8.2 7.8 6.7 8.0 7.3 3.3 0.0 3.7 28.7 4.9 3.1 2.1 2.9 6.8 4.2 3.5 3.0 4.0 1.5 4.6 3.7 8.4 7.8 3.1 3.5 1.9 4.4 129.2 4.5 6.2 5.1 1.2 2.5 25.9 3.0 3.5 6.0 4.6 8.5 3.8 3.8 10.8 5.4 12.4 1.7 22.2 2.2 0.0 9.4 6.3 115.9 5.0 8.7 0.0 32.8 7.8 2.7 4.1 17.6 16.8 4.1 1.3 6.8 4.0 2.0 5.7 5.8 5.7 4.8 0.0 3.0 4.5 8.7 5.3 8.9 6.5 7.0 7.1 7.6 3.0 1.3 TRIM8 "GERP, RNF27" ENSG00000171206 "Tripartite motif containing 8" Q9BZR9 10 102644479-102658318 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023560, HPA023561" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Vesicles, Cytosol" "HPA023560: AB_10600414, HPA023561: AB_10601861" "unprognostic (4.32e-2)" "unprognostic (6.90e-2)" "unprognostic (3.02e-3)" "unprognostic (1.45e-1)" "unprognostic (1.78e-1)" "unprognostic (5.03e-1)" "unprognostic (3.82e-2)" "unprognostic (1.03e-1)" "unprognostic (2.15e-3)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (1.52e-1)" "unprognostic (9.55e-2)" "unprognostic (1.48e-1)" "unprognostic (3.12e-2)" "unprognostic (8.34e-2)" "unprognostic (1.36e-2)" 80.1 47.6 67.2 21.5 68.1 26.0 58.4 62.9 55.0 63.0 35.8 50.9 17.8 53.5 9.3 42.0 55.6 22.0 67.8 55.0 56.5 77.9 62.2 70.3 18.3 72.4 72.7 45.2 80.4 36.6 43.5 21.3 64.7 55.5 9.5 18.1 69.1 21.9 80.8 48.3 43.8 17.1 60.4 42.8 61.9 20.1 84.4 18.7 67.4 38.8 11.8 62.9 49.9 54.2 96.4 18.7 16.3 28.7 17.2 40.6 21.1 34.4 59.3 32.1 24.6 30.7 93.0 30.7 102.9 57.5 11.4 32.7 12.2 40.4 21.3 34.4 23.4 78.3 12.9 67.4 55.8 15.5 28.3 47.0 21.9 64.8 32.9 83.4 40.6 13.6 17.3 33.4 24.3 45.5 27.8 57.7 12.7 25.6 38.0 18.6 49.2 16.6 37.4 48.0 12.3 26.2 18.8 17.2 42.6 16.9 58.4 28.2 94.8 40.9 22.4 23.3 68.8 49.0 28.5 16.3 65.5 39.2 9.7 14.0 5.2 2.7 6.8 4.6 6.5 8.9 7.3 5.4 4.5 7.4 6.4 5.7 17.9 6.0 5.7 12.4 7.5 4.5 67.2 68.1 62.9 55.0 55.0 56.5 72.4 72.7 64.7 60.4 84.4 54.2 46.0 57.7 71.2 33.6 29.5 31.5 12.6 21.2 21.6 33.4 53.9 45.3 38.0 38.6 33.6 88.3 8.4 13.0 52.8 15.4 41.1 63.2 1.1 91.5 61.7 30.1 21.6 2.5 8.9 44.9 2.6 38.9 20.4 81.6 8.8 32.2 31.8 33.3 25.4 28.6 13.6 32.8 18.3 40.5 24.1 1.7 31.1 43.5 17.8 13.1 58.1 26.1 24.7 18.1 17.6 65.0 16.4 34.3 18.6 30.5 32.0 53.0 38.5 15.1 13.1 35.7 38.4 2.4 5.1 19.8 22.9 10.9 26.6 38.9 21.4 30.1 ARL3 ARFL3 ENSG00000138175 "ADP ribosylation factor like GTPase 3" P36405 10 102673731-102714397 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 96.3" "Cell type enhanced" "Detected in all" "Muller glia cells: 289.1;Rod photoreceptor cells: 318.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036292, HPA063596" Approved Supported Nucleoplasm,Centrosome NA NA 44000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 77: Retina - Visual perception" "Cluster 6: T47d - Mammary gland" "Cluster 46: Photoreceptor cells - Phototransduction" Centrosome Nucleoplasm "HPA036292: AB_10673618, HPA063596: AB_2685053" "unprognostic (1.36e-1)" "unprognostic (2.89e-3)" "unprognostic (4.19e-2)" "unprognostic (7.58e-2)" "unprognostic (2.98e-2)" "unprognostic (3.24e-2)" "unprognostic (2.45e-2)" "unprognostic (7.69e-2)" "unprognostic (4.00e-2)" "unprognostic (3.21e-1)" "unprognostic (3.99e-3)" "unprognostic (5.58e-2)" "prognostic favorable (1.71e-6)" "unprognostic (5.62e-2)" "unprognostic (3.09e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-1)" 8.1 8.9 20.2 4.2 21.3 1.7 8.1 20.8 25.1 12.4 19.1 11.3 4.2 11.5 10.6 4.6 15.2 5.2 13.5 20.8 19.5 15.4 5.2 8.3 3.6 19.3 19.1 16.8 6.4 19.8 21.0 4.9 19.7 8.7 4.6 96.3 6.3 9.0 5.6 7.2 6.1 8.7 18.5 4.5 8.8 11.0 20.5 5.7 11.4 5.9 4.7 9.8 8.3 19.5 14.7 25.0 33.6 24.7 15.2 22.7 5.9 11.4 17.3 13.6 14.7 8.7 7.4 6.1 10.8 18.5 16.4 10.7 12.7 15.3 16.9 16.1 13.4 9.9 16.9 8.3 16.4 4.6 9.5 11.5 12.6 18.8 11.0 36.1 15.8 12.0 4.5 6.0 23.0 15.1 9.5 7.3 13.0 9.2 9.8 7.9 24.8 5.4 18.1 7.7 11.8 25.7 8.7 1.8 14.1 18.5 45.1 4.6 9.1 9.2 12.9 18.9 16.0 4.2 8.9 11.3 24.4 13.6 8.1 2.0 7.2 2.6 3.7 6.1 9.4 4.5 6.5 5.5 7.1 3.9 3.9 4.7 13.4 4.4 5.4 5.2 4.9 5.4 20.2 21.3 20.8 25.1 20.8 19.5 19.3 19.1 19.7 18.5 20.5 19.5 46.0 54.5 39.3 47.7 16.7 32.1 70.4 144.3 29.0 167.6 48.2 57.5 135.5 31.5 85.8 62.5 116.7 45.5 12.1 9.4 234.8 70.7 46.5 250.5 85.2 41.6 74.8 9.4 30.8 43.6 37.8 61.7 19.4 84.6 33.0 94.1 43.9 25.5 64.7 97.6 37.6 31.6 73.2 16.4 33.6 25.8 60.6 26.8 76.5 13.1 67.3 289.1 13.4 31.7 23.4 31.1 13.5 104.2 18.6 54.2 23.1 225.8 268.3 318.6 26.3 50.8 122.0 145.6 43.4 11.9 31.7 32.3 20.8 58.6 25.4 50.5 SFXN2 SLC56A2 ENSG00000156398 "Sideroflexin 2" Q96NB2 10 102714538-102743492 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 17.9;parathyroid gland: 12.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 33.3;Hepatocytes: 21.2;Proximal tubular cells: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 38.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018150, HPA026834" Enhanced Approved Mitochondria NA NA "Cluster 32: T-cells - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 6: T47d - Mammary gland" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA018150: AB_1856790, HPA026834: AB_1856791" "unprognostic (1.70e-2)" "prognostic favorable (2.28e-4)" "unprognostic (3.30e-2)" "unprognostic (2.95e-1)" "unprognostic (6.10e-2)" "unprognostic (1.44e-2)" "prognostic favorable (9.95e-4)" "unprognostic (4.24e-2)" "unprognostic (9.69e-2)" "unprognostic (3.98e-2)" "unprognostic (1.32e-1)" "unprognostic (8.98e-3)" "prognostic favorable (2.28e-5)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (3.77e-2)" "prognostic favorable (6.52e-4)" 1.5 1.1 1.2 1.9 2.8 3.0 2.8 3.9 1.7 1.6 3.6 1.9 2.5 2.7 3.6 1.4 3.6 1.1 0.6 1.8 0.8 17.9 4.2 1.6 2.6 1.0 0.5 3.4 3.1 12.7 2.7 3.4 1.2 2.2 3.0 2.7 4.9 1.3 0.7 1.9 1.9 1.1 0.2 2.1 3.3 1.2 1.8 3.2 3.8 0.2 1.9 0.9 0.7 2.1 4.2 2.3 3.5 3.7 1.3 0.9 5.1 1.4 0.6 1.8 0.9 7.2 1.9 9.1 2.7 1.2 1.0 3.0 0.7 4.8 1.0 1.6 2.8 13.1 4.4 4.5 0.6 7.5 1.1 1.0 0.7 1.8 1.8 1.1 1.7 7.7 6.0 4.2 1.1 4.0 11.5 2.5 2.3 4.0 0.8 5.5 4.3 1.3 1.7 3.5 2.6 2.5 1.2 3.1 0.6 1.4 38.4 1.6 1.2 1.4 4.4 1.8 3.1 4.6 6.5 7.9 1.7 9.0 1.2 1.6 0.5 0.2 1.9 0.2 1.7 0.8 1.9 2.0 0.7 2.5 3.0 2.5 0.9 1.9 0.3 1.7 2.0 0.7 1.2 2.8 3.9 1.7 1.8 0.8 1.0 0.5 1.2 0.2 1.8 2.1 1.0 0.0 10.1 5.2 3.8 0.9 3.0 0.8 4.0 6.1 7.3 5.2 2.5 4.3 2.0 1.8 33.3 9.1 2.4 2.5 9.8 1.9 0.8 7.3 4.2 2.2 3.6 4.2 5.4 2.8 4.4 3.2 8.2 10.0 0.0 9.2 5.0 21.2 9.6 0.0 5.5 5.0 0.0 7.5 0.6 0.5 2.1 2.4 0.0 8.4 0.8 1.1 4.1 7.1 2.9 1.4 0.8 1.5 6.7 4.4 2.4 43.1 0.4 15.1 0.0 2.7 1.7 1.2 1.3 3.3 1.3 4.5 2.8 2.6 7.3 2.9 WBP1L "C10orf26, FLJ20154, OPAL1" ENSG00000166272 "WW domain binding protein 1 like" Q9NX94 10 102743948-102834516 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037635, HPA038371" Uncertain Approved Nucleoplasm,Microtubules NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 59: Non-specific - Transcription" Microtubules Nucleoplasm "HPA037635: AB_10672462, HPA038371: AB_2675980" "unprognostic (3.28e-2)" "unprognostic (6.46e-2)" "unprognostic (1.14e-2)" "prognostic favorable (4.03e-4)" "unprognostic (5.35e-3)" "unprognostic (2.73e-2)" "unprognostic (3.33e-2)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.43e-3)" "unprognostic (2.55e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.56e-6)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (4.88e-2)" "unprognostic (1.53e-1)" 34.9 43.2 21.3 22.3 23.1 5.0 25.8 20.7 20.1 26.4 28.7 27.7 15.2 27.4 18.9 21.1 29.4 25.1 24.1 19.8 22.4 20.8 42.1 24.5 21.4 32.0 23.9 26.5 15.5 41.7 22.9 23.5 23.6 26.9 15.0 5.7 22.6 22.4 54.6 37.5 19.9 26.2 25.9 21.3 25.7 14.2 24.7 33.7 41.1 49.0 18.9 24.5 20.5 22.6 21.0 26.8 14.5 24.5 47.0 37.9 29.5 21.0 56.7 20.5 25.8 18.3 31.9 18.1 27.8 32.5 16.5 22.7 10.7 18.2 15.5 18.3 11.3 36.6 11.6 13.3 30.3 17.8 41.7 41.2 32.0 26.4 20.3 47.0 40.5 21.6 18.1 22.0 35.6 27.5 21.7 19.8 11.0 16.1 12.9 42.9 38.3 11.7 18.2 20.4 3.4 13.9 11.5 11.6 24.1 26.0 47.2 19.5 30.4 19.6 20.1 22.3 19.1 40.6 22.9 13.0 27.7 33.6 8.8 7.8 12.2 16.2 8.7 14.8 7.0 6.5 7.3 8.4 8.7 6.1 6.5 6.9 15.2 12.9 19.4 5.4 8.2 10.6 21.3 23.1 20.7 20.1 19.8 22.4 32.0 23.9 23.6 25.9 24.7 22.6 13.3 22.4 19.0 29.4 12.2 8.2 8.0 17.0 11.4 6.4 25.0 15.4 15.7 12.8 17.8 12.9 0.0 33.9 17.2 26.4 1.9 14.2 2.0 9.7 11.0 20.4 9.1 11.1 24.6 25.3 14.6 29.3 16.8 12.7 38.1 16.4 27.1 56.2 27.7 13.5 26.4 14.6 14.2 46.6 13.1 1.8 13.1 28.8 10.6 40.3 28.9 9.8 29.9 19.1 26.3 24.6 13.7 19.5 9.0 29.9 18.3 8.9 20.5 3.8 19.7 16.6 17.7 4.4 5.8 11.3 11.8 40.0 14.4 8.9 12.2 11.3 CYP17A1 "CPT7, CYP17, P450C17, S17AH" ENSG00000148795 "Cytochrome P450 family 17 subfamily A member 1" P05093 10 102830531-102837472 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Steroidogenesis "Lyase, Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 84 "adrenal gland: 8229.5" "Cell type enriched" "Detected in some" 17 "Theca cells: 1871.0" "Cancer enriched" "Detected in many" 5 "liver cancer: 22.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 3.0;SCLC-21H: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048533 Enhanced Approved Vesicles "Intracellular and membrane" NA NA "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Vesicles "HPA048533: AB_2680432" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (3.01e-2)" "unprognostic (9.08e-2)" "unprognostic (1.91e-1)" "unprognostic (6.29e-2)" "unprognostic (2.92e-3)" "unprognostic (2.39e-4)" "unprognostic (8.26e-2)" "unprognostic (2.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.13e-1)" "prognostic favorable (5.43e-7)" "unprognostic (1.07e-1)" "unprognostic (5.56e-2)" "unprognostic (1.66e-2)" "unprognostic (2.94e-4)" 0.4 8229.5 0.0 2.1 0.0 0.0 0.4 0.1 0.1 1.1 0.0 0.5 0.0 0.8 0.1 0.9 1.0 0.4 1.0 0.0 0.0 52.9 6.7 1.4 0.0 0.0 0.1 16.6 1.7 10.5 0.7 0.0 0.0 0.7 0.0 0.2 3.4 0.0 1.0 0.7 0.6 0.0 0.0 0.9 1.3 98.3 0.0 0.0 2.9 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.2 0.1 0.4 0.1 0.0 0.5 0.0 0.1 0.7 0.0 0.0 1.8 0.0 0.4 0.1 0.1 21.5 0.0 41.6 0.1 0.0 0.7 0.0 2.7 0.1 0.2 0.0 1.3 0.0 0.1 0.0 0.1 0.4 6.1 0.1 1.7 0.1 0.0 0.0 0.6 0.7 10.6 1.8 0.9 0.0 0.0 0.1 0.2 3.1 0.5 0.1 0.7 0.0 0.0 0.0 0.3 0.0 104.3 0.0 1.2 0.0 1.2 0.6 0.3 0.1 0.0 0.0 0.3 0.4 1871.0 0.0 0.1 BORCS7 "C10orf32, FLJ40752" ENSG00000166275 "BLOC-1 related complex subunit 7" Q96B45 10 102854259-102864961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 201.5;Proximal tubular cells: 208.5;Theca cells: 209.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA037648 Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 1: Thyroid gland - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear speckles" Cytosol "HPA037648: AB_10673634" "unprognostic (2.16e-1)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (2.05e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-3)" "unprognostic (3.55e-2)" "unprognostic (1.35e-2)" "unprognostic (7.46e-3)" "unprognostic (3.16e-2)" "unprognostic (1.77e-1)" "prognostic favorable (9.08e-8)" "unprognostic (9.85e-2)" "unprognostic (1.77e-1)" "unprognostic (1.06e-1)" "unprognostic (1.67e-3)" 25.4 58.5 20.5 12.8 20.9 23.4 29.8 20.3 25.1 21.3 22.3 19.7 23.2 21.8 23.7 13.4 29.7 22.4 22.3 21.5 23.1 39.8 67.0 23.8 15.1 21.2 21.7 21.8 17.5 53.3 23.7 21.7 21.3 27.2 15.2 20.2 16.9 17.4 28.6 13.9 19.5 16.7 22.5 24.4 20.9 20.2 22.7 14.6 55.3 25.9 12.3 17.4 16.0 23.0 14.9 19.8 23.4 20.7 25.6 35.1 19.5 21.6 44.1 16.3 15.5 13.3 16.6 9.4 11.1 34.6 17.1 12.2 7.9 11.1 12.0 12.1 16.7 21.7 12.5 27.7 29.5 39.4 35.9 44.1 29.8 11.0 17.4 34.0 28.9 13.2 13.0 9.7 26.4 10.9 11.0 16.2 7.9 20.3 18.4 19.8 31.4 13.8 13.6 16.1 6.6 25.5 8.0 14.2 34.7 10.4 27.0 22.2 21.6 13.7 14.6 14.1 15.3 24.9 40.8 11.1 29.0 22.7 5.0 31.3 30.1 22.9 17.3 35.0 19.4 26.5 17.9 18.0 22.1 23.2 19.8 18.4 9.6 27.7 32.9 47.1 19.7 15.1 20.5 20.9 20.3 25.1 21.5 23.1 21.2 21.7 21.3 22.5 22.7 23.0 85.2 54.5 79.6 0.0 49.1 0.0 61.0 0.0 45.5 50.9 94.5 62.9 0.0 48.6 32.2 42.3 39.6 89.6 57.4 18.0 201.5 35.3 21.1 61.1 38.8 67.3 34.0 18.3 0.0 33.3 39.2 60.4 39.8 31.9 34.1 44.2 68.2 74.9 51.7 63.9 0.0 33.4 0.0 49.8 0.0 22.8 42.3 54.1 0.0 0.0 52.1 109.8 53.5 0.0 0.0 28.5 48.5 62.1 28.6 53.8 70.1 208.5 43.7 50.6 39.5 53.3 44.0 80.1 52.4 44.7 0.0 121.5 39.8 209.5 41.0 54.5 AS3MT CYT19 ENSG00000214435 "Arsenite methyltransferase" Q9HBK9 10 102869470-102901899 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "adrenal gland: 302.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Basal squamous epithelial cells: 1.2;Proximal tubular cells: 1.0" "Cancer enhanced" "Detected in single" "liver cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.8;REH: 54.6;SH-SY5Y: 27.8;T-47d: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017856 Enhanced Approved Mitochondria NA NA "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 50: Fibroblasts - ECM organization" Mitochondria "HPA017856: AB_1847420" "unprognostic (1.11e-1)" "unprognostic (2.02e-4)" "unprognostic (2.45e-1)" "unprognostic (2.25e-1)" "unprognostic (3.39e-1)" "unprognostic (1.66e-1)" "unprognostic (7.02e-4)" "unprognostic (3.22e-1)" "unprognostic (1.42e-1)" "unprognostic (3.90e-2)" "unprognostic (2.03e-1)" "unprognostic (1.83e-1)" "unprognostic (3.83e-10)" "unprognostic (1.04e-2)" "unprognostic (4.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-2)" 5.1 302.4 7.4 1.3 7.5 0.7 6.3 11.5 8.7 7.5 9.3 6.4 3.0 7.7 4.4 3.6 5.8 6.7 26.8 6.7 8.4 19.2 59.2 4.0 2.0 7.9 8.3 8.7 11.7 65.7 6.6 1.0 8.0 9.1 1.8 4.8 4.8 5.2 11.4 4.3 3.3 3.9 6.6 18.3 4.7 8.7 7.7 3.7 7.7 15.2 1.6 3.2 5.0 8.3 0.0 7.6 26.8 17.4 0.6 0.6 5.1 8.1 6.7 11.9 14.3 21.3 1.2 0.0 2.4 10.7 0.6 0.4 23.8 1.4 12.4 0.3 6.7 0.0 3.2 20.9 7.7 0.2 0.6 3.7 3.1 1.6 0.0 21.3 0.5 25.3 0.0 0.4 10.8 0.1 4.9 0.7 13.2 0.1 1.0 54.6 0.0 0.2 2.7 0.0 0.4 27.8 0.0 0.4 3.7 8.8 43.9 0.6 0.1 2.6 0.0 3.9 0.0 0.2 0.4 0.0 8.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.4 7.5 11.5 8.7 6.7 8.4 7.9 8.3 8.0 6.6 7.7 8.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 CNNM2 ACDP2 ENSG00000148842 "Cyclin and CBS domain divalent metal cation transport mediator 2" Q9H8M5 10 102918294-103090222 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease variant, Epilepsy, Mental retardation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 37.9;parathyroid gland: 31.6" "Cell type enhanced" "Detected in many" "Astrocytes: 60.1;Excitatory neurons: 112.6;Inhibitory neurons: 146.9;Oligodendrocyte precursor cells: 92.5;Oligodendrocytes: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059954, HPA071631" Enhanced Vesicles NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 16: U-266 - Nucleosome" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA059954: AB_2684177, HPA071631: AB_2686427" "unprognostic (2.18e-1)" "unprognostic (6.46e-2)" "unprognostic (1.24e-1)" "unprognostic (2.65e-3)" "unprognostic (3.19e-1)" "unprognostic (2.44e-1)" "unprognostic (1.93e-1)" "unprognostic (4.80e-2)" "unprognostic (4.51e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-2)" "unprognostic (2.39e-1)" "prognostic favorable (2.39e-8)" "unprognostic (2.44e-1)" "unprognostic (1.13e-1)" "unprognostic (2.65e-3)" "unprognostic (1.56e-1)" 3.3 11.5 5.1 2.3 5.5 9.3 2.5 7.9 5.7 3.7 37.9 7.0 3.8 3.6 2.1 1.7 4.8 4.1 2.1 4.2 3.3 9.1 4.8 3.8 1.5 4.9 4.8 4.8 3.6 31.6 5.7 8.7 4.7 2.7 6.4 5.0 3.0 3.0 1.6 4.5 4.5 3.7 1.8 2.1 3.3 4.5 4.6 1.8 5.6 1.5 1.1 3.2 2.9 9.7 5.0 8.1 3.1 8.5 7.8 3.2 8.6 2.3 9.7 3.1 3.9 5.8 4.3 1.9 3.5 3.4 6.0 6.3 6.9 4.6 2.4 3.3 12.1 2.8 4.2 11.8 4.6 2.0 3.6 4.2 6.6 3.2 10.7 7.9 1.9 5.5 4.8 10.9 1.8 8.6 2.3 2.2 5.1 4.9 5.0 5.5 4.0 2.4 2.4 2.9 4.5 5.8 5.9 1.3 6.3 9.1 10.4 3.7 1.6 4.2 6.2 3.0 4.2 11.7 14.1 3.6 7.4 6.6 1.7 0.3 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.2 1.5 0.0 0.3 0.3 0.1 5.1 5.5 7.9 5.7 4.2 3.3 4.9 4.8 4.7 1.8 4.6 9.7 3.0 6.4 8.4 60.1 7.9 2.4 2.3 1.7 6.8 16.4 3.3 2.4 4.5 2.8 5.6 5.5 12.5 18.8 8.1 46.7 1.9 2.2 10.7 7.4 4.2 4.2 6.7 6.7 112.6 5.4 3.4 6.3 12.8 6.4 3.8 13.7 3.3 6.1 3.8 32.0 146.9 5.0 0.0 3.2 2.5 15.1 3.4 4.7 7.2 39.4 2.3 7.0 2.1 92.5 92.3 2.3 9.0 3.4 6.2 2.0 11.7 5.5 9.5 15.8 13.1 5.7 16.7 15.5 6.9 8.1 4.1 39.8 5.1 3.8 11.6 2.2 NT5C2 "cN-II, GMP, NT5B, PNT5, SPG45, SPG65" ENSG00000076685 "5'-nucleotidase, cytosolic II" P49902 10 103087185-103277605 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" "Allosteric enzyme, Hydrolase" "Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 141.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003751 Approved NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "HPA003751: AB_1854664" "unprognostic (8.18e-2)" "unprognostic (1.98e-1)" "unprognostic (2.55e-2)" "unprognostic (2.46e-1)" "unprognostic (5.54e-2)" "unprognostic (4.87e-3)" "unprognostic (2.24e-2)" "unprognostic (1.72e-1)" "unprognostic (6.41e-2)" "unprognostic (9.59e-2)" "unprognostic (2.93e-3)" "unprognostic (6.20e-2)" "unprognostic (3.26e-2)" "unprognostic (3.70e-2)" "unprognostic (6.40e-2)" "unprognostic (3.43e-1)" "unprognostic (1.50e-1)" 24.6 27.0 25.0 19.0 27.2 29.7 23.0 27.3 28.5 37.6 36.8 27.3 9.9 18.8 17.3 67.1 26.5 16.4 28.5 25.2 28.8 32.5 27.8 30.8 18.3 26.9 29.5 32.4 22.0 21.7 34.0 17.9 27.2 32.4 16.7 47.3 46.4 18.4 51.6 19.9 20.4 13.4 26.4 32.8 22.3 30.8 27.2 28.6 55.4 18.1 24.5 33.3 42.7 28.6 148.4 52.5 32.6 67.5 27.2 33.2 18.2 66.0 64.7 29.9 32.4 34.6 91.7 49.2 47.7 45.6 27.6 62.8 23.4 33.8 38.3 40.3 21.6 38.7 21.1 39.6 48.5 64.2 21.0 50.4 34.1 28.0 24.8 57.5 25.6 19.4 29.4 36.4 54.5 73.8 53.7 64.6 34.6 43.2 68.6 102.6 30.0 19.6 43.3 72.5 10.0 24.9 35.8 25.9 50.3 33.7 39.2 38.1 30.5 20.5 24.8 39.7 51.7 32.9 71.6 85.5 23.9 64.6 7.8 29.5 16.5 31.3 10.0 18.8 10.3 8.9 8.4 8.7 14.7 5.2 6.7 8.0 27.4 14.4 23.0 9.6 9.3 10.5 25.0 27.2 27.3 28.5 25.2 28.8 26.9 29.5 27.2 26.4 27.2 28.6 16.2 83.3 34.9 141.7 17.2 7.4 29.0 26.9 5.7 24.4 13.9 13.6 2.6 18.6 60.4 27.6 45.9 19.4 23.3 48.7 11.7 28.5 103.7 29.5 17.1 19.8 11.5 12.4 79.8 26.0 11.7 17.5 25.5 46.2 8.8 18.2 13.9 17.4 19.9 47.1 83.6 17.6 18.3 29.8 14.2 61.9 24.8 27.1 26.6 78.7 25.9 85.5 16.5 70.4 107.5 57.9 23.1 13.5 21.0 35.7 11.7 15.3 44.1 59.1 32.9 22.9 21.7 25.3 20.5 22.9 7.5 35.0 16.6 15.8 18.0 80.5 RPEL1 ENSG00000235376 "Ribulose-5-phosphate-3-epimerase like 1" Q2QD12 10 103245887-103248016 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.1;Cone photoreceptor cells: 8.4;Ionocytes: 2.0;Rod photoreceptor cells: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (7.52e-2)" "unprognostic (1.69e-1)" "unprognostic (4.78e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.83e-1)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.91e-2)" "unprognostic (6.59e-2)" "unprognostic (4.34e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (1.62e-1)" "unprognostic (6.72e-2)" "unprognostic (5.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.0 3.1 0.0 0.0 1.9 0.0 0.7 0.0 8.4 0.3 1.3 0.5 0.0 0.5 0.1 0.1 0.0 0.3 1.8 0.0 0.6 0.2 0.5 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.5 2.0 0.0 1.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.2 4.4 0.0 0.0 0.4 0.1 0.3 0.0 0.3 0.4 0.1 0.0 0.7 0.0 INA "NEF5, NF-66" ENSG00000148798 "Internexin neuronal intermediate filament protein alpha" Q16352 10 103277138-103290346 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 160.7;pituitary gland: 41.4;retina: 97.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 62.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.4;Excitatory neurons: 28.7;Horizontal cells: 45.4;Inhibitory neurons: 39.8;Late spermatids: 26.5;Rod photoreceptor cells: 48.2;Spermatocytes: 20.3" "Group enriched" "Detected in many" 4 "glioma: 4.7;testis cancer: 18.2;urothelial cancer: 14.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 53.0;SCLC-21H: 103.3;SH-SY5Y: 58.7;SiHa: 71.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002059, HPA007572, HPA008057" Enhanced Supported Approved "Intermediate filaments,Cytosol" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" "Intermediate filaments" Cytosol "CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833" "unprognostic (1.77e-1)" "unprognostic (2.50e-2)" "unprognostic (9.54e-2)" "unprognostic (5.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.45e-3)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "unprognostic (8.09e-3)" "unprognostic (3.07e-2)" "unprognostic (1.78e-3)" "unprognostic (1.66e-1)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" 0.2 12.1 34.2 1.2 35.5 0.0 0.0 63.3 160.7 0.0 0.0 3.3 0.6 0.0 0.0 0.6 0.0 0.1 0.0 31.8 109.5 0.0 0.0 0.2 0.1 107.9 37.5 0.0 2.0 0.4 41.4 0.1 98.1 0.2 1.2 97.3 0.1 0.0 0.0 0.8 1.1 0.8 25.3 0.0 1.1 2.7 72.8 1.7 0.1 0.0 0.2 1.1 0.5 51.9 0.0 25.4 11.8 0.0 0.1 0.0 19.3 13.3 3.3 3.1 0.3 0.0 0.0 0.0 5.4 0.9 1.5 1.9 11.0 0.0 0.7 24.6 4.9 0.0 6.8 0.1 0.2 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 13.6 0.0 53.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 103.3 58.7 71.6 0.1 0.0 2.7 0.0 0.7 0.1 0.0 0.1 0.0 0.0 3.4 3.1 0.0 0.1 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 35.5 63.3 160.7 31.8 109.5 107.9 37.5 98.1 25.3 72.8 51.9 0.1 0.0 0.0 6.2 0.0 0.3 0.1 0.0 0.0 62.4 0.0 0.4 0.5 0.0 0.0 0.0 22.9 0.2 0.0 0.1 0.0 0.1 41.4 0.4 0.2 0.9 7.8 0.0 28.7 0.0 0.2 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.5 45.4 39.8 0.0 0.0 0.0 0.0 26.5 0.3 0.1 0.0 2.8 0.0 8.7 0.0 1.0 5.4 0.4 0.0 0.4 0.0 0.5 0.0 0.0 0.0 48.2 0.0 0.0 0.6 20.3 4.1 1.0 0.4 0.1 0.1 0.1 0.0 0.6 PCGF6 "MBLR, RNF134" ENSG00000156374 "Polycomb group ring finger 6" Q9BYE7 10 103302796-103351144 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 76.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "unprognostic (7.73e-2)" "unprognostic (8.93e-3)" "unprognostic (1.72e-1)" "unprognostic (7.74e-2)" "unprognostic (1.11e-2)" "unprognostic (1.92e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-1)" "unprognostic (1.77e-2)" "unprognostic (1.84e-1)" "unprognostic (1.71e-1)" "unprognostic (9.44e-2)" "prognostic unfavorable (4.54e-9)" "unprognostic (5.14e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-3)" "unprognostic (4.53e-2)" 7.3 4.7 2.8 5.0 3.0 4.5 6.3 3.2 5.3 6.9 2.5 7.8 4.4 7.5 3.3 4.4 6.0 4.3 5.4 2.8 3.0 4.4 11.6 4.0 5.6 3.0 2.9 5.5 6.6 4.3 3.3 4.7 3.3 4.8 4.3 2.6 4.1 5.2 10.9 4.1 4.7 7.5 3.2 4.3 5.1 8.9 2.9 5.8 3.8 6.9 5.0 6.2 5.3 3.5 29.8 11.6 16.3 33.7 7.3 12.2 15.3 19.9 20.0 21.0 16.9 14.7 10.6 22.4 9.1 18.3 9.3 16.2 18.5 14.8 21.5 15.1 34.2 20.2 11.6 19.3 17.7 29.9 9.4 16.3 13.5 19.1 23.7 12.1 13.5 19.2 30.1 13.6 14.9 22.1 21.3 32.0 16.4 8.6 16.4 23.4 24.3 11.7 7.0 12.3 5.8 14.5 14.8 7.5 21.8 8.7 8.0 19.4 10.5 15.8 19.1 17.8 34.5 14.9 19.9 30.5 13.5 32.3 6.9 5.4 1.9 1.4 2.3 2.3 3.4 1.7 3.1 2.9 2.7 2.6 3.7 3.2 0.2 3.6 1.7 2.5 4.1 1.7 2.8 3.0 3.2 5.3 2.8 3.0 3.0 2.9 3.3 3.2 2.9 3.5 10.5 3.2 3.6 12.7 8.9 9.6 5.6 5.9 12.0 12.4 6.4 7.2 5.5 10.0 4.4 11.0 12.5 14.6 9.4 4.1 11.7 7.4 7.9 5.4 12.7 11.1 4.2 15.6 23.9 7.3 20.3 12.8 5.1 4.2 3.8 10.7 10.8 12.2 8.7 6.7 21.3 4.8 2.0 8.8 7.0 5.3 10.2 7.9 8.8 7.5 7.0 6.8 15.5 17.6 11.8 5.7 4.6 7.2 11.1 8.1 4.9 12.4 5.0 13.2 6.6 5.5 12.7 76.2 39.3 15.3 8.8 4.5 11.5 12.8 7.3 4.1 TAF5 "TAF2D, TAFII100" ENSG00000148835 "TATA-box binding protein associated factor 5" Q15542 10 103367976-103389065 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 48.7;Spermatogonia: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006195, HPA006474" Supported Supported Nucleoplasm NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 23: Testis - Cell cycle regulation" "Cluster 32: U-937 - Innate immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA006195: AB_1080188, HPA006474: AB_1080185" "unprognostic (3.09e-2)" "unprognostic (2.44e-3)" "unprognostic (2.95e-1)" "unprognostic (3.18e-3)" "unprognostic (3.59e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (5.36e-3)" "unprognostic (2.21e-1)" "unprognostic (1.18e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (1.36e-9)" "prognostic favorable (7.39e-5)" "unprognostic (2.79e-2)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" 2.2 1.8 2.7 2.8 2.9 4.9 2.3 5.0 3.3 2.5 2.3 3.1 2.9 2.3 1.7 2.4 2.3 1.5 2.0 2.6 2.6 1.7 2.6 1.9 4.4 2.8 2.7 3.0 2.9 1.7 2.1 3.5 2.9 2.0 3.1 3.5 2.0 2.2 3.0 2.5 2.4 2.1 2.7 3.1 2.1 11.2 2.6 7.0 2.0 3.6 4.3 2.2 2.5 3.1 9.7 4.4 10.6 19.2 5.9 4.8 12.4 6.8 7.7 9.6 12.0 8.7 5.0 23.0 3.8 3.6 5.6 9.6 18.1 3.7 12.2 8.5 15.6 10.6 5.0 8.7 2.7 20.6 11.0 2.2 2.7 5.7 6.1 3.9 7.3 10.1 15.4 11.2 6.5 6.4 16.8 26.9 12.9 12.2 5.7 14.2 12.9 7.0 2.7 2.8 7.4 8.2 4.4 3.2 4.1 10.1 3.7 8.5 4.3 5.6 7.1 6.3 12.2 6.3 8.1 14.0 3.1 24.2 3.6 0.2 0.6 0.8 0.4 0.2 0.3 0.1 0.4 0.8 0.3 1.3 1.0 0.5 0.0 0.3 0.3 0.4 1.1 0.2 2.7 2.9 5.0 3.3 2.6 2.6 2.8 2.7 2.9 2.7 2.6 3.1 5.8 6.4 2.6 3.6 6.9 14.4 4.5 1.7 6.2 6.9 3.0 2.7 2.9 1.5 2.5 1.8 6.2 5.6 8.3 2.7 3.9 2.8 19.7 1.8 3.8 5.2 2.4 11.2 4.9 2.2 9.3 5.6 2.0 2.1 8.9 4.1 2.9 2.8 3.8 1.7 5.3 2.9 4.1 2.8 6.3 14.1 1.8 3.6 1.8 3.7 4.9 1.3 4.1 3.5 5.8 1.9 3.3 2.6 14.9 4.3 3.3 1.0 0.7 7.5 0.0 7.2 6.5 48.7 52.3 5.9 14.2 6.8 8.6 3.0 4.0 3.8 ATP5MD "bA792D24.4, DAPIT, MGC14697, USMG5" ENSG00000173915 "ATP synthase membrane subunit DAPIT" Q96IX5 10 103389041-103396492 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1340.2;Ductal cells: 705.9;Exocrine glandular cells: 723.1;Pancreatic endocrine cells: 884.5;Proximal tubular cells: 1879.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044798 Supported Mitochondria NA NA 55000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA044798: AB_2679091" "unprognostic (4.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.59e-1)" "unprognostic (7.93e-2)" "unprognostic (1.65e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (5.67e-2)" "unprognostic (1.57e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (7.46e-2)" "unprognostic (1.03e-2)" 332.3 343.0 502.9 155.1 517.7 193.0 324.6 514.9 721.8 215.1 515.2 484.6 273.5 176.9 410.2 426.1 194.3 140.8 1229.7 526.1 539.0 546.7 587.1 215.3 180.3 501.2 501.9 157.5 321.4 519.2 309.2 157.4 506.1 254.2 449.6 245.3 234.8 236.4 1019.3 204.6 261.7 229.8 511.8 185.4 369.8 142.5 509.3 319.0 191.2 1325.5 251.0 284.7 258.9 518.0 557.8 559.4 528.4 648.2 570.2 696.0 348.3 523.2 612.7 501.0 556.6 925.2 605.3 312.4 288.9 575.3 398.6 559.4 502.2 522.7 697.9 414.7 887.3 331.8 682.1 1057.7 545.7 688.3 491.3 569.2 801.1 456.4 715.7 849.2 661.5 470.0 441.5 517.5 849.4 842.0 552.0 1167.5 397.8 830.1 959.1 355.8 326.0 495.3 1218.4 878.4 203.7 464.8 269.4 419.7 824.9 723.5 373.4 619.9 388.6 255.2 394.2 394.0 692.8 537.2 958.4 543.5 545.2 678.2 200.3 575.3 271.2 395.8 214.7 384.0 248.0 301.6 296.3 259.8 314.1 219.1 251.4 256.7 231.1 230.5 375.3 456.3 307.9 304.4 502.9 517.7 514.9 721.8 526.1 539.0 501.2 501.9 506.1 511.8 509.3 518.0 169.1 211.5 173.2 0.0 40.9 0.0 0.0 0.0 0.0 0.0 323.4 417.6 0.0 0.0 91.0 388.1 0.0 298.0 76.3 0.0 1340.2 705.9 0.0 406.0 245.4 114.5 0.0 0.0 0.0 723.1 439.4 81.8 0.0 424.5 118.6 176.9 0.0 0.0 543.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.4 0.0 0.0 432.6 0.0 0.0 0.0 0.0 884.5 0.0 0.0 0.0 0.0 0.0 1879.7 121.0 0.0 0.0 0.0 127.9 0.0 0.0 0.0 0.0 305.8 69.4 209.9 0.0 0.0 PDCD11 "ALG-4, KIAA0185, NFBP, RRP5" ENSG00000148843 "Programmed cell death 11" Q14690 10 103396626-103446294 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017924, CAB026472" Approved Supported "Nucleoli rim,Vesicles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoli rim" Vesicles "CAB026472: , HPA017924: AB_10601045" "unprognostic (1.34e-1)" "unprognostic (6.84e-2)" "unprognostic (1.48e-1)" "unprognostic (2.31e-2)" "unprognostic (1.80e-1)" "unprognostic (8.94e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.16e-1)" "unprognostic (6.49e-2)" "unprognostic (3.25e-2)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (1.77e-1)" "unprognostic (6.28e-2)" "unprognostic (5.59e-2)" 8.1 7.8 4.1 10.0 4.8 7.5 9.4 4.5 4.6 8.7 4.5 7.7 5.9 9.9 5.9 11.7 9.0 4.4 7.5 4.4 4.7 9.8 9.1 7.3 11.0 4.4 4.5 10.4 11.6 8.5 6.4 7.5 4.6 8.0 7.9 6.1 7.2 6.2 15.8 15.5 7.7 9.1 4.1 9.5 7.3 14.8 5.1 11.9 6.9 8.1 11.8 9.9 8.4 5.0 27.4 39.8 27.2 77.0 23.3 20.9 30.5 29.6 20.7 29.2 23.7 54.7 26.3 74.9 20.5 21.4 18.0 48.0 70.6 37.1 32.5 34.8 47.5 43.7 26.0 44.2 27.7 88.0 28.7 21.8 33.3 44.8 101.3 21.0 31.6 19.4 71.5 32.7 28.4 30.9 44.5 49.9 55.9 21.7 37.9 44.3 39.0 34.1 18.1 26.6 18.2 34.1 19.9 23.2 32.6 26.4 22.8 24.8 34.5 21.5 27.0 29.0 55.9 41.2 61.8 69.5 19.0 83.3 16.2 0.1 2.8 0.9 3.2 2.6 5.2 3.4 3.1 2.7 2.8 2.2 2.7 3.2 0.3 2.1 2.3 3.3 2.3 2.5 4.1 4.8 4.5 4.6 4.4 4.7 4.4 4.5 4.6 4.1 5.1 5.0 8.8 12.8 14.1 5.9 13.6 16.4 9.3 10.8 8.0 15.0 18.6 15.6 14.6 20.0 17.4 9.2 29.2 12.8 18.1 9.6 13.7 23.6 61.2 12.6 25.4 14.4 9.5 14.9 11.8 15.8 15.8 14.0 5.6 11.7 18.9 18.5 8.9 24.5 10.9 6.7 9.3 12.9 4.1 7.7 5.2 19.6 11.1 10.7 10.6 8.4 9.8 4.9 9.2 7.5 7.6 29.1 4.9 10.1 9.6 17.9 4.4 8.2 20.2 13.8 6.6 16.8 11.0 27.5 30.7 14.0 16.9 8.2 11.6 19.0 19.9 8.7 CALHM2 FAM26B ENSG00000138172 "Calcium homeostasis modulator family member 2" Q9HA72 10 103446786-103452402 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 75.1;Fibroblasts: 38.2;Hepatic stellate cells: 48.2;Hofbauer cells: 53.7;Leydig cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 45.1;BJ: 37.7;BJ hTERT+: 37.5;fHDF/TERT166: 43.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014706 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Mitochondria" Cytosol "HPA014706: AB_2243916" "unprognostic (2.45e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (2.48e-1)" "unprognostic (3.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (8.85e-2)" "unprognostic (5.78e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (8.59e-2)" "unprognostic (2.47e-1)" "unprognostic (3.56e-1)" "unprognostic (4.74e-1)" 49.7 18.5 7.2 12.5 6.5 2.1 38.9 6.3 9.0 54.4 7.0 18.4 6.5 58.1 5.5 12.2 43.3 21.6 34.2 7.0 7.3 10.7 4.5 23.2 13.7 8.0 6.4 48.1 7.1 3.1 7.3 10.0 7.8 21.1 4.3 0.4 14.9 10.6 9.7 17.9 19.6 15.9 7.7 35.3 13.8 11.5 8.0 5.6 21.6 11.1 6.1 33.9 39.3 7.9 11.0 7.5 1.8 2.4 27.3 45.1 9.1 37.7 37.5 11.2 15.7 3.3 5.3 3.3 4.2 43.2 0.7 5.0 3.8 0.0 2.1 0.4 21.5 7.8 2.5 0.6 12.4 1.3 0.7 15.6 0.0 3.3 0.1 20.8 13.5 8.3 1.8 19.8 7.5 25.0 3.0 3.7 4.8 2.3 6.7 9.2 3.0 7.5 1.0 0.9 5.3 2.3 1.5 6.2 2.1 0.8 1.2 2.5 24.5 3.6 4.4 12.6 2.7 3.0 7.6 3.8 31.0 24.0 0.8 70.0 91.9 1.8 83.7 178.4 69.6 27.7 56.5 69.7 152.1 7.3 10.8 42.3 3.6 62.9 214.6 17.8 82.7 85.6 7.2 6.5 6.3 9.0 7.0 7.3 8.0 6.4 7.8 7.7 8.0 7.9 18.2 3.2 0.6 1.0 4.9 5.4 2.9 0.6 4.0 0.1 3.4 4.4 3.3 1.5 0.0 3.7 0.0 3.1 11.3 0.1 0.0 4.2 1.0 1.4 19.8 25.5 1.2 5.7 2.3 0.2 75.1 38.2 1.5 2.1 8.8 11.4 48.2 0.6 53.7 0.0 0.5 0.1 2.0 28.8 18.8 2.5 45.7 21.5 8.8 2.8 17.3 0.2 33.0 1.0 0.2 0.1 0.1 16.1 3.1 0.8 0.0 0.3 0.0 0.1 19.7 16.8 27.9 0.8 0.9 0.8 3.8 19.2 19.4 6.0 0.0 1.0 CALHM1 FAM26C ENSG00000185933 "Calcium homeostasis modulator 1" Q8IU99 10 103453240-103458900 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Sensory transduction, Taste, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.1" "Group enriched" "Detected in some" 4 "Excitatory neurons: 1.6;NK-cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPMI-8226: 1.3;U-266/70: 1.1;U-266/84: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA061816 Enhanced NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA061816: " "unprognostic (2.46e-1)" "unprognostic (2.66e-1)" "unprognostic (2.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.65e-3)" "unprognostic (3.44e-2)" "unprognostic (2.86e-2)" "unprognostic (1.67e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.44e-1)" "unprognostic (2.21e-8)" "unprognostic (1.96e-1)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" "unprognostic (1.38e-2)" 0.0 0.0 0.8 0.1 0.6 0.1 0.0 1.1 1.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 1.2 0.8 0.0 0.0 0.0 1.9 0.9 0.0 0.1 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 1.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.8 0.6 1.1 1.1 0.7 1.2 1.9 0.9 2.1 0.1 0.5 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CALHM3 "bA225H22.7, FAM26A" ENSG00000183128 "Calcium homeostasis modulator 3" Q86XJ0 10 103472804-103479240 "Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Taste, Transport" "Ion channel" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.2;Early spermatids: 2.2;Extravillous trophoblasts: 6.7;Late spermatids: 2.0;Syncytiotrophoblasts: 1.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-266/84: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA018205 Uncertain Approved Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "HPA018205: AB_2069267" "unprognostic (2.88e-1)" "unprognostic (4.00e-1)" "unprognostic (3.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.87e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (7.42e-3)" "unprognostic (1.44e-1)" "unprognostic (4.89e-2)" "unprognostic (3.07e-1)" "unprognostic (5.05e-2)" "unprognostic (1.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.3 2.6 0.3 1.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 14.3 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.1 0.0 NEURL1 "h-neu, neu-1, NEURL, RNF67" ENSG00000107954 "Neuralized E3 ubiquitin protein ligase 1" O76050 10 103493979-103592552 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Notch signaling pathway, Translation regulation, Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 146.9;tongue: 60.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 93.8;Early spermatids: 128.7;Intestinal goblet cells: 105.4;Late spermatids: 461.2;Paneth cells: 183.4;Syncytiotrophoblasts: 113.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 13 "intermediate monocyte: 45.1;non-classical monocyte: 112.0" "Lineage enriched" "Detected in many" 19 "monocytes: 112.0" "Cell line enhanced" "Detected in some" "BEWO: 13.7;HeLa: 8.6;HMC-1: 6.9;JURKAT: 7.4;SCLC-21H: 17.1;SiHa: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044204 Enhanced NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "HPA044204: AB_10959383" "unprognostic (1.21e-2)" "unprognostic (8.14e-2)" "unprognostic (1.18e-3)" "unprognostic (1.58e-4)" "unprognostic (1.31e-2)" "unprognostic (2.60e-1)" "unprognostic (5.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (4.31e-2)" "unprognostic (1.32e-3)" "unprognostic (1.08e-1)" "unprognostic (8.61e-3)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (2.91e-4)" "unprognostic (3.23e-1)" 0.5 4.6 25.5 3.8 29.6 2.2 0.4 20.8 37.4 14.1 0.0 15.2 10.9 25.8 15.1 4.3 2.6 1.9 0.5 32.2 7.2 2.4 1.2 0.9 0.8 1.7 4.1 1.9 18.8 8.3 15.9 4.6 1.3 1.4 10.3 39.5 2.9 1.3 146.9 1.8 17.2 5.2 0.0 1.9 5.2 13.0 5.0 1.1 0.5 60.5 0.5 18.7 2.6 17.2 0.9 0.2 1.3 0.0 0.2 0.1 13.7 0.5 0.9 0.2 0.1 0.3 0.2 0.4 0.7 0.1 0.9 0.6 0.4 0.2 0.1 0.4 0.8 0.2 8.6 0.3 0.0 0.3 6.9 0.2 0.5 0.1 0.7 0.2 0.0 7.4 2.3 0.5 0.2 1.2 1.4 0.9 0.0 0.5 4.2 0.2 0.7 1.5 0.0 0.5 17.1 5.9 8.8 0.0 0.4 2.5 0.7 1.7 0.0 0.1 0.9 0.3 0.2 1.0 0.2 0.3 0.5 0.0 0.4 0.8 2.8 0.5 0.7 45.1 1.1 1.1 1.0 1.1 5.8 0.7 1.2 0.8 2.3 0.6 112.0 4.7 0.4 4.1 25.5 29.6 20.8 37.4 32.2 7.2 1.7 4.1 1.3 0.0 5.0 17.2 0.3 0.0 0.6 1.3 1.5 0.5 1.5 0.2 0.0 53.2 2.0 2.7 1.6 0.0 0.2 0.0 93.8 4.6 3.1 7.9 0.0 12.0 128.7 0.0 0.8 2.2 78.3 4.6 47.9 0.7 12.9 2.2 13.3 0.1 0.0 1.2 0.0 0.2 4.5 3.3 32.9 105.4 32.6 4.6 2.4 461.2 5.6 4.8 0.0 0.0 5.5 9.0 2.1 1.0 4.2 0.5 183.4 5.3 0.6 1.3 7.2 0.0 0.2 88.0 6.6 2.4 1.0 56.6 33.6 0.0 1.8 113.4 1.7 8.4 9.4 0.7 SH3PXD2A "FISH, KIAA0418, SH3MD1" ENSG00000107957 "SH3 and PX domains 2A" Q5TCZ1 10 103594027-103855543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 86.8;BJ hTERT+: 84.8;fHDF/TERT166: 68.5;HSkMC: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037922, HPA037923" Approved NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "HPA037922: AB_10697088, HPA037923: AB_10672612" "unprognostic (1.03e-1)" "unprognostic (1.04e-1)" "unprognostic (1.95e-2)" "unprognostic (3.00e-2)" "unprognostic (1.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.80e-2)" "unprognostic (1.38e-1)" "unprognostic (4.83e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (5.83e-2)" "unprognostic (3.76e-2)" "prognostic unfavorable (2.04e-6)" "unprognostic (1.25e-1)" "unprognostic (2.59e-1)" "unprognostic (5.78e-3)" "unprognostic (2.62e-2)" 18.9 8.5 49.2 11.5 45.1 1.4 14.5 25.6 38.6 49.0 2.9 27.3 5.7 31.2 7.2 30.3 25.7 17.4 16.9 32.8 32.2 7.0 23.0 17.2 4.7 38.1 40.9 29.5 8.4 1.2 14.0 16.3 39.1 18.5 13.4 17.1 14.1 13.9 19.0 29.4 14.3 26.7 44.8 13.3 13.0 3.0 42.4 6.7 9.2 14.3 5.9 21.5 31.9 64.7 1.3 5.3 13.7 16.5 48.1 86.8 7.3 39.5 84.8 13.1 12.4 0.5 0.4 0.0 7.7 68.5 1.5 13.3 0.8 35.5 11.6 2.3 14.3 16.5 21.8 19.2 31.0 8.2 4.5 64.5 27.2 20.1 43.5 9.8 8.8 17.9 6.1 9.7 16.6 0.5 0.2 8.0 5.8 11.4 2.5 6.8 5.2 1.0 5.5 4.8 10.2 5.5 3.8 0.9 19.9 7.4 0.2 5.8 15.4 11.0 7.6 14.3 17.7 10.9 24.1 0.5 10.7 11.1 42.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 49.2 45.1 25.6 38.6 32.8 32.2 38.1 40.9 39.1 44.8 42.4 64.7 22.6 6.4 45.4 10.1 7.6 91.0 26.4 45.2 56.3 46.1 9.3 13.5 22.9 22.8 37.8 3.7 27.1 12.1 3.4 48.1 0.0 5.3 3.2 7.7 109.9 23.9 37.1 10.5 59.5 0.6 32.0 42.2 12.8 11.5 17.7 21.8 23.9 87.3 13.0 89.2 96.6 74.8 22.4 7.6 34.9 7.3 105.9 7.7 33.8 15.0 19.0 1.7 2.1 5.0 117.2 6.2 27.0 80.5 7.9 32.1 4.1 1.3 21.6 35.7 39.5 32.1 55.6 1.9 3.7 37.5 38.1 4.7 6.8 15.0 22.7 61.1 STN1 "bA541N10.2, FLJ22559, OBFC1" ENSG00000107960 "STN1 subunit of CST complex" Q9H668 10 103877569-103918184 "Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 37.4;Distal tubular cells: 41.1;Ductal cells: 34.6;Exocrine glandular cells: 79.2;Pancreatic endocrine cells: 62.9;Theca cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037924, HPA037925" Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA037924: AB_10671636, HPA037925: AB_10672469" "unprognostic (1.50e-1)" "unprognostic (4.22e-2)" "unprognostic (2.18e-2)" "unprognostic (5.58e-3)" "unprognostic (6.01e-2)" "unprognostic (1.53e-2)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (5.93e-2)" "unprognostic (1.72e-1)" "unprognostic (1.12e-3)" "unprognostic (3.76e-1)" "prognostic favorable (1.12e-6)" "unprognostic (1.21e-1)" "unprognostic (1.74e-1)" "unprognostic (1.20e-1)" "unprognostic (1.83e-2)" 15.7 22.2 8.8 12.2 10.1 13.5 17.1 11.3 9.4 13.3 11.5 14.5 12.0 12.0 9.8 41.0 12.2 18.3 35.0 8.2 11.1 17.9 13.1 25.2 16.0 13.1 11.0 22.2 20.9 33.6 14.9 17.1 11.5 10.2 16.4 6.4 18.7 13.3 22.4 13.3 11.0 15.4 9.9 15.3 22.2 23.4 11.5 24.5 17.6 28.9 22.8 22.5 18.5 11.2 26.8 19.7 23.8 19.6 18.6 57.6 7.6 12.6 36.5 16.4 14.6 11.4 43.6 16.7 22.2 16.1 14.7 24.8 8.7 31.0 15.3 24.1 11.9 15.3 7.0 23.5 25.6 12.7 12.9 37.2 52.1 15.9 43.9 42.9 32.0 31.2 8.5 34.9 27.3 21.7 31.5 22.0 5.5 38.7 28.5 22.7 16.4 19.2 40.5 31.3 13.7 16.1 9.3 14.9 24.4 13.4 12.5 11.0 47.1 20.4 14.1 14.5 19.4 47.3 13.1 16.6 30.4 26.4 9.0 41.7 33.2 110.3 65.1 21.3 103.4 25.5 71.9 60.4 40.2 29.6 52.3 62.6 48.8 71.3 23.7 37.1 100.2 51.5 8.8 10.1 11.3 9.4 8.2 11.1 13.1 11.0 11.5 9.9 11.5 11.2 14.7 22.4 20.9 0.0 2.3 0.0 0.0 0.0 0.0 0.0 12.7 16.9 0.0 0.0 5.0 9.2 0.0 37.4 17.2 0.0 41.1 34.6 0.0 9.2 9.9 6.4 0.0 0.0 0.0 79.2 14.0 3.9 0.0 15.4 5.1 23.8 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 13.5 0.0 0.0 0.0 0.0 62.9 0.0 0.0 1.0 0.0 0.0 12.8 7.3 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 27.0 13.3 52.4 0.0 0.0 SLK "KIAA0204, se20-9, STK2" ENSG00000065613 "STE20 like kinase" Q9H2G2 10 103967140-104029233 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Urothelial cells: 201.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015757 Approved Approved "Plasma membrane,Cytosol" NA NA 140000 "Cluster 49: Eosinophils - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane, Cytosol" "HPA015757: AB_1857236" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (8.67e-2)" "unprognostic (6.85e-2)" "unprognostic (1.01e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (1.95e-1)" "prognostic favorable (3.95e-5)" "unprognostic (8.48e-2)" "unprognostic (3.95e-1)" "unprognostic (3.09e-2)" "unprognostic (1.07e-1)" 20.5 15.1 10.9 15.2 19.9 28.9 21.7 20.9 13.7 19.9 15.3 20.4 13.3 21.3 16.2 56.4 14.1 21.3 22.4 11.7 10.0 20.6 17.8 24.0 11.8 11.5 11.1 24.0 16.7 26.3 9.6 25.8 11.7 17.6 20.8 15.1 21.9 17.7 23.1 26.3 14.7 20.6 10.3 14.9 24.1 15.2 12.3 15.2 22.4 25.1 17.5 30.5 28.6 18.5 50.5 28.9 33.7 24.3 36.6 50.1 14.2 30.6 40.7 22.5 20.9 18.4 53.7 26.6 18.6 31.8 19.1 53.7 18.0 39.5 33.5 21.3 24.7 27.0 23.5 15.6 26.6 32.7 22.4 25.5 49.5 30.9 87.6 31.7 40.9 16.9 34.6 17.9 29.8 18.6 23.0 18.0 8.4 32.4 18.2 22.2 41.4 13.8 29.0 60.3 8.0 13.8 26.6 25.7 25.8 17.2 13.8 23.4 63.4 16.6 16.9 30.6 36.3 21.6 28.0 16.7 24.2 43.1 10.7 0.6 0.5 1.7 1.4 0.5 1.5 0.4 0.8 1.0 0.5 0.6 0.6 1.0 2.7 0.5 0.4 0.9 0.8 0.3 10.9 19.9 20.9 13.7 11.7 10.0 11.5 11.1 11.7 10.3 12.3 18.5 73.5 179.5 129.5 38.5 19.9 57.0 87.1 30.9 26.7 32.2 32.0 35.1 110.4 30.0 100.9 44.1 25.0 37.4 40.1 70.0 3.9 34.0 8.4 43.3 77.1 80.2 18.5 25.5 35.3 54.0 13.6 52.6 44.9 90.3 35.3 54.6 50.7 25.3 19.9 25.2 39.3 37.2 18.3 24.5 36.9 16.6 46.6 37.5 8.8 34.7 43.9 25.7 27.8 34.2 63.9 85.5 81.6 63.2 22.3 67.8 21.9 11.5 57.9 25.4 6.6 68.1 49.3 46.3 35.3 61.4 68.5 52.4 44.2 71.7 37.4 201.0 COL17A1 "BP180, BPAG2" ENSG00000065618 "Collagen type XVII alpha 1 chain" Q9UMD9 10 104031286-104085880 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 580.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 585.7;Basal respiratory cells: 136.0;Basal squamous epithelial cells: 299.9;Distal enterocytes: 211.5;Proximal enterocytes: 108.5;Suprabasal keratinocytes: 139.4" "Cancer enriched" "Detected in many" 5 "head and neck cancer: 227.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 204.3;HaCaT: 463.8;HBEC3-KT: 745.8;hTCEpi: 914.1;hTERT-HME1: 783.7" "Region enriched" "Detected in single" 4 "cerebellum: 1.0" "Low region specificity" "Detected in many" "HPA043673, HPA052963" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to extracellular matrix" NA NA 32000 "Cluster 1: Neutrophils - Mixed function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Golgi apparatus" "HPA043673: AB_10960893, HPA052963: AB_2681999" "prognostic favorable (1.38e-4)" "unprognostic (1.33e-1)" "unprognostic (4.01e-1)" "unprognostic (1.01e-1)" "unprognostic (9.65e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (6.82e-3)" "unprognostic (1.63e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.75e-2)" "unprognostic (8.35e-2)" 1.5 0.4 0.8 6.6 1.1 12.2 37.3 1.0 1.4 50.1 0.6 37.4 10.7 0.6 6.6 116.6 1.1 0.3 0.5 0.5 0.6 0.3 0.3 0.9 0.1 0.6 0.7 0.2 0.4 0.0 1.2 35.4 0.6 17.9 27.3 0.0 82.2 9.6 0.5 580.3 37.2 1.0 0.5 2.3 19.8 25.4 0.6 42.7 5.1 0.0 19.8 9.9 102.0 0.8 26.3 0.4 1.5 0.2 0.1 0.0 80.6 0.5 0.3 0.1 0.2 0.3 204.3 0.0 5.1 0.3 3.9 463.8 0.7 745.8 0.7 0.0 0.7 0.0 0.3 0.2 0.1 0.0 0.4 0.7 914.1 0.5 783.7 0.2 3.5 0.1 0.1 0.9 0.0 0.0 0.0 0.3 1.7 5.1 2.6 0.0 0.0 0.3 35.9 26.4 0.2 0.3 0.0 0.2 0.9 4.0 0.2 0.0 1.5 0.5 5.0 0.3 5.5 0.1 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 1.1 1.0 1.4 0.5 0.6 0.6 0.7 0.6 0.5 0.6 0.8 1.0 0.0 1.1 0.7 0.3 585.7 17.7 136.0 299.9 0.6 1.7 85.5 1.1 0.0 16.5 0.0 0.0 10.2 0.3 211.5 0.0 0.8 14.2 23.7 2.3 3.7 2.4 0.0 0.1 0.9 18.9 2.4 23.0 8.1 0.0 0.1 0.0 0.0 1.3 0.0 0.2 5.7 6.1 0.0 28.9 3.6 0.3 0.7 33.8 0.0 0.0 0.4 0.0 0.0 0.4 78.8 35.7 0.7 1.4 16.6 108.5 0.1 5.9 0.4 0.0 0.4 3.0 22.7 1.5 31.9 139.4 5.6 1.3 0.1 21.6 10.7 SFR1 "bA373N18.1, C10orf78, FLJ41960, MEI5, MEIR5" ENSG00000156384 "SWI5 dependent homologous recombination repair protein 1" Q86XK3 10 104122058-104126385 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Spermatocytes: 233.6;Spermatogonia: 76.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA039617 Uncertain NA NA "Cluster 44: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA039617: AB_10805482" "unprognostic (2.79e-2)" "unprognostic (2.58e-3)" "unprognostic (1.94e-2)" "unprognostic (3.78e-1)" "unprognostic (8.54e-2)" "unprognostic (4.42e-3)" "prognostic unfavorable (2.59e-5)" "unprognostic (6.20e-2)" "unprognostic (9.39e-2)" "unprognostic (5.19e-2)" "unprognostic (8.88e-3)" "unprognostic (2.21e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (2.86e-2)" "unprognostic (4.66e-2)" "unprognostic (8.44e-2)" "unprognostic (2.24e-2)" 4.8 4.4 5.6 7.2 8.2 10.0 6.6 7.1 7.9 3.8 6.1 5.2 4.7 5.4 7.3 4.9 5.4 4.9 7.6 5.5 5.9 4.9 3.1 6.3 9.0 7.9 7.0 8.9 5.9 3.5 2.9 3.9 7.6 3.9 6.4 4.2 4.0 3.4 4.1 4.4 6.1 5.6 6.5 6.3 5.5 18.3 7.0 11.7 7.3 5.3 7.6 5.4 3.2 11.2 22.2 12.4 13.1 5.5 5.0 8.9 7.7 11.6 14.0 7.4 9.7 5.5 45.7 17.7 10.9 3.1 15.5 18.4 6.6 15.8 11.8 15.6 7.5 13.3 5.4 7.0 9.3 15.7 8.5 4.9 5.8 14.8 20.3 9.9 15.3 18.2 8.6 12.5 9.3 6.8 16.0 28.3 6.2 13.0 9.0 19.8 19.1 9.4 16.0 5.9 7.2 7.4 7.4 4.0 9.9 10.9 10.1 6.9 7.1 4.2 15.2 12.9 18.8 14.9 19.2 18.0 12.2 16.6 5.7 23.6 16.8 10.4 14.3 16.5 14.6 16.6 14.9 15.2 11.9 19.2 21.7 18.3 5.4 12.8 12.1 10.3 13.5 14.9 5.6 8.2 7.1 7.9 5.5 5.9 7.9 7.0 7.6 6.5 7.0 11.2 12.1 3.2 11.8 1.3 9.9 21.5 14.6 10.4 2.8 3.5 6.8 7.0 8.5 8.6 13.8 1.8 0.0 9.7 9.8 4.7 17.6 12.1 20.0 8.0 6.3 13.7 3.0 21.8 1.3 12.3 13.7 10.2 2.6 7.8 12.0 8.1 18.2 1.9 17.6 5.0 2.6 6.3 18.3 16.3 12.4 11.3 9.6 12.5 3.6 4.7 17.8 9.6 15.5 1.0 14.0 19.1 5.1 6.0 4.5 5.1 5.7 10.1 5.3 4.9 0.0 13.0 9.0 233.6 76.7 5.5 7.4 3.8 10.4 5.6 7.2 8.7 CFAP43 "bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96" ENSG00000197748 "Cilia and flagella associated protein 43" Q8NDM7 10 104129888-104232364 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 34.7;choroid plexus: 80.2;fallopian tube: 48.9;testis: 57.3" "Cell type enhanced" "Detected in many" "Early spermatids: 103.0;Endometrial ciliated cells: 161.0;Late spermatids: 58.4;Respiratory ciliated cells: 231.0;Spermatocytes: 53.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;U-266/70: 3.3;U-266/84: 2.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 5.9" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.20e-2)" "unprognostic (3.05e-2)" "unprognostic (3.61e-2)" "unprognostic (6.46e-3)" "unprognostic (2.03e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "unprognostic (1.78e-1)" "unprognostic (1.56e-1)" "unprognostic (2.80e-1)" "unprognostic (6.88e-3)" "unprognostic (2.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.41e-1)" "unprognostic (3.35e-2)" "unprognostic (9.11e-4)" "unprognostic (6.67e-2)" 0.3 1.0 8.4 0.2 8.2 0.2 2.5 4.7 4.3 6.0 80.2 0.3 0.4 2.9 7.8 0.2 48.9 0.9 0.2 8.8 10.5 5.9 0.4 8.2 0.3 33.9 34.7 1.8 2.2 3.8 10.1 0.3 23.5 1.5 0.2 10.7 0.9 1.3 0.1 1.0 0.6 0.2 23.8 0.2 0.6 57.3 9.8 0.4 5.3 0.0 0.2 0.2 0.5 14.6 1.7 0.6 0.6 1.1 0.0 0.3 0.1 0.0 0.5 0.3 0.2 0.0 4.3 0.0 0.0 0.0 1.5 0.6 0.1 0.6 0.7 0.2 0.7 0.0 0.3 0.2 0.1 0.0 0.1 0.4 0.5 0.4 0.3 0.9 0.1 0.3 1.2 0.1 0.0 1.1 0.1 0.2 0.1 0.4 0.2 0.1 0.0 0.0 1.5 0.0 0.9 0.9 0.4 0.0 0.8 0.5 0.5 0.0 0.0 0.1 0.3 0.5 0.2 3.3 2.9 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.4 8.2 4.7 4.3 8.8 10.5 33.9 34.7 23.5 23.8 9.8 14.6 0.3 3.2 8.4 16.6 0.1 0.0 0.6 0.0 0.6 0.8 1.9 1.7 0.8 0.0 38.4 1.8 10.4 0.1 0.0 0.0 0.0 1.2 103.0 161.0 2.1 1.0 3.6 0.8 16.6 0.0 0.2 1.2 1.1 3.6 6.3 0.6 0.4 0.1 0.1 0.0 23.5 0.1 0.0 0.0 0.0 58.4 1.5 0.7 0.0 1.9 0.6 1.3 0.0 1.5 6.1 0.2 0.1 2.2 0.2 0.6 0.1 1.2 231.0 8.8 0.0 0.6 0.1 53.7 4.4 0.3 0.0 0.0 0.7 0.4 0.2 0.3 GSTO1 "GSTTLp28, P28" ENSG00000148834 "Glutathione S-transferase omega 1" P78417 10 104235356-104267459 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 657.7" "Cell type enhanced" "Detected in all" "Hofbauer cells: 676.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 1106.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037603, HPA037604" Enhanced NA NA 120000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 51: Myeloid cells - Hemostasis" "HPA037603: AB_2675574, HPA037604: AB_10672283" "prognostic favorable (6.95e-4)" "unprognostic (9.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.83e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.23e-3)" "unprognostic (4.57e-2)" "unprognostic (7.65e-2)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.86e-2)" "unprognostic (1.29e-1)" "unprognostic (5.51e-3)" "unprognostic (5.82e-2)" 95.0 145.4 119.1 102.8 123.1 191.6 89.9 121.3 166.7 90.1 118.0 92.7 167.6 72.0 96.2 79.3 75.4 84.8 277.4 117.3 124.8 154.4 657.7 154.7 93.1 121.3 127.1 83.1 80.5 129.7 102.9 113.6 122.7 80.3 94.8 38.2 75.6 89.6 148.4 63.8 165.2 86.9 122.2 107.1 93.3 14.9 128.8 124.8 82.9 122.5 77.4 109.6 82.6 136.4 287.7 194.5 142.9 249.3 201.4 385.1 62.8 358.3 640.7 237.9 257.2 247.2 292.8 254.2 152.8 245.6 296.8 158.8 97.0 329.2 244.5 128.4 233.7 186.6 122.1 542.7 359.7 241.5 294.5 291.5 136.7 346.3 414.5 331.3 464.1 231.2 394.4 153.4 511.4 159.3 188.3 330.0 130.4 308.1 134.8 136.0 94.9 108.1 358.4 185.1 72.1 88.6 117.6 81.0 1106.0 238.2 92.0 192.7 426.6 276.9 143.6 427.3 328.4 2.7 3.3 2.0 517.7 416.2 112.0 842.8 532.4 157.9 133.0 457.0 164.5 148.8 164.6 172.9 429.3 111.9 143.0 144.3 151.8 185.0 369.1 203.0 204.8 632.1 119.1 123.1 121.3 166.7 117.3 124.8 121.3 127.1 122.7 122.2 128.8 136.4 107.4 76.9 72.6 8.8 64.8 93.7 328.2 297.6 51.2 36.9 63.5 105.5 328.2 218.8 113.3 101.2 20.9 394.2 82.0 101.6 332.6 341.0 22.4 68.1 79.6 164.5 103.5 192.8 12.1 248.4 176.6 173.0 49.5 81.7 146.3 107.6 388.0 628.2 676.5 23.5 11.7 163.8 124.1 321.8 223.6 17.3 114.6 484.5 126.3 8.4 277.7 81.2 95.8 8.5 21.8 347.6 150.7 112.8 39.9 169.4 483.2 538.0 114.3 29.8 151.2 85.3 176.1 5.7 5.1 55.8 78.7 111.0 81.4 224.8 196.6 204.9 GSTO2 ENSG00000065621 "Glutathione S-transferase omega 2" Q9H4Y5 10 104268873-104304950 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 35.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 133.1;Early spermatids: 314.6;Late spermatids: 442.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 16.9;CAPAN-2: 17.1;hTCEpi: 16.2;hTERT-HME1: 18.3;OE19: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA048141 Approved NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 34: Spermatids - Unknown function" "HPA048141: AB_2680281" "unprognostic (5.77e-2)" "unprognostic (6.69e-2)" "unprognostic (7.15e-2)" "unprognostic (1.80e-1)" "unprognostic (2.48e-1)" "unprognostic (3.11e-2)" "unprognostic (3.12e-1)" "unprognostic (2.15e-1)" "unprognostic (7.42e-2)" "unprognostic (5.28e-2)" "unprognostic (1.44e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.10e-7)" "unprognostic (4.56e-2)" "unprognostic (3.92e-2)" "unprognostic (1.75e-2)" "unprognostic (3.47e-1)" 0.5 3.5 5.0 0.3 5.7 2.0 5.2 3.4 5.3 4.3 0.4 4.4 2.8 2.2 4.9 11.8 4.3 1.2 0.6 4.4 4.1 14.0 2.8 2.4 0.3 2.2 2.5 5.4 16.7 5.0 14.6 1.0 2.6 8.3 3.1 6.0 7.5 3.2 1.4 14.8 3.5 1.2 1.1 0.5 10.9 35.9 4.3 2.2 7.0 1.3 0.7 3.8 7.5 5.3 10.2 1.4 0.5 0.6 0.6 1.3 1.4 9.6 16.9 4.7 4.9 0.6 17.1 1.6 4.0 0.8 0.5 10.7 0.5 5.3 1.2 1.1 3.2 0.5 3.1 2.4 2.1 0.7 0.7 1.7 16.2 0.3 18.3 1.3 0.8 1.7 1.5 2.9 1.3 12.3 0.1 0.5 1.7 22.1 1.1 0.5 0.7 0.3 4.6 6.5 0.6 1.1 3.3 2.4 2.9 0.8 12.6 0.3 2.4 1.5 5.1 0.6 0.5 2.8 6.4 0.4 1.5 0.8 0.5 0.2 0.1 0.7 0.5 0.2 0.3 0.3 0.5 0.3 0.0 0.5 0.7 0.4 1.7 1.0 0.1 0.3 1.2 0.2 5.0 5.7 3.4 5.3 4.4 4.1 2.2 2.5 2.6 1.1 4.3 5.3 3.6 3.2 21.0 13.1 1.3 34.2 62.1 94.5 50.1 19.0 61.7 78.2 3.0 21.5 46.4 40.5 16.7 14.4 3.8 12.8 133.1 30.6 314.6 26.9 7.6 5.4 54.2 3.6 33.9 63.3 9.9 4.7 31.6 37.6 2.5 3.3 15.7 3.6 1.8 0.0 28.7 34.0 50.8 1.6 3.7 442.8 2.8 2.7 17.8 1.9 2.1 11.1 1.0 24.1 20.1 31.6 29.1 9.8 0.9 25.6 27.1 43.8 31.2 23.0 6.6 3.1 7.4 22.0 8.9 46.0 47.3 6.7 4.3 11.6 40.7 58.0 ITPRIP "bA127L20.2, DANGER, KIAA1754" ENSG00000148841 "Inositol 1,4,5-trisphosphate receptor interacting protein" Q8IWB1 10 104309698-104338465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 203.2" "Cell type enhanced" "Detected in many" "Adipocytes: 98.0;Hepatic stellate cells: 82.1;Squamous epithelial cells: 108.4;Suprabasal keratinocytes: 72.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 30.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 103.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043626 Uncertain Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" Vesicles "HPA043626: AB_10963078" "unprognostic (2.45e-2)" "unprognostic (3.06e-1)" "unprognostic (1.59e-2)" "unprognostic (3.22e-2)" "unprognostic (1.08e-2)" "unprognostic (4.20e-1)" "unprognostic (7.87e-2)" "prognostic unfavorable (3.59e-4)" "unprognostic (9.74e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (4.00e-2)" "unprognostic (5.37e-3)" "unprognostic (1.01e-3)" "unprognostic (2.65e-1)" "unprognostic (2.75e-1)" "unprognostic (2.11e-3)" 36.3 13.7 5.7 16.9 5.9 203.2 25.4 5.3 10.5 31.6 15.5 13.6 3.1 16.3 3.7 52.9 15.1 21.2 72.5 5.5 6.6 18.0 13.3 38.5 10.4 8.0 6.3 29.1 9.4 8.0 15.9 26.8 6.4 14.0 5.0 1.7 14.1 9.0 10.1 66.3 8.8 18.2 7.0 12.6 12.3 7.4 8.0 12.8 21.1 10.4 11.9 23.7 43.5 7.7 6.4 16.1 19.2 8.6 32.8 31.4 10.9 35.0 75.9 25.8 32.0 1.2 2.8 11.2 7.7 22.5 51.2 20.7 6.5 17.4 26.6 9.6 7.6 6.6 24.6 4.9 64.3 15.9 12.3 29.2 103.5 53.8 42.8 29.9 48.7 11.4 28.4 21.5 32.0 2.7 3.1 17.0 14.3 2.2 17.9 14.3 9.9 6.8 10.6 2.8 10.7 7.0 6.7 7.8 16.0 11.6 0.6 11.8 82.7 51.9 13.6 34.5 34.5 7.8 9.8 7.3 38.0 27.9 24.8 4.4 9.5 14.0 4.5 5.8 4.5 2.5 2.7 2.6 6.2 2.8 3.2 2.9 30.6 5.0 5.8 4.2 2.3 21.3 5.7 5.9 5.3 10.5 5.5 6.6 8.0 6.3 6.4 7.0 8.0 7.7 98.0 3.2 8.3 1.3 9.0 37.9 15.3 13.2 44.3 0.0 3.0 2.4 7.8 1.5 9.0 3.7 0.0 7.3 37.0 1.7 0.0 3.7 6.3 11.7 10.0 42.5 0.0 8.8 0.6 2.4 22.6 15.5 3.6 46.7 20.3 3.6 82.1 2.3 10.8 0.0 0.4 2.6 2.0 17.2 20.6 1.6 5.0 28.1 8.8 6.5 7.0 3.8 10.3 0.5 0.9 3.0 0.5 5.7 13.6 5.8 0.2 0.5 5.2 0.6 13.1 6.3 14.7 8.1 1.8 108.4 72.7 5.1 23.8 4.4 1.1 20.5 CFAP58 "bA554P13.1, C10orf80, CCDC147, FLJ35908" ENSG00000120051 "Cilia and flagella associated protein 58" Q5T655 10 104353833-104455102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 8.4;testis: 13.4" "Group enriched" "Detected in some" 4 "Early spermatids: 73.3;Endometrial ciliated cells: 25.1;Late spermatids: 58.9;Respiratory ciliated cells: 56.9;Spermatocytes: 34.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 2.1" "Lineage enriched" "Detected in single" 21 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.1;U-2 OS: 6.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.9" "HPA036555, HPA071938" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 9: U-2 OS - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "Plasma membrane, Cytosol" "HPA036555: AB_10673622, HPA071938: " "unprognostic (5.32e-1)" "unprognostic (2.59e-1)" "unprognostic (6.26e-2)" "unprognostic (1.57e-3)" "unprognostic (5.41e-3)" "unprognostic (1.01e-1)" "unprognostic (9.62e-2)" "unprognostic (5.64e-2)" "unprognostic (3.11e-1)" "unprognostic (2.18e-1)" "unprognostic (8.93e-2)" "unprognostic (3.15e-1)" "unprognostic (1.65e-1)" "unprognostic (3.97e-2)" "unprognostic (6.81e-2)" "unprognostic (4.19e-2)" "unprognostic (1.59e-1)" 0.4 0.6 1.0 0.5 1.3 0.4 0.4 0.4 0.7 2.2 2.4 0.5 0.1 1.8 0.2 0.2 8.4 0.2 2.5 0.8 1.2 0.7 0.1 1.3 0.3 2.9 3.7 0.5 0.3 0.7 1.5 0.4 2.2 0.5 0.0 0.6 0.2 0.4 1.3 0.3 0.2 0.6 2.0 0.3 0.3 13.4 1.0 0.1 0.8 0.8 0.4 0.3 0.6 1.1 0.1 0.0 0.7 0.1 0.1 0.3 0.1 1.0 3.1 0.6 1.6 0.0 0.0 2.4 0.2 0.4 1.7 0.2 0.0 0.2 1.8 0.3 0.1 0.5 0.9 0.0 0.3 0.3 0.4 0.3 1.3 0.5 1.6 1.3 1.0 0.1 0.7 0.7 0.8 0.0 0.0 0.7 0.2 0.0 0.0 0.2 0.2 0.3 0.3 0.0 0.4 0.2 0.0 0.1 0.5 0.7 0.1 0.4 2.0 0.6 6.5 0.3 1.8 0.2 0.0 0.1 0.7 0.8 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.4 0.7 0.8 1.2 2.9 3.7 2.2 2.0 1.0 1.1 0.4 0.0 0.5 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 10.0 0.0 9.3 0.0 0.0 0.1 0.1 0.0 0.0 0.6 73.3 25.1 0.3 0.4 0.0 0.0 4.0 0.2 0.4 0.7 0.0 0.4 0.0 0.3 1.8 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.0 58.9 0.6 0.2 0.0 1.9 0.1 0.7 1.0 1.0 0.0 0.3 0.0 1.2 0.0 0.2 0.0 0.0 56.9 0.3 0.0 0.8 1.0 34.4 4.0 0.0 0.0 0.1 0.0 0.6 0.0 0.2 SORCS3 "KIAA1059, SORCS" ENSG00000156395 "Sortilin related VPS10 domain containing receptor 3" Q9UPU3 10 104641290-105265242 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 11.7" "Group enriched" "Detected in some" 15 "Excitatory neurons: 270.4;Inhibitory neurons: 193.7;Oligodendrocyte precursor cells: 462.9" "Group enriched" "Detected in some" 13 "glioma: 1.8;renal cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPTEC TERT1: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (2.39e-2)" "unprognostic (8.47e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-1)" "unprognostic (1.98e-1)" "unprognostic (3.63e-1)" "unprognostic (4.78e-1)" "unprognostic (1.84e-1)" "unprognostic (3.01e-1)" "prognostic unfavorable (5.72e-4)" "unprognostic (2.63e-2)" "unprognostic (1.97e-1)" 0.2 2.0 6.5 0.1 7.7 0.0 0.1 1.8 7.5 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 7.0 11.7 0.2 0.0 0.0 0.0 3.6 4.1 0.8 0.0 0.0 0.2 0.0 2.2 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.2 1.7 0.0 0.1 1.0 10.3 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 7.7 1.8 7.5 7.0 11.7 3.6 4.1 2.2 1.7 10.3 4.8 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.1 0.1 0.0 0.0 270.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 193.7 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.7 0.0 0.0 0.0 462.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SORCS1 ENSG00000108018 "Sortilin related VPS10 domain containing receptor 1" Q8WY21 10 106573663-107164534 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;thyroid gland: 11.0" "Group enriched" "Detected in some" 7 "Excitatory neurons: 522.2;Inhibitory neurons: 179.7;Oligodendrocyte precursor cells: 381.5" "Cancer enhanced" "Detected in some" "melanoma: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "RH-30: 80.8;SH-SY5Y: 104.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011948 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cytosol" "HPA011948: AB_1857366" "unprognostic (5.86e-3)" "unprognostic (8.45e-3)" "unprognostic (1.55e-2)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (2.92e-2)" "unprognostic (3.52e-2)" "unprognostic (5.58e-2)" "unprognostic (6.82e-3)" "unprognostic (5.81e-2)" "unprognostic (6.48e-4)" "unprognostic (2.51e-2)" "unprognostic (8.89e-3)" "unprognostic (2.22e-1)" "unprognostic (2.69e-4)" 0.6 3.1 3.0 1.9 6.2 0.0 1.3 0.0 10.3 2.5 0.0 9.4 0.7 1.1 0.3 0.9 1.6 1.1 3.1 5.4 5.8 4.7 0.1 0.1 1.0 0.6 4.5 0.7 1.6 0.0 0.9 0.0 2.7 2.2 1.9 9.6 1.1 2.5 0.3 1.5 3.6 1.4 0.5 0.8 2.5 1.2 5.8 1.0 11.0 1.7 1.5 3.6 2.8 6.6 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 80.8 0.1 0.0 0.0 0.0 104.9 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.6 6.1 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 6.2 0.0 10.3 5.4 5.8 0.6 4.5 2.7 0.5 5.8 6.6 0.0 0.0 0.5 7.2 0.0 0.6 0.0 0.0 1.2 2.0 0.1 0.5 2.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 16.6 0.1 4.9 0.2 0.0 0.0 522.2 0.0 0.0 3.6 0.0 0.1 0.0 1.0 0.0 0.0 0.2 1.7 179.7 0.0 0.0 0.3 0.3 5.2 0.0 0.2 1.8 26.2 0.0 49.1 0.0 381.5 10.0 0.1 0.0 0.4 0.0 0.0 0.0 2.2 0.0 2.1 0.0 1.0 0.3 0.2 1.9 0.2 0.1 0.0 0.3 0.0 0.0 0.0 XPNPEP1 "XPNPEP, XPNPEPL, XPNPEPL1" ENSG00000108039 "X-prolyl aminopeptidase 1" Q9NQW7 10 109864766-109923553 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025196, HPA030419, HPA030420, HPA030422" Supported Enhanced Cytosol NA NA 810000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783" "unprognostic (3.17e-2)" "unprognostic (2.36e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.46e-1)" "unprognostic (2.01e-3)" "prognostic unfavorable (2.12e-5)" "unprognostic (8.03e-2)" "unprognostic (2.10e-2)" "unprognostic (1.88e-1)" "unprognostic (4.89e-2)" "unprognostic (7.61e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (5.18e-2)" 19.7 19.4 13.2 22.9 13.6 23.3 20.1 13.1 14.8 19.7 17.2 32.2 51.7 19.4 22.7 25.1 22.3 27.5 27.9 15.3 13.4 21.4 18.9 19.2 25.4 13.2 12.7 19.8 62.0 24.5 19.2 26.6 13.1 21.7 40.4 18.7 30.4 15.7 28.4 29.5 61.8 28.2 13.2 19.3 24.4 18.1 13.3 19.5 23.6 22.1 28.4 24.6 19.3 13.7 78.1 33.6 52.3 72.1 83.6 77.4 40.2 42.4 85.5 61.8 66.5 65.4 65.2 110.3 35.9 65.0 31.3 40.5 41.7 52.2 60.4 33.0 40.3 74.0 20.5 27.6 58.2 58.3 59.0 76.9 31.8 67.8 60.1 94.6 103.1 70.0 24.3 34.3 80.1 26.3 41.7 36.0 20.6 58.7 35.7 46.1 105.3 19.8 78.5 24.3 15.9 60.5 36.9 23.1 70.6 56.9 28.3 53.6 53.9 25.3 32.9 40.4 38.1 58.4 30.4 92.8 59.4 80.0 20.3 25.7 26.8 11.3 19.5 42.2 13.4 10.6 12.6 17.5 46.4 8.9 8.7 11.7 2.2 30.5 36.8 36.4 15.5 29.6 13.2 13.6 13.1 14.8 15.3 13.4 13.2 12.7 13.1 13.2 13.3 13.7 13.4 6.4 14.4 24.5 14.6 8.9 13.2 32.9 11.4 20.5 12.1 9.7 17.0 18.6 26.3 3.7 6.2 38.2 33.1 34.5 17.6 37.4 6.4 12.3 16.5 18.2 16.8 14.7 18.9 72.9 29.6 22.7 24.5 13.6 11.4 17.0 15.7 12.1 30.9 26.9 25.3 37.1 18.3 20.5 9.6 5.1 18.3 37.5 8.8 15.9 33.5 27.1 24.7 21.6 27.0 54.4 35.1 29.7 18.1 22.5 63.5 31.1 22.8 19.5 13.1 9.8 14.2 17.5 35.9 18.6 8.7 25.2 19.4 30.0 36.5 27.1 ADD3 ADDL ENSG00000148700 "Adducin 3" Q9UEY8 10 109996368-110135565 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 449.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 313.2;ASC TERT1: 292.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009797, HPA035696" Supported Supported "Plasma membrane" NA NA 260000 "Cluster 2: Granulocytes - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "CAB009797: AB_2223583, HPA035696: AB_2674740" "unprognostic (2.66e-1)" "unprognostic (2.63e-2)" "unprognostic (1.46e-3)" "unprognostic (1.64e-1)" "unprognostic (2.65e-2)" "unprognostic (1.75e-2)" "unprognostic (1.57e-3)" "unprognostic (6.42e-2)" "unprognostic (5.73e-2)" "unprognostic (2.37e-2)" "unprognostic (7.58e-2)" "unprognostic (9.12e-2)" "unprognostic (2.34e-3)" "unprognostic (1.36e-1)" "unprognostic (4.03e-1)" "unprognostic (3.68e-2)" "unprognostic (5.92e-2)" 57.7 21.7 105.6 38.8 97.2 37.5 89.4 88.6 129.3 57.6 65.9 58.2 71.9 24.9 62.4 39.0 47.6 72.0 59.9 113.3 108.1 102.7 27.8 38.4 70.9 107.3 94.8 46.4 67.9 18.8 25.3 36.6 102.0 32.7 66.0 99.4 59.1 31.8 9.6 33.6 85.4 23.9 105.2 40.0 63.7 51.5 95.6 87.4 87.7 25.6 65.4 42.3 40.1 122.4 29.2 6.0 41.7 19.8 313.2 292.1 17.7 41.2 110.9 25.4 49.9 60.3 90.6 89.9 45.2 63.9 26.4 10.0 37.3 27.1 39.5 9.0 46.5 8.8 28.5 45.9 35.5 30.5 66.0 142.5 12.9 63.3 2.6 96.4 37.8 109.9 23.5 48.7 46.7 0.8 32.3 31.0 25.8 69.2 15.3 27.7 58.2 4.8 65.7 14.2 6.1 67.9 27.6 8.9 66.5 62.2 10.7 11.4 9.5 16.0 42.0 33.5 9.1 68.9 31.5 82.7 47.8 16.2 27.7 139.5 29.6 98.0 68.8 26.5 55.7 51.4 72.9 59.1 24.8 42.9 83.2 67.6 47.1 73.4 32.6 16.3 73.3 94.9 105.6 97.2 88.6 129.3 113.3 108.1 107.3 94.8 102.0 105.2 95.6 122.4 67.3 22.4 52.9 449.2 110.6 55.7 35.9 77.4 38.7 26.8 56.0 34.4 128.2 74.4 85.5 36.8 60.5 55.6 112.7 125.2 60.7 27.2 51.4 70.3 76.0 77.7 102.4 32.6 83.4 61.1 12.1 182.4 100.9 56.0 26.0 18.8 126.7 12.2 25.7 116.1 141.1 71.6 48.8 88.5 41.1 25.7 226.5 66.3 58.7 70.3 65.3 339.0 151.4 236.8 279.6 59.8 167.1 251.3 68.4 38.4 135.2 162.2 151.9 121.7 65.7 27.6 36.2 122.7 62.1 53.2 50.6 22.3 111.5 30.9 166.7 98.6 MXI1 "bHLHc11, MAD2, MXD2, MXI" ENSG00000119950 "MAX interactor 1, dimerization protein" P50539 10 110207605-110287365 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 264.7;Oligodendrocytes: 214.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 108.2;SK-MEL-30: 167.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035319, HPA035320, HPA056762" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" Yes No "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Nucleoli, Nucleoli rim, Cytosol" "HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229" "unprognostic (1.77e-2)" "unprognostic (2.02e-1)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.26e-3)" "prognostic unfavorable (9.17e-4)" "prognostic unfavorable (1.02e-5)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-1)" 34.0 32.7 86.8 13.2 98.0 68.0 45.1 92.9 106.1 38.8 67.0 55.9 24.4 45.6 36.2 52.3 42.4 32.8 63.2 84.9 91.1 39.2 51.1 26.4 13.8 93.9 91.8 81.4 44.7 50.6 22.1 28.5 94.7 41.0 35.0 80.2 80.1 52.1 47.3 47.6 29.6 29.8 89.3 14.8 28.0 23.3 94.9 31.2 54.5 53.2 12.3 34.6 41.2 110.8 18.2 8.3 18.0 39.6 30.7 21.4 7.4 11.1 39.2 7.1 23.1 3.2 33.5 24.6 17.6 20.0 11.3 24.3 23.5 27.8 20.0 13.5 30.9 7.3 15.7 14.5 19.5 14.3 14.4 21.7 96.0 12.4 55.2 108.2 7.1 17.5 26.9 54.9 11.3 12.3 10.1 26.1 7.7 31.0 21.2 6.1 26.0 39.9 22.8 1.6 34.3 52.4 11.1 7.3 167.1 23.3 9.9 42.2 7.7 13.5 21.0 13.6 5.6 44.6 26.1 10.0 34.3 46.1 12.7 1.8 2.7 9.7 2.7 2.3 5.1 3.9 5.1 2.8 1.6 3.6 7.7 1.9 5.6 1.4 5.0 1.7 4.8 2.0 86.8 98.0 92.9 106.1 84.9 91.1 93.9 91.8 94.7 89.3 94.9 110.8 28.9 16.0 16.8 139.1 27.9 58.0 57.9 22.8 51.2 49.9 67.2 66.8 80.2 41.5 27.6 33.1 47.9 5.4 23.0 160.7 46.9 19.3 5.1 29.1 36.4 34.1 16.9 264.7 60.8 14.8 20.1 36.0 15.8 37.3 3.8 19.1 27.8 56.6 11.1 52.2 102.5 20.1 18.3 24.1 20.5 8.8 45.1 22.6 104.9 30.9 29.9 144.2 9.2 131.7 214.9 10.4 52.5 55.7 22.5 73.4 57.0 67.1 25.3 46.0 46.0 69.6 63.0 23.8 28.2 37.4 67.3 9.7 36.9 27.4 16.6 36.9 SMNDC1 "SMNR, SPF30, TDRD16C" ENSG00000119953 "Survival motor neuron domain containing 1" O75940 10 110290730-110304938 "Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061214, HPA070666" Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Nuclear bodies" "HPA061214: AB_2684451, HPA070666: " "unprognostic (4.65e-2)" "unprognostic (1.68e-2)" "unprognostic (2.64e-1)" "unprognostic (3.07e-2)" "unprognostic (3.63e-3)" "unprognostic (5.03e-3)" "prognostic unfavorable (8.08e-6)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (7.20e-4)" "unprognostic (2.68e-3)" "unprognostic (6.88e-3)" "unprognostic (1.35e-1)" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (2.00e-1)" 16.3 12.0 7.0 15.1 7.5 31.8 13.7 10.8 11.1 13.8 7.7 13.4 9.9 14.4 8.7 16.2 13.3 11.6 12.4 6.5 7.2 13.6 14.9 14.2 16.9 7.1 6.9 13.5 10.2 13.1 8.9 18.4 7.0 10.0 11.1 16.6 11.5 10.2 24.8 13.2 11.5 14.6 7.5 14.7 11.5 13.1 7.1 20.4 12.1 17.9 18.3 17.3 13.7 9.4 36.2 27.0 38.9 44.9 29.6 35.1 28.9 41.0 42.6 53.3 54.6 35.1 43.7 51.2 25.7 25.9 30.5 38.5 57.8 28.2 59.9 29.0 30.6 51.1 21.9 41.2 35.3 56.9 47.2 27.4 29.7 42.2 71.1 39.5 30.0 29.0 46.8 46.5 41.9 17.1 61.0 55.0 43.5 27.8 18.4 52.0 77.9 26.8 30.0 25.7 19.4 26.0 26.6 22.4 48.9 33.3 27.7 32.3 33.0 31.2 35.2 28.9 52.9 37.8 42.4 76.7 31.4 77.9 24.6 5.7 8.9 14.5 5.2 9.2 6.4 5.4 6.8 6.7 8.6 4.8 5.9 5.9 16.6 6.3 9.8 5.2 8.1 4.3 7.0 7.5 10.8 11.1 6.5 7.2 7.1 6.9 7.0 7.5 7.1 9.4 57.7 28.9 37.1 6.8 53.4 69.6 42.5 27.2 89.4 27.3 31.7 26.7 23.4 14.3 27.9 11.0 20.9 33.0 55.7 23.9 33.2 22.8 10.7 34.2 52.0 41.5 18.6 37.0 7.8 18.0 32.0 39.1 37.8 58.8 58.3 27.3 27.1 26.5 32.4 33.7 8.0 21.4 38.7 40.9 79.7 4.4 29.2 47.7 35.6 6.5 45.8 23.0 22.6 5.0 11.2 21.7 21.0 22.2 45.7 53.3 20.6 40.9 28.6 33.0 19.7 30.8 39.7 46.2 37.7 72.4 83.4 46.1 57.4 33.5 24.1 65.8 DUSP5 HVH3 ENSG00000138166 "Dual specificity phosphatase 5" Q16690 10 110497907-110511533 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 175.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 409.1;Langerhans cells: 298.4;Plasma cells: 412.2;Urothelial cells: 1063.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 10.3;plasmacytoid DC: 14.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 408.0;Karpas-707: 161.2;U-266/70: 227.8" "Region enhanced" "Detected in all" "cerebellum: 60.7" "Region enriched" "Detected in many" 5 "cerebellum: 45.4" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (1.25e-1)" "unprognostic (3.57e-1)" "unprognostic (5.19e-2)" "unprognostic (1.03e-1)" "unprognostic (1.76e-2)" "unprognostic (3.27e-3)" "unprognostic (6.35e-2)" "prognostic unfavorable (8.30e-6)" "unprognostic (1.70e-2)" "unprognostic (4.60e-2)" "unprognostic (2.91e-2)" "unprognostic (1.20e-2)" "unprognostic (4.20e-3)" "unprognostic (3.79e-1)" "unprognostic (3.78e-3)" "unprognostic (2.32e-1)" "unprognostic (9.09e-2)" 38.8 37.6 8.5 26.8 8.6 38.5 26.6 26.1 17.3 39.4 13.3 22.3 12.2 19.7 2.0 115.5 12.7 51.4 34.1 17.9 12.4 26.4 25.6 23.2 12.8 7.7 9.3 7.6 8.0 6.7 20.0 48.3 7.4 17.7 26.3 9.8 23.4 12.5 2.7 16.9 19.5 21.1 8.3 28.4 26.5 20.1 10.7 14.9 18.8 3.7 32.5 175.7 37.9 7.9 22.0 14.6 3.0 7.3 11.1 46.5 10.6 50.9 114.6 26.8 32.2 9.4 28.9 2.6 9.4 12.4 56.9 7.0 2.8 26.7 43.2 62.8 1.8 12.1 2.6 5.8 41.8 3.2 15.1 17.9 35.9 85.7 408.0 11.8 17.1 1.2 2.1 161.2 81.4 5.9 0.9 9.2 9.6 2.1 22.2 0.2 6.3 38.8 92.0 42.3 1.6 4.0 3.3 8.0 17.4 25.6 4.5 3.8 26.5 9.0 6.2 21.7 24.7 227.8 44.7 6.2 34.9 16.4 6.4 0.5 0.2 0.0 3.5 2.2 1.3 0.2 1.8 1.0 0.9 0.0 0.1 1.0 0.2 0.0 10.3 14.5 0.1 0.6 8.5 8.6 26.1 17.3 17.9 12.4 7.7 9.3 7.4 8.3 10.7 7.9 150.7 3.2 7.8 0.3 71.2 66.0 409.1 91.4 30.7 9.0 72.7 77.0 33.5 11.5 78.3 35.0 6.2 44.0 97.7 63.5 5.9 29.1 1.5 50.6 32.2 90.8 48.9 0.4 4.4 4.8 11.2 42.7 39.3 196.6 3.8 5.5 158.5 4.1 10.7 0.0 2.2 12.8 22.4 16.6 298.4 3.3 1.5 91.5 158.3 1.0 46.9 2.3 4.1 1.0 0.0 49.1 93.2 0.7 412.2 127.0 44.4 0.6 27.3 12.6 0.0 25.8 37.3 1.2 19.8 61.8 101.9 137.4 122.0 3.3 9.2 1063.2 SMC3 "BAM, bamacan, CSPG6, HCAP, SMC3L1" ENSG00000108055 "Structural maintenance of chromosomes 3" Q9UQE7 10 110567695-110606048 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Spermatocytes: 994.2;Spermatogonia: 799.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043206 Approved Supported Nucleoplasm NA NA 630000 "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA043206: AB_2678362" "unprognostic (3.40e-1)" "unprognostic (1.73e-2)" "unprognostic (9.05e-2)" "unprognostic (3.00e-2)" "unprognostic (3.73e-2)" "unprognostic (8.89e-3)" "unprognostic (9.74e-3)" "unprognostic (8.06e-2)" "unprognostic (5.31e-2)" "unprognostic (6.32e-2)" "unprognostic (3.53e-2)" "unprognostic (1.17e-2)" "unprognostic (8.73e-3)" "unprognostic (7.22e-2)" "unprognostic (5.18e-2)" "unprognostic (7.95e-2)" "unprognostic (1.32e-1)" 19.5 13.3 9.0 18.7 10.9 43.9 19.1 18.5 11.7 18.5 11.7 18.3 15.5 20.3 15.7 19.2 16.5 11.1 12.9 8.6 10.2 14.0 15.3 14.5 25.2 10.2 9.4 25.7 19.6 20.0 14.2 20.7 10.4 14.0 16.7 27.6 16.2 15.2 21.1 20.6 19.4 16.9 9.6 18.6 14.7 38.1 9.5 39.2 16.5 14.1 24.3 15.5 17.8 12.7 73.1 44.5 95.4 67.8 30.7 26.3 40.9 57.7 56.7 51.9 50.7 56.4 59.7 94.2 24.5 38.6 40.0 56.5 68.7 35.0 78.6 77.3 60.1 76.5 56.2 51.2 30.8 109.8 56.6 21.1 28.0 57.4 89.5 48.5 38.8 31.7 61.7 70.4 45.4 38.1 85.2 58.3 66.1 38.6 35.1 71.1 171.5 51.4 32.4 31.7 53.7 61.8 62.0 17.7 48.6 61.8 28.5 53.1 40.1 41.6 65.5 47.6 84.4 40.9 38.8 99.6 37.5 103.9 34.8 20.7 6.1 15.8 9.6 8.4 12.1 11.0 11.3 10.6 6.8 11.0 11.3 11.2 6.5 12.6 7.6 8.7 14.5 6.2 9.0 10.9 18.5 11.7 8.6 10.2 10.2 9.4 10.4 9.6 9.5 12.7 74.9 80.1 62.0 16.6 73.5 60.5 53.2 64.1 34.7 81.3 44.3 49.9 64.5 47.1 64.4 55.2 75.0 119.6 94.3 29.8 25.4 96.9 56.9 52.0 65.0 74.9 40.7 104.6 26.2 45.6 111.4 66.0 20.9 49.0 56.3 124.9 40.4 31.9 59.1 60.6 29.2 40.7 54.9 37.9 42.5 34.6 115.2 49.8 37.4 19.7 96.1 54.9 98.9 33.2 43.4 53.0 70.1 114.0 65.0 44.7 70.7 30.3 68.3 78.9 184.1 102.0 110.6 994.2 799.1 48.1 64.5 49.1 80.9 112.7 51.9 37.5 RBM20 ENSG00000203867 "RNA binding motif protein 20" Q5T481 10 110644336-110839468 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 40.8;pancreas: 20.2" "Cell type enriched" "Detected in many" 8 "Cardiomyocytes: 151.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 6.0;HEL: 5.2;K-562: 5.0;RH-30: 16.2;SH-SY5Y: 15.0;SuSa: 4.9;T-47d: 9.2" "Low region specificity" "Detected in single" "HPA035806, HPA070358" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge" Yes No "Cluster 38: Heart - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Golgi apparatus" "Nucleoli, Cytokinetic bridge" "HPA035806: AB_10672097, HPA070358: " "unprognostic (2.43e-1)" "unprognostic (8.24e-3)" "unprognostic (5.81e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (2.75e-2)" "unprognostic (5.47e-3)" "unprognostic (1.33e-1)" "unprognostic (2.78e-2)" "unprognostic (4.14e-3)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "unprognostic (3.34e-1)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (6.46e-2)" 1.5 0.1 0.8 0.2 2.6 0.1 2.5 0.4 0.8 1.5 1.8 4.1 0.1 2.9 0.6 5.6 2.6 0.4 40.8 0.8 0.4 0.7 0.1 0.9 0.1 0.8 0.9 2.7 20.2 1.2 1.7 1.6 0.6 1.3 0.4 1.2 7.3 0.7 15.6 1.2 0.8 2.2 0.5 0.1 1.0 0.8 0.8 0.5 1.0 3.8 0.6 1.0 5.5 0.7 0.0 1.6 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.0 2.5 6.0 5.2 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 16.2 0.0 0.0 0.0 0.1 15.0 0.1 0.0 0.6 4.9 9.2 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.6 0.4 0.8 0.8 0.4 0.8 0.9 0.6 0.5 0.8 0.7 0.3 0.0 0.0 0.7 0.2 0.1 0.2 0.4 1.2 1.4 0.8 0.5 151.5 0.0 0.1 0.0 2.1 1.6 0.0 0.7 1.9 0.0 0.8 0.5 1.2 1.5 0.0 0.0 14.8 0.2 0.2 3.3 0.0 0.1 0.0 14.6 1.4 0.0 0.1 0.0 15.4 0.7 2.0 0.0 0.0 0.8 4.4 0.0 0.0 17.8 0.0 0.1 0.0 1.5 0.6 0.0 0.1 13.5 1.0 0.0 2.0 1.5 12.4 2.7 6.6 3.7 5.4 0.5 0.8 3.7 0.0 3.1 0.2 1.7 0.2 0.3 PDCD4 H731 ENSG00000150593 "Programmed cell death 4" Q53EL6 10 110871795-110900006 "Predicted intracellular proteins" Apoptosis RNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 505.4" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 786.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 295.6;U-266/70: 320.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001032, HPA027214, CAB037024" Enhanced Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107" "unprognostic (4.22e-3)" "unprognostic (1.23e-1)" "unprognostic (5.39e-2)" "unprognostic (1.00e-2)" "unprognostic (2.49e-1)" "unprognostic (1.78e-1)" "unprognostic (6.37e-2)" "unprognostic (3.79e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-2)" "unprognostic (1.41e-1)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (1.62e-1)" "unprognostic (1.69e-1)" "unprognostic (2.07e-2)" "unprognostic (4.25e-1)" 45.7 30.7 15.0 53.2 15.7 74.0 146.6 18.1 16.9 49.3 24.7 157.6 90.7 67.0 36.2 151.3 57.7 43.4 22.4 13.7 17.2 26.2 36.2 32.8 60.7 15.7 18.5 133.6 505.4 283.9 40.3 97.0 15.4 55.3 130.4 50.4 255.0 60.4 11.8 104.2 100.2 51.3 15.5 67.6 102.3 29.9 16.6 73.9 154.5 18.7 95.4 42.2 61.8 17.3 26.5 25.4 40.6 43.7 61.6 110.7 23.8 29.9 89.7 14.7 25.7 16.0 65.0 252.3 81.7 43.5 11.4 118.8 26.1 79.4 32.4 219.7 50.6 127.5 146.9 27.9 26.9 65.2 135.8 88.0 247.4 15.7 84.0 67.6 28.2 40.1 35.3 119.6 37.6 69.7 24.2 76.4 10.6 19.0 46.3 10.4 71.6 138.7 24.8 36.8 17.8 73.6 58.7 31.6 109.1 44.6 295.6 121.3 71.8 22.6 16.8 17.1 11.0 320.1 163.8 143.6 22.2 87.4 24.5 186.1 19.5 52.4 54.0 27.0 96.0 54.1 49.7 59.8 23.0 39.5 43.0 53.2 38.3 84.7 29.6 38.5 29.0 40.4 15.0 15.7 18.1 16.9 13.7 17.2 15.7 18.5 15.4 15.5 16.6 17.3 85.3 19.2 50.0 16.3 132.0 133.1 88.1 104.6 113.3 61.8 148.1 113.9 16.8 42.9 90.3 25.8 31.3 229.5 246.1 348.0 35.2 70.8 20.2 66.7 132.5 79.1 33.6 94.2 26.2 101.4 78.4 72.1 82.0 59.4 132.9 111.7 97.1 23.6 56.5 21.9 44.4 150.6 81.4 84.1 49.7 11.0 145.1 66.1 291.7 46.9 57.4 40.9 75.2 36.7 70.6 45.0 244.3 222.7 134.7 51.3 292.1 28.1 47.8 206.1 39.5 69.4 48.6 63.3 72.2 200.8 165.2 786.0 229.2 176.8 190.3 73.3 BBIP1 "bA348N5.3, BBIP10, BBS18, NCRNA00081" ENSG00000214413 "BBSome interacting protein 1" A8MTZ0 10 110898730-110919201 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Bardet-Biedl syndrome, Ciliopathy, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 102.8" "Group enriched" "Detected in all" 4 "Early spermatids: 597.4;Late spermatids: 501.6;Spermatocytes: 399.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA055206 Approved NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA055206: AB_2682737" "unprognostic (6.05e-2)" "unprognostic (1.61e-2)" "unprognostic (1.50e-1)" "unprognostic (6.25e-3)" "unprognostic (3.08e-2)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (6.26e-2)" "unprognostic (2.60e-2)" "unprognostic (3.00e-2)" "unprognostic (6.79e-3)" "unprognostic (3.90e-2)" "unprognostic (1.06e-1)" "unprognostic (2.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.81e-1)" "unprognostic (3.85e-2)" 17.6 24.9 25.8 16.0 29.9 10.1 15.5 29.8 41.2 18.7 23.7 16.6 10.3 16.6 25.3 10.5 20.0 12.3 20.4 25.3 26.9 29.8 23.5 14.1 16.4 28.8 26.9 19.5 13.8 19.0 25.6 13.8 29.0 19.2 10.7 50.1 10.5 16.2 15.5 7.3 12.4 16.0 27.2 16.7 14.3 102.8 26.6 17.8 21.7 10.1 16.6 16.2 12.9 37.2 22.1 28.9 33.0 34.0 41.4 51.0 9.8 27.2 56.4 30.9 42.7 14.4 26.9 13.3 19.2 44.9 31.4 21.5 23.9 30.1 47.5 26.9 28.6 22.0 28.3 18.9 54.4 18.9 37.0 31.8 27.1 42.4 75.7 68.9 50.3 23.7 16.5 49.8 37.0 13.9 23.8 27.0 14.0 15.3 18.1 10.5 59.7 18.8 48.6 13.9 24.9 39.6 20.7 9.1 45.4 21.1 10.4 16.9 36.5 22.3 27.2 27.3 38.2 27.9 26.0 19.9 63.4 33.5 17.6 25.5 11.2 47.6 9.7 15.0 11.5 8.2 14.5 12.0 9.5 7.2 17.6 14.9 53.6 7.8 13.0 8.4 18.8 7.4 25.8 29.9 29.8 41.2 25.3 26.9 28.8 26.9 29.0 27.2 26.6 37.2 32.3 25.6 10.0 25.8 24.2 11.2 36.2 41.4 17.1 32.3 13.9 16.3 18.5 22.8 24.3 22.0 31.3 19.3 21.4 9.5 105.7 35.8 597.4 60.4 27.1 26.4 16.9 18.3 58.8 34.5 25.6 27.7 14.3 24.4 16.5 21.0 25.4 22.1 20.0 45.4 52.6 18.4 50.8 22.4 15.8 501.6 46.6 22.4 23.2 14.0 27.1 52.4 26.8 27.6 67.5 36.0 12.0 33.8 32.2 21.6 13.5 69.4 75.7 63.8 52.6 46.0 32.7 399.5 36.5 12.5 11.9 12.3 27.2 21.0 10.0 29.7 SHOC2 "KIAA0862, SOC-2, SOC2, SUR-8, SUR8" ENSG00000108061 "SHOC2 leucine rich repeat scaffold protein" Q9UQ13 10 110919593-111013666 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009164, HPA048134" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "HPA009164: AB_1079960, HPA048134: " "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" "unprognostic (4.23e-3)" "unprognostic (3.27e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (6.09e-2)" "unprognostic (5.56e-2)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (4.33e-2)" "unprognostic (1.01e-1)" "unprognostic (3.70e-3)" "unprognostic (6.97e-3)" "unprognostic (8.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.67e-1)" 25.0 16.3 16.4 22.5 17.8 45.7 19.3 19.3 22.1 20.3 12.0 20.4 16.4 20.7 21.0 21.6 16.4 20.1 19.5 19.4 22.3 21.9 23.7 17.9 29.9 16.6 21.7 19.8 20.4 30.3 14.6 20.8 22.0 18.0 21.5 19.7 14.2 17.5 21.3 15.4 18.4 23.3 16.4 22.2 17.3 36.4 18.2 26.9 25.2 26.8 31.2 25.0 14.8 15.5 29.2 17.8 22.7 38.2 50.9 51.2 14.5 35.0 51.9 31.9 38.5 16.5 25.8 63.1 17.1 62.8 19.9 24.1 27.8 25.0 46.2 34.7 16.5 28.8 25.7 16.2 37.0 49.6 49.4 57.3 38.6 36.9 69.1 43.6 32.8 22.1 18.3 43.8 45.7 15.6 24.7 38.9 14.1 15.6 18.6 34.8 45.2 18.1 33.3 19.4 11.7 23.4 30.7 15.0 34.9 25.8 77.2 41.5 33.3 25.6 22.6 32.5 24.3 40.2 44.0 100.1 30.6 50.3 18.6 52.3 22.8 33.5 12.6 26.8 15.5 30.3 14.8 15.0 22.3 24.4 15.6 15.2 65.8 19.5 27.8 15.2 19.2 23.9 16.4 17.8 19.3 22.1 19.4 22.3 16.6 21.7 22.0 16.4 18.2 15.5 73.8 54.5 48.1 35.6 95.4 55.8 35.2 37.5 27.9 27.6 51.4 39.1 83.6 45.8 42.3 31.3 16.7 22.2 77.5 80.8 64.6 48.5 44.2 65.1 54.6 63.5 26.3 67.5 59.9 59.2 23.0 50.7 49.5 54.9 73.4 20.2 53.2 69.0 29.4 30.3 53.1 36.2 46.8 78.3 67.3 89.7 65.6 76.0 49.8 57.1 116.5 31.5 57.7 46.3 61.0 64.0 51.6 80.9 53.4 37.1 51.7 67.7 57.0 32.7 72.3 59.9 58.7 108.8 69.3 38.1 69.9 60.6 65.8 17.0 30.1 49.7 ADRA2A "ADRA2, ADRA2R, ADRAR" ENSG00000150594 "Adrenoceptor alpha 2A" P08913 10 111077029-111080907 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 50.5;cervix: 46.6" "Cell type enhanced" "Detected in many" "Cholangiocytes: 52.9;Paneth cells: 105.9;Smooth muscle cells: 118.7" "Cancer enhanced" "Detected in all" "pancreatic cancer: 17.7" "Region enhanced" "Detected in all" "pons: 26.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.5;ASC TERT1: 12.9;HEL: 20.3;HeLa: 10.7;HSkMC: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 36: HEL - Hemostasis" "Cluster 48: Smooth muscle cells - ECM organization" "unprognostic (3.87e-2)" "unprognostic (1.63e-2)" "unprognostic (1.38e-1)" "prognostic favorable (8.06e-4)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "unprognostic (4.78e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-1)" "unprognostic (4.64e-3)" "unprognostic (5.86e-2)" "unprognostic (5.63e-2)" "unprognostic (3.08e-6)" "unprognostic (1.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.35e-2)" "unprognostic (1.89e-3)" 50.5 1.7 3.4 4.9 3.4 0.0 32.9 1.6 4.3 46.6 7.7 7.4 10.0 6.8 1.6 2.9 4.1 19.9 2.1 3.4 7.4 6.0 1.1 4.3 11.2 5.9 5.8 18.1 30.5 1.3 2.3 3.7 26.8 6.9 3.7 0.0 7.0 6.1 1.0 10.9 4.9 2.8 1.4 14.7 3.7 5.0 3.2 1.0 9.0 0.6 13.1 15.9 23.4 6.1 0.0 0.0 0.0 0.0 10.5 12.9 0.0 0.1 0.0 1.1 2.5 0.0 0.0 0.0 0.1 6.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 20.3 10.7 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.4 1.6 4.3 3.4 7.4 5.9 5.8 26.8 1.4 3.2 6.1 8.3 0.0 1.3 1.0 0.0 10.3 0.4 0.0 1.2 0.0 17.2 12.2 1.5 52.9 1.3 0.0 0.0 0.1 0.0 11.7 0.0 5.9 3.5 6.9 9.1 4.9 12.4 0.0 2.2 3.3 0.1 7.3 10.7 25.8 7.0 19.4 0.7 0.0 0.1 0.0 5.9 3.5 0.0 0.3 17.3 1.2 22.4 7.3 28.4 1.0 0.0 0.0 0.0 0.0 0.2 0.3 105.9 4.9 0.0 0.9 3.5 0.6 0.0 0.0 6.6 3.1 118.7 5.4 0.1 0.2 6.1 0.1 1.2 8.5 8.6 1.1 GPAM "GPAT1, KIAA1560, MGC26846" ENSG00000119927 "Glycerol-3-phosphate acyltransferase, mitochondrial" Q9HCL2 10 112149865-112215377 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 305.7;liver: 144.1" "Cell type enhanced" "Detected in many" "Astrocytes: 90.8;Hepatocytes: 184.5;Horizontal cells: 45.4" "Cancer enriched" "Detected in all" 5 "liver cancer: 20.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "ASC diff: 250.3;Hep G2: 71.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046339, HPA060090" Approved Approved Mitochondria NA NA "Cluster 24: B-cells - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 2: Hepatocytes - Metabolism" Mitochondria "HPA046339: AB_2679627, HPA060090: AB_2684202" "unprognostic (1.82e-1)" "unprognostic (6.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.30e-1)" "unprognostic (6.80e-2)" "unprognostic (8.75e-2)" "unprognostic (1.40e-2)" "unprognostic (2.16e-2)" "unprognostic (4.59e-1)" "unprognostic (4.80e-1)" "unprognostic (2.37e-2)" "unprognostic (5.44e-2)" "prognostic favorable (4.54e-6)" "unprognostic (2.84e-1)" "unprognostic (4.41e-2)" "unprognostic (2.52e-2)" "unprognostic (1.37e-1)" 305.7 33.9 14.9 4.8 17.1 3.4 67.7 12.2 14.0 3.0 6.9 6.4 4.0 4.2 75.1 2.9 3.1 6.0 12.3 12.4 13.0 4.4 144.1 4.1 4.6 12.9 16.0 5.3 5.0 4.3 2.1 3.0 12.1 3.9 4.7 5.1 17.2 5.3 8.3 3.2 6.1 4.9 11.5 2.9 4.9 5.6 15.7 3.6 12.4 8.8 4.3 4.8 2.6 10.5 9.9 7.4 9.7 12.9 250.3 9.1 12.7 9.2 10.5 6.6 5.1 17.3 5.7 6.9 5.0 6.5 6.1 12.3 15.5 7.9 12.3 5.0 8.4 6.4 7.9 71.8 7.7 11.2 3.4 43.8 13.1 11.7 23.6 49.7 5.8 9.7 8.5 6.1 7.7 5.6 9.6 8.8 8.1 5.6 10.1 9.7 25.4 5.1 4.3 6.8 4.1 12.1 12.8 6.1 14.5 8.9 6.3 4.0 4.4 7.5 4.6 9.4 14.8 6.1 7.3 14.3 8.8 9.8 5.8 0.0 0.3 0.1 0.7 0.4 0.9 0.5 0.5 0.5 0.4 1.1 0.5 0.9 0.0 0.3 0.3 0.6 0.6 0.3 14.9 17.1 12.2 14.0 12.4 13.0 12.9 16.0 12.1 11.5 15.7 10.5 9.1 9.6 27.1 90.8 5.2 0.4 0.8 1.6 4.6 5.3 8.1 8.4 18.9 20.0 4.3 5.5 10.4 5.2 4.3 1.7 1.9 2.7 0.5 5.1 10.0 5.0 1.2 12.2 8.2 3.3 2.9 5.1 3.6 4.2 2.5 12.7 6.4 184.5 3.1 45.4 9.4 3.0 0.0 9.3 1.0 0.9 5.3 1.9 1.8 10.3 1.4 6.1 3.1 10.1 10.1 3.4 2.7 12.0 6.4 1.1 3.7 3.3 4.7 9.1 6.6 4.3 6.6 4.0 3.2 5.4 0.1 1.9 3.3 8.6 5.0 0.6 TECTB ENSG00000119913 "Tectorin beta" Q96PL2 10 112283400-112305038 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Late spermatids: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted in other tissues" NA NA "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (3.14e-2)" "unprognostic (2.84e-2)" "unprognostic (9.75e-3)" "unprognostic (1.65e-1)" "unprognostic (1.32e-2)" "unprognostic (5.54e-2)" "unprognostic (2.80e-2)" "unprognostic (8.10e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACSL5 "ACS2, ACS5, FACL5" ENSG00000197142 "Acyl-CoA synthetase long chain family member 5" Q9ULC5 10 112374018-112428380 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 217.8;intestine: 418.0;liver: 165.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 164.9;Endometrial ciliated cells: 159.9;Glandular and luminal cells: 292.3;Proximal enterocytes: 462.5" "Cancer enhanced" "Detected in all" "colorectal cancer: 87.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 138.8;RT4: 143.3;U-937: 70.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007162, CAB035986, CAB062546" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 9: Intestine - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" Mitochondria Nucleoplasm "CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (3.08e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.45e-1)" "unprognostic (2.13e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-2)" "unprognostic (1.67e-1)" "unprognostic (4.06e-2)" "unprognostic (4.18e-3)" "unprognostic (7.40e-2)" "unprognostic (5.25e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (5.92e-3)" "unprognostic (1.08e-3)" 23.8 4.2 13.1 29.0 12.6 16.2 21.3 13.0 15.5 51.4 10.4 111.7 358.9 30.3 217.8 7.9 45.0 21.5 9.4 12.1 13.4 9.0 165.5 35.6 28.0 14.4 13.1 17.0 5.5 2.2 2.6 8.6 14.9 12.3 116.6 1.5 5.5 20.3 3.9 3.4 418.0 15.5 14.0 25.7 44.2 9.6 15.3 16.4 7.2 8.8 28.0 76.3 7.6 13.2 38.6 0.9 0.7 0.1 2.5 0.4 3.3 1.1 7.3 0.3 0.6 34.8 138.8 46.7 8.4 1.9 6.8 0.3 0.0 0.2 0.8 39.4 0.0 36.5 1.3 60.9 8.8 57.3 59.2 5.9 0.0 0.8 0.0 2.7 2.8 0.0 0.1 20.6 0.1 0.0 0.1 26.3 0.1 32.2 1.3 12.9 0.2 28.6 3.8 143.3 0.1 0.9 55.8 21.0 0.1 0.1 0.1 31.7 40.5 0.5 0.4 2.2 2.5 14.8 0.1 22.6 1.2 70.5 0.1 27.4 15.1 27.5 25.2 27.9 24.9 16.3 20.4 27.8 31.1 13.1 13.8 21.4 3.9 26.1 27.7 9.8 41.5 21.1 13.1 12.6 13.0 15.5 12.1 13.4 14.4 13.1 14.9 14.0 15.3 13.2 23.4 12.8 51.3 0.0 20.1 3.8 10.3 10.7 8.6 0.1 7.0 4.6 1.7 12.8 23.6 0.0 4.2 1.8 10.5 164.9 0.0 13.3 92.6 159.9 37.6 24.7 40.8 10.7 1.3 6.4 2.6 5.7 41.8 292.3 17.2 0.5 16.1 88.6 18.9 0.0 1.1 79.0 0.0 22.4 57.8 42.6 15.8 24.9 3.6 17.8 11.5 0.1 16.5 1.0 1.0 48.0 122.4 12.0 20.3 7.1 462.5 0.2 8.2 1.2 0.0 0.8 3.3 4.0 1.9 3.3 1.7 0.7 24.0 6.4 103.3 50.0 ZDHHC6 "FLJ21952, ZNF376" ENSG00000023041 "Zinc finger DHHC-type palmitoyltransferase 6" Q9H6R6 10 112424428-112446917 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014357 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 32: U-937 - Innate immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA014357: AB_2304658" "unprognostic (1.21e-1)" "unprognostic (1.00e-1)" "unprognostic (6.31e-2)" "unprognostic (2.51e-2)" "unprognostic (1.80e-1)" "unprognostic (2.07e-1)" "unprognostic (3.29e-2)" "unprognostic (6.24e-2)" "unprognostic (5.21e-1)" "unprognostic (3.54e-2)" "unprognostic (1.56e-1)" "unprognostic (7.14e-3)" "unprognostic (3.00e-2)" "unprognostic (9.30e-2)" "unprognostic (8.87e-2)" "unprognostic (7.64e-2)" "unprognostic (1.22e-2)" 19.5 19.9 15.2 24.6 16.0 21.8 22.7 16.7 18.9 21.2 20.2 24.5 44.6 24.0 33.2 23.7 19.3 23.2 17.0 15.4 16.1 59.3 29.5 20.0 30.6 15.5 15.7 25.7 21.3 21.4 15.4 25.9 15.6 22.4 29.9 21.3 23.9 20.6 14.9 20.5 45.8 17.8 15.9 24.8 25.9 13.6 16.9 25.0 26.2 18.1 30.6 23.9 20.8 17.9 51.7 39.4 40.3 50.2 38.2 28.8 28.5 49.3 46.7 38.2 45.3 37.7 89.6 28.4 22.1 30.2 43.0 60.0 33.8 31.5 44.3 67.0 41.4 29.4 46.4 47.3 24.7 67.9 49.5 21.9 20.7 41.9 48.9 58.7 48.6 42.0 32.4 46.1 41.7 43.3 38.1 75.6 23.6 57.0 32.1 31.4 51.1 26.6 45.3 28.1 15.0 20.9 25.5 40.1 49.1 31.4 22.4 49.2 34.8 43.7 27.6 29.5 47.3 25.7 31.7 37.5 38.7 118.0 29.0 10.4 17.4 21.6 14.7 16.2 18.9 16.7 16.7 18.5 16.6 14.0 14.1 15.9 11.3 16.0 13.7 13.6 23.9 15.9 15.2 16.0 16.7 18.9 15.4 16.1 15.5 15.7 15.6 15.9 16.9 17.9 21.0 22.4 20.1 11.8 35.9 20.3 31.9 23.2 23.9 11.0 21.9 16.1 14.3 31.5 27.4 35.0 8.4 34.8 25.7 31.3 60.7 35.8 72.4 14.9 15.5 18.7 11.4 26.1 15.0 29.8 46.9 17.9 16.3 23.8 23.5 17.8 19.2 21.2 34.4 15.2 15.7 22.7 10.2 20.2 35.9 17.7 16.1 28.6 12.4 12.2 22.2 21.0 23.7 15.1 14.4 31.2 27.9 19.5 23.7 25.7 66.9 39.7 13.4 15.5 6.6 13.9 18.2 11.7 12.5 27.6 22.3 36.5 33.0 10.9 28.5 47.7 VTI1A "MVti1, Vti1-rp2" ENSG00000151532 "Vesicle transport through interaction with t-SNAREs 1A" Q96AJ9 10 112446998-112818744 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 135.2;Excitatory neurons: 244.7;Inhibitory neurons: 199.5;Late spermatids: 102.8;Microglial cells: 195.8;Oligodendrocyte precursor cells: 172.4;Oligodendrocytes: 218.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054108 Supported Supported "Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Vesicles" "HPA054108: AB_2682382" "unprognostic (9.81e-2)" "unprognostic (6.42e-2)" "unprognostic (4.49e-2)" "unprognostic (1.50e-1)" "unprognostic (1.66e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (6.50e-5)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic favorable (7.27e-5)" "unprognostic (3.74e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-3)" "unprognostic (2.61e-1)" 6.6 4.7 3.7 7.0 3.7 13.8 4.7 2.3 4.7 3.5 1.1 6.4 7.2 3.8 4.9 7.3 3.2 4.6 5.8 4.8 2.6 6.8 4.7 5.1 7.7 2.8 3.7 3.1 3.9 7.5 2.6 4.0 3.5 4.7 7.5 4.2 5.2 4.8 7.4 5.9 7.2 5.7 1.8 5.6 5.5 4.5 4.3 8.6 6.3 6.1 9.4 5.2 4.4 4.6 13.5 11.2 10.1 14.1 15.5 13.4 6.1 14.1 17.4 11.0 12.2 12.7 13.6 14.0 5.3 16.0 9.3 15.6 8.8 11.2 14.9 18.0 8.1 11.9 8.1 13.3 11.0 16.8 16.8 10.4 13.9 12.6 25.9 12.4 11.9 14.1 11.3 16.9 14.8 9.5 13.3 12.8 4.4 10.5 6.5 13.9 14.6 6.2 11.5 11.9 4.6 9.0 10.0 8.6 9.5 8.4 7.8 9.3 17.0 8.7 7.4 10.8 15.8 7.4 11.0 15.9 14.2 15.3 8.6 9.2 7.0 9.6 5.4 9.3 5.1 5.5 4.5 4.4 5.2 4.6 4.3 4.4 11.4 5.7 8.7 4.9 7.2 4.6 3.7 3.7 2.3 4.7 4.8 2.6 2.8 3.7 3.5 1.8 4.3 4.6 13.5 12.8 10.3 135.2 33.1 11.2 14.5 8.8 13.6 16.5 7.8 4.6 14.0 7.2 11.6 5.5 43.8 7.6 31.5 17.0 7.9 15.4 42.9 11.4 15.5 13.6 18.5 18.1 244.7 25.0 12.3 12.9 21.9 17.0 19.6 10.2 8.9 8.1 18.8 21.9 199.5 10.7 14.2 17.0 27.0 102.8 6.8 20.9 12.4 195.8 19.0 6.0 25.7 172.4 218.6 29.7 12.2 5.7 23.9 12.6 17.2 9.4 11.7 20.7 0.0 13.5 14.1 11.1 9.2 17.0 16.3 14.4 25.4 9.7 12.1 19.7 TCF7L2 "TCF-4, TCF4" ENSG00000148737 "Transcription factor 7 like 2" Q9NQB0 10 112950247-113167678 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "brain: 244.9" "Cell type enhanced" "Detected in many" "Astrocytes: 264.8;Distal enterocytes: 260.0;Extravillous trophoblasts: 231.4;Paneth cells: 211.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "thalamus: 244.9" "Group enriched" "Detected in many" 10 "intermediate monocyte: 28.9;non-classical monocyte: 86.6" "Lineage enriched" "Detected in many" 14 "monocytes: 86.6" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in all" 9 "midbrain: 67.2;thalamus: 86.6" "Group enriched" "Detected in all" 5 "midbrain: 146.8;pons: 97.8;thalamus: 164.3" "CAB013535, HPA038800" Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No "Cluster 51: Monocytes - Innate immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "CAB013535: AB_2533167, HPA038800: " "unprognostic (1.79e-2)" "unprognostic (3.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (4.59e-3)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-2)" "unprognostic (5.09e-1)" "unprognostic (7.10e-2)" "unprognostic (6.10e-3)" "unprognostic (3.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (3.64e-1)" "unprognostic (7.36e-3)" 28.1 9.4 47.4 8.6 6.3 7.6 25.0 0.2 12.1 18.9 1.0 22.9 20.4 25.1 6.7 9.9 18.1 9.4 11.3 4.3 46.9 9.9 22.4 13.9 5.4 5.1 98.0 22.9 12.4 11.1 9.6 17.7 1.7 12.3 21.3 4.6 14.5 13.1 8.4 17.2 19.3 16.4 1.6 22.2 23.3 7.6 244.9 5.8 12.9 6.9 3.7 13.8 14.3 3.2 15.0 37.8 40.7 39.6 20.8 13.7 48.5 10.3 20.0 7.1 8.5 24.9 45.3 0.1 11.3 19.4 9.6 10.5 14.0 17.6 9.1 1.7 13.1 10.4 25.2 23.6 22.0 4.2 3.7 24.4 6.3 11.0 18.2 29.7 12.0 8.8 11.0 0.7 8.2 28.0 6.7 2.5 29.2 16.6 21.6 19.0 29.8 6.9 15.2 20.4 0.8 12.4 15.7 15.4 17.0 31.5 10.0 2.2 27.9 6.8 18.7 16.9 21.3 2.6 0.3 0.4 6.5 8.7 14.9 0.4 4.5 0.4 1.5 28.9 0.9 0.0 0.4 1.2 4.1 0.0 0.4 0.6 6.0 0.0 86.6 0.2 0.0 3.5 47.4 6.3 0.2 12.1 4.3 46.9 5.1 98.0 1.7 1.6 244.9 3.2 62.0 22.4 26.5 264.8 3.3 42.6 27.3 35.8 64.9 2.8 53.0 54.9 13.6 52.9 35.5 40.5 6.2 44.2 9.1 260.0 11.7 39.3 8.8 40.1 140.6 46.1 19.8 4.8 35.1 43.6 231.4 90.8 90.2 64.2 0.0 37.6 52.8 74.2 17.5 5.0 16.6 87.7 16.2 99.9 20.6 5.0 59.0 54.6 32.0 107.7 22.4 34.4 5.2 192.5 34.9 59.0 211.1 48.5 6.0 38.4 75.3 16.2 26.8 6.1 92.1 37.3 51.3 9.4 28.9 61.1 39.8 28.5 6.7 13.1 73.9 49.0 HABP2 "FSAP, HABP, HGFAL, PHBP" ENSG00000148702 "Hyaluronan binding protein 2" Q14520 10 113550837-113589602 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "liver: 437.3" "Group enriched" "Detected in some" 5 "Cholangiocytes: 124.4;Hepatocytes: 221.4" "Cancer enriched" "Detected in many" 5 "liver cancer: 92.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "OE19: 64.7;RPTEC TERT1: 50.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA019518 Uncertain "Secreted to blood" NA NA 20200000000 4400000000 "Cluster 62: Liver - Hemostasis" "Cluster 21: OE19 - Mitochondria" "Cluster 15: Hepatocytes - Hemostasis" "HPA019518: AB_1850467" "unprognostic (3.89e-2)" "unprognostic (6.15e-2)" "unprognostic (1.33e-1)" "unprognostic (1.24e-1)" "unprognostic (1.45e-1)" "unprognostic (6.92e-2)" "unprognostic (1.01e-1)" "unprognostic (5.86e-3)" "unprognostic (1.67e-1)" "unprognostic (9.78e-2)" "unprognostic (5.10e-2)" "unprognostic (4.77e-2)" "unprognostic (9.18e-3)" "unprognostic (2.62e-3)" "unprognostic (2.11e-1)" "unprognostic (3.22e-1)" "unprognostic (9.05e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.9 0.9 0.0 0.0 3.1 2.9 1.7 0.0 2.2 36.0 3.8 0.1 0.0 14.2 437.3 0.8 0.0 0.0 0.0 0.0 17.3 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.1 12.1 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 64.7 0.0 0.0 0.1 0.0 50.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 2.3 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 124.4 0.0 1.8 0.0 0.0 0.0 0.0 3.9 31.4 0.5 10.8 0.8 0.4 0.0 5.3 1.0 3.9 0.0 0.0 17.9 6.5 0.0 0.0 5.3 221.4 1.0 0.0 0.0 0.2 0.0 5.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 12.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.1 NRAP ENSG00000197893 "Nebulin related anchoring protein" Q86VF7 10 113588714-113664070 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 2363.9;tongue: 1144.8" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 534.1" "Group enriched" "Detected in some" 7 "head and neck cancer: 8.2;prostate cancer: 3.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA037953, HPA037954, HPA075074" Enhanced Approved "Vesicles,Intermediate filaments,Cytosol" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" "Vesicles, Cytosol" "HPA037953: AB_2675755, HPA037954: AB_10672394, HPA075074: " "unprognostic (1.13e-1)" "unprognostic (2.95e-1)" "unprognostic (3.61e-2)" "unprognostic (2.05e-2)" "unprognostic (5.75e-2)" "unprognostic (1.97e-2)" "unprognostic (1.25e-2)" "unprognostic (3.03e-3)" "unprognostic (3.72e-2)" "unprognostic (4.20e-2)" "unprognostic (6.40e-2)" "unprognostic (2.88e-1)" "unprognostic (5.39e-4)" "unprognostic (8.21e-2)" "unprognostic (1.16e-1)" "unprognostic (3.16e-1)" 0.3 0.1 0.1 0.0 0.5 0.0 0.4 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 24.8 0.0 0.2 428.6 0.2 0.0 0.1 0.5 0.4 0.1 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.0 20.4 1.0 0.0 22.1 0.0 2363.9 0.8 0.1 0.0 0.0 0.1 0.3 0.6 0.3 0.0 0.4 1144.8 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 534.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.4 0.1 0.0 3.7 0.0 0.0 0.3 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 4.8 0.0 0.0 0.3 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 57.3 3.3 1.0 2.3 0.0 0.1 0.0 0.2 0.0 0.5 0.0 CASP7 "CMH-1, ICE-LAP3, MCH3" ENSG00000165806 "Caspase 7" P55210 10 113679162-113730907 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 229.1;Paneth cells: 113.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB025563 Enhanced NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 9: Intestine - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "CAB025563: " "prognostic favorable (2.11e-4)" "unprognostic (3.18e-2)" "unprognostic (2.82e-2)" "unprognostic (2.18e-1)" "unprognostic (2.85e-1)" "unprognostic (1.33e-1)" "unprognostic (2.63e-3)" "unprognostic (3.96e-1)" "unprognostic (2.04e-1)" "unprognostic (1.22e-2)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "prognostic unfavorable (5.90e-4)" "unprognostic (5.45e-3)" "unprognostic (2.62e-1)" "unprognostic (2.86e-1)" "unprognostic (4.33e-3)" 21.0 10.3 11.8 26.2 12.2 8.4 18.6 11.5 20.4 18.4 12.8 75.1 65.3 16.3 10.5 15.4 17.9 16.8 11.3 11.8 12.0 19.6 23.6 24.9 16.9 12.3 12.5 16.2 22.4 10.4 7.0 20.9 11.9 21.3 58.2 6.8 34.1 12.3 13.8 17.4 68.1 18.5 11.4 17.5 45.5 6.8 12.8 19.8 10.2 14.5 18.4 31.6 16.1 12.8 28.9 29.4 24.1 13.0 43.4 37.5 16.7 32.9 49.9 56.1 69.7 22.4 51.0 30.1 19.0 29.8 21.1 24.8 30.4 24.2 39.5 46.9 41.0 19.6 22.0 38.0 28.9 20.9 24.7 24.5 15.9 32.0 13.3 25.0 75.4 28.2 5.3 39.8 21.1 38.2 51.1 16.0 4.4 31.7 17.3 51.7 98.0 18.1 44.8 21.4 1.9 14.4 24.9 35.5 17.6 23.1 43.1 18.4 37.8 12.8 24.1 13.5 27.7 30.7 20.1 0.8 13.1 38.7 14.3 22.9 14.7 11.7 11.1 21.3 9.5 11.5 9.2 14.1 10.4 9.2 7.1 9.7 2.6 7.4 18.5 1.4 14.0 9.8 11.8 12.2 11.5 20.4 11.8 12.0 12.3 12.5 11.9 11.4 12.8 12.8 36.3 9.6 12.3 27.4 13.8 19.8 21.2 26.0 13.1 0.6 15.8 9.9 2.5 11.5 26.2 22.0 0.0 12.4 10.3 229.1 11.7 46.1 0.3 21.0 22.9 23.8 9.6 4.0 1.6 39.0 25.5 16.2 30.1 13.5 12.7 10.9 17.2 15.6 17.0 0.0 1.1 81.1 28.5 12.8 6.9 0.6 9.6 18.4 7.2 10.3 68.9 7.9 13.4 1.0 0.8 37.2 113.4 4.1 21.5 42.6 88.0 25.9 42.8 1.7 19.7 12.3 16.3 2.9 28.2 13.3 14.8 10.9 15.7 5.2 50.7 39.0 PLEKHS1 "bA211N11.2, C10orf81, FLJ23537" ENSG00000148735 "Pleckstrin homology domain containing S1" Q5SXH7 10 113751262-113783429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 30.5;cervix: 63.6;intestine: 43.9;pancreas: 36.9;salivary gland: 57.0" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 35.1;Club cells: 70.7;Endometrial ciliated cells: 33.8;Exocrine glandular cells: 31.1;Ionocytes: 38.7;Proximal enterocytes: 42.1;Respiratory ciliated cells: 157.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.1;OE19: 53.5;RT4: 22.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA037583 Approved Vesicles,Centrosome NA NA "Cluster 4: Stomach - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Centrosome Vesicles "HPA037583: AB_10671762" "unprognostic (2.64e-1)" "unprognostic (1.64e-2)" "unprognostic (2.74e-2)" "unprognostic (3.60e-2)" "unprognostic (1.07e-1)" "unprognostic (2.63e-2)" "unprognostic (1.74e-2)" "unprognostic (2.36e-2)" "unprognostic (8.43e-2)" "unprognostic (6.82e-2)" "unprognostic (2.57e-1)" "unprognostic (1.21e-2)" "unprognostic (0.00e+0)" "unprognostic (4.00e-3)" "unprognostic (2.19e-1)" "unprognostic (2.27e-1)" "prognostic favorable (1.03e-4)" 0.3 0.1 0.0 7.3 0.0 0.3 30.5 0.0 0.3 63.6 0.0 3.6 43.9 1.8 3.9 1.0 9.4 2.7 0.4 0.0 0.0 0.9 0.1 6.7 0.2 0.2 0.0 0.1 36.9 0.1 0.2 0.1 0.0 6.0 4.7 0.4 57.0 3.3 0.0 0.8 38.7 0.5 0.0 0.2 8.8 0.9 0.0 0.1 0.1 0.0 2.8 1.5 0.0 0.1 0.2 1.4 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.1 0.7 0.2 10.1 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.0 53.5 0.0 0.2 6.4 0.3 1.7 22.3 0.1 0.2 0.1 1.4 0.0 0.0 6.3 0.0 0.0 0.2 0.2 0.2 0.5 4.7 0.2 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 3.2 3.2 0.3 0.0 0.1 0.3 35.1 0.0 0.0 16.6 8.3 0.4 0.0 70.7 0.0 0.0 0.0 0.1 6.7 0.0 4.9 13.2 33.8 0.3 0.5 0.0 0.0 0.2 31.1 0.0 0.6 3.1 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 5.6 38.7 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.2 2.8 0.4 0.0 1.4 42.1 0.3 157.3 0.0 0.0 0.3 3.7 0.2 0.1 0.6 0.0 0.0 0.3 0.0 12.1 0.5 DCLRE1A "hSNM1, KIAA0086, PSO2, SNM1" ENSG00000198924 "DNA cross-link repair 1A" Q6PJP8 10 113834725-113854383 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036907 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm "Nucleoli fibrillar center" "HPA036907: AB_10673626" "unprognostic (1.22e-1)" "unprognostic (7.55e-2)" "unprognostic (4.84e-2)" "unprognostic (3.82e-2)" "unprognostic (1.09e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (5.74e-5)" "unprognostic (1.04e-1)" "unprognostic (1.15e-1)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.40e-2)" "unprognostic (4.05e-2)" "unprognostic (2.85e-1)" "unprognostic (3.07e-1)" "unprognostic (6.34e-2)" 2.1 3.8 3.9 3.9 4.2 4.6 5.2 4.2 5.5 4.0 4.1 4.3 4.1 2.9 5.5 3.3 4.1 2.8 4.4 4.2 4.3 6.0 9.8 3.6 5.3 3.8 3.9 5.3 7.4 8.4 2.9 4.2 4.0 5.9 5.2 8.0 5.0 4.0 3.6 3.7 4.0 3.2 3.8 4.0 5.2 4.7 4.1 5.0 5.1 3.3 5.3 3.2 1.9 4.1 15.8 13.0 19.3 19.7 2.5 4.2 11.0 9.4 9.5 12.5 14.3 10.2 21.1 12.2 10.4 4.8 9.7 12.9 18.6 8.2 16.1 24.2 16.0 20.7 8.0 13.1 8.2 21.9 18.8 2.8 9.8 10.5 18.5 8.3 7.7 16.3 24.1 12.9 7.1 9.4 10.6 8.8 9.4 12.5 6.9 6.1 23.0 8.0 8.3 7.3 8.4 13.9 5.4 9.2 13.8 13.2 11.0 10.5 6.8 7.2 14.1 9.8 15.6 14.9 18.2 18.6 10.7 31.5 10.5 1.3 0.3 0.7 2.8 0.2 1.8 0.6 1.2 1.9 1.1 0.3 0.8 1.4 0.1 1.0 0.5 0.4 3.2 1.2 3.9 4.2 4.2 5.5 4.2 4.3 3.8 3.9 4.0 3.8 4.1 4.1 0.9 6.4 4.1 4.9 1.3 0.6 0.6 2.8 0.6 4.2 2.9 1.9 9.6 5.7 3.6 1.8 0.0 3.0 2.0 2.2 7.9 1.9 0.7 2.9 1.8 1.6 3.5 6.5 4.9 1.1 1.8 2.5 1.5 2.0 1.3 3.6 1.8 7.7 3.2 6.7 4.7 2.5 4.1 3.8 0.6 0.5 1.5 10.3 0.0 2.8 3.6 3.9 2.1 8.0 4.1 1.6 2.3 1.5 3.0 1.3 1.6 3.7 5.1 3.9 0.0 1.7 1.2 6.0 5.4 2.5 0.6 0.7 3.1 2.4 3.4 0.7 NHLRC2 "DKFZp779F115, FLJ20147, FLJ25621, FLJ33312, MGC45492" ENSG00000196865 "NHL repeat containing 2" Q8NBF2 10 113854661-113917194 "Disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038493, HPA057564" Approved Approved Nucleoplasm NA NA 120000 "Cluster 14: Monocytes - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA038493: AB_10672519, HPA057564: AB_2683469" "unprognostic (7.09e-2)" "unprognostic (7.33e-2)" "unprognostic (3.00e-1)" "unprognostic (4.74e-2)" "unprognostic (5.15e-2)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" "unprognostic (1.66e-1)" "unprognostic (3.49e-1)" "unprognostic (1.36e-1)" "unprognostic (4.88e-2)" "unprognostic (8.98e-2)" "unprognostic (1.05e-1)" "unprognostic (8.99e-2)" "unprognostic (2.52e-1)" "unprognostic (8.60e-2)" "unprognostic (1.68e-2)" 5.9 5.6 4.4 4.9 5.1 4.2 6.2 5.8 5.2 7.0 7.6 6.5 5.4 6.2 6.9 4.7 5.7 4.1 16.5 3.5 4.3 5.4 8.7 6.6 5.9 5.1 4.8 7.2 7.9 10.5 5.3 6.4 5.1 8.8 5.8 10.1 6.7 4.8 10.6 7.0 6.2 5.2 4.2 7.2 6.4 3.8 4.6 4.6 7.6 7.5 5.5 6.2 6.2 6.0 10.8 6.8 13.1 10.8 4.7 8.4 8.3 7.4 8.8 6.3 6.9 4.7 10.3 5.8 5.2 7.5 5.5 9.4 10.8 6.1 10.7 7.0 5.4 6.2 5.7 6.7 7.1 8.9 6.8 5.8 7.4 7.0 14.4 12.2 7.7 4.1 7.4 6.5 8.6 5.0 5.1 6.9 3.9 6.6 3.4 4.7 18.8 3.4 7.8 5.9 3.4 6.9 5.8 7.3 9.1 6.1 5.3 6.6 9.9 7.5 7.6 4.8 11.3 4.4 2.3 5.7 6.2 14.0 5.1 0.9 0.5 0.7 0.6 0.4 0.6 0.6 0.4 0.7 0.6 0.6 0.4 0.5 0.3 0.6 0.9 0.8 0.5 0.3 4.4 5.1 5.8 5.2 3.5 4.3 5.1 4.8 5.1 4.2 4.6 6.0 22.4 19.2 21.3 40.5 13.7 7.9 13.1 8.9 11.4 20.8 15.2 9.7 74.4 18.6 18.8 36.8 14.6 16.8 8.3 8.5 7.9 10.9 5.4 15.6 24.1 19.4 10.3 27.6 45.5 12.3 12.9 19.3 16.3 14.4 10.8 23.3 19.2 28.2 10.1 28.6 34.7 15.8 10.2 17.6 6.7 8.6 18.0 13.7 7.2 44.0 13.2 20.6 13.4 58.3 55.2 11.1 15.4 26.4 9.1 17.3 12.4 11.8 8.9 25.7 65.7 29.1 19.1 16.0 11.4 9.9 8.4 18.2 10.9 18.7 12.3 14.1 ADRB1 ADRB1R ENSG00000043591 "Adrenoceptor beta 1" P08588 10 114043866-114046904 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 23.7;lung: 13.1;placenta: 29.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 85.7;Cytotrophoblasts: 84.5;Sertoli cells: 52.6;Syncytiotrophoblasts: 38.4" "Cancer enriched" "Detected in many" 10 "prostate cancer: 12.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.1;PC-3: 2.6;THP-1: 4.5;TIME: 5.8;U-937: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067972 Enhanced NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA067972: AB_2685936" "unprognostic (1.45e-3)" "unprognostic (1.18e-3)" "unprognostic (1.44e-1)" "unprognostic (4.92e-2)" "unprognostic (3.22e-1)" "unprognostic (8.88e-2)" "unprognostic (9.28e-2)" "unprognostic (3.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-2)" "unprognostic (2.77e-4)" "unprognostic (1.33e-1)" "unprognostic (7.80e-3)" "unprognostic (1.53e-1)" "unprognostic (1.85e-1)" "unprognostic (1.59e-2)" "unprognostic (1.44e-1)" 4.0 0.2 5.5 0.3 10.3 0.5 2.3 0.7 12.0 0.1 0.2 3.1 0.9 0.1 0.1 0.9 0.1 0.1 23.7 6.8 3.3 1.1 1.4 13.1 0.2 1.8 3.1 0.0 1.3 0.8 0.8 29.1 2.4 4.4 0.6 2.1 5.4 0.1 2.3 0.4 1.9 0.1 0.9 1.5 0.7 0.5 5.0 0.1 0.6 0.0 0.3 0.7 0.1 7.8 1.4 0.8 0.1 0.8 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.3 1.0 0.2 0.2 0.0 0.4 0.3 0.1 0.1 0.1 7.1 0.4 0.3 0.1 0.1 0.0 0.2 0.4 0.0 0.7 0.0 1.3 0.1 0.1 1.0 0.0 0.1 0.1 0.8 1.1 0.9 0.3 0.2 2.6 0.2 0.2 0.1 0.0 1.1 0.1 0.2 0.0 0.5 0.0 0.3 0.2 4.5 5.8 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.0 3.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 10.3 0.7 12.0 6.8 3.3 1.8 3.1 2.4 0.9 5.0 7.8 1.1 19.2 7.8 15.0 0.5 1.0 3.9 0.8 1.2 21.8 1.0 0.5 85.7 2.8 9.8 0.0 0.0 84.5 3.0 0.1 1.9 0.1 0.1 0.4 0.6 11.3 0.0 0.0 12.8 0.2 5.2 5.3 0.0 0.3 0.0 0.0 0.4 0.2 4.4 13.5 2.5 3.3 2.0 2.2 1.6 0.2 0.0 2.8 1.8 7.5 0.6 0.7 3.1 1.0 0.3 0.1 1.4 0.4 1.2 6.1 0.8 0.0 12.1 1.7 52.6 0.4 8.2 0.5 0.2 0.1 0.0 38.4 4.8 0.0 0.6 3.9 CCDC186 "C10orf118, CCCP-1, FLJ10188, FLJ35301, golgin104" ENSG00000165813 "Coiled-coil domain containing 186" Q7Z3E2 10 114120862-114174232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 49.3" "Group enriched" "Detected in all" 4 "dendritic cells: 49.3;granulocytes: 26.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014569, HPA018019" Approved Approved "Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA014569: AB_2066352, HPA018019: AB_1845513" "unprognostic (1.66e-2)" "unprognostic (1.76e-2)" "unprognostic (9.14e-2)" "unprognostic (2.14e-1)" "unprognostic (2.61e-1)" "unprognostic (1.85e-3)" "unprognostic (2.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.06e-1)" "unprognostic (3.20e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "prognostic favorable (7.65e-8)" "unprognostic (8.45e-3)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" 7.4 7.3 2.8 9.0 3.3 32.8 12.5 8.6 5.4 8.5 9.2 12.4 15.4 7.5 9.6 12.5 8.2 6.8 9.4 2.8 5.9 14.9 7.2 10.8 9.1 3.4 2.9 8.0 21.1 13.1 7.1 9.4 3.7 15.1 11.9 14.1 15.6 9.2 7.1 12.6 16.1 6.2 2.5 11.0 16.7 16.6 4.8 12.0 14.7 9.2 10.2 7.7 6.8 4.3 17.9 6.1 6.0 6.9 6.8 7.9 7.8 11.0 13.2 5.1 8.1 11.2 18.3 4.2 7.0 9.1 6.3 14.1 7.1 9.8 9.8 21.9 7.3 3.3 7.0 6.6 6.3 9.6 14.6 5.9 11.1 6.0 16.9 12.6 7.7 11.1 6.1 13.5 6.0 6.5 8.8 5.3 3.5 10.6 3.9 8.4 20.7 6.6 9.0 10.9 4.2 4.4 9.7 13.4 6.6 9.7 8.6 4.1 11.2 3.9 7.8 3.9 9.3 7.6 13.3 8.4 4.1 0.1 3.0 26.5 3.3 11.7 8.6 3.8 8.5 7.9 6.6 7.8 4.0 8.6 6.4 6.4 19.9 5.8 3.7 49.3 8.7 2.6 2.8 3.3 8.6 5.4 2.8 5.9 3.4 2.9 3.7 2.5 4.8 4.3 63.2 141.1 85.7 23.8 46.7 0.0 79.5 0.0 63.2 63.8 73.5 49.0 57.4 38.6 57.6 77.3 62.6 94.9 174.6 107.1 66.5 78.2 221.9 98.4 40.6 41.3 64.6 33.1 53.0 70.7 40.7 43.7 48.9 108.9 24.7 28.1 21.0 20.9 21.4 107.7 49.9 78.9 0.0 25.0 0.0 143.6 50.1 37.1 0.0 33.7 40.0 31.7 70.0 25.6 27.7 74.9 89.9 44.4 77.8 94.8 91.4 84.0 64.1 74.0 26.3 61.7 28.3 83.7 69.2 56.1 0.0 113.6 62.1 32.5 53.7 120.3 TDRD1 CT41.1 ENSG00000095627 "Tudor domain containing 1" Q9BXT4 10 114179270-114232304 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 17.5" "Cell type enhanced" "Detected in some" "Early spermatids: 7.1;Late spermatids: 5.3;Spermatocytes: 25.6;Spermatogonia: 25.5" "Cancer enriched" "Detected in some" 5 "prostate cancer: 4.1" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "SK-BR-3: 51.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA037729 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 83: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA037729: AB_10670527" "unprognostic (6.77e-2)" "unprognostic (2.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "unprognostic (1.26e-2)" "unprognostic (3.96e-2)" "unprognostic (3.15e-2)" "unprognostic (6.13e-2)" "unprognostic (1.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.51e-2)" "unprognostic (9.60e-2)" "unprognostic (3.98e-2)" "unprognostic (4.75e-1)" "unprognostic (1.68e-1)" 0.2 0.0 0.2 0.1 0.3 0.0 0.3 0.1 0.6 0.1 0.2 0.1 0.2 0.1 0.0 0.2 0.2 0.1 0.6 0.1 0.2 2.0 0.2 0.0 0.2 0.3 0.3 0.4 0.5 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 17.5 0.3 0.2 0.1 0.5 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 51.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.2 0.3 0.1 0.6 0.1 0.2 0.3 0.3 0.2 0.1 0.3 0.4 0.6 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.9 3.5 2.8 0.0 0.0 0.0 0.3 2.7 0.3 0.0 0.2 7.1 0.4 0.5 0.2 0.0 0.0 0.5 0.6 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 2.0 0.0 0.3 5.3 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.7 0.0 0.0 0.0 1.2 2.7 0.0 0.0 0.5 0.5 25.6 25.5 0.0 0.0 0.1 0.1 0.7 0.1 0.0 VWA2 "AMACO, CCSP-2, FLJ16213, FLJ45857, NET42" ENSG00000165816 "Von Willebrand factor A domain containing 2" Q5GFL6 10 114239254-114294489 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 8.4" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 6.8;Early spermatids: 9.6;Gastric mucus-secreting cells: 5.1;Late spermatids: 15.8;Microglial cells: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 5.7;HaCaT: 3.0;SCLC-21H: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037847 Uncertain "Secreted to extracellular matrix" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA037847: AB_10670961" "unprognostic (6.03e-2)" "unprognostic (8.29e-2)" "unprognostic (3.27e-2)" "unprognostic (7.33e-2)" "unprognostic (1.26e-2)" "unprognostic (6.82e-2)" "unprognostic (3.02e-2)" "unprognostic (9.33e-3)" "unprognostic (2.44e-1)" "unprognostic (3.70e-1)" "unprognostic (1.37e-3)" "unprognostic (3.14e-1)" "unprognostic (7.27e-3)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "unprognostic (9.30e-2)" "unprognostic (1.22e-1)" 0.5 0.0 2.7 0.4 1.6 0.5 3.1 2.2 1.6 4.0 0.3 1.3 1.6 0.9 1.0 1.2 6.4 0.2 0.0 1.4 1.3 0.5 0.0 3.3 0.2 1.9 1.7 0.1 2.3 0.2 0.3 0.4 1.8 5.4 1.0 0.3 4.5 1.0 0.3 6.4 1.4 0.1 1.7 1.4 8.4 1.1 2.1 3.4 0.8 0.2 0.5 0.7 0.9 1.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.3 0.0 0.0 3.0 0.0 0.6 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.7 1.6 2.2 1.6 1.4 1.3 1.9 1.7 1.8 1.7 2.1 1.5 0.4 0.0 0.0 0.0 0.0 0.3 4.1 2.8 6.8 0.0 1.1 0.3 0.5 0.0 1.7 1.8 0.0 1.3 0.0 0.1 0.0 2.1 9.6 0.7 0.1 0.2 0.0 0.0 4.1 1.6 0.0 0.1 5.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.4 2.0 0.0 0.0 15.8 0.3 0.0 0.0 16.9 0.0 0.0 0.0 2.5 0.1 2.2 0.2 0.0 0.0 2.0 0.6 0.1 0.6 0.0 0.0 0.2 0.1 0.8 0.3 1.1 0.0 0.7 0.0 0.1 0.5 1.3 AFAP1L2 "Em:AC005383.4, FLJ14564, KIAA1914, XB130" ENSG00000169129 "Actin filament associated protein 1 like 2" Q8N4X5 10 114294824-114404756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 64.5;parathyroid gland: 68.7;thyroid gland: 82.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 40.5;Microglial cells: 34.7;Oligodendrocyte precursor cells: 122.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 39.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.6;T-cells: 1.8" "Cell line enhanced" "Detected in many" "A-431: 74.4;CAPAN-2: 77.4;EFO-21: 56.4;HaCaT: 98.7;RPMI-8226: 51.3;RPTEC TERT1: 59.7" "Low region specificity" "Detected in all" HPA037843 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 1: Thyroid gland - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 68: Oligodendrocytes - Mixed function" "Plasma membrane, Cytosol" "HPA037843: AB_10669990" "unprognostic (2.31e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-1)" "unprognostic (5.06e-3)" "unprognostic (4.14e-2)" "unprognostic (9.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (3.76e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.55e-5)" "unprognostic (1.11e-1)" "unprognostic (3.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.86e-1)" 7.6 2.4 15.7 4.2 12.9 0.1 10.2 21.5 13.1 21.8 5.9 13.0 3.9 23.9 13.2 9.3 22.9 4.5 4.7 11.8 12.4 17.6 1.7 5.3 4.3 12.9 12.8 15.1 11.9 68.7 2.4 18.4 13.6 13.1 5.1 3.7 6.9 23.9 3.0 9.8 6.4 18.9 13.6 64.5 5.9 1.4 13.3 13.5 82.2 4.4 7.6 5.9 14.7 13.5 74.4 10.8 10.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.1 77.4 0.1 56.4 0.6 1.1 98.7 0.2 27.2 0.2 1.5 0.1 0.0 0.7 0.0 3.0 0.0 2.7 0.0 28.9 8.1 7.1 0.3 0.3 2.8 0.0 0.2 0.0 3.1 1.9 0.1 0.5 2.0 0.5 0.9 0.8 51.3 59.7 0.6 0.3 0.5 2.3 1.7 2.9 16.0 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 1.1 1.6 1.1 1.2 0.0 1.6 0.3 0.9 0.1 0.4 0.0 0.1 1.8 0.6 15.7 12.9 21.5 13.1 11.8 12.4 12.9 12.8 13.6 13.6 13.3 13.5 14.6 0.0 0.0 0.7 1.2 12.4 7.3 3.1 5.2 0.8 1.8 5.3 2.2 0.0 1.8 40.5 0.0 1.5 2.4 8.1 0.0 0.6 1.0 5.3 7.4 14.5 0.0 0.8 6.5 14.3 1.2 10.7 3.1 9.5 0.0 0.3 13.2 0.0 0.5 1.7 10.1 1.8 0.0 0.0 3.7 3.0 3.1 0.5 5.4 34.7 0.6 3.2 0.0 122.6 0.6 23.2 1.7 1.9 0.1 3.7 2.2 0.4 1.5 0.6 19.7 21.4 24.7 0.0 0.8 2.3 6.8 0.3 3.4 2.4 2.2 4.3 ABLIM1 "ABLIM, LIMAB1, limatin" ENSG00000099204 "Actin binding LIM protein 1" O14639 10 114431113-114768061 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 875.6;Cardiomyocytes: 592.5;Peritubular cells: 413.0;Squamous epithelial cells: 481.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 139.1" "Group enriched" "Detected in many" 7 "B-cells: 52.2;NK-cells: 63.6;T-cells: 139.1" "Cell line enhanced" "Detected in many" "hTCEpi: 164.1;OE19: 159.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038951, HPA038952" Approved Supported Cytosol NA NA 6000 "Cluster 32: T-cells - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 61: Squamous epithelial cells - Keratinization" Cytosol "HPA038951: AB_10673017, HPA038952: AB_10670915" "unprognostic (2.25e-2)" "unprognostic (3.96e-2)" "unprognostic (2.91e-1)" "unprognostic (1.26e-1)" "unprognostic (5.89e-3)" "unprognostic (1.07e-2)" "unprognostic (3.19e-2)" "unprognostic (5.07e-2)" "unprognostic (4.39e-2)" "unprognostic (1.05e-1)" "unprognostic (3.20e-2)" "unprognostic (3.23e-1)" "prognostic favorable (2.72e-5)" "unprognostic (2.77e-2)" "unprognostic (1.92e-1)" "unprognostic (3.22e-1)" "unprognostic (5.87e-2)" 73.3 93.4 71.0 35.7 67.6 13.6 54.8 277.3 59.4 44.4 76.2 46.7 37.3 37.3 26.7 205.6 51.3 33.5 268.6 58.5 78.3 54.7 28.3 54.5 50.0 90.5 65.1 233.6 32.1 42.3 22.0 31.5 74.9 24.0 57.8 110.1 98.2 26.5 75.1 97.5 34.2 29.3 85.2 20.1 120.7 41.3 67.0 56.8 112.9 111.6 89.1 42.0 89.4 73.2 48.2 34.7 120.2 27.2 1.1 0.4 1.5 9.6 3.2 2.4 6.7 49.0 76.7 61.8 128.7 11.1 18.1 101.4 41.1 66.2 3.1 21.2 35.5 0.5 96.0 128.8 0.5 24.6 0.4 1.5 164.1 18.1 52.1 50.3 47.5 21.4 0.2 93.3 0.5 17.5 5.0 10.8 47.0 159.5 38.4 2.1 29.3 80.3 38.4 105.6 41.7 51.4 40.4 59.2 21.0 60.0 30.7 0.3 32.1 0.1 43.1 1.1 18.3 0.5 0.3 140.0 2.3 54.0 0.9 11.9 0.2 0.8 28.6 0.2 55.5 40.9 53.9 32.8 0.4 52.2 139.1 91.0 2.4 63.6 0.3 0.4 33.7 48.1 71.0 67.6 277.3 59.4 58.5 78.3 90.5 65.1 74.9 85.2 67.0 73.2 218.9 317.3 36.0 875.6 47.1 86.8 42.2 35.7 306.2 54.5 27.6 29.5 592.5 51.5 97.1 53.3 18.8 1.5 43.2 59.8 35.2 37.8 110.7 88.4 32.7 107.3 16.8 7.4 236.0 54.5 0.8 126.1 225.3 30.9 1.3 119.6 55.6 51.4 0.6 58.9 326.0 101.7 16.2 1.3 18.4 133.7 227.7 9.4 21.4 213.6 4.3 54.7 27.8 50.3 9.2 59.6 34.7 413.0 22.7 49.8 46.7 42.1 79.3 96.7 0.0 155.8 22.0 3.9 4.7 481.0 189.4 0.7 62.8 53.6 51.4 164.0 FAM160B1 "bA106M7.3, KIAA1600" ENSG00000151553 "Family with sequence similarity 160 member B1" Q5W0V3 10 114821744-114899832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043624 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA043624: AB_10797145" "unprognostic (2.61e-1)" "unprognostic (2.47e-2)" "unprognostic (2.62e-1)" "unprognostic (8.45e-3)" "unprognostic (6.43e-2)" "unprognostic (9.87e-3)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (2.29e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (4.02e-6)" "unprognostic (3.41e-3)" "unprognostic (3.35e-1)" "unprognostic (2.10e-1)" "unprognostic (1.25e-2)" 15.0 11.7 8.7 10.0 8.4 53.3 11.9 6.1 8.4 12.1 6.1 10.7 12.7 16.0 10.0 7.3 12.3 10.5 14.2 7.8 6.5 7.9 19.0 11.6 12.6 5.6 6.5 14.3 9.8 11.9 7.4 14.9 6.1 10.5 8.1 11.5 8.5 11.3 20.3 8.6 13.2 16.9 5.3 11.4 10.1 18.8 6.9 11.2 11.7 12.3 9.6 11.9 10.0 5.2 16.7 8.9 9.6 14.3 22.9 26.0 11.2 29.7 28.8 16.8 13.4 3.1 6.3 9.9 9.1 27.2 4.3 11.0 4.7 11.9 19.8 36.2 10.2 3.9 16.5 7.2 16.7 10.6 12.8 20.4 11.3 12.5 20.2 36.0 22.9 20.0 5.6 24.4 31.7 7.7 19.0 10.5 6.3 4.8 6.6 16.3 16.3 6.6 11.3 9.9 2.1 8.6 13.2 13.6 15.5 11.3 5.4 6.0 23.1 10.4 6.6 30.7 10.4 10.0 3.0 11.2 13.4 26.0 10.0 19.9 3.2 4.7 5.4 2.4 4.0 3.7 7.4 9.2 3.6 3.6 4.0 5.5 15.2 4.9 2.8 3.7 10.5 2.7 8.7 8.4 6.1 8.4 7.8 6.5 5.6 6.5 6.1 5.3 6.9 5.2 25.9 16.0 8.1 20.5 10.9 7.0 7.9 8.0 14.8 13.9 9.4 6.7 19.5 4.3 8.4 3.7 12.5 12.7 14.1 9.0 1.9 10.2 26.7 12.0 26.2 19.8 7.8 9.9 26.5 9.6 10.2 19.2 23.0 16.8 2.5 29.6 23.9 31.3 6.3 10.1 27.4 9.2 4.1 15.6 6.8 36.0 28.6 11.3 3.6 25.3 11.4 8.3 25.7 28.1 13.8 15.1 3.7 22.2 20.1 19.5 20.8 6.6 8.7 16.9 6.6 13.2 14.4 14.9 6.4 8.9 4.8 12.6 17.5 15.0 5.8 14.8 TRUB1 PUS4 ENSG00000165832 "TruB pseudouridine synthase family member 1" Q8WWH5 10 114938195-114977676 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 62.2;Theca cells: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037914, HPA057552" Approved Approved Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles "HPA037914: AB_10672399, HPA057552: AB_2683465" "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (1.27e-2)" "unprognostic (2.93e-2)" "unprognostic (3.20e-3)" "unprognostic (9.79e-2)" "unprognostic (9.26e-2)" "unprognostic (4.89e-2)" "unprognostic (6.87e-2)" "unprognostic (2.51e-2)" "unprognostic (2.26e-2)" "unprognostic (1.56e-1)" "unprognostic (1.50e-3)" "unprognostic (7.54e-2)" "unprognostic (2.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-1)" 7.4 29.3 6.3 7.5 7.4 4.2 11.3 5.1 9.0 9.8 7.3 9.5 8.9 12.8 9.3 8.3 9.7 7.7 21.5 7.6 7.1 16.0 12.9 6.6 10.0 5.8 6.0 16.8 6.8 15.8 4.9 7.5 6.1 11.7 10.4 6.7 9.3 9.9 7.5 6.5 8.2 11.1 5.6 9.3 8.7 17.9 7.0 11.5 12.3 9.7 10.1 7.8 4.8 6.4 25.5 19.6 18.8 47.0 13.3 17.7 25.3 21.4 24.1 28.4 32.0 16.1 25.5 31.4 24.2 16.9 12.4 21.3 25.6 26.5 41.8 23.9 27.5 14.4 9.2 28.8 22.8 27.2 20.7 18.2 35.8 20.2 39.6 30.1 16.2 24.9 15.1 12.5 34.1 12.3 25.7 21.6 17.8 17.0 19.1 25.4 47.5 19.2 37.4 12.7 17.5 19.3 18.0 26.4 47.7 20.0 21.1 16.6 14.5 13.0 13.0 20.8 26.5 23.6 20.4 26.3 18.3 34.2 11.9 4.0 2.6 0.9 4.4 4.0 6.5 7.3 4.7 4.7 4.8 5.9 6.2 5.8 0.2 8.1 7.3 4.3 6.2 4.6 6.3 7.4 5.1 9.0 7.6 7.1 5.8 6.0 6.1 5.6 7.0 6.4 6.9 12.8 8.4 8.8 11.2 5.6 4.7 15.3 6.2 13.9 11.9 8.1 13.6 4.3 12.0 9.2 2.1 9.1 10.5 7.1 21.5 7.6 62.2 11.1 12.8 6.6 7.7 9.0 23.0 4.9 6.6 11.2 6.6 12.0 10.2 26.7 12.1 20.2 7.6 25.2 22.0 8.2 6.1 7.3 4.2 9.6 8.4 5.0 3.6 8.4 5.4 10.4 9.2 31.2 16.7 7.0 3.6 10.1 12.7 4.2 6.2 27.9 9.8 5.6 6.6 8.4 9.3 14.5 23.3 15.9 7.0 6.2 8.0 74.1 12.9 5.8 ATRNL1 "ALP, FLJ45344, KIAA0534" ENSG00000107518 "Attractin like 1" Q5VV63 10 115093365-115948999 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 91.1" "Group enriched" "Detected in many" 13 "Excitatory neurons: 2134.6;Inhibitory neurons: 1473.4;Oligodendrocyte precursor cells: 1456.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 91.1;white matter: 58.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 21.4;RH-30: 18.4;U-266/70: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038070 Approved Nucleoplasm,Mitochondria NA NA 160000000 "Cluster 10: Brain - Neuronal signaling" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Mitochondria" "HPA038070: AB_10697237" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "unprognostic (5.88e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.88e-2)" "unprognostic (5.17e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" "unprognostic (2.50e-2)" "unprognostic (1.04e-3)" "unprognostic (3.10e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (2.08e-3)" 0.7 10.7 3.8 0.2 9.5 0.0 1.0 0.0 91.1 0.9 0.0 2.4 0.3 6.2 0.3 0.5 1.0 0.2 1.8 18.3 0.0 2.8 1.5 0.1 0.4 0.0 0.2 9.7 1.3 2.1 5.8 1.9 1.0 3.1 0.2 6.3 1.0 3.8 2.8 0.2 0.8 5.8 0.0 0.3 0.4 12.6 0.0 0.4 1.0 0.0 0.4 0.6 1.0 58.7 0.0 0.6 6.3 21.4 0.0 0.0 0.0 0.1 0.6 3.9 4.6 0.2 0.2 0.0 1.5 0.5 5.1 0.0 1.6 0.0 4.0 0.1 4.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 6.4 0.0 11.3 0.0 5.3 10.4 0.2 9.9 0.0 9.1 0.0 0.1 7.5 18.4 11.4 3.9 0.0 3.6 10.5 0.0 0.1 0.4 4.3 1.8 0.0 0.0 0.0 2.7 0.1 3.3 14.2 0.0 4.6 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 9.5 0.0 91.1 18.3 0.0 0.0 0.2 1.0 0.0 0.0 58.7 0.0 0.0 0.0 55.8 0.8 0.6 0.1 0.8 0.6 35.4 2.1 0.5 2.5 0.0 0.1 0.0 2.1 0.1 0.2 0.2 0.0 0.7 45.6 0.8 1.5 1.5 0.0 0.0 2134.6 0.4 0.0 5.3 0.0 1.8 0.0 24.9 21.0 0.1 3.0 10.1 1473.4 0.0 0.0 1.9 0.4 47.8 1.5 0.3 0.0 128.4 0.0 4.3 0.0 1456.7 34.2 0.3 0.0 0.7 0.0 0.1 0.0 0.5 0.1 4.7 0.0 2.4 2.6 46.6 11.5 0.0 0.1 0.3 0.1 53.1 0.0 0.1 GFRA1 "GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1" ENSG00000151892 "GDNF family receptor alpha 1" P56159 10 116056925-116273284 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 40.5;Breast glandular cells: 33.1;Fibroblasts: 51.2;Hepatocytes: 42.2;Oligodendrocyte precursor cells: 91.0;Skeletal myocytes: 100.1" "Cancer enriched" "Detected in many" 11 "breast cancer: 40.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 44.7;BJ hTERT+ SV40 Large T+ RasG12V: 77.2;EFO-21: 46.5;fHDF/TERT166: 89.3;HBF TERT88: 63.2;MCF7: 59.5;U-251 MG: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043829 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 140000 "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Nucleoplasm "HPA043829: AB_2678689" "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (7.60e-2)" "unprognostic (1.06e-3)" "unprognostic (4.10e-2)" "unprognostic (6.95e-3)" "unprognostic (2.35e-3)" "unprognostic (1.48e-3)" "unprognostic (3.16e-1)" "unprognostic (2.06e-3)" "unprognostic (1.31e-2)" "unprognostic (2.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.20e-3)" "unprognostic (1.69e-1)" "unprognostic (2.27e-2)" "unprognostic (3.64e-2)" 10.9 3.4 7.2 4.2 14.9 0.0 23.2 2.6 9.5 9.9 0.3 18.3 1.7 4.9 20.5 6.9 17.2 5.6 4.8 9.7 18.0 6.0 16.0 2.8 4.0 7.8 28.5 4.5 6.6 2.7 3.2 0.0 7.2 4.5 3.9 3.2 6.0 5.4 4.3 7.2 8.2 4.8 6.2 3.9 8.2 3.1 7.6 4.1 2.8 13.9 6.4 7.0 9.2 6.1 0.1 3.7 12.2 0.0 0.0 0.1 0.0 7.9 0.4 44.7 77.2 0.0 0.0 0.0 46.5 89.3 0.0 0.0 0.1 0.0 63.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.0 11.5 0.0 3.9 0.0 9.1 0.0 0.0 5.6 59.5 7.6 0.0 5.0 0.0 0.0 0.0 1.9 0.0 5.0 0.0 1.6 0.1 0.0 0.0 0.1 2.1 0.4 0.0 0.4 0.0 0.4 0.1 53.5 0.0 0.0 0.1 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 14.9 2.6 9.5 9.7 18.0 7.8 28.5 7.2 6.2 7.6 6.1 6.1 0.0 0.0 40.5 0.5 5.7 0.0 0.0 1.8 4.1 33.1 11.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 13.2 0.0 0.2 3.2 6.0 0.0 5.1 13.5 0.0 51.2 3.1 0.0 6.3 0.1 0.4 42.2 0.0 0.0 6.6 0.0 0.0 1.0 9.6 12.8 8.1 1.0 5.4 1.9 0.0 12.6 0.0 91.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.5 0.0 100.1 16.7 0.1 10.4 0.7 4.5 0.0 0.7 0.1 0.0 0.2 CCDC172 "C10orf96, MGC35062" ENSG00000182645 "Coiled-coil domain containing 172" P0C7W6 10 116324448-116380029 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "retina: 3.1;testis: 12.2" "Cell type enhanced" "Detected in some" "Early spermatids: 32.9;Late spermatids: 9.6;Spermatocytes: 107.9;Spermatogonia: 22.9" "Cancer enriched" "Detected in single" 14 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "NTERA-2: 31.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 77: Retina - Visual perception" "Cluster 5: NTERA-2 - Transcription" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "unprognostic (9.85e-2)" 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 12.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.6 0.9 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 107.9 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNLIPRP3 ENSG00000203837 "Pancreatic lipase related protein 3" Q17RR3 10 116427847-116477957 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 9.0;skin 1: 14.4" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 1.1;Early spermatids: 1.5;Late spermatids: 1.9;Melanocytes: 1.8" "Cancer enhanced" "Detected in some" "head and neck cancer: 4.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "hTCEpi: 320.3" "Not detected" "Not detected" "HPA046202, HPA052009" Uncertain "Secreted - unknown location" NA NA "Cluster 61: Skin - Cornification" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA046202: AB_10959739, HPA052009: AB_2681692" "unprognostic (2.62e-4)" "unprognostic (1.60e-1)" "unprognostic (6.97e-2)" 2.2 0.1 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 320.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 PNLIP PL ENSG00000175535 "Pancreatic lipase" P16233 10 116545931-116567855 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2058 "pancreas: 444687.5" "Cell type enriched" "Detected in some" 8 "Exocrine glandular cells: 4086.8" "Cancer enriched" "Detected in some" 4854 "pancreatic cancer: 2731.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA062430, HPA062494" Enhanced "Secreted to digestive system" NA NA 14000000 "Cluster 25: Pancreas - Digestion" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "HPA062430: AB_2684761, HPA062494: AB_2684782" "unprognostic (2.05e-2)" "unprognostic (4.46e-2)" 13.8 3.1 0.0 10.5 0.0 1.1 8.9 0.0 0.0 7.2 0.0 3.8 64.8 9.1 0.4 4.8 1.5 0.0 78.2 0.0 0.0 3.0 10.2 2.1 16.9 0.0 0.0 216.0 444687.5 0.0 2.5 24.4 0.0 4.5 0.0 0.0 71.7 0.0 2.9 4.6 34.0 0.0 0.0 3.8 28.2 2.3 0.0 0.0 2.0 0.0 0.0 1.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.5 0.0 0.0 0.3 0.0 0.0 0.1 4086.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 14.5 0.0 0.0 0.5 0.1 507.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PNLIPRP1 PLRP1 ENSG00000187021 "Pancreatic lipase related protein 1" P54315 10 116590385-116609175 "Metabolic proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 2343 "pancreas: 10825.1" "Cell type enriched" "Detected in some" 10 "Exocrine glandular cells: 688.3" "Cancer enriched" "Detected in single" 476 "pancreatic cancer: 32.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA 340000 "Cluster 25: Pancreas - Digestion" "Cluster 16: U-266 - Nucleosome" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (1.21e-1)" "unprognostic (4.08e-3)" "unprognostic (1.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.76e-2)" "unprognostic (1.41e-1)" "unprognostic (1.46e-1)" "unprognostic (1.49e-1)" 1.7 0.2 0.0 0.2 0.0 0.3 0.6 0.0 0.0 0.9 0.0 0.2 2.1 0.3 0.0 0.4 0.1 0.0 2.0 0.0 0.0 0.2 0.8 0.2 0.4 0.0 0.0 4.6 10825.1 0.0 0.5 0.8 0.0 0.4 0.1 0.0 2.7 0.0 0.2 0.4 1.1 0.0 0.0 0.4 1.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.8 0.0 0.0 0.1 0.0 0.0 0.0 688.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 3.4 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.1 66.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.3 C10orf82 "Em:AC016825.4, MGC33547" ENSG00000165863 "Chromosome 10 open reading frame 82" Q8WW14 10 116663696-116670264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 84.5" "Group enriched" "Detected in some" 113 "Early spermatids: 1053.9;Late spermatids: 1926.7" "Cancer enhanced" "Detected in many" "breast cancer: 2.4" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 103 "basophil: 10.2" "Lineage enriched" "Detected in single" 103 "granulocytes: 10.2" "Cell line enhanced" "Detected in some" "BEWO: 1.2;Hep G2: 2.8;NTERA-2: 1.4;SuSa: 2.5;T-47d: 3.5" "Not detected" "Not detected" HPA043022 Approved Mitochondria Yes NA "Cluster 46: Basophils - DNA binding" "Cluster 83: Testis - Spermatogenesis" "Cluster 6: T47d - Mammary gland" "Cluster 34: Spermatids - Unknown function" Mitochondria "HPA043022: " "unprognostic (9.98e-2)" "unprognostic (2.09e-2)" "unprognostic (8.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.63e-2)" "unprognostic (9.52e-2)" "unprognostic (3.46e-3)" "unprognostic (3.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.50e-2)" "unprognostic (8.00e-2)" "unprognostic (1.47e-3)" "unprognostic (2.61e-2)" "unprognostic (1.94e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" 0.3 1.7 0.3 0.2 0.2 0.0 0.9 0.1 0.4 0.4 0.0 0.9 0.1 0.0 0.2 0.3 0.2 0.1 0.4 0.2 0.8 1.2 0.0 0.0 0.0 0.3 0.5 3.6 1.1 0.0 1.0 0.0 0.4 0.9 0.2 0.1 0.2 0.7 0.0 0.2 0.4 0.0 0.2 0.1 0.4 84.5 0.9 0.0 1.6 0.1 0.0 0.3 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.4 0.2 0.8 0.3 0.5 0.4 0.2 0.9 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 1.1 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1053.9 0.3 0.2 0.5 1.2 0.0 0.5 0.2 0.1 0.1 0.0 0.7 0.0 5.6 0.0 0.0 0.1 0.0 1.8 1.1 0.0 0.0 0.0 1926.7 9.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 5.3 0.0 0.7 0.1 0.1 0.0 0.0 13.1 0.4 0.2 10.5 8.0 0.0 0.0 0.0 0.1 8.0 1.2 0.3 HSPA12A "FLJ13874, KIAA0417" ENSG00000165868 "Heat shock protein family A (Hsp70) member 12A" O43301 10 116671192-116850251 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 205.0;Inhibitory neurons: 186.4;Leydig cells: 63.3;Peritubular cells: 68.4;Theca cells: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 1.3;naive B-cell: 1.7;T-reg: 1.0" "Group enriched" "Detected in many" 14 "B-cells: 1.7;T-cells: 1.0" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011273, HPA073244" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus, Cytosol" "HPA011273: AB_1851190, HPA073244: AB_2686586" "unprognostic (7.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-2)" "unprognostic (1.44e-1)" "unprognostic (7.31e-3)" "unprognostic (5.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.62e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (2.85e-2)" "unprognostic (1.66e-1)" "unprognostic (3.75e-1)" "unprognostic (5.55e-4)" 15.8 21.9 10.9 1.5 13.5 0.0 8.8 11.2 28.2 13.7 7.9 12.4 0.7 9.2 12.5 3.9 10.3 2.3 9.6 16.6 11.1 17.4 1.6 3.0 2.7 17.3 12.2 20.5 2.7 20.0 7.9 0.8 16.4 5.6 1.9 11.0 2.6 5.5 4.9 5.7 4.1 4.6 2.7 3.8 4.7 6.2 27.3 2.1 9.4 3.4 2.8 7.9 10.0 14.7 8.0 10.0 0.1 7.1 6.6 4.4 0.1 5.5 10.1 1.9 1.0 10.0 2.8 0.0 4.1 7.6 5.2 6.1 8.4 0.7 4.9 0.0 3.2 0.0 0.8 5.5 1.9 0.0 1.0 1.7 6.6 7.3 0.9 13.9 0.0 3.3 0.0 0.0 2.1 4.0 0.0 0.0 1.2 0.0 0.1 0.0 1.0 1.2 22.1 1.8 5.3 12.7 4.0 2.9 3.0 2.4 3.2 0.0 0.0 1.4 5.5 12.3 10.2 0.1 3.2 0.0 3.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 10.9 13.5 11.2 28.2 16.6 11.1 17.3 12.2 16.4 2.7 27.3 14.7 2.1 6.4 3.6 27.7 1.0 11.1 1.6 0.5 2.8 35.8 5.2 6.9 7.8 2.8 2.0 12.9 22.9 0.1 0.1 1.6 15.6 4.2 4.4 12.5 16.1 3.1 0.0 0.0 205.0 3.5 0.1 17.8 0.0 4.4 0.0 2.4 2.9 0.4 0.1 30.3 186.4 0.3 0.0 0.0 5.2 9.7 63.3 0.5 26.6 9.4 0.0 35.8 0.0 27.6 54.8 2.4 0.0 68.4 0.1 2.1 0.0 25.4 11.3 10.2 13.1 14.7 14.9 1.0 5.2 0.5 5.1 0.3 0.8 82.0 0.3 0.7 ENO4 "AC023283.3, C10orf134" ENSG00000188316 "Enolase 4" A6NNW6 10 116849499-116911788 "Enzymes, Predicted intracellular proteins" Glycolysis Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.5;choroid plexus: 4.7;fallopian tube: 5.0" "Cell type enhanced" "Detected in some" "Astrocytes: 16.3;Cone photoreceptor cells: 22.9;Early spermatids: 15.5;Endometrial ciliated cells: 15.8;Inhibitory neurons: 18.4;Late spermatids: 15.8;Oligodendrocytes: 62.4;Respiratory ciliated cells: 30.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037937, HPA037938" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria Nucleoplasm "HPA037937: AB_10697089, HPA037938: AB_2675746" "unprognostic (2.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (6.55e-4)" "unprognostic (8.38e-5)" "unprognostic (1.88e-1)" "unprognostic (2.21e-1)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (3.74e-3)" "unprognostic (2.06e-1)" "unprognostic (2.20e-3)" "unprognostic (1.18e-1)" "unprognostic (9.77e-3)" "unprognostic (9.87e-5)" "unprognostic (1.08e-2)" 0.2 0.3 1.7 0.0 5.3 0.0 0.4 1.7 3.4 0.4 4.7 0.3 0.0 0.6 1.3 0.1 5.0 0.3 0.1 2.1 2.6 0.6 1.3 0.6 0.1 4.8 4.5 0.5 0.6 1.0 1.0 0.0 3.5 0.3 0.1 2.0 0.2 0.4 0.0 0.2 0.2 0.2 2.6 0.2 0.3 2.5 4.0 0.1 0.7 0.0 0.0 0.1 0.2 11.5 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 5.3 1.7 3.4 2.1 2.6 4.8 4.5 3.5 2.6 4.0 11.5 0.0 0.0 0.0 16.3 0.0 0.1 0.3 0.8 0.6 4.9 0.4 0.3 0.3 0.0 0.4 0.0 22.9 0.3 0.0 0.2 0.0 0.5 15.5 15.8 0.7 0.1 1.8 0.0 12.2 0.2 0.2 0.7 0.0 1.1 0.0 0.5 0.0 0.0 0.0 5.0 18.4 0.0 0.0 0.0 0.6 15.8 1.2 0.2 0.0 8.4 0.6 1.3 0.0 4.5 62.4 0.2 0.1 0.7 0.0 0.1 0.3 0.8 30.2 8.4 0.0 1.0 0.5 9.4 2.9 0.1 0.0 0.1 0.0 1.0 0.3 0.1 SHTN1 "KIAA1598, shootin-1, shootin1" ENSG00000187164 "Shootin 1" A0MZ66 10 116881477-117126586 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 128.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 19.7;intermediate monocyte: 12.9;myeloid DC: 19.3;non-classical monocyte: 6.6;plasmacytoid DC: 12.9" "Group enriched" "Detected in many" 42 "dendritic cells: 19.3;monocytes: 19.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037942, HPA037943" Enhanced Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA037942: AB_2675748, HPA037943: AB_10671637" "unprognostic (1.00e-1)" "unprognostic (2.50e-2)" "unprognostic (6.77e-3)" "unprognostic (2.81e-1)" "unprognostic (7.85e-2)" "unprognostic (1.61e-1)" "unprognostic (2.42e-2)" "unprognostic (1.03e-1)" "unprognostic (2.56e-1)" "unprognostic (1.35e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.08e-6)" 1.9 4.0 63.2 4.5 94.5 0.7 4.9 42.7 54.1 2.9 10.0 4.3 4.1 2.4 4.6 3.1 2.9 3.8 1.6 46.9 73.9 4.7 7.6 6.2 2.9 77.5 70.1 3.9 12.2 8.0 6.2 3.1 69.5 4.2 5.2 10.6 6.7 1.4 0.3 5.6 4.8 2.0 48.6 4.5 5.7 6.4 79.5 2.7 7.5 0.8 2.3 2.1 2.1 128.1 24.2 13.4 1.3 2.8 0.0 0.0 12.8 2.0 5.3 4.0 7.6 15.1 15.5 0.0 4.0 7.4 11.8 12.2 10.6 8.9 4.1 0.0 11.0 0.0 14.5 8.9 1.7 4.3 3.7 0.5 7.5 4.0 7.5 10.3 9.7 6.4 6.7 0.1 2.8 9.6 0.0 0.1 5.0 4.8 8.9 0.0 17.5 5.4 10.3 3.3 14.5 5.7 16.0 23.3 13.8 15.7 18.4 3.8 17.0 1.4 9.4 0.1 11.7 2.4 0.1 0.0 7.1 0.0 7.2 0.0 19.7 0.2 0.0 12.9 0.0 0.0 0.1 0.0 19.3 0.0 0.1 0.0 0.4 0.0 6.6 12.9 0.4 5.6 63.2 94.5 42.7 54.1 46.9 73.9 77.5 70.1 69.5 48.6 79.5 128.1 1.4 76.9 35.7 0.0 2.0 0.0 18.9 0.0 15.4 92.3 31.8 15.9 4.9 35.8 23.5 23.9 62.6 42.1 24.7 10.6 21.5 46.4 7.5 43.4 10.6 5.1 17.0 1.7 0.0 53.2 30.9 11.2 36.7 81.1 2.5 23.6 1.8 50.5 37.3 48.8 0.0 15.5 0.0 83.6 0.0 11.7 11.1 77.2 0.0 0.0 90.3 13.8 1.0 0.0 0.0 46.2 42.5 5.3 0.8 25.2 21.2 58.4 18.2 59.4 13.1 18.2 5.0 22.0 39.6 20.5 0.0 20.0 3.1 28.4 15.7 15.4 VAX1 ENSG00000148704 "Ventral anterior homeobox 1" Q5SQQ9 10 117128521-117138301 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "brain: 8.4" "Cell type enriched" "Detected in some" 4 "Inhibitory neurons: 7.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 8.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 3.1;WM-115: 2.3" "Group enriched" "Detected in some" 6 "basal ganglia: 5.6;hypothalamus: 3.2;olfactory bulb: 1.5" "Low region specificity" "Detected in some" HPA028946 Uncertain Approved "Nucleoplasm,Nucleoli rim" Yes NA "Cluster 65: Brain - Ion transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoli rim" Nucleoplasm "HPA028946: AB_10602679" "unprognostic (1.08e-2)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (2.96e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (2.99e-1)" 0.0 0.0 1.6 0.0 4.4 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.4 0.0 2.8 0.2 8.4 0.1 0.2 0.0 0.0 2.3 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK18 "K2p18.1, TRESK, TRESK-2, TRESK2, TRIK" ENSG00000186795 "Potassium two pore domain channel subfamily K member 18" Q7Z418 10 117197489-117210299 "Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "choroid plexus: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044739 Uncertain NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "HPA044739: AB_10795008" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC18A2 "SVAT, SVMT, VMAT2" ENSG00000165646 "Solute carrier family 18 member A2" Q05940 10 117241093-117279430 "Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Disease variant, Dystonia, FDA approved drug targets, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.1;cervix: 30.0" "Cell type enriched" "Detected in many" 5 "granulocytes: 636.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 11 "hypothalamus: 20.8;midbrain: 81.1;pons: 70.5" "Immune cell enriched" "Detected in some" 15 "basophil: 59.5" "Lineage enriched" "Detected in many" 15 "granulocytes: 59.5" "Cell line enriched" "Detected in some" 19 "HMC-1: 351.0" "Region enhanced" "Detected in many" "midbrain: 62.7" "Region enriched" "Detected in all" 4 "midbrain: 111.6" HPA073224 Enhanced Approved Vesicles,Centrosome NA NA "Cluster 38: Basophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Vesicles, Centrosome" "HPA073224: AB_2732222" "unprognostic (1.49e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (9.00e-2)" "unprognostic (2.85e-1)" "unprognostic (5.33e-3)" "unprognostic (2.23e-1)" "unprognostic (1.71e-2)" "unprognostic (1.40e-1)" "unprognostic (4.55e-2)" "unprognostic (2.00e-1)" "unprognostic (6.06e-3)" "unprognostic (7.94e-5)" "unprognostic (2.95e-2)" "unprognostic (2.31e-1)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" 1.1 14.6 0.1 0.9 1.1 2.4 1.8 0.1 0.3 30.0 0.2 2.3 1.5 2.6 1.6 2.5 0.5 3.6 0.7 0.2 20.8 0.9 2.8 7.4 0.6 3.8 81.1 10.4 3.4 0.2 0.2 0.1 70.5 9.2 3.5 0.4 0.8 1.3 0.8 6.3 2.1 2.3 0.0 0.3 4.4 0.9 5.0 6.1 0.0 0.5 0.9 2.9 7.9 0.2 0.2 1.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.3 0.6 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.7 18.6 0.1 0.2 0.0 1.0 351.0 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 0.7 0.0 0.1 1.0 0.3 0.2 0.3 0.6 0.2 0.4 0.2 0.0 0.2 3.4 0.7 0.3 0.1 0.0 0.2 0.0 0.1 0.3 0.1 2.5 0.3 0.8 0.5 0.4 0.2 0.4 1.9 0.3 59.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 3.8 0.0 2.0 0.1 1.1 0.1 0.3 0.2 20.8 3.8 81.1 70.5 0.0 5.0 0.2 0.0 9.6 16.2 1.0 0.2 1.9 0.0 0.0 0.0 2.1 0.2 0.0 0.3 0.0 2.5 0.0 4.2 0.0 5.7 0.4 0.0 0.0 0.0 13.1 16.1 0.7 8.9 4.2 1.1 0.0 0.0 3.4 4.1 112.4 636.0 2.4 9.7 0.3 0.8 0.0 1.7 0.0 0.0 1.0 3.6 0.2 0.6 3.5 1.8 0.0 0.1 0.4 0.0 0.5 0.6 0.1 0.1 4.9 1.9 3.8 0.0 0.1 0.7 0.8 0.0 0.4 1.3 0.2 2.1 0.0 2.7 0.0 5.6 9.8 0.1 0.1 PDZD8 "bA129M16.2, FLJ34427, PDZK8" ENSG00000165650 "PDZ domain containing 8" Q8NEN9 10 117277274-117375440 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 73.0" "Cell type enhanced" "Detected in all" "Early spermatids: 208.7;Late spermatids: 477.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 124.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015716, HPA051610" Uncertain Approved "Nucleoli fibrillar center,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoli fibrillar center" "Plasma membrane" "HPA015716: AB_1855162, HPA051610: AB_2681549" "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (9.65e-3)" "unprognostic (2.75e-2)" "unprognostic (6.29e-2)" "unprognostic (3.36e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.53e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.90e-2)" "unprognostic (5.37e-3)" "unprognostic (7.60e-3)" "unprognostic (1.44e-2)" "unprognostic (3.18e-2)" "unprognostic (2.01e-2)" 7.1 7.0 8.9 4.7 12.1 73.0 4.7 15.7 8.6 7.9 17.9 9.3 14.0 9.1 14.1 10.8 6.8 9.7 5.1 8.1 11.8 13.1 15.8 6.0 3.2 11.9 13.8 8.9 14.1 28.3 4.2 5.4 12.2 6.4 11.2 14.1 12.9 10.6 4.9 5.5 10.6 6.9 11.3 3.7 10.4 13.2 12.5 5.8 6.8 5.8 3.6 6.6 5.8 13.2 12.6 21.1 7.6 14.7 12.8 11.4 4.3 11.9 10.2 5.2 4.2 10.7 16.4 14.7 10.5 18.1 6.0 18.4 13.4 12.6 10.3 9.4 11.8 124.3 8.6 10.6 9.4 52.4 11.2 11.2 14.7 9.5 27.9 19.3 9.3 12.1 11.5 15.0 13.0 5.1 10.2 6.7 6.0 6.6 18.8 8.2 29.2 6.4 15.5 9.0 6.0 9.6 12.6 5.4 9.7 6.9 3.7 7.6 15.1 8.6 9.4 15.8 20.5 8.0 7.2 10.5 10.8 23.6 7.7 1.4 0.5 2.6 0.9 0.5 0.9 0.3 0.7 0.7 0.7 0.4 0.5 0.7 2.3 1.2 0.9 0.5 0.3 0.2 8.9 12.1 15.7 8.6 8.1 11.8 11.9 13.8 12.2 11.3 12.5 13.2 22.1 12.8 30.7 32.3 13.7 29.7 24.4 10.3 24.5 31.9 16.4 17.0 19.8 40.0 21.0 18.4 22.9 9.8 36.1 26.9 9.8 31.9 208.7 78.3 46.7 24.0 33.7 82.0 49.2 81.9 7.2 27.3 48.4 111.2 44.2 14.6 18.9 58.6 7.5 32.0 61.0 38.8 10.2 16.0 31.8 477.6 23.6 25.2 23.2 30.0 15.5 29.0 23.7 51.8 56.4 57.6 23.1 28.6 28.1 41.1 27.0 26.5 28.5 45.0 26.3 46.3 24.5 25.8 29.1 36.3 32.4 6.7 28.4 90.8 50.2 44.6 EMX2 ENSG00000170370 "Empty spiracles homeobox 2" Q04743 10 117542445-117549546 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 79.0;epididymis: 104.3" "Cell type enhanced" "Detected in many" "Collecting duct cells: 239.1;Distal tubular cells: 90.1;Endometrial ciliated cells: 75.6;Endometrial stromal cells: 126.5;Glandular and luminal cells: 68.6;Granulosa cells: 88.3;Proximal tubular cells: 185.0" "Group enriched" "Detected in many" 13 "endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 25.4;fHDF/TERT166: 31.6;RPTEC TERT1: 31.1;RT4: 9.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 13.3;basal ganglia: 14.2;cerebral cortex: 17.8;hippocampal formation: 22.8;white matter: 8.1" "HPA003497, HPA065294" Enhanced Supported Approved Nucleoplasm NA NA "Cluster 42: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "HPA003497: , HPA065294: AB_2685455" "unprognostic (1.53e-1)" "prognostic favorable (2.80e-4)" "unprognostic (7.21e-3)" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (3.53e-2)" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (7.33e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "prognostic favorable (2.28e-13)" "unprognostic (3.65e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.88e-2)" 10.4 0.1 23.2 0.2 25.6 0.2 2.8 16.9 31.3 58.2 16.7 0.4 0.1 79.0 104.3 0.4 53.0 1.5 0.8 26.9 16.5 39.1 0.1 0.1 0.6 15.8 18.0 11.9 0.0 0.1 1.8 0.4 16.4 1.1 0.1 0.3 2.4 52.6 10.8 10.5 0.1 45.0 14.7 0.2 0.1 1.2 19.6 0.1 0.3 5.2 0.4 4.7 4.4 22.9 0.0 0.0 0.0 2.6 0.0 0.3 0.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 25.4 31.6 0.0 0.1 0.6 0.0 0.0 0.1 2.8 0.8 0.1 0.2 0.0 0.1 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 6.1 0.2 31.1 9.4 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 2.6 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 23.2 25.6 16.9 31.3 26.9 16.5 15.8 18.0 16.4 14.7 19.6 22.9 4.6 0.0 0.0 43.4 1.0 10.7 2.0 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.0 239.1 0.0 0.2 0.0 0.1 90.1 0.0 1.4 75.6 126.5 3.1 0.0 0.0 0.1 0.0 0.3 18.0 0.0 68.6 0.0 88.3 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 8.0 2.6 60.3 2.5 21.4 1.9 0.0 0.0 0.0 1.5 0.1 0.0 0.0 41.0 0.0 2.5 0.1 185.0 0.0 0.1 52.6 8.6 32.1 0.3 0.3 0.0 7.5 0.1 2.2 2.2 0.3 1.7 RAB11FIP2 "KIAA0941, nRip11, Rab11-FIP2" ENSG00000107560 "RAB11 family interacting protein 2" Q7L804 10 118004916-118046941 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037726 Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" Vesicles Nucleoplasm "HPA037726: AB_10672390" "unprognostic (1.97e-1)" "unprognostic (1.68e-2)" "unprognostic (3.61e-1)" "unprognostic (4.45e-2)" "unprognostic (1.30e-1)" "unprognostic (5.58e-2)" "unprognostic (2.17e-2)" "unprognostic (3.34e-2)" "unprognostic (1.83e-2)" "unprognostic (2.15e-1)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "prognostic favorable (9.69e-5)" "unprognostic (1.17e-1)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (2.17e-1)" 8.6 6.6 5.2 6.6 7.0 13.8 6.9 4.8 8.5 10.2 2.4 8.2 3.6 18.8 28.5 6.3 11.8 8.3 6.1 7.1 3.4 12.2 5.4 7.6 6.9 2.8 4.6 9.9 5.6 6.3 4.3 8.2 2.2 10.8 4.9 10.3 4.8 24.7 5.0 5.9 5.5 19.5 3.7 6.6 17.2 7.8 5.3 6.2 11.4 7.5 5.5 7.6 6.2 6.1 7.1 8.8 7.3 9.3 11.9 15.0 7.8 13.8 15.8 8.3 8.6 7.4 7.4 14.5 10.8 14.0 6.1 4.8 10.1 6.1 12.8 3.8 10.9 5.1 9.1 5.1 17.2 9.7 5.5 14.8 11.3 11.6 25.4 11.0 5.1 9.3 3.9 12.1 10.9 2.5 7.5 7.3 6.2 3.1 6.2 6.4 26.0 4.9 12.4 5.6 1.7 13.5 9.8 3.9 17.3 8.7 3.0 8.9 7.7 11.2 8.9 13.3 13.8 8.9 7.8 9.4 11.5 16.4 7.0 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.2 0.1 0.4 0.4 0.2 0.3 0.1 0.1 0.5 0.1 0.0 5.2 7.0 4.8 8.5 7.1 3.4 2.8 4.6 2.2 3.7 5.3 6.1 16.7 57.7 31.5 79.7 17.7 10.3 8.8 4.4 12.5 28.1 10.1 10.7 25.8 24.3 6.0 42.3 29.2 11.6 15.1 5.5 7.9 12.6 16.5 13.1 31.0 14.1 14.5 17.4 63.8 18.7 7.9 29.1 14.8 15.7 3.8 28.0 11.4 8.6 11.4 38.7 57.9 6.6 4.1 23.0 12.2 6.6 33.5 16.2 23.2 34.7 19.4 26.0 15.5 53.8 82.9 16.6 4.7 28.6 17.0 11.1 5.4 18.1 7.3 31.4 26.3 34.0 25.8 14.9 21.2 9.2 9.5 5.2 12.9 19.2 6.5 6.4 FAM204A "bA319I23.1, C10orf84, FLJ13188" ENSG00000165669 "Family with sequence similarity 204 member A" Q9H8W3 10 118297925-118342328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038182, HPA062025" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA038182: AB_10669519, HPA062025: AB_2684663" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (8.52e-3)" "unprognostic (4.47e-2)" "unprognostic (2.42e-2)" "unprognostic (2.13e-2)" "unprognostic (9.68e-2)" "unprognostic (1.32e-1)" "unprognostic (3.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (8.59e-4)" "unprognostic (5.55e-2)" "unprognostic (8.33e-2)" "unprognostic (1.22e-1)" "unprognostic (6.76e-3)" 27.9 19.3 15.7 22.5 16.9 54.4 31.4 13.4 23.6 22.2 11.5 27.5 20.9 26.6 32.2 26.1 20.0 21.8 35.3 17.1 16.1 27.7 29.0 25.0 27.4 15.8 14.8 28.4 24.8 30.3 14.1 20.9 14.8 20.7 24.1 15.9 25.3 22.1 36.7 18.7 18.5 26.5 15.0 24.8 21.7 49.2 16.0 28.4 29.3 27.6 27.9 25.8 17.1 15.8 56.4 24.9 40.2 56.2 39.1 42.4 22.8 43.6 81.4 61.6 55.4 29.4 51.2 39.7 26.3 47.2 27.7 47.3 34.0 45.5 55.6 62.8 42.0 33.0 23.4 26.2 58.4 86.7 44.9 29.4 54.8 45.3 94.3 51.7 53.3 50.2 35.3 45.5 51.6 31.5 53.6 80.1 28.6 24.7 22.0 45.2 77.7 29.3 56.0 28.2 25.8 40.5 29.9 27.7 66.8 19.6 44.0 61.7 37.4 32.2 30.1 28.8 67.4 32.4 31.0 57.0 62.8 92.2 33.3 73.5 57.5 70.4 36.9 64.2 39.0 50.6 41.8 34.4 59.6 35.2 35.6 41.8 32.0 34.4 69.3 43.0 51.5 57.1 15.7 16.9 13.4 23.6 17.1 16.1 15.8 14.8 14.8 15.0 16.0 15.8 71.9 60.9 55.7 54.5 66.0 55.6 63.0 60.9 63.7 38.8 61.0 67.4 78.6 52.9 47.3 44.1 73.0 39.5 84.8 30.2 135.0 85.5 255.8 62.5 79.4 67.8 41.9 59.5 49.9 113.7 49.8 72.4 41.8 60.3 68.4 140.6 64.6 49.8 62.4 33.7 48.3 56.0 63.1 69.4 76.2 132.0 76.4 73.0 60.5 27.2 77.2 62.5 92.7 53.3 45.4 95.3 68.9 70.0 62.9 54.6 35.4 115.7 44.2 55.4 26.3 73.7 78.3 258.5 170.3 55.6 50.6 30.6 62.8 62.6 48.4 61.6 PRLHR "GPR10, PrRPR" ENSG00000119973 "Prolactin releasing hormone receptor" P49683 10 118589997-118595648 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.2;brain: 12.7;pituitary gland: 6.9" "Group enriched" "Detected in some" 4 "Granulosa cells: 7.7;Horizontal cells: 13.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 1.7" "Low region specificity" "Detected in many" HPA039361 Enhanced NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 40: Granulosa cells - Unknown function" "HPA039361: AB_10673527" "unprognostic (1.83e-1)" "unprognostic (2.62e-3)" "unprognostic (1.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" 0.0 5.2 1.0 0.0 3.3 0.0 0.0 1.2 3.3 1.9 0.0 0.0 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.3 6.3 0.0 0.0 0.0 0.0 2.8 6.7 0.0 0.3 0.0 6.9 0.0 12.7 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.0 3.4 0.2 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.1 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 3.3 1.2 3.3 0.3 6.3 2.8 6.7 12.7 0.2 5.7 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.1 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.7 0.0 0.0 0.0 13.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 CACUL1 "C10orf46, CAC1, FLJ40409, MGC33215" ENSG00000151893 "CDK2 associated cullin domain 1" Q86Y37 10 118674167-118755249 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 237.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050611 Approved Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "HPA050611: AB_2797238" "unprognostic (1.48e-1)" "unprognostic (1.15e-2)" "unprognostic (2.83e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (1.34e-5)" "unprognostic (3.44e-2)" "unprognostic (1.84e-1)" "unprognostic (9.35e-2)" "unprognostic (1.26e-2)" "unprognostic (3.68e-2)" "unprognostic (1.68e-1)" "unprognostic (9.75e-2)" "unprognostic (8.48e-2)" "unprognostic (3.10e-2)" "unprognostic (1.54e-1)" 6.3 6.9 6.3 4.0 6.6 11.6 7.7 4.8 6.2 6.0 4.6 7.5 4.5 7.3 7.0 7.3 5.7 3.9 5.8 6.8 7.4 5.0 6.6 7.3 4.1 5.2 5.9 5.1 5.5 7.2 5.0 6.4 6.5 5.3 5.3 5.5 5.3 5.4 10.5 6.0 5.0 6.1 5.0 5.8 6.1 6.6 7.8 5.4 5.2 10.6 5.2 8.3 6.1 5.4 14.8 8.6 6.4 11.8 15.0 10.2 6.6 6.2 17.2 8.9 11.2 9.6 12.3 10.5 4.6 10.3 7.3 12.8 13.0 11.1 11.8 4.2 7.1 9.7 8.5 11.9 9.9 8.9 6.1 8.2 12.2 11.5 17.2 13.4 10.2 11.5 4.8 10.5 10.5 11.4 8.5 14.1 6.2 6.3 4.5 4.8 26.7 6.5 13.0 11.2 3.4 10.8 6.0 15.0 20.4 6.9 8.4 7.2 9.7 6.1 6.9 7.7 10.7 9.1 10.4 7.2 7.9 17.2 3.8 25.3 9.0 16.9 5.2 15.6 5.1 4.0 4.9 5.1 8.2 4.0 5.4 6.4 20.3 4.4 17.1 3.9 4.1 5.2 6.3 6.6 4.8 6.2 6.8 7.4 5.2 5.9 6.5 5.0 7.8 5.4 29.6 60.9 21.7 58.8 42.7 74.8 30.5 38.5 50.1 33.6 58.3 34.9 44.8 45.8 27.8 36.8 73.0 73.4 39.2 32.5 23.5 52.4 237.7 53.3 24.7 36.8 68.6 37.0 65.8 59.4 33.4 34.7 18.8 46.9 15.8 68.7 33.2 27.4 46.5 92.5 64.7 34.0 34.6 77.6 127.6 36.1 29.5 56.7 28.4 49.6 59.4 40.9 34.0 40.2 62.5 50.0 26.5 24.0 24.4 56.5 28.2 43.2 36.7 50.1 13.1 52.1 32.3 81.4 83.8 43.2 78.8 102.3 32.8 29.0 41.7 74.7 NANOS1 "NOS1, ZC2HC12A" ENSG00000188613 "Nanos C2HC-type zinc finger 1" Q8WY41 10 119029714-119033730 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 10.2;Cardiomyocytes: 11.3;Cone photoreceptor cells: 10.4;Muller glia cells: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 80.4;SK-BR-3: 46.7;SK-MEL-30: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB012219 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "CAB012219: " "prognostic unfavorable (1.52e-4)" "unprognostic (1.17e-1)" "unprognostic (1.50e-3)" "unprognostic (1.59e-3)" "unprognostic (7.07e-3)" "unprognostic (2.01e-1)" "unprognostic (2.19e-2)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (2.70e-1)" "unprognostic (8.22e-3)" "unprognostic (8.79e-2)" "unprognostic (2.64e-4)" "unprognostic (7.89e-2)" "unprognostic (6.99e-2)" "unprognostic (2.78e-2)" "unprognostic (2.52e-3)" 9.5 11.3 7.4 0.3 7.3 0.2 8.3 7.4 7.7 1.9 5.0 2.9 0.3 2.1 1.7 1.0 1.0 0.2 10.3 5.9 11.8 4.6 0.3 1.1 0.4 8.8 8.9 0.3 2.2 0.3 2.8 6.3 8.5 1.0 0.4 4.1 1.3 0.9 38.6 1.6 0.9 1.8 7.1 0.3 3.4 1.9 9.2 0.3 7.1 1.7 0.3 3.3 1.0 10.9 16.4 1.3 2.2 0.4 7.4 1.1 9.7 0.4 0.5 0.4 0.2 2.0 5.6 8.7 2.2 0.1 0.0 5.8 2.7 2.9 0.7 2.6 6.6 0.2 3.8 1.8 3.5 1.0 0.0 1.5 11.7 0.1 1.6 2.4 0.4 3.0 1.7 1.0 0.5 2.3 2.2 2.8 7.1 3.4 1.3 0.0 2.7 5.9 3.1 1.3 6.3 80.4 4.7 46.7 37.4 12.2 7.4 4.7 0.5 0.0 3.4 0.1 0.8 2.4 8.6 3.2 0.7 2.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 7.4 7.3 7.4 7.7 5.9 11.8 8.8 8.9 8.5 7.1 9.2 10.9 5.7 6.4 1.1 2.0 1.3 0.8 5.0 1.3 0.6 4.1 10.2 6.1 11.3 1.5 1.2 1.8 10.4 6.5 6.3 4.4 0.0 0.6 0.2 3.9 2.8 1.7 3.0 0.0 0.5 0.2 0.4 4.0 1.1 3.7 0.0 2.6 0.7 0.1 0.7 1.7 2.3 3.8 0.0 0.0 2.1 0.1 1.8 0.9 0.0 0.0 0.0 14.7 1.0 2.0 0.2 0.3 0.1 0.7 1.6 2.9 0.2 0.5 1.2 2.1 0.0 7.7 3.9 0.4 1.0 0.8 1.3 1.0 2.9 0.7 2.1 1.3 EIF3A "EIF3, eIF3-p170, eIF3-theta, EIF3S10, KIAA0139, TIF32" ENSG00000107581 "Eukaryotic translation initiation factor 3 subunit A" Q14152 10 119033670-119080823 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038315, HPA038316" Enhanced Supported Nucleoplasm,Cytosol Yes No 110000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 32: U-937 - Innate immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "HPA038315: AB_10672588, HPA038316: AB_10673168" "unprognostic (8.15e-2)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "unprognostic (3.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.16e-1)" "unprognostic (1.84e-1)" "unprognostic (9.38e-2)" "unprognostic (3.84e-3)" "unprognostic (9.07e-2)" "unprognostic (5.48e-3)" "unprognostic (8.07e-2)" "unprognostic (1.20e-1)" "unprognostic (9.07e-2)" "unprognostic (1.89e-2)" 83.0 53.2 27.5 73.7 30.9 120.7 62.5 28.4 31.8 48.8 38.0 62.9 65.8 60.1 34.9 69.3 44.8 50.1 69.0 25.7 33.7 58.1 77.9 49.5 75.1 34.8 30.0 61.7 155.1 70.2 24.4 57.0 35.4 55.5 63.9 31.6 73.3 46.3 178.2 69.9 60.0 62.8 31.6 57.4 72.8 44.8 32.4 78.3 70.3 89.8 74.6 76.4 51.8 32.4 258.5 190.9 154.0 211.6 163.6 235.0 119.4 228.9 235.9 144.0 143.7 181.2 165.5 300.2 83.2 190.3 113.3 252.0 202.5 175.7 203.5 166.1 166.3 258.3 143.6 203.2 186.2 382.3 183.9 204.6 193.0 212.7 362.8 240.7 165.7 119.8 269.7 191.9 188.7 152.5 159.4 179.8 147.8 99.4 96.3 162.1 332.1 143.7 137.0 213.9 71.6 151.3 180.2 166.9 244.9 132.0 107.2 241.1 245.6 138.7 128.0 147.1 335.8 164.9 194.0 286.9 147.2 368.2 97.6 49.0 38.2 23.9 27.4 41.8 31.7 25.6 33.1 25.2 36.1 24.7 22.6 24.7 10.0 26.6 58.1 20.5 50.9 28.3 27.5 30.9 28.4 31.8 25.7 33.7 34.8 30.0 35.4 31.6 32.4 32.4 122.1 233.9 323.8 24.5 147.3 304.2 279.1 129.0 203.7 60.1 155.8 133.7 320.7 111.5 198.5 64.4 62.6 169.1 181.1 130.2 27.4 157.2 199.4 230.3 248.6 145.3 141.2 270.0 32.7 185.4 159.5 152.5 159.0 371.8 145.4 132.6 74.3 184.5 126.3 43.7 34.9 168.2 87.5 200.3 169.0 119.1 108.7 196.5 147.7 29.0 235.9 78.2 135.9 24.6 38.9 192.8 105.4 117.8 258.6 253.6 98.5 58.7 158.3 54.1 59.2 209.7 221.6 158.0 112.9 255.3 363.8 252.3 171.1 145.0 227.7 302.3 DENND10 FAM45A ENSG00000119979 "DENN domain containing 10" Q8TCE6 10 119104086-119137984 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 36.5;Cytotrophoblasts: 53.8;Extravillous trophoblasts: 27.7;Hofbauer cells: 56.0;Syncytiotrophoblasts: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041159 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane, Centrosome, Cytosol" "HPA041159: AB_10793871" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (2.73e-2)" "unprognostic (1.90e-1)" "unprognostic (3.12e-1)" "unprognostic (1.88e-2)" "unprognostic (2.13e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-2)" "unprognostic (4.46e-2)" "unprognostic (2.64e-2)" "unprognostic (6.68e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.20e-2)" 16.7 14.3 18.7 14.0 20.2 32.4 14.0 18.7 23.6 14.2 17.4 17.9 12.6 13.3 16.7 20.5 11.4 12.7 15.5 18.8 19.2 26.1 31.1 12.6 13.1 19.8 18.9 20.9 9.4 18.0 2.9 15.6 19.8 13.4 14.4 10.6 10.9 10.6 17.6 18.7 15.2 13.2 19.8 14.1 14.2 7.3 19.3 13.1 19.9 11.1 14.6 14.8 9.3 21.7 23.7 24.9 38.6 45.5 75.9 59.1 15.9 32.3 85.9 29.4 30.1 23.7 35.8 16.1 12.8 41.4 33.8 42.2 25.7 28.0 27.0 29.2 24.1 3.8 11.5 32.9 75.4 11.0 10.3 63.7 31.5 20.9 32.6 75.0 36.1 16.8 7.8 22.9 42.0 20.0 17.2 48.5 23.6 22.1 14.6 17.0 40.6 14.3 38.6 25.9 6.9 27.7 21.7 30.2 67.5 36.1 24.9 48.5 36.6 23.3 12.3 28.9 19.4 23.0 10.0 17.7 35.9 54.7 11.2 44.9 26.6 55.6 6.9 31.8 6.6 3.9 10.9 10.0 16.6 3.6 5.7 7.1 40.0 6.1 36.4 5.0 20.4 11.6 18.7 20.2 18.7 23.6 18.8 19.2 19.8 18.9 19.8 19.8 19.3 21.7 9.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.5 0.0 0.0 0.0 0.0 53.8 11.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 27.7 9.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 45.3 1.7 0.0 0.0 0.0 SFXN4 SLC56A4 ENSG00000183605 "Sideroflexin 4" Q6P4A7 10 119140767-119165714 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018028, HPA020872" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Mitochondria" Vesicles "HPA018028: AB_1856792, HPA020872: AB_1856793" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (3.61e-1)" "unprognostic (1.12e-1)" "unprognostic (1.27e-2)" "unprognostic (9.49e-2)" "unprognostic (1.59e-2)" "unprognostic (1.72e-1)" "unprognostic (6.84e-2)" "unprognostic (4.56e-2)" "unprognostic (8.58e-2)" "unprognostic (2.94e-2)" "unprognostic (1.70e-3)" "unprognostic (4.22e-3)" "unprognostic (1.43e-1)" "unprognostic (6.21e-3)" "unprognostic (3.07e-3)" 13.3 35.9 9.9 10.1 12.5 16.4 14.1 12.8 13.6 14.2 17.0 21.9 20.4 11.1 13.5 19.1 14.3 8.6 33.1 10.2 12.4 24.5 36.4 8.5 14.4 11.3 12.5 16.0 33.7 23.1 21.5 8.8 11.6 18.8 22.7 5.7 27.8 13.2 51.4 11.5 17.3 12.2 10.6 20.9 17.3 11.9 11.3 11.0 24.7 59.3 17.8 16.4 13.8 12.5 26.2 27.6 8.7 41.8 10.4 19.7 33.0 16.3 19.8 21.0 21.8 45.9 43.2 62.6 15.6 14.9 22.4 48.2 57.5 36.3 24.3 33.1 65.7 28.7 18.4 47.3 37.1 49.7 28.8 21.1 34.4 22.0 63.8 19.5 25.0 46.5 45.2 17.5 13.6 29.6 53.8 60.4 11.8 50.2 32.5 51.7 27.1 49.0 24.3 17.3 25.2 13.9 10.8 42.2 61.9 11.1 26.0 28.4 11.5 10.6 21.9 19.8 37.6 42.6 53.0 56.3 16.2 72.6 7.2 2.5 18.1 1.9 6.5 19.5 10.8 12.5 7.9 7.1 21.2 7.0 12.1 9.8 2.2 7.3 15.9 10.6 6.0 11.1 9.9 12.5 12.8 13.6 10.2 12.4 11.3 12.5 11.6 10.6 11.3 12.5 8.0 6.4 5.6 29.0 16.9 12.0 25.8 39.9 23.3 7.9 17.8 18.2 36.2 12.8 19.1 14.7 2.1 37.6 6.2 13.2 58.7 28.4 27.4 7.6 8.9 8.4 18.0 33.6 22.3 23.8 25.8 12.4 14.3 7.9 5.7 28.5 7.1 31.5 29.2 6.7 29.1 24.7 30.5 17.6 5.0 69.3 8.7 13.1 12.4 8.4 11.3 7.7 10.3 22.1 19.5 17.6 12.1 13.5 31.9 28.0 29.8 65.6 13.5 11.3 6.6 22.3 10.6 27.7 15.2 26.9 9.1 21.9 9.2 44.5 45.8 20.5 PRDX3 "AOP-1, AOP1, MER5, SP-22" ENSG00000165672 "Peroxiredoxin 3" P30048 10 119167720-119178812 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 1060.4;Proximal tubular cells: 937.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008656, HPA041488, CAB079909" Enhanced Supported Mitochondria NA NA 1600000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "CAB008656: AB_1620979, CAB079909: AB_2809998, HPA041488: AB_2677508" "unprognostic (8.29e-2)" "unprognostic (1.02e-1)" "unprognostic (1.26e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (1.72e-3)" "unprognostic (4.62e-3)" "unprognostic (2.40e-1)" "unprognostic (2.06e-1)" "unprognostic (3.65e-2)" "unprognostic (1.29e-2)" "unprognostic (9.48e-2)" "unprognostic (6.03e-3)" "unprognostic (2.77e-1)" "unprognostic (2.77e-1)" "unprognostic (2.27e-1)" "unprognostic (1.21e-1)" 165.7 335.3 92.4 96.0 92.6 82.3 138.3 101.3 116.0 103.4 139.2 133.3 137.8 87.0 120.8 83.3 116.7 88.0 278.2 95.2 104.5 385.7 571.2 74.9 108.4 97.2 97.1 74.9 96.2 223.8 60.0 126.3 99.0 126.7 139.8 52.5 132.1 131.7 376.0 38.0 132.1 130.0 100.4 76.3 97.5 48.3 98.6 98.3 176.7 402.7 104.0 112.8 65.1 102.7 350.6 392.2 234.1 267.3 241.7 259.8 145.9 244.8 414.8 364.5 380.7 303.4 339.9 407.2 208.8 290.8 173.4 155.5 391.5 296.1 408.8 401.5 411.4 183.7 149.7 542.4 252.5 347.8 212.7 306.8 186.4 292.1 269.7 261.2 268.6 245.2 230.0 82.5 338.7 140.2 265.1 292.7 218.9 264.0 229.3 276.5 339.7 281.5 623.8 164.6 103.0 149.2 259.8 346.1 332.2 201.0 179.6 411.5 190.5 118.3 178.1 170.9 323.1 128.0 200.7 327.0 185.7 507.4 107.3 144.4 429.1 246.9 110.5 369.5 142.7 179.9 145.6 134.6 382.1 149.8 149.5 134.0 239.9 132.8 333.9 214.8 205.7 510.2 92.4 92.6 101.3 116.0 95.2 104.5 97.2 97.1 99.0 100.4 98.6 102.7 61.4 48.1 74.5 14.4 65.1 69.8 117.8 274.0 81.4 27.5 145.2 105.2 236.5 131.5 119.0 147.1 10.4 328.4 50.6 84.5 1060.4 124.5 5.0 105.1 76.0 78.3 110.9 132.8 15.4 75.1 212.0 100.8 116.7 77.3 52.6 131.0 73.2 390.0 247.6 40.4 15.4 132.5 221.8 164.2 96.0 10.5 77.3 127.9 133.4 10.3 158.4 76.9 39.1 12.5 18.8 63.8 99.3 101.2 153.7 95.1 176.1 937.8 163.4 24.8 72.3 63.1 105.3 11.2 23.2 146.4 52.6 155.0 56.1 440.0 207.0 119.6 GRK5 GPRK5 ENSG00000198873 "G protein-coupled receptor kinase 5" P34947 10 119207571-119459745 "Enzymes, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Microglial cells: 56.2;Sertoli cells: 59.2;Smooth muscle cells: 46.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 32.1;HUVEC TERT2: 24.9;OE19: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025579, HPA046838" Approved Supported "Nuclear membrane,Nuclear speckles,Plasma membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 50: Fibroblasts - ECM organization" "Nuclear membrane, Nuclear speckles" "Plasma membrane" "CAB025579: , HPA046838: AB_2679833" "unprognostic (1.09e-1)" "unprognostic (3.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.02e-2)" "unprognostic (6.56e-2)" "unprognostic (3.74e-2)" "unprognostic (4.62e-2)" "unprognostic (3.69e-1)" "unprognostic (4.11e-1)" "unprognostic (1.06e-1)" "unprognostic (3.70e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (2.38e-7)" "unprognostic (1.10e-1)" "unprognostic (3.27e-2)" "unprognostic (1.55e-2)" "unprognostic (1.90e-2)" 38.4 18.0 4.2 5.9 5.0 2.7 24.6 5.0 4.6 18.8 3.5 26.3 10.0 21.1 3.5 12.6 19.6 5.7 48.8 4.0 5.1 14.2 12.9 65.6 7.8 3.9 3.6 35.0 4.7 21.3 13.3 8.3 3.9 14.1 4.9 1.0 7.8 4.0 11.9 11.5 25.8 7.3 3.3 37.0 27.5 4.1 4.9 6.2 19.6 9.7 6.8 19.4 18.1 3.5 3.7 2.3 5.4 5.7 11.8 11.0 1.6 7.1 32.1 4.1 2.3 1.7 5.4 3.9 1.6 11.1 7.5 0.9 2.3 7.7 2.7 15.4 2.0 0.7 4.6 7.0 8.2 0.2 2.0 1.5 1.1 8.5 1.2 5.2 24.9 2.4 0.4 3.7 1.5 0.7 3.8 3.5 0.8 25.8 5.2 1.3 0.8 0.9 0.6 1.5 1.8 4.9 2.4 1.1 7.0 3.0 0.1 0.9 7.8 2.3 1.6 14.6 2.8 0.9 4.4 2.4 4.9 4.4 2.4 0.4 1.5 2.9 2.0 1.4 0.1 3.8 3.0 1.6 0.9 4.0 4.5 2.0 2.1 0.1 0.5 0.0 4.0 1.7 4.2 5.0 5.0 4.6 4.0 5.1 3.9 3.6 3.9 3.3 4.9 3.5 32.6 57.7 3.7 3.6 19.7 1.7 0.7 0.5 1.2 3.9 2.3 2.0 19.4 0.0 1.3 3.7 0.0 3.7 13.3 0.4 0.0 1.1 18.7 0.4 5.1 28.4 4.8 0.0 17.7 3.1 15.8 35.7 18.8 1.0 4.5 7.8 24.7 2.2 4.4 1.7 36.5 0.8 6.1 15.5 6.3 4.9 4.4 14.2 7.2 56.2 3.6 0.0 19.6 14.1 5.7 2.4 1.2 4.5 10.2 0.7 4.9 0.6 0.8 0.9 59.2 18.2 46.5 1.3 2.1 0.7 2.4 13.1 14.1 4.6 0.5 0.9 RGS10 ENSG00000148908 "Regulator of G protein signaling 10" O43665 10 119499817-119542719 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 222.9" "Cell type enhanced" "Detected in many" "granulocytes: 291.2;Hofbauer cells: 528.1;Kupffer cells: 297.2;Langerhans cells: 358.3;Macrophages: 529.3;monocytes: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 474.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004559, HPA021305, HPA058485" Enhanced Supported Supported "Nucleoplasm,Plasma membrane" NA NA 840000 "Cluster 32: T-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Plasma membrane" "CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732" "unprognostic (1.64e-2)" "prognostic favorable (6.81e-4)" "unprognostic (7.98e-2)" "prognostic favorable (6.32e-4)" "unprognostic (5.21e-2)" "unprognostic (6.19e-2)" "unprognostic (4.32e-3)" "unprognostic (6.35e-2)" "unprognostic (9.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.20e-10)" "unprognostic (2.50e-1)" "unprognostic (9.20e-2)" "unprognostic (7.70e-2)" "unprognostic (7.92e-3)" 25.1 20.6 20.0 59.3 20.2 74.5 40.7 22.3 30.4 63.9 22.3 114.3 34.2 38.5 15.8 51.5 28.5 38.3 13.4 20.7 24.5 18.8 11.4 28.1 119.0 28.6 24.5 22.5 7.0 6.9 13.8 45.6 28.9 43.2 49.7 2.6 41.0 20.3 31.5 22.9 58.3 42.8 26.1 48.7 30.0 4.9 26.1 222.9 33.0 11.6 96.5 50.3 45.8 37.2 165.2 31.2 2.4 294.7 41.4 262.6 25.9 74.9 118.1 45.3 73.5 9.8 38.7 66.8 38.1 60.9 45.7 35.4 44.3 48.2 123.8 32.0 42.8 183.1 8.9 24.2 63.1 40.0 474.0 100.7 63.1 88.3 84.4 159.4 88.2 65.4 47.6 58.5 55.0 79.2 221.9 134.8 13.5 21.2 71.1 43.8 0.3 26.1 24.7 40.4 10.8 9.3 14.4 192.6 285.3 36.3 35.1 71.7 108.3 25.4 21.9 36.1 67.8 2.7 46.0 27.0 7.6 166.5 11.4 184.8 116.0 1.4 77.9 151.4 82.9 36.0 169.6 134.9 224.3 21.7 397.5 303.3 52.5 44.3 130.4 133.2 202.3 372.5 20.0 20.2 22.3 30.4 20.7 24.5 28.6 24.5 28.9 26.1 26.1 37.2 10.4 0.0 13.1 2.6 60.3 36.8 25.7 104.5 27.9 0.2 68.9 96.6 1.1 1.5 39.7 1.8 0.0 14.0 70.1 7.1 60.7 0.8 2.1 89.8 25.1 12.7 18.7 156.6 0.2 6.4 34.8 68.6 11.2 53.6 291.2 101.2 13.2 1.5 528.1 0.0 1.8 85.7 32.6 297.2 358.3 5.1 50.1 529.3 94.3 67.5 294.5 1.8 50.4 0.5 0.2 9.9 10.0 9.4 32.1 88.8 3.3 5.2 24.6 0.8 13.1 14.4 31.8 0.3 9.3 39.6 28.1 10.1 164.7 3.5 19.3 41.4 TIAL1 TIAR ENSG00000151923 "TIA1 cytotoxic granule associated RNA binding protein like 1" Q01085 10 119571802-119597029 "Predicted intracellular proteins" Apoptosis RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060962 Approved Nucleoplasm,Vesicles NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 59: Non-specific - Translation" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Vesicles" "HPA060962: " "unprognostic (1.61e-2)" "unprognostic (9.30e-2)" "unprognostic (1.26e-1)" "unprognostic (3.76e-1)" "unprognostic (5.33e-2)" "unprognostic (3.91e-2)" "prognostic unfavorable (7.81e-6)" "unprognostic (5.54e-2)" "unprognostic (9.21e-2)" "unprognostic (3.89e-3)" "unprognostic (3.74e-1)" "unprognostic (1.32e-3)" "unprognostic (6.48e-3)" "unprognostic (6.35e-2)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (2.26e-2)" 32.2 29.7 14.3 26.8 18.3 49.0 31.3 27.5 20.2 32.2 16.7 33.2 23.9 43.6 37.4 46.1 29.8 28.7 31.5 13.0 15.7 29.9 34.1 30.6 40.1 15.8 15.3 35.3 36.3 28.2 28.3 32.5 16.9 27.1 27.8 29.6 34.9 18.6 58.1 35.3 35.8 25.6 14.7 35.1 35.0 32.6 15.4 25.0 32.0 21.7 27.6 29.3 34.2 24.5 50.0 26.8 68.9 83.5 35.8 53.9 34.0 46.1 46.1 31.7 36.5 22.1 51.1 48.2 29.4 31.6 24.9 53.8 42.3 25.0 42.9 63.5 34.1 30.4 47.1 36.6 29.2 57.5 52.3 41.1 30.3 30.5 76.1 137.9 41.6 32.9 23.2 47.7 33.3 15.2 62.2 60.5 37.9 29.5 24.3 43.9 52.2 35.2 43.3 26.7 19.3 32.8 39.2 35.0 40.4 35.1 30.9 29.5 38.9 34.9 25.2 35.6 47.2 35.5 62.3 48.4 31.7 57.9 27.1 2.5 2.5 2.4 3.8 2.3 4.2 3.2 4.3 3.7 2.5 2.8 4.5 4.8 2.5 4.5 3.0 4.1 4.6 1.9 14.3 18.3 27.5 20.2 13.0 15.7 15.8 15.3 16.9 14.7 15.4 24.5 64.6 44.8 60.1 24.5 72.7 63.6 75.8 54.0 66.6 55.7 52.7 53.1 37.9 42.9 54.7 23.9 31.3 66.0 87.3 54.6 46.9 54.4 13.7 45.2 69.1 58.5 52.7 90.7 37.7 54.7 108.3 57.8 48.9 53.3 35.4 73.7 57.1 49.6 58.4 45.4 50.6 46.5 30.5 57.0 46.4 8.2 61.2 61.3 37.4 38.4 79.7 49.3 61.8 54.8 91.9 70.0 43.4 45.1 73.7 99.1 49.5 48.0 40.7 48.9 52.6 53.9 63.6 62.9 49.1 72.6 64.2 77.4 80.6 53.6 53.8 94.2 BAG3 ENSG00000151929 "BAG cochaperone 3" O95817 10 119651380-119677819 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis Chaperone "Cardiomyopathy, Disease variant, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 349.1;skeletal muscle: 514.4" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 882.2;Basal squamous epithelial cells: 414.9;Squamous epithelial cells: 370.2;Urothelial cells: 488.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 4.1" "Lineage enriched" "Detected in single" 6 "T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018493, HPA020586" Enhanced Supported Cytosol NA NA 460000 "Cluster 32: T-cells - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "HPA018493: AB_1845257, HPA020586: AB_1845258" "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (2.12e-2)" "unprognostic (1.17e-1)" "unprognostic (2.82e-2)" "unprognostic (5.31e-3)" "unprognostic (4.51e-3)" "unprognostic (3.32e-2)" "unprognostic (1.98e-2)" "unprognostic (1.46e-2)" "unprognostic (1.30e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-3)" "unprognostic (4.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.46e-2)" "unprognostic (3.03e-2)" 73.5 40.3 81.6 16.1 80.6 5.1 40.5 96.9 349.1 41.7 61.3 72.4 12.3 45.2 20.4 86.0 37.7 35.1 153.3 82.1 124.3 42.2 38.4 77.9 8.2 127.2 100.2 33.3 20.5 53.6 36.6 36.0 101.3 39.1 12.6 12.6 50.1 24.5 514.4 61.9 25.9 43.3 106.3 15.9 72.4 23.1 84.1 5.7 31.1 187.8 17.3 60.4 55.3 95.5 100.1 111.2 30.5 39.6 77.2 53.9 56.9 89.1 74.7 66.6 56.8 47.5 47.6 3.8 41.4 76.9 86.6 145.2 31.5 157.2 45.7 49.1 51.8 5.4 28.6 60.1 65.2 0.3 22.1 54.6 89.0 48.6 76.2 70.5 75.5 17.1 43.3 24.0 67.2 142.7 5.5 22.3 12.0 33.1 125.8 0.3 43.2 17.2 50.7 22.3 5.6 5.1 35.4 61.9 47.2 32.9 38.8 13.4 94.8 35.0 30.1 47.8 129.5 22.1 14.0 2.4 65.2 1.5 27.1 0.0 0.6 0.0 0.6 0.7 1.1 0.1 2.4 0.8 0.4 0.0 4.1 1.4 0.2 0.1 0.3 0.1 1.7 0.6 81.6 80.6 96.9 349.1 82.1 124.3 127.2 100.2 101.3 106.3 84.1 95.5 77.8 22.4 43.2 34.9 10.9 79.4 882.2 51.0 414.9 6.1 48.3 62.9 196.0 18.6 48.1 7.3 18.8 41.4 4.9 61.7 27.4 19.4 29.3 56.7 60.0 107.0 38.5 0.8 1.3 25.3 57.0 142.7 51.5 89.1 23.6 7.3 22.5 15.3 33.7 1.7 2.5 87.0 46.8 8.7 95.4 32.8 22.4 146.9 55.2 10.3 4.7 32.6 3.1 1.0 1.2 37.3 69.2 24.0 29.5 225.1 8.3 42.8 39.4 1.7 19.7 141.6 134.3 21.8 18.7 370.2 76.1 73.5 85.6 10.0 53.9 488.1 INPP5F "hSac2, KIAA0966, SAC2" ENSG00000198825 "Inositol polyphosphate-5-phosphatase F" Q9Y2H2 10 119726042-119829147 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 135.3" "Cell type enhanced" "Detected in all" "Excitatory neurons: 79.5;Inhibitory neurons: 130.5;Late spermatids: 88.6;Oligodendrocytes: 70.5" "Cancer enhanced" "Detected in all" "testis cancer: 27.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 91.4;SK-MEL-30: 149.0;SuSa: 181.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042605 Supported Vesicles NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA042605: AB_10793886" "unprognostic (2.65e-2)" "unprognostic (3.23e-1)" "unprognostic (3.42e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-2)" "unprognostic (1.57e-3)" "unprognostic (2.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.09e-2)" "unprognostic (2.09e-1)" "unprognostic (6.46e-2)" "unprognostic (7.78e-2)" "unprognostic (1.02e-1)" "unprognostic (9.91e-2)" "unprognostic (2.96e-2)" "unprognostic (6.21e-2)" 9.9 16.8 53.8 9.9 49.4 4.7 7.6 45.3 63.9 15.7 10.1 15.5 4.6 15.4 22.8 9.3 8.3 6.9 5.9 50.6 135.3 10.5 3.2 9.1 10.7 71.2 57.3 12.3 6.7 7.4 57.1 10.9 75.0 10.9 8.0 32.9 10.8 10.0 11.0 13.7 9.5 13.2 50.3 7.5 8.6 14.8 62.7 7.0 10.5 3.8 13.0 9.2 12.5 55.2 13.5 8.2 91.4 14.3 6.9 10.6 8.5 18.4 9.3 8.4 8.4 12.0 15.2 8.3 7.6 19.7 10.6 14.4 7.9 9.8 11.9 6.0 10.3 6.5 3.9 11.0 13.5 4.4 19.0 9.7 8.6 14.2 13.5 15.7 23.2 6.1 5.7 13.8 20.8 7.0 5.5 15.7 9.2 9.9 12.0 7.0 18.8 2.3 12.5 5.3 6.5 70.2 19.8 7.2 149.0 181.5 4.3 3.4 19.6 9.9 12.2 11.0 17.5 15.2 7.7 4.5 11.0 12.8 32.3 0.9 3.4 1.3 1.0 3.0 1.3 6.7 2.2 1.3 6.2 9.1 2.2 1.1 0.8 3.4 3.6 1.4 5.3 1.9 53.8 49.4 45.3 63.9 50.6 135.3 71.2 57.3 75.0 50.3 62.7 55.2 7.8 6.4 4.8 52.5 21.5 9.1 11.7 7.5 10.2 24.2 6.9 9.5 5.4 1.5 7.8 12.9 16.7 9.3 7.9 15.1 11.7 3.6 58.7 4.3 18.3 8.6 1.2 5.2 79.5 4.5 10.6 7.9 5.1 6.9 2.5 9.7 4.2 3.5 9.9 42.1 130.5 5.6 10.2 6.0 27.8 88.6 5.3 13.1 19.6 34.7 16.3 21.7 6.2 52.8 70.5 6.8 6.6 3.8 4.7 8.2 6.5 24.7 4.0 21.6 6.6 7.8 13.8 22.4 41.0 13.1 10.4 13.3 7.7 19.3 6.5 13.1 MCMBP "C10orf119, FLJ13081, MCM-BP" ENSG00000197771 "Minichromosome maintenance complex binding protein" Q9BTE3 10 119829404-119892556 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013792, HPA038481" Uncertain Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Cell Junctions, Cytosol" "CAB013792: , HPA038481: AB_10794620" "unprognostic (1.26e-1)" "unprognostic (7.92e-2)" "unprognostic (4.62e-2)" "unprognostic (2.31e-2)" "unprognostic (1.72e-2)" "unprognostic (4.64e-2)" "unprognostic (1.31e-3)" "unprognostic (5.61e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (7.32e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (2.23e-2)" "unprognostic (8.24e-2)" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" 30.5 14.2 9.1 16.7 10.5 10.0 26.1 12.9 11.9 23.8 9.7 25.9 13.3 26.7 10.8 25.0 23.7 12.1 18.2 9.4 10.4 16.1 18.6 24.9 18.9 11.3 10.2 22.2 17.0 16.1 11.0 25.3 11.5 15.2 16.6 12.3 20.5 13.7 30.1 25.6 19.6 18.3 11.5 19.5 20.3 11.8 9.9 20.7 17.5 15.9 19.7 25.1 24.1 12.4 54.4 28.6 49.6 40.3 24.0 27.1 27.0 49.2 55.9 62.2 63.3 42.5 32.9 69.7 20.3 34.8 20.7 46.8 65.1 46.8 74.1 46.0 50.3 34.7 20.8 38.3 35.7 71.3 80.6 24.1 25.8 47.4 60.7 27.6 38.9 37.5 35.3 43.9 41.7 28.5 77.4 52.6 33.3 34.7 26.5 49.8 104.0 30.8 29.0 30.0 25.0 28.7 32.9 33.1 39.3 33.0 20.4 50.2 34.3 26.5 24.1 29.8 56.3 36.1 37.7 71.1 35.5 46.1 16.2 9.8 2.3 1.4 2.0 4.2 2.0 2.0 2.0 1.9 3.2 0.9 2.0 2.2 3.0 1.8 2.5 1.5 1.9 1.1 9.1 10.5 12.9 11.9 9.4 10.4 11.3 10.2 11.5 11.5 9.9 12.4 39.0 16.0 16.5 11.8 26.2 42.8 35.0 12.3 24.5 11.4 18.1 14.2 18.6 25.8 15.6 20.2 4.2 40.5 35.4 23.7 13.7 11.7 4.6 18.8 31.7 38.3 10.8 25.0 14.0 13.7 52.6 27.4 12.2 26.2 18.3 18.2 26.7 25.6 38.5 32.0 17.3 20.8 12.2 35.5 35.0 6.2 30.1 35.9 23.2 15.0 34.2 18.3 26.8 17.6 25.3 15.8 11.9 22.6 28.0 32.8 15.6 18.7 12.5 18.3 19.7 32.8 27.4 42.5 68.7 29.9 42.8 39.7 31.6 12.7 29.1 29.1 SEC23IP p125 ENSG00000107651 "SEC23 interacting protein" Q9Y6Y8 10 119892730-119944657 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038403, HPA043305" Approved Enhanced Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Vesicles "HPA038403: AB_10675796, HPA043305: AB_2678416" "unprognostic (4.05e-2)" "unprognostic (5.01e-2)" "unprognostic (8.70e-2)" "unprognostic (1.35e-1)" "unprognostic (3.12e-1)" "unprognostic (1.07e-1)" "unprognostic (9.52e-3)" "unprognostic (1.78e-1)" "unprognostic (3.36e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-1)" "unprognostic (6.81e-3)" "unprognostic (3.43e-2)" 10.3 9.7 3.5 12.0 3.9 14.1 11.8 6.2 4.6 11.2 6.4 12.6 10.4 11.9 12.1 9.4 8.8 9.6 7.7 4.0 4.0 10.3 12.6 10.2 13.7 4.2 4.3 10.0 11.1 9.8 8.5 12.4 4.0 13.1 13.0 9.0 10.3 9.9 9.8 10.4 9.5 16.4 3.1 11.7 17.5 11.5 4.6 11.1 12.5 8.4 13.4 12.0 8.3 6.3 32.4 30.2 24.3 31.9 22.4 25.3 19.0 27.2 39.5 26.1 31.6 31.0 22.9 30.2 14.7 36.2 32.5 23.9 27.9 29.2 39.5 27.2 28.7 25.1 16.3 34.0 31.0 29.6 29.9 31.4 18.4 30.8 30.5 28.3 36.3 15.5 19.1 21.4 28.7 19.2 25.9 28.2 29.5 28.6 20.9 23.7 44.7 17.3 26.1 25.6 9.6 25.5 25.0 19.9 24.1 24.9 17.5 21.7 29.6 15.8 18.5 23.8 35.1 33.5 32.6 38.7 27.6 37.4 14.1 14.3 10.5 10.3 10.7 16.3 13.9 11.3 10.5 12.4 11.9 9.1 11.1 10.7 3.8 13.0 18.1 7.2 11.9 9.6 3.5 3.9 6.2 4.6 4.0 4.0 4.2 4.3 4.0 3.1 4.6 6.3 15.1 12.8 28.3 21.9 20.9 8.4 19.3 18.1 13.1 17.3 19.1 12.1 17.4 27.1 24.5 18.4 6.2 17.8 18.7 19.7 5.9 16.8 26.1 15.1 22.1 19.9 19.9 21.2 28.3 14.4 18.9 21.4 44.9 15.5 22.1 21.0 14.3 25.5 23.3 11.8 30.2 24.3 26.4 24.6 12.2 24.9 14.0 23.3 8.8 39.4 21.3 14.6 16.5 31.7 37.5 20.2 19.8 15.1 23.7 23.4 16.0 19.2 25.4 23.7 0.0 16.8 17.9 25.0 19.8 19.1 13.9 23.1 18.2 24.2 20.8 21.1 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120457227-120592065 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "brain: 12.2" "Cell type enhanced" "Detected in some" "Cholangiocytes: 11.5;Distal tubular cells: 7.9;Early spermatids: 10.9;Erythroid cells: 9.7;Late spermatids: 10.7;Leydig cells: 19.3;Peritubular cells: 7.9;Proximal tubular cells: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 14.2;U-251 MG: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA045188: AB_2679246" "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.0 0.0 2.9 0.1 3.5 0.4 0.1 6.4 2.8 0.2 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.0 5.3 8.9 0.8 0.1 0.0 0.0 11.0 5.3 0.0 0.0 0.0 0.0 0.0 12.2 0.2 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.1 4.3 0.0 0.0 0.9 3.7 0.1 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.3 0.2 0.0 0.3 0.1 0.0 1.7 1.4 0.0 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 14.2 1.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.1 0.9 0.2 0.0 2.8 1.7 1.2 0.1 10.4 0.0 0.0 0.0 2.3 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.9 3.5 6.4 2.8 5.3 8.9 11.0 5.3 12.2 4.3 3.7 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 11.5 0.0 3.7 0.0 0.0 0.0 0.0 7.9 0.3 10.9 0.1 2.5 0.0 0.0 9.7 0.0 0.2 0.1 0.3 0.0 0.1 0.0 0.2 1.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 10.7 19.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 7.9 0.0 0.5 0.0 9.0 0.0 0.0 0.0 0.0 4.9 1.5 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 WDR11 "BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15" ENSG00000120008 "WD repeat domain 11" Q9BZH6 10 120851305-120909524 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038980 Approved Approved Microtubules,Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Microtubules, Cytosol" "HPA038980: AB_10675955" "unprognostic (8.98e-2)" "unprognostic (8.83e-3)" "unprognostic (1.27e-1)" "unprognostic (5.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.57e-3)" "unprognostic (1.45e-1)" "unprognostic (2.98e-3)" "unprognostic (2.84e-1)" "unprognostic (3.84e-1)" "unprognostic (8.31e-2)" "unprognostic (1.80e-3)" "prognostic favorable (5.04e-4)" "unprognostic (5.09e-2)" "unprognostic (1.87e-1)" "unprognostic (8.99e-2)" "unprognostic (2.38e-2)" 15.2 12.3 5.9 16.9 5.7 6.6 15.3 6.7 5.1 15.4 10.8 15.2 14.2 15.3 10.8 14.8 17.7 15.0 7.8 6.0 7.1 24.4 20.2 15.2 18.6 10.1 6.5 16.0 13.6 38.6 5.3 16.8 10.9 15.6 16.6 15.1 14.4 14.2 3.5 9.7 14.9 16.9 10.3 18.5 16.1 11.5 6.6 17.9 22.5 6.5 20.2 15.7 8.6 14.7 28.5 25.1 24.8 43.4 35.4 42.2 18.0 26.0 52.4 28.3 34.9 14.7 29.1 19.9 13.1 37.5 22.5 26.5 29.1 35.8 35.4 26.5 24.2 20.8 19.9 15.3 33.6 29.6 23.6 36.7 28.5 26.2 42.2 51.7 53.1 14.0 16.9 23.3 30.1 12.1 18.7 12.9 12.8 24.8 16.1 7.7 43.3 17.4 33.7 21.8 12.2 21.8 22.6 24.9 68.8 43.3 18.4 18.7 40.0 18.6 11.6 2.8 25.1 12.9 8.6 24.3 26.4 24.8 9.9 27.4 8.5 3.8 4.5 11.2 3.6 8.5 3.0 4.1 9.7 4.6 3.1 3.3 0.6 5.9 25.3 2.3 4.3 5.2 5.9 5.7 6.7 5.1 6.0 7.1 10.1 6.5 10.9 10.3 6.6 14.7 23.7 6.4 16.4 77.7 42.3 12.0 13.5 15.5 10.8 42.8 16.6 13.6 8.3 27.1 20.1 25.8 98.0 19.3 30.5 24.3 11.7 18.3 3.8 31.7 33.1 24.4 27.1 16.6 57.0 10.5 12.1 21.8 29.6 32.7 9.5 34.2 33.9 33.9 32.2 25.2 54.2 24.5 12.2 43.2 16.5 4.4 43.5 34.9 3.6 30.9 42.4 21.0 20.6 112.1 84.7 25.3 23.4 38.7 25.6 17.9 34.8 19.9 30.1 85.3 19.7 28.9 17.9 25.8 16.3 15.6 14.2 15.2 18.9 41.7 20.6 19.3 FGFR2 "BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25" ENSG00000066468 "Fibroblast growth factor receptor 2" P21802 10 121478332-121598458 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 273.8;choroid plexus: 198.1" "Group enriched" "Detected in many" 5 "Astrocytes: 228.2;Cholangiocytes: 213.1;Oligodendrocytes: 562.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 24 "basophil: 13.2;eosinophil: 3.8" "Lineage enriched" "Detected in single" 58 "granulocytes: 13.2" "Cell line enhanced" "Detected in many" "AN3-CA: 189.0;BEWO: 60.9;CACO-2: 49.6;HaCaT: 55.6;HAP1: 63.7;NTERA-2: 57.8;T-47d: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010886, HPA035305" Uncertain Supported "Nucleoplasm,Vesicles,Cell Junctions" "Secreted - unknown location" NA NA 1200000 "Cluster 34: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Cell Junctions" "Nucleoplasm, Vesicles" "CAB010886: AB_259379, HPA035305: AB_10672862" "unprognostic (5.53e-2)" "prognostic favorable (8.79e-4)" "unprognostic (1.08e-1)" "unprognostic (5.23e-2)" "unprognostic (1.73e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.53e-1)" "unprognostic (4.96e-3)" "unprognostic (1.74e-1)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "unprognostic (2.54e-1)" "unprognostic (6.93e-2)" "unprognostic (2.25e-1)" 5.7 21.3 103.9 8.2 186.8 0.3 22.9 178.9 198.9 19.7 198.1 44.8 10.4 54.6 15.3 25.2 29.6 31.3 5.6 109.9 124.7 26.3 41.0 30.9 2.9 250.9 185.9 18.0 31.0 61.0 6.8 15.7 220.5 27.4 21.2 1.2 59.1 54.6 0.5 109.3 12.2 43.6 165.5 0.8 22.5 7.6 148.0 10.1 54.6 0.2 9.1 16.6 27.4 273.8 7.2 0.4 30.2 189.0 0.1 0.0 60.9 0.4 0.0 0.0 0.0 49.6 1.1 0.1 12.5 2.8 0.1 55.6 63.7 13.0 0.0 0.1 12.7 0.0 0.2 1.2 1.5 0.2 11.7 0.1 26.2 0.0 0.6 0.0 0.0 0.3 0.2 0.2 0.0 11.7 0.2 0.1 57.8 8.7 0.0 0.1 0.0 7.5 18.0 15.8 0.5 0.5 0.4 33.4 0.0 36.6 49.3 0.0 0.1 0.3 8.5 0.2 0.7 0.1 0.1 0.0 0.3 0.0 0.5 13.2 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 103.9 186.8 178.9 198.9 109.9 124.7 250.9 185.9 220.5 165.5 148.0 273.8 1.4 19.2 36.0 228.2 0.6 40.1 34.3 18.4 58.6 0.2 8.7 25.4 9.1 213.1 38.4 36.8 0.0 16.5 0.3 7.3 0.0 7.4 4.1 28.1 4.4 1.0 2.4 2.7 14.8 0.2 3.0 9.0 13.3 53.1 0.0 0.1 1.8 5.0 2.3 0.0 31.2 40.8 10.2 0.6 4.4 9.6 1.2 1.1 5.4 10.3 0.6 2.0 1.0 6.0 562.5 0.7 3.0 6.0 0.1 15.0 1.8 13.6 15.3 0.2 0.0 1.6 2.6 0.7 9.9 18.7 27.7 4.0 1.5 0.4 3.8 31.4 ATE1 ENSG00000107669 "Arginyltransferase 1" O95260 10 121740424-121928492 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 137.7;Oligodendrocytes: 220.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038444, HPA057549" Approved Supported Nucleoplasm NA NA 83000 "Cluster 18: Basophils - Vesicular transport" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA038444: AB_10672745, HPA057549: AB_2683463" "unprognostic (1.37e-1)" "unprognostic (5.19e-2)" "unprognostic (2.75e-3)" "unprognostic (2.40e-1)" "unprognostic (4.67e-2)" "unprognostic (6.65e-3)" "unprognostic (1.85e-1)" "unprognostic (1.42e-1)" "unprognostic (1.71e-1)" "unprognostic (1.00e-1)" "unprognostic (2.52e-1)" "unprognostic (5.69e-2)" "prognostic favorable (2.67e-4)" "unprognostic (3.20e-1)" "unprognostic (8.08e-2)" "unprognostic (2.16e-1)" "unprognostic (1.02e-1)" 10.1 11.7 8.1 8.5 8.5 7.4 10.4 7.3 9.2 12.1 17.3 13.5 11.4 10.6 8.4 10.7 9.0 10.4 22.2 8.4 11.0 18.2 18.2 9.5 9.5 6.7 7.3 10.0 6.2 15.4 4.8 11.0 7.5 12.7 14.6 15.6 7.8 10.0 18.3 6.7 11.1 11.7 7.4 10.4 8.8 13.3 10.6 13.0 16.0 15.4 10.6 12.7 6.6 8.7 13.0 19.5 15.4 15.0 15.1 16.8 12.3 12.0 24.0 13.1 13.2 23.6 19.1 16.1 9.5 14.3 8.8 16.1 14.5 14.2 16.3 20.3 13.1 5.8 8.8 31.1 15.5 26.7 13.4 11.9 15.2 13.8 32.0 19.3 18.7 9.0 7.8 29.4 14.5 7.9 14.0 15.2 7.5 19.6 11.4 13.1 18.1 10.6 23.4 11.2 4.8 19.4 17.2 12.9 28.2 11.3 8.9 9.2 19.2 8.2 7.0 12.5 21.1 28.0 33.6 12.0 12.6 20.6 7.4 12.8 3.8 6.1 5.3 4.5 6.3 4.5 5.0 5.3 3.4 4.2 5.5 5.6 2.3 5.1 3.5 4.8 6.7 4.0 8.1 8.5 7.3 9.2 8.4 11.0 6.7 7.3 7.5 7.4 10.6 8.7 23.0 9.6 22.0 76.4 17.3 8.4 12.8 9.4 24.5 31.3 17.5 14.6 75.6 11.5 12.7 20.2 12.5 7.2 20.9 42.8 17.6 11.3 6.5 15.8 19.4 19.3 22.1 16.2 100.5 13.3 10.5 25.0 29.6 16.4 12.6 13.5 20.0 26.6 10.0 23.5 93.8 17.7 10.2 14.8 7.2 7.7 20.5 23.6 14.2 74.0 12.8 21.7 27.8 137.7 220.4 15.6 18.3 25.9 24.8 21.0 19.5 39.4 11.5 35.8 0.0 23.4 21.1 26.9 40.2 30.7 17.5 8.6 17.9 29.1 16.8 16.6 NSMCE4A "bA500G22.3, C10orf86, FLJ20003, NSE4A" ENSG00000107672 "NSE4 homolog A, SMC5-SMC6 complex component" Q9NXX6 10 121957091-121975217 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037459, HPA038412, HPA044872" Approved Enhanced Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 4: Stomach - Digestion" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA037459: AB_10696932, HPA038412: AB_2676005, HPA044872: AB_2679124" "unprognostic (1.16e-3)" "unprognostic (2.86e-2)" "unprognostic (1.56e-1)" "unprognostic (3.73e-2)" "unprognostic (4.09e-3)" "unprognostic (2.18e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.72e-5)" "unprognostic (3.16e-2)" "unprognostic (7.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.44e-3)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.64e-1)" "unprognostic (8.13e-2)" "unprognostic (1.35e-1)" "unprognostic (7.01e-3)" 27.3 20.6 9.3 14.6 11.8 20.2 27.4 10.8 13.3 23.0 9.3 37.0 24.7 23.4 12.4 19.2 22.8 14.4 21.2 9.5 10.0 15.6 25.2 16.9 23.8 10.9 10.8 22.7 30.0 15.1 11.2 14.1 10.9 24.8 21.0 10.7 24.4 16.5 20.6 19.4 26.8 17.7 10.4 23.3 29.5 4.9 10.6 21.5 21.1 8.4 19.7 30.0 20.8 13.2 43.4 51.9 55.0 49.0 18.9 24.7 40.3 23.7 42.3 40.0 55.2 40.5 32.8 57.2 17.9 18.9 22.0 36.7 32.5 26.0 31.5 69.0 76.3 37.5 17.0 76.5 16.0 43.2 25.5 16.9 19.4 23.5 37.9 22.4 42.8 51.5 35.1 40.3 22.6 35.1 78.2 62.8 28.7 30.7 40.4 66.9 42.4 61.2 27.7 35.4 14.9 29.1 27.0 18.1 38.2 22.0 20.0 40.3 35.3 15.8 28.0 26.8 49.6 53.0 60.6 88.0 19.7 57.5 17.3 0.3 31.5 19.5 29.6 38.3 34.4 50.6 39.5 38.7 33.1 46.6 41.4 33.6 2.9 41.7 38.5 51.5 48.3 36.5 9.3 11.8 10.8 13.3 9.5 10.0 10.9 10.8 10.9 10.4 10.6 13.2 49.3 22.4 33.1 9.4 35.5 17.0 45.0 47.0 23.9 20.3 30.4 34.3 23.1 30.0 31.8 12.9 33.3 56.4 40.0 35.8 35.2 28.0 0.7 16.8 15.4 33.9 21.6 26.1 5.3 61.2 38.0 25.9 28.5 17.0 11.4 34.6 18.5 33.3 35.6 26.9 5.4 35.1 46.8 20.0 19.2 1.6 35.4 22.4 21.4 7.5 48.6 33.3 40.2 7.5 17.4 30.4 37.0 33.4 36.3 41.9 36.8 39.2 21.6 37.4 26.3 27.1 31.3 6.7 16.6 35.5 21.6 66.2 29.3 39.6 44.8 47.9 TACC2 "AZU-1, ECTACC" ENSG00000138162 "Transforming acidic coiled-coil containing protein 2" O95359 10 121989163-122254545 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 251.7;skeletal muscle: 387.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 210.1;Syncytiotrophoblasts: 228.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 86.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031020, HPA031021, HPA061394" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 32000 "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA031020: AB_10669988, HPA031021: AB_2673701, HPA061394: AB_2684500" "unprognostic (3.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.75e-2)" "unprognostic (7.07e-2)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (9.15e-2)" "unprognostic (8.43e-3)" "unprognostic (1.14e-1)" "unprognostic (3.51e-1)" "unprognostic (2.13e-1)" "unprognostic (1.83e-2)" "prognostic favorable (2.50e-10)" "unprognostic (7.02e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (8.45e-4)" "unprognostic (1.61e-1)" 22.1 15.3 18.2 5.3 18.6 0.2 20.9 23.6 22.7 32.3 28.6 91.5 15.3 26.1 9.2 64.2 32.9 12.9 251.7 19.1 18.8 33.9 18.8 68.7 1.0 16.0 16.9 8.8 25.3 36.4 58.7 21.6 14.8 67.7 20.7 7.2 60.7 13.5 387.1 103.3 35.7 22.0 11.8 4.2 49.1 5.8 16.9 5.7 50.7 159.0 5.7 62.4 49.1 17.7 17.8 55.1 26.5 15.2 7.4 7.4 31.7 7.7 20.7 10.5 7.3 22.7 28.9 0.0 7.0 12.3 12.1 58.1 8.5 20.9 10.9 3.0 4.4 0.0 7.7 43.8 11.5 0.0 0.3 3.4 86.0 5.6 36.6 8.6 22.2 0.1 4.5 0.6 10.4 23.5 0.2 9.9 15.7 27.6 24.8 0.3 15.2 8.5 28.9 26.9 17.6 14.2 12.7 52.0 29.5 7.6 10.2 0.4 20.6 4.7 3.5 11.8 14.5 2.4 11.7 0.3 8.7 0.1 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 18.6 23.6 22.7 19.1 18.8 16.0 16.9 14.8 11.8 16.9 17.7 15.5 83.3 94.1 16.3 0.7 33.6 49.7 54.3 33.0 21.6 23.4 14.1 210.1 8.6 70.7 36.8 0.0 53.3 0.4 75.2 1.9 8.2 2.4 88.4 11.0 21.3 30.0 0.0 32.8 14.2 4.4 21.2 38.7 62.8 7.0 0.1 6.1 18.9 6.5 43.7 48.2 38.8 57.0 0.3 4.3 2.6 6.8 1.9 7.2 7.5 0.1 1.1 0.0 80.9 7.6 19.4 47.1 7.5 0.2 49.6 36.5 13.5 84.9 2.7 13.1 27.2 23.7 0.5 8.2 79.5 54.0 228.5 2.6 2.8 41.9 80.5 BTBD16 "C10orf87, Em:AC061711.1, FLJ25359" ENSG00000138152 "BTB domain containing 16" Q32M84 10 122271296-122338159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 8.3;testis: 7.8;urinary bladder: 20.2" "Group enriched" "Detected in some" 9 "Early spermatids: 123.2;Late spermatids: 69.9" "Cancer enriched" "Detected in many" 14 "urothelial cancer: 18.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "RT4: 33.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA040529, HPA057638" Uncertain Uncertain Nucleoli,Cytosol Yes NA "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 34: Spermatids - Unknown function" Nucleoli Cytosol "HPA040529: AB_2677022, HPA057638: " "unprognostic (1.41e-4)" "unprognostic (1.33e-1)" "unprognostic (5.97e-2)" "unprognostic (5.98e-3)" "unprognostic (2.08e-1)" "unprognostic (2.09e-3)" "unprognostic (2.88e-1)" "unprognostic (4.54e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-2)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (9.12e-2)" "unprognostic (9.44e-3)" 0.1 0.0 1.0 0.0 1.4 0.0 0.5 1.2 2.3 0.3 0.7 0.5 0.0 0.1 0.3 0.1 0.4 0.2 0.0 1.1 1.2 0.3 4.0 0.2 0.0 1.4 1.4 0.0 0.1 0.0 0.4 0.1 1.4 0.8 0.0 0.0 0.4 0.0 0.3 8.3 0.1 0.1 1.3 0.0 0.1 7.8 1.2 0.0 0.4 0.0 0.1 20.2 0.5 2.1 0.0 0.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 1.5 33.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 1.4 1.2 2.3 1.1 1.2 1.4 1.4 1.4 1.3 1.2 2.1 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.2 0.0 0.0 0.2 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.4 123.2 0.6 0.0 0.2 0.0 0.0 0.9 0.7 0.1 0.0 0.0 0.4 0.0 0.0 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.0 0.4 69.9 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.5 9.8 1.1 3.8 0.4 0.0 0.1 0.2 1.0 3.1 0.0 0.0 0.4 0.2 10.0 0.8 0.0 3.1 0.1 0.4 0.0 0.0 2.9 PLEKHA1 TAPP1 ENSG00000107679 "Pleckstrin homology domain containing A1" Q9HB21 10 122374696-122442602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 336.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 10.3;NK-cells: 21.3;T-cells: 27.1" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 203.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002043, HPA064795" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA002043: AB_1079632, HPA064795: AB_2685354" "unprognostic (1.79e-2)" "unprognostic (3.18e-2)" "unprognostic (2.70e-1)" "unprognostic (5.44e-3)" "unprognostic (7.41e-2)" "unprognostic (1.69e-1)" "unprognostic (5.50e-2)" "unprognostic (4.07e-2)" "unprognostic (3.88e-1)" "unprognostic (2.69e-1)" "unprognostic (7.98e-2)" "unprognostic (7.63e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-1)" "unprognostic (7.42e-2)" "unprognostic (4.31e-2)" "unprognostic (5.23e-2)" 18.0 10.4 21.2 13.9 25.5 4.4 19.6 10.7 42.0 18.6 5.0 21.4 25.9 25.9 20.5 39.4 12.7 24.0 29.2 25.9 14.8 39.1 38.7 36.6 14.9 12.4 14.9 19.2 27.3 27.6 21.8 37.3 13.3 17.9 20.1 19.8 25.2 18.8 31.8 66.5 25.1 23.6 13.2 13.7 21.2 40.7 13.7 15.6 27.3 57.4 18.0 24.9 21.7 36.9 25.9 23.5 23.3 16.1 33.1 37.5 28.0 28.2 49.1 16.8 18.0 20.0 31.8 16.1 13.3 25.6 17.0 55.4 22.3 86.1 15.4 11.4 21.8 0.0 22.6 23.6 21.8 2.9 7.3 20.5 69.7 13.9 58.3 27.5 56.8 33.2 24.3 0.1 15.6 9.9 14.8 2.5 18.1 39.3 15.5 4.0 33.1 3.2 203.2 28.3 31.6 15.5 36.4 26.8 28.9 32.7 14.9 0.3 54.6 14.1 11.5 15.4 14.3 0.1 0.0 5.4 21.6 0.1 8.8 0.3 2.7 2.3 27.1 2.4 17.5 5.1 16.3 21.9 3.2 10.3 25.4 21.9 0.8 21.3 2.9 1.6 11.9 11.6 21.2 25.5 10.7 42.0 25.9 14.8 12.4 14.9 13.3 13.2 13.7 36.9 48.6 144.2 42.0 19.9 28.0 72.8 54.7 51.6 97.9 46.5 25.6 19.2 55.9 55.8 46.0 57.0 75.0 58.4 47.6 39.1 41.1 63.1 202.0 50.2 30.6 70.8 22.3 6.9 133.8 85.3 53.9 34.3 28.1 83.7 5.1 20.8 32.5 45.1 37.2 26.9 92.9 19.6 22.4 23.7 23.6 336.5 44.1 20.4 24.9 35.6 28.5 20.2 147.2 35.2 161.9 71.4 26.9 36.1 7.4 91.4 64.4 118.1 29.1 49.5 26.3 32.2 28.9 119.4 86.1 71.6 84.8 39.7 39.7 14.7 27.5 83.5 ARMS2 "ARMD8, LOC387715" ENSG00000254636 "Age-related maculopathy susceptibility 2" P0C7Q2 10 122454653-122457352 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 2.9" "Group enriched" "Detected in some" 4 "Early spermatids: 16.9;Late spermatids: 59.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA067225 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "HPA067225: AB_2685806" "unprognostic (3.05e-1)" "unprognostic (1.50e-1)" "unprognostic (5.69e-3)" "unprognostic (2.29e-1)" "unprognostic (2.61e-2)" "unprognostic (2.84e-2)" "unprognostic (3.49e-2)" "unprognostic (1.98e-2)" "unprognostic (3.47e-3)" "unprognostic (3.60e-2)" "unprognostic (5.29e-5)" "unprognostic (2.53e-2)" "unprognostic (9.46e-3)" "unprognostic (2.68e-2)" "unprognostic (5.25e-2)" 0.2 0.0 0.3 0.0 0.3 0.0 0.1 0.2 1.3 0.1 0.3 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.6 0.4 0.4 0.1 0.2 0.0 0.0 0.3 0.4 0.7 0.0 0.0 0.4 1.3 0.4 0.1 0.0 0.5 0.8 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.1 2.9 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 1.3 0.4 0.4 0.3 0.4 0.4 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 16.9 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 59.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 8.6 0.0 0.0 0.0 0.0 HTRA1 "ARMD7, HtrA, IGFBP5-protease, PRSS11" ENSG00000166033 "HtrA serine peptidase 1" Q92743 10 122458551-122514907 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding, Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 269.3;Granulosa cells: 731.6;Horizontal cells: 625.9;Muller glia cells: 373.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 2417.8;ASC TERT1: 889.4;fHDF/TERT166: 862.3;HSkMC: 1581.4;LHCN-M2: 1238.2;U-87 MG: 1004.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036655 Approved Supported "Plasma membrane" "Secreted to blood" NA NA 24800000 7600000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane" "HPA036655: AB_10671966" "unprognostic (3.84e-1)" "unprognostic (3.42e-2)" "unprognostic (1.57e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-3)" "unprognostic (8.71e-3)" "unprognostic (2.33e-2)" "unprognostic (3.83e-1)" "unprognostic (7.22e-2)" "unprognostic (3.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (7.90e-7)" "unprognostic (7.12e-3)" "unprognostic (9.13e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (5.62e-6)" 246.0 81.3 382.1 37.0 436.6 0.5 202.8 422.6 595.7 352.1 316.2 154.8 20.8 197.1 247.1 57.8 122.9 301.2 114.7 377.7 411.4 230.9 226.4 69.9 39.9 427.1 447.0 425.5 55.9 111.8 184.1 281.9 425.3 85.7 51.8 243.6 101.1 114.5 31.1 130.5 73.5 152.3 382.1 54.2 87.3 19.5 423.6 21.2 78.8 80.9 27.3 137.3 188.3 464.2 0.3 45.6 19.4 5.7 2417.8 889.4 0.8 108.3 196.8 44.4 23.6 0.2 0.6 0.0 29.0 862.3 68.6 12.8 7.6 124.4 6.2 0.1 4.9 0.1 65.4 0.3 123.7 0.1 0.9 1581.4 444.6 25.8 205.3 503.6 207.1 0.0 0.1 1.5 1238.2 22.3 0.1 0.7 20.9 0.2 67.6 0.2 1.3 0.4 282.6 2.2 1.2 3.9 272.1 0.2 122.2 91.4 8.6 0.2 136.0 309.9 4.5 141.3 94.1 0.2 0.1 0.3 1004.6 0.2 148.5 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 382.1 436.6 422.6 595.7 377.7 411.4 427.1 447.0 425.3 382.1 423.6 464.2 55.1 22.4 6.9 116.5 0.9 44.1 32.5 10.8 23.9 53.3 5.4 31.2 26.4 14.3 0.9 64.4 54.2 30.9 1.3 0.0 0.0 2.0 3.5 11.3 76.5 107.0 0.0 2.7 2.2 4.6 164.6 269.3 4.6 14.4 1.3 731.6 57.8 157.8 51.3 625.9 31.2 0.3 8.2 18.1 59.9 4.2 31.7 22.0 46.2 86.2 8.5 373.8 0.0 193.0 112.5 2.7 1.3 77.5 1.9 8.7 0.2 22.6 10.1 150.3 6.6 63.3 140.5 0.2 0.7 7.0 30.5 87.7 7.2 2.5 0.6 11.9 DMBT1 "Gp-340, GP340, hensin, muclin, SALSA, vomeroglandin" ENSG00000187908 "Deleted in malignant brain tumors 1" Q9UGM3 10 122560665-122643736 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Antiviral defense, Differentiation, Host-virus interaction, Protein transport, Transport" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 19 "intestine: 1651.4;salivary gland: 519.1" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 192.9;Intestinal goblet cells: 113.4;Paneth cells: 388.2;Proximal enterocytes: 167.8;Undifferentiated cells: 314.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 47.6;stomach cancer: 76.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 9.9;LHCN-M2: 16.4;RH-30: 40.3" "Not detected" "Not detected" HPA040778 Enhanced Approved "Centriolar satellite" "Secreted in other tissues" NA NA 5200000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 45: Enterocytes - Digestion" "Centriolar satellite" "HPA040778: AB_2677132" "unprognostic (3.32e-2)" "unprognostic (2.17e-2)" "unprognostic (3.47e-2)" "prognostic favorable (1.43e-4)" "unprognostic (8.77e-2)" "unprognostic (2.56e-2)" "unprognostic (3.70e-1)" "unprognostic (7.97e-2)" "unprognostic (1.31e-1)" "unprognostic (4.51e-1)" "unprognostic (2.22e-1)" "unprognostic (2.20e-1)" "unprognostic (1.08e-9)" "unprognostic (2.26e-1)" "unprognostic (2.92e-4)" "unprognostic (2.00e-3)" "unprognostic (2.22e-1)" 0.5 0.2 0.6 45.3 2.9 0.1 0.3 4.4 1.5 12.8 0.0 55.6 1651.4 1.7 0.0 1.6 3.9 45.7 0.1 0.5 2.3 0.1 0.1 58.4 1.0 6.1 5.2 0.1 1.8 0.0 0.2 0.0 7.2 1.7 17.0 0.0 519.1 0.0 0.3 0.1 518.7 15.3 2.3 0.0 3.8 1.5 4.2 0.1 0.0 0.2 0.2 15.4 0.0 7.8 0.2 0.2 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.5 0.2 1.1 0.0 0.4 0.0 0.2 0.0 0.0 3.2 0.5 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.0 1.3 0.5 9.9 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 2.6 0.2 0.0 0.0 0.0 40.3 6.0 0.0 0.0 0.1 3.0 0.3 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.8 0.5 2.3 5.7 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 4.4 1.5 0.5 2.3 6.1 5.2 7.2 2.3 4.2 7.8 0.0 6.4 192.9 0.7 1.1 0.0 7.0 0.4 0.0 0.0 1.5 0.9 0.7 0.0 3.8 0.0 0.0 0.0 0.0 52.4 0.0 2.1 2.9 1.1 0.2 7.3 0.0 0.0 0.0 15.1 0.0 0.4 0.0 3.5 10.1 0.0 0.0 0.0 0.0 0.0 0.1 113.4 0.0 0.0 0.0 2.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.7 388.2 0.0 0.0 1.7 167.8 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.8 0.0 0.0 0.0 1.8 0.0 314.4 20.3 AL603764.2 ENSG00000286135 "Carbohydrate-binding protein AQN-1-like" 10 122672850-122679494 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 838 "epididymis: 118.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf120 bA318C4.1 ENSG00000183559 "Chromosome 10 open reading frame 120" Q5SQS8 10 122697709-122699846 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 154 "testis: 31.0" "Cell type enriched" "Detected in some" 4 "Early spermatids: 592.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: Early spermatids - Spermatogenesis" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 592.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123.6 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832158-122846175 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1631 "pancreas: 2414.2" "Cell type enriched" "Detected in some" 6 "Exocrine glandular cells: 266.9" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 1.9;U-937: 1.2" "Not detected" "Not detected" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles No No "Cluster 25: Pancreas - Digestion" "Cluster 30: Epithelial cell lines - Translation" "Cluster 1: Pancreatic cells - Digestion" Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663" "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.4 0.2 0.2 0.2 0.3 0.8 0.4 0.2 0.5 0.6 0.2 0.6 0.5 0.4 0.4 0.5 0.4 0.0 0.4 0.3 0.2 0.9 0.2 0.5 0.2 0.2 0.2 1.0 2414.2 0.0 1.4 0.1 0.4 0.7 0.0 0.4 0.5 0.0 0.1 0.7 0.9 0.0 0.2 1.1 0.4 1.0 0.2 0.3 0.5 0.0 0.0 0.5 0.5 0.3 0.3 0.5 0.1 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.7 0.0 0.1 0.1 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.9 0.1 0.2 0.3 0.3 0.3 1.0 0.1 0.4 0.3 0.4 0.4 0.0 0.0 0.4 0.0 0.4 0.1 0.4 0.2 0.3 0.0 0.3 0.5 0.4 0.6 0.5 0.0 0.5 0.2 0.0 0.0 0.4 0.8 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.5 0.3 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.7 0.2 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.9 2.8 0.1 0.1 0.1 0.0 0.4 0.0 266.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 5.0 0.0 0.1 0.0 0.3 0.3 6.7 0.3 0.1 0.0 0.0 3.7 0.1 0.0 0.0 0.0 43.6 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.4 0.1 0.7 0.2 0.0 0.1 0.0 0.7 0.1 0.2 0.1 FAM24B "AC073585.2, MGC45962" ENSG00000213185 "Family with sequence similarity 24 member B" Q8N5W8 10 122849078-122879641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 15.0" "Cell type enhanced" "Detected in many" "Distal tubular cells: 50.9;Early spermatids: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "hTERT-HME1: 135.5;LHCN-M2: 181.8;TIME: 58.3" HPA052490 Supported "Intracellular and membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 43: Testis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" "HPA052490: AB_2681851" "unprognostic (4.03e-2)" "unprognostic (4.27e-2)" "unprognostic (3.13e-3)" "unprognostic (8.40e-5)" "unprognostic (2.55e-2)" "unprognostic (3.31e-2)" "unprognostic (6.42e-7)" "unprognostic (2.99e-1)" "unprognostic (7.06e-3)" "unprognostic (3.00e-1)" "unprognostic (5.89e-2)" "unprognostic (3.59e-2)" "unprognostic (1.78e-1)" "unprognostic (2.58e-1)" "unprognostic (9.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.81e-3)" 2.1 1.3 4.9 2.6 5.0 2.6 3.0 4.9 6.4 2.8 3.7 2.8 2.3 2.3 2.9 2.4 2.2 2.1 1.5 5.2 6.3 15.0 0.9 2.4 5.9 5.3 5.0 2.9 7.8 1.0 10.9 0.4 5.2 3.0 4.0 5.9 1.9 1.4 0.9 4.2 3.6 1.6 4.9 3.8 3.1 9.2 5.2 4.9 2.4 0.2 4.7 2.6 2.3 5.8 8.1 12.8 3.1 0.1 1.9 3.7 4.0 11.8 11.1 4.8 4.4 14.2 16.6 3.0 3.6 6.5 1.4 5.2 0.0 7.1 13.1 14.0 5.3 23.8 18.4 7.6 10.4 0.0 13.8 4.3 0.9 10.4 135.5 0.9 12.6 15.5 9.5 6.0 181.8 7.3 13.9 13.9 5.0 8.1 13.3 0.0 18.5 2.8 8.6 7.2 8.6 3.7 5.5 2.9 15.0 7.7 4.7 14.1 58.3 1.4 6.7 5.0 1.2 6.5 7.1 18.0 9.7 23.3 0.0 2.2 1.5 1.0 1.7 1.5 0.6 4.2 3.4 2.4 2.1 2.3 3.5 2.1 1.0 2.1 1.5 8.1 3.6 1.2 4.9 5.0 4.9 6.4 5.2 6.3 5.3 5.0 5.2 4.9 5.2 5.8 2.5 0.0 0.5 0.0 7.1 6.6 1.6 4.2 14.2 3.6 3.7 5.8 0.2 2.8 1.2 9.2 0.0 0.1 7.7 1.6 50.9 4.3 28.2 0.5 0.7 1.9 4.8 6.5 0.0 7.3 0.2 3.8 2.0 0.6 8.9 0.5 1.8 0.8 1.2 1.7 0.0 3.5 12.2 4.1 2.9 4.1 3.7 3.3 1.8 0.0 3.5 2.9 8.2 0.0 0.0 8.7 2.7 4.1 2.7 2.0 2.3 1.8 1.2 4.3 0.0 1.7 2.3 12.9 4.6 5.5 5.4 0.0 6.7 0.2 3.5 1.2 FAM24A AC073585.4 ENSG00000203795 "Family with sequence similarity 24 member A" A6NFZ4 10 122910610-122913111 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 118 "testis: 17.6" "Cell type enriched" "Detected in some" 10 "Early spermatids: 303.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052490 Supported "Secreted in male reproductive system" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA052490: AB_2681851" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 303.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 C10orf88 "Em:AC073585.5, FLJ13490, PAAT" ENSG00000119965 "Chromosome 10 open reading frame 88" Q9H8K7 10 122930901-122954311 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 146.8;Late spermatids: 45.9;Spermatocytes: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039681, HPA040991" Approved NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA039681: AB_10796333, HPA040991: AB_10794432" "unprognostic (1.54e-1)" "unprognostic (5.05e-2)" "unprognostic (3.00e-2)" "unprognostic (1.36e-1)" "unprognostic (4.42e-2)" "unprognostic (4.04e-2)" "prognostic unfavorable (2.05e-5)" "unprognostic (2.65e-2)" "unprognostic (2.86e-1)" "unprognostic (7.59e-3)" "unprognostic (7.40e-3)" "unprognostic (2.69e-2)" "unprognostic (4.95e-2)" "unprognostic (3.74e-2)" "unprognostic (6.78e-2)" "unprognostic (2.06e-1)" "unprognostic (1.63e-2)" 2.9 4.4 4.2 4.4 4.2 1.5 4.0 4.3 6.4 3.6 3.7 3.1 3.5 3.9 4.3 3.1 2.9 2.9 3.3 4.3 4.7 3.4 3.3 2.9 5.8 4.4 4.4 4.6 2.3 4.2 2.1 4.4 4.5 3.6 3.6 6.6 2.7 2.9 4.3 3.5 3.3 3.2 4.1 3.9 3.0 10.7 4.5 5.1 4.2 4.2 4.8 3.8 1.5 4.6 6.1 6.3 7.9 7.7 5.9 8.4 6.0 9.8 11.9 10.4 12.2 5.1 5.8 6.0 4.1 7.6 9.2 6.6 8.5 4.9 15.3 10.3 7.0 6.6 5.7 5.9 8.8 7.0 10.0 6.6 9.6 9.9 13.5 14.1 10.9 7.9 6.3 6.8 17.7 3.5 7.8 7.8 4.7 5.2 5.4 7.6 9.2 1.8 6.1 3.8 4.4 9.0 5.1 4.9 11.2 8.8 4.1 4.8 8.2 7.6 4.6 7.4 12.2 6.9 6.7 7.8 8.1 9.6 6.3 1.4 1.7 3.3 2.7 0.8 3.2 3.0 3.6 3.6 2.4 3.1 3.5 3.4 0.2 3.9 1.0 2.1 5.3 2.7 4.2 4.2 4.3 6.4 4.3 4.7 4.4 4.4 4.5 4.1 4.5 4.6 4.7 3.2 4.8 9.4 5.8 6.0 2.3 6.9 6.8 9.8 3.4 3.0 4.6 5.7 6.8 0.0 6.2 5.6 7.2 2.8 11.7 5.3 146.8 4.0 7.0 4.6 4.8 6.9 10.9 3.0 5.3 6.0 3.6 6.0 2.5 4.9 2.2 2.4 4.9 6.7 11.9 3.2 6.1 3.3 2.0 45.9 4.1 4.1 3.6 6.5 3.1 6.1 5.2 13.0 16.7 4.5 1.3 5.7 2.4 2.2 2.5 5.5 5.6 9.2 6.6 5.0 5.7 52.2 14.8 5.3 4.1 3.6 5.9 3.2 3.2 1.7 PSTK "C10orf89, MGC35392" ENSG00000179988 "Phosphoseryl-tRNA kinase" Q8IV42 10 122954381-122997513 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 31.3;Spermatocytes: 37.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037780, HPA037781" Approved Approved "Nucleoli,Nuclear bodies,Actin filaments" No No "Cluster 24: B-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" "Actin filaments" "Nucleoli, Nuclear bodies" "HPA037780: AB_2675662, HPA037781: AB_10670530" "unprognostic (8.95e-3)" "unprognostic (5.51e-3)" "unprognostic (1.37e-1)" "unprognostic (7.39e-4)" "unprognostic (5.21e-2)" "unprognostic (4.08e-3)" "unprognostic (1.60e-2)" "unprognostic (5.92e-4)" "unprognostic (3.55e-2)" "unprognostic (1.16e-1)" "unprognostic (6.22e-3)" "unprognostic (7.10e-3)" "unprognostic (2.39e-1)" "unprognostic (4.50e-2)" "unprognostic (4.92e-2)" "unprognostic (3.02e-2)" "unprognostic (5.55e-4)" 0.9 2.2 1.3 0.6 1.5 6.1 2.9 1.5 2.2 1.9 0.3 1.6 1.9 1.9 3.5 1.5 1.9 0.7 1.7 1.5 1.6 2.0 4.1 1.0 0.9 1.6 1.5 1.3 2.1 1.1 2.6 1.3 2.5 2.0 1.5 0.5 1.9 1.1 3.5 1.6 1.0 1.9 1.3 1.1 1.3 3.2 1.4 1.8 2.4 0.9 1.2 1.3 1.3 2.8 4.1 3.4 1.7 0.8 1.6 3.2 2.1 2.0 3.5 3.0 3.7 4.6 3.4 4.4 3.9 2.5 2.0 2.3 0.7 3.1 3.4 2.4 8.7 2.7 1.2 4.0 4.3 6.7 3.6 3.3 5.2 2.9 5.2 2.7 2.3 3.9 4.3 6.0 4.3 6.6 2.0 3.9 3.3 1.6 4.3 4.5 3.0 4.4 4.3 2.6 1.6 2.1 3.9 3.8 5.3 1.4 1.8 0.4 3.1 2.8 2.6 1.2 4.5 2.6 1.6 5.8 2.4 4.3 0.9 0.0 5.0 6.0 7.4 3.1 8.8 6.2 5.7 7.0 6.7 5.9 7.5 7.7 0.6 6.8 3.6 6.7 3.8 5.3 1.3 1.5 1.5 2.2 1.5 1.6 1.6 1.5 2.5 1.3 1.4 2.8 3.0 9.6 7.3 14.4 4.6 4.5 5.0 11.0 5.2 8.3 7.1 11.7 5.9 10.0 7.5 5.5 8.4 7.7 8.0 1.6 9.8 4.6 31.3 5.7 5.2 3.2 4.2 3.4 18.8 6.3 3.1 6.0 1.5 11.6 2.5 8.1 3.6 6.3 4.8 5.0 20.3 2.6 14.2 2.1 4.3 5.4 5.3 3.0 5.4 4.7 6.1 8.8 5.2 12.5 29.4 3.7 3.8 5.7 3.3 3.5 3.0 7.7 8.3 11.4 0.0 5.6 8.6 37.5 20.6 5.5 4.7 9.6 6.9 10.8 4.3 3.5 IKZF5 "FLJ22973, Pegasus, ZNFN1A5" ENSG00000095574 "IKAROS family zinc finger 5" Q9H5V7 10 122990807-123008812 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015297, HPA051574" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm "Plasma membrane, Cytosol" "HPA015297: AB_1855183, HPA051574: AB_2681538" "unprognostic (2.42e-1)" "unprognostic (1.08e-1)" "unprognostic (4.64e-2)" "unprognostic (2.76e-2)" "unprognostic (1.44e-2)" "unprognostic (1.66e-3)" "unprognostic (2.68e-1)" "unprognostic (9.14e-3)" "unprognostic (5.43e-2)" "unprognostic (2.99e-1)" "unprognostic (6.88e-2)" "unprognostic (1.63e-2)" "unprognostic (3.98e-3)" "unprognostic (4.17e-2)" "unprognostic (6.03e-2)" "unprognostic (6.96e-2)" "unprognostic (3.15e-2)" 8.3 8.5 8.7 7.3 11.5 34.0 12.2 10.2 15.1 8.8 5.9 7.6 6.6 9.3 9.7 7.2 8.4 6.1 7.1 8.3 10.3 8.7 12.2 8.2 11.1 10.4 10.4 13.9 11.1 9.3 10.1 8.1 11.2 8.3 7.1 13.6 8.4 6.0 9.7 11.3 8.5 7.1 10.0 9.2 7.9 10.5 9.8 10.5 10.0 9.4 9.6 7.3 8.4 17.7 7.5 3.7 7.3 12.5 11.5 10.5 7.9 6.2 13.3 8.1 9.8 6.0 8.6 18.8 4.5 7.6 4.4 10.1 13.0 9.3 11.9 10.6 11.5 12.1 6.0 9.0 7.6 14.8 10.6 8.3 12.5 9.7 20.8 11.1 9.0 12.3 16.9 12.2 8.8 5.5 13.6 16.1 6.7 5.6 5.1 10.9 9.1 10.8 6.7 5.1 7.9 7.1 5.1 6.3 12.2 5.8 5.2 9.3 9.3 5.8 4.9 8.6 10.1 11.4 6.6 17.6 7.4 25.5 3.5 6.0 4.1 5.7 5.8 5.3 6.8 4.0 5.3 5.7 4.5 4.7 7.2 8.4 4.0 6.7 5.6 3.1 7.5 4.3 8.7 11.5 10.2 15.1 8.3 10.3 10.4 10.4 11.2 10.0 9.8 17.7 11.2 12.8 13.1 8.8 16.0 32.2 11.0 7.2 20.5 12.7 23.8 15.0 15.6 8.6 11.3 5.5 14.6 5.8 20.5 7.7 9.8 5.1 8.6 12.0 13.2 11.5 18.0 12.4 10.9 5.3 5.7 15.6 7.7 20.7 17.1 11.3 9.7 15.7 6.5 11.8 13.0 9.2 4.1 10.6 11.4 3.7 13.4 11.0 16.0 17.8 8.9 9.0 17.5 13.0 30.9 4.7 4.9 10.5 14.2 16.1 7.4 11.4 10.9 14.1 13.1 14.3 11.6 22.8 22.3 20.4 32.4 14.4 19.3 7.0 6.7 11.9 ACADSB "ACAD7, SBCAD" ENSG00000196177 "Acyl-CoA dehydrogenase short/branched chain" P45954 10 123008979-123058290 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 360.1" "Cell type enhanced" "Detected in all" "Hepatocytes: 499.5;Proximal tubular cells: 137.9" "Cancer enhanced" "Detected in all" "liver cancer: 32.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041458, HPA063555" Enhanced Supported Mitochondria NA NA 37000 "Cluster 2: Granulocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Mitochondria "HPA041458: AB_2677491, HPA063555: " "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.91e-3)" "unprognostic (2.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.87e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-3)" "unprognostic (1.30e-1)" "unprognostic (3.67e-1)" "prognostic favorable (3.40e-4)" "unprognostic (9.37e-3)" "prognostic favorable (6.37e-12)" "unprognostic (2.69e-1)" "unprognostic (7.20e-2)" "unprognostic (1.60e-3)" "unprognostic (7.14e-2)" 14.8 27.4 8.0 7.1 8.5 3.8 23.9 13.9 10.3 7.8 13.1 15.9 52.4 9.9 7.7 12.6 9.7 7.6 38.5 8.6 6.7 90.2 360.1 12.7 8.2 6.3 7.6 12.8 15.8 33.4 8.8 5.1 6.8 22.7 16.8 12.4 15.7 11.2 42.4 9.8 11.0 8.5 5.9 6.4 14.0 8.4 8.0 7.4 12.3 69.1 10.3 10.8 8.1 8.4 15.4 10.9 7.9 14.5 10.6 13.1 7.0 9.3 18.8 9.2 9.1 9.6 4.9 16.0 6.3 7.9 5.6 6.3 12.5 6.5 15.1 10.6 12.9 8.3 3.3 54.8 7.5 12.0 7.6 9.7 6.5 5.8 5.3 13.5 9.0 13.2 8.1 11.5 11.5 7.1 11.4 9.8 4.8 8.5 6.7 13.4 16.6 5.1 13.1 16.9 1.4 9.1 14.3 4.2 14.4 7.5 12.9 5.8 9.5 4.9 4.4 11.4 11.4 12.9 15.5 8.5 7.6 11.1 3.8 17.4 4.5 11.8 8.8 4.7 10.2 5.5 8.1 7.6 6.4 5.7 7.4 8.3 2.9 8.5 2.9 3.8 7.1 5.7 8.0 8.5 13.9 10.3 8.6 6.7 6.3 7.6 6.8 5.9 8.0 8.4 7.7 28.9 53.1 29.4 11.6 9.3 9.2 8.2 14.2 17.4 58.6 27.8 80.7 37.1 21.1 11.0 10.4 20.1 8.7 11.2 46.9 7.3 7.0 6.8 9.1 8.2 12.1 21.4 39.8 4.8 3.5 10.6 10.7 18.8 3.8 29.1 15.4 499.5 7.3 21.9 49.6 13.7 26.4 17.4 5.9 8.1 13.4 7.1 7.2 12.2 7.9 12.0 7.2 15.6 38.3 4.6 13.1 10.9 9.1 19.8 9.2 137.9 15.2 7.7 19.7 12.3 11.0 8.5 3.7 14.7 13.8 30.1 13.3 18.9 18.3 12.0 HMX3 NKX5-1 ENSG00000188620 "H6 family homeobox 3" A6NHT5 10 123135970-123139423 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "brain: 6.9" "Cell type enriched" "Detected in single" 10 "Cardiomyocytes: 1.0" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HAP1: 8.1;HEL: 6.1;HeLa: 7.0;K-562: 17.9;NB-4: 13.4;SiHa: 7.0;THP-1: 5.7" "Region enriched" "Detected in single" 4 "hypothalamus: 1.1" "Group enriched" "Detected in some" 5 "basal ganglia: 1.4;hypothalamus: 4.8" HPA069659 Approved "Nucleoplasm,Centriolar satellite" Yes No "Cluster 17: Basophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 1: K-562 - Erythropoiesis" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "Centriolar satellite" "HPA069659: AB_2686165" "unprognostic (1.79e-1)" "unprognostic (9.65e-2)" "unprognostic (6.07e-2)" 0.9 0.1 0.4 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.5 0.1 0.0 0.0 0.1 1.3 6.9 0.0 0.1 0.0 0.2 0.0 2.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.1 0.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 8.1 0.0 0.0 0.7 0.4 6.1 7.0 0.2 0.1 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 17.9 0.1 0.0 0.0 0.0 13.4 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.4 0.2 0.0 7.0 0.0 0.1 0.0 0.0 5.7 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 1.6 0.3 0.4 0.2 0.2 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.3 0.9 0.4 0.2 0.4 0.2 0.1 0.4 0.1 0.3 0.1 0.1 6.5 1.3 6.9 2.4 0.1 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HMX2 NKX5-2 ENSG00000188816 "H6 family homeobox 2" A2RU54 10 123148136-123150672 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 2.2;kidney: 1.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "cervical cancer: 0.9" "Region enhanced" "Detected in some" "midbrain: 2.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "REH: 38.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 2.3" "CAB013268, CAB022752" Approved NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "CAB013268: , CAB022752: " "unprognostic (3.98e-2)" "unprognostic (1.00e-3)" "unprognostic (1.44e-1)" "unprognostic (7.18e-2)" "unprognostic (2.73e-2)" "unprognostic (7.64e-2)" "unprognostic (3.29e-1)" "unprognostic (2.10e-3)" "unprognostic (5.29e-1)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 2.2 0.7 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 BUB3 BUB3L ENSG00000154473 "BUB3 mitotic checkpoint protein" O43684 10 123154402-123170467 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003601, CAB037075" Supported Supported Nucleoplasm NA Yes 39000 "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB037075: AB_1078310, HPA003601: AB_1078309" "unprognostic (7.82e-2)" "prognostic favorable (2.04e-4)" "unprognostic (9.07e-2)" "unprognostic (1.83e-1)" "unprognostic (7.93e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (4.45e-5)" "unprognostic (6.04e-3)" "unprognostic (9.41e-2)" "unprognostic (6.30e-3)" "unprognostic (2.69e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (3.81e-7)" "unprognostic (8.80e-2)" "unprognostic (7.64e-2)" "unprognostic (1.51e-1)" "unprognostic (7.71e-2)" 36.6 49.8 27.3 63.3 34.5 102.9 41.1 35.0 35.0 36.0 30.7 49.0 42.2 35.7 35.2 56.6 37.6 35.8 28.0 31.9 36.4 32.6 34.9 33.5 99.9 34.1 50.6 42.9 30.1 32.6 36.0 38.2 39.6 30.6 49.1 25.5 39.5 28.8 36.9 44.1 47.7 36.4 35.7 52.9 38.4 58.5 33.0 100.6 37.4 33.5 87.2 49.5 40.4 48.6 309.8 302.5 190.4 211.5 105.4 100.3 166.2 316.2 329.5 340.3 268.8 266.3 203.2 275.9 116.3 145.2 163.6 195.9 285.1 343.0 349.9 228.8 294.2 173.0 355.1 291.8 110.1 338.1 206.8 86.5 132.9 307.9 382.4 182.1 232.7 228.9 216.1 266.7 308.4 264.1 281.8 206.9 117.6 159.0 293.0 378.6 96.2 175.7 156.3 333.1 141.4 143.1 179.2 116.6 151.9 77.5 135.0 173.4 188.5 262.4 163.9 167.6 473.8 143.0 220.6 433.9 143.0 333.2 113.2 200.3 113.2 165.7 246.0 122.2 224.1 216.7 223.0 251.0 119.1 209.7 237.9 249.3 56.1 241.6 112.3 127.6 366.9 294.0 27.3 34.5 35.0 35.0 31.9 36.4 34.1 50.6 39.6 35.7 33.0 48.6 55.8 25.6 36.5 15.3 99.7 130.5 65.5 154.6 73.4 30.8 53.4 48.8 39.2 44.3 66.9 38.6 10.4 108.1 119.0 37.1 70.5 68.8 160.8 26.1 41.4 62.1 40.7 93.6 14.4 58.9 136.5 62.6 34.7 28.1 50.7 56.3 45.0 43.0 80.7 10.1 12.9 57.3 118.0 58.1 68.6 159.3 45.1 53.1 96.0 16.9 140.4 55.7 97.9 21.6 35.9 64.1 40.2 46.3 107.1 64.7 44.5 78.4 51.2 25.1 105.2 42.2 70.6 199.8 145.4 86.3 133.3 65.0 150.3 84.1 67.8 62.9 GPR26 ENSG00000154478 "G protein-coupled receptor 26" Q8NDV2 10 123666355-123697399 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 23 "brain: 7.7" "Cell type enriched" "Detected in some" 6 "Excitatory neurons: 11.4" "Cancer enriched" "Detected in single" 13 "breast cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 62.7" HPA062736 Enhanced NA NA "Cluster 65: Brain - Ion transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA062736: AB_2684855" "unprognostic (4.15e-2)" "unprognostic (5.75e-2)" "unprognostic (3.42e-1)" "unprognostic (2.12e-1)" "unprognostic (9.09e-2)" "unprognostic (9.98e-2)" "unprognostic (2.12e-2)" "unprognostic (1.16e-2)" "unprognostic (1.12e-1)" 0.0 0.0 1.2 0.0 1.5 0.0 0.0 0.0 3.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 2.0 0.0 0.0 0.0 0.0 2.6 7.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 0.0 3.5 6.4 2.0 2.6 7.7 1.6 1.7 3.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CPXM2 "CPX2, UNQ676" ENSG00000121898 "Carboxypeptidase X, M14 family member 2" Q8N436 10 123706207-123940267 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 81.3;intestine: 75.4" "Cell type enhanced" "Detected in many" "Early spermatids: 106.8;Late spermatids: 202.5;Oligodendrocytes: 35.6;Peritubular cells: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "BJ: 18.4;fHDF/TERT166: 71.8;SuSa: 28.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048375 Uncertain "Secreted - unknown location" NA NA 62000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA048375: AB_2680377" "unprognostic (1.50e-1)" "unprognostic (3.66e-1)" "unprognostic (2.58e-2)" "unprognostic (4.02e-3)" "unprognostic (2.69e-2)" "unprognostic (6.48e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.57e-2)" "unprognostic (4.42e-2)" "unprognostic (2.14e-1)" "prognostic favorable (9.02e-4)" "unprognostic (3.48e-2)" "unprognostic (2.54e-2)" "unprognostic (1.27e-1)" "unprognostic (1.16e-3)" 29.1 6.4 3.9 5.9 7.2 0.0 20.8 9.2 2.6 5.8 81.3 75.4 6.2 10.2 59.8 18.4 16.0 11.2 18.0 3.5 7.2 11.2 2.4 7.0 2.7 16.1 10.7 16.7 5.2 2.5 10.9 1.2 11.6 15.1 7.0 0.5 9.3 12.7 3.8 7.3 14.9 56.9 20.0 16.8 19.9 9.6 10.4 7.8 15.0 7.9 6.6 28.3 9.2 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.4 0.7 1.1 0.1 0.0 0.0 0.0 0.0 71.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 28.0 0.5 0.0 0.0 0.1 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 7.2 9.2 2.6 3.5 7.2 16.1 10.7 11.6 20.0 10.4 18.3 22.3 0.0 0.6 0.3 0.1 2.2 0.0 0.2 6.2 0.0 0.3 0.4 2.4 0.0 0.0 1.8 0.0 8.3 0.1 0.2 1.9 0.4 106.8 0.2 0.2 26.1 0.0 0.0 5.0 0.2 0.3 23.0 1.1 0.3 0.0 0.1 16.8 0.0 0.3 1.7 0.5 0.7 0.0 0.0 2.7 202.5 10.8 0.6 3.6 0.0 0.0 0.0 0.0 1.0 35.6 0.1 0.1 79.0 1.4 0.0 0.4 0.0 0.0 0.1 0.0 1.6 2.0 1.3 1.9 0.6 2.0 5.1 0.2 0.0 2.7 0.2 CHST15 "BRAG, GALNAC4S-6ST, KIAA0598" ENSG00000182022 "Carbohydrate sulfotransferase 15" Q7LFX5 10 124007668-124093598 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 50.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 69.0" "Group enriched" "Detected in many" 11 "granulocytes: 69.0;monocytes: 38.7" "Cell line enhanced" "Detected in many" "Karpas-707: 66.0;REH: 90.4;U-266/70: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017584 Approved Approved Centrosome,Cytosol NA NA 690000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol Centrosome "HPA017584: AB_1849437" "unprognostic (1.19e-1)" "unprognostic (2.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-2)" "unprognostic (4.12e-2)" "unprognostic (1.18e-2)" "unprognostic (1.90e-1)" "unprognostic (3.02e-2)" "unprognostic (2.40e-2)" "unprognostic (7.62e-3)" "unprognostic (7.90e-2)" "unprognostic (8.16e-2)" "prognostic unfavorable (2.22e-7)" "unprognostic (6.47e-3)" "unprognostic (7.80e-2)" "unprognostic (4.63e-3)" "unprognostic (5.26e-3)" 17.0 10.4 9.3 19.8 25.4 7.0 11.4 5.3 14.6 10.6 23.8 19.8 9.8 7.9 8.3 9.4 15.0 12.8 5.5 17.2 6.0 9.6 13.6 17.2 17.8 8.3 8.2 37.0 14.1 2.8 8.4 6.6 6.7 9.7 8.8 2.8 9.4 13.8 13.7 9.2 15.4 10.6 10.2 36.7 11.5 4.3 9.5 9.3 19.8 5.8 14.2 12.4 9.2 11.6 32.3 21.2 7.8 1.7 7.5 4.0 0.1 6.4 8.6 3.4 4.9 0.6 17.1 0.0 20.1 26.4 2.3 35.9 1.5 20.8 2.9 0.2 5.9 0.1 9.3 16.0 2.4 0.0 39.2 2.5 23.5 9.5 8.0 8.3 6.9 0.1 0.0 66.0 17.0 18.0 0.1 0.1 6.8 4.9 0.1 90.4 10.6 21.6 17.1 3.1 0.8 1.7 17.1 9.6 0.0 19.3 7.0 0.1 8.3 0.9 0.3 24.3 1.0 59.5 15.7 16.9 0.2 0.0 0.1 0.0 21.8 15.3 0.0 33.3 0.0 4.5 0.0 0.0 4.2 4.4 0.3 0.0 69.0 0.0 38.7 4.9 0.3 9.1 9.3 25.4 5.3 14.6 17.2 6.0 8.3 8.2 6.7 10.2 9.5 11.6 14.3 22.4 9.6 4.2 13.5 16.8 16.1 15.3 2.2 5.6 10.5 5.2 2.2 12.8 12.1 20.2 0.0 1.8 7.2 0.1 0.0 9.7 29.5 7.4 5.9 18.2 1.8 0.0 43.8 0.7 2.3 8.4 0.5 14.0 5.7 0.4 42.1 9.0 10.5 0.0 33.2 0.0 16.2 50.2 3.6 34.8 10.2 34.0 1.8 43.1 30.3 0.1 2.1 35.2 1.0 9.8 0.0 1.9 34.3 14.7 0.0 0.7 11.9 0.5 19.7 13.4 11.5 10.4 10.0 2.4 11.6 1.0 1.4 0.8 0.1 15.8 OAT HOGA ENSG00000065154 "Ornithine aminotransferase" P04181 10 124397303-124418976 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 781.8" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 1222.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033576, HPA040098, HPA064742" Enhanced Supported Nucleoplasm,Mitochondria NA NA 12000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 56: Intestine - Transmembrane transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 45: Enterocytes - Digestion" Mitochondria Nucleoplasm "CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343" "unprognostic (1.61e-2)" "unprognostic (1.70e-2)" "unprognostic (9.96e-2)" "unprognostic (1.02e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (4.43e-3)" "unprognostic (1.65e-1)" "unprognostic (2.37e-2)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.21e-1)" "unprognostic (2.19e-1)" "unprognostic (2.72e-2)" "unprognostic (2.00e-2)" 60.0 119.6 69.4 40.8 71.2 106.4 150.1 74.6 97.4 99.7 75.4 75.6 750.0 82.5 63.7 105.0 56.0 68.7 52.3 71.2 78.7 114.6 162.5 42.7 38.1 76.5 72.0 77.0 36.1 46.1 53.5 65.0 85.2 74.3 67.2 51.1 225.4 94.6 58.2 71.6 781.8 97.8 73.6 34.1 70.1 56.2 73.3 30.2 67.7 60.0 69.1 58.9 63.8 81.7 241.5 42.8 27.5 98.7 272.4 260.8 93.4 142.2 288.0 124.2 135.2 110.5 30.8 0.5 101.0 241.8 118.0 249.4 126.5 265.7 134.0 42.4 174.9 268.1 28.1 82.7 139.9 0.4 169.3 172.1 134.5 111.9 129.5 204.9 147.1 48.4 470.8 50.0 175.5 62.6 72.1 15.3 55.1 73.2 59.6 66.3 104.5 65.3 119.8 3.9 57.3 60.9 89.7 235.1 209.5 156.6 78.6 65.8 114.3 70.5 65.3 117.9 90.2 42.4 47.6 64.6 97.4 72.0 34.4 38.0 39.6 36.0 28.8 35.3 31.2 15.2 24.0 30.5 44.3 16.2 29.5 29.8 40.0 16.9 37.2 9.4 24.6 29.6 69.4 71.2 74.6 97.4 71.2 78.7 76.5 72.0 85.2 73.6 73.3 81.7 49.0 19.2 49.7 37.9 44.7 151.3 144.0 362.8 185.5 35.2 154.2 163.7 21.8 18.6 182.7 35.0 27.1 120.8 80.3 38.2 90.1 34.6 30.4 37.0 90.4 37.7 43.1 317.0 31.8 13.4 90.5 124.2 55.5 40.6 43.8 32.2 37.5 152.2 66.2 43.7 33.4 104.1 197.4 31.8 68.1 15.2 104.1 56.7 85.4 17.8 34.8 37.4 18.6 22.1 41.9 12.6 74.6 120.0 32.9 82.6 1222.6 196.4 76.4 24.4 78.9 106.1 115.1 46.3 33.2 161.8 126.0 48.2 65.0 92.4 214.5 82.2 NKX1-2 "bB238F13.2, C10orf121" ENSG00000229544 "NK1 homeobox 2" Q9UD57 10 124445243-124450035 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Basal squamous epithelial cells: 2.2" "Cancer enhanced" "Detected in some" "testis cancer: 3.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 5.7;hTCEpi: 5.4;NTERA-2: 10.8;SCLC-21H: 4.7;SuSa: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA029367 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" "unprognostic (2.43e-1)" "unprognostic (7.85e-3)" "unprognostic (6.81e-5)" "unprognostic (1.55e-2)" "unprognostic (3.61e-2)" "unprognostic (5.40e-2)" "unprognostic (7.28e-2)" "unprognostic (2.20e-1)" "unprognostic (3.73e-2)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (8.68e-2)" 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 5.7 0.5 0.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.1 0.0 0.1 12.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 LHPP HDHD2B ENSG00000107902 "Phospholysine phosphohistidine inorganic pyrophosphate phosphatase" Q9H008 10 124461823-124617888 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 198.8;choroid plexus: 104.0" "Cell type enhanced" "Detected in many" "Early spermatids: 114.9;Late spermatids: 163.3;Proximal tubular cells: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009163, HPA009269" Enhanced Supported "Nuclear speckles,Cytosol" NA NA 820000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 70: Brain - Nervous system development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nuclear speckles, Cytosol" "HPA009163: AB_1079250, HPA009269: AB_1079249" "unprognostic (3.46e-2)" "unprognostic (1.23e-2)" "unprognostic (4.78e-2)" "unprognostic (3.89e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (5.77e-3)" "unprognostic (2.02e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-1)" "unprognostic (6.42e-2)" "unprognostic (5.55e-2)" "unprognostic (1.79e-3)" "unprognostic (2.52e-1)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" 12.9 32.0 135.1 8.2 173.7 10.5 13.0 159.3 190.6 18.5 104.0 27.1 23.4 20.2 13.4 24.1 10.0 10.2 17.5 129.7 156.5 28.4 60.2 9.2 11.8 179.2 165.8 9.0 15.9 9.2 14.5 8.6 170.7 14.0 8.5 7.5 18.3 12.5 10.2 15.3 21.1 10.2 151.1 14.0 20.1 24.2 156.3 9.7 29.4 4.8 15.2 14.7 16.1 198.8 24.7 12.0 4.7 12.1 18.2 14.7 12.8 8.2 18.0 5.5 10.0 2.1 22.4 24.4 19.7 13.5 6.1 26.1 1.4 4.7 5.7 5.4 16.3 17.6 4.1 11.4 18.5 3.6 27.6 11.0 20.0 5.4 13.0 16.0 8.8 21.4 8.9 9.5 6.9 24.5 12.0 11.3 8.5 10.4 6.8 12.4 5.3 31.8 12.1 3.2 2.7 14.2 6.3 22.6 8.2 6.5 17.2 0.6 4.2 8.5 12.2 7.2 2.3 7.9 2.5 7.8 7.7 6.8 2.0 8.1 28.8 25.3 16.1 24.5 20.8 41.0 18.7 17.2 35.6 43.3 22.4 16.0 4.8 7.9 29.0 13.4 32.1 24.4 135.1 173.7 159.3 190.6 129.7 156.5 179.2 165.8 170.7 151.1 156.3 198.8 5.0 3.2 14.8 22.9 29.1 7.4 9.4 22.1 13.1 6.0 19.8 19.8 15.8 12.8 19.4 7.3 0.0 54.2 6.2 17.9 33.2 5.3 114.9 17.7 12.7 4.6 9.5 19.8 29.4 2.3 24.7 11.2 19.9 8.2 10.8 23.3 6.1 61.1 26.5 11.8 27.8 21.3 24.4 16.0 8.1 163.3 5.9 12.9 17.8 8.4 15.6 9.8 8.2 15.6 76.4 3.3 30.2 10.5 19.7 6.7 80.5 93.8 24.9 6.4 13.1 5.2 9.5 33.1 11.3 30.7 5.4 24.2 12.1 12.4 23.0 16.3 FAM53B "bA12J10.2, KIAA0140, smp" ENSG00000189319 "Family with sequence similarity 53 member B" Q14153 10 124619292-124744378 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-MEL-30: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037751, HPA037752" Approved Approved Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA037751: AB_2675645, HPA037752: AB_10672285" "unprognostic (7.88e-2)" "prognostic favorable (4.96e-4)" "unprognostic (1.73e-2)" "unprognostic (2.92e-1)" "unprognostic (4.91e-1)" "prognostic favorable (1.97e-4)" "unprognostic (2.52e-2)" "unprognostic (5.03e-3)" "unprognostic (1.51e-2)" "unprognostic (4.02e-2)" "prognostic favorable (7.00e-6)" "unprognostic (1.93e-1)" "prognostic favorable (4.81e-7)" "prognostic favorable (3.26e-4)" "unprognostic (3.41e-1)" "unprognostic (2.03e-1)" "unprognostic (2.45e-2)" 12.6 19.2 21.6 14.3 33.3 25.8 8.3 18.1 30.5 12.8 8.4 12.4 15.4 23.6 3.9 13.2 11.2 5.7 18.9 21.1 16.5 10.6 4.2 10.7 31.0 30.3 25.6 19.1 7.2 12.4 12.7 4.9 22.7 8.9 7.1 6.3 15.2 7.0 55.0 14.4 17.1 12.8 17.3 20.1 9.6 15.6 35.9 32.9 16.2 22.3 21.7 8.6 8.0 51.7 10.7 12.5 9.6 27.5 11.3 5.8 26.2 4.8 6.7 5.6 4.9 6.6 6.7 37.2 9.7 6.5 5.5 20.8 12.7 15.4 2.4 44.6 13.2 18.1 6.3 16.7 7.6 16.6 11.8 5.6 16.2 5.2 8.3 7.0 9.1 21.2 13.2 17.0 5.5 20.4 18.7 22.4 5.9 9.5 10.9 32.9 3.6 18.2 4.6 19.3 12.8 12.2 4.7 17.8 60.2 3.8 7.2 21.8 5.0 6.7 5.5 6.6 10.7 2.7 5.3 23.8 5.1 13.6 3.8 0.8 2.2 2.2 6.9 2.1 3.3 3.5 3.0 3.7 1.4 6.0 1.2 2.0 3.2 0.7 2.6 1.9 3.6 3.4 21.6 33.3 18.1 30.5 21.1 16.5 30.3 25.6 22.7 17.3 35.9 51.7 13.4 9.6 12.6 14.0 22.4 3.6 5.9 8.5 12.5 6.1 4.3 2.4 17.9 1.5 6.7 3.7 10.4 4.7 31.5 25.9 1.9 3.1 19.4 12.9 18.6 8.7 15.0 8.6 27.1 4.0 4.9 6.0 6.6 8.3 5.1 9.0 16.8 3.7 13.3 1.7 15.0 17.4 10.2 27.8 5.1 6.2 5.6 16.4 8.8 24.4 14.5 4.5 30.9 16.1 79.4 2.8 12.2 10.5 20.0 3.7 22.4 4.3 14.1 25.6 0.0 9.8 4.6 7.0 8.6 12.1 5.7 0.8 21.4 6.9 15.3 6.7 EEF1AKMT2 "C10orf138, Efm4, METTL10" ENSG00000203791 "EEF1A lysine methyltransferase 2" Q5JPI9 10 124748149-124791887 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 29.1;Distal tubular cells: 66.5;Extravillous trophoblasts: 29.8;Proximal tubular cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA050138 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Vesicles, Cytosol" "HPA050138: AB_2681030" "unprognostic (1.64e-3)" "unprognostic (3.42e-2)" "unprognostic (1.34e-1)" "unprognostic (9.75e-2)" "unprognostic (7.19e-2)" "unprognostic (1.17e-1)" "unprognostic (2.33e-2)" "unprognostic (2.29e-3)" "unprognostic (9.04e-3)" "unprognostic (9.76e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (4.82e-4)" "unprognostic (3.90e-2)" "unprognostic (4.44e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (9.09e-2)" 4.8 3.8 3.0 2.1 3.3 3.6 5.3 4.8 4.2 4.6 3.0 3.7 1.8 4.0 4.6 4.0 3.8 2.1 4.1 3.1 3.0 4.9 5.2 3.3 2.5 2.8 3.1 5.5 4.4 4.5 4.3 2.7 2.8 4.3 3.8 2.5 5.1 2.8 4.0 5.0 3.5 2.6 2.7 3.5 3.7 5.6 2.8 3.3 5.1 3.3 3.1 3.4 4.2 3.6 12.6 3.3 4.8 8.0 3.1 8.0 3.1 5.8 7.6 7.4 6.5 4.3 7.1 8.4 3.0 4.7 2.5 3.8 6.8 4.2 11.5 7.0 2.5 6.8 4.2 3.9 6.0 10.9 4.1 3.9 3.9 4.1 9.9 6.2 4.7 7.0 7.6 9.3 9.3 3.7 5.2 8.5 5.9 4.6 4.8 2.3 5.7 2.6 4.6 2.7 1.5 3.8 3.7 6.2 8.7 3.3 5.4 8.5 5.8 2.7 2.9 4.5 8.8 4.3 3.7 6.8 4.9 5.7 3.9 0.8 1.0 1.6 1.6 1.1 2.5 1.9 1.6 2.0 1.2 1.3 2.2 1.6 0.1 4.4 0.8 1.5 1.9 1.1 3.0 3.3 4.8 4.2 3.1 3.0 2.8 3.1 2.8 2.7 2.8 3.6 23.2 3.2 11.3 0.0 8.9 0.0 0.0 0.0 0.0 0.0 20.5 22.4 0.0 0.0 2.5 11.0 0.0 29.1 13.4 0.0 66.5 20.0 0.0 11.4 11.8 7.5 0.0 0.0 0.0 20.4 29.8 10.4 0.0 10.5 2.5 17.8 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 11.4 0.0 0.0 0.0 0.0 19.8 0.0 0.0 2.8 0.0 0.0 30.5 3.6 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 17.1 7.1 14.7 0.0 0.0 ABRAXAS2 "ABRO1, Em:AC068896.4, FAM175B, KIAA0157" ENSG00000165660 "Abraxas 2, BRISC complex subunit" Q15018 10 124801819-124836667 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6;Collecting duct cells: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037591, HPA037592, HPA074089" Approved Supported Cytosol Yes No "Cluster 41: Basophils - Cellular respiration" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA037591: AB_10671877, HPA037592: AB_2675566, HPA074089: AB_2686659" "unprognostic (2.78e-1)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (6.47e-2)" "unprognostic (1.08e-1)" "unprognostic (3.51e-2)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (6.81e-2)" "unprognostic (3.72e-2)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.09e-2)" "unprognostic (1.58e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" 9.1 10.5 8.0 10.3 8.3 12.3 12.2 8.0 9.9 8.8 6.6 9.9 10.2 9.4 9.3 9.8 9.0 8.2 10.0 8.4 8.6 12.3 13.7 9.3 12.5 7.8 8.4 10.4 8.3 12.7 3.9 10.3 8.5 9.5 10.3 5.3 8.5 8.8 19.0 11.6 10.8 10.5 7.7 10.0 9.5 6.7 8.2 12.9 12.7 16.2 13.3 9.7 6.8 7.9 22.2 14.9 15.7 21.6 19.9 19.6 13.5 22.4 35.1 26.2 24.1 12.1 20.9 24.7 18.6 24.4 14.2 24.4 25.0 21.0 27.5 21.6 17.2 18.8 11.8 15.0 25.4 32.6 18.9 21.6 25.1 25.8 46.4 28.3 20.1 21.7 20.0 16.6 21.6 14.5 25.1 29.1 13.5 20.0 13.8 20.0 16.6 15.1 19.5 11.1 10.8 19.8 17.9 17.0 24.4 15.8 14.0 22.2 17.4 14.0 11.2 16.5 27.1 17.2 17.1 23.6 18.3 15.9 10.1 22.8 10.5 9.8 7.6 14.5 10.5 10.5 8.8 10.6 12.9 11.6 9.3 10.3 4.1 7.7 11.8 8.7 11.4 7.0 8.0 8.3 8.0 9.9 8.4 8.6 7.8 8.4 8.5 7.7 8.2 7.9 15.1 25.6 14.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 9.4 10.3 0.0 0.0 6.2 23.9 0.0 16.9 7.0 0.0 17.6 13.7 0.0 11.1 15.6 6.3 0.0 0.0 0.0 12.5 13.0 5.5 0.0 12.3 12.6 12.4 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 20.7 0.0 0.0 0.0 0.0 10.2 0.0 0.0 1.6 0.0 0.0 18.6 12.4 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 16.0 4.3 13.5 0.0 0.0 ZRANB1 TRABID ENSG00000019995 "Zinc finger RANBP2-type containing 1" Q9UGI0 10 124942123-124988189 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029239, HPA029240, HPA029241" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205" "unprognostic (2.06e-1)" "unprognostic (5.16e-2)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (1.40e-1)" "unprognostic (9.53e-3)" "unprognostic (4.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (4.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.76e-1)" "unprognostic (1.26e-1)" "unprognostic (1.47e-2)" 13.9 21.1 17.9 6.6 18.7 22.5 13.1 26.7 21.8 14.4 18.8 13.8 5.1 14.4 12.4 10.5 10.8 9.7 18.4 18.1 17.8 10.9 24.8 10.6 8.2 17.7 17.8 19.3 8.8 16.8 8.7 10.6 17.8 11.2 8.8 17.5 9.0 13.6 52.9 15.0 7.7 15.2 18.0 8.7 8.3 19.7 18.3 13.6 10.1 46.4 10.7 10.3 11.7 19.4 15.1 8.6 17.8 13.1 27.1 22.7 7.5 14.5 39.6 27.1 31.3 12.8 11.7 15.7 10.6 18.4 8.8 10.7 22.8 10.7 36.2 16.8 11.3 9.0 9.7 13.8 57.6 13.6 6.6 25.2 30.8 19.9 42.2 37.7 17.3 14.2 1.3 12.7 14.8 12.1 16.2 11.9 6.5 8.2 9.1 13.7 12.7 7.2 12.0 10.9 9.1 15.2 12.3 9.4 16.4 16.7 10.4 11.5 12.9 11.5 11.8 9.7 18.3 13.4 12.5 18.1 13.1 9.5 5.8 0.9 0.4 1.2 0.8 0.1 0.6 0.9 0.9 0.7 0.3 1.3 1.5 1.2 1.7 1.3 0.2 0.5 0.9 0.3 17.9 18.7 26.7 21.8 18.1 17.8 17.7 17.8 17.8 18.0 18.3 19.4 28.6 19.2 25.3 61.7 17.9 24.6 22.8 10.7 22.2 36.9 29.0 21.2 22.9 15.7 17.3 18.4 50.1 12.3 26.3 16.2 0.0 13.1 80.2 29.4 38.6 21.7 26.8 25.7 58.2 11.6 9.8 21.4 14.3 38.5 26.0 34.3 14.6 43.8 12.5 37.0 58.5 19.0 4.1 16.7 22.4 30.3 23.9 24.3 16.0 52.5 13.2 24.2 19.6 56.3 76.0 19.3 11.5 23.0 21.0 31.4 11.9 10.5 19.2 26.0 13.1 34.6 27.6 28.8 19.1 20.5 27.8 27.5 21.4 23.7 13.1 31.1 CTBP2 ribeye ENSG00000175029 "C-terminal binding protein 2" P56545 10 124984317-125161170 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023559, HPA023564, CAB031916, HPA044971, CAB079018" Approved Approved Approved Nucleoplasm NA NA 10000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "CAB031916: AB_2086774, CAB079018: , HPA023559: AB_1847309, HPA023564: AB_1847310, HPA044971: AB_2679161" "unprognostic (8.69e-2)" "unprognostic (1.27e-2)" "unprognostic (4.14e-2)" "unprognostic (1.41e-2)" "unprognostic (6.84e-3)" "unprognostic (4.05e-3)" "unprognostic (3.63e-2)" "unprognostic (5.60e-3)" "unprognostic (1.46e-1)" "unprognostic (2.12e-1)" "unprognostic (3.24e-2)" "unprognostic (3.99e-3)" "prognostic favorable (1.70e-4)" "unprognostic (4.34e-2)" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (1.62e-1)" 27.1 25.4 21.4 17.1 23.7 17.2 30.6 32.9 20.1 47.9 47.8 36.7 33.3 46.8 21.0 30.4 37.3 22.1 19.9 22.8 25.5 31.7 5.7 33.1 9.4 24.3 24.1 41.8 40.7 21.9 23.6 24.7 22.0 38.6 29.2 55.4 36.7 24.0 22.8 16.7 33.4 30.0 22.1 21.6 36.9 19.7 28.8 9.0 53.9 19.8 9.1 29.9 30.9 23.7 87.3 96.5 83.6 70.2 43.9 43.0 46.1 66.4 77.0 61.2 69.3 60.4 99.7 0.1 33.6 66.9 38.6 67.2 83.8 106.5 45.8 0.3 63.8 63.8 61.6 1.3 91.7 27.2 48.9 37.1 82.7 63.5 125.5 80.9 79.1 4.9 2.6 0.5 38.7 96.5 3.0 27.8 63.0 90.3 61.3 77.4 35.0 0.8 72.5 38.8 25.5 73.1 64.7 56.0 86.5 64.7 39.7 43.9 64.4 36.8 46.2 53.0 57.9 1.4 5.3 0.3 46.1 0.3 37.1 30.8 8.5 16.4 8.5 9.0 1.1 0.5 0.4 2.3 11.2 0.3 0.5 3.6 14.3 34.6 22.4 9.4 0.3 4.7 21.4 23.7 32.9 20.1 22.8 25.5 24.3 24.1 22.0 22.1 28.8 23.7 64.7 32.1 27.2 72.1 4.0 47.2 83.4 41.5 33.6 182.5 75.8 59.8 32.7 55.8 53.2 38.6 158.4 22.3 50.7 81.7 68.4 69.3 29.9 125.0 65.1 63.0 55.0 42.3 41.8 60.8 70.5 42.3 40.2 163.0 17.7 43.1 61.4 1.2 29.6 107.7 35.0 93.9 50.8 49.3 46.9 38.1 60.3 47.0 58.7 127.4 60.6 63.2 124.6 44.2 87.1 83.8 61.6 77.8 6.9 89.3 45.1 31.6 94.1 107.5 59.2 59.6 67.0 12.7 45.5 42.1 39.8 19.3 15.3 81.3 106.1 102.7 TEX36 "bA383C5.1, C10orf122" ENSG00000175018 "Testis expressed 36" Q5VZQ5 10 125576522-125683163 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 26.8" "Group enriched" "Detected in some" 53 "Early spermatids: 358.7;Late spermatids: 347.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-2197: 8.3" "Region enriched" "Detected in single" 15 "cerebellum: 2.3" "Low region specificity" "Detected in some" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 34: Spermatids - Unknown function" "unprognostic (7.72e-3)" "unprognostic (3.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 358.7 0.5 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 347.6 1.8 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 3.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EDRF1 "C10orf137, DKFZp586F1019, FLJ21617" ENSG00000107938 "Erythroid differentiation regulatory factor 1" Q3B7T1 10 125719515-125764143 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 145.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031820 Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Centrosome, Cytosol" "HPA031820: AB_10600753" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (1.53e-1)" "unprognostic (3.64e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-2)" "unprognostic (8.84e-4)" "unprognostic (4.76e-3)" "unprognostic (8.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.63e-3)" "unprognostic (4.62e-2)" "prognostic unfavorable (3.16e-5)" "unprognostic (3.44e-3)" "unprognostic (5.51e-2)" "unprognostic (1.38e-1)" "unprognostic (7.68e-3)" 4.1 4.0 2.0 6.1 2.7 21.8 5.6 5.3 2.9 5.6 2.7 4.0 5.0 7.4 4.9 4.7 4.6 4.1 5.1 2.9 2.0 3.6 2.8 4.2 9.7 1.7 1.7 8.0 7.2 4.3 2.9 5.7 2.3 6.8 5.2 4.6 12.3 4.1 5.7 5.1 4.5 5.2 1.5 5.4 4.7 15.1 1.7 9.4 5.2 5.1 8.2 4.4 3.3 4.1 12.6 11.7 15.4 16.5 7.2 10.0 7.8 14.8 13.6 16.3 18.5 15.7 10.4 16.5 6.9 9.6 9.5 15.3 22.6 4.7 18.0 10.3 18.3 12.0 12.5 8.9 9.6 17.0 12.1 6.5 6.0 16.2 8.1 15.6 7.8 8.9 11.1 11.2 10.6 5.3 16.9 11.8 20.6 7.7 10.2 14.0 13.2 9.7 6.5 7.2 7.6 14.9 10.7 5.9 10.1 13.9 10.3 6.8 5.4 8.8 9.6 12.4 17.1 15.0 11.4 26.1 9.3 8.8 5.0 5.9 2.3 1.4 2.7 2.0 3.4 3.1 2.2 2.5 3.0 2.3 2.2 2.8 2.9 2.9 1.3 2.9 3.1 1.4 2.0 2.7 5.3 2.9 2.9 2.0 1.7 1.7 2.3 1.5 1.7 4.1 12.4 12.8 9.7 26.1 19.1 5.9 5.7 5.1 15.4 23.9 9.3 8.4 12.9 8.6 9.0 11.0 33.3 6.7 28.5 5.1 0.0 4.3 145.1 11.2 14.6 9.5 4.2 7.6 40.9 7.2 6.0 12.1 17.3 27.2 20.3 24.7 7.5 7.0 4.1 20.2 31.7 7.5 4.1 7.7 4.2 61.5 21.1 9.2 7.2 22.5 12.2 9.1 13.4 22.1 36.2 8.3 4.9 19.9 27.1 6.6 7.1 2.7 8.6 24.4 6.6 13.0 11.0 26.8 21.4 10.6 8.2 4.5 20.1 18.5 7.3 5.2 MMP21 ENSG00000154485 "Matrix metallopeptidase 21" Q8N119 10 125753580-125775821 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" Heterotaxy "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "epididymis: 53.9" "Cell type enhanced" "Detected in some" "Distal tubular cells: 1.9;Granulosa cells: 1.4;Microglial cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.32e-2)" "unprognostic (1.28e-1)" "unprognostic (8.51e-2)" "unprognostic (2.19e-2)" "unprognostic (4.02e-2)" "unprognostic (2.21e-2)" "unprognostic (4.22e-3)" "unprognostic (1.01e-1)" "unprognostic (2.12e-1)" "unprognostic (1.48e-1)" "unprognostic (2.89e-2)" "unprognostic (3.62e-2)" "unprognostic (9.70e-8)" "unprognostic (1.30e-2)" "unprognostic (7.69e-2)" "unprognostic (7.00e-2)" "unprognostic (2.18e-1)" 0.2 0.3 0.4 0.6 0.7 0.7 0.2 1.7 0.7 0.2 0.2 0.2 0.5 0.5 53.9 0.5 0.4 0.7 0.8 0.5 0.4 0.1 0.3 0.2 1.0 0.3 0.3 3.7 0.7 0.0 0.1 0.1 0.2 0.5 0.1 1.8 1.2 0.2 0.3 1.2 0.4 0.2 0.1 0.6 0.4 1.0 0.5 0.0 0.5 0.0 0.2 0.2 0.0 0.9 0.4 0.2 0.6 0.4 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.4 0.1 0.9 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.3 0.3 0.0 0.3 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.2 0.5 0.2 0.2 0.3 0.5 0.4 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 1.7 0.7 0.5 0.4 0.3 0.3 0.2 0.1 0.5 0.9 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 UROS ENSG00000188690 "Uroporphyrinogen III synthase" P10746 10 125784980-125823258 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 231.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044038 Approved Approved Nucleoplasm,Cytosol NA NA 69000 "Cluster 24: B-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm Cytosol "HPA044038: AB_10966692" "unprognostic (8.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.77e-1)" "unprognostic (7.19e-2)" "unprognostic (1.90e-1)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (5.82e-2)" "unprognostic (1.27e-1)" "unprognostic (4.35e-3)" "unprognostic (4.23e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (1.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.68e-1)" "unprognostic (3.93e-1)" 27.9 41.3 54.1 13.4 55.3 67.5 26.9 40.6 64.5 15.9 33.0 29.9 20.9 21.4 56.9 24.9 19.3 15.6 73.2 56.3 45.8 40.7 59.7 20.5 18.8 41.6 48.1 22.5 32.9 30.0 29.9 11.3 43.5 27.4 16.5 26.2 29.6 19.1 83.8 23.0 24.2 18.1 40.2 28.0 29.6 31.2 51.8 18.6 32.5 80.0 19.1 27.3 17.0 47.8 45.5 56.3 29.8 74.9 38.5 42.2 51.9 51.4 94.5 39.0 34.6 22.9 54.0 58.4 24.7 72.9 24.3 23.5 18.5 43.1 31.3 78.1 39.9 125.3 27.9 40.1 67.3 50.7 29.7 59.3 20.7 25.8 66.0 47.5 34.4 48.5 24.4 54.1 63.5 65.2 51.2 72.8 37.7 31.8 54.0 33.1 34.1 37.3 53.9 28.2 26.2 46.8 51.6 41.8 80.7 30.8 40.4 59.1 33.8 52.3 19.6 38.1 48.2 50.7 36.8 40.6 75.6 23.1 26.3 4.9 31.9 4.6 30.1 33.1 33.9 30.1 29.3 38.6 53.5 37.5 38.1 29.6 2.1 53.6 31.9 25.3 29.8 38.1 54.1 55.3 40.6 64.5 56.3 45.8 41.6 48.1 43.5 40.2 51.8 47.8 19.0 19.2 23.1 20.5 34.3 9.3 12.0 31.8 9.6 49.3 36.2 39.5 70.5 40.0 28.6 36.8 45.9 60.8 36.3 19.1 101.8 59.7 57.0 11.2 25.5 22.2 14.5 231.5 23.9 59.6 47.4 33.3 23.9 16.9 11.4 112.3 28.2 53.4 79.3 47.1 25.2 25.6 40.7 47.8 20.8 123.7 35.8 31.6 62.2 9.4 58.7 77.0 69.0 13.6 29.6 42.7 15.8 40.6 46.9 27.3 52.9 142.6 20.4 42.3 6.6 22.8 36.7 55.7 100.9 28.5 12.8 20.0 37.8 55.0 38.8 21.3 BCCIP "BCCIPalpha, TOK-1" ENSG00000107949 "BRCA2 and CDKN1A interacting protein" Q9P287 10 125823546-125853695 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038011 Supported Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA038011: AB_2675784" "unprognostic (1.05e-1)" "unprognostic (2.38e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-2)" "unprognostic (3.54e-2)" "unprognostic (1.38e-2)" "unprognostic (1.93e-3)" "unprognostic (2.51e-1)" "unprognostic (3.04e-2)" "unprognostic (6.62e-3)" "unprognostic (1.88e-1)" "unprognostic (1.30e-3)" "unprognostic (1.90e-3)" "unprognostic (4.75e-2)" "unprognostic (1.58e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" 40.0 35.1 37.7 38.3 39.1 62.4 52.4 41.1 43.4 31.4 42.3 37.6 32.3 31.0 54.6 38.5 33.0 26.6 48.0 37.5 38.7 55.3 67.9 27.2 49.3 38.3 38.3 42.8 47.1 41.6 24.8 32.5 39.2 42.4 41.1 55.7 58.2 28.6 77.5 31.8 31.7 31.4 38.7 29.8 42.8 48.3 39.0 50.0 39.8 63.6 48.7 55.9 30.1 40.8 225.6 114.4 126.9 141.3 70.9 77.2 105.9 117.9 112.1 142.3 131.2 188.2 146.4 156.6 72.1 108.6 107.1 121.4 219.3 167.0 197.6 145.3 148.5 157.9 97.5 210.0 89.4 219.7 96.1 79.9 98.7 170.1 178.3 108.0 137.7 145.1 177.7 78.1 122.5 134.7 142.7 220.4 98.2 188.0 170.2 134.7 133.5 94.3 126.6 106.0 67.2 68.5 88.1 142.4 149.9 102.7 76.9 96.3 93.0 65.9 116.9 98.2 215.9 79.3 94.9 233.0 129.7 112.5 52.0 30.3 68.3 41.1 56.2 86.6 77.8 76.8 63.7 61.9 75.2 71.4 71.1 64.4 11.2 68.2 94.3 65.0 75.6 48.1 37.7 39.1 41.1 43.4 37.5 38.7 38.3 38.3 39.2 38.7 39.0 40.8 21.6 64.1 67.9 16.6 46.9 66.9 59.3 60.6 58.1 24.2 32.2 27.3 80.4 28.6 67.0 23.9 22.9 41.4 28.2 16.7 78.2 52.7 14.7 37.6 36.6 30.4 25.8 47.3 21.3 44.1 38.0 43.2 40.2 33.2 27.1 33.6 23.2 50.4 35.8 16.8 21.0 23.1 42.7 28.9 22.2 9.4 37.0 29.3 23.2 11.2 36.2 30.2 28.8 22.1 25.7 45.1 19.6 31.2 57.7 51.9 22.7 62.4 74.7 25.1 26.3 47.5 37.5 105.3 117.2 57.8 52.1 33.8 38.6 28.3 33.3 55.5 DHX32 "DDX32, DHLP1, FLJ10694, FLJ10889" ENSG00000089876 "DEAH-box helicase 32 (putative)" Q7L7V1 10 125836337-125896436 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 101.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048872 Approved NA NA "Cluster 37: B-cells - Transcription" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA048872: AB_2680540" "unprognostic (1.05e-1)" "unprognostic (3.02e-1)" "unprognostic (3.97e-2)" "unprognostic (6.40e-2)" "unprognostic (2.40e-1)" "unprognostic (3.57e-1)" "unprognostic (1.55e-2)" "unprognostic (9.88e-2)" "unprognostic (2.85e-1)" "unprognostic (6.89e-3)" "prognostic unfavorable (9.49e-5)" "prognostic unfavorable (6.34e-4)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (8.62e-2)" "unprognostic (1.98e-1)" "unprognostic (2.49e-1)" 12.6 18.5 11.5 9.0 12.9 7.2 20.6 12.7 12.8 14.9 23.6 30.6 17.5 11.6 13.7 25.2 12.7 10.9 35.5 11.0 12.2 16.4 15.3 14.6 6.9 12.9 12.5 25.7 30.4 20.1 10.0 15.4 12.8 17.8 36.0 21.6 23.8 11.9 21.3 24.8 17.8 12.5 12.8 9.4 33.7 33.0 13.6 8.9 14.7 21.3 12.7 17.2 16.4 14.7 70.0 37.8 25.0 51.6 32.4 29.9 44.6 30.3 69.8 27.1 30.2 8.9 67.4 0.3 22.2 35.4 29.9 49.9 11.5 50.9 22.2 35.2 22.5 8.6 18.3 13.6 36.0 17.0 27.4 29.6 52.3 26.6 59.3 48.4 39.9 0.4 24.3 0.3 26.3 31.5 0.3 26.7 19.0 34.2 25.9 0.3 40.6 15.1 39.4 32.1 3.4 18.2 28.1 49.7 42.6 32.5 18.3 14.9 36.0 21.0 12.8 27.0 27.0 26.4 27.5 0.6 37.9 0.4 11.0 0.1 1.7 1.8 1.4 1.8 1.1 4.6 0.6 0.5 1.2 2.0 2.7 1.1 0.0 2.7 0.9 0.7 0.2 0.5 11.5 12.9 12.7 12.8 11.0 12.2 12.9 12.5 12.8 12.8 13.6 14.7 11.7 16.0 17.2 31.3 6.5 5.0 14.8 10.0 9.6 13.5 12.0 9.9 25.4 12.8 15.3 7.3 22.9 19.4 4.0 41.8 15.6 32.4 101.8 19.7 20.2 13.9 4.2 16.2 20.3 37.7 29.8 9.8 38.2 24.7 11.4 27.1 6.8 10.6 12.1 11.8 27.9 48.2 14.2 6.7 2.4 28.3 10.5 7.4 7.2 9.4 8.2 29.1 2.1 23.6 30.2 54.5 22.2 17.0 9.0 25.0 14.6 13.9 22.1 15.2 13.1 14.4 11.2 51.3 5.9 13.2 7.0 44.2 4.6 22.9 22.5 26.1 FANK1 ENSG00000203780 "Fibronectin type III and ankyrin repeat domains 1" Q8TC84 10 125896564-126009592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 34.2;fallopian tube: 35.1;testis: 56.5" "Cell type enhanced" "Detected in many" "Early spermatids: 603.8;Late spermatids: 603.0;Respiratory ciliated cells: 222.2;Spermatocytes: 126.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 16 "T-reg: 61.2" "Lineage enriched" "Detected in single" 612 "T-cells: 61.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.3;hTCEpi: 9.8;hTERT-RPE1: 13.0;RPTEC TERT1: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038413 Supported Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA038413: AB_10697249" "unprognostic (4.25e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.83e-4)" "unprognostic (1.17e-3)" "unprognostic (4.02e-2)" "unprognostic (6.29e-2)" "unprognostic (1.44e-1)" "unprognostic (3.12e-3)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (3.42e-2)" "unprognostic (9.53e-3)" "unprognostic (2.84e-2)" "unprognostic (1.17e-2)" "unprognostic (1.10e-2)" "unprognostic (1.44e-1)" 0.9 3.6 5.1 0.7 5.2 1.0 4.6 3.7 3.5 3.3 34.2 3.1 2.3 2.4 12.0 3.6 35.1 2.1 0.8 6.2 6.9 5.8 0.2 5.7 0.5 15.6 18.8 5.5 4.2 4.5 7.4 1.3 10.5 2.2 4.6 15.8 2.4 3.0 0.2 5.7 2.1 1.4 10.7 0.3 5.3 56.5 6.7 1.6 8.3 0.5 1.3 2.3 2.5 5.9 7.2 2.4 0.6 4.0 3.0 3.0 4.5 2.7 1.9 0.7 0.6 0.1 19.3 0.0 0.5 2.0 1.0 9.3 0.0 3.4 0.5 0.2 0.1 0.0 1.0 0.0 1.1 0.4 0.6 0.9 9.8 2.7 0.9 13.0 1.0 0.0 0.4 0.0 1.1 6.1 0.0 1.4 0.4 6.5 0.2 0.0 0.3 0.6 13.6 2.0 0.5 2.0 2.2 4.5 0.5 7.4 0.7 0.3 0.9 1.3 2.2 1.8 0.1 0.0 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.2 0.2 5.1 5.2 3.7 3.5 6.2 6.9 15.6 18.8 10.5 10.7 6.7 5.9 0.9 12.8 6.3 18.9 0.2 5.1 3.4 18.6 1.2 1.5 7.2 5.7 0.8 1.5 26.6 12.9 33.3 2.6 0.0 5.2 13.7 12.3 603.8 94.9 3.1 1.7 0.0 0.4 15.9 8.9 5.9 2.2 2.0 6.0 3.8 16.5 1.1 0.0 1.0 3.3 14.1 12.4 12.2 0.3 2.3 603.0 3.7 1.1 1.8 2.8 0.2 6.3 0.0 3.0 2.7 11.1 6.9 4.5 0.2 3.2 1.5 11.1 222.2 10.0 0.0 0.8 6.1 126.7 15.5 1.3 3.4 5.1 2.4 12.2 3.6 3.6 ADAM12 "MCMPMltna, MLTN" ENSG00000148848 "ADAM metallopeptidase domain 12" O43184 10 126012381-126388455 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "placenta: 166.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 102.2;Extravillous trophoblasts: 400.8;Oligodendrocyte precursor cells: 99.0;Syncytiotrophoblasts: 129.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "MAIT T-cell: 6.1" "Lineage enriched" "Detected in single" 62 "T-cells: 6.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 154.2;hTEC/SVTERT24-B: 94.3;U-2197: 93.2;U-251 MG: 86.2;U-87 MG: 70.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030866, HPA030867, HPA030868" Enhanced Supported "Plasma membrane" "Secreted in female reproductive system" NA NA 14000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 18: U-2197 - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" "Plasma membrane" "HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638" "unprognostic (3.35e-1)" "unprognostic (1.05e-3)" "unprognostic (3.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.34e-2)" "unprognostic (2.16e-1)" "unprognostic (2.91e-6)" "unprognostic (2.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.53e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.39e-14)" "unprognostic (3.11e-3)" "unprognostic (9.06e-3)" "unprognostic (4.70e-3)" "unprognostic (3.47e-3)" 11.4 0.1 2.0 6.0 4.0 0.1 4.6 1.6 2.1 18.2 3.5 0.4 0.2 6.3 0.0 0.4 0.2 11.8 0.7 1.0 2.5 1.0 0.2 1.3 3.2 6.0 2.7 8.8 0.5 0.1 1.1 166.5 3.1 0.3 0.6 0.3 1.1 0.0 0.1 0.4 0.5 4.3 1.8 1.6 0.5 0.9 10.4 1.8 0.3 0.0 3.5 11.6 0.5 3.0 16.8 2.5 6.5 0.1 18.7 38.3 0.0 42.7 3.5 14.2 35.5 0.0 0.0 0.0 0.0 154.2 30.0 0.0 0.2 1.4 15.5 1.9 0.6 0.2 25.1 0.0 2.9 0.0 33.2 47.0 0.0 94.3 2.9 27.1 0.0 0.0 0.0 0.2 11.8 0.0 0.0 0.0 0.1 0.0 2.8 0.0 4.8 4.4 0.4 44.1 0.5 28.4 5.0 0.0 0.7 2.5 0.1 0.1 0.0 50.9 16.9 93.2 86.2 0.0 0.5 0.0 70.7 0.1 32.3 0.0 0.0 0.0 0.3 0.0 6.1 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 2.0 4.0 1.6 2.1 1.0 2.5 6.0 2.7 3.1 1.8 10.4 3.0 0.5 0.0 1.9 22.5 0.3 1.5 0.4 3.0 0.0 2.1 1.7 3.6 2.3 0.0 0.5 0.0 102.2 14.0 0.5 0.7 0.0 8.0 10.9 10.7 16.6 1.6 0.0 0.0 7.4 1.1 400.8 34.5 0.5 1.8 49.5 7.8 2.5 0.2 15.5 6.7 19.0 1.0 4.1 0.6 3.1 1.7 16.8 0.8 1.8 14.0 9.0 3.3 1.0 99.0 52.2 2.2 0.1 0.7 0.3 1.0 0.7 0.4 6.5 30.5 0.0 5.1 13.4 6.0 5.0 0.0 0.6 129.2 4.7 28.1 0.9 0.5 C10orf90 "bA422P15.2, FATS, FLJ32938" ENSG00000154493 "Chromosome 10 open reading frame 90" Q96M02 10 126424997-126798708 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 112.1" "Cell type enriched" "Detected in some" 4 "Oligodendrocytes: 819.4" "Cancer enriched" "Detected in some" 5 "melanoma: 4.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-MEL-30: 118.8;U-2197: 36.1;U-266/84: 27.2;U-87 MG: 37.0;WM-115: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038648, HPA075229" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Plasma membrane, Cytosol" "HPA038648: AB_10672721, HPA075229: " "unprognostic (1.21e-2)" "unprognostic (3.34e-1)" "unprognostic (7.50e-2)" "unprognostic (2.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.30e-2)" "unprognostic (1.98e-3)" "unprognostic (5.06e-2)" "unprognostic (9.34e-3)" "unprognostic (3.73e-2)" "unprognostic (9.52e-2)" "unprognostic (1.22e-1)" "unprognostic (5.06e-11)" "unprognostic (2.69e-3)" "unprognostic (9.91e-3)" "unprognostic (1.26e-1)" "unprognostic (2.88e-1)" 0.7 0.0 30.4 0.1 74.4 0.0 4.7 41.9 47.7 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 29.9 37.4 0.3 0.1 0.0 0.0 60.4 53.8 0.1 0.2 0.0 0.3 0.3 57.0 0.0 0.1 0.0 10.6 0.0 0.1 1.1 0.1 0.0 29.8 0.0 0.0 6.5 68.0 1.1 0.3 0.4 0.7 0.0 0.0 112.1 0.3 0.1 0.0 0.0 0.8 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 2.3 0.0 1.6 0.0 0.9 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.0 0.0 118.8 0.0 0.0 0.2 0.0 4.7 0.0 36.1 0.7 0.0 27.2 0.0 37.0 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 74.4 41.9 47.7 29.9 37.4 60.4 53.8 57.0 29.8 68.0 112.1 0.2 0.0 0.0 24.5 0.1 0.0 0.0 0.0 0.0 0.0 3.0 2.7 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 120.5 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.0 142.7 0.3 0.0 0.0 3.7 0.0 0.0 0.0 181.0 819.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 1.3 0.5 0.0 0.0 4.2 0.1 0.0 0.0 0.0 DOCK1 "ced5, DOCK180" ENSG00000150760 "Dedicator of cytokinesis 1" Q14185 10 126905409-127452517 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 186.4;Oligodendrocyte precursor cells: 331.3;Oligodendrocytes: 429.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004378, HPA048692, HPA053277" Approved Enhanced Nucleoplasm NA NA "Cluster 70: Brain - Nervous system development" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "CAB004378: AB_2094604, HPA048692: AB_2680495, HPA053277: AB_2682097" "unprognostic (4.27e-2)" "unprognostic (4.22e-3)" "unprognostic (1.49e-3)" "unprognostic (8.98e-3)" "unprognostic (2.57e-2)" "unprognostic (3.31e-1)" "unprognostic (4.12e-1)" "unprognostic (4.80e-2)" "unprognostic (6.85e-2)" "unprognostic (1.55e-1)" "unprognostic (2.75e-2)" "unprognostic (2.42e-1)" "unprognostic (2.61e-3)" "unprognostic (1.87e-1)" "unprognostic (3.85e-2)" "unprognostic (1.18e-1)" "unprognostic (4.83e-2)" 19.9 8.2 38.1 7.3 54.3 0.7 19.9 39.1 34.6 23.3 22.5 17.7 13.4 19.6 15.5 16.1 18.1 17.2 14.2 29.9 37.2 19.3 9.6 13.7 4.6 44.7 51.8 24.7 14.1 25.6 5.6 19.6 44.5 16.5 13.8 2.3 17.7 18.4 5.2 33.4 15.1 19.2 35.6 9.9 13.3 6.9 45.3 8.5 26.6 10.6 5.7 16.5 18.9 50.1 16.1 29.8 57.2 41.2 29.2 38.7 12.6 31.5 66.2 21.9 23.1 18.8 18.0 0.0 10.3 47.4 19.8 18.0 18.4 23.8 25.4 0.3 17.9 10.0 18.8 22.7 28.9 0.0 14.2 31.8 7.0 22.7 49.3 53.0 51.3 0.0 0.0 0.1 33.1 16.4 0.0 0.0 14.1 12.4 13.5 0.0 37.3 0.4 22.1 17.5 3.4 24.5 32.9 18.6 28.9 40.6 4.7 0.1 54.2 39.7 15.3 9.8 30.7 0.0 0.1 0.0 31.3 0.0 25.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 38.1 54.3 39.1 34.6 29.9 37.2 44.7 51.8 44.5 35.6 45.3 50.1 55.9 32.1 20.3 186.4 0.4 17.2 15.5 9.5 43.9 0.5 18.5 17.3 11.8 12.8 17.9 22.0 0.0 14.1 3.2 28.0 0.0 14.7 11.3 20.2 36.8 35.2 5.4 1.7 2.4 7.1 11.5 27.7 16.8 17.1 0.0 33.3 26.4 7.8 5.7 0.0 4.8 15.3 6.1 4.6 5.9 24.5 32.6 5.1 7.2 105.9 2.8 6.6 0.0 331.3 429.1 13.6 9.4 36.5 0.1 13.7 17.5 11.5 20.6 1.2 13.1 30.5 24.1 2.0 6.7 21.5 16.2 12.6 1.1 35.4 12.3 10.3 INSYN2A "C10orf141, FAM196A, FLJ45557, INSYN2" ENSG00000188916 "Inhibitory synaptic factor 2A" Q6ZSG2 10 127135426-127196591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 8.0" "Cell type enhanced" "Detected in single" "Endothelial cells: 1.4" "Group enriched" "Detected in some" 13 "breast cancer: 3.4;glioma: 3.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 2.7;U-87 MG: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035898, HPA035899" Uncertain NA NA "Cluster 65: Brain - Ion transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA035898: AB_10964352, HPA035899: AB_10961723" "unprognostic (4.00e-2)" "unprognostic (9.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.66e-3)" "unprognostic (2.18e-1)" "unprognostic (4.70e-2)" "unprognostic (7.30e-2)" "unprognostic (3.62e-1)" "unprognostic (2.18e-2)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (5.47e-2)" "unprognostic (5.07e-2)" "unprognostic (2.86e-2)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" 0.1 0.0 4.5 0.1 6.2 0.0 0.6 2.8 5.8 0.1 1.2 0.2 0.1 0.1 0.3 0.0 0.0 0.1 0.1 3.4 5.3 0.3 0.0 0.2 0.0 4.4 5.4 0.7 0.1 0.0 0.2 0.0 4.2 0.7 0.1 1.6 0.2 0.1 0.0 0.1 0.3 0.1 2.6 0.3 0.2 0.6 8.0 1.1 0.1 0.1 0.1 0.2 0.1 2.3 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.5 6.2 2.8 5.8 3.4 5.3 4.4 5.4 4.2 2.6 8.0 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPS ENSG00000214285 "Neuropeptide S" P0C0P6 10 127549309-127553540 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "head and neck cancer: 4.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "midbrain: 5.4;pons and medulla: 5.1" "Group enriched" "Detected in some" 6 "cerebral cortex: 4.8;white matter: 2.2" CAB020139 Uncertain "Secreted in brain" NA NA "CAB020139: AB_776718" "unprognostic (2.83e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXI2 FLJ46831 ENSG00000186766 "Forkhead box I2" Q6ZQN5 10 127737185-127741183 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 1.9;kidney: 3.0" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 2.2;Distal tubular cells: 3.9;Squamous epithelial cells: 1.4;Urothelial cells: 1.7" "Cancer enriched" "Detected in some" 6 "renal cancer: 3.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 39: Non-specific - Basic cellular processes" "unprognostic (4.39e-2)" "unprognostic (1.62e-2)" "unprognostic (1.28e-1)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "unprognostic (5.12e-3)" "unprognostic (4.71e-4)" "unprognostic (6.78e-3)" "prognostic favorable (4.23e-7)" "unprognostic (6.31e-3)" "unprognostic (2.66e-1)" "unprognostic (7.18e-3)" "unprognostic (1.65e-2)" 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.3 1.9 0.2 0.1 0.3 0.0 0.2 3.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.1 0.5 0.1 0.2 0.1 0.5 0.2 0.0 0.3 0.3 0.0 0.2 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 2.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.7 CLRN3 "MGC32871, TMEM12, USH3AL1" ENSG00000180745 "Clarin 3" Q8NCR9 10 127877841-127892941 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 89.0;kidney: 43.9;liver: 79.9" "Group enriched" "Detected in some" 5 "Distal enterocytes: 102.0;Enteroendocrine cells: 41.5;Hepatocytes: 43.0;Intestinal goblet cells: 75.3;Paneth cells: 95.9;Proximal enterocytes: 155.4;Proximal tubular cells: 68.3;Undifferentiated cells: 45.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 45.3;renal cancer: 30.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 41 "OE19: 96.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA014482 Approved NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" "HPA014482: AB_2082885" "unprognostic (7.34e-3)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (1.46e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (2.62e-1)" "unprognostic (6.22e-2)" "unprognostic (4.67e-1)" "unprognostic (8.86e-2)" "prognostic favorable (8.98e-4)" "unprognostic (1.74e-1)" "unprognostic (2.89e-3)" "unprognostic (3.00e-2)" 0.6 0.1 0.4 5.6 0.4 0.0 0.3 0.3 0.5 0.0 0.3 71.1 73.4 0.1 0.0 0.0 0.0 15.2 0.0 0.4 0.3 43.9 79.9 0.0 0.1 0.3 0.3 0.0 0.3 0.0 0.2 0.0 0.4 0.0 70.3 0.0 0.0 0.2 0.0 0.0 89.0 1.7 0.3 0.1 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 96.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.4 0.3 0.5 0.4 0.3 0.3 0.3 0.4 0.3 0.4 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 102.0 15.6 0.4 0.0 0.2 0.0 0.1 41.5 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 43.0 0.0 0.0 0.1 75.3 0.0 0.6 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.5 95.9 0.0 0.0 0.0 155.4 68.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 45.6 0.0 PTPRE PTPE ENSG00000132334 "Protein tyrosine phosphatase receptor type E" P23469 10 127907103-128085855 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 46.9" "Cell type enhanced" "Detected in many" "dendritic cells: 256.6;Inhibitory neurons: 191.6;Langerhans cells: 307.9;Macrophages: 276.3;Oligodendrocyte precursor cells: 247.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 634.6;plasmacytoid DC: 475.9" "Group enriched" "Detected in all" 12 "dendritic cells: 475.9;granulocytes: 634.6;monocytes: 175.4" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 38.6;HUVEC TERT2: 41.6;NB-4: 32.5;TIME: 79.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015870, HPA021872" Supported Approved "Intermediate filaments" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 41: Macrophages - Immune response" "Intermediate filaments" "HPA015870: AB_1855759, HPA021872: AB_1855760" "unprognostic (5.23e-2)" "unprognostic (1.37e-1)" "unprognostic (1.99e-1)" "unprognostic (7.11e-2)" "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (6.50e-2)" "unprognostic (4.49e-2)" "unprognostic (2.11e-1)" "unprognostic (2.56e-2)" "unprognostic (8.71e-3)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (1.52e-1)" "unprognostic (6.71e-3)" "unprognostic (2.49e-2)" "unprognostic (5.59e-2)" 13.6 16.7 13.9 25.3 8.9 46.9 6.7 5.7 13.9 3.9 7.7 9.2 9.5 3.5 2.6 7.9 4.9 10.3 10.6 14.2 11.1 4.3 4.4 16.0 16.4 11.6 9.0 1.6 2.7 2.7 5.0 7.8 10.7 3.4 9.3 1.0 5.8 2.4 1.3 4.7 12.9 7.4 10.8 20.6 7.4 2.6 10.7 8.6 5.5 3.1 9.8 12.7 4.4 14.2 4.3 0.9 0.5 0.0 2.5 0.4 7.5 0.1 0.0 1.6 3.6 1.7 25.1 3.3 2.6 2.1 5.2 2.3 2.1 12.2 0.7 4.0 1.9 0.4 1.4 0.0 4.1 16.2 11.6 0.8 6.9 6.1 12.1 38.6 41.6 10.3 0.0 1.9 2.6 4.0 4.9 32.5 0.2 4.6 1.5 19.1 2.6 6.4 6.8 18.0 0.0 2.5 7.4 1.3 0.3 1.8 0.6 20.1 79.5 1.7 1.8 7.8 8.9 0.9 1.3 4.6 11.3 12.5 0.0 174.3 175.4 147.2 36.6 64.5 22.3 7.7 16.5 25.1 97.9 8.3 11.5 19.6 634.6 31.6 54.9 475.9 26.7 43.3 13.9 8.9 5.7 13.9 14.2 11.1 11.6 9.0 10.7 10.8 10.7 14.2 25.0 83.3 57.2 22.5 26.2 59.5 54.3 42.4 15.9 5.2 14.2 23.6 20.3 8.6 23.7 3.7 0.0 43.2 256.6 15.7 0.0 3.7 2.1 3.6 10.6 78.0 6.7 10.3 112.7 4.4 67.4 17.5 10.7 7.7 31.6 3.7 47.5 2.3 57.5 0.0 191.6 15.8 18.3 166.7 307.9 2.5 0.6 276.3 24.9 165.8 139.5 0.0 150.4 247.3 93.4 49.2 13.3 0.4 38.5 21.3 13.9 2.2 7.8 0.9 0.0 86.0 12.8 0.5 1.9 20.4 64.6 17.0 59.3 9.2 11.7 40.3 MKI67 "MIB-1, PPP1R105" ENSG00000148773 "Marker of proliferation Ki-67" P46013 10 128096659-128126423 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 46.3;lymphoid tissue: 52.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 232.9;Extravillous trophoblasts: 86.1;Granulosa cells: 87.0;Plasma cells: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB000058, HPA000451, HPA001164, CAB068198" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" "unprognostic (3.37e-1)" "unprognostic (9.92e-3)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.61e-6)" "unprognostic (7.16e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (9.47e-5)" "unprognostic (2.45e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (4.61e-1)" 0.9 0.7 0.0 8.5 0.1 46.3 1.7 0.0 0.1 1.2 0.2 8.1 6.2 1.0 0.0 10.0 0.3 0.9 0.3 0.1 0.1 0.4 0.8 1.4 14.9 0.1 1.0 0.2 0.2 0.1 0.1 4.1 0.6 0.4 9.2 0.0 1.4 0.1 0.0 6.6 5.8 2.6 0.0 4.8 4.2 2.3 0.9 52.7 0.4 0.1 16.4 1.8 2.8 0.3 204.6 101.5 103.2 73.6 4.3 8.7 32.1 75.7 55.3 70.3 62.3 83.9 82.3 152.6 21.3 51.9 46.4 120.7 109.3 56.8 104.7 161.8 53.1 131.0 79.4 52.7 0.1 186.0 68.0 2.0 2.5 72.2 73.2 17.2 69.8 69.5 61.2 142.1 70.5 80.9 111.7 56.6 41.3 52.7 45.7 82.2 135.1 20.3 25.6 56.2 35.9 38.9 107.1 38.0 17.3 33.9 31.4 39.3 65.0 37.0 73.6 53.0 206.8 64.2 54.9 177.2 30.7 83.3 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.6 0.0 0.9 0.3 0.6 0.0 5.4 0.0 16.0 6.4 1.6 5.3 0.6 0.0 3.9 3.2 1.6 1.5 5.3 0.0 0.0 30.6 7.4 25.0 0.0 0.8 4.2 2.3 10.2 6.7 6.7 232.9 0.0 0.0 86.1 13.5 34.7 13.2 1.3 87.0 5.7 1.7 42.1 0.0 0.0 22.4 2.0 12.9 13.7 0.9 0.3 16.6 3.6 0.0 0.2 0.0 8.2 0.0 0.0 0.1 3.0 0.4 107.4 4.6 2.6 0.1 1.6 0.0 0.0 0.5 13.6 8.1 24.1 50.4 3.0 7.8 23.0 2.7 47.1 4.8 MGMT ENSG00000170430 "O-6-methylguanine-DNA methyltransferase" P16455 10 129467190-129770983 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.3" "Cell type enhanced" "Detected in all" "Hepatocytes: 465.7;Proximal tubular cells: 340.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 60.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002786, HPA032135, HPA032136, HPA069497, CAB069881" Supported Enhanced Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 85: Liver - Metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm "CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134" "unprognostic (1.10e-1)" "prognostic favorable (9.42e-4)" "unprognostic (1.48e-1)" "unprognostic (5.81e-2)" "unprognostic (7.84e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.54e-4)" "unprognostic (6.54e-3)" "unprognostic (4.71e-2)" "unprognostic (2.03e-1)" "unprognostic (1.26e-1)" "unprognostic (6.32e-1)" "unprognostic (4.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" 21.5 17.0 14.7 10.3 15.1 12.7 20.4 14.8 18.6 13.9 16.6 14.7 16.9 13.3 8.1 15.9 23.7 19.6 18.5 14.1 14.5 23.5 89.3 11.7 19.4 15.9 15.4 16.9 26.5 12.3 9.5 6.8 16.0 15.0 5.0 3.9 22.7 7.8 25.5 17.1 15.3 8.0 14.7 14.3 18.2 15.2 15.0 23.2 16.3 16.0 11.1 18.4 13.8 15.2 0.0 7.0 7.1 35.2 14.9 30.9 27.1 15.6 17.0 10.9 10.7 44.0 45.6 33.0 24.6 20.2 0.0 20.8 4.5 16.4 4.6 0.0 2.7 6.6 16.2 28.6 22.7 0.7 17.8 19.7 0.0 6.6 0.0 0.0 0.1 53.5 0.1 22.0 14.0 60.0 26.1 34.0 1.6 29.9 27.8 29.3 0.1 12.7 20.7 16.0 7.2 18.0 18.3 7.7 0.0 5.5 29.8 25.3 0.0 14.6 7.1 0.1 0.0 0.0 0.0 17.1 0.0 10.8 0.0 9.6 37.2 17.1 43.9 39.2 43.6 49.7 40.4 42.0 39.0 48.2 39.6 42.8 4.6 49.5 37.2 43.7 54.0 42.1 14.7 15.1 14.8 18.6 14.1 14.5 15.9 15.4 16.0 14.7 15.0 15.2 106.0 12.8 19.0 32.0 59.2 51.2 80.6 91.5 49.5 17.4 69.0 112.9 49.3 94.4 48.7 103.0 8.4 51.3 51.1 55.6 127.2 50.0 107.6 138.0 29.6 70.4 54.5 48.2 28.5 58.7 67.0 59.2 31.1 34.1 64.7 93.9 108.1 465.7 89.7 15.2 16.9 73.1 50.8 75.0 48.7 140.6 67.4 44.6 65.8 62.8 56.4 37.2 78.2 23.1 30.7 82.4 57.9 55.3 37.0 47.1 108.4 340.3 102.5 45.6 46.0 48.6 70.6 45.3 81.4 46.9 42.6 26.8 52.5 87.4 63.8 75.2 EBF3 "COE3, DKFZp667B0210" ENSG00000108001 "EBF transcription factor 3" Q9H4W6 10 129835233-129973053 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.9;brain: 16.9" "Group enriched" "Detected in some" 5 "Adipocytes: 29.6;Endothelial cells: 13.1;Fibroblasts: 14.9;Skeletal myocytes: 33.5;Smooth muscle cells: 11.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 16.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 12.5;HAP1: 13.6;LHCN-M2: 25.4;NB-4: 35.7;RH-30: 13.2;SCLC-21H: 28.7;THP-1: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061169 Approved Nucleoplasm,Vesicles NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Vesicles "HPA061169: AB_2684441" "unprognostic (2.96e-1)" "unprognostic (3.78e-2)" "unprognostic (8.63e-3)" "unprognostic (2.60e-2)" "unprognostic (7.68e-2)" "unprognostic (4.50e-3)" "unprognostic (8.53e-6)" "unprognostic (2.93e-2)" "unprognostic (3.99e-2)" "unprognostic (1.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.63e-1)" "unprognostic (4.16e-3)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (9.49e-2)" "unprognostic (4.58e-2)" 23.9 0.6 0.3 1.0 0.1 0.1 13.7 1.4 0.2 4.1 0.4 2.7 0.2 2.3 0.8 1.4 4.8 2.4 9.4 0.1 2.7 0.5 0.5 0.2 6.9 6.5 8.5 1.0 1.3 2.1 0.9 2.5 3.8 2.4 0.5 1.9 3.0 1.1 7.9 3.3 1.0 1.5 16.9 0.2 1.6 1.6 3.2 1.3 7.3 7.7 1.0 3.3 5.5 1.1 0.0 0.0 0.6 0.1 12.5 10.3 0.1 0.8 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.5 0.0 0.0 13.6 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 2.4 0.0 0.0 0.0 0.7 0.0 0.0 25.4 0.0 0.0 35.7 0.0 0.0 0.0 0.3 13.2 0.0 0.0 0.1 28.7 0.4 0.0 0.0 0.0 0.1 0.0 14.3 0.0 0.0 1.3 8.7 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.4 0.2 0.1 2.7 6.5 8.5 3.8 16.9 3.2 1.1 29.6 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.0 1.8 0.3 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.1 13.1 0.0 0.0 0.9 0.0 0.0 14.9 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.5 0.4 0.3 0.4 0.0 1.9 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.7 0.0 33.5 11.7 0.0 3.4 0.1 0.9 0.0 0.2 0.1 0.0 0.1 C10orf143 LINC00959 ENSG00000237489 "Chromosome 10 open reading frame 143" A0A1B0GUT2 10 130020025-130110830 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 6.7;Breast glandular cells: 8.2;Breast myoepithelial cells: 9.7;Collecting duct cells: 11.0;Distal tubular cells: 13.7;Proximal tubular cells: 12.8;Theca cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 9.6;MCF7: 8.8;NB-4: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 7: Non-specific - Mitochondria" "unprognostic (3.58e-2)" "unprognostic (3.36e-2)" "unprognostic (5.61e-2)" "unprognostic (1.24e-2)" "unprognostic (8.12e-2)" "unprognostic (6.64e-3)" "unprognostic (8.68e-3)" "unprognostic (2.48e-3)" "unprognostic (1.59e-1)" "unprognostic (8.61e-2)" "unprognostic (7.26e-4)" "unprognostic (1.34e-1)" "unprognostic (2.36e-7)" "unprognostic (2.06e-1)" "unprognostic (3.29e-1)" "unprognostic (1.90e-1)" "unprognostic (1.49e-2)" 3.5 4.1 3.5 3.3 3.6 2.3 4.9 3.6 4.7 4.7 3.7 6.9 5.2 5.5 5.8 3.5 4.7 3.8 2.4 3.1 3.4 5.7 4.7 2.9 5.2 3.8 3.6 3.9 4.3 3.9 4.5 1.0 3.7 5.7 3.3 1.6 3.8 6.6 9.6 4.3 4.5 3.9 3.7 5.4 4.2 3.9 3.6 5.5 5.8 5.0 4.7 6.0 4.3 3.5 1.1 1.5 1.7 3.5 9.6 3.6 0.2 2.1 3.0 0.9 1.3 0.0 0.9 7.3 0.4 2.0 1.1 1.5 0.6 0.1 0.3 2.0 1.1 1.3 0.1 0.9 3.8 3.5 1.4 3.5 1.9 0.4 2.2 1.1 0.5 5.9 0.2 1.6 3.3 8.8 1.5 13.5 3.5 1.6 1.4 1.3 0.2 0.3 3.2 0.6 0.8 1.0 1.3 0.4 0.9 1.3 0.2 1.1 0.4 1.3 0.2 3.7 0.3 2.1 4.3 1.1 2.5 0.6 0.0 0.0 6.5 4.0 16.7 10.6 17.8 20.7 18.1 19.3 11.4 17.6 17.9 23.6 1.2 22.0 9.7 7.3 23.6 9.1 3.5 3.6 3.6 4.7 3.1 3.4 3.8 3.6 3.7 3.7 3.6 3.5 3.1 0.0 6.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 8.2 9.7 0.0 0.0 2.5 11.0 0.0 0.7 5.0 0.0 13.7 4.2 0.0 3.9 3.2 1.1 0.0 0.0 0.0 3.1 0.1 1.4 0.0 2.2 1.3 3.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 12.8 5.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 3.1 7.8 0.0 0.0 GLRX3 "bA500G10.4, GLRX4, GRX3, GRX4, PICOT, TXNL2" ENSG00000108010 "Glutaredoxin 3" O76003 10 130136391-130184521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 280.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028941 Approved NA NA 350000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "HPA028941: AB_10601015" "unprognostic (7.11e-3)" "unprognostic (4.02e-2)" "unprognostic (1.67e-2)" "unprognostic (5.39e-3)" "unprognostic (5.66e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (9.03e-6)" "unprognostic (9.29e-2)" "unprognostic (1.13e-1)" "unprognostic (5.76e-2)" "unprognostic (1.46e-3)" "unprognostic (1.08e-3)" "prognostic unfavorable (9.24e-6)" "unprognostic (4.01e-1)" "unprognostic (1.20e-1)" "unprognostic (7.57e-2)" "unprognostic (1.11e-1)" 36.0 44.6 24.3 40.5 25.7 38.0 35.2 25.9 30.9 29.8 26.9 32.9 35.9 29.4 28.4 58.4 25.3 28.6 54.3 25.5 28.4 37.7 42.9 28.4 54.5 27.6 26.9 24.0 35.4 36.1 21.2 40.9 28.4 27.1 38.7 27.8 32.3 29.5 53.5 41.4 31.3 40.8 25.8 27.1 33.4 64.4 26.5 39.6 32.6 55.1 63.0 49.8 38.0 26.9 209.9 134.2 126.8 195.3 84.0 130.8 136.5 149.9 148.3 182.5 153.5 234.4 164.5 157.8 94.2 118.3 160.4 133.7 170.8 179.5 198.0 123.6 145.7 84.0 87.2 201.9 108.8 163.9 80.8 85.4 205.0 167.2 227.3 164.2 147.3 116.8 190.1 72.4 201.1 103.0 119.4 239.8 146.7 121.5 142.8 161.3 131.8 59.8 179.5 114.1 62.4 84.7 85.8 93.2 194.2 139.2 69.2 103.0 111.6 96.2 96.4 130.7 219.2 52.7 87.4 316.0 201.6 88.9 59.5 25.7 45.2 21.5 40.6 58.8 48.2 52.1 45.1 45.4 70.3 37.8 34.4 41.7 7.3 59.1 51.8 44.8 76.7 49.5 24.3 25.7 25.9 30.9 25.5 28.4 27.6 26.9 28.4 25.8 26.5 26.9 47.6 41.7 28.1 20.9 38.4 82.8 90.1 167.1 32.5 24.1 42.1 40.5 61.5 40.0 74.4 27.6 14.6 122.9 47.3 38.3 62.6 160.1 252.7 39.6 43.4 57.0 34.0 44.6 24.7 147.7 162.2 48.3 28.5 38.7 42.5 47.7 43.2 36.2 113.2 42.1 24.6 50.7 77.3 44.6 54.2 138.9 40.7 46.1 49.8 15.0 72.9 37.9 47.4 22.1 22.5 150.2 32.3 50.4 41.0 115.2 58.7 100.7 58.3 25.1 19.7 41.2 95.1 280.9 188.1 62.7 99.0 163.1 41.8 49.7 64.7 100.5 TCERG1L FLJ38950 ENSG00000176769 "Transcription elongation regulator 1 like" Q5VWI1 10 131092391-131311721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.0;retina: 6.1;thyroid gland: 14.9" "Group enriched" "Detected in some" 5 "Excitatory neurons: 69.9;Horizontal cells: 102.6" "Cancer enriched" "Detected in some" 14 "thyroid cancer: 20.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.3;RPMI-8226: 1.1;SuSa: 1.9;U-2 OS: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA030816 Approved Nucleoplasm,Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Cytosol "HPA030816: AB_10601721" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "unprognostic (8.99e-2)" "unprognostic (1.45e-2)" "unprognostic (3.03e-1)" "unprognostic (6.69e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-1)" "unprognostic (9.71e-2)" "unprognostic (2.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.08e-5)" "unprognostic (1.28e-1)" "unprognostic (2.83e-1)" "unprognostic (2.96e-2)" "unprognostic (2.03e-1)" 0.0 0.9 1.3 0.0 3.5 0.0 0.1 0.3 5.0 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 2.5 1.6 0.2 0.0 0.0 0.0 2.2 1.5 3.0 0.3 0.5 1.3 0.0 0.9 0.6 0.0 6.1 0.0 0.6 0.0 0.5 0.0 0.0 1.5 0.2 0.0 1.6 2.0 0.6 14.9 0.0 0.1 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.5 0.3 5.0 2.5 1.6 2.2 1.5 0.9 1.5 2.0 2.1 0.0 0.0 0.0 0.7 0.0 0.6 0.2 0.0 2.2 5.9 0.5 0.1 1.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 69.9 0.0 0.7 0.9 0.5 0.1 0.0 0.1 0.0 0.0 0.0 102.6 14.5 0.0 0.0 0.0 0.0 0.1 4.7 0.2 10.6 1.0 0.0 0.9 0.0 3.0 2.3 0.1 0.0 4.5 0.0 0.7 0.0 0.0 0.0 4.3 0.0 0.3 0.2 0.4 3.7 2.8 0.6 0.1 0.1 2.5 0.0 0.1 PPP2R2D "B55D, B55delta, MDS026" ENSG00000175470 "Protein phosphatase 2 regulatory subunit Bdelta" Q66LE6 10 131901008-131959834 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042122, HPA042770" Approved Approved Cytosol NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" Cytosol "HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (7.75e-3)" "unprognostic (7.11e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (1.40e-1)" "unprognostic (3.57e-1)" "unprognostic (9.64e-3)" "unprognostic (1.83e-1)" "unprognostic (3.13e-2)" "unprognostic (1.76e-2)" "unprognostic (8.74e-2)" "unprognostic (8.46e-2)" "unprognostic (8.04e-2)" "unprognostic (4.41e-3)" "unprognostic (1.10e-1)" "unprognostic (6.57e-2)" "unprognostic (6.66e-2)" "unprognostic (1.90e-2)" 1.5 3.0 4.5 1.2 5.4 0.0 1.4 7.0 5.8 2.1 3.8 2.8 2.1 1.6 2.0 1.6 1.6 1.6 3.3 4.9 4.1 1.8 1.6 2.3 2.4 4.1 4.1 3.6 15.9 3.2 2.3 1.9 4.1 1.8 1.9 2.8 3.3 1.9 2.8 2.7 2.4 1.3 3.6 1.8 2.1 1.3 4.6 1.7 2.2 2.9 1.5 2.3 1.9 4.9 4.4 3.8 2.4 1.8 3.3 2.6 3.4 1.5 3.1 2.9 3.1 3.1 3.6 1.8 1.0 1.8 1.8 7.9 3.2 0.7 3.1 4.5 4.2 3.0 3.7 1.8 1.1 3.2 3.4 0.9 6.7 3.2 4.5 4.6 2.0 2.6 3.9 0.8 3.2 2.1 1.5 7.3 1.5 1.5 3.4 2.0 1.6 0.5 2.3 0.6 1.9 2.6 1.9 1.6 1.8 2.5 1.4 2.4 2.8 1.6 0.7 2.3 8.1 2.8 1.6 2.3 1.4 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 5.4 7.0 5.8 4.9 4.1 4.1 4.1 4.1 3.6 4.6 4.9 26.8 19.2 14.3 22.2 20.0 37.3 37.4 6.4 20.5 55.0 25.8 23.6 36.3 14.3 10.2 9.2 10.4 10.6 36.1 27.6 19.6 9.8 12.7 21.5 24.8 19.0 10.7 18.7 43.0 17.7 13.6 21.8 19.9 32.3 6.3 33.1 13.2 23.2 14.1 52.2 37.5 18.2 8.2 12.0 17.6 6.4 17.4 23.3 12.4 26.2 10.5 28.3 18.6 29.7 38.1 16.8 18.0 20.7 20.3 39.1 20.0 29.6 5.7 32.6 26.3 29.2 23.2 14.3 20.1 18.8 34.0 11.8 24.4 39.5 19.1 39.6 BNIP3 Nip3 ENSG00000176171 "BCL2 interacting protein 3" Q12983 10 131966455-131982013 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 361.5;skeletal muscle: 214.4" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 544.1;Hepatocytes: 437.4;Proximal tubular cells: 714.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 390.1;hTERT-RPE1: 286.7;U-87 MG: 347.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003015, CAB011676" Supported NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 59: Non-specific - Translation" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "CAB011676: , HPA003015: AB_1078290" "unprognostic (1.01e-3)" "unprognostic (1.42e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.58e-2)" "unprognostic (1.62e-3)" "unprognostic (6.57e-3)" "unprognostic (1.12e-1)" "unprognostic (2.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (2.37e-3)" "unprognostic (1.04e-1)" "unprognostic (3.29e-2)" "unprognostic (2.98e-1)" 49.2 35.0 52.3 8.1 54.9 5.9 35.7 63.6 63.0 30.1 38.1 25.9 7.7 17.4 23.8 30.0 20.5 16.8 92.8 71.2 55.8 63.9 126.4 25.9 10.0 61.5 67.9 82.2 361.5 20.3 36.7 30.0 67.4 40.6 4.8 81.4 46.9 12.8 214.4 36.3 14.9 12.1 55.5 13.7 27.9 15.7 65.8 10.0 23.2 91.4 7.9 28.2 39.4 62.3 390.1 30.7 21.6 60.9 56.7 59.5 110.9 92.7 85.3 68.3 193.2 6.4 8.4 0.7 146.5 53.6 79.5 23.3 46.2 131.4 254.7 20.7 34.9 13.8 19.2 90.1 75.4 17.9 10.6 41.4 32.7 66.6 66.8 286.7 48.1 23.6 36.0 1.4 112.9 31.0 9.2 99.3 18.5 2.7 91.1 21.8 11.0 33.3 75.1 6.4 28.5 66.3 18.9 38.7 54.3 91.1 23.7 24.7 55.4 96.0 32.3 36.4 74.4 63.5 58.1 54.0 347.4 0.9 16.8 4.2 6.3 9.8 16.6 4.2 17.7 11.4 23.4 17.7 5.6 11.6 39.1 26.3 1.5 4.3 6.2 4.3 25.4 16.5 52.3 54.9 63.6 63.0 71.2 55.8 61.5 67.9 67.4 55.5 65.8 62.3 49.3 48.1 56.5 34.3 22.5 29.8 98.3 101.0 34.7 98.2 75.8 63.1 159.2 137.2 43.6 84.6 39.6 173.8 24.7 2.6 301.3 185.1 110.3 84.7 64.4 53.6 81.0 21.5 39.6 87.9 544.1 64.6 27.5 98.1 0.0 107.4 61.4 437.4 79.1 333.1 30.0 10.3 59.0 28.4 20.4 112.1 70.2 28.2 33.8 7.5 28.1 169.2 27.8 16.1 22.8 133.8 9.5 103.4 37.5 140.5 63.5 714.8 72.7 64.6 39.5 53.1 60.0 35.3 100.2 6.5 13.1 247.4 38.4 47.3 5.3 48.9 JAKMIP3 "bA140A10.5, C10orf14, C10orf39, FLJ37857, KIAA4091, NECC2" ENSG00000188385 "Janus kinase and microtubule interacting protein 3" Q5VZ66 10 132036336-132184858 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 20.7" "Cell type enhanced" "Detected in some" "Astrocytes: 14.4;Excitatory neurons: 39.4;Inhibitory neurons: 32.3;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 92.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.0;RPMI-8226: 2.0;U-266/84: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022872 Uncertain NA NA "Cluster 70: Brain - Nervous system development" "Cluster 16: U-266 - Nucleosome" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA022872: AB_2249331" "unprognostic (1.75e-1)" "unprognostic (1.76e-2)" "unprognostic (4.55e-3)" "unprognostic (8.90e-2)" "unprognostic (2.72e-1)" "unprognostic (9.39e-2)" "unprognostic (2.31e-3)" "unprognostic (1.40e-1)" "unprognostic (2.22e-1)" "unprognostic (1.80e-1)" "unprognostic (5.28e-5)" "unprognostic (1.55e-2)" "unprognostic (5.71e-6)" "unprognostic (1.43e-1)" "unprognostic (2.11e-1)" "unprognostic (7.19e-4)" "unprognostic (1.59e-2)" 0.1 1.0 1.9 0.1 5.1 0.1 0.2 2.8 5.1 0.3 0.0 0.6 0.1 0.6 0.2 0.2 0.5 0.4 0.6 1.5 5.1 0.0 0.0 0.1 0.0 9.2 5.2 1.7 0.4 0.1 3.1 0.0 10.4 1.5 0.1 0.7 0.3 0.5 1.4 0.2 0.2 0.4 2.1 0.1 0.2 0.7 6.8 0.1 0.3 0.1 0.0 0.5 0.3 20.7 0.0 3.0 0.1 1.4 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.1 1.1 0.1 1.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.9 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.2 8.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 5.1 2.8 5.1 1.5 5.1 9.2 5.2 10.4 2.1 6.8 20.7 0.2 0.0 0.0 14.4 0.0 0.0 0.2 0.0 0.0 3.7 0.4 0.4 6.2 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.3 0.6 0.0 0.0 39.4 0.2 0.0 1.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 3.3 32.3 0.1 0.0 0.3 0.0 0.8 2.1 0.1 0.0 3.7 0.1 1.4 1.0 27.2 92.8 0.0 0.1 1.5 0.0 0.6 0.0 0.0 0.0 0.5 0.0 2.2 0.4 0.0 0.1 0.0 0.0 0.1 0.1 1.3 0.0 0.0 DPYSL4 "CRMP3, DRP-4, ULIP4" ENSG00000151640 "Dihydropyrimidinase like 4" O14531 10 132186948-132205759 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;heart muscle: 33.7;retina: 15.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 64.9;Cardiomyocytes: 20.1;Cone photoreceptor cells: 58.4;Horizontal cells: 33.7;Oligodendrocytes: 18.4" "Cancer enhanced" "Detected in many" "glioma: 13.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 53.2;AN3-CA: 70.0;SH-SY5Y: 72.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049066 Approved Approved Vesicles,Mitochondria NA NA "Cluster 32: T-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 62: Horizontal cells - Visual perception" "Vesicles, Mitochondria" "HPA049066: AB_2680619" "unprognostic (6.27e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "unprognostic (1.81e-1)" "unprognostic (3.95e-1)" "unprognostic (5.99e-2)" "unprognostic (8.36e-5)" "unprognostic (1.72e-1)" "unprognostic (8.91e-2)" "unprognostic (1.08e-2)" "unprognostic (3.81e-2)" "unprognostic (6.36e-2)" "unprognostic (7.47e-6)" "unprognostic (3.04e-3)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "prognostic unfavorable (3.11e-4)" 1.3 2.2 18.4 0.7 18.6 0.1 1.5 10.3 25.9 2.5 2.4 1.6 0.1 3.3 0.7 0.6 1.5 0.7 33.7 20.3 12.6 0.6 0.3 1.2 0.3 14.8 15.0 5.3 0.9 0.0 10.4 0.2 15.1 4.9 0.0 15.9 2.6 2.0 2.0 1.2 0.9 1.1 12.1 1.2 1.3 7.9 16.4 0.0 1.0 0.2 0.2 1.0 1.3 18.1 0.1 15.2 53.2 70.0 0.1 0.4 0.0 4.6 0.6 2.9 0.6 0.0 0.4 0.0 1.8 2.4 5.1 0.0 10.4 10.3 0.3 0.0 2.0 0.0 0.1 5.7 9.3 0.0 10.6 4.7 4.9 1.7 0.2 0.9 5.4 0.0 0.0 0.5 7.7 4.5 0.0 0.0 9.1 0.9 5.1 0.0 0.0 8.7 0.0 1.1 8.3 72.0 1.7 0.1 9.7 3.1 0.2 0.1 9.0 13.1 21.7 0.0 12.8 0.1 3.9 0.0 22.0 0.0 1.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.1 0.0 0.3 0.1 0.0 0.0 0.1 18.4 18.6 10.3 25.9 20.3 12.6 14.8 15.0 15.1 12.1 16.4 18.1 0.3 0.0 0.0 7.2 0.1 0.5 0.5 0.1 0.6 64.9 0.4 0.6 20.1 0.0 0.1 0.0 58.4 0.0 0.1 0.0 0.0 0.3 5.3 0.1 5.0 1.2 1.8 0.0 12.2 0.0 0.1 2.7 2.0 0.3 0.0 0.7 0.0 0.0 0.2 33.7 13.6 0.0 0.0 0.0 0.8 9.0 4.1 0.1 1.8 0.0 0.1 7.5 0.0 12.1 18.4 0.5 0.0 4.5 0.0 0.7 0.0 0.0 0.0 13.8 0.0 1.0 5.7 7.0 5.2 0.3 0.1 0.0 0.5 4.5 0.0 0.2 STK32C "MGC23665, PKE, YANK3" ENSG00000165752 "Serine/threonine kinase 32C" Q86UX6 10 132207492-132331847 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 54.1" "Group enriched" "Detected in many" 4 "Early spermatids: 278.9;Late spermatids: 83.3;Spermatocytes: 89.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 55.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017894 Uncertain NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 29: Early spermatids - Spermatogenesis" "HPA017894: AB_1857591" "unprognostic (2.11e-1)" "unprognostic (8.40e-2)" "unprognostic (4.80e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.65e-2)" "unprognostic (5.52e-2)" "prognostic unfavorable (1.68e-6)" "unprognostic (2.03e-1)" "unprognostic (7.79e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.31e-6)" "unprognostic (8.65e-2)" "unprognostic (3.20e-1)" "unprognostic (5.05e-2)" "unprognostic (1.36e-1)" 11.0 12.5 31.4 7.1 39.6 7.6 8.9 17.8 37.5 8.1 13.5 9.1 5.2 6.9 14.8 5.4 9.4 6.5 7.4 31.3 23.2 15.6 5.0 8.8 10.0 24.6 26.1 6.7 7.4 6.0 12.3 4.9 20.5 6.6 4.7 7.9 5.7 5.2 13.7 7.6 6.8 5.0 23.4 15.1 6.2 54.1 30.9 10.8 6.4 9.1 6.4 8.3 6.5 25.9 69.4 43.5 13.3 33.5 18.4 23.3 2.7 14.1 10.7 17.4 22.2 10.0 46.0 14.8 10.3 16.4 22.0 14.9 18.6 5.5 16.9 8.9 31.1 8.9 46.1 47.1 22.9 7.9 31.1 17.6 20.8 15.7 17.3 22.0 15.6 25.1 15.4 10.2 19.0 21.1 10.4 30.4 8.8 12.6 31.4 12.2 8.2 4.9 23.3 11.7 34.6 27.3 10.2 9.3 20.9 7.9 10.5 19.2 10.6 13.6 14.2 18.2 11.3 19.1 3.8 38.7 31.4 7.4 7.1 55.3 17.9 16.5 5.8 19.6 7.3 6.2 4.7 6.6 25.1 10.2 5.8 4.5 2.4 6.1 17.3 14.5 9.2 7.0 31.4 39.6 17.8 37.5 31.3 23.2 24.6 26.1 20.5 23.4 30.9 25.9 6.6 0.0 7.2 13.4 7.3 5.2 6.8 5.7 4.6 8.4 10.3 11.0 3.7 2.8 6.1 12.9 12.5 3.4 9.3 3.2 19.6 5.4 278.9 25.9 8.2 8.2 19.2 15.8 22.9 8.7 2.3 7.2 6.6 11.8 15.8 6.0 13.6 5.5 14.6 37.0 13.9 7.4 12.2 24.3 28.5 83.3 9.0 14.8 12.4 7.5 14.0 11.0 6.2 9.5 10.0 6.0 5.1 6.8 4.8 11.4 3.8 13.2 13.7 14.6 6.6 10.5 5.6 89.8 20.0 5.9 5.1 1.5 9.3 10.1 7.6 7.3 LRRC27 KIAA1674 ENSG00000148814 "Leucine rich repeat containing 27" Q9C0I9 10 132332154-132381508 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 75.6" "Group enriched" "Detected in many" 6 "Early spermatids: 491.0;Late spermatids: 953.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 17.2;hTERT-RPE1: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037595, HPA067395" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA037595: , HPA067395: AB_2732766" "unprognostic (1.97e-1)" "unprognostic (5.76e-4)" "unprognostic (1.48e-3)" "unprognostic (1.94e-3)" "unprognostic (6.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.41e-1)" "unprognostic (1.04e-2)" "unprognostic (8.26e-2)" "unprognostic (1.75e-2)" "unprognostic (5.94e-3)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (5.74e-2)" "unprognostic (1.72e-1)" "unprognostic (4.49e-2)" "unprognostic (9.27e-4)" 3.2 4.1 11.6 1.9 12.1 1.6 5.0 9.4 13.3 4.5 12.0 4.7 2.5 4.5 6.7 2.0 13.1 4.3 3.5 13.0 11.2 7.1 3.0 3.9 2.6 12.1 11.8 6.3 3.9 8.0 8.0 2.6 10.9 5.2 2.5 10.9 3.3 4.7 2.0 2.7 3.3 4.2 11.5 5.5 3.9 75.6 11.8 2.8 6.4 1.6 1.4 4.0 2.8 10.9 3.1 5.6 12.2 17.2 10.4 10.6 1.2 3.0 9.7 4.9 4.4 1.0 6.3 1.7 1.7 7.0 3.7 2.1 2.7 1.5 3.1 3.6 2.4 0.5 4.5 3.0 7.4 1.4 2.0 4.6 9.4 5.0 6.6 21.9 3.5 4.2 1.1 1.3 3.8 5.2 2.7 3.9 3.4 2.2 1.9 2.4 1.9 1.0 8.9 0.8 2.2 6.1 1.5 1.0 3.9 2.4 2.8 3.1 4.7 1.9 2.4 4.4 1.9 0.9 0.4 1.0 8.9 2.7 1.2 4.1 4.7 0.8 1.1 4.1 0.9 2.3 0.7 0.7 5.2 2.9 1.8 1.0 0.6 2.4 2.8 5.6 0.5 2.0 11.6 12.1 9.4 13.3 13.0 11.2 12.1 11.8 10.9 11.5 11.8 10.9 2.9 9.6 12.8 23.8 5.0 2.8 2.5 5.1 3.4 8.2 6.3 3.8 5.2 5.7 6.9 3.7 10.4 3.6 6.0 1.7 19.6 8.2 491.0 18.8 5.4 4.9 5.4 2.5 14.2 5.1 1.3 5.5 7.1 4.8 8.8 10.3 11.4 2.2 7.7 8.4 10.9 2.3 2.0 10.4 6.0 953.9 4.7 6.7 7.2 6.5 9.0 10.5 8.2 8.0 9.3 3.3 1.3 11.7 0.9 2.9 3.8 13.9 37.7 18.3 6.6 3.8 3.5 119.9 19.2 2.3 3.1 1.4 2.9 6.2 3.5 1.8 PWWP2B "bA432J24.1, FLJ46823, PWWP2" ENSG00000171813 "PWWP domain containing 2B" Q6NUJ5 10 132397168-132417859 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 70.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 56.2;MCF7: 44.5;SK-BR-3: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038056, HPA038502, HPA078118" Approved Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA038056: AB_10697093, HPA038502: AB_2676048, HPA078118: " "unprognostic (2.28e-1)" "unprognostic (5.47e-2)" "unprognostic (1.11e-2)" "unprognostic (1.30e-2)" "unprognostic (5.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.67e-2)" "unprognostic (8.82e-2)" "unprognostic (2.66e-1)" "unprognostic (2.40e-1)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "prognostic favorable (5.75e-4)" "unprognostic (4.77e-2)" "unprognostic (1.46e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-2)" 10.4 31.0 9.5 3.2 15.1 2.4 10.1 3.6 10.8 9.8 9.1 19.1 4.8 10.4 1.0 22.1 9.3 2.0 14.0 10.6 7.1 11.6 5.9 11.0 2.9 8.5 7.2 8.3 38.1 6.5 14.5 4.2 7.9 11.3 2.3 1.9 15.4 3.9 22.3 16.1 10.6 1.2 4.7 27.2 16.3 17.4 7.8 1.0 13.5 5.1 1.6 12.1 12.2 5.2 21.9 12.9 1.6 8.2 1.2 1.0 56.2 2.6 2.6 1.5 1.4 5.8 12.4 0.0 8.8 1.6 3.2 22.9 2.3 3.1 0.2 16.5 6.4 2.5 12.4 5.7 5.8 7.2 9.3 0.8 8.0 0.9 2.3 1.3 1.2 2.9 4.3 1.8 1.0 44.5 0.2 27.0 2.5 8.5 9.5 5.2 0.1 5.0 0.7 16.3 10.4 12.9 1.7 33.1 6.9 1.6 10.2 17.5 4.3 0.8 4.4 4.0 1.8 0.4 0.2 4.5 5.0 6.4 1.6 0.0 1.6 2.6 1.3 3.5 1.0 0.9 0.7 0.8 1.5 3.3 0.5 0.5 0.3 5.4 5.3 0.9 0.0 0.8 9.5 15.1 3.6 10.8 10.6 7.1 8.5 7.2 7.9 4.7 7.8 5.2 5.8 22.4 11.0 2.3 18.0 17.6 14.0 5.8 9.1 7.3 13.5 11.0 5.4 14.3 10.2 9.2 8.4 31.8 12.1 33.5 13.7 15.0 33.0 29.5 4.7 7.1 25.3 2.1 4.3 22.0 47.4 4.1 16.3 19.9 2.5 13.6 13.2 1.6 13.1 15.2 3.8 29.1 10.2 12.6 17.2 70.8 3.7 13.3 14.2 5.6 7.3 3.1 6.2 2.0 0.2 10.6 25.5 2.2 2.2 16.3 5.5 1.5 29.4 14.9 0.0 3.9 5.0 1.2 1.6 8.8 20.3 52.9 7.8 17.4 19.4 31.8 INPP5A 5PTASE ENSG00000068383 "Inositol polyphosphate-5-phosphatase A" Q14642 10 132537787-132783480 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "basophil: 6.7" "Lineage enriched" "Detected in single" 28 "granulocytes: 6.7" "Low cell line specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 250.8" "Low region specificity" "Detected in all" HPA012285 Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 80: Striated muscle - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol "Plasma membrane" "HPA012285: AB_1851802" "prognostic unfavorable (7.47e-4)" "unprognostic (2.38e-1)" "unprognostic (2.54e-1)" "unprognostic (1.68e-3)" "unprognostic (1.43e-1)" "unprognostic (3.25e-2)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (5.65e-2)" "unprognostic (4.35e-1)" "unprognostic (4.70e-2)" "unprognostic (1.70e-2)" "prognostic favorable (3.15e-4)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (8.91e-3)" "unprognostic (8.66e-2)" 22.5 16.9 26.8 12.0 85.5 9.5 17.3 56.9 30.4 29.6 10.9 54.2 19.2 49.5 19.5 29.6 30.7 15.2 75.0 20.4 21.3 14.1 14.6 25.1 8.4 20.5 37.7 19.5 12.8 12.2 14.7 28.8 20.4 24.5 16.7 16.9 13.5 23.6 75.4 22.9 23.4 42.1 17.5 13.9 27.6 22.9 50.5 6.8 14.1 50.3 7.3 35.5 22.7 27.0 35.4 13.7 22.6 21.9 33.8 23.7 18.4 36.4 27.9 23.3 15.4 32.6 14.0 3.1 13.7 38.8 15.1 19.5 24.8 15.2 27.9 10.8 14.4 5.1 17.3 44.7 24.3 12.9 11.9 16.0 14.9 15.0 28.2 18.6 16.3 6.6 7.6 18.2 12.6 28.3 3.6 40.9 10.5 21.0 24.3 7.6 14.9 5.6 19.4 19.9 5.4 18.5 18.3 26.5 22.6 20.5 17.2 30.4 13.7 14.9 17.2 20.1 21.6 3.6 18.4 11.0 14.4 8.6 6.5 6.7 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.3 26.8 85.5 56.9 30.4 20.4 21.3 20.5 37.7 20.4 17.5 50.5 27.0 14.7 9.6 19.7 14.7 4.5 5.4 4.4 1.9 0.0 10.5 7.1 5.3 10.1 4.3 6.4 7.3 0.0 3.9 5.0 24.8 0.0 6.5 12.3 2.8 22.8 10.0 6.1 3.2 33.5 9.2 3.7 5.6 6.6 5.9 8.8 8.6 15.0 17.9 2.9 8.4 25.2 9.9 2.0 7.2 12.0 17.0 7.2 6.9 1.8 19.7 4.1 9.6 0.0 18.1 29.2 12.1 11.5 11.7 2.5 6.5 13.8 4.3 2.5 5.2 6.6 6.5 24.3 6.3 7.3 2.8 5.8 2.5 2.7 10.7 13.9 8.6 NKX6-2 "GTX, NKX6.1, NKX6B" ENSG00000148826 "NK6 homeobox 2" Q9C056 10 132783179-132786147 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding, Repressor" "Disease variant, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 112.9" "Group enriched" "Detected in some" 11 "Gastric mucus-secreting cells: 92.2;Oligodendrocytes: 121.6" "Cancer enriched" "Detected in some" 5 "glioma: 3.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "white matter: 15.7" "Low region specificity" "Detected in many" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "unprognostic (1.92e-1)" "unprognostic (4.39e-2)" "unprognostic (2.26e-1)" "unprognostic (2.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.57e-1)" "unprognostic (1.62e-1)" 0.1 0.0 40.3 0.0 68.4 0.0 0.1 60.9 52.4 0.2 14.7 0.2 0.0 0.1 0.0 0.6 0.1 0.0 0.2 37.5 42.1 0.2 0.0 0.1 0.0 74.7 70.1 0.0 0.2 0.0 0.1 0.0 61.5 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 46.3 0.0 16.4 1.4 58.6 0.0 0.0 0.0 0.0 0.1 0.7 112.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 68.4 60.9 52.4 37.5 42.1 74.7 70.1 61.5 46.3 58.6 112.9 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.1 92.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 121.6 9.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 CFAP46 "bA288G11.4, bA288G11.5, bB137A17.2, bB137A17.3, C10orf123, C10orf124, C10orf92, C10orf93, DKFZp434A1721, FLJ25954, TTC40" ENSG00000171811 "Cilia and flagella associated protein 46" Q8IYW2 10 132808392-132942823 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 22.5;skeletal muscle: 33.4;testis: 41.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 95.9;Endometrial ciliated cells: 70.8;Excitatory neurons: 42.8;Respiratory ciliated cells: 59.0;Rod photoreceptor cells: 74.4;Spermatocytes: 53.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037786, HPA038034, HPA038867, HPA038868" Uncertain NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA037786: AB_10672392, HPA038034: AB_2675796, HPA038867: AB_2676246, HPA038868: AB_2676247" "unprognostic (2.83e-2)" "unprognostic (4.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-2)" "unprognostic (1.08e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (1.83e-1)" "unprognostic (4.11e-1)" "unprognostic (5.40e-2)" "unprognostic (6.41e-3)" "unprognostic (1.39e-1)" "unprognostic (1.64e-4)" "unprognostic (1.21e-2)" "unprognostic (8.08e-2)" "unprognostic (4.56e-3)" "unprognostic (2.08e-2)" 0.0 0.2 5.9 0.0 7.0 0.0 0.1 4.2 10.0 1.5 22.5 0.0 0.1 0.1 1.3 0.2 16.1 0.1 0.7 6.5 6.1 1.0 0.2 3.4 0.0 13.5 17.3 0.2 0.4 1.1 2.2 0.0 8.5 0.2 0.0 3.9 0.4 0.4 33.4 0.1 0.1 0.0 9.4 0.1 2.4 41.8 6.6 0.0 4.2 10.7 0.0 0.0 0.0 4.6 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 5.9 7.0 4.2 10.0 6.5 6.1 13.5 17.3 8.5 9.4 6.6 4.6 0.2 0.0 4.8 9.8 0.3 0.0 0.5 0.0 0.6 6.3 1.3 1.1 3.7 0.0 9.3 7.3 95.9 0.0 0.0 0.0 5.9 4.8 18.0 70.8 0.9 0.9 0.0 0.0 42.8 0.2 0.0 1.5 5.1 1.5 3.8 4.3 5.0 0.2 0.6 1.7 22.0 0.0 0.0 0.6 0.0 11.3 1.2 0.3 0.0 1.0 0.0 4.7 0.0 2.0 0.9 1.6 0.0 2.2 0.2 0.7 0.0 5.6 59.0 74.4 0.0 0.4 0.4 53.7 7.2 0.7 0.0 0.0 0.3 7.3 0.0 0.6 ADGRA1 "GPR123, KIAA1828" ENSG00000197177 "Adhesion G protein-coupled receptor A1" Q86SQ6 10 133070929-133131675 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 38.4" "Group enriched" "Detected in some" 4 "Excitatory neurons: 25.2;Hepatic stellate cells: 11.7;Inhibitory neurons: 24.6;Oligodendrocyte precursor cells: 29.1" "Cancer enriched" "Detected in single" 13 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "RH-30: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042773 Approved NA NA "Cluster 65: Brain - Ion transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA042773: AB_10794764" "unprognostic (8.31e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (1.09e-2)" "unprognostic (7.51e-3)" "unprognostic (2.48e-2)" "unprognostic (3.33e-1)" "unprognostic (1.66e-1)" 0.0 3.8 16.3 0.0 14.2 0.0 0.0 3.3 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 18.8 15.2 0.4 0.2 0.1 0.0 9.8 18.5 0.0 0.1 0.0 2.8 0.0 10.9 0.0 0.0 0.9 1.8 0.0 0.0 0.0 0.0 0.0 4.2 0.2 0.0 0.7 38.4 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 14.2 3.3 27.5 18.8 15.2 9.8 18.5 10.9 4.2 38.4 15.7 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.5 0.0 2.7 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 24.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.5 0.0 29.1 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KNDC1 "bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND" ENSG00000171798 "Kinase non-catalytic C-lobe domain containing 1" Q76NI1 10 133160219-133226412 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;pituitary gland: 27.5" "Cell type enhanced" "Detected in many" "Astrocytes: 93.4;Excitatory neurons: 41.9;Inhibitory neurons: 36.3;Respiratory ciliated cells: 25.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;EFO-21: 1.2;MCF7: 1.1;NTERA-2: 1.4;RPMI-8226: 2.1;SuSa: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039624, HPA056143" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 38: EFO-21 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane, Cytosol" Vesicles "HPA039624: AB_10671045, HPA056143: " "unprognostic (2.32e-1)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (1.59e-3)" "unprognostic (1.96e-2)" "unprognostic (2.76e-1)" "unprognostic (5.61e-2)" "unprognostic (2.75e-2)" "unprognostic (6.77e-2)" "unprognostic (1.15e-1)" "unprognostic (6.80e-3)" "unprognostic (2.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.53e-1)" "unprognostic (1.94e-1)" "unprognostic (9.41e-2)" 1.5 13.7 31.1 0.1 17.9 0.0 0.2 8.4 44.0 2.3 0.0 0.3 0.0 2.8 0.7 0.2 9.0 0.2 0.3 19.8 9.1 0.8 6.5 2.8 0.0 17.3 13.3 8.5 0.5 0.4 27.5 0.4 10.3 1.1 0.0 0.9 0.6 0.9 0.0 0.2 0.2 0.4 3.0 0.5 0.3 1.8 22.7 0.0 2.5 0.0 0.0 0.2 0.9 13.1 0.2 0.3 0.2 1.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.2 0.0 1.2 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 1.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 31.1 17.9 8.4 44.0 19.8 9.1 17.3 13.3 10.3 3.0 22.7 13.1 0.0 0.0 9.0 93.4 0.2 0.0 0.1 0.4 0.0 1.6 0.2 0.0 2.4 1.5 4.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 14.2 1.5 0.2 3.0 0.0 41.9 0.0 0.1 1.4 0.0 0.3 0.0 1.5 0.4 4.6 0.2 1.7 36.3 0.0 0.0 1.0 0.4 1.0 3.7 1.2 0.0 5.6 0.3 4.5 0.0 6.6 2.1 0.0 0.0 1.2 0.0 0.1 0.0 0.0 25.9 1.0 0.0 0.1 0.5 0.0 1.7 0.0 0.3 0.1 0.4 1.2 0.0 0.0 UTF1 ENSG00000171794 "Undifferentiated embryonic cell transcription factor 1" Q5T230 10 133230217-133231558 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 5.9" "Group enriched" "Detected in some" 5 "Langerhans cells: 42.1;Spermatogonia: 40.0" "Cancer enriched" "Detected in single" 243 "testis cancer: 49.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "NTERA-2: 5.5;RPMI-8226: 2.0" CAB022384 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 5: NTERA-2 - Transcription" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "CAB022384: " "unprognostic (9.19e-2)" "unprognostic (1.95e-1)" "unprognostic (8.57e-2)" "unprognostic (1.78e-1)" "unprognostic (2.99e-3)" "unprognostic (2.88e-1)" "unprognostic (3.82e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.1 0.9 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 2.0 42.1 1.1 0.3 7.0 0.0 0.0 4.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 40.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 VENTX "HPX42B, VENTX2" ENSG00000151650 "VENT homeobox" O95231 10 133237855-133241928 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Kupffer cells: 6.2;Langerhans cells: 7.9;Macrophages: 7.8;monocytes: 5.0" "Cancer enriched" "Detected in some" 15 "testis cancer: 30.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 7 "dendritic cells: 1.8;granulocytes: 1.9;monocytes: 3.2" "Group enriched" "Detected in some" 10 "NB-4: 18.2;NTERA-2: 10.9" HPA050955 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 41: Macrophages - Immune response" "Nucleoli fibrillar center" Cytosol "HPA050955: AB_2681288" "unprognostic (9.41e-2)" "unprognostic (8.89e-2)" "unprognostic (2.34e-1)" "unprognostic (4.26e-1)" "unprognostic (3.22e-2)" "unprognostic (2.01e-1)" "unprognostic (2.54e-1)" "unprognostic (9.62e-3)" "unprognostic (2.22e-1)" "unprognostic (3.00e-3)" "unprognostic (3.70e-4)" "unprognostic (4.22e-1)" "unprognostic (2.51e-3)" "unprognostic (3.43e-2)" "unprognostic (3.48e-1)" "unprognostic (7.54e-2)" "unprognostic (3.14e-1)" 4.8 2.3 1.6 3.6 1.1 2.8 1.9 1.6 1.5 1.5 1.9 1.9 0.4 1.6 0.5 0.5 1.8 1.5 1.5 1.5 1.5 1.7 0.5 3.8 0.5 1.9 1.7 1.5 1.2 0.5 1.4 0.5 1.5 1.3 0.4 0.2 1.3 0.8 0.9 1.2 1.0 1.2 0.9 5.7 0.9 1.0 2.5 0.2 0.8 0.1 0.4 1.4 1.0 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 18.2 10.9 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 1.9 2.6 0.3 0.1 3.2 0.0 0.3 0.1 0.0 1.8 0.2 0.1 0.1 0.9 0.3 2.4 0.1 0.0 0.7 1.6 1.1 1.6 1.5 1.5 1.5 1.9 1.7 1.5 0.9 2.5 1.8 0.0 0.0 1.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 7.9 0.2 0.0 7.8 0.0 0.0 5.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 ADAM8 "CD156, CD156A, MS2" ENSG00000151651 "ADAM metallopeptidase domain 8" P78325 10 133262420-133276868 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 68.6;lymphoid tissue: 48.5" "Cell type enhanced" "Detected in many" "dendritic cells: 54.7;Extravillous trophoblasts: 96.4;Langerhans cells: 124.9;monocytes: 81.3;NK-cells: 82.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 21.2" "Group enriched" "Detected in many" 5 "basophil: 107.4;eosinophil: 259.0;neutrophil: 139.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 259.0" "Cell line enhanced" "Detected in many" "A-431: 60.0;BEWO: 81.8;CAPAN-2: 70.4;HaCaT: 69.8;HDLM-2: 45.9;U-87 MG: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA064637 Approved "Intracellular and membrane" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" "HPA064637: AB_2685306" "unprognostic (8.24e-2)" "unprognostic (6.07e-3)" "unprognostic (1.27e-3)" "unprognostic (5.18e-2)" "unprognostic (8.26e-2)" "unprognostic (6.47e-2)" "unprognostic (5.59e-2)" "unprognostic (2.22e-1)" "unprognostic (2.57e-1)" "unprognostic (1.94e-3)" "unprognostic (3.37e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (3.99e-10)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.28e-1)" "unprognostic (9.32e-2)" 5.6 2.4 2.1 22.1 2.3 68.6 2.7 1.4 21.2 4.2 1.7 3.6 5.8 2.2 2.1 3.5 6.0 5.1 2.5 1.8 1.8 4.7 8.4 21.5 11.6 3.2 1.9 3.0 4.3 0.3 3.6 3.1 4.4 4.5 1.6 1.5 4.2 1.1 1.2 3.2 11.3 2.1 1.6 48.5 11.5 2.6 5.9 4.0 3.8 1.7 8.2 11.9 3.2 3.4 60.0 1.7 0.5 0.9 0.4 0.1 81.8 0.7 1.4 0.3 0.4 4.6 70.4 1.0 1.7 0.1 0.5 69.8 0.2 11.9 0.1 45.9 1.0 0.8 0.5 0.0 0.7 3.6 15.9 0.2 1.1 0.6 1.0 3.7 0.1 0.5 3.2 2.4 0.0 4.8 0.2 20.2 0.3 7.1 1.7 0.4 0.7 6.6 0.8 1.4 0.1 0.8 0.4 0.2 1.0 1.1 1.0 2.0 1.7 0.0 1.5 0.6 1.0 3.4 2.2 0.6 34.5 2.0 0.2 107.4 24.8 259.0 22.2 9.2 15.9 10.2 14.8 21.4 37.2 5.6 5.6 8.2 139.4 24.7 9.4 0.7 16.9 25.2 2.1 2.3 1.4 21.2 1.8 1.8 3.2 1.9 4.4 1.6 5.9 3.4 1.3 3.2 10.5 3.3 23.2 7.8 6.6 14.3 0.0 4.3 2.2 1.8 2.4 2.8 9.5 0.0 8.4 7.7 54.7 0.3 1.9 3.1 1.0 1.5 0.9 1.7 0.0 5.7 3.5 2.7 96.4 2.4 6.1 2.1 12.6 1.1 2.5 2.4 23.3 0.0 3.0 0.6 2.0 8.8 124.9 0.4 0.9 33.9 7.2 0.0 81.3 0.2 82.4 2.0 2.9 39.1 0.1 0.0 20.7 11.0 0.3 0.5 10.0 5.1 0.0 0.8 1.0 1.5 0.8 0.6 6.5 20.0 39.4 0.2 0.5 42.5 TUBGCP2 "GCP2, SPBC97, Spc97p" ENSG00000130640 "Tubulin gamma complex associated protein 2" Q9BSJ2 10 133278635-133312337 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Epilepsy, Lissencephaly, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037885 Approved Supported Nucleoplasm,Centrosome NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Centrosome" "HPA037885: AB_10672397" "unprognostic (3.57e-2)" "unprognostic (5.53e-2)" "unprognostic (6.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.96e-1)" "unprognostic (7.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.09e-2)" "unprognostic (1.64e-1)" "unprognostic (5.71e-2)" "unprognostic (1.95e-2)" "unprognostic (3.52e-1)" "unprognostic (4.24e-2)" "unprognostic (5.21e-2)" "unprognostic (1.41e-1)" "unprognostic (4.89e-2)" 20.0 22.2 14.4 20.9 15.4 35.0 13.4 13.5 19.3 15.7 18.2 18.2 22.1 16.0 10.5 17.3 30.3 14.9 20.4 14.8 14.1 19.3 16.4 17.3 20.9 17.1 15.2 26.8 28.3 26.0 3.5 15.8 17.5 17.8 13.3 11.8 28.2 17.1 33.2 22.5 22.1 14.9 13.0 21.9 20.4 21.7 15.0 20.7 19.0 24.4 14.4 15.9 5.8 14.5 64.2 84.2 30.7 35.6 28.3 29.8 42.9 47.5 66.5 50.0 49.5 97.0 45.9 42.1 27.7 48.6 21.6 47.2 35.8 32.3 22.8 50.5 75.7 24.6 46.7 52.3 35.5 63.4 57.0 31.3 29.9 46.5 58.0 55.3 33.3 29.9 36.4 45.6 41.2 79.9 41.4 56.3 30.4 37.2 64.6 32.7 32.9 19.5 32.7 40.8 20.6 43.0 33.0 40.1 36.1 17.9 23.6 38.3 45.6 30.9 27.6 38.0 47.9 43.7 25.9 53.8 102.3 27.3 19.8 6.4 22.5 15.9 15.3 23.2 14.8 11.4 13.3 14.6 27.6 12.3 14.0 15.4 13.8 27.7 25.8 11.7 18.3 19.0 14.4 15.4 13.5 19.3 14.8 14.1 17.1 15.2 17.5 13.0 15.0 14.5 29.1 48.1 38.5 18.9 36.7 13.9 27.4 30.2 23.3 45.7 25.9 25.3 33.9 22.8 38.8 40.5 31.3 41.4 40.1 34.8 23.5 34.5 25.9 78.0 41.6 26.4 29.3 28.0 17.5 37.1 32.9 35.9 38.7 37.1 39.9 49.5 28.9 27.5 44.4 38.7 15.9 36.2 8.2 42.7 25.5 28.6 33.8 51.6 14.2 15.9 75.0 39.3 62.8 9.5 20.1 37.3 33.5 35.3 37.2 28.6 37.3 53.4 112.2 74.8 32.9 39.9 32.1 74.3 65.3 29.0 13.8 42.5 35.7 50.4 36.0 30.3 ZNF511 "MGC30006, Zfp511" ENSG00000198546 "Zinc finger protein 511" Q8NB15 10 133308914-133313162 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035360 Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Intracellular and membrane" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 80: Striated muscle - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA035360: AB_10601931" "unprognostic (3.35e-2)" "unprognostic (2.19e-1)" "unprognostic (1.91e-1)" "unprognostic (8.84e-2)" "unprognostic (1.31e-1)" "unprognostic (1.16e-1)" "unprognostic (3.04e-1)" "unprognostic (1.68e-2)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (1.40e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.94e-2)" "unprognostic (3.91e-2)" "unprognostic (2.55e-1)" "unprognostic (4.52e-2)" 12.7 11.6 15.9 8.7 16.2 17.1 11.3 15.5 17.2 15.8 17.5 19.7 16.1 15.7 10.7 10.8 15.4 9.4 21.2 15.4 15.4 10.4 21.3 11.4 12.6 16.7 15.9 20.4 15.5 14.7 12.7 8.7 15.7 16.1 12.8 5.8 16.7 10.7 49.1 7.9 13.2 11.1 16.4 12.5 12.5 9.6 16.8 11.4 10.9 31.9 9.7 13.6 12.5 16.5 54.1 54.0 30.3 43.8 25.6 21.6 32.6 25.2 39.3 53.3 44.4 88.0 50.9 48.2 24.4 29.5 33.9 48.8 41.9 36.0 23.2 38.8 92.1 29.1 22.1 53.4 21.0 57.5 52.1 22.0 19.2 43.7 26.5 30.6 24.3 22.7 40.0 22.4 18.6 71.2 27.5 76.1 37.3 50.2 74.6 37.1 37.1 12.4 28.3 18.6 16.9 37.0 16.8 30.0 38.2 18.7 23.2 33.1 23.3 23.1 35.4 26.5 68.5 31.3 36.4 66.1 37.5 26.8 12.9 40.2 61.1 68.6 45.4 52.6 35.6 66.6 37.0 46.6 61.0 51.8 41.6 40.8 8.5 41.0 51.1 65.9 36.2 47.3 15.9 16.2 15.5 17.2 15.4 15.4 16.7 15.9 15.7 16.4 16.8 16.5 16.3 16.0 14.5 7.5 33.6 29.6 45.6 40.7 39.3 19.5 37.3 52.6 23.6 25.8 21.9 22.0 8.4 61.2 36.7 33.3 70.5 39.5 29.5 18.5 22.4 20.9 53.4 40.2 10.7 41.2 62.9 34.0 20.4 15.2 78.1 40.6 20.3 54.4 47.4 21.9 7.6 128.8 22.4 33.9 38.0 8.8 41.7 39.9 16.0 5.6 64.3 27.4 41.2 3.5 12.3 38.6 44.0 30.5 40.4 43.0 60.8 72.1 23.2 23.6 26.3 27.3 34.5 58.1 48.0 36.3 35.9 28.2 33.0 38.6 65.9 41.5 ZNF511-PRAP1 ENSG00000283496 "ZNF511-PRAP1 readthrough" 10 133309410-133352529 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 9.2;kidney: 8.4;liver: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.3;RPMI-8226: 1.0" "HPA035360, HPA038713, HPA052451" Supported Uncertain "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 2: Karpas-707 - Immune response" "Cluster 11: Alveolar cells - Smell perception" "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839" 0.2 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 6.2 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 30.4 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 9.2 0.0 0.1 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.3 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.1 0.1 1.0 0.0 0.1 0.0 0.7 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CALY "CALCYON, DRD1IP, NSG3" ENSG00000130643 "Calcyon neuron specific vesicular protein" Q9NYX4 10 133324072-133336935 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 236.9;pituitary gland: 167.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 155.7;Excitatory neurons: 72.6;Horizontal cells: 72.3;Inhibitory neurons: 128.5" "Cancer enriched" "Detected in some" 4 "pancreatic cancer: 7.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042283 Enhanced NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 56: Bipolar cells - Visual perception" "HPA042283: AB_10794417" "unprognostic (1.43e-2)" "unprognostic (7.84e-2)" "unprognostic (3.77e-3)" "unprognostic (1.41e-2)" "unprognostic (7.32e-2)" "unprognostic (9.81e-3)" "unprognostic (2.56e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "prognostic favorable (3.54e-4)" "unprognostic (1.23e-2)" "unprognostic (4.19e-10)" "unprognostic (8.04e-3)" "unprognostic (1.29e-1)" "unprognostic (3.60e-1)" "unprognostic (1.63e-1)" 0.2 17.9 55.4 0.8 42.4 0.1 0.1 2.5 75.0 0.2 0.0 4.7 2.4 0.0 0.1 0.1 0.2 0.0 0.2 38.1 236.9 0.2 0.3 0.4 0.2 47.6 74.8 0.2 3.4 0.6 167.6 0.0 71.8 0.5 0.5 11.1 0.2 0.1 0.1 0.3 2.3 0.3 30.1 0.6 2.4 4.3 88.5 0.0 0.4 0.0 0.1 0.2 0.9 35.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.4 42.4 2.5 75.0 38.1 236.9 47.6 74.8 71.8 30.1 88.5 35.0 0.2 0.0 0.0 26.1 0.1 0.3 0.0 0.0 0.0 155.7 0.8 0.9 2.8 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 2.2 0.0 0.5 0.6 19.5 0.0 72.6 0.0 0.0 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.1 72.3 128.5 1.5 0.0 0.0 0.4 2.0 0.0 0.2 0.0 18.7 0.0 11.5 0.0 10.6 20.1 0.6 0.0 0.4 0.1 0.6 0.0 0.4 0.0 31.7 0.0 0.2 0.5 16.3 7.9 0.0 0.0 0.3 2.8 0.2 0.1 0.0 PRAP1 UPA ENSG00000165828 "Proline rich acidic protein 1" Q96NZ9 10 133347368-133352683 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 1135.4;liver: 675.2" "Cell type enriched" "Detected in some" 9 "Proximal enterocytes: 17736.9" "Cancer enriched" "Detected in many" 5 "liver cancer: 348.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 34.2;Hep G2: 128.3" "HPA038713, HPA052451" Supported "Secreted to digestive system" NA NA 210000000 "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "HPA038713: AB_10673117, HPA052451: AB_2681839" "unprognostic (1.63e-3)" "unprognostic (1.79e-2)" "unprognostic (1.09e-1)" "unprognostic (1.89e-3)" "unprognostic (1.18e-1)" "unprognostic (1.11e-1)" "unprognostic (8.90e-2)" "unprognostic (3.60e-2)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" "unprognostic (4.35e-3)" "unprognostic (4.91e-2)" "unprognostic (8.23e-3)" "unprognostic (2.25e-1)" "unprognostic (3.15e-1)" "unprognostic (2.92e-2)" "unprognostic (2.22e-3)" 0.6 0.5 0.7 4.2 0.7 0.5 0.3 0.4 0.7 0.2 6.5 74.6 1053.8 0.8 0.1 0.4 0.7 2.6 0.3 0.6 0.4 145.4 675.2 0.2 1.5 1.2 0.7 0.4 0.1 0.1 0.8 0.1 1.1 0.3 35.7 0.0 1.7 0.3 0.2 1.3 1135.4 1.7 0.4 0.8 2.7 12.2 0.6 0.3 0.2 0.3 0.1 0.3 0.2 0.8 0.2 0.5 0.1 1.2 0.1 0.0 14.6 0.0 0.0 0.0 0.0 34.2 0.6 0.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.5 128.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.6 0.0 3.5 0.4 5.0 0.0 0.2 0.9 2.9 0.0 0.0 0.9 4.6 0.4 0.0 0.0 0.8 0.0 0.2 0.0 0.0 1.4 1.3 0.0 1.4 0.1 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.4 0.7 0.6 0.4 1.2 0.7 1.1 0.4 0.6 0.8 0.0 0.0 0.0 0.0 7.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 8.6 0.0 9.2 0.0 0.2 0.0 773.7 33.2 0.1 1.9 0.6 0.0 0.6 18.4 13.5 0.1 0.2 0.2 0.2 1.5 0.1 8.9 0.0 12.5 1021.3 0.2 0.0 0.0 676.2 0.0 20.9 0.0 7.3 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1815.7 1.5 0.0 0.1 17736.9 412.0 0.1 0.0 0.0 0.0 0.1 140.2 38.2 0.0 0.0 0.3 3.5 0.0 607.1 0.1 FUOM "C10orf125, FLJ26016, FucM, FucU" ENSG00000148803 "Fucose mutarotase" A2VDF0 10 133355158-133358025 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 228.3" "Cell type enhanced" "Detected in many" "Hepatocytes: 564.7;Hofbauer cells: 172.0;Proximal enterocytes: 690.7;Proximal tubular cells: 368.1" "Cancer enriched" "Detected in all" 5 "liver cancer: 61.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039207 Approved NA NA 2000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" "HPA039207: AB_10795033" "unprognostic (1.15e-2)" "unprognostic (1.16e-1)" "unprognostic (4.48e-2)" "unprognostic (7.19e-2)" "unprognostic (4.82e-1)" "unprognostic (2.66e-2)" "unprognostic (1.66e-2)" "unprognostic (2.45e-1)" "unprognostic (6.25e-2)" "unprognostic (7.56e-2)" "unprognostic (4.50e-2)" "unprognostic (8.67e-2)" "unprognostic (3.65e-2)" "unprognostic (4.02e-2)" "unprognostic (1.50e-1)" "unprognostic (4.88e-3)" "unprognostic (1.65e-1)" 12.9 8.8 4.2 11.3 4.4 6.6 13.0 4.0 7.2 7.3 8.2 12.0 52.0 5.5 3.2 8.7 7.9 9.6 17.4 4.2 4.6 46.7 228.3 14.1 16.8 5.3 4.7 7.3 18.3 8.0 6.0 5.2 5.7 7.0 5.4 0.3 28.8 3.6 3.0 7.4 46.8 3.6 4.9 23.7 8.5 5.6 5.1 6.1 6.6 2.6 8.0 7.9 7.7 4.8 23.3 7.2 13.6 28.4 3.8 9.2 24.8 18.3 20.7 6.5 8.1 46.4 12.4 0.0 20.7 13.8 0.0 1.2 4.9 6.3 0.5 8.4 4.9 22.3 10.3 50.7 20.1 25.2 14.8 9.6 0.2 2.6 1.4 3.0 9.2 22.9 22.2 29.7 13.9 23.0 3.9 33.6 9.5 13.5 3.2 21.8 0.4 13.0 7.5 0.0 1.4 11.0 6.7 20.6 25.3 6.8 0.2 38.3 18.7 0.1 18.4 0.0 0.1 15.5 2.7 16.7 5.5 10.2 7.1 0.1 68.9 6.5 16.0 73.2 14.7 36.0 14.0 13.4 57.2 34.5 14.9 13.1 3.3 17.1 15.7 79.0 10.4 28.6 4.2 4.4 4.0 7.2 4.2 4.6 5.3 4.7 5.7 4.9 5.1 4.8 20.4 6.4 10.0 0.0 32.7 12.1 9.2 8.5 6.2 0.1 12.2 25.7 10.9 22.8 11.4 9.2 0.0 10.3 25.1 79.2 31.3 13.6 3.7 3.8 9.7 14.1 3.0 24.4 0.6 12.7 9.0 25.6 8.6 7.7 27.3 15.5 25.0 564.7 172.0 0.0 1.2 49.7 6.1 103.0 55.4 10.3 10.2 68.7 26.6 1.9 85.6 3.5 13.4 0.0 1.0 12.5 119.5 3.8 29.6 17.8 690.7 368.1 4.0 1.1 13.1 11.6 14.9 20.2 23.7 10.0 9.9 6.6 21.5 4.1 61.1 12.1 ECHS1 SCEH ENSG00000127884 "Enoyl-CoA hydratase, short chain 1" P30084 10 133362485-133373354 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 1128.7" "Cell type enhanced" "Detected in all" "Hepatocytes: 1476.3;Proximal tubular cells: 2336.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003783, HPA021995, HPA022476" Enhanced Enhanced Mitochondria NA NA 1200000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 85: Liver - Metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975" "unprognostic (3.68e-1)" "unprognostic (2.46e-3)" "unprognostic (9.57e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (2.51e-3)" "unprognostic (2.30e-1)" "unprognostic (1.82e-2)" "unprognostic (2.28e-2)" "unprognostic (1.60e-1)" "unprognostic (1.27e-1)" "prognostic favorable (8.57e-5)" "unprognostic (2.84e-2)" "unprognostic (1.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.50e-2)" 302.4 127.1 127.7 53.7 127.8 43.9 116.9 131.3 136.1 59.8 149.7 143.1 171.6 47.0 89.3 107.9 90.5 66.7 226.4 133.1 129.9 481.7 1128.7 48.5 52.4 129.4 129.9 71.3 96.8 98.7 74.3 73.6 128.8 102.0 104.6 39.8 163.4 123.2 294.3 68.2 153.6 59.4 130.3 48.4 84.5 52.6 134.6 40.0 88.5 271.6 59.0 87.4 57.8 136.0 185.1 229.2 120.4 303.4 173.0 111.4 110.5 132.2 175.9 183.2 154.1 509.5 174.0 139.2 111.9 151.4 94.4 167.7 160.2 136.1 132.0 107.4 281.2 138.5 128.1 367.2 145.0 180.4 93.5 124.5 115.9 121.2 153.6 160.8 165.1 98.3 127.8 117.4 181.6 443.9 90.7 352.0 84.4 289.8 272.1 152.8 146.4 74.6 227.8 236.0 78.1 123.4 137.0 224.1 178.9 69.4 174.8 171.5 132.1 81.3 115.9 169.9 177.4 87.0 58.8 159.8 192.4 98.8 68.7 96.1 184.7 86.8 105.5 212.2 137.6 178.7 117.8 115.8 242.6 148.9 119.3 115.8 19.8 166.0 168.1 104.9 123.0 233.0 127.7 127.8 131.3 136.1 133.1 129.9 129.4 129.9 128.8 130.3 134.6 136.0 99.2 44.8 82.7 16.3 60.5 68.2 86.9 271.8 62.6 57.0 98.5 119.6 255.2 210.1 161.5 174.7 6.2 470.2 34.0 298.6 565.4 162.8 29.9 148.9 92.7 71.4 131.7 72.2 11.6 101.1 163.5 92.5 87.7 226.4 91.2 120.0 88.5 1476.3 221.1 45.4 11.0 223.0 175.0 92.1 61.5 39.1 77.6 88.0 135.2 10.3 113.0 145.2 45.3 10.6 24.3 107.8 248.6 91.7 57.5 88.0 486.2 2336.5 93.2 55.2 85.5 57.0 98.8 52.9 66.1 125.2 76.3 299.1 62.5 220.0 317.2 127.8 PAOX PAO ENSG00000148832 "Polyamine oxidase" Q6QHF9 10 133379261-133391694 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.4" "Group enriched" "Detected in many" 6 "Early spermatids: 143.4;Late spermatids: 456.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.7;K-562: 3.9;U-266/70: 13.7" HPA047782 Uncertain Nucleoplasm,Centrosome NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Centrosome Nucleoplasm "HPA047782: " "unprognostic (3.67e-3)" "prognostic favorable (6.07e-5)" "unprognostic (2.49e-2)" "unprognostic (1.28e-3)" "unprognostic (1.96e-2)" "prognostic favorable (1.38e-5)" "unprognostic (7.39e-2)" "unprognostic (1.99e-3)" "unprognostic (2.20e-1)" "unprognostic (4.48e-2)" "unprognostic (1.11e-2)" "unprognostic (2.99e-1)" "prognostic favorable (9.49e-4)" "unprognostic (3.56e-2)" "unprognostic (2.86e-1)" "unprognostic (7.61e-2)" "unprognostic (8.29e-3)" 1.9 2.3 0.6 0.5 1.1 0.0 1.9 0.9 1.5 2.8 1.1 2.6 1.8 2.5 0.0 6.2 2.7 0.1 1.5 0.6 0.5 3.4 7.7 1.5 0.5 0.8 0.6 2.4 2.5 0.3 1.6 0.1 0.8 2.7 0.0 0.0 3.1 1.1 3.1 2.8 4.4 0.3 0.9 4.8 2.5 27.4 0.5 0.1 1.6 0.0 0.4 2.8 3.3 1.6 5.7 0.0 0.3 1.2 0.0 0.5 0.4 1.5 1.1 1.7 0.1 0.5 0.1 0.0 0.4 0.7 0.4 1.8 0.0 0.7 0.3 2.7 0.0 0.4 0.0 0.0 1.3 0.0 0.3 0.0 0.1 0.4 0.1 0.0 0.0 0.0 3.9 0.4 0.0 0.1 0.0 0.2 0.6 0.0 1.9 3.3 0.0 0.0 0.1 0.0 0.1 1.3 1.1 0.0 0.0 0.0 1.4 0.0 1.8 0.0 0.6 1.1 0.0 13.7 2.8 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.6 1.1 0.9 1.5 0.6 0.5 0.8 0.6 0.8 0.9 0.5 1.6 3.8 0.0 4.6 4.2 17.5 3.7 8.5 3.4 8.6 4.0 4.2 5.0 1.7 8.6 1.9 1.8 0.0 1.1 5.8 4.3 5.9 5.4 143.4 4.0 3.0 3.3 0.0 1.3 3.3 3.3 2.3 3.6 5.6 3.9 5.7 2.5 3.3 13.5 4.6 5.0 1.7 4.0 4.1 14.5 2.3 456.3 9.6 9.0 0.0 3.7 12.3 9.2 2.1 3.0 9.7 3.4 3.4 7.9 22.0 8.7 29.9 18.0 3.3 3.0 19.7 2.4 3.6 46.9 6.0 12.8 3.7 0.3 5.4 3.7 4.1 10.5 MTG1 GTPBP7 ENSG00000148824 "Mitochondrial ribosome associated GTPase 1" Q9BT17 10 133394094-133422520 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037826, HPA037827" Approved Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 59: Non-specific - Transcription" Mitochondria "HPA037826: AB_2675692, HPA037827: AB_10670959" "unprognostic (2.94e-2)" "unprognostic (8.08e-2)" "unprognostic (5.90e-3)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-2)" "unprognostic (5.85e-2)" "unprognostic (6.20e-2)" "unprognostic (1.32e-1)" "unprognostic (2.21e-1)" "prognostic favorable (5.08e-4)" "unprognostic (4.63e-3)" "prognostic unfavorable (6.79e-7)" "unprognostic (3.88e-2)" "unprognostic (5.96e-2)" "unprognostic (5.19e-2)" "prognostic favorable (1.03e-5)" 15.1 28.1 10.0 13.6 9.9 12.5 16.3 11.0 12.2 17.0 11.4 16.0 19.7 15.2 2.8 21.4 15.0 8.4 15.0 9.7 9.6 27.1 48.4 13.0 16.2 10.8 9.9 17.2 19.7 17.6 16.2 11.2 10.2 19.3 11.2 3.4 16.3 10.4 18.5 17.7 18.9 10.1 9.3 26.1 18.4 31.2 10.4 12.7 18.0 13.0 14.1 15.4 15.4 9.9 42.5 43.3 28.3 63.4 17.0 12.5 42.0 24.2 20.8 38.5 31.4 55.0 25.8 31.2 36.2 20.5 16.3 33.5 30.6 43.2 17.4 29.8 37.7 30.5 23.5 52.1 40.2 20.6 30.4 31.5 22.9 37.3 58.6 27.7 56.5 27.9 26.2 28.0 30.6 47.4 20.2 28.9 39.3 45.2 14.4 29.6 28.0 7.1 34.6 29.6 10.7 37.9 36.4 32.1 51.4 15.8 28.2 29.6 37.1 14.2 29.2 14.6 26.1 13.5 8.3 43.3 25.2 18.3 19.8 0.5 21.5 23.0 26.9 35.5 27.7 41.5 23.8 22.7 20.3 48.8 18.6 19.2 3.1 47.5 42.9 42.8 27.5 20.3 10.0 9.9 11.0 12.2 9.7 9.6 10.8 9.9 10.2 9.3 10.4 9.9 4.5 9.6 3.6 30.7 27.1 4.2 5.9 8.8 33.0 0.0 6.1 5.3 1.6 8.6 5.9 3.7 0.0 9.4 8.1 8.4 5.9 13.5 2.2 5.9 9.9 7.7 12.6 26.1 25.1 9.6 7.3 9.0 43.8 5.9 6.3 10.8 7.5 5.5 5.4 0.0 31.8 7.5 4.1 6.3 4.7 5.4 9.0 7.1 5.4 21.5 8.1 0.0 12.3 29.7 33.9 10.4 9.2 4.9 37.5 7.2 12.5 6.9 6.1 0.0 13.1 6.1 6.0 9.0 9.3 32.9 3.4 6.7 16.6 6.7 10.1 7.4 SPRN "bA108K14.1, FLJ41197, Shadoo" ENSG00000203772 "Shadow of prion protein" Q5BIV9 10 133420666-133424572 "Predicted intracellular proteins, Transporters" Prion "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.4;liver: 17.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 7.5;Hepatocytes: 22.5;Horizontal cells: 3.3;Inhibitory neurons: 5.1;Oligodendrocyte precursor cells: 5.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 15: Hepatocytes - Hemostasis" "unprognostic (2.66e-1)" "unprognostic (1.64e-3)" "unprognostic (3.38e-3)" "unprognostic (1.95e-1)" "unprognostic (1.35e-1)" "unprognostic (3.31e-2)" "unprognostic (1.07e-1)" "unprognostic (3.90e-3)" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "prognostic favorable (1.54e-6)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.95e-4)" "unprognostic (1.76e-2)" "unprognostic (1.13e-1)" "unprognostic (7.17e-2)" "prognostic favorable (1.58e-7)" 1.5 4.1 6.2 0.3 8.4 0.0 1.6 5.9 13.4 2.2 0.0 2.4 0.5 1.6 0.0 2.9 1.8 0.2 1.7 7.7 1.4 5.4 17.7 1.7 0.1 0.9 1.9 2.1 3.0 0.2 5.1 0.2 0.2 3.7 0.0 0.6 2.1 0.0 1.9 1.9 3.3 0.3 0.2 4.7 3.6 3.1 2.6 0.0 3.5 0.0 0.0 1.7 2.0 4.3 0.6 0.2 0.4 0.9 0.0 0.0 1.2 1.6 0.0 0.7 0.1 1.2 0.5 1.2 0.3 1.6 0.0 0.9 0.5 0.0 0.0 0.6 1.3 0.3 2.3 0.8 0.2 1.6 0.5 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.6 0.4 0.4 0.8 0.6 1.2 0.5 0.0 0.3 2.2 0.4 0.4 0.0 0.4 0.2 0.8 0.0 0.1 0.8 0.2 0.4 0.3 0.6 0.6 1.1 0.8 0.9 0.8 0.7 1.1 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 8.4 5.9 13.4 7.7 1.4 0.9 1.9 0.2 0.2 2.6 4.3 0.1 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 2.4 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.2 0.7 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.4 22.5 0.0 3.3 5.1 0.0 0.0 2.1 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.5 0.0 5.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SCART1 CD163c-alpha ENSG00000214279 "Scavenger receptor family member expressed on T cells 1" Q4G0T1 10 133453928-133523558 "Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 3.7;NB-4: 3.6;THP-1: 1.1;U-266/84: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA043101 Supported NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA043101: AB_10797026" "unprognostic (4.32e-2)" "unprognostic (2.15e-2)" "unprognostic (1.13e-2)" "unprognostic (2.40e-2)" "unprognostic (7.42e-2)" "unprognostic (8.20e-4)" "unprognostic (1.29e-3)" "unprognostic (4.28e-3)" "unprognostic (2.63e-2)" "unprognostic (1.68e-1)" "unprognostic (2.91e-1)" "unprognostic (2.24e-2)" "unprognostic (6.24e-5)" "unprognostic (8.53e-2)" "unprognostic (1.25e-1)" "unprognostic (5.03e-2)" "unprognostic (1.94e-1)" 0.0 0.1 0.2 0.0 0.4 0.2 0.1 0.8 1.0 0.1 0.7 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.4 0.1 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.1 3.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 3.6 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.2 0.2 4.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.8 1.0 0.7 0.4 0.2 0.4 0.2 0.2 0.4 0.3 0.8 0.0 1.5 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 7.4 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.9 0.8 0.5 0.0 0.0 1.3 0.2 0.0 0.4 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 1.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.1 0.0 CYP2E1 CYP2E ENSG00000130649 "Cytochrome P450 family 2 subfamily E member 1" P05181 10 133520406-133561220 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 309 "liver: 10379.8" "Cell type enriched" "Detected in many" 58 "Hepatocytes: 6272.7" "Cancer enriched" "Detected in some" 278 "liver cancer: 265.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.5;myeloid DC: 6.2" "Group enriched" "Detected in many" 16 "dendritic cells: 6.2;T-cells: 2.5" "Cell line enhanced" "Detected in many" "HaCaT: 11.0;HL-60: 8.9;HMC-1: 8.9;NB-4: 24.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA009128, HPA029564" Enhanced Approved "Endoplasmic reticulum,Mitochondria" "Intracellular and membrane" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 24: NB-4 - Immune response" "Cluster 2: Hepatocytes - Metabolism" "Endoplasmic reticulum, Mitochondria" "HPA009128: AB_1078613, HPA029564: AB_10602213" "unprognostic (6.32e-2)" "unprognostic (1.51e-2)" "unprognostic (3.83e-5)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.26e-1)" "unprognostic (2.92e-3)" "unprognostic (6.36e-3)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.70e-4)" "unprognostic (1.72e-1)" "unprognostic (8.36e-2)" "unprognostic (3.78e-1)" "unprognostic (9.59e-2)" 2.8 2.9 5.4 0.6 5.4 0.8 3.0 9.1 7.5 4.9 3.0 5.0 1.4 4.5 8.3 16.7 5.5 2.5 2.1 5.5 5.5 9.1 10379.8 2.6 2.0 6.1 5.5 4.1 12.4 0.6 4.1 1.4 6.7 5.3 1.2 11.5 3.6 6.1 2.8 13.8 2.2 2.2 5.0 7.2 6.7 3.7 6.3 1.7 4.0 0.9 33.6 3.5 3.2 7.5 0.1 0.0 0.3 1.0 3.5 1.9 0.7 1.6 4.5 0.0 0.3 0.0 2.7 1.4 0.2 0.5 0.0 11.0 0.0 0.2 0.4 0.3 1.5 1.8 0.2 1.3 0.6 8.9 8.9 1.0 0.2 0.0 0.7 1.9 0.0 3.1 0.6 0.4 1.0 0.7 0.6 24.0 6.4 4.3 0.4 0.4 6.1 0.0 2.0 0.0 0.0 0.0 4.2 0.0 0.6 0.2 0.3 0.9 0.0 1.4 0.4 2.3 1.0 2.2 1.0 3.0 1.5 7.4 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.1 0.6 6.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.2 5.4 5.4 9.1 7.5 5.5 5.5 6.1 5.5 6.7 5.0 6.3 7.5 0.8 0.0 1.1 5.5 9.2 2.3 0.2 0.7 0.6 5.7 0.6 0.5 2.8 48.6 1.9 0.0 2.1 0.0 0.4 0.1 0.0 1.6 2.1 0.6 0.8 4.6 0.0 67.6 6.7 1.3 0.1 1.1 1.5 0.5 1.3 0.7 67.1 6272.7 0.0 8.4 5.3 0.0 0.0 108.0 2.8 2.1 1.5 0.3 0.0 1.9 0.4 0.7 0.0 2.0 2.2 3.2 0.0 2.6 0.3 0.6 0.0 0.6 2.2 5.8 0.0 0.2 0.6 4.1 4.2 2.0 7.5 0.1 5.7 0.2 0.0 0.0 SYCE1 "bA108K14.6, C10orf94, CT76" ENSG00000171772 "Synaptonemal complex central element protein 1" Q8N0S2 10 133553901-133569835 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 70.9" "Group enriched" "Detected in many" 6 "Early spermatids: 141.2;Late spermatids: 112.6;Spermatocytes: 362.8;Spermatogonia: 170.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "K-562: 18.5;U-2 OS: 15.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040208 Enhanced Approved Nucleoplasm,Vesicles,Cytosol No No "Cluster 39: Non-specific - mRNA processing" "Cluster 78: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "Vesicles, Cytosol" "HPA040208: AB_10796450" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-2)" "unprognostic (1.61e-1)" "unprognostic (3.20e-1)" "unprognostic (5.75e-1)" "unprognostic (5.38e-2)" "unprognostic (3.36e-1)" "unprognostic (2.22e-2)" "unprognostic (7.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" 1.9 1.6 8.5 0.6 8.5 0.0 1.4 9.1 11.6 1.3 2.0 0.9 0.1 0.9 0.3 0.7 1.2 1.2 0.7 9.0 6.3 1.2 4.0 0.4 0.2 6.6 5.4 2.0 3.8 0.0 1.2 9.4 6.4 1.7 0.4 2.3 0.2 0.4 0.9 0.5 0.5 0.6 3.7 0.9 0.6 70.9 6.7 0.2 1.4 1.7 0.5 0.4 0.4 8.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.5 0.0 0.0 0.1 0.1 0.5 0.3 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.1 15.5 0.2 0.4 0.2 0.3 0.4 0.0 0.1 0.0 0.0 0.5 0.1 0.9 0.6 0.8 0.2 0.6 0.2 0.3 0.3 0.3 0.8 0.0 0.0 0.8 0.6 0.7 0.4 8.5 8.5 9.1 11.6 9.0 6.3 6.6 5.4 6.4 3.7 6.7 8.1 0.7 0.0 1.5 0.7 0.3 1.0 1.2 0.0 0.0 2.7 1.0 2.4 0.3 1.5 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 141.2 1.2 3.2 1.3 0.0 0.0 29.8 1.1 0.2 5.6 0.5 0.6 0.0 0.0 0.0 7.8 0.7 10.1 19.1 0.0 0.0 0.3 0.9 112.6 5.3 0.9 0.0 0.0 0.0 0.3 0.0 7.1 0.8 0.4 0.3 3.8 0.1 0.6 0.0 0.5 1.5 2.1 26.3 0.5 0.9 362.8 170.9 0.0 1.0 0.3 0.5 7.0 0.0 0.6 FRG2B ENSG00000225899 "FSHD region gene 2 family member B" Q96QU4 10 133623895-133626795 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 39 "Distal tubular cells: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "HDLM-2: 4.3" "HPA039264, HPA047769" Uncertain NA NA "Cluster 44: HDLM-2 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "HPA039264: AB_2676420, HPA047769: AB_2680149" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0